PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bian, XJ; Shen, YJ; Zhang, GM; Gu, CY; Cai, Y; Wang, CF; Zhu, YP; Zhu, Y; Zhang, HL; Dai, B; Ye, DW				Bian, Xiaojie; Shen, Yijun; Zhang, Guiming; Gu, Chenyuan; Cai, Ying; Wang, Chaofu; Zhu, Yiping; Zhu, Yao; Zhang, Hailiang; Dai, Bo; Ye, Dingwei			Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; DOWN-REGULATION; MICRORNA; MIR-31; APOPTOSIS; INVASION	Dicer is aberrantly expressed in several types of malignancies. Cleaved by Dicer, the small noncoding microRNAs (miRNAs) are considered potential tools for the diagnosis and prognosis of cancer. This study investigated the expression of miRNAs thought to target Dicer. Expression of 1,205 human miRNAs and miRNA*s were examined in four patients with prostate cancer (PCa) by miRNA array in which the threshold was set as two-fold. Seventy-three miRNAs and miRNA*s were significantly down-regulated while 10 were up-regulated in PCa tissues compared with matched histologically normal glands. Of these, miR-29b-1, miR-200a, miR-370, and miR-31, which were the most down/up-regulated and closely potentially target to the Dicer 3' UTR, were investigated further. Tissues of primary tumors and matched normal prostate glands from 185 patients with PCa were collected for further investigation. Dicer mRNA levels were negatively correlated with miR-29b-1 (rho s = -0.177, p = 0.017), miR-200a (rho s = -0.489, p < 0.0001) and miR-31 (rho s = -0.314, p < 0.0001) expression. Compared with adjacent normal glands, PCa tissues showed significantly lower miR-200a and miR-31 expression levels. Furthermore, in metastatic PCa, the expression levels of miR-200a, miR-370, and miR-31 were dramatically higher than in localized PCa. Additionally, elevated expression levels of miR-200a and miR-31 appeared to be associated with castration-resistant PCa. These findings suggest possibilities that miR-200a and miR-31 target Dicer and are involved in the carcinogenesis, migration, and behavior of castration-resistant PCa, indicating that they could be potential biomarkers for monitoring PCa progression.	[Bian, Xiaojie; Shen, Yijun; Zhang, Guiming; Gu, Chenyuan; Zhu, Yiping; Zhu, Yao; Zhang, Hailiang; Dai, Bo; Ye, Dingwei] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China; [Bian, Xiaojie; Shen, Yijun; Zhang, Guiming; Gu, Chenyuan; Cai, Ying; Wang, Chaofu; Zhu, Yiping; Zhu, Yao; Zhang, Hailiang; Dai, Bo; Ye, Dingwei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Cai, Ying; Wang, Chaofu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Ye, DW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China.	dwyeli@163.com	Shen, Yi/GRS-3602-2022; Wang, Chao/GXF-8353-2022; Zhang, Hailiang/AAF-4937-2020	Shen, Yijun/0000-0002-7138-1221	National Natural Science Foundation of China [81272837]; Advanced Technology Foundation of Shanghai [SHDC12013122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advanced Technology Foundation of Shanghai	Funding: This study was supported in part by grants from National Natural Science Foundation of China (No. 81272837) and Advanced Technology Foundation of Shanghai (SHDC12013122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Bian XJ, 2014, TUMOR BIOL, V35, P11571, DOI 10.1007/s13277-014-2462-3; Boyd LK, 2012, NAT REV UROL, V9, P652, DOI 10.1038/nrurol.2012.185; Cekaite L, 2012, NEOPLASIA, V14, P868, DOI 10.1593/neo.121094; Chan YT, 2013, PLOS ONE, V8, pe58169, DOI [doi: 10.1371/ journal. pone. 0058169 PMID: 23472152, DOI 10.1371/J0URNAL.P0NE.0058169]; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Ferraz C, 2013, J CLIN ENDOCR METAB, V98, pE8, DOI 10.1210/jc.2012-2564; Han L, 2010, INT J ONCOL, V37, P299, DOI 10.3892/ijo_00000678; Han YH, 2013, J SURG ONCOL, V107, P201, DOI 10.1002/jso.23214; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Kala Rishabh, 2013, J Clin Bioinforma, V3, P6, DOI 10.1186/2043-9113-3-6; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lo SS, 2012, ONCOGENE, V31, P226, DOI 10.1038/onc.2011.226; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Namiki M, 2010, JPN J CLIN ONCOL, V40, pi70, DOI 10.1093/jjco/hyq130; Narayanan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013637; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Stratmann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-345; Vaksman O, 2012, HUM PATHOL, V43, P2062, DOI 10.1016/j.humpath.2012.02.016; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wu QH, 2011, GYNECOL ONCOL, V122, P149, DOI 10.1016/j.ygyno.2011.03.026; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Yang JS, 2012, RNA, V18, P945, DOI 10.1261/rna.032938.112; Zhang B, 2014, ONCOGENE, V33, P3099, DOI 10.1038/onc.2013.281	34	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120159	10.1371/journal.pone.0120159	http://dx.doi.org/10.1371/journal.pone.0120159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768283	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500111
J	Fagerberg, B; Gullberg, UP; Alm, R; Nilsson, J; Fredrikson, GN				Fagerberg, Bjoern; Gullberg, Ulrica Prahl; Alm, Ragnar; Nilsson, Jan; Fredrikson, Gunilla Nordin			Circulating Autoantibodies against the Apolipoprotein B-100 Peptides p45 and p210 in Relation to the Occurrence of Carotid Plaques in 64-Year-Old Women	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; IMPAIRED GLUCOSE-TOLERANCE; CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; OXIDIZED LDL; CARDIOVASCULAR EVENTS; IMMUNE-RESPONSES; APO B-100; VASCULAR COMPLICATIONS; IGM AUTOANTIBODIES	Objectives Immune responses against oxidized low density lipoprotein (LDL) play a key role in atherosclerosis. Previous studies have indicated inverse associations between autoantibodies to epitopes in oxidized LDL and cardiovascular disease. In this study we investigated the associations between autoantibodies against the apolipoprotein B-100 (apoB-100) peptides p45 and p210 and occurrence of carotid plaques. Design The study cohort consisted of a population-based sample of 64-year-old women with varying degrees of glucose tolerance (n=594). To identify and record the occurrence of carotid atherosclerotic plaques ultrasonography was used. Measurements of plasma IgM and IgG autoantibodies against the native and malondialdehyde (MDA)-modified apoB-100 peptides p45 and p210 were performed by ELISA. Results Women with carotid plaques were found to have lower levels of IgM MDA-p210 autoantibodies compared to plaque-free women. The number of carotid plaques in each subject and the total carotid plaque area correlated inversely with IgM MDA-p210 levels (r=-0.11, P=0.009 and r=-0.11, P=0.013, respectively). Furthermore, levels of IgM MDA-p210 above the lowest tertile were associated with an odds ratio of 0.55 (95% CI 0.38-0.79, P=0.001) for occurrence of carotid plaques, independently of other risk markers and statin treatment. Associations between apo-B100 peptide autoantibodies and cardiovascular risk factors were generally weak but subjects with impaired glucose tolerance had higher levels of IgM against MDA-p210. Conclusion The present study demonstrates that high levels of IgM against MDA-p210 are associated with less severe carotid disease in women. These findings provide additional support for a role of immune responses against oxidized LDL in cardiovascular disease.	[Fagerberg, Bjoern; Gullberg, Ulrica Prahl] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Alm, Ragnar; Nilsson, Jan; Fredrikson, Gunilla Nordin] Lund Univ, Skane Univ, Hosp Malmo, Dept Clin Sci, Malmo, Sweden	University of Gothenburg; Lund University; Skane University Hospital	Fredrikson, GN (corresponding author), Lund Univ, Skane Univ, Hosp Malmo, Dept Clin Sci, Malmo, Sweden.	gunilla.nordin_fredrikson@med.lu.se			Swedish Research Council [K2011-65X-0125-01-6]; Swedish Heart-Lung Foundation [20120407]; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg foundation; VINNOVA; Albert Pahlsson foundation; AstraZeneca R&D Molndal, Sweden; Region Vastra Gotaland; Sahlgrenska University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); VINNOVA(Vinnova); Albert Pahlsson foundation; AstraZeneca R&D Molndal, Sweden(AstraZeneca); Region Vastra Gotaland; Sahlgrenska University Hospital	Funding: This study was supported by the Swedish Research Council (GNF, K2011-65X-0125-01-6), the Swedish Heart-Lung Foundation (GNF, 20120407), the Swedish Foundation for Strategic Research (JN), the Knut and Alice Wallenberg foundation (JN), VINNOVA (JN), the Albert Pahlsson foundation (GNF), AstraZeneca R&D Molndal, Sweden (BF), and the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital (BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Behre CJ, 2006, J INTERN MED, V260, P238, DOI 10.1111/j.1365-2796.2006.01683.x; BOULLIER A, 1995, CLIN CHIM ACTA, V238, P1, DOI 10.1016/0009-8981(95)06054-H; Brohall G, 2006, DIABETIC MED, V23, P609, DOI 10.1111/j.1464-5491.2005.01725.x; Brohall G, 2006, DIABETES CARE, V29, P363, DOI 10.2337/diacare.29.02.06.dc05-1229; Brohall G, 2009, NUTR METAB CARDIOVAS, V19, P327, DOI 10.1016/j.numecd.2008.02.002; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Choi SH, 2008, J AM COLL CARDIOL, V52, P24, DOI 10.1016/j.jacc.2008.02.066; Engelbertsen D, 2012, J INTERN MED, V271, P82, DOI 10.1111/j.1365-2796.2011.02411.x; Festa A, 1998, DIABETOLOGIA, V41, P350, DOI 10.1007/s001250050914; Fredrikson GN, 2008, J INTERN MED, V264, P563, DOI 10.1111/j.1365-2796.2008.01995.x; Fredrikson GN, 2009, DIABETOLOGIA, V52, P1426, DOI 10.1007/s00125-009-1377-9; Fredrikson GN, 2005, AUTOIMMUNITY, V38, P171, DOI 10.1080/08916930500050525; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P872, DOI 10.1161/01.ATV.0000067935.02679.B0; Fredrikson GN, 2007, ATHEROSCLEROSIS, V194, pE188, DOI 10.1016/j.atherosclerosis.2006.12.014; FROSTEGARD J, 1992, ARTERIOSCLER THROMB, V12, P461, DOI 10.1161/01.ATV.12.4.461; Garrido-Sanchez L, 2010, INT J CARDIOL, V145, P263, DOI 10.1016/j.ijcard.2009.09.472; Garrido-Sanchez L, 2009, EUR J CLIN INVEST, V39, P800, DOI 10.1111/j.1365-2362.2009.02156.x; Goncalves I, 2005, ARTERIOSCL THROM VAS, V25, P1250, DOI 10.1161/01.ATV.0000166518.96137.38; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hulthe J, 2001, ARTERIOSCL THROM VAS, V21, P101, DOI 10.1161/01.ATV.21.1.101; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; McLeod O, 2014, ATHEROSCLEROSIS, V232, P242, DOI 10.1016/j.atherosclerosis.2013.11.041; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Nilsson J, 2005, ARTERIOSCL THROM VAS, V25, P18, DOI 10.1161/01.ATV.0000149142.42590.a2; Nilsson J, 2008, CURR OPIN LIPIDOL, V19, P519, DOI 10.1097/MOL.0b013e32830f47cd; Niskanen L, 1998, DIABETES CARE, V21, P1861, DOI 10.2337/diacare.21.11.1861; Palinski W, 2000, J INTERN MED, V247, P371, DOI 10.1046/j.1365-2796.2000.00656.x; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Prahl U, 2010, ANGIOLOGY, V61, P793, DOI 10.1177/0003319710370959; Prahl U, 2010, ULTRASOUND MED BIOL, V36, P218, DOI 10.1016/j.ultrasmedbio.2009.10.002; Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776; Sampi M, 2010, J CLIN ENDOCR METAB, V95, P2467, DOI 10.1210/jc.2009-1858; Schiopu A, 2004, CIRCULATION, V110, P2047, DOI 10.1161/01.CIR.0000143162.56057.B5; Sjogren P, 2008, EUR HEART J, V29, P2218, DOI 10.1093/eurheartj/ehn336; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Su J, 2006, ATHEROSCLEROSIS, V188, P160, DOI 10.1016/j.atherosclerosis.2005.10.017; Tornvall P, 2003, ATHEROSCLEROSIS, V167, P347, DOI 10.1016/S0021-9150(03)00021-2; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32	44	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120744	10.1371/journal.pone.0120744	http://dx.doi.org/10.1371/journal.pone.0120744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768285	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500135
J	Gaudet, JM; Ribot, EJ; Chen, YH; Gilbert, KM; Foster, PJ				Gaudet, Jeffrey M.; Ribot, Emeline J.; Chen, Yuhua; Gilbert, Kyle M.; Foster, Paula J.			Tracking the Fate of Stem Cell Implants with Fluorine-19 MRI	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; IN-VIVO TRACKING; DENDRITIC CELLS; TRANSPLANTATION; SURVIVAL; PLATFORM; BIOLOGY; IMAGE	Background In this study we used cellular magnetic resonance imaging (MRI) to detect mesenchymal stem cells (MSC) labeled with a Fluorine-19 (F-19) agent. F-19-MRI offers unambiguous detection and in vivo quantification of labeled cells. Methods We investigated two common stem cell transplant mouse models: an immune competent, syngeneic transplant model and an immune compromised, xenograft transplant model. 19F labelled stem cells were implanted intramuscularly into the hindlimb of healthy mice. The transplant was then monitored for up to 17 days using F-19-MRI, after which the tissue was excised for fluorescence microscopy and immunohistochemisty. Results Immediately following transplantation, F-19-MRI quantification correlated very well with the expected cell number in both models. The 19F signal decreased over time in both models, with a more rapid decrease in the syngeneic model. By endpoint, only 2/7 syngeneic mice had any detectable 19F signal. In the xenograft model, all mice had detectable signal at endpoint. Fluorescence microscopy and immunohistochemistry were used to show that the 19F signal was related to the presence of bystander labeled macrophages, and not original MSC. Conclusions Our results show that F-19-MRI is an excellent tool for verifying the delivery of therapeutic cells early after transplantation. However, in certain circumstances the transfer of cellular label to other bystander cells may confuse interpretation of the long-term fate of the transplanted cells.	[Gaudet, Jeffrey M.; Ribot, Emeline J.; Chen, Yuhua; Gilbert, Kyle M.; Foster, Paula J.] Robarts Res Inst, Imaging Res Labs, London, ON N6A 5C1, Canada; [Gaudet, Jeffrey M.; Foster, Paula J.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Gaudet, JM (corresponding author), Robarts Res Inst, Imaging Res Labs, London, ON N6A 5C1, Canada.	jgaudet@robarts.ca	Foster, Paula/M-2201-2013	Foster, Paula/0000-0002-4868-3395; Gaudet, Jeffrey/0000-0003-3519-5015; RIBOT, Emeline/0000-0002-3063-1263	Ontario Preclinical Imaging Consortium, Ontario Research Fund [R4174A17]	Ontario Preclinical Imaging Consortium, Ontario Research Fund	This study was supported by R4174A17 Ontario Preclinical Imaging Consortium, Ontario Research Fund, PF (URL:https://www.ontario.ca/business-and-economy/ontario-research-fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOTONICS INT; Addicott B, 2011, CONTRAST MEDIA MOL I, V6, P7, DOI 10.1002/cmmi.396; Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Ahrens ET, 2014, MAGN RESON MED; Becker Daniel E, 2008, Anesth Prog, V55, P124, DOI 10.2344/0003-3006-55.4.124; Boehm-Sturm P, 2014, BIOMATERIALS, V35, P2218, DOI 10.1016/j.biomaterials.2013.11.085; Bonetto F, 2011, INT J CANCER, V129, P365, DOI 10.1002/ijc.25672; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chagastelles Pedro Cesar, 2010, Science Progress, V93, P113, DOI 10.3184/003685010X12708175591515; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Frangioni JV, 2004, CIRCULATION, V110, P3378, DOI 10.1161/01.CIR.0000149840.46523.FC; Gonzalez-Lara LE, 2011, MOL IMAGING BIOL, V13, P702, DOI 10.1007/s11307-010-0393-y; Helfer BM, 2010, CYTOTHERAPY, V12, P238, DOI 10.3109/14653240903446902; Heyn C, 2005, MAGN RESON MED, V53, P312, DOI 10.1002/mrm.20356; Janjic JM, 2008, J AM CHEM SOC, V130, P2832, DOI 10.1021/ja077388j; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Li XX, 2013, INT J NANOMED, V8, P1063, DOI 10.2147/IJN.S42578; Mathiasen AB, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/353105; Meirelles LD, 2009, FRONT BIOSCI-LANDMRK, V14, P4281, DOI 10.2741/3528; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Noad J, 2012, NMR BIOMED; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Reddy AM, 2010, J KOREAN MED SCI, V25, P211, DOI 10.3346/jkms.2010.25.2.211; Ribot EJ, 2014, INT J NANOMED, V9, P1731, DOI 10.2147/IJN.S59127; Ruiz-Cabello J, 2008, MAGN RESON MED, V60, P1506, DOI 10.1002/mrm.21783; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Srinivas M, 2009, MAGN RESON MED, V62, P747, DOI 10.1002/mrm.22063; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Xu CJ, 2012, NANO LETT, V12, P4131, DOI 10.1021/nl301658q	37	55	56	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118544	10.1371/journal.pone.0118544	http://dx.doi.org/10.1371/journal.pone.0118544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767871	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500028
J	Li, WY; Zhang, B; Li, RZ; Chang, XP; Jing, RL				Li, Weiyu; Zhang, Bin; Li, Runzhi; Chang, Xiaoping; Jing, Ruilian			Favorable Alleles for Stem Water-Soluble Carbohydrates Identified by Association Analysis Contribute to Grain Weight under Drought Stress Conditions in Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORYZA-SATIVA L.; GENOTYPIC VARIATION; POSTANTHESIS CHANGES; WINTER-WHEAT; BREAD WHEAT; AESTIVUM L.; DRY-MATTER; ACCUMULATION; MOBILIZATION	Drought is a major environmental constraint to crop distribution and productivity. Stem water-soluble carbohydrates (WSC) buffer wheat grain yield against conditions unfavorable for photosynthesis during the grain filling stage. In this study, 262 winter wheat accessions and 209 genome-wide SSR markers were collected and used to undertake association analysis based on a mixed linear model (MLM). The WSC in different internodes at three growth stages and 1000-grain weight (TGW) were investigated under four environmental regimes (well-watered, drought stress during the whole growth period, and two levels of terminal drought stress imposed by chemical desiccation under the well-watered and drought stress during the whole growth period conditions). Under diverse drought stress conditions, WSC in lower internodes showed significant positive correlations with TGW, especially at the flowering stage under well-watered conditions and at grain filling under drought stress. Sixteen novel WSC-favorable alleles were identified, and five of them contributed to significantly higher TGW. In addition, pyramiding WSC favorable alleles was not only effective for obtaining accessions with higher WSC, but also for enhancing TGW under different water regimes. During the past fifty years of wheat breeding, WSC was selected incidentally. The average number of favorable WSC alleles increased from 1.13 in the pre-1960 period to 4.41 in the post-2000 period. The results indicate a high potential for using marker-assisted selection to pyramid WSC favorable alleles in improving WSC and TGW in wheat.	[Li, Weiyu; Zhang, Bin; Chang, Xiaoping; Jing, Ruilian] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Li, Weiyu; Li, Runzhi] Shanxi Agr Univ, Agron Coll, Taigu 030801, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University	Jing, RL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	jingrl@caas.net.cn		Zhang, Bin/0000-0002-7347-0367	National High-tech RD Program [2011AA100501]; National Natural Science Foundation of China [31271720]	National High-tech RD Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High-tech R&D Program (2011AA100501), and the National Natural Science Foundation of China (31271720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero RA, 2011, FUNCT INTEGR GENOMIC, V11, P37, DOI 10.1007/s10142-010-0208-x; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BLUM A, 1994, AUST J PLANT PHYSIOL, V21, P771, DOI 10.1071/PP9940771; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; DEVRIES AP, 1971, EUPHYTICA, V20, P152, DOI 10.1007/BF00056076; Dreccer MF, 2009, FIELD CROP RES, V112, P43, DOI 10.1016/j.fcr.2009.02.006; Ehdaie B, 2006, CROP SCI, V46, P2093, DOI 10.2135/cropsci2006.01.0013; Ehdaie B, 2006, CROP SCI, V46, P735, DOI 10.2135/cropsci2005.04-0033; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; GALLAGHER JN, 1976, NATURE, V264, P541, DOI 10.1038/264541a0; Goggin DE, 2004, FUNCT PLANT BIOL, V31, P11, DOI 10.1071/FP03123; Gupta A. K., 2011, American Journal of Plant Sciences, V2, P70, DOI 10.4236/ajps.2011.21010; Hao CY, 2006, MOL BREEDING, V17, P69, DOI 10.1007/s11032-005-2453-6; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; He Z, 2012, CROP SCI, V52, P44; Homayoun H., 2011, Advances in Environmental Biology, V5, P1721; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jing R., 1999, AGR RES ARID AREAS, V17, P79; LAWLOR DW, 1981, J AGR SCI-CAMBRIDGE, V96, P167, DOI 10.1017/S002185960003197X; Li WeiYu, 2012, Acta Agronomica Sinica, V38, P962; Nagata K, 2002, BREEDING SCI, V52, P275, DOI 10.1270/jsbbs.52.275; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NICOLAS ME, 1993, FIELD CROP RES, V31, P155, DOI 10.1016/0378-4290(93)90058-U; Rebetzke GJ, 2008, AUST J AGR RES, V59, P891, DOI 10.1071/AR08067; REGAN KL, 1993, AUST J AGR RES, V44, P1683, DOI 10.1071/AR9931683; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Rosenow, 1981, P 36 ANN CORN SORGH, P18; Ruuska SA, 2006, FUNCT PLANT BIOL, V33, P799, DOI 10.1071/FP06062; Shearman VJ, 2005, CROP SCI, V45, P175; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Teulat B, 2001, THEOR APPL GENET, V103, P161, DOI 10.1007/s001220000503; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Turner LB, 2006, NEW PHYTOL, V169, P45, DOI 10.1111/j.1469-8137.2005.01575.x; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wang J, 2005, CHINESE J SOIL SCI, V36, P908; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wang ZH, 2011, ANAL LETT, V44, P2478, DOI 10.1080/00032719.2011.551859; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P255, DOI 10.1071/PP9940255; Yang DL, 2007, GENETICS, V176, P571, DOI 10.1534/genetics.106.068361; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2003, PLANT CELL ENVIRON, V26, P1621, DOI 10.1046/j.1365-3040.2003.01081.x; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu LX, 2012, THEOR APPL GENET, V125, P749, DOI 10.1007/s00122-012-1867-x; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102917; Zhang DL, 2012, PLANTA, V236, P1507, DOI 10.1007/s00425-012-1708-9; Zhang JH, 1998, FIELD CROP RES, V59, P91, DOI 10.1016/S0378-4290(98)00104-X; Zhang JA, 2011, PLANTA, V234, P891, DOI 10.1007/s00425-011-1434-8	50	28	30	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119438	10.1371/journal.pone.0119438	http://dx.doi.org/10.1371/journal.pone.0119438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768726	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500081
J	Meyer, MA; Chand, T; Priess, JA				Meyer, Markus A.; Chand, Tanzila; Priess, Joerg A.			Comparing Bioenergy Production Sites in the Southeastern US Regarding Ecosystem Service Supply and Demand	PLOS ONE			English	Article							LAND-USE; LANDSCAPE STRUCTURE; BIODIVERSITY CONSERVATION; CORN STOVER; CARBON; TRADE; SOIL; CERTIFICATION; INDICATORS; BIOFUELS	Biomass for bioenergy is debated for its potential synergies or tradeoffs with other provisioning and regulating ecosystem services (ESS). This biomass may originate from different production systems and may be purposefully grown or obtained from residues. Increased concerns globally about the sustainable production of biomass for bioenergy has resulted in numerous certification schemes focusing on best management practices, mostly operating at the plot/field scale. In this study, we compare the ESS of two watersheds in the southeastern US. We show the ESS tradeoffs and synergies of plantation forestry, i.e., pine poles, and agricultural production, i.e., wheat straw and corn stover, with the counterfactual natural or semi-natural forest in both watersheds. The plantation forestry showed less distinct tradeoffs than did corn and wheat production, i.e., for carbon storage, P and sediment retention, groundwater recharge, and biodiversity. Using indicators of landscape composition and configuration, we showed that landscape planning can affect the overall ESS supply and can partly determine if locally set environmental thresholds are being met. Indicators on landscape composition, configuration and naturalness explained more than 30% of the variation in ESS supply. Landscape elements such as largely connected forest patches or more complex agricultural patches, e.g., mosaics with shrub and grassland patches, may enhance ESS supply in both of the bioenergy production systems. If tradeoffs between biomass production and other ESS are not addressed by landscape planning, it may be reasonable to include rules in certification schemes that require, e.g., the connectivity of natural or semi-natural forest patches in plantation forestry or semi-natural landscape elements in agricultural production systems. Integrating indicators on landscape configuration and composition into certification schemes is particularly relevant considering that certification schemes are governance tools used to ensure comparable sustainability standards for biomass produced in countries with variable or absent legal frameworks for landscape planning.	[Meyer, Markus A.; Chand, Tanzila; Priess, Joerg A.] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Meyer, MA (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany.	markus.meyer@ufz.de	Meyer, Markus/HIK-1821-2022; Meyer, Markus/AAY-9170-2020; Meyer, Markus/AAV-5608-2020; Priess, Joerg A./G-1697-2012	Meyer, Markus/0000-0003-4872-7164; Meyer, Markus/0000-0002-9463-1975; Priess, Joerg A./0000-0002-0384-9240	European Union [282826]; Higher Education Commission Pakistan	European Union(European Commission); Higher Education Commission Pakistan(Higher Education Commission of Pakistan)	This work was partly funded by the European Union FP7 project SECTOR (Production of Solid Sustainable Energy Carriers by Means of Torrefaction), grant agreement number 282826, https://sector-project.eu/, and the Higher Education Commission Pakistan in cooperation with the German Academic Exchange Service (DAAD), http://www.hec.gov.pk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2008, ENVIRON SCI TECHNOL, V42, P822, DOI 10.1021/es0716103; Allen RG, 2001, CROP EVAPOTRANSPIRAT; [Anonymous], 2013, GROUNDWATER DEPLETIO; Arnold JG, 2005, HYDROL PROCESS, V19, P563, DOI 10.1002/hyp.5611; Baessler C, 2006, AGR ECOSYST ENVIRON, V115, P43, DOI 10.1016/j.agee.2005.12.007; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bennett EM, 2007, FRONT ECOL ENVIRON, V5, P191, DOI 10.1890/1540-9295(2007)5[191:TFOPSI]2.0.CO;2; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Birdsey R, 1992, CARBON STORAGE ACCUM, DOI DOI 10.2737/WO-GTR-59; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Board M, 2005, ECOSYSTEMS HUMAN WEL; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bourke D, 2014, GCB BIOENERGY, V6, P275, DOI 10.1111/gcbb.12089; Brandt P, 2014, BIOL CONSERV, V169, P362, DOI 10.1016/j.biocon.2013.12.003; Bridgeman TG, 2008, FUEL, V87, P844, DOI 10.1016/j.fuel.2007.05.041; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Bringezu S, 2012, LAND USE POLICY, V29, P224, DOI 10.1016/j.landusepol.2011.06.010; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brockerhoff EG, 2013, FOREST ECOL MANAG, V301, P43, DOI 10.1016/j.foreco.2012.09.018; Burns LA, 1992, PESTICIDE IND CHEM R; Campbell Group, 2013, JUV PIN PLANT UNPUB; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chum H, 2011, IPCC SPECIAL REPORT; Clark B. R., 2011, 1785 US GEOL SOC; Convertino M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065056; Dale VH, 2007, ECOL ECON, V64, P286, DOI 10.1016/j.ecolecon.2007.05.009; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dauber J, 2003, AGR ECOSYST ENVIRON, V98, P321, DOI 10.1016/S0167-8809(03)00092-6; Desiree JI, 2014, GCB BIOENERGY, V6, P183, DOI 10.1111/gcbb.12067; Diaz-Chavez R, 2011, BIOFUEL BIOPROD BIOR, V5, P445, DOI 10.1002/bbb.319; DISSMEYER GE, 1984, GUIDE PREDICTING SHE; Dripps WR, 2007, HYDROGEOL J, V15, P433, DOI 10.1007/s10040-007-0160-6; Efroymson RA, 2013, ENVIRON MANAGE, V51, P291, DOI 10.1007/s00267-012-9907-5; EPD, 2001, SAT RIV BAS DISS OX; *FAO GEON, 2004, GLOB MAP MONTHL REF; Fernandez C, 2003, J SOIL WATER CONSERV, V58, P128; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fonseca M.B., 2010, IMPACTS EU BIOFUEL T; Frank S, 2014, LANDSCAPE ECOLOGY, P1; Frank S, 2012, ECOL INDIC, V21, P30, DOI 10.1016/j.ecolind.2011.04.027; Franzluebbers AJ, 2005, SOIL TILL RES, V83, P120, DOI 10.1016/j.still.2005.02.012; Gasparatos A, 2011, AGR ECOSYST ENVIRON, V142, P111, DOI 10.1016/j.agee.2011.04.020; Ghazoul J, 2009, FOREST ECOL MANAG, V258, P1889, DOI 10.1016/j.foreco.2009.01.038; Goh CS, 2013, BIOFUEL BIOPROD BIOR, V7, P24, DOI 10.1002/bbb.1366; Goldman RL, 2007, ECOL ECON, V64, P333, DOI 10.1016/j.ecolecon.2007.01.012; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Gos Pierre, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P93, DOI 10.1080/21513732.2011.646303; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Harmel D, 2006, J AM WATER RESOUR AS, V42, P1163, DOI 10.1111/j.1752-1688.2006.tb05604.x; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; IPCC, 2019, 2006 IPCC GUIDELINES, DOI DOI 10.35-10.49; Johnson JMF, 2014, BIOENERG RES, V7, P68, DOI 10.1007/s12155-013-9349-9; Jones KB, 2001, LANDSCAPE ECOL, V16, P301, DOI 10.1023/A:1011175013278; Junginger M, 2011, ENERG POLICY, V39, P2028, DOI 10.1016/j.enpol.2011.01.040; Kadam KL, 2003, BIORESOURCE TECHNOL, V88, P17, DOI 10.1016/S0960-8524(02)00269-9; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kim KH, 2007, LAND USE POLICY, V24, P264, DOI 10.1016/j.landusepol.2005.12.001; KRAMER E, 2003, GAP ANAL GEORGIA; Kremen C., 2012, ECOLOGY SOC, V17; Lamers P, 2013, BIOMASS BIOENERG, V55, P212, DOI 10.1016/j.biombioe.2013.02.002; Lamers P, 2012, RENEW SUST ENERG REV, V16, P3176, DOI 10.1016/j.rser.2012.02.027; Lautenbach S, 2013, ENVIRON MODELL SOFTW, V48, P98, DOI 10.1016/j.envsoft.2013.06.006; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lewandowski I, 2006, BIOMASS BIOENERG, V30, P83, DOI 10.1016/j.biombioe.2005.11.003; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Manning P, 2014, GCB BIOENERGY; Martin A, 2003, ENVIRON SCI POLLUT R, V10, P245, DOI 10.1065/espr2003.05.153; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; McBride AC, 2011, ECOL INDIC, V11, P1277, DOI 10.1016/j.ecolind.2011.01.010; McCarty JL, 2007, REMOTE SENS ENVIRON, V108, P151, DOI 10.1016/j.rse.2006.03.020; McCarty JL, 2011, J AIR WASTE MANAGE, V61, P22, DOI 10.3155/1047-3289.61.1.22; McGarigal K., 2012, TECH REP; MDEQ, 2003, TMDL FOR ORGANIC ENR; MDEQ, 2008, TOT MAX DAIL LOAD TO; Meehan TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080093; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Meyer MA, 2014, BIOMASS BIOENERG, V65, P151, DOI 10.1016/j.biombioe.2014.03.041; Meyfroidt P, 2010, P NATL ACAD SCI USA, V107, P20917, DOI 10.1073/pnas.1014773107; Mishra HS, 1997, IRRIGATION SCI, V17, P69, DOI 10.1007/s002710050024; Mitchell MGE, 2013, ECOSYSTEMS, V16, P894, DOI 10.1007/s10021-013-9647-2; Morgan R.P.C, 2005, SOIL EROSION CONSERV, V3rd, DOI DOI 10.1111/J.1365-2389.2005.0756F.X; Mouchet MA, 2014, GLOBAL ENVIRON CHANG, V28, P298, DOI 10.1016/j.gloenvcha.2014.07.012; Mullen CA, 2010, BIOMASS BIOENERG, V34, P67, DOI 10.1016/j.biombioe.2009.09.012; Muth DJ, 2013, APPL ENERG, V102, P403, DOI 10.1016/j.apenergy.2012.07.028; Natural Resources Conservation Service (NRCS), 2012, NRCS ENG FIELD HDB; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Payne DF, 2005, SIMULATION GROUND WA; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perica S., 2013, PRECIPITATION FREQUE; Perlack RD, 2011, IEA BIOENERGY; Priest S, 2004, EVALUATION GROUND WA; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; R Core Team, 2020, R LANG ENV STAT COMP; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reckhow KH, 1980, MODELING PHOSPHOROUS; Roose E, 1996, LAND HUSBANDRY COMPO; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Sainju UM, 2005, PLANT SOIL, V273, P219, DOI 10.1007/s11104-004-7611-9; Scarlat N, 2011, ENERG POLICY, V39, P1630, DOI 10.1016/j.enpol.2010.12.039; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Scurlock J.M.O., 2001, WORLDWIDE HIST ESTIM; Smith JE., 2006, METHODS CALCULATING; Snipes C., 2005, CURRENT AGR PRACTICE; Suarez LA., 2005, PRZM 3 MODEL PREDICT; Susaeta A, 2013, INT J SUSTAIN ENERGY, V32, P544, DOI 10.1080/14786451.2013.774003; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis HT, 2013, VEST 2 5 7 USERS GUI; Terrado M, 2014, ECOL INDIC, V37, P199, DOI 10.1016/j.ecolind.2013.01.016; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2014, CONSERVATION LETT; USDA NASS, 2014, CORN WINT WHEAT PROD; USDA NASS, 2010, CROPL DAT LAYER CDL; USDA NRCS, 2014, WEB SOIL SURV SOIL S; USDA NRCS, 2002, C FACT US ER PRED MI; USDA NRCS and ARS, 2000, REV UN SOIL LOSS EQ; USGS and USDOI, 2010, LANDF 1 2 0 ENV SIT; USGS GAP, 2011, ASPECT; USGS GAP, 2011, SLOP; USGS GAP, 2011, HUM IMP AV; USGS GAP (US Geological Survey Gap Analysis Program), 2011, NAT LAND COV VERS 2; van Dam J, 2010, RENEW SUST ENERG REV, V14, P2445, DOI 10.1016/j.rser.2010.07.010; Vigerstol KL, 2011, J ENVIRON MANAGE, V92, P2403, DOI 10.1016/j.jenvman.2011.06.040; VILELLA FJ, 2003, GAP ANAL MISSISSIPPI; Villa F, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0220, DOI 10.1098/RSTB.2013.0220]; Welch HL, 2011, HYDROGEOL J, V19, P1239, DOI 10.1007/s10040-011-0748-8; Werling BP, 2014, P NATL ACAD SCI; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107; Westenbroek S., 2010, SWB A MODIFIED THORN; Wischmeier W.H., 1978, PREDICTING RAINFALL; Wolock D.M., 2003, ESTIMATED MEAN ANN N; Wrbka T, 2004, LAND USE POLICY, V21, P289, DOI 10.1016/j.landusepol.2003.10.012; Yeh S, 2011, BIOFUEL BIOPROD BIOR, V5, P361, DOI 10.1002/bbb.308; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	135	18	18	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116336	10.1371/journal.pone.0116336	http://dx.doi.org/10.1371/journal.pone.0116336			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768660	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500008
J	Valdes-Baizabal, C; Soto, E; Vega, R				Valdes-Baizabal, Catalina; Soto, Enrique; Vega, Rosario			Dopaminergic Modulation of the Voltage-Gated Sodium Current in the Cochlear Afferent Neurons of the Rat	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; GUINEA-PIG COCHLEA; D1 RECEPTOR; CONSTITUTIVE ACTIVITY; EFFERENT INNERVATION; SIGNAL-TRANSDUCTION; MOUSE COCHLEA; D-1 RECEPTORS; NA+ CHANNELS; IMMUNOREACTIVITY	The cochlear inner hair cells synapse onto type I afferent terminal dendrites, constituting the main afferent pathway for auditory information flow. This pathway receives central control input from the lateral olivocochlear efferent neurons that release various neurotransmitters, among which dopamine (DA) plays a salient role. DA receptors activation exert a protective role in the over activation of the afferent glutamatergic synapses, which occurs when an animal is exposed to intense sound stimuli or during hypoxic events. However, the mechanism of action of DA at the cellular level is still not completely understood. In this work, we studied the actions of DA and its receptor agonists and antagonists on the voltage-gated sodium current (I-Na) in isolated cochlear afferent neurons of the rat to define the mechanisms of dopaminergic control of the afferent input in the cochlear pathway. Experiments were performed using the voltage and current clamp techniques in the whole-cell configuration in primary cultures of cochlear spiral ganglion neurons (SGNs). Recordings of the INa showed that DA receptor activation induced a significant inhibition of the peak current amplitude, leading to a significant decrease in cell excitability. Inhibition of the INa was produced by a phosphorylation of the sodium channels as shown by the use of phosphatase inhibitor that produced an inhibition analogous to that caused by DA receptor activation. Use of specific agonists and antagonists showed that inhibitory action of DA was mediated both by activation of D1- and D2-like DA receptors. The action of the D1- and D2-like receptors was shown to be mediated by a G(as)/AC/cAMP/PKA and G(alpha q)/PLC/PKC pathways respectively. These results showed that DA receptor activation constitutes a significant modulatory input to SGNs, effectively modulating their excitability and information flow in the auditory pathway.	[Valdes-Baizabal, Catalina; Soto, Enrique; Vega, Rosario] Benemerita Univ Autonoma Puebla, Inst Fisiol, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla	Vega, R (corresponding author), Benemerita Univ Autonoma Puebla, Inst Fisiol, Puebla, Mexico.	axolotl_56@yahoo.com.mx	Baizabal, Catalina Valdés/V-8463-2018; soto, Enrique/C-4073-2013; Valdés-Baizabal, Catalina/ABB-8697-2020	Baizabal, Catalina Valdés/0000-0002-4063-7546; soto, Enrique/0000-0003-2428-7416; Vega, Rosario/0000-0001-7532-2483	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT) [167052]; VIEP-BUAP; PIFI; CONACyT [216652]	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); VIEP-BUAP; PIFI; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding: This work was supported by a grant from Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT) grant 167052 to ES, grants VIEP-BUAP to RV and ES, and PIFI 2012-2013 grant. CVB was supported by CONACyT fellowship 216652. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CL, 2002, J NEUROSCI, V22, P1385, DOI 10.1523/JNEUROSCI.22-04-01385.2002; ALTSCHULER RA, 1985, BRAIN RES, V338, P1, DOI 10.1016/0006-8993(85)90242-2; ALTSCHULER RA, 1986, AM J OTOLARYNG, V7, P100, DOI 10.1016/S0196-0709(86)80038-2; Arrang JM, 2007, TRENDS PHARMACOL SCI, V28, P350, DOI 10.1016/j.tips.2007.05.002; Bartolome M Visitacion, 2005, Int Tinnitus J, V11, P119; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Cabello N, 2009, J NEUROCHEM, V109, P1497, DOI 10.1111/j.1471-4159.2009.06078.x; Cantrell AR, 1999, J NEUROSCI, V19, P5301; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; DALDIN C, 1995, HEARING RES, V90, P202, DOI 10.1016/0378-5955(95)00167-5; Darrow KN, 2006, J COMP NEUROL, V498, P403, DOI 10.1002/cne.21050; Drescher MJ, 2006, NEUROSCIENCE, V142, P139, DOI 10.1016/j.neuroscience.2006.05.065; EYBALIN M, 1984, HEARING RES, V13, P135, DOI 10.1016/0378-5955(84)90104-7; EYBALIN M, 1988, NEUROSCIENCE, V24, P29, DOI 10.1016/0306-4522(88)90308-9; Ferrada C, 2009, BRIT J PHARMACOL, V157, P64, DOI 10.1111/j.1476-5381.2009.00152.x; Franco R, 2007, J NEURAL TRANSM, V114, P93, DOI 10.1007/s00702-006-0566-7; Garrett AR, 2011, AUDIOL NEURO-OTOL, V16, P145, DOI 10.1159/000316674; GILLOYZAGA P, 1989, DEV BRAIN RES, V48, P157, DOI 10.1016/0165-3806(89)90100-4; GILLOYZAGA P, 1994, HEARING RES, V79, P178, DOI 10.1016/0378-5955(94)90138-4; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Hossain WA, 2005, J NEUROSCI, V25, P6857, DOI 10.1523/JNEUROSCI.0123-05.2005; Inoue T, 2006, NEUROSCI LETT, V399, P226, DOI 10.1016/j.neulet.2006.01.063; Karadaghy AA, 1997, MOL BRAIN RES, V44, P151, DOI 10.1016/S0169-328X(96)00261-6; Kozell LB, 1997, MOL PHARMACOL, V52, P1137, DOI 10.1124/mol.52.6.1137; Kuroiwa M, 2008, J NEUROCHEM, V107, P1014, DOI 10.1111/j.1471-4159.2008.05702.x; Lee FJS, 2004, BIOCHEM SOC T, V32, P1032, DOI 10.1042/BST0321032; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Limon A, 2005, J NEUROPHYSIOL, V94, P3751, DOI 10.1152/jn.00177.2005; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; LU SM, 1987, HEARING RES, V31, P137, DOI 10.1016/0378-5955(87)90119-5; Maison SF, 2012, J NEUROSCI, V32, P344, DOI 10.1523/JNEUROSCI.4720-11.2012; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mo ZL, 1997, J NEUROPHYSIOL, V78, P3019, DOI 10.1152/jn.1997.78.6.3019; Niu X, 2006, NEUROSCIENCE, V137, P981, DOI 10.1016/j.neuroscience.2005.10.044; Niu X, 2004, NEUROSCIENCE, V125, P725, DOI 10.1016/j.neuroscience.2004.02.023; Niu XZ, 2007, PHYSIOL BEHAV, V92, P34, DOI 10.1016/j.physbeh.2007.05.020; Oestreicher E, 1997, HEARING RES, V107, P46, DOI 10.1016/S0378-5955(97)00023-3; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Perreault ML, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00031; Polony G, 2014, NEUROSCIENCE, V265, P263, DOI 10.1016/j.neuroscience.2014.01.057; PUJOL R, 1994, BRIT J AUDIOL, V28, P185, DOI 10.3109/03005369409086567; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Ruel J, 2006, J NEUROCHEM, V97, P190, DOI 10.1111/j.1471-4159.2006.03722.x; Ruel J, 2001, EUR J NEUROSCI, V14, P977, DOI 10.1046/j.0953-816x.2001.01721.x; SLIWINSKAKOWALSKA M, 1989, HEARING RES, V42, P83, DOI 10.1016/0378-5955(89)90119-6; SPOENDLIN H, 1985, AM J OTOLARYNG, V6, P453, DOI 10.1016/S0196-0709(85)80026-0; Sun W, 2001, NEUROREPORT, V12, P803, DOI 10.1097/00001756-200103260-00037; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Szabo ZS, 2002, EUR J NEUROSCI, V16, P1887, DOI 10.1046/j.1460-9568.2002.02258.x; Sziklai I, 2011, LARYNGOSCOPE, V121, P888, DOI 10.1002/lary.21461; Verma V, 2010, J BIOL CHEM, V285, P35092, DOI 10.1074/jbc.M109.088625; WARR WB, 1979, BRAIN RES, V173, P152, DOI 10.1016/0006-8993(79)91104-1	53	20	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120808	10.1371/journal.pone.0120808	http://dx.doi.org/10.1371/journal.pone.0120808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768433	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500136
J	Ellis, JM; Bowman, CE; Wolfgang, MJ				Ellis, Jessica M.; Bowman, Caitlyn E.; Wolfgang, Michael J.			Metabolic and Tissue-Specific Regulation of Acyl-CoA Metabolism	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; COENZYME-A-SYNTHETASE; STRUCTURAL BASIS; THIOESTERASE; MOUSE; PROTEIN; LOCALIZATION; PURIFICATION; EXPRESSION; OXIDATION	Acyl-CoA formation initiates cellular fatty acid metabolism. Acyl-CoAs are generated by the ligation of a fatty acid to Coenzyme A mediated by a large family of acyl-CoA synthetases (ACS). Conversely, acyl-CoAs can be hydrolyzed by a family of acyl-CoA thioesterases (ACOT). Here, we have determined the transcriptional regulation of all ACS and ACOT enzymes across tissues and in response to metabolic perturbations. We find patterns of coordinated regulation within and between these gene families as well as distinct regulation occurring in a tissue- and physiologically-dependent manner. Due to observed changes in long-chain ACOT mRNA and protein abundance in liver and adipose tissue, we determined the consequence of increasing cytosolic long-chain thioesterase activity on fatty acid metabolism in these tissues by generating transgenic mice overexpressing a hyperactive mutant of Acot7 in the liver or adipose tissue. Doubling cytosolic acyl-CoA thioesterase activity failed to protect mice from diet-induced obesity, fatty liver or insulin resistance, however, overexpression of Acot7 in adipocytes rendered mice cold intolerant. Together, these data suggest distinct modes of regulation of the ACS and ACOT enzymes and that these enzymes act in a coordinated fashion to control fatty acid metabolism in a tissue-dependent manner.	[Ellis, Jessica M.; Bowman, Caitlyn E.; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University	Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	mwolfga1@jhmi.edu			National Institutes of Health grant [NS072241]; Baltimore Diabetes Research and Training Center (DRTC) [P60DK079637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baltimore Diabetes Research and Training Center (DRTC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.J.W. was supported by a National Institutes of Health grant (NS072241) and the Baltimore Diabetes Research and Training Center (DRTC) Grant P60DK079637.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brocker Chad, 2010, Hum Genomics, V4, P411; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Choi JY, 1996, J BIOL CHEM, V271, P3581; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Smith ME, 2013, BIOCHEM BIOPH RES CO, V430, P272, DOI 10.1016/j.bbrc.2012.10.138; Faergeman NJ, 1997, BIOCHEM J, V323, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Fujita M, BIOL PHARM B, V34, P87; Gargiulo CE, 1999, J LIPID RES, V40, P881; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Hunt MC, 2007, CELL MOL LIFE SCI, V64, P1558, DOI 10.1007/s00018-007-7062-6; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Hunt MC, 1999, J BIOL CHEM, V274, P34317, DOI 10.1074/jbc.274.48.34317; Kang HW, 2012, FASEB J, V26, P2209, DOI 10.1096/fj.11-202853; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kuramochi Y, 2002, MOL BRAIN RES, V98, P81; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; LI QL, 1993, J CELL BIOCHEM, V51, P458, DOI 10.1002/jcb.2400510411; LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Melton EM, 2013, BIOCHEM BIOPH RES CO, V440, P743, DOI 10.1016/j.bbrc.2013.09.137; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Moffat C, 2014, J LIPID RES, V55, P2458, DOI 10.1194/jlr.M046961; NAGGERT J, 1987, BIOCHEM J, V243, P597, DOI 10.1042/bj2430597; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Reamy AA, 2011, J NEUROCHEM, V118, P388, DOI 10.1111/j.1471-4159.2011.07312.x; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Rodriguez S, 2012, CHEM BIOL, V19, P391, DOI 10.1016/j.chembiol.2011.12.022; Rodriguez-Guilbe M, 2013, J BIOL CHEM, V288, P10841, DOI 10.1074/jbc.M112.446765; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Serek R, 2006, ACTA CRYSTALLOGR F, V62, P133, DOI 10.1107/S1744309106000030; Sone H, 2002, AM J PHYSIOL-ENDOC M, V282, pE222, DOI 10.1152/ajpendo.00189.2001; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; WAKU K, 1992, BIOCHIM BIOPHYS ACTA, V1124, P101, DOI 10.1016/0005-2760(92)90085-A; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Yamada J, 2004, NEUROSCI LETT, V355, P89, DOI 10.1016/j.neulet.2003.10.049; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]; Zhang YZ, 2012, P NATL ACAD SCI USA, V109, P5417, DOI 10.1073/pnas.1116011109; Zhuravleva E, 2012, MOL CELL BIOL, V32, P2685, DOI 10.1128/MCB.00312-12	60	61	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116587	10.1371/journal.pone.0116587	http://dx.doi.org/10.1371/journal.pone.0116587			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760036	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000007
J	Forreryd, A; Albrekt, HJ; Borrebaeck, CAK; Lindstedt, M				Forreryd, Andy; Albrekt, Henrik Johansson; Borrebaeck, Carl A. K.; Lindstedt, Malin			Prediction of Chemical Respiratory Sensitizers Using GARD, a Novel In Vitro Assay Based on a Genomic Biomarker Signature	PLOS ONE			English	Article							DISCRIMINATING GENETIC-MARKERS; SERUM IGE CONCENTRATION; EPITHELIAL-CELL LINE; LYMPH-NODE ASSAY; TEST H-CLAT; OCCUPATIONAL ASTHMA; SKIN SENSITIZERS; TRIMELLITIC ANHYDRIDE; PATHWAY ANALYSIS; BROWN-NORWAY	Background Repeated exposure to certain low molecular weight (LMW) chemical compounds may result in development of allergic reactions in the skin or in the respiratory tract. In most cases, a certain LMW compound selectively sensitize the skin, giving rise to allergic contact dermatitis (ACD), or the respiratory tract, giving rise to occupational asthma (OA). To limit occurrence of allergic diseases, efforts are currently being made to develop predictive assays that accurately identify chemicals capable of inducing such reactions. However, while a few promising methods for prediction of skin sensitization have been described, to date no validated method, in vitro or in vivo, exists that is able to accurately classify chemicals as respiratory sensitizers. Results Recently, we presented the in vitro based Genomic Allergen Rapid Detection (GARD) assay as a novel testing strategy for classification of skin sensitizing chemicals based on measurement of a genomic biomarker signature. We have expanded the applicability domain of the GARD assay to classify also respiratory sensitizers by identifying a separate biomarker signature containing 389 differentially regulated genes for respiratory sensitizers in comparison to non-respiratory sensitizers. By using an independent data set in combination with supervised machine learning, we validated the assay, showing that the identified genomic biomarker is able to accurately classify respiratory sensitizers. Conclusions We have identified a genomic biomarker signature for classification of respiratory sensitizers. Combining this newly identified biomarker signature with our previously identified biomarker signature for classification of skin sensitizers, we have developed a novel in vitro testing strategy with a potent ability to predict both skin and respiratory sensitization in the same sample.	[Forreryd, Andy; Albrekt, Henrik Johansson; Borrebaeck, Carl A. K.; Lindstedt, Malin] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Albrekt, Henrik Johansson] SenzaGen AB, Lund, Sweden	Lund University	Lindstedt, M (corresponding author), Lund Univ, Dept Immunotechnol, Lund, Sweden.	Malin.Lindstedt@immun.lth.se	Lindstedt, Malin/A-3855-2009	Lindstedt, Malin/0000-0001-9136-1087	Swedish Fund for Research Without Animal Experiments; Swedish Research Council [K2010-79X-21371-01-3]; Swedish Research Council Formas [2011-1418]; Carl Trygger Foundation; Faculty of Engineering at Lund University; SenzaGen AB	Swedish Fund for Research Without Animal Experiments; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Carl Trygger Foundation; Faculty of Engineering at Lund University; SenzaGen AB	This work was supported by grants from the Swedish Fund for Research Without Animal Experiments (http://www.forskautandjurforsok.se), the Swedish Research Council (K2010-79X-21371-01-3) (http://www.vr.se), Swedish Research Council Formas (2011-1418) (http://www.formas.se), the Carl Trygger Foundation (http://www.carltryggersstiftelse.se/) and the Faculty of Engineering at Lund University (http://www.lth.se/). HJ is employed by SenzaGen AB. SenzaGen AB provided support in the form of salaries for HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrekt AS, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-5; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2010, OFF J EUR UNION, VL 276, P33; Arts JHE, 1997, TOXICOLOGY, V117, P229, DOI 10.1016/S0300-483X(96)03576-7; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Banks D E, 2000, Curr Opin Pulm Med, V6, P37, DOI 10.1097/00063198-200001000-00008; Basketter DA, 2002, FOOD CHEM TOXICOL, V40, P593, DOI 10.1016/S0278-6915(01)00130-2; Bello D, 2007, ENVIRON HEALTH PERSP, V115, P328, DOI 10.1289/ehp.9557; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERNSTEIN DI, 1982, J ALLERGY CLIN IMMUN, V69, P311, DOI 10.1016/S0091-6749(82)80009-2; Bharadwaj A, 2004, INT IMMUNOPHARMACOL, V4, P495, DOI 10.1016/j.intimp.2004.02.001; BOURNE MS, 1979, BRIT MED J, V2, P10, DOI 10.1136/bmj.2.6181.10; Boverhof DR, 2008, TOXICOL APPL PHARM, V226, P1, DOI 10.1016/j.taap.2007.10.008; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P507, DOI 10.1016/0091-6749(89)90364-3; Cary R, 1999, CONCISE INT CHEM ASS; COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cullinan P, 1998, CLIN EXP ALLERGY, V28, P668; Dearman RJ, 2001, J APPL TOXICOL, V21, P153, DOI 10.1002/jat.743; Dearman RJ, 1999, METHODS, V19, P56, DOI 10.1006/meth.1999.0827; DEARMAN RJ, 1992, J APPL TOXICOL, V12, P317, DOI 10.1002/jat.2550120505; DOCKER A, 1987, BRIT J IND MED, V44, P534; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; European Commission, 2008, OJ L, VL353, P1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213; Haneke KE, 2001, REGUL TOXICOL PHARM, V34, P274, DOI 10.1006/rtph.2001.1498; Hilton J, 1996, J APPL TOXICOL, V16, P165, DOI 10.1002/(SICI)1099-1263(199603)16:2<165::AID-JAT325>3.0.CO;2-M; Holsapple MP, 2006, TOXICOL SCI, V91, P4, DOI 10.1093/toxsci/kfj074; Hu ZB, 1996, LEUKEMIA, V10, P1025; Huang S, 2013, TOXICOL IN VITRO, V27, P1151, DOI 10.1016/j.tiv.2012.10.010; Institute for Health and Consumer Protection European Chemicals Bureau, 2005, EUR UN RISK ASS REP, V56, P159; Isola D, 2008, J APPL TOXICOL, V28, P249, DOI 10.1002/jat.1336; Johansson H, 2014, TOXICOL SCI, V139, P362, DOI 10.1093/toxsci/kfu046; Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019; Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; KAROL MH, 1981, TOXICOL APPL PHARM, V58, P221, DOI 10.1016/0041-008X(81)90426-9; Kimber I, 2003, FOOD CHEM TOXICOL, V41, P1799, DOI 10.1016/S0278-6915(03)00223-0; Kimber I, 2002, TOXICOLOGY, V181, P311, DOI 10.1016/S0300-483X(02)00299-8; Kimber I, 2007, ATLA-ALTERN LAB ANIM, V35, P243, DOI 10.1177/026119290703500212; Kimber I, 2014, TOXICOLOGY, V318, P32, DOI 10.1016/j.tox.2014.02.001; Kopferschmitt-Kubler MC, 2002, EUR RESPIR J, V19, P84, DOI 10.1183/09031936.02.00102202; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lalko JF, 2011, TOXICOL IN VITRO, V25, P433, DOI 10.1016/j.tiv.2010.11.007; Larsson K, 2006, IMMUNOLOGY, V117, P156, DOI 10.1111/j.1365-2567.2005.02274.x; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Masterson AJ, 2002, BLOOD, V100, P701, DOI 10.1182/blood.V100.2.701; Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6; Meuleman L, 1999, ALLERGY, V54, P752, DOI 10.1111/j.1398-9995.1999.00103.x; Meyer D, 2014, E1071 MISC FUNCTIONS; Munoz X, 2003, CHEST, V123, P2124, DOI 10.1378/chest.123.6.2124; MURDOCH RD, 1986, BRIT J IND MED, V43, P37; Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014; Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228; Nukada Y, 2011, CONTACT DERMATITIS, V65, P343, DOI 10.1111/j.1600-0536.2011.01952.x; OECD, 2010, TEST 429 SKIN SENS L, DOI [10.1787/9789264071100-en, DOI 10.1787/9789264071100-EN]; OECD, 2012, OECD ENV HLTH SAF PU, V168, P1, DOI DOI 10.1787/9789264221444-EN; Orriols R, 2006, OCCUP ENVIRON MED, V63, P255, DOI 10.1136/oem.2005.022525; Pauluhn J, 2003, TOXICOLOGY, V194, P1, DOI 10.1016/S0300-483X(03)00285-3; Pauluhn J, 2002, TOXICOLOGY, V171, P147, DOI 10.1016/S0300-483X(01)00571-6; Piccolo SR, 2012, GENOMICS, V100, P337, DOI 10.1016/j.ygeno.2012.08.003; Quentmeier H, 1996, IMMUNOLOGY, V89, P606, DOI 10.1046/j.1365-2567.1996.d01-780.x; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Sallstad DM, 2003, TOXICOLOGY, V194, P147, DOI 10.1016/S030-483X(03)00338-X; Santegoets SJAM, 2006, J LEUKOCYTE BIOL, V80, P1337, DOI 10.1189/jlb.0206111; Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103; Scheerens H, 1996, AM J RESP CRIT CARE, V154, P858, DOI 10.1164/ajrccm.154.4.8887575; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tarlo SM, 2014, NEW ENGL J MED, V370, P640, DOI 10.1056/NEJMra1301758; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Vanoirbeek JAJ, 2003, TOXICOL SCI, V76, P338, DOI 10.1093/toxsci/kfg235; Vanoirbeek JAJ, 2006, J ALLERGY CLIN IMMUN, V117, P1090, DOI 10.1016/j.jaci.2006.01.027; Verstraelen S, 2008, TOXICOL IN VITRO, V22, P1419, DOI 10.1016/j.tiv.2008.05.008; Verstraelen S, 2009, TOXICOL IN VITRO, V23, P1151, DOI 10.1016/j.tiv.2009.06.007; Verstraelen S, 2009, TOXICOL LETT, V185, P16, DOI 10.1016/j.toxlet.2008.11.017; Verstraelen S, 2009, TOXICOLOGY, V255, P151, DOI 10.1016/j.tox.2008.10.014; Warbrick EV, 2002, J APPL TOXICOL, V22, P1, DOI 10.1002/jat.830; ZAMMITTABONA M, 1983, AM REV RESPIR DIS, V128, P226	81	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118808	10.1371/journal.pone.0118808	http://dx.doi.org/10.1371/journal.pone.0118808			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760038	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000040
J	Nilsson, J; Ohlsson, M; Hoglund, P; Ekmehag, B; Koul, B; Andersson, B				Nilsson, Johan; Ohlsson, Mattias; Hoglund, Peter; Ekmehag, Bjorn; Koul, Bansi; Andersson, Bodil			The International Heart Transplant Survival Algorithm (IHTSA): A New Model to Improve Organ Sharing and Survival	PLOS ONE			English	Article							MORTALITY PREDICTION; UNITED NETWORK; RISK INDEX; DONOR; OUTCOMES; IMPACT; LIMITATIONS; ALLOCATION; REGISTRY; SOCIETY	Background Heart transplantation is life saving for patients with end-stage heart disease. However, a number of factors influence how well recipients and donor organs tolerate this procedure. The main objective of this study was to develop and validate a flexible risk model for prediction of survival after heart transplantation using the largest transplant registry in the world. Methods and Findings We developed a flexible, non-linear artificial neural networks model (IHTSA) and classification and regression tree to comprehensively evaluate the impact of recipient-donor variables on survival over time. We analyzed 56,625 heart-transplanted adult patients, corresponding to 294,719 patient-years. We compared the discrimination power with three existing scoring models, donor risk index (DRI), risk-stratification score (RSS) and index for mortality prediction after cardiac transplantation (IMPACT). The accuracy of the model was excellent (C-index 0.600 [95% CI: 0.595-0.604]) with predicted versus actual 1-year, 5-year and 10-year survival rates of 83.7% versus 82.6%, 71.4% - 70.8%, and 54.8% - 54.3% in the derivation cohort; 83.7% versus 82.8%, 71.5% - 71.1%, and 54.9% - 53.8% in the internal validation cohort; and 84.5% versus 84.4%, 72.9% - 75.6%, and 57.5% - 57.5% in the external validation cohort. The IHTSA model showed superior or similar discrimination in all of the cohorts. The receiver operating characteristic area under the curve to predict one-year mortality was for the IHTSA: 0.650 (95% CI: 0.640-0.655), DRI 0.56 (95% CI: 0.56-0.57), RSS 0.61 (95% CI: 0.60-0.61), and IMPACT 0.61 (0.61-0.62), respectively. The decision-tree showed that recipients matched to a donor younger than 38 years had additional expected median survival time of 2.8 years. Furthermore, the number of suitable donors could be increased by up to 22%. Conclusions We show that the IHTSA model can be used to predict both short-term and long-term mortality with high accuracy globally. The model also estimates the expected benefit to the individual patient.	[Nilsson, Johan; Koul, Bansi] Lund Univ, Dept Clin Sci Lund Cardiothorac Surg, Lund, Sweden; [Nilsson, Johan; Koul, Bansi] Skane Univ Hosp, Dept Clin Sci Lund Cardiothorac Surg, Lund, Sweden; [Ohlsson, Mattias] Lund Univ, Dept Astron & Theoret Phys Computat Biol & Biol P, Lund, Sweden; [Hoglund, Peter] Lund Univ, Competence Ctr Clin Res, Lund, Sweden; [Hoglund, Peter] Skane Univ Hosp, Competence Ctr Clin Res, Lund, Sweden; [Ekmehag, Bjorn] Lund Univ, Dept Clin Sci Lund Cardiol, Lund, Sweden; [Ekmehag, Bjorn] Skane Univ Hosp, Dept Clin Sci Lund Cardiol, Lund, Sweden; [Andersson, Bodil] Lund Univ, Dept Clin Sci Lund Surg, Lund, Sweden; [Andersson, Bodil] Skane Univ, Dept Clin Sci Lund Surg, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Lund University	Nilsson, J (corresponding author), Lund Univ, Dept Clin Sci Lund Cardiothorac Surg, Lund, Sweden.	johan.nilsson@med.lu.se	Höglund, Peter/H-4774-2014; Nilsson, Johan/A-4742-2011	Höglund, Peter/0000-0002-8395-922X; Nilsson, Johan/0000-0001-6860-6090; Ohlsson, Mattias/0000-0003-1145-4297	Swedish National Infrastructure for Computing; Swedish Heart-Lung Foundation; Swedish Society of Medicine; Government grant for clinical research; Region Skane Research Funds; Donation Funds of Lund University Hospital; Crafoord Foundation	Swedish National Infrastructure for Computing; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society of Medicine; Government grant for clinical research; Region Skane Research Funds; Donation Funds of Lund University Hospital; Crafoord Foundation	Funding provided to JN: Swedish National Infrastructure for Computing (http://www.snic.vr.se); JN: Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se); JN: Swedish Society of Medicine (http://www.sls.se); JN: Government grant for clinical research (http://www.skane.se/fou/alf); JN: Region Skane Research Funds (http://www.skane.se/fou); JN: Donation Funds of Lund University Hospital (http://www.skane.se/fou); JN: Crafoord Foundation (http://www.crafoord.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GLOBAL OBSERVATORY D; Ansari D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01922; Anyanwu AC, 1999, EUR J CARDIO-THORAC, V16, P424, DOI 10.1016/S1010-7940(99)00238-9; Biganzoli E, 1998, STAT MED, V17, P1169, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1169::AID-SIM796>3.0.CO;2-D; Breiman L., 1984, CLASSIFICATION REGRE; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Dellgren G, 2013, EUR J HEART FAIL, V15, P308, DOI 10.1093/eurjhf/hfs160; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dickinson DM, 2004, AM J TRANSPLANT, V4, P13, DOI 10.1111/j.1600-6135.2004.00395.x; Dorent R, 2011, J HEART LUNG TRANSPL, V30, P1299, DOI 10.1016/j.healun.2011.06.008; Dronavalli VB, 2010, J AM COLL CARDIOL, V56, P352, DOI 10.1016/j.jacc.2010.02.055; Harrell FE, 2001, REGRESSION MODELING; Hong KN, 2011, ANN THORAC SURG, V92, P520, DOI 10.1016/j.athoracsur.2011.02.086; John R, 2005, SEMIN THORAC CARDIOV, V16, P364; Kattan MW, 1998, COMPUT BIOMED RES, V31, P363, DOI 10.1006/cbmr.1998.1488; Khush KK, 2013, CIRC-HEART FAIL, V6, P300, DOI 10.1161/CIRCHEARTFAILURE.112.000165; Kilic A, 2013, J HEART LUNG TRANSPL, V32, P492, DOI 10.1016/j.healun.2013.02.001; Kilic A, 2012, ANN THORAC SURG, V93, P699, DOI 10.1016/j.athoracsur.2011.09.037; Klein AS, 2010, AM J TRANSPLANT, V10, P973, DOI 10.1111/j.1600-6143.2009.03008.x; Koch A, 2006, THORAC CARDIOV SURG, V54, P414, DOI 10.1055/s-2006-924245; Krakauer H, 2005, J HEART LUNG TRANSPL, V24, P680, DOI 10.1016/j.healun.2004.04.015; Lietz K, 2004, J AM COLL CARDIOL, V43, P1553, DOI 10.1016/j.jacc.2004.02.002; Lippmann RP, 1997, ANN THORAC SURG, V63, P1635, DOI 10.1016/S0003-4975(97)00225-7; Medved D, 2013, STREAMLINING TRANSPL; Nativi JN, 2010, J HEART LUNG TRANSPL, V29, P235, DOI 10.1016/j.healun.2009.05.036; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; OPELZ G, 1994, NEW ENGL J MED, V330, P816, DOI 10.1056/NEJM199403243301203; Patel ND, 2008, CIRCULATION, V118, pS83, DOI 10.1161/CIRCULATIONAHA.107.756866; Pedotti P, 2005, TRANSPLANTATION, V80, P1026, DOI 10.1097/01.tp.0000172215.14630.a1; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; REICHART B, 1992, J HEART LUNG TRANSPL, V11, pS199; Russo MJ, 2007, J THORAC CARDIOV SUR, V133, P554, DOI 10.1016/j.jtcvs.2006.09.019; Russo MJ, 2010, TRANSPLANTATION, V90, P444, DOI 10.1097/TP.0b013e3181e6f1eb; Smits JM, 2012, J HEART LUNG TRANSPL, V31, P387, DOI 10.1016/j.healun.2011.11.005; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Thompson David, 2004, Health Care Manag Sci, V7, P331, DOI 10.1007/s10729-004-7541-3; Weiss ES, 2012, J HEART LUNG TRANSPL, V31, P266, DOI 10.1016/j.healun.2011.10.004; Weiss ES, 2011, ANN THORAC SURG, V92, P914, DOI 10.1016/j.athoracsur.2011.04.030; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69	40	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118644	10.1371/journal.pone.0118644	http://dx.doi.org/10.1371/journal.pone.0118644			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760647	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000033
J	Young, M; Carr, M				Young, Mary; Carr, Mark			Assessment of Habitat Representation across a Network of Marine Protected Areas with Implications for the Spatial Design of Monitoring	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; REEF FISH ASSEMBLAGE; RIPPLED SCOUR DEPRESSIONS; BIOLOGICAL DIVERSITY; MULTIBEAM BATHYMETRY; CONTINENTAL-SHELF; RESERVE NETWORKS; CALIFORNIA; CONSERVATION; SEA	Networks of marine protected areas (MPAs) are being adopted globally to protect ecosystems and supplement fisheries management. The state of California recently implemented a coast-wide network of MPAs, a statewide seafloor mapping program, and ecological characterizations of species and ecosystems targeted for protection by the network. The main goals of this study were to use these data to evaluate how well seafloor features, as proxies for habitats, are represented and replicated across an MPA network and how well ecological surveys representatively sampled fish habitats inside MPAs and adjacent reference sites. Seafloor data were classified into broad substrate categories (rock and sediment) and finer scale geomorphic classifications standard to marine classification schemes using surface analyses (slope, ruggedness, etc.) done on the digital elevation model derived from multibeam bathymetry data. These classifications were then used to evaluate the representation and replication of seafloor structure within the MPAs and across the ecological surveys. Both the broad substrate categories and the finer scale geomorphic features were proportionately represented for many of the classes with deviations of 1-6% and 0-7%, respectively. Within MPAs, however, representation of seafloor features differed markedly from original estimates, with differences ranging up to 28%. Seafloor structure in the biological monitoring design had mismatches between sampling in the MPAs and their corresponding reference sites and some seafloor structure classes were missed entirely. The geomorphic variables derived from multibeam bathymetry data for these analyses are known determinants of the distribution and abundance of marine species and for coastal marine biodiversity. Thus, analyses like those performed in this study can be a valuable initial method of evaluating and predicting the conservation value of MPAs across a regional network.	[Young, Mary; Carr, Mark] Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Young, Mary] Deakin Univ, Ctr Integrat Ecol, Warrnambool, Vic, Australia	University of California System; University of California Santa Cruz; Deakin University	Young, M (corresponding author), Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	mary.young@deakin.edu.au			California Ocean Protection Council; California State Coastal Conservancy; California Department of Fish and Wildlife; NOAA National Marine Sanctuaries; NOAA Office of Coast Survey; Seafloor Mapping Lab at CSUMB; Fugro Pelagos, Inc.; San Diego Office; U. S. Geological Survey; Western Coastal and Marine Geology; Moss Landing Marine Lab; Center for Habitat Studies; Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO) [448]; David and Lucile Packard Foundation; Directorate For Geosciences [1232779] Funding Source: National Science Foundation; Division Of Ocean Sciences [1233839] Funding Source: National Science Foundation	California Ocean Protection Council; California State Coastal Conservancy; California Department of Fish and Wildlife; NOAA National Marine Sanctuaries; NOAA Office of Coast Survey; Seafloor Mapping Lab at CSUMB; Fugro Pelagos, Inc.; San Diego Office; U. S. Geological Survey(United States Geological Survey); Western Coastal and Marine Geology; Moss Landing Marine Lab; Center for Habitat Studies; Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors received no specific funding for this project, but the data used in the study were funded by the following: We thank all the partners in the California State Mapping Program for the funding and collection of the data used in this study (California Ocean Protection Council, California State Coastal Conservancy, California Department of Fish and Wildlife, NOAA National Marine Sanctuaries, NOAA Office of Coast Survey, Seafloor Mapping Lab at CSUMB, Fugro Pelagos, Inc., San Diego Office, U. S. Geological Survey, Western Coastal and Marine Geology, Moss Landing Marine Lab, Center for Habitat Studies). Support and data for this study were provided by the Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO; contribution # 448), a Long-Term Ecological Consortium funded by the David and Lucile Packard Foundation.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Allen LG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P1; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Allison GW, 2003, ECOL APPL, V13, pS8; Bianchi Carlo Nike, 2012, Diversity-Basel, V4, P419, DOI 10.3390/d4040419; Botsford LW, 2014, ADV MARINE IN PRESS; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Brown JH, 2011, P NATL ACAD SCI USA, V108, P11735, DOI 10.1073/pnas.1109139108; California Marine Life Protection Act Initiative, 2008, METH US EV DRAFT MPA; Carr MH, 2011, FRONT ECOL ENVIRON, V9, P342, DOI 10.1890/090096; Carr MH, 2003, ECOL APPL, V13, pS90; Carr MH, ECOSYSTEMS IN PRESS; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; Clarke JEH, 1996, MAR GEOPHYS RES, V18, P607, DOI 10.1007/BF00313877; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J., 2011, MARINE PROTECTED ARE; Cogan CB, 2009, ICES J MAR SCI, V66, P2033, DOI 10.1093/icesjms/fsp214; Conroy MJ, 1996, ECOL APPL, V6, P763, DOI 10.2307/2269481; Copeland A, 2013, J COAST CONSERV, V17, P225, DOI 10.1007/s11852-011-0172-1; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Curley BG, 2002, MAR FRESHWATER RES, V53, P1197, DOI 10.1071/MF01199; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Davis ACD, 2013, CONT SHELF RES, V69, P88, DOI 10.1016/j.csr.2013.09.010; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P39, DOI 10.3354/meps064039; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Gilliland PM, 2008, MAR POLICY, V32, P787, DOI 10.1016/j.marpol.2008.03.022; Gleason M, 2013, OCEAN COAST MANAGE, V74, P90, DOI 10.1016/j.ocecoaman.2012.08.013; Gleason M, 2010, OCEAN COAST MANAGE, V53, P52, DOI 10.1016/j.ocecoaman.2009.12.001; Gleason MG, 2006, FRONT ECOL ENVIRON, V4, P249, DOI 10.1890/1540-9295(2006)004[0249:AGIMCI]2.0.CO;2; GREENE HG, 2004, FISHERIES HABITAT CH; Grorud-Colvert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102298; Hallenbeck TR, 2012, MAR ECOL PROG SER, V468, P119, DOI 10.3354/meps09948; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2012, MAR POLICY, V36, P198, DOI 10.1016/j.marpol.2011.05.004; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Iampietro PJ, 2005, MAR TECHNOL SOC J, V39, P83, DOI 10.4031/002533205787442495; Jagielo T, 2003, FISH B-NOAA, V101, P545; Jordan A, 2005, AQUAT CONSERV, V15, P51, DOI 10.1002/aqc.657; Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121; Kvitek R, 2010, OCEAN GLOBE, P75; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lubchenco J, 2003, ECOL APPL, V13, pS3; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MAPSTONE BD, 1995, ECOL APPL, V5, P401, DOI 10.2307/1942031; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Nasby-Lucas NM, 2002, FISH B-NOAA, V100, P739; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Rees MJ, 2014, DIVERS DISTRIB, V20, P284, DOI 10.1111/ddi.12134; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts DM, 2000, FULLY PROTECTED MARI; Rovere A, 2013, J MAPS, V9, P279, DOI 10.1080/17445647.2013.778081; Rovere A, 2010, J MAPS, V6, P505, DOI 10.4113/jom.2010.1137; Saarman E, 2013, OCEAN COAST MANAGE, V74, P45, DOI 10.1016/j.ocecoaman.2012.08.021; Sobel JA, 2004, MARINE RESERVES GUID; Starr RM, 2010, MAR COAST FISH, V2, P159, DOI 10.1577/C08-056.1; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Ward TJ, 1999, ECOL APPL, V9, P691; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Young MA, 2010, MAR ECOL PROG SER, V415, P247, DOI 10.3354/meps08760	66	18	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116200	10.1371/journal.pone.0116200	http://dx.doi.org/10.1371/journal.pone.0116200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760858	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000002
J	Meng, JX; Mao, JF; Zhao, W; Xing, FQ; Chen, XY; Liu, H; Xing, Z; Wang, XR; Li, Y				Meng, Jingxiang; Mao, Jian-Feng; Zhao, Wei; Xing, Fangqian; Chen, Xinyu; Liu, Hao; Xing, Zhen; Wang, Xiao-Ru; Li, Yue			Adaptive Differentiation in Seedling Traits in a Hybrid Pine Species Complex, Pinus densata and Its Parental Species, on the Tibetan Plateau	PLOS ONE			English	Article							UV-B RADIATION; FROST HARDINESS; BUD SET; SPECIATION; GROWTH; FITNESS; HYBRIDIZATION; PLANTS; DNA; PHYLOGEOGRAPHY	Evidence from molecular genetics demonstrates that Pinus densata is a natural homoploid hybrid originating from the parent species Pinus tabuliformis and Pinus yunnanensis, and ecological selection may have played a role in the speciation of Pinus densata. However, data on differentiation in adaptive traits in the species complex are scarce. In this study, we performed a common garden test on 16 seedling traits to examine the differences between Pinus densata and its parental species in a high altitude environment. We found that among the 16 analyzed traits, 15 were significantly different among the species. Pinus tabuliformis had much earlier bud set and a relatively higher bud set ratio but poorer seedling growth, and Pinus yunnanensis had opposite responses for the same traits. Pinus densata had the greatest fitness with higher viability and growth rates than the parents. The relatively high genetic contribution of seedling traits among populations suggested that within each species the evolutionary background is complex. The correlations between the seedling traits of a population within a species and the environmental factors indicated different impacts of the environment on species evolution. The winter temperature is among the most important climate factors that affected the fitness of the three pine species. Our investigation provides empirical evidence on adaptive differentiation among this pine species complex at seedling stages.	[Meng, Jingxiang; Mao, Jian-Feng; Xing, Fangqian; Chen, Xinyu; Li, Yue] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, State Engn Lab Forest Tree Breeding, Beijing, Peoples R China; [Meng, Jingxiang; Mao, Jian-Feng; Xing, Fangqian; Chen, Xinyu; Li, Yue] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Zhao, Wei] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Liu, Hao; Xing, Zhen] Tibet Univ, Coll Agr & Anim Husb, Coll Resources & Environm, Linzhi, Tibet, Peoples R China; [Wang, Xiao-Ru] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Beijing Forestry University; Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS; Tibet University; Umea University	Wang, XR (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	xiao-ru.wang@emg.umu.se; liyue@bjfu.edu.cn	Mao, Jian-Feng/V-9251-2019; Meng, Jingxiang/F-6727-2019; Wang, Xiao-Ru/H-6811-2012; Wang, Xiao-Ru/AAC-4444-2020	Mao, Jian-Feng/0000-0001-9735-8516; Wang, Xiao-Ru/0000-0002-6150-7046; Wang, Xiao-Ru/0000-0002-6150-7046	Natural Science Foundation of China [31070591]; State Forestry Administration of China of special public-funded project [201104022]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Forestry Administration of China of special public-funded project	This study was supported by grants from the Natural Science Foundation of China (31070591, http://www.nsfc.gov.cn/), and YL is the person who received the funding. This funder play role in study, data collection and analysis. This study was also supported by grants from the State Forestry Administration of China of special public-funded projects (201104022), and YL is the person who received the funding.	Allen PJ, 2010, PASW STAT SPSS PRACT; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], [No title captured]; Arnold ML, 2008, PLANT BIOSYST, V142, P166, DOI 10.1080/11263500701873018; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Blair AC, 2012, EVOL APPL, V5, P17, DOI 10.1111/j.1752-4571.2011.00203.x; BORCHERT R, 1975, PHYSIOL PLANTARUM, V35, P152, DOI 10.1111/j.1399-3054.1975.tb03885.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Burger J, 1996, PLANT CELL PHYSIOL, V37, P395, DOI 10.1093/oxfordjournals.pcp.a028959; Campbell DR, 2007, AM NAT, V169, P298, DOI 10.1086/510758; Campbell LG, 2009, NEW PHYTOL, V184, P806, DOI 10.1111/j.1469-8137.2009.03036.x; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; Day TA, 1996, PLANT CELL ENVIRON, V19, P101, DOI 10.1111/j.1365-3040.1996.tb00231.x; Di XiaoYan, 2009, Bulletin of Botanical Research, V29, P539; ELLIS RH, 1994, ANN BOT-LONDON, V74, P519, DOI 10.1006/anbo.1994.1149; Fenner M, 1985, SEED ECOLOGY; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Gao J, 2012, MOL ECOL, V21, P4811, DOI 10.1111/j.1365-294X.2012.05712.x; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Grant V., 1981, PLANT SPECIATION; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Guo LD, 2008, J INTEGR PLANT BIOL, V50, P997, DOI 10.1111/j.1744-7909.2008.00394.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hu XS, 1999, GENETICS, V152, P441; Hurme P, 1997, CAN J FOREST RES, V27, P716, DOI 10.1139/cjfr-27-5-716; Jin ZZ, 2004, P YUNNANENSIS; Johnston JA, 2003, J ECOL, V91, P438, DOI 10.1046/j.1365-2745.2003.00774.x; Kebreab E, 1999, J EXP BOT, V50, P655, DOI 10.1093/jexbot/50.334.655; Lehmkuhl F, 2005, BOREAS, V34, P87, DOI 10.1080/03009480510012908; Ma F, 2013, ENVIRON EXP BOT, V85, P85, DOI 10.1016/j.envexpbot.2012.08.005; Mao JF, 2011, AM NAT, V177, P424, DOI 10.1086/658905; Mao JF, 2009, EVOL ECOL, V23, P447, DOI 10.1007/s10682-008-9244-6; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Metcalfe DJ, 1997, FUNCT ECOL, V11, P215, DOI 10.1046/j.1365-2435.1997.00070.x; NILSSON JE, 1995, SILVAE GENET, V44, P20; Pinheiro J., 2007, LINEAR NONLINEAR MIX; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rohde A, 2011, TREE PHYSIOL, V31, P472, DOI 10.1093/treephys/tpr038; Savolainen O, 2004, FOREST ECOL MANAG, V197, P79, DOI 10.1016/j.foreco.2004.05.006; Singh A, 1996, CAN J BOT, V74, P135, DOI 10.1139/b96-018; Song BH, 2003, MOL ECOL, V12, P2995, DOI 10.1046/j.1365-294X.2003.01962.x; Song BH, 2002, MOL ECOL, V11, P1057, DOI 10.1046/j.1365-294X.2002.01502.x; Soto A, 2010, MOL ECOL, V19, P1396, DOI 10.1111/j.1365-294X.2010.04571.x; STAFFORD HA, 1994, PLANT SCI, V101, P91, DOI 10.1016/0168-9452(94)90244-5; STAPLETON AE, 1994, PLANT PHYSIOL, V105, P881, DOI 10.1104/pp.105.3.881; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Sun YS, 2014, MOL ECOL, V23, P343, DOI 10.1111/mec.12599; TAKAHASHI A, 1991, PLANT CELL PHYSIOL, V32, P541; TERAMURA AH, 1994, PHOTOSYNTH RES, V39, P463, DOI 10.1007/BF00014599; Tierney DA, 2008, AM J BOT, V95, P146, DOI 10.3732/ajb.95.2.146; Tilman D., 1997, 8 MECH PLANT COMPETI; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang XR, 2001, GENETICS, V159, P337; WANG XR, 1994, EVOLUTION, V48, P1020, DOI 10.1111/j.1558-5646.1994.tb05290.x; Woodall GS, 1998, J EXP BOT, V49, P1447, DOI 10.1093/jexbot/49.325.1447; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang YM, 2010, SHAANXI FOREST SCI T, V4, P1; Zhang YZ, 1990, J BEIJING FORESTRY U, V12, P57; Zhao W, 2014, EVOLUTION, V68, P3120, DOI 10.1111/evo.12496	62	11	12	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118501	10.1371/journal.pone.0118501	http://dx.doi.org/10.1371/journal.pone.0118501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757072	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700022
J	Shankar, J; Nabi, IR				Shankar, Jay; Nabi, Ivan R.			Actin Cytoskeleton Regulation of Epithelial Mesenchymal Transition in Metastatic Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; E-CADHERIN; TUMOR PROGRESSION; GENE-EXPRESSION; RHO; PATHWAY; CARCINOMA; DYNAMICS; INVASION; DISEASE	Epithelial-mesenchymal transition (EMT) is associated with loss of the cell-cell adhesion molecule E-cadherin and disruption of cell-cell junctions as well as with acquisition of migratory properties including reorganization of the actin cytoskeleton and activation of the RhoA GTPase. Here we show that depolymerization of the actin cytoskeleton of various metastatic cancer cell lines with Cytochalasin D (Cyt D) reduces cell size and F-actin levels and induces E-cadherin expression at both the protein and mRNA level. Induction of E-cadherin was dose dependent and paralleled loss of the mesenchymal markers N-cadherin and vimentin. E-cadherin levels increased 2 hours after addition of Cyt D in cells showing an E-cadherin mRNA response but only after 10-12 hours in HT-1080 fibrosarcoma and MDA-MB-231 cells in which E-cadherin mRNA level were only minimally affected by Cyt D. Cyt D treatment induced the nuclear-cytoplasmic translocation of EMT-associated SNAI 1 and SMAD1/2/3 transcription factors. In non-metastatic MCF-7 breast cancer cells, that express E-cadherin and represent a cancer cell model for EMT, actin depolymerization with Cyt D induced elevated E-cadherin while actin stabilization with Jasplakinolide reduced E-cadherin levels. Elevated E-cadherin levels due to Cyt D were associated with reduced activation of Rho A. Expression of dominant-negative Rho A mutant increased and dominant-active Rho A mutant decreased E-cadherin levels and also prevented Cyt D induction of E-cadherin. Reduced Rho A activation downstream of actin remodelling therefore induces E-cadherin and reverses EMT in cancer cells. Cyt D treatment inhibited migration and, at higher concentrations, induced cytotoxicity of both HT-1080 fibrosarcoma cells and normal Hs27 fibroblasts, but only induced mesenchymal-epithelial transition in HT-1080 cancer cells. Our studies suggest that actin remodelling is an upstream regulator of EMT in metastatic cancer cells.	[Shankar, Jay; Nabi, Ivan R.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Nabi, IR (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	irnabi@mail.ubc.ca	Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513	Cancer Research Society grant; Canadian Breast Cancer Foundation Postdoctoral Fellowship; Canadian Cancer Society Research Institute Innovation Grant	Cancer Research Society grant; Canadian Breast Cancer Foundation Postdoctoral Fellowship; Canadian Cancer Society Research Institute Innovation Grant	This work was supported by a Cancer Research Society grant (IRN), a Canadian Breast Cancer Foundation Postdoctoral Fellowship (JS) and a Canadian Cancer Society Research Institute Innovation Grant (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach JR, 2011, P NATL ACAD SCI USA, V108, P17991, DOI 10.1073/pnas.1106499108; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bosco D, 2007, J ENDOCRINOL, V194, P21, DOI 10.1677/JOE-06-0169; Chen YH, 2000, MOL BIOL CELL, V11, P849, DOI 10.1091/mbc.11.3.849; Cho HJ, 2007, CELL BIOL INT, V31, P1225, DOI 10.1016/j.cellbi.2007.04.006; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Gordon MC, 2005, DEV FUTURE TRENDS AN; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Huang FY, 2012, EUR J CANCER, V48, P2260, DOI 10.1016/j.ejca.2011.12.018; Iwaya K, 2007, MODERN PATHOL, V20, P339, DOI 10.1038/modpathol.3800741; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.37; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Newman DJ, 2004, J NAT PROD, V67, P1216, DOI 10.1021/np040031y; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; STEVENSON BR, 1994, J CELL SCI, V107, P367; Su HT, 2013, MOL CANCER RES, V11, P768, DOI 10.1158/1541-7786.MCR-12-0511; Tavares ALP, 2006, DEV DYNAM, V235, P1589, DOI 10.1002/dvdy.20771; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tripathi V, 2014, ONCOGENE, V33, P724, DOI 10.1038/onc.2013.7; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeng QQ, 2012, P NATL ACAD SCI USA, V109, P1127, DOI 10.1073/pnas.1111053108; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	34	96	96	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119954	10.1371/journal.pone.0119954	http://dx.doi.org/10.1371/journal.pone.0119954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756282	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275700055
J	Xu, B; Liu, W; Deng, Y; Yang, TY; Feng, S; Xu, ZF				Xu, Bin; Liu, Wei; Deng, Yu; Yang, Tian-Yao; Feng, Shu; Xu, Zhao-Fa			Inhibition of Calpain Prevents Manganese-Induced Cell Injury and Alpha-Synuclein Oligomerization in Organotypic Brain Slice Cultures	PLOS ONE			English	Article							PARKINSONS-DISEASE; EXPOSURE; AGGREGATION; EXPRESSION; CLEAVAGE; CALCIUM; NEURONS; STRESS; DEATH; RAT	Overexposure to manganese has been known to promote alpha-synuclein oligomerization and enhance cellular toxicity. However, the exact mechanism of Mn-induced alpha-synuclein oligomerization is unclear. To explore whether alpha-synuclein oligomerization was associated with the cleavage of alpha-synuclein by calpain, we made a rat brain slice model of manganism and pretreated slices with calpain inhibitor II, a cell-permeable peptide that restricts the activity of calpain. After slices were treated with 400 mu M Mn for 24 h, there were significant increases in the percentage of apoptotic cells, lactate dehydrogenase release, intracellular [Ca2+](i), calpain activity, and the mRNA and protein expression of calpain 1 and alpha-synuclein. Moreover, the number of C- and N-terminal fragments of alpha-synuclein and the amount of alpha-synuclein oligomerization also increased. These results also showed that calpain inhibitor II pretreatment could reduce Mn-induced nerve cell injury and alpha-synuclein oligomerization. Additionally, there was a significant decrease in the number of C- and N-terminal fragments of alpha-synuclein in calpain inhibitor II-pretreated slices. These findings revealed that Mn induced the cleavage of alpha-synuclein protein via overactivation of calpain and subsequent alpha-synuclein oligomerization in cultured slices. Moreover, the cleavage of alpha-synuclein by calpain 1 is an important signaling event in Mn-induced alpha-synuclein oligomerization.	[Xu, Bin; Liu, Wei; Deng, Yu; Yang, Tian-Yao; Feng, Shu; Xu, Zhao-Fa] China Med Univ, Sch Publ Hlth, Dept Environm Hlth, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Xu, B (corresponding author), China Med Univ, Sch Publ Hlth, Dept Environm Hlth, Shenyang 110001, Liaoning, Peoples R China.	xubin@mail.cmu.edu.cn			National Natural Science Foundation of China [81372942, 81102098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China, Grant no. 81372942 and 81102098, http://www.nsfc.gov.cn/; http://nsfc.biomart.cn/6a4cc8df8; http://nsfc. biomart.cn/73d4080855. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnandis T, 2014, BIOCHEM J, V459, P355, DOI 10.1042/BJ20130847; Boudia N, 2006, SCI TOTAL ENVIRON, V366, P143, DOI 10.1016/j.scitotenv.2005.09.094; BUROKERKILGORE M, 1993, ANAL BIOCHEM, V208, P387, DOI 10.1006/abio.1993.1066; Criswell SR, 2012, OCCUP ENVIRON MED, V69, P437, DOI 10.1136/oemed-2011-100119; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Maria A, 2009, J BIOL CHEM, V284, P13542, DOI 10.1074/jbc.M900561200; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Fabiani G, 2007, ARQ NEURO-PSIQUIAT, V65, P685, DOI 10.1590/S0004-282X2007000400027; Fukushima T, 2010, NEUROEPIDEMIOLOGY, V34, P18, DOI 10.1159/000255462; Hardy IJ, 2008, CURR OPIN CLIN NUTR, V11, P289, DOI 10.1097/MCO.0b013e3282f9e889; He Y, 2011, ASN NEURO, V3, P13, DOI 10.1042/AN20100025; Martinez-Finley EJ, 2013, FREE RADICAL BIO MED, V62, P65, DOI 10.1016/j.freeradbiomed.2013.01.032; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; Mortimer JA, 2012, NEUROLOGY, V79, P1174, DOI 10.1212/WNL.0b013e3182698ced; Ohnishi M, 2010, BRAIN RES, V1347, P170, DOI 10.1016/j.brainres.2010.05.077; Paillusson S, 2010, J NEUROCHEM, V115, P694, DOI 10.1111/j.1471-4159.2010.06962.x; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Prasad K, 2012, BRAIN PATHOL, V22, P811, DOI 10.1111/j.1750-3639.2012.00597.x; Ryan BJ, 2014, FREE RADICAL BIO MED, V67, P58, DOI 10.1016/j.freeradbiomed.2013.10.008; Sakaue M, 2005, TOXICOLOGY, V213, P97, DOI 10.1016/j.tox.2005.05.013; Sidoryk-Wegrzynowicz M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-23; Silverman-Gavrila LB, 2013, J NEUROSCI, V33, P1975, DOI 10.1523/JNEUROSCI.3092-12.2013; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tuschl K, 2013, INT REV NEUROBIOL, V110, P277, DOI 10.1016/B978-0-12-410502-7.00013-2; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Verina T, 2013, TOXICOL LETT, V217, P177, DOI 10.1016/j.toxlet.2012.12.006; VILLALBA M, 1995, NEUROBIOL AGING, V16, P809, DOI 10.1016/0197-4580(95)00087-U; Wan OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038545; Xu B, 2014, MOL NEUROBIOL, V49, P399, DOI 10.1007/s12035-013-8527-2; Xu B, 2013, TOXICOLOGY, V305, P71, DOI 10.1016/j.tox.2013.01.006; Xu B, 2009, NEUROTOXICOLOGY, V30, P941, DOI 10.1016/j.neuro.2009.07.011; Xu LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076657	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119205	10.1371/journal.pone.0119205	http://dx.doi.org/10.1371/journal.pone.0119205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756858	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700040
J	Laukkanen, MO; Cammarota, F; Esposito, T; Salvatore, M; Castellone, MD				Laukkanen, Mikko O.; Cammarota, Francesca; Esposito, Tiziana; Salvatore, Marco; Castellone, Maria D.			Extracellular Superoxide Dismutase Regulates the Expression of Small GTPase Regulatory Proteins GEFs, GAPs, and GDI	PLOS ONE			English	Article							EC-SOD; PANCREATIC-CANCER; DIFFERENTIAL EXPRESSION; BETA-CATENIN; CELL-LINES; GROWTH; KINASE; OVEREXPRESSION; RECEPTOR; THERAPY	Extracellular superoxide dismutase (SOD3), which catalyzes the dismutation of superoxide anions to hydrogen peroxide at the cell membranes, regulates the cellular growth in a dose-dependent manner. This enzyme induces primary cell proliferation and immortalization at low expression levels whereas it activates cancer barrier signaling through the p53-p21 pathway at high expression levels, causing growth arrest, senescence, and apoptosis. Because previous reports suggested that the SOD3-induced reduction in the rates of cellular growth and migration also occurred in the absence of functional p53 signaling, in the current study we investigated the SOD3-induced growth-suppressive mechanisms in anaplastic thyroid cancer cells. Based on our data, the robust over-expression of SOD3 increased the level of phosphorylation of the EGFR, ERBB2, RYK, ALK, FLT3, and EPHA10 receptor tyrosine kinases with the consequent downstream activation of the SRC, FYN, YES, HCK, and LYN kinases. However, pull-down experiments focusing on the small GTPase RAS, RAC, CDC42, and RHO revealed a reduced level of growth and migration signal transduction, such as the lack of stimulation of the mitogen pathway, in the SOD3 over-expressing cells, which was confirmed by MEK1/2 and ERK1/2 Western blotting analysis. Interestingly, the mRNA expression analyses indicated that SOD3 regulated the expression of guanine nucleotide-exchange factors (RHO GEF16, RAL GEF RGL1), GTPase-activating proteins (ARF-GAP ADAP2, RAS GAP RASAL1, RGS4), and a Rho guanine nucleotide-disassociation inhibitor (RHO GDI 2) in a dose dependent manner, thus controlling signaling through the small G protein GTPases. Therefore, our current data may suggest the occurrence of dose-dependent SOD3-driven control of the GTP loading of small G proteins indicating a novel growth regulatory mechanism of this enzyme.	[Laukkanen, Mikko O.; Cammarota, Francesca; Esposito, Tiziana] IRCCS SDN, Naples, Italy; [Salvatore, Marco] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy; [Castellone, Maria D.] CNR, Inst Expt Endocrinol & Oncol IEOS, I-80125 Naples, Italy; [Castellone, Maria D.] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Laukkanen, MO (corresponding author), IRCCS SDN, Naples, Italy.	mlaukkanen@sdn-napoli.it	Laukkanen, Mikko/K-5868-2016; Salvatore, Marco/K-8083-2016	Laukkanen, Mikko/0000-0002-1004-7131; CASTELLONE, MARIADOMENICA/0000-0003-0507-8037; Salvatore, Marco/0000-0001-9734-7702; Cammarota, Francesca/0000-0002-3691-1514	Fondazione SDN [RC2010-M-0001]	Fondazione SDN	This work was supported by Fondazione SDN (decision number RC2010-M-0001, http://www.sdn-napoli.it/).	BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Castellone MD, 2014, ANTIOXID REDOX SIGN, V21, P1460, DOI 10.1089/ars.2013.5475; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; CIARDIELLO F, 1991, P NATL ACAD SCI USA, V88, P7792, DOI 10.1073/pnas.88.17.7792; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; D'Uva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080742; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; Hu LD, 2007, ONCOL REP, V17, P1383; Irani K, 1998, BIOCHEM PHARMACOL, V55, P1339; JIA R, 1992, J VIROL, V66, P5975, DOI 10.1128/JVI.66.10.5975-5987.1992; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kim SH, 2005, ONCOL RES, V15, P333, DOI 10.3727/096504005776449725; Kwon MJ, 2012, ANTIOXID REDOX SIGN, V16, P297, DOI 10.1089/ars.2011.4066; Laatikainen LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024456; Laatikainen LE, 2010, ENDOCR-RELAT CANCER, V17, P785, DOI 10.1677/ERC-10-0021; Laukkanen MO, 2002, CIRCULATION, V106, P1999, DOI 10.1161/01.CIR.0000031331.05368.9D; Laurila JP, 2009, MOL THER, V17, P448, DOI 10.1038/mt.2008.282; Laurila JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005786; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; Nozik-Grayck E, 2008, AM J PHYSIOL-LUNG C, V295, pL422, DOI 10.1152/ajplung.90293.2008; Oliver AW, 2011, BRIT J CANCER, V104, P324, DOI 10.1038/sj.bjc.6606026; Pechlivanis M, 2006, BBA-PROTEINS PROTEOM, V1764, P1914, DOI 10.1016/j.bbapap.2006.09.017; Pesse B, 2005, J MOL CELL CARDIOL, V38, P765, DOI 10.1016/j.yjmcc.2005.02.020; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Sibenaller ZA, 2014, FREE RADICAL BIO MED, V69, P357, DOI 10.1016/j.freeradbiomed.2014.02.002; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; Song Y, 2007, J CLIN ENDOCR METAB, V92, P3764, DOI 10.1210/jc.2007-0660; Svensk AM, 2004, AM J CLIN PATHOL, V122, P395, DOI 10.1309/A45QHB0QRRX6CT9A; Tanaka M, 2001, GENE THER, V8, P149, DOI 10.1038/sj.gt.3301362; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Teoh ML, 2007, CLIN CANCER RES, V13, P7441, DOI 10.1158/1078-0432.CCR-07-0851; Teoh MLT, 2009, CANCER RES, V69, P6355, DOI 10.1158/0008-5472.CAN-09-1195; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Timeus F, 2001, LAB INVEST, V81, P1025, DOI 10.1038/labinvest.3780314; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Wheeler MD, 2003, MOL CANCER RES, V1, P871	48	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0121441	10.1371/journal.pone.0121441	http://dx.doi.org/10.1371/journal.pone.0121441			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751262	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700039
J	Viljoen, KS; Dakshinamurthy, A; Goldberg, P; Blackburn, JM				Viljoen, Katie S.; Dakshinamurthy, Amirtha; Goldberg, Paul; Blackburn, Jonathan M.			Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESCHERICHIA-COLI; ENTEROCOCCUS-FAECALIS; MLH1 METHYLATION; DNA METHYLATION; IN-VIVO; CARCINOGENESIS; QUANTIFICATION; TUMORIGENESIS; COLONIZATION	Various studies have presented clinical or in vitro evidence linking bacteria to colorectal cancer, but these bacteria have not previously been concurrently quantified by qPCR in a single cohort. We quantify these bacteria (Fusobacterium spp., Streptococcus gallolyticus, Enterococcus faecalis, Enterotoxigenic Bacteroides fragilis (ETBF), Enteropathogenic Escherichia coli (EPEC), and afaC- or pks-positive E. coli) in paired tumour and normal tissue samples from 55 colorectal cancer patients. We further investigate the relationship between a) the presence and b) the level of colonisation of each bacterial species with site and stage of disease, age, gender, ethnicity and MSI-status. With the exception of S. gallolyticus, we detected all bacteria profiled here in both tumour and normal samples at varying frequencies. ETBF (FDR = 0.001 and 0.002 for normal and tumour samples) and afaC-positive E. coli (FDR = 0.03, normal samples) were significantly enriched in the colon compared to the rectum. ETBF (FDR = 0.04 and 0.002 for normal and tumour samples, respectively) and Fusobacterium spp. (FDR = 0.03 tumour samples) levels were significantly higher in late stage (III/IV) colorectal cancers. Fusobacterium was by far the most common bacteria detected, occurring in 82% and 81% of paired tumour and normal samples. Fusobacterium was also the only bacterium that was significantly higher in tumour compared to normal samples (p = 6e-5). We also identified significant associations between high-level colonisation by Fusobacterium and MSI-H (FDR = 0.05), age (FDR = 0.03) or pks-positive E. coli (FDR = 0.01). Furthermore, we exclusively identified atypical EPEC in our cohort, which has not been previously reported in association with colorectal cancer. By quantifying colorectal cancer-associated bacteria across a single cohort, we uncovered inter-and intra-individual patterns of colonization not previously recognized, as well as important associations with clinicopathological features, especially in the case of Fusobacterium and ETBF.	[Viljoen, Katie S.; Dakshinamurthy, Amirtha; Blackburn, Jonathan M.] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Goldberg, Paul] Groote Schuur Hosp, Surg Gastroenterol Unit, Dept Surg, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Blackburn, JM (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Med Biochem, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	jonathan.blackburn@uct.ac.za		Goldberg, Paul/0000-0003-1612-7519	Cancer Association of South Africa	Cancer Association of South Africa	This study was supported by the Cancer Association of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulamir AS, 2010, MOL CANCER, V9, P1, DOI [10.1186/1476-4598-9-1, DOI 10.1186/1476-4598-9-1]; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x; Balish E, 2002, AM J PATHOL, V160, P2253, DOI 10.1016/S0002-9440(10)61172-8; Bettstetter M, 2007, CLIN CANCER RES, V13, P3221, DOI 10.1158/1078-0432.CCR-06-3064; Biarc J, 2004, CARCINOGENESIS, V25, P1477, DOI 10.1093/carcin/bgh091; Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609; Bonnet M, 2014, CLIN CANCER RES, V20, P859, DOI 10.1158/1078-0432.CCR-13-1343; BREMNER CG, 1970, CANCER, V26, P991, DOI 10.1002/1097-0142(197011)26:5<991::AID-CNCR2820260505>3.0.CO;2-J; Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964; CAMPBELL BJ, 2003, GLYCOCONJUGATE J, V18, P851; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Corredoira-Sanchez J, 2012, CLIN INFECT DIS, V55, P491, DOI 10.1093/cid/cis434; Cronje L, 2009, SAMJ S AFR MED J, V99, P103; Cronje L, 2009, S AFR J SCI, V105, P68, DOI 10.1590/s0038-23532009000100023; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Cummins J, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-11; Degiannis E, 1995, Trop Gastroenterol, V16, P55; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Dutilh BE, 2013, BEST PRACT RES CL GA, V27, P85, DOI 10.1016/j.bpg.2013.03.008; Ellmerich S, 2000, CARCINOGENESIS, V21, P753, DOI 10.1093/carcin/21.4.753; Fitzhenry RJ, 2002, GUT, V50, P180, DOI 10.1136/gut.50.2.180; Gebert J, 2012, HISTOCHEM CELL BIOL, V138, P339, DOI 10.1007/s00418-012-0957-9; Gupta A, 2010, COLORECTAL DIS, V12, P164, DOI 10.1111/j.1463-1318.2009.01814.x; Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Jass Jeremy R, 2004, Fam Cancer, V3, P93; Kaz A, 2007, INT J CANCER, V120, P1922, DOI 10.1002/ijc.22544; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kostic AD, 2013, CANCER IMMUNOL RES, V1, P150, DOI 10.1158/2326-6066.CIR-13-0101; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Lindor BNM, 2002, IMMUNOHISTOCHEMISTRY, V20, P1043; Loukola A, 2001, CANCER RES, V61, P4545; Machado AMD, 2010, BBA-REV CANCER, V1806, P58, DOI 10.1016/j.bbcan.2010.01.007; Maddocks ODK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005517; Maddocks ODK, 2013, MBIO, V4, DOI 10.1128/mBio.00152-13; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; McCoy WC, 1951, J MED ASS STATE ALAB, V21; Miquel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012714; Mundy R, 2007, MICROBIOL-SGM, V153, P959, DOI 10.1099/mic.0.2006/003467-0; Ollikainen M, 2007, ONCOGENE, V26, P4541, DOI 10.1038/sj.onc.1210236; Parsons MT, 2012, J MED GENET, V49, P151, DOI 10.1136/jmedgenet-2011-100714; Patil DT, 2012, MODERN PATHOL, V25, P1423, DOI 10.1038/modpathol.2012.98; Phillips AD, 2000, GUT, V47, P377, DOI 10.1136/gut.47.3.377; Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Sedgley CM, 2005, ARCH ORAL BIOL, V50, P575, DOI 10.1016/j.archoralbio.2004.10.017; Speake D, 2011, INT J SURG ONCOL, V2011, DOI 10.1155/2011/653163; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vogelmann R, 2007, CURR OPIN MICROBIOL, V10, P76, DOI 10.1016/j.mib.2006.12.004; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wheeler JMD, 2000, J MED GENET, V37, P588, DOI 10.1136/jmg.37.8.588; Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang GM, 1999, CLIN INFECT DIS, V29, P590, DOI 10.1086/598639; Zhang J, 2006, CANCER RES, V66, P659, DOI 10.1158/0008-5472.CAN-05-4043; Zhang XH, 2013, J MED MICROBIOL, V62, P1665, DOI 10.1099/jmm.0.054551-0	71	132	137	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119462	10.1371/journal.pone.0119462	http://dx.doi.org/10.1371/journal.pone.0119462			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751261	Green Published, gold, Green Submitted			2022-12-27	WOS:000350692700023
J	Bird, CW; Candelaria-Cook, FT; Magcalas, CM; Davies, S; Valenzuela, CF; Savage, DD; Hamilton, DA				Bird, Clark W.; Candelaria-Cook, Felicha T.; Magcalas, Christy M.; Davies, Suzy; Valenzuela, C. Fernando; Savage, Daniel D.; Hamilton, Derek A.			Moderate Prenatal Alcohol Exposure Enhances GluN2B Containing NMDA Receptor Binding and Ifenprodil Sensitivity in Rat Agranular Insular Cortex	PLOS ONE			English	Article							LONG-TERM-POTENTIATION; INDUCED LEARNING-DEFICITS; ETHANOL EXPOSURE; FETAL ALCOHOL; SOCIAL-BEHAVIOR; SYNAPTIC PLASTICITY; SEX-DIFFERENCES; SPECTRUM DISORDERS; SUBUNIT EXPRESSION; NUCLEUS-ACCUMBENS	Prenatal exposure to alcohol affects the expression and function of glutamatergic neurotransmitter receptors in diverse brain regions. The present study was undertaken to fill a current gap in knowledge regarding the regional specificity of ethanol-related alterations in glutamatergic receptors in the frontal cortex. We quantified subregional expression and function of glutamatergic neurotransmitter receptors (AMPARs, NMDARs, GluN2B-containing NMDARs, mGluR1s, and mGluR5s) by radioligand binding in the agranular insular cortex (AID), lateral orbital area (LO), prelimbic cortex (PrL) and primary motor cortex (M1) of adult rats exposed to moderate levels of ethanol during prenatal development. Increased expression of GluN2B-containing NMDARs was observed in AID of ethanol-exposed rats compared to modest reductions in other regions. We subsequently performed slice electrophysiology measurements in a whole-cell patch-clamp preparation to quantify the sensitivity of evoked NMDAR-mediated excitatory postsynaptic currents (EPSCs) in layer II/III pyramidal neurons of AID to the GluN2B negative allosteric modulator ifenprodil. Consistent with increased GluN2B expression, ifenprodil caused a greater reduction in NMDAR-mediated EPSCs from prenatal alcohol-exposed rats than saccharin-exposed control animals. No alterations in AMPAR-mediated EPSCs or the ratio of AMPARs/NMDARs were observed. Together, these data indicate that moderate prenatal alcohol exposure has a significant and lasting impact on GluN2B-containing receptors in AID, which could help to explain ethanol-related alterations in learning and behaviors that depend on this region.	[Bird, Clark W.; Magcalas, Christy M.; Hamilton, Derek A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Davies, Suzy; Valenzuela, C. Fernando; Savage, Daniel D.; Hamilton, Derek A.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Hamilton, DA (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	dahamilt@unm.edu	Hamilton, Derek A/H-4447-2013	Hamilton, Derek A/0000-0001-7021-3288; Bird, Clark/0000-0001-7712-6531; Candelaria-Cook, Felicha/0000-0002-1416-9099	National Institutes of Health [R01 AA019462, R01 AA019884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019884, R01AA019462, T32AA014127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by National Institutes of Health (www.nih.gov) grants R01 AA019462 to DAH and R01 AA019884 to DDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Allan AM, 1997, ALCOHOL CLIN EXP RES, V21, P1534; Allan AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096200; AUTTIRAMO I, 1991, NEUROPEDIATRICS, V22, P59, DOI 10.1055/s-2008-1071418; Badanich KA, 2013, NEUROPSYCHOPHARMACOL, V38, P1176, DOI 10.1038/npp.2013.12; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bellinger FP, 2002, DEV BRAIN RES, V136, P77, DOI 10.1016/S0165-3806(02)00363-2; Boulougouris V, 2007, BEHAV BRAIN RES, V179, P219, DOI 10.1016/j.bbr.2007.02.005; Brady ML, 2013, J NEUROSCI, V33, P1062, DOI 10.1523/JNEUROSCI.1217-12.2013; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Fabio MC, 2013, PHARMACOL BIOCHEM BE, V103, P842, DOI 10.1016/j.pbb.2012.12.009; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P273; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P529; Chasnoff IJ, 2010, J DEV BEHAV PEDIATR, V31, P192, DOI 10.1097/DBP.0b013e3181d5a4e2; Clayton DA, 2002, J NEUROSCI, V22, P3628; Colvin L, 2007, ALCOHOL CLIN EXP RES, V31, P276, DOI 10.1111/j.1530-0277.2006.00303.x; CONRY J, 1990, ALCOHOL CLIN EXP RES, V14, P650, DOI 10.1111/j.1530-0277.1990.tb01222.x; Costa ET, 2000, J BIOL CHEM, V275, P38268, DOI 10.1074/jbc.M004136200; Croxford J, 1999, S AFR MED J, V89, P962; DAY NL, 1993, CLIN OBSTET GYNECOL, V36, P232, DOI 10.1097/00003081-199306000-00005; DeCoteau WE, 1997, BEHAV BRAIN RES, V88, P239, DOI 10.1016/S0166-4328(97)00044-2; Dettmer TS, 2003, ALCOHOL CLIN EXP RES, V27, P677, DOI 10.1097/01.ALC.0000060521.32215.E9; Diaz MR, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00046; DiazGranados JL, 1997, ALCOHOL CLIN EXP RES, V21, P874, DOI 10.1097/00000374-199708000-00016; Duncan GE, 2009, BRAIN RES, V1265, P186, DOI 10.1016/j.brainres.2009.02.002; Duncan GE, 2004, BEHAV BRAIN RES, V153, P507, DOI 10.1016/j.bbr.2004.01.008; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; Frizelle PA, 2006, MOL PHARMACOL, V70, P1022, DOI 10.1124/mol.106.024042; Gabbott PLA, 2003, BRAIN RES, V993, P59, DOI 10.1016/j.brainres.2003.08.056; Garcia-Algar O, 2008, THER DRUG MONIT, V30, P249, DOI 10.1097/FTD.0b013e31816a8657; GOODLETT CR, 1995, NEUROBIOL LEARN MEM, V64, P265, DOI 10.1006/nlme.1995.0009; Grant TM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.871; Hamilton DA, 2003, BEHAV BRAIN RES, V143, P85, DOI 10.1016/S0166-4328(03)00028-7; Hamilton DA, 2014, BEHAV BRAIN RES, V269, P44, DOI 10.1016/j.bbr.2014.04.029; Hamilton DA, 2010, BEHAV BRAIN RES, V214, P66, DOI 10.1016/j.bbr.2010.05.048; Hamilton DA, 2010, BEHAV BRAIN RES, V207, P290, DOI 10.1016/j.bbr.2009.10.012; HANNIGAN JH, 1991, NEUROTOXICOL TERATOL, V13, P649, DOI 10.1016/0892-0362(91)90049-3; HASHIMOTO K, 1994, EUR J PHARM-MOLEC PH, V266, P67, DOI 10.1016/0922-4106(94)90211-9; Honse Y, 2003, ALCOHOL CLIN EXP RES, V27, P1993, DOI 10.1097/01.ALC.0000099029.55026.C6; Honse Y, 2003, NEUROSCIENCE, V122, P689, DOI 10.1016/S0306-4522(03)00603-1; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hughes PD, 1998, ALCOHOL CLIN EXP RES, V22, P1255, DOI 10.1111/j.1530-0277.1998.tb03906.x; Hughes PD, 2001, DEV BRAIN RES, V129, P135, DOI 10.1016/S0165-3806(01)00192-4; Incerti M, 2010, OBSTET GYNECOL, V115, P350, DOI 10.1097/AOG.0b013e3181cb59da; Jacobs SA, 2014, GENES BRAIN BEHAV, V13, P376, DOI 10.1111/gbb.12123; Jacobs SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036387; Kelly SJ, 1997, NEUROTOXICOL TERATOL, V19, P383, DOI 10.1016/S0892-0362(97)00064-0; KELLY SJ, 1994, NEUROTOXICOL TERATOL, V16, P377, DOI 10.1016/0892-0362(94)90026-4; Kelly SJ, 2000, NEUROTOXICOL TERATOL, V22, P143, DOI 10.1016/S0892-0362(99)00073-2; Kesner RP, 2007, NEUROBIOL LEARN MEM, V88, P82, DOI 10.1016/j.nlm.2007.02.002; Kim SM, 2014, DRUG ALCOHOL DEPEN, V141, P124, DOI 10.1016/j.drugalcdep.2014.05.017; Kodituwakku PW, 2007, NEUROSCI BIOBEHAV R, V31, P192, DOI 10.1016/j.neubiorev.2006.06.020; Kristjanson AF, 2007, ALCOHOL CLIN EXP RES, V31, P299, DOI 10.1111/j.1530-0277.2006.00315.x; Lawrence RC, 2012, NEUROTOXICOL TERATOL, V34, P128, DOI 10.1016/j.ntt.2011.08.002; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; LUNDQUIST F, 1959, BIOCHEM J, V72, P409, DOI 10.1042/bj0720409; Mameli M, 2005, J NEUROSCI, V25, P8027, DOI 10.1523/JNEUROSCI.2434-05.2005; Marchetta Claire M., 2012, Morbidity and Mortality Weekly Report, V61, P534; Mattson SN, 2013, ALCOHOL CLIN EXP RES, V37, P517, DOI 10.1111/j.1530-0277.2012.01952.x; Mattson SN, 1999, J INT NEUROPSYCH SOC, V5, P462, DOI 10.1017/S1355617799555082; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; May PA, 2011, INT J ENV RES PUB HE, V8, P2331, DOI 10.3390/ijerph8062331; McGivern RF, 1998, ALCOHOL CLIN EXP RES, V22, P868, DOI 10.1097/00000374-199806000-00015; Middleton FA, 2012, DEV NEUROSCI-BASEL, V34, P115, DOI 10.1159/000337858; Miguez HA, 2009, ACTA PSIQUIAT PSICOL, V55, P76; Mihalick SM, 2001, NEUROTOXICOL TERATOL, V23, P453, DOI 10.1016/S0892-0362(01)00168-4; MOLINA JC, 1987, NEUROTOXICOL TERATOL, V9, P121, DOI 10.1016/0892-0362(87)90088-2; Montaron MF, 1996, NEUROSCIENCE, V71, P371, DOI 10.1016/0306-4522(95)00455-6; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mooney SM, 2011, BEHAV BRAIN RES, V216, P358, DOI 10.1016/j.bbr.2010.08.014; Moraes CL, 2007, REV SAUDE PUBL, V41, P695, DOI 10.1590/S0034-89102007000500002; Naseer MI, 2014, NEUROL SCI, V35, P1681, DOI 10.1007/s10072-014-1812-7; Nguyen TT, 2013, NEUROTOXICOL TERATOL, V35, P14, DOI 10.1016/j.ntt.2012.11.003; Nixon K, 2004, ALCOHOL CLIN EXP RES, V28, P105, DOI 10.1097/01.ALC.0000106311.88523.7B; Nizhnikov ME, 2014, ALCOHOL CLIN EXP RES, V38, P1630, DOI 10.1111/acer.12416; Osborn JA, 1998, ALCOHOL CLIN EXP RES, V22, P685, DOI 10.1097/00000374-199805000-00021; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Patten AR, 2013, NEUROSCI LETT, V551, P7, DOI 10.1016/j.neulet.2013.05.051; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Peadon E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-584; Pinheiro SN, 2005, REV SAUDE PUBL, V39, P593, DOI 10.1590/S0034-89102005000400012; Rema V, 1999, J NEUROSCI, V19, P10993, DOI 10.1523/JNEUROSCI.19-24-10993.1999; Rice JP, 2014, ALCOHOL CLIN EXP RES, V38, p112A; Rice JP, 2012, ALCOHOL, V46, P577, DOI 10.1016/j.alcohol.2011.11.008; Riebe I, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-14; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Roebuck-Spencer TM, 2004, J INT NEUROPSYCH SOC, V10, P536, DOI 10.1017/S1355617704104116; Samudio-Ruiz SL, 2010, ALCOHOL CLIN EXP RES, V34, P342, DOI 10.1111/j.1530-0277.2009.01096.x; Savage DD, 2010, ALCOHOL CLIN EXP RES, V34, P1793, DOI 10.1111/j.1530-0277.2010.01266.x; SAVAGE DD, 1991, ALCOHOL, V8, P193, DOI 10.1016/0741-8329(91)90806-8; Shea KM, 2012, BEHAV PHARMACOL, V23, P105, DOI 10.1097/FBP.0b013e32834ed866; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sickmann HM, 2014, HIPPOCAMPUS, V24, P54, DOI 10.1002/hipo.22203; Simmons RW, 2010, ALCOHOL, V44, P371, DOI 10.1016/j.alcohol.2010.02.013; Sinai L, 2012, GENES BRAIN BEHAV, V11, P559, DOI 10.1111/j.1601-183X.2012.00775.x; Sliwowska JH, 2014, ALCOHOL CLIN EXP RES, V38, P152, DOI 10.1111/acer.12224; Smith MD, 2002, NEUROSCIENCE, V109, P517, DOI 10.1016/S0306-4522(01)00490-0; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961; Toso L, 2006, AM J OBSTET GYNECOL, V194, P681, DOI 10.1016/j.ajog.2006.01.003; Toso L, 2005, AM J OBSTET GYNECOL, V193, P1534, DOI 10.1016/j.ajog.2005.02.105; Tunc-Ozcan E, 2013, ALCOHOL CLIN EXP RES, V37, P1986, DOI 10.1111/acer.12183; VACCARINO FM, 1992, MOL BRAIN RES, V12, P233, DOI 10.1016/0169-328X(92)90089-T; Valenzuela CF, 2012, TRENDS NEUROSCI, V35, P284, DOI 10.1016/j.tins.2012.01.006; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Varaschin RK, 2014, ALCOHOL CLIN EXP RES, V38, P1902, DOI 10.1111/acer.12430; Varaschin RK, 2010, J PHARMACOL EXP THER, V334, P191, DOI 10.1124/jpet.109.165027; Walker MJ, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-52; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wang HY, 2013, BRAIN RES, V1520, P36, DOI 10.1016/j.brainres.2013.04.054; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; WEINBERG J, 1992, ALCOHOL, V9, P219, DOI 10.1016/0741-8329(92)90057-H; Wenzel A, 1997, J NEUROCHEM, V68, P469; WHISHAW IQ, 1983, PHYSIOL BEHAV, V30, P471, DOI 10.1016/0031-9384(83)90154-3; WHISHAW IQ, 1989, BEHAV BRAIN RES, V32, P101, DOI 10.1016/S0166-4328(89)80078-6; Williams L, 2014, ALCOHOL CLIN EXP RES, V38, P116, DOI 10.1111/acer.12225; Xiang XJ, 2011, BEHAV BRAIN RES, V222, P326, DOI 10.1016/j.bbr.2011.03.068; Zamzow DR, 2013, J NEUROSCI, V33, P12300, DOI 10.1523/JNEUROSCI.0312-13.2013; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zhou R, 2010, NEUROSCIENCE, V170, P749, DOI 10.1016/j.neuroscience.2010.07.055; ZIMMERBERG B, 1990, BRAIN RES, V537, P115, DOI 10.1016/0006-8993(90)90347-E	124	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118721	10.1371/journal.pone.0118721	http://dx.doi.org/10.1371/journal.pone.0118721			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747876	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400026
J	Buchacz, K; Chen, MJ; Parisi, MK; Yoshida-Cervantes, M; Antunez, E; Delgado, V; Moss, NJ; Scheer, S				Buchacz, Kate; Chen, Miao-Jung; Parisi, Maree Kay; Yoshida-Cervantes, Maya; Antunez, Erin; Delgado, Viva; Moss, Nicholas J.; Scheer, Susan			Using HIV Surveillance Registry Data to Re-Link Persons to Care: The RSVP Project in San Francisco	PLOS ONE			English	Article							NEW-YORK-CITY; UNITED-STATES; ANTIRETROVIRAL THERAPY; PUBLIC-HEALTH; MEDICAL-CARE; PREVENTION; ENGAGEMENT; RETENTION; SUPPRESSION; INFECTION	Background Persons with unsuppressed HIV viral load (VL) who disengage from care may experience poor clinical outcomes and potentially transmit HIV. We assessed the feasibility and yield of using the San Francisco Department of Public Health (SFDPH) enhanced HIV surveillance system (eHARS) to identify and re-engage such persons in care. Methods Using SFDPH eHARS data as of 4/20/2012 (index date), we selected HIV-infected adults who were alive, had no reported VL or CD4 cell count results in the past nine months (proxy for "out-of-care") and a VL > 200 copies/mL drawn nine to 15 months earlier. We prioritized cases residing locally for investigation, and used information from eHARS and medical and public health databases to contact them for interview and referral to the SFDPH linkage services (LINCS). Twelve months later, we matched-back to eHARS data to assess how HIV laboratory reporting delays affected original eligibility, and if persons had any HIV laboratory results performed and reported within 12 months after index date ('new labs'). Results Among 434 eligible persons, 282 were prioritized for investigation, of whom 75 (27%) were interviewed, 79 (28%) could not be located, and 48 (17%) were located out of the area. Among the interviewed, 54 (72%) persons accepted referral to LINCS. Upon match-back to eHARS data, 324 (75%) in total were confirmed as eligible, including 221 (78%) of the investigated; most had new labs. Conclusions Among the investigated persons presumed out-of-care, we interviewed and offered LINCS referral to about one-quarter, demonstrating the feasibility but limited yield of our project. Matching to updated surveillance data revealed that a substantial minority did not disengage from care and that most re-engaged in HIV care. Verifying persons' HIV care status with medical providers and improving timeliness of transfer and cross-jurisdictional sharing of HIV laboratory data may aid future efforts.	[Buchacz, Kate] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Chen, Miao-Jung; Parisi, Maree Kay; Yoshida-Cervantes, Maya; Antunez, Erin; Delgado, Viva; Scheer, Susan] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; [Moss, Nicholas J.] Alameda Cty Publ Hlth Dept, Oakland, CA USA	Centers for Disease Control & Prevention - USA; San Francisco Department of Public Health	Scheer, S (corresponding author), San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA.	Susan.Scheer@sfdph.org			Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention (CDC) provides funding to the San Francisco Department of Public Health and to other state and local health departments in the United States to conduct surveillance of HIV disease in accordance with their own disease reporting regulations. CDC provides technical guidance for the collection of data by the state and local health departments and data are sent to CDC for national-level analyses. Aside from CDC's support to surveillance of HIV disease, the authors received no specific funding for this work. Role of the Sponsors: The CDC reviewed and approved final submission but the findings and conclusions in this report are those of the authors and do not necessarily represent the views of the CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Bureau of AIDS Tuberculosis and Sexually Transmitted Infections Department of Disease Control Ministry of Public Health, 2019, THAIL NAT GUID HIV A; Buskin S. E., 2011, J HIV AIDS SURVEILLA, V3, P3; Buskin SE, 2014, SEX TRANSM DIS, V41, P35, DOI 10.1097/OLQ.0000000000000072; California Department of Public Health Office of AIDS, 2011, HIV AIDS CAS REP; California Department of Public Health Office of AIDS, 2013, CONT HIV CAR CAL; Centers for Disease Control and Prevention, 2010, DIST PUBL HLTH RES P; Centers for Disease Control and Prevention, 2003, GUIDANCE CDC DEP HLT, V52, P12; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; *DEP HLTH HUM SERV, 2008, GUID US ANT AG HIV I; Department of Health and Human Services, 2013, GUID US ANT AG HIV I; Department of Health and Human Services, 2013, HIV AIDS BUR HAB HIV; Department of Health and Human Services, 2011, HIGH IMP HIV PREV CD; Dombrowski JC, 2012, AIDS, V26, P77, DOI 10.1097/QAD.0b013e32834dcee9; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; El-Sadr WM, 2010, JAIDS-J ACQ IMM DEF, V55, pS116, DOI 10.1097/QAI.0b013e3181fbca6e; Fairchild AL, 2011, NEW ENGL J MED, V365, P685, DOI 10.1056/NEJMp1107294; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner EM, 2013, COLARADO J INT ASS P, V12, P384, DOI DOI 10.1177/2325957413500532; Gardner LI, 2012, CLIN INFECT DIS, V55, P1124, DOI 10.1093/cid/cis623; Hall HI, 2007, J PUBLIC HEALTH MAN, V13, P519; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS31, DOI 10.1089/apc.2011.9878; Hsu LC, 2011, AIDS CARE, V23, P383, DOI 10.1080/09540121.2010.507740; Magnus M, 2012, INT J MED INFORM, V81, pE30, DOI 10.1016/j.ijmedinf.2012.06.005; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Muthulingam D, 2013, JAIDS-J ACQ IMM DEF, V63, P112, DOI 10.1097/QAI.0b013e3182894555; Office of National AIDS Policy, 2013, NAT HIV AIDS STRAT U; Project Inform, 2012, US SURV OTH DAT IMPR; San Francisco Department of Public Health, 2012, HIV AIDS EP ANN REP; San Francisco Department of Public Health, 2014, LINK INT NAV COMPR S; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Sweeney P, 2013, MILBANK Q, V91, P558, DOI 10.1111/milq.12018; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Udeagu CC, 2012, J INT AIDS SOC, V15, P146; Udeagu CCN, 2013, AIDS, V27, P2271, DOI 10.1097/QAD.0b013e328362fdde; Valdiserri RO, 2013, PUBLIC HEALTH REP, V128, P12; Wohl AR, 2011, AIDS CARE, V23, P988, DOI 10.1080/09540121.2010.542125	44	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118923	10.1371/journal.pone.0118923	http://dx.doi.org/10.1371/journal.pone.0118923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25748668	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400031
J	Carr-Harris, C; Gottesfeld, AS; Moore, JW				Carr-Harris, Charmaine; Gottesfeld, Allen S.; Moore, Jonathan W.			Juvenile Salmon Usage of the Skeena River Estuary	PLOS ONE			English	Article							CHINOOK SALMON; SOCKEYE-SALMON; BRITISH-COLUMBIA; INDIVIDUAL IDENTIFICATION; STOCK COMPOSITION; MARINE MORTALITY; PACIFIC SALMON; PUGET-SOUND; CHUM SALMON; PINK SALMON	Migratory salmon transit estuary habitats on their way out to the ocean but this phase of their life cycle is more poorly understood than other phases. The estuaries of large river systems in particular may support many populations and several species of salmon that originate from throughout the upstream river. The Skeena River of British Columbia, Canada, is a large river system with high salmon population-and species-level diversity. The estuary of the Skeena River is under pressure from industrial development, with two gas liquefaction terminals and a potash loading facility in various stages of environmental review processes, providing motivation for understanding the usage of the estuary by juvenile salmon. We conducted a juvenile salmonid sampling program throughout the Skeena River estuary in 2007 and 2013 to investigate the spatial and temporal distribution of different species and populations of salmon. We captured six species of juvenile anadromous salmonids throughout the estuary in both years, and found that areas proposed for development support some of the highest abundances of some species of salmon. Specifically, the highest abundances of sockeye (both years), Chinook in 2007, and coho salmon in 2013 were captured in areas proposed for development. For example, juvenile sockeye salmon were 2-8 times more abundant in the proposed development areas. Genetic stock assignment demonstrated that the Chinook salmon and most of the sockeye salmon that were captured originated from throughout the Skeena watershed, while some sockeye salmon came from the Nass, Stikine, Southeast Alaska, and coastal systems on the northern and central coasts of British Columbia. These fish support extensive commercial, recreational, and First Nations fisheries throughout the Skeena River and beyond. Our results demonstrate that estuary habitats integrate species and population diversity of salmon, and that if proposed development negatively affects the salmon populations that use the estuary, then numerous fisheries would also be negatively affected.	[Carr-Harris, Charmaine; Gottesfeld, Allen S.] Skeena Fisheries Commiss, Kispiox, BC, Canada; [Carr-Harris, Charmaine; Moore, Jonathan W.] Simon Fraser Univ, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Carr-Harris, C (corresponding author), Skeena Fisheries Commiss, 3135 Barnes Crescent, Kispiox, BC, Canada.	ccarrharris@gmail.com			Lax Kw'alaams Fisheries Program; Liber Ero Foundation; Simon Fraser University; Mitacs; SkeenaWild Conservation Trust	Lax Kw'alaams Fisheries Program; Liber Ero Foundation; Simon Fraser University; Mitacs; SkeenaWild Conservation Trust	Financial support for this project was provided by: Lax Kw'alaams Fisheries Program to CCH (http://www.laxkwalaams.ca/corporate/index.php?page=fishery), Liber Ero Foundation to JWM, Simon Fraser University to JWM (http://www.sfu.ca), Mitacs to CCH (http://www.mitacs.ca/), and SkeenaWild Conservation Trust to JWM and CCH (http://skeenawild.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argue AW, 2005, CAN TECH REP FISH AQ, V2601; Barraclough WE, 1978, DISTRIBUTION JUVENIL, P826; BAX NJ, 1983, CAN J FISH AQUAT SCI, V40, P426, DOI 10.1139/f83-061; Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Beacham TD, 2006, T AM FISH SOC, V135, P861, DOI 10.1577/T05-241.1; Beacham TD, 2014, N AM J FISH MANAGE, V34, P335, DOI 10.1080/02755947.2014.880761; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Blyth GY, 1991, SALMON CANNERIES BRI; Bond MH, 2008, CAN J FISH AQUAT SCI, V65, P2242, DOI 10.1139/F08-131; Bottom DL, 2005, ESTUAR COAST SHELF S, V64, P79, DOI 10.1016/j.ecss.2005.02.008; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Cox-Rogers S, 2012, CAN TECH REP FISH AQ, P2956; English KK., 2012, DATASETS EXTENDED TI; Gibson RB, 2012, IMPACT ASSESS PROJ A, V30, P179, DOI 10.1080/14615517.2012.720417; Gottesfeld A., 2008, SKEENA RIVER FISH TH; Gottesfeld AS, 2009, J FISH DIS, V32, P45, DOI 10.1111/j.1365-2761.2008.01003.x; Government of Canada, 2012, EC ACTION PLAN, V2012, P89; Healey M., 1982, ESTUARINE COMP, P315; HEALEY MC, 1979, FISH B-NOAA, V77, P653; Heard W.R., 1991, P119; Higgins RJ, 1973, BIOL ASSESSMENT FISH; Hoos LM, 1975, ESTUARY WORKING GROU, V3; Hooton R.S., 2011, SKEENA STEELHEAD UNK; Hutchings JA, 2013, FISHERIES, V38, P497, DOI 10.1080/03632415.2013.848345; IWATA M, 1984, CAN J FISH AQUAT SCI, V41, P744, DOI 10.1139/f84-086; Joint Northern Boundary Technical Committee, 2014, 141 TCNB JOINT NO BO; Karieva P, 2010, SCIENCE, V290, P977; Krkosek M, 2007, P R SOC B, V274, P3141, DOI 10.1098/rspb.2007.1122; LEVY DA, 1982, CAN J FISH AQUAT SCI, V39, P270, DOI 10.1139/f82-038; Lyons DE, 2007, NORTHWEST SCI, V81, P91, DOI 10.3955/0029-344X-81.2.91; MACDONALD JS, 1988, CAN J FISH AQUAT SCI, V45, P1366, DOI 10.1139/f88-160; Magnusson A, 2003, ESTUARIES, V26, P1094, DOI 10.1007/BF02803366; Manzer JI, 1956, PROG REP FISH RES BO, V106, P24; Manzer JI, 1969, J FISH RES BD CAN; Meador JP, 2014, CAN J FISH AQUAT SCI, V71, P162, DOI 10.1139/cjfas-2013-0130; Mobrand LE, 1997, CAN J FISH AQUAT SCI, V54, P2964, DOI 10.1139/cjfas-54-12-2964; Moore KD, 2013, CONSERV LETT, V6, P1, DOI 10.1111/j.1755-263X.2012.00300.x; Morrell M., 2000, STATUS SALMON SPAWNI; Mortensen D, 2000, FISH B-NOAA, V98, P319; Munsch SH, 2014, N AM J FISH MANAGE, V34, P814, DOI 10.1080/02755947.2014.910579; Neaves P.I., 2005, CBAYES COMPUTER PROG; Neher TDH, 2013, T AM FISH SOC, V142, P1481, DOI 10.1080/00028487.2013.815660; Orsi J. A., 2012, N PAC ANADR FISH COM, V8, P130; PARKER RR, 1968, J FISH RES BOARD CAN, V25, P757, DOI 10.1139/f68-068; PARKER RR, 1971, J FISH RES BOARD CAN, V28, P1503, DOI 10.1139/f71-231; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Pella J, 2001, FISH B-NOAA, V99, P151; Price MHH, 2013, T AM FISH SOC, V142, P989, DOI 10.1080/00028487.2013.790842; Price MHH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016851; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinones RM, 2005, T AM FISH SOC, V134, P1147, DOI 10.1577/T04-092.1; R Core Team, 2021, R LANGUAGE ENV STAT; Reimers P. E, 1973, RES REPORTS FISH COM, V4, P1; Roegner GC, 2010, T AM FISH SOC, V139, P1211, DOI 10.1577/T09-082.1; Rutherford DT, 1995, CAN TECH REP FISH AQ, P2295; Safriel U, 1968, IBIS, P110; Semmens BX, 2008, CAN J FISH AQUAT SCI, V65, P2053, DOI 10.1139/F08-107; SHREFFLER DK, 1992, ESTUARIES, V15, P204, DOI 10.2307/1352693; Simenstad CA, 2000, ECOL ENG, V15, P283, DOI 10.1016/S0925-8574(00)00082-3; Simmons RK, 2013, MAR ECOL PROG SER, V481, P211, DOI 10.3354/meps10190; Smith HD, 1987, SOCKEYE SALMON POPUL, P280; Stantec, 2014, PAC NW LNG ENV IMP A; Straty R. R., 1980, SALMONID ECOSYSTEMS, P247; THORPE JE, 1994, ESTUARIES, V17, P76, DOI 10.2307/1352336; Toft JD, 2007, N AM J FISH MANAGE, V27, P465, DOI 10.1577/M05-158.1; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Weitkamp LA, 2014, REV FISH BIOL FISHER, V24, P713, DOI 10.1007/s11160-014-9345-y; Withler RE, 2000, CAN J FISH AQUAT SCI, V57, P1985, DOI 10.1139/cjfas-57-10-1985; WOOD CC, 1987, CAN J FISH AQUAT SCI, V44, P941, DOI 10.1139/f87-112; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	73	24	24	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118988	10.1371/journal.pone.0118988	http://dx.doi.org/10.1371/journal.pone.0118988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749488	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400035
J	Starmans, LWE; Moonen, RPM; Aussems-Custers, E; Daemen, MJAP; Strijkers, GJ; Nicolay, K; Grull, H				Starmans, Lucas W. E.; Moonen, Rik P. M.; Aussems-Custers, Erica; Daemen, Mat J. A. P.; Strijkers, Gustav J.; Nicolay, Klaas; Grull, Holger			Evaluation of Iron Oxide Nanoparticle Micelles for Magnetic Particle Imaging (MPI) of Thrombosis	PLOS ONE			English	Article							TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ENERGY-TRANSFER; PROTEIN CORONA; DIAGNOSIS; SURFACE; MRI	Magnetic particle imaging (MPI) is an emerging medical imaging modality that directly visualizes magnetic particles in a hot-spot like fashion. We recently developed an iron oxide nanoparticle-micelle (ION-Micelle) platform that allows highly sensitive MPI. The goal of this study was to assess the potential of the ION-Micelles for MPI-based detection of thrombi. To this aim, an in vivo carotid artery thrombosis mouse model was employed and ex vivo magnetic particle spectrometer (MPS) measurements of the carotid arteries were performed. In addition, we studied the effect of functionalization of the ION-Micelle nanoplatform with fibrin-binding peptides (FibPeps) with respect to nanoparticle thrombus uptake and hence thrombus detection. In vivo quantitative MR imaging pre- and post-ION-Micelle injection was performed as reference for visualization of ION-micelle uptake. ION-Micelles significantly decreased T-2 values in the thrombi with respect to pre-injection T-2 values (p < 0.01) and significantly increased ex vivo MPS thrombus signal with respect to the noninjured, contralateral carotid (p < 0.01). Functionalization of the ION-Micelles with the FibPep peptides did not result in an increased MPS thrombus signal with respect to the non-fibrin binding ION-Micelles. The lack of a significant increased thrombus uptake for the FibPep-ION-Micelles indicates that (non-fibrin-specific) entrapment of nanoparticles in the meshlike thrombi is the key contributor to thrombus nanoparticle uptake. Therefore, (nontargeted) ION-Micelles might be of value for noninvasive MPI-based diagnosis, characterization and treatment monitoring of thrombosis.	[Starmans, Lucas W. E.; Moonen, Rik P. M.; Strijkers, Gustav J.; Nicolay, Klaas; Grull, Holger] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Aussems-Custers, Erica] Philips Res, Appl Chem, Eindhoven, Netherlands; [Daemen, Mat J. A. P.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Grull, Holger] Philips Res, Oncol Solut, Eindhoven, Netherlands	Eindhoven University of Technology; Philips; Philips Research; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Philips; Philips Research	Grull, H (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.	h.gruell@tue.nl		Grull, Holger/0000-0002-0993-9300; Strijkers, Gustav/0000-0001-6700-5058; Moonen, Rik/0000-0002-2294-0226; Nicolay, Klaas/0000-0002-4179-616X; Daemen, Mat/0000-0003-1076-199X; Starmans, Luc/0000-0003-4569-1725	Center for Translational Molecular Medicine; Netherlands Heart Foundation PARISK [01C-202]	Center for Translational Molecular Medicine; Netherlands Heart Foundation PARISK	This research was supported by the Center for Translational Molecular Medicine (http://www.ctmm.nl) and the Netherlands Heart Foundation (www.hartstichting.nl): PARISK, grant 01C-202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Biederer S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/20/205007; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; Chen DX, 2009, J APPL PHYS, V106, DOI 10.1063/1.3211307; Coolen BF, 2014, MAGN RESON MED, V72, P409, DOI 10.1002/mrm.24952; Dai Q, 2014, ANGEW CHEM INT EDIT, V53, P5093, DOI 10.1002/anie.201309464; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Jansen CHP, 2011, CIRCULATION, V124, P416, DOI 10.1161/CIRCULATIONAHA.110.965442; Kim DE, 2013, ANN NEUROL, V73, P617, DOI 10.1002/ana.23849; Kronzon I, 2006, CIRCULATION, V114, P63, DOI 10.1161/CIRCULATIONAHA.105.593418; Litmanovich D, 2009, AM J ROENTGENOL, V193, P928, DOI 10.2214/AJR.08.2166; Lu Y, 2014, CHEST, V145, P1079, DOI 10.1378/chest.13-2090; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; MARKEL A, 1995, ANGIOLOGY, V46, P65, DOI 10.1177/000331979504600109; Omran H, 1999, HEART, V81, P192, DOI 10.1136/hrt.81.2.192; Sachs UJH, 2007, CIRC RES, V100, P979, DOI 10.1161/01.RES.0000261936.85776.5f; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Schmitz SA, 2001, RADIOLOGY, V221, P237, DOI 10.1148/radiol.2211001632; Srichai MB, 2006, AM HEART J, V152, P75, DOI 10.1016/j.ahj.2005.08.021; Starmans LWE, 2011, CONTRAST MEDIA MOL I, V6, P100, DOI 10.1002/cmmi.411; Starmans LWE, 2013, MOL PHARMACEUT, V10, P4309, DOI 10.1021/mp400406x; Starmans LWE, 2013, CONTRAST MEDIA MOL I, V8, P229, DOI 10.1002/cmmi.1521; Starmans LWE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057335; van Bochove GS, 2012, EUR J INORG CHEM, P2115, DOI 10.1002/ejic.201200010; Weizenecker J, 2007, PHYS MED BIOL, V52, P6363, DOI 10.1088/0031-9155/52/21/001; Wolters M, 2013, J THROMB HAEMOST, V11, P1766, DOI 10.1111/jth.12340; Zhao YM, 2014, SMALL, V10, P1163, DOI 10.1002/smll.201301962; Zhao YM, 2013, ACS NANO, V7, P10362, DOI 10.1021/nn404782p	27	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119257	10.1371/journal.pone.0119257	http://dx.doi.org/10.1371/journal.pone.0119257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746677	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400059
J	Hussain, RS; McGarvey, ST; Fruzzetti, LM				Hussain, Rashid S.; McGarvey, Stephen T.; Fruzzetti, Lina M.			Partition and Poliomyelitis: An Investigation of the Polio Disparity Affecting Muslims during India's Eradication Program	PLOS ONE			English	Article							UTTAR-PRADESH; HEALTH; IMMUNIZATION; CAMPAIGN; RESISTANCE; DISCRIMINATION; PERCEPTIONS; ATTITUDES; LESSONS; HISTORY	Background Significant disparities in the incidence of polio existed during its eradication campaign in India. In 2006, Muslims, who comprise 16% of the population in affected states, comprised 70% of paralytic polio cases. This disparity was initially blamed on the Muslims and a rumor that the vaccination program was a plot to sterilize their children. Using the framework of structural violence, this paper describes how the socio-political and historical context of Muslim populations in India shaped the polio disparity. Methods and Findings A qualitative study utilizing methods of rapid ethnography was conducted from May-August 2009 in Aligarh, Uttar Pradesh, India. Field methods included participant observation of vaccination teams, historical document research, and 107 interviews with both Global Polio Eradication Initiative (GPEI) stakeholders and families with vaccine-eligible children. Almost all respondents agreed that Aligarh was a highly segregated city, mostly due to riots after Partition and during the 1990s. Since the formation of segregated neighborhoods, most respondents described that "Muslim areas" had been underdeveloped compared to "Hindu areas," facilitating the physical transmission of poliovirus. Distrust of the government and resistance to vaccination were linked to this disparate development and fears of sterilization influenced by the "Family Planning Program" from 1976-1977. Conclusions Ethnic violence and social marginalization since the Partition and during the rise of Hindu nationalism led to distrust of the government, the formation of segregated slums, and has made Muslims victims of structural violence. This led to the creation of disease-spreading physical environments, lowered vaccine efficacy, and disproportionately higher levels of resistance to vaccination. The causes of the polio disparity found in this study elucidate the nature of possible other health disparities affecting minorities in India. Limitations This study is limited by the manual coding of the transcribed data, size, and some dialectal difficulties in translation.	[Hussain, Rashid S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [McGarvey, Stephen T.] Brown Univ, Int Hlth Inst, Dept Epidemiol, Providence, RI 02912 USA; [McGarvey, Stephen T.; Fruzzetti, Lina M.] Brown Univ, Dept Anthropol, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Hussain, RS (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	Rashid_Hussain@med.brown.edu			Watson Institute for International Studies' Brown International Scholars Program	Watson Institute for International Studies' Brown International Scholars Program	This project was made possible by funding from the Watson Institute for International Studies' Brown International Scholars Program. The Watson Institute was not involved in the collection, analysis, and interpretation of the data.	Abimbola S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001529; Allen K, 2003, BBC WORLD NEWS HLTH; [Anonymous], 2003, TIMES INDIA; Ansari MA, 2007, J R SOC PROMO HEALTH, V127, P276, DOI 10.1177/1466424007083705; Ansari MA, 2014, SE ASIA J PUBLIC HLT, V3, P23; Arokiasamy P, 2012, J BIOSOC SCI, V54, P167; Asadullah NM, 2009, SOCIAL DIVISIONS SCH; Aylward B, 2011, VACCINE, V29, pD80, DOI 10.1016/j.vaccine.2011.10.005; Bhattacharya S, 2009, AM J PUBLIC HEALTH, V99, P1176, DOI 10.2105/AJPH.2008.135624; Bonell C, 2006, BMJ-BRIT MED J, V333, P346, DOI 10.1136/bmj.333.7563.346; Bonu S, 2003, SOC SCI MED, V57, P1807, DOI 10.1016/S0277-9536(03)00056-X; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Brass PaulR., 2005, PRODUCTION HINDU MUS; C Chaturvedi G., 2008, VITAL DROP COMMUNICA; Chatterjee A, 2013, VACCINE, V31, P1268, DOI 10.1016/j.vaccine.2012.12.060; Chaturvedi S, 2009, INDIAN PEDIATR, V46, P963; Choudhury P, 2011, VACCINE, V29, P8317, DOI 10.1016/j.vaccine.2011.08.099; Closser S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001528; DeVotta Neil, 2002, J INT AFF, V56, P53; Farmer P.E, 2001, INFECT INEQUALITIES; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; GAYER L., 2012, MUSLIMS INDIAN CITIE; Gilmartin D, 1998, J ASIAN STUD, V57, P1068, DOI 10.2307/2659304; GOI-Ministry of Home Affairs, 2001, POP REL COMM; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Greene JA, 2004, CULT MED PSYCHIAT, V28, P401, DOI 10.1023/B:MEDI.0000046429.55801.c8; GREENOUGH P, 1995, SOC SCI MED, V41, P633, DOI 10.1016/0277-9536(95)00035-6; GWATKIN DR, 1979, POPUL DEV REV, V5, P29, DOI 10.2307/1972317; Hardy Peter, 1972, MUSLIMS BRIT INDIA; Harris KJ, 1997, HUM ORGAN, V56, P375, DOI 10.17730/humo.56.3.w525025611458003; Heath AF, 2010, DIVERSITY CHANGE MOD; Hussain RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046274; Jeffery P, 2008, MOD ASIAN STUD, V42, P519, DOI 10.1017/S0026749X07003162; Jeffery P, 2011, CONTEMP SOUTH ASIA, V19, P117, DOI 10.1080/09584935.2010.537744; Jeffery P, 2010, SOC SCI MED, V71, P1711, DOI 10.1016/j.socscimed.2010.05.002; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kishore J, 2003, NATL MED J INDIA, V16, P131; Kleinman A., 1988, ILLNESS NARRATIVES; Krieger N, 2005, J EPIDEMIOL COMMUN H, V59, P350, DOI 10.1136/jech.2004.024562; Kumar S, 2012, HEALTH POLICY PLANN, V27, P516, DOI 10.1093/heapol/czr075; Leach M, 2008, B WORLD HEALTH ORGAN, V86, P418, DOI 10.2471/BLT.08.054726; McNeil D. G., 2012, NY TIMES; Mohammadi D, 2012, LANCET, V380, P460, DOI 10.1016/S0140-6736(12)61279-3; Obadare E, 2005, PATTERNS PREJUDICE, V39, P265, DOI 10.1080/00313220500198185; Obregon R, 2010, J HEALTH COMMUN, V15, P25, DOI 10.1080/10810731003695367; Pallansch MA, 2006, NEW ENGL J MED, V355, P2508, DOI 10.1056/NEJMp068200; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Pipes D, 2005, CONSPIRACY THEORY SP; Poortinga W, 2008, HEALTH PLACE, V14, P562, DOI 10.1016/j.healthplace.2007.10.003; Rauf TA, 2011, EC POLITICAL WEEKLY, V46; Renne E, 2006, SOC SCI MED, V63, P1857, DOI 10.1016/j.socscimed.2006.04.025; Robbins A, 2012, J PUBLIC HEALTH POL, V33, P387, DOI 10.1057/jphp.2012.37; Rubincam Clara, 2009, Health Hum Rights, V11, P87; Secretariat C, 2006, SOC EC ED STAT MUSL; Sensarma P, 2012, HEALTH SOC CARE COMM, V20, P645, DOI 10.1111/j.1365-2524.2012.01080.x; Shavers VL, 2000, J NATL MED ASSOC, V92, P563; Singh J, 2008, ISLAM HINDUISMS BLUR; Singh M, 2009, TIME MAGAZINE; Singh P., 2012, PLOS ONE, V7; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Thacker N, 2007, INDIAN PEDIATR, V44, P81; Thacker Naveen, 2004, Indian Journal of Pediatrics, V71, P241, DOI 10.1007/BF02724277; Thacker N, 2013, J TROP PEDIATRICS, V59, P266, DOI 10.1093/tropej/fmt008; The World Health Organization and the Government of India, 2009, NAT POL SURV PROJ AL; Thompson AK, 2006, BMC MED ETHICS, V7, P12, DOI [10.1186/1472-6939-7-12, DOI 10.1186/1472-6939-7-12]; VAN DER VEER P., 1994, RELIG NATL HINDUS MU; Varshney A., 2003, ETHNIC CONFLICT CIVI; Washburn S, 2013, CIAS FAKE VACCINATIO; Weiss WM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-117; Williams DR, 2008, AM J PUBLIC HEALTH, V98, pS29, DOI 10.2105/AJPH.98.Supplement_1.S29; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Zakaria Rafiq, 2004, INDIAN MUSLIMS HAVE	75	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0115628	10.1371/journal.pone.0115628	http://dx.doi.org/10.1371/journal.pone.0115628			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742622	gold, Green Submitted, Green Published			2022-12-27	WOS:000350688100001
J	Kern, DW; Schumm, LP; Wroblewski, KE; Pinto, JM; Hummel, T; McClintock, MK				Kern, David W.; Schumm, L. Philip; Wroblewski, Kristen E.; Pinto, Jayant M.; Hummel, Thomas; McClintock, Martha K.			Olfactory Thresholds of the US Population of Home-Dwelling Older Adults: Development and Validation of a Short, Reliable Measure	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; NATIONAL SOCIAL-LIFE; ODOR DISCRIMINATION; IDENTIFICATION; SENSITIVITY; PERFORMANCE; ALCOHOL; HEALTH	Current methods of olfactory sensitivity testing are logistically challenging and therefore infeasible for use in in-home surveys and other field settings. We developed a fast, easy and reliable method of assessing olfactory thresholds, and used it in the first study of olfactory sensitivity in a nationally representative sample of U.S. home-dwelling older adults. We validated our method via computer simulation together with a model estimated from 590 normosmics. Simulated subjects were assigned n-butanol thresholds drawn from the estimated normosmic distribution and based on these and the model, we simulated administration of both the staircase and constant stimuli methods. Our results replicate both the correlation between the two methods and their reliability as previously reported by studies using human subjects. Further simulations evaluated the reliability of different constant stimuli protocols, varying both the range of dilutions and number of stimuli (6-16). Six appropriately chosen dilutions were sufficient for good reliability (0.67) in normosmic subjects. Finally, we applied our method to design a 5-minute, in-home assessment of older adults (National Social Life, Health and Aging Project, or NSHAP), which had comparable reliability (0.56), despite many subjects having estimated thresholds above the strongest dilution. Thus, testing with a fast, 6-item constant stimuli protocol is informative, and permits olfactory testing in previously inaccessible research settings.	[Kern, David W.; McClintock, Martha K.] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; [Kern, David W.; McClintock, Martha K.] Univ Chicago, Dept Comparat Human Dev, Chicago, IL 60637 USA; [Schumm, L. Philip; Wroblewski, Kristen E.] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Pinto, Jayant M.] Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; [Hummel, Thomas] Tech Univ Dresden, ENT Clin, Interdisciplinary Ctr Smell & Taste, Dresden, Germany	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Technische Universitat Dresden	Kern, DW (corresponding author), Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA.	dkern@uchicago.edu		Schumm, Phil/0000-0002-3050-2429	National Institute on Aging [AG033903-01, AG030481, AG12857, K23 AG036762]; Center on Aging Specialized Training Program in the Demography and Economics of Aging [National Institute on Aging] [T32000243]; Mellon Foundation Social Sciences Dissertation-Year Fellowship; Gianinno Graduate Research Fund; McHugh Otolaryngology Research Fund; American Geriatrics Society/Dennis W. Jahnigen Scholars Award; Institute for Translational Medicine at The University of Chicago [KL2RR025000, UL1RR024999]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999, KL2RR025000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG012857, K23AG036762, R01AG033903, P20AG012857, R01AG043538, R01AG021487, T32AG000243, R37AG030481] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center on Aging Specialized Training Program in the Demography and Economics of Aging [National Institute on Aging]; Mellon Foundation Social Sciences Dissertation-Year Fellowship; Gianinno Graduate Research Fund; McHugh Otolaryngology Research Fund; American Geriatrics Society/Dennis W. Jahnigen Scholars Award; Institute for Translational Medicine at The University of Chicago; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NSHAP was supported by the National Institute on Aging [AG033903-01 and AG030481]. DWK was supported by The Center on Aging Specialized Training Program in the Demography and Economics of Aging [National Institute on Aging T32000243], a Mellon Foundation Social Sciences Dissertation-Year Fellowship, and the Gianinno Graduate Research Fund. JMP was supported by the McHugh Otolaryngology Research Fund, an American Geriatrics Society/Dennis W. Jahnigen Scholars Award, the National Institute on Aging [AG12857, K23 AG036762]. JMP was also supported by the Institute for Translational Medicine at The University of Chicago [KL2RR025000, UL1RR024999]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2008, CHEM SENSES, V33, P461, DOI 10.1093/chemse/bjn013; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Boesveldt S, 2011, RHINOLOGY, V49, P324, DOI 10.4193/Rhino10.155; CAIN WS, 1983, AM J OTOLARYNG, V4, P252, DOI 10.1016/S0196-0709(83)80068-4; Cohen AS, 2005, J EDUC MEAS, V42, P133, DOI 10.1111/j.1745-3984.2005.00007; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; Croy I, 2009, CHEM SENSES, V34, P523, DOI 10.1093/chemse/bjp029; Denzer MY, 2014, CHEMOSENS PERCEPT, V7, P91, DOI 10.1007/s12078-014-9168-1; Doty RL, 2003, CHEM SENSES, V28, P523, DOI 10.1093/chemse/28.6.523; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL, 2014, FRONT PSYCHOL, V5, P20, DOI [DOI 10.3389/FPSYG.2014.00020, DOI 10.3389/fpsyg.2014.00020]; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Fox JP, 2010, STAT SOC BEHAV SC, P1, DOI 10.1007/978-1-4419-0742-4; Haehner A, 2009, CHEM SENSES, V34, P705, DOI 10.1093/chemse/bjp057; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kern DW, 2014, FIELD METHOD, V26, P421, DOI 10.1177/1525822X14547499; Kobal G, 2001, EUR ARCH OTO-RHINO-L, V258, P168, DOI 10.1007/s004050100328; Landis BN, 2011, KIDNEY INT, V80, P886, DOI 10.1038/ki.2011.189; Lotsch J, 2004, CHEM SENSES, V29, P311, DOI 10.1093/chemse/bjh034; O'Muircheartaigh C, 2009, J GERONTOL B-PSYCHOL, V64, pI12, DOI 10.1093/geronb/gbp045; Rupp CI, 2003, ALCOHOL CLIN EXP RES, V27, P432, DOI 10.1097/01.ALC.0000057945.57330.2C; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schreder T, 2008, RHINOLOGY, V46, P175; Schumm LP, 2009, J GERONTOL B-PSYCHOL, V64, pI76, DOI 10.1093/geronb/gbp048; Schumm LP, 2014, SIMULATION PROTOCOLS; Skrondal A., 2004, WORKING PAPER SERIES, V160; Skrondal A., 2004, GEN LATENT VARIABLE; Skrondal A, 2009, J R STAT SOC A STAT, V172, P659, DOI 10.1111/j.1467-985X.2009.00587.x; Snow JB, 1991, SMELL TASTE HLTH DIS, P1803; Statacorp, 2013, STAT 13 BAS REF MAN; Waite L.J., 2014, ICPSR34921V1, DOI [10.3886/ICPSR34921.v1, DOI 10.3886/ICPSR34921.V1]; WHITTEMORE AS, 1989, AM STAT, V43, P226, DOI 10.2307/2685366; Wise PM, 2008, CHEMOSENS PERCEPT, V1, P16, DOI 10.1007/s12078-008-9010-8; Wolfensberger M, 2000, ACTA OTO-LARYNGOL, V120, P303, DOI 10.1080/000164800750001134	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118589	10.1371/journal.pone.0118589	http://dx.doi.org/10.1371/journal.pone.0118589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768291	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500031
J	Leal, MF; Belangero, PS; Figueiredo, EA; Cohen, C; Loyola, LC; Andreoli, CV; Smith, MC; Pochini, AD; Ejnisman, B; Cohen, M				Leal, Mariana Ferreira; Belangero, Paulo Santoro; Figueiredo, Eduardo Antonio; Cohen, Carina; Loyola, Leonor Casilla; Andreoli, Carlos Vicente; Smith, Marilia Cardoso; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises			Identification of Suitable Reference Genes for Gene Expression Studies in Tendons from Patients with Rotator Cuff Tear	PLOS ONE			English	Article							REAL-TIME PCR; ANTERIOR CRUCIATE LIGAMENTS; MESSENGER-RNA LEVELS; HOUSEKEEPING GENES; NORMALIZATION; DEGENERATION; COLLAGEN; TISSUES; SUPRASPINATUS; PUBLICATION	Rotator cuff tear is one of the most common causes of shoulder dysfunction. Gene expression analysis may be a useful tool for understanding tendon tears and the failure of cuff healing, and reverse-transcription quantitative polymerase chain reaction (RT-qPCR) has become an effective method for such studies. However, this technique requires the use of suitable reference genes for data normalization. Here, we evaluate the suitability of six reference genes (18S, ACTB, B2M, GAPDH, HPRT1 and TBP) using samples from the rotator cuff tendons of 28 individuals with tendon tears (3 tendons regions) and 8 controls (2 tendon regions); for the tear patients, we evaluated ruptured and non-ruptured tendon samples. The stability of the candidate reference genes was determined using the NormFinder, geNorm, BestKeeper and DataAssist software packages. Overall, HPRT1 was the best single reference gene, and HPRT1+TBP composed the best pair and HPRT1+TBP+ACTB composed the best trio of reference genes from the analysis of different groups, including the simultaneous analysis of all tissue samples. To identify the optimal combination of reference genes, we evaluated the expression of COL1A1 and COL3A1, and no obvious differences were observed when using 2, 3 or 4 reference genes for most of the analyses. However, COL3A1 expression differed between ruptured and non-ruptured (posterior superior region) tendons of patients only when normalized by HPRT1+TBP+B2M and HPRT1+TBP. On the other hand, the comparison between these two groups using the best trio of reference genes (HPRT1+TBP+ACTB) and 4 reference genes did not revealed a significant difference in COL3A1 expression. Consequently, the use of suitable reference genes for a reliable gene expression evaluation by RT-qPCR should consider the type of tendon samples investigated. HPRT1+TBP+ACTB seems to be the best combination of reference genes for the analysis of involving different tendon samples of individuals with rotator cuff tears.	[Leal, Mariana Ferreira; Belangero, Paulo Santoro; Figueiredo, Eduardo Antonio; Cohen, Carina; Loyola, Leonor Casilla; Andreoli, Carlos Vicente; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises] Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil; [Leal, Mariana Ferreira; Loyola, Leonor Casilla; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Genet, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil.	mariana.morf@epm.br	Andreoli, Carlos Vicente/AAW-1228-2021; de A. C. Smith, Marilia/C-4397-2012; Leal, Mariana/C-4010-2012; Belangero, Paulo/AAD-8299-2021; Ejnisman, Benno/J-1556-2015	de A. C. Smith, Marilia/0000-0002-1441-1033; Leal, Mariana/0000-0003-4375-2563; Ejnisman, Benno/0000-0002-3301-1457	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; MC and MCS) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; LCL, MC and MFL) as grants and fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Belangero PS, 2014, J ORTHOP RES, V32, P1311, DOI 10.1002/jor.22680; Bramono DS, 2005, CONNECT TISSUE RES, V46, P53, DOI 10.1080/03008200590935556; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Cheung EV, 2010, CLIN ORTHOP RELAT R, V468, P1476, DOI 10.1007/s11999-010-1323-7; Clements DN, 2008, OSTEOARTHR CARTILAGE, V16, P195, DOI 10.1016/j.joca.2007.06.013; COFIELD RH, 1982, SURG GYNECOL OBSTET, V154, P667; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dines JS, 2007, J SHOULDER ELB SURG, V16, p204S, DOI 10.1016/j.jse.2007.03.004; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Fabis J, 2014, J SHOULDER ELBOW SUR; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Gotoh M, 2013, KNEE SURG SPORT TR A, V21, P1807, DOI 10.1007/s00167-012-2209-x; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Leal MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105002; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Lichtenberg, 2006, CLASSIFICATIONS SCOR; Lo IKY, 2003, CLIN ORTHOP RELAT R, P249, DOI 10.1097/01.blo.0000037442.23683.35; Lo IKY, 2005, ARTHROSCOPY, V21, P645, DOI 10.1016/j.arthro.2005.03.008; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Nho SJ, 2008, AM J SPORT MED, V36, P987, DOI 10.1177/0363546508317344; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Robertson CM, 2012, AM J SPORT MED, V40, P1993, DOI 10.1177/0363546512456519; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; Taylor SC, 2014, J MOL MICROB BIOTECH, V24, P46, DOI 10.1159/000356189; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Wisnieski F, 2013, WORLD J GASTROENTERO, V19, P7121, DOI 10.3748/wjg.v19.i41.7121; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007; Zhou ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088892	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118821	10.1371/journal.pone.0118821	http://dx.doi.org/10.1371/journal.pone.0118821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768100	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500046
J	Liu, CJ; Hu, LY; Yeh, CM; Hu, YW; Chen, PM; Chen, TJ; Lu, T				Liu, Chia-Jen; Hu, Li-Yu; Yeh, Chiu-Mei; Hu, Yu-Wen; Chen, Pan-Ming; Chen, Tzeng-Ji; Lu, Ti			Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder	PLOS ONE			English	Article							INFLAMMATORY DISEASE; ANXIETY DISORDER; CO-MORBIDITIES; PREVALENCE; COMORBIDITY; DEPRESSION; MOOD; PATHOPHYSIOLOGY; EPIDEMIOLOGY; ASSOCIATION	Objective We explored the association between IBS and the development of bipolar disorder, and the risk factors for bipolar disorders in patients with IBS. Methods We identified patients who were newly diagnosed with IBS between 2000 and 2010 in the Taiwan National Health Insurance Research Database. We also identified a comparison matched cohort without IBS. The occurrence of new-onset bipolar disorder was evaluated in both cohorts. Results The IBS cohort consisted of 30,796 patients and the comparison cohort consisted of 30,796 matched patients without IBS. The incidence of bipolar disorder (incidence rate ratio, 2.63, 95% confidence interval (CI) 2.10-3.31, P < .001) was higher in the IBS patients than in the matched cohort. Multivariate matched regression models indicated that autoimmune diseases (HR 1.52, 95% CI 1.07-2.17, P = .020), and asthma (HR 1.45, 95% CI 1.08-1.95, P = .013) were independent risk factors for the development of bipolar disorder in the IBS patients. Conclusion IBS may increase the risk of developing subsequent bipolar disorder. Additional prospective studies are required to confirm these findings.	[Hu, Li-Yu; Lu, Ti] Kaohsiung Vet Gen Vet Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Liu, Chia-Jen; Hu, Yu-Wen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yeh, Chiu-Mei] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Chen, Pan-Ming; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Yuanshan & Suao Branch, Dept Psychiat, Yilan, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lu, T (corresponding author), Kaohsiung Vet Gen Vet Hosp, Dept Psychiat, Kaohsiung, Taiwan.	tlu@vghks.gov.tw	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X	Taipei Veterans General Hospital [V103B-022, V103E10-001]; Taiwan Clinical Oncology Research Foundation	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taiwan Clinical Oncology Research Foundation	This study is supported in part by grants from Taipei Veterans General Hospital (V103B-022 and V103E10-001) and Taiwan Clinical Oncology Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bai YM, 2013, J CHIN MED ASSOC, V76, P547, DOI 10.1016/j.jcma.2013.06.013; Chen MH, 2013, J AFFECT DISORD; Crane C, 2003, PSYCHOSOM MED, V65, P919, DOI 10.1097/01.PSY.0000088590.01737.07; De Dios C, 2010, J AFFECT DISORDERS, V125, P74, DOI 10.1016/j.jad.2009.12.006; Drake C, 2011, BRAIN BEHAV IMMUN, V25, P1113, DOI 10.1016/j.bbi.2011.02.008; El-Salhy M, 2012, WORLD J GASTROENTERO, V18, P5151, DOI 10.3748/wjg.v18.i37.5151; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Gwee KA, 2009, J GASTROEN HEPATOL, V24, P1601, DOI 10.1111/j.1440-1746.2009.05984.x; Hamdani Nora, 2012, Front Biosci (Elite Ed), V4, P2170; Hao Jing-xin, 2011, Zhonghua Yi Xue Za Zhi, V91, P1886; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Hsiao CW, 2014, EUR J INTERN MED, V25, P82, DOI 10.1016/j.ejim.2013.11.005; Hu LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073057; Huang KL, 2009, PSYCHIAT CLIN NEUROS, V63, P401, DOI 10.1111/j.1440-1819.2009.01974.x; Jerrell JM, 2010, J CLIN PSYCHIAT, V71, P1518, DOI 10.4088/JCP.09m05585ora; Kwan ACP, 2002, J GASTROEN HEPATOL, V17, P1180, DOI 10.1046/j.1440-1746.2002.02871.x; Lai SW, 2014, EUR J EPIDEMIOL, V29, P57, DOI [10.1007/s10654-014-9878-3, 10.1007/s10654-014-9903-6]; Lampa J, 2012, P NATL ACAD SCI USA, V109, P12728, DOI 10.1073/pnas.1118748109; Lau EMC, 2002, DIGEST DIS SCI, V47, P2621, DOI 10.1023/A:1020549118299; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Modabbernia Mohamad-Jafar, 2012, BMC Res Notes, V5, P112, DOI 10.1186/1756-0500-5-112; Mykletun A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-88; Norgaard M, 2011, BRIT J CANCER, V104, P1202, DOI 10.1038/bjc.2011.65; O'Malley D, 2011, BRAIN BEHAV IMMUN, V25, P1333, DOI 10.1016/j.bbi.2011.04.009; Omagari K, 2013, INTERNAL MED, V52, P1295, DOI 10.2169/internalmedicine.52.0248; Post RM, 2013, J AFFECT DISORD; Post RM, 2013, J AFFECT DISORDERS, V147, P288, DOI 10.1016/j.jad.2012.11.020; Proudfoot J, 2012, J AFFECT DISORDERS, V143, P196, DOI 10.1016/j.jad.2012.05.052; Rege S., 2013, AUST NZ J PSYCHIAT; Robbins Steven E, 2013, Expert Rev Gastroenterol Hepatol, V7, P413, DOI 10.1586/17474124.2013.811043; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sperber AD, 2012, AM J GASTROENTEROL, V107, P1602, DOI 10.1038/ajg.2012.106; Stertz L, 2013, CURR OPIN PSYCHIATR, V26, P19, DOI 10.1097/YCO.0b013e32835aa4b4; Su T.P., 2013, J PSYCHIAT RES; Thomsen AF, 2005, BIPOLAR DISORD, V7, P351, DOI 10.1111/j.1399-5618.2005.00205.x; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu KY, 2013, BIPOLAR DISORD, V15, P787, DOI 10.1111/bdi.12116	43	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118209	10.1371/journal.pone.0118209	http://dx.doi.org/10.1371/journal.pone.0118209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768120	Green Submitted, gold, Green Published			2022-12-27	WOS:000351277500022
J	Yao, S; Zhang, JX; Wang, DD; Hou, JJ; Yang, WZ; Da, J; Cai, LY; Yang, M; Jiang, BH; Liu, X; Guo, DA; Wu, WY				Yao, Shuai; Zhang, Jingxian; Wang, Dandan; Hou, Jinjun; Yang, Wenzhi; Da, Juan; Cai, Luying; Yang, Min; Jiang, Baohong; Liu, Xuan; Guo, De-an; Wu, Wanying			Discriminatory Components Retracing Strategy for Monitoring the Preparation Procedure of Chinese Patent Medicines by Fingerprint and Chemometric Analysis	PLOS ONE			English	Article							CARTHAMUS-TINCTORIUS L.; IONIZATION MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; DANHONG INJECTION; RADIX ASTRAGALI; QUALITY-CONTROL; IDENTIFICATION; CONSTITUENTS; CLASSIFICATION; METABOLITES	Chinese patent medicines (CPM), generally prepared from several traditional Chinese medicines (TCMs) in accordance with specific process, are the typical delivery form of TCMs in Asia. To date, quality control of CPMs has typically focused on the evaluation of the final products using fingerprint technique and multi-components quantification, but rarely on monitoring the whole preparation process, which was considered to be more important to ensure the quality of CPMs. In this study, a novel and effective strategy labeling "retracing" way based on HPLC fingerprint and chemometric analysis was proposed with Shenkang injection (SKI) serving as an example to achieve the quality control of the whole preparation process. The chemical fingerprints were established initially and then analyzed by similarity, principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) to evaluate the quality and to explore discriminatory components. As a result, the holistic inconsistencies of ninety-three batches of SKIs were identified and five discriminatory components including emodic acid, gallic acid, caffeic acid, chrysophanol-O-glucoside, and p-coumaroylO- galloyl-glucose were labeled as the representative targets to explain the retracing strategy. Through analysis of the targets variation in the corresponding semi-products (ninety-three batches), intermediates (thirty-three batches), and the raw materials, successively, the origins of the discriminatory components were determined and some crucial influencing factors were proposed including the raw materials, the coextraction temperature, the sterilizing conditions, and so on. Meanwhile, a reference fingerprint was established and subsequently applied to the guidance of manufacturing. It was suggested that the production process should be standardized by taking the concentration of the discriminatory components as the diagnostic marker to ensure the stable and consistent quality for multi-batches of products. It is believed that the effective and practical strategy would play a critical role in the guidance of manufacturing and help improve the safety of the final products.	[Yao, Shuai; Zhang, Jingxian; Wang, Dandan; Hou, Jinjun; Yang, Wenzhi; Da, Juan; Cai, Luying; Yang, Min; Jiang, Baohong; Liu, Xuan; Guo, De-an; Wu, Wanying] Chinese Acad Sci, Natl Engn Lab TCM Standardizat Technol, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Wu, WY (corresponding author), Chinese Acad Sci, Natl Engn Lab TCM Standardizat Technol, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai Inst Mat Med, 501 Haike Rd, Shanghai 201203, Peoples R China.	wanyingwu@simm.ac.cn	Zhang, Jing/GWZ-7332-2022; Hou, Jinjun/GQA-6071-2022; zhou, ju/M-3255-2017	Hou, Jinjun/0000-0003-1470-5127; 	Twelfth Five-Year National Science and Technology Support Program [2012BAI29B06]; Chinese Medicine Industry of State Administration of traditional Chinese Medicine [201307002]	Twelfth Five-Year National Science and Technology Support Program(Chinese Academy of Sciences); Chinese Medicine Industry of State Administration of traditional Chinese Medicine	Funding: This study was financially supported by the Twelfth Five-Year National Science and Technology Support Program (2012BAI29B06), and special scientific research in the Chinese Medicine Industry of State Administration of traditional Chinese Medicine (201307002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts G, 2014, J PHARMACEUT BIOMED, V95, P34, DOI 10.1016/j.jpba.2014.02.006; China Pharmacopoeia Committee, 2002, GUID TCM INJ CHROM F; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE; Chu C, 2010, CURR ORG CHEM, V14, P1792, DOI 10.2174/138527210792927663; Guo YX, 2007, J PHARMACEUT BIOMED, V43, P1249, DOI 10.1016/j.jpba.2006.10.025; Hakimzadeh N, 2014, J CHROMATOGR A, V1326, P63, DOI 10.1016/j.chroma.2013.12.045; Jin Y, 2008, RAPID COMMUN MASS SP, V22, P1275, DOI 10.1002/rcm.3468; Jin Y, 2008, J PHARMACEUT BIOMED, V46, P418, DOI 10.1016/j.jpba.2007.10.036; Liang J, 2013, J CHROMATOGR A, V1294, P58, DOI 10.1016/j.chroma.2013.04.016; Liu AH, 2007, J CHROMATOGR A, V1161, P170, DOI 10.1016/j.chroma.2007.05.081; Liu HT, 2013, BIOMED CHROMATOGR, V27, P655, DOI 10.1002/bmc.2842; Liu XS, 2013, J PHARMACEUT BIOMED, V76, P70, DOI 10.1016/j.jpba.2012.12.013; Parastar H, 2012, J CHROMATOGR A, V1251, P176, DOI 10.1016/j.chroma.2012.06.011; Peng L, 2011, FOOD CHEM, V125, P1064, DOI 10.1016/j.foodchem.2010.09.079; Qi LW, 2009, J CHROMATOGR A, V1216, P2087, DOI 10.1016/j.chroma.2008.02.095; Qi Y, 2014, TALANTA, V118, P21, DOI 10.1016/j.talanta.2013.09.054; Sheridan H, 2012, J ETHNOPHARMACOL, V140, P482, DOI 10.1016/j.jep.2012.01.050; Song R, 2008, BIOMED CHROMATOGR, V22, P1230, DOI 10.1002/bmc.1050; Tistaert C, 2009, ANAL CHIM ACTA, V652, P189, DOI 10.1016/j.aca.2009.08.024; Tistaert C, 2011, ANAL CHIM ACTA, V690, P148, DOI 10.1016/j.aca.2011.02.023; Wan JB, 2013, J PHARMACEUT BIOMED, V83, P34, DOI 10.1016/j.jpba.2013.04.019; Wang SF, 2014, J CHROMATOGR A, V1348, P105, DOI 10.1016/j.chroma.2014.04.084; Wu FF, 2011, J SEP SCI, V34, P3194, DOI 10.1002/jssc.201100253; Ye CH, 1997, Patent, Patent No. 96117626; Ye M, 2007, J AM SOC MASS SPECTR, V18, P82, DOI 10.1016/j.jasms.2006.08.009; Zhou WJ, 2013, J PHARMACEUT BIOMED, V84, P59, DOI 10.1016/j.jpba.2013.05.034; Zhou XD, 2014, J ETHNOPHARMACOL, V151, P27, DOI 10.1016/j.jep.2013.10.050; Zhu JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087462	28	14	16	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121366	10.1371/journal.pone.0121366	http://dx.doi.org/10.1371/journal.pone.0121366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768096	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500142
J	Zaidi, SH; Smith-Morris, C				Zaidi, Saira H.; Smith-Morris, Carolyn			Diapers in War Zones: Ethnomedical Factors in Acute Childhood Gastroenteritis in Peshawar, Pakistan	PLOS ONE			English	Article							DIARRHEAL DISEASES; CHILDREN; HEALTH; PERCEPTIONS; PATRIARCHY; HYGIENE; SCALE	This article considers ethnomedical knowledge and practices among parents related to contraction of acute gastroenteritis among children in Peshawar, Pakistan. Research methods included analysis of the Emergency Pediatric Services' admission register, a structured interview administered to 47 parents of patients seen in the Khyber Medical College Teaching Hospital, semi-structured interviews of 12 staff, and four home visits among families with children treated at the hospital. The use of native research assistants and participant observation contributed to the reliability of the findings, though the ethnographic, home-visit sample is small. Our research indicated that infection rates are exacerbated in homes through two culturally salient practices and one socioeconomic condition. Various misconceptions propagate the recurrence or perserverance of acute gastroenteritis including assumptions about teething leading to poor knowledge of disease etiology, rehydration solutions leading to increased severity of disease, and diaper usage leading to the spread of disease. In our Discussion, we suggest how hospital structures of authority and gender hierarchy may impact hospital interactions, the flow of information, and its respective importance to the patient's parents leading to possible propagation of disease. These ethnographic data offer a relatively brief but targeted course of action to improve the effectiveness of prevention and treatment efforts.	[Zaidi, Saira H.] Univ Calif Berkeley, Sch Publ Hlth, Dept Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Smith-Morris, Carolyn] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA	University of California System; University of California Berkeley; Southern Methodist University	Zaidi, SH (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Dept Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	sairahusain618@gmail.com			Richter Research Fellowship Program by Southern Methodist University	Richter Research Fellowship Program by Southern Methodist University	This research project was funded by the Richter Research Fellowship Program by Southern Methodist University received by SHZ (http://smu.edu/univhonors/Richter%20International%20Fellowships.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, MED ANTHROPOL Q, V19, P267, DOI 10.1525/maq.2005.19.3.267; Ahmad N, 2004, PAK J MED RES, V43, P3; Ai AL, 2002, J TRAUMA STRESS, V15, P157, DOI 10.1023/A:1014864225889; Bajolet O, 1998, B SOC PATHOL EXOT, V91, P432; Barrett H, 1996, SOC SCI MED, V43, P1579, DOI 10.1016/S0277-9536(96)00054-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bloomfield SF, 2009, INT SCI FOR HOM HYG, V24; Brown P, 1987, ANTHR INFECT DIS INT; El Katsha S., 1989, Water International, V4, P103, DOI 10.1080/02508068908692072; ELLIOTT EJ, 2008, PAEDIAT CHILD HLTH, V32, P18; Fagundes-Neto U, 1999, J AM COLL NUTR, V18, P303, DOI 10.1080/07315724.1999.10718868; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; FERRECCIO C, 1991, AM J EPIDEMIOL, V134, P614, DOI 10.1093/oxfordjournals.aje.a116134; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Goldman RD, 2008, PEDIATRICS, V122, P545, DOI 10.1542/peds.2007-3141; Gupte S, 1983, J Diarrhoeal Dis Res, V1, P109; Halvorson SJ, 2004, HEALTH PLACE, V10, P43, DOI 10.1016/S1353-8292(03)00018-2; Hershey C. L., 2011, CONFL HEALTH, V5, P1; Huda TMN, 2012, SOC SCI MED, V75, P604, DOI 10.1016/j.socscimed.2011.10.042; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kleinman A, 2005, CULTURE PSYCHIAT DIA; Lambert H, 2002, BRIT MED J, V325, P210, DOI 10.1136/bmj.325.7357.210; Macknin ML, 2000, PEDIATRICS, V105, P747, DOI 10.1542/peds.105.4.747; MEEUWISSE GW, 1983, ACTA PAEDIATR SCAND, V72, P161, DOI 10.1111/j.1651-2227.1983.tb09689.x; MOGHADAM VM, 1992, INT SOCIOL, V7, P35, DOI 10.1177/026858092007001002; Moghadam VM, 2004, J COMP FAM STUD, V35, P137, DOI 10.3138/jcfs.35.2.137; Mumtaz S, 2010, AFR J BIOTECHNOL, V9, P1230; Nagamani K, 2007, Indian J Med Microbiol, V25, P133; Parkin PC, 2010, CLIN PEDIATR, V49, P235, DOI 10.1177/0009922809336670; Rabbani F, 2009, INT J HEALTH CARE Q, V22, P498, DOI 10.1108/09526860910975607; Smith-Morris C, 2014, MED ANTHROPOL Q, V28, P141, DOI 10.1111/maq.12093; STAPLETON MC, 1989, SOC SCI MED, V28, P593, DOI 10.1016/0277-9536(89)90254-2; Strand TA, 2012, PLOS ONE, V10, P1371; VAN R, 1991, JAMA-J AM MED ASSOC, V265, P1840, DOI 10.1001/jama.265.14.1840; Vecchiato NL, 1997, MED ANTHROPOL Q, V11, P183, DOI 10.1525/maq.1997.11.2.183; Walker CLF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029151; Wilson SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033273; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Zwane AP, 2007, WORLD BANK RES OBSER, V22, P1, DOI 10.1093/wbro/lkm002	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119069	10.1371/journal.pone.0119069	http://dx.doi.org/10.1371/journal.pone.0119069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768117	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500062
J	Kajikawa, M; Kinohira, S; Ando, A; Shimoyama, M; Kato, M; Fukuzawa, H				Kajikawa, Masataka; Kinohira, Seiko; Ando, Akira; Shimoyama, Miki; Kato, Misako; Fukuzawa, Hideya			Accumulation of Squalene in a Microalga Chlamydomonas reinhardtii by Genetic Modification of Squalene Synthase and Squalene Epoxidase Genes	PLOS ONE			English	Article							BIOSYNTHESIS PATHWAY; BOTRYOCOCCUS-BRAUNII; EXPRESSION; CLONING; CELLS; CDNA; TRANSFORMATION; OPTIMIZATION; MUTANTS; STRAINS	Several microalgae accumulate high levels of squalene, and as such provide a potentially valuable source of this useful compound. However, the molecular mechanism of squalene biosynthesis in microalgae is still largely unknown. We obtained the sequences of two enzymes involved in squalene synthesis and metabolism, squalene synthase (CrSQS) and squalene epoxidase (CrSQE), from the model green alga Chlamydomonas reinhardtii. CrSQS was functionally characterized by expression in Escherichia coli and CrSQE by complementation of a budding yeast erg1 mutant. Transient expression of CrSQS and CrSQE fused with fluorescent proteins in onion epidermal tissue suggested that both proteins were co-localized in the endoplasmic reticulum. CrSQS-overexpression increased the rate of conversion of C-14-labeled farnesylpyrophosphate into squalene but did not lead to over-accumulation of squalene. Addition of terbinafine caused the accumulation of squalene and suppression of cell survival. On the other hand, in CrSQE-knockdown lines, the expression level of CrSQE was reduced by 59-76% of that in wild-type cells, and significant levels of squalene (0.9-1.1 mu g mg(-1) cell dry weight) accumulated without any growth inhibition. In co-transformation lines with CrSQS-overexpression and CrSQE-knockdown, the level of squalene was not increased significantly compared with that in solitary CrSQE-knockdown lines. These results indicated that partial knockdown of CrSQE is an effective strategy to increase squalene production in C. reinhardtii cells.	[Kajikawa, Masataka; Kinohira, Seiko; Fukuzawa, Hideya] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Ando, Akira; Shimoyama, Miki; Kato, Misako] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 112, Japan	Kyoto University; Ochanomizu University	Fukuzawa, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	fukuzawa@lif.kyoto-u.ac.jp	Fukuzawa, Hideya/I-5906-2018	Fukuzawa, Hideya/0000-0003-0963-5662; Kajikawa, Masataka/0000-0003-0361-2769	Advanced Low Carbon Technology Research and Development (ALCA) Program	Advanced Low Carbon Technology Research and Development (ALCA) Program	This study was supported by Advanced Low Carbon Technology Research and Development (ALCA) Program (to H. F. and M. Kato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Bhattacharjee P, 2001, WORLD J MICROB BIOT, V17, P811, DOI 10.1023/A:1013573912952; Blaby IK, 2014, TRENDS PLANT SCI, V19, P672, DOI 10.1016/j.tplants.2014.05.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brumfield KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008659; Busquets A, 2008, PLANT MOL BIOL, V67, P25, DOI 10.1007/s11103-008-9299-3; Fabris M, 2014, NEW PHYTOL, V204, P521, DOI 10.1111/nph.12917; Fan KW, 2010, WORLD J MICROB BIOT, V26, P1303, DOI 10.1007/s11274-009-0301-2; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guevara-Garcia A, 2005, PLANT CELL, V17, P628, DOI 10.1105/tpc.104.028860; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Haubrich BA, 2015, PHYTOCHEMISTRY, V113, P64, DOI 10.1016/j.phytochem.2014.07.019; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hong WK, 2013, J MICROBIOL BIOTECHN, V23, P759, DOI 10.4014/jmb.1212.12023; JANDROSITZ A, 1991, GENE, V107, P155, DOI 10.1016/0378-1119(91)90310-8; JIANG GJ, 1993, J BIOL CHEM, V268, P12818; Jiang Y, 2004, J AGR FOOD CHEM, V52, P1196, DOI 10.1021/jf035004c; Kong F, 2014, J BIOSCI BIOENG, V117, P613, DOI 10.1016/j.jbiosc.2013.10.025; Kribii R, 1997, EUR J BIOCHEM, V249, P61, DOI 10.1111/j.1432-1033.1997.00061.x; Laden BP, 2000, ARCH BIOCHEM BIOPHYS, V374, P381, DOI 10.1006/abbi.1999.1629; Landl KM, 1996, YEAST, V12, P609, DOI 10.1002/(SICI)1097-0061(199605)12:6<609::AID-YEA949>3.0.CO;2-B; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; Lee HK, 2000, ARCH BIOCHEM BIOPHYS, V381, P43, DOI 10.1006/abbi.2000.1966; Lin HW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001105; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Matsushima D, 2012, PLANT SCI, V185, P309, DOI 10.1016/j.plantsci.2012.01.002; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller MB, 2012, J LIPID RES, V53, P1636, DOI 10.1194/jlr.M027482; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; NAKASHIMA T, 1995, P NATL ACAD SCI USA, V92, P2328, DOI 10.1073/pnas.92.6.2328; Nakazawa A, 2012, BIORESOURCE TECHNOL, V109, P287, DOI 10.1016/j.biortech.2011.09.127; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; Nowosieski M, 2011, J CHEM INF MODEL, V51, P455, DOI 10.1021/ci100403b; Ohnishi N, 2010, PLANT CELL, V22, P3105, DOI 10.1105/tpc.109.071811; Okada S, 2000, ARCH BIOCHEM BIOPHYS, V373, P307, DOI 10.1006/abbi.1999.1568; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Reddy LH, 2009, ADV DRUG DELIVER REV, V61, P1412, DOI 10.1016/j.addr.2009.09.005; ROBINSON GW, 1993, MOL CELL BIOL, V13, P2706, DOI 10.1128/MCB.13.5.2706; Salimova E, 1999, PLANT PHYSIOL BIOCH, V37, P241, DOI 10.1016/S0981-9428(99)80022-9; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Spanova M, 2011, EUR J LIPID SCI TECH, V113, P1299, DOI 10.1002/ejlt.201100203; SUMMERS C, 1993, GENE, V136, P185, DOI 10.1016/0378-1119(93)90462-C; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Ta MT, 2012, FEBS J, V279, P4231, DOI 10.1111/febs.12015; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang LY, 2014, PHOTOSYNTH RES, V121, P175, DOI 10.1007/s11120-014-9983-x; Wentzinger LF, 2002, PLANT PHYSIOL, V130, P334, DOI 10.1104/pp.004655; Yamano T, 2013, J BIOSCI BIOENG, V115, P691, DOI 10.1016/j.jbiosc.2012.12.020	53	47	49	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120446	10.1371/journal.pone.0120446	http://dx.doi.org/10.1371/journal.pone.0120446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764133	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300041
J	Zhong, GC; Wang, Y; Zhang, Y; Guo, JJ; Zhao, Y				Zhong, Guochao; Wang, Yi; Zhang, Yong; Guo, Jeff Jianfei; Zhao, Yong			Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers	PLOS ONE			English	Article							40-YEAR FOLLOW-UP; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; CIGARETTE-SMOKING; CARDIOVASCULAR-DISEASE; VASCULAR DEMENTIA; MENDELIAN RANDOMIZATION; DIAGNOSTIC-CRITERIA; INCIDENT DEMENTIA; PHYSICAL-ACTIVITY	Background Previous studies showed inconsistent results on the association of smoking with all-cause dementia and vascular dementia (VaD), and are limited by inclusion of a small number of studies and unexplained heterogeneity. Our review aimed to assess the risk of all-cause dementia, Alzheimer's disease (AD) and VaD associated with smoking, and to identify potential effect modifiers. Methods and Findings The PubMed, Embase, Cochrane Library and Psychinfo databases were searched to identify studies that provided risk estimates on smoking and incidence of dementia. A random-effects model was used to yield pooled results. Thirty-seven studies were included. Compared with never smokers, current smokers showed an increased risk of all-cause dementia (risk ratio (RR) 1.30, 95% confidence interval (CI) 1.18-1.45), AD (RR 1.40, 95% CI 1.13-1.73) and VaD (RR 1.38, 95% CI 1.15-1.66). For all-cause dementia, the risk increased by 34% for every 20 cigarettes per day (RR 1.34, 95% CI 1.25-1.43). Former smokers did not show an increased risk of all-cause dementia (RR 1.01, 95% CI 0.96-1.06), AD (RR 1.04, 95% CI 0.96-1.13) and VaD (RR 0.97, 95% CI 0.83-1.13). Subgroup analyses indicated that (1) the significantly increased risk of AD from current smoking was seen only in apolipoprotein E epsilon 4 noncarriers; (2) current smokers aged 65 to 75 years at baseline showed increased risk of all-cause dementia and AD compared to those aged over 75 or under 65 years; and (3) sex, race, study location and diagnostic criteria difference in risk of dementia was not found. Conclusions Smokers show an increased risk of dementia, and smoking cessation decreases the risk to that of never smokers. The increased risk of AD from smoking is more pronounced in apolipoprotein E epsilon 4 noncarriers. Survival bias and competing risk reduce the risk of dementia from smoking at extreme age.	[Zhong, Guochao; Wang, Yi] Chongqing Med Univ, Coll Clin Med 2, Chongqing, Peoples R China; [Zhang, Yong; Zhao, Yong] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Guo, Jeff Jianfei] Univ Cincinnati, Coll Pharm, Div Pharm Practice & Adm Sci, Cincinnati, OH 45221 USA	Chongqing Medical University; Chongqing Medical University; University System of Ohio; University of Cincinnati	Zhao, Y (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China.	yongzhao1970@sina.cn	Zhao, Yong/Z-3231-2019; zhong, feng/G-4623-2015; Zhang, Yong/B-7089-2016	Zhao, Yong/0000-0001-9290-109X; Zhang, Yong/0000-0003-1436-5951; Zhong, Guo-Chao/0000-0002-0280-7938				Aggarwal NT, 2006, NEUROEPIDEMIOLOGY, V26, P140, DOI 10.1159/000091654; Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Association AP, 1987, DIAGN STAT MAN MENT; Batty GD, 2014, J NEGAT RESULTS BIOM, V13, DOI 10.1186/1477-5751-13-8; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beydoun MA, 2008, AM J EPIDEMIOL, V168, P1179, DOI 10.1093/aje/kwn229; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Bowen ME, 2012, AM J HEALTH PROMOT, V26, P333, DOI 10.4278/ajhp.110311-QUAN-115; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Burke A, 2003, PROG CARDIOVASC DIS, V46, P79, DOI 10.1016/S0033-0620(03)00076-8; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chang CCH, 2012, ALZ DIS ASSOC DIS, V26, P300, DOI 10.1097/WAD.0b013e3182420b6e; Chen RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024817; Cherubini A, 2005, NEUROBIOL AGING, V26, P987, DOI 10.1016/j.neurobiolaging.2004.09.002; Chuang YF, 2010, DEMENT GERIATR COGN, V29, P248, DOI 10.1159/000285166; Dahl AK, 2008, J AM GERIATR SOC, V56, P2261, DOI 10.1111/j.1532-5415.2008.01958.x; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Doll R, 2000, BRIT MED J, V320, P1097, DOI 10.1136/bmj.320.7242.1097; Durazzo TC, 2014, ALZHEIMERS DEMENT, V10, pS122, DOI 10.1016/j.jalz.2014.04.009; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Erkinjuntti T, 1997, NEW ENGL J MED, V337, P1667, DOI 10.1056/NEJM199712043372306; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gao SJ, 2011, J AM GERIATR SOC, V59, P18, DOI 10.1111/j.1532-5415.2010.03169.x; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hassing LB, 2009, INT J OBESITY, V33, P893, DOI 10.1038/ijo.2009.104; HEBERT LE, 1992, AM J EPIDEMIOL, V135, P347, DOI 10.1093/oxfordjournals.aje.a116296; Hernan MA, 2008, EPIDEMIOLOGY, V19, P448, DOI 10.1097/EDE.0b013e31816bbe14; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirayama T, 1992, TOB CONTROL, V1, P176; Huriletemuer, 2010, J NEUROL SCI, V288, P167, DOI 10.1016/j.jns.2009.08.058; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Juan D, 2004, EUR J NEUROL, V11, P277, DOI 10.1046/j.1468-1331.2003.00779.x; Karantzoulis S, 2011, EXPERT REV NEUROTHER, V11, P1579, DOI [10.1586/ERN.11.155, 10.1586/ern.11.155]; Katz MJ, 2012, ALZ DIS ASSOC DIS, V26, P335, DOI 10.1097/WAD.0b013e31823dbcfc; Kaur-Knudsen D, 2012, EUR RESPIR J, V40, P1538, DOI 10.1183/09031936.00176811; Kimm H, 2011, ARCH GERONTOL GERIAT, V52, pE117, DOI 10.1016/j.archger.2010.09.004; Kivipelto M, 2008, J CELL MOL MED, V12, P2762, DOI 10.1111/j.1582-4934.2008.00296.x; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Laurin D, 2004, AM J EPIDEMIOL, V159, P959, DOI 10.1093/aje/kwh124; Laurin D, 2007, CIRCULATION, V116, P2269, DOI 10.1161/CIRCULATIONAHA.106.686477; Laurin D, 2003, J ALZHEIMERS DIS, V5, P315, DOI 10.3233/JAD-2003-5407; Letenneur Luc, 1994, Annals of Epidemiology, V4, P449; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Merchant C, 1999, NEUROLOGY, V52, P1408, DOI 10.1212/WNL.52.7.1408; Moffat SD, 2004, NEUROLOGY, V62, P188, DOI 10.1212/WNL.62.2.188; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; Ogunniyi A, 2011, ACTA NEUROL SCAND, V124, P396, DOI 10.1111/j.1600-0404.2011.01491.x; Organization World Health, 2012, DEM PUBL HLTH PRIOR; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Paciaroni M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000656; Peters Ruth, 2008, BMC Geriatr, V8, P36, DOI 10.1186/1471-2318-8-36; Pohjasvaara T, 1997, STROKE, V28, P785, DOI 10.1161/01.STR.28.4.785; Power BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017902; Reitz C, 2007, NEUROLOGY, V69, P998, DOI 10.1212/01.wnl.0000271395.29695.9a; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Ronnemaa E, 2011, DEMENT GERIATR COGN, V31, P460, DOI 10.1159/000330020; Rosengren A, 2005, ARCH INTERN MED, V165, P321, DOI 10.1001/archinte.165.3.321; Rusanen M, 2010, DEMENT GERIATR COGN, V30, P277, DOI 10.1159/000320484; Rusanen M, 2011, ARCH INTERN MED, V171, P333, DOI 10.1001/archinternmed.2010.393; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Siristatidis C, 2013, HUM REPROD UPDATE, V19, P105, DOI 10.1093/humupd/dms051; Taylor AE, 2014, INT J EPIDEMIOL, V43, P1483, DOI 10.1093/ije/dyu151; Tyas SL, 2001, INT J EPIDEMIOL, V30, P590, DOI 10.1093/ije/30.3.590; Tyas SL, 2003, NEUROBIOL AGING, V24, P589, DOI 10.1016/S0197-4580(02)00156-2; Vardarajan BN, 2014, JAMA NEUROL, V71, P315, DOI 10.1001/jamaneurol.2013.5570; Wang HX, 1999, AM J EPIDEMIOL, V149, P640; Wells G, 2000, NEWCASTLE OTTAWA SCA; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; Zhou R, 2011, J ALZHEIMERS DIS, V24, P101, DOI 10.3233/JAD-2010-101467; Zoccali C, 2006, AM J KIDNEY DIS, V47, P332, DOI 10.1053/j.ajkd.2005.10.027	81	113	118	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118333	10.1371/journal.pone.0118333	http://dx.doi.org/10.1371/journal.pone.0118333			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763939	gold, Green Submitted, Green Published			2022-12-27	WOS:000351276300013
J	Bell, EH; Kirste, S; Fleming, JL; Stegmaier, P; Drendel, V; Mo, X; Ling, S; Fabian, D; Manring, I; Jilg, CA; Schultze-Seemann, W; McNulty, M; Zynger, DL; Martin, D; White, J; Werner, M; Grosu, AL; Chakravarti, A				Bell, Erica Hlavin; Kirste, Simon; Fleming, Jessica L.; Stegmaier, Petra; Drendel, Vanessa; Mo, Xiaokui; Ling, Stella; Fabian, Denise; Manring, Isabel; Jilg, Cordula A.; Schultze-Seemann, Wolfgang; McNulty, Maureen; Zynger, Debra L.; Martin, Douglas; White, Julia; Werner, Martin; Grosu, Anca L.; Chakravarti, Arnab			A Novel MiRNA-Based Predictive Model for Biochemical Failure Following Post-Prostatectomy Salvage Radiation Therapy	PLOS ONE			English	Article							LOCALIZED-PROSTATE-CANCER; NF-KAPPA-B; LYMPH-NODE METASTASIS; BIOPSY GLEASON SCORE; HUMAN GASTRIC-CANCER; HUMAN BREAST-CANCER; RADICAL PROSTATECTOMY; ANALYTICAL VALIDATION; 10-YEAR PROBABILITY; IONIZING-RADIATION	Purpose To develop a microRNA (miRNA)-based predictive model for prostate cancer patients of 1) time to biochemical recurrence after radical prostatectomy and 2) biochemical recurrence after salvage radiation therapy following documented biochemical disease progression post-radical prostatectomy. Methods Forty three patients who had undergone salvage radiation therapy following biochemical failure after radical prostatectomy with greater than 4 years of follow-up data were identified. Formalin-fixed, paraffin-embedded tissue blocks were collected for all patients and total RNA was isolated from 1mm cores enriched for tumor (> 70%). Eight hundred miRNAs were analyzed simultaneously using the nCounter human miRNA v2 assay (NanoString Technologies; Seattle, WA). Univariate and multivariate Cox proportion hazards regression models as well as receiver operating characteristics were used to identify statistically significant miRNAs that were predictive of biochemical recurrence. Results Eighty eight miRNAs were identified to be significantly (p<0.05) associated with biochemical failure post-prostatectomy by multivariate analysis and clustered into two groups that correlated with early (<= 36 months) versus late recurrence (>36 months). Nine miRNAs were identified to be significantly (p<0.05) associated by multivariate analysis with biochemical failure after salvage radiation therapy. A new predictive model for biochemical recurrence after salvage radiation therapy was developed; this model consisted of miR-4516 and miR-601 together with, Gleason score, and lymph node status. The area under the ROC curve (AUC) was improved to 0.83 compared to that of 0.66 for Gleason score and lymph node status alone. Conclusion miRNA signatures can distinguish patients who fail soon after radical prostatectomy versus late failures, giving insight into which patients may need adjuvant therapy. Notably, two novel miRNAs (miR-4516 and miR-601) were identified that significantly improve prediction of biochemical failure post-salvage radiation therapy compared to clinico-histopathological factors, supporting the use of miRNAs within clinically used predictive models. Both findings warrant further validation studies.	[Bell, Erica Hlavin; Kirste, Simon; Fleming, Jessica L.; Stegmaier, Petra; Ling, Stella; Fabian, Denise; Manring, Isabel; McNulty, Maureen; Martin, Douglas; White, Julia; Chakravarti, Arnab] Ohio State Comprehens Canc Ctr, Arthur G James Hosp, Dept Radiat Oncol, Columbus, OH 43210 USA; [Kirste, Simon; Stegmaier, Petra; Grosu, Anca L.] Univ Med Ctr Freiburg, Dept Radiat Oncol, Freiburg, Germany; [Drendel, Vanessa; Werner, Martin] Univ Med Ctr Freiburg, Dept Pathol, Freiburg, Germany; [Mo, Xiaokui] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Jilg, Cordula A.; Schultze-Seemann, Wolfgang] Univ Med Ctr Freiburg, Dept Urol, Freiburg, Germany; [Zynger, Debra L.] Ohio State Univ, Wexner Med Ctr, Dept Pathol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Freiburg; University of Freiburg; University System of Ohio; Ohio State University; University of Freiburg; University System of Ohio; Ohio State University	Bell, EH (corresponding author), Ohio State Comprehens Canc Ctr, Arthur G James Hosp, Dept Radiat Oncol, Columbus, OH 43210 USA.	Erica.Bell@osumc.edu	Bell, Erica/J-2950-2015		Ohio State University Comprehensive Cancer Center; NIH/NCI [1U10CA180850-01, 1R01CA188500-01]; NATIONAL CANCER INSTITUTE [R01CA188500, U10CA180850] Funding Source: NIH RePORTER	Ohio State University Comprehensive Cancer Center; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by funds from The Ohio State University Comprehensive Cancer Center (to AC); NIH/NCI 1U10CA180850-01 and 1R01CA188500-01 (To AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amling CL, 2006, UROL CLIN N AM, V33, P147, DOI 10.1016/j.ucl.2005.12.002; Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blenkiron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080171; Botticella A, 2014, J CANCER RES CLIN, V140, P1111, DOI 10.1007/s00432-014-1673-8; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Cao Yi-Xiong, 2010, Zhonghua Xue Ye Xue Za Zhi, V31, P361; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Cheng C, 2014, TUMOR BIOL, V35, P4177, DOI 10.1007/s13277-013-1546-9; Chiavacci E, 2014, CYTOTECHNOLOGY; Chowdhari S, 2014, J CELL PHYSL; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; Cooperberg MR, 2006, CANCER, V107, P2384, DOI 10.1002/cncr.22262; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Corcoran C, 2014, PROSTATE, V74, P1320, DOI 10.1002/pros.22848; D'Amico AV, 2000, UROLOGY, V55, P572, DOI 10.1016/S0090-4295(99)00479-3; Den RB, 2014, INT J RADIAT ONCOL, V89, P1038, DOI 10.1016/j.ijrobp.2014.04.052; Dong L, 2014, INT J ONCOL, V45, P746, DOI 10.3892/ijo.2014.2459; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Fan YH, 2013, PROTEIN CELL, V4, P176, DOI 10.1007/s13238-013-2084-3; Fendler A, 2011, INT J ONCOL, V39, P1183, DOI 10.3892/ijo.2011.1128; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gordanpour A, 2012, PROSTATE CANCER P D, V15, P314, DOI 10.1038/pcan.2012.3; Greene FL, 2009, AJCC CANC STAGING MA; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haj-Ahmad TA, 2014, J CANCER, V5, P182, DOI 10.7150/jca.6799; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hessvik NP, 2012, BBA-GENE REGUL MECH, V1819, P1154, DOI 10.1016/j.bbagrm.2012.08.016; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Kim WT, 2013, PROSTATE INT, V1, P3, DOI 10.12954/PI.12011; Knezevic D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-690; Larne O, 2013, INT J CANCER, V132, P2867, DOI 10.1002/ijc.27973; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Liang SQ, 2013, TURK NEUROSURG, V23, P721, DOI 10.5137/1019-5149.JTN.7425-12.1; Lichner Z, 2013, CLIN CHEM, V59, P1595, DOI 10.1373/clinchem.2013.205450; Liu AH, 2011, METHODS MOL BIOL, V724, P259, DOI 10.1007/978-1-61779-055-3_16; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; Makarov DV, 2007, UROLOGY, V69, P1095, DOI 10.1016/j.urology.2007.03.042; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; May M, 2007, J UROLOGY, V178, P1957, DOI 10.1016/j.juro.2007.07.043; Mazeh H, 2013, J CANCER, V4, P281, DOI 10.7150/jca.5836; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mosakhani N, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-24; Nielsen T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-177; Noto JM, 2013, AM J PHYSIOL-GASTR L, V305, pG786, DOI 10.1152/ajpgi.00279.2013; Nygren MK, 2014, BRIT J CANCER, V110, P2072, DOI 10.1038/bjc.2014.113; Ohdaira H, 2009, COMPUT BIOL CHEM, V33, P429, DOI 10.1016/j.compbiolchem.2009.09.003; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Quek SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045656; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schubert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065064; Shang Y, 2014, ONCOGENE, V33, P3267, DOI 10.1038/onc.2013.297; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Sobin L, 2009, TNM CLASSIFICATION M; Srivastava A, 2014, TUMOR BIOL, V35, P4867, DOI 10.1007/s13277-014-1638-1; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Veuger SJ, 2009, ONCOGENE, V28, P832, DOI 10.1038/onc.2008.439; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Wang ZS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-76; Wu YY, 2014, ANGIOGENESIS, V17, P247, DOI 10.1007/s10456-013-9394-1; Yan H, 2013, PHARMACOLOGY, V92, P167, DOI 10.1159/000354585; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang M, 2013, ONCOL REP, V29, P169, DOI 10.3892/or.2012.2105; Yang Y, 2013, BIOMED REP, V1, P495, DOI 10.3892/br.2013.109; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Yu XT, 2013, TUMOR BIOL, V34, P3501, DOI 10.1007/s13277-013-0928-3; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhao BS, 2013, ASIAN PAC J CANCER P, V14, P139, DOI 10.7314/APJCP.2013.14.1.139; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x; Ziliak D, 2012, MOL CANCER THER, V11, P2054, DOI 10.1158/1535-7163.MCT-12-0221	89	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118745	10.1371/journal.pone.0118745	http://dx.doi.org/10.1371/journal.pone.0118745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760964	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000036
J	Hadas, L; Hermon, D; Boldo, A; Arieli, G; Gafny, R; King, R; Bar-Gal, GK				Hadas, Lia; Hermon, Dalia; Boldo, Amizor; Arieli, Gal; Gafny, Ron; King, Roni; Bar-Gal, Gila Kahila			Wild Gazelles of the Southern Levant: Genetic Profiling Defines New Conservation Priorities	PLOS ONE			English	Article							OVINE MICROSATELLITES; POLYMORPHIC BOVINE; TAXONOMIC STATUS; GENUS GAZELLA; POPULATION; SOFTWARE; DORCAS; MTDNA; DNA; PURIFICATION	The mountain gazelle (Gazella gazelle), Dorcas gazelle (Gazella Dorcas) and acacia gazelle (Gazella arabica acacia) were historically abundant in the southern Levant, and more specifically in Israel. Anthropogenic and natural changes have caused a rapid decline in gazelle populations, raising concerns about their conservation status and future survival. The genetic profile of 111 wild gazelles from Israel was determined based on three regions of mitochondrial DNA (control region, Cytochrome b and 12S ribosomal RNA) and nine nuclear microsatellite markers. Genetic analysis of the mountain gazelle population, the largest known population of this rare species, revealed adequate diversity levels and gene flow between subpopulations. Nevertheless, ongoing habitat degradation and other human effects, such as poaching, suggest the need for drastic measures to prevent species extinction. Dorcas gazelles in Israel displayed inbreeding within subpopulations while still maintaining considerable genetic diversity overall. This stable population, represented by a distinctive genetic profile, is fragmented and isolated from its relatives in neighboring localities. Based on the genetic profile of a newly sampled subpopulation in Israel, we provide an alternative hypothesis for the historic dispersal of Dorcas gazelle, from the Southern Levant to northern Africa. The small acacia gazelle population was closest to gazelles from the Farasan Islands of Saudi Arabia, based on mitochondrial markers. The two populations did not share haplotypes, suggesting that these two populations may be the last remnant wild gazelles of this species worldwide. Only a dozen acacia gazelles survive in Israel, and urgent steps are needed to ensure the survival of this genetically distinctive lineage. The genetic assessments of our study recognize new conservation priorities for each gazelle species in the Southern Levant.	[Hadas, Lia; Bar-Gal, Gila Kahila] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Hermon, Dalia; Gafny, Ron] Israel Police, Natl Headquarters, Div Identificat & Forens Sci, DNA & Forens Biol Lab, Jerusalem, Israel; [Boldo, Amizor; Arieli, Gal] Israel Nat & Parks Author, Supervis & Enforcement Div, Jerusalem, Israel; [King, Roni] Israel Nat & Parks Author, Sci & Conservat Div, Jerusalem, Israel	Hebrew University of Jerusalem	Bar-Gal, GK (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel.	gila.kahila@mail.huji.ac.il			Israel Nature and Parks Authority	Israel Nature and Parks Authority	The Israel Nature and Parks Authority provided partial support for the work. AB GA and RK are employees of the Israel Nature and Parks Authority and assisted in the design of the study and contributed to the manuscript.	Barmann EV, 2013, ZOOL J LINN SOC-LOND, V169, P673, DOI 10.1111/zoj.12066; Barmann EV, 2013, MAMM BIOL, V78, P220, DOI 10.1016/j.mambio.2012.07.003; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bar-Oz G, 2004, J ARCHAEOL SCI, V31, P217, DOI 10.1016/j.jas.2003.08.003; BISHOP MD, 1994, GENETICS, V136, P619; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Buchanan F. C., 1993, Animal Genetics, V24, P145, DOI 10.1111/j.1365-2052.1993.tb00269.x; BUCHANAN FC, 1994, ANIM GENET, V25, P60, DOI 10.1111/j.1365-2052.1994.tb00069.x; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; Danin A, 1998, ATLAS KARTA HA HAI V; Davis S.J.M., 1983, PALEORIENT, V9, P55; Dolev A., 2004, RED BOOK VERTEBRATES; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Durant SM, 2014, DIVERS DISTRIB, V20, P114, DOI 10.1111/ddi.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Geffen H, 1999, J ZOOL, V247, P113, DOI 10.1017/S0952836999001119; Georges M, 1992, Patent, Patent No. [WO 92/13102, 92130102]; Getraida S, 1990, RES REPORT; Gingold G, 2009, ANIM CONSERV, V12, P155, DOI 10.1111/j.1469-1795.2009.00235.x; Godinho R, 2012, CONSERV GENET, V13, P1003, DOI 10.1007/s10592-012-0348-8; Habibi K, 1992, NATL COMMISSION WILD; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; IUCN SSC Antelope Specialist Group, 2008, IUCN 2013 IUCN RED L; Kankilic T, 2012, FOLIA ZOOL, V61, P129, DOI 10.25225/fozo.v61.i2.a6.2012; Kaplan D, 2002, Z JAGDWISS, V48, P167, DOI 10.1007/BF02192405; KEMP SJ, 1995, ANIM GENET, V26, P299, DOI 10.1111/j.1365-2052.1995.tb02663.x; Lerp H, 2013, SPECIATION NATURAL P, P59; Lerp H, 2012, MAMM BIOL, V78, P383; Lerp H, 2011, ORG DIVERS EVOL, V11, P317, DOI 10.1007/s13127-011-0057-z; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorenzen ED, 2010, J BIOGEOGR, V37, P571, DOI 10.1111/j.1365-2699.2009.02207.x; Manor R, 2005, J WILDLIFE MANAGE, V69, P1683, DOI 10.2193/0022-541X(2005)69[1683:EOHDOU]2.0.CO;2; Manor R, 2004, BIOL CONSERV, V119, P231, DOI 10.1016/j.biocon.2003.11.005; Oron T, 2009, ISRAEL NATURE PARKS, P20; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Penty JM, 1993, ANIM GENET, V24, P219, DOI 10.1111/j.1365-2052.1993.tb00295.x; Perktas U, 2011, BIOL J LINN SOC, V104, P710, DOI 10.1111/j.1095-8312.2011.01750.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2012, FIGTREE V142; Rambaut A, 2013, TRACER V1 5; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roca AL, 2004, NATURE, V429, P649, DOI 10.1038/nature02597; SUNDEN SLF, 1993, ANIM GENET, V24, P69, DOI 10.1111/j.1365-2052.1993.tb00924.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchernov E., 1987, Journal of Vertebrate Paleontology, V7, P284; TCHERNOV E, 1986, Israel Journal of Zoology, V34, P51; Thieven U, 1997, MAMM GENOME, V8, P52, DOI 10.1007/s003359900348; TOLDO SS, 1993, MAMM GENOME, V4, P720, DOI 10.1007/BF00357796; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VAIMAN D, 1994, MAMM GENOME, V5, P288, DOI 10.1007/BF00389543; Willard J M, 1998, Methods Mol Biol, V98, P9; Wronski T, 2010, ISLAND GAZELLE NEWS, P20; Wronski T, 2010, SYST BIODIVERS, V8, P119, DOI 10.1080/14772001003613192; Yeshurun R, 2013, MIDDLE PALEOLITHIC P, P45; YOMTOV Y, 1987, BIOL CONSERV, V40, P245, DOI 10.1016/0006-3207(87)90118-2	60	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116401	10.1371/journal.pone.0116401	http://dx.doi.org/10.1371/journal.pone.0116401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760948	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275000003
J	Ahn, YS; Jeong, KS				Ahn, Yeon-Soon; Jeong, Kyoung Sook			Mortality Due to Malignant and Non-Malignant Diseases in Korean Professional Emergency Responders	PLOS ONE			English	Article							WORLD-TRADE-CENTER; FIRE FIGHTERS; STRUCTURAL FIRES; FIREFIGHTERS; CANCER; SYMPTOMS; OVERHAUL; COHORT; RISK	Objective This study was conducted to estimate the cause-specific mortality in male emergency responders (ER), compare with that of Korean men. Mortality was also compared between more experienced firefighters (i.e., firefighters employed >= 20 years and firefighters employed >= 10 to <20 years) and less experienced firefighters and non-firefighters (i.e., firefighters employed <10 years and non-firefighters) to investigate associations between mortality and exposure to occupational hazards. Methods The cohort was comprised of 33,442 males who were employed as ERs between 1980 and 2007 and not deceased as of 1991. Work history was merged with the death registry from the National Statistical Office of Korea to follow-up on mortality between 1992 and 2007. Standardized mortality ratios (SMR) for ERs were calculated in reference to the Korean male population. Adjusted relative risks (ARRs) of mortalities for firefighters employed >= 20 years and >= 10 years to <20 years were calculated in reference to non-firefighters and firefighters employed <10 years. Results Overall (SMR=0.43, 95% CI=0.39-0.47) and some kinds of cause-specific mortalities were significantly lower among ERs compared with the Korean male population. No significant increase in mortality was observed across the major ICD-10 classifications among ERs. Mortality due to exposure to smoke, fire, and flames (SMR=3.11, 95% CI=1.87-4.85), however, was significantly increased among ERs. All-cause mortality (ARR=1.46, 95% CI=1.13-1.89), overall cancer mortality (ARR=1.54, 95% CI=1.02-2.31) and mortality of external injury, poisoning and external causes (ARR=3.13, 95% CI=1.80-5.46) were significantly increased among firefighters employed >= 20 years compared to those of non-firefighters and firefighters employed <10 years. Conclusions An increase in mortality due to all cancer and external injury, poisoning, and external causes in firefighters employed >= 20 years compared with non- firefighters and firefighters employed <10 years suggests occupational exposure.	[Ahn, Yeon-Soon; Jeong, Kyoung Sook] Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Goyang, South Korea	Dongguk University; NHIS Ilsan Hospital	Ahn, YS (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Goyang, South Korea.	ysahn@dongguk.ac.kr	Jeong, Kyoung Sook/AAI-6244-2021	Jeong, Kyoung Sook/0000-0002-6897-8289	Korea National Emergency Management Agency [KFI-2009-Next generation-001]	Korea National Emergency Management Agency	This study was supported by Grant No. KFI-2009-Next generation-001 from Korea National Emergency Management Agency.	Ahn Y.S., 2011, ANAL RISK FACTORS RE; Ahn YS, 2012, AM J IND MED, V55, P768, DOI 10.1002/ajim.22068; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Austin CC, 2001, J TOXICOL ENV HEAL A, V63, P437, DOI 10.1080/152873901300343470; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Baris D, 2001, AM J IND MED, V39, P463, DOI 10.1002/ajim.1040; BEAUMONT JJ, 1991, AM J IND MED, V19, P357, DOI 10.1002/ajim.4700190309; Bogucki S, 2005, TXB CLIN OCCUPATIONA, P275; Bolstad-Johnson DM, 2000, AIHAJ, V61, P636, DOI 10.1202/0002-8894(2000)061<0636:COFEDF>2.0.CO;2; BRANDTRAUF PW, 1988, BRIT J IND MED, V45, P606; Burgess JL, 2004, J OCCUP ENVIRON MED, V46, P1013, DOI 10.1097/01.jom.0000141668.70006.52; Burgess JL, 2001, J OCCUP ENVIRON MED, V43, P467, DOI 10.1097/00043764-200105000-00007; Choi BCK, 2000, J OCCUP ENVIRON MED, V42, P1021, DOI 10.1097/00043764-200010000-00009; Fahy R F., 2009, FIREFIGHTER FATALITI; Feldman DM, 2004, CHEST, V125, P1256, DOI 10.1378/chest.125.4.1256; Gaughan DM, 2008, J OCCUP ENVIRON MED, V50, P1019, DOI 10.1097/JOM.0b013e3181754161; GUIDOTTI TL, 1993, AM J IND MED, V23, P921, DOI 10.1002/ajim.4700230608; GUIDOTTI TL, 1992, INT ARCH OCC ENV HEA, V64, P1, DOI 10.1007/BF00625945; Haas NS, 2003, INT J OCCUP ENV HEAL, V9, P95, DOI 10.1179/oeh.2003.9.2.95; IARC working group, 2010, PAINT FIR SHIFTW, P403; JANKOVIC J, 1991, ANN OCCUP HYG, V35, P581, DOI 10.1093/annhyg/35.6.581; Kim KS, 2008, STATUS HLTH MANAGEME; LeMasters GK, 2006, J OCCUP ENVIRON MED, V48, P1189, DOI 10.1097/01.jom.0000246229.68697.90; LOWRY WT, 1985, J FORENSIC SCI, V30, P59; Ma FC, 2005, AM J IND MED, V47, P509, DOI 10.1002/ajim.20160; MUSK AW, 1978, BRIT J IND MED, V35, P104; Mustajbegovi J, 2001, AM J IND MED, V40, P55, DOI 10.1002/ajim.1071; NEMA, 2009, 2009 MAJ STAT NAT EM; Park RM, 2005, AM J IND MED, V48, P194, DOI 10.1002/ajim.20197; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Ribeiro M, 2009, AM J IND MED, V52, P261, DOI 10.1002/ajim.20669; Scannell CH, 1995, OCCUP MED, V10, P789; TORNLING G, 1994, AM J IND MED, V25, P219, DOI 10.1002/ajim.4700250208; VENA JE, 1987, AM J IND MED, V11, P671, DOI 10.1002/ajim.4700110608; Webber MP, 2009, ENVIRON HEALTH PERSP, V117, P975, DOI 10.1289/ehp.0800291	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120305	10.1371/journal.pone.0120305	http://dx.doi.org/10.1371/journal.pone.0120305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756281	gold, Green Published			2022-12-27	WOS:000351275700065
J	Scopel, JF; Queiroz, LD; O'Dowd, FP; Franca, MC; Nucci, A; Honnicke, MG				Scopel, Jonas Francisco; Queiroz, Luciano de Souza; O'Dowd, Francis Pierce; Franca Junior, Marcondes Cavalcante; Nucci, Anamarli; Hoennicke, Marcelo Goncalves			Are Human Peripheral Nerves Sensitive to X-Ray Imaging?	PLOS ONE			English	Article							PHASE-CONTRAST; RADIOGRAPHY; TOMOGRAPHY	Diagnostic imaging techniques play an important role in assessing the exact location, cause, and extent of a nerve lesion, thus allowing clinicians to diagnose and manage more effectively a variety of pathological conditions, such as entrapment syndromes, traumatic injuries, and space-occupying lesions. Ultrasound and nuclear magnetic resonance imaging are becoming useful methods for this purpose, but they still lack spatial resolution. In this regard, recent phase contrast x-ray imaging experiments of peripheral nerve allowed the visualization of each nerve fiber surrounded by its myelin sheath as clearly as optical microscopy. In the present study, we attempted to produce high-resolution x-ray phase contrast images of a human sciatic nerve by using synchrotron radiation propagation-based imaging. The images showed high contrast and high spatial resolution, allowing clear identification of each fascicle structure and surrounding connective tissue. The outstanding result is the detection of such structures by phase contrast x-ray tomography of a thick human sciatic nerve section. This may further enable the identification of diverse pathological patterns, such as Wallerian degeneration, hypertrophic neuropathy, inflammatory infiltration, leprosy neuropathy and amyloid deposits. To the best of our knowledge, this is the first successful phase contrast x-ray imaging experiment of a human peripheral nerve sample. Our long-term goal is to develop peripheral nerve imaging methods that could supersede biopsy procedures.	[Scopel, Jonas Francisco] Univ Fed Goias, Inst Ciencias Saude, BR-75804020 Jatai, Goias, Brazil; [Queiroz, Luciano de Souza] Univ Estadual Campinas, Dept Anat Patol, BR-13083887 Campinas, SP, Brazil; [O'Dowd, Francis Pierce] Lab Nacl Luz Sincrotron, BR-13083970 Campinas, SP, Brazil; [Franca Junior, Marcondes Cavalcante; Nucci, Anamarli] Univ Estadual Campinas, Dept Neurol, BR-13083887 Campinas, SP, Brazil; [Hoennicke, Marcelo Goncalves] Univ Fed Integracao Latino Amer, Inst Latino Amer Ciencias Vida & Nat, BR-85867970 Foz Do Iguacu, Parana, Brazil	Universidade Federal de Goias; Universidade Estadual de Campinas; Laboratorio Nacional de Luz Sincrotron (LNLS); Universidade Estadual de Campinas; Universidade Federal da Integracao Latino-Americana	Scopel, JF (corresponding author), Univ Fed Goias, Inst Ciencias Saude, BR-75804020 Jatai, Goias, Brazil.	jonasscopel@ufg.br	Honnicke, Marcelo G/I-8624-2012	Honnicke, Marcelo G/0000-0003-3276-4323	Conselho Nacional de Desenvolvimento Cientifico eTecnologico [309109/2013-2]; UNILA [23422.010903/2014-47]	Conselho Nacional de Desenvolvimento Cientifico eTecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UNILA	The authors acknowledge Laboratorio Nacional de Luz Sincrotron/Ministerio da Ciencia e Tecnologia (lnls.cnpem.br) for the beamtime (under proposals D09B-Friendly User and D10A-XRD2-16169). MGH thanks Conselho Nacional de Desenvolvimento Cientifico eTecnologico (www.cnpq.br), grant no. 309109/2013-2, for the research fellow. The authors acknowledge UNILA (no. 23422.010903/2014-47) for the publication support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M., 1972, P 6 INT C XRAY OPT M, P63; Antunes A, 2005, NUCL INSTRUM METH B, V238, P28, DOI 10.1016/j.nimb.2005.06.013; Barohn RJ, 1998, SEMIN NEUROL, V18, P7, DOI 10.1055/s-2008-1040857; Bech M, 2009, J SYNCHROTRON RADIAT, V16, P43, DOI 10.1107/S090904950803464X; Beckmann F, 1999, BIOPHYS J, V76, P98, DOI 10.1016/S0006-3495(99)77181-X; Bewer B, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478018; Chapman D, 2006, NUCL INSTRUM METH A, V562, P461, DOI 10.1016/j.nima.2006.02.185; Cloetens P, 1997, OBSERVATION MICROSTR, V81; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; FORSTER E, 1980, KRIST TECH, V15, P937, DOI 10.1002/crat.19800150812; Giles C, 2003, J SYNCHROTRON RADIAT, V10, P421, DOI 10.1107/S0909049503020144; Honnicke MG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2814022; Honnicke MG, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4767243; Honnicke MG, 2008, OPT EXPRESS, V16, P9284, DOI 10.1364/OE.16.009284; Honnicke MG, 2008, NUCL INSTRUM METH A, V584, P418, DOI 10.1016/j.nima.2007.10.036; Honnicke MG, 2009, J APPL CRYSTALLOGR, V42, P999, DOI 10.1107/S0021889809040199; Honnicke MG, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2018456; INGAL VN, 1995, J PHYS D APPL PHYS, V28, P2314, DOI 10.1088/0022-3727/28/11/012; Kelly ME, 2007, CAN J OPHTHALMOL, V42, P731, DOI 10.3129/i07-132; Kermarrec E, 2010, SEMIN MUSCULOSKEL R, V14, P463, DOI 10.1055/s-0030-1268067; Kim BI, 2008, MICROSC RES TECHNIQ, V71, P443, DOI 10.1002/jemt.20571; Lareida A, 2009, J MICROSC-OXFORD, V234, P95, DOI 10.1111/j.1365-2818.2009.03143.x; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Liu R, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/25002; Martinoli C, 2010, SEMIN MUSCULOSKEL R, V14, P461, DOI 10.1055/s-0030-1268395; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; Momose A, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0023; Nugent KA, 2007, J OPT SOC AM A, V24, P536, DOI 10.1364/JOSAA.24.000536; Olivo A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772193; Parham C, 2009, ACAD RADIOL, V16, P911, DOI 10.1016/j.acra.2009.02.007; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Podurets K. M., 1989, Soviet Physics - Technical Physics, V34, P654; Rosenberg NR, 2001, J NEUROL NEUROSUR PS, V71, P205, DOI 10.1136/jnnp.71.2.205; Sarapata A, 2014, MED PHYS, V41, DOI 10.1118/1.4860275; Strengell S, 2014, J SYNCHROTRON RADIAT, V21, P1305, DOI 10.1107/S160057751401697X; Suortti P, 2003, PHYS MED BIOL, V48, pR1, DOI 10.1088/0031-9155/48/13/201; Tuohimaa T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2769760; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006; Zhou SA, 2011, NUCL INSTRUM METH A, V648, pS284, DOI 10.1016/j.nima.2010.11.050	40	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116831	10.1371/journal.pone.0116831	http://dx.doi.org/10.1371/journal.pone.0116831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757086	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275700012
J	Welcome, SE; Alton, AC				Welcome, Suzanne E.; Alton, Amanda C.			Individual Differences in the Effect of Orthographic/Phonological Conflict on Rhyme and Spelling Decisions	PLOS ONE			English	Article							AUDITORY WORD RECOGNITION; ORTHOGRAPHIC FACILITATION; BRAIN POTENTIALS; NORMAL READERS; TASKS; STUDENTS; CHILDREN; SPEECH	In typical readers, orthographic knowledge has been shown to influence phonological decisions. In the present study, we used visual rhyme and spelling tasks to investigate the interaction of orthographic and phonological information in adults with varying reading skill. Word pairs that shared both orthography and phonology (e.g., throat/boat), differed in both orthography and phonology (e.g., snow/arm), shared only orthography (e.g., farm/warm), and shared only phonology (e.g., vote/boat) were visually presented to university students who varied in reading ability. For rhyme judgment, participants were slower and less accurate to accept rhyming pairs when words were spelled differently and to reject non-rhyming pairs when words were spelled similarly. Similarly, for spelling judgments, participants were slower and less accurate when indicating that word endings were spelled differently when words rhymed, and slower and less accurate when indicating that words were spelled similarly when words did not rhyme. Crucially, while these effects were clear at the group level, there were large individual differences in the extent to which participants were impacted by conflict. In two separate samples, reading skill was associated with the extent to which orthographic conflict impacted rhyme decisions such that individuals with better nonword reading performance were less impacted by orthographic conflict. Thus, university students with poorer reading skills may differ from their peers either in the reading strategies they use or in the degree to which they automatically access word form information. Understanding these relationships is important for understanding the roles that reading processes play in readers of different skill.	[Welcome, Suzanne E.; Alton, Amanda C.] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Welcome, SE (corresponding author), Univ Missouri, Dept Psychol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	welcomes@umsl.edu			University of Missouri Research Board Grant	University of Missouri Research Board Grant	This research was supported by a University of Missouri Research Board Grant to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown L., 1997, TEST NONVERBAL INTEL; Chereau C, 2007, COGNITION, V102, P341, DOI 10.1016/j.cognition.2006.01.001; Damian MF, 2010, EUR J COGN PSYCHOL, V22, P106, DOI 10.1080/09541440902734263; Desroches AS, 2010, BRAIN RES, V1356, P73, DOI 10.1016/j.brainres.2010.07.097; Dich N, 2011, APPL PSYCHOLINGUIST, V32, P169, DOI 10.1017/S0142716410000330; DIJKSTRA T, 1995, CAN J EXP PSYCHOL, V49, P264, DOI 10.1037/1196-1961.49.2.264; Greenberg D, 1997, J EDUC PSYCHOL, V89, P262; Greenberg D., 2002, SCI STUD READ, V6, P221, DOI [10.1207/S1532799XSSR0603_2, DOI 10.1207/S1532799XSSR0603_2]; Grossi G, 2001, J COGNITIVE NEUROSCI, V13, P610, DOI 10.1162/089892901750363190; Hanna G.S., 1993, NELSON DENNY READING; Holmes VM, 1996, COGN NEUROPSYCHOL, V13, P1207; HOWARD D, 1997, J RES READ, V20, P55; Jackson NE, 2005, LEARN INDIVID DIFFER, V15, P113, DOI 10.1016/j.lindif.2004.11.001; KRAMER AF, 1987, J EXP PSYCHOL LEARN, V13, P76, DOI 10.1037/0278-7393.13.1.76; Lefly DL, 2000, J LEARN DISABIL-US, V33, P286, DOI 10.1177/002221940003300306; McPherson WB, 1998, BRAIN LANG, V62, P163, DOI 10.1006/brln.1997.1893; Medler D.A., 2005, MCWORD ONLINE ORTHOG; Miller-Shaul S, 2005, DYSLEXIA, V11, P132, DOI 10.1002/dys.290; Pattamadilok C, 2014, ANN DYSLEXIA, V64, P57, DOI 10.1007/s11881-013-0086-8; Peereman R, 2009, PSYCHON B REV, V16, P363, DOI 10.3758/PBR.16.2.363; PRAAMSTRA P, 1993, COGNITIVE BRAIN RES, V1, P73, DOI 10.1016/0926-6410(93)90013-U; RUGG MD, 1987, BRAIN LANG, V32, P336, DOI 10.1016/0093-934X(87)90132-5; SEIDENBERG MS, 1979, J EXP PSYCHOL-HUM L, V5, P546, DOI 10.1037/0278-7393.5.6.546; Standish VHAJ, 1996, COGN NEUROPSYCHOL, V13, P1207; Torgesen J.K., 1999, TOWRE TEST WORD READ; Welcome SE, 2010, BRAIN LANG, V113, P73, DOI 10.1016/j.bandl.2010.01.003; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; ZECKER SG, 1991, ANN DYSLEXIA, V41, P178, DOI 10.1007/BF02648085; Zeno S.M., 1995, ED WORD FREQUENCY GU; Ziegler JC, 1998, PSYCHON B REV, V5, P683, DOI 10.3758/BF03208845; Ziegler JC, 2003, J MEM LANG, V48, P779, DOI 10.1016/S0749-596X(03)00006-8; Ziegler JC, 2007, PSYCHON B REV, V14, P75, DOI 10.3758/BF03194031	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119734	10.1371/journal.pone.0119734	http://dx.doi.org/10.1371/journal.pone.0119734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9LT	25751539	Green Published, gold			2022-12-27	WOS:000350692700033
J	Ding, JM; Wang, CF; Xie, ZR; Li, JJ; Yang, YJ; Mu, YL; Tang, XH; Xu, B; Zhou, JP; Huang, ZX				Ding, Junmei; Wang, Chaofan; Xie, Zhenrong; Li, Junjun; Yang, Yunjuan; Mu, Yuelin; Tang, Xianghua; Xu, Bo; Zhou, Junpei; Huang, Zunxi			Properties of a Newly Identified Esterase from Bacillus sp K91 and Its Novel Function in Diisobutyl Phthalate Degradation	PLOS ONE			English	Article							MICROCOCCUS SP YGJ1; ACID-ESTERS; DIPENTYL PHTHALATE; MOLECULAR-CLONING; ESCHERICHIA-COLI; GORDONIA SP; PURIFICATION; EXPRESSION; GENE; METABOLISM	The widely used plasticizer phthalate esters (PAEs) have become a public concern because of their effects on environmental contamination and toxicity on mammals. However, the biodegradation of PAEs, especially diisobutyl phthalate (DiBP), remains poorly understood. In particular, genes involved in the hydrolysis of these compounds were not conclusively identified. In this study, the CarEW gene, which encodes an enzyme that is capable of hydrolyzing rho-nitrophenyl esters of fatty acids, was cloned from a thermophilic bacterium Bacillus sp. K91 and heterologously expressed in Escherichia coli BL21 using the pEASYE2 expression system. The enzyme showed a monomeric structure with a molecular mass of approximately 53.76 kDa and pl of 4.88. The enzyme exhibited maximal activity at pH 7.5 and 45 degrees C, with rho-NP butyrate as the best substrate. The enzyme was fairly stable within the pH range from 7.0 to 8.5. High-pressure liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESI-MS) were employed to detect the catabolic pathway of DiBP. Two intermediate products were identified, and a potential biodegradation pathway was proposed. Altogether, our findings present a novel DiBP degradation enzyme and indicate that the purified enzyme may be a promising candidate for DiBP detoxification and for environmental protection.	[Ding, Junmei; Wang, Chaofan; Xie, Zhenrong; Li, Junjun; Yang, Yunjuan; Mu, Yuelin; Tang, Xianghua; Xu, Bo; Huang, Zunxi] Yunnan Normal Univ, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Minist Educ, Kunming 650500, Yunnan, Peoples R China; [Ding, Junmei; Wang, Chaofan; Li, Junjun; Yang, Yunjuan; Mu, Yuelin; Tang, Xianghua; Xu, Bo; Huang, Zunxi] Yunnan Normal Univ, Key Lab Enzyme Engn, Kunming 650500, Yunnan, Peoples R China	Yunnan Normal University; Yunnan Normal University	Huang, ZX (corresponding author), Yunnan Normal Univ, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Minist Educ, Kunming 650500, Yunnan, Peoples R China.	huangzunxi@163.com			National Natural Science Foundation Program of PR China [31160229]	National Natural Science Foundation Program of PR China(National Natural Science Foundation of China (NSFC))	This project was supported by a grant from National Natural Science Foundation Program of PR China (31160229) to Z. Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, CURR MICROBIOL, V52, P340, DOI 10.1007/s00284-005-0124-9; Akita K, 2001, BIOSCI BIOTECH BIOCH, V65, P1680, DOI 10.1271/bbb.65.1680; Bajkin Ivana, 2014, Med Pregl, V67, P172; Beverly BEJ, 2014, TOXICOL SCI, V141, P524, DOI 10.1093/toxsci/kfu149; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang HK, 1998, J BACTERIOL, V180, P6529, DOI 10.1128/JB.180.24.6529-6537.1998; Chatterjee S, 2003, BIOCHEM BIOPH RES CO, V309, P36, DOI 10.1016/S0006-291X(03)01513-4; Christensen KLY, 2014, REGUL TOXICOL PHARM, V69, P380, DOI 10.1016/j.yrtph.2014.04.019; Eaton RW, 2001, J BACTERIOL, V183, P3689, DOI 10.1128/JB.183.12.3689-3703.2001; EATON RW, 1982, J BACTERIOL, V151, P48, DOI 10.1128/JB.151.1.48-57.1982; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graham P R, 1973, Environ Health Perspect, V3, P3, DOI 10.2307/3428023; Gu JD, 2005, WATER SCI TECHNOL, V52, P241, DOI 10.2166/wst.2005.0269; Habe H, 2003, APPL MICROBIOL BIOT, V61, P44, DOI 10.1007/s00253-002-1166-6; Hara H, 2010, APPL ENVIRON MICROB, V76, P1516, DOI 10.1128/AEM.02621-09; HWANG CS, 1993, J BIOL CHEM, V268, P14278; Jiao YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075977; LEE YP, 1993, BIOCHIM BIOPHYS ACTA, V1169, P156; Luo ZH, 2012, PROCESS BIOCHEM, V47, P687, DOI 10.1016/j.procbio.2012.01.015; Luo ZH, 2009, MAR POLLUT BULL, V58, P765, DOI 10.1016/j.marpolbul.2009.03.005; Maruyama K, 2005, J BIOCHEM, V137, P27, DOI 10.1093/jb/mvi004; Miyazaki M, 2003, BIOCHEM J, V370, P101, DOI 10.1042/BJ20021446; Nishioka T, 2006, APPL ENVIRON MICROB, V72, P2394, DOI 10.1128/AEM.72.4.2394-2399.2006; NOZAWA T, 1988, J BACTERIOL, V170, P5778, DOI 10.1128/jb.170.12.5778-5784.1988; Nthangeni MB, 2005, J MICROBIOL METH, V61, P225, DOI 10.1016/j.mimet.2004.11.021; Pant N, 2014, ENVIRON SCI POLLUT R, V21, P11066, DOI 10.1007/s11356-014-2986-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pindel EV, 1997, J BIOL CHEM, V272, P14769, DOI 10.1074/jbc.272.23.14769; Qiu YL, 2004, APPL ENVIRON MICROB, V70, P1617, DOI 10.1128/AEM.70.3.1617-1626.2004; SAEGER VW, 1976, APPL ENVIRON MICROB, V31, P29, DOI 10.1128/AEM.31.1.29-34.1976; Saito T, 2010, CHEMOSPHERE, V81, P1544, DOI 10.1016/j.chemosphere.2010.08.020; Shapiro SD, 2004, SCI TOTAL ENVIRON, V321, P201, DOI 10.1016/j.scitotenv.2003.09.007; SHELTON DR, 1984, ENVIRON SCI TECHNOL, V18, P93, DOI 10.1021/es00120a008; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang JL, 2000, CHEMOSPHERE, V41, P1245, DOI 10.1016/S0045-6535(99)00552-4; Weir SM, 2014, CHEMOSPHERE, V103, P44, DOI 10.1016/j.chemosphere.2013.10.097; Wu J, 2013, APPL MICROBIOL BIOT, V97, P2483, DOI 10.1007/s00253-012-4232-8; Zhang XY, 2014, APPL ENVIRON MICROB, V80, P6870, DOI 10.1128/AEM.02072-14	42	36	40	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119216	10.1371/journal.pone.0119216	http://dx.doi.org/10.1371/journal.pone.0119216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746227	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400057
J	Sharma, S; Citti, C; Sagne, E; Marenda, MS; Markham, PF; Browning, GF				Sharma, Shukriti; Citti, Chistine; Sagne, Eveline; Marenda, Marc S.; Markham, Philip F.; Browning, Glenn F.			Development and Host Compatibility of Plasmids for Two Important Ruminant Pathogens, Mycoplasma bovis and Mycoplasma agalactiae	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; ORIC PLASMIDS; ACHOLEPLASMA-LAIDLAWII; SPIROPLASMA-CITRI; GENE DISRUPTION; GALLISEPTICUM; PNEUMONIA; CONSTRUCTION; REPLICATION; CHROMOSOME	Mycoplasma bovis is a cause of pneumonia, mastitis, arthritis and otitis media in cattle throughout the world. However, despite its clinical significance, there is a paucity of tools to genetically manipulate it, impeding our capacity to further explore the molecular basis of its virulence. To address this limitation, we developed a series of homologous and heterologous replicable plasmids from M. bovis and M. agalactiae. The shortest replicable oriC plasmid based on the region downstream of dnaA in M. bovis was 247 bp and contained two DnaA boxes, while oriC plasmids based on the region downstream of dnaA in M. agalactiae strains 5632 and PG2 were 219 bp and 217 bp in length, respectively, and contained only a single DnaA box. The efficiency of transformation in M. bovis and M. agalactiae was inversely correlated with the size of the oriC region in the construct, and, in general, homologous oriC plasmids had a higher transformation efficiency than heterologous oriC plasmids. The larger pWholeoriC45 and pMM21-7 plasmids integrated into the genomic oriC region of M. bovis, while the smaller oriC plasmids remained extrachromosomal for up to 20 serial passages in selective media. Although specific gene disruptions were not be achieved in M. bovis in this study, the oriC plasmids developed here could still be useful as tools in complementation studies and for expression of exogenous genes in both M. bovis and M. agalactiae.	[Sharma, Shukriti; Marenda, Marc S.; Markham, Philip F.; Browning, Glenn F.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic 3010, Australia; [Citti, Chistine; Sagne, Eveline] INRA, ENVT, UMR 1225, F-31076 Toulouse, France	University of Melbourne; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Browning, GF (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic 3010, Australia.	glenfb@unimelb.edu.au	Browning, Glenn Francis/P-4459-2014	Browning, Glenn Francis/0000-0002-0903-2469; Citti, Christine/0000-0003-4754-6003; MARENDA, MARC/0000-0001-6778-1110	Australian Government Australia Award scholarship	Australian Government Australia Award scholarship(Australian Government)	SS was supported by an Australian Government Australia Award scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam AB, 2010, APPL ENVIRON MICROB, V76, P6951, DOI 10.1128/AEM.00056-10; ALUOTTO B B, 1970, International Journal of Systematic Bacteriology, V20, P35; Arcangioli MA, 2008, VET J, V177, P89, DOI 10.1016/j.tvjl.2007.03.008; Baranowski E, 2010, INFECT IMMUN, V78, P1542, DOI 10.1128/IAI.01195-09; CAO J, 1994, J BACTERIOL, V176, P4459, DOI 10.1128/jb.176.14.4459-4462.1994; Caswell JL, 2010, VET CLIN N AM-FOOD A, V26, P365, DOI 10.1016/j.cvfa.2010.03.003; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chopra-Dewasthaly R, 2005, FEMS MICROBIOL LETT, V253, P89, DOI 10.1016/j.femsle.2005.09.021; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Chopra-Dewasthaly R, 2008, MOL MICROBIOL, V67, P1196, DOI 10.1111/j.1365-2958.2007.06103.x; Cordova CMM, 2002, J BACTERIOL, V184, P5426, DOI 10.1128/JB.184.19.5426-5435.2002; Dhandayuthapani S, 1999, P NATL ACAD SCI USA, V96, P5227, DOI 10.1073/pnas.96.9.5227; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Duret S, 1999, J BACTERIOL, V181, P7449, DOI 10.1128/JB.181.24.7449-7456.1999; DYBVIG K, 1992, PLASMID, V28, P262, DOI 10.1016/0147-619X(92)90058-I; DYBVIG K, 1987, SCIENCE, V235, P1392, DOI 10.1126/science.3029869; Gagea MI, 2006, J VET DIAGN INVEST, V18, P29, DOI 10.1177/104063870601800105; Janis C, 2005, APPL ENVIRON MICROB, V71, P2888, DOI 10.1128/AEM.71.6.2888-2893.2005; Kadoya R, 2002, MOL MICROBIOL, V45, P73, DOI 10.1046/j.1365-2958.2002.03016.x; Lartigue C, 2003, NUCLEIC ACIDS RES, V31, P6610, DOI 10.1093/nar/gkg848; Lartigue C, 2002, PLASMID, V48, P149, DOI 10.1016/S0147-619X(02)00121-X; Lee SW, 2008, MICROBIOL-SGM, V154, P2571, DOI 10.1099/mic.0.2008/019208-0; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022185, 10.1371/journal.pone.0026302]; Maglennon GA, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-63; MAHAIRAS GG, 1989, PLASMID, V21, P43, DOI 10.1016/0147-619X(89)90085-1; Markham PF, 2003, J BACTERIOL, V185, P2538, DOI 10.1128/JB.185.8.2538-2547.2003; Nicholas RAJ, 2003, RES VET SCI, V74, P105, DOI 10.1016/S0034-5288(02)00155-8; Qi J, 2012, PLOS ONE, V7, DOI [10.1371/journal. pone.0038239, DOI 10.1371/J0URNAL.P0NE.0038239, 10.1371/journal.pone.0038239]; Qin MH, 1997, J BACTERIOL, V179, P6311, DOI 10.1128/jb.179.20.6311-6317.1997; RENAUDIN J, 1995, J BACTERIOL, V177, P2870, DOI 10.1128/jb.177.10.2870-2877.1995; Renaudin J, 2005, MYCOPLASMAS: MOLECULAR BIOLOGY PATHOGENICITY AND STRATEGIES FOR CONTROL, P3; Renaudin J., 2014, MOLLICUTES MOL BIOL, P55; Rocha E, 2005, MYCOPLASMAS: MOLECULAR BIOLOGY PATHOGENICITY AND STRATEGIES FOR CONTROL, P31; Rodriguez F, 1996, J COMP PATHOL, V115, P151, DOI 10.1016/S0021-9975(96)80037-5; ROSENGARTEN R, 1999, MYCOPLASMAS RUMINANT, V3, P14; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sharma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097100; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119000	10.1371/journal.pone.0119000	http://dx.doi.org/10.1371/journal.pone.0119000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746296	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400037
J	Angeletti, D; Sandalova, T; Wahlgren, M; Achour, A				Angeletti, Davide; Sandalova, Tatyana; Wahlgren, Mats; Achour, Adnane			Binding of Subdomains 1/2 of PfEMP1-DBL1 alpha to Heparan Sulfate or Heparin Mediates Plasmodium falciparum Rosetting	PLOS ONE			English	Article							CEREBRAL MALARIA; IN-VIVO; PFEMP1; PROTEIN; DOMAIN; ERYTHROCYTES; ANTIGEN; CELLS	The capacity of Plasmodium falciparum parasitized erythrocytes (pRBC) to adhere to the endothelial lining in the microvasculature and to red blood cells (RBC) is associated with the virulence of the parasite, the pathogenesis and development of severe malaria. Rosetting, the binding of uninfected RBC to pRBC, is frequently observed in individuals with severe malaria and is mediated by the N-terminal NTS-DBL1 alpha domain of the adhesin Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) expressed at the surface of the pRBC. Heparan sulfate has been suggested to be an important receptor for the NTS-DBL1 alpha variant IT4(var60) expressed by the parasite FCR3S1.2. Here, we have determined the binding site of NTS-DBL1 alpha (IT4var60) to the RBC and heparin using a set of recombinant, mutated proteins expressed in and purified from E. coli. All the variants were studied for their ability to bind to RBC, their capacities to disrupt FCR3S1.2 rosettes, their affinities for heparin and their binding to rosette-disruptive mAbs. Our results suggest that NTS-DBL1 alpha mediates binding to RBC through a limited number of basic amino acid residues localized on the surface of subdomains 1 (SD1) and 2 (SD2). The SD2-binding site is localized in close proximity to one of two previously identified binding sites in the rosetting PfEMP1 of the parasite PaloAlto-varO. The binding site in SD2 of NTS-DBL1 alpha could represent a template for the development of anti-rosetting drugs.	[Angeletti, Davide; Sandalova, Tatyana; Achour, Adnane] Karolinska Inst, Dept Med Solna, Sci Life Lab, Stockholm, Sweden; [Angeletti, Davide; Wahlgren, Mats] Karolinska Inst, Dept Microbiol, Tumor & Cell Biol MTC, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Wahlgren, M (corresponding author), Karolinska Inst, Dept Microbiol, Tumor & Cell Biol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se; adnane.achour@ki.se	Angeletti, Davide/H-7350-2019	Angeletti, Davide/0000-0002-5256-1972; Achour, Adnane/0000-0003-0432-710X; Sandalova, Tatyana/0000-0002-7694-6420	Karolinska Institute; European Union (EvimalaR); Swedish Research Council; Karolinska Institutet; Swedish International Development Cooperation Agency (Sida/SAREC)	Karolinska Institute(Karolinska Institutet); European Union (EvimalaR); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish International Development Cooperation Agency (Sida/SAREC)	This study was supported by a grant from the Karolinska Institute (AA) as well as grants from the European Union (EvimalaR), the Swedish Research Council, Karolinska Institutet, and the Swedish International Development Cooperation Agency (Sida/SAREC)(MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; [Anonymous], 2013, METHODS MALARIA RES; Barragan A, 2000, BLOOD, V95, P3594, DOI 10.1182/blood.V95.11.3594.011k21_3594_3599; Barragan A, 2000, INFECT IMMUN, V68, P2971, DOI 10.1128/IAI.68.5.2971-2975.2000; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Blomqvist K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052679; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Dahlback M, 2010, TRENDS PARASITOL, V26, P230, DOI 10.1016/j.pt.2010.02.002; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; KAUL DK, 1991, BLOOD, V78, P812; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Miller LH, 2002, MOL BIOCHEM PARASIT, V120, P321, DOI 10.1016/S0166-6851(02)00011-7; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Siddiqui AA, 2012, INFECT IMMUN, V80, P2920, DOI 10.1128/IAI.00206-12; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; White NJ, 2013, J INFECT DIS, V208, P192, DOI 10.1093/infdis/jit116; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WHO, 2012, WORLD MALARIA REPORT 2012, P1	42	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118898	10.1371/journal.pone.0118898	http://dx.doi.org/10.1371/journal.pone.0118898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742651	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100058
J	Chen, YL; Lin, HC; Lin, KH; Lin, LS; Hsieh, CE; Ko, CJ; Hung, YJ; Lin, PY				Chen, Yao-Li; Lin, Hui-Chuan; Lin, Kuo-Hua; Lin, Li-Si; Hsieh, Chia-En; Ko, Chih-Jan; Hung, Yu-Ju; Lin, Ping-Yi			Low Hemoglobin Level Is Associated with the Development of Delirium after Hepatectomy for Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							POSTOPERATIVE DELIRIUM; RISK-FACTORS; NONCARDIAC SURGERY; DIAGNOSIS	Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide and liver resection is the only potential curative treatment option for those patients. Postoperative complications specific to elderly surgical patients such as delirium will be increasingly relevant in the coming decades. Herein, we aimed to investigate the risk factors for postoperative delirium in patients who have received hepatectomy for HCC. Methods This is a single medical center observational study and the study subjects comprised 401 individuals who underwent liver resection for hepatocellular carcinoma during January 2009 to October 2013. Multivariate analysis was used to examine whether preoperative, intra-operative, or postoperative variables were associated with the development of delirium. Results Of the 401 patients who underwent hepatectomy, 34 developed postoperative delirium (8.4%). In the majority of those patients, symptoms and signs of the syndrome occurred on postoperative day 2 and the mean duration of symptoms was 3.61 +/- 3.71 days. Multivariate analysis revealed that advanced age (> 71 years) [odds ratio (OR) = 1.133, 95% confidence interval (CI): 1.071-1.200, p< 0.001], prolonged operative time (> 190 minutes) (OR = 1.009, 95% CI: 1.000-1.017, p = 0.038), a decreased postoperative hemoglobin level (< 10.16 g/dL) (OR = 0.777, 95% CI: 0.613-0.983, p = 0.036), and history of hypnotic drug use (OR = 3.074, 95% CI: 1.045-9.039, p = 0.041) were independent risk factors for the development of postoperative delirium after hepatectomy. Conclusions Although the mechanism of postoperative delirium is not well understood, numbers of studies have shown that patients with postoperative delirium tend to have prolonged hospital stay, worse postoperative outcome and an increased risk of short- and long-term mortality. In this study, we found that advanced age, prolonged operative time, postoperative low hemoglobin level and history of hypnotic drug use are independent risk factors for postoperative delirium.	[Chen, Yao-Li; Lin, Kuo-Hua; Lin, Li-Si; Hsieh, Chia-En; Ko, Chih-Jan; Hung, Yu-Ju] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan; [Lin, Ping-Yi] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Lin, Hui-Chuan] Hung Kuang Univ, Dept Senior Citizen Welf & Business, Taichung, Taiwan; [Chen, Yao-Li] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Ping-Yi] Cent Taiwan Univ Sci & Technol, Dept Nursing, Taichung, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Hungkuang University; Chung Shan Medical University; Kaohsiung Medical University; Central Taiwan University Science & Technology	Hung, YJ (corresponding author), Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan.	149116@cch.org.tw; 69221@cch.org.tw						BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Dasgupta M, 2006, J AM GERIATR SOC, V54, P1578, DOI 10.1111/j.1532-5415.2006.00893.x; DeBellis Ronald, 2005, J Intensive Care Med, V20, P164, DOI 10.1177/0885066605275353; DICKSON LR, 1991, PSYCHOSOMATICS, V32, P317, DOI 10.1016/S0033-3182(91)72071-9; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jochum T, 2011, OPEN CRITICAL CARE M, V4, P47; Kawaguchi Yoshiharu, 2006, Spine J, V6, P164, DOI 10.1016/j.spinee.2005.06.010; Lee JK, 2010, SPINE, V35, P1729, DOI 10.1097/BRS.0b013e3181c423fc; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; MULLER WE, 1991, ACTA PSYCHIAT SCAND, V83, P34, DOI 10.1111/j.1600-0447.1991.tb03107.x; National Clinical Guideline Centre, 2010, PAT DEL EXP VID; OKEEFE ST, 1994, BRIT J ANAESTH, V73, P673, DOI 10.1093/bja/73.5.673; RICH MW, 1989, AM J CARDIOL, V63, P714, DOI 10.1016/0002-9149(89)90257-9; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Robinson TN, 2008, CLIN INTERV AGING, V3, P351, DOI 10.2147/CIA.S2759; Schneider F, 2002, GEN HOSP PSYCHIAT, V24, P28, DOI 10.1016/S0163-8343(01)00168-2; Steiner LA, 2011, EUR J ANAESTH, V28, P723, DOI 10.1097/EJA.0b013e328349b7db; Steiner LA, 2011, EUR J ANAESTH, V28, P628, DOI 10.1097/EJA.0b013e328349b7f5; Takeuchi M, 2012, ANN SURG ONCOL, V19, P3963, DOI 10.1245/s10434-012-2432-1; Tei M, 2010, SURG ENDOSC, V24, P2135, DOI 10.1007/s00464-010-0911-7; Trzepacz P T, 2000, Semin Clin Neuropsychiatry, V5, P132; WHO, 2010, INT STAT CLASS DIS R; Yildizeli B, 2005, ANN THORAC SURG, V79, P1004, DOI 10.1016/j.athoracsur.2004.06.022; Yoshimura Y, 2004, WORLD J SURG, V28, P982, DOI 10.1007/s00268-004-7344-1	26	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119199	10.1371/journal.pone.0119199	http://dx.doi.org/10.1371/journal.pone.0119199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768121	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500070
J	Filipek-Gorniok, B; Carlsson, P; Haitina, T; Habicher, J; Ledin, J; Kjellen, L				Filipek-Gorniok, Beata; Carlsson, Pernilla; Haitina, Tatjana; Habicher, Judith; Ledin, Johan; Kjellen, Lena			The Ndst Gene Family in Zebrafish: Role of Ndst1b in Pharyngeal Arch Formation	PLOS ONE			English	Article							HEPARAN-SULFATE SULFOTRANSFERASES; COMBINATORIAL EXPRESSION PATTERNS; GENOME DUPLICATION; MICE DEFICIENT; HSPG SYNTHESIS; DOMAIN; 6-O-SULFOTRANSFERASE; BIOSYNTHESIS; HYPOPLASIA; MUTATIONS	Heparan sulfate (HS) proteoglycans are ubiquitous components of the extracellular matrix and plasma membrane of metazoans. The sulfation pattern of the HS glycosaminoglycan chain is characteristic for each tissue and changes during development. The glucosaminyl N-deacetylase/N-sulfotransferase (NDST) enzymes catalyze N-deacetylation and N-sulfation during HS biosynthesis and have a key role in designing the sulfation pattern. We here report on the presence of five NDST genes in zebrafish. Zebrafish ndst1a, ndst1b, ndst2a and ndst2b represent duplicated mammalian orthologues of NDST1 and NDST2 that arose through teleost specific genome duplication. Interestingly, the single zebrafish orthologue ndst3, is equally similar to tetrapod Ndst3 and Ndst4. It is likely that a local duplication in the common ancestor of lobe-finned fish and tetrapods gave rise to these two genes. All zebrafish Ndst genes showed distinct but partially overlapping expression patterns during embryonic development. Morpholino knockdown of ndst1b resulted in delayed development, craniofacial cartilage abnormalities, shortened body and pectoral fin length, resembling some of the features of the Ndst1 mouse knockout.	[Filipek-Gorniok, Beata; Carlsson, Pernilla; Kjellen, Lena] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Haitina, Tatjana; Habicher, Judith; Ledin, Johan] Uppsala Univ, Sci Life Lab, Dept Organismal Biol, SE-75236 Uppsala, Sweden	Uppsala University; Uppsala University	Kjellen, L (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Husargatan 3,POB 582, SE-75123 Uppsala, Sweden.	lena.kjellen@imbim.uu.se		Haitina, Tatjana/0000-0002-8754-5534; Ledin, Johan/0000-0002-7319-7735	Knut and Alice Wallenberg Foundation; Swedish Research Council; Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations"; Swedish Cancer Society; Stiftelsen for Proteoglykanforskning; Uppsala University	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations"; Swedish Cancer Society(Swedish Cancer Society); Stiftelsen for Proteoglykanforskning; Uppsala University	This work was supported by grants from the Knut and Alice Wallenberg Foundation (to J.L.), the Swedish Research Council (to T.H., J.L., L.K.), the Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations" (to J.L.), the Swedish Cancer Society (L.K.), Stiftelsen for Proteoglykanforskning (L.K.), and Uppsala University (to J.L. and L.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Berninsone P, 1998, J BIOL CHEM, V273, P25556, DOI 10.1074/jbc.273.40.25556; Bink RJ, 2003, J BIOL CHEM, V278, P31118, DOI 10.1074/jbc.M213124200; Cadwallader AB, 2007, DEV DYNAM, V236, P581, DOI 10.1002/dvdy.21051; Cadwallader AB, 2006, DEV DYNAM, V235, P3432, DOI 10.1002/dvdy.20990; Cadwallader AB, 2006, DEV DYNAM, V235, P3423, DOI 10.1002/dvdy.20991; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chen E, 2005, DEV BIOL, V284, P364, DOI 10.1016/j.ydbio.2005.05.032; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Filipek-Gorniok B, 2013, DEV DYN; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Ghiselli G, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-19; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Harfouche R, 2009, CIRCULATION, V120, P1883, DOI 10.1161/CIRCULATIONAHA.108.837724; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ledin J, 2004, J BIOL CHEM; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; LEV R, 1964, J HISTOCHEM CYTOCHEM, V12, P309, DOI 10.1177/12.4.309; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; Monnich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020051; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neugebauer JM, 2013, DEVELOPMENT, V140, P3892, DOI 10.1242/dev.096388; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Nusslein-Volhard C, 2005, ZEBRAFISH, P1, DOI [10.1089/zeb.2005.2.1, DOI 10.1089/ZEB.2005.2.1]; Ohno S., 1970, EVOLUTION GENE DUPLI; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Pallerla SR, 2007, DEV DYNAM, V236, P556, DOI 10.1002/dvdy.21038; Pan Y, 2013, MATRIX BIOL; Reuter MS, 2014, AM J MED GENET A; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Ringvall M, 2010, PROG MOL BIOL TRANSL, V93, P35, DOI 10.1016/S1877-1173(10)93003-2; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Samson SC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001727; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wei Z, 1999, J BIOL CHEM, V274, P1966, DOI 10.1074/jbc.274.4.1966	58	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119040	10.1371/journal.pone.0119040	http://dx.doi.org/10.1371/journal.pone.0119040			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767878	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500060
J	Hauser, B; Zhao, Y; Pang, XW; Ling, ZQ; Myers, E; Wang, P; Califano, J; Gu, XB				Hauser, Belinda; Zhao, Yuan; Pang, Xiaowu; Ling, Zhiqiang; Myers, Ernest; Wang, Paul; Califano, Joseph; Gu, Xinbin			Functions of MiRNA-128 on the Regulation of Head and Neck Squamous Cell Carcinoma Growth and Apoptosis	PLOS ONE			English	Article							SALVIANOLIC ACID B; IN-VIVO; CANCER STATISTICS; SELF-RENEWAL; LUNG-CANCER; BMI-1; MICRORNAS; PROLIFERATION; TUMORIGENESIS; MECHANISM	Background Incidence of head and neck squamous cell carcinoma (HNSCC) has continuously increased in past years while its survival rate has not been significantly improved. There is a critical need to better understand the genetic regulation of HNSCC tumorigenesis and progression. In this study, we comprehensively analyzed the function of miRNA-128 (miR-128) in the regulation of HNSCC growth and its putative targets in vitro and in vivo systems. Methods The function and targets of miR-128 were investigated in human HNSCC cell lines (JHU-13 and JHU-22), which were stably transfected with the miR-128 gene using a lentiviral delivery system. The expression levels of miR-128 and its targeted proteins were analyzed with qRT-PCR, Western blotting and flow cytometry. The binding capacity of miRNA-128 to its putative targets was determined using a luciferase report assay. MTT, colony formation, and a tumor xenograft model further evaluated the effects of miR-128 on HNSCC growth. Results We generated two miR-128 stably transfected human HNSCC cell lines (JHU-13miR-128 and JHU-22miR-128). Enforced expression of miR-128 was detected in both cultured JHU-13miR128 and JHU-22miR-128 cell lines, approximately seventeen to twenty folds higher than in vector control cell lines. miRNA-128 was able to bind with the 30-untranslated regions of BMI-1, BAG-2, BAX, H3f3b, and Paip2 mRNAs, resulting in significant reduction of the targeted protein levels. We found that upregulated miR-128 expression significantly inhibited both JHU-13miR-128 and JHU-22miR-128 cell viability approximately 20 to 40%, and the JHU-22miR128 tumor xenograft growth compared to the vector control groups. Conclusions miR-128 acted as a tumor suppressor inhibiting the HNSCC growth by directly mediating the expression of putative targets. Our results provide a better understanding of miRNA-128 function and its potential targets, which may be valuable for developing novel diagnostic markers and targeted therapy.	[Hauser, Belinda; Gu, Xinbin] Howard Univ, Dept Genet & Human Genet, Washington, DC 20059 USA; [Zhao, Yuan; Pang, Xiaowu; Gu, Xinbin] Howard Univ, Dept Oral Pathol, Washington, DC 20059 USA; [Ling, Zhiqiang] Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Myers, Ernest] Howard Univ, Dept Otolaryngol Head & Neck Surg, Washington, DC 20059 USA; [Wang, Paul] Howard Univ, Dept Radiol, Washington, DC 20059 USA; [Wang, Paul; Gu, Xinbin] Howard Univ, Ctr Canc, Washington, DC 20059 USA; [Califano, Joseph] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Califano, Joseph] Johns Hopkins Univ, Dept Head & Neck Res Div, Baltimore, MD USA	Howard University; Howard University; Zhejiang Cancer Hospital; Howard University; Howard University; Howard University; Johns Hopkins University; Johns Hopkins University	Gu, XB (corresponding author), Howard Univ, Dept Genet & Human Genet, Washington, DC 20059 USA.	xgu@howard.edu			National Cancer Institute, NIH [P20 CA118770, CA192989-01]; National Institute of Minority Health Disparity, NIH [RCMI-NIH 2G12RR003048]; National Dental Association Foundation/Colgate Palmolive Research Fund; NATIONAL CANCER INSTITUTE [P20CA118770, P20CA192989] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Minority Health Disparity, NIH; National Dental Association Foundation/Colgate Palmolive Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by funding P20 CA118770 and CA192989-01 from National Cancer Institute, NIH; RCMI-NIH 2G12RR003048 from National Institute of Minority Health Disparity, NIH; and National Dental Association Foundation/Colgate Palmolive Research Fund.	Adlakha YK aSN, 2013, CELL DEATH DIS, P4; Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Cui JG, 2010, J NEURO-ONCOL, V98, P297, DOI 10.1007/s11060-009-0077-0; Daury L, 2006, EMBO REP, V7, P66, DOI 10.1038/sj.embor.7400561; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Farnebo L, 2009, INT J MOL MED, V24, P549, DOI 10.3892/ijmm_00000264; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hao YB, 2009, INT J CANCER, V124, P2200, DOI 10.1002/ijc.24160; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu J, 2014, EUR J CANCER, V50, P2336, DOI 10.1016/j.ejca.2014.06.005; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lippman SM, 2005, J CLIN ONCOL, V23, P346, DOI 10.1200/JCO.2005.09.128; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rapidis AD, 2009, J ONCOL, V2009, DOI 10.1155/2009/346345; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Tran N, 2010, HEAD NECK-J SCI SPEC, V32, P1099, DOI 10.1002/hed.21356; Voncken JW, 1999, J CELL SCI, V112, P4627; Wangpermtam P, 2011, ASIAN PAC J CANCER P, V12, P2081; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhao YA, 2010, CANCER PREV RES, V3, P787, DOI 10.1158/1940-6207.CAPR-09-0243	38	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0116321	10.1371/journal.pone.0116321	http://dx.doi.org/10.1371/journal.pone.0116321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764126	Green Submitted, gold, Green Published			2022-12-27	WOS:000351276300005
J	Colli, CM; Bezagio, RC; Nishi, L; Bignotto, TS; Ferreira, EC; Falavigna-Guilherme, AL; Gomes, ML				Colli, Cristiane Maria; Bezagio, Renata Coltro; Nishi, Leticia; Bignotto, Thais Souto; Ferreira, Erika Cristina; Falavigna-Guilherme, Ana Lucia; Gomes, Monica Lucia			Identical Assemblage of Giardia duodenalis in Humans, Animals and Vegetables in an Urban Area in Southern Brazil Indicates a Relationship among Them	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SEQUENCE-ANALYSIS; SAO-PAULO; WATER; TRANSMISSION; INFECTION; CHILDREN; STATE; CRYPTOSPORIDIUM; IDENTIFICATION	Background Giardia duodenalis infects humans and other mammals by ingestion of cysts in contaminated water or food, or directly in environments with poor hygiene. Eight assemblages, designated A-H, are described for this species. Methodology/Principal Findings We investigated by microscopy or by direct immunofluorescence technique the occurrence of G. duodenalis in 380 humans, 34 animals, 44 samples of water and 11 of vegetables. G. duodenalis cysts present in samples were genotyped through PCR-RFLP of beta giardin and glutamate dehydrogenase (gdh) genes and sequencing of gdh. The gdh gene was amplified in 76.5%(26/34) of the human faeces samples with positive microscopy and in 2.9% (1/34) of negative samples. In 70.4%(19/27) of the positive samples were found BIV assemblage. In two samples from dogs with positive microscopy and one negative sample, assemblages BIV, C, and D were found. Cysts of Giardia were not detected in water samples, but three samples used for vegetable irrigation showed total coliforms above the allowed limit, and Escherichia coli was observed in one sample. G. duodenalis BIV was detected in two samples of Lactuca sativa irrigated with this sample of water. BIV was a common genotype, with 100% similarity, between different sources or hosts (humans, animals and vegetables), and the one most often found in humans. Conclusions/Significance This is the first study in Brazil that reports the connection among humans, dogs and vegetables in the transmission dynamics of G. duodenalis in the same geographic area finding identical assemblage. BIV assemblage was the most frequently observed among these different links in the epidemiological chain.	[Colli, Cristiane Maria; Bezagio, Renata Coltro; Falavigna-Guilherme, Ana Lucia; Gomes, Monica Lucia] State Univ Maring uem, Environm & Food Parasitol Lab, Maringa, Parana, Brazil; [Nishi, Leticia] Univ Estadual Maringa, Dept Chem Engn, Maringa, Parana, Brazil; [Bignotto, Thais Souto] State Univ West Parana, Engn & Exact Sci Ctr, Maringa, Parana, Brazil; [Ferreira, Erika Cristina] Univ Estadual Maringa, Dept Stat, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual do Oeste do Parana; Universidade Estadual de Maringa	Colli, CM (corresponding author), State Univ Maring uem, Environm & Food Parasitol Lab, Maringa, Parana, Brazil.	criscolli@yahoo.com.br	Nishi, Leticia/G-3746-2010; Colli, Cristiane Maria/G-4974-2013; Colli, Cristiane Maria/ABH-9857-2020	Nishi, Leticia/0000-0001-8796-5769; Colli, Cristiane Maria/0000-0002-6899-7519; Falavigna-Guilherme, Ana Lucia/0000-0001-7361-5223	Coordination for the Improvement of Higher Education Personnel (CAPES); Support for scientific and technological development of the Parana (Fundacao Araucaria)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Support for scientific and technological development of the Parana (Fundacao Araucaria)	1. Coordination for the Improvement of Higher Education Personnel (CAPES): www.capes.gov.br, CMC. 2. Support for scientific and technological development of the Parana (Fundacao Araucaria): www.fappr.pr.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; APHA, 2012, 3120 APHA, V22nd; Pereira Maria das Graças Cabral, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P139; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Cantusio Neto N, 2004, HIG ALIMENT, V18, P52; Christenson E, 2014, SCI TOTAL ENVIRON, V490, P301, DOI 10.1016/j.scitotenv.2014.05.010; CONAMA (Conselho Nacional do Meio Ambiente), 2005, DIARIO OFICIAL UNIAO; Coradi ST, 2011, J VENOM ANIM TOXINS, V17, P353, DOI 10.1590/S1678-91992011000300016; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Fernandes LN, 2011, J WATER HEALTH, V9, P361, DOI 10.2166/wh.2011.098; Ferreira FS, 2012, PARASITOL RES, V111, P2173, DOI 10.1007/s00436-012-3068-6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoque M. Ekramul, 2002, International Journal of Infectious Diseases, V6, P191, DOI 10.1016/S1201-9712(02)90110-4; Hunter PR, 2005, INT J PARASITOL, V35, P1181, DOI 10.1016/j.ijpara.2005.07.009; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Karon AE, 2011, EPIDEMIOL INFECT, V139, P713, DOI 10.1017/S0950268810001573; Kohli Anita, 2008, Trans R Soc Trop Med Hyg, V102, P718, DOI 10.1016/j.trstmh.2008.03.002; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Molina N, 2011, ANN TROP MED PARASIT, V105, P299, DOI 10.1179/136485911X12987676649665; Mota A, 2009, J FOOD PROTECT, V72, P2184, DOI 10.4315/0362-028X-72.10.2184; Nishi L, 2009, ZOONOSES PUBLIC HLTH, V56, P221, DOI 10.1111/j.1863-2378.2008.01189.x; Oliveira-Rocha M, 2011, PARASITOLOGIA HUMANA, P514; Otenio MH, 2007, SALUSVITA, V26, P197; Pupulin ART, 2004, PR RBAC, V36, P147; Ratanapo S, 2008, AM J TROP MED HYG, V78, P611, DOI 10.4269/ajtmh.2008.78.611; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Sorensen JP, 2014, WATER RES IN PRESS; Souza SLP, 2007, VET PARASITOL, V149, P258, DOI 10.1016/j.vetpar.2007.08.019; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5; Uda-Shimoda CF, 2014, DIAGN MICR INFEC DIS, V78, P53, DOI 10.1016/j.diagmicrobio.2013.09.008; Volotao AC, 2007, ACTA TROP, V102, P10, DOI 10.1016/j.actatropica.2007.02.010; Zhang Ping, 2012, Parasitol Res, V111, P2157, DOI 10.1007/s00436-012-3064-x	39	42	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118065	10.1371/journal.pone.0118065	http://dx.doi.org/10.1371/journal.pone.0118065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761119	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275000017
J	Meyer, M; McEntee, RK; Nyotowidjojo, I; Chu, GX; LeWinter, MM				Meyer, Markus; McEntee, Rachel K.; Nyotowidjojo, Iwan; Chu, Guoxiang; LeWinter, Martin M.			Relationship of Exercise Capacity and Left Ventricular Dimensions in Patients with a Normal Ejection Fraction. An Exploratory Study	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; DIASTOLIC HEART-FAILURE; CARDIAC STRUCTURE; AMERICAN-SOCIETY; BED-REST; DISEASE; DYSFUNCTION; HYPERTROPHY; ATROPHY; VOLUME	Objectives Extreme endurance exercise is known to be associated with an enlargement of the left ventricular (LV) chamber, whereas inactivity results in inverse changes. It is unknown if these dimensional relationships exist in patients. Methods We analyzed the relationship of exercise capacity and LV dimension in a cohort of sequential patients with a normal ejection fraction undergoing stress echocardiography. In a total of 137 studies the following questions were addressed: (a) is there a difference in LV dimensions of patients with an excellent exercise capacity versus patients with a poor exercise capacity, (b) how is LV dimension and exercise capacity affected by LV wall thickness and (c) how do LV dimensions of patients who are unable to walk on a treadmill compare to the above groups. Results Patients with a poor exercise capacity or who are unable to physically exercise have a 34 percent smaller LV cavity size when compared to patients with an excellent exercise capacity (p<0.001). This reduction in LV chamber size is associated with concentric LV hypertrophy and a reciprocal increase in resting heart rate. In addition, cardiac output reserve is further blunted by chronotropic incompetence and a tachycardia-induced LV volume reduction. In conclusion the relationship of exercise capacity and cardiac dimensions described in extreme athletes also applies to patients. Our exploratory analysis suggests that patients who cannot sufficiently exercise have small LV cavities.	[Meyer, Markus; McEntee, Rachel K.; Nyotowidjojo, Iwan; Chu, Guoxiang; LeWinter, Martin M.] Univ Vermont, Coll Med, Div Cardiol, Burlington, VT 05405 USA	University of Vermont	Meyer, M (corresponding author), Univ Vermont, Coll Med, Div Cardiol, Burlington, VT 05405 USA.	markus.meyer@vtmednet.org		Meyer, Markus/0000-0002-4398-5642	American Heart Association Scientist Development Grant [0730056N]; NIH [1R21HL94807-01]; NIH Institutional Training Grant [T32 HL07647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122744, T32HL007647, R21HL094807] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by an American Heart Association Scientist Development Grant 0730056N (MM), NIH grants 1R21HL94807-01 (MM) and NIH Institutional Training Grant T32 HL07647 (MML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abergel E, 2004, J AM COLL CARDIOL, V44, P144, DOI 10.1016/j.jacc.2004.02.057; ALPERT MA, 1985, AM J CARDIOL, V55, P783, DOI 10.1016/0002-9149(85)90156-0; Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74; Baggish AL, 2008, J APPL PHYSIOL, V104, P1121, DOI 10.1152/japplphysiol.01170.2007; Berry JD, 2013, CIRC-HEART FAIL, V6, P627, DOI 10.1161/CIRCHEARTFAILURE.112.000054; Borlaug BA, 2006, CIRCULATION, V114, P2138, DOI 10.1161/CIRCULATIONAHA.106.632745; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; CUOCOLO A, 1990, CIRCULATION, V81, P978, DOI 10.1161/01.CIR.81.3.978; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Fujimoto N, 2010, CIRCULATION, V122, P1797, DOI 10.1161/CIRCULATIONAHA.110.973784; Gaasch WH, 2011, J AM COLL CARDIOL, V58, P1733, DOI 10.1016/j.jacc.2011.07.022; Grewal J, 2009, JAMA-J AM MED ASSOC, V301, P286, DOI 10.1001/jama.2008.1022; HIGGINBOTHAM MB, 1986, CIRC RES, V58, P281, DOI 10.1161/01.RES.58.2.281; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Jorgensen K, 2003, CHEST, V124, P1863, DOI 10.1378/chest.124.5.1863; Kass DA, 2010, J CARD FAIL, V16, P17, DOI 10.1016/j.cardfail.2009.08.008; Kitzman DW, 2010, CIRC-HEART FAIL, V3, P659, DOI 10.1161/CIRCHEARTFAILURE.110.958785; KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levine BD, 1997, CIRCULATION, V96, P517; LeWinter MM, 2011, BRAUNWALDS HEART DIS, P1651; Linzbach AJ, 1960, J AM COLL CARDIOL, V5, P370; LIU CP, 1993, CIRCULATION, V88, P1893, DOI 10.1161/01.CIR.88.4.1893; Manders E, 2014, J AM COLL CARDIOL, V64, P28, DOI 10.1016/j.jacc.2014.04.031; Meyer M, 2014, J AM COLL CARDIOL, V64, P38, DOI 10.1016/j.jacc.2014.04.027; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; Pellikka PA, 2007, J AM SOC ECHOCARDIOG, V20, P1021, DOI 10.1016/j.echo.2007.07.003; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; SAWADA SG, 1991, CIRCULATION, V83, P1605, DOI 10.1161/01.CIR.83.5.1605; Schoos MM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-84; Selby DE, 2011, J AM COLL CARDIOL, V58, P147, DOI 10.1016/j.jacc.2010.10.069; Udelson JE, 2011, CIRCULATION, V124, pE540, DOI 10.1161/CIRCULATIONAHA.111.071696; Wachter R, 2009, EUR HEART J, V30, P3027, DOI 10.1093/eurheartj/ehp341; Watz H, 2010, CHEST, V138, P32, DOI 10.1378/chest.09-2810; Westermann D, 2008, CIRCULATION, V117, P2051, DOI 10.1161/CIRCULATIONAHA.107.716886; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	39	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119432	10.1371/journal.pone.0119432	http://dx.doi.org/10.1371/journal.pone.0119432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756359	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275700046
J	Seth, A; Ritchie, FK; Wibowo, N; Lua, LHL; Middelberg, APJ				Seth, Arjun; Ritchie, Fiona K.; Wibowo, Nani; Lua, Linda H. L.; Middelberg, Anton P. J.			Non-Carrier Nanoparticles Adjuvant Modular Protein Vaccine in a Particle-Dependent Manner	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; IMMUNE-RESPONSE; PATHOGEN RECOGNITION; L1 CAPSOMERES; IN-VITRO; DELIVERY; SIZE; IMMUNIZATION; PLATFORM; MICROPARTICLES	Nanoparticles are increasingly used to adjuvant vaccine formulations due to their biocompatibility, ease of manufacture and the opportunity to tailor their size, shape, and physicochemical properties. The efficacy of similarly-sized silica (Si-OH), poly (D,L-lactic-co-glycolic acid) (PLGA) and poly caprolactone (PCL) nanoparticles (nps) to adjuvant recombinant capsomere presenting antigenic M2e modular peptide from Influenza A virus (CapM2e) was investigated in vivo. Formulation of CapM2e with Si-OH or PLGA nps significantly boosted the immunogenicity of modular capsomeres, even though CapM2e was not actively attached to the nanoparticles prior to injection (i.e., formulation was by simple mixing). In contrast, PCL nps showed no significant adjuvant effect using this simple-mixing approach. The immune response induced by CapM2e alone or formulated with nps was antibody-biased with very high antigen-specific antibody titer and less than 20 cells per million splenocytes secreting interferon gamma. Modification of silica nanoparticle surface properties through amine functionalization and pegylation did not lead to significant changes in immune response. This study confirms that simple mixing-based formulation can lead to effective adjuvanting of antigenic protein, though with antibody titer dependent on nanoparticle physicochemical properties.	[Seth, Arjun; Ritchie, Fiona K.; Wibowo, Nani; Middelberg, Anton P. J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Lua, Linda H. L.] Univ Queensland, Prot Express Facil, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Middelberg, APJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	a.middelberg@uq.edu.au	Lua, Linda/B-4879-2010	Lua, Linda/0000-0002-9756-7083; Ritchie, Fiona/0000-0002-4545-6402; Middelberg, Anton/0000-0001-5922-5704	Queensland State Government	Queensland State Government	Funding for this study was provided by the Queensland State Government in the form of a Premier's Fellowship to APJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Champion JA, 2009, PHARM RES-DORDR, V26, P244, DOI 10.1007/s11095-008-9626-z; Chu CH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/18/185601; Correia-Pinto JF, 2013, INT J PHARMACEUT, V440, P27, DOI 10.1016/j.ijpharm.2012.04.047; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dey AK, 2011, EXPERT REV VACCINES, V10, P227, DOI 10.1586/ERV.10.142; Diwan M, 2002, J CONTROL RELEASE, V85, P247, DOI 10.1016/S0168-3659(02)00275-4; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Fifis T, 2004, VACCINE, V23, P258, DOI 10.1016/j.vaccine.2004.05.022; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grgacic EVL, 2006, METHODS, V40, P60, DOI 10.1016/j.ymeth.2006.07.018; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; Ibanez LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059081; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Kohli AK, 2004, INT J PHARMACEUT, V275, P13, DOI 10.1016/j.ijpharm.2003.10.038; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Liew MWO, 2012, BIOCHEM ENG J, V67, P88, DOI 10.1016/j.bej.2012.05.007; Lua LHL, 2014, BIOTECHNOL BIOENG, V111, P425, DOI 10.1002/bit.25159; Manish M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061885; McCarthy MP, 1998, J VIROL, V72, P32, DOI 10.1128/JVI.72.1.32-41.1998; Middelberg APJ, 2011, VACCINE, V29, P7154, DOI 10.1016/j.vaccine.2011.05.075; Moon JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031472; Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905; Murata Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-81; Nakanishi T, 1999, J CONTROL RELEASE, V61, P233, DOI 10.1016/S0168-3659(99)00097-8; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Niikura K, 2013, ACS NANO, V7, P3926, DOI 10.1021/nn3057005; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0; Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI 10.1586/ERV.10.89; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Pejawar-Gaddy S, 2010, CANCER IMMUNOL IMMUN, V59, P1685, DOI 10.1007/s00262-010-0895-0; Plotkin S.L., 2004, VACCINES-BASEL, V5, P1; Raghuvanshi RS, 2002, INT J PHARMACEUT, V245, P109, DOI 10.1016/S0378-5173(02)00342-3; Rivera-Hernandez T, 2013, VACCINE, V31, P1950, DOI 10.1016/j.vaccine.2013.02.013; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Rose RC, 1998, J VIROL, V72, P6151, DOI 10.1128/JVI.72.7.6151-6154.1998; Roy S, 2010, LANGMUIR, V26, P18125, DOI 10.1021/la103212d; Sapp M, 2009, VIROLOGY, V384, P400, DOI 10.1016/j.virol.2008.12.022; Sayin B, 2008, INT J PHARMACEUT, V363, P139, DOI 10.1016/j.ijpharm.2008.06.029; Schadlich L, 2009, J VIROL, V83, P7690, DOI 10.1128/JVI.02588-08; Schussek S, 2013, INFECT IMMUN, V81, P3586, DOI 10.1128/IAI.00544-13; Senger T, 2010, VACCINE, V28, P1583, DOI 10.1016/j.vaccine.2009.11.048; Singh J, 2006, METHODS, V38, P96, DOI 10.1016/j.ymeth.2005.11.003; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488; Souza J, 2012, BIOMED RES INT, V2012; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Vallhov H, 2012, SMALL, V8, P2116, DOI 10.1002/smll.201102620; Wibowo N, 2014, VACCINE, V32, P3664, DOI 10.1016/j.vaccine.2014.04.043; Wibowo N, 2013, CHEM ENG SCI, V103, P12, DOI 10.1016/j.ces.2012.04.001; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Yan SY, 2013, J COLLOID INTERF SCI, V395, P1, DOI 10.1016/j.jcis.2012.11.061; Zhang WF, 2014, BIOMATERIALS, V35, P6086, DOI 10.1016/j.biomaterials.2014.04.022; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069; Zhou C, 2012, VACCINE, V30, P3463, DOI 10.1016/j.vaccine.2012.03.021	61	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117203	10.1371/journal.pone.0117203	http://dx.doi.org/10.1371/journal.pone.0117203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756283	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700015
J	Verhulst, A; Sun, S; McKenna, CE; D'Haese, PC				Verhulst, Anja; Sun, Shuting; McKenna, Charles E.; D'Haese, Patrick C.			Endocytotic Uptake of Zoledronic Acid by Tubular Cells May Explain Its Renal Effects in Cancer Patients Receiving High Doses of the Compound	PLOS ONE			English	Article							NITROGEN-CONTAINING BISPHOSPHONATES; FLOW-CYTOMETRIC IMMUNODISSECTION; RECEPTOR-MEDIATED ENDOCYTOSIS; GTP-BINDING PROTEINS; DOUBLE-BLIND; PHARMACOKINETICS; PHARMACODYNAMICS; ACIDIFICATION; LOCALIZATION; RISEDRONATE	Zoledronic acid, a highly potent nitrogen-containing bisphosphonate used for the treatment of pathological bone loss, is excreted unmetabolized via the kidney if not bound to the bone. In cancer patients receiving high doses of the compound renal excretion may be associated with acute tubular necrosis. The question of how zoledronic acid is internalized by renal tubular cells has not been answered until now. In the current work, using a primary human tubular cell culture system, the pathway of cellular uptake of zoledronic acid (fluorescently/radiolabeled) and its cytotoxicity were investigated. Previous studies in our laboratory have shown that this primary cell culture model consistently mimics the physiological characteristics of molecular uptake/transport of the epithelium in vivo. Zoledronic acid was found to be taken up by tubular cells via fluid-phase-endocytosis (from apical and basolateral side) as evidenced by its co-localization with dextran. Cellular uptake and the resulting intracellular level was twice as high from the apical side compared to the basolateral side. Furthermore, the intracellular zoledronic acid level was found to be dependent on the administered concentration and not saturable. Cytotoxic effects however, were only seen at higher administration doses and/or after longer incubation times. Although zoledronic acid is taken up by tubular cells, no net tubular transport could be measured. It is concluded that fluidphase-endocytosis of zoledronic acid and cellular accumulation at high doses may be responsible for the acute tubular necrosis observed in some cancer patients receiving high doses of the compound.	[Verhulst, Anja; D'Haese, Patrick C.] Univ Antwerp, Lab Pathophysiol, Antwerp, Belgium; [Sun, Shuting; McKenna, Charles E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	University of Antwerp; University of Southern California	Verhulst, A (corresponding author), Univ Antwerp, Lab Pathophysiol, Antwerp, Belgium.	anja.verhulst@uantwerpen.be	D'Haese, Patrick C/C-9599-2019	Sun, Shuting/0000-0002-3635-9029	Novartis	Novartis(Novartis)	AV is a postdoctoral fellow of the Fund for Scientific Research Flanders (www.fwo.be). PD received a research Grant from Novartis. Staff members of Novartis did read the manuscript and gave the permission for publication of the data but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript	Asselman M, 2005, KIDNEY INT, V68, P71, DOI 10.1111/j.1523-1755.2005.00382.x; Barrett J, 2004, J CLIN PHARMACOL, V44, P951, DOI 10.1177/0091270004267594; Brown CDA, 2008, TOXICOL APPL PHARM, V233, P428, DOI 10.1016/j.taap.2008.09.018; Burckhardt G, 2012, PHARMACOL THERAPEUT, V136, P106, DOI 10.1016/j.pharmthera.2012.07.010; Chen TL, 2002, J CLIN PHARMACOL, V42, P1228, DOI 10.1177/009127002762491316; Coxon FP, 2003, CALCIFIED TISSUE INT, V72, P80, DOI 10.1007/s00223-002-2017-2; DAVIS BH, 1986, CYTOMETRY, V7, P251, DOI 10.1002/cyto.990070305; Deng JT, 1996, HEPATOLOGY, V23, P445; Gibson d'Ambrosio RE, 1983, IN VITRO, V23, P279; Gorvin CM, 2013, P NATL ACAD SCI USA, V110, P7014, DOI 10.1073/pnas.1302063110; Helbert MJF, 2001, KIDNEY INT, V59, P554, DOI 10.1046/j.1523-1755.2001.059002554.x; Helbert MJF, 1997, KIDNEY INT, V52, P414, DOI 10.1038/ki.1997.348; Helbert MJF, 1999, EXP NEPHROL, V7, P360; Kashemirov BA, 2008, BIOCONJUGATE CHEM, V19, P2308, DOI 10.1021/bc800369c; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kim MY, 2014, BIOMOL THER, V22, P295, DOI 10.4062/biomolther.2014.055; LACAVE R, 1993, J CELL SCI, V104, P705; Lepist EI, 2012, EXPERT OPIN DRUG MET, V8, P433, DOI 10.1517/17425255.2012.667401; Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Luhe A, 2008, TOXICOL IN VITRO, V22, P899, DOI 10.1016/j.tiv.2008.01.006; Markowitz GS, 2003, KIDNEY INT, V64, P281, DOI 10.1046/j.1523-1755.2003.00071.x; Martin D, 2007, BBA-MOL CELL RES, V1773, P419, DOI 10.1016/j.bbamcr.2006.11.015; Michaelson D, 2002, JNCI-J NATL CANCER I, V94, P1458; Mitchell DY, 2000, J CLIN PHARMACOL, V40, P258, DOI 10.1177/00912700022008928; Perazella MA, 2008, KIDNEY INT, V74, P1385, DOI 10.1038/ki.2008.356; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Roelofs AJ, 2009, BRIT J HAEMATOL, V144, P245, DOI 10.1111/j.1365-2141.2008.07435.x; Rogers Maurice, 2011, Scottish Forestry, V65, P34; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Rosen LS, 2003, J CLIN ONCOL, V21, P3150, DOI 10.1200/JCO.2003.04.105; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Sato K, 2009, LIFE SCI, V85, P800, DOI 10.1016/j.lfs.2009.10.012; Skerjanec A, 2003, J CLIN PHARMACOL, V43, P154, DOI 10.1177/0091270002239824; Sun ST, 2011, PHOSPHORUS SULFUR, V186, P970, DOI 10.1080/10426507.2010.526674; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; Thompson K, 2006, MOL PHARMACOL, V69, P1624, DOI 10.1124/mol.105.020776; Verhulst A, 2004, J AM SOC NEPHROL, V15, P2249, DOI 10.1097/01.ASN.0000136778.32499.05; Verhulst A, 2002, J AM SOC NEPHROL, V13, P1210, DOI 10.1681/ASN.V1351210; Verhulst A, 2002, J AM SOC NEPHROL, V14, P107; Verhulst A, 2008, MOL PHARMACOL, V74, P1084, DOI 10.1124/mol.108.047647	42	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0121861	10.1371/journal.pone.0121861	http://dx.doi.org/10.1371/journal.pone.0121861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756736	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700079
J	Kumar, A; Tiwary, BK; Kachhap, S; Nanda, AK; Chakraborty, R				Kumar, Arvind; Tiwary, Bipransh Kumar; Kachhap, Sangita; Nanda, Ashis Kumar; Chakraborty, Ranadhir			An Escherichia coli Strain, PGB01, Isolated from Feral Pigeon Faeces, Thermally Fit to Survive in Pigeon, Shows High Level Resistance to Trimethoprim	PLOS ONE			English	Article							GROWTH-RATE; INTEGRONS; TEMPERATURE; SUSCEPTIBILITY; IDENTIFICATION; ENTEROCOCCUS; POPULATIONS; MECHANISMS; BACTERIA	In this study, of the hundred Escherichia coli strains isolated from feral Pigeon faeces, eighty five strains were resistant to one or more antibiotics and fifteen sensitive to all the antibiotics tested. The only strain (among all antibiotic-resistant E. coli isolates) that possessed class 1 integron was PGB01. The dihydrofolate reductase gene of the said integron was cloned, sequenced and expressed in E. coli JM109. Since PGB01 was native to pigeon's gut, we have compared the growth of PGB01 at two different temperatures, 42 degrees C (normal body temperature of pigeon) and 37 degrees C (optimal growth temperature of E. coli; also the human body temperature), with E. coli K12. It was found that PGB01 grew better than the laboratory strain E. coli K12 at 37 degrees C as well as at 42 degrees C. In the thermal fitness assay, it was observed that the cells of PGB01 were better adapted to 42 degrees C, resembling the average body temperature of pigeon. The strain PGB01 also sustained more microwave mediated thermal stress than E. coli K12 cells. The NMR spectra of the whole cells of PGB01 varied from E. coli K12 in several spectral peaks relating some metabolic adaptation to thermotolerance. On elevating the growth temperature from 37 degrees C to 42 degrees C, susceptibility to kanamycin (both strains were sensitive to it) of E. coli K12 was increased, but in case of PGB01 no change in susceptibility took place. We have also attempted to reveal the basis of trimethoprim resistance phenotype conferred by the dfrA7 gene homologue of PGB01. Molecular Dynamics (MD) simulation study of docked complexes, PGB01-DfrA7 and E. coli TMP-sensitive-Dfr with trimethoprim (TMP) showed loss of some of the hydrogen and hydrophobic interaction between TMP and mutated residues in PGB01-DfrA7-TMP complex compared to TMP-sensitive-Dfr-TMP complex. This loss of interaction entails decrease in affinity of TMP for PGB01-DfrA7 compared to TMP-sensitive-Dfr.	[Kumar, Arvind; Tiwary, Bipransh Kumar; Chakraborty, Ranadhir] Univ N Bengal, Dept Biotechnol, OMICS Lab, Darjeeling 734013, India; [Kumar, Arvind] Univ Delhi, Lignocellulose Biotechnol Lab, Dept Microbiol, New Delhi 110021, India; [Kachhap, Sangita] CSIR Inst Microbial Technol, Bioinformatis Ctr, Chandigarh, India; [Nanda, Ashis Kumar] Univ N Bengal, Dept Chem, Darjeeling 734013, India	University of North Bengal; University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of North Bengal	Chakraborty, R (corresponding author), Univ N Bengal, Dept Biotechnol, OMICS Lab, Darjeeling 734013, India.	rcnbusiliguri@gmail.com	CHAKRABORTY, RANADHIR/M-4439-2016; kachhap, sangita/X-2198-2019	kachhap, sangita/0000-0003-2009-1782; Kumar, Arvind/0000-0003-3405-2426; Tiwary, Bipransh/0000-0002-9479-8740	 [DBT-JRF/05-06/71/29.08.05];  [Biotechnology/BIO-CARe/06/141/2010-2011]	; 	AK was provided with independent Ph.D fellowships (Award No. DBT-JRF/05-06/71/29.08.05.). BKT was provided with fellowship funded by Biotechnology/BIO-CARe/06/141/2010-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT IL, 1960, BACTERIOL REV, V24, P16, DOI 10.1128/MMBR.24.1.16-34.1960; Bergey DH, 1984, BERGEYS MANUAL SYSTE; Bourne R, 2001, J CLIN MICROBIOL, V39, P2916, DOI 10.1128/JCM.39.8.2916-2923.2001; Bronikowski AM, 2001, EVOLUTION, V55, P33; Caldas T, 1999, MICROBIOL-SGM, V145, P2543, DOI 10.1099/00221287-145-9-2543; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Cooper VS, 2001, EVOLUTION, V55, P889, DOI 10.1554/0014-3820(2001)055[0889:EOTDOG]2.0.CO;2; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Gross WB, 1994, ESCHERICHIA COLI DOM, P237; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; ISHIGURO EE, 1985, J BACTERIOL, V164, P1233, DOI 10.1128/JB.164.3.1233-1237.1985; Jamshidi A, 2010, AFR J MICROBIOL RES, V4, P2371; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ko J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-198; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Kumar A, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-19; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; LEROI AM, 1994, P NATL ACAD SCI USA, V91, P1917, DOI 10.1073/pnas.91.5.1917; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; MACKOWIAK PA, 1981, AM J CLIN PATHOL, V76, P57; Martinez-Freijo P, 1998, J ANTIMICROB CHEMOTH, V42, P689, DOI 10.1093/jac/42.6.689; MATTHEWS DA, 1985, J BIOL CHEM, V260, P381; Menon S, 2007, Indian J Med Microbiol, V25, P330; Morabito S, 2001, VET MICROBIOL, V82, P275, DOI 10.1016/S0378-1135(01)00393-5; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mukherjee S, 2006, RES MICROBIOL, V157, P220, DOI 10.1016/j.resmic.2005.08.003; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Ponce-Rivas E, 2012, APPL ENVIRON MICROB, V78, P5444, DOI 10.1128/AEM.00660-12; Radimersky T, 2010, J APPL MICROBIOL, V109, P1687, DOI 10.1111/j.1365-2672.2010.04797.x; RAY PH, 1971, J GEN MICROBIOL, V66, P133, DOI 10.1099/00221287-66-2-133; Reisinger E, 1996, SCAND J INFECT DIS, V28, P155, DOI 10.3109/00365549609049067; Roberts Mary F., 2006, V39, P103; RON EZ, 1971, J BACTERIOL, V107, P391, DOI 10.1128/JB.107.2.391-396.1971; Shaffer MF, 1936, J EXP MED, V64, P281, DOI 10.1084/jem.64.2.281; Sharma SK, 1999, J MICROBIOL METH, V39, P45, DOI 10.1016/S0167-7012(99)00101-3; Silva VL, 2009, CURR MICROBIOL, V59, P302, DOI 10.1007/s00284-009-9434-7; SMALL PM, 1986, INFECT IMMUN, V52, P484, DOI 10.1128/IAI.52.2.484-487.1986; Sonntag AK, 2005, BERL MUNCH TIERARZTL, V118, P464; Tanaka C, 2005, J VET MED SCI, V67, P951, DOI 10.1292/jvms.67.951; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiwary BK, 2014, INT J PHARM PHARM S, V6, P2393; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	44	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119329	10.1371/journal.pone.0119329	http://dx.doi.org/10.1371/journal.pone.0119329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25750990	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700020
J	Escobar, MAH; Uribe, SV; Chiappe, R; Estades, CF				Escobar, Martin A. H.; Uribe, Sandra V.; Chiappe, Romina; Estades, Cristian F.			Effect of Clearcutting Operations on the Survival Rate of a Small Mammal	PLOS ONE			English	Article							SPRUCE-FIR FORESTS; SHORT-TERM IMPACT; TIMBER HARVEST; SILVICULTURAL SYSTEMS; BIRD POPULATIONS; SOIL COMPACTION; BOREAL FOREST; CENTRAL CHILE; HOME-RANGE; COMMUNITIES	Clearcutting is a common timber harvesting technique that represents a significant and abrupt change in habitat conditions for wildlife living in industrial forests. Most research on this type of impact has focused on comparing populations or communities in mature forests/plantations and the resulting clearcut stands. However, this approach does not separate the effect of changes in habitat attributes from direct mortality produced by the intensive use of heavy machinery required for cutting down trees and dragging them to a road. Because knowing the fate of individuals after a disturbance is important for modelling landscape-scale population dynamics in industrial forests, we conducted a study in South-Central Chile to understand the short-term response to clearcutting operations of the long-haired Akodont (Abrothrix longipillis), a forest specialist mouse. Between 2009 and 2013 we radio-tracked a total of 51 adult male Akodonts, before, during and after the clearcutting of the pine plantations in which they lived. A minimum of 52.4% of the individuals died as a direct cause of the timbering operations, being crushed by vehicles or logs during logging operations. Our observations suggest that, instead of fleeing the area, the response of long-haired Akodonts to the approaching machinery is to hide under the forest litter or in burrows, which exposes them to a serious risk of death. The real mortality rate associated to clearcutting may be higher than that estimated by us because of some methodological biases (i.e. individuals with crushed radiotransmitters not recorded) and the fact that additional mortality sources may affect the population in the weeks following logging operations (e.g. higher exposure to predation, effects of site preparation for the new plantation, etc).	[Escobar, Martin A. H.; Uribe, Sandra V.; Chiappe, Romina; Estades, Cristian F.] Univ Chile, Fac Ciencias Forest & Conservac Nat, Lab Ecol Vida Silvestre, Santiago, Chile	Universidad de Chile	Estades, CF (corresponding author), Univ Chile, Fac Ciencias Forest & Conservac Nat, Lab Ecol Vida Silvestre, Santiago, Chile.	cestades@u.uchile.cl	Estades, Cristian F/A-5221-2008	Estades, Cristian F/0000-0002-4479-7774	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt) [1080463, 1120314]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)	Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funding for this study was provided by "Fondo Nacional de Desarrollo Cientifico y Tecnologico" (Fondecyt) by grants 1080463 and 1120314 to CFE. MAHE was supported by a "Comision Nacional de Investigacion Cientifica y Tecnologica" (CONICYT) grant during his Ph.D. studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampoorter E, 2007, FOREST ECOL MANAG, V241, P162, DOI 10.1016/j.foreco.2007.01.019; ASH A N, 1988, Journal of the Elisha Mitchell Scientific Society, V104, P116; Battigelli JP, 2004, CAN J FOREST RES, V34, P1136, DOI [10.1139/x03-267, 10.1139/X03-267]; Bliss JC, 2000, J FOREST, V98, P4; Brennan KEC, 2011, AUSTRAL ECOL, V36, P131, DOI 10.1111/j.1442-9993.2010.02127.x; Camp MJ, 2012, ETHOLOGY, V118, P1010, DOI 10.1111/eth.12000; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; Di Rienzo J., INFOSTAT VERSION 201; Estades CF, 1999, ECOL APPL, V9, P573, DOI 10.1890/1051-0761(1999)009[0573:DFBCIA]2.0.CO;2; Estades CF, 2012, BIODIVERS CONSERV, P77; Ferron J, 1998, CAN J FOREST RES, V28, P1335, DOI 10.1139/cjfr-28-9-1335; Fuller AK, 2004, FOREST ECOL MANAG, V191, P373, DOI 10.1016/j.foreco.2004.01.014; Gajardo R., 1994, VEGETACION NATURAL C; Hagan JM, 1996, CONSERV BIOL, V10, P188, DOI 10.1046/j.1523-1739.1996.10010188.x; HANSIS R, 1995, HUM ORGAN, V54, P95, DOI 10.17730/humo.54.1.yj5338v42768002r; Hartmann H, 2010, FOREST CHRON, V86, P354, DOI 10.5558/tfc86354-3; INFOR, 2013, AN FOR B EST; Iroume A, 2006, HYDROL PROCESS, V20, P37, DOI 10.1002/hyp.5897; Jacob J, 2004, ECOSCIENCE, V11, P16, DOI 10.1080/11956860.2004.11682805; Jones Clyde, 1996, P115; Kerr G, 1999, FORESTRY, V72, P191, DOI 10.1093/forestry/72.3.191; Klenner W, 2003, CAN J FOREST RES, V33, P2283, DOI 10.1139/X03-142; LEVINE RL, 1979, FOREST SCI, V25, P317; LUCKENBACH RA, 1983, J APPL ECOL, V20, P265, DOI 10.2307/2403392; Mann-Fischer G., 1978, GAYANA ZOOL, V40, P1; MANNAN RW, 1984, J WILDLIFE MANAGE, V48, P1219, DOI 10.2307/3801783; McDonald J.H., 2009, HDB BIOL STAT; Mendonca M, 2007, TR0733 ERDCCERL USA; Metcalf CJE, 2007, ANIM CONSERV, V10, P478, DOI 10.1111/j.1469-1795.2007.00138.x; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Munoz-Pedreros A., 2009, MAMIFEROS CHILE; MUNOZPEDREROS A, 1992, REV CHIL HIST NAT, V65, P417; Niwa CG, 2001, NORTHWEST SCI, V75, P141; Acuna MP, 2011, BIOL CONSERV, V144, P1577, DOI 10.1016/j.biocon.2011.02.003; PETRANKA JW, 1994, FOREST ECOL MANAG, V67, P135, DOI 10.1016/0378-1127(94)90012-4; Picchio R, 2012, FOREST ECOL MANAG, V285, P38, DOI 10.1016/j.foreco.2012.08.008; Potvin F, 2005, CAN J FOREST RES, V35, P151, DOI 10.1139/X04-151; Prescott CE, 1997, FOREST ECOL MANAG, V95, P253, DOI 10.1016/S0378-1127(97)00027-3; Previtali MA, 2010, ECOLOGY, V91, P582, DOI 10.1890/08-2308.1; Reinert HK, 2011, J WILDLIFE MANAGE, V75, P19, DOI 10.1002/jwmg.35; Saavedra B, 2005, MAMMALIA, V69, P337, DOI 10.1515/mamm.2005.027; Sallabanks R, 2000, WILDLIFE SOC B, V28, P1144; San Martin J, 1996, ECOLOGIA BOSQUES NAT, P163, DOI 10.1016/ j. watres. 2013.08.031; Selmants PC, 2003, FOREST ECOL MANAG, V185, P275, DOI 10.1016/S0378-1127(03)00224-X; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Spellerberg IF, 1996, BIODIVERS CONSERV, V5, P447, DOI 10.1007/BF00056390; Steel RGD, 1988, BIOESTADISTICA PRINC, V1; Sullivan TP, 1999, J APPL ECOL, V36, P327, DOI 10.1046/j.1365-2664.1999.00408.x; Thompson ID, 2003, FOREST ECOL MANAG, V177, P441, DOI 10.1016/S0378-1127(02)00453-X; Tilghman JM, 2012, BIOL CONSERV, V152, P1, DOI 10.1016/j.biocon.2012.03.030; Todd BD, 2008, BIOL INVASIONS, V10, P539, DOI 10.1007/s10530-007-9150-9; TRENT TT, 1974, J WILDLIFE MANAGE, V38, P459, DOI 10.2307/3800877; Turcotte F, 2000, CAN J FOREST RES, V30, P202, DOI 10.1139/cjfr-30-2-202; Villasenor NR, 2013, EUR J WILDLIFE RES, V59, P749, DOI 10.1007/s10344-013-0730-y; Wegge P, 2011, FOREST ECOL MANAG, V261, P1520, DOI 10.1016/j.foreco.2011.01.041; White G.C., 1990, ANAL WILDLIFE RADIO; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	58	25	25	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118883	10.1371/journal.pone.0118883	http://dx.doi.org/10.1371/journal.pone.0118883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748217	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400028
J	Koster, R; Duzel, E; Dolan, RJ				Koster, Raphael; Duzel, Emrah; Dolan, Raymond J.			Action and Valence Modulate Choice and Choice-Induced Preference Change	PLOS ONE			English	Article							COGNITIVE-DISSONANCE; PUNISHMENT; REWARD; REPRESENTATIONS; INHIBITION; INACTION; HUMANS; REGRET	Choices are not only communicated via explicit actions but also passively through inaction. In this study we investigated how active or passive choice impacts upon the choice process itself as well as a preference change induced by choice. Subjects were tasked to select a preference for unfamiliar photographs by action or inaction, before and after they gave valuation ratings for all photographs. We replicate a finding that valuation increases for chosen items and decreases for unchosen items compared to a control condition in which the choice was made post re-evaluation. Whether choice was expressed actively or passively affected the dynamics of revaluation differently for positive and negatively valenced items. Additionally, the choice itself was biased towards action such that subjects tended to choose a photograph obtained by action more often than a photographed obtained through inaction. These results highlight intrinsic biases consistent with a tight coupling of action and reward and add to an emerging understanding of how the mode of action itself, and not just an associated outcome, modulates the decision making process.	[Koster, Raphael; Duzel, Emrah] UCL, Inst Cognit Neurosci, London, England; [Koster, Raphael; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Duzel, Emrah] Univ Magdeburg, Inst Cognit Neurol & Dementia Res, D-39106 Magdeburg, Germany; [Duzel, Emrah] German Ctr Neurodegenerat Dis, Magdeburg, Germany	University of London; University College London; University of London; University College London; Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Koster, R (corresponding author), UCL, Inst Cognit Neurosci, London, England.	raphael.koster.10@ucl.ac.uk	Duzel, Emrah/A-1794-2010	Duzel, Emrah/0000-0002-0139-5388	UCL Grand Challenge Studentship in Biomedicine; Wellcome Trust (Senior Investigator Award) [098362/Z/12/Z]; Deutsche Forschungsgemeinschaft [SFB 779 (A07)]; Wellcome Trust [091593/Z/10/Z]; MRC [G1002276] Funding Source: UKRI; Medical Research Council [G1002276] Funding Source: researchfish	UCL Grand Challenge Studentship in Biomedicine; Wellcome Trust (Senior Investigator Award)(Wellcome Trust); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a UCL Grand Challenge Studentship in Biomedicine to RK, the Wellcome Trust (Senior Investigator Award 098362/Z/12/Z to RJD) and Deutsche Forschungsgemeinschaft grant SFB 779 (A07) supporting ED. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. More information about the Wellcome Trust at http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2008, TRENDS COGN SCI, V12, P13, DOI 10.1016/j.tics.2007.10.008; Aronson E, 1999, SCI CON SER, P103, DOI 10.1037/10318-005; Brass M, 2007, J NEUROSCI, V27, P9141, DOI 10.1523/JNEUROSCI.0924-07.2007; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Byrne RMJ, 2002, TRENDS COGN SCI, V6, P426, DOI 10.1016/S1364-6613(02)01974-5; Cavanagh JF, 2013, J NEUROSCI, V33, P8541, DOI 10.1523/JNEUROSCI.5754-12.2013; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Chowdhury R, 2013, NEUROBIOL AGING, V34, P2261, DOI 10.1016/j.neurobiolaging.2013.03.030; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Gilovich T, 1998, PSYCHOL REV, V105, P602, DOI 10.1037/0033-295X.105.3.602; Guitart-Masip M, 2014, TRENDS COGN SCI, V18, P194, DOI 10.1016/j.tics.2014.01.003; Guitart-Masip M, 2014, PSYCHOPHARMACOLOGY, V231, P955, DOI 10.1007/s00213-013-3313-4; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Guitart-Masip M, 2011, J NEUROSCI, V31, P7867, DOI 10.1523/JNEUROSCI.6376-10.2011; Izuma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00041; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Johansson P, 2014, J BEHAV DECIS MAKING, V27, P281, DOI 10.1002/bdm.1807; KAHNEMAN D, 1982, SCI AM, V246, P160, DOI 10.1038/scientificamerican0182-160; Lang P.J., 2008, A8 U FLOR; Levita L, 2012, NEUROIMAGE, V62, P189, DOI 10.1016/j.neuroimage.2012.04.059; Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072071; Ngbala A, 1997, J EXP SOC PSYCHOL, V33, P324, DOI 10.1006/jesp.1996.1322; Norton MI, 2012, J CONSUM PSYCHOL, V22, P453, DOI 10.1016/j.jcps.2011.08.002; Parkinson J, 2013, CONSCIOUS COGN, V22, P1253, DOI 10.1016/j.concog.2013.08.009; Rajagopal P, 2006, J EXP SOC PSYCHOL, V42, P302, DOI 10.1016/j.jesp.2005.05.003; Schonberg T, 2014, NAT NEUROSCI, V17, P625, DOI 10.1038/nn.3673; Sharot T, 2012, PSYCHOL SCI, V23, P1123, DOI 10.1177/0956797612438733; Sharot T, 2010, PSYCHOL SCI, V21, P1231, DOI 10.1177/0956797610379235; Sharot T, 2009, CURR BIOL, V19, P2077, DOI 10.1016/j.cub.2009.10.025; Sharot T, 2009, J NEUROSCI, V29, P3760, DOI 10.1523/JNEUROSCI.4972-08.2009; SPRANCA M, 1991, J EXP SOC PSYCHOL, V27, P76, DOI 10.1016/0022-1031(91)90011-T; Wessel JR, 2014, J EXP PSYCHOL GEN, V143, P2316, DOI 10.1037/xge0000022; Zentall TR, 2010, CURR DIR PSYCHOL SCI, V19, P296, DOI 10.1177/0963721410383381	36	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119682	10.1371/journal.pone.0119682	http://dx.doi.org/10.1371/journal.pone.0119682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25747703	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400085
J	Thampi, N; Gurol-Urganci, I; Crowcroft, NS; Sander, B				Thampi, Nisha; Gurol-Urganci, Ipek; Crowcroft, Natasha S.; Sander, Beate			Pertussis Post-Exposure Prophylaxis among Household Contacts: A Cost-Utility Analysis	PLOS ONE			English	Article							HYPERTROPHIC PYLORIC-STENOSIS; BORDETELLA-PERTUSSIS; ECONOMIC-EVALUATION; UNITED-STATES; ERYTHROMYCIN PROPHYLAXIS; EPIDEMIOLOGIC FEATURES; VACCINATION STRATEGIES; WHOOPING-COUGH; FUTURE COSTS; WHOLE-CELL	Background Recent pertussis outbreaks have prompted re-examination of post-exposure prophylaxis (PEP) strategies, when immunization is not immediately protective. Chemoprophylaxis is recommended to household contacts; however there are concerns of clinical failure and significant adverse events, especially with erythromycin among infants who have the highest disease burden. Newer macrolides offer fewer side effects at higher drug costs. We sought to determine the cost-effectiveness of PEP strategies from the health care payer perspective. Methods A Markov model was constructed to examine 4 mutually exclusive strategies: erythromycin, azithromycin, clarithromycin, or no intervention, stratified by age group of contacts ("infant", "child", and "adult"). Transition probabilities, costs and quality-adjusted life years (QALYs) were derived from the literature. Chronic neurologic sequelae were modeled over a lifetime, with costs and QALYs discounted at 5%. Associated health outcomes and costs were compared, and incremental cost-effectiveness ratios (ICER) were calculated in 2012 Canadian dollars. Deterministic and probabilistic sensitivity analyses were performed to evaluate the degree of uncertainty in the results. Findings Azithromycin offered the highest QALYs in all scenarios. While this was the dominant strategy among infants, it produced an ICER of $16,963 per QALY among children and $2,415 per QALY among adults. Total QALYs with azithromycin were 19.7 for a 5-kg infant, 19.4 for a 10-year-old child, and 18.8 for a 30-year-old adult. The costs of azithromycin PEP among infants, children and adults were $1,976, $132 and $90, respectively. While results were sensitive to changes in PEP effectiveness (11% to 87%), disease transmission (variable among age groups) and hospitalization costs ($379 to $59,644), the choice of strategy remained unchanged. Interpretation Pertussis PEP is a cost-effective strategy compared with no intervention and plays an important role in contact management, potentially in outbreak situations. From a healthcare payer perspective, azithromycin is the optimal strategy among all contact groups.	[Thampi, Nisha] Childrens Hosp Eastern Ontario, Div Infect Dis, Ottawa, ON K1H 8L1, Canada; [Thampi, Nisha] Univ Ottawa, Ottawa, ON, Canada; [Gurol-Urganci, Ipek] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Crowcroft, Natasha S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Crowcroft, Natasha S.; Sander, Beate] Publ Hlth Ontario, Toronto, ON, Canada; [Sander, Beate] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Sander, Beate] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Sander, Beate] Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University of Toronto; University of Toronto	Thampi, N (corresponding author), Childrens Hosp Eastern Ontario, Div Infect Dis, Ottawa, ON K1H 8L1, Canada.	nthampi@cheo.on.ca	Sander, Beate/P-7665-2018	Sander, Beate/0000-0003-2128-9133; Gurol-Urganci, Ipek/0000-0002-6517-3485				Altunaiji S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004404.pub3; Bank of Canada, 2012, INFLATION CALCULATOR; Bank of Canada, 2012, EXCHANGE RATES; Bank of Canada, 2012, YEAR AVERAGE OF EXCH; Bettinger JA, 2007, PEDIATR INFECT DIS J, V26, P31, DOI 10.1097/01.inf.0000247055.81541.04; BINKIN NJ, 1992, PEDIATR INFECT DIS J, V11, P653; BORTOLUSSI R, 1995, PEDIATR INFECT DIS J, V14, P870, DOI 10.1097/00006454-199510000-00010; Briggs A, 2006, DECISION MODELLING F; Bureau of Labor Statistics, 2012, CPI INFLATION CALCUL; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS48, DOI 10.1097/01.inf.0000160929.35004.86; Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation, 2016, PROBIOTICS ANTIBIOTI; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P73; Cherry J D, 1984, Curr Probl Pediatr, V14, P1; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Cherry JD, 1998, ANN INTERN MED, V128, P64, DOI 10.7326/0003-4819-128-1-199801010-00010; Clark TA, 2012, J PEDIATR-US, V161, P980, DOI 10.1016/j.jpeds.2012.07.014; Cohen E, 2012, PEDIATRICS, V130, pE1463, DOI 10.1542/peds.2012-0175; Coudeville L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006284; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Davis JP, 2005, PEDIATR INFECT DIS J, V24, pS109, DOI 10.1097/01.inf.0000166156.14422.9b; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; De Serres G, 2000, J INFECT DIS, V182, P174, DOI 10.1086/315648; DESERRES G, 1995, PEDIATR INFECT DIS J, V14, P969, DOI 10.1097/00006454-199511000-00009; Dodhia H, 2002, J PUBLIC HEALTH MED, V24, P200, DOI 10.1093/pubmed/24.3.200; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; FINE PEM, 1982, LANCET, V1, P666; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Goins WP, 2012, CLIN INFECT DIS, V54, P938, DOI 10.1093/cid/cir973; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; GROB PR, 1981, LANCET, V1, P772; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Halperin SA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e42; Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792; *HLTH CAN, 2003, CAN COMMUN DIS REP, V2953, P1; Honein MA, 1999, LANCET, V354, P2101, DOI 10.1016/S0140-6736(99)10073-4; HOPPE JE, 1989, EUR J CLIN MICROBIOL, V8, P653, DOI 10.1007/BF01968151; Iskedjian M, 2001, PHARMACOECONOMICS, V19, P551, DOI 10.2165/00019053-200119050-00009; Iskedjian M, 2010, VACCINE, V28, P714, DOI 10.1016/j.vaccine.2009.10.079; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; KOPLAN JP, 1979, NEW ENGL J MED, V301, P906, DOI 10.1056/NEJM197910253011703; Kuczmarski R J, 2000, Adv Data, P1; Langley JM, 2004, PEDIATRICS, V114, pE96, DOI 10.1542/peds.114.1.e96; Lebel MH, 2001, PEDIATR INFECT DIS J, V20, P1149, DOI 10.1097/00006454-200112000-00011; Lee GM, 2005, PEDIATRICS, V115, P1675, DOI 10.1542/peds.2004-2509; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2008, VACCINE, V26, P3673, DOI 10.1016/j.vaccine.2008.04.068; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; Lee RH, 2008, J HEALTH ECON, V27, P809, DOI 10.1016/j.jhealeco.2007.09.011; Mahon BE, 2001, J PEDIATR-US, V139, P380, DOI 10.1067/mpd.2001.117577; Meltzer D, 1997, J HEALTH ECON, V16, P33, DOI 10.1016/S0167-6296(96)00507-3; MILLER CL, 1976, BRIT MED J, V1, P117, DOI 10.1136/bmj.1.6002.117; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; Morrison W, 2007, PEDIATR INFECT DIS J, V26, P186, DOI 10.1097/01.inf.0000253063.87338.60; O'Brien JA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-57; Oh PI, 1996, CLIN THER, V18, P160, DOI 10.1016/S0149-2918(96)80188-3; Ontario Ministry of Health and Long-Term Care, 2011, ONTARIO CASE COSTING; Ontario Ministry of Health and Long-Term Care, 2008, ONTARIO DRUG BENEFIT; Ontario Ministry of Health and Long-Term Care, 2013, ONTARIO DRUG BENEFIT; Pichichero ME, 1997, ARCH PEDIAT ADOL MED, V151, P35, DOI 10.1001/archpedi.1997.02170380039006; Public Health Ontario, 2012, MONTHLY INFECTIOUS D; Rodgers L, 2013, CLIN INFECT DIS, V56, P322, DOI 10.1093/cid/cis888; Roehr B, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4627; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; SPRAUER MA, 1992, AM J DIS CHILD, V146, P177, DOI 10.1001/archpedi.1992.02160140043018; Statistics Canada, 2011, DEATHS AND MORTALITY; Statistics Canada, 2012, CANADIAN VITAL STATI; STEKETEE RW, 1988, J INFECT DIS, V157, P434, DOI 10.1093/infdis/157.3.434; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Tiwari Tejpratap, 2005, Morbidity and Mortality Weekly Report, V54, P1; Tjepkema M, 2011, HEALTH REPORTS, P22; Tozzi AE, 2003, PEDIATRICS, V112, P1069, DOI 10.1542/peds.112.5.1069; Ungar WJ, 2011, PHARMACOECONOMICS, V29, P641, DOI 10.2165/11591570-000000000-00000; Vickers D, 2006, CAN MED ASSOC J, V175, P1213, DOI 10.1503/cmaj.051637; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Westra TA, 2010, CLIN THER, V32, P1479, DOI 10.1016/j.clinthera.2010.07.017; WHO, 2003, WHO GUIDE TO COST EF; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041	82	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119271	10.1371/journal.pone.0119271	http://dx.doi.org/10.1371/journal.pone.0119271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747269	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000350689400062
J	Trepanier, JC; Ellis, KN; Tucker, CS				Trepanier, Jill C.; Ellis, Kelsey N.; Tucker, Clay S.			Hurricane Risk Variability along the Gulf of Mexico Coastline	PLOS ONE			English	Article							TROPICAL CYCLONE INTENSITY; SEA-SURFACE TEMPERATURE; RETURN PERIODS; MAXIMUM INTENSITY; SENSITIVITY; ATLANTIC; WINDS	Hurricane risk characteristics are examined across the U.S. Gulf of Mexico coastline using a hexagonal tessellation. Using an extreme value model, parameters are collected representing the rate or lambda (frequency), the scale or sigma (range), and the shape or xi (intensity) of the extreme wind distribution. These latent parameters and the 30-year return level are visualized across the grid. The greatest 30-year return levels are located toward the center of the Gulf of Mexico, and for inland locations, along the borders of Louisiana, Mississippi, and Alabama. Using a geographically weighted regression model, the relationship of these parameters to sea surface temperature (SST) is found to assess sensitivity to change. It is shown that as SSTs increase near the coast, the frequency of hurricanes in these grids decrease significantly. This reinforces the importance of SST in areas of likely tropical cyclogenesis in determining the number of hurricanes near the coast, along with SSTs along the lifespan of the storm, rather than simply local SST. The range of hurricane wind speeds experienced near Florida is shown to increase with increasing SSTs (insignificant), suggesting that increased temperatures may allow hurricanes to maintain their strength as they pass over the Florida peninsula. The modifiable areal unit problem is assessed using multiple grid sizes. Moran's I and the local statistic G are calculated to examine spatial autocorrelation in the parameters. This research opens up future questions regarding rapid intensification and decay close to the coast and the relationship to changing SSTs.	[Trepanier, Jill C.; Tucker, Clay S.] Louisiana State Univ, Dept Geog & Anthropol, Baton Rouge, LA 70803 USA; [Ellis, Kelsey N.] Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA	Louisiana State University System; Louisiana State University; University of Tennessee System; University of Tennessee Knoxville	Ellis, KN (corresponding author), Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA.	ellis@utk.edu		Ellis, Kelsey/0000-0003-1699-6132				BIVAND R., 2014, SPDEP SPATIAL DEPEND; Blake E.S., 2011, DEADLIEST COSTLIEST; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Chu PS, 1998, J APPL METEOROL, V37, P951, DOI 10.1175/1520-0450(1998)037<0951:MRPOTC>2.0.CO;2; Cohen AE, 2010, NATL WEATHER DIGEST, V34, P99; Coles S., 2001, INTRO STAT MODELING; DEMARIA M, 1994, J CLIMATE, V7, P1324, DOI 10.1175/1520-0442(1994)007<1324:SSTATM>2.0.CO;2; Ellis KN, 2015, NAT HAZARDS, V75, P2733, DOI 10.1007/s11069-014-1461-4; Elsner JB, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053002; Elsner J.B., 2013, HURRICANE CLIMATOLOG; Elsner JB, 2013, J CLIMATE, V26, P5949, DOI 10.1175/JCLI-D-12-00433.1; Elsner JB, 2012, CLIM DYNAM, V39, P21, DOI 10.1007/s00382-011-1066-5; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2004, J ATMOS SCI, V61, P843, DOI 10.1175/1520-0469(2004)061<0843:ECOTCI>2.0.CO;2; EMANUEL KA, 1988, J ATMOS SCI, V45, P1143, DOI 10.1175/1520-0469(1988)045<1143:TMIOH>2.0.CO;2; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Emanuel KA, 1999, NATURE, V401, P665, DOI 10.1038/44326; EVANS JL, 1993, J CLIMATE, V6, P1133, DOI 10.1175/1520-0442(1993)006<1133:SOTCIT>2.0.CO;2; Fotheringham AS, 2000, QUANTITATIVE GEOGRAP; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Haining R., 2003, SPATIAL DATA ANAL TH; Jagger TH, 2006, J CLIMATE, V19, P3220, DOI 10.1175/JCLI3913.1; Jarvinen B.R., 1984, TECHNICAL REPORT; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Keim BD, 2007, J CLIMATE, V20, P3498, DOI 10.1175/JCLI4187.1; Knabb RD, 2005, TECHNICAL B NATL HUR; Kotz S., 2000, EXTREME VALUE DISTRI; Malmstadt JC, 2010, J APPL METEOROL CLIM, V49, P2121, DOI 10.1175/2010JAMC2420.1; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Parisi F, 2008, J CLIMATE, V21, P403, DOI 10.1175/2007JCLI1772.1; Scheitlin KN, 2011, THEOR APPL CLIMATOL, V105, P287, DOI 10.1007/s00704-010-0386-4; Trepanier JC, 2014, NAT HAZARDS, V71, P1733, DOI 10.1007/s11069-013-0985-3; Trepanier JC, 2014, NAT HAZARDS, V70, P1181, DOI 10.1007/s11069-013-0869-6; Vickery P, 2009, J WIND ENG IND AEROD, P1; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448	35	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118196	10.1371/journal.pone.0118196	http://dx.doi.org/10.1371/journal.pone.0118196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767885	Green Published, gold			2022-12-27	WOS:000351277500020
J	Anselmino, M; Scarsoglio, S; Camporeale, C; Saglietto, A; Gaita, F; Ridolfi, L				Anselmino, Matteo; Scarsoglio, Stefania; Camporeale, Carlo; Saglietto, Andrea; Gaita, Fiorenzo; Ridolfi, Luca			Rate Control Management of Atrial Fibrillation: May a Mathematical Model Suggest an Ideal Heart Rate?	PLOS ONE			English	Article							STRICT RATE CONTROL; RATE CONTROL EFFICACY; RHYTHM CONTROL; RACE II; LENIENT; INTERVALS; VOLUME	Background Despite the routine prescription of rate control therapy for atrial fibrillation (AF), clinical evidence demonstrating a heart rate target is lacking. Aim of the present study was to run a mathematical model simulating AF episodes with a different heart rate (HR) to predict hemodynamic parameters for each situation. Methods The lumped model, representing the pumping heart together with systemic and pulmonary circuits, was run to simulate AF with HR of 50, 70, 90, 110 and 130 bpm, respectively. Results Left ventricular pressure increased by 57%, from 33.92 +/- 37.56 mmHg to 53.15 +/- 47.56 mmHg, and mean systemic arterial pressure increased by 27%, from 82.66 +/- 14.04 mmHg to 105.3 +/- 7.6 mmHg, at the 50 and 130 bpm simulations, respectively. Stroke volume (from 77.45 +/- 8.50 to 39.09 +/- 8.08 mL), ejection fraction (from 61.10 +/- 4.40 to 39.32 +/- 5.42%) and stroke work (SW, from 0.88 +/- 0.04 to 0.58 +/- 0.09 J) decreased by 50, 36 and 34%, at the 50 and 130 bpm simulations, respectively. In addition, oxygen consumption indexes (rate pressure product - RPP, tension time index per minute - TTI/min, and pressure volume area per minute - PVA/min) increased from the 50 to the 130 bpm simulation, respectively, by 186% (from 5598 +/- 1939 to 15995 +/- 3219 mmHg/min), 56% (from 2094 +/- 265 to 3257 +/- 301 mmHg s/min) and 102% (from 57.99 +/- 17.90 to 117.4 +/- 26.0 J/min). In fact, left ventricular efficiency (SW/PVA) decreased from 80.91 +/- 2.91% at 50 bpm to 66.43 +/- 3.72% at the 130 bpm HR simulation. Conclusion Awaiting compulsory direct clinical evidences, the present mathematical model suggests that lower HRs during permanent AF relates to improved hemodynamic parameters, cardiac efficiency, and lower oxygen consumption.	[Anselmino, Matteo; Saglietto, Andrea; Gaita, Fiorenzo] Univ Turin, Citta Salute & Sci Hosp, Div Cardiol, Dept Med Sci, Turin, Italy; [Scarsoglio, Stefania] Politecn Torino, DIMEAS Dept Mech & Aerosp Engn, Turin, Italy; [Camporeale, Carlo; Ridolfi, Luca] Politecn Torino, DIATI Dept Environm Land & Infrastruct Engn, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Polytechnic University of Turin; Polytechnic University of Turin	Ridolfi, L (corresponding author), Politecn Torino, DIATI Dept Environm Land & Infrastruct Engn, Turin, Italy.	luca.ridolfi@polito.it	Scarsoglio, Stefania/ABC-4325-2020; Saglietto, Andrea/E-2184-2015; Scarsoglio, Stefania/E-8067-2015; Camporeale, Carlo/I-1247-2019	Scarsoglio, Stefania/0000-0002-9427-6491; Saglietto, Andrea/0000-0001-9475-1507; Scarsoglio, Stefania/0000-0002-9427-6491; Camporeale, Carlo/0000-0002-7311-6018; RIDOLFI, Luca/0000-0003-2947-8641; Gaita, Fiorenzo/0000-0003-3178-6205; Anselmino, Matteo/0000-0002-6311-4270				Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; [Anonymous], 2014, MATLAB 42014A; Epstein AE, 2002, AM HEART J, V143, P991, DOI 10.1067/mhj.2002.122875; ERBEL R, 1984, AM J CARDIOL, V53, P590, DOI 10.1016/0002-9149(84)90036-5; Go Orson, 2009, Curr Cardiol Rep, V11, P430; Groenveld HF, 2011, J AM COLL CARDIOL, V58, P1795, DOI 10.1016/j.jacc.2011.06.055; Hennig T, 2006, J BIOL PHYS, V32, P383, DOI 10.1007/s10867-006-9022-z; January CT, 2014, J AM COLL CARDIOL, DOI [10.1016/j.jacc.2014,03,022, DOI 10.1016/J.JACC.2014,03,022]; Lip GYH, 2015, EUROPACE, V17, P194, DOI 10.1093/europace/euu201; NISHIKAWA Y, 1994, J PHYSIOL-LONDON, V481, P457, DOI 10.1113/jphysiol.1994.sp020454; Scaglione M, 2014, HEART RHYTHM, V11, P777, DOI 10.1016/j.hrthm.2014.02.018; Scarsoglio S, 2014, MED BIOL ENG COMPUT, V52, P905, DOI 10.1007/s11517-014-1192-4; Smit MD, 2011, J AM COLL CARDIOL, V58, P942, DOI 10.1016/j.jacc.2011.04.030; Suga H, 2003, CLIN EXP PHARMACOL P, V30, P580, DOI 10.1046/j.1440-1681.2003.03879.x; TAKAOKA H, 1993, CIRCULATION, V87, P59, DOI 10.1161/01.CIR.87.1.59; Tateno K, 2001, MED BIOL ENG COMPUT, V39, P664, DOI 10.1007/BF02345439; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2006, AM HEART J, V152, P420, DOI 10.1016/j.ahj.2006.02.033; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Westerhof N, 2010, SNAPSHOTS OF HEMODYNAMICS: AN AID FOR CLINICAL RESEARCH AND GRADUATE EDUCATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-6363-5; Wyse DG, 2011, J AM COLL CARDIOL, V58, P950, DOI 10.1016/j.jacc.2011.04.028; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	22	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119868	10.1371/journal.pone.0119868	http://dx.doi.org/10.1371/journal.pone.0119868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764321	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300033
J	Berger, Z; Perkins, S; Ambroise, C; Oborski, C; Calabrese, M; Noell, S; Riddell, D; Hirst, WD				Berger, Zdenek; Perkins, Sarah; Ambroise, Claude; Oborski, Christine; Calabrese, Matthew; Noell, Stephen; Riddell, David; Hirst, Warren D.			Tool Compounds Robustly Increase Turnover of an Artificial Substrate by Glucocerebrosidase in Human Brain Lysates	PLOS ONE			English	Article							ACID-BETA-GLUCOSIDASE; GAUCHER-DISEASE; CEREBROSPINAL-FLUID; ISOFAGOMINE INCREASES; MUTATIONS; MULTICENTER; CHAPERONES; PROTOTYPE; VARIANTS; DEMENTIA	Mutations in glucocerebrosidase (GBA1) cause Gaucher disease and also represent a common risk factor for Parkinson's disease and Dementia with Lewy bodies. Recently, new tool molecules were described which can increase turnover of an artificial substrate 4MUG when incubated with mutant N370S GBA1 from human spleen. Here we show that these compounds exert a similar effect on the wild-type enzyme in a cell-free system. In addition, these tool compounds robustly increase turnover of 4MUG by GBA1 derived from human cortex, despite substantially lower glycosylation of GBA1 in human brain, suggesting that the degree of glycosylation is not important for compound binding. Surprisingly, these tool compounds failed to robustly alter GBA1 turnover of 4MUG in the mouse brain homogenate. Our data raise the possibility that in vivo models with humanized glucocerebrosidase may be needed for efficacy assessments of such small molecules.	[Berger, Zdenek; Perkins, Sarah; Ambroise, Claude; Oborski, Christine; Riddell, David; Hirst, Warren D.] Pfizer, Neurosci Res Unit, Cambridge, MA 02140 USA; [Calabrese, Matthew] Pfizer Inc, Struct Biol Grp, Groton, CT 06340 USA; [Noell, Stephen] Pfizer Inc, Primary Pharmacol Grp, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Berger, Z (corresponding author), Pfizer, Neurosci Res Unit, 610 Main St, Cambridge, MA 02140 USA.	zdenek.berger@pfizer.com		Hirst, Warren/0000-0003-0389-8891				Balducci C, 2007, MOVEMENT DISORD, V22, P1481, DOI 10.1002/mds.21399; Deegan PB, 2012, DRUG DES DEV THER, V6, DOI 10.2147/DDDT.S14395; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Goldin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029861; Grabowski GA, 1996, CRIT REV ONCOL HEMAT, V23, P25, DOI 10.1016/1040-8428(96)00199-0; Khanna R, 2010, FEBS J, V277, P1618, DOI 10.1111/j.1742-4658.2010.07588.x; Kurzawa-Akanbi M, 2012, J NEUROCHEM, V123, P298, DOI 10.1111/j.1471-4159.2012.07879.x; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Motabar O, 2012, ANAL BIOANAL CHEM, V402, P731, DOI 10.1007/s00216-011-5496-z; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; Parnetti L, 2009, NEUROBIOL DIS, V34, P484, DOI 10.1016/j.nbd.2009.03.002; Parnetti L, 2014, MOV DISORD; Patnaik S, 2012, J MED CHEM, V55, P5734, DOI 10.1021/jm300063b; Premkumar L, 2007, GAUCHER DIS; Ron I, 2005, BLOOD CELL MOL DIS, V35, P57, DOI 10.1016/j.bcmd.2005.03.006; Sanders A, 2013, BLOOD CELL MOL DIS, V51, P109, DOI 10.1016/j.bcmd.2013.03.006; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sun Y, 2012, J BIOL CHEM, V287, P4275, DOI 10.1074/jbc.M111.280016; Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019037; van de Berg WDJ, 2013, AD PD M FLOR IT; van Dijk KD, 2013, MOVEMENT DISORD, V28, P747, DOI 10.1002/mds.25495; Westbroek W, 2011, TRENDS MOL MED, V17, P485, DOI 10.1016/j.molmed.2011.05.003; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Zhao H, 2002, CELL MOL LIFE SCI, V59, P694, DOI 10.1007/s00018-002-8458-y; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104	29	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119141	10.1371/journal.pone.0119141	http://dx.doi.org/10.1371/journal.pone.0119141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763858	gold, Green Submitted, Green Published			2022-12-27	WOS:000351276300020
J	Tansiri, Y; Rowland-Jones, SL; Ananworanich, J; Hansasuta, P				Tansiri, Yada; Rowland-Jones, Sarah L.; Ananworanich, Jintanat; Hansasuta, Pokrath			Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8(+) T-Cell-Mediated HIV Suppression	PLOS ONE			English	Article							VIRUS TYPE-1 REPLICATION; VIRAL LOAD; NASOPHARYNGEAL CARCINOMA; IMMUNE CONTROL; EX-VIVO; INFECTION; RESPONSES; GAG; LYMPHOCYTES; ACTIVATION	In this cross-sectional study we evaluated T-cell responses using several assays to determine immune correlates of HIV control that distinguish untreated viraemic controllers (VC) from noncontrollers (NC) with similar CD4 counts. Samples were taken from 65 ART-naive chronically HIV-infected VC and NC from Thailand with matching CD4 counts in the normal range (>450 cells/mu l). We determined HIVp24-specific T-cell responses using standard Interferon- gamma (IFN gamma) ELISpot assays, and compared the functional quality of HIVp24-specific CD8(+) T-cell responses using polychromatic flow cytometry. Finally, in vitro HIV suppression assays were performed to evaluate directly the activity of CD8(+) T cells in HIV control. Autologous CD4(+) T cells were infected with primary patient-derived HIV isolates and the HIV suppressive activity of CD8(+) T cells was determined after co-culture, measuring production of HIVp24 Ag by ELISA. The HIVp24-specific T-cell responses of VC and NC could not completely be differentiated through measurement of IFN gamma-producing cells using ELISpot assays, nor by the absolute cell numbers of polyfunctional HIVp24-specific CD8(+) T cells. However, in vitro HIV suppression assays showed clear differences between VC and NC. HIV suppressive activity, mediated by either ex vivo unstimulated CD8(+) T cells or HIVp24-specific T-cell lines, was significantly greater using cells from VC than NC cells. Additionally, we were able to demonstrate a significant correlation between the level of HIV suppressive activity mediated by ex vivo unstimulated CD8(+) T cells and plasma viral load (pVL) (Spearman r = -0.7345, p = 0.0003). This study provides evidence that in vitro HIV suppression assays are the most informative in the functional evaluation of CD8(+) T-cell responses and can distinguish between VC and NC.	[Tansiri, Yada; Hansasuta, Pokrath] Chulalongkorn Univ, Fac Med, Div Virol, Dept Microbiol, Bangkok 10330, Thailand; [Rowland-Jones, Sarah L.] Univ Oxford, Nuffield Dept Med, Oxford OX3 7FZ, England; [Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand	Chulalongkorn University; University of Oxford; Chulalongkorn University	Hansasuta, P (corresponding author), Chulalongkorn Univ, Fac Med, Div Virol, Dept Microbiol, Bangkok 10330, Thailand.	Pokrath.H@Chula.ac.th	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Tansiri, Yada/0000-0002-0329-0133	Government Grant through National Research Council of Thailand (NRCT); Chulalongkorn University, Bangkok, Thailand [GRB_BSS_49_55_30_08]; Thailand Research Fund (TRF) through TRF Senior Research Scholar; Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program [PHD/0148/2549]	Government Grant through National Research Council of Thailand (NRCT); Chulalongkorn University, Bangkok, Thailand(Chulalongkorn University); Thailand Research Fund (TRF) through TRF Senior Research Scholar; Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This study was financial supported by Government Grant through National Research Council of Thailand (NRCT) and Chulalongkorn University, Bangkok, Thailand (GRB_BSS_49_55_30_08). PH was partially supported by the Thailand Research Fund (TRF) through TRF Senior Research Scholar; YT was also supported by the Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program (PHD/0148/2549). The funders had no role in study design, data collection, data analysis, decision to publish, and manuscript preparation.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; COFFIN J, 1986, SCIENCE, V232, P697, DOI 10.1126/science.3008335; Comoli P, 2005, J CLIN ONCOL, V23, P8942, DOI 10.1200/JCO.2005.02.6195; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fogg MH, 2009, P NATL ACAD SCI USA, V106, P3318, DOI 10.1073/pnas.0813320106; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kottilil S, 2000, J CLIN IMMUNOL, V20, P175, DOI 10.1023/A:1006633429087; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lecuroux C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059767; Luo XH, 2010, BIOL BLOOD MARROW TR, V16, P994, DOI 10.1016/j.bbmt.2010.02.007; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Spentzou A, 2010, J INFECT DIS, V201, P720, DOI 10.1086/650492; Sriwanthana B, 2001, AIDS RES HUM RETROV, V17, P719, DOI 10.1089/088922201750236997; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Techakriengkrai N, 2013, AIDS, V27, P17, DOI 10.1097/QAD.0b013e32835ac0e1; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Zhang YH, 2011, J IMMUNOL, V187, P684, DOI 10.4049/jimmunol.1100316	45	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118871	10.1371/journal.pone.0118871	http://dx.doi.org/10.1371/journal.pone.0118871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764310	gold, Green Published, Green Submitted			2022-12-27	WOS:000351276300016
J	Nishikawa, N; Shimo, Y; Wada, M; Hattori, N; Kitazawa, S				Nishikawa, Natsuko; Shimo, Yasushi; Wada, Makoto; Hattori, Nobutaka; Kitazawa, Shigeru			Effects of Aging and Idiopathic Parkinson's Disease on Tactile Temporal Order Judgment	PLOS ONE			English	Article							DISCRIMINATION; STIMULATION; PERCEPTION; HANDEDNESS; MOVEMENTS; PARIETAL; SACCADES; MODEL; AGE	It is generally accepted that the basal ganglia play an important role in interval timing that requires the measurement of temporal durations. By contrast, it remains controversial whether the basal ganglia play an essential role in temporal order judgment (TOJ) of successive stimuli, a behavior that does not necessarily require the measurement of durations in time. To address this issue, we compared the effects of idiopathic Parkinson's disease (PD) on the TOJ of two successive taps delivered to each hand, with the arms uncrossed in one condition and crossed in another. In addition to age-matched elderly participants without PD (non-PD), we examined young healthy participants so that the effect of aging could serve as a control for evaluating the effects of PD. There was no significant difference between PD and non-PD participants in any parameter of TOJ under either arm posture, although reaction time was significantly longer in PD compared with non-PD participants. By contrast, the effect of aging was apparent in both conditions. With their arms uncrossed, the temporal resolution (the interstimulus interval that yielded 84% correct responses) in elderly participants was significantly worse compared with young participants. With their arms crossed, elderly participants made more errors at longer intervals (similar to 1 s) than young participants, although both age groups showed similar judgment reversal at moderately short intervals (similar to 200 ms). These results indicate that the basal ganglia and dopaminergic systems do not play essential roles in tactile TOJ involving both hands and that the effect of aging on TOJ is mostly independent of the dopaminergic systems.	[Nishikawa, Natsuko; Shimo, Yasushi; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138421, Japan; [Wada, Makoto; Kitazawa, Shigeru] Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan; [Wada, Makoto] Res Inst Natl Rehabil Ctr Persons Disabil, Dept Rehabil Brain Funct, Dev Disorders Sect, Tokorozawa, Saitama, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontiers Biosci, Dynam Brain Network Lab, Osaka, Japan	Juntendo University; Juntendo University; Osaka University; Osaka University	Kitazawa, S (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan.	kitazawa@fbs.osaka-u.ac.jp	Hattori, Nobutaka/ACR-0069-2022		 [21240029];  [25119002]	; 	This work was supported by Grants-in-Aid for Scientific Research (A) 21240029, and Grants-in-Aid for Scientific Research on Innovative Areas 25119002 to S.K. (http://www.mext.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; AXELROD S, 1968, J GERONTOL, V23, P191, DOI 10.1093/geronj/23.2.191; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; Brown LN, 2000, J CLIN EXP NEUROPSYC, V22, P587, DOI 10.1076/1380-3395(200010)22:5;1-9;FT587; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Conte A, 2010, BRAIN, V133, P2656, DOI 10.1093/brain/awq191; Coppinger NW, 1955, J GERONTOL, V10, P48, DOI 10.1093/geronj/10.1.48; Craig JC, 2010, ATTEN PERCEPT PSYCHO, V72, P226, DOI 10.3758/APP.72.1.226; Davis B, 2009, J NEUROSCI, V29, P3182, DOI 10.1523/JNEUROSCI.5793-08.2009; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; DESMEDT JE, 1980, ELECTROEN CLIN NEURO, V50, P404, DOI 10.1016/0013-4694(80)90007-3; Fiorio M, 2008, J NEUROL, V255, P1372, DOI 10.1007/s00415-008-0923-6; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujisaki W., 2012, NEW HDB MULTISENSORY, P301; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; Groh JM, 1996, J NEUROPHYSIOL, V75, P412, DOI 10.1152/jn.1996.75.1.412; Haggard P, 2008, SENSORIMOTOR FDN HIG; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Heed T, 2010, J COGNITIVE NEUROSCI, V22, P184, DOI 10.1162/jocn.2008.21168; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; JASKOWSKI P, 1991, PERCEPT PSYCHOPHYS, V50, P76, DOI 10.3758/BF03212206; Kitazawa S, 2002, CONSCIOUS COGN, V11, P475, DOI 10.1016/S1053-8100(02)00031-4; Laasonen M, 2002, NEUROREPORT, V13, P1111, DOI 10.1097/00001756-200207020-00008; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Nakano T, 2011, I-PERCEPTION, V2, P800; Nelson AJ, 2012, CAN J NEUROL SCI, V39, P52, DOI 10.1017/S0317167100012683; Nolano M, 2008, BRAIN, V131, P1903, DOI 10.1093/brain/awn102; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overvliet KE, 2011, NEUROPSYCHOLOGIA, V49, P3046, DOI 10.1016/j.neuropsychologia.2011.07.005; Oyama G, 2011, PARKINSONISM RELAT D, V17, P189, DOI 10.1016/j.parkreldis.2010.12.004; PASTOR MA, 1992, BRAIN, V115, P875, DOI 10.1093/brain/115.3.875; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Poliakoff E, 2006, NEUROSCI LETT, V396, P207, DOI 10.1016/j.neulet.2005.11.034; Rigato S, 2013, EUR J NEUROSCI, V38, P2884, DOI 10.1111/ejn.12292; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Soto-Faraco S, 2013, NEUROPSYCHOLOGIA, V51, P1584, DOI 10.1016/j.neuropsychologia.2013.04.012; Takahashi T, 2013, CEREB CORTEX, V23, P1952, DOI 10.1093/cercor/bhs179; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118331	10.1371/journal.pone.0118331	http://dx.doi.org/10.1371/journal.pone.0118331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760621	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000022
J	Sun, WL; Valero, MC; Seong, KM; Steele, LD; Huang, IT; Lee, CH; Clark, JM; Qiu, XH; Pittendrigh, BR				Sun, Weilin; Valero, M. Carmen; Seong, Keon Mook; Steele, Laura D.; Huang, I-Ting; Lee, Chien-Hui; Clark, John M.; Qiu, Xinghui; Pittendrigh, Barry R.			A Glycine Insertion in the Estrogen-Related Receptor (ERR) Is Associated with Enhanced Expression of Three Cytochrome P450 Genes in Transgenic Drosophila melanogaster	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; DDT RESISTANCE; TRANSCRIPTIONAL CONTROL; METABOLIC RESISTANCE; RESPONSES; CYP6A2; DATABASE; STRAINS; CYP12D1; NRF2	Insecticide-resistant Drosophila melanogaster strains represent a resource for the discovery of the underlying molecular mechanisms of cytochrome P450 constitutive overexpression, even if some of these P450s are not directly involved in the resistance phenotype. For example, in select 4,4'-dichlorodiphenyltrichloroethane (DDT) resistant strains the glucocorticoid receptor-like (GR-like) potential transcription factor binding motifs (TFBMs) have previously been shown to be associated with constitutively differentially-expressed cytochrome P450s, Cyp12d1, Cyp6g2 and Cyp9c1. However, insects are not known to have glucocorticoids. The only ortholog to the mammalian glucocorticoid receptor (GR) in D. melanogaster is an estrogen-related receptor (ERR) gene, which has two predicted alternative splice isoforms (ERRa and ERRb). Sequencing of ERRa and ERRb in select DDT susceptible and resistant D. melanogaster strains has revealed a glycine (G) codon insertion which was only observed in the ligand binding domain of ERR from the resistant strains tested (ERR-G). Transgenic flies, expressing the ERRa-G allele, constitutively over-expressed Cyp12d1, Cyp6g2 and Cyp9c1. Only Cyp12d1 and Cyp6g2 were over-expressed in the ERRb-G transgenic flies. Phylogenetic studies show that the G-insertion appeared to be located in a less conserved domain in ERR and this insertion is found in multiple species across the Sophophora subgenera.	[Sun, Weilin; Valero, M. Carmen; Seong, Keon Mook; Steele, Laura D.; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Huang, I-Ting; Lee, Chien-Hui] Chung Hwa Univ Med Technol, Tainan, Taiwan; [Clark, John M.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Qiu, Xinghui] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Chung Hua University; University of Massachusetts System; University of Massachusetts Amherst; Chinese Academy of Sciences; Institute of Zoology, CAS	Sun, WL (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	wsn@illinois.edu			C. W. Kearns, C. L. Metcalf and W. P. Flint Endowment	C. W. Kearns, C. L. Metcalf and W. P. Flint Endowment	This work was primarily funded by the C. W. Kearns, C. L. Metcalf and W. P. Flint Endowment. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Ansell PJ, 2005, MOL CELL ENDOCRINOL, V243, P27, DOI 10.1016/j.mce.2005.08.002; Ariazi EA, 2002, CANCER RES, V62, P6510; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bardet PL, 2006, TRENDS ENDOCRIN MET, V17, P166, DOI 10.1016/j.tem.2006.03.005; Brandt A, 2002, INSECT MOL BIOL, V11, P337, DOI 10.1046/j.1365-2583.2002.00344.x; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Dvorak Z, 2010, DRUG METAB REV, V42, P621, DOI 10.3109/03602532.2010.484462; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kazemian M, 2011, NUCLEIC ACIDS RES, V39, pW79, DOI 10.1093/nar/gkr291; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kuruganti S, 2007, GENE, V388, P43, DOI 10.1016/j.gene.2006.09.019; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Maitra S, 2000, GENE, V248, P147, DOI 10.1016/S0378-1119(00)00129-3; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McDonnell CM, 2012, J MOL EVOL, V74, P281, DOI 10.1007/s00239-012-9506-3; McKenzie JA, 1998, PHILOS T ROY SOC B, V353, P1729, DOI 10.1098/rstb.1998.0325; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Misra JR, 2013, INSECT BIOCHEM MOLEC, V43, P1116, DOI 10.1016/j.ibmb.2013.09.005; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, pW24, DOI 10.1093/nar/gkr393; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Ostberg T, 2003, BIOCHEMISTRY-US, V42, P6427, DOI 10.1021/bi027279b; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PLAPP FW, 1984, PESTIC BIOCHEM PHYS, V22, P194, DOI 10.1016/0048-3575(84)90089-0; Qiu XH, 2013, PEST MANAG SCI, V69, P930, DOI 10.1002/ps.3454; Strycharz JP, 2013, PESTIC BIOCHEM PHYS, V107, P207, DOI 10.1016/j.pestbp.2013.06.010; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Wan H, 2014, PEST MANAG SCI, V70, P1048, DOI 10.1002/ps.3645; Zhou W, 2007, MOL CELL ENDOCRINOL, V278, P52, DOI 10.1016/j.mce.2007.08.011	48	12	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118779	10.1371/journal.pone.0118779	http://dx.doi.org/10.1371/journal.pone.0118779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761142	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000039
J	Szymanska, P; Martin, KR; MacKeigan, JP; Hlavacek, WS; Lipniacki, T				Szymanska, Paulina; Martin, Katie R.; MacKeigan, Jeffrey P.; Hlavacek, William S.; Lipniacki, Tomasz			Computational Analysis of an Autophagy/Translation Switch Based on Mutual Inhibition of MTORC1 and ULK1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DEPENDENT PHOSPHORYLATION; MAMMALIAN TARGET; MAINTAINS ENERGY; BINDING PARTNER; CELL-GROWTH; S6 KINASE; AUTOPHAGY; COMPLEX; RAPTOR	We constructed a mechanistic, computational model for regulation of (macro) autophagy and protein synthesis (at the level of translation). The model was formulated to study the system-level consequences of interactions among the following proteins: two key components of MTOR complex 1 (MTORC1), namely the protein kinase MTOR (mechanistic target of rapamycin) and the scaffold protein RPTOR; the autophagy-initiating protein kinase ULK1; and the multimeric energy-sensing AMP-activated protein kinase (AMPK). Inputs of the model include intrinsic AMPK kinase activity, which is taken as an adjustable surrogate parameter for cellular energy level or AMP: ATP ratio, and rapamycin dose, which controls MTORC1 activity. Outputs of the model include the phosphorylation level of the translational repressor EIF4EBP1, a substrate of MTORC1, and the phosphorylation level of AMBRA1 (activating molecule in BECN1-regulated autophagy), a substrate of ULK1 critical for autophagosome formation. The model incorporates reciprocal regulation of mTORC1 and ULK1 by AMPK, mutual inhibition of MTORC1 and ULK1, and ULK1-mediated negative feedback regulation of AMPK. Through analysis of the model, we find that these processes may be responsible, depending on conditions, for graded responses to stress inputs, for bistable switching between autophagy and protein synthesis, or relaxation oscillations, comprising alternating periods of autophagy and protein synthesis. A sensitivity analysis indicates that the prediction of oscillatory behavior is robust to changes of the parameter values of the model. The model provides testable predictions about the behavior of the AMPK-MTORC1-ULK1 network, which plays a central role in maintaining cellular energy and nutrient homeostasis.	[Szymanska, Paulina] Univ Warsaw, Coll Inter, Fac Individual Studies Math & Nat Sci, Warsaw, Poland; [Martin, Katie R.; MacKeigan, Jeffrey P.] Van Andel Inst, Grand Rapids, MI USA; [Hlavacek, William S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Hlavacek, William S.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Lipniacki, Tomasz] Inst Fundamental Technol Res, PL-00049 Warsaw, Poland	University of Warsaw; Van Andel Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Hlavacek, WS (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA.	wish@lanl.gov; tlipnia@ippt.pan.pl	Lipniacki, Tomasz/AAC-6744-2019	Lipniacki, Tomasz/0000-0002-3488-2561; Martin, Katie/0000-0002-3689-4814; Szymanska-Rozek, Paulina/0000-0002-2527-5081; Hlavacek, William/0000-0003-4383-8711; MacKeigan, Jeffrey/0000-0002-0198-5679	National Institutes of Health/National Institute of General Medical Science [P50GM085273]; US Department of Energy through the Los Alamos Center for Nonlinear Studies [DE-AC52-06NA25396]; Laboratory-directed Research and Development (LDRD) Program; National Science Center (Poland) [2011/03/B/NZ2/00281]; EU through the European Social Fund [UDA-POKL.04.01.01-00-072/09-00]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy through the Los Alamos Center for Nonlinear Studies(United States Department of Energy (DOE)); Laboratory-directed Research and Development (LDRD) Program; National Science Center (Poland)(National Science Centre, Poland); EU through the European Social Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WSH is supported by National Institutes of Health/National Institute of General Medical Science grant P50GM085273, (www.nih.gov/www.nigms.nih.gov) and US Department of Energy Contract DE-AC52-06NA25396 through the Los Alamos Center for Nonlinear Studies and the Laboratory-directed Research and Development (LDRD) Program, (www.energy.gov). TL is supported by National Science Center (Poland) Grant No. 2011/03/B/NZ2/00281, (www.ncn.gov.pl). PS is supported by EU through the European Social Fund, contract number UDA-POKL.04.01.01-00-072/09-00, (http://ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-7; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chylek LA, 2014, WIRES SYST BIOL MED, V6, P13, DOI 10.1002/wsbm.1245; Chylek LA, 2011, MOL BIOSYST, V7, P2779, DOI 10.1039/c1mb05077j; Coffman K, 2014, J BIOL CHEM, V289, P4723, DOI 10.1074/jbc.M113.482067; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dunlop EA, 2013, BIOCHEM SOC T, V41, P939, DOI 10.1042/BST20130030; Dunlop EA, 2011, AUTOPHAGY, V7, P737, DOI 10.4161/auto.7.7.15491; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kapuy O, 2009, PROG BIOPHYS MOL BIO, V100, P47, DOI 10.1016/j.pbiomolbio.2009.06.004; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kuznetsov, 2013, ELEMENTS APPL BIFURC; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Loffler AS, 2011, AUTOPHAGY, V7, P696, DOI 10.4161/auto.7.7.15451; Lomnitz JG, 2014, ACS SYNTH BIOL; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu W, 2011, BIOINFORMATICS, V27, P1721, DOI 10.1093/bioinformatics/btr197; Xu YQ, 2013, AUTOPHAGY, V9, P1418, DOI 10.4161/auto.25080; Yang J, 2011, MATH BIOSCI, V232, P164, DOI 10.1016/j.mbs.2011.06.003; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116550	10.1371/journal.pone.0116550	http://dx.doi.org/10.1371/journal.pone.0116550			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761126	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000006
J	Muuronen, AT; Taina, M; Hedman, M; Marttila, J; Kuusisto, J; Onatsu, J; Vanninen, R; Jakala, P; Sipola, P; Mustonen, P				Muuronen, Antti T.; Taina, Mikko; Hedman, Marja; Marttila, Jarkko; Kuusisto, Johanna; Onatsu, Juha; Vanninen, Ritva; Jakala, Pekka; Sipola, Petri; Mustonen, Pirjo			Increased Visceral Adipose Tissue as a Potential Risk Factor in Patients with Embolic Stroke of Undetermined Source (ESUS)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; COMPUTED-TOMOGRAPHY; ISCHEMIC-STROKE; FAT MASS; INFLAMMATION; ECHOCARDIOGRAPHY; CLASSIFICATION; ASSOCIATION	Purpose The etiology of an ischemic stroke remains undetermined in 20-35% of cases and many patients do not have any of the conventional risk factors. Increased visceral adipose tissue (VAT) is a suggested new risk factor for both carotid artery atherosclerosis (CAA) and atrial fibrillation (AF), but its role in the remaining stroke population is unknown. We assessed the amount of VAT in patients with embolic stroke of undetermined source (ESUS) after excluding major-risk cardioembolic sources, occlusive atherosclerosis, and lacunar stroke. Methods Altogether 58 patients (mean age 57.7 +/- 10.2 years, 44 men) with ischemic stroke of unknown etiology but without CAA, known AF or small vessel disease underwent computed tomography angiography and assessment of VAT. For comparison VAT values from three different reference populations were used. Conventional risk factors (smoking, hypertension, diabetes, increased total and LDL-cholesterol, decreased HDL-cholesterol) were also registered. Results Mean VAT area was significantly higher in stroke patients (205 +/- 103 cm(2) for men and 168 +/- 99 cm(2) for women) compared to all reference populations (P<0.01). 50% of male and 57% of female patients had an increased VAT area. In male patients, VAT was significantly higher despite similar body mass index (BMI). Increased VAT was more common than any of the conventional risk factors. Conclusion Increased VAT was found in over half of our patients with ESUS suggesting it may have a role in the pathogenesis of thromboembolism in this selected group of patients.	[Muuronen, Antti T.; Taina, Mikko; Hedman, Marja; Marttila, Jarkko; Vanninen, Ritva; Sipola, Petri] Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Kuusisto, Johanna] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, Neuro Ctr, SF-70210 Kuopio, Finland; [Vanninen, Ritva; Sipola, Petri] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital	Muuronen, AT (corresponding author), Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Antti.Muuronen@kuh.fi			Kuopio University Hospital [5063519]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 5063519-URL: http://www.psshp.fi/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Arboix A, 2010, CURR CARDIOL REV, V6, P150, DOI 10.2174/157340310791658730; Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Berker D, 2010, DIAGN INTERV RADIOL, V16, P99, DOI 10.4261/1305-3825.DIR.2749-09.1; Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099; Carroll JF, 2009, OBESITY, V17, P1420, DOI 10.1038/oby.2008.657; CHOWDHURY B, 1994, INT J OBESITY, V18, P219; Cohen J, 1998, STAT POWER ANAL BEHA, P273; Davi G, 2002, JAMA-J AM MED ASSOC, V288, P2008, DOI 10.1001/jama.288.16.2008; DiTomasso D, 2010, ATHEROSCLEROSIS, V208, P531, DOI 10.1016/j.atherosclerosis.2009.08.015; Gautier A, 2013, CLIN ENDOCRINOL, V78, P373, DOI 10.1111/j.1365-2265.2012.04401.x; Guercini F, 2008, J THROMB HAEMOST, V6, P549, DOI 10.1111/j.1538-7836.2008.02903.x; Hanzu FA, 2011, J THROMB HAEMOST, V9, P1236, DOI 10.1111/j.1538-7836.2011.04285.x; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Jensky NE, 2011, OBESITY, V19, P2418, DOI 10.1038/oby.2011.70; Karcher HS, 2013, CEREBROVASC DIS, V35, P341, DOI 10.1159/000348703; Karttunen V, 2002, EUR J NEUROL, V9, P625, DOI 10.1046/j.1468-1331.2002.00464.x; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Klopfenstein BJ, 2012, BRIT J RADIOL, V85, pE826, DOI 10.1259/bjr/57987644; KUHNS LR, 1978, AM J ROENTGENOL, V131, P115, DOI 10.2214/ajr.131.1.115; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mazzoccoli G, 2012, ATHEROSCLEROSIS, V223, P378, DOI 10.1016/j.atherosclerosis.2012.05.033; Mertens I, 2001, HORM METAB RES, V33, P602, DOI 10.1055/s-2001-17907; Mosteller RD, 1987, NEW ENGL J MED, V317, P1098; Nicklas BJ, 2003, DIABETES CARE, V26, P1413, DOI 10.2337/diacare.26.5.1413; Nieuwdorp M, 2005, CURR OPIN PHARMACOL, V5, P155, DOI 10.1016/j.coph.2004.10.003; Pepi M, 2010, EUR J ECHOCARDIOGR, V11, P461, DOI 10.1093/ejechocard/jeq045; Quetelet L A, 1994, Obes Res, V2, P72; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; ROSSNER S, 1990, INT J OBESITY, V14, P893; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Salmenniemi U, 2005, INT J OBESITY, V29, P1464, DOI 10.1038/sj.ijo.0803041; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Schoen RE, 1998, INT J OBESITY, V22, P338, DOI 10.1038/sj.ijo.0800591; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; SJOSTROM L, 1986, AM J PHYSIOL, V250, pE736, DOI 10.1152/ajpendo.1986.250.6.E736; Starr ME, 2013, AGING CELL, V12, P194, DOI 10.1111/acel.12040; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; THAETE FL, 1995, INT J OBESITY, V19, P464; Toss F, 2011, INT J OBESITY, V35, P1427, DOI 10.1038/ijo.2011.9; Uchida Y, 2012, DIABETES, V61, P1552, DOI 10.2337/db11-0828; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, SOURCES AND EFFECTS, V1; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wiklund P, 2008, J CLIN ENDOCR METAB, V93, P4360, DOI 10.1210/jc.2008-0804; World Health Organization, 2012, WORLD HLTH STAT 2012; Yoshizumi T, 1999, RADIOLOGY, V211, P283; Yudkin JS, 2004, METABOLISM, V53, P852, DOI 10.1016/j.metabol.2004.02.004	55	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120598	10.1371/journal.pone.0120598	http://dx.doi.org/10.1371/journal.pone.0120598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756793	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700069
J	Nielsen, LA; Bojsoe, C; Kloppenborg, JT; Trier, C; Gamborg, M; Holm, JC				Nielsen, Louise A.; Bojsoe, Christine; Kloppenborg, Julie T.; Trier, Caecilie; Gamborg, Michael; Holm, Jens-Christian			The Influence of Familial Predisposition to Cardiovascular Complications upon Childhood Obesity Treatment	PLOS ONE			English	Article							BODY-MASS INDEX; CHRONIC CARE TREATMENT; PARENTAL OBESITY; CHILDREN; OVERWEIGHT; RISK; PROGRAM; HISTORY; DISEASE; WEIGHT	Introduction The aim was to investigate whether a familial predisposition to obesity related cardiovascular complications was associated with the degree of obesity at baseline and/or changes in the degree of obesity during a multidisciplinary childhood obesity treatment program. Methods The study included 1421 obese children (634 boys) with a median age of 11.5 years (range 3.1-17.9 years), enrolled in treatment for 0.04 to 5.90 years (median 1.3 years) at the Children's Obesity Clinic, Denmark. At baseline, weight and height were measured, body mass index (BMI) standard deviation score (SDS) calculated, and self-reported information on familial predisposition to obesity, hypertension, type 2 diabetes mellitus (T2DM), thromboembolic events, and dyslipidaemia were obtained. A familial predisposition included events in biological parents, siblings, grandparents, uncles, and aunts. The treatment outcomes were categorically analysed according to the prevalence of familial predispositions. Results The median BMI SDS at enrolment was 3.2 in boys and 2.8 in girls. One-thousand-and-forty-one children had obesity in their family, 773 had hypertension, 551 had T2DM, 568 had thromboembolic events, and 583 had dyslipidaemia. Altogether, 733 had three or more predispositions. At baseline, familial T2DM was associated with a higher mean BMI SDS (p = 0.03), but no associations were found between the other predispositions and the children's degree of obesity. During treatment, girls with familial obesity lost more weight, compared to girls without familial obesity (p = 0.04). No other familial predispositions were associated with changes in BMI SDS during treatment. Conclusion Obese children with a familial predisposition to T2DM showed a significantly higher degree of obesity at baseline and girls with familial obesity responded better to treatment. Besides these findings, no other associations were found between the occurrence of familial predispositions and the degree of obesity or changes herein during multidisciplinary childhood obesity treatment.	[Nielsen, Louise A.; Bojsoe, Christine; Kloppenborg, Julie T.; Trier, Caecilie; Holm, Jens-Christian] Copenhagen Univ Hosp Holbaek, Dept Paediat, Childrens Obes Clin, DK-4300 Holbaek, Denmark; [Kloppenborg, Julie T.] Copenhagen Univ Hosp Herlev, Dept Paediat, DK-2730 Herlev, Denmark; [Trier, Caecilie] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2200 Copenhagen, Denmark; [Gamborg, Michael] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Capital Reg, DK-2000 Copenhagen, Denmark; [Holm, Jens-Christian] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Nielsen, LA (corresponding author), Copenhagen Univ Hosp Holbaek, Dept Paediat, Childrens Obes Clin, DK-4300 Holbaek, Denmark.	loani@regionsjaelland.dk	Holm, Louise Aas/GOG-8527-2022; Holm, Jens-Christian/T-4594-2017	Holm, Louise Aas/0000-0002-5439-5429; Holm, Jens-Christian/0000-0003-4653-342X	Region Zealand Health Scientific Research Foundation; Danish Council for Strategic Research [11-115917, 11-116714]	Region Zealand Health Scientific Research Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study is part of research activities in TARGET (The impact of our genomes on individual treatment response in obese children, see www.target.ku.dk) and BIOCHILD (Genetics and systems biology of childhood obesity in India and Denmark, see (www.biochild.ku.dk)) consortia supported by the Region Zealand Health Scientific Research Foundation (see, http://www.regionsjaelland.dk/Sundhed/forskning/forskningsfinansiering/Sider/oekonomi.aspx) and the Danish Council for Strategic Research (grant 11-115917 and 11-116714) (see, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-strategic-research). Funding was received by J-CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinli S, 2011, J PEDIAT ENDOCRINOL, V20, P431, DOI [10.1515/JPEM.2007.20.3.431, DOI 10.1515/JPEM.2007.20.3.431]; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; BLONDE CV, 1981, PREV MED, V10, P25, DOI 10.1016/0091-7435(81)90003-7; Cook S, 2011, PEDIATR CLIN N AM, V58, P1363, DOI 10.1016/j.pcl.2011.09.003; Danielsson P, 2012, ARCH PEDIAT ADOL MED, V166, P1103, DOI 10.1001/2013.jamapediatrics.319; Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756; Davis MM, 2008, J AM BOARD FAM MED, V21, P549, DOI 10.3122/jabfm.2008.06.070140; Davison KK, 2001, INT J OBESITY, V25, P1834, DOI 10.1038/sj.ijo.0801835; Eliakim A, 2004, J PEDIATR ENDOCR MET, V17, P1055; Glowinska B, 2002, EUR J PEDIATR, V161, P511, DOI 10.1007/s00431-002-1040-7; Holm JC, 2011, INT J PEDIATR OBES, V6, P188, DOI 10.3109/17477166.2011.575157; Morgen CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069860; Neef M, 2013, BEST PRACT RES CL EN, V27, P229, DOI 10.1016/j.beem.2013.02.007; Nielsen TRH, 2012, CHILD OBES, V8, P533, DOI 10.1089/chi.2011.0098; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Polley DC, 2005, J AM DIET ASSOC, V105, P262, DOI 10.1016/j.jada.2004.11.004; Pott W, 2009, INT J EAT DISORDER, V42, P284, DOI 10.1002/eat.20655; Pulgaron ER, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0508-y; Reinehr T, 2009, INT J OBESITY, V33, P418, DOI 10.1038/ijo.2009.50; Reinehr T, 2013, NAT REV ENDOCRINOL, V9, P607, DOI 10.1038/nrendo.2013.149; Sabin MA, 2007, J EVAL CLIN PRACT, V13, P364, DOI 10.1111/j.1365-2753.2006.00706.x; Weiss R, 2003, LANCET, V362, P951, DOI 10.1016/S0140-6736(03)14364-4	23	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120177	10.1371/journal.pone.0120177	http://dx.doi.org/10.1371/journal.pone.0120177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756875	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700060
J	Damgaard, C; Magnussen, K; Enevold, C; Nilsson, M; Tolker-Nielsen, T; Holmstrup, P; Nielsen, CH				Damgaard, Christian; Magnussen, Karin; Enevold, Christian; Nilsson, Martin; Tolker-Nielsen, Tim; Holmstrup, Palle; Nielsen, Claus Henrik			Viable Bacteria Associated with Red Blood Cells and Plasma in Freshly Drawn Blood Donations	PLOS ONE			English	Article							DONOR-ARM DISINFECTION; STAPHYLOCOCCUS-EPIDERMIDIS; PROPIONIBACTERIUM-ACNES; TRANSFUSION; INFECTION; RISK; CONTAMINATION; ENDOCARDITIS; DIVERSION; PRODUCTS	Objectives Infection remains a leading cause of post-transfusion mortality and morbidity. Bacterial contamination is, however, detected in less than 0.1% of blood units tested. The aim of the study was to identify viable bacteria in standard blood-pack units, with particular focus on bacteria from the oral cavity, and to determine the distribution of bacteria revealed in plasma and in the red blood cell (RBC)-fraction. Design Cross-sectional study. Blood were separated into plasma and RBC-suspensions, which were incubated anaerobically or aerobically for 7 days on trypticase soy blood agar (TSA) or blue lactose plates. For identification colony PCR was performed using primers targeting 16S rDNA. Setting Blood donors attending Capital Region Blood Bank, Copenhagen University Hospital, Rig-shospitalet, Hvidovre, Denmark, October 29th to December 10th 2013. Participants 60 donors (>= 50 years old), self-reported medically healthy. Results Bacterial growth was observed on plates inoculated with plasma or RBCs from 62% of the blood donations. Growth was evident in 21 (35%) of 60 RBC-fractions and in 32 (53%) of 60 plasma-fractions versus 8 of 60 negative controls (p = 0.005 and p = 2.6x10(-6), respectively). Propionibacterium acnes was found in 23% of the donations, and Staphylococcus epidermidis in 38%. The majority of bacteria identified in the present study were either facultative anaerobic (59.5%) or anaerobic (27.8%) species, which are not likely to be detected during current routine screening. Conclusions Viable bacteria are present in blood from donors self-reported as medically healthy, indicating that conventional test systems employed by blood banks insufficiently detect bacteria in plasma. Further investigation is needed to determine whether routine testing for anaerobic bacteria and testing of RBC-fractions for adherent bacteria should be recommended.	[Damgaard, Christian; Enevold, Christian; Holmstrup, Palle; Nielsen, Claus Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark; [Damgaard, Christian; Enevold, Christian; Nielsen, Claus Henrik] Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Dept Infect Dis & Rheumatol, Copenhagen, Denmark; [Magnussen, Karin] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Hvidovre, Denmark; [Magnussen, Karin] Copenhagen Univ Hosp, Rigshosp, Ctr Blood, Hvidovre, Denmark; [Nilsson, Martin; Tolker-Nielsen, Tim] Univ Copenhagen, Costerton Biofilm Ctr, Dept Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Damgaard, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Odontol, Sect Periodontol Microbiol & Community Dent, Copenhagen, Denmark.	chrd@sund.ku.dk	Damgaard, Christian/S-8145-2019; Nilsson, Martin/AHH-2943-2022	Damgaard, Christian/0000-0003-2394-746X; Tolker-Nielsen, Tim/0000-0002-9751-474X; Nielsen, Claus Henrik/0000-0001-7543-9016; Magnussen, Karin/0000-0003-2039-4986; Enevold, Christian/0000-0002-2748-1997	Research Account, Danish Dental Association	Research Account, Danish Dental Association	This study was supported by a grant from the Research Account, Danish Dental Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartold PM, 2013, PERIODONTOL 2000, V62, P203, DOI 10.1111/j.1600-0757.2012.00450.x; Belstrom D, 2011, INFECT IMMUN, V79, P1559, DOI 10.1128/IAI.01036-10; Benjamin RJ, 2014, TRANSFUS MED REV, V28, P61, DOI 10.1016/j.tmrv.2014.01.001; Bolton-Maggs PHB, 2013, BRIT J HAEMATOL, V163, P303, DOI 10.1111/bjh.12547; Bosshard PP, 2004, J CLIN MICROBIOL, V42, P2065, DOI 10.1128/JCM.42.5.2065-2073.2004; Brecher ME, 2013, TRANSFUSION, V53, P911, DOI 10.1111/trf.12148; Cargill JS, 2012, J MED MICROBIOL, V61, P755, DOI 10.1099/jmm.0.039693-0; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Goldman M, 2001, TRANSFUSION, V41, P1075, DOI 10.1046/j.1537-2995.2001.41081075.x; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Klausen SS, 2014, TRANSFUS APHER SCI, V51, P87, DOI [10.1016/j.transci.2014.10.020, DOI 10.1016/J.TRANSCI.2014.10.020]; Kuehnert MJ, 2001, TRANSFUSION, V41, P1493, DOI 10.1046/j.1537-2995.2001.41121493.x; Kunishima S, 2001, TRANSFUSION, V41, P1126, DOI 10.1046/j.1537-2995.2001.41091126.x; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; McDonald CP, 2006, TRANSFUSION MED, V16, P381, DOI 10.1111/j.1365-3148.2006.00697.x; McDonald CP, 2004, VOX SANG, V86, P178, DOI 10.1111/j.0042-9007.2004.00404.x; McLellan E, 2009, J MED MICROBIOL, V58, P144, DOI 10.1099/jmm.0.005553-0; Montag T, 2008, CLIN CHEM LAB MED, V46, P926, DOI 10.1515/CCLM.2008.176; MUDER RR, 1992, TRANSFUSION, V32, P771, DOI 10.1046/j.1537-2995.1992.32893032109.x; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; NG YC, 1988, CLIN EXP IMMUNOL, V71, P481; Offner PJ, 2002, ARCH SURG-CHICAGO, V137, P711, DOI 10.1001/archsurg.137.6.711; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Parahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P386, DOI 10.1128/CMR.00011-09; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Perel P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001664; Perez P, 2001, TRANSFUSION, V41, P862, DOI 10.1046/j.1537-2995.2001.41070862.x; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Pessi T, 2013, CIRCULATION, V127, P1219, DOI 10.1161/CIRCULATIONAHA.112.001254; Pratt RJ, 2007, J HOSP INFECT, V65, pS1, DOI 10.1016/S0195-6701(07)60002-4; Horliana ACRT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098271; Regalado NG, 2009, TRAVEL MED INFECT DI, V7, P316, DOI 10.1016/j.tmaid.2009.06.001; Rogers MAM, 2006, AM HEART J, V152, P1028, DOI 10.1016/j.ahj.2006.07.009; Rogers MAM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-37; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; SEIFERT H, 1995, ZBL BAKT-INT J MED M, V282, P431; SHAYEGANI M, 1991, J CLIN MICROBIOL, V29, P2768, DOI 10.1128/JCM.29.12.2768-2773.1991; Soeterboek AM, 1997, VOX SANG, V72, P61, DOI 10.1046/j.1423-0410.1997.00061.x; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Walther-Wenke G, 2008, CLIN CHEM LAB MED, V46, P919, DOI 10.1515/CCLM.2008.151; Zhou WW, 2013, CAN J INFECT DIS MED, V24, P155, DOI 10.1155/2013/470413	43	61	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0120826	10.1371/journal.pone.0120826	http://dx.doi.org/10.1371/journal.pone.0120826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751254	Green Published, gold, Green Submitted			2022-12-27	WOS:000350692700038
J	Bhattacharjee, A; Ghangal, R; Garg, R; Jain, M				Bhattacharjee, Annapurna; Ghangal, Rajesh; Garg, Rohini; Jain, Mukesh			Genome-Wide Analysis of Homeobox Gene Family in Legumes: Identification, Gene Duplication and Expression Profiling	PLOS ONE			English	Article							LEUCINE ZIPPER GENE; INTERACTING TRANSCRIPTION FACTORS; ABIOTIC STRESS RESPONSES; ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; HOMEODOMAIN PROTEINS; MEDICAGO-TRUNCATULA; CELL-DIFFERENTIATION; LOTUS-JAPONICUS; GLYCINE-MAX	Homeobox genes encode transcription factors that are known to play a major role in different aspects of plant growth and development. In the present study, we identified homeobox genes belonging to 14 different classes in five legume species, including chickpea, soybean, Medicago, Lotus and pigeonpea. The characteristic differences within homeodomain sequences among various classes of homeobox gene family were quite evident. Genome-wide expression analysis using publicly available datasets (RNA-seq and microarray) indicated that homeobox genes are differentially expressed in various tissues/developmental stages and under stress conditions in different legumes. We validated the differential expression of selected chickpea homeobox genes via quantitative reverse transcription polymerase chain reaction. Genome duplication analysis in soybean indicated that segmental duplication has significantly contributed in the expansion of homeobox gene family. The Ka/Ks ratio of duplicated homeobox genes in soybean showed that several members of this family have undergone purifying selection. Moreover, expression profiling indicated that duplicated genes might have been retained due to sub-functionalization. The genome-wide identification and comprehensive gene expression profiling of homeobox gene family members in legumes will provide opportunities for functional analysis to unravel their exact role in plant growth and development.	[Bhattacharjee, Annapurna; Ghangal, Rajesh; Garg, Rohini; Jain, Mukesh] Natl Inst Plant Genome Res NIPGR, Funct & Appl Genom Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Jain, M (corresponding author), Natl Inst Plant Genome Res NIPGR, Funct & Appl Genom Lab, Aruna Asaf Ali Marg, New Delhi, India.	mjain@nipgr.ac.in	Jain, Mukesh/AAP-5816-2021	Jain, Mukesh/0000-0002-7622-1083	Department of Biotechnology, Government of India [BT/PR12919/AGR/02/676/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study was funded by the Department of Biotechnology, Government of India, under the Next Generation Challenge Programme on Chickpea Genomics (grant number BT/PR12919/AGR/02/676/2009 from 2009-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel F, 2010, PLANT CELL, V22, P2171, DOI 10.1105/tpc.110.074823; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bharathan G, 1997, P NATL ACAD SCI USA, V94, P13749, DOI 10.1073/pnas.94.25.13749; Bhattacharjee A., 2013, PLANT ACCLIMATION EN, P163, DOI [DOI 10.1007/978-1-4614-5001-6_7, 10.1007/978-1-4614-5001-6_7]; Burglin Thomas R., 1994, P25; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Chen H, 2003, PLANT PHYSIOL, V132, P1391, DOI 10.1104/pp.103.022434; Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087156; Chew W, 2013, INT J MOL SCI, V14, P8122, DOI 10.3390/ijms14048122; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; Deng X, 2002, PLANT MOL BIOL, V49, P601, DOI 10.1023/A:1015501205303; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; Deveaux Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-291; Deyhle F, 2007, DEV BIOL, V302, P154, DOI 10.1016/j.ydbio.2006.09.013; Dezar CA, 2005, TRANSGENIC RES, V14, P429, DOI 10.1007/s11248-005-5076-0; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Gago GM, 2002, PLANT CELL ENVIRON, V25, P633, DOI 10.1046/j.1365-3040.2002.00853.x; Garg R, 2015, PLANT MOL BIOL REP, V33, P388, DOI 10.1007/s11105-014-0753-x; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hofer J, 2001, PLANT MOL BIOL, V45, P387, DOI 10.1023/A:1010739812836; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Jain M, 2008, FEBS J, V275, P2845, DOI 10.1111/j.1742-4658.2008.06424.x; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P36, DOI 10.1007/s10142-005-0142-5; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Johannesson H, 2001, PLANT MOL BIOL, V45, P63, DOI 10.1023/A:1006423324025; Jorgensen JE, 1999, PLANT MOL BIOL, V40, P65, DOI 10.1023/A:1026463506376; Kurdyukov S, 2014, PLANT CELL REP, V33, P349, DOI 10.1007/s00299-013-1535-x; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Liu JH, 2014, PLANT MOL BIOL REP, V32, P303, DOI 10.1007/s11105-013-0667-z; Luo HL, 2005, J EXP BOT, V56, P2673, DOI 10.1093/jxb/eri260; Masucci JD, 1996, DEVELOPMENT, V122, P1253; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Meijer AH, 2000, MOL GEN GENET, V263, P12, DOI 10.1007/PL00008671; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nagasaki H, 2001, PLANT CELL, V13, P2085, DOI 10.1105/tpc.13.9.2085; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; Ni YX, 2008, ACTA BIOCH BIOPH SIN, V40, P78, DOI 10.1111/j.1745-7270.2008.00371.x; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Steindler C, 1999, DEVELOPMENT, V126, P4235; Tan QKG, 2006, PLANT PHYSIOL, V140, P1095, DOI 10.1104/pp.105.070565; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119; Wang Y, 2003, DEV BIOL, V264, P228, DOI 10.1016/j.ydbio.2003.07.017; Wang YJ, 2005, PLANTA, V221, P831, DOI 10.1007/s00425-005-1496-6; Windhovel A, 2001, PLANT MOL BIOL, V45, P201, DOI 10.1023/A:1006450005648; Yoon J, 2014, PLANT J, V79, P717, DOI 10.1111/tpj.12581; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang SX, 2012, PLANT MOL BIOL, V80, P571, DOI 10.1007/s11103-012-9967-1	70	42	47	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119198	10.1371/journal.pone.0119198	http://dx.doi.org/10.1371/journal.pone.0119198			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25745864	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400056
J	Kawano, Y; Otsuka, C; Sanzo, J; Higgins, C; Nirei, T; Schilling, T; Ishikawa, T				Kawano, Yoshihiro; Otsuka, Chino; Sanzo, James; Higgins, Christopher; Nirei, Tatsuo; Schilling, Tobias; Ishikawa, Takuji			Expanding Imaging Capabilities for Microfluidics: Applicability of Darkfield Internal Reflection Illumination (DIRI) to Observations in Microfluidics	PLOS ONE			English	Article							MICRO-PIV MEASUREMENTS; IN-VITRO MODEL; CANCER-CELLS; BLOOD-FLOW; MICROCHANNEL; ADHESION; BUBBLES; FUTURE; BIFURCATIONS; ENDOTHELIUM	Microfluidics is used increasingly for engineering and biomedical applications due to recent advances in microfabrication technologies. Visualization of bubbles, tracer particles, and cells in a microfluidic device is important for designing a device and analyzing results. However, with conventional methods, it is difficult to observe the channel geometry and such particles simultaneously. To overcome this limitation, we developed a Darkfield Internal Reflection Illumination (DIRI) system that improved the drawbacks of a conventional darkfield illuminator. This study was performed to investigate its utility in the field of microfluidics. The results showed that the developed system could clearly visualize both microbubbles and the channel wall by utilizing brightfield and DIRI illumination simultaneously. The methodology is useful not only for static phenomena, such as clogging, but also for dynamic phenomena, such as the detection of bubbles flowing in a channel. The system was also applied to simultaneous fluorescence and DIRI imaging. Fluorescent tracer beads and channel walls were observed clearly, which may be an advantage for future microparticle image velocimetry (mu PIV) analysis, especially near a wall. Two types of cell stained with different colors, and the channel wall, can be recognized using the combined confocal and DIRI system. Whole-slide imaging was also conducted successfully using this system. The tiling function significantly expands the observing area of microfluidics. The developed system will be useful for a wide variety of engineering and biomedical applications for the growing field of microfluidics.	[Kawano, Yoshihiro] Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 980, Japan; [Kawano, Yoshihiro; Otsuka, Chino] Olympus Corp, Shinjuku Ku, Tokyo, Japan; [Sanzo, James; Higgins, Christopher] Olympus Sci Solut Amer, Waltham, MA USA; [Nirei, Tatsuo] Olympus Engn, Hachioji, Tokyo, Japan; [Schilling, Tobias] Olympus Soft Imaging Solut GmbH, Munster, Germany; [Ishikawa, Takuji] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan	Tohoku University; Olympus Corporation; Olympus Corporation; Olympus Corporation; Olympus Corporation; Tohoku University	Kawano, Y (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 980, Japan.	b3wd1002@s.tohoku.ac.jp	; Kawano, Yoshihiro/B-6208-2016	Ishikawa, Takuji/0000-0002-3573-8414; Kawano, Yoshihiro/0000-0001-6442-8733	 [26242039]; Grants-in-Aid for Scientific Research [26242039] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors used the following grant for their study: Grants-in-Aid for Scientific Research (A), No. 26242039, http://www.jsps.go.jp/english/e-grants/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Bourdon CJ, 2006, J FLUID ENG-T ASME, V128, P883, DOI 10.1115/1.2201649; Solvas XCI, 2011, CHEM COMMUN, V47, P1936, DOI 10.1039/c0cc02474k; Chakraborty S, 2013, BIOMICROFLUIDICS, V7; Chen YC, 2014, LAB CHIP, V14, P626, DOI 10.1039/c3lc90136j; Choi W, 2011, LAB CHIP, V11, P3970, DOI 10.1039/c1lc20444k; Das T, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4789750; Das T, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4774309; Du Z, 2006, BIOSENS BIOELECTRON, V21, P1991, DOI 10.1016/j.bios.2005.09.005; Epstein IR, 2007, SCIENCE, V315, P775, DOI 10.1126/science.1138325; Garstecki P, 2006, LAB CHIP, V6, P693; Garstecki P, 2004, APPL PHYS LETT, V85, P2649, DOI 10.1063/1.1796526; Gravesen P., 1993, Journal of Micromechanics and Microengineering, V3, P168, DOI 10.1088/0960-1317/3/4/002; Heath JR, 2008, ANNU REV MED, V59, P251, DOI 10.1146/annurev.med.59.061506.185523; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Huang Y, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3555195; Ishikawa T, 2011, BIOMED MICRODEVICES, V13, P159, DOI 10.1007/s10544-010-9481-7; Kawano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058344; Kim MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010441; Kinoshita H, 2007, LAB CHIP, V7, P338, DOI 10.1039/b617391h; Kirby BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035976; Leble V, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3672689; Lima R, 2008, BIOMED MICRODEVICES, V10, P153, DOI 10.1007/s10544-007-9121-z; Lima R, 2008, J BIOMECH, V41, P2188, DOI 10.1016/j.jbiomech.2008.04.033; Lima R, 2007, J BIOMECH, V40, P2752, DOI 10.1016/j.jbiomech.2007.01.012; Lima R, 2006, MEAS SCI TECHNOL, V17, P797, DOI 10.1088/0957-0233/17/4/026; Lima R, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/3/035005; Lima R, 2009, ANN BIOMED ENG, V37, P1546, DOI 10.1007/s10439-009-9732-z; Link DR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054503; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; Mauk MG, 2007, ANN NY ACAD SCI, V1098, P467, DOI 10.1196/annals.1384.025; Meinhart CD, 1999, EXP FLUIDS, V27, P414, DOI 10.1007/s003480050366; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Park JS, 2004, EXP FLUIDS, V37, P105, DOI 10.1007/s00348-004-0790-6; Prabhakarpandian B, 2008, BIOMED MICRODEVICES, V10, P585, DOI 10.1007/s10544-008-9170-y; Prabhakarpandian B, 2011, MICROVASC RES, V82, P210, DOI 10.1016/j.mvr.2011.06.013; Prabhakarpandian B, 2011, MICROCIRCULATION, V18, P380, DOI 10.1111/j.1549-8719.2011.00099.x; Prakash M, 2007, SCIENCE, V315, P832, DOI 10.1126/science.1136907; PRASAD AK, 1992, EXP FLUIDS, V13, P105, DOI 10.1007/BF00218156; Rosano JM, 2009, BIOMED MICRODEVICES, V11, P1051, DOI 10.1007/s10544-009-9322-8; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Santiago JG, 1998, EXP FLUIDS, V25, P316, DOI 10.1007/s003480050235; Schleifman EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090761; Smith ZJ, 2014, LAB CHIP, V14, P3029, DOI 10.1039/c4lc00567h; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Sorger PK, 2008, NAT BIOTECHNOL, V26, P1345, DOI 10.1038/nbt1208-1345; Tanaka T, 2012, LAB CHIP, V12, P4336, DOI 10.1039/c2lc40354d; Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g; Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653; Tousi N, 2010, MICROVASC RES, V80, P384, DOI 10.1016/j.mvr.2010.07.001; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wlodkowic D, 2010, WORLD J CLIN ONCOL, V1, P18, DOI 10.5306/wjco.v1.i1.18; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang H, 2013, ENGINEERING, V5, P146; Zhang W, 2013, SCI REPORTS, V3, DOI 1016/j.mvr.2011.06.013	59	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116925	10.1371/journal.pone.0116925	http://dx.doi.org/10.1371/journal.pone.0116925			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748425	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400007
J	Lee, H; Park, HY; Jeon, K; Jeong, BH; Hwang, JW; Lee, J; Cha, HS; Koh, EM; Kang, ES; Koh, WJ				Lee, Hyun; Park, Hye Yun; Jeon, Kyeongman; Jeong, Byeong-Ho; Hwang, Ji-Won; Lee, Jaejoon; Cha, Hoon-Suk; Koh, Eun-Mi; Kang, Eun-Suk; Koh, Won-Jung			QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; RHEUMATOLOGY BIOLOGICS REGISTER; ANTI-TNF THERAPY; SKIN-TEST; ANTIRHEUMATIC DRUGS; BRITISH SOCIETY; KOREAN PATIENTS; RISK; RECOMMENDATIONS; DIAGNOSIS	Background Patients undergoing anti-tumor necrosis factor (TNF) treatment are at an increased risk of reactivating a latent tuberculosis infection (LTBI). This study evaluated the effectiveness of the QuantiFERON-TB Gold In-Tube (QFT) assay for diagnosing LTBI in arthritis patients undergoing anti-TNF treatment. Methods We enrolled 342 consecutive patients from August 2007 to October 2013: 176 (51.5%) patients with ankylosing spondylitis and 166 (48.5%) with rheumatoid arthritis. Screening tests included tuberculin skin test (TST) and QFT assay. Positive QFT results, regardless of TST results, were considered an indicator for LTBI treatment. Results Bacillus Calmette-Guerin scars were found in 236 (69.0%) patients. Of 342 patients, TST and QFT were positive in 122 (35.7%) and 103 (30.1%) patients, respectively, and discordant in 101 (29.5%) patients. During a median follow-up duration of 41.7 months, five patients (1.5%) developed TB in a median of 20.8 months after initiation of anti-TNF treatment (428/100,000 person-years). TB did not occur in 62 TST+/QFT+ patients who received LTBI treatment. Of 41 TST-/QFT+ patients who received LTBI treatment, one (2.4%) developed TB 20.5 months after starting anti-TNF treatment (705/100,000 person-years). Of 60 TST+/QFT- patients who did not receive LTBI treatment, two (3.3%) developed TB 20.8 and 22.0 months after starting anti-TNF treatment (871/100,000 person-years). Of 179 TST-/QFT- patients, two (1.1%) developed TB 7.2 and 22.7 months, respectively, after initiating anti-TNF treatment (341/100,000 person-years). TB incidence rate during the follow-up period did not differ among TST-/QFT+, TST+/QFT-, and TST-/QFT- patients (P = 0.661). Conclusion QFT might be used instead of TST for diagnosing LTBI in patients before starting anti-TNF therapy in countries, such as Korea, where the TB prevalence is intermediate and the BCG vaccination is mandatory at birth. In the absence of a true gold standard test for LTBI, however, there is still a risk of TB development during anti-TNF treatment.	[Lee, Hyun; Park, Hye Yun; Jeon, Kyeongman; Jeong, Byeong-Ho; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Hwang, Ji-Won; Lee, Jaejoon; Cha, Hoon-Suk; Koh, Eun-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Rheumatol, Seoul, South Korea; [Kang, Eun-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea.	wjkoh@skku.edu	Koh, Won-Jung/D-9586-2018; park, hy/O-5934-2014; Koh, Won Jung/C-9595-2011; Jeon, Kyeongman/F-5963-2019; Lee, Hyun/G-1336-2018	Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772; Jeong, Byeong-Ho/0000-0002-3124-1718; Lee, Hyun/0000-0002-1269-0913	Korean Health technology Ramp;D Project, Ministry for Health amp; Welfare, Republic of Korea [HI13C0871]	Korean Health technology Ramp;D Project, Ministry for Health amp; Welfare, Republic of Korea	This study was supported by a grant of the Korean Health technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI13C0871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen KJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043508, 10.1371/journal.pone.0030275]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Baronnet L, 2011, JOINT BONE SPINE, V78, P279, DOI 10.1016/j.jbspin.2010.12.004; Beglinger C, 2007, SWISS MED WKLY, V137, P621; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Callhoff J, 2014, ANN RHEUM DIS; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Chang B, 2011, CLIN RHEUMATOL, V30, P1535, DOI 10.1007/s10067-011-1771-9; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; de Leon DP, 2008, J RHEUMATOL, V35, P776; de Leon DP, 2005, ANN RHEUM DIS, V64, P1360, DOI 10.1136/ard.2004.029041; Diel R, 2009, Pneumologie, V63, P329, DOI 10.1055/s-0029-1214673; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fonseca Joao Eurico, 2006, Acta Reumatol Port, V31, P247; Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Hsia EC, 2012, ARTHRITIS RHEUM-US, V64, P2068, DOI 10.1002/art.34382; Jo KW, 2013, RESP MED, V107, P1797, DOI 10.1016/j.rmed.2013.08.011; Jung YJ, 2014, INT J TUBERC LUNG D, V18, P428, DOI 10.5588/ijtld.13.0644; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim JH, 2013, SEMIN ARTHRITIS RHEU, V42, P424, DOI 10.1016/j.semarthrit.2012.07.001; Kleinert S, 2012, ANN RHEUM DIS, V71, P1791, DOI 10.1136/annrheumdis-2011-200941; Korea Centers for Disease Control and Prevention, 2011, KOREAN GUIDELINES FO; Korea Centers for Disease Control and Prevention, 2014, KOREAN GUIDELINES FO; Lee E, 2002, CLIN INFECT DIS, V34, P365, DOI 10.1086/338149; Mariette X, 2003, Ann Rheum Dis, V62, P791, DOI 10.1136/ard.62.8.791; Mariette X, 2012, ANN RHEUM DIS, V71, P1783, DOI 10.1136/annrheumdis-2011-200408; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Tamborenea MN, 2010, RHEUMATOL INT, V30, P613, DOI 10.1007/s00296-009-1027-z; Ormerod LP, 2005, THORAX, V60, P800, DOI 10.1136/thx.2005.046797; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Park YK, 2013, TUBERC RESPIR DIS, V74, P104, DOI 10.4046/trd.2013.74.3.104; Sellam J, 2007, ANN RHEUM DIS, V66, P1610, DOI 10.1136/ard.2007.069799; Seong SS, 2007, J RHEUMATOL, V34, P706; Shim TS, 2014, TUBERC RESPIR DIS, V76, P261, DOI 10.4046/trd.2014.76.6.261; Singanayagam A, 2013, THORAX, V68, P955, DOI 10.1136/thoraxjnl-2013-203436; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smith R, 2011, CURR OPIN RHEUMATOL, V23, P377, DOI 10.1097/BOR.0b013e3283474d62; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Son CN, 2014, J KOREAN MED SCI, V29, P1090, DOI 10.3346/jkms.2014.29.8.1090; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wallis RS, 2008, ARTHRITIS RHEUM, V58, P947, DOI 10.1002/art.23285; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; Winthrop KL, 2012, ANN RHEUM DIS, V71, P1757, DOI 10.1136/annrheumdis-2012-201979	49	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119260	10.1371/journal.pone.0119260	http://dx.doi.org/10.1371/journal.pone.0119260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746854	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400060
J	McCrink, K; Galamba, J				McCrink, Koleen; Galamba, Jennifer			The Impact of Symbolic and Non-Symbolic Quantity on Spatial Learning	PLOS ONE			English	Article							WORKING-MEMORY; STEREOTYPE THREAT; SEX-DIFFERENCES; MENTAL REPRESENTATION; GENDER-DIFFERENCES; PERFORMANCE; NUMBER; ASSOCIATION; ANXIETY; SPACE	An implicit mapping of number to space via a "mental number line" occurs automatically in adulthood. Here, we systematically explore the influence of differing representations of quantity (no quantity, non-symbolic magnitudes, and symbolic numbers) and directional flow of stimuli (random flow, left-to-right, or right-to-left) on learning and attention via a match-to-sample working memory task. When recalling a cognitively demanding string of spatial locations, subjects performed best when information was presented right-to-left. When non-symbolic or symbolic numerical arrays were embedded in these spatial locations, and mental number line congruency prompted, this effect was attenuated and in some cases reversed. In particular, low-performing female participants who viewed increasing non-symbolic number arrays paired with the spatial locations exhibited better recall for left-to-right directional flow information relative to right-to-left, and better processing for the left side of space relative to the right side of space. The presence of symbolic number during spatial learning enhanced recall to a greater degree than non-symbolic number-especially for female participants, and especially when cognitive load is high-and this difference was independent of directional flow of information. We conclude that quantity representations have the potential to scaffold spatial memory, but this potential is subtle, and mediated by the nature of the quantity and the gender and performance level of the learner.	[McCrink, Koleen; Galamba, Jennifer] Columbia Univ, Dept Psychol, Barnard Coll, New York, NY 10027 USA	Columbia University	McCrink, K (corresponding author), Columbia Univ, Dept Psychol, Barnard Coll, New York, NY 10027 USA.	kmccrink@barnard.edu		McCrink, Koleen/0000-0003-3066-357X	National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [R15 HD077518-01A1]; Undergraduate Science Education Program of the Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD077518] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; Undergraduate Science Education Program of the Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health R15 HD077518-01A1 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov/) to KM and a grant to JG while at Barnard College from the Undergraduate Science Education Program of the Howard Hughes Medical Institute (https://www.hhmi.org/programs/science-education-research-training). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton-Erxleben K, 2013, NAT REV NEUROSCI, V14, P188, DOI 10.1038/nrn3443; Balz GW, 1997, VISION RES, V37, P1499, DOI 10.1016/S0042-6989(96)00296-9; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bulf H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099499; Bull R, 2013, J EXP PSYCHOL GEN, V142, P181, DOI 10.1037/a0028387; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P127, DOI 10.1080/138033990513681; Chai XJ, 2010, BEHAV BRAIN RES, V208, P336, DOI 10.1016/j.bbr.2009.11.039; Corsi P., 1972, THESIS MCGILL U MONT, V34; de Hevia MD, 2014, P NATL ACAD SCI USA, V111, P4809, DOI 10.1073/pnas.1323628111; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; de Hevia MD, 2006, EXP BRAIN RES, V168, P254, DOI 10.1007/s00221-005-0084-0; De Lillo C, 2004, BRAIN COGNITION, V55, P415, DOI 10.1016/j.bandc.2004.02.071; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S., 2011, NUMBER SENSE MIND CR; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; Fumarola A, 2014, ATTEN PERCEPT PSYCHO, V76, P759, DOI 10.3758/s13414-013-0614-y; Ganley CM, 2014, J EDUC PSYCHOL, V106, P105, DOI 10.1037/a0034099; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Good C, 2012, J PERS SOC PSYCHOL, V102, P700, DOI 10.1037/a0026659; GROSSI D, 1979, CORTEX, V15, P667, DOI 10.1016/S0010-9452(79)80054-4; GROSSI D, 1980, CORTEX, V16, P339, DOI 10.1016/S0010-9452(80)80071-2; Herrera A, 2008, ACTA PSYCHOL, V128, P225, DOI 10.1016/j.actpsy.2008.01.002; Hollander A, 2005, NEUROPSYCHOLOGIA, V43, P35, DOI 10.1016/j.neuropsychologia.2004.06.006; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Kahneman D., 2011, THINKING FAST SLOW; Koscik T, 2009, BRAIN COGNITION, V69, P451, DOI 10.1016/j.bandc.2008.09.004; Lourenco SF, 2010, PSYCHOL SCI, V21, P873, DOI 10.1177/0956797610370158; Lyons IM, 2012, J EXP PSYCHOL GEN, V141, P635, DOI 10.1037/a0027248; Maloney EA, 2013, RES MATH EDUCAT, V15, P115, DOI 10.1080/14794802.2013.797744; McCrink K, 2014, COGNITIVE DEV, V30, P1, DOI 10.1016/j.cogdev.2013.11.002; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Opfer JE, 2010, DEVELOPMENTAL SCI, V13, P761, DOI 10.1111/j.1467-7687.2009.00934.x; Previtali P, 2010, EXP BRAIN RES, V201, P599, DOI 10.1007/s00221-009-2063-3; Ramirez G, 2013, J COGN DEV, V14, P187, DOI 10.1080/15248372.2012.664593; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Shah DS, 2013, BEHAV BRAIN RES, V257, P90, DOI 10.1016/j.bbr.2013.09.027; Shaki S, 2012, J EXP CHILD PSYCHOL, V112, P275, DOI 10.1016/j.jecp.2011.12.005; Shaki S, 2012, J EXP PSYCHOL HUMAN, V38, P515, DOI 10.1037/a0026729; Shaki S, 2009, PSYCHON B REV, V16, P328, DOI 10.3758/PBR.16.2.328; SIEGLER RS, 1987, J EXP PSYCHOL GEN, V116, P250; Siegler RS., 1984, ORIGINS COGNITIVE SK, P229; Smigasiewicz K, 2010, NEUROPSYCHOLOGIA, V48, P2852, DOI 10.1016/j.neuropsychologia.2010.05.027; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stoet G, 2012, REV GEN PSYCHOL, V16, P93, DOI 10.1037/a0026617; SWELLER J, 1988, COGNITIVE SCI, V12, P257, DOI 10.1207/s15516709cog1202_4; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; van Dijck JP, 2009, COGNITION, V113, P248, DOI 10.1016/j.cognition.2009.08.005; Van Opstal F, 2009, NEUROIMAGE, V47, P367, DOI 10.1016/j.neuroimage.2009.04.035; Voyer D, 2007, PSYCHON B REV, V14, P23, DOI 10.3758/BF03194024; Zebian S, 2005, J COGN CULT, V5, P165, DOI 10.1163/1568537054068660	53	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119395	10.1371/journal.pone.0119395	http://dx.doi.org/10.1371/journal.pone.0119395			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25748826	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400071
J	Mitter, C; Prayer, D; Brugger, PC; Weber, M; Kasprian, G				Mitter, Christian; Prayer, Daniela; Brugger, Peter C.; Weber, Michael; Kasprian, Gregor			In Vivo Tractography of Fetal Association Fibers	PLOS ONE			English	Article							MATTER DEVELOPMENT; BRAIN-DEVELOPMENT; DIFFUSION; WHITE; MR; CONNECTIVITY; UTERO; MATURATION; TRACTS; PREMYELINATION	Association fibers connect different cortical areas within the same hemisphere and constitute an essential anatomical substrate for a diverse range of higher cognitive functions. So far a comprehensive description of the prenatal in vivo morphology of these functionally important pathways is lacking. In the present study, diffusion tensor imaging (DTI) and tractography were used to visualize major association fiber tracts and the fornix in utero in preselected non-motion degraded DTI datasets of 24 living unsedated fetuses between 20 and 34 gestational weeks (GW). The uncinate fasciculus and inferior fronto-occipital fasciculus were depicted as early as 20 GW, while in vivo 3D visualization of the inferior longitudinal fasciculus, cingulum and fornix was successful in older fetuses during the third trimester. Provided optimal scanning conditions, in utero DTI and tractography have the potential to provide a more accurate anatomical definition of developing neuronal networks in the human fetal brain. Knowledge about the normal prenatal 3D association tract morphology may serve as reference for their assessment in common developmental diseases.	[Mitter, Christian; Prayer, Daniela; Weber, Michael; Kasprian, Gregor] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Neuroradiol & Musculoskeletal Radiol, Vienna, Austria; [Brugger, Peter C.] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Systemat Anat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Mitter, C (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Neuroradiol & Musculoskeletal Radiol, Vienna, Austria.	christian.mitter@meduniwien.ac.at	Kasprian, Gregor/AAJ-5052-2020; Weber, Michael/L-9836-2016	Kasprian, Gregor/0000-0003-3858-3347; Weber, Michael/0000-0002-8507-2219				ACR-SPR, 2010, PRACT PAR SAF OPT PE; Al-Mukhtar A, 2009, SEMIN PERINATOL, V33, P251, DOI 10.1053/j.semperi.2009.04.008; Bartolomeo P, 2007, CEREB CORTEX, V17, P2479, DOI 10.1093/cercor/bhl181; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Brugger PC, 2006, EUR J RADIOL, V57, P172, DOI 10.1016/j.ejrad.2005.11.017; Bui T, 2006, PEDIATR RADIOL, V36, P1133, DOI 10.1007/s00247-006-0266-3; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Counsell SJ, 2007, NEUROIMAGE, V34, P896, DOI 10.1016/j.neuroimage.2006.09.036; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Enders C. K., 2010, APPL MISSING DATA AN; Flechsig P., 1920, ANATOMIE MENSCHLICHE; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Garel C, 2001, AM J NEURORADIOL, V22, P184; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; GIRARD N, 1995, AM J NEURORADIOL, V16, P407; Hand JW, 2006, MAGN RESON MED, V55, P883, DOI 10.1002/mrm.20824; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Jiang SZ, 2009, MAGN RESON MED, V62, P645, DOI 10.1002/mrm.22032; Kasprian G, 2008, NEUROIMAGE, V43, P213, DOI 10.1016/j.neuroimage.2008.07.026; Kasprian G, 2013, BRAIN, V136, P168, DOI 10.1093/brain/aws332; Kasprian G, 2011, CEREB CORTEX, V21, P1076, DOI 10.1093/cercor/bhq179; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kostovic I, 2009, SEMIN PERINATOL, V33, P220, DOI 10.1053/j.semperi.2009.04.003; Kretschmann H. J., 1986, BRAIN GROWTH; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Maas LC, 2004, NEUROIMAGE, V22, P1134, DOI 10.1016/j.neuroimage.2004.02.035; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Prayer D, 2006, EUR J RADIOL, V57, P199, DOI 10.1016/j.ejrad.2005.11.020; Prayer D, 2001, AM J NEURORADIOL, V22, P1572; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; SMITH FW, 1983, LANCET, V1, P61; Takahashi E, 2012, CEREB CORTEX, V22, P455, DOI 10.1093/cercor/bhr126; Takahashi E, 2010, NEUROIMAGE, V49, P1231, DOI 10.1016/j.neuroimage.2009.09.002; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Vasung L, 2011, BRAIN STRUCT FUNCT, V215, P237, DOI 10.1007/s00429-010-0279-4; Vasung L, 2010, J ANAT, V217, P400, DOI 10.1111/j.1469-7580.2010.01260.x; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yoo SS, 2005, INVEST RADIOL, V40, P110, DOI 10.1097/01.rli.0000149491.69201.cb	58	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119536	10.1371/journal.pone.0119536	http://dx.doi.org/10.1371/journal.pone.0119536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742520	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100119
J	Pardo, LM; Rosas, Y; Fuentes, JP; Riveros, MP; Chaparro, OR				Miguel Pardo, Luis; Rosas, Yenifer; Pablo Fuentes, Juan; Paz Riveros, Marcela; Roberto Chaparro, Oscar			Fishery Induces Sperm Depletion and Reduction in Male Reproductive Potential for Crab Species under Male-Biased Harvest Strategy	PLOS ONE			English	Article							SPINY KING CRAB; MALE-MALE COMPETITION; CALLINECTES-SAPIDUS; BLUE-CRAB; PARALITHODES-BREVIPES; MALE SIZE; UNNATURAL SELECTION; MATING HISTORY; BIRGUS-LATRO; LIMITATION	Sperm depletion in males can occur when polygynous species are intensively exploited under a male-biased management strategy. In fisheries involving crabs species, the effects of this type of management on the reproductive potential is far from being understood. This study tests whether male-biased management of the principal Chilean crab fishery is able to affect the potential capacity of Metacarcinus edwardsii males to transfer sperm to females. Five localities in southern Chile, recording contrasting crab fishery landing, were selected to assess the potential of sperm depletion triggered by fishery. Seasonally, male crabs from each locality were obtained. Dry weight and histological condition of vasa deferentia and the Vaso-Somatic Index (VSI) were determined in order to use them as proxies for sperm depletion and male reproductive condition. A manipulative experiment was performed in the laboratory to estimate vasa deferentia weight and VSI from just-mated males in order to obtain a reference point for the potential effects of the fishery on sperm reserves. Sperm storage capacity is significantly affected by fisheries; during the mating season vasa deferentia from localities with low fishery intensity were heavier than those from high intensity fisheries, and these differences were even more evident in large males. Histological section showed that this disparity in vasa deferentia weight was explained principally by differences in the quantity of spermatophores rather than other seminal material. VSI was always higher in males from localities with low fishery intensity. Males from localities with high fishery intensity showed little capacity to recover sperm reserves and the VSI of these males remained below the values of the just-mated males. Detriment in the capacity of males to transfer sperm is the first step to sperm limitation in an exploited population, thus detection of sperm depletion can be an alert to introduce changes in the current management of crabs.	[Miguel Pardo, Luis; Rosas, Yenifer; Pablo Fuentes, Juan; Paz Riveros, Marcela; Roberto Chaparro, Oscar] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile	Pardo, LM (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	luispardo@uach.cl	Pardo, L M/A-3178-2008; Chaparro, Oscar R/A-5070-2009	Pardo, L M/0000-0003-2005-4922; Pardo, Luis Miguel/0000-0002-8179-5057	FONDECYT [1110445]; DID Universidad Austral de Chile	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DID Universidad Austral de Chile	LMP acknowledges funding from FONDECYT project 1110445 and DID Universidad Austral de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockerhoff AM, 2005, MAR ECOL PROG SER, V290, P179, DOI 10.3354/meps290179; Carver AM, 2005, J EXP MAR BIOL ECOL, V319, P29, DOI 10.1016/j.jembe.2004.06.013; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Gardner C, 2002, MAR FRESHWATER RES, V53, P661, DOI 10.1071/MF01097; Gosselin T, 2003, BEHAV ECOL SOCIOBIOL, V55, P151, DOI 10.1007/s00265-003-0695-z; Hines AH, 2003, B MAR SCI, V72, P287; Hinojosa I, 2003, ANIM BEHAV, V66, P449, DOI 10.1006/anbe.2003.2220; Jivoff P, 2003, B MAR SCI, V72, P273; Kendall MS, 1999, J EXP MAR BIOL ECOL, V239, P23, DOI 10.1016/S0022-0981(99)00022-2; Kendall MS, 2002, MAR ECOL PROG SER, V230, P235, DOI 10.3354/meps230235; Kendall MS, 2001, CAN J FISH AQUAT SCI, V58, P1168, DOI 10.1139/cjfas-58-6-1168; Krol R.M., 1992, DECAPOD CRUSTACEA MI, V10, P295; Pardo LM, 2013, INVERTEBR BIOL, V132, P386, DOI 10.1111/ivb.12038; Pardo LM, 2009, J MAR BIOL ASSOC UK, V89, P1627, DOI 10.1017/S0025315409000010; Olguin A, 2006, FIPIT0416; Olguin A, 2011, TECHNICAL REPORT; Pillans S, 2005, MAR ECOL PROG SER, V295, P201, DOI 10.3354/meps295201; Pool H, 1998, FIPIT9635; Rondeau A, 2001, BIOL BULL-US, V201, P204, DOI 10.2307/1543335; Rubolini D, 2007, FRESHWATER BIOL, V52, P1898, DOI 10.1111/j.1365-2427.2007.01814.x; Sainte-Marie Bernard, 2007, P191; Sainte-Marie B, 2008, B MAR SCI, V83, P131; Sato T, 2005, MAR ECOL PROG SER, V296, P251, DOI 10.3354/meps296251; Sato T, 2007, CAN J FISH AQUAT SCI, V64, P735, DOI 10.1139/F07-044; Sato T, 2006, MAR ECOL PROG SER, V312, P189, DOI 10.3354/meps312189; Sato T, 2011, AQUAT BIOL, V13, P11, DOI 10.3354/ab00350; Sato T, 2010, AQUAT BIOL, V10, P23, DOI 10.3354/ab00263; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Xuan FJ, 2014, AQUAT BIOL, V20, P145, DOI 10.3354/ab00555; Zar JH, 1999, BIOSTATISTICAL ANAL	31	27	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0115525	10.1371/journal.pone.0115525	http://dx.doi.org/10.1371/journal.pone.0115525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768728	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500001
J	Ozaki, K; Chikashige, Y; Hiraoka, Y; Matsumoto, T				Ozaki, Kanako; Chikashige, Yuji; Hiraoka, Yasushi; Matsumoto, Tomohiro			Fission Yeast Scp3 Potentially Maintains Microtubule Orientation through Bundling	PLOS ONE			English	Article							ISOPROPYL N-3-CHLOROPHENYL CARBAMATE; GAMMA-TUBULIN COMPLEXES; N-PHENYL CARBAMATE; SCHIZOSACCHAROMYCES-POMBE; MITOTIC SPINDLE; CELL-DIVISION; MUTATION; TRANSFORMATION; MORPHOGENESIS; NUCLEAR	Microtubules play important roles in organelle transport, the maintenance of cell polarity and chromosome segregation and generally form bundles during these processes. The fission yeast gene scp3(+) was identified as a multicopy suppressor of the cps3-81 mutant, which is hypersensitive to isopropyl N-3-chlorophenylcarbamate (CIPC), a poison that induces abnormal multipolar spindle formation in higher eukaryotes. In this study, we investigated the function of Scp3 along with the effect of CIPC in the fission yeast Schizosaccharomyces pombe. Microscopic observation revealed that treatment with CIPC, cps3-81 mutation and scp3+ gene deletion disturbed the orientation of microtubules in interphase cells. Overexpression of scp3+ suppressed the abnormal orientation of microtubules by promoting bundling. Functional analysis suggested that Scp3 functions independently from Ase1, a protein largely required for the bundling of the mitotic spindle. A strain lacking the ase1(+) gene was more sensitive to CIPC, with the drug affecting the integrity of the mitotic spindle, indicating that CIPC has a mitotic target that has a role redundant with Ase1. These results suggested that multiple systems are independently involved to ensure microtubule orientation by bundling in fission yeast.	[Ozaki, Kanako; Matsumoto, Tomohiro] Kyoto Univ, Grad Sch Biostudies, Kyoto, Kyoto, Japan; [Chikashige, Yuji; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo, Japan; [Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Matsumoto, Tomohiro] Kyoto Univ, Ctr Radiat Biol, Kyoto, Kyoto 606, Japan	Kyoto University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; Kyoto University	Matsumoto, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Kyoto, Japan.	tmatsumo@house.rbc.kyoto-u.ac.jp	Hiraoka, Yasushi/B-5111-2009	Hiraoka, Yasushi/0000-0001-9407-8228	Ministry of Education, Culture, Sports, Science and Technology [22019020]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: The authors received funding from Ministry of Education, Culture, Sports, Science and Technology, [http://www.mext.go.jp/] grant number: 22019020 (Tokutei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BOKROS CL, 1993, BIOCHEMISTRY-US, V32, P3437, DOI 10.1021/bi00064a030; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Chikashige Y, 2014, CELL STRUCT FUNCT, V39, P93, DOI 10.1247/csf.14007; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; COSS RA, 1974, J CELL BIOL, V63, P84, DOI 10.1083/jcb.63.1.84; COSS RA, 1975, EXP CELL RES, V92, P394, DOI 10.1016/0014-4827(75)90393-6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DOONAN JH, 1985, J CELL SCI, V75, P131; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haraguchi T, 1999, CELL STRUCT FUNCT, V24, P291, DOI 10.1247/csf.24.291; Hashimoto T, 2013, CURR OPIN PLANT BIOL, V16, P698, DOI 10.1016/j.pbi.2013.09.002; Iimori M, 2012, EXP CELL RES, V318, P262, DOI 10.1016/j.yexcr.2011.11.006; Ishiguro J, 1996, FEBS LETT, V392, P237, DOI 10.1016/0014-5793(96)00819-8; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; ISHIGURO J, 1992, JPN J GENET, V67, P97, DOI 10.1266/jjg.67.97; ISHIGURO J, 1994, JPN J GENET, V69, P671, DOI 10.1266/jjg.69.671; ISHIGURO J, 1993, JPN J GENET, V68, P265, DOI 10.1266/jjg.68.265; Ishijima SA, 1999, FEMS MICROBIOL LETT, V180, P31, DOI 10.1111/j.1574-6968.1999.tb08774.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; LIU B, 1995, CELL MOTIL CYTOSKEL, V31, P113, DOI 10.1002/cm.970310204; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Masuda H, 2006, GENES CELLS, V11, P319, DOI 10.1111/j.1365-2443.2006.00946.x; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; MOREJOHN LC, 1991, PHARMACOL THERAPEUT, V51, P217, DOI 10.1016/0163-7258(91)90078-Z; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; NURSE P, 1994, MOL BIOL CELL, V5, P613, DOI 10.1091/mbc.5.6.613; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; OLIVER JM, 1978, EXP CELL RES, V116, P229, DOI 10.1016/0014-4827(78)90079-4; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Subramanian R, 2012, DEV CELL, V23, P874, DOI 10.1016/j.devcel.2012.10.011; Takeshita N, 2014, CURR OPIN MICROBIOL, V20, P34, DOI 10.1016/j.mib.2014.04.005; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Warner SL, 2008, CURR ONCOL REP, V10, P122, DOI 10.1007/s11912-008-0020-0; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Young DH, 2000, PLANT PHYSIOL, V124, P115, DOI 10.1104/pp.124.1.115	50	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120109	10.1371/journal.pone.0120109	http://dx.doi.org/10.1371/journal.pone.0120109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767875	Green Submitted, gold, Green Published			2022-12-27	WOS:000351277500108
J	Salazar-Pelaez, LM; Abraham, T; Herrera, AM; Correa, MA; Ortega, JE; Pare, PD; Seow, CY				Salazar-Pelaez, Lina M.; Abraham, Thomas; Herrera, Ana M.; Correa, Mario A.; Ortega, Jorge E.; Pare, Peter D.; Seow, Chun Y.			Vitronectin Expression in the Airways of Subjects with Asthma and Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SERUM SPREADING FACTOR; BRONCHOALVEOLAR LAVAGE FLUID; HEPARIN-BINDING PEPTIDES; S-PROTEIN; EPITHELIAL-CELLS; GENE-EXPRESSION; MESSENGER-RNA; ORGANISM ATTACHMENT; BIOLOGICAL ROLE; LUNG-DISEASE	Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling. The primary cellular source of vitronectin is hepatocytes; it is not known whether resident cells of airways produce vitronectin, even though the glycoprotein has been found in exhaled breath condensate and bronchoalveolar lavage from healthy subjects and patients with interstitial lung disease. It is also not known whether vitronectin expression is altered in subjects with asthma and COPD. In this study, bronchial tissue from 7 asthmatic, 10 COPD and 14 control subjects was obtained at autopsy and analyzed by immunohistochemistry to determine the percent area of submucosal glands occupied by vitronectin. In a separate set of experiments, quantitative colocalization analysis was performed on tracheobronchial tissue sections obtained from donor lungs (6 asthmatics, 4 COPD and 7 controls). Vitronectin RNA and protein expressions in bronchial surface epithelium were examined in 12 subjects who undertook diagnostic bronchoscopy. Vitronectin was found in the tracheobronchial epithelium from asthmatic, COPD, and control subjects, although its expression was significantly lower in the asthmatic group. Colocalization analysis of 3D confocal images indicates that vitronectin is expressed in the glandular serous epithelial cells and in respiratory surface epithelial cells other than goblet cells. Expression of the 65-kDa vitronectin isoform was lower in bronchial surface epithelium from the diseased subjects. The cause for the decreased vitronectin expression in asthma is not clear, however, the reduced concentration of vitronectin in the epithelial/submucosal layer of airways may be linked to airway remodeling.	[Salazar-Pelaez, Lina M.; Herrera, Ana M.; Seow, Chun Y.] Univ CES, Sch Med, Medellin, Colombia; [Abraham, Thomas] Penn State Hershey Coll Med, Penn State Microscopy Imaging Core, Hershey, PA USA; [Correa, Mario A.] Inst Nacl Med Legal & Ciencias Forenses, Medellin, Colombia; [Ortega, Jorge E.] Clin Cardio VID, Medellin, Colombia; [Pare, Peter D.; Seow, Chun Y.] Univ British Columbia, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of British Columbia	Seow, CY (corresponding author), Univ CES, Sch Med, Medellin, Colombia.	chun.seow@hli.ubc.ca	Abraham, Thomas/AAJ-7950-2020; Salazar-Pelaéz, Lina/AAH-2360-2021; Seow, Chun/AAQ-4099-2020; Ortega, Jorge Emilio/U-7558-2019; Abraham, Thomas/J-7080-2014; Pare, Peter D/C-7425-2011	Ortega, Jorge Emilio/0000-0001-8188-874X; Abraham, Thomas/0000-0003-0750-8774; Herrera-Gonzalez, Ana M/0000-0002-7534-7004; Salazar-Pelaez, Lina/0000-0001-6224-1078	Knowledge Management Division and School of Medicine at Universidad CES [2011CI09]; Canadian Institutes of Health Research (CIHR) [MOP-13271, MOP-37924]; Colciencias Doctoral Fellowship [494/2009]	Knowledge Management Division and School of Medicine at Universidad CES; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Colciencias Doctoral Fellowship	This work was supported by Knowledge Management Division and School of Medicine at Universidad CES (Grant code 2011CI09) and operating grants from the Canadian Institutes of Health Research (CIHR grant number MOP-13271, MOP-37924). Lina M. Salazar-Pelaez was supported by Colciencias Doctoral Fellowship (Becas Francisco Jose de Caldas, Contract 494/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Anderson DH, 1999, INVEST OPHTH VIS SCI, V40, P3305; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Bari M R, 2010, Mymensingh Med J, V19, P576; BARNES DW, 1983, J BIOL CHEM, V258, P2548; BARNES DW, 1983, P NATL ACAD SCI-BIOL, V80, P1362, DOI 10.1073/pnas.80.5.1362; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; BeruBe K, 2010, TOXICOLOGY, V278, P311, DOI 10.1016/j.tox.2010.04.004; Boublil L, 2013, TOXICOL IN VITRO, V27, P533, DOI 10.1016/j.tiv.2012.11.008; Carpagnano GE, 2003, RESPIRATION, V70, P154, DOI 10.1159/000070062; Chin LYM, 2012, EUR RESPIR J, V40, P45, DOI 10.1183/09031936.00065411; Contoli M, 2009, MINERVA MED, V100, P467; EKLUND AG, 1992, AM REV RESPIR DIS, V145, P646, DOI 10.1164/ajrccm/145.3.646; FINK TM, 1992, HUM GENET, V88, P569, DOI 10.1007/BF00219346; Francois PP, 1999, J BIOL CHEM, V274, P37611, DOI 10.1074/jbc.274.53.37611; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HETLAND G, 1989, SCAND J IMMUNOL, V29, P15, DOI 10.1111/j.1365-3083.1989.tb01094.x; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Husain A.N, 2010, ROBBINS COTRAN PATHO, P677; INUZUKA S, 1994, PATHOL RES PRACT, V190, P903; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Johnston Neil W, 2007, Proc Am Thorac Soc, V4, P591, DOI 10.1513/pats.200706-064TH; Kelsen SG, 2000, ASTHMA MECH PROTOCOL, P41; Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675; LIMPER AH, 1994, IMMUNOL LETT, V42, P139, DOI 10.1016/0165-2478(94)90077-9; LIMPER AH, 1993, INFECT IMMUN, V61, P4302, DOI 10.1128/IAI.61.10.4302-4309.1993; Lin HX, 2007, J PHARM SCI-US, V96, P341, DOI 10.1002/jps.20803; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; MANDERS EMM, 1992, J CELL SCI, V103, P857; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; McDonald VM, 2012, CLIN EXP ALLERGY, V42, P670, DOI 10.1111/j.1365-2222.2012.03981.x; NICULESCU F, 1987, ATHEROSCLEROSIS, V65, P1, DOI 10.1016/0021-9150(87)90002-5; OHRN MB, 1995, RESPIRATION, V62, P136; Ozaki S, 1999, BIOCHEM BIOPH RES CO, V258, P524, DOI 10.1006/bbrc.1999.0672; Papi A, 2007, CURR OPIN PHARMACOL, V7, P259, DOI 10.1016/j.coph.2006.11.015; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; POHL WR, 1991, AM REV RESPIR DIS, V143, P1369, DOI 10.1164/ajrccm/143.6.1369; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; PREISSNER KT, 1989, BLUT, V59, P419, DOI 10.1007/BF00349063; REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SEIFFERT D, 1991, P NATL ACAD SCI USA, V88, P9402, DOI 10.1073/pnas.88.21.9402; SEIFFERT D, 1994, J BIOL CHEM, V269, P19836; SEIFFERT D, 1995, J IMMUNOL, V155, P3180; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Singh B, 2010, MOL MICROBIOL, V75, P1426, DOI 10.1111/j.1365-2958.2010.07066.x; Skold CM, 2010, CLIN RESPIR J, V4, P20, DOI 10.1111/j.1752-699X.2010.00193.x; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; SUZUKI S, 1984, J BIOL CHEM, V259, P5307; TESCHLER H, 1993, AM REV RESPIR DIS, V147, P332, DOI 10.1164/ajrccm/147.2.332; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P4103, DOI 10.1021/bi00411a029; Yamada S, 1996, CLIN CHIM ACTA, V252, P95, DOI 10.1016/0009-8981(96)06320-6; Zhang DZ, 2011, AM J PHYSIOL-RENAL, V300, pF475, DOI 10.1152/ajprenal.00407.2010	64	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119717	10.1371/journal.pone.0119717	http://dx.doi.org/10.1371/journal.pone.0119717			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768308	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500095
J	Samani, A; Pontonnier, C; Dumont, G; Madeleine, P				Samani, Afshin; Pontonnier, Charles; Dumont, Georges; Madeleine, Pascal			Shoulder Kinematics and Spatial Pattern of Trapezius Electromyographic Activity in Real and Virtual Environments	PLOS ONE			English	Article							BIOMECHANICAL EXPOSURE; IMAGE REGISTRATION; STATISTICAL POWER; MUSCLE ACTIVATION; MOTION ANALYSIS; MODEL; VARIABILITY; SIMULATION; JOINT; PAIN	The design of an industrial workstation tends to include ergonomic assessment steps based on a digital mock-up and a virtual reality setup. Lack of interaction and system fidelity is often reported as a main issue in such virtual reality applications. This limitation is a crucial issue as thorough ergonomic analysis is required for an investigation of the biomechanics. In the current study, we investigated the biomechanical responses of the shoulder joint in a simulated assembly task for comparison with the biomechanical responses in virtual environments. Sixteen male healthy novice subjects performed the task on three different platforms: real (RE), virtual (VE), and virtual environment with force feedback (VEF) with low and high precision demands. The subjects repeated the task 12 times (i.e., 12 cycles). High density electromyography from the upper trapezius and rotation angles of the shoulder joint were recorded and split into the cycles. The angular trajectories and velocity profiles of the shoulder joint angles over a cycle were computed in 3D. The inter-subject similarity in terms of normalized mutual information on kinematics and electromyography was investigated. Compared with RE the task in VE and VEF was characterized by lower kinematic maxima. The inter-subject similarity in RE compared with intra-subject similarity across the platforms was lower in terms of movement trajectories and greater in terms of trapezius muscle activation. The precision demand resulted in lower inter-and intra-subject similarity across platforms. The proposed approach identifies biomechanical differences in the shoulder joint in both VE and VEF compared with the RE platform, but these differences are less marked in VE mostly due to technical limitations of co-localizing the force feedback system in the VEF platform.	[Samani, Afshin; Madeleine, Pascal] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Lab Ergon & Work Related Disorders, DK-9220 Aalborg, Denmark; [Pontonnier, Charles] Ecoles Mil St Cyr Coetquidan, Ctr Rech, Ecoles Coetquidan, F-56381 Guer, France; [Pontonnier, Charles; Dumont, Georges] IRISA INRIA Ctr Bretagne, MimeTIC, F-35042 Rennes, France; [Dumont, Georges] ENS Rennes, F-35170 Bruz, France	Aalborg University; Ecole Normale Superieure de Rennes (ENS Rennes)	Samani, A (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Lab Ergon & Work Related Disorders, Fredrik Bajers Vej 7 D-3, DK-9220 Aalborg, Denmark.	afsamani@hst.aau.dk	Samani, Afshin/F-9808-2019; Madeleine, Pascal/AAD-3201-2021; DUMONT, Georges/K-8173-2013	Samani, Afshin/0000-0001-6119-8231; DUMONT, Georges/0000-0002-0709-0921; Pontonnier, Charles/0000-0003-1140-3772	European Project VISIONAIR [262044]; Danish Council for Independent Research Technology and Production Sciences (FTP) [10092821]; Danish Rheumatism Association [R77-A1202]	European Project VISIONAIR; Danish Council for Independent Research Technology and Production Sciences (FTP)(Det Frie Forskningsrad (DFF)); Danish Rheumatism Association	This work was supported by the European Project VISIONAIR, grant agreement 262044 (http://www.infra-visionair.eu/); the Danish Council for Independent Research vertical bar Technology and Production Sciences (FTP), grant number: 10092821 (http://fivu.dk/en/research-and-innovation/councils-andcommissions/ the-danishcouncil-for-independent-research/the-council-1/the-danish-council-for-independent-research-technology-and-production-sciences); and the Danish Rheumatism Association, grant number: R77-A1202 (http://www.gigtforeningen.dk/).	Arias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030021; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; Chaffin D. B., 2001, DIGITAL HUMAN MODELI; Chryssolouris G, 2000, ROBOT CIM-INT MANUF, V16, P267, DOI 10.1016/S0736-5845(00)00013-2; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleury C, 2010, P ICAT 2010 20 INT C; Gallina A, 2013, EUR J APPL PHYSIOL, V113, P887, DOI 10.1007/s00421-012-2498-2; HOGFORS C, 1991, J BIOMECH, V24, P699, DOI 10.1016/0021-9290(91)90334-J; Holtermann A, 2005, J ELECTROMYOGR KINES, V15, P131, DOI 10.1016/j.jelekin.2004.09.003; Hu B, 2011, INT J IND ERGONOM, V41, P64, DOI 10.1016/j.ergon.2010.10.001; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; INMAN VT, 1993, CLIN ORTHOP RELAT R, P3; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jeong J, 2001, CLIN NEUROPHYSIOL, V112, P827, DOI 10.1016/S1388-2457(01)00513-2; Johansen TI, 2013, EUR J APPL PHYSIOL, V113, P175, DOI 10.1007/s00421-012-2425-6; Kapandji IA, 1987, PHYSL JOINTS, V2; Karwowski W, 2012, HUM FACTORS, V54, P983, DOI 10.1177/0018720812467459; Kojadinovic I., 2005, P INT S APPL STOCHAS, P738; Lovern B, 2010, COMPUT METHOD BIOMEC, V13, P803, DOI 10.1080/10255841003630637; Ma L, 2009, INT J IND ERGONOM, V39, P211, DOI 10.1016/j.ergon.2008.04.004; Madeleine P, 2010, ACTA PHYSIOL, V199, P1, DOI 10.1111/j.1748-1716.2010.02145.x; Madeleine P, 2008, ERGONOMICS, V51, P1078, DOI 10.1080/00140130801958659; Madeleine P, 2006, CLIN NEUROPHYSIOL, V117, P2436, DOI 10.1016/j.clinph.2006.06.753; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Maes F, 2003, P IEEE, V91, P1699, DOI 10.1109/JPROC.2003.817864; Mathiassen SE, 2005, SCAND J WORK ENV HEA, V31, P138, DOI 10.5271/sjweh.861; Mathiassen SE, 2002, J ELECTROMYOGR KINES, V12, P45, DOI 10.1016/S1050-6411(01)00028-1; Mathiassen SE, 2006, APPL ERGON, V37, P419, DOI 10.1016/j.apergo.2006.04.006; MCATAMNEY L, 1993, APPL ERGON, V24, P91, DOI 10.1016/0003-6870(93)90080-S; McMahan RP, 2012, IEEE T VIS COMPUT GR, V18, P626, DOI 10.1109/TVCG.2012.43; Merletti R, 2008, J ELECTROMYOGR KINES, V18, P879, DOI 10.1016/j.jelekin.2008.09.002; Pontonnier C, 2011, P TECHN GROUP COMP S, P83; Pontonnier C, 2014, J MULTIMODAL USER IN, V8, P199, DOI 10.1007/s12193-013-0138-8; Pontonnier C, 2014, IEEE T VIS COMPUT GR, V20, P664, DOI 10.1109/TVCG.2013.252; Pontonnier C, 2014, APPL ERGON, V45, P592, DOI 10.1016/j.apergo.2013.08.003; Pontonnier C, 2012, 3RD IEEE INTERNATIONAL CONFERENCE ON COGNITIVE INFOCOMMUNICATIONS (COGINFOCOM 2012), P249; Pontonnier C, 2009, LECT NOTES COMPUT SC, V5903, P137, DOI 10.1007/978-3-642-10470-1_12; Rebelo F, 2012, HUM FACTORS, V54, P964, DOI 10.1177/0018720812465006; Rotea MA, 1998, DYNAM CONTROL, V8, P57, DOI 10.1023/A:1008278929841; Samani A, 2010, EUR J APPL PHYSIOL, V110, P415, DOI 10.1007/s00421-010-1515-6; Sanders M.S., 1987, HUMAN FACTORS ENG DE; SOECHTING JF, 1984, EXP BRAIN RES, V54, P121; Stoffregen TA, 2003, VIRTUAL AND ADAPTIVE ENVIRONMENTS: APPLICATIONS, IMPLICATIONS, AND HUMAN PERFORMANCE ISSUES, P111, DOI 10.1201/9781410608888.ch6; Svendsen SW, 2005, OCCUP ENVIRON MED, V62, P18, DOI 10.1136/oem.2004.015966; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; van Tulder MW, 2001, SPINE, V26, P270, DOI 10.1097/00007632-200102010-00012; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Visser B, 2004, ERGONOMICS, V47, P202, DOI 10.1080/00140130310001617967; West B. T., 2007, LINEAR MIXED MODELS; Whitman LE, 2004, PROCEEDINGS OF THE 2004 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1740; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	54	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116211	10.1371/journal.pone.0116211	http://dx.doi.org/10.1371/journal.pone.0116211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768123	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500006
J	Schmid, D; Ricci, C; Leitzmann, MF				Schmid, Daniela; Ricci, Cristian; Leitzmann, Michael F.			Associations of Objectively Assessed Physical Activity and Sedentary Time with All-Cause Mortality in US Adults: The NHANES Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; TELEVISION VIEWING TIME; BODY-MASS INDEX; ENERGY-EXPENDITURE; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; UNITED-STATES; SITTING TIME; CANCER-RISK; LIFE-STYLE	Background Sedentary behavior is related to increased mortality risk. Whether such elevated risk can be offset by enhanced physical activity has not been examined using accelerometry data. Materials and Methods We examined the relations of sedentary time and physical activity to mortality from any cause using accelerometry data among 1,677 women and men aged 50 years or older from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 cycle with follow-up through December 31, 2006. Results During an average follow-up of 34.67 months and 4,845.42 person-years, 112 deaths occurred. In multivariate Cox proportional hazard models, greater sedentary time (>= median of 8.60 hours/day) was associated with increased risk of mortality from any cause (relative risk (RR) = 2.03; 95% confidence interval (CI) = 1.09-3.81). Low level of moderate to vigorous physical activity (< median of 6.60 minutes/day) was also related to enhanced allcause mortality risk (RR = 3.30; 95% CI = 1.33-8.17). In combined analyses, greater time spent sedentary and low levels of moderate to vigorous physical activity predicted a substantially elevated all-cause mortality risk. As compared with the combination of a low sedentary level and a high level of moderate to vigorous physical activity, the risks of mortality from all causes were 4.38 (95% CI = 1.26-15.16) for low levels of both sedentary time and physical activity, 2.79 (95% CI = 0.77-10.12) for greater time spent sedentary and high physical activity level, and 7.79 (95% CI = 2.26-26.82) for greater time spent sedentary and low physical activity level. The interaction term between sedentary time and moderate to vigorous physical activity was not statistically significant (p = 0.508). Conclusions Both high levels of sedentary time and low levels of moderate to vigorous physical activity are strong and independent predictors of early death from any cause. Whether a high physical activity level removes the increased risk of all-cause mortality related to sedentariness requires further investigation.	[Schmid, Daniela; Ricci, Cristian; Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany	University of Regensburg	Schmid, D (corresponding author), Univ Regensburg, Dept Epidemiol & Prevent Med, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	daniela.schmid@klinik.uni-regensburg.de	Ricci, Cristian/AAV-3315-2021; Schmid, Daniela/GPG-1151-2022	Ricci, Cristian/0000-0003-4113-8682; 				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Arem H, 2014, INT J CANCER, V135, P423, DOI 10.1002/ijc.28659; Australian Government. Department of Health, AUSTRALIAS PHYSICAL; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Blanck HM, 2007, OBESITY, V15, P1578, DOI 10.1038/oby.2007.187; Bowman Shanthy A, 2006, Prev Chronic Dis, V3, pA38; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Canadian Society for Exercise Physiology, CAN PHYS ACT GUID CA; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Centers for Disease Control and Prevention, 2012, FACTS PHYS ACT; Centers for Disease control and Prevention/National Center for Health Statistics/U.S. Department of Health and Human Services, NAT HLTH NUTR EX SUR; Chau JY, 2015, BRIT J SPORT MED, V49, P737, DOI 10.1136/bjsports-2012-091974; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Dhaliwal SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083435; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Key T, 2002, JNCI-J NATL CANCER I, V94, P606, DOI DOI 10.1093/JNCI/94.8.606; Klenk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084817; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Krogh-Madsen R, 2010, J APPL PHYSIOL, V108, P1034, DOI 10.1152/japplphysiol.00977.2009; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Lavie CJ, 2011, J CARDIOPULM REHABIL, V31, P137, DOI 10.1097/HCR.0b013e3182122827; Leenders NYJM, 2003, INT J SPORTS MED, V24, P43, DOI 10.1055/s-2003-37196; Leenders NYJM, 2001, MED SCI SPORT EXER, V33, P1233; Lukanova A, 2003, INT J CANCER, V104, P636, DOI 10.1002/ijc.10990; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Mathews CE, 2012, EXERC SPORT SCI REV, V40, P118, DOI 10.1097/JES.0b013e31825b34a0; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; McTiernan A, 2004, CANCER EPIDEM BIOMAR, V13, P1099; McTiernan A, 2004, CANCER RES, V64, P2923, DOI 10.1158/0008-5472.CAN-03-3393; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mitchell JA, 2014, MED SCI SPORT EXER, V46, P2244, DOI 10.1249/MSS.0000000000000366; Neilson HK, 2009, CANCER EPIDEM BIOMAR, V18, P11, DOI 10.1158/1055-9965.EPI-08-0756; NHANES, 1999, LINK MORT FIL; O'Keefe JH, 2008, J AM COLL CARDIOL, V51, P249, DOI 10.1016/j.jacc.2007.10.016; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Panagiotakos Demosthenes B, 2004, Prev Cardiol, V7, P190, DOI 10.1111/j.1520-037X.2004.03539.x; Parker L, 2014, CLIN PHYSIOL FUNCT I, V34, P377, DOI 10.1111/cpf.12108; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Pavey TG, 2012, BRIT J SPORT MED, V0, P1, DOI DOI 10.1136/BJSP0RTS-2012-091676; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Schatzkin A, 2009, CANCER EPIDEM BIOMAR, V18, P1026, DOI 10.1158/1055-9965.EPI-08-1129; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Tambalis K, 2009, ANGIOLOGY, V60, P614, DOI 10.1177/0003319708324927; Thomson CA, 2014, CANCER PREV RES, V7, P42, DOI 10.1158/1940-6207.CAPR-13-0258; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Willcox BJ, 2004, J GERONTOL A-BIOL, V59, P789; Yngve A, 2003, MED SCI SPORT EXER, V35, P320, DOI 10.1249/01.MSS.0000048829.75758.A0	74	102	106	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119591	10.1371/journal.pone.0119591	http://dx.doi.org/10.1371/journal.pone.0119591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768112	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500086
J	Son, SJ; Lee, KS; Chung, JH; Chang, KJ; Roh, HW; Kim, SH; Jin, T; Back, JH; Kim, HJ; Lee, Y; Choi, SH; Noh, JS; Lim, KY; Chung, YK; Hong, CH; Oh, BH				Son, Sang Joon; Lee, Kang Soo; Chung, Ji Hyung; Chang, Ki Jung; Roh, Hyun Woong; Kim, Soo Hyun; Jin, Taewon; Back, Joung Hwan; Kim, Hyun Jung; Lee, Yunhwan; Choi, Seong Hye; Noh, Jai Sung; Lim, Ki Young; Chung, Young Ki; Hong, Chang Hyung; Oh, Byoung Hoon			Increased Plasma Levels of Heat Shock Protein 70 Associated with Subsequent Clinical Conversion to Mild Cognitive Impairment in Cognitively Healthy Elderly	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; VASCULAR-DISEASE; NERVOUS-SYSTEM; BRAIN PROTEINS; RISK-FACTORS; HSP70; PROTECTION	Background and Aims Heat shock proteins (HSPs) have been regarded as cytoprotectants that protect brain cells during the progression of neurodegenerative diseases and from damage resulting from cerebral ischemia. In this study, we assessed the association between plasma HSP 70/27 levels and cognitive decline. Methods Among participants in the community-based cohort study of dementia called the Gwangju Dementia and Mild Cognitive Impairment Study, subjects without cognitive impairment at baseline, who then either remained without impairment (non-conversion group), or suffered mild cognitive impairment (MCI) (conversion group) (non-conversion group, N = 36; conversion group, N = 30) were analyzed. Results After a five to six year follow-up period, comparison of the plasma HSP 70 and HSP 27 levels of the two groups revealed that only the plasma HSP 70 level was associated with a conversion to MCI after adjustments for age, gender, years of education, follow-up duration, APOE e4, hypertension, and diabetes (repeated measure analysis of variance: F = 7.59, p = 0.008). Furthermore, an increase in plasma HSP 70 level was associated with cognitive decline in language and executive function (linear mixed model: Korean Boston Naming Test, -0.426 [-0.781, -0.071], p = 0.019; Controlled Oral Word Association Test, -0.176 [-0.328, -0.023], p = 0.024; Stroop Test, -0.304 [-0.458, -0.150], p< 0.001). Conclusions These findings suggest that the plasma HSP 70 level may be related to cognitive decline in the elderly.	[Son, Sang Joon; Chang, Ki Jung; Roh, Hyun Woong; Noh, Jai Sung; Lim, Ki Young; Chung, Young Ki; Hong, Chang Hyung] Ajou Univ, Sch Med, Dept Psychiat, Suwon 443380, Gyeonggi Do, South Korea; [Lee, Kang Soo] CHA Univ, Gangnam Med Ctr, Dept Psychiat, Seoul 135081, South Korea; [Chung, Ji Hyung] CHA Univ, Coll Life Sci, Dept Appl Biosci, Songnam 463400, Gyeonggi Do, South Korea; [Kim, Soo Hyun; Jin, Taewon] Yonsei Univ, Grad Program Sci Aging, Seoul 120752, South Korea; [Back, Joung Hwan] Hlth Insurance Policy Res Inst, Natl Hlth Insurance Serv, Seoul 121749, South Korea; [Kim, Hyun Jung] Natl Med Ctr, Dept Psychiat, Seoul 100799, South Korea; [Lee, Yunhwan] Ajou Univ, Sch Med, Dept Prevent Med & Publ Hlth, Suwon 443380, Gyeonggi Do, South Korea; [Choi, Seong Hye] Inha Univ, Coll Med, Dept Neurol, Inchon 400711, South Korea; [Oh, Byoung Hoon] Yonsei Univ, Coll Med, Dept Psychiat, Seoul 120752, South Korea; [Oh, Byoung Hoon] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul 120752, South Korea	Ajou University; Pochon Cha University; Pochon Cha University; Yonsei University; National Health Insurance Service; National Medical Center - Korea; Ajou University; Inha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Hong, CH (corresponding author), Ajou Univ, Sch Med, Dept Psychiat, 164 Worldcup Ro, Suwon 443380, Gyeonggi Do, South Korea.	antiaging@ajou.ac.kr; drobh@yuhs.ac	Lee, Yunhwan/F-4967-2010	Lee, Yunhwan/0000-0001-8484-4750	Faculty Research Grant of Yonsei University College of Medicine [2011(6-2011-0151)]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI10C2020]	Faculty Research Grant of Yonsei University College of Medicine; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a Faculty Research Grant of Yonsei University College of Medicine for 2011(6-2011-0151) and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI C, 1995, CANCER RES, V55, P4452; Arawaka S, 2010, CURR PHARM BIOTECHNO, V11, P158, DOI 10.2174/138920110790909713; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Butterfield DA, 2006, NEUROBIOL DIS, V22, P223, DOI 10.1016/j.nbd.2005.11.002; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Calabrese V, 2002, J NEUROSCI RES, V68, P65, DOI 10.1002/jnr.10177; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Di Domenico F, 2010, BRAIN RES, V1333, P72, DOI 10.1016/j.brainres.2010.03.085; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Kang Y., 2012, SEOUL NEUROPSYCHOLOG, V2nd; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kim E, 2012, PSYCHONEUROENDOCRINO, V37, P358, DOI 10.1016/j.psyneuen.2011.07.005; Kramer JH, 2002, J NEUROL NEUROSUR PS, V72, P217, DOI 10.1136/jnnp.72.2.217; Lee KS, 2008, NEUROSCI LETT, V436, P223, DOI 10.1016/j.neulet.2008.03.025; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Maineri ND, 2007, ARQ BRAS CARDIOL, V89, P158, DOI 10.1590/S0066-782X2007001500003; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Njemini R, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-24; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Rajdev S, 2000, ANN NEUROL, V47, P782, DOI 10.1002/1531-8249(200006)47:6<782::AID-ANA11>3.0.CO;2-3; Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P511; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Son SJ, 2012, J CLIN PSYCHIAT, V73, P1555, DOI 10.4088/JCP.12m07702; Sultana R, 2009, J BIOENERG BIOMEMBR, V41, P441, DOI 10.1007/s10863-009-9241-7; Tervo S, 2004, DEMENT GERIATR COGN, V17, P196, DOI 10.1159/000076356; Wang BW, 2012, CAN J NEUROL SCI, V39, P592, DOI 10.1017/S0317167100015316; Wright BH, 2000, HEART VESSELS, V15, P18, DOI 10.1007/s003800070043	40	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119180	10.1371/journal.pone.0119180	http://dx.doi.org/10.1371/journal.pone.0119180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768018	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500069
J	Wijemanne, P; Xing, J; Berberov, EM; Marx, DB; Francis, DH; Moxley, RA				Wijemanne, Prageeth; Xing, Jun; Berberov, Emil M.; Marx, David B.; Francis, David H.; Moxley, Rodney A.			Relationship between Heat-Labile Enterotoxin Secretion Capacity and Virulence in Wild Type Porcine-Origin Enterotoxigenic Escherichia coli Strains	PLOS ONE			English	Article							PROTEIN MODEL QUALITY; SCORING FUNCTION; VIBRIO-CHOLERAE; COLIBACILLOSIS; IDENTIFICATION; PATHOGENICITY; PREVALENCE; RELEASE; PATHWAY; RABBIT	Heat-labile enterotoxin (LT) is an important virulence factor secreted by some strains of enterotoxigenic Escherichia coli (ETEC). The prototypic human-origin strain H10407 secretes LT via a type II secretion system(T2SS). We sought to determine the relationship between the capacity to secrete LT and virulence in porcine-origin wild type (WT) ETEC strains. Sixteen WT ETEC strains isolated from cases of severe diarrheal disease were analyzed by GM1ganglioside enzyme- linked immunosorbent assay tomeasure LT concentrations in culture supernatants. All strains had detectable LT in supernatants by 2 h of culture and 1 strain, which was particularly virulent in gnotobiotic piglets (3030-2), had the highest LT secretion level all porcine-origin WT strains tested (P<0.05). The level of LT secretion (concentration in supernatants at 6-h culture) explained 92% of the variation in time-to-a-moribund-condition (R-2 = 0.92, P<0.0001) in gnotobiotic piglets inoculated with either strain 3030-2, or an ETEC strain of lesser virulence (2534-86), or a non-enterotoxigenicWT strain (G58-1). All 16 porcine ETEC strains were positive by PCR analysis for the T2SS genes, gspD and gspK, and bioinformatic analysis of 4 porcine-origin strains for which complete genomic sequences were available revealed a T2SS with a high degree of homology to that of H10407. MaximumLikelihood phylogenetic trees constructed using T2SS genes gspC, gspD, gspE and homologs showed that strains 2534-86 and 3030-2 clustered together in the same clade with other porcine-origin ETEC strains in the database, UMNK88 and UMN18. Protein modeling of the ATPase gene (gspE) further revealed a direct relationship between the predicted ATP-binding capacities and LT secretion levels as follows: H10407, -8.8 kcal/mol and 199 ng/ml; 3030-2, -8.6 kcal/mol and 133 ng/ml; and 2534-86, -8.5 kcal/mol and 80 ng/ml. This study demonstrated a direct relationship between predicted ATP-binding capacity of GspE and LT secretion, and between the latter and virulence.	[Wijemanne, Prageeth; Xing, Jun; Berberov, Emil M.; Moxley, Rodney A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Xing, Jun] Canada Immunoassay Dev, Windsor, ON, Canada; [Berberov, Emil M.] Univ Saskatchewan, Vaccine & Infect Dis Org, Int Vaccine Ctr, Saskatoon, SK, Canada; [Marx, David B.] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Francis, David H.] S Dakota State Univ, Dept Vet Sci, Brookings, SD 57007 USA	University of Nebraska System; University of Nebraska Lincoln; University of Saskatchewan; University of Nebraska System; University of Nebraska Lincoln; South Dakota State University	Moxley, RA (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	rmoxley1@unl.edu		Moxley, Rodney/0000-0002-5377-7716	United States Department of Agriculture Multi-State Research [NC1202, NEB-39-167]	United States Department of Agriculture Multi-State Research	Support was provided by the United States Department of Agriculture Multi-State Research Project NC1202, NEB-39-167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; Bodero MD, 2009, INFECT IMMUN, V77, P791, DOI 10.1128/IAI.00928-08; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; CHEN TM, 1985, INFECT IMMUN, V47, P5, DOI 10.1128/IAI.47.1.5-10.1985; Erume J, 2010, VET MICROBIOL, V144, P160, DOI 10.1016/j.vetmic.2009.12.043; Erume J, 2008, INFECT IMMUN, V76, P3141, DOI 10.1128/IAI.01743-07; Erume J, 2013, VET MICROBIOL, V161, P315, DOI 10.1016/j.vetmic.2012.07.048; EVANS DG, 1973, INFECT IMMUN, V7, P873, DOI 10.1128/IAI.7.6.873-880.1973; FRANCIS DH, 1991, AM J VET RES, V52, P1051; Francis DH, 2002, J SWINE HEALTH PROD, V10, P171; GILLIGAN PH, 1979, INFECT IMMUN, V23, P99, DOI 10.1128/IAI.23.1.99-107.1979; Gonzales L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074069; GUINEE PAM, 1977, INFECT IMMUN, V15, P549; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hegde A, 2009, INDIAN J MED MICROBI, V27, P325, DOI 10.4103/0255-0857.55446; KUNKEL SL, 1979, INFECT IMMUN, V23, P652, DOI 10.1128/IAI.23.3.652-659.1979; McVeigh A, 2000, INFECT IMMUN, V68, P5710, DOI 10.1128/IAI.68.10.5710-5715.2000; MOON HW, 1971, LAB INVEST, V25, P133; MOON HW, 1980, INFECT IMMUN, V27, P222, DOI 10.1128/IAI.27.1.222-230.1980; Moxley RA, 1998, INFECT IMMUN, V66, P5031, DOI 10.1128/IAI.66.10.5031-5035.1998; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nivaskumar M, 2014, BBA-MOL CELL RES, V1843, P1568, DOI 10.1016/j.bbamcr.2013.12.020; RISTAINO PA, 1983, J CLIN MICROBIOL, V18, P808, DOI 10.1128/JCM.18.4.808-815.1983; SACK DA, 1975, INFECT IMMUN, V11, P334, DOI 10.1128/IAI.11.2.334-336.1975; Shepard SM, 2012, J BACTERIOL, V194, P395, DOI 10.1128/JB.06225-11; Lasaro MAS, 2006, FEMS IMMUNOL MED MIC, V48, P123, DOI 10.1111/j.1574-695X.2006.00134.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; Walker RI, 2007, VACCINE, V25, P2545, DOI 10.1016/j.vaccine.2006.12.028; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	37	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0117663	10.1371/journal.pone.0117663	http://dx.doi.org/10.1371/journal.pone.0117663			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768732	Green Published, gold			2022-12-27	WOS:000351277500017
J	Zhang, T; Nie, SP; Liu, BQ; Yu, YD; Zhang, Y; Liu, JB				Zhang, Ting; Nie, Shaoping; Liu, Boqun; Yu, Yiding; Zhang, Yan; Liu, Jingbo			Activity Prediction and Molecular Mechanism of Bovine Blood Derived Angiotensin I-Converting Enzyme Inhibitory Peptides	PLOS ONE			English	Article							BIOACTIVE PEPTIDES; IDENTIFICATION; PROTEIN; QSAR; DIGESTION; PURIFICATION; HEMOGLOBIN; MODEL; MILK; MEAT	Development of angiotensin I-converting enzyme (ACE, EC 3.4.15.1) inhibitory peptides from food protein is under extensive research as alternative for the prevention of hypertension. However, it is difficult to identify peptides released from food sources. To accelerate the progress of peptide identification, a three layer back propagation neural network model was established to predict the ACE-inhibitory activity of pentapeptides derived from bovine hemoglobin by simulated enzyme digestion. The pentapeptide WTQRF has the best predicted value with experimental IC50 23.93 mu M. The potential molecular mechanism of the WTQRF / ACE interaction was investigated by flexible docking.	[Zhang, Ting; Liu, Boqun; Yu, Yiding; Zhang, Yan; Liu, Jingbo] Jilin Univ, Lab Nutr & Funct Food, Changchun 130023, Jilin, Peoples R China; [Nie, Shaoping] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China	Jilin University; Nanchang University	Liu, JB (corresponding author), Jilin Univ, Lab Nutr & Funct Food, Changchun 130023, Jilin, Peoples R China.	ljb168@sohu.com	Liu, Boqun/V-9297-2019; Nie, S/K-1124-2019	Nie, Shao-Ping/0000-0002-2412-4679; zhang, ting/0000-0003-4229-6332	National Natural Science Foundation of China [31271907, 31471597]; Specialized Research Fund for the Doctoral Program of Higher [20130061110088]; Project of National Key Technology Research and Development Program for the 12th Five-year Plan [2012BAD33B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher; Project of National Key Technology Research and Development Program for the 12th Five-year Plan	This work was supported by the Grant 31271907 and 31471597 of the National Natural Science Foundation of China, the Specialized Research Fund for the Doctoral Program of Higher (No. 20130061110088), and the Project of National Key Technology Research and Development Program for the 12th Five-year Plan (NO. 2012BAD33B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catiau L, 2011, PEPTIDES, V32, P1463, DOI 10.1016/j.peptides.2011.05.021; Catiau L, 2011, PEPTIDES, V32, P633, DOI 10.1016/j.peptides.2010.12.016; Chen JR, 2002, J FOOD BIOCHEM, V26, P543, DOI 10.1111/j.1745-4514.2002.tb00772.x; Cu YC, 2011, FOOD RES INT, V44, P2465, DOI 10.1016/j.foodres.2011.01.051; Contreras MD, 2009, INT DAIRY J, V19, P566, DOI 10.1016/j.idairyj.2009.05.004; Donkor ON, 2007, INT DAIRY J, V17, P1321, DOI 10.1016/j.idairyj.2007.02.009; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Escudero E, 2010, J AGR FOOD CHEM, V58, P2895, DOI 10.1021/jf904204n; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Gomez-Ruiz JA, 2007, ELECTROPHORESIS, V28, P4202, DOI 10.1002/elps.200700324; Gomez-Ruiz JA, 2006, EUR FOOD RES TECHNOL, V223, P595, DOI 10.1007/s00217-005-0238-0; Gouda KGM, 2006, J AGR FOOD CHEM, V54, P4568, DOI 10.1021/jf060264q; Guang C, 2009, J AGR FOOD CHEM, V57, P5113, DOI 10.1021/jf900494d; Hanif K, 2010, HYPERTENS RES, V33, P11, DOI 10.1038/hr.2009.184; Hasan F, 2006, FOOD BIOPROD PROCESS, V84, P135, DOI 10.1205/fbp.05152; He R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091051; Hernandez-Ledesma B, 2007, INT DAIRY J, V17, P42, DOI 10.1016/j.idairyj.2005.12.012; Hernandez-Ledesma B, 2006, J CHROMATOGR A, V1116, P31, DOI 10.1016/j.chroma.2006.03.006; Hernandez-Ledesma B, 2011, ADV COLLOID INTERFAC, V165, P23, DOI 10.1016/j.cis.2010.11.001; Jalali-Heravi M, 2008, EUR J MED CHEM, V43, P548, DOI 10.1016/j.ejmech.2007.04.014; Jang A, 2005, MEAT SCI, V69, P653, DOI 10.1016/j.meatsci.2004.10.014; Kodera T, 2006, J FOOD SCI, V71, pC164, DOI 10.1111/j.1365-2621.2006.tb15612.x; Kuba M, 2005, PROCESS BIOCHEM, V40, P2191, DOI 10.1016/j.procbio.2004.08.010; Kuba M, 2003, BIOSCI BIOTECH BIOCH, V67, P1278, DOI 10.1271/bbb.67.1278; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; Lee DH, 2004, PEPTIDES, V25, P621, DOI 10.1016/j.peptides.2004.01.015; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Liu B., 2013, QUANTITATIVE STRUCTU; Liu JB, 2010, FOOD CHEM, V122, P1159, DOI 10.1016/j.foodchem.2010.03.108; Lu J, 2011, J AGR FOOD CHEM, V59, P559, DOI 10.1021/jf104126a; Majumder K, 2009, J AGR FOOD CHEM, V57, P471, DOI 10.1021/jf8028557; Majumder K, 2010, FOOD RES INT, V43, P1371, DOI 10.1016/j.foodres.2010.04.027; MATERSON BJ, 1994, ARCH INTERN MED, V154, P513, DOI 10.1001/archinte.154.5.513; Matsui T, 1999, J PEPT SCI, V5, P289, DOI 10.1002/(SICI)1099-1387(199907)5:7<289::AID-PSC196>3.0.CO;2-6; Motoi H, 2003, NAHRUNG, V47, P354, DOI 10.1002/food.200390081; Muguruma M, 2009, FOOD CHEM, V114, P516, DOI 10.1016/j.foodchem.2008.09.081; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nedjar-Arroume N, 2008, PEPTIDES, V29, P969, DOI 10.1016/j.peptides.2008.01.011; Nedjar-Arroume N, 2006, PEPTIDES, V27, P2082, DOI 10.1016/j.peptides.2006.03.033; Ni H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037077; Peng WJ, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-54; Ren Y., 2011, SCI RES ESSAYS, V6, P6262; Sagardia I, 2013, FOOD CHEM, V136, P1370, DOI 10.1016/j.foodchem.2012.09.092; Shen Q, 2004, EUR J PHARM SCI, V22, P145, DOI 10.1016/j.ejps.2004.03.002; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Sturrock ED, 2004, CELL MOL LIFE SCI, V61, P2677, DOI 10.1007/s00018-004-4239-0; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Udenigwe CC, 2014, TRENDS FOOD SCI TECH, V36, P137, DOI 10.1016/j.tifs.2014.02.004; Vermeirssen V, 2004, BRIT J NUTR, V92, P357, DOI 10.1079/BJN20041189; Watermeyer JM, 2008, STRUCTURAL DETERMINA; Wu H, 2008, PROCESS BIOCHEM, V43, P457, DOI 10.1016/j.procbio.2008.01.018; Wu JP, 2007, J PEPT SCI, V13, P63, DOI 10.1002/psc.800; Wu JP, 2006, QSAR COMB SCI, V25, P873, DOI 10.1002/qsar.200630005; Wu JP, 2002, FOOD RES INT, V35, P367, DOI 10.1016/S0963-9969(01)00131-4; Yu ZP, 2012, FOOD CHEM, V133, P315, DOI 10.1016/j.foodchem.2012.01.032; Yu ZP, 2011, FOOD CHEM, V129, P1376, DOI 10.1016/j.foodchem.2011.05.067; Yu ZP, 2011, J SCI FOOD AGR, V91, P921, DOI 10.1002/jsfa.4266; Zhong M, 2013, J FOOD SCI, V78, pS1445, DOI 10.1111/1750-3841.12199	60	10	11	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119598	10.1371/journal.pone.0119598	http://dx.doi.org/10.1371/journal.pone.0119598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768442	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500088
J	Ciepiela, P; Baczkowski, T; Drozd, A; Kazienko, A; Stachowska, E; Kurzawa, R				Ciepiela, Przemyslaw; Baczkowski, Tomasz; Drozd, Arleta; Kazienko, Anna; Stachowska, Ewa; Kurzawa, Rafal			Arachidonic and Linoleic Acid Derivatives Impact Oocyte ICSI Fertilization - A Prospective Analysis of Follicular Fluid and a Matched Oocyte in a 'One Follicle - One Retrieved Oocyte - One Resulting Embryo' Investigational Setting	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; POLYUNSATURATED FATTY-ACIDS; OXIDATIVE STRESS; BIOCHEMICAL MARKERS; PARAMETERS; MORPHOLOGY; GLUTATHIONE; PREGNANCY; QUALITY; IVF	Objective To evaluate human oocyte ability to undergo fertilization and subsequent preimplantation embryonic development in relation to a wide panel of follicular fluid (FF) arachidonic acid derivatives (AAD) and linoleic acid derivatives (LAD) of prospectively selected patients undergoing intracytoplasmic sperm injection (ICSI). Methodology Study was designed as a two center (a university clinic and a private clinic) prospective study. 54 women of 181 consecutive couples undergoing ICSI were prospectively found to be eligible for analysis. 'One follicle - one retrieved oocyte - one resulting embryo' approach was used. Each individual follicle was aspirated independently and matched to an oocyte growing in this particular follicular milieu. FF samples were assessed for AAD and LAD by high-performance liquid chromatography; additionally, activity of secretory phospholipase A (sPLA(2)) was determined by enzyme-linked immunosorbent assay. Principal Findings Increased activity of sPLA(2) and significantly higher AAD and LAD levels were found in FF of oocytes that did not show two pronuclei or underwent degeneration after ICSI in comparison to oocytes with the appearance of two pronuclei. Receiver operating characteristics curve analysis identified acids with the highest sensitivity and specificity: 5oxo-hydroxyeicosate-traenoic, 16-hydroxyeicosatetraenoic, 9-hydroxyoctadecadieneoic and 12-hydroxyeicosatetraenoic. No significant differences between AAD and LAD related to embryo quality were found. Conclusions/Significance Our study demonstrates for the first time that elevated concentrations of AAD and LAD in FF at the time of oocyte retrieval significantly decrease the ability of oocytes to form pronuclei after ICSI. This may serve as a new tool for non-invasive assessment of oocyte developmental capacity. However, levels of AAD and LAD are not associated with subsequent embryo quality or pregnancy rate, and therefore more studies are needed to determine their usefulness in human IVF procedure.	[Ciepiela, Przemyslaw; Baczkowski, Tomasz; Kazienko, Anna; Kurzawa, Rafal] Pomeranian Med Univ, Dept Reprod Med & Gynecol, Szczecin, Zachodniopomors, Poland; [Baczkowski, Tomasz; Kurzawa, Rafal] VitroLive Fertil Clin, Szczecin, Zachodniopomors, Poland; [Drozd, Arleta; Stachowska, Ewa] Pomeranian Med Univ, Dept Biochem & Human Nutr, Szczecin, Zachodniopomors, Poland	Pomeranian Medical University; Pomeranian Medical University	Kurzawa, R (corresponding author), Pomeranian Med Univ, Dept Reprod Med & Gynecol, Szczecin, Zachodniopomors, Poland.	kurzawa@pum.edu.pl	Stachowska, Ewa/L-5627-2019; Drozd, Arleta/AAE-8033-2020; stachowska, Ewa/G-9521-2017; Drozd, Arleta/AGF-1128-2022	Drozd, Arleta/0000-0002-5816-2040; stachowska, Ewa/0000-0002-4009-1977; Drozd, Arleta/0000-0002-5816-2040; Ciepiela, Przemyslaw/0000-0001-9705-0490; Kurzawa, Rafal/0000-0001-7853-6591	National Science Centre of Poland [N407 217040]	National Science Centre of Poland(National Science Centre, Poland)	National Science Centre of Poland supported this work. [Grant number: N N407 217040.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaran M, 2000, INT J FERTIL WOMEN M, V45, P314; Baczkowski Tomasz, 2004, Reprod Biol, V4, P5; Baka S, 2006, REPROD BIOMED ONLINE, V12, P500, DOI 10.1016/S1472-6483(10)62005-6; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Capalbo A, 2014, HUM REPROD, V29, P1173, DOI 10.1093/humrep/deu033; Carbone MC, 2003, MOL HUM REPROD, V9, P639, DOI 10.1093/molehr/gag090; Chen SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039257; Choi YA, 2010, BIOL CELL, V102, P107, DOI 10.1042/BC20090073; Collins JA, 2008, FERTIL STERIL, V89, P823, DOI 10.1016/j.fertnstert.2007.04.055; Das S, 2006, HUM REPROD, V21, P2403, DOI 10.1093/humrep/del156; Braga DPDF, 2011, UROLOGY, V78, P786, DOI 10.1016/j.urology.2011.06.018; Ebisch IMW, 2006, HUM REPROD, V21, P1725, DOI 10.1093/humrep/del081; Einstein FH, 2010, J GERONTOL A-BIOL, V65, P800, DOI 10.1093/gerona/glq078; ESPEY LL, 1994, BIOL REPROD, V50, P233, DOI 10.1095/biolreprod50.2.233; Fujimoto VY, 2011, FERTIL STERIL, V96, P1357, DOI 10.1016/j.fertnstert.2011.09.032; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Glujovsky D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002118.pub4, 10.1002/14651858.CD002118.pub5]; Jenko-Praznikar Z, 2013, NEUROTOXICOLOGY, V35, P91, DOI 10.1016/j.neuro.2012.12.007; Jozwik M, 1999, MOL HUM REPROD, V5, P409, DOI 10.1093/molehr/5.5.409; Kaser DJ, 2014, HUM REPROD UPDATE, V20, P617, DOI 10.1093/humupd/dmu023; Kawano Y, 2001, AM J REPROD IMMUNOL, V45, P1, DOI 10.1111/j.8755-8920.2001.450101.x; Li M, 2008, DOMEST ANIM ENDOCRIN, V34, P360, DOI 10.1016/j.domaniend.2007.10.001; Lin MH, 2008, FERTIL STERIL, V90, P352, DOI 10.1016/j.fertnstert.2007.06.018; Newman JW, 2004, ENDOCRINOLOGY, V145, P5097, DOI 10.1210/en.2004-0710; Nicoli A, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-64; Ola SI, 2012, J REPROD DEVELOP, V58, P385, DOI 10.1262/jrd.11-084H; Oyawoye O, 2003, HUM REPROD, V18, P2270, DOI 10.1093/humrep/deg450; Pasqualotto EB, 2004, FERTIL STERIL, V81, P973, DOI 10.1016/j.fertnstert.2003.11.021; Pasqualotto EB, 2009, HUM FERTIL, V12, P166, DOI 10.1080/14647270903207941; PASZKOWSKI T, 1995, CLIN CHIM ACTA, V236, P173, DOI 10.1016/0009-8981(95)98130-9; Raszeja-Wyszomirska J, 2012, PROSTAG OTH LIPID M, V99, P51, DOI 10.1016/j.prostaglandins.2012.06.001; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Rienzi L, 2011, HUM REPROD UPDATE, V17, P34, DOI 10.1093/humupd/dmq029; Roitt I., 1998, IMMUNOLOGY; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Rosen MP, 2006, FERTIL STERIL, V85, P1736, DOI 10.1016/j.fertnstert.2005.12.017; Ruvolo G, 2013, J ASSIST REPROD GEN, V30, P207, DOI 10.1007/s10815-013-9943-y; Sabatini L, 1999, FERTIL STERIL, V72, P1027, DOI 10.1016/S0015-0282(99)00411-2; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Scott L, 2000, HUM REPROD, V15, P2394, DOI 10.1093/humrep/15.11.2394; Setti AS, 2011, EUR J OBSTET GYN R B, V159, P364, DOI 10.1016/j.ejogrb.2011.07.031; Smith MP, 2005, HUM REPROD, V20, P3526, DOI 10.1093/humrep/dei240; Stachowska E, 2007, J AGR FOOD CHEM, V55, P5335, DOI 10.1021/jf0701077; Tarin JJ, 1998, MOL HUM REPROD, V4, P281, DOI 10.1093/molehr/4.3.281; Tarin JJ, 1996, MOL HUM REPROD, V2, P895, DOI 10.1093/molehr/2.12.895; Villa-Diaz LG, 2004, BIOL REPROD, V71, P691, DOI 10.1095/biolreprod.103.026310; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; Wiener-Megnazi Z, 2004, FERTIL STERIL, V82, P1171, DOI 10.1016/j.fertnstert.2004.06.013; Wonnacott KE, 2010, REPRODUCTION, V139, P57, DOI 10.1530/REP-09-0219; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Yu JA, 2012, ANTICANCER RES, V32, P3601; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095; Zuelke KA, 1997, BIOL REPROD, V57, P1413, DOI 10.1095/biolreprod57.6.1413	53	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119087	10.1371/journal.pone.0119087	http://dx.doi.org/10.1371/journal.pone.0119087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763593	Green Submitted, Green Published, gold			2022-12-27	WOS:000351276300018
J	Foley, RA; Lahr, MM				Foley, Robert A.; Lahr, Marta Mirazon			Lithic Landscapes: Early Human Impact from Stone Tool Production on the Central Saharan Environment	PLOS ONE			English	Article							EARLIEST EVIDENCE; AGE; STRATEGIES; AGRICULTURE; EXTINCTION; OCCUPATION; FIRE	Humans have had a major impact on the environment. This has been particularly intense in the last millennium but has been noticeable since the development of food production and the associated higher population densities in the last 10,000 years. The use of fire and overexploitation of large mammals has also been recognized as having an effect on the world's ecology, going back perhaps 100,000 years or more. Here we report on an earlier anthropogenic environmental change. The use of stone tools, which dates back over 2.5 million years, and the subsequent evolution of a technologically-dependent lineage required the exploitation of very large quantities of rock. However, measures of the impact of hominin stone exploitation are rare and inherently difficult. The Messak Settafet, a sandstone massif in the Central Sahara (Libya), is littered with Pleistocene stone tools on an unprecedented scale and is, in effect, a man-made landscape. Surveys showed that parts of the Messak Settafet have as much as 75 lithics per square metre and that this fractured debris is a dominant element of the environment. The type of stone tools-Acheulean and Middle Stone Age-indicates that extensive stone tool manufacture occurred over the last half million years or more. The lithic-strewn pavement created by this ancient stone tool manufacture possibly represents the earliest human environmental impact at a landscape scale and is an example of anthropogenic change. The nature of the lithics and inferred age may suggest that hominins other than modern humans were capable of unintentionally modifying their environment. The scale of debris also indicates the significance of stone as a critical resource for hominins and so provides insights into a novel evolutionary ecology.	[Foley, Robert A.; Lahr, Marta Mirazon] Univ Cambridge, Dept Archaeol & Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England	University of Cambridge	Foley, RA (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England.	raf10@cam.ac.uk		Mirazon Lahr, Marta/0000-0001-5752-5770	Society for Libyan Studies; RPS Environmental Management	Society for Libyan Studies; RPS Environmental Management	This work was supported by the Society for Libyan Studies (www.societyforlibyanstudies.org) and RPS Environmental Management (www.rpsgroup.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Blades B., 2009, LITHIC MAT PALEOLITH, P174; ANDREFSKY W, 1994, AM ANTIQUITY, V59, P21, DOI 10.2307/3085499; Barham LS, 1996, J HUM EVOL, V30, P287, DOI 10.1006/jhev.1996.0023; Barkai R, 2002, ANTIQUITY, V76, P672, DOI 10.1017/S0003598X00091110; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Bird RB, 2008, P NATL ACAD SCI USA, V105, P14796, DOI 10.1073/pnas.0804757105; Bradley B, 1986, STONE AGE PREHISTORY, P29; Brantingham PG, 2000, J ARCHAEOL SCI, V27, P255, DOI 10.1006/jasc.1999.0456; Cancellieri E, 2013, QUATERN INT, V300, P142, DOI 10.1016/j.quaint.2012.08.2054; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Cremaschi M, 1998, GEOARCHAEOLOGICAL SU; DELCOURT HR, 1987, TRENDS ECOL EVOL, V2, P39, DOI 10.1016/0169-5347(87)90097-8; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; di Lernia S, 2006, QUATERN INT, V151, P50, DOI 10.1016/j.quaint.2006.01.014; Diamond J., 2011, COLLAPSE SOC CHOOSE; Dietrich WE, 2006, NATURE, V439, P411, DOI 10.1038/nature04452; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Foley R, 1997, CAMB ARCHAEOL J, V7, P3, DOI 10.1017/S0959774300001451; Foley R., 1981, OFF SITE ARCHAEOLOGY; Foley RA, 2013, QUATERN INT, V300, P153, DOI 10.1016/j.quaint.2012.12.017; Goudie Andrew, 2013, HUMAN IMPACT NATURAL; Hardaker T., 2011, NEW APPROACHES STUDY; Herries Andy I R, 2011, Int J Evol Biol, V2011, P961401, DOI 10.4061/2011/961401; Isaac G., 1981, PATTERN STUDIEHONO, P131; Kelly Robert L, 2013, LIFEWAYS HUNTER GATH; Klein R., 2009, HUMAN CAREER; Lahr MM, 2010, VERTEBR PALEOBIOL PA, P27, DOI 10.1007/978-90-481-9036-2_3; Lahr MM, 2008, BLOCK 131 JARMA FEZZ; LAHR MM, 2008, LIBYAN STUDIES, V39, P263; Lahr MM, 2009, AREA 131 JARMA FEZZA; Lepre CJ, 2011, NATURE, V477, P82, DOI 10.1038/nature10372; Levy J., 2005, GREAT PYRAMID GIZA M; Li XQ, 2009, QUATERN INT, V202, P41, DOI 10.1016/j.quaint.2008.02.009; Mattingly D., 2007, LIBYAN STUDIES, V38, P1; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Mirazon Lahr M, 2009, LIBYAN STUDIES, P1; Mirazon Lahr M, 2010, LIBYAN STUDIES, P1; Morgan LE, 2008, GEOLOGY, V36, P967, DOI 10.1130/G25213A.1; Olszewski DI, 2010, J HUM EVOL, V59, P188, DOI 10.1016/j.jhevol.2010.06.001; Perego A, 2011, J MAPS, V7, P464, DOI 10.4113/jom.2011.1207; Petraglia M, 1999, J ANTHROPOL RES, V55, P39, DOI 10.1086/jar.55.1.3630977; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Roche H, 2005, STONE KNAPPING NECES, P35; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Sandom C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3254; Scerri EML, 2014, QUATERNARY SCI REV, V101, P207, DOI 10.1016/j.quascirev.2014.07.019; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; STILES DN, 1974, WORLD ARCHAEOL, V5, P285, DOI 10.1080/00438243.1974.9979575; Toth N, 2009, ANNU REV ANTHROPOL, V38, P289, DOI 10.1146/annurev-anthro-091908-164521; Van Peer P., 2010, EGYPTIAN PREHISTORY; Vermeersch P.M., 2002, PALAEOLITHIC QUARRYI; Wroe S, 2013, P NATL ACAD SCI USA, V110, P8777, DOI 10.1073/pnas.1302698110; Zerboni A, 2011, GEOMORPHOLOGY, V125, P319, DOI 10.1016/j.geomorph.2010.10.015	55	32	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116482	10.1371/journal.pone.0116482	http://dx.doi.org/10.1371/journal.pone.0116482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CD7MQ	25760999	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000004
J	Hirotsu, T; Sonoda, H; Uozumi, T; Shinden, Y; Mimori, K; Maehara, Y; Ueda, N; Hamakawa, M				Hirotsu, Takaaki; Sonoda, Hideto; Uozumi, Takayuki; Shinden, Yoshiaki; Mimori, Koshi; Maehara, Yoshihiko; Ueda, Naoko; Hamakawa, Masayuki			A Highly Accurate Inclusive Cancer Screening Test Using Caenorhabditis elegans Scent Detection	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; LUNG-CANCER; C-ELEGANS; OLFACTORY BEHAVIOR; GUANYLYL CYCLASE; SENSORY NEURONS; RECEPTORS; RESPONSES; BREATH; CHEMOTAXIS	Early detection and treatment are of vital importance to the successful eradication of various cancers, and development of economical and non-invasive novel cancer screening systems is critical. Previous reports using canine scent detection demonstrated the existence of cancer-specific odours. However, it is difficult to introduce canine scent recognition into clinical practice because of the need to maintain accuracy. In this study, we developed a Nematode Scent Detection Test (NSDT) using Caenorhabditis elegans to provide a novel highly accurate cancer detection system that is economical, painless, rapid and convenient. We demonstrated wild-type C. elegans displayed attractive chemotaxis towards human cancer cell secretions, cancer tissues and urine from cancer patients but avoided control urine; in parallel, the response of the olfactory neurons of C. elegans to the urine from cancer patients was significantly stronger than to control urine. In contrast, G protein a mutants and olfactory neurons-ablated animals were not attracted to cancer patient urine, suggesting that C. elegans senses odours in urine. We tested 242 samples to measure the performance of the NSDT, and found the sensitivity was 95.8%; this is markedly higher than that of other existing tumour markers. Furthermore, the specificity was 95.0%. Importantly, this test was able to diagnose various cancer types tested at the early stage (stage 0 or 1). To conclude, C. elegans scent-based analyses might provide a new strategy to detect and study disease-associated scents.	[Hirotsu, Takaaki; Uozumi, Takayuki; Hamakawa, Masayuki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Hirotsu, Takaaki] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 812, Japan; [Sonoda, Hideto; Uozumi, Takayuki] Kyushu Univ, Res & Dev Ctr Taste & Odor Sensing, Div Appl Med Sensing, Fukuoka 812, Japan; [Hirotsu, Takaaki; Ueda, Naoko] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Sonoda, Hideto] Imari Arita Kyoritsu Hosp, Dept Gen Surg, Saga, Japan; [Shinden, Yoshiaki; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Oita, Japan; [Sonoda, Hideto; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; Kyushu University; Kyushu University	Hirotsu, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	hirotsu.takaaki.056@m.kyushu-u.ac.jp; sonoda-hideto@imari-arita-hp.or.jp		Mimori, Koshi/0000-0003-3897-9974	JSPS; Senri Life Science Foundation; Inamori Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Health Foundation; Mishima Kaiun Memorial Foundation; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development [Type E-4, 24425]; Grants-in-Aid for Scientific Research [26430019] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Senri Life Science Foundation; Inamori Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Health Foundation(Japan Health Foundation); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a JSPS Grant-in-aid for Young Scientists (A), Grant-in-Aid for Scientific Research (C), Senri Life Science Foundation, Inamori Foundation, The Kurata Memorial Hitachi Science and Technology Foundation, The Japan Health Foundation, Mishima Kaiun Memorial Foundation and Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (Type E-4, 24425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bianchi Laura, 2006, WormBook, P1; Bijland LR, 2013, NETH J MED, V71, P300; Boyle P., 2008, World Cancer Report 2008; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chen X, 2007, CANCER-AM CANCER SOC, V110, P835, DOI 10.1002/cncr.22844; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; D'Amico Arnaldo, 2012, Expert Opin Med Diagn, V6, P175, DOI 10.1517/17530059.2012.665870; Di Natale C, 2003, BIOSENS BIOELECTRON, V18, P1209, DOI 10.1016/S0956-5663(03)00086-1; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Hanai Y, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-7; Hirotsu T, 2005, GENES CELLS, V10, P517, DOI 10.1111/j.1365-2443.2005.00856.x; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Kajikawa J, 2010, JPN J MED PHARM SCI, V63, P523; Kawakita M, 2011, METHODS MOL BIOL, V720, P367, DOI 10.1007/978-1-61779-034-8_23; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Luo L, 2008, J NEUROPHYSIOL, V99, P2617, DOI 10.1152/jn.00053.2008; Machado RF, 2005, AM J RESP CRIT CARE, V171, P1286, DOI 10.1164/rccm.200409-1184OC; Matsumura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008819; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nuttley WM, 2001, LEARN MEMORY, V8, P170, DOI 10.1101/lm.36501; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026003; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robertson Hugh M, 2006, WormBook, P1; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shinkai Y, 2011, J NEUROSCI, V31, P3007, DOI 10.1523/JNEUROSCI.4691-10.2011; Sonoda H, 2014, SURG TODAY, P17, DOI [10.1007/s00595-014-0850-3, DOI 10.1007/S00595-014-0850-3]; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; Suzuki N, 2006, JPN J MED PHARM SCI, V56, P897; Taniguchi G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005136; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Uozumi T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00500; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	42	41	46	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118699	10.1371/journal.pone.0118699	http://dx.doi.org/10.1371/journal.pone.0118699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760772	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000034
J	Matsue, Y; Tsutsumi, M; Hayashi, N; Saito, T; Tsuchishima, M; Toshikuni, N; Arisawa, T; George, J				Matsue, Yasuhiro; Tsutsumi, Mikihiro; Hayashi, Nobuhiko; Saito, Takashi; Tsuchishima, Mutsumi; Toshikuni, Nobuyuki; Arisawa, Tomiyasu; George, Joseph			Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection	PLOS ONE			English	Article							MOLECULAR PATHOGENESIS; FIBROTIC LIVER; CIRRHOSIS; ENGAGEMENT; TESTS	Background & Aims Osteopontin (OPN) is a matricellular protein that upregulates during pathogenesis of hepatic fibrosis. The present study was aimed to evaluate whether serum OPN could be used as a biomarker to assess the degree of hepatic fibrosis in patients with hepatitis C virus (HCV) infection. Methods Needle biopsy was performed on HCV patients and scored as zero fibrosis (F0), mild fibrosis (F1), moderate fibrosis (F2), severe fibrosis (F3) and liver cirrhosis (F4) based on Masson's trichrome and a-smooth muscle actin (alpha-SMA) staining. Serum OPN levels were measured using ELISA and correlated with the degree of fibrosis. Furthermore, the OPN values were correlated and evaluated with platelets count, serum hyaluronic acid (HA), and collagen type IV and subjected to receiver operating characteristic (ROC) curve analysis. Results Serum OPN levels were remarkably increased from F0 through F4 in a progressive manner and the differences were significant (P < 0.001) between each group. The data were highly correlated with the degree of hepatic fibrosis. The ROC curve analysis depicted that serum OPN is an independent risk factor and an excellent biomarker and a prognostic index in HCV patients. Conclusions The results of the present study indicate that serum OPN levels reflect the degree of hepatic fibrosis and could be used as a biomarker to assess the stage of fibrosis in HCV patients which would help to reduce the number of liver biopsies. Furthermore, serum OPN serves as a prognostic index towards the progression of hepatic fibrosis to cirrhosis and hepatocellular carcinoma.	[Matsue, Yasuhiro; Tsutsumi, Mikihiro; Hayashi, Nobuhiko; Saito, Takashi; Tsuchishima, Mutsumi; Toshikuni, Nobuyuki; George, Joseph] Kanazawa Med Univ, Dept Hepatol, Uchinada, Ishikawa 92002, Japan; [Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinada, Ishikawa 92002, Japan	Kanazawa Medical University; Kanazawa Medical University	George, J (corresponding author), Kanazawa Med Univ, Dept Hepatol, Uchinada, Ishikawa 92002, Japan.	georgej@kanazawa-med.ac.jp	George, Joseph/P-8447-2018	George, Joseph/0000-0001-5354-7884	Kanazawa Medical University [SR2012-04]; Ministry of Health, Labor, and Welfare of Japan	Kanazawa Medical University; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grant for Specially Promoted Research from Kanazawa Medical University (SR2012-04) and the Ministry of Health, Labor, and Welfare of Japan to M. Tsutsumi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El Makarem MA, 2011, ANN HEPATOL, V10, P296, DOI 10.1016/S1665-2681(19)31541-8; Arai M, 2006, SCAND J GASTROENTERO, V41, P102, DOI 10.1080/00365520510024061; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bose SK, 2014, WORLD J DIABETES, V5, P52, DOI 10.4239/wjd.v5.i1.52; CHICHIBU K, 1989, CLIN CHIM ACTA, V181, P317, DOI 10.1016/0009-8981(89)90237-4; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Andrade LJD, 2009, J GLOB INFECT DIS, V1, P33, DOI 10.4103/0974-777X.52979; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; George J, 2004, CLIN CHIM ACTA, V348, P189, DOI 10.1016/j.cccn.2004.05.018; George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8; George J, 1996, BBA-PROTEIN STRUCT M, V1292, P215, DOI 10.1016/0167-4838(95)00202-2; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Huang WB, 2010, CLIN CHIM ACTA, V411, P675, DOI 10.1016/j.cca.2010.01.029; Lee SH, 2004, BIOCHEM PHARMACOL, V68, P2367, DOI 10.1016/j.bcp.2004.08.022; Lorena D, 2006, J HEPATOL, V44, P383, DOI 10.1016/j.jhep.2005.07.024; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; MISAKI M, 1990, CLIN CHEM, V36, P522; Morales-Ibanez O, 2013, HEPATOLOGY, V58, P1742, DOI 10.1002/hep.26521; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Nagoshi S, 2014, HEPATOL RES, V44, P22, DOI 10.1111/hepr.12166; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Vezali E, 2010, CLIN THER, V32, P2117, DOI 10.1016/S0149-2918(11)00022-1; Wong N, 2000, CLIN CANCER RES, V6, P4000; Zhao L, 2008, INT J CLIN PRACT, V62, P1056, DOI 10.1111/j.1742-1241.2007.01368.x; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200	40	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118744	10.1371/journal.pone.0118744	http://dx.doi.org/10.1371/journal.pone.0118744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760884	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000035
J	Boas, IMV; Pidde-Queiroz, G; Magnoli, FC; Goncalves-de-Andrade, RM; van den Berg, CW; Tambourgi, DV				Villas Boas, Isadora Maria; Pidde-Queiroz, Giselle; Magnoli, Fabio Carlos; Goncalves-de-Andrade, Rute M.; van den Berg, Carmen W.; Tambourgi, Denise V.			A Serine Protease Isolated from the Bristles of the Amazonic Caterpillar, Premolis semirufa, Is a Potent Complement System Activator	PLOS ONE			English	Article							LOXOSCELES-INTERMEDIA; VENOM; C5A; METALLOPROTEINASE; ANAPHYLATOXINS; ENVENOMATION; IMMUNOLOGY; COMPONENT; PROTEINS; CLEAVAGE	Background The caterpillar of the moth Premolis semirufa, commonly named pararama, is found in the Brazilian Amazon region. Accidental contact with the caterpillar bristles causes an intense itching sensation, followed by symptoms of an acute inflammation, which last for three to seven days after the first incident. After multiple accidents a chronic inflammatory reaction, called "Pararamose", characterized by articular synovial membrane thickening with joint deformities common to chronic synovitis, frequently occurs. Although complement mediated inflammation may aid the host defense, inappropriate or excessive activation of the complement system and generation of anaphylatoxins can lead to inflammatory disorder and pathologies. The aim of the present study was to evaluate, in vitro, whether the Premolis semirufa's bristles extract could interfere with the human complement system. Results The bristles extract was able to inhibit the haemolytic activity of the alternative pathway, as well as the activation of the lectin pathway, but had no effect on the classical pathway, and this inhibition seemed to be caused by activation and consumption of complement components. The extract induced the production of significant amounts of all three anaphylatoxins, C3a, C4a and C5a, promoted direct cleavage of C3, C4 and C5 and induced a significant generation of terminal complement complexes in normal human serum. By using molecular exclusion chromatography, a serine protease of 82 kDa, which activates complement, was isolated from P. semirufa bristles extract. The protease, named here as Ps82, reduced the haemolytic activity of the alternative and classical pathways and inhibited the lectin pathway. In addition, Ps82 induced the cleavage of C3, C4 and C5 and the generation of C3a and C4a in normal human serum and it was capable to cleave human purified C5 and generate C5a. The use of Phenanthroline, metalloprotease inhibitor, in the reactions did not significantly interfere with the activity of the Ps82, whereas the presence of PMSF, serine protease inhibitor, totally blocked the activity. Conclusion These data show that a serine protease present in the Premolis semirufa's bristles extract has the ability to activate the complement system, which may contribute to the inflammatory process presented in humans after envenomation.	[Villas Boas, Isadora Maria; Pidde-Queiroz, Giselle; Magnoli, Fabio Carlos; Goncalves-de-Andrade, Rute M.; Tambourgi, Denise V.] Butantan Inst, Immunochem Lab, Sao Paulo, SP, Brazil; [van den Berg, Carmen W.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Instituto Butantan; Cardiff University	Tambourgi, DV (corresponding author), Butantan Inst, Immunochem Lab, Sao Paulo, SP, Brazil.	denise.tambourgi@butantan.gov.br	Tambourgi, Denise/H-7114-2016; Boas, Isadora Maria Villas/H-3499-2013; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015	Tambourgi, Denise/0000-0003-1896-9074; Villas Boas, Isadora/0000-0001-6034-9544	FAPESP; CNPq; Instituto Nacional de Ciencia e Tecnologia em Toxinas (INCTTOX)	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Toxinas (INCTTOX)	This study was supported by grants from FAPESP, CNPq and Instituto Nacional de Ciencia e Tecnologia em Toxinas (INCTTOX).	Addis-Lieser E, 2005, J IMMUNOL, V175, P1894, DOI 10.4049/jimmunol.175.3.1894; Bertazzi DT, 2005, INT IMMUNOPHARMACOL, V5, P1077, DOI 10.1016/j.intimp.2005.02.007; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Costa R M, 1993, Rev Paul Med, V111, P462; Costa RM, 2003, ANIMAIS PECONHENTOS, P233, DOI [10.1016/j.ttbdis.2014.03.010, DOI 10.1016/J.TTBDIS.2014.03.010]; Dias LB, 1997, DOENCAS INFECCIOSAS; EGGERTSEN G, 1980, TOXICON, V18, P87, DOI 10.1016/0041-0101(80)90034-3; EMBER JA, 1998, HUMAN COMPLEMENT SYS, P241; Farsky SHP, 2000, MEDIAT INFLAMM, V9, P213, DOI 10.1080/09629350020025728; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; HUGLI T E, 1986, Complement, V3, P111; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jusko M, 2014, J INNATE IMMUN, V6, P31, DOI 10.1159/000351458; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Ministerio da Saude, 1992, MAN DIAGN TRAT AC AN; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MULLEREBERHARD HJ, 1985, J INVEST DERMATOL, V85, pS47; Nataf S, 1999, J IMMUNOL, V162, P4018; Ottonello L, 1999, J IMMUNOL, V162, P6510; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Pidde-Queiroz G, 2010, MOL IMMUNOL, V47, P2537, DOI 10.1016/j.molimm.2010.07.003; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Tambourgi DV, 2014, MOL IMMUNOL, V61, P153, DOI 10.1016/j.molimm.2014.06.020; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; TAMBOURGI DV, 1995, J IMMUNOL, V155, P4459; Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683; TAMBOURGI DV, 1994, BRIT J PHARMACOL, V112, P723, DOI 10.1111/j.1476-5381.1994.tb13137.x; Tanaka GD, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-4; Villas-Boas IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071938; Villas-Boas IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001531; Vogel CW, 2010, TOXICON, V56, P1198, DOI 10.1016/j.toxicon.2010.04.007; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118615	10.1371/journal.pone.0118615	http://dx.doi.org/10.1371/journal.pone.0118615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760458	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275000032
J	Zimmer, L; Vaubel, J; Mohr, P; Hauschild, A; Utikal, J; Simon, J; Garbe, C; Herbst, R; Enk, A; Kampgen, E; Livingstone, E; Bluhm, L; Rompel, R; Griewank, KG; Fluck, M; Schilling, B; Schadendorf, D				Zimmer, Lisa; Vaubel, Julia; Mohr, Peter; Hauschild, Axel; Utikal, Jochen; Simon, Jan; Garbe, Claus; Herbst, Rudolf; Enk, Alexander; Kaempgen, Eckhart; Livingstone, Elisabeth; Bluhm, Leonie; Rompel, Rainer; Griewank, Klaus G.; Fluck, Michael; Schilling, Bastian; Schadendorf, Dirk			Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naive Patients with Metastatic Uveal Melanoma	PLOS ONE			English	Article							INTRAVENOUS FOTEMUSTINE; DOSE-ESCALATION; SURVIVAL; SAFETY; MUTATIONS; CANCER; TUMORS; TRIAL; IMMUNOTHERAPY; CONJUNCTIVAL	Purpose Up to 50% of patients with uveal melanoma (UM) develop metastatic disease with limited treatment options. The immunomodulating agent ipilimumab has shown an overall survival (OS) benefit in patients with cutaneous metastatic melanoma in two phase III trials. As patients with UM were excluded in these studies, the Dermatologic Cooperative Oncology Group (DeCOG) conducted a phase II to assess the efficacy and safety of ipilimumab in patients with metastatic UM. Patients and Methods We undertook a multicenter phase II study in patients with different subtypes of metastatic melanoma. Here we present data on patients with metastatic UM (pretreated and treatment-naive) who received up to four cycles of ipilimumab administered at a dose of 3 mg/kg in 3 week intervals. Tumor assessments were conducted at baseline, weeks 12, 24, 36 and 48 according to RECIST 1.1 criteria. Adverse events (AEs), including immune-related AEs were graded according to National Cancer Institute Common Toxicity Criteria (CTC) v.4.0. Primary endpoint was the OS rate at 12 months. Results Forty five pretreated (85%) and eight treatment-naive (15%) patients received at least one dose of ipilimumab. 1-year and 2-year OS rates were 22% and 7%, respectively. Median OS was 6.8 months (95% CI 3.7-8.1), median progression-free survival 2.8 months (95% CI 2.5-2.9). The disease control rate at weeks 12 and 24 was 47% and 21%, respectively. Sixteen patients had stable disease (47%), none experienced partial or complete response. Treatment-related AEs were observed in 35 patients (66%), including 19 grade 3-4 events (36%). One drug-related death due to pancytopenia was observed. Conclusions Ipilimumab has very limited clinical activity in patients with metastatic UM. Toxicity was manageable when treated as per protocol-specific guidelines.	[Zimmer, Lisa; Vaubel, Julia; Livingstone, Elisabeth; Griewank, Klaus G.; Schilling, Bastian; Schadendorf, Dirk] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany; [Mohr, Peter; Bluhm, Leonie] Dept Dermatol, Buxtehude, Germany; [Hauschild, Axel] Univ Dept Dermatol, Kiel, Germany; [Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Utikal, Jochen] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Simon, Jan] Univ Dept Dermatol, Leipzig, Germany; [Garbe, Claus] Univ Dept Dermatol, Tubingen, Germany; [Herbst, Rudolf] Dept Dermatol, Erfurt, Germany; [Enk, Alexander] Heidelberg Univ, Univ Hosp, Dept Dermatol, Heidelberg, Germany; [Kaempgen, Eckhart] Univ Hosp, Dept Dermatol, Erlangen, Germany; [Rompel, Rainer] Dept Dermatol, Kassel, Germany; [Fluck, Michael] Dept Dermatol Hornheide, Munster, Germany	University of Duisburg Essen; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg	Zimmer, L (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany.	lisa.zimmer@uk-essen.de	Schadendorf, Dirk/AAE-8206-2019; Zimmer, Lisa/AAP-8495-2021; Schilling, Bastian/AAY-8646-2020; Griewank, Klaus G/A-9097-2017; Garbe, Claus/ABH-2128-2021; Livingstone, Elisabeth/AHE-9171-2022	Zimmer, Lisa/0000-0002-3680-3521; Schilling, Bastian/0000-0001-8859-4103; Griewank, Klaus G/0000-0003-3899-9449; Garbe, Claus/0000-0001-8530-780X; Utikal, Jochen/0000-0001-5316-0241	Bristol-Myers Squibb [CA184-137]	Bristol-Myers Squibb(Bristol-Myers Squibb)	DS received funding from Bristol-Myers Squibb. 1. Bristol-Myers Squibb study number: CA184-137; www.b-ms.de. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augsburger JJ, 2009, AM J OPHTHALMOL, V148, P119, DOI 10.1016/j.ajo.2009.01.023; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bhatia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048787; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Buder K, 2013, CANCER MED-US, V2, P674, DOI 10.1002/cam4.133; Carvajal RD, 2014, JAMA-J AM MED ASSOC, V311, P2397, DOI 10.1001/jama.2014.6096; Chang CL, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.9007; Cruz F, 2003, CANCER RES, V63, P5761; Danielli R, 2012, CANCER IMMUNOL IMMUN, V61, P41, DOI 10.1007/s00262-011-1089-0; Delyon J, 2013, ANN ONCOL, V24, P1697, DOI 10.1093/annonc/mdt027; Deo MA, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.3060; Di Giacomo AM, 2010, SEMIN ONCOL, V37, P499, DOI 10.1053/j.seminoncol.2010.09.007; Diener-West M, 2005, ARCH OPHTHALMOL-CHIC, V123, P1639; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Griewank KG, 2013, BRIT J CANCER, V109, P497, DOI 10.1038/bjc.2013.312; Hamid O, 2013, ASCO M S, V31, P9010, DOI DOI 10.1200/jco.2013.31.15_suppl.9010; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Homsi J, 2010, MELANOMA RES, V20, P507, DOI 10.1097/CMR.0b013e3283403ce9; Kelderman S, 2013, ACTA ONCOL, V52, P1786, DOI 10.3109/0284186X.2013.786839; Khattak MA, 2013, MELANOMA RES, V23, P79, DOI 10.1097/CMR.0b013e32835b554f; Ku GY, 2010, CANCER-AM CANCER SOC, V116, P1767, DOI 10.1002/cncr.24951; Leyvraz S, 2014, ANN ONCOL, V25, P742, DOI 10.1093/annonc/mdt585; Luke JJ, 2013, CANCER-AM CANCER SOC, V119, P3687, DOI 10.1002/cncr.28282; Maio M, 2013, ANN ONCOL, V24, P2911, DOI 10.1093/annonc/mdt376; Peggs KS, 2009, CLIN EXP IMMUNOL, V157, P9, DOI 10.1111/j.1365-2249.2009.03912.x; Piperno-Neumann S, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.9030; Piulats Rodriguez J, 2014, J CLIN ONCOL S, V32, P9033; Robert C, 2014, N ENGL J MED; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Spagnolo F, 2013, MELANOMA RES, V23, P196, DOI 10.1097/CMR.0b013e3283610586; Spendlove HE, 2004, MELANOMA RES, V14, P449, DOI 10.1097/00008390-200412000-00003; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yang WH, 2008, INVEST OPHTH VIS SCI, V49, P2518, DOI 10.1167/iovs.07-1606	40	155	158	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118564	10.1371/journal.pone.0118564	http://dx.doi.org/10.1371/journal.pone.0118564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761109	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000028
J	Ohtsuki, H; Awano, T; Tsugeki, NK; Ishida, S; Oda, H; Makino, W; Urabe, J				Ohtsuki, Hajime; Awano, Tamotsu; Tsugeki, Narumi K.; Ishida, Seiji; Oda, Hirotaka; Makino, Wataru; Urabe, Jotaro			Historical Changes in the Ecosystem Condition of a Small Mountain Lake over the Past 60 Years as Revealed by Plankton Remains and Daphnia Ephippial Carapaces Stored in Lake Sediments	PLOS ONE			English	Article							WHOLE-LAKE; ZOOPLANKTON COMMUNITY; NITROGEN SATURATION; LARGEMOUTH BASS; FISH ABUNDANCE; RESTING EGGS; LONG-TERM; EUTROPHICATION; DEPOSITION; JAPAN	To examine if changes in species composition of a plankton community in the past due to anthropogenic activities can be clarified in lakes without any monitoring data, we analyzed genetically ephippial carapaces of Daphnia with plankton remains stored in the bottom sediments of Lake Hataya Ohunma in Japan. In the lake, abundance of most plankton remains in the sediments was limited and TP flux was at low levels (2-4 mg/m(2)/y) before 1970. However TP flux increased two-fold during the period from 1980s to 1990s. In parallel with this increase, abundance of most plankton remains increased although abundance of benthic testate amoebae's remains decreased, indicating that the lake trophic condition had changed from oligo-to mesotrophic for the past 60 years. According to cluster analysis, the stratigraphic sediments were divided into two periods with different features of the phytoplankton composition. Chronological comparison with events in the watershed suggested that eutrophication occurred because of an increase in visitors to the watershed and deposition of atmospheric dust. In this lake more than 50% of resting eggs produced by Daphnia over the past 60 years hatched. However, genetic analysis of the ephippial carapaces (remains) showed that the Daphnia population was originally composed of D. dentifera but that D. galeata, or its hybrid with D. dentifera, invaded and increased the population density when the lake was eutrophied. Subsequently, large D. pulex established populations in the 1980s when largemouth bass were anonymously introduced. These results indicated that the Lake Hataya Ohunma plankton community underwent significant changes despite the fact that there were no notable changes in land cover or land use in the watershed. Since increases in atmospheric deposition and release of fish have occurred in many Japanese lakes, the changes in the plankton community described here may be widespread in these lakes.	[Ohtsuki, Hajime; Awano, Tamotsu; Tsugeki, Narumi K.; Ishida, Seiji; Makino, Wataru; Urabe, Jotaro] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Oda, Hirotaka] Nagoya Univ, Chronol Res, Nagoya, Aichi 4648601, Japan	Tohoku University; Nagoya University	Ohtsuki, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	ohtsuki-hajime@m.tohoku.ac.jp	Tsugeki, Narumi/AAV-2862-2021; Urabe, Jotaro/ABI-7692-2020; Urabe, Jotaro/A-6256-2012	Tsugeki, Narumi/0000-0003-1236-906X; Urabe, Jotaro/0000-0001-5111-687X; Urabe, Jotaro/0000-0001-5111-687X	MEXT Japan [19207003]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [D-1002]; Global COE (Centers of Excellence) Program of MEXT, Japan [J03, E07]	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Global COE (Centers of Excellence) Program of MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research A (no. 19207003) from MEXT Japan, by the Environment Research and Technology Development Fund (D-1002) of the Ministry of the Environment, Japan, and by the Global COE (Centers of Excellence) Program (J03, E07) of MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association A. W. W. A. Water Environment Federation APHA AWWA and WEF, 1998, STANDARD METHODS EXA; ANDERSON NJ, 1993, TRENDS ECOL EVOL, V8, P356; Azuma M, 1998, ENVIRON BIOL FISH, V52, P379, DOI 10.1023/A:1007476104352; Bennice CO, 2009, AQUAC RES, V40, P582, DOI 10.1111/j.1365-2109.2008.02134.x; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Brede N, 2009, P NATL ACAD SCI USA, V106, P4758, DOI 10.1073/pnas.0807187106; Caceres CE, 2004, OECOLOGIA, V141, P425, DOI 10.1007/s00442-004-1657-5; Carpenter S. R., 1996, TROPHIC CASCADE LAKE; Catalan J, 2013, J PALEOLIMNOL, V49, P513, DOI 10.1007/s10933-013-9681-2; Davidson TA, 2010, FRESHWATER BIOL, V55, P584, DOI 10.1111/j.1365-2427.2009.02391.x; DEMOTT WR, 1982, ECOLOGY, V63, P1949, DOI 10.2307/1940132; Escobar J, 2008, J PALEOLIMNOL, V40, P715, DOI 10.1007/s10933-008-9195-5; Fitzsimmons JM, 2006, HYDROBIOLOGIA, V568, P187, DOI 10.1007/s10750-006-0104-5; Frey D.G., 1986, P667; Frisch D, 2014, ECOL LETT, V17, P360, DOI 10.1111/ele.12237; Gliwicz M., 1989, P253; GOULDEN CE, 1982, ECOLOGY, V63, P1780, DOI 10.2307/1940120; Han BP, 2008, HYDROBIOLOGIA, V596, P197, DOI 10.1007/s10750-007-9096-z; Hanazato Takayuki, 2001, Japanese Journal of Limnology, V62, P151; Hariston NG, 1999, LIMNOL OCEANOGR, V44, P477; Ishida S, 2012, LIMNOLOGY, V13, P261, DOI 10.1007/s10201-012-0380-x; Ishida S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-209; Jankowski T, 2003, LIMNOL OCEANOGR, V48, P1948, DOI 10.4319/lo.2003.48.5.1948; Jeppesen E, 2001, TRENDS ECOL EVOL, V16, P191, DOI 10.1016/S0169-5347(01)02100-0; Jeppesen E, 2003, HYDROBIOLOGIA, V491, P321, DOI 10.1023/A:1024488525225; Jeppesen E, 2002, J PALEOLIMNOL, V27, P133, DOI 10.1023/A:1013561208488; Kanai Y., 1995, BULL GEOL SURV JPN, V46, P225; KOHATA K, 1991, J CHROMATOGR, V558, P131, DOI 10.1016/0021-9673(91)80118-Z; KOMEIJI T, 1990, ATMOS ENVIRON A-GEN, V24, P2099, DOI 10.1016/0960-1686(90)90243-G; Lampert KP, 2014, FRESHWATER BIOL, V59, P1735, DOI 10.1111/fwb.12378; LAMPERT W, 1996, LIMNOECOLOGY ECOLOGY; Leavitt PR, 1994, J PALEOLIMNOL, V11, P133, DOI 10.1007/BF00686862; Leavitt PR, 1999, LIMNOL OCEANOGR, V44, P757, DOI 10.4319/lo.1999.44.3_part_2.0757; Makino W, 2001, HYDROBIOLOGIA, V442, P309, DOI 10.1023/A:1017532717135; Markova S, 2006, BIOLOGIA, V61, pS135, DOI 10.2478/s11756-006-0126-5; MEDIOLI FS, 1988, PALAEOGEOGR PALAEOCL, V62, P361, DOI 10.1016/0031-0182(88)90062-4; Mergeay J, 2005, HYDROBIOLOGIA, V542, P261, DOI 10.1007/s10750-004-4952-6; MITTELBACH GG, 1995, ECOLOGY, V76, P2347, DOI 10.2307/2265812; Neff JC, 2008, NAT GEOSCI, V1, P189, DOI 10.1038/ngeo133; Nykanen M, 2009, J PALEOLIMNOL, V42, P551, DOI 10.1007/s10933-008-9304-5; Ohrui K, 1997, ECOL APPL, V7, P391, DOI 10.1890/1051-0761(1997)007[0391:NSIJFW]2.0.CO;2; Ohte N, 2001, WATER AIR SOIL POLL, V130, P649, DOI 10.1023/A:1013804728336; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Pollard HG, 2003, AMBIO, V32, P214, DOI 10.1639/0044-7447(2003)032[0214:ROCDCI]2.0.CO;2; R Core Team, R LANG ENV STAT COMP; Reid VA, 2002, J PALEOLIMNOL, V27, P481, DOI 10.1023/A:1020380918518; Rellstab C, 2011, LIMNOL OCEANOGR, V56, P292, DOI 10.4319/lo.2011.56.1.0292; SCOTT DB, 1983, J PALEONTOL, V57, P809; Shiraishi Y., 1961, B FRESHWATER FISH RE, V10, P1; Sorf M, 2014, ANN LIMNOL-INT J LIM, V50, P71, DOI 10.1051/limn/2014001; Takamura K, 2007, ECOL RES, V22, P940, DOI 10.1007/s11284-007-0415-7; TAKAMURA N, 1992, ARCH HYDROBIOL, V124, P129; Takamura N, 2012, ECOL RES, V27, P837, DOI 10.1007/s11284-012-0971-3; Tsugeki N, 2003, LIMNOLOGY, V4, P101, DOI 10.1007/s10201-003-0097-y; Tsugeki NK, 2014, J LIMNOL, V73, P191, DOI 10.4081/jlimnol.2014.569; Tsugeki NK, 2012, ECOL RES, V27, P1041, DOI 10.1007/s11284-012-0984-y; Tsugeki NK, 2010, J PALEOLIMNOL, V44, P69, DOI 10.1007/s10933-009-9386-8; Tsugeki NK, 2009, J PALEOLIMNOL, V42, P155, DOI 10.1007/s10933-008-9268-5; URABE J, 1990, LIMNOL OCEANOGR, V35, P1703, DOI 10.4319/lo.1990.35.8.1703; Wakamatsu Shinji, 2013, Asian Journal of Atmospheric Environment, V7, P177, DOI 10.5572/ajae.2013.7.4.177; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yamagata Prefecture, 1968, HIST YAMAGATA PREFEC, V1	62	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119767	10.1371/journal.pone.0119767	http://dx.doi.org/10.1371/journal.pone.0119767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757090	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700052
J	Liu, J; Ai, HW; Xiong, Y; Li, F; Wen, Z; Liu, WY; Li, TY; Qin, K; Wu, JG; Liu, YL				Liu, Jia; Ai, Hongwu; Xiong, Ying; Li, Fu; Wen, Zhou; Liu, Weiyong; Li, Tongya; Qin, Kai; Wu, Jianguo; Liu, Yingle			Prevalence and Correlation of Infectious Agents in Hospitalized Children with Acute Respiratory Tract Infections in Central China	PLOS ONE			English	Article							VIRAL-INFECTIONS; HUMAN METAPNEUMOVIRUS; SYNCYTIAL VIRUS; PATHOGENS; INFANTS; PNEUMONIA; SURVEILLANCE; ASSAYS	Acute respiratory tract infections (ARTIs) are associated with significant morbidity and mortality worldwide, especially in children under the age of 5 years. Almost 2 million children die from ARTIs each year, and most of them are from developing countries. The prevalence and correlation of pathogens in ARTIs are poorly understood, but are critical for improving case prevention, treatment, and management. In this study, we investigated the prevalence and correlation of infectious agents in children with ARTIs. A total of 39,756 children with one or more symptoms, including fever, cough, sore throat, tonsillitis, pharyngitis, herpangina, pneumonia, and bronchiolitis, were enrolled in the study. All patients were hospitalized in Wuhan Children's Hospital between October 1, 2010 and September 30, 2012, and were evaluated for infectious agents. Pathogens, including Mycoplasma pneumoniae, influenza A virus, influenza B virus, adenoviruses, respiratory syncytial virus, parainfluenza virus, Legionella pneumophila, Chlamydophila pneumoniae, and Coxiella burnetii, were screened simultaneously in patient blood samples using anti-pathogen IgM tests. Regression analysis was used to reveal correlations among the pathogens. Our results showed that one or more pathogens were identified in 10,206 patients, and that Mycoplasma pneumoniae, adenoviruses, and influenza B virus were the leading infectious agents. Mixed-infections of pathogens were detected in 2,391 cases, with Mycoplasma pneumoniae as the most frequent pathogen. The most common agents in the co-infections were Mycoplasma pneumoniae and influenza B virus. Regression analysis revealed a linear correlation between the proportion of mixed infections and the incidence of multi-pathogen infections. The prevalence of infectious agents in children with ARTIs was determined. Equations were established to estimate multiple infections by single-pathogen detection. This revealed a linear correlation for pathogens in children with ARTIs. This study provides useful information for improving case prevention and management.	[Liu, Jia; Xiong, Ying; Li, Fu; Wen, Zhou; Liu, Weiyong; Li, Tongya; Qin, Kai; Wu, Jianguo; Liu, Yingle] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Jia; Xiong, Ying; Li, Fu; Wen, Zhou; Liu, Weiyong; Li, Tongya; Qin, Kai; Wu, Jianguo; Liu, Yingle] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Ai, Hongwu] Wuhan Childrens Hosp, Dept Clin Lab, Wuhan, Peoples R China	Wuhan University; Wuhan University	Wu, JG (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	jwu@whu.edu.cn; mvlwu@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895	Major State Basic Research Development Program (973 Program) [2012CB518900]; National Natural Science Foundation of China [31230005, 81171525]; National Mega Project on Major Infectious Disease Prevention [2012ZX10002006-003, 2012ZX10004-207]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention	This work was supported by research grants from the Major State Basic Research Development Program (973 Program) (2012CB518900), the National Natural Science Foundation of China (31230005 and 81171525), the National Mega Project on Major Infectious Disease Prevention (2012ZX10002006-003 and 2012ZX10004-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bielawska-Drozd A, 2014, VET MICROBIOL, V174, P600, DOI 10.1016/j.vetmic.2014.09.034; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012; Chalker VJ, 2012, EUROSURVEILLANCE, V17, P5; Dwigh A, 1996, NELLSON TXB PEDIAT, V1, P824; El-Sahrigy S. A. F., 2006, Journal of Medical Sciences (Pakistan), V6, P793; Fabbiani M, 2009, J MED VIROL, V81, P750, DOI 10.1002/jmv.21457; Gonzalez-Del Vecchio M, 2014, MEDICINE, V93, P364, DOI 10.1097/MD.0000000000000218; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Jacobs E, 2012, EUROSURVEILLANCE, V17, P2; Jin Y, 2012, CLIN MICROBIOL INFEC, V18, P74, DOI 10.1111/j.1469-0691.2011.03541.x; KELLOGG JA, 1991, ARCH PATHOL LAB MED, V115, P451; Kim MR, 2000, J INFECTION, V41, P152, DOI 10.1053/jinf.2000.0715; Lin TY, 2004, J CLIN VIROL, V30, P81, DOI 10.1016/j.jcv.2003.08.014; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; Long SS, 1999, PRINCIPLES PRACTICE; Lu R, 2010, PLOS ONE, V7; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Nir-Paz R, 2012, EUROSURVEILLANCE, V17, P5; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Huong PLT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1304; Polkowska A, 2012, EUROSURVEILLANCE, V17, P8; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; Rastawicki W, 1998, Euro Surveill, V3, P99; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Stempel HE, 2009, ACTA PAEDIATR, V98, P123, DOI 10.1111/j.1651-2227.2008.01023.x; Tang LF, 2008, INDIAN PEDIATR, V45, P971; Tjhie JHT, 2000, SCAND J INFECT DIS, V32, P13, DOI 10.1080/00365540050164155; TRISTRAM DA, 1988, AM J DIS CHILD, V142, P834, DOI 10.1001/archpedi.1988.02150080040017; Tseng Ren-Ku, 1995, Journal of the Formosan Medical Association, V94, pS126; Weigl JAI, 2000, EUR J CLIN MICROBIOL, V19, P336, DOI 10.1007/s100960050490; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Yu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032174; Zamberi S, 2003, Med J Malaysia, V58, P681; Zavattoni M, 2003, MICROBIOLOGICA, V26, P133; Zhou WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079477	39	29	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119170	10.1371/journal.pone.0119170	http://dx.doi.org/10.1371/journal.pone.0119170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751402	Green Submitted, gold, Green Published			2022-12-27	WOS:000350692700017
J	Bronner, A; Morignat, E; Henaux, V; Madouasse, A; Gay, E; Calavas, D				Bronner, Anne; Morignat, Eric; Henaux, Viviane; Madouasse, Aurelien; Gay, Emilie; Calavas, Didier			Devising an Indicator to Detect Mid-Term Abortions in Dairy Cattle: A First Step Towards Syndromic Surveillance of Abortive Diseases	PLOS ONE			English	Article							VIRUS SEROTYPE 8; BLUETONGUE VIRUS; BOVINE ABORTION; INFECTION; OUTBREAKS; FERTILITY; ALGORITHM; FRANCE; DEATH; COWS	Bovine abortion surveillance is essential for human and animal health because it plays an important role in the early warning of several diseases. Due to the limited sensitivity of traditional surveillance systems, there is a growing interest for the development of syndromic surveillance. Our objective was to assess whether, routinely collected, artificial insemination (AI) data could be used, as part of a syndromic surveillance system, to devise an indicator of mid-term abortions in dairy cattle herds in France. A mid-term abortion incidence rate (MAIR) was computed as the ratio of the number of mid-term abortions to the number of female-weeks at risk. A mid-term abortion was defined as a return-to-service (i.e. a new AI) taking place 90 to 180 days after the previous AI. Weekly variations in the MAIR in heifers and parous cows were modeled with a time-dependent Poisson model at the departement level (French administrative division) during the period of 2004 to 2010. The usefulness of monitoring this indicator to detect a disease-related increase in mid-term abortions was evaluated using data from the 2007-2008 episode of bluetongue serotype 8 (BT8) in France. An increase in the MAIR was identified in heifers and parous cows in 47% (n = 24) and 71% (n = 39) of the departements. On average, the weekly MAIR among heifers increased by 3.8% (min-max: 0.02-57.9%) when the mean number of BT8 cases that occurred in the previous 8 to 13 weeks increased by one. The weekly MAIR among parous cows increased by 1.4% (0.01-8.5%) when the mean number of BT8 cases occurring in the previous 6 to 12 weeks increased by one. These results underline the potential of the MAIR to identify an increase in mid-term abortions and suggest that it is a good candidate for the implementation of a syndromic surveillance system for bovine abortions.	[Bronner, Anne; Morignat, Eric; Henaux, Viviane; Gay, Emilie; Calavas, Didier] ANSES Lyon, Unite Epidemiol, F-69364 Lyon 07, France; [Madouasse, Aurelien] INRA, Biol Epidemiol & Anal Risque & Sante Anim, UMR1300, F-44307 Nantes, France; [Madouasse, Aurelien] LUNAM Univ, Oniris Ecole Natl Vet Agroalimentaire & Alimentat, UMR BioEpAR, F-44307 Nantes, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Bronner, A (corresponding author), ANSES Lyon, Unite Epidemiol, 31 Ave Tony Garnier, F-69364 Lyon 07, France.	anne.bronner@anses.fr	Madouasse, Aurélien/AAC-2814-2019	Madouasse, Aurélien/0000-0002-9254-5707				Anderson ML, 2007, THERIOGENOLOGY, V68, P474, DOI 10.1016/j.theriogenology.2007.04.001; [Anonymous], 2005, EFSA OPINION SCI PAN; [Anonymous], 2011, LANCET, V378, P1833, DOI [10.1016/S0140-6736(11)60834-9, DOI 10.1016/S0140-6736(11)60834-9]; Bolker B, 2013, PACKAGE BBMLE; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Bronner A, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-93; Bronner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063246; Brugger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060330; Buehler JW, 2004, FRAMEWORK EVALUATING; Burnham K. P., 1998, MODEL SELECTION INFE; Curriero FC, 2005, VECTOR-BORNE ZOONOT, V5, P267, DOI 10.1089/vbz.2005.5.267; Dal Pozzo F, 2009, VET J, V182, P142, DOI 10.1016/j.tvjl.2009.05.004; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P352, DOI 10.1111/j.1865-1682.2008.01044.x; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Elbers A.R., 2007, NATURE SEVERITY DIS; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Fediaevsky A., 2011, B EPIDEMIOL SANTE AN, V46, P10; Haile-Mariam M, 2013, J DAIRY SCI, V96, P655, DOI 10.3168/jds.2012-5671; Hohle M, 2007, COMPUTATION STAT, V22, P571, DOI 10.1007/s00180-007-0074-8; InVS, 2008, RAPP ANN 2007; KALLELA K, 1984, NORD VET MED, V36, P305; Mailles A., 2012, EURO SURVEILL, V17; Malher X, 2006, THERIOGENOLOGY, V65, P1215, DOI 10.1016/j.theriogenology.2005.08.003; Marce C, 2009, THERIOGENOLOGY, V71, P807, DOI 10.1016/j.theriogenology.2008.10.017; Marceau A, 2014, J DAIRY SCI, V97, P6135, DOI 10.3168/jds.2013-7346; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; Mounaix B, 2008, IMPACT TECHNICO EC F; Nicoletti P, 1980, Adv Vet Sci Comp Med, V24, P69; Nusinovici S, 2012, THERIOGENOLOGY, V78, P1140, DOI 10.1016/j.theriogenology.2012.05.010; Nusinovici S, 2011, THESIS U NANTES ANGE; Nusinovici S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100137; OIE, 2012, OIE COUNTR REP; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAY AC, 1986, J AM VET MED ASSOC, V188, P1187; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Riet-Correa F, 2012, J APPL TOXICOL, V32, P245, DOI 10.1002/jat.1754; Robinson DL, 2007, LIVEST SCI, V110, P174, DOI 10.1016/j.livsci.2006.11.004; Santman-Berends IMGA, 2010, THERIOGENOLOGY, V74, P1377, DOI 10.1016/j.theriogenology.2010.06.008; Shone SM, 2006, J MED ENTOMOL, V43, P393, DOI 10.1603/0022-2585(2006)043[0393:CPDOAS]2.0.CO;2; Stengel B, 1995, EPIDEMIOLOGIE PRINCI; STILL PE, 1971, NATURE, V234, P563, DOI 10.1038/234563a0; Triple-S, 2014, SYNDROMIC SURVEILLAN; Van Den Wijngaard CC, 2011, EPIDEMIOL INFECT, V139, P19, DOI 10.1017/S0950268810001032; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Yahav I, 2007, LECT NOTES COMPUT SC, V4506, P91; Yamamoto T, 2008, PREV VET MED, V86, P57, DOI 10.1016/j.prevetmed.2008.03.004; Zientara S, 2010, B EPIDEMIOL SANTE AN, V35, P2, DOI [10.3945/jn.111.146258, DOI 10.3945/JN.111.146258]	51	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119012	10.1371/journal.pone.0119012	http://dx.doi.org/10.1371/journal.pone.0119012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746469	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400038
J	Bull, C; Christensen, H; Fenech, M				Bull, Caroline; Christensen, Helen; Fenech, Michael			Cortisol Is Not Associated with Telomere Shortening or Chromosomal Instability in Human Lymphocytes Cultured under Low and High Folate Conditions	PLOS ONE			English	Article							FOLIC-ACID DEFICIENCY; LIFE-STYLE CHANGES; DNA-DAMAGE; ALZHEIMERS-DISEASE; STRESS-RESPONSE; LENGTH; HOMOCYSTEINE; CANCER; RISK; MAINTENANCE	Chronic psychological stress and nutritional deficiencies are factors that impact negatively on human health and disease risk. Chronic stress has been associated with accelerated leukocyte telomere shortening in numerous cohorts, however, a mechanistic link has proven elusive. This study tested the hypotheses that chronic exposure to the stress hormone, cortisol, causes telomere shortening and chromosome instability (CIN) in vitro, and that these effects would be further exacerbated by folate (vitamin B9) deficiency. Primary human lymphocytes were maintained in vitrofor 12 days in medium containing either 25 nM folic acid (FA(low)) or 100 nM FA (FA(high)), together with either 0, 400, 1000 or 3500 nM cortisol. The interactive effects of cortisol and FA were examined by comparing telomere length (TL), biomarkers of DNA damage, and cytostasis. At day 12 TL was 5-17% longer in lymphocytes cultured in FA(low) conditions (mean +/- SD; 10.2% +/- 1.6), compared with those in FA(high) medium (9.1% +/- 1, p = 0.02). Refuting the hypothesis, TL was consistently greater in the presence of cortisol. The effect of FA deficiency on the frequency of DNA damage was significant for nucleoplasmic bridges, circular nuclei, micronuclei and nuclear buds, (p < 0.0001 - 0.001). The effect of cortisol, however, was negligible, only reaching statistical significance for the frequency of fused nuclei (p = 0.04). Cortisol was significantly associated with reduced cell division and growth and had an apparent protective effect on cell viability in the FA(low) conditions. Conclusions: Both chronic cortisol exposure, and folate deficiency, resulted in telomere elongation, however, the effect of cortisol was marginal relative to that of folate. Cortisol was not associated with increased chromosomal instability, but caused a significant reduction in cell division and growth. Together these results indicate that cortisol is not directly genotoxic and that the telomere shortening associated with increased psychological stress in vivo may not be explained by a direct effect of cortisol.	[Bull, Caroline; Fenech, Michael] CSIRO, Anim Food & Hlth Sci, Nutr Genom & DNA Damage Diagnost Lab, Adelaide, SA, Australia; [Bull, Caroline] Univ Adelaide, Sch Mol & Biomed Sci, Dept Microbiol & Immunol, Adelaide, SA, Australia; [Christensen, Helen] Prince Wales Hosp, Black Dog Inst, Randwick, NSW 2031, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; Black Dog Institute	Bull, C (corresponding author), CSIRO, Anim Food & Hlth Sci, Nutr Genom & DNA Damage Diagnost Lab, Adelaide, SA, Australia.	caroline.bull@csiro.au	Bull, Caroline F/H-4966-2013; Christensen, Helen/F-5053-2012	Bull, Caroline F/0000-0002-4478-2230; Christensen, Helen/0000-0003-0435-2065	Science Industry Endowment Fund (SIEF) John Stocker Postdoctoral Research Fellowship; CSIRO's Preventative Health Research Flagship	Science Industry Endowment Fund (SIEF) John Stocker Postdoctoral Research Fellowship; CSIRO's Preventative Health Research Flagship	CB was supported by a Science Industry Endowment Fund (SIEF) John Stocker Postdoctoral Research Fellowship and CSIRO's Preventative Health Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizaki M, 2007, METABOLISM, V56, P222, DOI 10.1016/j.metabol.2006.09.017; Beetstra S, 2005, MUTAT RES-FUND MOL M, V578, P317, DOI 10.1016/j.mrfmmm.2005.05.012; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Berg AL, 2006, CLIN CHEM LAB MED, V44, P628, DOI 10.1515/CCLM.2006.114; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2003, EUR J CELL BIOL, V82, P441, DOI 10.1078/0171-9335-00335; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; Bull C, 2008, P NUTR SOC, V67, P146, DOI 10.1017/S0029665108006988; Bull CF, 2014, CANCER PREV RES, V7, P128, DOI 10.1158/1940-6207.CAPR-13-0264; Bull CF, 2012, ENVIRON MOL MUTAGEN, V53, P311, DOI 10.1002/em.21688; Bull CF, 2009, REJUV RES, V12, P341, DOI 10.1089/rej.2009.0868; Cascalheira JF, 2008, ANN NUTR METAB, V53, P67, DOI 10.1159/000158636; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Crott JW, 2001, CANCER EPIDEM BIOMAR, V10, P1089; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Djurhuus CB, 2004, AM J PHYSIOL-ENDOC M, V286, pE488, DOI 10.1152/ajpendo.00199.2003; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2012, MUTAT RES-FUND MOL M, V733, P21, DOI 10.1016/j.mrfmmm.2011.11.003; Fenech Michael F, 2010, Genome Integr, V1, P11, DOI 10.1186/2041-9414-1-11; Fenech MF, 2010, AM J CLIN NUTR, V91, p1438S, DOI 10.3945/ajcn.2010.28674D; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Flint MS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3189; Gidron Y, 2008, CURR OPIN ONCOL, V20, P386, DOI 10.1097/CCO.0b013e3282fbcd0d; Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Heaphy CM, 2011, J CELL MOL MED, V15, P1227, DOI 10.1111/j.1582-4934.2011.01284.x; Hinterberger M, 2013, J AM GERIATR SOC, V61, P648, DOI 10.1111/jgs.12178; Hooshmand B, 2010, NEUROLOGY, V75, P1408, DOI 10.1212/WNL.0b013e3181f88162; Humphreys J, 2012, BIOL RES NURS, V14, P115, DOI 10.1177/1099800411398479; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kennedy DO, 2010, PSYCHOPHARMACOLOGY, V211, P55, DOI 10.1007/s00213-010-1870-3; Kuebler U, 2013, PSYCHONEUROENDOCRINO, V38, P1381, DOI 10.1016/j.psyneuen.2012.12.003; Malvandi AM, 2010, STRESS, V13, P276, DOI 10.3109/10253890903296710; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Mishra GD, 2009, PUBLIC HEALTH NUTR, V12, P166, DOI 10.1017/S1368980008002413; O'Donovan A, 2009, BRAIN BEHAV IMMUN, V23, P446, DOI 10.1016/j.bbi.2008.11.006; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Paul L, 2009, J NUTR, V139, P1273, DOI 10.3945/jn.109.104984; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Shalev I, 2012, BIOESSAYS, V34, P943, DOI 10.1002/bies.201200084; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Tucker Katherine L, 2005, J Med Invest, V52 Suppl, P252, DOI 10.2152/jmi.52.252; Umegaki K, 2000, MUTAGENESIS, V15, P261, DOI 10.1093/mutage/15.3.261; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; von Kanel R, 2003, ANN BEHAV MED, V26, P42, DOI 10.1207/S15324796ABM2601_06; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; York TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055337	53	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119367	10.1371/journal.pone.0119367	http://dx.doi.org/10.1371/journal.pone.0119367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748629	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400070
J	Hengen, KB; Nelson, NR; Stang, KM; Johnson, SM; Smith, SM; Watters, JJ; Mitchell, GS; Behan, M				Hengen, Keith B.; Nelson, Nathan R.; Stang, Kyle M.; Johnson, Stephen M.; Smith, Stephanie M.; Watters, Jyoti J.; Mitchell, Gordon S.; Behan, Mary			Daily Isoflurane Exposure Increases Barbiturate Insensitivity in Medullary Respiratory and Cortical Neurons via Expression of epsilon-Subunit Containing GABA (A)Rs	PLOS ONE			English	Article							DELTA-SUBUNIT; NEUROSTEROID MODULATION; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; RECEPTORS; EXCITABILITY; PLASTICITY; CURRENTS; RHYTHM; BRAIN	The parameters governing GABA(A) receptor subtype expression patterns are not well understood, although significant shifts in subunit expression may support key physiological events. For example, the respiratory control network in pregnant rats becomes relatively insensitive to barbiturates due to increased expression of epsilon-subunit-containing GABA(A)Rs in the ventral respiratory column. We hypothesized that this plasticity may be a compensatory response to a chronic increase in inhibitory tone caused by increased central neurosteroid levels. Thus, we tested whether increased inhibitory tone was sufficient to induce epsilon-subunit upregulation on respiratory and cortical neurons in adult rats. Chronic intermittent increases in inhibitory tone in male and female rats was induced via daily 5-min exposures to 3% isoflurane. After 7d of treatment, phrenic burst frequency was less sensitive to barbiturate in isoflurane-treated male and female rats in vivo. Neurons in the ventral respiratory group and cortex were less sensitive to pentobarbital in vitro following 7d and 30d of intermittent isoflurane-exposure in both male and female rats. The pentobarbital insensitivity in 7d isoflurane-treated rats was reversible after another 7d. We hypothesize that increased inhibitory tone in the respiratory control network and cortex causes a compensatory increase in epsilon-subunit-containing GABA(A)Rs.	[Hengen, Keith B.] Brandeis Univ, Neurosci Training Program, Waltham, MA 02254 USA; [Nelson, Nathan R.; Stang, Kyle M.; Johnson, Stephen M.; Smith, Stephanie M.; Watters, Jyoti J.; Mitchell, Gordon S.; Behan, Mary] Brandeis Univ, Sch Vet Med, Dept Comparat Biosci, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Hengen, KB (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	khengen@brandeis.edu		Hengen, Keith/0000-0001-5017-4090	National Institutes of Health [R01 AG18760, R01 NS049033]; NIH [T32 HL 7654-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health R01 AG18760 (MB) and R01 NS049033 (JJW). At the time this work was completed, KBH was supported by a training grant provided by the NIH (PI GM; T32 HL 7654-24). None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramian AM, 2014, P NATL ACAD SCI USA, V111, P7132, DOI 10.1073/pnas.1403285111; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Cagetti E, 2003, MOL PHARMACOL, V63, P53, DOI 10.1124/mol.63.1.53; Chen XD, 2010, J NEUROSCI, V30, P2611, DOI 10.1523/JNEUROSCI.3771-09.2010; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Feng HJ, 2010, J BIOL CHEM, V285, P23614, DOI 10.1074/jbc.M110.122564; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Grasshoff C, 2006, BRIT J ANAESTH, V97, P687, DOI 10.1093/bja/ael239; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Gutierrez ML, 2014, NEUROSCIENCE, V257, P119, DOI 10.1016/j.neuroscience.2013.10.077; Hengen KB, 2011, AM J PHYSIOL-REG I, DOI [10.1152/ajpregu.0067.2010, DOI 10.1152/AJPREGU.0067.2010]; Hengen KB, 2013, NEURON, V80, P335, DOI 10.1016/j.neuron.2013.08.038; Hengen KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030608; Hengen KB, 2009, AM J PHYSIOL-REG I, V297, pR1028, DOI 10.1152/ajpregu.00239.2009; Herd MB, 2007, PHARMACOL THERAPEUT, V116, P20, DOI 10.1016/j.pharmthera.2007.03.007; Irnaten M, 2002, ANESTHESIOLOGY, V97, P717, DOI 10.1097/00000542-200209000-00027; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; Kang MH, 1998, ALCOHOL CLIN EXP RES, V22, P2165; Lambo ME, 2013, J NEUROSCI, V33, P8810, DOI 10.1523/JNEUROSCI.4502-12.2013; Lesch A, 2014, BRIT J PHARMACOL, V171, P2645, DOI 10.1111/bph.12524; Liang J, 2009, J NEUROPHYSIOL, V102, P224, DOI 10.1152/jn.90484.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKenzie G, 2014, PSYCHOPHARMACOLOGY, V231, P3333, DOI 10.1007/s00213-013-3423-z; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Maguire Jamie, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS84, DOI 10.1016/j.psyneuen.2009.06.019; Maguire J, 2009, J NEUROSCI, V29, P9592, DOI 10.1523/JNEUROSCI.2162-09.2009; Marutha Ravindran CR, 2007, BRAIN RES; Meera P, 2010, MOL PHARMACOL, V78, P918, DOI 10.1124/mol.109.062687; Orser BA, 2006, J CLIN SLEEP MED, V2, pS12; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Ren J, 2006, J PHYSIOL-LONDON, V574, P535, DOI 10.1113/jphysiol.2006.108829; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Sanna E, 2009, J NEUROSCI, V29, P1755, DOI 10.1523/JNEUROSCI.3684-08.2009; Sebe JY, 2010, EUR J NEUROSCI, V32, P1310, DOI 10.1111/j.1460-9568.2010.07373.x; Sekine S, 2006, NEUROCHEM RES, V31, P439, DOI 10.1007/s11064-005-9024-4; Sergeeva OA, 2005, J NEUROSCI, V25, P88, DOI 10.1523/JNEUROSCI.3209-04.2005; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Tokuda K, 2011, J NEUROSCI, V31, P9905, DOI 10.1523/JNEUROSCI.1660-11.2011; Wagner DA, 2005, J NEUROSCI, V25, P10462, DOI 10.1523/JNEUROSCI.1658-05.2005; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; Wang X, 2011, J PHYSIOL-LONDON, V589, P5431, DOI 10.1113/jphysiol.2011.215392; Wang X, 2009, ANESTH ANALG, V108, P142, DOI 10.1213/ane.0b013e31818d8b79; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zuperku EJ, 2002, RESP PHYSIOL NEUROBI, V131, P121, DOI 10.1016/S1569-9048(02)00042-3	53	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119351	10.1371/journal.pone.0119351	http://dx.doi.org/10.1371/journal.pone.0119351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748028	Green Submitted, gold, Green Published			2022-12-27	WOS:000350689400067
J	Pound, CM; Moreau, K; Rohde, K; Barrowman, N; Aglipay, M; Farion, KJ; Plint, AC				Pound, Catherine M.; Moreau, Katherine; Rohde, Kristina; Barrowman, Nick; Aglipay, Mary; Farion, Ken J.; Plint, Amy C.			Lactation Support and Breastfeeding Duration in Jaundiced Infants: A Randomized Controlled Trial	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDES; HOSPITALIZATION; PHYSICIANS; RISK	Objectives Neonatal jaundice is the most common problem in full-term infants during the immediate post-natal period. We examined the effect of a lactation support intervention on breastfeeding duration in hospitalized jaundiced infants. Study Design We conducted a randomized controlled trial with a qualitative component involving mothers of hospitalized jaundiced breastfed infants <4 weeks of age. Mothers receiving the intervention met with an International Board-Certified Lactation Consultant in hospital and 1-3 times post discharge. Both groups received the standard care for jaundice. The primary outcome was exclusive breastfeeding at 3 months. To the exception of research assistants enrolling participants and completing qualitative interviews, all research staff, investigators and statisticians were blinded to group assignment. Qualitative interviews elicited feedback on breastfeeding experiences for both groups. Results 99 participants were recruited, and 86 analyzed for primary outcome. There was no difference in exclusive breastfeeding at 3 months between groups (RR 0.84, 95% CI 0.56-1.24, p = 0.40) or in the secondary outcomes. 31 participants were included in the qualitative analysis. Participants in the intervention group described an increase in comfort and confidence levels with breastfeeding. Participants in the control group reported limited lactation support. Conclusions Our hospital-based lactation support program did not result in a higher proportion of mothers exclusively breastfeeding at 3 months compared to current hospital standard care. Qualitative feedback from the intervention group suggests that mothers' confidence was increased, which is linked to breastfeeding duration. The decision to breastfeed is multifactorial and hospital-based lactation support may be only a small piece of the puzzle in hospitalized jaundiced infants. Further studies may be needed to fully elucidate the impact of an in-hospital lactation support program on successful breastfeeding for these infants.	[Pound, Catherine M.; Farion, Ken J.; Plint, Amy C.] Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Pound, Catherine M.; Moreau, Katherine; Rohde, Kristina; Barrowman, Nick; Farion, Ken J.; Plint, Amy C.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Rohde, Kristina; Aglipay, Mary] Childrens Hosp Eastern Ontario, Clin Res Unit, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario	Pound, CM (corresponding author), Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada.	cpound@cheo.on.ca	Barrowman, Nick/AAL-3166-2020; Plint, Amy/AAE-2250-2020	Barrowman, Nick/0000-0002-4704-9595; 	Physicians' Services Incorporated Foundation	Physicians' Services Incorporated Foundation	All phases of this study were supported by a grant from the Physicians' Services Incorporated Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 2005, PEDIATRICS, V116, P1408, DOI 10.1542/peds.2005-0013; Al-Nassaj H H, 2004, East Mediterr Health J, V10, P871; American Academy of Pediatrics, 2012, PEDIATRICS, V129, DOI 10.1542/peds.2011-3552; Bachrach VRG, 2003, ARCH PEDIAT ADOL MED, V157, P237, DOI 10.1001/archpedi.157.3.237; Bertini G, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e41; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Brodribb W, 2008, J HUM LACT, V24, P422, DOI 10.1177/0890334408323547; Dunn S, 2006, JOGNN-J OBST GYN NEO, V35, P87, DOI [10.1111/j.1552-6909.2006.00005.x, 10.1111/J.1552-6909.2006.00005.x]; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Finneran B, 2004, Ir Med J, V97, P268; FREED GL, 1995, JAMA-J AM MED ASSOC, V273, P472, DOI 10.1001/jama.273.6.472; Guise Jeanne-Marie, 2003, Ann Fam Med, V1, P70, DOI 10.1370/afm.56; Heinig MJ, 2001, PEDIATR CLIN N AM, V48, P105, DOI 10.1016/S0031-3955(05)70288-1; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kramer MS, 2000, ADV EXP MED BIOL, V478, P327; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; McLaughlin Marie, 2011, Breastfeed Rev, V19, P13; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Nakar S, 2007, ACTA PAEDIATR, V96, P848, DOI 10.1111/j.1651-2227.2007.00310.x; Ottawa Public Health, 2006, INF CAR SURV 2005; Talayero JMP, 2006, PEDIATRICS, V118, pE92, DOI 10.1542/peds.2005-1629; Plint AC, 2004, ACAD EMERG MED, V11, P353, DOI 10.1197/j.aem.2003.12.003; Plint AC, 2000, ACAD EMERG MED, V7, P1097, DOI 10.1111/j.1553-2712.2000.tb01258.x; Pound CM, 2014, J HUM LACT, V30, P298, DOI 10.1177/0890334414535507; Pound CM, 2012, PAED CHILD HEALT-CAN, V17, P317, DOI 10.1093/pch/17.6.317; Pound CM, 2009, PAED CHILD HEALT-CAN, V14, P445, DOI 10.1093/pch/14.7.445; Saadeh M Randa, 2003, Forum Nutr, V56, P236; Spatz DL, 2006, MCN-AM J MATERN-CHIL, V31, P45, DOI 10.1097/00005721-200601000-00010; Stewart M, 2003, BREASTFEEDING BEST P; Tesch R., 1990, QUALITATIVE RES ANAL; Willis Sharla K, 2002, J Fam Pract, V51, P465	31	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119624	10.1371/journal.pone.0119624	http://dx.doi.org/10.1371/journal.pone.0119624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747308	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400082
J	Singh, N; Wang, C; Cooper, R				Singh, Narinderpal; Wang, Changlu; Cooper, Richard			Role of Vision and Mechanoreception in Bed Bug, Cimex lectularius L. Behavior	PLOS ONE			English	Article							CARBON-DIOXIDE; COLOR-VISION; SPECTRAL SENSITIVITY; CHEMICAL LURE; TRAP COLOR; DIPTERA; ATTRACTION; COLEOPTERA; CAPTURES; HETEROPTERA	The role of olfactory cues such as carbon dioxide, pheromones, and kairomones in bed bug, Cimex lectularius L. behavior has been demonstrated. However, the role of vision and mechanoreception in bed bug behavior is poorly understood. We investigated bed bug vision by determining their responses to different colors, vertical objects, and their ability to detect colors and vertical objects under low and complete dark conditions. Results show black and red paper harborages are preferred compared to yellow, green, blue, and white harborages. A bed bug trapping device with a black or red exterior surface was significantly more attractive to bed bugs than that with a white exterior surface. Bed bugs exhibited strong orientation behavior toward vertical objects. The height (15 vs. 30 cm tall) and color (brown vs. black) of the vertical object had no significant effect on orientation behavior of bed bugs. Bed bugs could differentiate color and detect vertical objects at very low background light conditions, but not in complete darkness. Bed bug preference to different substrate textures (mechanoreception) was also explored. Bed bugs preferred dyed tape compared to painted tape, textured painted plastic, and felt. These results revealed that substrate color, presence of vertical objects, and substrate texture affect host-seeking and harborage-searching behavior of bed bugs. Bed bugs may use a combination of vision, mechanoreception, and chemoreception to locate hosts and seek harborages.	[Singh, Narinderpal; Wang, Changlu; Cooper, Richard] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Singh, N (corresponding author), Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA.	nsingh@aesop.rutgers.edu			U.S. Department of Housing and Urban Development Healthy Homes Technical Studies grant program [NJLHH0197-09]; New Jersey Agricultural Experiment Station; USDA-National Institute for Food and Agriculture, Hatch Multistate project [NJ08127]	U.S. Department of Housing and Urban Development Healthy Homes Technical Studies grant program; New Jersey Agricultural Experiment Station; USDA-National Institute for Food and Agriculture, Hatch Multistate project	This project was funded by a grant from the U.S. Department of Housing and Urban Development Healthy Homes Technical Studies grant program (NJLHH0197-09)CW. Partial support was provided by the New Jersey Agricultural Experiment Station and by the USDA-National Institute for Food and Agriculture, Hatch Multistate project number NJ08127 CW NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aak A, 2014, PHYSIOL ENTOMOL, V39, P199, DOI 10.1111/phen.12062; ABOUL-NASR A E, 1967, Bulletin de la Societe Entomologique d'Egypte, V51, P43; Aboul-Nasr A. E., 1968, Bulletin de la Societe Entomologique d'Egypte, V52, P353; Aboul-Nasr AE, 1968, B SOC ENTOMOL EGYPT, V52, P363; ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; Anderson JF, 2009, MED VET ENTOMOL, V23, P99, DOI 10.1111/j.1365-2915.2008.00790.x; Benoit Joshua B., 2011, Insects, V2, P151, DOI 10.3390/insects2020151; BRADBURY WC, 1974, CAN J ZOOL, V52, P251, DOI 10.1139/z74-030; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; BROWNE SM, 1981, J MED ENTOMOL, V18, P505, DOI 10.1093/jmedent/18.6.505; Cammaerts MC, 2009, BELG J ZOOL, V139, P40; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; Cilek JE, 2003, FLA ENTOMOL, V86, P420, DOI 10.1653/0015-4040(2003)086[0000:AOCPCB]2.0.CO;2; COLLETT TS, 1980, J COMP PHYSIOL, V138, P271, DOI 10.1007/BF00657045; DeValois RL, 1997, READINGS COLOR, V2, P93; GRANOVSKY TA, 1983, ENVIRON ENTOMOL, V12, P744, DOI 10.1093/ee/12.3.744; HAMILTON DW, 1971, J ECON ENTOMOL, V64, P430, DOI 10.1093/jee/64.2.430; Harraca V, 2012, J EXP BIOL, V215, P623, DOI 10.1242/jeb.065748; Jacobs GH, 1981, COMP COLOR VISION, P209; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; KOEHLER PG, 1987, ANN ENTOMOL SOC AM, V80, P820, DOI 10.1093/aesa/80.6.820; Kusakabe Y., 1990, Japanese Journal of Sanitary Zoology, V41, P219; Lanier G.N., 1983, P161; LEHANE MJ, 1991, BIOL BLOOD SUCKING I, P288; LEHRER M, 1994, VISION RES, V34, P2363, DOI 10.1016/0042-6989(94)90282-8; LEVINSON HZ, 1974, J INSECT PHYSIOL, V20, P1231, DOI 10.1016/0022-1910(74)90229-7; Liburd OE, 1998, J ECON ENTOMOL, V91, P243, DOI 10.1093/jee/91.1.243; Lie R., 1981, MANAGEMENT INSECT PE, P175; Lindh JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001661; Machial LA, 2012, AGR FOREST ENTOMOL, V14, P286, DOI 10.1111/j.1461-9563.2012.00568.x; Menzel R., 1979, HDB SENSORY PHYSL, V7 / 6 / 6, P503, DOI DOI 10.1007/978-3-642-66999-6_9; Menzel Randolf, 1991, P262; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Mramba F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002063; Nalepa CA, 2005, ENVIRON ENTOMOL, V34, P425, DOI 10.1603/0046-225X-34.2.425; Pinero JC, 2006, ENTOMOL EXP APPL, V121, P261, DOI [10.1111/j.1570-8703.2006.00485.x, 10.1111/j.1570-7458.2006.00485.x]; Rayaisse JB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001491; Reddy GVP, 2009, J CHEM ECOL, V35, P111, DOI 10.1007/s10886-008-9580-6; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Reis Matthew D., 2011, Insects, V2, P186, DOI 10.3390/insects2020186; Reisenman CE, 2000, J COMP PHYSIOL A, V186, P961, DOI 10.1007/s003590000149; Reisenman CE, 2006, J COMP PHYSIOL A, V192, P39, DOI 10.1007/s00359-005-0045-x; Reza AMS, 2006, ISJ-INVERT SURVIV J, V3, P84; Romero A, 2010, J INSECT PHYSIOL, V56, P1516, DOI 10.1016/j.jinsphys.2010.04.025; Roubos CR, 2008, J AGR URBAN ENTOMOL, V25, P99, DOI 10.3954/1523-5475-25.2.99; Semeao AA, 2011, J STORED PROD RES, V47, P88, DOI 10.1016/j.jspr.2011.01.002; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Siljander E, 2007, ENTOMOL EXP APPL, V125, P215, DOI 10.1111/j.1570-7458.2007.00617.x; Singh N, 2013, J ECON ENTOMOL, V106, P1802, DOI 10.1603/EC13075; Singh Narinderpal, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/273613; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; STEINBRECHT RA, 1976, TISSUE CELL, V8, P615, DOI 10.1016/0040-8166(76)90035-5; Strom BL, 2001, ANN ENTOMOL SOC AM, V94, P948, DOI 10.1603/0013-8746(2001)094[0948:EOSCOT]2.0.CO;2; Suchy James T., 2011, Insects, V2, P22, DOI 10.3390/insects2010022; Szyndler MW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0174; Toews M.D., 2012, STORED PRODUCT PROTE, P243; Usinger R., 1966, MONOGRAPH CIMICIDAE, V7; Vaidyanathan R, 2013, AM J TROP MED HYG, V88, P619, DOI 10.4269/ajtmh.12-0493; VERNON RS, 1995, J ECON ENTOMOL, V88, P288, DOI 10.1093/jee/88.2.288; Wang C., 2012, P POST DEM TRACK, P4; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Weeks ENI, 2011, B ENTOMOL RES, V101, P1, DOI 10.1017/S0007485309990599; Wehner R, 1997, EXS, V84, P145	64	12	13	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118855	10.1371/journal.pone.0118855	http://dx.doi.org/10.1371/journal.pone.0118855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748041	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400027
J	Werbeloff, N; Dohrenwend, BP; Yoffe, R; van Os, J; Davidson, M; Weiser, M				Werbeloff, Nomi; Dohrenwend, Bruce P.; Yoffe, Rinat; van Os, Jim; Davidson, Michael; Weiser, Mark			The Association between Negative Symptoms, Psychotic Experiences and Later Schizophrenia: A Population-Based Longitudinal Study	PLOS ONE			English	Article							GENERAL-POPULATION; AFFECTIVE-DISORDERS; MENTAL-DISORDERS; DIAGNOSES; EXPRESSION; 10-YEAR; TOOL	Background Psychotic experiences are common in the general population, and predict later psychotic illness. Much less is known about negative symptoms in the general population. Method This study utilized a sample of 4,914 Israel-born individuals aged 25-34 years who were screened for psychopathology in the 1980's. Though not designed to specifically assess negative symptoms, data were available on 9 self-report items representing avolition and social withdrawal, and on 5 interviewer-rated items assessing speech deficits, flat affect and poor hygiene. Psychotic experiences were assessed using the False Beliefs and Perceptions subscale of the Psychiatric Epidemiology Research Interview. Psychiatric hospitalization was ascertained 24 years later using a nation-wide psychiatric hospitalization registry. Results After removing subjects with diagnosable psychotic disorders at baseline, 20.2% had at least one negative symptom. Negative symptoms were associated with increased risk of later schizophrenia only in the presence of strong (frequent) psychotic experiences (OR = 13.0, 9% CI: 2.1-79.4). Conclusions Negative symptoms are common in the general population, though the majority of people with negative symptoms do not manifest a clinically diagnosed psychiatric disorder. Negative symptoms and psychotic experiences critically depend on each other's co-occurrence in increasing risk for later schizophrenia.	[Werbeloff, Nomi; Davidson, Michael; Weiser, Mark] Sheba Med Ctr, Dept Psychiat, Tel Hashomer, Israel; [Dohrenwend, Bruce P.] Columbia Univ, Dept Psychiat, New York, NY USA; [Dohrenwend, Bruce P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Dohrenwend, Bruce P.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Yoffe, Rinat] Minist Hlth, Div Mental Hlth Serv, Jerusalem, Israel; [van Os, Jim] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, London, England	Chaim Sheba Medical Center; Columbia University; Columbia University; New York State Psychiatry Institute; Maastricht University; University of London; King's College London	Werbeloff, N (corresponding author), Sheba Med Ctr, Dept Psychiat, Tel Hashomer, Israel.	nwerbeloff@gmail.com	van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; 	Eli Lilly; Bristol-Myers Squibb; Lundbeck; Organon; Janssen-Cilag; GlaxoSmithKline; AstraZeneca; Pfizer; Servier; JNJ; Teva; BioLineRx; Sanofi-Aventis; Roche; GSK; Envivo; Novartis	Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Lundbeck(Lundbeck Corporation); Organon; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Pfizer(Pfizer); Servier(Servier); JNJ; Teva(Teva Pharmaceutical Industries); BioLineRx; Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); GSK(GlaxoSmithKline); Envivo; Novartis(Novartis)	Nomi Werbeloff, Bruce P. Dohrenwend, and Rinat Yoffe report no conflicts of interest in relation to the subject of this study. Jim van Os has received unrestricted investigator-led research grants or recompense for presenting his research from Eli Lilly, Bristol-Myers Squibb, Lundbeck, Organon, Janssen-Cilag, GlaxoSmithKline, AstraZeneca, Pfizer and Servier, companies that have an interest in the treatment of psychosis. Michael Davidson holds stocks in TGD and BiolineRx and has received research grant support and/or travel support and/or speaker fees and/or consultancy fees from JNJ, Pfizer, Lundbeck, Teva, BioLineRx, Eli Lilly, Sanofi-Aventis, Roche, GSK, Servier, Envivo, and Novartis. Mark Weiser has received research grant support and/or travel support and/or consultant fees and/or speaker fees from Eli Lilly, AstraZeneca, Janssen-Cilag, Pfizer, Lundbeck, Teva, BioLineRx, Sanofi-Aventis and Roche. The authors confirm that their declaration of competing interests does not alter their adherence to PLOS ONE policies on sharing data and materials.	Alphs L, 2011, INT J METH PSYCH RES, V20, pE31, DOI 10.1002/mpr.339; Andreasen NC, 1981, SCALE ASSESMENT NEGA; [Anonymous], 2008, STATACORP STATA STAT; Barrantes-Vidal N, 2010, SCHIZOPHR RES, V122, P219, DOI 10.1016/j.schres.2010.01.006; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Davidson M, 1999, AM J PSYCHIAT, V156, P1328; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; DOHRENWEND BP, 1980, ARCH GEN PSYCHIAT, V37, P1229; DOHRENWEND BP, 1990, PSYCHOL MED, V20, P195, DOI 10.1017/S0033291700013374; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Dominguez MDG, 2010, AM J PSYCHIAT, V167, P1075, DOI 10.1176/appi.ajp.2010.09060883; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Hanssen MSS, 2003, ACTA PSYCHIAT SCAND, V107, P369, DOI 10.1034/j.1600-0447.2003.00058.x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kaymaz N, 2012, PSYCHOL MED, V42, P2239, DOI 10.1017/S0033291711002911; LEVAV I, 1993, PSYCHOL MED, V23, P691, DOI 10.1017/S0033291700025472; Levav Itzhak, 2004, Int Psychiatry, V1, P10; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Messias EL, 2007, PSYCHIAT CLIN N AM, V30, P323, DOI 10.1016/j.psc.2007.04.007; Moller HJ, 2007, EUR PSYCHIAT, V22, P380, DOI 10.1016/j.eurpsy.2007.03.010; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; PULVER AE, 1988, AM J PSYCHIAT, V145, P218; Scheaffer R. L., 2012, ELEMENTARY SURVEY SA, V7th; Selten JP, 2007, CURR OPIN PSYCHIATR, V20, P111, DOI 10.1097/YCO.0b013e328017f68e; SHROUT PE, 1986, J CONSULT CLIN PSYCH, V54, P314, DOI 10.1037/0022-006X.54.3.314; van Os J, 2001, ARCH GEN PSYCHIAT, V58, P663, DOI 10.1001/archpsyc.58.7.663; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Weiser M, 2012, SCHIZOPHR RES, V135, P187, DOI 10.1016/j.schres.2011.12.023; Weisera M, 2005, COMPR PSYCHIAT, V46, P38, DOI 10.1016/j.comppsych.2004.07.016; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580; Whaley AL, 1997, J PSYCHOPATHOL BEHAV, V19, P1, DOI 10.1007/BF02263226	33	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119852	10.1371/journal.pone.0119852	http://dx.doi.org/10.1371/journal.pone.0119852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25748557	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400090
J	Lee, M; Kim, MK; Kim, SM; Park, H; Park, CG; Park, HK				Lee, Myoungsook; Kim, Mi Kyung; Kim, Seon-Mee; Park, Hyesoon; Park, Chang Gyu; Park, Hye Kyung			Gender-Based Differences on the Association between Salt-Sensitive Genes and Obesity in Korean Children Aged between 8 and 9 Years	PLOS ONE			English	Article							METABOLIC SYNDROME; SODIUM-INTAKE; HYPERTENSION; POLYMORPHISMS; ADOLESCENTS; PREVALENCE; DISEASE; LEPTIN; RISK; MASS	Background High sodium intake is associated with the development of chronic diseases such as obesity. Although its role in obesity remains controversial, there may be a correlation between salt sensitivity and the early onset of chronic diseases in obese children. Methods In all, 2,163 Korean children (1,106 boys and 1,057 girls) aged 8-9 years were recruited from seven elementary schools in Seoul. To evaluate whether obesity risk was modulated by the salt sensitivity, 11 SNPs related to salt sensitive genes (SSG) became the target of sodium intakes in obese children. Results BP, HOMA-IR, LDLc, TG, and the girls' sodium intake significantly increased, but HDLc significantly decreased with increase in BMI. Regardless of sex, the obesity risk was 5.27-fold (CI; 1.320-27.560) higher in the Q2 to Q5 of sodium intake adjusted by energy (4044.9-5058.9 mg/day) than in the lowest Q1 level (2287.6 mg/day) in obese children. BP was sensitively dependent on insulin resistance and lipid accumulation in all subjects; however, sodium intake may be an independent risk factor of obesity without increasing BP in girls. GRK4 A486V mutant homozygote was highly distributed in the obese group, but other SNPs had no impact. The obesity risk increased 7.06, 16.8, and 46.09-fold more in boys with GRK4 A486V, ACE, and SLC12A3 mutants as sodium intake increased. Among girls, the obesity risk increased in GRK4 A486V heterozygote and CYP11 beta-2 mutant homozygote although sodium intake was relatively lower, implying that ACE, SLC12A, CYP11 beta-2, and GRK4 A486V polymorphisms showed gender-based differences with regard to interaction between sodium intake and obesity. Conclusion A high sodium intake markedly increased the obesity risk in variants of GRK4 A486V regardless of sex. The obesity risk increased with GRK4 A486V, ACE, and SLC12A3 variants in boys, whereas it increased with GRK4 A486V and CYP11B2 variants in girls as sodium intake increased. Obese children with the specific gene variants are recommended to reduce their sodium intake.	[Lee, Myoungsook] Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Lee, Myoungsook] Sungshin Womens Univ, Res Inst Obes Sci, Seoul, South Korea; [Kim, Mi Kyung] Natl Canc Ctr, Dept Epidemiol, Ilsan, South Korea; [Kim, Seon-Mee] Korea Univ, Guro Hosp, Dept Internal Med, Div Family Med, Seoul, South Korea; [Park, Hyesoon] Univ Ulsan, Asan Hosp, Sch Med, Dept Family Med, Seoul, South Korea; [Park, Chang Gyu] Korea Univ, Guro Hosp, Dept Internal Med, Div Cardiovasc Dis, Seoul, South Korea; [Park, Hye Kyung] Korean Food & Drug Adm, Div Nutr Policy, Cheongju, South Korea	Sungshin Women's University; Sungshin Women's University; National Cancer Center - Korea (NCC); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Korea University; Korea University Medicine (KU Medicine)	Lee, M (corresponding author), Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea.	mlee@sungshin.ac.kr		Lee, Myoungsook/0000-0003-1344-6979; Kim, Seon Mee/0000-0002-1957-2928; Park, Chang/0000-0001-9654-9257	Korea Food & Drug Administration [11162KFDA162]; Korea Food Research Institute; National Research Foundation of Korea [MSIP: 2014R1A2A1A11049611/1]	Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Korea Food Research Institute; National Research Foundation of Korea(National Research Foundation of Korea)	Funding: This study was funded by Korea Food & Drug Administration (11162KFDA162), Korea Food Research Institute, and National Research Foundation of Korea grant (MSIP: 2014R1A2A1A11049611/1).	Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Calo LA, 2011, HYPERTENS RES, V34, P1017, DOI 10.1038/hr.2011.72; Calson SH, 2010, HYPERTENSION, V35, P403; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; Deji N, 2012, BIOCHEM BIOPH RES CO, V418, P559, DOI 10.1016/j.bbrc.2012.01.070; Delles C, 2012, CAN J CARDIOL, V28, P296, DOI 10.1016/j.cjca.2012.02.004; ELLIOTT P, 1988, BRIT MED J, V297, P319; Felder RA, 2006, NAT CLIN PRACT NEPHR, V2, P637, DOI 10.1038/ncpneph0301; Felder RA, 2013, CURR OPIN NEPHROL HY, V22, P65, DOI 10.1097/MNH.0b013e32835b3693; Fonseca-Alaniz MH, 2007, OBESITY, V15, P2200, DOI 10.1038/oby.2007.261; Han JY, 2008, LUNG CANCER, V59, P69, DOI 10.1016/j.lungcan.2007.07.019; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; Kim JH, 2006, DIABETES, V55, P843, DOI 10.2337/diabetes.55.03.06.db05-1013; Kim TH, 2008, EXP MOL MED, V40, P418, DOI 10.3858/emm.2008.40.4.418; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Li K, 2010, AM J PHYSIOL-REG I, V299, pR590, DOI 10.1152/ajpregu.00207.2009; Morrison AC, 2005, AM J HYPERTENS, V18, P653, DOI 10.1016/j.amjhyper.2004.11.030; Olson JE, 2007, BREAST CANCER RES TR, V102, P237, DOI 10.1007/s10549-006-9324-7; Pan XQ, 2010, EUR J EPIDEMIOL, V25, P813, DOI 10.1007/s10654-010-9504-y; Park J, 2010, J KOREAN MED SCI, V25, P75, DOI 10.3346/jkms.2010.25.1.75; Park SJ, 2013, NUTR RES PRACT, V7, P139, DOI 10.4162/nrp.2013.7.2.139; Poch E, 2001, HYPERTENSION, V38, P1204, DOI 10.1161/hy1101.099479; Radin MJ, 2003, MOL CELL BIOCHEM, V242, P57, DOI 10.1023/A:1021181527060; Ramachandran V, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-11; Republic of Korea: Ministry of Health & Welfare, 2010, KOR NAT HLTH NUTR EX; Sanada H, 2006, CLIN CHEM, V52, P352, DOI 10.1373/clinchem.2005.059139; Seo JY, 2013, OBES RES CLIN PRACT, V7, pE182, DOI 10.1016/j.orcp.2011.12.001; Speirs HJL, 2004, J HYPERTENS, V22, P931, DOI 10.1097/00004872-200405000-00014; Tanaka N, 2003, DIABETES, V52, P2848, DOI 10.2337/diabetes.52.11.2848; Trivedi M, 2005, AM J PHYSIOL-RENAL, V289, pF298, DOI 10.1152/ajprenal.00362.2004; Wang XF, 2008, CLIN CHIM ACTA, V388, P95, DOI 10.1016/j.cca.2007.10.017; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; Willett W, 1998, EPIDEMIOLOGY, P273; Yang SJ, 2013, NUTRITION, V29, P525, DOI 10.1016/j.nut.2012.09.001	34	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120111	10.1371/journal.pone.0120111	http://dx.doi.org/10.1371/journal.pone.0120111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768006	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500109
J	Xu, XY; Nakazawa, N; Yanagida, M				Xu, Xingya; Nakazawa, Norihiko; Yanagida, Mitsuhiro			Condensin HEAT Subunits Required for DNA Repair, Kinetochore/Centromere Function and Ploidy Maintenance in Fission Yeast	PLOS ONE			English	Article							SISTER-CHROMATID SEPARATION; MAD2-DEPENDENT SPINDLE CHECKPOINT; MITOTIC CHROMOSOME CONDENSATION; NUCLEOTIDE EXCISION-REPAIR; UBIQUITOUS PROTEIN FAMILY; SCHIZOSACCHAROMYCES-POMBE; CENTROMERE PROTEIN; NUCLEAR PROTEASOME; ESCHERICHIA-COLI; REPEAT PROTEINS	Condensin, a central player in eukaryotic chromosomal dynamics, contains five evolutionarily-conserved subunits. Two SMC (structural maintenance of chromosomes) subunits contain ATPase, hinge, and coiled-coil domains. One non-SMC subunit is similar to bacterial kleisin, and two other non-SMC subunits contain HEAT (similar to armadillo) repeats. Here we report isolation and characterization of 21 fission yeast (Schizosaccharomyces pombe) mutants for three non-SMC subunits, created using error-prone mutagenesis that resulted in single-amino acid substitutions. Beside condensation, segregation, and DNA repair defects, similar to those observed in previously isolated SMC and cnd2 mutants, novel phenotypes were observed for mutants of HEAT-repeats containing Cnd1 and Cnd3 subunits. cnd3-L269P is hypersensitive to the microtubule poison, thiabendazole, revealing defects in kinetochore/centromere and spindle assembly checkpoints. Three cnd1 and three cnd3 mutants increased cell size and doubled DNA content, thereby eliminating the haploid state. Five of these mutations reside in helix B of HEAT repeats. Two non-SMC condensin subunits, Cnd1 and Cnd3, are thus implicated in ploidy maintenance.	[Xu, Xingya; Nakazawa, Norihiko; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan; [Xu, Xingya] Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka, Japan	Okinawa Institute of Science & Technology Graduate University; Osaka University	Yanagida, M (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan.	myanagid@gmail.com			JSPS fellowship; JSPS [25840013]	JSPS fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	X.X. was a recipient of the JSPS fellowship (1979) and was supported by a Grant-in-Aid for JSPS fellows from JSPS. N.N. was supported by a Grantin- Aid for Young Scientists (B) 25840013 from JSPS. The JSPS URL is http://www.jsps.go.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Akai Y, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110023; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; COSTELLO G, 1986, CURR GENET, V11, P119, DOI 10.1007/BF00378203; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Cuylen S, 2011, TRENDS CELL BIOL, V21, P552, DOI 10.1016/j.tcb.2011.06.003; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; George Carolyn M, 2014, Cells, V3, P865, DOI 10.3390/cells3030865; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hayashi T, 2014, GENES CELLS, V19, P541, DOI 10.1111/gtc.12152; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kimata Y, 2008, J CELL SCI, V121, P1107, DOI 10.1242/jcs.024224; KINOSHITA N, 1993, GENE DEV, V7, P1059, DOI 10.1101/gad.7.6.1059; Kitayama C, 1997, J CELL BIOL, V137, P1309, DOI 10.1083/jcb.137.6.1309; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Malik HS, 1997, P NATL ACAD SCI USA, V94, P13738, DOI 10.1073/pnas.94.25.13738; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Mitchison JM, 1970, METHOD CELL PHYSIOL, V4, P131; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; NAKASEKO Y, 1984, J BACTERIOL, V157, P334, DOI 10.1128/JB.157.1.334-336.1984; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; NIWA O, 1988, NATURE, V336, P430, DOI 10.1038/336430a0; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ouspenski II, 2000, MOL BIOL CELL, V11, P1305, DOI 10.1091/mbc.11.4.1305; Perche O, 2013, EUR J MED GENET, V56, P635, DOI 10.1016/j.ejmg.2013.07.007; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Petrova B, 2013, MOL CELL BIOL, V33, P984, DOI 10.1128/MCB.01400-12; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Robellet X, 2014, G3-GENES GENOM GENET, V4, P373, DOI 10.1534/g3.113.009621; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Saitoh S, 2005, MOL BIOL CELL, V16, P3666, DOI 10.1091/mbc.E05-01-0014; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; SAMEJIMA I, 1994, MOL CELL BIOL, V14, P6361, DOI 10.1128/MCB.14.9.6361; SAMEJIMA I, 1993, J CELL SCI, V105, P135; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Setoguchi K, 2011, ANIM GENET, V42, P650, DOI 10.1111/j.1365-2052.2011.02196.x; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Takeda K, 2011, P NATL ACAD SCI USA, V108, P16950, DOI 10.1073/pnas.1103617108; Toyoda Y, 2002, CURR BIOL, V12, P347, DOI 10.1016/S0960-9822(02)00692-9; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	79	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119347	10.1371/journal.pone.0119347	http://dx.doi.org/10.1371/journal.pone.0119347			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764183	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300023
J	Fournier, S; Taffe, P; Radovanovic, D; Von Elm, E; Morawiec, B; Stauffer, JC; Erne, P; Beggah, A; Monney, P; Pascale, P; Iglesias, JF; Eeckhout, E; Muller, O				Fournier, Stephane; Taffe, Patrick; Radovanovic, Dragana; Von Elm, Erik; Morawiec, Beata; Stauffer, Jean-Christophe; Erne, Paul; Beggah, Ahmed; Monney, Pierre; Pascale, Patrizio; Iglesias, Juan-Fernando; Eeckhout, Eric; Muller, Olivier			Myocardial Infarct Size and Mortality Depend on the Time of Day-A Large Multicenter Study	PLOS ONE			English	Article							CIRCADIAN DEPENDENCE; ISCHEMIC BURDEN	Background Different studies have shown circadian variation of ischemic burden among patients with ST-Elevation Myocardial Infarction (STEMI), but with controversial results. The aim of this study was to analyze circadian variation of myocardial infarction size and in-hospital mortality in a large multicenter registry. Methods This retrospective, registry-based study was based on data from AMIS Plus, a large multicenter Swiss registry of patients who suffered myocardial infarction between 1999 and 2013. Peak creatine kinase (CK) was used as a proxy measure for myocardial infarction size. Associations between peak CK, in-hospital mortality, and the time of day at symptom onset were modelled using polynomial-harmonic regression methods. Results 6,223 STEMI patients were admitted to 82 acute-care hospitals in Switzerland and treated with primary angioplasty within six hours of symptom onset. Only the 24-hour harmonic was significantly associated with peak CK (p = 0.0001). The maximum average peak CK value (2,315 U/L) was for patients with symptom onset at 23: 00, whereas the minimum average (2,017 U/L) was for onset at 11: 00. The amplitude of variation was 298 U/L. In addition, no correlation was observed between ischemic time and circadian peak CK variation. Of the 6,223 patients, 223 (3.58%) died during index hospitalization. Remarkably, only the 24-hour harmonic was significantly associated with in-hospital mortality. The risk of death from STEMI was highest for patients with symptom onset at 00: 00 and lowest for those with onset at 12: 00. Discussion As a part of this first large study of STEMI patients treated with primary angioplasty in Swiss hospitals, investigations confirmed a circadian pattern to both peak CK and in-hospital mortality which were independent of total ischemic time. Accordingly, this study proposes that symptom onset time be incorporated as a prognosis factor in patients with myocardial infarction.	[Fournier, Stephane; Morawiec, Beata; Beggah, Ahmed; Monney, Pierre; Pascale, Patrizio; Iglesias, Juan-Fernando; Eeckhout, Eric; Muller, Olivier] CHU Vaudois, Univ Hosp Ctr, Dept Cardiol, Lausanne, Switzerland; [Taffe, Patrick; Von Elm, Erik] Inst Social & Prevent Med, Lausanne, Switzerland; [Radovanovic, Dragana; Erne, Paul] Univ Zurich, Inst Social & Prevent Med, AMIS Plus Data Ctr, CH-8006 Zurich, Switzerland; [Stauffer, Jean-Christophe] Fribourg Hosp, Dept Cardiol, Fribourg, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich	Muller, O (corresponding author), CHU Vaudois, Univ Hosp Ctr, Dept Cardiol, Lausanne, Switzerland.	olivier.muller@chuv.ch	Iglesias, Juan F./ABB-1115-2020; Taffé, Patrick/AAW-2701-2020; Radovanovic, Dragana I/F-7908-2013	Iglesias, Juan F./0000-0002-1669-6036; Radovanovic, Dragana I/0000-0002-9507-6272; Pascale, Patrizio/0000-0001-7328-2481; Morawiec, Beata/0000-0002-0187-1364; Fournier, Stephane/0000-0002-9422-9521; von Elm, Erik/0000-0002-7412-0406; Taffe, Patrick/0000-0002-2049-6651	Faculty of Biology and Medicine of Lausanne, Switzerland	Faculty of Biology and Medicine of Lausanne, Switzerland	This work was supported by grant from the Faculty of Biology and Medicine of Lausanne, Switzerland [grant for young researcher]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirati E, 2013, CIRC RES, V112, pE110, DOI 10.1161/CIRCRESAHA.112.300778; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; EUBANK RL, 1990, BIOMETRIKA, V77, P1; Fournier S, 2013, CIRC RES, V113, pE42, DOI 10.1161/CIRCRESAHA.113.301883; Fournier S, 2012, AM HEART J, V163, P208, DOI 10.1016/j.ahj.2011.11.006; Heinze G, 2003, COMPUT METH PROG BIO, V71, P155, DOI 10.1016/S0169-2607(02)00077-9; Holmes DR, 2010, CIRC-CARDIOVASC QUAL, V3, P382, DOI 10.1161/CIRCOUTCOMES.109.913343; Hsing AW, 2010, CANCER EPIDEM BIOMAR, V19, P932, DOI 10.1158/1055-9965.EPI-10-0004; Radovanovic D, 2010, HEART, V96, P917, DOI 10.1136/hrt.2009.192302; Reiter R, 2012, CIRC RES, V110, P105, DOI 10.1161/CIRCRESAHA.111.254284; Schemper M, 2003, STAT MED, V22, P2299, DOI 10.1002/sim.1486; Staessen JA, 1997, HYPERTENSION, V29, P30, DOI 10.1161/01.HYP.29.1.30; Suarez-Barrientos A, 2011, HEART, V97, P970, DOI 10.1136/hrt.2010.212621; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189	16	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119157	10.1371/journal.pone.0119157	http://dx.doi.org/10.1371/journal.pone.0119157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760988	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000049
J	Kim, SB; Lee, HY; Seo, S; Lee, JH; Choi, D				Kim, Saet-Byul; Lee, Hye-Young; Seo, Seungyeon; Lee, Joo Hyun; Choi, Doil			RNA-Dependent RNA Polymerase (NIb) of the Potyviruses Is an Avirulence Factor for the Broad-Spectrum Resistance Gene Pvr4 in Capsicum annuum cv. CM334	PLOS ONE			English	Article							POTATO-VIRUS-Y; HELPER COMPONENT PROTEINASE; TOBACCO ETCH POTYVIRUS; COAT PROTEIN; MUTATIONAL ANALYSIS; PLANTA EXPRESSION; GENOME SEQUENCE; PEPPER; IDENTIFICATION; INFECTION	Potyviruses are one of the most destructive viral pathogens of Solanaceae plants. In Capsicum annuum landrace CM334, a broad-spectrum gene, Pvr4 is known to be involved in resistance against multiple potyviruses, including Pepper mottle virus (PepMoV), Pepper severe mosaic virus (PepSMV), and Potato virus Y (PVY). However, a potyvirus avirulence factor against Pvr4 has not been identified. To identify the avirulence factor corresponding to Pvr4 in potyviruses, we performed Agrobacterium-mediated transient expressions of potyvirus protein coding regions in potyvirus-resistant (Pvr4) and -susceptible (pvr4) pepper plants. Hypersensitive response (HR) was observed only when a RNA-dependent RNA polymerase (NIb) of PepMoV, PepSMV, or PVY was expressed in Pvr4-bearing pepper leaves in a genotype-specific manner. In contrast, HR was not observed when the NIb of Tobacco etch virus (TEV), a virulent potyvirus, was expressed in Pvr4-bearing pepper leaves. Our results clearly demonstrate that NIbs of PepMoV, PepSMV, and PVY serve as avirulence factors for Pvr4 in pepper plants.	[Kim, Saet-Byul; Lee, Hye-Young; Seo, Seungyeon; Lee, Joo Hyun; Choi, Doil] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea	Seoul National University (SNU)	Choi, D (corresponding author), Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea.	doil@snu.ac.kr	Kim, Saet-Byul/AAK-7920-2021; Choi, Doil/F-5002-2011	Kim, Saet-Byul/0000-0001-8826-6265; 	National Research Foundation of Korea, Ministry of Science, ICT and Future Planning [2010-0015105]; Vegetable Breeding Research Center of an ARC from the Ministry for Food, Agriculture, Forestry, and Fisheries of the Korean government [PJ710001-05]	National Research Foundation of Korea, Ministry of Science, ICT and Future Planning; Vegetable Breeding Research Center of an ARC from the Ministry for Food, Agriculture, Forestry, and Fisheries of the Korean government	This work was supported by a grant from National Research Foundation of Korea, Ministry of Science, ICT and Future Planning (Project No. 2010-0015105) and a Vegetable Breeding Research Center of an ARC Grant (PJ710001-05) from the Ministry for Food, Agriculture, Forestry, and Fisheries of the Korean government to DC.	ABDALLA OA, 1991, PLANT DIS, V75, P1019, DOI 10.1094/PD-75-1019; Ahn HI, 2006, ARCH VIROL, V151, P2037, DOI 10.1007/s00705-006-0776-1; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Arnedo-Andres MS, 2002, THEOR APPL GENET, V105, P1067, DOI 10.1007/s00122-002-1058-2; ATREYA PL, 1995, J GEN VIROL, V76, P265, DOI 10.1099/0022-1317-76-2-265; Ayme V, 2007, J GEN VIROL, V88, P1594, DOI 10.1099/vir.0.82702-0; Bae C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063533; Baldauf PM, 2006, PLANT DIS, V90, P559, DOI 10.1094/PD-90-0559; Caranta C, 1999, GENOME, V42, P1111, DOI 10.1139/gen-42-6-1111; CARRINGTON JC, 1987, J VIROL, V61, P2540, DOI 10.1128/JVI.61.8.2540-2548.1987; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Elena SF, 2012, CURR OPIN VIROL, V2, P719, DOI 10.1016/j.coviro.2012.09.004; Grube RC, 2000, THEOR APPL GENET, V101, P852, DOI 10.1007/s001220051552; Hong YL, 1996, VIROLOGY, V226, P146, DOI 10.1006/viro.1996.0639; HONG YL, 1995, VIROLOGY, V214, P159, DOI 10.1006/viro.1995.9944; Ivanov KI, 2014, J GEN VIROL, V95, P1415, DOI 10.1099/vir.0.064220-0; Janzac B, 2009, PLANT PATHOL, V58, P443, DOI 10.1111/j.1365-3059.2008.01992.x; Janzac B, 2010, MOL PLANT MICROBE IN, V23, P823, DOI 10.1094/MPMI-23-6-0823; Kim HJ, 2011, THEOR APPL GENET, V122, P1051, DOI 10.1007/s00122-010-1510-7; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Lee MY, 2011, VIRUS RES, V155, P487, DOI 10.1016/j.virusres.2010.12.004; Mestre P, 2000, PLANT J, V23, P653, DOI 10.1046/j.1365-313x.2000.00834.x; Moury B, 2011, MOL PLANT MICROBE IN, V24, P787, DOI 10.1094/MPMI-10-10-0246; Oh SK, 2010, MOL CELLS, V30, P557, DOI 10.1007/s10059-010-0156-2; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Quenouille J, 2013, MOL PLANT PATHOL, V14, P439, DOI 10.1111/mpp.12024; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388, DOI 10.1128/JVI.68.4.2388-2397.1994; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Szittya G, 2001, J VIROL, V75, P2411, DOI 10.1128/JVI.75.5.2411-2420.2001; Tian YP, 2013, MOL PLANT MICROBE IN, V26, P297, DOI 10.1094/MPMI-09-12-0219-R; Valkonen JPT, 1996, ANN APPL BIOL, V129, P25, DOI 10.1111/j.1744-7348.1996.tb05728.x; VERCHOT J, 1992, VIROLOGY, V190, P298, DOI 10.1016/0042-6822(92)91216-H; Vijayapalani P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002639; Wei TY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000962; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; ZITTER TA, 1972, PLANT DIS REP, V56, P586	39	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119639	10.1371/journal.pone.0119639	http://dx.doi.org/10.1371/journal.pone.0119639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760376	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000064
J	Starr, RM; Wendt, DE; Barnes, CL; Marks, CI; Malone, D; Waltz, G; Schmidt, KT; Chiu, J; Launer, AL; Hall, NC; Yochum, N				Starr, Richard M.; Wendt, Dean E.; Barnes, Cheryl L.; Marks, Corina I.; Malone, Dan; Waltz, Grant; Schmidt, Katherine T.; Chiu, Jennifer; Launer, Andrea L.; Hall, Nathan C.; Yochum, Noelle			Variation in Responses of Fishes across Multiple Reserves within a Network of Marine Protected Areas in Temperate Waters	PLOS ONE			English	Article							REEF-FISH; CENTRAL CALIFORNIA; COMMUNITY; POPULATIONS; PATTERNS; IMPLEMENTATION; PRODUCTIVITY; VARIABILITY; INDICATORS; SPILLOVER	Meta-analyses of field studies have shown that biomass, density, species richness, and size of organisms protected by no-take marine reserves generally increase over time. The magnitude and timing of changes in these response variables, however, vary greatly and depend upon the taxonomic groups protected, size and type of reserve, oceanographic regime, and time since the reserve was implemented. We conducted collaborative, fishery-independent surveys of fishes for seven years in and near newly created marine protected areas (MPAs) in central California, USA. Results showed that initially most MPAs contained more and larger fishes than associated reference sites, likely due to differences in habitat quality. The differences between MPAs and reference sites did not greatly change over the seven years of our study, indicating that reserve benefits will be slow to accumulate in California's temperate eastern boundary current. Fishes in an older reserve that has been closed to fishing since 1973, however, were significantly more abundant and larger than those in associated reference sites. This indicates that reserve benefits are likely to accrue in the California Current ecosystem, but that 20 years or more may be needed to detect significant changes in response variables that are due to MPA implementation. Because of the high spatial and temporal variability of fish recruitment patterns, long-term monitoring is needed to identify positive responses of fishes to protection in the diverse set of habitats in a dynamic eastern boundary current. Qualitative estimates of response variables, such as would be obtained from an expert opinion process, are unlikely to provide an accurate description of MPA performance. Similarly, using one species or one MPA as an indicator is unlikely to provide sufficient resolution to accurately describe the performance of multiple MPAs.	[Starr, Richard M.] Moss Landing Marine Labs, Calif Sea Grant Extens Program, Moss Landing, CA 95039 USA; [Starr, Richard M.; Barnes, Cheryl L.; Marks, Corina I.; Schmidt, Katherine T.; Chiu, Jennifer; Launer, Andrea L.] Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [Wendt, Dean E.; Waltz, Grant; Hall, Nathan C.] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Malone, Dan] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Yochum, Noelle] Oregon State Univ, Corvallis, OR 97331 USA	Moss Landing Marine Laboratories; Moss Landing Marine Laboratories; California State University System; California Polytechnic State University San Luis Obispo; University of California System; University of California Santa Cruz; Oregon State University	Starr, RM (corresponding author), Moss Landing Marine Labs, Calif Sea Grant Extens Program, Moss Landing, CA 95039 USA.	starr@mlml.calstate.edu		Wendt, Dean/0000-0002-1732-5616; Barnes, Cheryl L./0000-0002-2650-5299	California Coastal and Marine Initiative of the Resources Legacy Fund Foundation; California Ocean Protection Council; California Sea Grant College Program [10-066, R/OPCFISH-13B]; David and Lucile Packard Foundation; Keith Campbell Foundation for the Environment; FishWise; Santa Monica Seafood	California Coastal and Marine Initiative of the Resources Legacy Fund Foundation; California Ocean Protection Council; California Sea Grant College Program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Keith Campbell Foundation for the Environment; FishWise; Santa Monica Seafood	The authors thank the California Coastal and Marine Initiative of the Resources Legacy Fund Foundation (http://www.resourceslegacyfund.org), the California Ocean Protection Council (http://www.opc.ca.gov/), the California Sea Grant College Program (http://www-csgc.ucsd.edu, grant number 10-066 Project R/OPCFISH-13B), the David and Lucile Packard Foundation (http://www.packard.org/), the Keith Campbell Foundation for the Environment (http://www.campbellfoundation.org/), FishWise (fishwise.org/), and Santa Monica Seafood (http://www.santamonicaseafood.com) for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P1; Auth TD, 2008, FISH OCEANOGR, V17, P316, DOI 10.1111/j.1365-2419.2008.00481.x; Babcock EA, 2011, CAN J FISH AQUAT SCI, V68, P343, DOI 10.1139/F10-146; Beverton R.J.H., 1957, FISH INVEST SER, P19; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Botsford LW, 2006, DEEP-SEA RES PT II, V53, P3116, DOI 10.1016/j.dsr2.2006.07.011; California Seafloor Mapping Project, 2009, SEAFL HAB DAT ACC CA; Caselle JE, 2010, CAL COOP OCEAN FISH, V51, P91; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cvitanovic C, 2013, J ENVIRON MANAGE, V114, P84, DOI 10.1016/j.jenvman.2012.10.051; DEMARTINI EE, 1993, FISH B-NOAA, V91, P414; Dorman JG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046245; Fox HE, 2012, MAR POLICY, V36, P1131, DOI 10.1016/j.marpol.2012.02.007; Freiwald J, 2012, CAN J FISH AQUAT SCI, V69, P1362, DOI 10.1139/F2012-068; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; GARRISON DL, 1976, FISH B-NOAA, V74, P183; Gleason M, 2013, OCEAN COAST MANAGE, V74, P90, DOI 10.1016/j.ocecoaman.2012.08.013; Green KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098976; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2010, CONSERV BIOL, V24, P312, DOI 10.1111/j.1523-1739.2009.01358.x; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Kaplan DM, 2009, ECOL APPL, V19, P433, DOI 10.1890/07-1705.1; Keister JE, 2009, DEEP-SEA RES PT I, V56, P212, DOI 10.1016/j.dsr.2008.09.004; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Kirlin J, 2013, OCEAN COAST MANAGE, V74, P3, DOI 10.1016/j.ocecoaman.2012.08.015; Krueger T, 2012, ENVIRON MODELL SOFTW, V36, P4, DOI 10.1016/j.envsoft.2012.01.011; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Love M. S., 2002, ROCKFISHES NE PACIFI; Lowe CG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P524; Marinesque S, 2012, MAR POLICY, V36, P727, DOI 10.1016/j.marpol.2011.10.010; Messie M, 2011, J CLIMATE, V24, P4314, DOI 10.1175/2011JCLI3941.1; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Ortiz DM, 2008, MAR ECOL PROG SER, V365, P217, DOI 10.3354/meps07492; Paddack MJ, 2000, ECOL APPL, V10, P855, DOI 10.2307/2641050; Parrish JK, 2007, MAR ECOL PROG SER, V352, P275, DOI 10.3354/meps07077; Pelletier D, 2008, CAN J FISH AQUAT SCI, V65, P765, DOI 10.1139/F08-026; PFMC, 2008, ASS FACT AFF NAT AR; Polacheck T., 1990, NAT RESOUR MODEL, V4, P327; Ralston S, 2013, FISH OCEANOGR, V22, P288, DOI 10.1111/fog.12022; Rodwell LD, 2003, CAN J FISH AQUAT SCI, V60, P171, DOI 10.1139/F03-009; Russ GR, 2005, MAR ECOL PROG SER, V292, P1, DOI 10.3354/meps292001; Saarman E, 2013, OCEAN COAST MANAGE, V74, P45, DOI 10.1016/j.ocecoaman.2012.08.021; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sladek JN, 1999, US FISH B, V97, P604; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; Wendt DE, 2009, MAR COAST FISH, V1, P315, DOI 10.1577/C08-054.1; White JW, 2011, FRONT ECOL ENVIRON, V9, P390, DOI 10.1890/100138; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Wilson JR, 2010, MAR COAST FISH, V2, P14, DOI 10.1577/C08-026.1; Yochum N, 2011, FISHERIES, V36, P593, DOI 10.1080/03632415.2011.633467; [No title captured]	57	40	41	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118502	10.1371/journal.pone.0118502	http://dx.doi.org/10.1371/journal.pone.0118502			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760856	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000024
J	Zorb, C; Muhling, KH; Kutschera, U; Geilfus, CM				Zoerb, Christian; Muehling, Karl H.; Kutschera, Ulrich; Geilfus, Christoph-Martin			Salinity Stiffens the Epidermal Cell Walls of Salt-Stressed Maize Leaves: Is the Epidermis Growth-Restricting?	PLOS ONE			English	Article							DEEP-WATER RICE; ZEA-MAYS L.; VICIA-FABA L.; LEAF ELONGATION; NACL STRESS; STEM ELONGATION; PLANT-GROWTH; ACID-GROWTH; TOLERANCE; EXPANSINS	As a result of salt (NaCl)-stress, sensitive varieties of maize (Zea mays L.) respond with a strong inhibition of organ growth. The reduction of leaf elongation investigated here has several causes, including a modification of the mechanical properties of the cell wall. Among the various tissues that form the leaf, the epidermis plays a special role in controlling organ growth, because it is thought to form a rigid outer leaf coat that can restrict elongation by interacting with the inner cell layers. This study was designed to determine whether growthrelated changes in the leaf epidermis and its cell wall correspond to the overall reduction in cell expansion of maize leaves during an osmotic stress-phase induced by salt treatment. Two different maize varieties contrasting in their degree of salt resistance (i.e., the hybrids Lector vs. SR03) were compared in order to identify physiological features contributing to resistance towards salinity. Wall loosening-related parameters, such as the capacity of the epidermal cell wall to expand, beta-expansin abundance and apoplastic pH values, were analysed. Our data demonstrate that, in the salt-tolerant maize hybrid which maintained leaf growth under salinity, the epidermal cell wall was more extensible under salt stress. This was associated with a shift of the epidermal apoplastic pH into a range more favourable for acid growth. The more sensitive hybrid that displayed a pronounced leaf growth-reduction was shown to have stiffer epidermal cell walls under stress. This may be attributable to the reduced abundance of cell wall-loosening beta-expansin proteins following a high salinity-treatment in the nutrient solution (100 mM NaCl, 8 days). This study clearly documents that salt stress impairs epidermal wall-loosening in growth-reduced maize leaves.	[Zoerb, Christian] Univ Hohenheim, Qual Plant Prod, Inst Crop Sci, Stuttgart, Germany; [Muehling, Karl H.; Geilfus, Christoph-Martin] Univ Kiel, Inst Plant Nutr & Soil Sci, Kiel, Germany; [Kutschera, Ulrich] Univ Kassel, Inst Biol, D-34125 Kassel, Germany	University Hohenheim; University of Kiel; Universitat Kassel	Zorb, C (corresponding author), Univ Hohenheim, Qual Plant Prod, Inst Crop Sci, Stuttgart, Germany.	Christian.zoerb@uni-hohenheim.de	Mühling, Karl H./L-6443-2014	Mühling, Karl H./0000-0002-9922-6581	Deutsche Forschungsgemeinschaft (DFG) [ZO118/6]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by a research grant (ZO118/6) of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Plant, Cell and Environment, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; BERNSTEIN N, 1993, PLANTA, V191, P433, DOI 10.1007/BF00195744; Cho HT, 1998, PLANT J, V15, P805, DOI 10.1046/j.1365-313X.1998.00258.x; Cho HT, 1997, PLANT PHYSIOL, V113, P1137, DOI 10.1104/pp.113.4.1137; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; CRAMER GR, 1991, J EXP BOT, V42, P1417, DOI 10.1093/jxb/42.11.1417; De Costa W, 2007, PHYSIOL PLANTARUM, V131, P311, DOI 10.1111/j.1399-3054.2007.00962.x; Fan L, 2004, PLANT PHYSIOL, V135, P2291, DOI 10.1104/pp.104.041426; Geilfus C.-M., 2011, THESIS CHRISTIAN ALB; Geilfus CM, 2014, PLANT SCI, V223, P109, DOI 10.1016/j.plantsci.2014.03.012; Geilfus CM, 2013, NEW PHYTOL, V197, P1117, DOI 10.1111/nph.12046; Geilfus CM, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00013; Geilfus CM, 2012, PLANT CELL ENVIRON, V35, P578, DOI 10.1111/j.1365-3040.2011.02437.x; Geilfus CM, 2011, J PLANT GROWTH REGUL, V30, P387, DOI 10.1007/s00344-011-9201-4; Geilfus CM, 2010, PLANT PHYSIOL BIOCH, V48, P993, DOI 10.1016/j.plaphy.2010.09.011; Geilfus CM, 2010, J IMMUNOL METHODS, V362, P89, DOI 10.1016/j.jim.2010.09.006; GREEN PB, 1980, ANNU REV PLANT PHYS, V31, P51, DOI 10.1146/annurev.pp.31.060180.000411; Hu YC, 2000, INT J PLANT SCI, V161, P575, DOI 10.1086/314280; Kohler W., 1984, EINFUHRUNG STAT BIOL, P101; Kutschera U, 2008, TRENDS PLANT SCI, V13, P105, DOI 10.1016/j.tplants.2007.12.002; Kutschera U, 2008, ANN BOT-LONDON, V101, P615, DOI 10.1093/aob/mcn015; Kutschera U, 2007, J PLANT PHYSIOL, V164, P1395, DOI 10.1016/j.jplph.2007.08.002; KUTSCHERA U, 1988, PLANT PHYSIOL, V88, P361, DOI 10.1104/pp.88.2.361; Kutschera U, 2006, SCIENCE, V311, P952; KUTSCHERA U, 1992, BOT ACTA, V105, P246, DOI 10.1111/j.1438-8677.1992.tb00294.x; KUTSCHERA U, 1994, NEW PHYTOL, V126, P549, DOI 10.1111/j.1469-8137.1994.tb02951.x; Kutschera U, 2001, PLANT BIOLOGY, V3, P466, DOI 10.1055/s-2001-17731; Marcotrigiano M, 2010, AM J BOT, V97, P224, DOI 10.3732/ajb.0900102; Moll S, 2002, PLANT PHYSIOL, V130, P47, DOI 10.1104/pp.004259; Muhling KH, 2010, P INT PLANT NUTR C 1; Muller B, 2007, PLANT PHYSIOL, V143, P278, DOI 10.1104/pp.106.087494; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MUNNS R, 1993, PLANT CELL ENVIRON, V16, P15, DOI 10.1111/j.1365-3040.1993.tb00840.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pitann B, 2009, J PLANT NUTR SOIL SC, V172, P535, DOI 10.1002/jpln.200800349; PYEE J, 1994, ARCH BIOCHEM BIOPHYS, V311, P460, DOI 10.1006/abbi.1994.1263; PYKE KA, 1991, J EXP BOT, V42, P1407, DOI 10.1093/jxb/42.11.1407; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Schubert S, 2009, PLANT SCI, V177, P196, DOI 10.1016/j.plantsci.2009.05.011; Sumer A, 2004, J APPL BOT FOOD QUAL, V78, P135; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; VANVOLKENBURGH E, 1985, PLANT PHYSIOL, V77, P190, DOI 10.1104/pp.77.1.190; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yeats TH, 2010, J EXP BOT, V61, P3759, DOI 10.1093/jxb/erq194; Zorb C, 2013, J PLANT PHYSIOL, V170, P220, DOI 10.1016/j.jplph.2012.09.012; Zorb C, 2004, PLANT SCI, V167, P91, DOI [10.1016/S0168-9452(04)00111-6, 10.1016/j.plantsci.2004.03.004]	47	43	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118406	10.1371/journal.pone.0118406	http://dx.doi.org/10.1371/journal.pone.0118406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760715	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000023
J	Ciaranello, AL; Myer, L; Kelly, K; Christensen, S; Daskilewicz, K; Doherty, K; Bekker, LG; Hou, T; Wood, R; Francke, JA; Wools-Kaloustian, K; Freedberg, KA; Walensky, RP				Ciaranello, Andrea L.; Myer, Landon; Kelly, Kathleen; Christensen, Sarah; Daskilewicz, Kristen; Doherty, Katie; Bekker, Linda-Gail; Hou, Taige; Wood, Robin; Francke, Jordan A.; Wools-Kaloustian, Kara; Freedberg, Kenneth A.; Walensky, Rochelle P.			Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SINGLE-DOSE NEVIRAPINE; CAPE-TOWN; HIV TRANSMISSION; PREGNANT-WOMEN; PILOT PROGRAM; THERAPY; PREVENTION; PERIPARTUM; ZIDOVUDINE	Background Many prevention of mother-to-child HIV transmission (PMTCT) programs currently prioritize antiretroviral therapy (ART) for women with advanced HIV. Point-of-care (POC) CD4 assays may expedite the selection of three-drug ART instead of zidovudine, but are costlier than traditional laboratory assays. Methods We used validated models of HIV infection to simulate pregnant, HIV-infected women (mean age 26 years, gestational age 26 weeks) in a general antenatal clinic in South Africa, and their infants. We examined two strategies for CD4 testing after HIV diagnosis: laboratory (test rate: 96%, result-return rate: 87%, cost: $14) and POC (test rate: 99%, result-return rate: 95%, cost: $26). We modeled South African PMTCT guidelines during the study period (WHO "Option A"): antenatal zidovudine (CD4 <= 350/mu L) or ART (CD4 > 350/mu L). Outcomes included MTCT risk at weaning (age 6 months), maternal and pediatric life expectancy (LE), maternal and pediatric lifetime healthcare costs (2013 USD), and cost-effectiveness ($/life-year saved). Results In the base case, laboratory led to projected MTCT risks of 5.7%, undiscounted pediatric LE of 53.2 years, and undiscounted PMTCT plus pediatric lifetime costs of $1,070/infant. POC led to lower modeled MTCT risk (5.3%), greater pediatric LE (53.4 years) and lower PMTCT plus pediatric lifetime costs ($1,040/infant). Maternal outcomes following laboratory were similar to POC (LE: 21.2 years; lifetime costs: $23,860/person). Compared to laboratory, POC improved clinical outcomes and reduced healthcare costs. Conclusions In antenatal clinics implementing Option A, the higher initial cost of a one-time POC CD4 assay will be offset by cost-savings from prevention of pediatric HIV infection.	[Ciaranello, Andrea L.; Freedberg, Kenneth A.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Kelly, Kathleen; Christensen, Sarah; Doherty, Katie; Hou, Taige; Francke, Jordan A.; Freedberg, Kenneth A.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Gen Med, Boston, MA 02114 USA; [Ciaranello, Andrea L.; Hou, Taige; Freedberg, Kenneth A.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Myer, Landon; Daskilewicz, Kristen] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, ZA-7925 Cape Town, South Africa; [Bekker, Linda-Gail; Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Wools-Kaloustian, Kara] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46202 USA; [Freedberg, Kenneth A.; Walensky, Rochelle P.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; University of Cape Town; University of Cape Town; Indiana University System; Indiana University Bloomington; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Ciaranello, AL (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.	aciaranello@partners.org; rwalensky@partners.org	, Andrea/ABB-3330-2021; Bekker, Linda-Gail/AAZ-8929-2020	, Andrea/0000-0002-4268-3263; Walensky, Rochelle P./0000-0002-8795-379X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	March of Dimes Foundation; National Institutes of Health (NIAID) [K01 AI078754, R01 AI058736, R01 AI093269]; East African IeDEA Consortium [U01 AI069911]; IMPAACT network [U01 AI068632]; Massachusetts General Hospital Executive Committee on Research; Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [N01-DK-9-001/HHSN267200800001C]; National Cancer Institute; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [UM1AI068632, UM1AI068616]; National Institute of Mental Health (NIMH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093269, U01AI068632, R01AI058736, UM1AI068632, K01AI078754, U01AI069911, UM1AI068616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009001] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); East African IeDEA Consortium; IMPAACT network; Massachusetts General Hospital Executive Committee on Research; Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the March of Dimes Foundation (ALC, LM, KK, SC, K. Daskilewicz, K. Doherty, LGB, TH), National Institutes of Health (NIAID) (K01 AI078754 (ALC), R01 AI058736 ((KK, K. Doherty, TH, KAF, RPW), R01 AI093269 (KAF, RPW), East African IeDEA Consortium U01 AI069911, <SUP>star</SUP>and IMPAACT network U01 AI068632<SUP>star star</SUP> (KK, SC, K. Doherty, TH, KAF, RW)), the Massachusetts General Hospital Executive Committee on Research (ALC), and the Elizabeth Glaser Pediatric AIDS Foundation (ALC, LM). Point-of-care CD4 measurement devices for use in the pilot evaluation were donated by Alere Healthcare. The funders and the suppliers of CD4 measurement devices had no role in study design, interpretation of results, or decision to publish. <SUP>star</SUP>Overall support for the IeDEA network is provided by the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Cancer Institute. <SUP>star star</SUP>Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under Award Numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Support of the sites was provided by the National Institute of Allergy and Infectious Diseases (NIAID) and the NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network funded by NICHD (contract number N01-DK-9-001/HHSN267200800001C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2013, CURR OPIN HIV AIDS, V8, P474, DOI 10.1097/COH.0b013e328363a8f2; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Balakrishnan P, 2011, INDIAN J MED RES, V134, P823, DOI 10.4103/0971-5916.92628; Black Samantha, 2013, S Afr Med J, V103, P557, DOI 10.7196/samj.6565; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Carter RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P404, DOI 10.1097/QAI.0b013e3181e73f4b; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Ciaranello A, 2014, PEDIATR INFECT DIS J, V33, P623, DOI 10.1097/INF.0000000000000223; Ciaranello AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083389; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156; Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224; Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe; Cleary S, 2005, HLTH SYSTEMS TRUST S; Clinton Health Access Initiative, 2012, ANT ARV CEIL PRIC LI; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Dabis F, 2005, AIDS, V19, P309; Department of Health Republic of South Africa, 2012, 5 DEP HLTH REP S AFR; Fao P, 2012, CLIN INFECT DIS, V55, P449, DOI 10.1093/cid/cis461; Fitzgerald FC, 2010, SAMJ S AFR MED J, V100, P827, DOI 10.7196/SAMJ.4045; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Goga A, 2012, IMPACT NATL PREVENTI; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Gopalappa C, 2014, AIDS, V28, pS5, DOI 10.1097/QAD.0000000000000083; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; International Monetary Fund (IMF), 2014, WORLD EC OUTL DAT; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Jani IV, 2011, COST COMP POINT OF C; Kellerman SE, 2013, AIDS, V27, pS225, DOI 10.1097/QAD.0000000000000107; Kesho Bora Study Group, 2011, LANCET INFECT DIS, V1, P159; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Myer L, 2013, COMMUNICATION; Myer L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18649; Myer L, 2012, AIDS CARE, V24, P986, DOI 10.1080/09540121.2012.668173; National Institutes of Health: IMPAACT Trial Network, 2012, PROMISE STUD PROM MA; Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Rollins N, 2012, SEX TRANSM INFECT, V88, pI44, DOI 10.1136/sextrans-2012-050709; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; South Africa National Department of Health, 2010, CLIN GUID PMTCT PREV; South Africa National Department of Health, 2010, ANT TREATM GUID; South African Department of Health, 2013, S AFR ANT TREATM GUI; South African National Department of Health, 2010, GUID MAN HIV CHILDR; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Thairu L, 2011, AIDS CARE, V23, P814, DOI 10.1080/09540121.2010.541416; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thomas LS, 2006, COSTING HIV AIDS SER; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; UNAIDS, 2012, REP GLOB AIDS EP GEN; UNITAID, 2014, HIV AIDS DIAGN TECHN; Vander Plaetse B, 2005, HEALTH POLICY PLANN, V20, P243, DOI 10.1093/heapol/czi028; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Vyankandondera J, 2003, REDUCING RISK HIV 1; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; Warszawski J, 2008, AIDS, V22, P289, DOI 10.1097/QAD.0b013e3282f3d63c; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2010, WHO CHOICE COST EFF; World Health Organization, 2010, NEW GUID PREV MOTH T; World Health Organization, 2013, CONS GUID US ANT TRE; World Health Organization, 2010, ANTIRETROVIRAL THERA; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization Department of Maternal Newborn Child and Adolescent Health, 2014, DOES PROV POINT CAR	83	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117751	10.1371/journal.pone.0117751	http://dx.doi.org/10.1371/journal.pone.0117751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756498	gold, Green Published			2022-12-27	WOS:000351275700017
J	Cohen, BC; Shamay, A; Argov-Argaman, N				Cohen, Bat-Chen; Shamay, Avi; Argov-Argaman, Nurit			Regulation of Lipid Droplet Size in Mammary Epithelial Cells by Remodeling of Membrane Lipid Composition-A Potential Mechanism	PLOS ONE			English	Article							MILK-FAT GLOBULE; GLAND; GENES; ACIDS; BIOSYNTHESIS; METHYLATION; PRECURSORS; PGC-1-BETA; EXPRESSION; SECRETION	Milk fat globule size is determined by the size of its precursors-intracellular lipid droplets-and is tightly associated with its composition. We examined the relationship between phospholipid composition of mammary epithelial cells and the size of both intracellular and secreted milk fat globules. Primary culture of mammary epithelial cells was cultured in medium without free fatty acids (control) or with 0.1 mM free capric, palmitic or oleic acid for 24 h. The amount and composition of the cellular lipids and the size of the lipid droplets were determined in the cells and medium. Mitochondrial quantity and expression levels of genes associated with mitochondrial biogenesis and polar lipid composition were determined. Cells cultured with oleic and palmitic acids contained similar quantities of triglycerides, 3.1- and 3.8-fold higher than in controls, respectively (P < 0.0001). When cultured with oleic acid, 22% of the cells contained large lipid droplets (> 3 mu m) and phosphatidylethanolamine concentration was higher by 23 and 63% compared with that in the control and palmitic acid treatments, respectively (P < 0.0001). In the presence of palmitic acid, only 4% of the cells contained large lipid droplets and the membrane phosphatidylcholine concentration was 22% and 16% higher than that in the control and oleic acid treatments, respectively (P < 0.0001). In the oleic acid treatment, approximately 40% of the lipid droplets were larger than 5 mu m whereas in that of the palmitic acid treatment, only 16% of the droplets were in this size range. Triglyceride secretion in the oleic acid treatment was 2- and 12-fold higher compared with that in the palmitic acid and control treatments, respectively. Results imply that membrane composition of bovine mammary epithelial cells plays a role in controlling intracellular and secreted lipid droplets size, and that this process is not associated with cellular triglyceride content.	[Cohen, Bat-Chen; Argov-Argaman, Nurit] Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel; [Shamay, Avi] Minist Agr, Dept Anim Sci, Volcani Ctr, Rehovot, Israel	Hebrew University of Jerusalem; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Argov-Argaman, N (corresponding author), Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, Rehovot, Israel.	argov.nurit@mail.huji.ac.il	argovArgaman, Nurit/AAB-1846-2020					Argov-Argaman N, 2012, J DAIRY SCI, V95, P5776, DOI 10.3168/jds.2012-5569; Argov-Argaman N, 2014, J DAIRY SCI, V97, P6286, DOI 10.3168/jds.2014-8174; Argov-Argaman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068707; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; BITMAN J, 1990, J DAIRY SCI, V73, P1208, DOI 10.3168/jds.S0022-0302(90)78784-X; Briard V, 2003, EUR J LIPID SCI TECH, V105, P677, DOI 10.1002/ejlt.200300812; Briard-Bion V, 2008, J AGR FOOD CHEM, V56, P9374, DOI 10.1021/jf801333j; Burgess JW, 2005, J LIPID RES, V46, P350, DOI 10.1194/jlr.M400438-JLR200; Couvreur S, 2007, J DAIRY SCI, V90, P392, DOI 10.3168/jds.S0022-0302(07)72640-1; DEENEY JT, 1985, EUR J CELL BIOL, V38, P16; DILLEHAY DL, 1994, J NUTR, V124, P615, DOI 10.1093/jn/124.5.615; DYLEWSKI DP, 1984, EUR J CELL BIOL, V35, P99; Feuermann Y, 2006, J ENDOCRINOL, V191, P407, DOI 10.1677/joe.1.06913; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hadsell DL, 2011, PHYSIOL GENOMICS, V43, P271, DOI 10.1152/physiolgenomics.00133.2010; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horl G, 2011, J BIOL CHEM, V286, P17338, DOI 10.1074/jbc.M111.234534; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lopez C, 2008, J AGR FOOD CHEM, V56, P5226, DOI 10.1021/jf7036104; Lopez C, 2011, FOOD CHEM, V125, P355, DOI 10.1016/j.foodchem.2010.09.005; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; Menard O, 2010, FOOD CHEM, V120, P544, DOI 10.1016/j.foodchem.2009.10.053; Mesilati-Stahy R, 2014, FOOD CHEM, V145, P562, DOI 10.1016/j.foodchem.2013.08.077; Mesilati-Stahy R, 2011, J AGR FOOD CHEM, V59, P7427, DOI 10.1021/jf201373j; Michalski MC, 2005, J DAIRY SCI, V88, P1927, DOI 10.3168/jds.S0022-0302(05)72868-X; Michalski MC, 2003, LAIT, V83, P131, DOI 10.1051/lait:2003003; Mikhaleva NI, 2001, FEBS LETT, V493, P85, DOI 10.1016/S0014-5793(01)02288-8; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; O'Mahony JA, 2005, J DAIRY RES, V72, P338, DOI 10.1017/S0022029905001044; Pereira L, 2012, INT J CELL BIOL; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Rodriguez-Cruz M, 2006, J LIPID RES, V47, P553, DOI 10.1194/jlr.M500407-JLR200; Russell TD, 2011, J CELL SCI, V124, P3247, DOI 10.1242/jcs.082974; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stringer DM, 2010, BBA-MOL CELL BIOL L, V1801, P1375, DOI 10.1016/j.bbalip.2010.08.011; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Vesper H, 1999, J NUTR, V129, P1239, DOI 10.1093/jn/129.7.1239; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walstra P, 1974, MILK FAT GLOBULE EMU; Walther Tobias C, 2009, Biochim Biophys Acta, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wiking L, 2004, INT DAIRY J, V14, P909, DOI 10.1016/j.idairyj.2004.03.005; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zhou Y, 2008, J DAIRY SCI, V91, P100, DOI 10.3168/jds.2007-0509	54	48	53	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0121645	10.1371/journal.pone.0121645	http://dx.doi.org/10.1371/journal.pone.0121645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756421	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275700077
J	Borst, JP; Nijboer, M; Taatgen, NA; van Rijn, H; Anderson, JR				Borst, Jelmer P.; Nijboer, Menno; Taatgen, Niels A.; van Rijn, Hedderik; Anderson, John R.			Using Data-Driven Model-Brain Mappings to Constrain Formal Models of Cognition	PLOS ONE			English	Article							INFORMATION-PROCESSING MODEL; PREFRONTAL CORTEX; PROBLEM STATE; MEMORY RETRIEVAL; CORTICAL REGIONS; DECISION-MAKING; CONTROL NETWORK; WORKING-MEMORY; GOOD FIT; FMRI	In this paper we propose a method to create data-driven mappings from components of cognitive models to brain regions. Cognitive models are notoriously hard to evaluate, especially based on behavioral measures alone. Neuroimaging data can provide additional constraints, but this requires a mapping from model components to brain regions. Although such mappings can be based on the experience of the modeler or on a reading of the literature, a formal method is preferred to prevent researcher-based biases. In this paper we used model-based fMRI analysis to create a data-driven model-brain mapping for five modules of the ACT-R cognitive architecture. We then validated this mapping by applying it to two new datasets with associated models. The new mapping was at least as powerful as an existing mapping that was based on the literature, and indicated where the models were supported by the data and where they have to be improved. We conclude that data-driven model-brain mappings can provide strong constraints on cognitive models, and that model-based fMRI is a suitable way to create such mappings.	[Borst, Jelmer P.; Anderson, John R.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Borst, Jelmer P.; Nijboer, Menno; Taatgen, Niels A.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [van Rijn, Hedderik] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	Carnegie Mellon University; University of Groningen; University of Groningen	Borst, JP (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	j.p.borst@rug.nl	Borst, Jelmer/C-4666-2008; Taatgen, Niels/A-3216-2008; van Rijn, Hedderik/L-3685-2014	Borst, Jelmer/0000-0002-4493-8223; Taatgen, Niels/0000-0001-7286-3460; van Rijn, Hedderik/0000-0002-0461-9850	ERC-StG grant [283597]; James S. McDonnell Scholar Award	ERC-StG grant; James S. McDonnell Scholar Award	This research was funded by ERC-StG grant 283597 awarded to NAT and by a James S. McDonnell Scholar Award awarded to JRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Anderson JR, 2008, CEREB CORTEX, V18, P904, DOI 10.1093/cercor/bhm123; Anderson JR, 2007, COGNITIVE PSYCHOL, V54, P185, DOI 10.1016/j.cogpsych.2006.06.003; Anderson JR, 2011, COGN AFFECT BEHAV NE, V11, P52, DOI 10.3758/s13415-010-0011-0; Anderson JR, 2008, COGNITIVE SCI, V32, P1323, DOI 10.1080/03640210802451588; Anderson JR, 2003, BEHAV BRAIN SCI, V26, P587, DOI 10.1017/S0140525X0300013X; Anderson JR, 2003, PSYCHON B REV, V10, P241, DOI 10.3758/BF03196490; Anderson JR, 1995, J LEARN SCI, V4, P167, DOI 10.1207/s15327809jls0402_2; Anderson JR, 2013, COGNITIVE SCI, V37, P1, DOI [10.1111/cogs.12010, DOI 10.1111/COGS.12010]; Anderson JR, 2007, HOW CAN THE HUMAN MI, DOI [10.1162/jocn.2008.20108, DOI 10.1162/JOCN.2008.20108]; BINDER JR, 1994, ANN NEUROL, V35, P662, DOI 10.1002/ana.410350606; Borst JP, 2013, ACTA PSYCHOL, V144, P373, DOI 10.1016/j.actpsy.2013.07.016; Borst JP, 2013, P NATL ACAD SCI USA, V110, P1628, DOI 10.1073/pnas.1221572110; Borst JP, 2011, NEUROIMAGE, V58, P137, DOI 10.1016/j.neuroimage.2011.05.084; Borst JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012966; Borst JP, 2010, J EXP PSYCHOL LEARN, V36, P363, DOI 10.1037/a0018106; Borst JP, 2015, MODEL BASED COGNITIV, DOI DOI 10.1016/J.TICS.2013.10.014; Borst JP, 2013, NEUROERGONOMICS; BRETT M, 2002, NEUROIMAGE, P16; Byrne MD, 2001, PSYCHOL REV, V108, P847, DOI 10.1037/0033-295X.108.4.847; Cabeza R, 2003, NEUROPSYCHOLOGIA, V41, P390, DOI 10.1016/S0028-3932(02)00170-7; Chen M. C., 2001, HUMAN FACTORS COMPUT, P281, DOI DOI 10.1145/634067.634234; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Davis T, 2012, CEREB CORTEX, V22, P260, DOI 10.1093/cercor/bhr036; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Forstmann BU, 2011, TRENDS COGN SCI, V15, P272, DOI 10.1016/j.tics.2011.04.002; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Glascher JP, 2010, WIRES COGN SCI, V1, P501, DOI 10.1002/wcs.57; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gluth S, 2012, J NEUROSCI, V32, P10686, DOI 10.1523/JNEUROSCI.0727-12.2012; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Huang J, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1225; Just MA, 2007, COGN AFFECT BEHAV NE, V7, P153, DOI 10.3758/CABN.7.3.153; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Nijboer M, 2013, PROCEEDINGS OF THE 1; Nijboer M, 2014, NEUROIMAGE, V100, P60, DOI 10.1016/j.neuroimage.2014.05.082; Nijboer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079583; O'Doherty JP, 2007, ANN NY ACAD SCI, V1104, P35, DOI 10.1196/annals.1390.022; Oberauer K, 2008, PSYCHOL REV, V115, P544, DOI 10.1037/0033-295X.115.3.544; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Pitt MA, 2002, PSYCHOL REV, V109, P472, DOI 10.1037//0033-295X.109.3.472; Pitt MA, 2002, TRENDS COGN SCI, V6, P421, DOI 10.1016/S1364-6613(02)01964-2; Qin YL, 2003, P NATL ACAD SCI USA, V100, P4951, DOI 10.1073/pnas.0431053100; Roberts S, 2000, PSYCHOL REV, V107, P358, DOI 10.1037/0033-295X.107.2.358; Rodgers JL, 2002, PSYCHOL REV, V109, P599, DOI 10.1037//0033-295X.109.3.599; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; Salvucci DD, 2014, J FRANKLIN I, V351, P98, DOI 10.1016/j.jfranklin.2012.06.013; Salvucci DD, 2011, THE MULTITASKING MIN; Shiffrin R, 2008, COGNITIVE SCI, V32, P1248, DOI 10.1080/03640210802414826; Sohn MH, 2005, NEUROIMAGE, V25, P21, DOI 10.1016/j.neuroimage.2004.11.001; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sohn MH, 2003, P NATL ACAD SCI USA, V100, P7412, DOI 10.1073/pnas.0832374100; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stocco A, 2008, J COGNITIVE NEUROSCI, V20, P1300, DOI 10.1162/jocn.2008.20089; Taatgen NA, 2008, CAMB HANDB PSYCHOL, P170; Tenison C, 2014, NEUROPSYCHOLOGIA, V54, P41, DOI 10.1016/j.neuropsychologia.2013.12.011; Tucker LR, 1951, REPORT NO 984; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Maanen L, 2011, J NEUROSCI, V31, P17488, DOI 10.1523/JNEUROSCI.2924-11.2011; van Vugt MK, 2014, NEUROIMAGE, V85, P685, DOI 10.1016/j.neuroimage.2013.09.076; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wintermute S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050154; Wunderlich K, 2009, P NATL ACAD SCI USA, V106, P17199, DOI 10.1073/pnas.0901077106	72	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119673	10.1371/journal.pone.0119673	http://dx.doi.org/10.1371/journal.pone.0119673			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747601	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400084
J	Geue, C; Lorgelly, P; Lewsey, J; Hart, C; Briggs, A				Geue, Claudia; Lorgelly, Paula; Lewsey, James; Hart, Carole; Briggs, Andrew			Hospital Expenditure at the End-of-Life: What Are the Impacts of Health Status and Health Risks?	PLOS ONE			English	Article							TIME-TO-DEATH; CARE EXPENDITURE; MEDICAL EXPENDITURES; CIGARETTE-SMOKING; POPULATION; COSTS; MORTALITY; SCOTLAND; RENFREW; MIDSPAN	Background It is important for health policy and expenditure projections to understand the relationship between age, death and expenditure on health care (HC). Research has shown that older age groups incur lower hospital costs than previously anticipated and that remaining time to death (TTD) was a much stronger indicator for expenditure than age. How health behaviour or risk factors impact on HC utilisation and costs at the end of life is relatively unknown. Smoking and Body Mass Index (BMI) have featured most prominently and mixed findings exist as to the exact nature of this association. Methods This paper considers the relationship between TTD, age and expenditure for inpatient care in the last 12 quarters of life; and introduces measures of health status and risks. A longitudinal dataset covering 35 years is utilised, including baseline survey data linked to hospital and death records. The effect of age, TTD and health indicators on expenditure for inpatient care is estimated using a two-part model. Results As individuals approach death costs increase. This effect is highly significant (p<0.01) from the last until the 8th quarter before death and influenced by age. Statistically significant effects on costs were found for: smoking status, systolic blood pressure and lung function (FEV1). On average, smokers incurred lower quarterly costs in their last 12 quarters of life than non-smokers (similar to 7%). Participants' BMI at baseline did show a negative association with probability of HC utilisation however this effect disappeared when costs were estimated. Conclusions Health risk measures obtained at baseline provide a good indication of individuals' probability of needing medical attention later in life and incurring costs, despite the small size of the effect. Utilising a linked dataset, where such measures are available can add substantially to our ability to explain the relationship between TTD and costs.	[Geue, Claudia; Lewsey, James; Briggs, Andrew] Univ Glasgow, Inst Hlth & Wellbeing, Hlth Econ & Hlth Technol Assessment, Glasgow G12 8RZ, Lanark, Scotland; [Lorgelly, Paula] Monash Univ, Ctr Hlth Econ, Clayton, Vic 3800, Australia; Univ Glasgow, Inst Hlth & Wellbeing, Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow; Monash University; University of Glasgow	Geue, C (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Hlth Econ & Hlth Technol Assessment, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.	Claudia.Geue@glasgow.ac.uk	Briggs, Andrew/ABA-9009-2020; Harding, Richard/G-9729-2012	Briggs, Andrew/0000-0002-0777-1997; Lorgelly, Paula/0000-0002-8990-9514	Medical Research Council (UK) [G0800122]; Chief Scientist Office [PDF/13/03] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office	This work was funded by a grant from the Medical Research Council (UK). Grant Number: G0800122. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barendregt JJ, 1997, NEW ENGL J MED, V337, P1052, DOI 10.1056/NEJM199710093371506; Breyer F, 2015, EUR J HEALTH ECON, V16, P95, DOI 10.1007/s10198-014-0564-x; Carstairs V., 1991, DEPRIVATION HLTH SCO; Cleves M., 2008, INTRO SURVIVAL ANAL; Geue C, 2014, EUR J HEALTH ECON, V15, P885, DOI 10.1007/s10198-013-0543-7; Geue C, 2012, HEALTH ECON, V21, P1201, DOI 10.1002/hec.1785; Graham B, 2001, PROXIMITY DEATH ACUT; Gray AM, 2012, APPL METHODS COST EF, P72; Hart CL, 2005, INT J EPIDEMIOL, V34, P28, DOI 10.1093/ije/dyh348; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; HODGSON TA, 1992, MILBANK Q, V70, P81, DOI 10.2307/3350086; ISD Scotland, SCOTT HLTH SERV COST; Miller LS, 1998, PUBLIC HEALTH REP, V113, P447; Moorin R, 2012, J HEALTH SERV RES PO, V17, P197, DOI 10.1258/jhsrp.2012.011130; Moorin RE, 2008, HEALTH POLICY, V85, P380, DOI 10.1016/j.healthpol.2007.08.003; Payne G, 2007, MILBANK Q, V85, P213, DOI 10.1111/j.1468-0009.2007.00485.x; Popham F, 2010, HEALTH PLACE, V16, P759, DOI 10.1016/j.healthplace.2010.03.007; Seshamani M, 2004, AGE AGEING, V33, P556, DOI 10.1093/ageing/afh187; Seshamani M, 2004, HEALTH ECON, V13, P303, DOI 10.1002/hec.826; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Stearns SC, 2004, HEALTH ECON, V13, P315, DOI 10.1002/hec.831; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Wang FF, 2006, J OCCUP ENVIRON MED, V48, P668, DOI 10.1097/01.jom.0000225045.77734.f4; Whitley E, 2014, ANN BEHAV MED, V47, P148, DOI 10.1007/s12160-013-9539-x; Williams A, 1997, BRIT MED J, V314, P820, DOI 10.1136/bmj.314.7083.820; Zweifel P, 2004, GENEVA PAP R I-ISS P, V29, P652, DOI 10.1111/j.1468-0440.2004.00308.x; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119035	10.1371/journal.pone.0119035	http://dx.doi.org/10.1371/journal.pone.0119035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25746728	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000350689400039
J	Lin, YY; Shiau, S; Fang, CT				Lin, Ying-Ying; Shiau, Stephanie; Fang, Chi-Tai			Risk Factors for Invasive Cryptococcus neoformans Diseases: A Case-Control Study	PLOS ONE			English	Article							EPIDEMIOLOGY; INFECTIONS; NUDE; CALCINEURIN; MENINGITIS; INHIBITOR; CIRRHOSIS; FEATURES	Background Cryptococcus neoformans is a ubiquitous environmental fungus that can cause life-threatening meningitis and fungemia, often in the presence of acquired immunodeficiency syndrome (AIDS), liver cirrhosis, diabetes mellitus, or other medical conditions. To distinguish risk factors from comorbidities, we performed a hospital-based, density-sampled, matched case-control study. Methods All new-onset cryptococcal meningitis cases and cryptococcemia cases at a university hospital in Taiwan from 2002-2010 were retrospectively identified from the computerized inpatient registry and were included in this study. Controls were selected from those hospitalized patients not experiencing cryptococcal meningitis or cryptococcemia. Controls and cases were matched by admission date, age, and gender. Conditional logistic regression was used to analyze the risk factors. Results A total of 101 patients with cryptococcal meningitis (266 controls) and 47 patients with cryptococcemia (188 controls), of whom 32 patients had both cryptococcal meningitis and cryptococcemia, were included in this study. Multivariate regression analysis showed that AIDS (adjusted odds ratio [aOR] = 181.4; p < 0.001), decompensated liver cirrhosis (aOR = 8.5; p = 0.008), and cell-mediated immunity (CMI)-suppressive regimens without calcineurin inhibitors (CAs) (aOR = 15.9; p < 0.001) were independent risk factors for cryptococcal meningitis. Moreover, AIDS (aOR = 216.3, p < 0.001), decompensated liver cirrhosis (aOR = 23.8; p < 0.001), CMI-suppressive regimens without CAs (aOR = 7.3; p = 0.034), and autoimmune diseases (aOR = 9.3; p = 0.038) were independent risk factors for developing cryptococcemia. On the other hand, diabetes mellitus and other medical conditions were not found to be risk factors for cryptococcal meningitis or cryptococcemia. Conclusions The findings confirm AIDS, decompensated liver cirrhosis, CMI-suppressive regimens without CAs, and autoimmune diseases are risk factors for invasive C. neoformans diseases.	[Lin, Ying-Ying; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Shiau, Stephanie] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Fang, Chi-Tai] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; Columbia University; National Taiwan University; National Taiwan University Hospital	Fang, CT (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	fangct@ntu.edu.tw	Fang, Chi-Tai/P-2908-2016; MQ, Li/HGU-6545-2022	Fang, Chi-Tai/0000-0002-7380-1699; Shiau, Stephanie/0000-0003-2944-3406				AKALIN HE, 1985, Q J MED, V56, P431; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; BERMAS BL, 1994, J CLIN IMMUNOL, V14, P169, DOI 10.1007/BF01533366; CAULEY LK, 1979, INFECT IMMUN, V23, P644, DOI 10.1128/IAI.23.3.644-651.1979; Child C G, 1964, Major Probl Clin Surg, V1, P1; Chuang YM, 2008, EUR J CLIN MICROBIOL, V27, P307, DOI 10.1007/s10096-007-0430-1; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Cruz MC, 2000, ANTIMICROB AGENTS CH, V44, P143, DOI 10.1128/AAC.44.1.143-149.2000; DEMEO AN, 1972, NEW ENGL J MED, V286, P735, DOI 10.1056/NEJM197204062861401; Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024; ENG RHK, 1986, AM J MED, V81, P19, DOI 10.1016/0002-9343(86)90176-2; GAL AA, 1986, ARCH PATHOL LAB MED, V110, P502; GRAYBILL JR, 1978, CELL IMMUNOL, V40, P263, DOI 10.1016/0008-8749(78)90334-9; HANSEMANN DV, 1905, VERH DTSCH GES PATHO, V9, P21; HOLDSTOCK G, 1982, GASTROENTEROLOGY, V82, P206; Jean SS, 2005, J FORMOS MED ASSOC, V104, P39; Jean SS, 2002, QJM-INT J MED, V95, P511, DOI 10.1093/qjmed/95.8.511; Jiang YD, 2012, J FORMOS MED ASSOC, V111, P599, DOI 10.1016/j.jfma.2012.09.014; Kiertiburanakul S, 2006, INT J INFECT DIS, V10, P72, DOI 10.1016/j.ijid.2004.12.004; KOVACS JA, 1985, ANN INTERN MED, V103, P533, DOI 10.7326/0003-4819-103-4-533; LEE TK, 1959, J FORMOS MED ASSOC, V58, P567; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; NISHIMURA K, 1979, MYCOPATHOLOGIA, V68, P145, DOI 10.1007/BF00578522; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; SALKOWSKI CA, 1990, INFECT IMMUN, V58, P3300, DOI 10.1128/IAI.58.10.3300-3306.1990; SALKOWSKI CA, 1991, INFECT IMMUN, V59, P1785, DOI 10.1128/IAI.59.5.1785-1789.1991; SALKOWSKI CA, 1991, J LEUKOCYTE BIOL, V49, P533, DOI 10.1002/jlb.49.6.533; SHIMIZU RY, 1986, J INFECT DIS, V154, P1042, DOI 10.1093/infdis/154.6.1042; Singh N, 2004, MEDICINE, V83, P188, DOI 10.1097/01.md.0000126760.45299.69; Singh N, 2007, J INFECT DIS, V195, P756, DOI 10.1086/511438; Sun HY, 2004, CLIN INFECT DIS, V38, P1790, DOI 10.1086/421272; Tseng HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061921; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M; ZOLLER WG, 1989, KLIN WOCHENSCHR, V67, P598, DOI 10.1007/BF01721688; ZUGER A, 1986, ANN INTERN MED, V104, P234, DOI 10.7326/0003-4819-104-2-234	39	59	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119090	10.1371/journal.pone.0119090	http://dx.doi.org/10.1371/journal.pone.0119090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747471	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400043
J	McGill, LM; Shannon, AJ; Pisani, D; Felix, MA; Ramlov, H; Dix, I; Wharton, DA; Burnell, AM				McGill, Lorraine M.; Shannon, Adam J.; Pisani, Davide; Felix, Marie-Anne; Ramlov, Hans; Dix, Ilona; Wharton, David A.; Burnell, Ann M.			Anhydrobiosis and Freezing-Tolerance: Adaptations That Facilitate the Establishment of Panagrolaimus Nematodes in Polar Habitats	PLOS ONE			English	Article							PHYLOGENETIC NICHE CONSERVATISM; ANTARCTIC-NEMATODE; CRYOPROTECTIVE DEHYDRATION; ANTIFREEZE PROTEINS; DESICCATION-TOLERANCE; SURVIVAL; RECRYSTALLIZATION; EVOLUTION; DAVIDI; PLANTS	Anhydrobiotic animals can survive the loss of both free and bound water from their cells. While in this state they are also resistant to freezing. This physiology adapts anhydrobiotes to harsh environments and it aids their dispersal. Panagrolaimus davidi, a bacterial feeding anhydrobiotic nematode isolated from Ross Island Antarctica, can survive intracellular ice formation when fully hydrated. A capacity to survive freezing while fully hydrated has also been observed in some other Antarctic nematodes. We experimentally determined the anhydrobiotic and freezing-tolerance phenotypes of 24 Panagrolaimus strains from tropical, temperate, continental and polar habitats and we analysed their phylogenetic relationships. We found that several other Panagrolaimus isolates can also survive freezing when fully hydrated and that tissue extracts from these freezing-tolerant nematodes can inhibit the growth of ice crystals. We show that P. davidi belongs to a clade of anhydrobiotic and freezing- tolerant panagrolaimids containing strains from temperate and continental regions and that P. superbus, an early colonizer at Surtsey island, Iceland after its volcanic formation, is closely related to a species from Pennsylvania, USA. Ancestral state reconstructions show that anhydrobiosis evolved deep in the phylogeny of Panagrolaimus. The early-diverging Panagrolaimus lineages are strongly anhydrobiotic but weakly freezing-tolerant, suggesting that freezing tolerance is most likely a derived trait. The common ancestors of the davidi and the superbus clades were anhydrobiotic and also possessed robust freezing tolerance, along with a capacity to inhibit the growth and recrystallization of ice crystals. Unlike other endemic Antarctic nematodes, the life history traits of P. davidi do not show evidence of an evolved response to polar conditions. Thus we suggest that the colonization of Antarctica by P. davidi and of Surtsey by P. superbus may be examples of recent "ecological fitting" of freezing-tolerant anhydrobiotic propagules to the respective abiotic conditions in Ross Island and Surtsey.	[McGill, Lorraine M.; Shannon, Adam J.; Dix, Ilona; Burnell, Ann M.] Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland; [Shannon, Adam J.] Technol Sci Grp Europe LLP, Knaresborough HG5 8QB, N Yorkshire, England; [Pisani, Davide] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Pisani, Davide] Univ Bristol, Sch Earth Sci, Bristol BS8 1UG, Avon, England; [Felix, Marie-Anne] Ecole Normale Super, Inst Biol, F-75230 Paris 05, France; [Ramlov, Hans] Roskilde Univ, Dept Sci Syst & Models, DK-4000 Roskilde, Denmark; [Wharton, David A.] Univ Otago, Dept Zool, Dunedin 9054, New Zealand	Maynooth University; University of Bristol; University of Bristol; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Roskilde University; University of Otago	Burnell, AM (corresponding author), Maynooth Univ, Dept Biol, Maynooth, Kildare, Ireland.	ann.burnell@nuim.ie	Pisani, Davide/ABD-5225-2021	Pisani, Davide/0000-0003-0949-6682; Ramlov, Hans/0000-0003-1113-0583; Wharton, David/0000-0001-6369-4984	Science Foundation Ireland [08/RFP/EOB166, 09/RFP/EOB2506]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This project was funded by Science Foundation Ireland (Projects 08/RFP/EOB166 and 09/RFP/EOB2506).	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; Ansart A, 2014, EVOL ECOL, V28, P471, DOI 10.1007/s10682-013-9680-9; AROIAN RV, 1993, J NEMATOL, V25, P500; Barriere Antoine, 2006, WormBook, P1; Best RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057550; Bladursson S, 2007, NOMINATION SURTSEY U; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; BOSTROM S, 1988, NEMATOLOGICA, V34, P144, DOI 10.1163/002825988X00233; BRENNER S, 1974, GENETICS, V77, P71; Brown IM, 2004, NEMATOLOGY, V6, P883, DOI 10.1163/1568541044038641; Burnell AM, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P126, DOI 10.1079/9781845936877.0126; CALDWELL J R, 1981, British Antarctic Survey Bulletin, P33; Christner BC, 2010, APPL MICROBIOL BIOT, V85, P481, DOI 10.1007/s00253-009-2291-2; Clark MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-328; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; Convey P, 2000, CRYO-LETT, V21, P327; Cornette R, 2011, IUBMB LIFE, V63, P419, DOI 10.1002/iub.463; Crisp MD, 2012, NEW PHYTOL, V196, P681, DOI 10.1111/j.1469-8137.2012.04298.x; CROWE JH, 1981, MOL PHYSIOL, V1, P145; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DAVIES PL, 1990, FASEB J, V4, P2460, DOI 10.1096/fasebj.4.8.2185972; Doucet D, 2009, CELL MOL LIFE SCI, V66, P1404, DOI 10.1007/s00018-009-8320-6; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Farrant JM, 2011, CURR OPIN PLANT BIOL, V14, P340, DOI 10.1016/j.pbi.2011.03.018; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; FORGE TA, 1992, CAN J ZOOL, V70, P1553, DOI 10.1139/z92-214; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Galtier N, 1998, MOL BIOL EVOL, V15, P871, DOI 10.1093/oxfordjournals.molbev.a025991; GOLDMAN N, 1990, SYST ZOOL, V39, P345, DOI 10.2307/2992355; Graham LA, 2005, SCIENCE, V310, P461, DOI 10.1126/science.1115145; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Holmstrup M, 2002, P NATL ACAD SCI USA, V99, P5716, DOI 10.1073/pnas.082580699; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; KNIGHT CA, 1995, CRYOBIOLOGY, V32, P23, DOI 10.1006/cryo.1995.1002; KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lieu YC, 2000, PROTEIN EXPRES PURIF, V19, P148, DOI 10.1006/prep.2000.1219; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Nkem JN, 2006, POLAR BIOL, V29, P346, DOI 10.1007/s00300-005-0061-x; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; O'Meara BC, 2006, EVOLUTION, V60, P922; ODELL SJ, 1979, CRYOBIOLOGY, V16, P534, DOI 10.1016/0011-2240(79)90071-3; Orme CDL, 2013, CAPER COMP ANAL PHYL, DOI DOI 10.1371/journal.pone.0066213; OVERHOFF A, 1993, POLAR BIOL, V13, P151, DOI 10.1007/BF00238924; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Proctor MCF, 2007, BRYOLOGIST, V110, P595, DOI 10.1639/0007-2745(2007)110[595:DIBAR]2.0.CO;2; Ramlov H, 1996, CRYOBIOLOGY, V33, P607, DOI 10.1006/cryo.1996.0064; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Shannon AJ, 2005, J EXP BIOL, V208, P2433, DOI 10.1242/jeb.01629; Sinclair BJ, 2013, INTEGR COMP BIOL, V53, P545, DOI 10.1093/icb/ict004; SOHLENIUS B, 1988, NEMATOLOGICA, V34, P208, DOI 10.1163/002825988X00305; Sorensen JG, 2011, J INSECT PHYSIOL, V57, P1147, DOI 10.1016/j.jinsphys.2011.03.001; Swart A, 1996, S AFR J ZOOL, V31, P15; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 2005, CRYOBIOLOGY, V50, P21, DOI 10.1016/j.cryobiol.2004.09.004; Wharton DA, 2003, J EXP BIOL, V206, P215, DOI 10.1242/jeb.00083; WHARTON DA, 1993, FUND APPL NEMATOL, V16, P17; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; Womersley CZ, 1987, VISTAS NEMATOLOGY	73	17	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116084	10.1371/journal.pone.0116084	http://dx.doi.org/10.1371/journal.pone.0116084			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747673	gold, Green Submitted, Green Published			2022-12-27	WOS:000350689400003
J	Pachschwoll, C; Garcia, PE; Winkler, M; Schneeweiss, GM; Schonswetter, P				Pachschwoell, Clemens; Garcia, Pedro Escobar; Winkler, Manuela; Schneeweiss, Gerald M.; Schoenswetter, Peter			Polyploidisation and Geographic Differentiation Drive Diversification in a European High Mountain Plant Group (Doronicum clusii Aggregate, Asteraceae)	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; NUCLEAR-DNA CONTENT; SENECIO-CARNIOLICUS ASTERACEAE; ARCTIC-ALPINE PHYLOGEOGRAPHY; POPULATION-STRUCTURE; GLACIAL REFUGIA; FLOW-CYTOMETRY; EASTERN ALPS; GENETIC-STRUCTURE; POSTGLACIAL COLONIZATION	Range shifts (especially during the Pleistocene), polyploidisation and hybridization are major factors affecting high-mountain biodiversity. A good system to study their role in the European high mountains is the Doronicum clusii aggregate (Asteraceae), whose four taxa (D. clusii s.s., D. stiriacum, D. glaciale subsp. glaciale and D. glaciale subsp. calcareum) are differentiated geographically, ecologically (basiphilous versus silicicolous) and/or via their ploidy levels (diploid versus tetraploid). Here, we use DNA sequences (three plastid and one nuclear spacer) and AFLP fingerprinting data generated for 58 populations to infer phylogenetic relationships, origin of polyploids-whose ploidy level was confirmed by chromosomally calibrated DNA ploidy level estimates-and phylogeographic history. Taxonomic conclusions were informed, among others, by a Gaussian clustering method for species delimitation using dominant multilocus data. Based on molecular data we identified three lineages: (i) silicicolous diploid D. clusii s. s. in the Alps, (ii) silicicolous tetraploid D. stiriacum in the eastern Alps (outside the range of D. clusii s. s.) and the Carpathians and (iii) the basiphilous diploids D. glaciale subsp. glaciale (eastern Alps) and D. glaciale subsp. calcareum (northeastern Alps); each taxon was identified as distinct by the Gaussian clustering, but the separation of D. glaciale subsp. calcareum and D. glaciale subsp. glaciale was not stable, supporting their taxonomic treatment as subspecies. Carpathian and Alpine populations of D. stiriacum were genetically differentiated suggesting phases of vicariance, probably during the Pleistocene. The origin (autopolyploid versus allopolyploid) of D. stiriacum remained unclear. Doronicum glaciale subsp. calcareum was genetically and morphologically weakly separated from D. glaciale subsp. glaciale but exhibited significantly higher genetic diversity and rarity. This suggests that the more widespread D. glaciale subsp. glaciale originated from D. glaciale subsp. calcareum, which is restricted to a prominent Pleistocene refugium previously identified in other alpine plant species.	[Pachschwoell, Clemens; Garcia, Pedro Escobar; Winkler, Manuela; Schneeweiss, Gerald M.] Univ Vienna, Dept Bot & Biodivers Res, A-1030 Vienna, Austria; [Garcia, Pedro Escobar] Nat Hist Museum, Dept Bot, A-1010 Vienna, Austria; [Winkler, Manuela] Univ Nat Resources & Life Sci Vienna, GLORIA Coordinat, Ctr Global Change & Sustainabil, A-1190 Vienna, Austria; [Winkler, Manuela] Austrian Acad Sci, Inst Interdisciplinary Mt Res, A-1190 Vienna, Austria; [Schoenswetter, Peter] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria	University of Vienna; University of Natural Resources & Life Sciences, Vienna; Austrian Academy of Sciences; University of Innsbruck	Schneeweiss, GM (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, A-1030 Vienna, Austria.	gerald.schneeweiss@univie.ac.at	Schönswetter, Peter/T-8241-2017; Pachschwöll, Clemens/O-2582-2019; Schneeweiss, Gerald M./B-4344-2013; Winkler, Manuela/K-5434-2012; Pachschwöll, Clemens/D-3550-2014	Schönswetter, Peter/0000-0001-9225-4566; Pachschwöll, Clemens/0000-0002-8281-7545; Schneeweiss, Gerald M./0000-0003-2811-3317; Winkler, Manuela/0000-0002-8655-9555; 	Open Access Publishing Fund of the University of Vienna; Society for the Advancement of Plant Sciences (Vienna, Austria)	Open Access Publishing Fund of the University of Vienna; Society for the Advancement of Plant Sciences (Vienna, Austria)	This article was supported by the Open Access Publishing Fund of the University of Vienna. This work was financed by a grant of the Society for the Advancement of Plant Sciences (Vienna, Austria) to CP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2009, GLOBAL ECOL BIOGEOGR, V18, P223, DOI 10.1111/j.1466-8238.2008.00439.x; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; Badanina V. A., 1997, Ukrayins'kyi Botanichnyi Zhurnal, V54, P372; Benedi C., 1992, INT ORGAN PLANT BIOS, V18/19, P6; Benham J, 1999, J AGR GENOMICS, V4, P399; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; Birks HH, 2008, PLANT ECOL DIVERS, V1, P135, DOI 10.1080/17550870802328652; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Brysting AK, 2011, TAXON, V60, P333, DOI 10.1002/tax.602004; Burnier J, 2009, MOL ECOL, V18, P3730, DOI 10.1111/j.1365-294X.2009.04281.x; Casazza G, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-56; Cavillier F, 1907, ANN CONSERV JARD BOT, V10, P177; Cavillier F, 1911, ANN CONSERV JARD BOT, V13-14, P195; Choler P, 2004, P NATL ACAD SCI USA, V101, P171, DOI 10.1073/pnas.2237235100; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CORRIVEAU J L, 1988, American Journal of Botany, V75, P1443, DOI 10.2307/2444695; Despres L, 2003, MOL PHYLOGENET EVOL, V27, P185, DOI 10.1016/S1055-7903(02)00445-1; Dillenberger MS, 2013, AM J BOT, V100, P1171, DOI 10.3732/ajb.1300060; Dixon CJ, 2009, MOL PHYLOGENET EVOL, V50, P74, DOI 10.1016/j.ympev.2008.10.009; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Doyle J. J., 1987, PHYTOCHEM B, P11; Dullinger S, 2012, GLOBAL ECOL BIOGEOGR, V21, P829, DOI 10.1111/j.1466-8238.2011.00732.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Essl F, 2011, J BIOGEOGR, V38, P604, DOI 10.1111/j.1365-2699.2010.02425.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FAVARGER C., 1949, BULL SOC NEUCHATEL SCI NAT, V72, P15; Favarger C, 1968, COLLECT BOT, V7, P325; FAVARGER C, 1991, POLISH BOT STUD, V2, P23; Favarger C., 1950, ARCH JUL KLAUS STIFT, V25, P472; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez IA, 2003, ANN MO BOT GARD, V90, P319, DOI 10.2307/3298534; Fernandez IA, 2001, FOLIA GEOBOT, V36, P423, DOI 10.1007/BF02899989; Fernandez IA, 2001, MOL PHYLOGENET EVOL, V20, P41, DOI 10.1006/mpev.2001.0954; Fischer MA, 2008, LIECHTENSTEIN SUDTIR; Frajman B, 2014, PHYTON-ANN REI BOT A, V54, P27; Garcia PE, 2012, MOL ECOL, V21, P1255, DOI 10.1111/j.1365-294X.2012.05456.x; Guggisberg A, 2009, SYST BIOL, V58, P55, DOI 10.1093/sysbio/syp010; GUNTHART A, 1926, PFLANZENLEBEN ALPEN, P1028; Gyorffy I, 1909, MAGYAR BOT LAPOK, V8, P47; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hausdorf B, 2010, SYST BIOL, V59, P491, DOI 10.1093/sysbio/syq039; Hennig C, 2012, PRABCLUS PACKAGE VER; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Hurdu Bogdan Iuliu, 2012, Contributii Botanice, V47, P25; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Joly S, 2007, SYST BIOL, V56, P857, DOI 10.1080/10635150701633153; Kadereit JW, 2004, PHILOS T R SOC B, V359, P265, DOI 10.1098/rstb.2003.1389; Kolar F, 2013, ANN BOT-LONDON, V111, P1095, DOI 10.1093/aob/mct074; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lihova J, 2009, J BIOGEOGR, V36, P104, DOI 10.1111/j.1365-2699.2008.01998.x; Lindner L, 2003, GEOL Q, V47, P269; Lopez P, 2012, ANN BOT-LONDON, V109, P351, DOI 10.1093/aob/mcr291; Lovka M., 1972, TAXON, V21, P333; Magauer M, 2014, BOT J LINN SOC, V176, P486, DOI 10.1111/boj.12214; MAJOVSKY J, 1978, Acta Facultatis Rerum Naturalium Universitatis Comenianae Botanica, V26, P1; Makos M, 2011, GEOL Q, V55, P253; Merxmuller H., 1953, JB VEREINS ZUM SCHUT, V18, P138; Merxmuller H., 1952, JB VER SCHUTZE ALPEN, V17, P96; Merxmuller H, 1954, JB VEREINS SCHUTZE A, V19, P97; Mraz P, 2007, J BIOGEOGR, V34, P2100, DOI 10.1111/j.1365-2699.2007.01765.x; Muller H, 1881, ALPENBLUMEN IHRE BEF; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ortiz MA, 2008, MOL ECOL, V17, P3654, DOI 10.1111/j.1365-294X.2008.03835.x; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Pachschwoell Clemens, 2013, Contributii Botanice, V48, P7; Pachschwoll C, 2011, BIOLOGIA, V66, P977, DOI 10.2478/s11756-011-0111-5; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Peruzzi L, 2012, PLANT BIOSYST, V146, P867, DOI 10.1080/11263504.2011.634445; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Polatschek A., 1966, OSTERR BOT Z, V113, P101; Pritchard JK, 2000, GENETICS, V155, P945; Ronikier M, 2012, MOL ECOL, V21, P5561, DOI 10.1111/mec.12030; Ronikier M, 2011, TAXON, V60, P373, DOI 10.1002/tax.602008; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanz M, 2014, BOT J LINN SOC, V174, P214, DOI 10.1111/boj.12132; Schmickl R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042691; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schneeweiss GM, 2010, J BIOGEOGR, V37, P2016, DOI 10.1111/j.1365-2699.2010.02350.x; Schneeweiss GM, 2011, MOL ECOL, V20, P190, DOI 10.1111/j.1365-294X.2010.04927.x; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Schonswetter P, 2003, BOT J LINN SOC, V141, P437, DOI 10.1046/j.0024-4074.2002.00134.x; Schonswetter P, 2002, MOL ECOL, V11, P2637, DOI 10.1046/j.1365-294X.2002.01651.x; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Schonswetter P, 2007, MOL PHYLOGENET EVOL, V42, P92, DOI 10.1016/j.ympev.2006.06.016; Schonswetter P, 2009, TAXON, V58, P1326, DOI 10.1002/tax.584020; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SKALINSKA M, 1950, ACTA SOC BOTANICORUM, V20, P45, DOI DOI 10.5586/ASBP.1950.003; Slovak M, 2012, BIOL J LINN SOC, V105, P741, DOI 10.1111/j.1095-8312.2011.01826.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Sonnleitner M, 2010, ANN BOT-LONDON, V106, P967, DOI 10.1093/aob/mcq192; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stejskal J, 1931, ACTA PALAEOBOT, V6, P55; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stuessy T.F., 2009, PLANT TAXONOMY SYSTE; Suda J., 2006, CURR PROTOCOL CYTOM, V38; Suda J, 2007, AM J BOT, V94, P1391, DOI 10.3732/ajb.94.8.1391; Suda J, 2006, TAXON, V55, P447, DOI 10.2307/25065591; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2012, ECOL LETT, V15, P1439, DOI 10.1111/ele.12004; Tackenberg O, 2008, J VEG SCI, V19, P109, DOI 10.3170/2007-8-18338; TASENKEVICH L A, 1989, Botanicheskii Zhurnal (St. Petersburg), V74, P1669; Tel-Zur N, 1999, PLANT MOL BIOL REP, V17, P249, DOI 10.1023/A:1007656315275; Thiel-Egenter C, 2011, J BIOGEOGR, V38, P772, DOI 10.1111/j.1365-2699.2010.02441.x; Travnicek P, 2011, ANN BOT-LONDON, V107, P77, DOI 10.1093/aob/mcq217; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; Tribsch A, 2002, AM J BOT, V89, P2024, DOI 10.3732/ajb.89.12.2024; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Tribsch A, 2010, DATA MINING FOR GLOBAL TRENDS IN MOUNTAIN BIODIVERSITY, P89; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vierhapper F, 1900, STERR BOT Z, V50, P173; Vierhapper F, 1900, STERR BOT Z, V50, P202; Vierhapper F, 1900, STERR BOT Z, V50, P109; Vierhapper F, 1900, STERR BOT Z, V50, P257; Vierhapper F, 1900, STERR BOT Z, V50, P501; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wcis H, 1952, B INT ACAD POL B1 SM, V1951, P147; Widder FJ, 1934, MITT NATURWISS VEREI, V71, P132; Willis KJ, 2004, PHILOS T R SOC B, V359, P159, DOI 10.1098/rstb.2003.1387; Winkler M, 2013, BOT J LINN SOC, V173, P622, DOI 10.1111/boj.12104; Winkler M, 2012, MOL ECOL, V21, P4618, DOI 10.1111/j.1365-294X.2012.05705.x; Winkler M, 2010, MOL PHYLOGENET EVOL, V54, P571, DOI 10.1016/j.ympev.2009.08.009	144	17	18	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118197	10.1371/journal.pone.0118197	http://dx.doi.org/10.1371/journal.pone.0118197			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749621	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400015
J	Bertoldo, MJ; Guibert, E; Faure, M; Rame, C; Foretz, M; Viollet, B; Dupont, J; Froment, P				Bertoldo, Michael J.; Guibert, Edith; Faure, Melanie; Rame, Christelle; Foretz, Marc; Viollet, Benoit; Dupont, Joelle; Froment, Pascal			Specific Deletion of AMP-Activated Protein Kinase (alpha 1AMPK) in Murine Oocytes Alters Junctional Protein Expression and Mitochondrial Physiology	PLOS ONE			English	Article							IN-VITRO MATURATION; MOUSE OOCYTES; DEVELOPMENTAL COMPETENCE; MEIOTIC RESUMPTION; GRANULOSA-CELLS; PROGESTERONE SECRETION; HISTONE DEACETYLATION; PORCINE OOCYTES; FOLLICLE CELLS; COMMUNICATION	Oogenesis and folliculogenesis are dynamic processes that are regulated by endocrine, paracrine and autocrine signals. These signals are exchanged between the oocyte and the somatic cells of the follicle. Here we analyzed the role of AMP-activated protein kinase (AMPK), an important regulator of cellular energy homeostasis, by using transgenic mice deficient in alpha 1AMPK specifically in the oocyte. We found a decrease of 27% in litter size was observed in ZP3-alpha 1AMPK(-/-)(ZP3-KO) female mice. Following in vitro fertilization, where conditions are stressful for the oocyte and embryo, ZP3-KO oocytes were 68% less likely to pass the 2-cell stage. In vivo and in cumulus-oocyte complexes, several proteins involved in junctional communication, such as connexin37 and N-cadherin were downregulated in the absence of alpha 1AMPK. While the two signalling pathways (PKA and MAPK) involved in the junctional communication between the cumulus/granulosa cells and the oocyte were stimulated in control oocytes, ZP3-KO oocytes exhibited only low phosphorylation of MAPK or CREB proteins. In addition, MII oocytes deficient in alpha 1AMPK had a 3-fold lower ATP concentration, an increase in abnormal mitochondria, and a decrease in cytochrome C and PGC1 alpha levels, suggesting perturbed energy production by mitochondria. The absence of alpha 1AMPK also induced a reduction in histone deacetylase activity, which was associated with an increase in histone H3 acetylation (K9/K14 residues). Together, the results of the present study suggest that absence of AMPK, modifies oocyte quality through energy processes and oocyte/somatic cell communication. The limited effect observed in vivo could be partly due to a favourable follicle microenvironment where nutrients, growth factors, and adequate cell interaction were present. Whereas in a challenging environment such as that of in vitro culture following IVF, the phenotype is revealed.	[Bertoldo, Michael J.; Guibert, Edith; Faure, Melanie; Rame, Christelle; Dupont, Joelle; Froment, Pascal] Univ Tours, CNRS, Haras Nationaux Physiol Reprod & Comportements, INRA,UMR 7247, F-37380 Nouzilly, France; [Foretz, Marc; Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit; Dupont, Joelle] CNRS, UMR8104, Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bertoldo, Michael J.] Univ New S Wales, Discipline Obstet & Gynaecol, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of New South Wales Sydney	Froment, P (corresponding author), Univ Tours, CNRS, Haras Nationaux Physiol Reprod & Comportements, INRA,UMR 7247, F-37380 Nouzilly, France.	pascal.froment@tours.inra.fr	FORETZ, Marc/O-7334-2017; Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Froment, Pascal/0000-0002-7388-9598	Region Centre; Institut National de la Recherche Agronomique; French National Research Agency (ANR)	Region Centre(Region Centre-Val de Loire); Institut National de la Recherche Agronomique; French National Research Agency (ANR)(French National Research Agency (ANR))	Melanie Faure was supported by the Region Centre and Institut National de la Recherche Agronomique (Ph.D Grant). The national FERTiNERGY programme funded by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2006, P NATL ACAD SCI USA, V103, P7339, DOI 10.1073/pnas.0510946103; Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; Alesutan I, 2011, J MEMBRANE BIOL, V240, P151, DOI 10.1007/s00232-011-9353-y; Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; Bendale DS, 2013, BRIT J PHARMACOL, V170, P779, DOI 10.1111/bph.12290; Bertoldo MJ, 2014, CRYOBIOLOGY, V68, P262, DOI 10.1016/j.cryobiol.2014.02.006; Bertoldo MJ, 2014, REPRODUCTION FERTILI; BROWER PT, 1982, DEV BIOL, V90, P144, DOI 10.1016/0012-1606(82)90219-6; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Cerda J, 1999, BIOL REPROD, V61, P692, DOI 10.1095/biolreprod61.3.692; Chen J, 2006, DEV BIOL, V291, P227, DOI 10.1016/j.ydbio.2005.11.039; Chen J, 2008, DEV BIOL, V313, P47, DOI 10.1016/j.ydbio.2007.09.043; Chi Y, 2014, J CELL SCI, V127, P1487, DOI 10.1242/jcs.139089; Choi T, 1996, P NATL ACAD SCI USA, V93, P4730, DOI 10.1073/pnas.93.10.4730; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; DOWNS SM, 1994, DEV BIOL, V162, P154, DOI 10.1006/dbio.1994.1075; Downs SM, 2006, MOL REPROD DEV, V73, P1159, DOI 10.1002/mrd.20439; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Edry I, 2006, MOL CELL ENDOCRINOL, V252, P102, DOI 10.1016/j.mce.2006.03.009; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Frank LA, 2014, HUM REPROD, V29, P1292, DOI 10.1093/humrep/deu066; Froment P, 2004, ENDOCRINOLOGY, V145, P2080, DOI 10.1210/en.2003-0956; Froment P, 2008, CELL CYCLE, V7, P3098, DOI 10.4161/cc.7.19.6807; Fu X, 2013, MOL CELL BIOL, V33, P4517, DOI 10.1128/MCB.01078-13; Funahashi H, 1997, BIOL REPROD, V57, P49, DOI 10.1095/biolreprod57.1.49; Gabriel AM, 2009, INT J BIOCHEM CELL B, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; Gharibi S, 2013, THERIOGENOLOGY, V80, P302, DOI 10.1016/j.theriogenology.2013.04.012; Gittens JEI, 2005, J CELL SCI, V118, P5071, DOI 10.1242/jcs.02624; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; Hernandez M, 2006, PROSTATE, V66, P1151, DOI 10.1002/pros.20451; Jennings PC, 2011, HUM REPROD, V26, P878, DOI 10.1093/humrep/deq393; Jorgensen JS, 2013, MOL REPROD DEV, V80, P960, DOI 10.1002/mrd.22232; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalma Y, 2004, ENDOCRINOLOGY, V145, P1617, DOI 10.1210/en.2003-1051; Kidder GM, 2010, CAN J PHYSIOL PHARM, V88, P399, DOI [10.1139/Y10-009, 10.1139/y10-009]; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; LaRosa C, 2006, BIOL REPROD, V74, P585, DOI 10.1095/biolreprod.105.046524; LaRosa C, 2007, BIOL REPROD, V76, P476, DOI 10.1095/biolreprod.106.057422; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Luciano AM, 2004, BIOL REPROD, V70, P465, DOI 10.1095/biolreprod.103.020644; Machell NH, 2003, REPRODUCTION, V125, P791, DOI 10.1530/rep.0.1250791; Mayes MA, 2007, BIOL REPROD, V76, P589, DOI 10.1095/biolreprod.106.057828; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; MOLEY KH, 1991, J REPROD FERTIL, V93, P325; Nakano A, 2012, GENES CELLS, V17, P737, DOI 10.1111/j.1365-2443.2012.01629.x; Nelson LE, 2012, AM J PHYSIOL-CELL PH, V303, pC4, DOI 10.1152/ajpcell.00296.2011; Ogawa T, 2005, CANCER RES, V65, P9771, DOI 10.1158/0008-5472.CAN-05-0227; Peluso JJ, 2006, REPRODUCTION, V131, P429, DOI 10.1530/rep.1.00863; Perez GI, 2000, NATURE, V403, P500, DOI 10.1038/35000651; QUINN P, 1973, J REPROD FERTIL, V35, P301, DOI 10.1530/jrf.0.0350301; Ratchford AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1198, DOI 10.1152/ajpendo.00097.2007; Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495; Reverchon M, 2013, MOL HUM REPROD, V19, P313, DOI 10.1093/molehr/gat002; Rufas O, 2000, MOL HUM REPROD, V6, P163, DOI 10.1093/molehr/6.2.163; Schelbach CJ, 2010, REPROD FERT DEVELOP, V22, P771, DOI 10.1071/RD09193; Silvestre MFP, 2014, LIFE SCI, V100, P55, DOI 10.1016/j.lfs.2014.01.080; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Tartarin P, 2012, ENDOCRINOLOGY, V153, P3468, DOI 10.1210/en.2011-1911; Thomas RE, 2004, BIOL REPROD, V70, P548, DOI 10.1095/biolreprod.103.021204; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Tosca L, 2005, ENDOCRINOLOGY, V146, P4500, DOI 10.1210/en.2005-0301; Tosca L, 2007, BIOL REPROD, V77, P452, DOI 10.1095/biolreprod.107.060848; Tosca L, 2006, J ENDOCRINOL, V190, P85, DOI 10.1677/joe.1.06828; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Ya R, 2014, ZYGOTE, V22, P91, DOI 10.1017/S0967199412000457; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zheng HX, 2013, EUR J CANCER, V49, P2734, DOI 10.1016/j.ejca.2013.03.014; Ziv S, 2002, MOL REPROD DEV, V62, P547, DOI 10.1002/mrd.10149	74	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119680	10.1371/journal.pone.0119680	http://dx.doi.org/10.1371/journal.pone.0119680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767884	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500092
J	Ferru-Clement, R; Fresquet, F; Norez, C; Metaye, T; Becq, F; Kitzis, A; Thoreau, V				Ferru-Clement, Romain; Fresquet, Fleur; Norez, Caroline; Metaye, Thierry; Becq, Frederic; Kitzis, Alain; Thoreau, Vincent			Involvement of the Cdc42 Pathway in CFTR Post-Translational Turnover and in Its Plasma Membrane Stability in Airway Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; CYSTIC-FIBROSIS GENE; RHO-GTPASES; ENDOCYTIC TRAFFICKING; FUNCTIONAL EXPRESSION; VESICLE TRAFFICKING; ACTIN CYTOSKELETON; CHLORIDE CHANNEL; QUALITY-CONTROL; N-WASP	Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel that is expressed on the apical plasma membrane (PM) of epithelial cells. The most common deleterious allele encodes a trafficking-defective mutant protein undergoing endoplasmic reticulum-associated degradation (ERAD) and presenting lower PM stability. In this study, we investigated the involvement of the Cdc42 pathway in CFTR turnover and trafficking in a human bronchiolar epithelial cell line (CFBE41o-) expressing wild-type CFTR. Cdc42 is a small GTPase of the Rho family that fulfils numerous cell functions, one of which is endocytosis and recycling process via actin cytoskeleton remodelling. When we treated cells with chemical inhibitors such as ML141 against Cdc42 and wiskostatin against the downstream effector N-WASP, we observed that CFTR channel activity was inhibited, in correlation with a decrease in CFTR amount at the cell surface and an increase in dynamin-dependent CFTR endocytosis. Anchoring of CFTR to the cortical cytoskeleton was then presumably impaired by actin disorganization. When we performed siRNA-mediated depletion of Cdc42, actin polymerization was not impacted, but we observed actin-independent consequences upon CFTR. Total and PM CFTR amounts were increased, resulting in greater activation of CFTR. Pulse-chase experiments showed that while CFTR degradation was slowed, CFTR maturation through the Golgi apparatus remained unaffected. In addition, we observed increased stability of CFTR in PM and reduction of its endocytosis. This study highlights the involvement of the Cdc42 pathway at several levels of CFTR biogenesis and trafficking: (i) Cdc42 is implicated in the first steps of CFTR biosynthesis and processing; (ii) it contributes to the stability of CFTR in PM via its anchoring to cortical actin; (iii) it promotes CFTR endocytosis and presumably its sorting toward lysosomal degradation.	[Ferru-Clement, Romain; Fresquet, Fleur; Kitzis, Alain; Thoreau, Vincent] Univ Poitiers, Lab Genet Malad Rares, Poitiers, France; [Fresquet, Fleur; Kitzis, Alain] Ctr Hosp Univ Poitiers, Serv Genet, Poitiers, France; [Norez, Caroline; Becq, Frederic] Univ Poitiers, CNRS, Lab Signalisat & Transports Ion Membranaires, Poitiers, France; [Metaye, Thierry] Ctr Hosp Univ Poitiers, Lab Biophys Med, Poitiers, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Thoreau, V (corresponding author), Univ Poitiers, Lab Genet Malad Rares, Poitiers, France.	vincent.thoreau@univ-poitiers.fr	Becq, Frederic/P-9233-2016; Norez, Caroline/P-9567-2016	Becq, Frederic/0000-0003-3915-0973; Ferru-Clement, Romain/0000-0001-5309-0861	University of Poitiers; French Ministry of Higher Education and Research; Vaincre la Mucoviscidose	University of Poitiers; French Ministry of Higher Education and Research; Vaincre la Mucoviscidose	This work was supported by the University of Poitiers, the French Ministry of Higher Education and Research and Vaincre la Mucoviscidose (www.vaincrelamuco.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Aspenstrom P, 2014, BIOL CHEM, V395, P477, DOI 10.1515/hsz-2013-0296; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Benharouga M, 2003, J BIOL CHEM, V278, P22079, DOI 10.1074/jbc.M301030200; Bilan F, 2008, EXP CELL RES, V314, P2199, DOI 10.1016/j.yexcr.2008.04.012; Bompard G, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-42; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Chen HY, 2013, EMBO MOL MED, V5, P723, DOI 10.1002/emmm.201202140; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Collaco A, 2010, J BIOL CHEM, V285, P17177, DOI 10.1074/jbc.M110.127613; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fischer H, 1995, J PHYSIOL-LONDON, V489, P745, DOI 10.1113/jphysiol.1995.sp021088; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Ganeshan R, 2007, BBA-MOL CELL RES, V1773, P192, DOI 10.1016/j.bbamcr.2006.09.031; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Guerriero CJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1562, DOI 10.1152/ajpcell.00426.2006; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; HOOGEVEEN AT, 1991, EXP CELL RES, V193, P435, DOI 10.1016/0014-4827(91)90118-E; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; Norez Caroline, 2004, J Cyst Fibros, V3 Suppl 2, P119, DOI 10.1016/j.jcf.2004.05.025; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; PRAT AG, 1995, AM J PHYSIOL-CELL PH, V268, pC1552, DOI 10.1152/ajpcell.1995.268.6.C1552; Prat AG, 1999, AM J PHYSIOL-CELL PH, V277, pC1160, DOI 10.1152/ajpcell.1999.277.6.C1160; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Surviladze Z., 2010, PROBE REPORTS NIH MO; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Tang BL, 2011, TRAFFIC, V12, P364, DOI 10.1111/j.1600-0854.2011.01161.x; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118943	10.1371/journal.pone.0118943	http://dx.doi.org/10.1371/journal.pone.0118943			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768293	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500055
J	Perroni, F; Guidetti, L; Cignitti, L; Baldari, C				Perroni, Fabrizio; Guidetti, Laura; Cignitti, Lamberto; Baldari, Carlo			Absolute vs. Weight-Related Maximum Oxygen Uptake in Firefighters: Fitness Evaluation with and without Protective Clothing and Self-Contained Breathing Apparatus among Age Group	PLOS ONE			English	Article							COLLEGE STEP TEST; PHYSIOLOGICAL-RESPONSES; METABOLIC DEMANDS; PHYSICAL-FITNESS; SIMULATED RESCUE; AEROBIC CAPACITY; FIRE FIGHTERS; RISK-FACTORS; PERFORMANCE; VALIDITY	During fire emergencies, firefighters wear personal protective devices (PC) and a self-contained breathing apparatus (S.C.B.A.) to be protected from injuries. The purpose of this study was to investigate the differences of aerobic level in 197 firefighters (age: 34 +/- 7 yr; BMI: 24.4 +/- 2.3 kg.m(-2)), evaluated by a Queen's College Step field Test (QCST), performed with and without fire protective garments, and to analyze the differences among age groups (<25 yr; 26-30 yr, 31-35 yr, 36-40 yr and >40 yr). Variance analysis was applied to assess differences (p < 0.05) between tests and age groups observed in absolute and weight-related values, while a correlation was examined between QCST with and without PC+S.C.B.A. The results have shown that a 13% of firefighters failed to complete the test with PC+S.C.B.A. and significant differences between QCST performed with and without PC+S.C.B.A. in absolute (F(1,169) = 42.6, p < 0.0001) and weight-related (F(1,169) = 339.9, p < 0.0001) terms. A better correlation has been found in L.min(-1) (r=0.67) than in ml.kg(-1).min(-1) (r=0.54). Moreover, we found significant differences among age groups both in absolute and weightrelated values. The assessment of maximum oxygen uptake of firefighters in absolute term can be a useful tool to evaluate the firefighters' cardiovascular strain.	[Perroni, Fabrizio] Univ Turin, Dept Med Sci, Sch Exercise & Sport Sci SUISM, Turin, Italy; [Guidetti, Laura; Baldari, Carlo] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Cignitti, Lamberto] Italian Fire Fighter Corp, Rome, Italy	University of Turin; Foro Italico University of Rome	Baldari, C (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.	carlo.baldari@uniroma4.it	Guidetti, Laura/K-1142-2014; Baldari, Carlo/N-6756-2014	Guidetti, Laura/0000-0002-1419-4550; Perroni, Fabrizio/0000-0003-2094-4351; Baldari, Carlo/0000-0001-6227-3571	Italian Firefighters Corp	Italian Firefighters Corp	The authors would like to express their gratitude to the Italian Firefighters Corp for the support in carrying out the experimental sessions.	ASTRAND I, 1960, Acta Physiol Scand Suppl, V49, P1; Bakri I, 2012, ERGONOMICS, V55, P782, DOI 10.1080/00140139.2012.663506; Barr D, 2010, APPL ERGON, V41, P161, DOI 10.1016/j.apergo.2009.07.001; Bilzon JLJ, 2001, ERGONOMICS, V44, P766, DOI 10.1080/00140130118253; Chatterjee S, 2005, INDIAN J MED RES, V121, P32; Chatterjee S, 2004, BRIT J SPORT MED, V38, P289, DOI 10.1136/bjsm.2002.002212; Cohen J.E., 1988, STAT POWER ANAL BEHA; Donovan R, 2009, OCCUP MED-OXFORD, V59, P487, DOI 10.1093/occmed/kqp095; Dreger RW, 2007, APPL PHYSIOL NUTR ME, V32, P454, DOI 10.1139/H07-020; Eglin CM, 2004, ERGONOMICS, V47, P483, DOI 10.1080/0014013031000107568; Elsner KL, 2008, ERGONOMICS, V51, P1418, DOI 10.1080/00140130802120259; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P207; Griefahn B, 2003, APPL ERGON, V34, P157, DOI 10.1016/S0003-6870(02)00143-6; Hammer RL, 2013, J STRENGTH COND RES, V27, P1435, DOI 10.1519/JSC.0b013e318265aaf7; Holmer I, 2007, APPL ERGON, V38, P45, DOI 10.1016/j.apergo.2006.01.004; Hopkins WG, 2013, NEW VIEW STAT; HOROWITZ MR, 1993, CAN J PUBLIC HEALTH, V84, P50; Knapik JJ, 2001, MED SCI SPORT EXER, V33, P946, DOI 10.1097/00005768-200106000-00014; Lindberg AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068047; Mattila VM, 2007, MED SCI SPORT EXER, V39, P1061, DOI 10.1249/01.mss.0b013e318053721d; MCARDLE WD, 1972, MED SCI SPORT EXER, V4, P182; Michaelides MA, 2008, RES Q EXERCISE SPORT, V79, P468, DOI 10.1080/02701367.2008.10599513; National Fire Protection Association, 2007, NFPA ASS 1500 STAND; OCONNELL ER, 1986, J OCCUP ENVIRON MED, V28, P282; Oldham JA, 2000, OCCUP MED-OXFORD, V50, P599, DOI 10.1093/occmed/50.8.599; Perroni F, 2009, ERGONOMICS, V52, P484, DOI 10.1080/00140130802707873; Perroni F., 2014, OPEN SPORTS SCI J, V7, P8, DOI [DOI 10.2174/1875399X01407010008, 10.2174/1875399X01407010008]; Perroni F, 2008, SPORT SCI HLTH, V4, P27; Perroni F, 2014, APPL ERGON, V45, P456, DOI 10.1016/j.apergo.2013.06.005; Perroni F, 2010, J STRENGTH COND RES, V24, P3457, DOI 10.1519/JSC.0b013e3181b2c7ff; Portney LG, 2009, FDN CLIN RES APPL PR; Punakallio A, 1997, EXPERIENCE INNOVATIO; Punakallio A, 2012, J OCCUP ENVIRON MED, V54, P1133, DOI 10.1097/JOM.0b013e3182554b11; Qu XD, 2011, J BIOMECH, V44, P1259, DOI 10.1016/j.jbiomech.2011.02.016; Rhea MR, 2004, J STRENGTH COND RES, V18, P348; Richmond VL, 2008, ERGONOMICS, V51, P1023, DOI 10.1080/00140130801939709; Rodriguez-Marroyo JA, 2011, ERGONOMICS, V54, P1101, DOI 10.1080/00140139.2011.611895; SAUPE K, 1991, AM J PUBLIC HEALTH, V81, P1192, DOI 10.2105/AJPH.81.9.1192; Smith DL, 1997, ERGONOMICS, V40, P500, DOI 10.1080/001401397188125; Smith DL, 2005, ERGONOMICS, V48, P55, DOI 10.1080/00140130412331303911; SOTHMANN MS, 1992, J OCCUP ENVIRON MED, V34, P797, DOI 10.1097/00043764-199208000-00014; Swank AM, 2000, J STRENGTH COND RES, V14, P170; TRAFIMOW JH, 1993, SPINE, V18, P364, DOI 10.1097/00007632-199303000-00011; von Heimburg ED, 2006, ERGONOMICS, V49, P111, DOI 10.1080/00140130500435793; von Heimburg E, 2013, INT J OCCUP SAF ERGO, V19, P227, DOI 10.1080/10803548.2013.11076981; Williams-Bell FM, 2009, MED SCI SPORT EXER, V41, P653, DOI 10.1249/MSS.0b013e31818ad117; Williford HN, 1999, ERGONOMICS, V42, P1179, DOI 10.1080/001401399185063	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119757	10.1371/journal.pone.0119757	http://dx.doi.org/10.1371/journal.pone.0119757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764201	gold, Green Published			2022-12-27	WOS:000351276300032
J	Segura, J; Marin-Lopez, MA; Jones, PF; Oliva, B; Fernandez-Fuentes, N				Segura, Joan; Alejandro Marin-Lopez, Manuel; Jones, Pamela F.; Oliva, Baldo; Fernandez-Fuentes, Narcis			VORFFIP-Driven Dock: V-(DOCK)-O-2, a Fast and Accurate Protein Docking Strategy	PLOS ONE			English	Article							SERVER; INFORMATION; COMPLEXES; ALGORITHM; DIAGRAMS	The experimental determination of the structure of protein complexes cannot keep pace with the generation of interactomic data, hence resulting in an ever-expanding gap. As the structural details of protein complexes are central to a full understanding of the function and dynamics of the cell machinery, alternative strategies are needed to circumvent the bottleneck in structure determination. Computational protein docking is a valid and valuable approach to model the structure of protein complexes. In this work, we describe a novel computational strategy to predict the structure of protein complexes based on data-driven docking: VORFFIP-driven dock (V-D2OCK). This new approach makes use of our newly described method to predict functional sites in protein structures, VORFFIP, to define the region to be sampled during docking and structural clustering to reduce the number of models to be examined by users. V-D2OCK has been benchmarked using a validated and diverse set of protein complexes and compared to a state-of-art docking method. The speed and accuracy compared to contemporary tools justifies the potential use of (VDOCK)-O-2 for high-throughput, genome-wide, protein docking. Finally, we have developed a web interface that allows users to browser and visualize V-D2OCK predictions from the convenience of their web-browsers.	[Segura, Joan; Jones, Pamela F.; Fernandez-Fuentes, Narcis] Univ Leeds, Sch Med, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Alejandro Marin-Lopez, Manuel; Oliva, Baldo] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Struct Bioinformat Lab GRIB IMIM, Barcelona 08003, Catalonia, Spain	University of Leeds; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University	Fernandez-Fuentes, N (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3EB, Dyfed, Wales.	narcis.fernandez@gmail.com	Gasull, Martina/J-4076-2019; Oliva, Baldomero/A-2690-2009	Oliva, Baldomero/0000-0003-0702-0250; Segura, Joan/0000-0001-5593-735X; Fernandez-Fuentes, Narcis/0000-0002-6421-1080; Marin Lopez, Manuel Alejandro/0000-0003-0833-3574	Research Councils UK (RCUK) under the RCUK Academic Fellowship program (NFF); University of Leeds; Spanish Ministry of Economy and Competitiveness; Generalitat of Catalonia [FI-DGR2012];  [BIO2011-22568]; BBSRC [BBS/E/W/10962A01D] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10962A01D] Funding Source: researchfish	Research Councils UK (RCUK) under the RCUK Academic Fellowship program (NFF); University of Leeds; Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat of Catalonia; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Research Councils UK (RCUK) under the RCUK Academic Fellowship program (NFF) and a PhD scholarship awarded by the University of Leeds (JS). BO acknowledges support from the Spanish Ministry of Economy and Competitiveness; grant number BIO2011-22568 and MAML a PhD scholarship awarded by the Generalitat of Catalonia (FI-DGR2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Feliu E, 2011, PROTEIN SCI, V20, P529, DOI 10.1002/pro.585; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Kirby TW, 2006, J BIOL CHEM, V281, P38466, DOI 10.1074/jbc.M606917200; Kummel D, 2006, J MOL BIOL, V361, P22, DOI 10.1016/j.jmb.2006.06.012; Lesk VI, 2008, BIOINFORMATICS, V24, P1137, DOI 10.1093/bioinformatics/btn093; Li B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-7; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Segura J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-352; Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118107	10.1371/journal.pone.0118107	http://dx.doi.org/10.1371/journal.pone.0118107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763838	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300011
J	Sabbagh, HJ; Hassan, MHA; Innes, NPT; Elkodary, HM; Little, J; Mossey, PA				Sabbagh, Heba J.; Hassan, Mona Hassan Ahmed; Innes, Nicola P. T.; Elkodary, Heba M.; Little, Julian; Mossey, Peter A.			Passive Smoking in the Etiology of Non-Syndromic Orofacial Clefts: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ENVIRONMENTAL TOBACCO-SMOKE; NONSMOKING PREGNANT-WOMEN; SECONDHAND SMOKE; ORAL CLEFTS; MATERNAL SMOKING; RISK-FACTORS; CIGARETTE-SMOKING; EXPOSURE; CHINA; COTININE	Background Studies have found a consistent positive association between maternal smoking and non-syndromic orofacial clefts (NSOFC). However, no comprehensive assessment of the association between NSOFC and passive smoking has been undertaken. This systematic review and meta-analysis explores the relationship between maternal passive smoking and NSOFC, and compares the associations between passive and active smoking. Methods and Findings Search strategy, inclusion / exclusion criteria, and data extraction from studies reporting maternal passive smoking and NSOFC was implemented without language restrictions. Risks of bias in the identified studies were assessed and this information was used in sensitivity analyses to explain heterogeneity. Meta-analysis and meta-regression of the extracted data were performed. Egger's test was used to test for small study effects. Fourteen eligible articles were identified. Maternal passive smoking exposure was associated with a twofold increase in risk of NSOFC (odds ratio: 2.11, 95% confidence interval: 1.54-2.89); this was apparent for both cleft lip with and without palate (OR: 2.05, 95% CI: 1.27-3.3) and cleft palate (OR: 2.11, 95% CI: 1.23-3.62). There was substantial heterogeneity between studies. In the studies that provided data enabling crude and adjusted odd ratios to be compared, adjustment for potential confounders attenuated the magnitude of association to about a 1.5-fold increase in risk. Conclusion Overall, maternal passive smoking exposure results in a 1.5 fold increase in risk of NSOFC, similar to the magnitude of risk reported for active smoking, but there is marked heterogeneity between studies. This heterogeneity is not explained by differences in the distribution of cleft types, adjustment for covariates, broad geographic region, or study bias/quality. This thorough meta-analysis provides further evidence to minimize exposure to environmental tobacco smoke in policy making fora and in health promotion initiatives.	[Sabbagh, Heba J.; Elkodary, Heba M.] King Abdulaziz Univ, Fac Dent, Dept Pediat Dent, Jeddah 21413, Saudi Arabia; [Sabbagh, Heba J.] Univ Dundee, Dept Oral Hlth Sci, Dundee, Scotland; [Hassan, Mona Hassan Ahmed] King Abdulaziz Univ, Fac Dent, Dept Dent Publ Hlth, Jeddah 21413, Saudi Arabia; [Hassan, Mona Hassan Ahmed] Univ Alexandria, High Inst Publ Hlth, Dept Biostat, Alexandria, Egypt; [Innes, Nicola P. T.] Univ Dundee, Dept Oral Hlth Sci, Paediat Dent, Dundee, Scotland; [Elkodary, Heba M.] Al Azhar Univ, Fac Med Dent, Girls Branch, Cairo, Egypt; [Little, Julian] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Human Genome Epidemiol, Ottawa, ON, Canada; [Mossey, Peter A.] Univ Dundee, Div Oral Hlth Sci, Dundee, Scotland; [Mossey, Peter A.] Univ Dundee, WHO Collaborating Ctr Oral Hlth & Craniofacial An, Dundee, Scotland	King Abdulaziz University; University of Dundee; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Alexandria University; University of Dundee; Egyptian Knowledge Bank (EKB); Al Azhar University; University of Ottawa; University of Dundee; University of Dundee	Sabbagh, HJ (corresponding author), King Abdulaziz Univ, Fac Dent, Dept Pediat Dent, Jeddah 21413, Saudi Arabia.	hjsabbagh@gmail.com	Elkhodary, Heba/GNO-9779-2022; Sabbagh, Heba/GZK-8259-2022; Little, Julian/AAR-6117-2020; Innes, Nicola/G-3703-2015; Hassan, Mona HA/J-4084-2013; Hassan, Mona/N-4505-2014	Elkhodary, Heba/0000-0002-3593-3025; Little, Julian/0000-0001-5026-5531; Innes, Nicola/0000-0002-9984-0012; Hassan, Mona/0000-0003-3678-5877; Mossey, Peter/0000-0002-9914-6901; Sabbagh, Heba/0000-0002-9788-0379	WHO Collaborating Centre for Oral Health and Craniofacial Anomalies at the University of Dundee Dental School; King Abdulaziz University	WHO Collaborating Centre for Oral Health and Craniofacial Anomalies at the University of Dundee Dental School; King Abdulaziz University	This study was conducted under the auspices of (1) the WHO Collaborating Centre for Oral Health and Craniofacial Anomalies at the University of Dundee Dental School; (2) King Abdulaziz University. Professor Julian Little holds a tier 1 Canada Research Chair in Human Genome Epidemiology.	[Anonymous], 2014, REV MAN REVMAN COMP; [Anonymous], WHY TOB IS PUBL HLTH; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Beaty TH, 2001, ANN EPIDEMIOL, V11, P434, DOI 10.1016/S1047-2797(01)00222-8; Chen CI, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-359; Chevrier C, 2008, AM J MED GENET A, V146A, P2396, DOI 10.1002/ajmg.a.32505; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Honein MA, 2007, EPIDEMIOLOGY, V18, P226, DOI 10.1097/01.ede.0000254430.61294.c0; Jia ZL, 2011, ORAL DIS, V17, P584, DOI 10.1111/j.1601-0825.2011.01810.x; Jianyan L, 2010, INT J ORAL MAX SURG, V39, P50, DOI 10.1016/j.ijom.2009.10.010; KAUFMAN NJ, 2001, WOMEN TOBACCO EPIDEM, P69; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Leite Isabel Cristina Gonçalves, 2009, Braz. oral res., V23, P31, DOI 10.1590/S1806-83242009000100006; Leonardi-Bee J, 2011, PEDIATRICS, V127, P734, DOI 10.1542/peds.2010-3041; Li L, 2011, AM J MED GENET A, V155A, P2940, DOI 10.1002/ajmg.a.34254; Li ZW, 2010, EPIDEMIOLOGY, V21, P240, DOI 10.1097/EDE.0b013e3181c9f941; Lie RT, 2008, EPIDEMIOLOGY, V19, P606, DOI 10.1097/EDE.0b013e3181690731; Little J, 2004, CLEFT PALATE-CRAN J, V41, P381, DOI 10.1597/02-142.1; Little J, 2004, B WORLD HEALTH ORGAN, V82, P213; Loke AY, 2000, ACTA OBSTET GYN SCAN, V79, P947, DOI 10.1034/j.1600-0412.2000.079011947.x; MAKIN J, 1991, NEUROTOXICOL TERATOL, V13, P5, DOI 10.1016/0892-0362(91)90021-N; Menzies D, 2011, CURR OPIN PULM MED, V17, P116, DOI 10.1097/MCP.0b013e328341ce98; Mirilas P, 2011, INT J PEDIATR OTORHI, V75, P695, DOI 10.1016/j.ijporl.2011.02.018; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Nieuwenhuijsen MJ, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-6; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Salmasi G, 2010, ACTA OBSTET GYN SCAN, V89, P423, DOI 10.3109/00016340903505748; Shaw GM, 1996, AM J HUM GENET, V58, P551; Sims M, 2012, ENVIRON HEALTH PERSP, V120, P425, DOI 10.1289/ehp.1103680; Surgeon General, 2014, HLTH CONS SMOK 50 YE; Taghavi N, 2012, IRAN RED CRESCENT ME, V14, P25; Wang W, 2009, PAEDIATR PERINAT EP, V23, P310, DOI 10.1111/j.1365-3016.2009.01025.x; Wen WQ, 2006, BMJ-BRIT MED J, V333, P376, DOI 10.1136/bmj.38834.522894.2F; WINDSOR RA, 2001, WOMEN TOBACCO EPIDEM, P147; Wong SL, 2013, NICOTINE TOB RES, V15, P693, DOI 10.1093/ntr/nts195; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Zhang B, 2011, J CRANIO MAXILL SURG, V39, P313, DOI 10.1016/j.jcms.2010.07.005	39	65	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116963	10.1371/journal.pone.0116963	http://dx.doi.org/10.1371/journal.pone.0116963			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760440	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000010
J	Anthony, SM; Howard, ME; Hailemichael, Y; Overwijk, WW; Schluns, KS				Anthony, Scott M.; Howard, Megan E.; Hailemichael, Yared; Overwijk, Willem W.; Schluns, Kimberly S.			Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways	PLOS ONE			English	Article							DENDRITIC CELLS; IL-15 EXPRESSION; ANTITUMOR-ACTIVITY; CUTTING EDGE; NK CELLS; ALPHA; TRANS; HOMEOSTASIS; INDUCTION; RECEPTOR	Interleukin (IL)-15 associates with IL-15R alpha on the cell surface where it can be cleaved into soluble cytokine/receptor complexes that have the potential to stimulate CD8 T cells and NK cells. Unfortunately, little is known about the in vivo production of soluble IL-15R alpha/IL-15 complexes (sIL-15 complexes), particularly regarding the circumstances that induce them and the mechanisms responsible. The main objective of this study was to elucidate the signals leading to the generation of sIL-15 complexes. In this study, we show that sIL-15 complexes are increased in the serum of mice in response to Interferon (IFN)-alpha. In bone marrow derived dendritic cells (BMDC), IFN-alpha increased the activity of ADAM17, a metalloproteinase implicated in cleaving IL-15 complexes from the cell surface. Moreover, knocking out ADAM17 in BMDCs prevented the ability of IFN-alpha to induce sIL-15 complexes demonstrating ADAM17 as a critical protease mediating cleavage of IL-15 complexes in response to type I IFNs. Type I IFN signaling was required for generating sIL-15 complexes as in vivo induction of sIL-15 complexes by Poly I:C stimulation or total body irradiation (TBI) was impaired in IFNAR-/- mice. Interestingly, serum sIL-15 complexes were also induced in mice infected with Vesicular stomatitis virus (VSV) or mice treated with agonistic CD40 antibodies; however, sIL-15 complexes were still induced in IFNAR-/- mice after VSV infection or CD40 stimulation indicating pathways other than type I IFNs induce sIL-15 complexes. Overall, this study has shown that type I IFNs, VSV infection, and CD40 stimulation induce sIL-15 complexes suggesting the generation of sIL-15 complexes is a common event associated with immune activation. These findings reveal an unrealized mechanism for enhanced immune responses occurring during infection, vaccination, inflammation, and autoimmunity.	[Anthony, Scott M.; Howard, Megan E.; Schluns, Kimberly S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Anthony, Scott M.; Overwijk, Willem W.; Schluns, Kimberly S.] Univ Texas Houston, Grad Sch Biomed Sci, Grad Program Immunol, Houston, TX 77025 USA; [Hailemichael, Yared; Overwijk, Willem W.] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Schluns, KS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	kschluns@mdanderson.org	Schluns, Kimberly/R-5635-2019	Anthony, Scott/0000-0002-1590-7401	National Institutes of Health (NIH) [CA009598]; NIH [R01 CA143077]; MD Anderson Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009598, P30CA016672, R01CA143077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health (NIH) training grant CA009598 (to SMA), NIH R01 CA143077 (to WWO) and by the MD Anderson Cancer Foundation via the Institutional Research Grant program at the University of Texas MD Anderson Cancer Center (to KSS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bamford RN, 1998, J IMMUNOL, V160, P4418; Bamford RN, 1996, J LEUKOCYTE BIOL, V59, P476, DOI 10.1002/jlb.59.4.476; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Burnette BC, 2011, CANCER RES, V71, P2488, DOI 10.1158/0008-5472.CAN-10-2820; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Castillo EF, 2012, CYTOKINE, V59, P479, DOI 10.1016/j.cyto.2012.06.017; Castillo EF, 2009, J IMMUNOL, V183, P4948, DOI 10.4049/jimmunol.0900719; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Colpitts SL, 2013, J IMMUNOL, V191, P3017, DOI 10.4049/jimmunol.1301389; Colpitts SL, 2012, J IMMUNOL, V188, P2483, DOI 10.4049/jimmunol.1103609; Doherty TM, 1996, J IMMUNOL, V156, P735; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois SP, 2005, P NATL ACAD SCI USA, V102, P8662, DOI 10.1073/pnas.0503360102; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Khawam K, 2009, CANCER RES, V69, P1561, DOI 10.1158/0008-5472.CAN-08-3198; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; Mitani A, 1999, IMMUNOLOGY, V97, P92; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Nestle FO, 2005, J INVEST DERMATOL, V125, pXIV, DOI 10.1111/j.0022-202X.2005.23923.x; Nishimura H, 2000, J EXP MED, V191, P157, DOI 10.1084/jem.191.1.157; Nishimura H, 1996, J IMMUNOL, V156, P663; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Sakai T, 1998, GASTROENTEROLOGY, V114, P1237, DOI 10.1016/S0016-5085(98)70430-5; Sandau MM, 2007, J IMMUNOL, V179, P120, DOI 10.4049/jimmunol.179.1.120; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sikora AG, 2009, J IMMUNOL, V182, P7398, DOI 10.4049/jimmunol.0802982; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Stonier SW, 2008, BLOOD, V112, P4546, DOI 10.1182/blood-2008-05-156307; Tamzalit F, 2014, P NATL ACAD SCI USA, V111, P8565, DOI 10.1073/pnas.1405514111; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Verbist KC, 2011, J IMMUNOL, V186, P174, DOI 10.4049/jimmunol.1002613; Villadsen LS, 2003, J CLIN INVEST, V112, P1571, DOI 10.1172/JCI200318986; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Zhang ML, 2012, J IMMUNOL, V188, P6156, DOI 10.4049/jimmunol.1102604; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	46	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120274	10.1371/journal.pone.0120274	http://dx.doi.org/10.1371/journal.pone.0120274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756182	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700063
J	Boe, AE; Eren, M; Morales-Nebreda, L; Murphy, SB; Budinger, GRS; Mutlu, GM; Miyata, T; Vaughan, DE				Boe, Amanda E.; Eren, Mesut; Morales-Nebreda, Luisa; Murphy, Sheila B.; Budinger, G. R. Scott; Mutlu, Goekhan M.; Miyata, Toshio; Vaughan, Douglas E.			Nitric Oxide Prevents Alveolar Senescence and Emphysema in a Mouse Model	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR SYSTEM; SMOKE-INDUCED EMPHYSEMA; PULMONARY-EMPHYSEMA; OXIDATIVE STRESS; SYNTHASE; HYPERTENSION; INHIBITION; MICE; EXPRESSION; GROWTH	N-omega-nitro-L-arginine methyl ester (L-NAME) treatment induces arteriosclerosis and vascular senescence. Here, we report that the systemic inhibition of nitric oxide (NO) production by L-NAME causes pulmonary emphysema. L-NAME-treated lungs exhibited both the structural (alveolar tissue destruction) and functional (increased compliance and reduced elastance) characteristics of emphysema development. Furthermore, we found that L-NAME-induced emphysema could be attenuated through both genetic deficiency and pharmacological inhibition of plasminogen activator inhibitor-1 (PAI-1). Because PAI-1 is an important contributor to the development of senescence both in vitro and in vivo, we investigated whether L-NAME-induced senescence led to the observed emphysematous changes. We found that L-NAME treatment was associated with molecular and cellular evidence of premature senescence in mice, and that PAI-1 inhibition attenuated these increases. These findings indicate that NO serves to protect and defend lung tissue from physiological aging.	[Boe, Amanda E.; Eren, Mesut; Morales-Nebreda, Luisa; Murphy, Sheila B.; Budinger, G. R. Scott; Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Boe, Amanda E.; Murphy, Sheila B.; Vaughan, Douglas E.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Mutlu, Goekhan M.] Univ Chicago, Dept Med, Pulm & Crit Care Sect, Chicago, IL 60637 USA; [Miyata, Toshio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med ART, Sendai, Miyagi 980, Japan	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Chicago; Tohoku University	Vaughan, DE (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	d-vaughan@northwestern.edu	Mutlu, Gokhan/HIR-2545-2022; Miyata, Toshio/A-4872-2010; Eren, Mesut/J-3818-2016	Morales-Nebreda, Luisa/0000-0002-7126-0518	National Institutes of Health [1P01HL108795-01, R01HL051387]; Northwestern University's Center for Advanced Microscopy; Cancer Center Support Grant [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108795, R01HL051387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University's Center for Advanced Microscopy; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants 1P01HL108795-01 and R01HL051387, both awarded to DEV by the National Institutes of Health (www.nih.gov). This work was also supported by Northwestern University's Center for Advanced Microscopy and a Cancer Center Support Grant (NCI CA060553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera JA, 2001, AM J RESP CRIT CARE, V164, P709, DOI 10.1164/ajrccm.164.4.2101023; Boe AE, 2013, CIRCULATION; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Ferrer E, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-76; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Ito H, 2013, SURG TODAY, V43, P293, DOI 10.1007/s00595-012-0293-7; Kaikita K, 2002, J MOL CELL CARDIOL, V34, P617, DOI 10.1006/jmcc.2002.2001; Kaikita K, 2001, CIRCULATION, V104, P839, DOI 10.1161/hc3301.092803; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Lanzetti M, 2012, FREE RADICAL BIO MED, V53, P1993, DOI 10.1016/j.freeradbiomed.2012.09.015; Leuwerke SM, 2002, AM J PHYSIOL-LUNG C, V282, pL1272, DOI 10.1152/ajplung.00490.2001; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Siafakas Nikolaos M, 2007, Int J Chron Obstruct Pulmon Dis, V2, P453; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; To M, 2013, CHEST, V144, P515, DOI 10.1378/chest.12-2381; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Valenca SS, 2011, PULM PHARMACOL THER, V24, P587, DOI 10.1016/j.pupt.2011.05.006; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Xu X, 2009, EXP LUNG RES, V35, P795, DOI 10.3109/01902140902912519; Zhang Y, 2012, J INT MED RES, V40, P976, DOI 10.1177/147323001204000316	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116504	10.1371/journal.pone.0116504	http://dx.doi.org/10.1371/journal.pone.0116504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756287	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275700005
J	Glaser, T; Lewandowski, J; Dusing, J				Glaser, Tina; Lewandowski, Joshua; Duesing, Jessica			The Long and Winding Road to Uncertainty: The Link between Spatial Distance and Feelings of Uncertainty	PLOS ONE			English	Article							PSYCHOLOGICAL DISTANCE; CONSTRUAL-LEVEL; PROBABILITY; INFORMATION; FOREST	Construal Level Theory (CLT) [1] defines psychological distance as any object, event, or person that cannot be experienced by the self in the here and now. The goal of the present research was to demonstrate that feelings of uncertainty are closely linked to the concept of psychological distance. Two experiments tested the assumption that spatial distance and uncertainty are bidirectionally related. In the first experiment, we show that perceived spatial distance leads to a feeling of uncertainty. The second experiment revealed that a feeling of uncertainty leads to a perception of greater distance. By demonstrating that distance is closely tied to uncertainty, the present research extends previous research on both distance and uncertainty by incorporating previously unexplained findings within CLT. Implications of these findings such as the role of uncertainty within CLT are discussed.	[Glaser, Tina] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [Lewandowski, Joshua] Claremont Grad Univ, Sch Behav & Org Sci, Claremont, CA USA; [Duesing, Jessica] Univ Trier, Dept Psychol, Trier, Germany	University of Bielefeld; Claremont Colleges; Claremont Graduate School; Universitat Trier	Glaser, T (corresponding author), Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany.	tina.glaser@uni-bielefeld.de		Glaser, Tina/0000-0003-2955-6910	young academics of the University of Bielefeld	young academics of the University of Bielefeld	The work was funded by a research grant for young academics of the University of Bielefeld, awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Anan Y, 2007, J EXP PSYCHOL GEN, V136, P610, DOI 10.1037/0096-3445.136.4.610; Bar-Anan Y, 2009, EMOTION, V9, P123, DOI 10.1037/a0014607; BERLYNE DE, 1962, BRIT J PSYCHOL, V53, P27, DOI 10.1111/j.2044-8295.1962.tb00811.x; CLORE GL, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P133; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; de Bruin WB, 2000, ORGAN BEHAV HUM DEC, V81, P115, DOI 10.1006/obhd.1999.2868; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Forster J, 2004, J PERS SOC PSYCHOL, V87, P177, DOI 10.1037/0022-3514.87.2.177; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; GILBERT DT, 1990, J PERS SOC PSYCHOL, V59, P601, DOI 10.1037/0022-3514.59.4.601; Hansen J, 2010, PERS SOC PSYCHOL B, V36, P1576, DOI 10.1177/0146167210386238; Helzer EG, 2012, SOC COGNITION, V30, P519, DOI 10.1521/soco.2012.30.5.519; Hogg MA, 2007, ADV EXP SOC PSYCHOL, V39, P69, DOI 10.1016/S0065-2601(06)39002-8; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; KAGAN J, 1972, J PERS SOC PSYCHOL, V22, P51, DOI 10.1037/h0032356; Karelitz TM, 2004, J EXP PSYCHOL-APPL, V10, P25, DOI 10.1037/1076-898X.10.1.25; Knight, 1933, RISK UNCERTAINTY PRO; Liberman N, 2002, J EXP SOC PSYCHOL, V38, P523, DOI 10.1016/S0022-1031(02)00535-8; Liberman N., 2007, SOCIAL PSYCHOL HDB B, P353; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Maglio SJ, 2013, J EXP PSYCHOL GEN, V142, P644, DOI 10.1037/a0030258; Marguc J, 2011, J PERS SOC PSYCHOL, V101, P883, DOI 10.1037/a0025013; Namkoong JE, 2014, SOC PSYCHOL PERS SCI, V5, P352, DOI 10.1177/1948550613499240; Nussbaum S, 2006, J EXP PSYCHOL GEN, V135, P152, DOI 10.1037/0096-3445.135.2.152; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; Smith PK, 2006, J PERS SOC PSYCHOL, V90, P578, DOI 10.1037/0022-3514.90.4.578; Snodgrass JG, 1975, EXPT SENSORY PSYCHOL, P17; Tormala ZL, 2007, SOC PERSONAL PSYCHOL, V1, P469, DOI 10.1111/j.1751-9004.2007.00025.x; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2011, HDB THEORIES SOCIAL, P118, DOI DOI 10.4135/9781446249215.N7; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van den Bos K, 2009, PSYCHOL INQ, V20, P197, DOI 10.1080/10478400903333411; VELTEN E, 1968, BEHAV RES THER, V6, P473, DOI 10.1016/0005-7967(68)90028-4; Wakslak C, 2009, PSYCHOL SCI, V20, P52, DOI 10.1111/j.1467-9280.2008.02250.x; Wakslak CJ, 2006, J EXP PSYCHOL GEN, V135, P641, DOI 10.1037/0096-3445.135.4.641; Wakslak CJ, 2012, ORGAN BEHAV HUM DEC, V117, P150, DOI 10.1016/j.obhdp.2011.10.004; WEARY G, 1994, J PERS SOC PSYCHOL, V67, P308, DOI 10.1037/0022-3514.67.2.308; Wichman AL, 2008, J EXP SOC PSYCHOL, V44, P1106, DOI 10.1016/j.jesp.2007.12.002; Windschitl PD, 1999, J EXP PSYCHOL LEARN, V25, P1514, DOI 10.1037/0278-7393.25.6.1514	40	2	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119108	10.1371/journal.pone.0119108	http://dx.doi.org/10.1371/journal.pone.0119108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756619	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700038
J	Grieshaber, NA; Tattersall, JS; Liguori, J; Lipat, JN; Runac, J; Grieshaber, SS				Grieshaber, Nicole A.; Tattersall, Jeremiah S.; Liguori, Johella; Lipat, Joseph N.; Runac, Justin; Grieshaber, Scott S.			Identification of the Base-Pairing Requirements for Repression of hctA Translation by the Small RNA IhtA Leads to the Discovery of a New mRNA Target in Chlamydia trachomatis	PLOS ONE			English	Article							HISTONE H1-LIKE PROTEIN; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; DEVELOPMENTAL CYCLE; GENE-EXPRESSION; NONCODING RNAS; HC1; DNA; REGULATOR; FEATURES	The non-coding small RNA, IhtA expressed by the obligate intracellular human pathogen Chlamydia trachomatis modulates the translation of HctA, a key protein involved in replicative to infectious cell type differentiation. Using a combination of bioinformatics and mutagenesis we sought to identify the base pairing requirement for functional repression of HctA protein expression, with an eye to applying our findings towards the identification of additional targets. IhtA is predicted to fold into a three stem: loop structure. We found that loop 1 occludes the initiation codon of hctA, while loop 2 and 3 are not required for function. This 7 nucleotide region forms G/C rich interactions surrounding the AUG of hctA. Two additional genes in the chlamydial genome, CTL0322 and CTL0097, contained some elements of the hctA: IhtA recognition sequence. The mRNA of both CTL0322and CTL0097 interacted with IhtA in vitro as measured by biolayer interferometry. However, using a CheZ reporter expression system, IhtA only inhibited the translation of CTL0322. The proposed IhtA recognition site in the CTL0322message contains significant G/C base pairing on either side of the initiation codon while CTL0097 only contains G/C base pairing 3' to the AUG initiation codon. These data suggest that as the functional interacting region is only 6-7nt in length that full translation repression is dependent on the degree of G/C base pairing. Additionally our results indicate that IhtA may regulate multiple mRNAs involved in the chlamydial infectious cycle.	[Grieshaber, Nicole A.; Grieshaber, Scott S.] Univ Idaho, Coll Sci, Dept Biol Sci, Moscow, ID 83843 USA; [Tattersall, Jeremiah S.; Liguori, Johella; Lipat, Joseph N.; Runac, Justin] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA	Idaho; University of Idaho; State University System of Florida; University of Florida	Grieshaber, SS (corresponding author), Univ Idaho, Coll Sci, Dept Biol Sci, Moscow, ID 83843 USA.	scottg@uidaho.edu			National Institutes of Health, National Institutes of Allergy and Infectious Diseases [AI079193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079193, R21AI113617] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health, National Institutes of Allergy and Infectious Diseases, http://www.niaid.nih.gov/Pages/default.aspx, grant AI079193 to NAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2011, NUCLEIC ACIDS RES, V39, P1843, DOI 10.1093/nar/gkq1065; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARRY CE, 1992, SCIENCE, V256, P377, DOI 10.1126/science.256.5055.377; BARRY CE, 1993, MOL MICROBIOL, V9, P273, DOI 10.1111/j.1365-2958.1993.tb01689.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Chabelskaya S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000927; CHRISTIANSEN G, 1993, J BACTERIOL, V175, P1785, DOI 10.1128/JB.175.6.1785-1795.1993; Coornaert A, 2010, MOL MICROBIOL, V76, P467, DOI 10.1111/j.1365-2958.2010.07115.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FAHR MJ, 1995, J BACTERIOL, V177, P4252, DOI 10.1128/jb.177.15.4252-4260.1995; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Grieshaber NA, 2004, P NATL ACAD SCI USA, V101, P7451, DOI 10.1073/pnas.0400754101; Grieshaber NA, 2006, J BACTERIOL, V188, P5289, DOI 10.1128/JB.00526-06; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; HACKSTADT T, 1991, P NATL ACAD SCI USA, V88, P3937, DOI 10.1073/pnas.88.9.3937; HUANG CX, 1993, BIOCHIM BIOPHYS ACTA, V1202, P297, DOI 10.1016/0167-4838(93)90019-N; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; KUO SC, 1987, J BACTERIOL, V169, P1307, DOI 10.1128/jb.169.3.1307-1314.1987; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; PEDERSEN LB, 1994, MOL MICROBIOL, V11, P1085, DOI 10.1111/j.1365-2958.1994.tb00385.x; PERARA E, 1992, P NATL ACAD SCI USA, V89, P2125, DOI 10.1073/pnas.89.6.2125; Richter AS, 2012, RNA BIOL, V9, P954, DOI 10.4161/rna.20294; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; TAO S, 1991, J BACTERIOL, V173, P2818, DOI 10.1128/JB.173.9.2818-2822.1991; Tattersall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047439; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; WHO, 2001, GLOBAL PREVALENCE AN	49	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116593	10.1371/journal.pone.0116593	http://dx.doi.org/10.1371/journal.pone.0116593			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756658	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700008
J	Iaccarino, L; Crespi, C; Della Rosa, PA; Catricala, E; Guidi, L; Marcone, A; Tagliavini, F; Magnani, G; Cappa, SF; Perani, D				Iaccarino, Leonardo; Crespi, Chiara; Della Rosa, Pasquale Anthony; Catricala, Eleonora; Guidi, Lucia; Marcone, Alessandra; Tagliavini, Fabrizio; Magnani, Giuseppe; Cappa, Stefano F.; Perani, Daniela			The Semantic Variant of Primary Progressive Aphasia: Clinical and Neuroimaging Evidence in Single Subjects	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; CEREBRAL GLUCOSE-METABOLISM; ANTERIOR TEMPORAL-LOBE; WHITE-MATTER DAMAGE; BEHAVIORAL FEATURES; ALZHEIMERS-DISEASE; DEMENTIA; ATROPHY; LANGUAGE; PATTERNS	Background/Aim We present a clinical-neuroimaging study in a series of patients with a clinical diagnosis of semantic variant of primary progressive aphasia (svPPA), with the aim to provide clinical-functional correlations of the cognitive and behavioral manifestations at the single-subject level. Methods We performed neuropsychological investigations, F-18-FDG-PET single-subject and group analysis, with an optimized SPM voxel-based approach, and correlation analyses. A measurement of white matter integrity by means of diffusion tensor imaging (DTI) was also available for a subgroup of patients. Results Cognitive assessment confirmed the presence of typical semantic memory deficits in all patients, with a relative sparing of executive, attentional, visuo-constructional, and episodic memory domains. F-18-FDG-PET showed a consistent pattern of cerebral hypometabolism across all patients, which correlated with performance in semantic memory tasks. In addition, a majority of patients also presented with behavioral disturbances associated with metabolic dysfunction in limbic structures. In a subgroup of cases the DTI analysis showed FA abnormalities in the inferior longitudinal and uncinate fasciculi. Discussion Each svPPA individual had functional derangement involving an extended, connected system within the left temporal lobe, a crucial part of the verbal semantic network, as well as an involvement of limbic structures. The latter was associated with behavioral manifestations and extended beyond the area of atrophy shown by CT scan. Conclusion Single-subject F-18-FDG-PET analysis can account for both cognitive and behavioral alterations in svPPA. This provides useful support to the clinical diagnosis.	[Iaccarino, Leonardo; Crespi, Chiara; Perani, Daniela] Univ Vita Salute San Raffaele, Milan, Italy; [Iaccarino, Leonardo; Crespi, Chiara; Perani, Daniela] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Crespi, Chiara; Cappa, Stefano F.; Perani, Daniela] Univ Vita Salute San Raffaele, CERMAC, Milan, Italy; [Della Rosa, Pasquale Anthony; Perani, Daniela] CNR, Ist Bioimmagini & Fisiol Mol, Segrate, Italy; [Catricala, Eleonora; Guidi, Lucia; Cappa, Stefano F.] IUSS, Pavia, Italy; [Marcone, Alessandra] Hosp San Raffaele, Dept Clin Neurosci, I-20132 Milan, Italy; [Tagliavini, Fabrizio] IRCCS Fdn, Carlo Besta Neurol Inst, Milan, Italy; [Magnani, Giuseppe] Hosp San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Perani, Daniela] Hosp San Raffaele, Nucl Med Unit, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); IUSS PAVIA; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Perani, D (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	perani.daniela@hsr.it	Cappa, Stefano/B-1874-2014; Rosa, Pasquale Anthony Della/AAC-3459-2019; Crespi, Chiara/H-5251-2018; Perani, Daniela/AAN-3221-2020; Crespi, Chiara/M-9039-2019; Crespi, Chiara/K-6484-2016; Tagliavini, Fabrizio/AAO-7891-2021; Magnani, Giuseppe/AAN-2242-2020	Cappa, Stefano/0000-0003-1003-3925; Rosa, Pasquale Anthony Della/0000-0002-3137-1731; Crespi, Chiara/0000-0002-7851-9887; Crespi, Chiara/0000-0002-7851-9887; Crespi, Chiara/0000-0002-7851-9887; Tagliavini, Fabrizio/0000-0003-1039-7315; Magnani, Giuseppe/0000-0001-8436-2903; catricala, eleonora/0000-0003-1622-4415	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This research was supported by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2011, BRAIN, V134, P2025, DOI 10.1093/brain/awr119; Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288; Agosta F, 2014, NEUROBIOL AGING, V35, P2646, DOI 10.1016/j.neurobiolaging.2014.05.017; Agosta F, 2010, BRAIN, V133, P286, DOI 10.1093/brain/awp233; Ali N, 2010, J COGNITIVE NEUROSCI, V22, P2369, DOI 10.1162/jocn.2009.21352; Ash S, 2006, NEUROLOGY, V66, P1405, DOI 10.1212/01.wnl.0000210435.72614.38; Basso A, 1987, Funct Neurol, V2, P189; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Blaizot X, 2010, CEREB CORTEX, V20, P2198, DOI 10.1093/cercor/bhp289; Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178; Brambati SM, 2009, NEUROBIOL AGING, V30, P103, DOI 10.1016/j.neurobiolaging.2007.05.014; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Carlesimo GA, 1995, ARCH NEUROLOGIA PSIC, P1; Catani M, 2012, ATLAS OF HUMAN BRAIN; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Catricala E, 2013, NEUROL SCI, V34, P985, DOI 10.1007/s10072-012-1181-z; Cerami C, 2013, J ALZHEIMERS DIS, V36, P415, DOI 10.3233/JAD-130317; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Chare L, 2014, J NEUROL NEUROSUR PS, V85, P866, DOI 10.1136/jnnp-2013-306948; Chen KHM, 2010, BRAIN COGNITION, V72, P400, DOI 10.1016/j.bandc.2009.11.007; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Davies RR, 2009, NEUROBIOL AGING, V30, P2043, DOI 10.1016/j.neurobiolaging.2008.02.005; de Zubicaray GI, 2011, NEUROIMAGE, V54, P1488, DOI 10.1016/j.neuroimage.2010.08.058; Della Rosa PA, 2014, NEUROINFORMATICS, V12, P575, DOI 10.1007/s12021-014-9235-4; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Desgranges B, 2007, NEUROBIOL AGING, V28, P1904, DOI 10.1016/j.neurobiolaging.2006.08.006; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl-Schmid J, 2006, DEMENT GERIATR COGN, V22, P346, DOI 10.1159/000095624; Drzezga A, 2008, NEUROIMAGE, V39, P619, DOI 10.1016/j.neuroimage.2007.09.020; EdwardsLee T, 1997, BRAIN, V120, P1027, DOI 10.1093/brain/120.6.1027; Fan L, 2013, CEREB CORTEX, P1; Farias ST, 2005, AM J NEURORADIOL, V26, P2492; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Galton CJ, 2001, NEUROLOGY, V57, P216, DOI 10.1212/WNL.57.2.216; Gamboz N, 2009, NEUROL SCI, V30, P453, DOI 10.1007/s10072-009-0130-y; Gefen T, 2013, NEUROLOGY, V81, P658, DOI 10.1212/WNL.0b013e3182a08f83; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Guo CC, 2013, BRAIN, V136, P2979, DOI 10.1093/brain/awt222; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Howard D, 1992, PURAMIDS PALM TREES; Kertesz A, 2003, J INT NEUROPSYCH SOC, V9, P710, DOI 10.1017/S1355617703950041; Kertesz A, 2010, ARCH NEUROL-CHICAGO, V67, P483, DOI 10.1001/archneurol.2010.55; Kim EJ, 2012, DEMENT GERIATR COGN, V34, P300, DOI 10.1159/000345506; La Joie R, 2014, NEURON, V81, P1417, DOI 10.1016/j.neuron.2014.01.026; Lauro-Grotto R, 1997, CORTEX, V33, P593, DOI 10.1016/S0010-9452(08)70720-2; Liljestrom M, 2009, HUM BRAIN MAPP, V30, P1845, DOI 10.1002/hbm.20785; LUDERS H, 1991, BRAIN, V114, P743, DOI 10.1093/brain/114.2.743; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marczinski CA, 2006, BRAIN LANG, V97, P258, DOI 10.1016/j.bandl.2005.11.001; MCCARTHY R, 1990, NATURE, V343, P599, DOI 10.1038/343599a0; MCCARTHY RA, 1988, NATURE, V334, P428, DOI 10.1038/334428a0; Mesulam MM, 2013, NEUROLOGY, V81, P456, DOI 10.1212/WNL.0b013e31829d87df; Miceli G., 1994, BATTERIA LANALISI DE; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Mummery CJ, 2000, ANN NEUROL, V47, P36; Mummery CJ, 1999, BRAIN, V122, P61, DOI 10.1093/brain/122.1.61; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nestor PJ, 2006, NEUROIMAGE, V30, P1010, DOI 10.1016/j.neuroimage.2005.10.008; Noppeney U, 2007, BRAIN, V130, P1138, DOI 10.1093/brain/awl344; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P278; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Pascual B, 2013, CEREB CORTEX, P1; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Perani D, 2014, NEUROIMAGE-CLIN, V6, P445, DOI 10.1016/j.nicl.2014.10.009; Pijnenburg YAL, 2004, DEMENT GERIATR COGN, V17, P302, DOI 10.1159/000077159; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Rankin KP, 2003, NEUROLOGY, V60, P266, DOI 10.1212/01.WNL.0000041497.07694.D2; Rohrer JD, 2010, NEUROLOGY, V75, P2204, DOI 10.1212/WNL.0b013e318202038c; Rohrer JD, 2009, NEUROLOGY, V72, P1562, DOI 10.1212/WNL.0b013e3181a4124e; Rosen HJ, 2006, NEUROLOGY, V67, P1752, DOI 10.1212/01.wnl.0000247630.29222.34; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rosen HJ, 2002, BRAIN, V125, P2286, DOI 10.1093/brain/awf225; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schwindt GC, 2013, HUM BRAIN MAPP, V34, P973, DOI 10.1002/hbm.21484; Seeley WW, 2005, NEUROLOGY, V64, P1384, DOI 10.1212/01.WNL.0000158425.46019.5C; Snowden J., 1989, BEHAV NEUROL, V2, P167, DOI [DOI 10.1093/NEUCAS/1.1.39-Y, https://doi.org/10.1155/1989/124043, DOI 10.1155/1989/124043]; Snowden JS, 2004, BRAIN, V127, P860, DOI 10.1093/brain/awh099; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Spinnler H, 1987, ITALIAN J NEUROLOGIC, P1; Tan LH, 2011, P NATL ACAD SCI USA, V108, P2540, DOI 10.1073/pnas.0909623108; Tan RH, 2014, BRAIN, P1; Tettamanti M, 2005, NEUROREPORT, V16, P397, DOI 10.1097/00001756-200503150-00018; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; TYRRELL PJ, 1990, BRAIN, V113, P1321, DOI 10.1093/brain/113.5.1321; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Visser M, 2011, J COGNITIVE NEUROSCI, V23, P3121, DOI 10.1162/jocn_a_00007; Visser M, 2010, J COGNITIVE NEUROSCI, V22, P1083, DOI 10.1162/jocn.2009.21309; Vitali P, 2005, BRAIN LANG, V93, P32, DOI 10.1016/j.bandl.2004.08.005; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Whitwell JL, 2010, NEUROLOGY, V74, P1279, DOI 10.1212/WNL.0b013e3181d9edde; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910	104	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120197	10.1371/journal.pone.0120197	http://dx.doi.org/10.1371/journal.pone.0120197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756991	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275700061
J	Alvankarian, J; Majlis, BY				Alvankarian, Jafar; Majlis, Burhanuddin Yeop			Exploiting the Oxygen Inhibitory Effect on UV Curing in Microfabrication: A Modified Lithography Technique	PLOS ONE			English	Article							FRONTAL PHOTOPOLYMERIZATION; MICROFLUIDIC DEVICE; ACRYLATE COATINGS	Rapid prototyping (RP) of microfluidic channels in liquid photopolymers using standard lithography (SL) involves multiple deposition steps and curing by ultraviolet (UV) light for the construction of a microstructure layer. In this work, the conflicting effect of oxygen diffusion and UV curing of liquid polyurethane methacrylate (PUMA) is investigated in microfabrication and utilized to reduce the deposition steps and to obtain a monolithic product. The conventional fabrication process is altered to control for the best use of the oxygen presence in polymerization. A novel and modified lithography technique is introduced in which a single step of PUMA coating and two steps of UV exposure are used to create a microchannel. The first exposure is maskless and incorporates oxygen diffusion into PUMA for inhibition of the polymerization of a thin layer from the top surface while the UV rays penetrate the photopolymer. The second exposure is for transferring the patterns of the microfluidic channels from the contact photomask onto the uncured material. The UV curing of PUMA as the main substrate in the presence of oxygen is characterized analytically and experimentally. A few typical elastomeric microstructures are manufactured. It is demonstrated that the obtained heights of the fabricated structures in PUMA are associated with the oxygen concentration and the UV dose. The proposed technique is promising for the RP of molds and microfluidic channels in terms of shorter processing time, fewer fabrication steps and creation of microstructure layers with higher integrity.	[Alvankarian, Jafar; Majlis, Burhanuddin Yeop] Natl Univ Malaysia, Inst Microengn & Nanoelect, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya	Alvankarian, J (corresponding author), Natl Univ Malaysia, Inst Microengn & Nanoelect, Bangi, Selangor, Malaysia.	alvankarian@gmail.com			Universiti Kebangsaan Malaysia (UKM); Ministry of Higher Education of Malaysia [DIP-2012-16]	Universiti Kebangsaan Malaysia (UKM); Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	The present research was financially supported by Universiti Kebangsaan Malaysia (UKM) and Ministry of Higher Education of Malaysia under grant DIP-2012-16 (Nanoelectronics and MEMS sensors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvankarian J, 2013, BIOMICROFLUIDICS, P7; Alvankarian J, 2012, SEM EL ICSE 2012 10, P333; Alvankarian J, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/3/035006; [Anonymous], 2001, PROGR POLYM SCI, V26, P605; [Anonymous], CONSIDERATI IN PRESS; Buhler N, 1995, PURE APPL CHEM, V67, P7; Cabral JT, 2004, LANGMUIR, V20, P10020, DOI 10.1021/la049501e; Cramer NB, 2008, POLYMER, V49, P4756, DOI 10.1016/j.polymer.2008.08.051; Cui YY, 2007, POLYMER, V48, P5994, DOI 10.1016/j.polymer.2007.08.013; Cui YY, 2007, EUR POLYM J, V43, P3912, DOI 10.1016/j.eurpolymj.2007.06.047; Decker C, 2004, JCT RES, V1, P127, DOI 10.1007/s11998-004-0007-1; Dendukuri D, 2008, MACROMOLECULES, V41, P8547, DOI 10.1021/ma801219w; Haraldsson KT, 2006, SENSOR ACTUAT B-CHEM, V113, P454, DOI 10.1016/j.snb.2005.03.096; Jeong HE, 2009, NANOSCALE, V1, P331, DOI 10.1039/b9nr00106a; Jeong HE, 2008, LAB CHIP, V8, P1787, DOI 10.1039/b810348h; Kuo JS, 2009, LAB CHIP, V9, P870, DOI 10.1039/b818873d; Littlejohns JV, 2007, CHEM ENG J, V129, P67, DOI 10.1016/j.cej.2006.11.002; Natarajan S, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/4/045021; Studer K, 2003, PROG ORG COAT, V48, P101, DOI 10.1016/S0300-9440(03)00149-8; Studer K, 2003, PROG ORG COAT, V48, P92, DOI 10.1016/S0300-9440(03)00120-6	20	18	18	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119658	10.1371/journal.pone.0119658	http://dx.doi.org/10.1371/journal.pone.0119658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747514	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400083
J	Cao, CN; Luo, JW; Gao, L; Yi, JL; Huang, XD; Wang, K; Zhang, SP; Qu, Y; Li, SY; Xiao, JP; Zhang, Z; Xu, GZ				Cao, Cai-neng; Luo, Jing-wei; Gao, Li; Yi, Jun-lin; Huang, Xiao-dong; Wang, Kai; Zhang, Shi-ping; Qu, Yuan; Li, Su-yan; Xiao, Jian-ping; Zhang, Zhong; Xu, Guo-zhen			Concurrent Chemotherapy for T4 Classification Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							POSITIVE PROGNOSTIC-FACTOR; ACUTE ORGAN TOXICITY; RADIATION; OUTCOMES; CANCER; METAANALYSIS; EXPERIENCE; UPDATE; TRIAL	Objective To evaluate concurrent chemotherapy for T4 classification nasopharyngeal carcinoma (NPC) treated by intensity-modulated radiotherapy (IMRT). Methods From July 2004 to June 2011, 180 non-metastatic T4 classification NPC patients were retrospectively analyzed. Of these patients, 117 patients were treated by concurrent chemoradiotherapy (CCRT) using IMRT and 63 cases were treated by IMRT alone. Results The median follow-up time was 58.97 months (range, 2.79-114.92) months. For all the patients, the 1, 3 and 5-year local failure-free survival (LFFS) rates were 97.7%, 89.2% and 85.9%, regional failure free survival (RFFS) rates were 98.9%, 94.4% and 94.4%, distant failure-free survival (DFFS) rates were 89.7%, 79.9% and 76.2%, and overall survival (OS) rates were 92.7%, 78.9% and 65.3%, respectively. No statistically significant difference was observed in LFFS, RFFS, DFFS and OS between the CCRT group and the IMRT alone group. No statistically significant difference was observed in acute toxicity except leukopenia (p = 0.000) during IMRT between the CCRT group and the IMRT alone group. Conclusion IMRT alone for T4 classification NPC achieved similar treatment outcomes in terms of disease local control and overall survival as compared to concurrent chemotherapy plus IMRT. However, this is a retrospective study with a limited number of patients, such results need further investigation in a prospective randomized clinical trial.	[Cao, Cai-neng; Luo, Jing-wei; Gao, Li; Yi, Jun-lin; Huang, Xiao-dong; Wang, Kai; Zhang, Shi-ping; Qu, Yuan; Li, Su-yan; Xiao, Jian-ping; Zhang, Zhong; Xu, Guo-zhen] Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, Dept Radiat Oncol, Beijing 100730, Peoples R China; [Cao, Cai-neng] Zhejiang Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Zhejiang Cancer Hospital	Luo, JW (corresponding author), Chinese Acad Med Sci, Canc Hosp, Peking Union Med Coll, Dept Radiat Oncol, Beijing 100730, Peoples R China.	jingweiluo2013@163.com	Xiao, Jian/GYU-4351-2022					Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Cao CN, 2013, ORAL ONCOL, V49, P175, DOI 10.1016/j.oraloncology.2012.08.013; DAHL O, 1994, ACTA ONCOL, V33, P409, DOI 10.3109/02841869409098437; Kam MKM, 2007, J CLIN ONCOL, V25, P4873, DOI 10.1200/JCO.2007.11.5501; Kim Tae Hee, 2008, Cancer Res Treat, V40, P62, DOI 10.4143/crt.2008.40.2.62; Kuhnt T, 1998, STRAHLENTHER ONKOL, V174, P257, DOI 10.1007/BF03038718; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2011, RADIOTHER ONCOL, V98, P15, DOI 10.1016/j.radonc.2010.09.023; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Lin SJ, 2014, RADIOTHER ONCOL, V110, P385, DOI 10.1016/j.radonc.2014.01.011; Loong HH, 2014, ORAL ONCOL, DOI [10.1016/j.oraloncology.2014.01.010.1016/j.radonc.2012.08.013, DOI 10.1016/J.ORALONCOLOGY.2014.01.0]; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Sultanem K, 2000, INT J RADIAT ONCOL, V48, P711, DOI 10.1016/S0360-3016(00)00702-1; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Wang TJC, 2012, J RADIOL ONCOL, V1, P129, DOI 10.1007/s13566-012-0020-4; Wolff HA, 2011, RADIOLOGY, V258, P864, DOI 10.1148/radiol.10100705; Wolff HA, 2011, INT J RADIAT ONCOL, V79, P1467, DOI 10.1016/j.ijrobp.2010.01.010	21	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119101	10.1371/journal.pone.0119101	http://dx.doi.org/10.1371/journal.pone.0119101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747589	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400044
J	Chung, SD; Lee, CZ; Kao, LT; Lin, HC; Tsai, MC; Sheu, JJ				Chung, Shiu-Dong; Lee, Cha-Ze; Kao, Li-Ting; Lin, Herng-Ching; Tsai, Ming-Chieh; Sheu, Jau-Jiuan			Association between Neovascular Age-Related Macular Degeneration and Dementia: A Population-Based Case-Control Study in Taiwan	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RISK-FACTORS; COGNITIVE FUNCTION; VASCULAR DEMENTIA; EYE; IMPAIRMENT; PREVALENCE; ATHEROSCLEROSIS	Background Most available studies focusing on the association between neovascular age-related macular degeneration (AMD) and dementia have conflicting results. This study aimed to investigate the association between previously diagnosed AMD and dementia using a populationbased dataset in Taiwan. Methods Data for this case-control study were retrospectively collected from the Taiwan National Health Insurance Research Database. We identified 13,402 subjects who had a diagnosis of dementia as cases, and 40,206 subjects without dementia as controls. A conditional logistic regression was used to examine the association of dementia with previously diagnosed neovascular AMD. Results We found that of the study sample of 53,608 subjects, 1.01% had previously diagnosed neovascular AMD, 1.35% and 0.90% for cases and the controls, respectively (p<0.001). The conditional logistic regression analysis suggested that the odds ratio of prior neovascular AMD for cases was 1.37 (95% confidence interval: 1.14 similar to 1.65) compared to the controls after adjusting for subjects' age, monthly income, geographic location, urbanization level, and hyperlipidemia, diabetes, hypertension, stroke, ischemic heart disease, and whether or not a subjects underwent cataract surgery prior to index date than controls. Conclusions Dementia subjects were associated with a higher proportion of prior neovascular AMD than were the controls.	[Chung, Shiu-Dong] Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lee, Cha-Ze] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Herng-Ching; Tsai, Ming-Chieh] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sheu, Jau-Jiuan] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Taipei Medical University; Cathay General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Sheu, JJ (corresponding author), Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan.	jjs2239@tmu.edu.tw	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408				Baker ML, 2009, ARCH OPHTHALMOL-CHIC, V127, P667, DOI 10.1001/archophthalmol.2009.30; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Chauhan Ved, 2006, Pathophysiology, V13, P195, DOI 10.1016/j.pathophys.2006.05.004; Chen SJ, 2008, INVEST OPHTH VIS SCI, V49, P3126, DOI 10.1167/iovs.08-1803; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Clemons TE, 2006, ARCH OPHTHALMOL-CHIC, V124, P537; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; Ho YS, 2012, CURR PHARM DESIGN, V18, P15, DOI 10.2174/138161212798919039; Hu CC, 2010, STROKE, V41, P613, DOI 10.1161/STROKEAHA.109.571000; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kaarniranta K, 2011, J ALZHEIMERS DIS, V24, P615, DOI 10.3233/JAD-2011-101908; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Klaver CCW, 1999, AM J EPIDEMIOL, V150, P963; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lindekleiv H, 2013, EYE, V27, P1281, DOI 10.1038/eye.2013.181; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Ong SY, 2012, ARCH OPHTHALMOL-CHIC, V130, P895, DOI 10.1001/archophthalmol.2012.152; Pham TQ, 2006, GERONTOLOGY, V52, P353, DOI 10.1159/000094984; Rovner BW, 2002, AM J GERIAT PSYCHIAT, V10, P305; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wong TY, 2002, AM J OPHTHALMOL, V134, P828; Wortmann M, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt143	33	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120003	10.1371/journal.pone.0120003	http://dx.doi.org/10.1371/journal.pone.0120003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748702	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400091
J	Juhasz, G; Gonda, X; Hullam, G; Eszlari, N; Kovacs, D; Lazary, J; Pap, D; Petschner, P; Elliott, R; Deakin, JFW; Anderson, IM; Antal, P; Lesch, KP; Bagdy, G				Juhasz, Gabriella; Gonda, Xenia; Hullam, Gabor; Eszlari, Nora; Kovacs, David; Lazary, Judit; Pap, Dorottya; Petschner, Peter; Elliott, Rebecca; Deakin, John Francis William; Anderson, Ian Muir; Antal, Peter; Lesch, Klaus-Peter; Bagdy, Gyorgy			Variability in the Effect of 5-HTTLPR on Depression in a Large European Population: The Role of Age, Symptom Profile, Type and Intensity of Life Stressors	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; S-ALLELE; POLYMORPHISM; ASSOCIATION; EVENTS; ANXIETY; METAANALYSIS; NEUROTICISM; HYPOTHESIS; MODERATION	Background Although 5-HTTLPR has been shown to influence the risk of life stress-induced depression in the majority of studies, others have produced contradictory results, possibly due to weak effects and/or sample heterogeneity. Methods In the present study we investigated how age, type and intensity of life-stressors modulate the effect of 5-HTTLPR on depression and anxiety in a European population cohort of over 2300 subjects. Recent negative life events (RLE), childhood adversity (CHA), lifetime depression, Brief Symptoms Inventory (BSI) depression and anxiety scores were determined in each subject. Besides traditional statistical analysis we calculated Bayesian effect strength and relevance of 5-HTTLPR genotypes in specified models. Results The short (s) low expressing allele showed association with increased risk of depression related phenotypes, but all nominally significant effects would turn to non-significant after correction for multiple testing in the traditional analysis. Bayesian effect strength and relevance analysis, however, confirmed the role of 5-HTTLPR. Regarding current (BSI) and lifetime depression 5-HTTLPR-by-RLE interactions were confirmed. Main effect, with other words direct association, was supported with BSI anxiety. With more frequent RLE the prevalence or symptoms of depression increased in ss carriers. Although CHA failed to show an interaction with 5-HTTLPR, in young subjects CHA sensitized towards the depression promoting effect of even mild RLE. Furthermore, the direct association of anxiety with the s allele was driven by young (<= 30) individuals. Limitations Our study is cross-sectional and applies self-report questionnaires. Conclusions Albeit 5-HTTLPR has only weak/moderate effects, the s allele is directly associated with anxiety and modulates development of depression in homogeneous subgroups.	[Juhasz, Gabriella; Gonda, Xenia; Eszlari, Nora; Kovacs, David; Pap, Dorottya; Petschner, Peter; Bagdy, Gyorgy] Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, H-1085 Budapest, Hungary; [Juhasz, Gabriella; Gonda, Xenia; Hullam, Gabor; Eszlari, Nora; Kovacs, David; Pap, Dorottya; Petschner, Peter; Antal, Peter; Bagdy, Gyorgy] Semmelweis Univ, Hungarian Acad Sci, MTA SE Neuropsychopharmacol & Neurochem Res Grp, Budapest, Hungary; [Juhasz, Gabriella; Elliott, Rebecca; Deakin, John Francis William; Anderson, Ian Muir] Univ Manchester, Fac Med & Human Sci, Sch Community Based Med, Neurosci & Psychiat Unit, Manchester, Lancs, England; [Juhasz, Gabriella; Elliott, Rebecca; Deakin, John Francis William; Anderson, Ian Muir] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Gonda, Xenia; Lazary, Judit] Semmelweis Univ, Kutvolgyi Clin Ctr, Dept Clin & Theoret Mental Hlth, H-1085 Budapest, Hungary; [Hullam, Gabor; Antal, Peter] Budapest Univ Technol & Econ, Dept Measurement & Informat Syst, Budapest, Hungary; [Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Div Mol Psychiat, Wurzburg, Germany; [Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci MHENS, Dept Translat Neurosci, NL-6200 MD Maastricht, Netherlands	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; University of Manchester; University of Manchester; Semmelweis University; Budapest University of Technology & Economics; University of Wurzburg; Maastricht University	Juhasz, G (corresponding author), Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, H-1085 Budapest, Hungary.	gabriella.juhasz@manchester.ac.uk	Eszlari, Nora/D-8826-2015; Gonda, Xenia/B-2713-2008; Juhasz, Gabriella/O-1753-2017; Bagdy, György/O-3893-2017; Lesch, Klaus-Peter/J-4906-2013; Petschner, Peter/O-1697-2017; Antal, Peter/G-7894-2012	Eszlari, Nora/0000-0003-4913-028X; Gonda, Xenia/0000-0001-9015-4203; Juhasz, Gabriella/0000-0002-5975-4267; Bagdy, György/0000-0001-8141-3410; Lesch, Klaus-Peter/0000-0001-8348-153X; Petschner, Peter/0000-0002-3198-858X; Anderson, Ian M/0000-0003-2205-9209; Deakin, John/0000-0002-2750-962X; Hullam, Gabor/0000-0002-4765-2351; Elliott, Rebecca/0000-0002-7602-010X; Antal, Peter/0000-0002-4370-2198	Sixth Framework Program of the European Union, NewMood [LSHM-CT-2004-503474]; National Institute for Health Research Manchester Biomedical Research Centre; Hungarian Brain Research Program [KTIA_13_NAP-A-II/14]; National Development Agency [KTIA_NAP_13-1-2013-0001]; Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); Hungarian Academy of Sciences;  [TAMOP-4.2.1.B-09/1/KMR-2010-0001]	Sixth Framework Program of the European Union, NewMood; National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Hungarian Brain Research Program; National Development Agency; Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); Hungarian Academy of Sciences(Hungarian Academy of Sciences); 	The study was supported by the Sixth Framework Program of the European Union, NewMood, LSHM-CT-2004-503474; by the National Institute for Health Research Manchester Biomedical Research Centre; the TAMOP-4.2.1.B-09/1/KMR-2010-0001; by the Hungarian Brain Research Program (Grant KTIA_13_NAP-A-II/14) and National Development Agency (Grant KTIA_NAP_13-1-2013-0001); the Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group). Dr. Gonda is a recipient of the Bolyai Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTAL P, 2006, P 3 EUR WORKSH PROB, P9; Bagdy Gyorgy, 2013, Expert Opin Med Diagn, V7, P417, DOI 10.1517/17530059.2013.821979; Bagdy Gyorgy, 2012, Neuropsychopharmacol Hung, V14, P213; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Brown GW, 2008, J AFFECT DISORDERS, V111, P1, DOI 10.1016/j.jad.2008.04.009; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Culverhouse RC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-304; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699; First MB, 2002, STRUCTURED CLIN INTE; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gonda X, 2007, PSYCHIAT RES, V149, P261, DOI 10.1016/j.psychres.2006.05.014; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hullam Gabor, 2012, Neuropsychopharmacol Hung, V14, P273; Juhasz G, 2011, BIOL PSYCHIAT, V69, P762, DOI 10.1016/j.biopsych.2010.11.019; Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kendler KS, 2012, MOL PSYCHIATR, V17, P377, DOI 10.1038/mp.2011.182; Kirilly E, 2012, ACTA PHYSIOL, V205, P41, DOI 10.1111/j.1748-1716.2012.02402.x; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Lazary J, 2011, TRENDS PHARMACOL SCI, V32, P270, DOI 10.1016/j.tips.2011.02.013; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Madigan D, 1996, COMMUN STAT THEORY, V25, P2493, DOI 10.1080/03610929608831853; McLaughlin KA, 2010, PSYCHOL MED, V40, P1647, DOI 10.1017/S0033291709992121; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murphy DL, 2011, CURR OPIN PHARMACOL, V11, P3, DOI 10.1016/j.coph.2011.02.008; Murphy SE, 2013, MOL PSYCHIATR, V18, P512, DOI 10.1038/mp.2012.19; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; SNAITH RP, 1982, BRIT J PSYCHIAT, V141, P518, DOI 10.1192/bjp.141.5.518; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Team R Core, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Uher R, 2011, J AFFECT DISORDERS, V135, P56, DOI 10.1016/j.jad.2011.03.010	45	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116316	10.1371/journal.pone.0116316	http://dx.doi.org/10.1371/journal.pone.0116316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747798	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400004
J	Larsen, MH; Johnsson, JI; Winberg, S; Wilson, ADM; Hammenstig, D; Thornqvist, PO; Midwood, JD; Aarestrup, K; Hoglund, E				Larsen, Martin H.; Johnsson, Jorgen I.; Winberg, Svante; Wilson, Alexander D. M.; Hammenstig, David; Thornqvist, Per-Ove; Midwood, Jonathan D.; Aarestrup, Kim; Hoglund, Erik			Effects of Emergence Time and Early Social Rearing Environment on Behaviour of Atlantic Salmon: Consequences for Juvenile Fitness and Smolt Migration	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; LIFE-HISTORY STRATEGIES; RAINBOW-TROUT; BROWN TROUT; ECOLOGICAL CONSEQUENCES; COPING STYLES; SALAR L; GROWTH; PERSONALITY; WILD	Consistent individual differences in behaviour have been well documented in a variety of animal taxa, but surprisingly little is known about the fitness and life-history consequences of such individual variation. In wild salmonids, the timing of fry emergence from gravel spawning nests has been suggested to be coupled with individual behavioural traits. Here, we further investigate the link between timing of spawning nest emergence and behaviour of Atlantic salmon (Salmo salar), test effects of social rearing environment on behavioural traits in fish with different emergence times, and assess whether behavioural traits measured in the laboratory predict growth, survival, and migration status in the wild. Atlantic salmon fry were sorted with respect to emergence time from artificial spawning nest into three groups: early, intermediate, and late. These emergence groups were hatchery-reared separately or in co-culture for four months to test effects of social rearing environment on behavioural traits. Twenty fish from each of the six treatment groups were then subjected to three individual-based behavioural tests: basal locomotor activity, boldness, and escape response. Following behavioural characterization, the fish were released into a near-natural experimental stream. Results showed differences in escape behaviour between emergence groups in a net restraining test, but the social rearing environment did not affect individual behavioural expression. Emergence time and social environment had no significant effects on survival, growth, and migration status in the stream, although migration propensity was 1.4 to 1.9 times higher for early emerging individuals that were reared separately. In addition, despite individuals showing considerable variation in behaviour across treatment groups, this was not translated into differences in growth, survival, and migration status. Hence, our study adds to the view that fitness (i.e., growth and survival) and life-history predictions from laboratory measures of behaviour should be made with caution and ideally tested in nature.	[Larsen, Martin H.; Aarestrup, Kim] Tech Univ Denmark, Natl Inst Aquat Resources, Sect Freshwater Fisheries & Ecol, Silkeborg, Denmark; [Johnsson, Jorgen I.; Hammenstig, David] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Winberg, Svante; Thornqvist, Per-Ove] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Wilson, Alexander D. M.; Midwood, Jonathan D.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Wilson, Alexander D. M.; Midwood, Jonathan D.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada; [Hoglund, Erik] Tech Univ Denmark, Natl Inst Aquat Resources, Aquaculture Sect, Hirtshals, Denmark; [Hoglund, Erik] Univ Agder, Res Secretariat, Kristiansand, Norway	Technical University of Denmark; University of Gothenburg; Uppsala University; Carleton University; Carleton University; Technical University of Denmark; University of Agder	Larsen, MH (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Sect Freshwater Fisheries & Ecol, Silkeborg, Denmark.	mhala@aqua.dtu.dk	Wilson, Alexander/B-3329-2011; Winberg, Svante/ABB-6458-2021; Aarestrup, Kim/AAK-9155-2021	Wilson, Alexander/0000-0002-7696-1671; Winberg, Svante/0000-0003-4252-3144; Aarestrup, Kim/0000-0001-8521-6270; Hage Larsen, Martin/0000-0001-9521-835X	Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was conducted as part of the strategic project SMOLTPRO, financed by the Swedish Research Council Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas O., 2011, ATLANTIC SALMON ECOL; Adriaenssens B, 2013, ECOL LETT, V16, P47, DOI 10.1111/ele.12011; Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Adriaenssens B, 2009, TRENDS ECOL EVOL, V24, P179, DOI 10.1016/j.tree.2008.12.003; Andersson MA, 2013, J FISH BIOL, V83, P214, DOI 10.1111/jfb.12153; Andersson MA, 2013, PHYSIOL BEHAV, V116, P30, DOI 10.1016/j.physbeh.2013.03.019; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; BRANNAS E, 1995, EVOL ECOL, V9, P411, DOI 10.1007/BF01237763; Brockmark S, 2010, P ROY SOC B-BIOL SCI, V277, P3035, DOI 10.1098/rspb.2010.0561; Brockmark S, 2010, CAN J FISH AQUAT SCI, V67, P288, DOI 10.1139/F09-185; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; CHANDLER GL, 1988, T AM FISH SOC, V117, P432, DOI 10.1577/1548-8659(1988)117<0432:AGAIOJ>2.3.CO;2; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Conrad JL, 2009, J FISH BIOL, V75, P1410, DOI 10.1111/j.1095-8649.2009.02372.x; DELEANIZ CG, 1993, CAN J ZOOL, V71, P1454, DOI 10.1139/z93-201; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; GLASS NR, 1969, J FISH RES BOARD CAN, V26, P2643, DOI 10.1139/f69-256; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Griffiths S.W., 2011, FISH COGNITION BEHAV, P186, DOI [DOI 10.1002/9781444342536.CH9, 10.1002/9781444342536.ch9]; GUSTAFSONMARJANEN KI, 1983, CAN J FISH AQUAT SCI, V40, P813, DOI 10.1139/f83-106; Gyuris E, 2012, ANIM BEHAV, V84, P103, DOI 10.1016/j.anbehav.2012.04.014; Harwood AJ, 2003, ANIM BEHAV, V65, P1141, DOI 10.1006/anbe.2003.2125; Hojesjo J, 1999, J FISH BIOL, V55, P1009, DOI 10.1111/j.1095-8649.1999.tb00736.x; Hojesjo J, 2002, BEHAV ECOL SOCIOBIOL, V52, P102, DOI 10.1007/s00265-002-0493-z; Hojesjo J, 2011, BEHAV ECOL SOCIOBIOL, V65, P1801, DOI 10.1007/s00265-011-1188-0; Johnsson JI, 1999, FUNCT ECOL, V13, P514, DOI 10.1046/j.1365-2435.1999.00341.x; Jonsson E, 1996, P ROY SOC B-BIOL SCI, V263, P647, DOI 10.1098/rspb.1996.0097; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Larsen M.H., 2013, ANIM BIOTELEM, V1, P1, DOI [10.1186/2050-3385-1-19, DOI 10.1186/2050-3385-1-19]; Lundqvist H, 2010, CONSERVATION MONITORING IN FRESHWATER HABITATS: A PRACTICAL GUIDE AND CASE STUDIES, P207, DOI 10.1007/978-1-4020-9278-7_20; Magnhagen C, 2005, BEHAV ECOL SOCIOBIOL, V57, P295, DOI 10.1007/s00265-004-0834-1; Martin JGA, 2008, ANIM BEHAV, V75, P309, DOI 10.1016/j.anbehav.2007.05.026; Martins CIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028084; MASON JC, 1965, J FISH RES BOARD CAN, V22, P173, DOI 10.1139/f65-015; METCALFE NB, 1992, J FISH BIOL, V41, P93, DOI 10.1111/j.1095-8649.1992.tb03871.x; METCALFE NB, 1995, ANIM BEHAV, V49, P431, DOI 10.1006/anbe.1995.0056; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Niemela PT, 2014, TRENDS ECOL EVOL, V29, P245, DOI 10.1016/j.tree.2014.02.007; Olsen EM, 2001, N AM J FISH MANAGE, V21, P967, DOI 10.1577/1548-8675(2001)021&lt;0967:AEOVIE&gt;2.0.CO;2; Petersson E, 1996, J FISH BIOL, V48, P776, DOI 10.1111/j.1095-8649.1996.tb01471.x; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Pottinger TG, 2006, AQUACULTURE, V256, P140, DOI 10.1016/j.aquaculture.2006.01.023; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Schuett W, 2011, DEV PSYCHOBIOL, V53, P631, DOI 10.1002/dev.20538; Sigourney DB, 2005, N AM J FISH MANAGE, V25, P1016, DOI 10.1577/M04-075.1; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Sloman KA, 2010, PHYSIOL BEHAV, V99, P599, DOI 10.1016/j.physbeh.2010.01.027; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Vaz-Serrano J, 2011, PHYSIOL BEHAV, V103, P359, DOI 10.1016/j.physbeh.2011.02.025; Wilson AJW, 2005, MARINERS MIRROR, V91, P111; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	66	7	7	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119127	10.1371/journal.pone.0119127	http://dx.doi.org/10.1371/journal.pone.0119127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747862	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000350689400046
J	Linhares, MB; Belloy, L; Origgi, FC; Lechner, I; Segner, H; Ryser-Degiorgis, MP				Linhares, Mainity Batista; Belloy, Luc; Origgi, Francesco C.; Lechner, Isabel; Segner, Helmut; Ryser-Degiorgis, Marie-Pierre			Investigating the Role of Free-Ranging Wild Boar (Sus scrofa) in the Re-Emergence of Enzootic Pneumonia in Domestic Pig Herds: A Pathological, Prevalence and Risk-Factor Study	PLOS ONE			English	Article							MYCOPLASMA-HYOPNEUMONIAE INFECTION; RESPIRATORY SYNDROME VIRUS; TIME PCR ASSAYS; SAMPLING SITES; BODY CONDITION; OUTDOOR PIGS; SWINE; TRANSMISSION; POPULATION; DISPERSAL	Enzootic pneumonia (EP) caused by Mycoplasma hyopneumoniae has a significant economic impact on domestic pig production. A control program carried out from 1999 to 2003 successfully reduced disease occurrence in domestic pigs in Switzerland, but recurrent outbreaks suggested a potential role of free-ranging wild boar (Sus scrofa) as a source of reinfection. Since little is known on the epidemiology of EP in wild boar populations, our aims were: (1) to estimate the prevalence of M. hyopneumoniae infections in wild boar in Switzerland; (2) to identify risk factors for infection in wild boar; and (3) to assess whether infection in wild boar is associated with the same gross and microscopic lesions typical of EP in domestic pigs. Nasal swabs, bronchial swabs and lung samples were collected from 978 wild boar from five study areas in Switzerland between October 2011 and May 2013. Swabs were analyzed by qualitative real time PCR and a histopathological study was conducted on lung tissues. Risk factor analysis was performed using multivariable logistic regression modeling. Overall prevalence in nasal swabs was 26.2% (95% CI 23.3-29.3%) but significant geographical differences were observed. Wild boar density, occurrence of EP out-breaks in domestic pigs and young age were identified as risk factors for infection. There was a significant association between infection and lesions consistent with EP in domestic pigs. We have concluded that M. hyopneumoniae is widespread in the Swiss wild boar population, that the same risk factors for infection of domestic pigs also act as risk factors for infection of wild boar, and that infected wild boar develop lesions similar to those found in domestic pigs. However, based on our data and the outbreak pattern in domestic pigs, we propose that spillover from domestic pigs to wild boar is more likely than transmission from wild boar to pigs.	[Linhares, Mainity Batista; Origgi, Francesco C.; Segner, Helmut; Ryser-Degiorgis, Marie-Pierre] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland; [Belloy, Luc] Inst Galli Valerio, Dept Terr & Environm, Lab Anal Vet, Lausanne, Switzerland; [Lechner, Isabel] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Bern, Switzerland	University of Bern; University of Bern	Ryser-Degiorgis, MP (corresponding author), Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland.	marie-pierre.ryser@vetsuisse.unibe.ch	LINHARES, Mainity BATISTA/AAU-5647-2021; Ryser-Degiorgis, Marie-Pierre/AAN-5249-2020	LINHARES, Mainity BATISTA/0000-0003-4988-6984; Ryser-Degiorgis, Marie-Pierre/0000-0003-1062-870X; Lechner, Isabel/0000-0001-5155-9734	Swiss Federal Food Safety and Veterinary Office (FSVO) [1.11.16]; University of Bern; Institut Galli-Valerio	Swiss Federal Food Safety and Veterinary Office (FSVO); University of Bern; Institut Galli-Valerio(Centre National de la Recherche Scientifique (CNRS))	The study was funded by the Swiss Federal Food Safety and Veterinary Office (FSVO; www.blv.admin.ch; contract nr. 1.11.16), with a contribution from the University of Bern and of the Institut Galli-Valerio (salary of mentors, infrastructure, materials). It is always part of contracts with the FSVO that study results should be published, as the FSVO wants to encourage the large distribution of research results. However, the FSVO has no influence on the studies' outcome or on the prepared manuscripts.	Abril C, 2011, VET MICROBIOL, V150, P405, DOI 10.1016/j.vetmic.2011.02.056; Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; [Anonymous], 2013, METEOSCHWEIZ 2013 KL, P1; [Anonymous], 2012, METEOSCHWEIZ 2012 KL, P1; Arey DS, 1998, LIVEST PROD SCI, V56, P61, DOI 10.1016/S0301-6226(98)00144-4; ASAI T, 1993, VET IMMUNOL IMMUNOP, V38, P253, DOI 10.1016/0165-2427(93)90085-I; Ashford RW, 2003, EMERG INFECT DIS, V9, P1495; Batista L, 2004, J SWINE HEALTH PROD, V12, P75; Batista Linhares M, 2012, JOINT 61 WDA 10 BIEN, P438; Beerli O, 2015, VET J, V203, P131, DOI 10.1016/j.tvjl.2014.10.023; Belthoff JR, 1998, ANIM BEHAV, V55, P405, DOI 10.1006/anbe.1997.0625; Blanchard B, 1996, MICROBIOL-SGM, V142, P1855, DOI 10.1099/13500872-142-7-1855; Bochev I., 2007, Bulgarian Journal of Veterinary Medicine, V10, P131; Boitani L, 2010, AM SOC MAMMAL, V75, P600; Bundesamt fur Lebensmittelsicherheit und Veterinarwesen BLV, 2014, THEM TIERG ENZ PNEUM; Butler JE, 2009, VET IMMUNOL IMMUNOP, V128, P147, DOI 10.1016/j.vetimm.2008.10.321; Cahill Sean, 2004, Galemys, V16, P37; Calsamiglia M, 1999, SWINE HEALTH PROD, V7, P263; Calsamiglia M, 2000, VET REC, V146, P530, DOI 10.1136/vr.146.18.530; Calsamiglia M, 2000, VET MICROBIOL, V76, P299, DOI 10.1016/S0378-1135(00)00245-5; Canton of Lucern, 2014, ANN CANT LUC; Caswell J.L., 2007, PATHOLOGY DOMESTIC A, V6th ed., P591; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chiari M, 2014, EUR J WILDLIFE RES, V60, P187, DOI 10.1007/s10344-013-0763-2; Choi C, 2006, J COMP PATHOL, V134, P40, DOI 10.1016/j.jcpa.2005.06.009; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Dawson A, 2002, VET REC, V151, P535, DOI 10.1136/vr.151.18.535; Dennis MM, 2008, VET MICROBIOL, V131, P154, DOI 10.1016/j.vetmic.2008.02.017; DONE SH, 1991, VET REC, V128, P582, DOI 10.1136/vr.128.25.582; Dubosson CR, 2004, VET MICROBIOL, V102, P55, DOI 10.1016/j.vetmic.2004.05.007; Fablet C, 2010, VET MICROBIOL, V143, P238, DOI 10.1016/j.vetmic.2009.12.001; Fano E, 2005, CAN J VET RES, V69, P223; Federal Office for the Environment, 2014, OP DAT FED OFF ENV F; Fernandez-Llario P, 2003, FOLIA ZOOL, V52, P143; Fernandez-Llario P., 1996, Miscellania Zoologica (Barcelona), V19, P9; Gonseth Y, 2001, UMWELT MAT, V137, P1; GOODWIN RFW, 1985, VET REC, V116, P690, DOI 10.1136/vr.116.26.690; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; He Y, 2011, TROP ANIM HEALTH PRO, V43, P695, DOI 10.1007/s11250-010-9755-3; Hebeisen C, 2008, EUR J WILDLIFE RES, V54, P391, DOI 10.1007/s10344-007-0156-5; Hebeisen C, 2007, THESIS U NEUCHATEL; Hyun Y, 1998, J ANIM SCI, V76, P721; Keuling O, 2010, THESIS TU DRESDEN; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Koppel C, 2007, EUR J WILDLIFE RES, V53, P212, DOI 10.1007/s10344-006-0080-0; Kuhnert P, 2011, VET MICROBIOL, V152, P191, DOI 10.1016/j.vetmic.2011.04.026; Kurth KT, 2002, J VET DIAGN INVEST, V14, P463, DOI 10.1177/104063870201400603; Leuenberger R, 2004, THESIS U BASEL; Lopez A, 2007, PATHOLOGIC BASIS VET, P510; Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008; Maes D, 1996, VET QUART, V18, P104, DOI 10.1080/01652176.1996.9694628; Maes D, 1999, VACCINE, V17, P1024, DOI 10.1016/S0264-410X(98)00254-0; Maes D, 2000, VET RES, V31, P313, DOI 10.1051/vetres:2000122; Marois C, 2007, VET MICROBIOL, V120, P96, DOI 10.1016/j.vetmic.2006.10.015; Marois C, 2010, J APPL MICROBIOL, V108, P1523, DOI 10.1111/j.1365-2672.2009.04556.x; Marois C, 2007, JOURN RECH PORC FRAN, V39, P433; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; Matheusen B, 2001, J VET MED B, V48, P733, DOI 10.1046/j.1439-0450.2001.00503.x; Maunsell FP, 2011, J VET INTERN MED, V26, P772; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; Mermod L, 2014, COMMUNICATION; MESSIER S, 1991, AM J VET RES, V52, P1497; Meylan S, 2002, HORM BEHAV, V42, P319, DOI 10.1006/hbeh.2002.1827; Meyns T, 2007, VET MICROBIOL, V120, P87, DOI 10.1016/j.vetmic.2006.10.010; Meyns T, 2006, VACCINE, V24, P7081, DOI 10.1016/j.vaccine.2006.07.004; MORRIS CR, 1995, CAN J VET RES, V59, P197; MORRIS CR, 1995, PREV VET MED, V21, P323, DOI 10.1016/0167-5877(94)00384-U; NEW JC, 1994, J WILDLIFE DIS, V30, P103, DOI 10.7589/0090-3558-30.1.103; Ochs H, 2004, BVET MAG, V33, P32; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Pieters M, 2009, VET MICROBIOL, V134, P261, DOI 10.1016/j.vetmic.2008.08.016; Pollock JM, 2006, VET MICROBIOL, V112, P141, DOI 10.1016/j.vetmic.2005.11.032; Ross RF, 1999, DIS SWINE, P701; Ruiz A, 2002, CAN J VET RES, V66, P79; Ryser-Degiorgis MP, 2009, VET MICROBIOL, V134, P368, DOI 10.1016/j.vetmic.2008.08.005; Schoning JM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054253, 10.1371/journal.pone.0060336]; Sibila M, 2007, VET MICROBIOL, V121, P352, DOI 10.1016/j.vetmic.2006.12.028; Sibila M, 2004, CAN J VET RES, V68, P12; Sibila M, 2010, VET MICROBIOL, V144, P214, DOI 10.1016/j.vetmic.2009.12.019; Sibila M, 2009, VET J, V181, P221, DOI 10.1016/j.tvjl.2008.02.020; Silverin B, 1997, ANIM BEHAV, V53, P451, DOI 10.1006/anbe.1996.0295; Sivakumar P, 2005, VET MICROBIOL, V108, P263, DOI 10.1016/j.vetmic.2005.04.002; Sorensen V, 1997, VET MICROBIOL, V54, P23, DOI 10.1016/S0378-1135(96)01266-7; Sparklin BD, 2009, J WILDLIFE MANAGE, V73, P497, DOI 10.2193/2007-585; Stark KDC, 1998, APPL ENVIRON MICROB, V64, P543; Stark KDC, 2000, VET J, V159, P37, DOI 10.1053/tvjl.1999.0421; STARK KDC, 1992, VET REC, V131, P532; Stark KDC, 1999, VET J, V158, P164, DOI 10.1053/tvjl.1998.0346; Stark KDC, 2001, SCHWEIZ ARCH TIERH, V143, P63; Strait EL, 2008, J CLIN MICROBIOL, V46, P2491, DOI 10.1128/JCM.02366-07; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Thacker EL, 2004, J SWINE HEALTH PROD, V12, P252; Thacker EL, 2007, ANIM HEAL RES REV, V5, P317; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Truve J, 2003, WILDLIFE BIOL, V9, P51, DOI 10.2981/wlb.2003.056; Vengust G, 2006, J VET MED B, V53, P24, DOI 10.1111/j.1439-0450.2006.00899.x; Verdin E, 2000, VET MICROBIOL, V76, P31, DOI 10.1016/S0378-1135(00)00228-5; Vicca J, 2003, VET MICROBIOL, V97, P177, DOI 10.1016/J.VETMIC.2003.08.008; Vicente J, 2004, VET RES, V35, P243, DOI 10.1051/vetres:2004008; Vicente J, 2002, J WILDLIFE DIS, V38, P649, DOI 10.7589/0090-3558-38.3.649; Villarreal I, 2009, VACCINE, V27, P1875, DOI 10.1016/j.vaccine.2008.12.005; Villarreal I, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-2; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; Woolley LK, 2012, VET MICROBIOL, V161, P186, DOI 10.1016/j.vetmic.2012.07.025; Wu N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-116; Wu N, 2011, J WILDLIFE DIS, V47, P868, DOI 10.7589/0090-3558-47.4.868; YAGIHASHI T, 1993, VET MICROBIOL, V34, P155, DOI 10.1016/0378-1135(93)90169-8; Zeeh F, 2005, SCHWEIZ ARCH TIERH, V147, P373, DOI 10.1024/0036-7281.147.9.373; Zellweger K, 2004, SCHWEIZ ARCH TIERH, V146, P471, DOI 10.1024/0036-7281.146.10.471	109	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119060	10.1371/journal.pone.0119060	http://dx.doi.org/10.1371/journal.pone.0119060			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747151	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400041
J	Chu, XM; Yu, H; Sun, XX; An, Y; Li, B; Li, XB				Chu, Xian-Ming; Yu, Hua; Sun, Xue-Xia; An, Yi; Li, Bing; Li, Xue-Bin			Identification of Bacteriology and Risk Factor Analysis of Asymptomatic Bacterial Colonization in Pacemaker Replacement Patients	PLOS ONE			English	Article							RHYTHM MANAGEMENT DEVICES; PERMANENT PACEMAKER; CARDIOVERTER-DEFIBRILLATORS; STAPHYLOCOCCUS-AUREUS; INFECTION; DIAGNOSIS; ENDOCARDITIS; PREVENTION; PREVALENCE; SONICATION	Background Recent researches revealed that asymptomatic bacterial colonization on PMs might be ubiquitous and increase the risk of clinical PM infection. Early diagnosis of patients with asymptomatic bacterial colonization could provide opportunity for targeted preventive measures. Objective The present study explores the incidence of bacterial colonization of generator pockets in pacemaker replacement patients without signs of infection, and to analyze risk factors for asymptomatic bacterial colonization. Methods From June 2011 to December 2013, 118 patients underwent pacemaker replacement or upgrade. Identification of bacteria was carried out by bacterial culture and 16S rRNA sequencing. Clinical risk characteristics were analyzed. Results The total bacterial positive rate was 37.3% (44 cases), and the coagulase-negative Staphylococcus aureus detection rate was the highest. Twenty two (18.6%) patients had positive bacterial culture results, of which 50% had coagulase-negative staphylococcus. The bacterial DNA detection rate was 36.4 %(43 cases). Positive bacterial DNA results from pocket tissues and the surface of the devices were 22.0% and 29.7%, respectively. During followup (median, 27.0 months), three patients (6.8%, 3/44) became symptomatic with the same genus of microorganism, S. aureus (n= 2) and S. epidermidis (n= 1). Multivariable logistic regression analysis showed that history of bacterial infection, use of antibiotics, application of antiplatelet drugs, replacement frequency were independent risk factors for asymptomatic bacterial colonization. Conclusion There was a high incidence of asymptomatic bacterial colonization in pacemaker patients with independent risk factors. Bacterial culture combined genetic testing could improve the detection rate.	[Chu, Xian-Ming; Sun, Xue-Xia; An, Yi] Qingdao Univ, Dept Cardiol, Affiliated Hosp, Qingdao 266100, Peoples R China; [Li, Bing] Qingdao Univ, Coll Med, Dept Biol, Qingdao 266021, Peoples R China; [Yu, Hua] Qingdao Univ, Affiliated Cardiovasc Hosp, Qingdao 266000, Peoples R China; [Li, Xue-Bin] Peking Univ, Peoples Hosp, Dept Cardiac Electrophysiol, Beijing 100044, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Peking University	Chu, XM (corresponding author), Qingdao Univ, Dept Cardiol, Affiliated Hosp, Qingdao 266100, Peoples R China.	chuxianming@medmail.com.cn; cxm19782001@sina.com		Li, Bing/0000-0002-5545-9674	National Natural Science Foundation of China [81471546]; Capital Project [Z121107001012016]; Shandong Project [2014WS0173, 2012YD18035, J12LL59]; Hospital Project [47-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Project; Shandong Project; Hospital Project	This project is supported by the National Natural Science Foundation of China (No. 81471546), Capital Project (No. Z121107001012016), Shandong Project (No. 2014WS0173, No. 2012YD18035, J12LL59), and Hospital Project (No. 47-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo Sarina Maciel Braga, 2012, Gen Dent, V60, pe123; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bak J, 2011, PHOTOCHEM PHOTOBIOL, V87, P1123, DOI 10.1111/j.1751-1097.2011.00962.x; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Bongiorni MG, 2012, EUROPACE, V14, P1666, DOI 10.1093/europace/eus350; Borer A, 2004, INFECT CONT HOSP EP, V25, P492, DOI 10.1086/502428; Chua JD, 2005, PACE, V28, P1276, DOI 10.1111/j.1540-8159.2005.00268.x; Dasgupta A, 2007, AM J KIDNEY DIS, V49, P656, DOI 10.1053/j.ajkd.2007.02.272; EMLEN W, 1982, J EXP MED, V155, P1210, DOI 10.1084/jem.155.4.1210; Gould PA, 2008, HEART RHYTHM, V5, P1675, DOI 10.1016/j.hrthm.2008.09.020; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Harcombe AA, 1998, HEART, V80, P240, DOI 10.1136/hrt.80.3.240; Jost GF, 2013, J CLIN NEUROSCI; Justesen US, 2010, J CLIN MICROBIOL, V48, P946, DOI 10.1128/JCM.02075-09; Kanaan N, 2013, OTOL NEUROTOL, V34, P539, DOI 10.1097/MAO.0b013e3182829792; Kleemann T, 2010, EUROPACE, V12, P58, DOI 10.1093/europace/eup334; Klug D, 2003, PACE, V26, P1489, DOI 10.1046/j.1460-9592.2003.t01-1-00215.x; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Klug D, 2010, EUROPACE, V12, P5, DOI 10.1093/europace/eup402; Lo Ronald, 2006, J Invasive Cardiol, V18, P599; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Margey R, 2010, EUROPACE, V12, P64, DOI 10.1093/europace/eup362; Martin A, 2014, PACE, V37, P242, DOI 10.1111/pace.12274; Mason PK, 2011, PACE, V34, P143, DOI 10.1111/j.1540-8159.2010.02820.x; Massoure PL, 2007, PACE, V30, P12; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Oliva A, 2010, J CLIN MICROBIOL, V48, P4669, DOI 10.1128/JCM.01532-10; Pichlmaier M, 2008, EUROPACE, V10, P1067, DOI 10.1093/europace/eun191; Pichlmaier M, 2013, TECHNOL HEALTH CARE, V21, P87, DOI 10.3233/THC-120711; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Sandvik EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055118; Sohail MR, 2007, INTERN MED J, V37, DOI 10.1111/j.1445-5994.2007.01415.x; Sohail MR, 2007, CLIN INFECT DIS, V45, P166, DOI 10.1086/518889; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Sohal M, 2014, EUROPACE, V16, P81, DOI 10.1093/europace/eut163; Uslan DZ, 2006, CLIN INFECT DIS, V43, P731, DOI 10.1086/506942; Vergidis P, 2012, INFECT DIS CLIN N AM, V26, P173, DOI 10.1016/j.idc.2011.09.012; Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020	39	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119232	10.1371/journal.pone.0119232	http://dx.doi.org/10.1371/journal.pone.0119232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768661	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500072
J	Miyazaki, M; Ouyang, C; Zhou, XZ; Murdoch, JB; Fushimi, Y; Okada, T; Fujimoto, K; Kido, A; Arakawa, Y; Miyamoto, S; Togashi, K				Miyazaki, Mitsue; Ouyang, Cheng; Zhou, Xiangzhi; Murdoch, James B.; Fushimi, Yasutaka; Okada, Tomohisa; Fujimoto, Koji; Kido, Aki; Arakawa, Yoshiki; Miyamoto, Susumu; Togashi, Kaori			Z-Spectrum Analysis Provides Proton Environment Data (ZAPPED): A New Two-Pool Technique for Human Gray and White Matter	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; IN-VIVO; MRI; RELAXATION; CONTRAST; BRAIN; EXCHANGE; TISSUE; POOL; 3T	A new technique - Z-spectrum Analysis Provides Proton Environment Data (ZAPPED) - was used to map cross-relaxing free and restricted protons in nine healthy subjects plus two brain tumor patients at 3T. First, MT data were acquired over a wide symmetric range of frequency offsets, and then a trio of quantitative biomarkers, i. e., the apparent spin-spin relaxation times (T-2,T-f, T-2,T-r) in both free and restricted proton pools as well as the restricted pool fraction F-r, were mapped by fitting the measured Z-spectra to a simple two-Lorentzian compartment model on a voxel-by-voxel basis. The mean restricted exchangeable proton fraction, Fr, was found to be 0.17 in gray matter (GM) and 0.28 in white matter (WM) in healthy subjects. Corresponding mean values for apparent spin-spin relaxation times were 785 mu s (T-2,T-f) and 17.7 mu s (T-2,T-r) in GM, 672 mu s (T-2,T-f) and 23.4 mu s (T-2,T-r) in WM. The percentages of F-f and F-r in GM are similar for all ages, whereas Fr shows a tendency to decrease with age in WM among healthy subjects. The patient ZAPPED images show higher contrast between tumor and normal tissues than traditional T-2-weighted and T-1-weighted images. The ZAPPED method provides a simple phenomenological approach to estimating fractions and apparent T-2 values of free and restricted MT-active protons, and it may offer clinical useful information.	[Miyazaki, Mitsue; Ouyang, Cheng; Zhou, Xiangzhi; Murdoch, James B.] Toshiba Med Res Inst, MR Res, Vernon Hills, IL 60061 USA; [Fushimi, Yasutaka; Okada, Tomohisa; Fujimoto, Koji; Kido, Aki; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Arakawa, Yoshiki; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan	Toshiba Corporation; Kyoto University; Kyoto University	Miyazaki, M (corresponding author), Toshiba Med Res Inst, MR Res, Vernon Hills, IL 60061 USA.	mmiyazaki@tmriusa.com	Okada, Tomohisa/C-5939-2008; Arakawa, Yoshiki/H-6067-2017; Fushimi, Yasutaka/L-8922-2017	Arakawa, Yoshiki/0000-0003-4626-4645; Fushimi, Yasutaka/0000-0002-1982-3168; Okada, Tomohisa/0000-0003-2312-5677; Kido, Aki/0000-0001-5131-2870	Toshiba Medical Systems Corporation, Japan [150100700014]	Toshiba Medical Systems Corporation, Japan	Toshiba Medical Systems Corporation, Japan, provided a sponsored research program, "Researches for improvement of MR visualization (No. 150100700014)" to one of the authors, Professor Kaori Togashi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BALABAN R S, 1992, Magnetic Resonance Quarterly, V8, P116; BOTTOMLEY PA, 1984, RADIOLOGY, V150, P441, DOI 10.1148/radiology.150.2.6691099; Coleman T.F., 1994, MATH PROGRAM, V67, P189, DOI DOI 10.1007/BF01582221; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Ge Y, 2000, AM J NEURORADIOL, V23, P1327; Guttmann CRG, 1998, NEUROLOGY, V50, P972, DOI 10.1212/WNL.50.4.972; KOENIG SH, 1990, MAGNET RESON MED, V14, P482, DOI 10.1002/mrm.1910140306; KOENIG SH, 1991, MAGNET RESON MED, V20, P285, DOI 10.1002/mrm.1910200210; MIYAZAKI M, 1994, MAGNET RESON MED, V32, P52, DOI 10.1002/mrm.1910320108; MORRISON C, 1995, J MAGN RESON SER B, V108, P103, DOI 10.1006/jmrb.1995.1111; Okuchi S, 2014, ACAD RADIOL, V21, P812, DOI 10.1016/j.acra.2014.03.007; PIKE GB, 1992, MAGNET RESON MED, V25, P372, DOI 10.1002/mrm.1910250217; Pirpamer L, 2014, P JOINT ANN M ISMRM, P206; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Soellinger M, 2011, MAGN RESON MED, V66, P717, DOI 10.1002/mrm.22846; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Yarnykh VL, 2012, MAGN RESON MED, V68, P166, DOI 10.1002/mrm.23224; Yarnykh VL, 2002, MAGNET RESON MED, V47, P929, DOI 10.1002/mrm.10120	24	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119915	10.1371/journal.pone.0119915	http://dx.doi.org/10.1371/journal.pone.0119915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768108	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500102
J	Rzem, R; Achouri, Y; Marbaix, E; Schakman, O; Wiame, E; Marie, S; Gailly, P; Vincent, MF; Veiga-da-Cunha, M; Van Schaftingen, E				Rzem, Rim; Achouri, Younes; Marbaix, Etienne; Schakman, Olivier; Wiame, Elsa; Marie, Sandrine; Gailly, Philippe; Vincent, Marie-Francoise; Veiga-da-Cunha, Maria; Van Schaftingen, Emile			A Mouse Model of L-2-Hydroxyglutaric Aciduria, a Disorder of Metabolite Repair	PLOS ONE			English	Article							NEUROPATHOLOGICAL FINDINGS; LYSINE METABOLISM; GENE; DEHYDROGENASE; IDENTIFICATION; BRAIN; KETOGLUTARATE; DEGENERATION; TRANSPORTERS; ASTROCYTES	The purpose of the present work was to progress in our understanding of the pathophysiology of L-2-hydroxyglutaric aciduria, due to a defect in L-2-hydroxyglutarate dehydrogenase, by creating and studying a mouse model of this disease. L-2-hydroxyglutarate dehydrogenase-deficient mice (l2hgdh(-/-)) accumulated L-2-hydroxyglutarate in tissues, most particularly in brain and testis, where the concentration reached approximate to 3.5 mu mol/g. Male mice showed a 30% higher excretion of L-2-hydroxyglutarate compared to female mice, supporting that this dicarboxylic acid is partially made in males by lactate dehydrogenase C, a poorly specific form of this enzyme exclusively expressed in testes. Involvement of mitochondrial malate dehydrogenase in the formation of L-2-hydroxyglutarate was supported by the commensurate decrease in the formation of this dicarboxylic acid when down-regulating this enzyme in mouse l2hgdh(-/-) embryonic fibroblasts. The concentration of lysine and arginine was markedly increased in the brain of l2hgdh(-/-) adult mice. Saccharopine was depleted and glutamine was decreased by approximate to 40%. Lysine-alpha-ketoglutarate reductase, which converts lysine to saccharopine, was inhibited by L-2-hydroxyglutarate with a Ki of approximate to 0.8 mM. As low but significant activities of the bifunctional enzyme lysine-alpha-ketoglutarate reductase/saccharopine dehydrogenase were found in brain, these findings suggest that the classical lysine degradation pathway also operates in brain and is inhibited by the high concentrations of L-2-hydroxyglutarate found in l2hgdh(-/-) mice. Pathological analysis of the brain showed significant spongiosis. The vacuolar lesions mostly affected oligodendrocytes and myelin sheats, as in other dicarboxylic acidurias, suggesting that the pathophysiology of this model of leukodystrophy may involve irreversible pumping of a dicarboxylate in oligodendrocytes. Neurobehavioral testing indicated that the mice mostly suffered from a deficit in learning capacity. In conclusion, the findings support the concept that L-2-hydroxyglutaric aciduria is a disorder of metabolite repair. The accumulation of L-2-hydroxyglutarate exerts toxic effects through various means including enzyme inhibition and glial cell swelling.	[Rzem, Rim; Achouri, Younes; Wiame, Elsa; Veiga-da-Cunha, Maria; Van Schaftingen, Emile] Catholic Univ Louvain, Welbio & Lab Physiol Chem, de Duve Inst, B-1200 Brussels, Belgium; [Marbaix, Etienne] Catholic Univ Louvain, Cell Unit, de Duve Inst, B-1200 Brussels, Belgium; [Schakman, Olivier; Gailly, Philippe] Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, B-1200 Brussels, Belgium; [Marie, Sandrine; Vincent, Marie-Francoise] Catholic Univ Louvain, Lab Metab Dis, Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Veiga-da-Cunha, M (corresponding author), Catholic Univ Louvain, Welbio & Lab Physiol Chem, de Duve Inst, B-1200 Brussels, Belgium.	maria.veiga@uclouvain.be; emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	ACHOURI, Younes/0000-0001-7409-1441; Van Schaftingen, Emile/0000-0002-6199-7647	Fonds National de la Recherche Scientifique (FNRS); Interuniversity Attraction Poles Programme, Belgian Science Policy [P7/43, P7/13]	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS) and the Interuniversity Attraction Poles Programme, Belgian Science Policy (Networks P7/43 and P7/13). Maria Veiga-da-Cunha is Chercheur Qualifie of the Belgian Fonds National de la Recherche Scientifique (FRS-FNRS). The Desordres Inflammatoires dans les Affections Neurologiques (DIANE) Centre of Excellence programme of the Region Wallonne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Audouard E, 2013, MOL CELL NEUROSCI, V56, P159, DOI 10.1016/j.mcn.2013.05.001; Barbot C, 1997, BRAIN DEV-JPN, V19, P268, DOI 10.1016/S0387-7604(97)00574-3; BARTH PG, 1992, ANN NEUROL, V32, P66, DOI 10.1002/ana.410320111; Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007; Brauburger K, 2011, J INHERIT METAB DIS, V34, P477, DOI 10.1007/s10545-010-9268-2; Chabli A, 2007, CLIN BIOCHEM, V40, P692, DOI 10.1016/j.clinbiochem.2007.02.005; Chen E, 1996, J INHERIT METAB DIS, V19, P335, DOI 10.1007/BF01799264; Chevronnay HPG, 2014, J AM SOC NEPHROL, V25, P1256, DOI 10.1681/ASN.2013060598; Cox RP, 2001, THE METABOLIC MOLECU, V2, P1965; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; Deguil J, 2010, NEUROTOX RES, V17, P142, DOI 10.1007/s12640-009-9091-4; Dombret C, 2012, HUM MOL GENET, V21, P4703, DOI 10.1093/hmg/dds310; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; Fujita T, 2005, J NEUROCHEM, V93, P706, DOI 10.1111/j.1471-4159.2005.03067.x; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; Hagos Y, 2008, PFLUG ARCH EUR J PHY, V457, P223, DOI 10.1007/s00424-008-0489-2; Hallen A, 2013, AMINO ACIDS, V45, P1249, DOI 10.1007/s00726-013-1590-1; Hallen A, 2011, J NEUROCHEM, V118, P379, DOI 10.1111/j.1471-4159.2011.07220.x; Houten SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-57; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Kamoun P, 2002, J INHERIT METAB DIS, V25, P1, DOI 10.1023/A:1015195009330; Kolker S, 2006, J INHERIT METAB DIS, V29, P701, DOI 10.1007/s10545-006-0415-8; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; LARNAOUT A, 1994, ACTA NEUROPATHOL, V88, P367, DOI 10.1007/BF00310381; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Louis DN, 2009, 1 NONNEOPLASTIC DIS, P345; Mignion L, 2013, MAGN RESON MED, V69, P248, DOI 10.1002/mrm.24245; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Papes F, 2001, FEBS LETT, V488, P34, DOI 10.1016/S0014-5793(00)02401-7; RAO VV, 1992, COMP BIOCHEM PHYS B, V103, P221, DOI 10.1016/0305-0491(92)90435-T; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Sadilkova K, 2009, J NEUROSCI METH, V184, P136, DOI 10.1016/j.jneumeth.2009.07.019; Sauer SW, 2011, BRAIN, V134, P157, DOI 10.1093/brain/awq269; SCHATZ L, 1969, J BIOL CHEM, V244, P4393; Scurrell E, 2008, J COMP PATHOL, V138, P160, DOI 10.1016/j.jcpa.2007.11.005; Seijo-Martinez M, 2005, ARCH NEUROL-CHICAGO, V62, P666, DOI 10.1001/archneur.62.4.666; Struys EA, 2007, J INHERIT METAB DIS, V30, P690, DOI 10.1007/s10545-007-0697-5; Sztriha L, 2002, PEDIATR NEUROL, V27, P141, DOI 10.1016/S0887-8994(02)00405-8; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Topcu M, 2005, TURKISH J PEDIATR, V47, P1; Topcu M, 2004, HUM MOL GENET, V13, P2803, DOI 10.1093/hmg/ddh300; Traka M, 2008, J NEUROSCI, V28, P11537, DOI 10.1523/JNEUROSCI.1490-08.2008; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Weil-Malherbe H, 1937, BIOCHEM J, V31, P2080, DOI 10.1042/bj0312080; Weimar C, 2013, CLIN NEUROL NEUROSUR, V115, P765, DOI 10.1016/j.clineuro.2012.06.040; Yodoya E, 2006, J NEUROCHEM, V97, P162, DOI 10.1111/j.1471-4159.2006.03720.x; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	54	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119540	10.1371/journal.pone.0119540	http://dx.doi.org/10.1371/journal.pone.0119540			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763823	Green Submitted, Green Published, gold			2022-12-27	WOS:000351276300028
J	Li, XJ; Fliegel, L				Li, Xiuju; Fliegel, Larry			A Novel Human Mutation in the SLC9A1 Gene Results in Abolition of Na+/H+ Exchanger Activity	PLOS ONE			English	Article							TRANSMEMBRANE SEGMENT-VII; NHE1 ISOFORM; FUNCTIONAL-ANALYSIS; AMINO-ACIDS; INSIGHTS; MODEL; TAIL; IV	The SLC9A1 gene, the Na+/H+ exchanger isoform 1 is the principal plasma membrane Na+/H+ exchanger of mammalian cells and functions by exchanging one intracellular proton for one extracellular sodium. The human protein is 815 amino acids in length. Five hundred N-terminal amino acids make up the transport domain of the protein and are believed to form 12 transmembrane segments. Recently, a genetic mutation of the Na+/H+ exchanger isoform 1, N266H, was discovered in a human patient through exome sequencing. We examined the effect of this mutation on expression, targeting and activity of the Na+/H+ exchanger. Mutant N266H protein was expressed in AP-1 cells, which lack their endogenous Na+/H+ exchanger protein. Targeting of the mutant protein to the cell surface was normal and expression levels were only slightly reduced relative to the wild type protein. However, the N266H mutant protein had no detectable Na+/H+ exchanger activity. A histidine residue at this location may disrupt the cation binding site or the pore of the Na+/H+ exchanger protein.	[Li, Xiuju; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	lfliegel@ualberta.ca			Canadian Institute of Health Sciences [MOP 114876]	Canadian Institute of Health Sciences	Funded by the Canadian Institute of Health Sciences (MOP 114876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves C, 2014, BIOCHEM CELL BIOL, V92, P524, DOI 10.1139/bcb-2014-0071; Alves C, 2014, BIOCHEMISTRY-US, V53, P3658, DOI 10.1021/bi500392y; Amith SR, 2013, CANCER RES, V73, P1259, DOI 10.1158/0008-5472.CAN-12-4031; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Ding J, 2007, CAN J PHYSIOL PHARM, V85, P319, DOI 10.1139/Y06-081; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Guissart C, 2014, HUM MOL GEN IN PRESS; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lee BL, 2013, J MOL CELL CARDIOL, V61, P60, DOI 10.1016/j.yjmcc.2012.11.019; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Ndayizeye M, 2009, BBA-BIOMEMBRANES, V1788, P983, DOI 10.1016/j.bbamem.2009.01.001; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Tzeng J, 2011, BBA-BIOMEMBRANES, V1808, P2327, DOI 10.1016/j.bbamem.2011.05.004; Tzeng J, 2010, J BIOL CHEM, V285, P36656, DOI 10.1074/jbc.M110.161471; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Zhu X, 2015, GENETICS ME IN PRESS	22	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119453	10.1371/journal.pone.0119453	http://dx.doi.org/10.1371/journal.pone.0119453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760855	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000057
J	Servia-Rodriguez, S; Noulas, A; Mascolo, C; Fernandez-Vilas, A; Diaz-Redondo, RP				Servia-Rodriguez, Sandra; Noulas, Anastasios; Mascolo, Cecilia; Fernandez-Vilas, Ana; Diaz-Redondo, Rebeca P.			The Evolution of Your Success Lies at the Centre of Your Co-Authorship Network	PLOS ONE			English	Article								Collaboration among scholars and institutions is progressively becoming essential to the success of research grant procurement and to allow the emergence and evolution of scientific disciplines. Our work focuses on analysing if the volume of collaborations of one author together with the relevance of his collaborators is somewhat related to his research performance over time. In order to prove this relation we collected the temporal distributions of scholars' publications and citations from the Google Scholar platform and the co-authorship network (of Computer Scientists) underlying the well-known DBLP bibliographic database. By the application of time series clustering, social network analysis and non-parametric statistics, we observe that scholars with similar publications (citations) patterns also tend to have a similar centrality in the co-authorship network. To our knowledge, this is the first work that considers success evolution with respect to co-authorship.	[Servia-Rodriguez, Sandra; Noulas, Anastasios; Mascolo, Cecilia] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Servia-Rodriguez, Sandra; Fernandez-Vilas, Ana; Diaz-Redondo, Rebeca P.] Univ Vigo, AtlantTIC Res Ctr, I&C Lab, Vigo 36310, Spain	University of Cambridge; Universidade de Vigo; atlanTTic	Servia-Rodriguez, S (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	sandra@det.uvigo.es	Redondo, Rebeca P. Díaz/L-3108-2014; Vilas, Ana Fernández/L-2055-2014	Redondo, Rebeca P. Díaz/0000-0002-2367-2219; Vilas, Ana Fernández/0000-0003-1047-2143; Mascolo, Cecilia/0000-0001-9614-4380	Spanish Ministry of Economy and Competitiveness under the National Science Program [TIN2010-20797, EEBB-I-13-06425]; European Regional Development Fund (ERDF); Galician Regional Government; Spanish Government	Spanish Ministry of Economy and Competitiveness under the National Science Program(Spanish Government); European Regional Development Fund (ERDF)(European Commission); Galician Regional Government; Spanish Government(Spanish GovernmentEuropean Commission)	The work was funded by the Spanish Ministry of Economy and Competitiveness under the National Science Program (TIN2010-20797, EEBB-I-13-06425); the European Regional Development Fund (ERDF) and the Galician Regional Government under agreement for funding the Atlantic Research Center for Information and Communication Technologies (AtlantTIC); and the Spanish Government and the European Regional Development Fund (ERDF) under project TACTICA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, INFORM PROCESS MANAG, V48, P671, DOI 10.1016/j.ipm.2011.09.001; Abbasi A, 2011, J INFORMETR, V5, P594, DOI 10.1016/j.joi.2011.05.007; Bellotti E, 2012, SOC NETWORKS, V34, P215, DOI 10.1016/j.socnet.2011.12.002; Berndt D.J., 1994, P 3 INT C KNOWL DAT, P359; Bollobas Bela, 1998, RANDOM GRAPHS; Deville P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04770; Ding Y, 2009, J AM SOC INF SCI TEC, V60, P2229, DOI 10.1002/asi.21171; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Gao ZK, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032910; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gargiulo F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04860; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK., 1988, TECHNOMETRICS; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; SAKOE H, 1978, IEEE T ACOUST SPEECH, V26, P43, DOI 10.1109/TASSP.1978.1163055; Sakoe H., 1971, P 7 INT C AC, V3, P65; Sarigol E, 2014, ARXIV14027268; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sun XL, 2013, INFORM PROCESS MANAG, V49, P454, DOI 10.1016/j.ipm.2012.09.001; Sun XL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01069; Wang J, 2013, SCIENTOMETRICS, V94, P851, DOI 10.1007/s11192-012-0775-9; Xiaoling Sun, 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P568, DOI 10.1109/PASSAT/SocialCom.2011.43; Xu XK, 2008, P NATL ACAD SCI USA, V105, P19601, DOI 10.1073/pnas.0806082105; Zhang J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238701	28	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0114302	10.1371/journal.pone.0114302	http://dx.doi.org/10.1371/journal.pone.0114302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760732	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000001
J	Yang, YH; Tsai, IJ; Chang, CJ; Chuang, YH; Hsu, HY; Chiang, BL				Yang, Yao-Hsu; Tsai, I-Jung; Chang, Chun-Jung; Chuang, Ya-Hui; Hsu, Hui-Yao; Chiang, Bor-Luen			The Interaction between Circulating Complement Proteins and Cutaneous Microvascular Endothelial Cells in the Development of Childhood Henoch-Schonlein Purpura	PLOS ONE			English	Article							ALTERNATIVE PATHWAY; ACUTE STAGE; IGA; CHILDREN; C5A; EXPRESSION; C3A; HYPOCOMPLEMENTEMIA; CLASSIFICATION; ANAPHYLATOXINS	Objective In addition to IgA, the deposition of complement (C)3 in dermal vessels is commonly found in Henoch-Schnlein purpura (HSP). The aim of this study is to elucidate the role of circulating complement proteins in the pathogenesis of childhood HSP. Methods Plasma levels of C3a, C4a, C5a, and Bb in 30 HSP patients and 30 healthy controls were detected by enzyme-linked immunosorbent assay (ELISA). The expression of C3a receptor (C3aR), C5a receptor (CD88), E-selectin, intercellular adhesion molecule 1 (ICAM-1), C3, C5, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, and RANTES by human dermal microvascular endothelial cells (HMVEC-d) was evaluated either by flow cytometry or by ELISA. Results At the acute stage, HSP patients had higher plasma levels of C3a (359.5 +/- 115.3 vs. 183.3 +/- 94.1 ng/ml, p < 0.0001), C5a (181.4 +/- 86.1 vs. 33.7 +/- 26.3 ng/ml, p < 0.0001), and Bb (3.7 +/- 2.6 vs. 1.0 +/- 0.6 mu g/ml, p < 0.0001), but not C4a than healthy controls. Although HSP patient-derived acute phase plasma did not alter the presentation of C3aR and CD88 on HMVEC-d, it enhanced the production of endothelial C3 and C5. Moreover, C5a was shown in vitro to up-regulate the expression of IL-8, MCP-1, E-selectin, and ICAM-1 by HMVEC-d with a dose-dependent manner. Conclusion In HSP, the activation of the complement system in part through the alternative pathway may have resulted in increased plasma levels of C3a and C5a, which, especially C5a, may play a role in the disease pathogenesis by activating endothelium of cutaneous small vessels.	[Yang, Yao-Hsu; Tsai, I-Jung; Hsu, Hui-Yao] Natl Taiwan Univ, Dept Pediat, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Chang, Chun-Jung] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Chuang, Ya-Hui] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Yang, YH (corresponding author), Natl Taiwan Univ, Dept Pediat, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan.	yan0126@ms15.hinet.net	; Yang, Yao-Hsu/A-3450-2019	CHUANG, YA-HUI/0000-0003-0857-0035; Yang, Yao-Hsu/0000-0002-6266-9864; Yang, Yao-Hsu/0000-0002-8080-0504; CHIANG, BOR-LUEN/0000-0002-6705-0286; Tsai, I-Jung/0000-0003-3967-9412	National Science Council of Taiwan [NSC 103-2314-B-002 -069 -]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan (grant number: NSC 103-2314-B-002 -069 -). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Aktas B, 2009, ANN PHARMACOTHER, V43, P792, DOI 10.1345/aph.1L608; Albrecht EA, 2004, AM J PATHOL, V164, P849, DOI 10.1016/S0002-9440(10)63173-2; Cines DB, 1998, BLOOD, V91, P3527; Foreman KE, 1996, INFLAMMATION, V20, P1, DOI 10.1007/BF01487740; Gardner-Medwin JMM, 2002, LANCET, V360, P1197, DOI 10.1016/S0140-6736(02)11279-7; Goldberg EI, 1999, INT J DERMATOL, V38, P706, DOI 10.1046/j.1365-4362.1999.00741.x; HIEMSTRA PS, 1987, EUR J IMMUNOL, V17, P321, DOI 10.1002/eji.1830170304; Hisano S, 2005, AM J KIDNEY DIS, V45, P295, DOI 10.1053/j.ajkd.2004.10.020; Jagels MA, 2000, IMMUNOPHARMACOLOGY, V46, P209, DOI 10.1016/S0162-3109(99)00178-2; Jariwala S, 2011, ANN ALLERG ASTHMA IM, V107, P180, DOI 10.1016/j.anai.2011.05.006; Jen HY, 2011, PEDIAT ALLERG IMM-UK, V22, P862, DOI 10.1111/j.1399-3038.2011.01198.x; JOHNSON E, 1991, SCAND J IMMUNOL, V33, P667, DOI 10.1111/j.1365-3083.1991.tb02539.x; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Lambert EM, 2003, PEDIATRICS, V112, pE491, DOI 10.1542/peds.112.6.e491; Langeggen H, 2000, CLIN EXP IMMUNOL, V121, P69, DOI 10.1046/j.1365-2249.2000.01238.x; Laufer J, 2001, MOL IMMUNOL, V38, P221, DOI 10.1016/S0161-5890(01)00044-X; Lin Q, 2012, PEDIATR NEPHROL, V27, P801, DOI 10.1007/s00467-011-2070-z; Motoyama O, 2005, PEDIATR INT, V47, P39, DOI 10.1111/j.1442-200x.2005.02005.x; Murphy K, 2012, JANEWAYS IMMUNOBIOLO, P48; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Reichel CA, 2009, ARTERIOSCL THROM VAS, V29, P1787, DOI 10.1161/ATVBAHA.109.193268; RIPOCHE J, 1988, J EXP MED, V168, P1917, DOI 10.1084/jem.168.5.1917; Rolle AS, 2013, JCR-J CLIN RHEUMATOL, V19, P90, DOI 10.1097/RHU.0b013e3182863027; Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861; Saulsbury FT, 1999, MEDICINE, V78, P395, DOI 10.1097/00005792-199911000-00005; Silva AR, 2002, J IMMUNOL, V168, P4112, DOI 10.4049/jimmunol.168.8.4112; Skeie JM, 2010, INVEST OPHTH VIS SCI, V51, P5336, DOI 10.1167/iovs.10-5322; Watanabe T, 2011, PEDIATR NEPHROL, V26, P795, DOI 10.1007/s00467-010-1722-8; Yang YH, 2008, AUTOIMMUN REV, V7, P179, DOI 10.1016/j.autrev.2007.11.012; Yang YH, 2014, AUTOIMMUN REV, V13, P355, DOI 10.1016/j.autrev.2014.01.031; Yang YH, 2012, BRIT J DERMATOL, V167, P874, DOI 10.1111/j.1365-2133.2012.11068.x; Yang YH, 2000, CLIN EXP IMMUNOL, V122, P285, DOI 10.1046/j.1365-2249.2000.01361.x; Yang YH, 2006, CLIN EXP IMMUNOL, V144, P247, DOI 10.1111/j.1365-2249.2006.03076.x; Yang YH, 2005, RHEUMATOLOGY, V44, P618, DOI 10.1093/rheumatology/keh544	37	29	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120411	10.1371/journal.pone.0120411	http://dx.doi.org/10.1371/journal.pone.0120411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760949	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275000069
J	McCaffrey, N; Agar, M; Harlum, J; Karnon, J; Currow, D; Eckermann, S				McCaffrey, Nikki; Agar, Meera; Harlum, Janeane; Karnon, Jonathon; Currow, David; Eckermann, Simon			Better Informing Decision Making with Multiple Outcomes Cost-Effectiveness Analysis under Uncertainty in Cost-Disutility Space	PLOS ONE			English	Article							ECONOMIC-EVALUATION; PALLIATIVE CARE; HEALTH-PROMOTION; NET-BENEFIT; COMPLEX INTERVENTIONS; PATIENTS PREFERENCES; INFORMATION; OPPORTUNITY; TECHNOLOGY; INCENTIVES	Introduction Comparing multiple, diverse outcomes with cost-effectiveness analysis (CEA) is important, yet challenging in areas like palliative care where domains are unamenable to integration with survival. Generic multi-attribute utility values exclude important domains and non-health outcomes, while partial analyses-where outcomes are considered separately, with their joint relationship under uncertainty ignored-lead to incorrect inference regarding preferred strategies. Objective The objective of this paper is to consider whether such decision making can be better informed with alternative presentation and summary measures, extending methods previously shown to have advantages in multiple strategy comparison. Methods Multiple outcomes CEA of a home-based palliative care model (PEACH) relative to usual care is undertaken in cost disutility (CDU) space and compared with analysis on the cost-effectiveness plane. Summary measures developed for comparing strategies across potential threshold values for multiple outcomes include: expected net loss (ENL) planes quantifying differences in expected net benefit; the ENL contour identifying preferred strategies minimising ENL and their expected value of perfect information; and cost-effectiveness acceptability planes showing probability of strategies minimising ENL. Results Conventional analysis suggests PEACH is cost-effective when the threshold value per additional day at home (k(1)) exceeds $1,068 or dominated by usual care when only the proportion of home deaths is considered. In contrast, neither alternative dominate in CDU space where cost and outcomes are jointly considered, with the optimal strategy depending on threshold values. For example, PEACH minimises ENL when k(1)=$2,000 and k(2)=$2,000 (threshold value for dying at home), with a 51.6% chance of PEACH being cost-effective. Conclusion Comparison in CDU space and associated summary measures have distinct advantages to multiple domain comparisons, aiding transparent and robust joint comparison of costs and multiple effects under uncertainty across potential threshold values for effect, better informing net benefit assessment and related reimbursement and research decisions.	[McCaffrey, Nikki] Flinders Univ S Australia, Flinders Clin Effectiveness, Bedford Pk, SA 5041, Australia; [Agar, Meera] Braeside Hosp, Dept Palliat Care, Prairiewood, NSW, Australia; [Harlum, Janeane] South Western Sydney Local Hlth Dist, Liverpool, NSW, Australia; [Karnon, Jonathon] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA, Australia; [McCaffrey, Nikki; Agar, Meera; Currow, David] Flinders Univ S Australia, Palliat Serv, Bedford Pk, SA 5041, Australia; [McCaffrey, Nikki; Agar, Meera; Currow, David] Flinders Univ S Australia, Support Serv, Bedford Pk, SA 5041, Australia; [Eckermann, Simon] Univ Wollongong, Ctr Hlth Serv Dev, Australian Hlth Serv Res Inst, Wollongong, NSW, Australia	Flinders University South Australia; University of Adelaide; Flinders University South Australia; Flinders University South Australia; University of Wollongong	McCaffrey, N (corresponding author), Flinders Univ S Australia, Flinders Clin Effectiveness, Bedford Pk, SA 5041, Australia.	nicola.mccaffrey@flinders.edu.au	Agar, Meera/AAI-4002-2021; McCaffrey, Nikki/AAX-1106-2020	Agar, Meera/0000-0002-6756-6119; McCaffrey, Nikki/0000-0003-3684-3723; Karnon, Jonathan/0000-0003-3220-2099; Currow, David/0000-0003-1988-1250	Australian Government's Department of Health under the National Palliative Care Strategy	Australian Government's Department of Health under the National Palliative Care Strategy(Australian GovernmentDepartment of Health & Ageing)	This study was funded by the Australian Government's Department of Health under the National Palliative Care Strategy. The funding agency has no control over study design, analysis, reporting nor dissemination.	Agar M, 2008, PALLIATIVE MED, V22, P787, DOI 10.1177/0269216308092287; Al-Janabi H, 2013, PATIENT, V6, P235, DOI 10.1007/s40271-013-0035-y; Al-Janabi H, 2011, PHARMACOECONOMICS, V29, P1015, DOI 10.2165/11593940-000000000-00000; [Anonymous], 1997, GUIDE FRONTIER VERSI; ARROW KJ, 1970, AM ECON REV, V60, P364; BIRCH S, 1992, J HEALTH ECON, V11, P279, DOI 10.1016/0167-6296(92)90004-K; Bjorner J, 2004, HEALTH ECON, V13, P1181, DOI 10.1002/hec.900; Brazier JE, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16320; Briggs AH, 2001, HEALTH ECON, V10, P179, DOI 10.1002/hec.584; Briggs AH, 2002, ANNU REV PUBL HEALTH, V23, P377, DOI 10.1146/annurev.publhealth.23.100901.140534; Brooks R., 2003, MEASUREMENT VALUATIO; Campbell MK, 1999, QJM-INT J MED, V92, P177, DOI 10.1093/qjmed/92.3.177; Claxton K, 2008, PHARMACOECONOMICS, V26, P781, DOI 10.2165/00019053-200826090-00008; Claxton K, 2008, BMJ-BRIT MED J, V336, P251, DOI 10.1136/bmj.39434.500185.25; Coast J, 2004, BRIT MED J, V329, P1233, DOI 10.1136/bmj.329.7476.1233; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Currow DC, 2011, J PAIN SYMPTOM MANAG, V41, P661, DOI 10.1016/j.jpainsymman.2010.06.017; Drummond M.F., 2005, METHODS EC EVALUATIO, P137; Eckermann S, 2004, THESIS U NEW S WALES; Eckermann S, 2008, MED DECIS MAKING, V28, P172, DOI 10.1177/0272989X07312474; Eckermann S, 2007, HEALTH ECON, V16, P195, DOI 10.1002/hec.1161; Eckermann S, 2014, SOC SCI MED, V114, P103, DOI 10.1016/j.socscimed.2014.05.056; Eckermann S, 2014, PHARMACOECONOMICS, V32, P319, DOI 10.1007/s40273-014-0140-3; Eckermann S, 2013, SOC SCI MED, V76, P159, DOI 10.1016/j.socscimed.2012.10.020; Eckermann S, 2011, PHARMACOECONOMICS, V29, P563, DOI 10.2165/11587100-000000000-00000; Eckermann S, 2010, PHARMACOECONOMICS, V28, P699, DOI 10.2165/11537370-000000000-00000; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Hanson LC, 2013, J PALLIAT MED, V16, P1175, DOI 10.1089/jpm.2013.9475; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Hawe P, 2000, SOC SCI MED, V51, P871, DOI 10.1016/S0277-9536(00)00067-8; Hawe P, 2008, HEALTH EDUC RES, V23, P62, DOI 10.1093/her/cyl162; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Hoch JS, 2007, PHARMACOECONOMICS, V25, P807, DOI 10.2165/00019053-200725100-00001; Kent S, 2013, INT J TECHNOL ASSESS, V29, P435, DOI 10.1017/S0266462313000433; Koerkamp BG, 2007, MED DECIS MAKING, V27, P101, DOI 10.1177/0272989X06297394; Lemmens KMM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-81; McCaffrey N, 2013, THESIS FLINDERS U CE; McCaffrey N, 2010, PALLIATIVE MED, V24, ps58; McCaffrey N, 2010, PALLIATIVE MED, V24, pS207, DOI [DOI 10.1177/0269216310366390, 10.1177/0269216310366390]; McCaffrey N, 2013, BMJ SUPPORT PALLIAT, V3, P431, DOI 10.1136/bmjspcare-2012-000361; McCaffrey Nikki, 2009, J Pain Symptom Manage, V37, pe7, DOI 10.1016/j.jpainsymman.2008.11.010; Menzel P, 1999, HASTINGS CENT REP, V29, P7, DOI 10.2307/3528187; National Institute for Clinical Excellence, 2008, GUID METH TECHN APPR; Negrin MA, 2006, HEALTH ECON, V15, P363, DOI 10.1002/hec.1056; Pekarsky BAK, 2012, THESIS U ADELAIDE; Pekarsky B, 2010, PHARMACOECONOMICS, V28, P1, DOI 10.2165/11318770-000000000-00000; Pharmaceutical Benefits Advisory Committee, 2008, GUID PREP SUBM PHARM; Postmus D, 2013, EUR J HLTH EC; Ratcliffe J, 2002, THORAX, V57, P503, DOI 10.1136/thorax.57.6.503; Ratcliffe J, 1999, INT J TECHNOL ASSESS, V15, P340, DOI 10.1017/S0266462399015263; Sculpher MJ, 2003, RESP MED, V97, P508, DOI 10.1053/rmed.2002.1474; Shiell A, 1996, HEALTH ECON, V5, P241, DOI 10.1002/(SICI)1099-1050(199605)5:3<241::AID-HEC197>3.3.CO;2-7; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; Shih A, 2007, MEASURING HOSP PERFO; Sindelar JL, 2004, DRUG ALCOHOL DEPEN, V73, P41, DOI 10.1016/j.drugalcdep.2003.09.002; Stinnett A, 1996, MED DECIS MAKING, V16, P463; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Tsiachristas A, 2013, INT J TECHNOL ASSESS, V29, P301, DOI 10.1017/S0266462313000202; Wilan AR, 2012, PHARMACOECONOMICS, V30, P447, DOI 10.2165/11592250-000000000-00000; Willan AR, 2001, STAT MED, V20, P1563, DOI 10.1002/sim.789; Williams I, 2008, HEALTH TECHNOL ASSES, V12, P1; Zethraeus N, 2003, PHARMACOECONOMICS, V21, P39, DOI 10.2165/00019053-200321010-00003	63	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0115544	10.1371/journal.pone.0115544	http://dx.doi.org/10.1371/journal.pone.0115544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9LT	25751629	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700001
J	Ogishi, M; Yotsuyanagi, H; Tsutsumi, T; Gatanaga, H; Ode, H; Sugiura, W; Moriya, K; Oka, S; Kimura, S; Koike, K				Ogishi, Masato; Yotsuyanagi, Hiroshi; Tsutsumi, Takeya; Gatanaga, Hiroyuki; Ode, Hirotaka; Sugiura, Wataru; Moriya, Kyoji; Oka, Shinichi; Kimura, Satoshi; Koike, Kazuhiko			Deconvoluting the Composition of Low-Frequency Hepatitis C Viral Quasispecies: Comparison of Genotypes and NS3 Resistance-Associated Variants between HCV/HIV Coinfected Hemophiliacs and HCV Monoinfected Patients in Japan	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; HUMAN-IMMUNODEFICIENCY-VIRUS; GENERATION SEQUENCING DATA; ACTING ANTIVIRAL AGENTS; 1 INFECTION; REVERSE-TRANSCRIPTASE; PEGYLATED INTERFERON; GENETIC DIVERSITY; INHIBITOR TMC435; DNA-POLYMERASE	Pre-existing low-frequency resistance-associated variants (RAVs) may jeopardize successful sustained virological responses (SVR) to HCV treatment with direct-acting antivirals (DAAs). However, the potential impact of low-frequency (similar to 0.1%) mutations, concatenated mutations (haplotypes), and their association with genotypes (Gts) on the treatment outcome has not yet been elucidated, most probably owing to the difficulty in detecting pre-existing minor haplotypes with sufficient length and accuracy. Herein, we characterize a methodological framework based on Illumina MiSeq next-generation sequencing (NGS) coupled with bioinformatics of quasispecies reconstruction (QSR) to realize highly accurate variant calling and genotype-haplotype detection. The core-to-NS3 protease coding sequences in 10 HCV monoinfected patients, 5 of whom had a history of blood transfusion, and 11 HCV/HIV coinfected patients with hemophilia, were studied. Simulation experiments showed that, for minor variants constituting more than 1%, our framework achieved a positive predictive value (PPV) of 100% and sensitivities of 91.7-100% for genotyping and 80.6% for RAV screening. Genotyping analysis indicated the prevalence of dominant Gt1a infection in coinfected patients (6/11 vs 0/10, p = 0.01). For clinical samples, minor genotype overlapping infection was prevalent in HCV/HIV coinfected hemophiliacs (10/11) and patients who experienced whole-blood transfusion (4/5) but none in patients without exposure to blood (0/5). As for RAV screening, the Q80K/R and S122K/R variants were particularly prevalent among minor RAVs observed, detected in 12/21 and 6/21 cases, respectively. Q80K was detected only in coinfected patients, whereas Q80R was predominantly detected in monoinfected patients (1/11 vs 7/10, p < 0.01). Multivariate interdependence analysis revealed the previously unrecognized prevalence of Gt1b-Q80K, in HCV/HIV coinfected hemophiliacs [Odds ratio = 13.4 (3.48-51.9), p < 0.01]. Our study revealed the distinct characteristics of viral quasispecies between the subgroups specified above and the feasibility of NGS and QSR-based genetic deconvolution of pre-existing minor Gts, RAVs, and their interrelationships.	[Ogishi, Masato; Yotsuyanagi, Hiroshi; Tsutsumi, Takeya; Moriya, Kyoji; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan; [Gatanaga, Hiroyuki; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Shinjuku Ku, Tokyo, Japan; [Ode, Hirotaka; Sugiura, Wataru] Nagoya Med Ctr, Clin Res Ctr, Dept Infect Dis & Immunol, Nagoya, Aichi, Japan; [Kimura, Satoshi] Tokyo Teishin Hosp, Tokyo, Japan; [Kimura, Satoshi] Tokyo Hlth Care Univ, Tokyo, Japan	University of Tokyo; National Center for Global Health & Medicine - Japan; Nagoya Medical Center	Yotsuyanagi, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan.	hyotsu-tky@umin.ac.jp	Ogishi, Masato/ABB-8347-2020	Ogishi, Masato/0000-0003-2421-7389; Ode, Hirotaka/0000-0001-8624-2382; Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labor and Welfare, japanese Government [HIV 28]	Ministry of Health, Labor and Welfare, japanese Government	This work was suppoted by The Ministry of Health, Labor and Welfare, japanese Government http://www.mhlw.go.jp/english/. The grant number is HIV 28. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman T, 2015, HEPATOLOGY, V61, P88, DOI 10.1002/hep.27192; Abe H, 2013, AM J GASTROENTEROL, V108, P1464, DOI 10.1038/ajg.2013.205; Acevedo A, 2014, NAT PROTOC, V9, P1760, DOI 10.1038/nprot.2014.118; Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Aitken C, 2004, J MED VIROL, V74, P543, DOI 10.1002/jmv.20212; [Anonymous], 2014, R LANG ENV STAT COMP; Arezi B, 2007, ANAL BIOCHEM, V360, P84, DOI 10.1016/j.ab.2006.10.009; Asnis GM, 2006, J CLIN GASTROENTEROL, V40, P322, DOI 10.1097/01.mcg.0000210099.36500.fe; Asselah T, 2014, LIVER INT, V34, P60, DOI 10.1111/liv.12424; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Chung RT, 2014, NEW ENGL J MED, V370, P1, DOI [10.1056/NEJMp1313927, DOI 10.1056/NEJMP1313927]; Cummings MD, 2010, ANGEW CHEM INT EDIT, V49, P1652, DOI 10.1002/anie.200906696; DAENEN S, 1987, TRANSFUSION, V27, P482, DOI 10.1046/j.1537-2995.1987.27688071700.x; Devereux H, 1996, J VIRAL HEPATITIS, V3, P43, DOI 10.1111/j.1365-2893.1996.tb00080.x; Di Giallonardo F, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku537; Donaldson EF, 2015, HEPATOLOGY, V61, P56, DOI 10.1002/hep.27375; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Eyster ME, 1999, J INFECT DIS, V179, P1062, DOI 10.1086/314708; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Fukuda Y, 1998, HAEMOPHILIA, V4, P595, DOI 10.1046/j.1365-2516.1998.440595.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; GIALLONARDO F, 2014, NUCLEIC ACIDS RES, V42, P1, DOI DOI 10.1093/NAR/GKT1324; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Jabara CB, 2014, ANTIMICROB AGENTS CH, V58, P6079, DOI 10.1128/AAC.03466-14; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kieffer TL, 2014, CURR OPIN VIROL, V8, P16, DOI 10.1016/j.coviro.2014.04.008; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lawitz E, 2014, LANCET, P1; Lee LY, 2012, INT J CLIN PRACT, V66, P342, DOI 10.1111/j.1742-1241.2012.02895.x; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin VW, 2014, HAEMOPHILIA, V20, P1; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Malet I, 2003, J VIROL METHODS, V109, P161, DOI 10.1016/S0166-0934(03)00067-3; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Ojosnegros S, 2011, VIRUS RES, V162, P203, DOI 10.1016/j.virusres.2011.09.018; Paolucci S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-355; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Prosperi MCF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02837; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Schirmer M, 2014, BRIEF BIOINFORM, V15, P431, DOI 10.1093/bib/bbs081; Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232; Yang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058; ZHANG LQ, 1991, AIDS, V5, P675, DOI 10.1097/00002030-199106000-00006; Zylberberg H, 1996, CLIN INFECT DIS, V23, P1117, DOI 10.1093/clinids/23.5.1117	59	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119145	10.1371/journal.pone.0119145	http://dx.doi.org/10.1371/journal.pone.0119145			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748426	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400049
J	Ge, BH; Song, YD; Zhang, Y; Liu, XW; Wen, YX; Guo, XM				Ge, Beihai; Song, Yadong; Zhang, Yi; Liu, Xiaowen; Wen, Yuxiang; Guo, Xiaomei			Glutathione S-Transferase M1 (GSTM1) and T1 (GSTT1) Null Polymorphisms and the Risk of Hypertension: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISMS; OXIDATIVE STRESS; ASSOCIATION; VARIANTS; DELETION; DISEASE; FAMILY	Background Some studies have recently focused on the association between glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms and hypertension; however, results have been inconsistent. Objective In order to drive a more precise estimation, the present systematic review and meta-analysis is performed to investigate the relationship between the GSTM1 and GSTT1 null polymorphisms and hypertension. Methods Eligible articles were identified by a search of several bibliographic databases for the period up to August 17, 2013. Odds ratios were pooled using either fixed-effects or random-effects models. Results Regarding the GSTM1 null/present genotype, 14 case-control studies were eligible (2773 hypertension cases and 3189 controls). The meta-analysis revealed that it might present a small increased risk for hypertension, although the effect was not statistically significant (odd ratio (OR) = 1.16, 95% confidence interval (CI): 0.96, 1.40; P = 0.002, I2 = 59.8%). Further subgroup analysis by ethnicity and control source suggested that the association was still not significant. Thirteen case-control studies were eligible for GSTT1 (2497 hypertension cases and 3078 controls). No statistically significant association was observed between the GSTT1 null genotype and hypertension risk (OR = 1.14, 95% CI: 0.85, 1.53; P = 0.000, I2 = 80.3%). Furthermore, stratification by ethnicity and control source indicated no association between the GSTT1 null genotype and hypertension risk. We further confirmed the association by sensitivity analysis. No publication bias was detected. Conclusion This meta-analysis suggests that the GSTM1 and GSTT1 null polymorphisms are not associated with the risk of hypertension. Future large well-designed epidemiological studies with individual information, lifestyle factors, and environmental factors are warranted to validate the present findings.	[Ge, Beihai; Zhang, Yi; Liu, Xiaowen; Wen, Yuxiang; Guo, Xiaomei] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Cardiol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Song, Yadong] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Nutr & Food Hyg, Tongji Med Coll, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guo, XM (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Cardiol, Tongji Med Coll, Wuhan 430030, Peoples R China.	xmguo@tjh.tjmu.edu.cn	beihai, ge/M-3944-2013	Song, Yadong/0000-0003-1424-2011	National Nature Science Foundation of China [30971244, 81270353]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (30971244,81270353) (URL:http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir B, 2007, ASIAN J ANDROL, V9, P108, DOI 10.1111/j.1745-7262.2007.00237.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bessa SS, 2009, EUR J INTERN MED, V20, P625, DOI 10.1016/j.ejim.2009.06.003; Borah PK, 2011, GENET TEST MOL BIOMA, V15, P771, DOI 10.1089/gtmb.2010.0186; Capoluongo E, 2009, CLIN CHIM ACTA, V399, P92, DOI 10.1016/j.cca.2008.09.017; Cavalieri E, 2000, J Natl Cancer Inst Monogr, P75; Cruz-Gonzalez I, 2009, J HUM HYPERTENS, V23, P556, DOI 10.1038/jhh.2009.19; DANIEL V, 1993, CRIT REV BIOCHEM MOL, V28, P173, DOI 10.3109/10409239309086794; Delles C, 2008, J HYPERTENS, V26, P1343, DOI 10.1097/HJH.0b013e3282fe1d67; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eslami S, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0432-1; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; Geisler SA, 2001, AM J EPIDEMIOL, V154, P95, DOI 10.1093/aje/154.2.95; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hengstler JG, 1998, RECENT RES CANCER, V154, P47; Hussain K, 2012, IRAN RED CRESCENT ME, V14, P479; Jiang XJ, 2010, CARCINOGENESIS, V31, P1964, DOI 10.1093/carcin/bgq173; Johnson RJ, 2005, AM J HYPERTENS, V18, P431, DOI 10.1016/j.amjhyper.2004.08.035; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lee BK, 2012, MOL CELL TOXICOL, V8, P203, DOI 10.1007/s13273-012-0025-5; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035408; Liang SQ, 2013, RESPIROLOGY, V18, P774, DOI 10.1111/resp.12097; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marcos M, 2011, ALIMENT PHARM THER, V34, P1159, DOI 10.1111/j.1365-2036.2011.04862.x; Marinho C, 2007, BIOCHEM BIOPH RES CO, V353, P344, DOI 10.1016/j.bbrc.2006.12.019; Miranda-Vilela AL, 2010, GENET MOL RES, V9, P2166, DOI 10.4238/vol9-4gmr973; Moonesinghe R, 2008, P NATL ACAD SCI USA, V105, P617, DOI 10.1073/pnas.0705554105; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Norppa H, 2004, TOXICOL LETT, V149, P309, DOI 10.1016/j.toxlet.2003.12.042; Okcu MF, 2004, CLIN CANCER RES, V10, P2618, DOI 10.1158/1078-0432.CCR-03-0053; Oniki K, 2008, PHARMACOGENET GENOM, V18, P275, DOI 10.1097/FPC.0b013e3282f56176; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; Pedro-Botet J, 2000, J HUM HYPERTENS, V14, P343, DOI 10.1038/sj.jhh.1001034; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Polimanti R, 2011, MOL CELL BIOCHEM, V357, P227, DOI 10.1007/s11010-011-0893-3; Rebbeck TR, 1997, CANCER EPIDEM BIOMAR, V6, P733; Santovito A, 2008, ARCH TOXICOL, V82, P903, DOI 10.1007/s00204-008-0316-8; Song GG, 2012, MOL BIOL REP, V39, P10739, DOI 10.1007/s11033-012-1965-5; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tang ST, 2013, GENE, V530, P301, DOI 10.1016/j.gene.2013.08.043; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Turkanoglu A, 2010, NEUROL SCI, V31, P727, DOI 10.1007/s10072-010-0330-5; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; Wang J, 2010, MUTAGENESIS, V25, P365, DOI 10.1093/mutage/geq014; Wang R, 2012, NEURAL REGEN RES, V7, P1420, DOI 10.3969/j.issn.1673-5374.2012.18.009; Xue H, 2012, MOL BIOL REP, V39, P5033, DOI 10.1007/s11033-011-1300-6; Yang Y, 2004, INT J MOL MED, V14, P855; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	54	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118897	10.1371/journal.pone.0118897	http://dx.doi.org/10.1371/journal.pone.0118897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742618	Green Submitted, gold, Green Published			2022-12-27	WOS:000350688100057
J	Munksgaard, NC; Zwart, C; Kurita, N; Bass, A; Nott, J; Bird, MI				Munksgaard, Niels C.; Zwart, Costijn; Kurita, Naoyuki; Bass, Adrian; Nott, Jon; Bird, Michael I.			Stable Isotope Anatomy of Tropical Cyclone Ita, North-Eastern Australia, April 2014	PLOS ONE			English	Article							HYDROGEN ISOTOPES; WATER ISOTOPES; DELTA-D; VARIABILITY; PRECIPITATION; OXYGEN	The isotope signatures registered in speleothems during tropical cyclones (TC) provides information about the frequency and intensity of past TCs but the precise relationship between isotopic composition and the meteorology of TCs remain uncertain. Here we present continuous delta O-18 and delta H-2 data in rainfall and water vapour, as well as in discrete rainfall samples, during the passage of TC Ita and relate the evolution in isotopic compositions to local and synoptic scale meteorological observations. High-resolution data revealed a close relationship between isotopic compositions and cyclonic features such as spiral rainbands, periods of stratiform rainfall and the arrival of subtropical and tropical air masses with changing oceanic and continental moisture sources. The isotopic compositions in discrete rainfall samples were remarkably constant along the similar to 450 km overland path of the cyclone when taking into account the direction and distance to the eye of the cyclone at each sampling time. Near simultaneous variations in delta O-18 and delta H-2 values in rainfall and vapour and a near-equilibrium rainfall-vapour isotope fractionation indicates strong isotopic exchange between rainfall and surface inflow of vapour during the approach of the cyclone. In contrast, after the passage of spiral rainbands close to the eye of the cyclone, different moisture sources for rainfall and vapour are reflected in diverging d-excess values. High-resolution isotope studies of modern TCs refine the interpretation of stable isotope signatures found in speleothems and other paleo archives and should aim to further investigate the influence of cyclone intensity and longevity on the isotopic composition of associated rainfall.	[Munksgaard, Niels C.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Munksgaard, Niels C.; Zwart, Costijn; Bass, Adrian; Nott, Jon; Bird, Michael I.] James Cook Univ, Coll Sci,Technol & Engn, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Kurita, Naoyuki] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	Charles Darwin University; James Cook University; Nagoya University	Munksgaard, NC (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	niels.munksgaard@cdu.edu.au	Bird, Michael/G-5364-2010; Bass, Adrian Michael/A-6133-2016; Kurita, Naoyuki/C-6120-2014; Nott, Jonathan/H-5156-2011	Bird, Michael/0000-0003-1801-8703; Bass, Adrian Michael/0000-0003-3982-6582; Nott, Jonathan/0000-0001-7258-017X	Australian Research Council [LE130100159]	Australian Research Council(Australian Research Council)	This work was supported by Grant LE130100159 from the Australian Research Council http://www.arc.gov.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; EHHALT DH, 1970, J GEOPHYS RES, V75, P2323, DOI 10.1029/JC075i012p02323; Frappier AB, 2007, GEOLOGY, V35, P111, DOI 10.1130/G23145A.1; Fudeyasu H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009313; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Gedzelman S, 2003, MON WEATHER REV, V131, P1112, DOI 10.1175/1520-0493(2003)131<1112:PHWSIO>2.0.CO;2; Gimeno L, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000389; Good SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091117; Haig J, 2014, NATURE, V505, P667, DOI 10.1038/nature12882; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; Jouzel J, 2013, WATER RESOUR RES, V49, P7469, DOI 10.1002/2013WR013508; Kurita N, 2012, ATMOS MEAS TECH, V5, P2069, DOI 10.5194/amt-5-2069-2012; Kurita N, 2013, J GEOPHYS RES-ATMOS, V118, P10376, DOI 10.1002/jgrd.50754; Kurita N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015209; Lawrence JR, 1996, GEOPHYS RES LETT, V23, P527, DOI 10.1029/96GL00425; Lawrence JR, 2002, J ATMOS CHEM, V41, P67, DOI 10.1023/A:1013808530364; Lawrence JR, 1998, CHEM GEOL, V144, P153, DOI 10.1016/S0009-2541(97)00090-9; Lee JE, 2008, HYDROL PROCESS, V22, P1, DOI 10.1002/hyp.6637; Li ZH, 2011, CHEM GEOL, V284, P138, DOI 10.1016/j.chemgeo.2011.02.015; Liu JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014403; Lonfat M, 2004, MON WEATHER REV, V132, P1645, DOI 10.1175/1520-0493(2004)132<1645:PDITCU>2.0.CO;2; MERLIVAT L, 1979, J GEOPHYS RES-OCEANS, V84, P5029, DOI 10.1029/JC084iC08p05029; Miller DL, 2006, P NATL ACAD SCI USA, V103, P14294, DOI 10.1073/pnas.0606549103; Munksgaard NC, 2012, HYDROL PROCESS, V26, P3630, DOI 10.1002/hyp.9505; Munksgaard NC, 2011, RAPID COMMUN MASS SP, V25, P3706, DOI 10.1002/rcm.5282; Nott J, 2007, EARTH PLANET SC LETT, V255, P367, DOI 10.1016/j.epsl.2006.12.023; Risi C, 2010, Q J ROY METEOR SOC, V136, P227, DOI 10.1002/qj.485; Rozanski K, 1993, GEOPHYS MONOGR SER, P78; Trenberth KE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008303	29	42	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119728	10.1371/journal.pone.0119728	http://dx.doi.org/10.1371/journal.pone.0119728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742628	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000350688100127
J	Matsuno, H; Ohi, K; Hashimoto, R; Yamamori, H; Yasuda, Y; Fujimoto, M; Yano-Umeda, S; Saneyoshi, T; Takeda, M; Hayashi, Y				Matsuno, Hitomi; Ohi, Kazutaka; Hashimoto, Ryota; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Yano-Umeda, Satomi; Saneyoshi, Takeo; Takeda, Masatoshi; Hayashi, Yasunori			A Naturally Occurring Null Variant of the NMDA Type Glutamate Receptor NR3B Subunit Is a Risk Factor of Schizophrenia	PLOS ONE			English	Article							ACOUSTIC STARTLE RESPONSE; HIGH-ACTIVITY ALLELE; GRIN1 GENE PROMOTER; SCHIZOTYPAL PERSONALITY; PREPULSE INHIBITION; CALCIUM PERMEABILITY; G1001C POLYMORPHISM; AMPA RECEPTORS; EXPRESSION; ASPARTATE	Hypofunction of the N-methyl-D-aspartate type glutamate receptor (NMDAR) has been implicated in the pathogenesis of schizophrenia. Here, we investigated the significance of a common human genetic variation of the NMDAR NR3B subunit that inserts 4 bases within the coding region (insCGTT) in the pathogenesis of schizophrenia. The cDNA carrying this polymorphism generates a truncated protein, which is electrophysiologically non-functional in heterologous expression systems. Among 586 schizophrenia patients and 754 healthy controls, insCGTT was significantly overrepresented in patients compared to controls (odds ratio = 1.37, p = 0.035). Among 121 schizophrenia patients and 372 healthy controls, genetic analyses of normal individuals revealed that those carrying insCGTT have a predisposition to schizotypal personality traits (F-1,F-356 = 4.69, p = 0.031). Furthermore, pre-pulse inhibition, a neurobiological trait disturbed in patients with schizophrenia, was significantly impaired in patients carrying insCGTT compared with those with the major allele (F-1,F-116 = 5.72, p = 0.018, F-1,F-238 = 4.46, p = 0.036, respectively). These results indicate that a naturally occurring null variant in NR3B could be a risk factor of schizophrenia.	[Matsuno, Hitomi; Saneyoshi, Takeo; Hayashi, Yasunori] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Ohi, Kazutaka; Hashimoto, Ryota; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka 5650871, Japan; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka 5650871, Japan; [Yamamori, Hidenaga; Yano-Umeda, Satomi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Osaka 5650871, Japan; [Hayashi, Yasunori] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan	RIKEN; Osaka University; Osaka University; Osaka University; Saitama University	Hashimoto, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka 5650871, Japan.	hashimor@psy.med.osaka-u.ac.jp; yhayashi@brain.riken.jp	Hayashi, Yasunori/C-2249-2008; Hashimoto, Ryota/P-8572-2014; Saneyoshi, Takeo/AAF-5170-2019; Ohi, Kazutaka/J-7851-2019; Hashimoto, Ryota/AAE-3200-2019; Hayashi, Yasunori/AAF-1408-2019	Hayashi, Yasunori/0000-0002-7560-3004; Hashimoto, Ryota/0000-0002-5941-4238; Ohi, Kazutaka/0000-0001-9577-9640; Hashimoto, Ryota/0000-0002-5941-4238; Hayashi, Yasunori/0000-0002-7560-3004	RIKEN; National Institutes of Health [R21NS46421]; Ministry of Education, Culture, Sports, Science and Technology, Japan [90466037, 22110006, 22390225, 23659565, 221S0003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS046421] Funding Source: NIH RePORTER	RIKEN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by RIKEN [to Y.H.]; National Institutes of Health grant [R21NS46421 to Y.H.]; Grant-in-Aid for Scientific Research A [grant number 90466037 to Y.H.]; Grant-in-Aid for Scientific Research on Innovative Area "Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science and Technology, Japan [22110006 to Y.H.]; a Grant-in-Aid for Scientific Research B [22390225 to R.H.]; Grant-in-Aid for Challenging Exploratory Research [23659565 to R.H.]; and Grant-in-Aid for Scientific Research on Innovative Areas "Comprehensive Brain Science Network" from the Ministry of Education, Culture, Sports, Science and Technology, Japan [221S0003 to R.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 1996, J NEUROSCI, V16, P19; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Andersson O, 2001, GENOMICS, V78, P178, DOI 10.1006/geno.2001.6666; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; Avramopoulos D, 2002, MOL PSYCHIATR, V7, P706, DOI 10.1038/sj.mp.4001070; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Banno M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028929; Begni S, 2003, BIOL PSYCHIAT, V53, P617, DOI 10.1016/S0006-3223(02)01783-3; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Bendel O, 2005, NEUROSCI LETT, V377, P31, DOI 10.1016/j.neulet.2004.11.064; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Cioffi CL, 2013, BIOORG MED CHEM LETT, V23, P5034, DOI 10.1016/j.bmcl.2013.07.019; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fukaya M, 2005, EUR J NEUROSCI, V21, P1432, DOI 10.1111/j.1460-9568.2005.03957.x; Fukumori R, 2010, NEUROCHEM INT, V57, P730, DOI 10.1016/j.neuint.2010.08.009; Galehdari H, 2009, J MOL NEUROSCI, V38, P178, DOI 10.1007/s12031-008-9148-5; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hashimoto R, 2011, NEUROPSYCHOPHARMACOL, V36, P1921, DOI 10.1038/npp.2011.78; Hong LE, 2008, BIOL PSYCHIAT, V63, P17, DOI 10.1016/j.biopsych.2007.05.011; IIJIMA Y, 2010, KOUDOURYOUHOUKENKYU, V36, P29; INTERNATIONAL S, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kircher T, 2009, PSYCHOL MED, V39, P1657, DOI 10.1017/S0033291709005388; Koide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036836; Lin YT, 2014, PSYCHIAT RES, V218, P356, DOI 10.1016/j.psychres.2014.04.032; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; Martucci L, 2006, SCHIZOPHR RES, V84, P214, DOI 10.1016/j.schres.2006.02.001; Matsuda K, 2003, J NEUROSCI, V23, P10064; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moriwaki M, 2009, NEUROSCI RES, V65, P259, DOI 10.1016/j.neures.2009.07.009; Niemann S, 2008, NEUROLOGY, V70, P666, DOI 10.1212/01.wnl.0000271078.51280.17; Niemann S, 2007, EUR J NEUROSCI, V26, P1407, DOI 10.1111/j.1460-9568.2007.05774.x; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Pulay Attila J, 2009, Prim Care Companion J Clin Psychiatry, V11, P53; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Quednow BB, 2008, BIOL PSYCHIAT, V64, P434, DOI 10.1016/j.biopsych.2008.02.019; Quednow BB, 2010, SCHIZOPHRENIA BULL, V36, P341, DOI 10.1093/schbul/sbn088; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Riley B, 2006, EUR J HUM GENET, V14, P669, DOI 10.1038/sj.ejhg.5201571; Schurhoff F, 2007, AM J MED GENET B, V144B, P64, DOI 10.1002/ajmg.b.30395; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Smothers CT, 2009, J PHARMACOL EXP THER, V331, P975, DOI 10.1124/jpet.109.158493; Snyder MA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00031; Someya T, 1994, P 32 SCI M U HLTH CA, P286; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Takahashi H, 2008, NEUROSCI RES, V62, P187, DOI 10.1016/j.neures.2008.08.006; Takahashi H, 2010, PSYCHOPHYSIOLOGY, V47, P831, DOI 10.1111/j.1469-8986.2010.01000.x; Takata A, 2013, BIOL PSYCHIAT, V73, P532, DOI 10.1016/j.biopsych.2012.10.024; Tarabeux J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.52; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wee KSL, 2008, J COMP NEUROL, V509, P118, DOI 10.1002/cne.21747; Wee KSL, 2010, NEUROCHEM INT, V57, P97, DOI 10.1016/j.neuint.2010.05.003; Yasuda Y, 2011, NEUROSCI LETT, V495, P216, DOI 10.1016/j.neulet.2011.03.069	64	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116319	10.1371/journal.pone.0116319	http://dx.doi.org/10.1371/journal.pone.0116319			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768306	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500007
J	Bronchalo-Vicente, L; Rodriguez-Del Rio, E; Freire, J; Calderon-Gonzalez, R; Frande-Cabanes, E; Gomez-Roman, JJ; Fernandez-Llaca, H; Yanez-Diaz, S; Alvarez-Dominguez, C				Bronchalo-Vicente, Lucia; Rodriguez-Del Rio, Estela; Freire, Javier; Calderon-Gonzalez, Ricardo; Frande-Cabanes, Elisabet; Javier Gomez-Roman, Jose; Fernandez-Llaca, Hector; Yanez-Diaz, Sonsoles; Alvarez-Dominguez, Carmen			A Novel Therapy for Melanoma Developed in Mice: Transformation of Melanoma into Dendritic Cells with Listeria monocytogenes	PLOS ONE			English	Article							ANTIGEN-EXPRESSION; ENHANCEMENT; VACCINATION; INFECTION; RESPONSES; EPITOPES; VACCINES	Listeria monocytogenes is a gram-positive bacteria and human pathogen widely used in cancer immunotherapy because of its capacity to induce a specific cytotoxic T cell response in tumours. This bacterial pathogen strongly induces innate and specific immunity with the potential to overcome tumour induced tolerance and weak immunogenicity. Here, we propose a Listeria based vaccination for melanoma based in its tropism for these tumour cells and its ability to transform in vitro and in vivo melanoma cells into matured and activated dendritic cells with competent microbicidal and antigen processing abilities. This Listeria based vaccination using low doses of the pathogen caused melanoma regression by apoptosis as well as bacterial clearance. Vaccination efficacy is LLO dependent and implies the reduction of LLO-specific CD4+ T cell responses, strong stimulation of innate pro-inflammatory immune cells and a prevalence of LLO-specific CD8+ T cells involved in tumour regression and Listeria elimination. These results support the use of low doses of pathogenic Listeria as safe melanoma therapeutic vaccines that do not require antibiotics for bacterial removal.	[Bronchalo-Vicente, Lucia; Rodriguez-Del Rio, Estela; Calderon-Gonzalez, Ricardo; Frande-Cabanes, Elisabet; Yanez-Diaz, Sonsoles; Alvarez-Dominguez, Carmen] Inst Invest Marques Valdecilla IDIVAL, Grp Genom Proteom & Vacunas, Santander, Spain; [Bronchalo-Vicente, Lucia; Fernandez-Llaca, Hector; Yanez-Diaz, Sonsoles] Hosp Univ Marques Valdecilla, Serv Dermatol, Santander, Spain; [Freire, Javier; Javier Gomez-Roman, Jose] Hosp Univ Marques Valdecilla, Serv Anat Patol, Santander, Cantabria, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Alvarez-Dominguez, C (corresponding author), Inst Invest Marques Valdecilla IDIVAL, Grp Genom Proteom & Vacunas, Santander, Spain.	calvarez@humv.es	Alvarez-Dominguez, Carmen/J-4675-2014; José Javier, Gómez-Román/AAC-8156-2021; González, Ricardo Calderón/N-6863-2013; Frande-Cabanes, Elisabet/F-9889-2016	Alvarez-Dominguez, Carmen/0000-0002-4585-6959; José Javier, Gómez-Román/0000-0002-2849-9435; González, Ricardo Calderón/0000-0003-0841-3814; Frande-Cabanes, Elisabet/0000-0003-1748-0584	 [SAF2009-08695];  [SAF2012-34203]	; 	This work was supported by grants SAF2009-08695 and SAF2012-34203. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-4; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Boyano Maria Dolores, 1998, Invasion and Metastasis, V18, P122, DOI 10.1159/000024505; BOYANO MD, 1994, PATHOBIOLOGY, V62, P186, DOI 10.1159/000163909; Calderon-Gonzalez R, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00022; Carrasco-Marin E, 2012, J BIOL CHEM, V287, P14310, DOI 10.1074/jbc.M112.348615; Carrasco-Marin E, 2011, J BIOL CHEM, V286, P3332, DOI 10.1074/jbc.M110.146761; Coley W B, 1910, Proc R Soc Med, V3, P1; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Elkadi OA, 2013, MED HYPOTHESES, V81, P207, DOI 10.1016/j.mehy.2013.05.001; Forschner A, 2004, CLIN MICROBIOL INFEC, V10, P86, DOI 10.1111/j.1469-0691.2004.00808.x; Frande-Cabanes E, 2014, GLIA, V62, P233, DOI 10.1002/glia.22602; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Gonzalez A, 1992, 21 NAT C DERM VEN LA; Gonzalez-Vela MC, 2008, ACTA DERM-VENEREOL, V88, P92, DOI 10.2340/00015555-0334; Guirnalda PD, 2012, ONCOIMMUNOLOGY, V1, P822, DOI 10.4161/onci.20491; Kim SH, 2009, CANCER RES, V69, P5860, DOI 10.1158/0008-5472.CAN-08-4855; Klarquist JS, 2012, ONCOIMMUNOLOGY, V1, P1584, DOI 10.4161/onci.22660; Kono M, 2012, VACCINE, V30, P2633, DOI 10.1016/j.vaccine.2012.02.026; Maciag PC, 2009, VACCINE, V27, P3975, DOI 10.1016/j.vaccine.2009.04.041; Mitchell LM, 2011, CELL IMMUNOL, V268, P79, DOI 10.1016/j.cellimm.2011.03.001; Oshita C, 2012, ONCOL REP, V28, P1131, DOI 10.3892/or.2012.1956; Pan ZK, 1999, CANCER RES, V59, P5264; Patyar S, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-21; Prevost G, 2003, CURR OPIN INFECT DIS, V16, P71, DOI 10.1097/00001432-200304000-00002; Robila V, 2008, J IMMUNOL, V181, P7843, DOI 10.4049/jimmunol.181.11.7843; Shahabi Vafa, 2010, Bioeng Bugs, V1, P235, DOI 10.4161/bbug.1.4.11243; Skoberne M, 2008, J CLIN INVEST, V118, P3990, DOI 10.1172/JCI31350; Wood LM, 2008, IMMUNOL RES, V42, P233, DOI 10.1007/s12026-008-8087-0; ZALOUDIK J, 1988, J CLIN PATHOL, V41, P1078, DOI 10.1136/jcp.41.10.1078; Zelenik K, 2014, ZOONOSES PUBLIC HLTH, V61, P238, DOI 10.1111/zph.12075	31	11	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0117923	10.1371/journal.pone.0117923	http://dx.doi.org/10.1371/journal.pone.0117923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760947	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275000014
J	Damodaran, SP; Eberhard, S; Boitard, L; Rodriguez, JG; Wang, Y; Bremond, N; Baudry, J; Bibette, J; Wollman, FA				Damodaran, Shima P.; Eberhard, Stephan; Boitard, Laurent; Rodriguez, Jairo Garnica; Wang, Yuxing; Bremond, Nicolas; Baudry, Jean; Bibette, Jerome; Wollman, Francis-Andre			A Millifluidic Study of Cell-to-Cell Heterogeneity in Growth-Rate and Cell-Division Capability in Populations of Isogenic Cells of Chlamydomonas reinhardtii	PLOS ONE			English	Article							SINGLE-CELL; ESCHERICHIA-COLI; GENE-EXPRESSION; ENVIRONMENTAL MICROBIOLOGY; NONGENETIC HETEROGENEITY; SACCHAROMYCES-CEREVISIAE; BACTERIAL PERSISTENCE; GENOME INSTABILITY; FLOW-CYTOMETRY; FISSION YEAST	To address possible cell-to-cell heterogeneity in growth dynamics of isogenic cell populations of Chlamydomonas reinhardtii, we developed a millifluidic drop-based device that not only allows the analysis of populations grown from single cells over periods of a week, but is also able to sort and collect drops of interest, containing viable and healthy cells, which can be used for further experimentation. In this study, we used isogenic algal cells that were first synchronized in mixotrophic growth conditions. We show that these synchronized cells, when placed in droplets and kept in mixotrophic growth conditions, exhibit mostly homogeneous growth statistics, but with two distinct subpopulations: a major population with a short doubling-time (fast-growers) and a significant subpopulation of slowly dividing cells (slow-growers). These observations suggest that algal cells from an isogenic population may be present in either of two states, a state of restricted division and a state of active division. When isogenic cells were allowed to propagate for about 1000 generations on solid agar plates, they displayed an increased heterogeneity in their growth dynamics. Although we could still identify the original populations of slow-and fast-growers, drops inoculated with a single progenitor cell now displayed a wider diversity of doubling-times. Moreover, populations dividing with the same growth-rate often reached different cell numbers in stationary phase, suggesting that the progenitor cells differed in the number of cell divisions they could undertake. We discuss possible explanations for these cell-to-cell heterogeneities in growth dynamics, such as mutations, differential aging or stochastic variations in metabolites and macromolecules yielding molecular switches, in the light of single-cell heterogeneities that have been reported among isogenic populations of other eu- and prokaryotes.	[Damodaran, Shima P.; Boitard, Laurent; Rodriguez, Jairo Garnica; Wang, Yuxing; Bremond, Nicolas; Baudry, Jean; Bibette, Jerome] PSL Res Univ, ParisTech, CNRS,UMR 8231, Inst Chem Biol & Innovat ESPCI,Lab Colloides & Ma, Paris, France; [Eberhard, Stephan; Wollman, Francis-Andre] UPMC, CNRS, Inst Biol Phys Chim, Lab Physiol Membranaire & Mol Chloroplaste, Paris, France; [Wang, Yuxing] Shanghai Jiao Tong Univ, Opt Sci & Engn Res Ctr, Dept Phys & Astron, Shanghai 200030, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Shanghai Jiao Tong University	Bibette, J (corresponding author), PSL Res Univ, ParisTech, CNRS,UMR 8231, Inst Chem Biol & Innovat ESPCI,Lab Colloides & Ma, Paris, France.	jerome.bibette@espci.fr; wollman@ibpc.fr	Baudry, Jean/A-7344-2016; Damodaran, Shima P/D-3737-2019; Baudry, Jean/AAX-6267-2020	Baudry, Jean/0000-0002-5526-499X; Damodaran, Shima P/0000-0002-7344-3545; Baudry, Jean/0000-0002-5526-499X; Eberhard, Stephan/0000-0002-1445-3110; Bremond, Nicolas/0000-0003-3724-7050	Unite Mixte de Recherche [7141]; CNRS; Universite Pierre et Marie Curie, Paris 06; DEFI CNRS Milli_Oil project; Agence Nationale de la Recherche (ANR) [13-BSV7-0001-01]; "Initiative d'Excellence" program [ANR-11-LABX-0011-01]; Fondation Pierre-Gilles de Gennes pour la Recherche [FPGG035]	Unite Mixte de Recherche; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie, Paris 06; DEFI CNRS Milli_Oil project; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); "Initiative d'Excellence" program; Fondation Pierre-Gilles de Gennes pour la Recherche	This work was supported by Unite Mixte de Recherche 7141, CNRS and Universite Pierre et Marie Curie, Paris 06, by the DEFI CNRS Milli_Oil project, by the Agence Nationale de la Recherche (ANR) contract 13-BSV7-0001-01, by the "Initiative d'Excellence" program (Grant "DYNAMO," ANR-11-LABX-0011-01), and by Fondation Pierre-Gilles de Gennes pour la Recherche contract FPGG035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Bae S, 2013, ANAL BIOANAL CHEM, V405, P9365, DOI 10.1007/s00216-013-7389-9; Baraban L, 2011, LAB CHIP, V11, P4057, DOI 10.1039/c1lc20545e; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Blaby IK, 2014, TRENDS PLANT SCI; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Boitard L, 2012, P NATL ACAD SCI USA, V109, P7181, DOI 10.1073/pnas.1200894109; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Capp JP, 2010, GENETICS, V185, P395, DOI 10.1534/genetics.110.118190; Claudi B, 2014, CELL, V158, P722, DOI 10.1016/j.cell.2014.06.045; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cooper VS, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001790; Czechowska K, 2008, CURR OPIN MICROBIOL, V11, P205, DOI 10.1016/j.mib.2008.04.006; DEMETS R, 1985, J GEN MICROBIOL, V131, P2919; Dewan A, 2012, BIOTECHNOL BIOENG, V109, P2987, DOI 10.1002/bit.24568; Dichosa AEK, 2014, NAT PROTOC, V9, P608, DOI 10.1038/nprot.2014.034; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Esquivel MG, 2011, TRENDS BIOTECHNOL, V29, P595, DOI 10.1016/j.tibtech.2011.06.008; Eun YJ, 2011, ACS CHEM BIOL, V6, P260, DOI 10.1021/cb100336p; Fischer BB, 2006, PLANT CELL PHYSIOL, V47, P1135, DOI 10.1093/pcp/pcj085; Flatscher R, 2012, GENET RES INT, V2012, DOI 10.1155/2012/698421; Fulneckova J, 2013, GENOME BIOL EVOL, V5, P468, DOI 10.1093/gbe/evt019; Garay LA, 2014, J AGR FOOD CHEM; Garz A, 2012, BIOPHYS J, V103, P1078, DOI 10.1016/j.bpj.2012.07.026; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Ghosh S, 2014, CURR OPIN GENET DEV, V26, P41, DOI 10.1016/j.gde.2014.05.003; Ghysels B, 2010, PHOTOSYNTH RES, V106, P145, DOI 10.1007/s11120-010-9582-4; Gimpel JA, 2013, CURR OPIN CHEM BIOL, V17, P489, DOI 10.1016/j.cbpa.2013.03.038; Grossman AR, 2000, CURR OPIN PLANT BIOL, V3, P132, DOI 10.1016/S1369-5266(99)00053-9; Grossman AR, 2003, EUKARYOT CELL, V2, P1137, DOI 10.1128/EC.2.6.1137-1150.2003; Grunberger A, 2014, CURR OPIN BIOTECH, V29, P15, DOI 10.1016/j.copbio.2014.02.008; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; HAILS T, 1995, CURR GENET, V28, P437, DOI 10.1007/BF00310812; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Helaine S, 2013, CURR OPIN MICROBIOL, V16, P184, DOI 10.1016/j.mib.2012.12.004; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Hippler M, 1998, BBA-BIOENERGETICS, V1367, P1, DOI 10.1016/S0005-2728(98)00136-4; Hoeck C, 1995, ALGAE INTRO PHYCOLOG; Hofer U, 2013, NAT REV MICROBIOL, V11, P598, DOI 10.1038/nrmicro3095; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Joers A, 2010, J BACTERIOL, V192, P3379, DOI 10.1128/JB.00056-10; Jones CS, 2012, CURR OPIN BIOTECH, V23, P346, DOI 10.1016/j.copbio.2011.10.013; Kelly CD, 1932, J BACTERIOL, V23, P147, DOI 10.1128/JB.23.2.147-153.1932; Kursten D, 2011, ENG LIFE SCI, V11, P580, DOI 10.1002/elsc.201100023; Kupiec M, 2014, FEMS MICROBIOL REV, V38, P144, DOI 10.1111/1574-6976.12054; Lee DH, 2013, ANAL CHEM, V85, P8749, DOI 10.1021/ac401836j; Lee L, 2011, GENE, V473, P57, DOI 10.1016/j.gene.2010.11.006; Lemaire SD, 1999, EUR J PHYCOL, V34, P279, DOI 10.1080/09670269910001736332; Leon R, 2007, TRANSGENIC MICROALGA; Levchenko A, 2014, CURR OPIN BIOTECH, V28, P156, DOI 10.1016/j.copbio.2014.05.002; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Longo VD, 2012, SUBCELL BIOCHEM, V57, P101, DOI 10.1007/978-94-007-2561-4_5; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maklakov AA, 2013, CURR BIOL, V23, pR1003, DOI 10.1016/j.cub.2013.10.002; MALONEY PC, 1973, J MOL BIOL, V73, P77, DOI 10.1016/0022-2836(73)90160-5; Mason PJ, 2013, TRANSL RES, V162, P333, DOI 10.1016/j.trsl.2013.08.009; Matsumura Kazunori, 2010, Journal of Nanobiotechnology, V8, P23, DOI 10.1186/1477-3155-8-23; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Misumi O, 2001, J PLANT RES, V114, P125, DOI 10.1007/PL00013975; Morgan AD, 2014, SPONTANEOUS MUTATION; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Ness RW, 2012, GENETICS, V192, P1447, DOI 10.1534/genetics.112.145078; Pan J, 2011, INTEGR BIOL-UK, V3, P1043, DOI 10.1039/c1ib00033k; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan Y, 2011, EXP GERONTOL, V46, P847, DOI 10.1016/j.exger.2011.08.007; Perrineau MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092533; PETRACEK ME, 1990, P NATL ACAD SCI USA, V87, P8222, DOI 10.1073/pnas.87.21.8222; PETRACEK ME, 1994, EMBO J, V13, P3648, DOI 10.1002/j.1460-2075.1994.tb06672.x; PETRACEK ME, 1992, NUCLEIC ACIDS RES, V20, P89, DOI 10.1093/nar/20.1.89; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Rando TA, 2013, ANNU REV PHYSIOL, V75, P617, DOI 10.1146/annurev-physiol-092712-103439; Rang CU, 2011, CURR BIOL, V21, P1813, DOI 10.1016/j.cub.2011.09.018; Ratcliff WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3742; Richards CL, 2010, BIOSCIENCE, V60, P232, DOI 10.1525/bio.2010.60.3.9; Richmond A, 2008, HDB MICROALGAL CULTU; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; Rochaix JD, 2002, PHOTOSYNTH RES, V73, P285, DOI 10.1023/A:1020484105601; Rochaix JD, 1995, ANNU REV GENET, V29, P209, DOI 10.1146/annurev.ge.29.120195.001233; Rosales-Mendoza S, 2012, PLANT CELL REP, V31, P479, DOI 10.1007/s00299-011-1186-8; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; Rupprecht J, 2009, J BIOTECHNOL, V142, P10, DOI 10.1016/j.jbiotec.2009.02.008; Saeed H, 2013, J BIOSCIENCES, V38, P641, DOI 10.1007/s12038-013-9346-3; Sanchez A, 2013, ANNU REV BIOPHYS, V42, P469, DOI 10.1146/annurev-biophys-083012-130401; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; Skjanes K, 2013, CRIT REV BIOTECHNOL, V33, P172, DOI 10.3109/07388551.2012.681625; Skommer J, 2011, FRONT BIOSCI-LANDMRK, V16, P307, DOI 10.2741/3689; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Specht EA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00060; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; SPUDICH JL, 1980, J CELL BIOL, V85, P136, DOI 10.1083/jcb.85.1.136; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Strenkert D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-35; Strenkert D, 2011, PLANT CELL, V23, P2285, DOI 10.1105/tpc.111.085266; Strovas TJ, 2007, J BACTERIOL, V189, P7127, DOI 10.1128/JB.00746-07; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; Vachova L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/601836; Velmurugan N, 2013, BIORESOURCE TECHNOL, V138, P30, DOI 10.1016/j.biortech.2013.03.078; Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Wu B, 2014, J THEOR BIOL, V347, P1, DOI 10.1016/j.jtbi.2013.12.001; Wu JC, 2013, BIOTECHNOL ADV, V31, P1047, DOI 10.1016/j.biotechadv.2013.09.001; Yin HB, 2012, CURR OPIN BIOTECH, V23, P110, DOI 10.1016/j.copbio.2011.11.002; Yu WL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-91	124	36	37	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118987	10.1371/journal.pone.0118987	http://dx.doi.org/10.1371/journal.pone.0118987			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760649	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000045
J	Neumann, B; Vafeidis, AT; Zimmermann, J; Nicholls, RJ				Neumann, Barbara; Vafeidis, Athanasios T.; Zimmermann, Juliane; Nicholls, Robert J.			Future Coastal Population Growth and Exposure to Sea-Level Rise and Coastal Flooding - A Global Assessment	PLOS ONE			English	Article							CLIMATE-CHANGE; PORT CITIES; SCENARIOS; IMPACT; 21ST-CENTURY; PROJECTIONS; MIGRATION; LOSSES	Coastal zones are exposed to a range of coastal hazards including sea-level rise with its related effects. At the same time, they are more densely populated than the hinterland and exhibit higher rates of population growth and urbanisation. As this trend is expected to continue into the future, we investigate how coastal populations will be affected by such impacts at global and regional scales by the years 2030 and 2060. Starting from baseline population estimates for the year 2000, we assess future population change in the low-elevation coastal zone and trends in exposure to 100-year coastal floods based on four different sea-level and socio-economic scenarios. Our method accounts for differential growth of coastal areas against the land-locked hinterland and for trends of urbanisation and expansive urban growth, as currently observed, but does not explicitly consider possible displacement or out-migration due to factors such as sea-level rise. We combine spatially explicit estimates of the baseline population with demographic data in order to derive scenario-driven projections of coastal population development. Our scenarios show that the number of people living in the low-elevation coastal zone, as well as the number of people exposed to flooding from 1-in-100 year storm surge events, is highest in Asia. China, India, Bangladesh, Indonesia and Viet Nam are estimated to have the highest total coastal population exposure in the baseline year and this ranking is expected to remain largely unchanged in the future. However, Africa is expected to experience the highest rates of population growth and urbanisation in the coastal zone, particularly in Egypt and sub-Saharan countries in Western and Eastern Africa. The results highlight countries and regions with a high degree of exposure to coastal flooding and help identifying regions where policies and adaptive planning for building resilient coastal communities are not only desirable but essential. Furthermore, we identify needs for further research and scope for improvement in this kind of scenario-based exposure analysis.	[Neumann, Barbara; Vafeidis, Athanasios T.; Zimmermann, Juliane] Univ Kiel, Inst Geog, Kiel, Germany; [Nicholls, Robert J.] Univ Southampton, Fac Engn Environm, Southampton, Hants, England; [Nicholls, Robert J.] Univ Southampton, Tyndall Ctr Climate Change Res, Southampton, Hants, England	University of Kiel; University of Southampton; University of Southampton	Neumann, B (corresponding author), Univ Kiel, Inst Geog, Kiel, Germany.	neumann@geographie.uni-kiel.de	Nicholls, Robert James/ABD-1481-2020; Vafeidis, Athanasios Thomas/Z-6053-2019; Neumann, Barbara/B-5232-2009; Nicholls, Robert James/G-3898-2010	Nicholls, Robert James/0000-0002-9715-1109; Vafeidis, Athanasios Thomas/0000-0002-3906-5544; Neumann, Barbara/0000-0003-0015-2314; Nicholls, Robert James/0000-0002-9715-1109	UK Government Office for Science; German Science Foundation (DFG) via the Kiel Cluster of Excellence "The Future Ocean"	UK Government Office for Science; German Science Foundation (DFG) via the Kiel Cluster of Excellence "The Future Ocean"(German Research Foundation (DFG))	Financial support has been provided by the UK Government Office for Science and by the German Science Foundation (DFG) via the Kiel Cluster of Excellence "The Future Ocean". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk D., 2009, POPULATION DYNAMICS, P80; Balk D., 2009, POPULATION DYNAMICS, P206; Black R, 2011, GLOBAL ENVIRON CHANG, V21, pS3, DOI 10.1016/j.gloenvcha.2011.10.001; Brown S., 2013, COASTAL HAZARDS, P117, DOI [10.1007/978-94-007-5234-4, DOI 10.1007/978-94-007-5234-4_5]; [Center for International Earth Science Information Network (CIESIN) Columbia University Centro Internacional de Agricultura Tropical (CIAT)], 2005, GRIDD POP WORLD VERS; Center for International Earth Science Information Network-CIESIN-Columbia University International Food Policy Research Institute-IFPRI, 2004, GLOB RUR URB MAPP PR; Church, 2010, UNDERSTANDING SEA LE, P17, DOI [10.1002/9781444323276.ch2, DOI 10.1002/9781444323276.CH2]; Church JA, 2013, CLIMATECHANGE 2013 P; Curtis KJ, 2011, POPUL ENVIRON, V33, P28, DOI 10.1007/s11111-011-0136-2; Dasgupta S, 2011, CLIMATIC CHANGE, V106, P567, DOI 10.1007/s10584-010-9959-6; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; de Sherbinin A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045602; Ericson JP, 2006, GLOBAL PLANET CHANGE, V50, P63, DOI 10.1016/j.gloplacha.2005.07.004; ESRI, 2008, ESRI DAT MAPS 9 3; Esteban M, 2013, INT J DISAST RISK RE, V5, P84, DOI 10.1016/j.ijdrr.2013.07.002; Foresight, 2011, MIGR GLOB ENV CHANG; Fragkias M, 2012, GLOBAL CHANGE MAGAZI, V78, P16; Gaffin SR, 2004, GLOBAL ENVIRON CHANG, V14, P105, DOI 10.1016/j.gloenvcha.2004.02.004; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hallegatte S, 2011, CLIMATIC CHANGE, V104, P1, DOI 10.1007/s10584-010-9981-8; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Hijmans R, 2008, GLOBAL ADM AREAS GAD; Hinkel J, 2011, REG ENV CHANG, V12, P1; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Hinkel J, 2010, MITIG ADAPT STRAT GL, V15, P703, DOI 10.1007/s11027-010-9237-y; Hugo G, 2011, GLOBAL ENVIRON CHANG, V21, pS21, DOI 10.1016/j.gloenvcha.2011.09.008; IPCC, 2012, MAN RISKS EXTR EV DI; ISciences L.L.C, 2003, ENH GLOB MAP EL SLOP; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Kron W, 2013, NAT HAZARDS, V66, P1363, DOI 10.1007/s11069-012-0215-4; Lichter M, 2011, J COASTAL RES, V27, P757, DOI 10.2112/JCOASTRES-D-10-00072.1; Lindeboom H., 2005, GLO CH IGBP, P1, DOI 10.1007/3-540-27851-6_1; Lutz W, 2014, SCIENCE, V346, P560, DOI 10.1126/science.346.6209.561-a; Lutz W, 2010, PHILOS T R SOC B, V365, P2779, DOI 10.1098/rstb.2010.0133; Maloney MC, 2014, CLIMATE RISK MANAGEM, V2, P26, DOI [10.5339/gcsp.2014.20, DOI 10.5339/GCSP.2014.20]; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; Mcleod E, 2010, SUSTAIN SCI, V5, P207, DOI 10.1007/s11625-010-0105-1; Mimura N, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P687; Mondal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048191; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Nicholls RJ, 2014, METRICS ASSESSING EC; Nicholls RJ, 2008, CLIMATIC CHANGE, V91, P171, DOI 10.1007/s10584-008-9424-y; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Nicholls RJ, 2008, SUSTAIN SCI, V3, P89, DOI 10.1007/s11625-008-0050-4; OECD, 2010, CIT CLIM CHANG; Patterson M., 2008, ECOLOGICAL EC OCEANS, P187; Potere D, 2007, GEOJOURNAL, V69, P55, DOI 10.1007/s10708-007-9102-z; Rodriguez E, 2006, PHOTOGRAMM ENG REM S, V72, P249, DOI 10.14358/PERS.72.3.249; Salvatore M., 2005, MAPPING GLOBAL URBAN; Samir KC, 2017, GLOBAL ENVIRON CHANG, V42, P181, DOI 10.1016/j.gloenvcha.2014.06.004; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2011, GLOBAL ENVIRON CHANG, V21, pS94, DOI 10.1016/j.gloenvcha.2011.08.005; Seto KC, 2010, ANNU REV ENV RESOUR, V35, P167, DOI 10.1146/annurev-environ-100809-125336; Small C, 2003, J COASTAL RES, V19, P584; Smith K, 2011, NAT CLIM CHANGE, V1, P331; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Tacoli  C., 2009, POPULATION DYNAMICS, P104; The Government Office for Science, 2011, MIGR GLOB ENV CHANG; United Nations, 2011, WORLD POP PROSP 2010; United Nations, 2011, ESAPWP220 UN; United Nations, 2010, 12 UN DEP EC SOC AFF; Vafeidis A, 2011, MR9 ANAL LAND AREA P; Vafeidis AT, 2005, DIVA DATABASE DOCUME; Vafeidis AT, 2008, J COASTAL RES, V24, P917, DOI 10.2112/06-0725.1; Visbeck M, 2014, MAR POLICY, V48, P184, DOI 10.1016/j.marpol.2014.03.005; Warner K, 2010, GLOBAL ENVIRON CHANG, V20, P402, DOI 10.1016/j.gloenvcha.2009.12.001; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Woodroffe C. D, 2002, COASTS FORM PROCESS	75	1073	1081	47	525	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118571	10.1371/journal.pone.0118571	http://dx.doi.org/10.1371/journal.pone.0118571			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760037	gold, Green Accepted, Green Published			2022-12-27	WOS:000351275000029
J	Warrener, AG; Lewton, KL; Pontzer, H; Lieberman, DE				Warrener, Anna G.; Lewton, Kristi L.; Pontzer, Herman; Lieberman, Daniel E.			A Wider Pelvis Does Not Increase Locomotor Cost in Humans, with Implications for the Evolution of Childbirth	PLOS ONE			English	Article							ENERGY-COST; METABOLIC COST; BRAIN SIZE; BODY-MASS; BIRTH; ENCEPHALIZATION; WALKING; MEN; PLEISTOCENE; ENERGETICS	The shape of the human female pelvis is thought to reflect an evolutionary trade-off between two competing demands: a pelvis wide enough to permit the birth of large-brained infants, and narrow enough for efficient bipedal locomotion. This trade-off, known as the obstetrical dilemma, is invoked to explain the relative difficulty of human childbirth and differences in locomotor performance between men and women. The basis for the obstetrical dilemma is a standard static biomechanical model that predicts wider pelves in females increase the metabolic cost of locomotion by decreasing the effective mechanical advantage of the hip abductor muscles for pelvic stabilization during the single-leg support phase of walking and running, requiring these muscles to produce more force. Here we experimentally test this model against a more accurate dynamic model of hip abductor mechanics in men and women. The results show that pelvic width does not predict hip abductor mechanics or locomotor cost in either women or men, and that women and men are equally efficient at both walking and running. Since a wider birth canal does not increase a woman's locomotor cost, and because selection for successful birthing must be strong, other factors affecting maternal pelvic and fetal size should be investigated in order to help explain the prevalence of birth complications caused by a neonate too large to fit through the birth canal.	[Warrener, Anna G.; Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Lewton, Kristi L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Pontzer, Herman] Hunter Coll, Dept Anthropol, New York, NY 10065 USA	Harvard University; Boston University; City University of New York (CUNY) System; Hunter College (CUNY)	Warrener, AG (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, 11 Div Ave, Cambridge, MA 02138 USA.	awarrener@fas.harvard.edu	Lewton, Kristi/AAC-2766-2022; Warrener, Anna/AAC-5225-2020	Lewton, Kristi/0000-0003-0674-2454; Pontzer, Herman/0000-0003-2397-6543	National Science Foundation; BSN [0850841]; Leakey Foundation; Wenner-Gren Foundation	National Science Foundation(National Science Foundation (NSF)); BSN; Leakey Foundation; Wenner-Gren Foundation	This research was supported by grants from the National Science Foundation (www.nsf.gov), BSN # 0850841, The Leakey Foundation (www.leakeyfoundation.org) and The Wenner-Gren Foundation (www.wennergren.org). Grants were obtained by AGW. Institutional support was provided by Washington University in St. Louis and obtained by AGW and HP. Institutional support for Harvard University was obtained by DEL and KLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano CJ, 2012, J APPL PHYSIOL, V112, P427, DOI 10.1152/japplphysiol.00554.2011; Arsuaga JL, 1999, NATURE, V399, P255, DOI 10.1038/20430; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; BOURDIN M, 1993, EUR J APPL PHYSIOL O, V66, P439, DOI 10.1007/BF00599618; Briese V, 2010, HOMO, V61, P64, DOI 10.1016/j.jchb.2009.11.002; Brown KM, 2013, INT UROGYNECOL J, V24, P431, DOI 10.1007/s00192-012-1876-y; Brown KM., 2012, THESIS J HOPKINS U; BUNC V, 1989, EUR J APPL PHYSIOL, V59, P178, DOI 10.1007/BF02386184; Correia H, 2005, HOMO, V56, P153, DOI 10.1016/j.jchb.2005.05.003; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; DeSilva JM, 2008, J HUM EVOL, V55, P1064, DOI 10.1016/j.jhevol.2008.07.008; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; Grabowski MW, 2013, EVOL BIOL, V40, P57, DOI 10.1007/s11692-012-9174-7; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hilton CE, 2008, CURR ANTHROPOL, V49, P144, DOI 10.1086/524760; HOLM S, 1979, SCAND J STAT, V6, P65; INMAN VT, 1947, J BONE JOINT SURG, V29, P607; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kurki HK, 2007, AM J PHYS ANTHROPOL, V133, P1152, DOI 10.1002/ajpa.20636; Kurki HK, 2011, INT J PALEOPATHOL, V1, P138, DOI 10.1016/j.ijpp.2011.10.004; Larkin JC, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.068; LEUTENEGGER W, 1974, J HUM EVOL, V3, P207, DOI 10.1016/0047-2484(74)90179-1; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Marlowe FW, 2010, THE HADZA; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P79, DOI 10.1002/ajpa.1330680108; MERCHANT AC, 1965, J BONE JOINT SURG AM, VA 47, P462, DOI 10.2106/00004623-196547030-00003; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; MILLER JF, 1987, J APPL PHYSIOL, V62, P1497, DOI 10.1152/jappl.1987.62.4.1497; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nuger RL., 2008, THESIS CITY U NEW YO; O'Brien TD, 2010, EXP PHYSIOL, V95, P202, DOI 10.1113/expphysiol.2009.048967; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Pontzer H, 2005, J EXP BIOL, V208, P1513, DOI 10.1242/jeb.01549; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Roberston D.G., 2004, RES METHODS BIOMECHA, P143; Roberts TJ, 1998, J EXP BIOL, V201, P2745; Rosenberg Karen, 1995, Evolutionary Anthropology, V4, P161, DOI 10.1002/evan.1360040506; Rosenberg KR., 1994, AM J PHYS ANTHROPOL, V35, P89; Rubenson J, 2007, J EXP BIOL, V210, P3513, DOI 10.1242/jeb.000992; Ruff CB, 1997, NATURE, V387, P173, DOI 10.1038/387173a0; RUFF CB, 1991, J HUM EVOL, V21, P81, DOI 10.1016/0047-2484(91)90001-C; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Larsen CS, 2006, QUATERN INT, V150, P12, DOI 10.1016/j.quaint.2006.01.004; Stalberg K, 2012, ACTA OBSTET GYNECOL, V85, P821; Strickland SS, 2010, NOMADIC PEOPLES, V33, P231; Thibault V, 2010, J SPORT SCI MED, V9, P214; Voigt M, 2008, Z Geburtshilfe Neonatol, V212, P201, DOI 10.1055/s-2008-1076995; Walrath D, 2003, CURR ANTHROPOL, V44, P5, DOI 10.1086/344489; Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wittman AB, 2007, OBSTET GYNECOL SURV, V62, P739, DOI 10.1097/01.ogx.0000286584.04310.5c	61	82	82	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118903	10.1371/journal.pone.0118903	http://dx.doi.org/10.1371/journal.pone.0118903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760381	Green Published, gold			2022-12-27	WOS:000351275000043
J	Huang, CM; Chen, SY; Huang, PH; Tsai, FJ				Huang, Chung-Ming; Chen, Shih-Yin; Huang, Po-Hao; Tsai, Fuu-Jen			Effect of MPG Gene rs2858056 Polymorphism, Copy Number Variation, and Level of Serum MPG Protein on the Risk for Rheumatoid Arthritis	PLOS ONE			English	Article							CELL LUNG-CANCER; HUMAN GENOME; COLORECTAL-CANCER; SUSCEPTIBILITY; ASSOCIATION; DISEASE; PTPN22; PADI4	Objective This study examined the role of SNP rs2858056 of the MPG gene on the incidence and severity of rheumatoid arthritis (RA). Methods This cohort study enrolled 365 RA patients and 375 age-and gender-matched healthy controls, all of whom had Han Chinese ethnicity and were from Taiwan. Gene polymorphism of the SNP rs2858056 of MPG was determined from genomic DNA. Allelic frequencies and genotypes were compared among cases and controls. Quantitation of rs2858056 copy number variation (CNV) was determined. Serum samples from RA patients and controls were analyzed to determine serum levels of MPG. The relationship between rs2858056 polymorphism and clinical manifestations of RA was evaluated. Results Our results indicated a statistically significant difference in genotype frequency distributions at rs2858056 for RA patients and controls (p = 0.05) and a significant difference in allelic frequency in patients and controls (p = 0.04). Furthermore, there was a significantly greater level of serum MPG protein in patients than controls (p < 0.001). However, the cases and controls had no significant differences in MPG CNV (p = 0.12). We also did not detect any association of the MPG rs2858056 with rheumatoid factor (RF), extraarticular involvement, or bone erosion in the RA patients. Conclusion Our study suggests that RA is associated with a polymorphism in the MPG gene (rs2858056) and increased serum level of the MPG protein.	[Huang, Chung-Ming; Huang, Po-Hao] China Med Univ Hosp, Div Rheumatol & Immunol, Dept Internal Med, Taichung, Taiwan; [Chen, Shih-Yin; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Huang, Chung-Ming; Huang, Po-Hao] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Chen, Shih-Yin; Tsai, Fuu-Jen] China Med Univ, Grad Inst Chinese Med Sci, Coll Chinese Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung, Taiwan.	d0704@mail.cmuh.org.tw	Tsai, Fuu-Jen/J-4140-2015		National Science Council in Taiwan [NSC99-2314-B-039-005]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council in Taiwan (NSC99-2314-B-039-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Broderick P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-243; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cerda SR, 1998, FEBS LETT, V431, P12, DOI 10.1016/S0014-5793(98)00697-8; Chen HM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-269; Chen SY, 2010, J APPL GENET, V51, P519, DOI 10.1007/BF03208883; Chen SY, 2012, RHEUMATOL INT, V32, P1165, DOI 10.1007/s00296-010-1738-1; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; GOMOLKA M, 1995, J MOL MED-JMM, V73, P19, DOI 10.1007/BF00203615; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Lo SF, 2012, RHEUMATOL INT, V32, P3723, DOI 10.1007/s00296-011-2185-3; Lo SF, 2012, RHEUMATOL INT, V32, P2301, DOI 10.1007/s00296-011-1961-4; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rusin M, 1999, Hum Mutat, V14, P269, DOI 10.1002/(SICI)1098-1004(1999)14:3<269::AID-HUMU13>3.0.CO;2-6; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Sliwinski T., 2009, Experimental Oncology, V31, P57; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; Zhang YY, 2006, INT J CANCER, V119, P2592, DOI 10.1002/ijc.22206; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	31	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120699	10.1371/journal.pone.0120699	http://dx.doi.org/10.1371/journal.pone.0120699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757089	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275700072
J	Hung, TH; Hsieh, TT				Hung, Tai-Ho; Hsieh, T'sang-T'ang			The Effects of Implementing the International Association of Diabetes and Pregnancy Study Groups Criteria for Diagnosing Gestational Diabetes on Maternal and Neonatal Outcomes	PLOS ONE			English	Article							RISK-FACTORS; MELLITUS; RECOMMENDATIONS; CLASSIFICATION; HYPERGLYCEMIA; PREVALENCE; IADPSG; WOMEN; AGE	Background In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommended a new strategy for the screening and diagnosis of gestational diabetes mellitus (GDM). However, no study has indicated that adopting the IADPSG recommendations improves perinatal outcomes. The objective of this study was to evaluate the effects of implementing the IADPSG criteria for diagnosing GDM on maternal and neonatal outcomes. Methodology/Principal Findings Previously, we used a two-step approach (a 1-h, 50-g glucose challenge test followed by a 3-h, 100-g glucose tolerance test when indicated) to screen for and diagnose GDM. In July 2011, we adopted the IADPSG recommendations in our routine obstetric care. In this study, we retrospectively compared the rates of various maternal and neonatal outcomes in all women who delivered after 24 weeks of gestation during the periods before (P1, between January 1, 2009 and December 31, 2010) and after (P2, between January 1, 2012 and December 31, 2013) the IADPSG criteria were implemented. Pregnancies complicated by multiple gestations, fetal chromosomal or structural anomalies, and pre-pregnancy diabetes mellitus were excluded. Our results showed that the incidence of GDM increased from 4.6% using the two-step method to 12.4% using the IADPSG criteria. Compared to the women in P1, the women in P2 experienced less weight gain during pregnancy, lower birth weights, shorter labor courses, and lower rates of macrosomia (< 4000 g) and large-for-gestational age (LGA) infants. P2 was a significant independent factor against macrosomia (adjusted odds ratio [OR] 0.63, 95% confidence interval [CI] 0.43-0.90) and LGA (adjusted OR 0.74, 95% CI 0.61-0.89) after multivariable logistic regression analysis. Conclusions/Significance The adoption of the IADPSG criteria for diagnosis of GDM was associated with significant reductions in maternal weight gain during pregnancy, birth weights, and the rates of macrosomia and LGA.	[Hung, Tai-Ho; Hsieh, T'sang-T'ang] Chang Gung Mem Hosp Taipei, Dept Obstet & Gynecol, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, TH (corresponding author), Chang Gung Mem Hosp Taipei, Dept Obstet & Gynecol, Taipei, Taiwan.	thh20@cgmh.org.tw	Hung, Tai-Ho/C-7584-2011; Hung, Tai-Ho/ABD-1800-2020	Hung, Tai-Ho/0000-0003-2354-7060; 				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2011, Obstet Gynecol, V118, P751, DOI 10.1097/AOG.0b013e3182310cc3; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Benhalima K, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/248121; Bodmer-Roy S, 2012, OBSTET GYNECOL, V120, P746, DOI 10.1097/AOG.0b013e31826994ec; Cheng YKY, 2013, INT J GYNECOL OBSTET, V120, P249, DOI 10.1016/j.ijgo.2012.10.019; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Fok TF, 2009, NEONATOLOGY, V95, P23, DOI 10.1159/000151752; Hadar E, 2013, CLIN OBSTET GYNECOL, V56, P758, DOI 10.1097/GRF.0b013e3182a8e08e; Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395; Hsieh Wu-Shiun, 2006, Acta Paediatrica Taiwanica, V47, P25; Hung TH, 2013, INT J GYNECOL OBSTET, V122, P212, DOI 10.1016/j.ijgo.2013.03.033; Landon MB, 2011, OBSTET GYNECOL, V118, P1379, DOI 10.1097/AOG.0b013e31823974e2; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lapolla A, 2011, DIABETIC MED, V28, P1074, DOI 10.1111/j.1464-5491.2011.03351.x; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Mission JF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.048; O'Sullivan EP, 2011, DIABETOLOGIA, V54, P1670, DOI 10.1007/s00125-011-2150-4; Reece EA, 2013, AM J OBSTET GYNECOL, V208, P255, DOI 10.1016/j.ajog.2012.10.887; Sevket O, 2014, J MATERN-FETAL NEO M, V27, P36, DOI 10.3109/14767058.2013.799656; Visser GHA, 2013, AM J OBSTET GYNECOL, V208, P260, DOI 10.1016/j.ajog.2012.10.881; Wei YM, 2012, CHINESE MED J-PEKING, V125, P1206, DOI 10.3760/cma.j.issn.0366-6999.2012.07.002; Werner EF, 2012, DIABETES CARE, V35, P529, DOI 10.2337/dc11-1643	26	47	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0122261	10.1371/journal.pone.0122261	http://dx.doi.org/10.1371/journal.pone.0122261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756838	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700080
J	Saarenheimo, J; Rissanen, AJ; Arvola, L; Nykanen, H; Lehmann, MF; Tiirola, M				Saarenheimo, Jatta; Rissanen, Antti J.; Arvola, Lauri; Nykanen, Hannu; Lehmann, Moritz F.; Tiirola, Marja			Genetic and Environmental Controls on Nitrous Oxide Accumulation in Lakes	PLOS ONE			English	Article							DENITRIFYING BACTERIA; MICROBIAL COMMUNITY; NATURAL WATERS; RIBOSOMAL-RNA; END-PRODUCT; NOSZ GENES; DENITRIFICATION; NITRATE; SOILS; N2O	We studied potential links between environmental factors, nitrous oxide (N2O) accumulation, and genetic indicators of nitrite and N2O reducing bacteria in 12 boreal lakes. Denitrifying bacteria were investigated by quantifying genes encoding nitrite and N2O reductases (nirS/nirK and nosZ, respectively, including the two phylogenetically distinct clades nosZ(I) and nosZ(II)) in lake sediments. Summertime N2O accumulation and hypolimnetic nitrate concentrations were positively correlated both at the inter-lake scale and within a depth transect of an individual lake (Lake Vanajavesi). The variability in the individual nirS, nirK, nosZ(I), and nosZ(II) gene abundances was high (up to tenfold) among the lakes, which allowed us to study the expected links between the ecosystem's nir-vs-nos gene inventories and N2O accumulation. Inter-lake variation in N2O accumulation was indeed connected to the relative abundance of nitrite versus N2O reductase genes, i.e. the (nirS+nirK)/nosZ(I) gene ratio. In addition, the ratios of (nirS+ nirK)/nosZ(I) at the inter-lake scale and (nirS+ nirK)/nosZ(I+II) within Lake Vanajavesi correlated positively with nitrate availability. The results suggest that ambient nitrate concentration can be an important modulator of the N2O accumulation in lake ecosystems, either directly by increasing the overall rate of denitrification or indirectly by controlling the balance of nitrite versus N2O reductase carrying organisms.	[Saarenheimo, Jatta; Rissanen, Antti J.; Nykanen, Hannu; Tiirola, Marja] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Arvola, Lauri] Univ Helsinki, Lammi Biol Stn, Lammi 16900, Finland; [Lehmann, Moritz F.] Univ Basel, Dept Environm Sci, CH-4058 Basel, Switzerland	University of Jyvaskyla; University of Helsinki; University of Basel	Saarenheimo, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland.	jatta.saarenheimo@jyu.fi	Saarenheimo, Jatta/AAX-1560-2021; Lehmann, Moritz F/A-3301-2014	Saarenheimo, Jatta/0000-0002-2580-2830; Lehmann, Moritz F/0000-0003-0626-5942; Tiirola, Marja/0000-0001-5589-3748; Rissanen, Antti Juhani/0000-0002-5678-3361	Academy of Finland [260797, 136455]; VVY; Maj and Tor Nessling Foundation; EnSTE graduate school	Academy of Finland(Academy of Finland); VVY; Maj and Tor Nessling Foundation; EnSTE graduate school	This study was supported by the Academy of Finland (MT project 260797 and HN project 136455), the VVY, the Maj and Tor Nessling Foundation, and EnSTE graduate school. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellido JL, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000923; BLEAKLEY BH, 1982, APPL ENVIRON MICROB, V44, P1342, DOI 10.1128/AEM.44.6.1342-1348.1982; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Ducey TF, 2011, J ENVIRON QUAL, V40, P610, DOI 10.2134/jeq2010.0387; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; FERRELL RT, 1967, J CHEM ENG DATA, V12, P111, DOI 10.1021/je60032a036; Freymond CV, 2013, BIOGEOSCIENCES, V10, P8373, DOI 10.5194/bg-10-8373-2013; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; GREENBERG EP, 1977, CAN J MICROBIOL, V23, P903, DOI 10.1139/m77-133; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; JACKSON MA, 1991, FEBS LETT, V291, P41, DOI 10.1016/0014-5793(91)81099-T; Jones CM, 2008, MOL BIOL EVOL, V25, P1955, DOI 10.1093/molbev/msn146; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Kampschreur MJ, 2009, WATER RES, V43, P4093, DOI 10.1016/j.watres.2009.03.001; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Kelso BHL, 1997, APPL ENVIRON MICROB, V63, P4679, DOI 10.1128/AEM.63.12.4679-4685.1997; Kim OS, 2011, AQUAT ECOL, V45, P99, DOI 10.1007/s10452-010-9335-7; Knapp CW, 2009, ENVIRON SCI TECHNOL, V43, P4273, DOI 10.1021/es9001407; Kortelainen P., 2000, VERH INT VER LIMNOL, V27, P1410, DOI 10.1080/03680770.1998.11901468; Kraft B, 2014, SCIENCE, V345, P676, DOI 10.1126/science.1254070; Lide D. R., 1995, CRC HDB CHEM PHYS; Magalhaes C, 2008, MICROB ECOL, V55, P259, DOI 10.1007/s00248-007-9273-7; Maljanen M, 2009, BIOGEOSCIENCES, V6, P2461, DOI 10.5194/bg-6-2461-2009; Martins G, 2011, FEMS MICROBIOL ECOL, V77, P666, DOI 10.1111/j.1574-6941.2011.01145.x; McCrackin ML, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003897; McCrackin ML, 2010, ECOLOGY, V91, P528, DOI 10.1890/08-2210.1; Mengis M, 1997, BIOGEOCHEMISTRY, V38, P281, DOI 10.1023/A:1005814020322; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Philippot L, 2009, ENVIRON MICROBIOL, V11, P1518, DOI 10.1111/j.1462-2920.2009.01879.x; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rissanen AJ, 2013, AQUAT MICROB ECOL, V69, P1, DOI 10.3354/ame01619; Rissanen AJ, 2011, AQUAT MICROB ECOL, V64, P27, DOI 10.3354/ame01506; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Stevens RJ, 1998, SOIL BIOL BIOCHEM, V30, P1119, DOI 10.1016/S0038-0717(97)00227-7; Swerts M, 1996, BIOL FERT SOILS, V23, P229, DOI 10.1007/s003740050165; Tatariw C, 2013, ECOLOGY, V94, P2249, DOI 10.1890/12-1765.1; Wallenstein MD, 2005, PEDOBIOLOGIA, V49, P665, DOI 10.1016/j.pedobi.2005.05.005; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Weiss RF., DEEP SEA RES, V17, P721; Whitfield CJ, 2011, SCI TOTAL ENVIRON, V410, P217, DOI 10.1016/j.scitotenv.2011.09.045; WOOD ED, 1967, J MAR BIOL ASSOC UK, V47, P23, DOI 10.1017/S002531540003352X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	50	42	44	12	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0121201	10.1371/journal.pone.0121201	http://dx.doi.org/10.1371/journal.pone.0121201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756328	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275700076
J	Tsivgoulis, G; Katsanos, AH; Grigoriadis, N; Hadjigeorgiou, GM; Heliopoulos, I; Kilidireas, C; Voumvourakis, K				Tsivgoulis, Georgios; Katsanos, Aristeidis H.; Grigoriadis, Nikolaos; Hadjigeorgiou, Georgios M.; Heliopoulos, Ioannis; Kilidireas, Constantinos; Voumvourakis, Konstantinos			The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CLINICAL-RELEVANCE; GLATIRAMER ACETATE; GOLD STANDARD; 1ST YEAR; OUTCOMES	Background The aim of the present meta-analysis was to evaluate the effect of disease-modifying drugs (DMD) on brain atrophy in patients with relapsing-remitting multiple sclerosis (RRMS) using available randomized-controlled trial (RCT) data. Methods We conducted a systematic review and meta-analysis according to PRISMA guidelines of all available RCTs of patients with RRMS that reported data on brain volume measurements during the study period. Results We identified 4 eligible studies, including a total of 1819 RRMS patients (71% women, mean age 36.5 years, mean baseline EDSS-score: 2.4). The mean percentage change in brain volume was found to be significantly lower in DMD versus placebo subgroup (standardized mean difference: -0.19; 95% CI: -0.27--0.11; p<0.001). We detected no evidence of heterogeneity between estimates (I-2 = 30%, p = 0.19) nor publication bias in the Funnel plots. Sensitivity analyses stratifying studies according to brain atrophy neuroimaging protocol disclosed no evidence of heterogeneity (p = 0.16). In meta-regression analyses, the percentage change in brain volume was found to be inversely related with duration of observation period in both DMD (meta-regression slope = -0.03; 95% CI: -0.04--0.02; p<0.001) and placebo subgroups (meta-regression slope = -0.05; 95%CI: -0.06--0.04; p<0.001). However, the rate of percentage brain volume loss over time was greater in placebo than in DMD subgroup (p = 0.017, ANCOVA). Conclusions DMD appear to be effective in attenuating brain atrophy in comparison to placebo and their benefit in delaying the rate of brain volume loss increases linearly with longer treatment duration.	[Tsivgoulis, Georgios; Katsanos, Aristeidis H.; Voumvourakis, Konstantinos] Univ Athens, Attikon Hosp, Sch Med, Dept Neurol 2, Athens, Greece; [Tsivgoulis, Georgios] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, Memphis, TN 38163 USA; [Tsivgoulis, Georgios] St Annes Univ Hosp Brno, Int Clin Res Ctr, Dept Neurol, Brno, Czech Republic; [Katsanos, Aristeidis H.] Univ Ioannina, Sch Med, Dept Neurol, GR-45110 Ioannina, Greece; [Grigoriadis, Nikolaos] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Neurol 2, GR-54006 Thessaloniki, Greece; [Hadjigeorgiou, Georgios M.] Univ Thessaly, Univ Hosp Larissa, Dept Neurol, Larisa, Greece; [Heliopoulos, Ioannis] Democritus Univ Thrace, Alexandroupolis Univ Hosp, Dept Neurol, Alexandroupolis, Greece; [Kilidireas, Constantinos] Univ Athens, Eginit Hosp, Sch Med, Dept Neurol 1, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; University of Tennessee System; University of Tennessee Health Science Center; St Anne's University Hospital Brno (FNUSA-ICRC); University of Ioannina; Aristotle University of Thessaloniki; Ahepa University Hospital; General University Hospital of Larissa; University of Thessaly; Democritus University of Thrace; Athens Medical School; National & Kapodistrian University of Athens	Tsivgoulis, G (corresponding author), Univ Athens, Attikon Hosp, Sch Med, Dept Neurol 2, Athens, Greece.	tsivgoulisgiorg@yahoo.gr	Katsanos, Aristeidis H/AAD-7458-2019; Tsivgoulis, Georgios/AAD-7467-2019; Heliopoulos, Ioannis/ABH-2614-2021; Tsivgoulis, Georgios/AAD-5360-2020	Katsanos, Aristeidis H/0000-0002-6359-0023; Tsivgoulis, Georgios/0000-0002-0640-3797	European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Teva Pharmaceutical Hellas; Novartis Hellas; Biogen Idec; Novartis; TEVA; Merck Serono; Genesis Pharma; Merck Hellas	European Regional Development Fund - Project FNUSA-ICRC; Teva Pharmaceutical Hellas(Teva Pharmaceutical Industries); Novartis Hellas; Biogen Idec(Biogen); Novartis(Novartis); TEVA(Teva Pharmaceutical Industries); Merck Serono(Merck & Company); Genesis Pharma; Merck Hellas	Dr. Georgios Tsivgoulis has been supported by European Regional Development Fund - Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123). Dr. Tsivgoulis has received research support (not related to this project) from Teva Pharmaceutical Hellas and Novartis Hellas. Dr. Katsanos reports no sources of funding. Dr. Grigoriadis has received research support (not related to this project) from Biogen Idec, Novartis, TEVA, Merck Serono, Genesis Pharma. Dr. Hadjigeorgiou reports no sources of funding. Dr. Heliopoulos reports no sources of funding. Dr. Kilidireas reports no sources of funding. Dr. Voumvourakis has received research support (not related to this project) from Teva Pharmaceutical Hellas, Merck Hellas, Genesis Pharma and Novartis Hellas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DL, 2013, MULT SCLER J, V19, P1007, DOI 10.1177/1352458513490550; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Benedict RHB, 2004, J NEUROIMAGING, V14, p36S, DOI 10.1111/j.1552-6569.2004.tb00277.x; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Bero LA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000075; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Comi G, 2013, MULT SCLER J, V19, P1074, DOI 10.1177/1352458512469695; De Stefano N, 2010, NEUROLOGY, V74, P1868, DOI 10.1212/WNL.0b013e3181e24136; De Stefano N, 2014, CNS DRUGS, V28, P147, DOI 10.1007/s40263-014-0140-z; De Stefano N, 2012, J NEUROL SCI, V312, P97, DOI 10.1016/j.jns.2011.08.013; Deeks J, CHAPTER 9 ANALYSING; Filippi M, 2004, LANCET, V364, P1489, DOI 10.1016/S0140-6736(04)17271-1; Filippi M, 2010, AM J NEURORADIOL, V31, P1171, DOI 10.3174/ajnr.A1944; Fisher E, 1997, SPIE MED IMAG, V3034, P599; Giorgio A, 2010, NEUROL SCI, V31, P245, DOI 10.1007/s10072-010-0370-x; Grassiot B, 2009, J NEUROL, V256, P1397, DOI 10.1007/s00415-009-5108-4; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Khoury S, 2010, ANN NEUROL, V68, P778, DOI 10.1002/ana.22254; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Petzold A, 2010, ANN NEUROL, V68, P806, DOI 10.1002/ana.22169; Rovaris M, 2001, BRAIN, V124, P1803, DOI 10.1093/brain/124.9.1803; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Rudick RA, 2013, MULT SCLER J, V19, P1003, DOI 10.1177/1352458513482385; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sormani MP, 2014, ANN NEUROL, V75, P43, DOI 10.1002/ana.24018; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Zivadinov R, 2008, NEUROLOGY, V71, P136, DOI 10.1212/01.wnl.0000316810.01120.05; Zivadinov R, 2008, J NEUROL, V255, P61, DOI 10.1007/s00415-008-1009-1	31	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116511	10.1371/journal.pone.0116511	http://dx.doi.org/10.1371/journal.pone.0116511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756363	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700006
J	Yip, BHK; Chung, RY; Chung, VCH; Kim, J; Chan, IWT; Wong, MCS; Wong, SYS; Griffiths, SM				Yip, Benjamin H. K.; Chung, Roger Y.; Chung, Vincent C. H.; Kim, Jean; Chan, Iris W. T.; Wong, Martin C. S.; Wong, Samuel Y. S.; Griffiths, Sian M.			Is Alcohol Use Disorder Identification Test (AUDIT) or Its Shorter Versions More Useful to Identify Risky Drinkers in a Chinese Population? A Diagnostic Study	PLOS ONE			English	Article							BRIEF SCREENING-TEST; PRIMARY-CARE; HEAVY DRINKING; BINGE DRINKING; CURVE; PREVALENCE; PREDICTION; HEALTH; TOOL	Objective To examine the diagnostic performance of shorter versions of Alcohol Use Disorder Identification Test (AUDIT), including Alcohol Consumption (AUDIT-C), in identifying risky drinkers in primary care settings using conventional performance measures, supplemented by decision curve analysis and reclassification table. Study design and Setting A cross-sectional study of adult males in general outpatient clinics in Hong Kong. The study included only patients who reported at least sometimes drinking alcoholic beverages. Timeline follow back alcohol consumption assessment method was used as the reference standard. A Chinese translated and validated 10-item AUDIT (Ch-AUDIT) was used as a screening tool of risky drinking. Results Of the participants, 21.7% were classified as risky drinkers. AUDIT-C has the best overall performance among the shorter versions of Ch-AUDIT. The AUC of AUDIT-C was comparable to Ch-AUDIT (0.898 vs 0.901, p-value = 0.959). Decision curve analysis revealed that when the threshold probability ranged from 15-30%, the AUDIT-C had a higher net-benefit than all other screens. AUDIT-C improved the reclassification of risky drinking when compared to Ch-AUDIT (net reclassification improvement = 0.167). The optimal cut-off of AUDIT-C was at >= 5. Conclusion Given the rising levels of alcohol consumption in the Chinese regions, this Chinese translated 3-item instrument provides convenient and time-efficient risky drinking screening and may become an increasingly useful tool.	[Chung, Vincent C. H.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Jockey Club, Hong Kong, Hong Kong, Peoples R China; Prince Wales Hosp, Sch Publ Hlth Bldg, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Chung, VCH (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Jockey Club, Hong Kong, Hong Kong, Peoples R China.	vchung@cuhk.edu.hk	Yip, Benjamin/AAC-7845-2019; Wong, Martin/L-4568-2014; WONG, Samuel Yeung Shan/D-7311-2013; Chung, Vincent CH/K-2447-2013; Chung, Roger Y. N./B-7288-2016	Yip, Benjamin/0000-0002-4749-7611; Wong, Martin/0000-0001-7706-9370; WONG, Samuel Yeung Shan/0000-0003-0934-6385; Chung, Vincent CH/0000-0002-5947-4492; /0000-0002-5799-5913	Faculty Of Medicine Direct Grant for Research, The Chinese University of Hong Kong [2010.2.058]	Faculty Of Medicine Direct Grant for Research, The Chinese University of Hong Kong	This study was funded by the Faculty Of Medicine Direct Grant for Research, The Chinese University of Hong Kong (Ref No. 2010.2.058). URL: http://www.cuhk.edu.hk/rao/about_rao.html. The funding was received by Prof SMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto M, 2006, ALCOHOL CLIN EXP RES, V30, P1884, DOI 10.1111/j.1530-0277.2006.00233.x; Aalto M, 2011, INT J GERIATR PSYCH, V26, P881, DOI 10.1002/gps.2498; Aalto M, 2009, DRUG ALCOHOL DEPEN, V103, P25, DOI 10.1016/j.drugalcdep.2009.02.013; Babor TF, 2001, BRIEF INTERVENTION F; Bray JW, 2012, J STUD ALCOHOL DRUGS, V73, P911, DOI 10.15288/jsad.2012.73.911; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chung VCH, 2013, ALCOHOL ALCOHOLISM, V48, P720, DOI 10.1093/alcalc/agt065; Coltart C, 2011, LANCET, V378, P1215, DOI 10.1016/S0140-6736(11)61461-X; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Darabi H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3110; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fleming MF, 1998, AM J PUBLIC HEALTH, V88, P90, DOI 10.2105/AJPH.88.1.90; Gomez A, 2005, J STUD ALCOHOL, V66, P305, DOI 10.15288/jsa.2005.66.305; Hao W., 2000, J SUBST USE, V5, P71, DOI [DOI 10.3109/14659890009053065, 10.3109/14659890009053065]; Hodgson R, 2002, ALCOHOL ALCOHOLISM, V37, P61, DOI 10.1093/alcalc/37.1.61; Hospital Authority, 2014, GENERAL OUT PATIENT; Kim JH, 2008, ALCOHOL ALCOHOLISM, V43, P360, DOI 10.1093/alcalc/agm181; Kim JW, 2013, ALCOHOL ALCOHOLISM, V48, P68, DOI 10.1093/alcalc/ags082; Kriston L, 2008, ANN INTERN MED, V149, P879, DOI 10.7326/0003-4819-149-12-200812160-00007; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li Q, 2011, ALCOHOL ALCOHOLISM, V46, P416, DOI 10.1093/alcalc/agr012; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; O'Connor PG, 1998, NEW ENGL J MED, V338, P592, DOI 10.1056/NEJM199802263380907; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Piccinelli M, 1997, BRIT MED J, V314, P420, DOI 10.1136/bmj.314.7078.420; Pun VC, 2013, J EPIDEMIOL COMMUN H, V67, P514, DOI 10.1136/jech-2012-201859; Purshouse RC, 2013, ALCOHOL ALCOHOLISM, V48, P180, DOI 10.1093/alcalc/ags103; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318; US National Institute on Alcohol Abuse and Alcoholism, 2007, HELPING PATIENTS WHO; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2013, STAT MED, V32, P1865, DOI 10.1002/sim.5601; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Vinson DC, 2004, ANN FAM MED, V2, P398, DOI 10.1370/afm.83; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	41	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117721	10.1371/journal.pone.0117721	http://dx.doi.org/10.1371/journal.pone.0117721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756353	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700016
J	Madelin, G; Babb, J; Xia, D; Regatte, RR				Madelin, Guillaume; Babb, James; Xia, Ding; Regatte, Ravinder R.			Repeatability of Quantitative Sodium Magnetic Resonance Imaging for Estimating Pseudo-Intracellular Sodium Concentration and Pseudo-Extracellular Volume Fraction in Brain at 3 T	PLOS ONE			English	Article							INVERSION-RECOVERY; WATER-CONTENT; DIFFUSION; MRI; SPACE; RATIONALE; SEQUENCES; DESIGN	The purpose of this study is to assess the repeatability of the quantification of pseudo-intracellular sodium concentration (C-1) and pseudo-extracellular volume fraction (a) estimated in brain in vivo using sodium magnetic resonance (MRI) at 3 T. Eleven healthy subjects were scanned twice, with two sodium MRI acquisitions (with and without fluid suppression by inversion recovery), and two double inversion recovery (DIR) proton MRI. DIR MRIs were used to create masks of gray and white matter (GM, WM), that were subsequently applied to the C-1 and a maps calculated from sodium MRI and a tissue three-compartment model, in order to measure the distributions of these two parameters in GM, WM or full brain (GM+WM) separately. The mean, median, mode, standard deviation (std), skewness and kurtosis of the C-1 and a distributions in whole GM, WM and full brain were calculated for each subject, averaged over all data, and used as parameters for the repeatability assessment. The coefficient of variation (CV) was calculated as a measure of reliability for the detection of intra-subject changes in C-1 and alpha for each parameter, while intraclass correlation (ICC) was used as a measure of repeatability. It was found that the CV of most of the parameters was around 10-20% (except for C-1 kurtosis which is about 40%) for C-1 and a measurements, and that ICC was moderate to very good (0.4 to 0.9) for C-1 parameters and for some of the a parameters (mainly skewness and kurtosis). In conclusion, the proposed method could allow to reliably detect changes of 50% and above of the different measurement parameters of C-1 and ain neuropathologies (multiple sclerosis, tumor, stroke, Alzheimer's disease) compared to healthy subjects, and that skewness and kurtosis of the distributions of C-1 and aseem to be the more sensitive parameters to these changes.	[Madelin, Guillaume; Babb, James; Xia, Ding; Regatte, Ravinder R.] NYU, Dept Radiol, Ctr Biomed Imaging, Langone Med Ctr, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Madelin, G (corresponding author), NYU, Dept Radiol, Ctr Biomed Imaging, Langone Med Ctr, 560 1St Ave, New York, NY 10016 USA.	guillaume.madelin@nyumc.org	Regatte, Ravinder/K-2364-2014	Regatte, Ravinder/0000-0002-4607-7682; Madelin, Guillaume/0000-0002-5556-5792; Babb, James/0000-0003-1798-1186	CTSI Pilot Project Award at NYU Langone Medical Center from National Institutes of Health/National Center for Advancing Translational Sciences [UL1 TR000038]; National Institutes of Health [R01 AR060238]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060238, R03AR065763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051] Funding Source: NIH RePORTER	CTSI Pilot Project Award at NYU Langone Medical Center from National Institutes of Health/National Center for Advancing Translational Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the following funding: CTSI Pilot Project Award at NYU Langone Medical Center from National Institutes of Health/National Center for Advancing Translational Sciences grant UL1 TR000038 (GM), and National Institutes of Health R01 AR060238 (RRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminghafari M, 2006, COMPUT STAT DATA AN, V50, P2381, DOI 10.1016/j.csda.2004.12.010; [Anonymous], 2012, SPM8 MANUAL FIL METH; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BAKAY L, 1970, Brain Behavior and Evolution, V93, P693, DOI 10.1093/brain/93.4.693; Boada FE, 2005, CURR TOP DEV BIOL, V70, P77, DOI 10.1016/S0070-2153(05)70004-1; Boada FE, 2012, TRANSL STROKE RES, V3, P236, DOI 10.1007/s12975-012-0168-7; Bottomley P, 2012, SODIUM MRI MAN TECHN; Busse RF, 2006, MAGN RESON MED, V55, P1030, DOI 10.1002/mrm.20863; CAMERON IL, 1980, CANCER RES, V40, P1493; CHEEK DB, 1961, J PEDIATR-US, V58, P103, DOI 10.1016/S0022-3476(61)80068-1; Fleiss J. L, 2011, DESIGN ANAL CLIN EXP, V73; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Jerschow A, 2005, PROG NUCL MAG RES SP, V46, P63, DOI 10.1016/j.pnmrs.2004.12.001; Kline RP, 2000, CLIN CANCER RES, V6, P2146; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lee JS, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3253970; Lodish H, 2000, MOL CELL BIOL; Lu A, 2010, SODIUM MAGNETIC RESO; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Madelin G, 2014, PROG NUCL MAG RES SP, V79, P14, DOI 10.1016/j.pnmrs.2014.02.001; Madelin G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04763; Madelin G, 2013, J MAGN RESON IMAGING, V38, P511, DOI 10.1002/jmri.24168; Meara SJP, 2005, MAGNET RESON MED, V54, P241, DOI 10.1002/mrm.20541; Mellon EA, 2009, AM J NEURORADIOL, V30, P978, DOI 10.3174/ajnr.A1495; Nagel AM, 2011, INVEST RADIOL, V46, P539, DOI 10.1097/RLI.0b013e31821ae918; Neeb H, 2008, NEUROIMAGE, V42, P1094, DOI 10.1016/j.neuroimage.2008.03.060; Nicholson C, 2011, COMPUT VIS SCI, V14, P309, DOI 10.1007/s00791-012-0185-9; Ouwerkerk R, 2003, RADIOLOGY, V227, P529, DOI 10.1148/radiol.2272020483; Ouwerkerk R, 2011, METHODS MOL BIOL, V711, P175, DOI 10.1007/978-1-61737-992-5_8; Pipe JG, 2011, MAGN RESON MED, V66, P1303, DOI 10.1002/mrm.22918; Pipe JG, 1999, MAGNET RESON MED, V41, P179, DOI 10.1002/(SICI)1522-2594(199901)41:1<179::AID-MRM25>3.0.CO;2-V; ROSE AM, 1994, CLIN CHEM, V40, P1674; Sabati M, 2013, MAGN RESON IMAGING, V31, P1752, DOI 10.1016/j.mri.2013.08.001; Schepkin VD, 2012, MAGN RESON MED, V67, P1159, DOI 10.1002/mrm.23077; Stobbe R, 2005, MAGN RESON MED, V54, P1305, DOI 10.1002/mrm.20696; Sykova E, 1997, NEUROSCIENTIST, V3, P28, DOI 10.1177/107385849700300113; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Thulborn KR, 2005, NEUROIMAG CLIN N AM, V15, P639, DOI 10.1016/j.nic.2005.08.003; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; ZSNAGY I, 1983, CANCER RES, V43, P5395	46	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118692	10.1371/journal.pone.0118692	http://dx.doi.org/10.1371/journal.pone.0118692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751272	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700008
J	Hippler, FWR; Boaretto, RM; Quaggio, JA; Boaretto, AE; Abreu, CH; Mattos, D				Rieger Hippler, Franz Walter; Boaretto, Rodrigo Marcelli; Quaggio, Jose Antonio; Boaretto, Antonio Enedi; Abreu-Junior, Cassio Hamilton; Mattos, Dirceu, Jr.			Uptake and Distribution of Soil Applied Zinc by Citrus Trees-Addressing Fertilizer Use Efficiency with Zn-68 Labeling	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; WILD-TYPE; FOLIAR; MANGANESE; BORON; L.; DEFICIENCY; ABSORPTION; MECHANISM; MUTANT	The zinc (Zn) supply increases the fruit yield of Citrus trees that are grown, especially in the highly weathered soils of the tropics due to the inherently low nutrient availability in the soil solution. Leaf sprays containing micronutrients are commonly applied to orchards, even though the nutrient supply via soil could be of practical value. This study aimed to evaluate the effect of Zn fertilizers that are applied to the soil surface on absorption and partitioning of the nutrient by citrus trees. A greenhouse experiment was conducted with one-year-old sweet orange trees. The plants were grown in soils with different textures (18.1 or 64.4% clay) that received 1.8 g Zn per plant, in the form of either ZnO or ZnSO4 enriched with the stable isotope Zn-68. Zinc fertilization increased the availability of the nutrient in the soil and the content in the orange trees. Greater responses were obtained when ZnSO4 was applied to the sandy loam soil due to its lower specific metal adsorption compared to that of the clay soil. The trunk and branches accumulated the most fertilizer-derived Zn (Zn-dff) and thus represent the major reserve organ for this nutrient in the plant. The trees recovered up to 4% of the applied Zn-dff. Despite this relative low recovery, the Zn requirement of the trees was met with the selected treatment based on the total leaf nutrient content and increased Cu/Zn-SOD activity in the leaves. We conclude that the efficiency of Zn fertilizers depends on the fertilizer source and the soil texture, which must be taken into account by guidelines for fruit crop fertilization via soil, in substitution or complementation of traditional foliar sprays.	[Rieger Hippler, Franz Walter; Boaretto, Rodrigo Marcelli; Mattos, Dirceu, Jr.] Inst Agron IAC, Ctr Citricultura Sylvio Moreira, Sao Paulo, Brazil; [Quaggio, Jose Antonio] Inst Agron IAC, Ctr Solos & Recursos Ambientais, Sao Paulo, Brazil; [Boaretto, Antonio Enedi; Abreu-Junior, Cassio Hamilton] Univ Sao Paulo, CENA, BR-09500900 Sao Paulo, Brazil	Instituto Agronomico de Campinas (IAC); Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo	Mattos, D (corresponding author), Inst Agron IAC, Ctr Citricultura Sylvio Moreira, Sao Paulo, Brazil.	ddm@centrodecitricultura.br	Mattos-Jr, Dirceu/F-3217-2012; Abreu-Junior, Cassio Hamilton/H-5024-2012; Rieger Hippler, Franz Walter/F-2872-2015; Hippler, Franz Walter Rieger/T-6988-2017	Mattos-Jr, Dirceu/0000-0002-6149-9189; Abreu-Junior, Cassio Hamilton/0000-0002-5955-4652; Rieger Hippler, Franz Walter/0000-0002-7545-001X; Hippler, Franz Walter Rieger/0000-0002-7545-001X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/17589-9, 2010/02981-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo #2010/17589-9 (http://www.bv.fapesp.br/en/auxilios/30606/efficiency-of-micronutrients-application-and-use-by-citrus-trees/)to Jose Antonio Quaggio and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo # 2010/02981-0 (http://www.bv.fapesp.br/en/bolsas/113380/efficiency-of-soil-application-of-micronutrients- in-citrus/) to Franz Walter Rieger Hippler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway BJ., 2008, ZINC SOILS CROP NUTR, P135; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Bataglia OC, 1983, IAC B TECNICO, P48; Benedicto A, 2011, J AGR FOOD CHEM, V59, P8829, DOI 10.1021/jf2002574; Boaretto AE, 2002, ACTA HORTIC, P203, DOI 10.17660/ActaHortic.2002.594.22; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan RF, 2005, AUST J EXP AGR ANIM, V46, P1615; Bustan A, 1998, PLANT CELL ENVIRON, V21, P217, DOI 10.1046/j.1365-3040.1998.00267.x; CAKMAK I, 1986, PHYSIOL PLANTARUM, V68, P483, DOI 10.1111/j.1399-3054.1986.tb03386.x; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; de Abreu CA, 1998, COMMUN SOIL SCI PLAN, V29, P1961, DOI 10.1080/00103629809370085; de Lima OF, 1998, COMMUN SOIL SCI PLAN, V29, P825, DOI 10.1080/00103629809369988; Franco HCJ, 2011, SUGAR TECH, V13, P86, DOI 10.1007/s12355-010-0057-x; Gislerod H. R., 1999, Acta Horticulturae, P345; Gomes-Junior RA, 2006, CHEMOSPHERE, V65, P1330, DOI 10.1016/j.chemosphere.2006.04.056; Goos RJ, 2000, BIOL FERT SOILS, V31, P343, DOI 10.1007/s003740050666; Haslett BS, 2001, ANN BOT-LONDON, V87, P379, DOI 10.1006/anbo.2000.1349; KRAUS TE, 1995, CAN J BOT, V73, P797, DOI 10.1139/b95-088; Lehto T, 2004, NEW PHYTOL, V163, P333, DOI 10.1111/j.1469-8137.2004.01105.x; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; LONERAGAN JF, 1993, DEV PLANT SOIL SCI, V55, P119; Lopez-Millan AF, 2005, PLANT SCI, V168, P1015, DOI 10.1016/j.plantsci.2004.11.018; Lopez-Valdivia LM, 2002, J AGR FOOD CHEM, V50, P1455, DOI 10.1021/jf010978v; Martinez Hermínia Emilia Prieto, 2005, Cienc. Rural, V35, P491, DOI 10.1590/S0103-84782005000300001; Mattos Jr D, 2005, CITROS, P198; McBeath TM, 2014, PLANT SOIL, V374, P843, DOI 10.1007/s11104-013-1919-2; Nebauer SG, 2011, TREE PHYSIOL, V31, P169, DOI 10.1093/treephys/tpq103; NEL D J, 1984, South African Journal of Plant and Soil, V1, P39; Pestana M, 2001, J PLANT NUTR, V24, P1913, DOI 10.1081/PLN-100107603; Pilon M, 2011, BBA-BIOENERGETICS, V1807, P989, DOI 10.1016/j.bbabio.2010.11.002; Quaggio JA, 2003, PESQUI AGROPECU BRAS, V38, P627, DOI 10.1590/S0100-204X2003000500011; Quaggio JA, 2011, BOAS PRATICAS USO EF, P373; Sanchez EE, 2006, J HORTIC SCI BIOTECH, V81, P839, DOI 10.1080/14620316.2006.11512147; Sanchez EE, 2002, ACTA HORTIC, P363, DOI 10.17660/ActaHortic.2002.594.45; Sartori RH, 2008, REV BRAS FRUTIC, V30, P523, DOI 10.1590/S0100-29452008000200044; Shenker M, 2004, J PLANT PHYSIOL, V161, P197, DOI 10.1078/0176-1617-00931; Smith PJ, 2008, SIGHT SOUND, V18, P53; Sposito G., 1989, The chemistry of soils.; Srivastava AK, 2006, J PLANT NUTR, V29, P1061, DOI 10.1080/01904160600689183; Stomph TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00008; Westfall D. G., 1999, Better Crops with Plant Food, V83, P18; Wu CY, 2011, J ZHEJIANG UNIV-SC B, V12, P408, DOI 10.1631/jzus.B1000291; Yin XH, 2011, AGRON J, V103, P1794, DOI 10.2134/agronj2011.0166; Zhang QL, 1999, J AM SOC HORTIC SCI, V124, P312, DOI 10.21273/JASHS.124.3.312	44	26	26	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0116903	10.1371/journal.pone.0116903	http://dx.doi.org/10.1371/journal.pone.0116903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751056	Green Submitted, Green Published, gold			2022-12-27	WOS:000350692700004
J	Delplanque, A; Wawrzynczyk, D; Jaworski, P; Matczyszyn, K; Pawlik, K; Buckle, M; Nyk, M; Nogues, C; Samoc, M				Delplanque, Aleksandra; Wawrzynczyk, Dominika; Jaworski, Pawel; Matczyszyn, Katarzyna; Pawlik, Krzysztof; Buckle, Malcolm; Nyk, Marcin; Nogues, Claude; Samoc, Marek			DNA Base Pair Resolution Measurements Using Resonance Energy Transfer Efficiency in Lanthanide Doped Nanoparticles	PLOS ONE			English	Article							UPCONVERTING NAYF4 NANOPARTICLES; UP-CONVERSION NANOPARTICLES; SURFACE MODIFICATION; ACID; NANOMATERIALS; OXIDATION; STRATEGY; GROWTH	Lanthanide-doped nanoparticles are of considerable interest for biodetection and bioimaging techniques thanks to their unique chemical and optical properties. As a sensitive luminescence material, they can be used as (bio) probes in Forster Resonance Energy Transfer (FRET) where trivalent lanthanide ions (La3+) act as energy donors. In this paper we present an efficient method to transfer ultrasmall (ca. 8 nm) NaYF4 nanoparticles dispersed in organic solvent to an aqueous solution via oxidation of the oleic acid ligand. Nanoparticles were then functionalized with single strand DNA oligomers (ssDNA) by inducing covalent bonds between surface carboxylic groups and a 5' amine modified-ssDNA. Hybridization with the 5' fluorophore (Cy5) modified complementary ssDNA strand demonstrated the specificity of binding and allowed the fine control over the distance between Eu3+ ions doped nanoparticle and the fluorophore by varying the number of the dsDNA base pairs. First, our results confirmed nonradiative resonance energy transfer and demonstrate the dependence of its efficiency on the distance between the donor (Eu3+) and the acceptor (Cy5) with sensitivity at a nanometre scale.	[Delplanque, Aleksandra; Nogues, Claude] ENS Cachan, IDA FR3242, LBPA, F-94235 Cachan, France; [Wawrzynczyk, Dominika; Matczyszyn, Katarzyna; Nyk, Marcin; Samoc, Marek] Wroclaw Univ Technol, Inst Phys & Theoret Chem, PL-50370 Wroclaw, Poland; [Jaworski, Pawel; Pawlik, Krzysztof] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; [Pawlik, Krzysztof] Wroclaw Med Univ, Dept Toxicol, PL-50556 Wroclaw, Poland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; Wroclaw University of Science & Technology; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University	Matczyszyn, K (corresponding author), Wroclaw Univ Technol, Inst Phys & Theoret Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	katarzyna.matczyszyn@pwr.edu.pl; claude.nogues@lbpa.ens-cachan.fr	Pawlik, Krzysztof Jakub/F-2637-2011; Nyk, Marcin/E-8815-2012; Pawlik, Krzysztof Kuba/P-5677-2019; Samoc, Marek/AAK-9439-2020	Pawlik, Krzysztof Jakub/0000-0002-5881-9292; Nyk, Marcin/0000-0002-0329-4038; Pawlik, Krzysztof Kuba/0000-0002-5881-9292; Samoc, Marek/0000-0002-5404-2455; Matczyszyn, Katarzyna/0000-0001-8578-8340; Wawrzynczyk, Dominika/0000-0002-8485-9562	Harmonia grant [DEC-2012/04/M/ST500340]; Opus grant [DEC-2013/09/B/ST5/0347]; programme Bourse Master Ile-de-France; Erasmus Mundus MONABIPHOT	Harmonia grant; Opus grant; programme Bourse Master Ile-de-France; Erasmus Mundus MONABIPHOT	This work was supported by Harmonia grant DEC-2012/04/M/ST500340 and Opus grant DEC-2013/09/B/ST5/0347. AD is grateful for funding from the programme Bourse Master Ile-de-France and Erasmus Mundus MONABIPHOT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer JC, 2010, LANGMUIR, V26, P1157, DOI 10.1021/la902260j; Cao TY, 2011, BIOMATERIALS, V32, P2959, DOI 10.1016/j.biomaterials.2010.12.050; CHEN GR, 2010, IEEE CIRC SYST MAG, V10, P4, DOI DOI 10.1021/NN100457J; Chen J, 2012, SENSORS-BASEL, V12, P2414, DOI 10.3390/s120302414; Chen ZG, 2008, J AM CHEM SOC, V130, P3023, DOI 10.1021/ja076151k; Eliseeva SV, 2010, CHEM SOC REV, V39, P189, DOI 10.1039/b905604c; Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Ghosh P, 2008, J PHYS CHEM C, V112, P3223, DOI 10.1021/jp7099114; Gnach A, 2012, NANO TODAY, V7, P532, DOI 10.1016/j.nantod.2012.10.006; Gu JQ, 2008, J PHYS CHEM C, V112, P6589, DOI 10.1021/jp801203w; Hemmer E, 2013, NANOSCALE, V5, P11339, DOI 10.1039/c3nr02286b; Jiang GC, 2012, LANGMUIR, V28, P3239, DOI 10.1021/la204020m; Kong DY, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/7/075601; Kumar M, 2009, LANGMUIR, V25, P6024, DOI 10.1021/la900936p; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEMIEUX RU, 1955, CAN J CHEM, V33, P1701, DOI 10.1139/v55-208; Li D, 2010, J PHYS CHEM C, V114, P8219, DOI 10.1021/jp100893k; Lin M, 2012, BIOTECHNOL ADV, V30, P1551, DOI 10.1016/j.biotechadv.2012.04.009; Liu YS, 2013, NANOSCALE, V5, P1369, DOI 10.1039/c2nr33239f; Selvin PR, 1996, IEEE J SEL TOP QUANT, V2, P1077, DOI 10.1109/2944.577339; Shimoyama A, 2013, PHOTODIAGN PHOTODYN, V10, P607, DOI 10.1016/j.pdpdt.2013.07.005; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Wang C, 2011, BIOMATERIALS, V32, P1110, DOI 10.1016/j.biomaterials.2010.09.069; Wang F, 2009, CHEM SOC REV, V38, P976, DOI 10.1039/b809132n; Wang GF, 2011, ACCOUNTS CHEM RES, V44, P322, DOI 10.1021/ar100129p; Wang LY, 2007, CHEM-EUR J, V13, P4203, DOI 10.1002/chem.200700005; Wawrzynczyk D, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1707-1; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Xiong LQ, 2010, BIOMATERIALS, V31, P7078, DOI 10.1016/j.biomaterials.2010.05.065; Yao CZ, 2012, TRAC-TREND ANAL CHEM, V39, P60, DOI 10.1016/j.trac.2012.07.007; Yi GS, 2007, CHEM MATER, V19, P341, DOI 10.1021/cm062447y; Zeng SJ, 2011, CRYSTENGCOMM, V13, P1384, DOI 10.1039/c0ce00325e; Zhang P, 2006, J AM CHEM SOC, V128, P12410, DOI 10.1021/ja0644024; Zhang QB, 2009, J COLLOID INTERF SCI, V336, P171, DOI 10.1016/j.jcis.2009.04.024; Zimmermann FO, 2005, TETRAHEDRON LETT, V46, P3201, DOI 10.1016/j.tetlet.2005.03.052	36	3	3	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0117277	10.1371/journal.pone.0117277	http://dx.doi.org/10.1371/journal.pone.0117277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748446	Green Published, gold			2022-12-27	WOS:000350689400008
J	Tandon, M; Salamoun, JM; Carder, EJ; Farber, E; Xu, SP; Deng, F; Tang, H; Wipf, P; Wang, QJ				Tandon, Manuj; Salamoun, Joseph M.; Carder, Evan J.; Farber, Elisa; Xu, Shuping; Deng, Fan; Tang, Hua; Wipf, Peter; Wang, Q. Jane			SD-208, a Novel Protein Kinase D Inhibitor, Blocks Prostate Cancer Cell Proliferation and Tumor Growth In Vivo by Inducing G2/M Cell Cycle Arrest	PLOS ONE			English	Article							ACTIVATION LOOP SER(744); MOLECULAR-CLONING; PHORBOL ESTERS; DNA-SYNTHESIS; EXPRESSION; POTENT; CONTRIBUTES; CHEMISTRY; APOPTOSIS; BOMBESIN	Protein kinase D (PKD) has been implicated in many aspects of tumorigenesis and progression, and is an emerging molecular target for the development of anticancer therapy. Despite recent advancement in the development of potent and selective PKD small molecule inhibitors, the availability of in vivo active PKD inhibitors remains sparse. In this study, we describe the discovery of a novel PKD small molecule inhibitor, SD-208, from a targeted kinase inhibitor library screen, and the synthesis of a series of analogs to probe the structureactivity relationship (SAR) vs. PKD1. SD-208 displayed a narrow SAR profile, was an ATP-competitive pan-PKD inhibitor with low nanomolar potency and was cell active. Targeted inhibition of PKD by SD-208 resulted in potent inhibition of cell proliferation, an effect that could be reversed by overexpressed PKD1 or PKD3. SD-208 also blocked prostate cancer cell survival and invasion, and arrested cells in the G2/M phase of the cell cycle. Mechanistically, SD-208-induced G2/M arrest was accompanied by an increase in levels of p21 in DU145 and PC3 cells as well as elevated phosphorylation of Cdc2 and Cdc25C in DU145 cells. Most importantly, SD-208 given orally for 24 days significantly abrogated the growth of PC3 subcutaneous tumor xenografts in nude mice, which was accompanied by reduced proliferation and increased apoptosis and decreased expression of PKD biomarkers including survivin and Bcl-xL. Our study has identified SD-208 as a novel efficacious PKD small molecule inhibitor, demonstrating the therapeutic potential of targeted inhibition of PKD for prostate cancer treatment.	[Tandon, Manuj; Carder, Evan J.; Xu, Shuping; Wang, Q. Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Salamoun, Joseph M.; Farber, Elisa; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15261 USA; [Deng, Fan] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [Tang, Hua] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Wang, QJ (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	qjw1@pitt.edu	Wang, Qiming Jane/B-6064-2012; Wipf, Peter/AAG-1771-2021	Wang, Qiming Jane/0000-0002-9502-4851; Wipf, Peter/0000-0001-7693-5863	National Institutes of Health [R01CA129127, R01CA142580]; oversea Hong Kong and Macao Scholars Collaborative Research Fund of NSFC in China [81328020]; NATIONAL CANCER INSTITUTE [R01CA142580, R01CA129127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); oversea Hong Kong and Macao Scholars Collaborative Research Fund of NSFC in China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health grant R01CA129127, R01CA142580, and oversea Hong Kong and Macao Scholars Collaborative Research Fund of NSFC in China (Grant #81328020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2003, ONCOGENE, V22, P8271, DOI 10.1038/sj.onc.1207158; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Backes AC, 2008, EXPERT OPIN DRUG DIS, V3, P1409, DOI 10.1517/17460440802579975; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; Guo JX, 2013, CANCER CHEMOTH PHARM, V71, P331, DOI 10.1007/s00280-012-2010-z; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hassan S, 2009, ONCOGENE, V28, P4386, DOI 10.1038/onc.2009.291; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Huck B, 2014, J BIOL CHEM, V289, P3138, DOI 10.1074/jbc.M113.502633; Huynh QK, 2006, ARCH BIOCHEM BIOPHYS, V450, P141, DOI 10.1016/j.abb.2006.02.014; Jaggi M, 2008, MOL CANCER THER, V7, P2703, DOI 10.1158/1535-7163.MCT-08-0119; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Karan D, 2003, INT J CANCER, V103, P285, DOI 10.1002/ijc.10813; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Mak P, 2008, BIOCHEM BIOPH RES CO, V373, P618, DOI 10.1016/j.bbrc.2008.06.097; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Mohammad KS, 2011, CANCER RES, V71, P175, DOI 10.1158/0008-5472.CAN-10-2651; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Takagaki N, 2005, INT J ONCOL, V26, P185; Tandon M, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0075601; Tandon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044653; Trauzold A, 2003, ONCOGENE, V22, P8939, DOI 10.1038/sj.onc.1207001; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; Yuan J, 2008, J CELL BIOCHEM, V103, P648, DOI 10.1002/jcb.21439; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200	43	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119346	10.1371/journal.pone.0119346	http://dx.doi.org/10.1371/journal.pone.0119346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747583	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000350689400064
J	Xu, L; Xiong, W; Yang, JK; Li, J; Tao, XW				Xu, Li; Xiong, Wei; Yang, Jiang-Ke; Li, Jia; Tao, Xing-Wu			Recombinant Escherichia coli Strains with Inducible Campylobacter jejuni Single Domain Hemoglobin CHb Expression Exhibited Improved Cell Growth in Bioreactor Culture	PLOS ONE			English	Article							VITREOSCILLA HEMOGLOBIN; TRANSCRIPTIONAL REGULATOR; GLOBIN GENE; PROMOTER; FNR; PURIFICATION; METABOLISM; RESISTANCE	Maintaining an appropriate concentration of dissolved oxygen in aqueous solution is critical for efficient operation of a bioreactor, requiring sophisticated engineering design and a system of regulation to maximize oxygen transfer from the injected air bubbles to the cells. Bacterial hemoglobins are oxygen-binding proteins that transfer oxygen from the environment to metabolic processes and allow bacteria to grow even under microaerophilic conditions. To improve the oxygen utilization efficiency of cells and overcome the oxygen shortage in bioreactors, the gene coding for the Campylobacter jejuni single domain hemoglobin (CHb) gene was artificially synthesized and functionally expressed under the control of inducible expression promoters P-T7 and P-vgh in Escherichia coli. The effects of the recombinants P-T7-CHb and P-vgh-CHb on cell growth were evaluated in aerobic shake flasks, anaerobic capped bottles and a 5-L bioreactor, and a pronounced improvement in cell biomass was observed for CHb-expressing cells. To determine the growth curves, CHb gene expression, and CHb oxygen-binding capacity of specific recombinants with different promoters, we determined the time course of CHb gene expression in the two recombinants by semi-quantitative RT-PCR and CO differential spectrum assays. Based on the growth patterns of the two recombinants in the bioreactor, we proposed different recombinant types with optimal performance under specific culture conditions.	[Xu, Li; Xiong, Wei; Yang, Jiang-Ke; Li, Jia; Tao, Xing-Wu] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Peoples R China	Wuhan Polytechnic University	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Peoples R China.	jiangke.yang@gmail.com	XU, LIWU/GYR-0963-2022		Science and Technology Supporting Program of Hubei Province; Science and Technology Research Program of the Education Department of Hubei Province [D20131703]; Chinese Ministry of Education [212118]	Science and Technology Supporting Program of Hubei Province; Science and Technology Research Program of the Education Department of Hubei Province; Chinese Ministry of Education(Ministry of Education, China)	Science and Technology Supporting Program of Hubei Province (2014), Key Project of Science and Technology Research Program of the Education Department of Hubei Province (no. D20131703), the Key Project of Chinese Ministry of Education (no. 212118).	Benz GT, 2008, CHEM ENG PROG, V104, P32; BLAKEBROUGH N, 1963, BIOTECHNOL BIOENG, V5, P59, DOI 10.1002/bit.260050110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIKSHIT KL, 1989, J GEN MICROBIOL, V135, P2601; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Frey AD, 2003, FEMS MICROBIOL REV, V27, P525, DOI 10.1016/S0168-6445(03)00056-1; Guardia Alba M J, 2001, J Biotechnol, V84, P107; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; JOSHI M, 1994, BIOCHEM BIOPH RES CO, V202, P535, DOI 10.1006/bbrc.1994.1961; KHOSLA C, 1989, J BACTERIOL, V171, P5995, DOI 10.1128/jb.171.11.5995-6004.1989; KHOSLA C, 1988, NATURE, V331, P633, DOI 10.1038/331633a0; Lin JM, 2003, J IND MICROBIOL BIOT, V30, P362, DOI 10.1007/s10295-003-0054-0; Pablos TE, 2014, BIOTECHNOL J, V9, P791, DOI 10.1002/biot.201300388; Pablos TE, 2011, BIOTECHNOL J, V6, P993, DOI 10.1002/biot.201000405; Park KW, 2002, J BIOL CHEM, V277, P33334, DOI 10.1074/jbc.M203820200; Ramandeep, 2001, J BIOL CHEM, V276, P24781, DOI 10.1074/jbc.M009808200; Rehm BHA, 2001, BIOCHEM J, V358, P263, DOI 10.1042/0264-6021:3580263; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Stark BC, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210002; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TSAI PS, 1995, BIOTECHNOL PROGR, V11, P288, DOI 10.1021/bp00033a008; Unden G, 1997, MOL MICROBIOL, V25, P205, DOI 10.1046/j.1365-2958.1997.4731841.x; Van't Riet K, 1991, BASIC BIOREACTOR DES, P33; Wainwright LM, 2006, BIOCHEMISTRY-US, V45, P6003, DOI 10.1021/bi052247k; WEBSTER DA, 1966, J BIOL CHEM, V241, P3308; WEBSTER DA, 1988, ADV INORG BIOCHEM, V7, P245; Yang JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036607; Zhang W, 2013, FEMS MICROBIOL LETT, V343, P127, DOI 10.1111/1574-6968.12139	28	7	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116503	10.1371/journal.pone.0116503	http://dx.doi.org/10.1371/journal.pone.0116503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748170	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400006
J	Zhang, NN; Sun, XJ; Sun, MJ; Zhu, ST; Wang, L; Ma, D; Wang, YJ; Zhang, ST; Li, P				Zhang, Nana; Sun, Xiujing; Sun, Mingjiong; Zhu, Shengtao; Wang, Li; Ma, Dan; Wang, Yongjun; Zhang, Shutian; Li, Peng			4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Promotes Esophageal Squamous Cell Carcinoma Growth via Beta-Adrenoceptors In Vitro and In Vivo	PLOS ONE			English	Article							EPITHELIAL-CELLS; CANCER CELLS; PROLIFERATION; EPIDEMIOLOGY; ACTIVATION; EXPRESSION; RECEPTORS; SURVIVAL; BLOCKERS; INVASION	Cigarette smoke is a risk factor for esophageal squamous cell carcinoma (ESCC). It contains several carcinogens known to initiate and promote tumorigenesis as well as metastasis. The nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is one of the strongest carcinogens in tobacco and our previous studies have shown its proliferation-promoting role in the progression of ESCC. Recently, NNK was identified as an agonist for both beta1- and beta2-adrenoceptors. Thus, we hypothesized that the cancer-promoting effect of NNK was likely mediated through beta-adrenoceptors in ESCC. Therefore, we investigated the comprehensive role of NNK in ESCC in vitro and in vivo, and found that NNK promoted many oncogenic features including ESCC cell proliferation and xenograft tumor growth as well as ESCC cell migration and invasion. Western blotting showed that NNK induced significant up-regulation of phosphorylated ERK1/2, cyclin D1, Bcl-2, and vascular endothelial growth factor as well as down-regulation of Bax. Importantly, the oncogenic effects of NNK in ESCC and the altered protein expression were reversed to some extent by down-regulation of beta1- and beta2-adrenoceptors with the beta2-adrenoceptor showing a greater rescue effect. Taken together, our in vitro and in vivo results demonstrate that NNK plays an oncogenic role in ESCC through beta-adrenoceptors. Furthermore, beta2-adrenoceptor might play a more important role in this process. Our findings might provide a chemoprevention and therapy strategy for cigarette smoke-related ESCC carcinogenesis.	[Zhang, Nana; Sun, Xiujing; Sun, Mingjiong; Zhu, Shengtao; Wang, Li; Ma, Dan; Wang, Yongjun; Zhang, Shutian; Li, Peng] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China	Capital Medical University	Zhang, ST (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China.	zhangst@ccmu.edu.cn; lipeng@ccmu.edu.cn			National Natural Science Foundation of China [81071974, 81272447]; Beijing Natural Science Foundation [7122055]; National Key Basic Research Program of China [2012CB526600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by funds from the National Natural Science Foundation of China (81071974), Beijing Natural Science Foundation (7122055), National Natural Science Foundation of China (81272447), and National Key Basic Research Program of China (2012CB526600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2013, LUNG CANCER, V82, P390, DOI 10.1016/j.lungcan.2013.09.012; Al-Wadei MH, 2012, MOL CANCER RES, V10, P239, DOI 10.1158/1541-7786.MCR-11-0332; Assayag J, 2014, EUR J CANCER, V50, P2838, DOI 10.1016/j.ejca.2014.08.006; BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P838, DOI 10.1164/ajrccm.152.3.7663795; Choi CH, 2014, J CANCER RES CLIN, V140, P1179, DOI 10.1007/s00432-014-1658-7; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Duell EJ, 2012, MOL CARCINOGEN, V51, P40, DOI 10.1002/mc.20786; Hicks BM, 2013, ANN ONCOL, V24, P3100, DOI 10.1093/annonc/mdt381; Ho YS, 2005, TOXICOL APPL PHARM, V205, P133, DOI 10.1016/j.taap.2004.09.019; Huang RY, 2011, ONCOGENE, V30, P106, DOI 10.1038/onc.2010.390; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lambert R, 2007, ENDOSCOPY, V39, P550, DOI 10.1055/s-2007-966530; Li P, 2009, DRUG CHEM TOXICOL, V32, P175, DOI 10.1080/01480540902875253; Lin XP, 2012, HEPATO-GASTROENTEROL, V59, P584, DOI 10.5754/hge11271; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu CT, 2013, DIGEST DIS SCI, V58, P1256, DOI 10.1007/s10620-012-2429-4; Liu X, 2008, J CELL BIOCHEM, V105, P53, DOI 10.1002/jcb.21802; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Mennecier G, 2014, MOL CARCINOGEN, V53, P392, DOI 10.1002/mc.21987; Nagaraja AS, 2013, EXPERT OPIN INV DRUG, V22, P1359, DOI 10.1517/13543784.2013.825250; Nishimura K, 1998, Nihon Kokyuki Gakkai Zasshi, V36, P428; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; Pluchino LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108698; Shen J, 2012, CANCER LETT, V318, P106, DOI 10.1016/j.canlet.2011.12.008; Spechler SJ, 2012, JAMA-J AM MED ASSOC, V310, P627; Sun XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077353; Tang J, 2013, SEMIN CANCER BIOL, V23, P533, DOI 10.1016/j.semcancer.2013.08.009; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Wang J, 2012, ASIAN PAC J CANCER P, V13, P2207, DOI 10.7314/APJCP.2012.13.5.2207; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Wong MCS, 2015, INT J CARDIOL, V179, P178, DOI 10.1016/j.ijcard.2014.10.028; Wu WKK, 2005, CANCER RES, V65, P5272, DOI 10.1158/0008-5472.CAN-05-0205; Yuan JM, 2011, CARCINOGENESIS, V32, P1366, DOI 10.1093/carcin/bgr125; Zhang D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-146; Zhang SY, 2009, CHEM RES TOXICOL, V22, P949, DOI 10.1021/tx900040j	37	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118845	10.1371/journal.pone.0118845	http://dx.doi.org/10.1371/journal.pone.0118845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742648	gold, Green Submitted, Green Published			2022-12-27	WOS:000350688100051
J	Anderson, K; Taylor, DA; Thompson, EL; Melwani, AR; Nair, SV; Raftos, DA				Anderson, Kelli; Taylor, Daisy A.; Thompson, Emma L.; Melwani, Aroon R.; Nair, Sham V.; Raftos, David A.			Meta-Analysis of Studies Using Suppression Subtractive Hybridization and Microarrays to Investigate the Effects of Environmental Stress on Gene Transcription in Oysters	PLOS ONE			English	Article							SYDNEY ROCK OYSTERS; CRASSOSTREA-GIGAS; PACIFIC OYSTER; HEAT-SHOCK-PROTEIN-70 GENE; ANTIOXIDANT ENZYMES; OCEAN ACIDIFICATION; THERMAL-STRESS; EXPRESSION; IDENTIFICATION; HEMOCYTES	Many microarray and suppression subtractive hybridization (SSH) studies have analyzed the effects of environmental stress on gene transcription in marine species. However, there have been no unifying analyses of these data to identify common stress response pathways. To address this shortfall, we conducted a meta-analysis of 14 studies that investigated the effects of different environmental stressors on gene expression in oysters. The stressors tested included chemical contamination, hypoxia and infection, as well as extremes of temperature, pH and turbidity. We found that the expression of over 400 genes in a range of oyster species changed significantly after exposure to environmental stress. A repeating pattern was evident in these transcriptional responses, regardless of the type of stress applied. Many of the genes that responded to environmental stress encoded proteins involved in translation and protein processing (including molecular chaperones), the mitochondrial electron transport chain, anti-oxidant activity and the cytoskeleton. In light of these findings, we put forward a consensus model of sub-cellular stress responses in oysters.	[Anderson, Kelli; Taylor, Daisy A.; Thompson, Emma L.; Melwani, Aroon R.; Raftos, David A.] Sydney Inst Marine Sci, Chowder Bay, NSW, Australia; [Anderson, Kelli; Taylor, Daisy A.; Thompson, Emma L.; Melwani, Aroon R.; Nair, Sham V.; Raftos, David A.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Sydney Institute of Marine Science; Macquarie University	Raftos, DA (corresponding author), Sydney Inst Marine Sci, Chowder Bay, NSW, Australia.	david.raftos@mq.edu.au	/AAL-3738-2021; Melwani, Aroon R/D-2216-2013; Anderson, Kelli/AAJ-6058-2020	Anderson, Kelli/0000-0001-7749-4641; Thompson, Emma/0000-0003-0850-0547; Melwani, Aroon/0000-0002-7939-2996	Macquarie University; Australian Research Council Discovery grant [DP120101946]	Macquarie University; Australian Research Council Discovery grant(Australian Research Council)	This was work supported by Macquarie University (http://www.mq.edu.au/) and by an Australian Research Council Discovery grant (DP120101946, http://www.arc.gov.au/) to DAR and others. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladaileh S, 2008, COMP BIOCHEM PHYS A, V151, P691, DOI 10.1016/j.cbpa.2008.08.028; Bocchetti R, 2006, CHEMOSPHERE, V65, P913, DOI 10.1016/j.chemosphere.2006.03.049; Boutet I, 2004, GENE, V329, P147, DOI 10.1016/j.gene.2003.12.027; Chapman RW, 2011, MOL ECOL, V20, P1431, DOI 10.1111/j.1365-294X.2011.05018.x; David E, 2005, FEBS J, V272, P5635, DOI 10.1111/j.1742-4658.2005.04960.x; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Donaghy L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046594; Fabbri E., 2008, ISJ, V5, P135; Farcy E, 2007, SCI TOTAL ENVIRON, V374, P328, DOI 10.1016/j.scitotenv.2006.11.014; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Gall ML, 2012, J ENVIRON MONITOR, V14, P830, DOI 10.1039/c2em10880a; Green TJ, 2009, FISH SHELLFISH IMMUN, V26, P799, DOI 10.1016/j.fsi.2009.03.003; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Hedge LH, 2009, MAR POLLUT BULL, V58, P832, DOI 10.1016/j.marpolbul.2009.01.020; Howell ET, 2012, J GREAT LAKES RES, V38, P32, DOI 10.1016/j.jglr.2011.12.005; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Ivanina AV, 2008, J EXP BIOL, V211, P577, DOI 10.1242/jeb.011262; Jeong WG, 2007, AQUACULTURE, V265, P343, DOI 10.1016/j.aquaculture.2007.02.021; Kuchel RP, 2011, FISH SHELLFISH IMMUN, V31, P365, DOI 10.1016/j.fsi.2011.05.025; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Labreuche Y, 2006, MICROBES INFECT, V8, P2715, DOI 10.1016/j.micinf.2006.07.020; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Luchmann KH, 2012, ENVIRON TOXICOL CHEM, V31, P1249, DOI 10.1002/etc.1837; Martin-Gomez L, 2012, GENE, V492, P81, DOI 10.1016/j.gene.2011.11.001; McDowell IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105097; Medeiros ID, 2008, ENVIRON TOXICOL PHAR, V26, P362, DOI 10.1016/j.etap.2008.05.004; Meistertzheim AL, 2007, FEBS J, V274, P6392, DOI 10.1111/j.1742-4658.2007.06156.x; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058563; Morga B, 2011, DEV COMP IMMUNOL, V35, P323, DOI 10.1016/j.dci.2010.10.005; Muralidharan S, 2012, PROTEOMICS, V12, P906, DOI 10.1002/pmic.201100417; Park MS, 2009, MOLLUSCAN RES, V29, P179; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Penuelas J, 2013, GLOBAL CHANGE BIOL, V19, P2303, DOI 10.1111/gcb.12143; Renault T, 2011, DEV COMP IMMUNOL, V35, P725, DOI 10.1016/j.dci.2011.02.004; Sano D, 2003, WATER RES, V37, P3490, DOI 10.1016/S0043-1354(03)00208-2; Sokolova IM, 2013, INTEGR COMP BIOL, V53, P597, DOI 10.1093/icb/ict028; Suarez-Ulloa V, 2013, MAR DRUGS, V11, P4370, DOI 10.3390/md11114370; Sussarellu R, 2010, MAR GENOM, V3, P133, DOI 10.1016/j.margen.2010.08.005; Tanguy A, 2005, FEBS J, V272, P390, DOI 10.1111/j.1742-4658.2004.04479.x; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Tedesco S, 2010, AQUAT TOXICOL, V100, P178, DOI 10.1016/j.aquatox.2010.03.001; Timmins-Schiffman E., 2014, PEERJ PREPRINTS, V2, DOI DOI 10.7717/PEERJ.388; Tomanek L, 2011, ANNU REV MAR SCI, V3, P373, DOI 10.1146/annurev-marine-120709-142729; Veerasingam S, 2011, J ENVIRON SCI, V23, P1129, DOI 10.1016/S1001-0742(10)60524-4; Wang SL, 2010, FISH SHELLFISH IMMUN, V29, P921, DOI 10.1016/j.fsi.2010.07.035; Wang ZL, 2009, FISH SHELLFISH IMMUN, V26, P639, DOI 10.1016/j.fsi.2008.10.011; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang ZH, 2012, GENE, V497, P172, DOI 10.1016/j.gene.2012.01.058; Zhao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046244	49	44	44	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118839	10.1371/journal.pone.0118839	http://dx.doi.org/10.1371/journal.pone.0118839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768438	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500048
J	Bao, LD; Peng, R; Wang, Y; Ma, RL; Ren, XH; Meng, WB; Sun, FS; Fang, JX; Chen, P; Wang, Y; Chen, QH; Cai, J; Jin, J; Guo, JH; Yang, SC; Mo, XM; Zhang, EJ; Zhang, YR; Lu, ZX; Chen, BB; Yue, XJ; Zhu, MJ; Wang, YY; Li, XC; Bian, Y; Kong, SS; Pan, WF; Ding, Q; Cao, J; Liu, RP; Chen, N; Huang, XL; Agula, B; Lyu, HJ				Bao, Lidao; Peng, Rui; Wang, Yi; Ma, Ruilian; Ren, Xianhua; Meng, Wenbin; Sun, Fusheng; Fang, Junxia; Chen, Ping; Wang, Yang; Chen, Qiuhong; Cai, Jian; Jin, Jian; Guo, Jinhui; Yang, Shucheng; Mo, Xiaomei; Zhang, Enjing; Zhang, Yuerong; Lu, Zhaoxin; Chen, Binbin; Yue, Xiujuan; Zhu, Meijun; Wang, Yingying; Li, Xinchao; Bian, Yuan; Kong, Shaoshan; Pan, Wenfei; Ding, Qian; Cao, Jun; Liu, Rupin; Chen, Nan; Huang, Xuelian; Agula, B.; Lyu, Haijun			Significant Reduction of Antibiotic Consumption and Patients' Costs after an Action Plan in China, 2010-2014	PLOS ONE			English	Article							RESISTANCE	Introduction On July 1, 2011, the Chinese government launched a national Action Plan for antibiotic stewardship targeting antibiotic misuse in public hospitals. The aim of this study was to evaluate the impacts of the Action Plan in terms of frequency and intensity of antibiotic utilization and patients costs in public general hospitals. Methods Administrative pharmacy data from July 2010 to June 2014 were sampled from 65 public general hospitals and divided into three segments: (1) July 2010 to June 2011 as the preparation period; (2) July 2011 to June 2012 as the intervention period; and (3) July 2012 to June 2014 as the assessment period. The outcome measures included (1) antibiotic prescribing rates; (2) intensity of antibiotic consumption; (3) patients costs; and (4) duration of peri-operative antibiotic treatment in clean surgeries of thyroidectomy, breast, hernia, and orthopedic procedures. Longitudinal and cross-sectional analyses were conducted. Results Longitudinal analyses showed significant trend changes in the frequency and intensity of antibiotic consumption, the patients' costs on antibiotics, and the duration of antibiotic treatment received by surgical patients undergoing the 4 clean procedures during the intervention period. Cross-sectional analyses showed that the antibiotic prescribing rates were reduced to 35.3% and 12.9% in inpatient and outpatient settings, that the intensity of antibiotic consumption was reduced to 35.9 DDD/100 bed-days, that patients' costs on antibiotics were reduced significantly, and that the duration of peri-operative antibiotic treatment received by surgical patients undergoing the 4 types of clean procedures decreased to less than 24 hour during the assessment period. Conclusion The Action Plan, as a combination of managerial and professional strategies, was effective in reducing the frequency and intensity of antibiotic consumption, patients' costs on antibiotics, and the duration of peri-operative antibiotic treatment in the 4 clean surgeries.	[Bao, Lidao; Peng, Rui; Wang, Yi; Ma, Ruilian; Ren, Xianhua] Inner Mongolia Med Univ, Dept Pharm, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Meng, Wenbin] Inner Mongolia Med Univ, Dept Obstet, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Sun, Fusheng] Peoples Hosp, Dept Pharm, Qingdao, Shandong, Peoples R China; [Fang, Junxia] Third Peoples Hosp, Dept Pharm, Fuyang, Zhejiang, Peoples R China; [Chen, Ping] Cent Hosp, Dept Pharm, Zibo, Shandong, Peoples R China; [Wang, Yang] Women & Childrens Hosp, Dept Pharm, Maanshan, Henan, Peoples R China; [Chen, Qiuhong] Peoples Liberat Army, Mil Hosp 175, Dept Pharm, Zhangzhou, Fujian, Peoples R China; [Cai, Jian] Fengxian Dist Psychiat Ctr, Dept Pharm, Shanghai, Peoples R China; [Jin, Jian] Shanghai Transport Univ, Affiliated Peoples Hosp 9, Dept Pharm, Shanghai, Peoples R China; [Guo, Jinhui] TB Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R China; [Yang, Shucheng] Women & Childrens Hosp, Dept Pharm, Taiyuan, Shanxi, Peoples R China; [Mo, Xiaomei] Women & Childrens Hosp, Dept Pharm, Qingdao, Shandong, Peoples R China; [Zhang, Enjing] Third Hosp, Dept Pharm, Wuhan, Hubei, Peoples R China; [Zhang, Yuerong] Huli Dist Women & Childrens Hosp, Dept Pharm, Xiamen, Fujian, Peoples R China; [Lu, Zhaoxin] Haici Med Grp, Dept Emergency, Qingdao, Shandong, Peoples R China; [Chen, Binbin] Ctr Psychiat, Dept Pharm, Xiamen, Fujian, Peoples R China; [Yue, Xiujuan] Capital Med Univ, Beijing Youan Hosp, Dept Pharm, Beijing, Peoples R China; [Zhu, Meijun] Minhang Dist Psychiat Ctr, Dept Pharm, Shanghai, Peoples R China; [Wang, Yingying] Dongchangfu Dist Women & Childrens Hosp, Dept Pharm, Liaocheng, Shandong, Peoples R China; [Li, Xinchao] Lintong Dist Chinese Med Hosp, Dept Pharm, Xian, Shanxi, Peoples R China; [Bian, Yuan] Peoples Hosp, Dept Pharm, Chengdu, Sichuan, Peoples R China; [Kong, Shaoshan] Women & Childrens Hosp, Dept Pharm, Zhuhai, Guangdong, Peoples R China; [Pan, Wenfei] Buwai Cardiol Hosp, Dept Pharm, Beijing, Peoples R China; [Ding, Qian] Capital Pediat Res Ctr, Affiliated Childrens Hosp, Dept Pharm, Beijing, Peoples R China; [Cao, Jun] Fifth Peoples Hosp, Dept Pharm, Suzhou, Zhejiang, Peoples R China; [Liu, Rupin] Cent Hosp, Dept Pharm, Xinyang, Henan, Peoples R China; [Chen, Nan] Southern China Med Univ, Peoples Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R China; [Huang, Xuelian] Peoples Hosp, Dept Pharm, Luo Cty, Guangdong, Peoples R China; [Agula, B.] Inner Mongolia Med Univ, Dept Mongolian Med, Hohhot, Inner Mongolia, Peoples R China; [Lyu, Haijun] Inner Mongolia Med Univ, Ctr Sci Res, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Medical University; Inner Mongolia Medical University; Capital Medical University; Inner Mongolia Medical University; Inner Mongolia Medical University	Agula, B (corresponding author), Inner Mongolia Med Univ, Dept Mongolian Med, Hohhot, Inner Mongolia, Peoples R China.	agulab@163.com; haijunlyu@outlook.com	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; Chen, QH/GXH-3158-2022		Nature Science Fund from Inner Mongolia Autonomous Region [2013MS1224]; Scientific Project Fund from Affiliated Hospital of Inner Mongolia Medical University [NYFY2010YB006]; Youth Innovation Fund from Inner Mongolia Medical University [NY2010QN002]; Key Scientific Fund from Affiliated Hospital of Inner Mongolia Medical University [NYFYZD20130158]	Nature Science Fund from Inner Mongolia Autonomous Region; Scientific Project Fund from Affiliated Hospital of Inner Mongolia Medical University; Youth Innovation Fund from Inner Mongolia Medical University; Key Scientific Fund from Affiliated Hospital of Inner Mongolia Medical University	This study was financially supported by Nature Science Fund from Inner Mongolia Autonomous Region to Lidao Bao (2013MS1224), Scientific Project Fund from Affiliated Hospital of Inner Mongolia Medical University to Yi Wang (NYFY2010YB006), Youth Innovation Fund from Inner Mongolia Medical University to Lidao Bao (NY2010QN002), and Key Scientific Fund from Affiliated Hospital of Inner Mongolia Medical University to Ruilian Ma (NYFYZD20130158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2013, INDIAN J PHARM SCI, V75, P11, DOI 10.4103/0250-474X.113531; Chinese Ministry of Health, 2012, CHIN HEALTHC ALM; Chinese Ministry of Health, 2010, REG PRESCR MAN; Chinese Ministry of Health, 2011, ACT PLAN ANT STEW CL; Chinese Ministry of Health, 2011, REG PHARM ADM MED I; Chinese Ministry of Heath, 2012, REG CLIN APPL ANT; Costelloe C., 2010, BMJ, V340; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Knobler SL, 2003, WHO GLOBAL STRATEGY; Li F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-353; Tao D, 2010, VOLUME, V2, P8; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wang JF, 2013, CURR TOP MED CHEM, V13, P1242, DOI 10.2174/15680266113139990011; WHO, 2020, WHO COLLABORATING CT; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001; Yezli S, 2012, INT J ANTIMICROB AG, V40, P389, DOI 10.1016/j.ijantimicag.2012.07.009	17	44	47	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118868	10.1371/journal.pone.0118868	http://dx.doi.org/10.1371/journal.pone.0118868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767891	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500052
J	Crisan, AF; Oancea, C; Timar, B; Fira-Mladinescu, O; Tudorache, V				Crisan, Alexandru Florian; Oancea, Cristian; Timar, Bogdan; Fira-Mladinescu, Ovidiu; Tudorache, Voicu			Balance Impairment in Patients with COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PREDICTING FALLS; POSTURAL CONTROL; ELDERLY-PEOPLE; RISK-FACTORS; DEPRESSION; COMMUNITY; FEAR; INDIVIDUALS; PREVENTION	Background/Purpose Chronic obstructive pulmonary disease (COPD) is a respiratory disease that results in progressive airflow limitation and respiratory distress. Physiopathological features of COPD suggest that people who suffer from this disease have many risk factors for falls that have been identified in older individuals. The aim of the study was to compare and quantify functional balance between COPD patients and healthy subjects; to investigate the risk of falls in acute stages of the disease and to identify risk factors that could lead to falls. Methods We studied 46 patients with moderate-severe COPD (29 stable and 17 in acute exacerbation - AECOPD) and 17 healthy subjects (control group) having similar demographic data. We analyzed the difference in Berg Balance Scale (BBS), Single Leg Stance (SLS) and Timed Up and Go test (TUG) between these three groups and the correlation of these scores with a number of incriminatory factors. Results The presence of COPD was associated with significant worsening of balance tests: BBS (55 control, vs. 53 COPD, vs. 44 AECOPD points p<0.001), TUG (8.6 control vs. 12.3 COPD vs. 15.9 AECOPD seconds. p<0.001), SLS (31.1 control vs. 17.7 COPD vs. 7.2 AECOPD seconds p<0.001) which may be associated with an increased risk of falls. Anxiety and depression were significantly associated with decreased balance test scores; anxiety (2 control vs. 6 COPD vs. 9 AECOPD points p<0.001) depression (2 control vs. 7 COPD vs. 12 AECOPD points p<0.001). Conclusions According to our results COPD patients in moderate-severe stages and especially those in exacerbation have a high risk of falls.	[Crisan, Alexandru Florian; Oancea, Cristian; Fira-Mladinescu, Ovidiu; Tudorache, Voicu] Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania; [Timar, Bogdan] Univ Med & Farm Timisoara, Dept Biostat & Med Informat, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Oancea, C (corresponding author), Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania.	oancea@umft.ro	Fira-Mladinescu, Ovidiu/C-5736-2011; Crișan, Alexandru/AHE-4031-2022	Fira-Mladinescu, Ovidiu/0000-0002-9034-5218; 				ALEXANDER NB, 1994, J AM GERIATR SOC, V42, P93, DOI 10.1111/j.1532-5415.1994.tb06081.x; [Anonymous], AM J RESP CRI CARE M, V166, P111; ARFKEN CL, 1994, AM J PUBLIC HEALTH, V84, P565, DOI 10.2105/AJPH.84.4.565; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Bean JF, 2002, J GERONTOL A-BIOL, V57, pM751, DOI 10.1093/gerona/57.11.M751; Beauchamp MK, 2010, MULTIDISCIP RESP MED, V5, P417, DOI 10.1186/2049-6958-5-6-417; Beauchamp MK, 2012, CHEST, V141, P1496, DOI 10.1378/chest.11-1708; Berg K, 1996, CLIN GERIATR MED, V12, P705; Biderman A, 2002, J EPIDEMIOL COMMUN H, V56, P631, DOI 10.1136/jech.56.8.631; Bohannon RW, 2006, TOP GERIATR REHABIL, V22, P70; Brown AP, 1999, PHYSIOTHER THEORY PR, V15, P59; Butcher Scott J, 2004, J Cardiopulm Rehabil, V24, P274, DOI 10.1097/00008483-200407000-00013; Casaburi R, 2000, CHEST, V118, P1294, DOI 10.1378/chest.118.5.1294; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Evans RA, 2014, CHEST; Gianjoppe-Santos J., 2013, Fisioter Pesqui, V20, P379, DOI 10.1590/S1809-29502013000400013; Kent BD, 2011, INT J CHRONIC OBSTR, V6, P199, DOI 10.2147/COPD.S10611; Lachman ME, 1998, J GERONTOL B-PSYCHOL, V53, pP43, DOI 10.1093/geronb/53B.1.P43; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Langley FA, 2007, INTERNET J ALLIED HE, V5; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Maltais F, 2000, CLIN CHEST MED, V21, P665, DOI 10.1016/S0272-5231(05)70176-3; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mikkelsen RL, 2004, NORD J PSYCHIAT, V58, P65, DOI 10.1080/08039480310000824; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Oga T, 2007, RESP MED, V101, P146, DOI 10.1016/j.rmed.2006.04.001; Ozge A, 2001, Electromyogr Clin Neurophysiol, V41, P185; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roig M, 2011, RESP MED, V105, P461, DOI 10.1016/j.rmed.2010.08.015; Roig M, 2009, RESP MED, V103, P1257, DOI 10.1016/j.rmed.2009.03.022; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Rubenstein LZ, 2006, MED CLIN N AM, V90, P807, DOI 10.1016/j.mcna.2006.05.013; Smith MD, 2010, GAIT POSTURE, V31, P456, DOI 10.1016/j.gaitpost.2010.01.022; Spruit MA, 2003, THORAX, V58, P752, DOI 10.1136/thorax.58.9.752; STUDENSKI S, 1994, J AM GERIATR SOC, V42, P297, DOI 10.1111/j.1532-5415.1994.tb01755.x; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; Turcu A, 2004, GERONTOLOGY, V50, P303, DOI 10.1159/000079128; Wouters EFM, 2002, THORAX, V57, P1067, DOI 10.1136/thorax.57.12.1067; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289	40	46	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120573	10.1371/journal.pone.0120573	http://dx.doi.org/10.1371/journal.pone.0120573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768731	Green Published, gold			2022-12-27	WOS:000351277500129
J	Kalaiarasan, P; Kumar, B; Chopra, R; Gupta, V; Subbarao, N; Bamezai, RNK				Kalaiarasan, Ponnusamy; Kumar, Bhupender; Chopra, Rupali; Gupta, Vibhor; Subbarao, Naidu; Bamezai, Rameshwar N. K.			In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2	PLOS ONE			English	Article							TUMOR M2-PYRUVATE KINASE; AMINO-ACID SUBSTITUTIONS; MISSENSE MUTATIONS; CANCER; PROTEIN; GROWTH; PKM2; METABOLISM; EXPRESSION; ISOFORM	Role of, 29-non-synonymous, 15-intronic, 3-close to UTR, single nucleotide polymorphisms (SNPs) and 2 mutations of Human Pyruvate Kinase (PK) M2 were investigated by in-silico and in-vitro functional studies. Prediction of deleterious substitutions based on sequence homology and structure based servers, SIFT, PANTHER, SNPs&GO, PhD-SNP, SNAP and PolyPhen, depicted that 19% emerged common between all the mentioned programs. SNPeffect and HOPE showed three substitutions (C31F, Q310P and S437Y) in-silico as deleterious and functionally important. In-vitro activity assays showed C31F and S437Y variants of PKM2 with reduced activity, while Q310P variant was catalytically inactive. The allosteric activation due to binding of fructose 1-6 bisphosphate (FBP) was compromised in case of S437Y nsSNP variant protein. This was corroborated through molecular dynamics (MD) simulation study, which was also carried out in other two variant proteins. The 5 intronic SNPs of PKM2, associated with sporadic breast cancer in a case-control study, when subjected to different computational analyses, indicated that 3 SNPs (rs2856929, rs8192381 and rs8192431) could generate an alternative transcript by influencing splicing factor binding to PKM2. We propose that these, potentially functional and important variations, both within exons and introns, could have a bearing on cancer metabolism, since PKM2 has been implicated in cancer in the recent past.	[Kalaiarasan, Ponnusamy; Chopra, Rupali] Shri Mata Vaishno Devi Univ, Sch Biotechnol, Katra, Jammu & Kashmir, India; [Kumar, Bhupender; Gupta, Vibhor; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Subbarao, Naidu; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Shri Mata Vaishno Devi University; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	bamezai@hotmail.com	Kumar, Bhupender/GLR-8413-2022; Subbarao, Prof Naidu/AAZ-1832-2020	Kumar, Bhupender/0000-0003-3887-5040; Subbarao, Prof Naidu/0000-0002-1720-2165; Bamezai, R.N.K/0000-0002-5128-2859	JK DST	JK DST	P.K thanks J&K DST for providing Senior Research Fellowship.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akhtar K, 2009, J BIOL CHEM, V284, P11971, DOI 10.1074/jbc.M808761200; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Anitha M, 2004, DNA CELL BIOL, V23, P442, DOI 10.1089/1044549041474797; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brunham LR, 2005, PLOS GENET, V1, P739, DOI 10.1371/journal.pgen.0010083; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Gupta V, 2010, J BIOL CHEM, V285, P16864, DOI 10.1074/jbc.M109.065029; Harris I, 2012, CELL RES, V22, P447, DOI 10.1038/cr.2011.203; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Huang CS, 2007, CLIN CHIM ACTA, V384, P69, DOI 10.1016/j.cca.2007.06.001; Hulleman E, 2009, HAEMATOL-HEMATOL J, V94, P1322, DOI 10.3324/haematol.2009.011437; Iqbal MA, 2014, FEBS LETT; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rabbani G, 2014, APPL MICROBIOL BIOT, V98, P2533, DOI 10.1007/s00253-013-5123-3; Schneider J, 2002, ANTICANCER RES, V22, P311; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie JY, 2014, BBA-BIOMEMBRANES, V1838, P994, DOI 10.1016/j.bbamem.2013.12.011; YAMADA K, 1990, J BIOL CHEM, V265, P19885; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang B, 2004, WORLD J GASTROENTERO, V10, P1643, DOI 10.3748/wjg.v10.i11.1643	45	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120469	10.1371/journal.pone.0120469	http://dx.doi.org/10.1371/journal.pone.0120469			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768091	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500126
J	Nishimura, T; Hosoi, H; Saito, O; Miyamae, R; Shimokura, R; Yamanaka, T; Kitahara, T; Levitt, H				Nishimura, Tadashi; Hosoi, Hiroshi; Saito, Osamu; Miyamae, Ryosuke; Shimokura, Ryota; Yamanaka, Toshiaki; Kitahara, Tadashi; Levitt, Harry			Cartilage Conduction Is Characterized by Vibrations of the Cartilaginous Portion of the Ear Canal	PLOS ONE			English	Article							BONE-CONDUCTION; HEARING; SOUND; TRANSMISSION; STIMULATION; THRESHOLDS; HEAD	Cartilage conduction (CC) is a new form of sound transmission which is induced by a transducer being placed on the aural cartilage. Although the conventional forms of sound transmission to the cochlea are classified into air or bone conduction (AC or BC), previous study demonstrates that CC is not classified into AC or BC (Laryngoscope 124: 1214-1219). Next interesting issue is whether CC is a hybrid of AC and BC. Seven volunteers with normal hearing participated in this experiment. The threshold-shifts by water injection in the ear canal were measured. AC, BC, and CC thresholds at 0.5-4 kHz were measured in the 0%-, 40%-, and 80%-water injection conditions. In addition, CC thresholds were also measured for the 20%-, 60%-, 100%-, and overflowing-water injection conditions. The contributions of the vibrations of the cartilaginous portion were evaluated by the threshold-shifts. For AC and BC, the threshold-shifts by the water injection were 22.6-53.3 dB and within 14.9 dB at the frequency of 0.5-4 kHz, respectively. For CC, when the water was filled within the bony portion, the thresholds were elevated to the same degree as AC. When the water was additionally injected to reach the cartilaginous portion, the thresholds at 0.5 and 1 kHz dramatically decreased by 27.4 and 27.5 dB, respectively. In addition, despite blocking AC by the injected water, the CC thresholds in force level were remarkably lower than those for BC. The vibration of the cartilaginous portion contributes to the sound transmission, particularly in the low frequency range. Although the airborne sound is radiated into the ear canal in both BC and CC, the mechanism underlying its generation is different between them. CC generates airborne sound in the canal more efficiently than BC. The current findings suggest that CC is not a hybrid of AC and BC.	[Nishimura, Tadashi; Saito, Osamu; Miyamae, Ryosuke; Shimokura, Ryota; Yamanaka, Toshiaki; Kitahara, Tadashi] Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Kashihara, Nara 634, Japan; [Hosoi, Hiroshi] Nara Med Univ, Kashihara, Nara 634, Japan; [Levitt, Harry] CUNY, New York, NY 10021 USA	Nara Medical University; Nara Medical University; City University of New York (CUNY) System	Nishimura, T (corresponding author), Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Kashihara, Nara 634, Japan.	t-nishim@naramed-u.ac.jp			Health and Labour Science Research Grants for the Sensory and Communicative Disorders from the Ministry of Health, Labour and Welfare, Japan; JSPS KAKENHI [26462564]	Health and Labour Science Research Grants for the Sensory and Communicative Disorders from the Ministry of Health, Labour and Welfare, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This research was supported by a Health and Labour Science Research Grants for the Sensory and Communicative Disorders from the Ministry of Health, Labour and Welfare, Japan. This study was also supported by JSPS KAKENHI Grant Number 26462564. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dillon H., 2001, HEARING AIDS; Donaldson JA, 1980, OTOLARYNGOLOGY, V1, P26; FARRIOR JB, 1983, LARYNGOSCOPE, V93, P75; Hosoi H., 2004, Japanese Patent, Patent No. [4541111, 4541111, 17]; Hosoi H., 2010, ARCH MAT SCI ENG, V42, P104; Ito T, 2011, AUDIOL NEURO-OTOL, V16, P12, DOI 10.1159/000314282; LAU C C, 1986, British Journal of Audiology, V20, P261, DOI 10.3109/03005368609079025; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lightfoot G R, 1979, Br J Audiol, V13, P53, DOI 10.3109/03005367909078877; Morimoto C, 2014, J REHABIL RES DEV, V51, P325, DOI 10.1682/JRRD.2013.05.0128; NILO ER, 1968, J SPEECH HEAR RES, V11, P805, DOI 10.1044/jshr.1104.805; Nishimura T, 2015, AURIS NASUS LARYNX, V42, P15, DOI 10.1016/j.anl.2014.08.001; Nishimura T, 2014, LARYNGOSCOPE, V124, P1214, DOI 10.1002/lary.24485; Nishimura T, 2013, AURIS NASUS LARYNX, V40, P440, DOI 10.1016/j.anl.2012.12.003; Shimokura R, 2015, J SOUND VIB, V335, P261, DOI 10.1016/j.jsv.2014.09.021; Shimokura R, 2014, J ACOUST SOC AM, V135, P1959, DOI 10.1121/1.4868372; Shimokura R, 2013, APPL ACOUST, V74, P1234, DOI 10.1016/j.apacoust.2013.04.013; Shipton M S, 1980, Br J Audiol, V14, P86, DOI 10.3109/03005368009078908; Sohmer H, 2000, HEARING RES, V146, P81, DOI 10.1016/S0378-5955(00)00099-X; Stenfelt S, 2005, OTOL NEUROTOL, V26, P1245, DOI 10.1097/01.mao.0000187236.10842.d5; Stenfelt S, 2003, J ACOUST SOC AM, V113, P902, DOI 10.1121/1.1534606; Watanabe T, 2008, EAR HEARING, V29, P667, DOI 10.1097/AUD.0b013e3181775dde; Williams P, 1980, GRAYS ANATOMY, P1190	23	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120135	10.1371/journal.pone.0120135	http://dx.doi.org/10.1371/journal.pone.0120135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768088	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500110
J	Cuesto, G; Jordan-Alvarez, S; Enriquez-Barreto, L; Ferrus, A; Morales, M; Acebes, A				Cuesto, German; Jordan-Alvarez, Sheila; Enriquez-Barreto, Lilian; Ferrus, Alberto; Morales, Miguel; Acebes, Angel			GSK3 beta Inhibition Promotes Synaptogenesis in Drosophila and Mammalian Neurons	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; MOLECULAR-MECHANISMS; LOCAL INTERNEURONS; BETA-CATENIN; ACTIVATION; PI3K; GSK3; SYNAPSE; GSK-3-BETA; GROWTH	The PI3K-dependent activation of AKT results in the inhibition of GSK3 beta in most signaling pathways. These kinases regulate multiple neuronal processes including the control of synapse number as shown for Drosophila and rodents. Alzheimer disease's patients exhibit high levels of circulating GSK3 beta and, consequently, pharmacological strategies based on GSK3 beta antagonists have been designed. The approach, however, has yielded inconclusive results so far. Here, we carried out a comparative study in Drosophila and rats addressing the role of GSK3 beta in synaptogenesis. In flies, the genetic inhibition of the shaggy-encoded GSK3 beta increases the number of synapses, while its upregulation leads to synapse loss. Likewise, in three weeks cultured rat hippocampal neurons, the pharmacological inhibition of GSK3 beta increases synapse density and Synapsin expression. However, experiments on younger cultures (12 days) yielded an opposite effect, a reduction of synapse density. This unexpected finding seems to unveil an age-and dosage-dependent differential response of mammalian neurons to the stimulation/inhibition of GSK3 beta, a feature that must be considered in the context of human adult neurogenesis and pharmacological treatments for Alzheimer's disease based on GSK3 beta antagonists.	[Cuesto, German; Enriquez-Barreto, Lilian; Morales, Miguel] Ctr Invest Biomed La Rioja, Dept Neurodegenerat Dis, Struct Synapt Plast Lab, La Rioja, Spain; [Jordan-Alvarez, Sheila; Ferrus, Alberto; Acebes, Angel] CSIC, Inst Cajal, Dept Cellular Mol & Dev Neurobiol, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Morales, M (corresponding author), Ctr Invest Biomed La Rioja, Dept Neurodegenerat Dis, Struct Synapt Plast Lab, La Rioja, Spain.	miguelmorales@spineup.es; aacebesv@ull.es	Jordan-Alvarez, Sheila/AAA-8006-2020; Jordán-Álvarez, Sheila/AAP-3219-2021; Morales, Miguel/G-8995-2014; Acebes, Angel/I-2127-2015	Jordán-Álvarez, Sheila/0000-0002-7701-4457; Morales, Miguel/0000-0002-8885-2333; Acebes, Angel/0000-0003-0020-1913; Cuesto Gil, German/0000-0002-8657-0607	Spanish Ministry of Research [BFU2009-12410/BMC, BFU 2010-17537]; Fundacion Reina Sofia [BES-2007-1659]; IMBRAIN Project [FP7-REGPOT-2012-CT2012-316137-IMBRAIN]; Fundacion Ramon Areces	Spanish Ministry of Research(Spanish Government); Fundacion Reina Sofia; IMBRAIN Project; Fundacion Ramon Areces	Spanish Ministry of Research (BFU2009-12410/BMC to AF; BFU 2010-17537 to MM) Fundacion Ramon Areces (AA and MM), Fundacion Reina Sofia (AA, AF and MM), Research Fellowship (grant number (BES-2007-1659)) to SJA and IMBRAIN Project (FP7-REGPOT-2012-CT2012-316137-IMBRAIN) to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; Acebes A, 2012, J NEUROSCI, V32, P417, DOI 10.1523/JNEUROSCI.2921-11.2012; Acebes A, 2011, J NEUROSCI, V31, P2734, DOI 10.1523/JNEUROSCI.5046-10.2011; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; Buttrick GJ, 2008, J CELL BIOL, V180, P537, DOI 10.1083/jcb.200705085; Calabrese B, 2014, NEUROREPORT, V25, P1331, DOI 10.1097/WNR.0000000000000268; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; DaRocha-Souto B, 2012, NEUROBIOL DIS, V45, P425, DOI 10.1016/j.nbd.2011.09.002; DaRocha-Souto B, 2003, J NEUROPATHOL EXP NE, V70, P360; Derossi D, 1998, BIOCHEM BIOPH RES CO, V251, P148, DOI 10.1006/bbrc.1998.9444; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Enriquez-Barreto L, 2014, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00054; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franciscovich AL, 2008, GENETICS, V180, P2057, DOI 10.1534/genetics.107.085555; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; FRANKE TF, 1994, ONCOGENE, V9, P141; Gartner A, 2006, J CELL SCI, V119, P3927, DOI 10.1242/jcs.03159; Gobrecht P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5561; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Hall AC, 2002, MOL CELL NEUROSCI, V20, P257, DOI 10.1006/mcne.2002.1117; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hernandez F, 2009, MINI-REV MED CHEM, V9, P1024, DOI 10.2174/138955709788922647; Ho A, 2001, CANCER RES, V61, P474; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jordan-Alvarez S, 2012, J CELL SCI, V125, P3621, DOI 10.1242/jcs.102806; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kim WY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00044; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Lee SJ, 2006, NEUROSCI LETT, V409, P134, DOI 10.1016/j.neulet.2006.09.026; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mines MA, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00035; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mukai F, 2002, J NEUROCHEM, V81, P1073, DOI 10.1046/j.1471-4159.2002.00918.x; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Sanchez S, 2001, J NEUROCHEM, V78, P468, DOI 10.1046/j.1471-4159.2001.00453.x; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Silver L, 2014, DEV NEUROBIOL, V74, P918, DOI 10.1002/dneu.22174; Smillie Karen Janet, 2011, Int J Alzheimers Dis, V2011, P263673, DOI 10.4061/2011/263673; Sofola O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001087; Twomey C, 2006, FEBS LETT, V580, P4015, DOI 10.1016/j.febslet.2006.06.035; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yoshimura T, 2006, ANN NY ACAD SCI, V1086, P116, DOI 10.1196/annals.1377.013; Zhang BY, 2014, BIOCHEM BIOPH RES CO, V443, P743, DOI 10.1016/j.bbrc.2013.12.037; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	75	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118475	10.1371/journal.pone.0118475	http://dx.doi.org/10.1371/journal.pone.0118475			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764078	Green Published, gold			2022-12-27	WOS:000351276300014
J	Debeb, BG; Smith, DL; Li, L; Larson, R; Xu, W; Woodward, WA				Debeb, Bisrat G.; Smith, Daniel L.; Li, Li; Larson, Richard; Xu, Wei; Woodward, Wendy A.			Differential Effect of Phosphorylation-Defective Survivin on Radiation Response in Estrogen Receptor-Positive and -Negative Breast Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; INITIATING CELLS; DOWN-REGULATION; EXPRESSION; APOPTOSIS; RESISTANCE; RADIORESISTANCE; GENE; RADIOSENSITIVITY; SENSITIZATION	Survivin is a key member of the inhibitor of apoptosis protein family, and is considered a promising therapeutic target due to its universal overexpression in cancers. Survivin is implicated in cellular radiation response through its role in apoptosis, cell division, and DNA damage response. In the present study, analysis of publically available data sets showed that survivin gene expression increased with breast cancer stage (p < 0.00001) and was significantly higher in estrogen receptor-negative cancers as compared to estrogen receptor-positive cancers (p = 9e-46). However, survivin was prognostic in estrogen receptor-positive tumors (p = 0.03) but not in estrogen receptor-negative tumors (p = 0.28). We assessed the effect of a survivin dominant-negative mutant on colony-formation (2D) and mammosphere-formation (3D) efficiency, and radiation response in the estrogen receptor-positive MCF7 and estrogen receptor-negative SUM149 breast cancer cell lines. The colony-formation efficiency was significantly lower in the dominant-negative survivin-transduced cells versus control MCF7 cells (0.42 vs. 0.58, p < 0.01), but it was significantly higher in dominant-negative population versus control-transduced SUM149 cells (0.29 vs. 0.20, p < 0.01). A similar, non-significant, trend in mammosphere-formation efficiency was observed. We compared the radiosensitivity of cells stably expressing dominant-negative survivin with their controls in both cell lines under 2D and 3D culture conditions following exposure to increasing doses of radiation. We found that the dominant-negative populations were radioprotective in MCF7 cells but radiosensitive in SUM149 cells compared to the control-transduced population; further, Taxol was synergistic with the survivin mutant in SUM149 but not MCF7. Our data suggests that survivin modulation influences radiation response differently in estrogen receptor-positive and estrogen receptor-negative breast cancer subtypes, warranting further investigation.	[Debeb, Bisrat G.; Smith, Daniel L.; Li, Li; Larson, Richard; Xu, Wei; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	wwoodward@mdanderson.org	Woodward, Wendy/AAX-6593-2020	Woodward, Wendy/0000-0002-7935-739X; Smith, Daniel/0000-0002-2440-1349	National Institutes of Health [R01CA138239-01]; State of Texas Grant for Rare and Aggressive Breast Cancer Research Program; Susan G. Komen [KG101478, KG111387]; M.D. Anderson Cancer Center; Center for Stem Cell and Developmental Biology; Estate of CW Johnson; NATIONAL CANCER INSTITUTE [R01CA138239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Texas Grant for Rare and Aggressive Breast Cancer Research Program; Susan G. Komen(Susan G. Komen Breast Cancer Foundation); M.D. Anderson Cancer Center; Center for Stem Cell and Developmental Biology; Estate of CW Johnson; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health R01CA138239-01; and The State of Texas Grant for Rare and Aggressive Breast Cancer Research Program. Bisrat G. Debeb and Wei Xu are recipients of Susan G. Komen for the cure (R) Postdoctoral Fellowships, KG101478 and KG111387, respectively. Daniel L. Smith is a recipient of a fellowship from the M.D. Anderson Cancer Center, Center for Stem Cell and Developmental Biology and the Estate of CW Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Asanuma K, 2000, JPN J CANCER RES, V91, P1204, DOI 10.1111/j.1349-7006.2000.tb00906.x; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Capalbo G, 2010, INT J RADIAT ONCOL, V77, P226, DOI 10.1016/j.ijrobp.2009.12.001; Chakravarti A, 2004, ONCOGENE, V23, P7494, DOI 10.1038/sj.onc.1208049; Chen MS, 2007, J CELL SCI, V120, P468, DOI 10.1242/jcs.03348; Chen XJ, 2009, MODERN PATHOL, V22, P699, DOI 10.1038/modpathol.2009.25; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Debeb BG, 2012, STEM CELLS, V30, P2366, DOI 10.1002/stem.1219; Debeb BG, 2010, INT J RADIAT ONCOL, V76, P889, DOI 10.1016/j.ijrobp.2009.09.052; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kami K, 2005, SURGERY, V138, P299, DOI 10.1016/j.surg.2005.05.009; Kennedy SM, 2003, BRIT J CANCER, V88, P1077, DOI 10.1038/sj.bjc.6600776; Lee CW, 2008, CANCER RES, V68, P5273, DOI 10.1158/0008-5472.CAN-07-6673; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Mamounas EP, 2012, J CLIN ONCOL, V30, P3960, DOI 10.1200/JCO.2011.40.8369; Mamounas EP, 2010, J CLIN ONCOL, V28, P1677, DOI 10.1200/JCO.2009.23.7610; Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI12983; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Peng XC, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-46; Pennati M, 2003, J INVEST DERMATOL, V120, P648, DOI 10.1046/j.1523-1747.2003.12082.x; Petrarca CR, 2011, CLIN BREAST CANCER, V11, P129, DOI 10.1016/j.clbc.2011.03.002; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Rodel C, 2003, INT J RADIAT ONCOL, V55, P1341, DOI 10.1016/S0360-3016(02)04618-7; Rodel F, 2011, CURR MED CHEM, V18, P191, DOI 10.2174/092986711794088362; Rodel F, 2008, INT J RADIAT ONCOL, V71, P247, DOI 10.1016/j.ijrobp.2008.02.011; Sah NK, 2006, INT J RADIAT ONCOL, V66, P852, DOI 10.1016/j.ijrobp.2006.06.049; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Span PN, 2004, CLIN CHEM, V50, P1986, DOI 10.1373/clinchem.2004.039149; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Woodward WA, 2010, CANCER-AM CANCER SOC, V116, P2840, DOI 10.1002/cncr.25173; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P87, DOI 10.1016/j.semradonc.2008.11.003; Yamanaka K, 2011, INT J ONCOL, V39, P569, DOI 10.3892/ijo.2011.1077	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120719	10.1371/journal.pone.0120719	http://dx.doi.org/10.1371/journal.pone.0120719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763854	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300047
J	Heiman-Patterson, TD; Blankenhorn, EP; Sher, RB; Jiang, J; Welsh, P; Dixon, MC; Jeffrey, JI; Wong, P; Cox, GA; Alexander, GM				Heiman-Patterson, Terry D.; Blankenhorn, Elizabeth P.; Sher, Roger B.; Jiang, Juliann; Welsh, Priscilla; Dixon, Meredith C.; Jeffrey, Jeremy I.; Wong, Philip; Cox, Gregory A.; Alexander, Guillermo M.			Genetic Background Effects on Disease Onset and Lifespan of the Mutant Dynactin p150(Glued) Mouse Model of Motor Neuron Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SOD1; MUTATIONS; TRANSPORT	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease primarily affecting motor neurons in the central nervous system. Although most cases of ALS are sporadic, about 5-10% of cases are familial (FALS) with approximately 20% of FALS caused by mutations in the Cu/Zn superoxide dismutase (SOD1) gene. We have reported that hSOD1G93A transgenic mice modeling this disease show a more severe phenotype when the transgene is bred on a pure SJL background and a milder phenotype when bred on a pure B6 background and that these phenotype differences link to a region on mouse Chromosome 17. To examine whether other models of motor neuron degeneration are affected by genetic background, we bred the mutant human dynactin p150Glued (G59S-hDCTN1) transgene onto inbred SJL and B6 congenic lines. This model is based on an autosomal dominant lower motor neuron disease in humans linked to a mutation in the p150Glued subunit of the dynactin complex. As seen in hSOD1-G93A mice, we observed a more severe phenotype with earlier disease onset (p<0.001) and decreased survival (p<0.00001) when the G59S-hDCTN1 transgene was bred onto the SJL background and delayed onset (p<0.0001) with increased survival (p<0.00001) when bred onto the B6 background. Furthermore, B6 mice with an SJL derived chromosome 17 interval previously shown to delay disease onset in hSOD1-G93A mice also showed delays onset in G59S-hDCTN1 mice suggesting that at least some genetic modifiers are shared. We have shown that genetic background influences phenotype in G59S-hDCTN1 mice, in part through a region of chromosome 17 similar to the G93-hSOD1 ALS mouse model. These results support the presence of genetic modifiers in both these models some of which may be shared. Identification of these modifiers will highlight intracellular pathways involved in motor neuron disease and provide new therapeutic targets that may be applicable to motor neuron degeneration.	[Heiman-Patterson, Terry D.; Jiang, Juliann; Welsh, Priscilla; Dixon, Meredith C.; Jeffrey, Jeremy I.; Alexander, Guillermo M.] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA; [Blankenhorn, Elizabeth P.] Drexel Univ, Coll Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Cox, Gregory A.] Jackson Lab, Bar Harbor, ME USA; [Wong, Philip] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Sher, Roger B.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA	Drexel University; Drexel University; Jackson Laboratory; Johns Hopkins University; University of Maine System; University of Maine Orono	Heiman-Patterson, TD (corresponding author), Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA.	theiman@drexelmed.edu			ALS Hope Foundation	ALS Hope Foundation	This work was funded by the ALS Hope Foundation. All of the funding was from the ALS Hope Foundation and the foundation played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The ALS Hope Foundation provides funds for ALS related projects in the lab and maintenance of the animal colonies.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Al-Chalabi A, 1998, HUM MOL GENET, V7, P2045, DOI 10.1093/hmg/7.13.2045; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Blankenhorn EP, 2011, ANN NEUROL, V70, P887, DOI 10.1002/ana.22642; Cooper-Knock J, 2012, BRAIN, V135, P751, DOI 10.1093/brain/awr365; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Julien JP, 2006, BBA-MOL BASIS DIS, V1762, P1013, DOI 10.1016/j.bbadis.2006.03.006; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Langefeld CD, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.07.017; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; Ludolph AC, 2012, CURR OPIN NEUROL, V25, P530, DOI 10.1097/WCO.0b013e328356d328; Magrane J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Peviani M, 2010, CNS NEUROL DISORD-DR, V9, P491, DOI 10.2174/187152710791556096; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 2005, ACTA NEUROPATHOL, V110, P48, DOI 10.1007/s00401-005-1021-9; Sher R, 2014, AMYOTROPH LATERAL SC, V10, P1; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Swarup V, 2011, PROG NEURO-PSYCHOPH, V35, P363, DOI 10.1016/j.pnpbp.2010.08.006; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0117848	10.1371/journal.pone.0117848	http://dx.doi.org/10.1371/journal.pone.0117848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763819	Green Submitted, Green Published, gold			2022-12-27	WOS:000351276300010
J	Pino-Barrio, MJ; Garcia-Garcia, E; Menendez, P; Martinez-Serrano, A				Jose Pino-Barrio, Maria; Garcia-Garcia, Elisa; Menendez, Pablo; Martinez-Serrano, Alberto			V-Myc Immortalizes Human Neural Stem Cells in the Absence of Pluripotency-Associated Traits	PLOS ONE			English	Article							SOMATIC-CELLS; IN-VITRO; C-MYC; MOUSE; FIBROBLASTS; GENERATION; LINES; EXPRESSION; CYCLE; GENE	A better understanding of the molecular mechanisms governing stem cell self-renewal will foster the use of different types of stem cells in disease modeling and cell therapy strategies. Immortalization, understood as the capacity for indefinite expansion, is needed for the generation of any cell line. In the case of v-myc immortalized multipotent human Neural Stem Cells (hNSCs), we hypothesized that v-myc immortalization could induce a more dedifferentiated state in v-myc hNSC lines. To test this, we investigated the expression of surface, biochemical and genetic markers of stemness and pluripotency in v-myc immortalized and control hNSCs (primary precursors, that is, neurospheres) and compared these two cell types to human Embryonic Stem Cells (hESCs) and fibroblasts. Using a Hierarchical Clustering method and a Principal Component Analysis (PCA), the v-myc hNSCs associated with their counterparts hNSCs (in the absence of v-myc) and displayed a differential expression pattern when compared to hESCs. Moreover, the expression analysis of pluripotency markers suggested no evidence supporting a reprogramming-like process despite the increment in telomerase expression. In conclusion, v-myc expression in hNSC lines ensures self-renewal through the activation of some genes involved in the maintenance of stem cell properties in multipotent cells but does not alter the expression of key pluripotency-associated genes.	[Jose Pino-Barrio, Maria; Garcia-Garcia, Elisa; Martinez-Serrano, Alberto] Univ Autonoma Madrid, CSIC, Dept Mol Biol, Madrid, Spain; [Jose Pino-Barrio, Maria; Garcia-Garcia, Elisa; Martinez-Serrano, Alberto] Univ Autonoma Madrid, CSIC, Ctr Mol Biol Severo Ochoa CBMSO, Madrid, Spain; [Menendez, Pablo] Univ Barcelona, Fac Med, Josep Carreras Leukemia Res Inst, Barcelona 7, Spain; [Menendez, Pablo] Univ Barcelona, Fac Med, Cell Therapy Program, Barcelona 7, Spain; [Menendez, Pablo] ICREA, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Barcelona; University of Barcelona; ICREA	Martinez-Serrano, A (corresponding author), Univ Autonoma Madrid, CSIC, Dept Mol Biol, Campus UAM Cantoblanco, Madrid, Spain.	amserrano@cbm.csic.uam	Martínez-Serrano, Alberto/J-8146-2014; Bujan, Pablo Menendez/W-3736-2017	Bujan, Pablo Menendez/0000-0001-9372-1007; Martinez Serrano, Alberto/0000-0003-3927-6699	Spanish Ministry of Economy and Competitiveness [PLE2009-0101, SAF2010-17167]; Comunidad Autonoma Madrid [S2011-BMD-2336]; European Union [NMP4-SL-2008-214706]; Instituto Salud Carlos III [RD12/0019/0006, FIS P110/0449]; ERANEt ISCIII-Fondos FEDER [PI12/03112]; Spanish Association of Cancer Research; MINECO [PLE2009-0101]; Fundacion Ramon Areces to the Center of Molecular Biology Severo Ochoa; Instituto de Salud Carlos III [PI12/03112, RD12/0019/0013, RD06/0019/0023]; Ministerio de Economia y Competitividad (MINECO) [SAF2013-43065]; Generalitat de Catalunya [SGR330]; Obra Social La Caixa-Fundacio Josep Carreras; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad Autonoma Madrid(Comunidad de Madrid); European Union(European Commission); Instituto Salud Carlos III(Instituto de Salud Carlos III); ERANEt ISCIII-Fondos FEDER; Spanish Association of Cancer Research; MINECO(Spanish Government); Fundacion Ramon Areces to the Center of Molecular Biology Severo Ochoa; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Obra Social La Caixa-Fundacio Josep Carreras; ICREA(ICREA)	This work was supported by grants from (to AMS): Spanish Ministry of Economy and Competitiveness (PLE2009-0101, SAF2010-17167), Comunidad Autonoma Madrid (S2011-BMD-2336), Instituto Salud Carlos III (RETICS TerCel, RD12/0019/0013) and European Union (Excell, NMP4-SL-2008-214706); (to PM): Instituto Salud Carlos III (RETICS TerCel, RD12/0019/0006; FIS P110/0449), ERANEt ISCIII-Fondos FEDER (PI12/03112) and the Spanish Association of Cancer Research (CIMEN2011). MJPB was funded by MINECO (PLE2009-0101) and Instituto Salud Carlos III (RETICS TerCel, RD06/0019/0023). This work was also supported by an institutional grant from Fundacion Ramon Areces to the Center of Molecular Biology Severo Ochoa. PM lab is supported by: Instituto de Salud Carlos III (ISCIII; E-Rare-2 Call PI12/03112), Ministerio de Economia y Competitividad (MINECO; SAF2013-43065), Generalitat de Catalunya (SGR330) and Obra Social La Caixa-Fundacio Josep Carreras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cacci E, 2007, EXP CELL RES, V313, P588, DOI 10.1016/j.yexcr.2006.11.001; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Garcia-Garcia E, 2012, MOL BIOL CELL, V23, P1167, DOI 10.1091/mbc.E11-06-0524; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Hirasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083769; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Jandial R, 2009, NAT MED, V15, P999, DOI 10.1038/nm0909-999; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim KS, 2011, P NATL ACAD SCI USA, V108, P4876, DOI 10.1073/pnas.1019743108; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Martinez-Serrano A, 1998, CNS REGENERATION BAS, P203; Martinez-Serrano Alberto, 2001, Current Gene Therapy, V1, P279, DOI 10.2174/1566523013348562; Martinez-Serrano A, 2010, FUTUR NEUROL, V5, P161, DOI 10.2217/FNL.10.6; MartinezSerrano A, 1997, TRENDS NEUROSCI, V20, P530, DOI 10.1016/S0166-2236(97)01119-3; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Na J, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt33; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Ramos-Mejia V, 2010, MOL THER, V18, P2173, DOI 10.1038/mt.2010.179; Real PJ, 2012, MOL THER, V20, P1443, DOI 10.1038/mt.2012.49; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2010, DEV GROWTH DIFFER, V52, P319, DOI 10.1111/j.1440-169X.2010.01169.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varlakhanova NV, 2009, CANCER RES, V69, P7487, DOI 10.1158/0008-5472.CAN-08-4832; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Villa A, 2002, BRAIN RES BULL, V57, P789, DOI 10.1016/S0361-9230(01)00776-6; Villa A, 2001, BIOMED PHARMACOTHER, V55, P91, DOI 10.1016/S0753-3322(00)00032-9; Villa A, 2009, EXP CELL RES, V315, P1860, DOI 10.1016/j.yexcr.2009.03.011; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zornig M, 1996, CURR BIOL, V6, P1553, DOI 10.1016/S0960-9822(02)70769-0	43	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118499	10.1371/journal.pone.0118499	http://dx.doi.org/10.1371/journal.pone.0118499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764185	Green Submitted, Green Published, gold			2022-12-27	WOS:000351276300015
J	Li, GW; Thabane, L; Ioannidis, G; Kennedy, C; Papaioannou, A; Adachi, JD				Li, Guowei; Thabane, Lehana; Ioannidis, George; Kennedy, Courtney; Papaioannou, Alexandra; Adachi, Jonathan D.			Comparison between Frailty Index of Deficit Accumulation and Phenotypic Model to Predict Risk of Falls: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton Cohort	PLOS ONE			English	Article							CANADIAN MULTICENTER OSTEOPOROSIS; OLDER-PEOPLE; HEALTH; EPIDEMIOLOGY; FRACTURES; ADULTS; DISABILITY; RATIONALE; MORTALITY; VALIDITY	Objectives To compare the predictive accuracy of the frailty index (FI) of deficit accumulation and the phenotypic frailty (PF) model in predicting risks of future falls, fractures and death in women aged >= 55 years. Methods Based on the data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) 3- year Hamilton cohort (n = 3,985), we compared the predictive accuracy of the FI and PF in risks of falls, fractures and death using three strategies: (1) investigated the relationship with adverse health outcomes by increasing per one-fifth (i.e., 20%) of the FI and PF; (2) trichotomized the FI based on the overlap in the density distribution of the FI by the three groups (robust, pre-frail and frail) which were defined by the PF; (3) categorized the women according to a predicted probability function of falls during the third year of follow-up predicted by the FI. Logistic regression models were used for falls and death, while survival analyses were conducted for fractures. Results The FI and PF agreed with each other at a good level of consensus (correlation coefficients >= 0.56) in all the three strategies. Both the FI and PF approaches predicted adverse health outcomes significantly. The FI quantified the risks of future falls, fractures and death more precisely than the PF. Both the FI and PF discriminated risks of adverse outcomes in multivariable models with acceptable and comparable area under the curve (AUCs) for falls (AUCs >= 0.68) and death (AUCs >= 0.79), and c-indices for fractures (c-indices >= 0.69) respectively. Conclusions The FI is comparable with the PF in predicting risks of adverse health outcomes. These findings may indicate the flexibility in the choice of frailty model for the elderly in the population-based settings.	[Li, Guowei; Thabane, Lehana; Kennedy, Courtney] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Thabane, Lehana; Adachi, Jonathan D.] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada; [Ioannidis, George; Papaioannou, Alexandra; Adachi, Jonathan D.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McGill University; McMaster University; McMaster University	Adachi, JD (corresponding author), McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada.	lig28@mcmaster.ca; jd.adachi@sympatico.ca	Li, Guowei/HCH-8923-2022		Father Sean O'Sullivan Research Award; Warner Chilcott Company, LLC; Sanofi-Aventis; Research Institute of St. Joe's Hamilton; China Scholarship Council	Father Sean O'Sullivan Research Award; Warner Chilcott Company, LLC; Sanofi-Aventis(Sanofi-Aventis); Research Institute of St. Joe's Hamilton; China Scholarship Council(China Scholarship Council)	Financial support for the GLOW study was provided by Warner Chilcott Company, LLC and Sanofi-Aventis to the Center for Outcomes Research, University of Massachusetts Medical School. This work was supported in part by a Father Sean O'Sullivan Research Award, the Research Institute of St. Joe's Hamilton [GL]; and the China Scholarship Council [GL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Aama T, 2011, CAN FAM PHYSICIAN, V57, P771; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Cesari M, 2014, AGE AGEING, V43, P10, DOI 10.1093/ageing/aft160; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Dent E, 2013, AGE AGEING, DOI [10.1093/ageing/aft059, DOI 10.1093/AGEING/AFT059]; Diez-Perez A, 2013, J BONE MINER RES; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Forti P, 2012, ARCH GERONTOL GERIAT, V54, P16, DOI 10.1016/j.archger.2011.01.007; FRAX&REG;, WHO FRACT RISK ASS T; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gobbens RJ, 2010, NURS OUTLOOK, V58, P76, DOI 10.1016/j.outlook.2009.09.005; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gregson CL, 2014, OSTEOPOROSIS INT, V25, P85, DOI 10.1007/s00198-013-2438-y; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hooven FH, 2009, OSTEOPOROSIS INT, V20, P1107, DOI 10.1007/s00198-009-0958-2; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Hundrup YA, 2004, SCAND J PUBLIC HEALT, V32, P136, DOI 10.1080/14034940310017490; Jung HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087958; Karlsson MK, 2013, SCAND J PUBLIC HLTH; Kreiger N, 1999, CAN J AGING, V18, P376, DOI 10.1017/S0714980800009934; Kulminski AM, 2008, J AM GERIATR SOC, V56, P898, DOI 10.1111/j.1532-5415.2008.01656.x; Li GW, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-185; Malmstrom TK, 2014, J AM GERIATR SOC, V62, P721, DOI 10.1111/jgs.12735; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Papaioannou A, 2005, OSTEOPOROSIS INT, V16, P568, DOI 10.1007/s00198-004-1735-x; Peel NM, 2011, CAN J AGING, V30, P7, DOI 10.1017/S071498081000070X; Rahman A, 2005, AM J EPIDEMIOL, V162, P491, DOI 10.1093/aje/kwi215; Ravindrarajah R, 2013, ARCH GERONTOL GERIAT, V57, P360, DOI 10.1016/j.archger.2013.06.010; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J AM MED DIR ASSOC, V8, P595, DOI 10.1016/j.jamda.2007.07.012; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Siminoski K, 2005, CAN ASSOC RADIOL J, V56, P178; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Tom SE, 2013, J AM GERIATR SOC, V61, P327, DOI 10.1111/jgs.12146; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; Whitson HE, 2007, J GERONTOL A-BIOL, V62, P728, DOI 10.1093/gerona/62.7.728; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x	48	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120144	10.1371/journal.pone.0120144	http://dx.doi.org/10.1371/journal.pone.0120144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764521	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300035
J	Zhou, T; Chen, BM; Liu, G; Huang, FF; Liu, JG; Liao, WB; Wang, YY; Ren, SJ; Chen, CQ; Peng, SL				Zhou, Ting; Chen, Bao-Ming; Liu, Gang; Huang, Fang-Fang; Liu, Jin-Gang; Liao, Wen-Bo; Wang, Ying-Yong; Ren, Si-Jie; Chen, Chun-Quan; Peng, Shao-Lin			Biodiversity of Jinggangshan Mountain: The Importance of Topography and Geographical Location in Supporting Higher Biodiversity	PLOS ONE			English	Article							BUTTERFLY SPECIES RICHNESS; ALTITUDINAL GRADIENT; REGIONAL-SCALE; DIVERSITY; CLIMATE; PATTERNS; DETERMINANTS; PROVINCE; FORESTS	Diversity is mainly determined by climate and environment. In addition, topography is a complex factor, and the relationship between topography and biodiversity is still poorly understood. To understand the role of topography, i.e., altitude and slope, in biodiversity, we selected Jinggangshan Mountain (JGM), an area with unique topography, as the study area. We surveyed plant and animal species richness of JGM and compared the biodiversity and the main geographic characteristics of JGM with the adjacent 4 mountains. Gleason's richness index was calculated to assess the diversity of species. In total, 2958 spermatophyte species, 418 bryophyte species, 355 pteridophyte species and 493 species of vertebrate animals were recorded in this survey. In general, the JGM biodiversity was higher than that of the adjacent mountains. Regarding topographic characteristics, 77% of JGM's area was in the mid-altitude region and approximately 40% of JGM's area was in the 10 degrees-20 degrees slope range, which may support more vegetation types in JGM area and make it a biodiversity hotspot. It should be noted that although the impact of topography on biodiversity was substantial, climate is still a more general factor driving the formation and maintenance of higher biodiversity. Topographic conditions can create microclimates, and both climatic and topographic conditions contribute to the formation of high biodiversity in JGM.	[Zhou, Ting; Chen, Bao-Ming; Liu, Gang; Huang, Fang-Fang; Liu, Jin-Gang; Liao, Wen-Bo; Wang, Ying-Yong; Ren, Si-Jie; Peng, Shao-Lin] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 51027, Guangdong, Peoples R China; [Zhou, Ting; Chen, Bao-Ming; Liu, Gang; Huang, Fang-Fang; Liu, Jin-Gang; Liao, Wen-Bo; Wang, Ying-Yong; Ren, Si-Jie; Peng, Shao-Lin] Sun Yat Sen Univ, Guangdong Key Lab Plant Resources, Sch Life Sci, Guangzhou 51027, Guangdong, Peoples R China; [Chen, Chun-Quan] Adm Bur Jinggangshan, Jian 343600, Jiangxi, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Peng, SL (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 51027, Guangdong, Peoples R China.	lsspsl@mail.sysu.edu.cn	Chen, Bao-Ming/H-9024-2016	Chen, Bao-Ming/0000-0003-1891-8752	National Natural Science Foundation of China [31300401]; study of Ecological Process and World Heritage application of Jinggangshan Mount [71020047]; Mount Jinggangshan region, China [71020993, 2013FY111500]; Guangdong Natural Science Foundation [S2012040007896]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); study of Ecological Process and World Heritage application of Jinggangshan Mount; Mount Jinggangshan region, China; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (31300401), the study of Ecological Process and World Heritage application of Jinggangshan Mount (71020047), a comprehensive scientific survey of the biodiversity from Mount Jinggangshan region, China (71020993, 2013FY111500), Guangdong Natural Science Foundation (S2012040007896), the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RB, 1991, J BIOGEOGR, V18, P123, DOI 10.2307/2845287; [Anonymous], 2005, FLORA CHINA; BEALS EW, 1969, SCIENCE, V165, P981, DOI 10.1126/science.165.3897.981; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Borges PAV, 2001, ECOGRAPHY, V24, P68, DOI 10.1034/j.1600-0587.2001.240109.x; Burke IC, 1999, ECOSYSTEMS, V2, P422, DOI 10.1007/s100219900091; Chang H, 2003, STUDIES BIODIVERSITY, P418; [陈宝明 Chen Baoming], 2012, [生态学报, Acta Ecologica Sinica], V32, P6326; [陈功锡 Chen Gongxi], 2004, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V24, P865; Cheng S, 2011, AVIAN RESOURCE WUYIS, P239; Coblentz DD, 2004, J BIOGEOGR, V31, P1125, DOI 10.1111/j.1365-2699.2004.00981.x; Conord C, 2012, ECOL EVOL, V2, P2595, DOI 10.1002/ece3.350; Costanza JK, 2011, LANDSCAPE ECOL, V26, P851, DOI 10.1007/s10980-011-9613-3; Cui BS, 2009, CAN J PLANT SCI, V89, P209, DOI 10.4141/CJPS08013; Curran M, 2012, J TROP ECOL, V28, P243, DOI 10.1017/S0266467412000193; Danz NP, 2011, ECOGRAPHY, V34, P402, DOI 10.1111/j.1600-0587.2010.06561.x; Duan S, 2004, J JINAGGANGSHAN NORM, V25, P12; Editorial Board of Physical Science, 1985, PHYS GEOGR CHIN BOT, P104; Fei Liang, 2012, P1; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; GOSZ JR, 1993, ECOL APPL, V3, P369, DOI 10.2307/1941905; Grytnesn J, 2007, ENCY BIODIVERSITY; Gu J, 2005, RESOURCE TRAGOPAN TE, P15; Illan JG, 2010, J BIOGEOGR, V37, P1706, DOI 10.1111/j.1365-2699.2010.02314.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Huang Zu-hao, 2007, Sichuan Journal of Zoology, V26, P368; Itoh A, 2003, ECOL RES, V18, P307, DOI 10.1046/j.1440-1703.2003.00556.x; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT CR; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jimenez-Valverde A, 2007, ECOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-2311.2006.00848.x; Kerr JT, 2001, P NATL ACAD SCI USA, V98, P11365, DOI 10.1073/pnas.201398398; Kong Ling-Jie, 2012, Plant Science Journal, V30, P584, DOI 10.3724/SP.J.1142.2012.60584; Korner C., 2002, MOUNTAIN BIODIVERSIT; Leuschner C, 2007, BASIC APPL ECOL, V8, P219, DOI 10.1016/j.baae.2006.02.004; Li Z, 2003, STUDY BIODIVERSITY N, P163; Li Z., 2001, SUBTROPICAL PLANT SC, V30, P28; Li ZuoZhou, 2005, Journal of Wuhan Botanical Research, V23, P592; Liang Q., 2003, STUDY BIODIVERSITY N, P402; Liao B, 2009, SHANDONG FORESTRY SC, V185, P8; Lieberman D, 1996, J ECOL, V84, P137, DOI 10.2307/2261350; Liu X, 2005, SCI INVESTIGATION RE, P150; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Luoto M, 2006, J BIOGEOGR, V33, P1764, DOI 10.1111/j.1365-2699.2005.01395.x; MacRinnon J, 2000, FIELD GUIDE BIRDS CH, P571; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Miao R, 2003, STUDY BIODIVERSITY N, P176; Ouyang Shan, 2012, Chinese Journal of Zoology, V47, P59; Parviainen M, 2008, J BIOGEOGR, V35, P1888, DOI 10.1111/j.1365-2699.2008.01922.x; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Peng S, 2011, STUDY BIODIVERSITY M; Peng S.L., 2008, STUDY BIODIVERSITY M; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P111, DOI 10.1111/j.1466-8238.2008.00415.x; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Shen You-Hui, 2008, Acta Zoologica Sinica, V54, P645; Smith AT, 2009, FIELD GUIDE MAMMALS, P1; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Wang Lei, 2013, Shengwu Duoyangxing, V21, P163, DOI 10.3724/SP.J.1003.2013.07210; Wang S, 2004, CHINA SPECIES RED LI, VI; Wang Y, 2013, ASIAN HERPETOL RES, P4; Wang YY, 2012, ZOOTAXA, P53; Wang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093075; Webb EL, 1999, J BIOGEOGR, V26, P887, DOI 10.1046/j.1365-2699.1999.00326.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Wu S, 2002, B BOT RES, V22, P284; Wu Z Y, 1979, ACTA BOT YUNNANICA, V1, P1; Xu Zhongxian, 2013, Sichuan Journal of Zoology, V32, P263; Yamaura Y, 2011, OIKOS, V120, P427, DOI 10.1111/j.1600-0706.2010.18764.x; Yang Jian-Huan, 2013, Chinese Journal of Zoology, V48, P129; Yang Li-Jun, 2014, Huanjing Kunchong Xuebao, V36, P679; Yang W, 2010, EEO COMPENSATION BIO, P7; [叶张煌 Ye Zhanghuang], 2013, [山地学报, Journal of Mountain Science], V31, P250; Yu YF, 1999, PLANTS, V151, P3; Yuan X, 2003, STUDY BIODIVERSITY N, P445; Zhang ZH, 2013, J MT SCI-ENGL, V10, P95, DOI 10.1007/s11629-013-2429-7; Zhao J, 2012, SICHUAN J ZOOLOGY, V31, P447; Zheng C, 2003, J FUJIAN FORESTRY SC, V30, P54; Zong Y, 1983, J AMPHIBIANS REPTILE, V2, P61; Zuo C. X., 2008, ENTOMOLOGICAL J E CH, V17, P220	86	4	7	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120208	10.1371/journal.pone.0120208	http://dx.doi.org/10.1371/journal.pone.0120208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763820	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300037
J	Derraik, JGB; Rowe, DL; Cutfield, WS; Hofman, PL				Derraik, Jose G. B.; Rowe, Deborah L.; Cutfield, Wayne S.; Hofman, Paul L.			Decreasing Birth Weight Is Associated with Adverse Metabolic Profile and Lower Stature in Childhood and Adolescence	PLOS ONE			English	Article							INSULIN-RESISTANCE; BLOOD-PRESSURE; BORN SMALL; ADULT HYPERTENSION; GESTATIONAL-AGE; PRETERM BIRTH; GROWTH; SENSITIVITY; STANDARDS; CHILDREN	Objective We aimed to evaluate the association of birth weight SDS with insulin resistance, blood pressure, and auxology in children and adolescents born 23-42 weeks of gestation. Methods We studied 143 singleton children and adolescents aged 9.3 +/- 3.3 years (range 2.0-17.9 years). Clinical assessments included insulin resistance measured by HOMA2-IR, auxology, and blood pressure from sphygmomanometer measurements. Continuous associations were examined, and stratified analyses carried out. For the latter, participants were divided into those of below-average birth weight (BABW, <0 SDS) and above-average birth weight (AABW, >= 0 SDS). Results Irrespective of gestational age, lower birth weight SDS was associated with progressively greater HOMA2-IR (p<0.0001) and higher fasting insulin concentrations (p<0.0001). Decreasing birth weight SDS was associated with higher systolic (p = 0.011) and diastolic (p = 0.006) blood pressure. Lower birth weight SDS was also associated with decreasing stature (p<0.010). The BABW group was similar to 40% more insulin resistant than AABW participants (p = 0.004), with the former also displaying fasting insulin concentrations 37% higher (p = 0.004). BABW participants were 0.54 SDS shorter than those of higher birth weight (p = 0.002). On average, BABW participants had not met their genetic potential, tending to be shorter than their parents (p = 0.065). As a result, when corrected for parents' heights, BABW participants were 0.62 SDS shorter than those born of higher birth weight (p = 0.001). Sub-group analyses on participants born appropriate-for-gestational-age (n = 128) showed that associations of birth weight SDS with both insulin resistance and stature remained (although attenuated). Conclusion Decreasing birth weight SDS (even within the normal range) is associated with adverse metabolic profile and lower stature in children and adolescents.	[Derraik, Jose G. B.; Rowe, Deborah L.; Cutfield, Wayne S.; Hofman, Paul L.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Rowe, Deborah L.] Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand	University of Auckland; University of Auckland	Hofman, PL (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	p.hofman@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956	Novo Nordisk	Novo Nordisk(Novo Nordisk)	This study was supported by an unrestricted grant from Novo Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D. J. P., 1994, MOTHERS BABIES DIS L; Chiavaroli V, 2009, PEDIATRICS, V124, P695, DOI 10.1542/peds.2008-3056; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Doyle LW, 2004, ARCH DIS CHILD, V89, P347, DOI 10.1136/adc.2002.025924; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; ELLIMAN A, 1992, ACTA PAEDIATR, V81, P311, DOI 10.1111/j.1651-2227.1992.tb12232.x; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Law CM, 1996, J HYPERTENS, V14, P935; Loomba-Albrecht LA, 2009, CURR OPIN ENDOCRINOL, V16, P10, DOI 10.1097/MED.0b013e328320d54c; Mathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081840; Mathai S, 2012, DIABETES, V61, P2479, DOI 10.2337/db11-1672; Moore VM, 1999, J HYPERTENS, V17, P883, DOI 10.1097/00004872-199917070-00003; Moran A, 2002, J CLIN ENDOCR METAB, V87, P4817, DOI 10.1210/jc.2002-020517; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Pandolfi C, 2008, METABOLISM, V57, P999, DOI 10.1016/j.metabol.2008.02.018; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Rowe DL, 2011, CLIN ENDOCRINOL, V75, P661, DOI 10.1111/j.1365-2265.2011.04116.x; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; TANNER JM, 1975, ARCH DIS CHILD, V50, P14, DOI 10.1136/adc.50.1.14; Tinnion R, 2014, ARCH DIS CHILD, V99, P362, DOI 10.1136/archdischild-2013-304615; WHINCUP P, 1995, BRIT MED J, V311, P773, DOI 10.1136/bmj.311.7008.773	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119433	10.1371/journal.pone.0119433	http://dx.doi.org/10.1371/journal.pone.0119433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760717	Green Published, gold			2022-12-27	WOS:000351275000056
J	Scherdel, P; Botton, J; Rolland-Cachera, MF; Leger, J; Pele, F; Ancel, PY; Simon, C; Castetbon, K; Salanave, B; Thibault, H; Lioret, S; Peneau, S; Gusto, G; Charles, MA; Heude, B				Scherdel, Pauline; Botton, Jeremie; Rolland-Cachera, Marie-Francoise; Leger, Juliane; Pele, Fabienne; Ancel, Pierre Yves; Simon, Chantal; Castetbon, Katia; Salanave, Benoit; Thibault, Helene; Lioret, Sandrine; Peneau, Sandrine; Gusto, Gaelle; Charles, Marie-Aline; Heude, Barbara			Should the WHO Growth Charts Be Used in France?	PLOS ONE			English	Article							CHILDHOOD OBESITY; FRENCH CHILDREN; PREVALENCE; OVERWEIGHT; WEIGHT; NUTRITION; STANDARDS; TRENDS; ASSOCIATION; DEFINITION	Background Growth charts are an essential clinical tool for evaluating a child's health and development. The current French reference curves, published in 1979, have recently been challenged by the 2006 World Health Organization (WHO) growth charts. Objective To evaluate and compare the growth of French children who were born between 1981 and 2007, with the WHO growth charts and the French reference curves currently used. Design Anthropometric measurements from French children, who participated in 12 studies, were analyzed: 82,151 measurements were available for 27,257 children in different age groups, from birth to 18 years. We calculated and graphically compared mean z-scores based on the WHO and French curves, for height, weight and Body Mass Index (BMI) according to age and sex. The prevalence of overweight using the WHO, the French and International Obesity Task Force definitions were compared. Results Our population of children was on average 0.5 standard deviations taller than the French reference population, from the first month of life until puberty age. Mean z-scores for height, weight and BMI were closer to zero based on the WHO growth charts than on the French references from infancy until late adolescence, except during the first six months. These differences not related to breastfeeding rates. As expected, the prevalence of overweight depended on the reference used, and differences varied according to age. Conclusion The WHO growth charts may be appropriate for monitoring growth of French children, as the growth patterns in our large population of French children were closer to the WHO growth charts than to the French reference curves, from 6 months onwards. However, there were some limitations in the use of these WHO growth charts, and further investigation is needed.	[Scherdel, Pauline; Botton, Jeremie; Lioret, Sandrine; Charles, Marie-Aline; Heude, Barbara] Paris Descartes Univ, INSERM, Early Determinants Childs Hlth & Dev Team ORCHAD, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Paris, France; [Botton, Jeremie] Univ Paris 11, Fac Pharm, Lab Biomath, F-92290 Chatenay Malabry, France; [Rolland-Cachera, Marie-Francoise] Univ Paris 13, INSERM, Nutr Epidemiol Res Team EREN, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Paris, France; [Rolland-Cachera, Marie-Francoise; Peneau, Sandrine] Univ Paris 07, Univ Paris 05, INRA, Cnam, Paris, France; [Leger, Juliane] Univ Paris Diderot, Hop Robert Debre, AP HP, Sorbonne Paris Cite,Serv Endocrinol Diabetol Pedi, Paris, France; [Leger, Juliane] INSERM, Ctr Reference Malad Endocriniennes Rares Croissan, UMR 676, Paris, France; [Pele, Fabienne] Univ Rennes 1, Fac Med, Ctr Hosp Univ Rennes, Inserm IRSET,Serv Epidemiol & Sante Publ,UMR 1085, Rennes, France; [Ancel, Pierre Yves] Paris Descartes Univ, INSERM, Obstetr Perinatal & Pediat Epidemiol Res Team EPO, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Paris, France; [Simon, Chantal] Univ Lyon 1, CRNH Rhone Alpes, INRA U1235, Carmen,Inserm U1060, F-69365 Lyon, France; [Castetbon, Katia; Salanave, Benoit] Inst Veille Sanitaire InVS, Dept Malad Chron & Traumatismes, USEN, F-94415 St Maurice, France; [Castetbon, Katia; Salanave, Benoit] Univ Paris 13, Sorbonne Paris Cite, Ctr Rech Epidemiol & Biostat, Bobigny, France; [Thibault, Helene] Univ Bordeaux, ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Thibault, Helene] ISPED, Ctr Inserm Epidemiol Biostat U897, Bordeaux, France; [Lioret, Sandrine] French Agcy Food Environm & Occupat Hlth Safety, ANSES, Ex AFSSA, Dietary Survey Unit, Maisons Alfort, France; [Gusto, Gaelle] IRSA, Dept Synergies, F-37521 La Riche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institute of Public Health Surveillance; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Scherdel, P (corresponding author), Paris Descartes Univ, INSERM, Early Determinants Childs Hlth & Dev Team ORCHAD, Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, Paris, France.	pauline.scherdel@inserm.fr	Marie-Françoise, Rolland-Cachera/F-3044-2017; Benoit, Salanave/F-3062-2017; LIORET, Sandrine/G-5568-2017; , simon/B-2895-2011; Carmen, Team1/Y-7382-2019; Botton, Jérémie/I-1584-2019; Peneau, Sandrine/F-2701-2017; Charles, Marie Aline/F-8567-2017; Charles, Marie Aline/S-1866-2019; Castetbon, Katia/F-2686-2017; thibault, helene/U-1517-2019; Heude, Barbara/GLU-9626-2022; Heude, Barbara/G-3095-2016	Marie-Françoise, Rolland-Cachera/0000-0002-0245-1687; Benoit, Salanave/0000-0002-4573-3166; LIORET, Sandrine/0000-0002-2483-7820; , simon/0000-0002-7820-3233; Carmen, Team1/0000-0003-4234-1746; Botton, Jérémie/0000-0002-4814-6370; Peneau, Sandrine/0000-0002-3463-0989; Charles, Marie Aline/0000-0003-4025-4390; Charles, Marie Aline/0000-0003-4025-4390; Heude, Barbara/0000-0002-1565-1629; Heude, Barbara/0000-0002-1565-1629; ANCEL, pierre-yves/0000-0001-9632-7494; Lab, Carmen/0000-0002-5935-3236; CASTETBON, Katia/0000-0002-1207-6729; Scherdel, Pauline/0000-0003-4517-9430	Ministry of Health (Direction Generale de la Sante)	Ministry of Health (Direction Generale de la Sante)	The funding source for this study: Ministry of Health (Direction Generale de la Sante) and all the funding sources for the different cohorts and surveys (EDEN, FLVS, ELFE, PELAGIE, EPIPAGE, ELANCE, ICAPS, ENNS, INVS/DGESCO, IRSA, PNNS en Aquitaine and INCA2 study; if required details can be provided in supplementary material). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad UN, 2013, J PAEDIAT CHILD HLTH; [Anonymous], 1993, NONPARAMETRIC REGRES; Binns C, 2007, LANCET, V370, P1542, DOI 10.1016/S0140-6736(07)61657-2; Bois C, 2010, ARCH PEDIATRIE, V17, P1035, DOI 10.1016/j.arcped.2010.03.017; Bonthuis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042506; CASTETBON K, 2008, OBESITE, V3, P19; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Deheeger M, 2002, J HUM NUTR DIET, V15, P429, DOI 10.1046/j.1365-277X.2002.00396.x; Diouf I, 2011, PAEDIATR PERINAT EP, V25, P210, DOI 10.1111/j.1365-3016.2010.01188.x; Diouf I, 2010, EPIDEMIOLOGY, V21, P360, DOI 10.1097/EDE.0b013e3181d5bff5; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; Heude B, 2006, EUR J CLIN NUTR, V60, P1430, DOI 10.1038/sj.ejcn.1602474; Heude B, 2003, DIABETES METAB, V29, P235, DOI 10.1016/S1262-3636(07)70032-0; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Lioret S, 2010, BRIT J NUTR, V103, P585, DOI 10.1017/S0007114509992078; Maillard G, 2000, INT J OBESITY, V24, P1608, DOI 10.1038/sj.ijo.0801446; Monasta L, 2011, OBES REV, V12, P295, DOI 10.1111/j.1467-789X.2010.00748.x; Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Pele F, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-102; Peneau S, 2009, INT J OBESITY, V33, P401, DOI 10.1038/ijo.2009.31; Pierrat V, 2011, ARCH DIS CHILD-FETAL, V96, pF348, DOI 10.1136/adc.2010.185470; Regnault N, 2010, AM J CLIN NUTR, V92, P594, DOI 10.3945/ajcn.2010.29292; Rodd C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-32; Roelants M, 2010, ANN HUM BIOL, V37, P2, DOI 10.3109/03014460903458080; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Rolland-Cachera MF, 2013, INT J OBESITY, V37, P1116, DOI 10.1038/ijo.2012.185; Rolland-Cachera MF, 2012, PEDIATR OBES, V7, P259, DOI 10.1111/j.2047-6310.2012.00077.x; Rolland-Cachera MF, 2011, INT J PEDIATR OBES, V6, P325, DOI 10.3109/17477166.2011.607458; Rolland-Cachera MF, 2011, AM J CLIN NUTR, V94, p1794S, DOI 10.3945/ajcn.110.000703; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Salanave B, 2009, INT J PEDIATR OBES, V4, P66, DOI 10.1080/17477160902811207; Scherdel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070871; Sempe M, 1979, AUXOLOGIE METHODE SE, P1; Simon C, 2006, DIABETES METAB, V32, P41, DOI 10.1016/S1262-3636(07)70245-8; Thibault H, 2010, ARCH PEDIATRIE, V17, P466, DOI 10.1016/j.arcped.2010.02.003; Turck D, 2013, J PEDIATR GASTR NUTR, V57, P258, DOI 10.1097/MPG.0b013e318298003f; Vandentorren S, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-58; Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854	42	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120806	10.1371/journal.pone.0120806	http://dx.doi.org/10.1371/journal.pone.0120806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761138	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000072
J	Zhang, GX; Xiong, N; Zhang, ZT; Liu, L; Huang, JS; Yang, JL; Wu, J; Lin, ZC; Wang, T				Zhang, Guoxin; Xiong, Nian; Zhang, Zhentao; Liu, Ling; Huang, Jinsha; Yang, Jiaolong; Wu, Jing; Lin, Zhicheng; Wang, Tao			Effectiveness of Traditional Chinese Medicine as an Adjunct Therapy for Parkinson's Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TAI-CHI; DAYTIME SLEEPINESS; GAIT INITIATION; PREVALENCE; DIAGNOSIS; DEMENTIA; SHANGHAI; BALANCE; XIAN	Background Idiopathic Parkinson disease (PD) is a common neurodegenerative disease that seriously hinders limb activities and affects patients' lives. We performed a meta-analysis aiming to systematically review and quantitatively synthesize the efficacy and safety of traditional Chinese medicine (TCM) as an adjunct therapy for clinical PD patients. Methods An electronic search was conducted in PubMed, Cochrane Controlled Trials Register, China National Knowledge Infrastructure, Chinese Scientific Journals Database and Wanfang data to identify randomized trials evaluating TCM adjuvant therapy versus conventional treatment. The change from baseline of the Unified Parkinson's Disease Rating Scale score (UPDRS) was used to estimate the effectiveness of the therapies. Results Twenty-seven articles involving 2314 patients from 1999 to 2013 were included. Potentially marked improvements were shown in UPDRS I (SMD 0.68, 95%CI 0.38, 0.98), II (WMD 2.41, 95%CI 1.66, 2.62), III (WMD 2.45, 95%CI 2.03, 2.86), IV (WMD 0.32, 95%CI 0.15, 049) and I-IV total scores (WMD 6.18, 95%CI 5.06, 7.31) in patients with TCM plus dopamine replacement therapy (DRT) compared to DRT alone. Acupuncture add-on therapy was markedly beneficial for improving the UPDRS I-IV total score of PD patients (WMD 10.96, 95%CI 5.85, 16.07). However, TCM monotherapy did not improve the score. The effectiveness seemed to be more obvious in PD patients with longer adjunct durations. TCM adjuvant therapy was generally safe and well tolerated. Conclusions Although the data were limited by methodological flaws in many studies, the evidence indicates the potential superiority of TCM as an alternative therapeutic for PD treatment and justifies further high-quality studies.	[Zhang, Guoxin; Xiong, Nian; Liu, Ling; Huang, Jinsha; Yang, Jiaolong; Wang, Tao] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Zhentao] Wuhan Univ, Renmin Hosp, Dept Neurol, Wuhan 430072, Hubei, Peoples R China; [Wu, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China; [Wu, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Lin, Zhicheng] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat,Div Alcohol & Drug Abuse, Belmont, MA USA; [Lin, Zhicheng] Mailman Neurosci Res Ctr, Belmont, MA USA; [Lin, Zhicheng] Harvard Neuro Discovery Ctr, Boston, MA USA	Huazhong University of Science & Technology; Wuhan University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; McLean Hospital	Wang, T (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430074, Hubei, Peoples R China.	wangtaowh@hust.edu.cn	Northcote, Matthew/B-8209-2019; Northcote, Matthew/L-1135-2019	Zhang, Zhentao/0000-0001-6708-1472	National Natural Science Foundation of China [30870866, 81071021, 31171211, 81301082, 81100958, 81200983]; China Medical Foundation [2012B09]; Hubei Molecular Imaging Key Laboratory [0203201343]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Medical Foundation(China Medical University); Hubei Molecular Imaging Key Laboratory	This work was supported by grants 30870866, 81071021 and 31171211 from the National Natural Science Foundation of China (to TW), grant 81200983 from the National Natural Science Foundation of China (to NX), grant 81100958 from the National Natural Science Foundation of China (to ZTZ), grant 81301082 from the National Natural Science Foundation of China (to JSH), grant 2012B09 from China Medical Foundation (to NX) and grant 0203201343 from Hubei Molecular Imaging Key Laboratory (to NX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2013, PARKINSONISM RELAT D, V19, P955, DOI 10.1016/j.parkreldis.2013.06.007; Cao Xue-Bing, 2006, Neurosci Bull, V22, P159; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Comella CL, 2002, JAMA-J AM MED ASSOC, V287, P509, DOI 10.1001/jama.287.4.509; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fan Y. P., 2010, TIANJIN J TRADITIONA, V27, P190; Hackney ME, 2008, GAIT POSTURE, V28, P456, DOI 10.1016/j.gaitpost.2008.02.005; Hass CJ, 2004, ARCH PHYS MED REHAB, V85, P1593, DOI 10.1016/j.apmr.2004.01.020; Hobson DE, 2002, JAMA-J AM MED ASSOC, V287, P455, DOI 10.1001/jama.287.4.455; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jiang SY, 2009, J LIAONING U TRADITI, V11, P118; Kim TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035695; Kum WF, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep116; Lam YC, 2008, J ALTERN COMPLEM MED, V14, P662, DOI 10.1089/acm.2007.0011; Li WT, 2012, SHAANXI J TRADITIONA, V33, P549; Lian XF, 2008, J NEW CHINESE MED, V40, P37; Lian Xin-Fu, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P796; Liang JF, 2008, LIAONING J TRADITION, V35, P82; Lohe M, 2010, J NEUROL SCI, V289, P104, DOI 10.1016/j.jns.2009.08.025; Luo XD, 2005, J LIAONING U TCM, V9, P93; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Pan WD, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/789506; Pohjasvaara T, 2000, STROKE, V31, P2952, DOI 10.1161/01.STR.31.12.2952; Shen W, 2006, SHANGHAI J TRADITION, V40, P21; Shen Y, 2008, J ZHEJIANG U TRADITI, V32, P197; [王文同 Wang Wentong], 2004, [中医杂志, Journal of Traditional Chinese Medicine], V45, P274; Wang Y, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/534861; Wang YX, 2013, CLIN J TRADITIONAL C, V25, P758; Wu G, 2002, J AM GERIATR SOC, V50, P746, DOI 10.1046/j.1532-5415.2002.50173.x; Yang DH., 2006, CHIN J CHIN REHABIL, V10, P14, DOI [10.3321/j.issn:1673-8225.2006.19.004, DOI 10.3321/J.ISSN:1673-8225.2006.19.004]; Yang Ming-hui, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P231, DOI 10.3736/jcim20100306; Yuan CX, 2010, SHANGHAI J TRADITION, V44, P3; Yuan H, 2010, NEUROSCI BULL, V26, P66, DOI 10.1007/s12264-010-0302-z; Zhang H, 2008, ACTA CHINESE MED PHA, V36, P34; Zhang HB, 2004, CHINESE J CLIN REHAB; Zhang Xin, 2013, Chinese Journal of Information on Traditional Chinese Medicine, V20, P16; Zhang Y, 2008, LIAONING J TRADITION, V35, P728; Zhang ZX, 2005, ARCH NEUROL-CHICAGO, V62, P447, DOI 10.1001/archneur.62.3.447; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1; Zhao G.H, 2013, CHINESE J INTEGRATED, V33, P467, DOI [10.1007/s11655-012-1177-9, DOI 10.1007/S11655-012-1177-9]; Zhao Guo-Hua, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P590; [郑春叶 Zheng Chunye], 2006, [中医杂志, Journal of Traditional Chinese Medicine], V47, P516; Zheng CY, 2011, J NEW CHINESE MED, V43, P40; Zhong C, 2012, CHINESE J EXPT TRADI, V18, P343; Zhu XY, 2009, J NEUROLOGY NEUROREH, V6, P114; 钟平, 2012, [中国老年学杂志, Chinese Journal of Gerontology], V32, P2720	46	38	38	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118498	10.1371/journal.pone.0118498	http://dx.doi.org/10.1371/journal.pone.0118498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756963	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700021
J	Chatterjee, N; Das, S; Bose, D; Banerjee, S; Jha, T; Das Saha, K				Chatterjee, Nabanita; Das, Subhadip; Bose, Dipayan; Banerjee, Somenath; Jha, Tarun; Das Saha, Krishna			Lipid from Infective L. donovani Regulates Acute Myeloid Cell Growth via Mitochondria Dependent MAPK Pathway	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NITRIC-OXIDE SYNTHESIS; INDUCED APOPTOSIS; U937 CELLS; MONONUCLEAR-CELLS; CYTOCHROME-C; CANCER-CELLS; P38 MAPK; ACTIVATION; INJURY	The microbial source, which includes live, attenuated, or genetically modified microbes or their cellular component(s) or metabolites, has gained increasing significance for therapeutic intervention against several pathophysiological conditions of disease including leukemia, which remains an incurable disease till now despite recent advances in the medical sciences. We therefore took up the present study to explore if the leishmanial lipid (pLLD) isolated from L. donovani can play an anti-neoplastic role in acute myeloid leukemia cells by regulating cellular growth. Indeed pLLD significantly inhibited cell proliferation of four AML cell lines (HL-60, MOLT-4, U937, and K562). Scanning electron microscopy and DNA fragmentation analysis revealed that it significantly induced apoptosis of U937 cells through morphological alteration. Occurrence of apoptosis was checked by using Annexin exposure and this established that the cell cycle was arrested at G0/G1 phase in time-dependent manner. pLLD increased the intracellular ROS with alteration of mitochondrial membrane potential, as detected using DCFDA. It also regulated the expression of apoptosis-related proteins like Bax, Bcl2, Bad and t-Bid besides causing cleavage of PARP as determined by western blot analysis. Treatment of U937 cells with pLLD induced the activation of extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK) 1/2, p38, and caspases 9/3. The results suggest that pLLD induces apoptosis in acute myeloid leukemia cells possibly via increasing intracellular ROS and regulating the MAPK pathway.	[Chatterjee, Nabanita; Das, Subhadip; Bose, Dipayan; Banerjee, Somenath; Das Saha, Krishna] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata 700032, W Bengal, India; [Jha, Tarun] Jadavpur Univ, Div Med & Pharmaceut Chem, Dept Pharmaceut Technol, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Jadavpur University	Das Saha, K (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	krishnaiicb@yahoo.com	Bose, Dipayan/Q-5230-2019; Banerjee, Somenath/AAA-1540-2021; Jha, Tarun/AAH-3939-2019; Chatterjee, Nabanita/GPX-3468-2022; Chatterjee, N/AAN-9821-2020	Bose, Dipayan/0000-0003-4789-2838; Banerjee, Somenath/0000-0002-1527-7550; Jha, Tarun/0000-0002-9996-738X; 	CSIR; Indian Council of Medical Research (ICMR; India)	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR; India)(Indian Council of Medical Research (ICMR))	The CSIR and Indian Council of Medical Research (ICMR; India) financially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa S, 2000, INFECT IMMUN, V68, P4611, DOI 10.1128/IAI.68.8.4611-4615.2000; Azuma H, 2003, ANTICANCER RES, V23, P3183; Balestieri FMP, 2002, MICROBES INFECT, V4, P23, DOI 10.1016/S1286-4579(01)01505-2; Bishop JF, 1997, SEMIN ONCOL, V24, P57; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cai J, 2002, BIOL PHARM BULL, V25, P193, DOI 10.1248/bpb.25.193; Chatterjee N, 2014, J LEUKOCYTE BIOL, V96, P325, DOI 10.1189/jlb.3A1113-582R; Chatterjee N, 2012, TOXICOL APPL PHARM, V264, P182, DOI 10.1016/j.taap.2012.07.032; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Das S, 2012, CELL PHYSIOL BIOCHEM, V29, P251, DOI 10.1159/000337606; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Dhuley JN, 1999, COMP IMMUNOL MICROB, V22, P15, DOI 10.1016/S0147-9571(98)00021-6; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fernandes J, 2012, MED HYPOTHESES, V78, P435, DOI 10.1016/j.mehy.2011.12.014; Fu SL, 2008, J SURG RES, V148, P77, DOI 10.1016/j.jss.2008.03.005; Ghosh S, 2005, BRIT J HAEMATOL, V128, P35, DOI 10.1111/j.1365-2141.2004.05256.x; GIRALT SA, 1994, BLOOD, V84, P3603, DOI 10.1182/blood.V84.11.3603.bloodjournal84113603; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kwan JM, 2009, LEUKEMIA RES, V33, P1392, DOI 10.1016/j.leukres.2009.01.024; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Li YZ, 1999, MOL MED, V5, P232, DOI 10.1007/BF03402120; Liew JCJ, 2010, J BIOSCI BIOENG, V110, P338, DOI 10.1016/j.jbiosc.2010.02.017; Liu XS, 2006, PLANTA MED, V72, P501, DOI 10.1055/s-2006-931534; Majumdar KN, 2008, ARTHRITIS RHEUM-US, V58, P696, DOI 10.1002/art.23295; MALMGREN RA, 1955, CANCER RES, V15, P473; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Minamino M, 2003, MICROBIOL-SGM, V149, P2071, DOI 10.1099/mic.0.25922-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUKHOPADHYAY R, 1994, BIOCHEM PHARMACOL, V47, P253, DOI 10.1016/0006-2952(94)90014-0; Pal S, 2004, INT J CANCER, V111, P270, DOI 10.1002/ijc.20246; Pramanik M, 2013, CHEM COMMUN, V49, P9461, DOI 10.1039/c3cc44989k; PROUDFOOT L, 1995, EUR J IMMUNOL, V25, P745, DOI 10.1002/eji.1830250318; Repicky A, 2009, CANCER LETT, V277, P55, DOI 10.1016/j.canlet.2008.11.026; Sinha D, 1999, LEUKEMIA, V13, P119, DOI 10.1038/sj.leu.2401239; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Tanner EA, 2011, DEVELOPMENT, V138, P327, DOI 10.1242/dev.057943; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Watabe M, 1998, ONCOGENE, V16, P779, DOI 10.1038/sj.onc.1201592; Wei MQ, 2008, CANCER LETT, V259, P16, DOI 10.1016/j.canlet.2007.10.034	44	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0120509	10.1371/journal.pone.0120509	http://dx.doi.org/10.1371/journal.pone.0120509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25750993	Green Published, gold, Green Submitted			2022-12-27	WOS:000350692700036
J	Korhonen, M; Muuronen, A; Arponen, O; Mustonen, P; Hedman, M; Jakala, P; Vanninen, R; Taina, M				Korhonen, Miika; Muuronen, Antti; Arponen, Otso; Mustonen, Pirjo; Hedman, Marja; Jakala, Pekka; Vanninen, Ritva; Taina, Mikko			Left Atrial Appendage Morphology in Patients with Suspected Cardiogenic Stroke without Known Atrial Fibrillation	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; THROMBUS FORMATION; RISK; VOLUME; CT	The left atrial appendage (LAA) is the typical origin for intracardiac thrombus formation. Whether LAA morphology is associated with increased stroke/TIA risk is controversial and, if it does, which morphological type most predisposes to thrombus formation. We assessed LAA morphology in stroke patients with cryptogenic or suspected cardiogenic etiology and in age-and gender-matched healthy controls. LAA morphology and volume were analyzed by cardiac computed tomography in 111 patients (74 males; mean age 60 +/- 11 years) with acute ischemic stroke of cryptogenic or suspected cardiogenic etiology other than known atrial fibrillation (AF). A subgroup of 40 patients was compared to an age-and gender-matched control group of 40 healthy individuals (21 males in each; mean age 54 +/- 9 years). LAA was classified into four morphology types (Cactus, ChickenWing, WindSock, Cauli-Flower) modified with a quantitative qualifier. The proportions of LAA morphology types in the main stroke group, matched stroke subgroup, and control group were as follows: Cactus (9.0%, 5.0%, 20.0%), ChickenWing (23.4%, 37.5%, 10.0%), WindSock (47.7%, 35.0%, 67.5%), and CauliFlower (19.8%, 22.5%, 2.5%). The distribution of morphology types differed significantly (P<0.001) between the matched stroke subgroup and control group. The proportion of single-lobed LAA was significantly higher (P<0.001) in the matched stroke subgroup (55%) than the control group (6%). LAA volumes were significantly larger (P<0.001) in both stroke study groups compared to controls patients. To conclude, LAA morphology differed significantly between stroke patients and controls, and single-lobed LAAs were overrepresented and LAA volume was larger in patients with acute ischemic stroke of cryptogenic or suspected cardiogenic etiology.	[Korhonen, Miika; Muuronen, Antti; Arponen, Otso; Hedman, Marja; Vanninen, Ritva; Taina, Mikko] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Korhonen, Miika; Muuronen, Antti; Arponen, Otso; Vanninen, Ritva; Taina, Mikko] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, NeuroCtr, SF-70210 Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland	Korhonen, M (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Miika.Korhonen@kuh.fi						Al-Saady NM, 1999, HEART, V82, P547, DOI 10.1136/hrt.82.5.547; Anselmino M, 2014, HEART RHYTHM, V11, P2, DOI 10.1016/j.hrthm.2013.10.020; Bansil Shalini, 2004, J Stroke Cerebrovasc Dis, V13, P12, DOI 10.1016/j.jstrokecerebrovasdis.2004.01.004; Beinart R, 2011, J CARDIOVASC ELECTR, V22, P10, DOI 10.1111/j.1540-8167.2010.01854.x; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; Chang SH, 2007, J CARDIOVASC ELECTR, V18, P47, DOI 10.1111/j.1540-8167.2006.00655.x; Christiaens L, 2010, INT J CARDIOL, V140, P189, DOI 10.1016/j.ijcard.2008.11.055; Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Erol B, 2011, EUR J RADIOL, V80, pE346, DOI 10.1016/j.ejrad.2010.11.008; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Hunter RJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P351, DOI 10.1161/CIRCEP.111.965541; Khurram IM, 2013, HEART RHYTHM, V10, P1843, DOI 10.1016/j.hrthm.2013.09.065; Kimura T, 2013, HEART RHYTHM, V10, P921, DOI 10.1016/j.hrthm.2013.01.036; Koplay M, 2012, EUR J RADIOL, V81, P1575, DOI 10.1016/j.ejrad.2011.04.060; Makino N, 2013, J AM COLL CARDIOL, V61, pE272, DOI 10.1016/S0735-1097(13)60272-7; Miller DJ, 2013, J NEUROL SCI, V324, P57, DOI 10.1016/j.jns.2012.10.001; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Okuyama H, 2006, CIRC J, V70, P971, DOI 10.1253/circj.70.971; Park HC, 2013, INT J CARDIOVAS IMAG, V29, P935, DOI 10.1007/s10554-012-0161-y; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Shi AW, 2012, J INT MED RES, V40, P1560, DOI 10.1177/147323001204000436; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Taina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090903; Walker DT, 2012, J INTERV CARD ELECTR, V34, P173, DOI 10.1007/s10840-011-9638-1; Wang Y, 2010, J CARDIOVASC ELECTR, V21, P973, DOI 10.1111/j.1540-8167.2010.01814.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamamoto M, 2014, CIRC-CARDIOVASC IMAG, V7, P337, DOI 10.1161/CIRCIMAGING.113.001317	28	36	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118822	10.1371/journal.pone.0118822	http://dx.doi.org/10.1371/journal.pone.0118822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751618	Green Submitted, Green Published, gold			2022-12-27	WOS:000350692700011
J	Zhang, X; Ren, JC; Yan, L; Tang, YQ; Zhang, WH; Li, DW; Zang, YW; Kong, F; Xu, ZH				Zhang, Xiang; Ren, Juchao; Yan, Lei; Tang, Yueqing; Zhang, Wenhua; Li, Dawei; Zang, Yuanwei; Kong, Feng; Xu, Zhonghua			Cytoplasmic Expression of Pontin in Renal Cell Carcinoma Correlates with Tumor Invasion, Metastasis and Patients' Survival	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; HEPATOCELLULAR-CARCINOMA; IN-VIVO; REPTIN; GENE; TRANSCRIPTION; OVEREXPRESSION; TRANSFORMATION; PROFILES; REVEALS	Renal cell carcinoma (RCC) is the most lethal of all genitourinary malignancies. Distant metastasis represents the major cause of death in patients with RCC. Recent studies have implicated the AAA+ ATPase pontin in many cellular activities that are highly relevant to carcinogenesis. In this study, we demonstrate for the first time that pontin was up-regulated in RCC, and plays a previously unknown pro-invasive role in the metastatic progression of RCC through epithelial-to-mesenchymal transition (EMT) pathway. 28 pairs of freshly frozen clear cell RCC samples and the matched normal renal tissues analyzed by quantitative RT-PCR and western blotting demonstrated that pontin was up-regulated in clear cell RCC tissues than in normal renal tissues. In addition, immunohistochemistry was used to evaluate subcellular pontin expression in 95 RCC patients, and found that overexpression of pontin in cytoplasm positively correlated with the metastatic features, predicting unfavorable outcomes of RCC patients. Furthermore, in vitro experiments show pontin was predominantly expressed in cytoplasm of RCC cell lines, and a significant suppression of cell migration and invasion in pontin siRNA treated RCC cell lines was observed. Mechanistic studies show that pontin depletion up-regulated the E-cadherin protein and down-regulated vimentin protein, and decreased nuclear beta-catenin expression, suggesting the involvement of EMT in pontin induced metastatic progression. Together, our data suggest pontin as a potential prognostic biomarker in RCC, and provide new promising therapeutic targets for clinical intervention of kidney cancers.	[Zhang, Xiang; Ren, Juchao; Yan, Lei; Tang, Yueqing; Zhang, Wenhua; Li, Dawei; Zang, Yuanwei; Xu, Zhonghua] Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China; [Zhang, Xiang; Ren, Juchao; Zang, Yuanwei] Shandong Univ, Inst Basic Med Sci, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Zhang, Xiang; Ren, Juchao; Zang, Yuanwei] Shandong Univ, Key Lab Cardiovasc Prote Shandong Prov, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Kong, Feng] Shandong Univ, Hosp 2, Cent Lab, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Ren, JC (corresponding author), Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China.	rjchao1983@163.com; xuzhonghuamd@aliyun.com			National Natural Science Foundation of China [81372335]; National Science Foundation of Shandong [ZR2010HM103]; China Postdoctoral Science Foundation [2014M551915]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Shandong(Natural Science Foundation of Shandong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This project was supported by the National Natural Science Foundation of China (No. 81372335), National Science Foundation of Shandong (No. ZR2010HM103) and China Postdoctoral Science Foundation (No. 2014M551915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Berasain C, 2010, J HEPATOL, V52, P633, DOI 10.1016/j.jhep.2010.01.020; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Cram EJ, 2006, J CELL SCI, V119, P4811, DOI 10.1242/jcs.03274; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Eble JN, 2004, WHO CLASSIFICATION T, P12; Eisengart LJ, 2012, ARCH PATHOL LAB MED, V136, P490, DOI 10.5858/arpa.2010-0308-RA; Feng Y, 2003, CANCER RES, V63, P8726; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002; Haurie V, 2009, HEPATOLOGY, V50, P1871, DOI 10.1002/hep.23215; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim JH, 2007, P NATL ACAD SCI USA, V104, P20793, DOI 10.1073/pnas.0710343105; Lauscher JC, 2007, HUM PATHOL, V38, P978, DOI 10.1016/j.humpath.2007.01.005; Lauscher JC, 2012, ONCOL REP, V28, P1619, DOI 10.3892/or.2012.1968; Li WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-132; Maslon MM, 2010, J MOL BIOL, V404, P418, DOI 10.1016/j.jmb.2010.09.035; Menard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029; Ren JC, 2013, UROL ONCOL-SEMIN ORI, V31, P1358, DOI 10.1016/j.urolonc.2012.01.004; Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang FL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003031; Whitehead J, 2008, HFSP J, V2, P286, DOI 10.2976/1.2955566; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X	32	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118659	10.1371/journal.pone.0118659	http://dx.doi.org/10.1371/journal.pone.0118659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751257	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700006
J	Pilosof, S; Morand, S; Krasnov, BR; Nunn, CL				Pilosof, Shai; Morand, Serge; Krasnov, Boris R.; Nunn, Charles L.			Potential Parasite Transmission in Multi-Host Networks Based on Parasite Sharing	PLOS ONE			English	Article							ECOLOGICAL NETWORKS; INFECTIOUS-DISEASE; HOST; DIVERSITY; DYNAMICS; POPULATIONS; CENTRALITY; REGRESSION; PATTERNS; WILD	Epidemiological networks are commonly used to explore dynamics of parasite transmission among individuals in a population of a given host species. However, many parasites infect multiple host species, and thus multi-host networks may offer a better framework for investigating parasite dynamics. We investigated the factors that influence parasite sharing - and thus potential transmission pathways - among rodent hosts in Southeast Asia. We focused on differences between networks of a single host species and networks that involve multiple host species. In host-parasite networks, modularity (the extent to which the network is divided into subgroups of rodents that interact with similar parasites) was higher in the multi-species than in the single-species networks. This suggests that phylogeny affects patterns of parasite sharing, which was confirmed in analyses showing that it predicted affiliation of individuals to modules. We then constructed "potential transmission networks" based on the host-parasite networks, in which edges depict the similarity between a pair of individuals in the parasites they share. The centrality of individuals in these networks differed between multi-and single-species networks, with species identity and individual characteristics influencing their position in the networks. Simulations further revealed that parasite dynamics differed between multi-and single-species networks. We conclude that multi-host networks based on parasite sharing can provide new insights into the potential for transmission among hosts in an ecological community. In addition, the factors that determine the nature of parasite sharing (i.e. structure of the host-parasite network) may impact transmission patterns.	[Pilosof, Shai] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Albert Katz Int Sch Desert Studies, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Morand, Serge] ISEM, CNRS, Montpellier, France; [Morand, Serge] Ctr Cooperat Int Rech Agron Dev, Unite Rech Anim & Gest Integree Risques, Montpellier, France; [Morand, Serge] CICML, Minist Hlth Lao PDR, Viangchan, Laos; [Krasnov, Boris R.] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Nunn, Charles L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Nunn, Charles L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Ben Gurion University; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Ben Gurion University; Duke University; Duke University	Pilosof, S (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Albert Katz Int Sch Desert Studies, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel.	shainova@gmail.com	Krasnov, Boris R./ABG-8403-2021; Pilosof, Shai/AAX-8055-2020; Krasnov, Boris R./F-2234-2012; Morand, Serge/M-5433-2018	Krasnov, Boris R./0000-0002-0382-3331; Pilosof, Shai/0000-0003-0430-5568; Krasnov, Boris R./0000-0002-0382-3331; Morand, Serge/0000-0003-3986-7659	French National Research Agency bio diversity Community Ecology of Rodent and their Pathogens project [ANR 07 BDIV 012 CERoPath]; Kreitman Foundation Fellowship, Ben-Gurion University of the Negev	French National Research Agency bio diversity Community Ecology of Rodent and their Pathogens project(French National Research Agency (ANR)); Kreitman Foundation Fellowship, Ben-Gurion University of the Negev	This work was supported by the French National Research Agency bio diversity Community Ecology of Rodent and their Pathogens project ANR 07 BDIV 012 CERoPath. (http://www.agence-nationale-recherche.fr/). SP was funded by the Kreitman Foundation Fellowship, Ben-Gurion University of the Negev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K., 2013, MUMIN MULTI MODEL IN; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canright Geoffrey S., 2006, ComPlexUs, V3, P131, DOI 10.1159/000094195; Cooper N, 2012, ECOL LETT, V15, P1370, DOI 10.1111/j.1461-0248.2012.01858.x; Corbin E, 2008, MAMMAL REV, V38, P108, DOI 10.1111/j.1365-2907.2007.00112.x; Craft ME, 2011, J R SOC INTERFACE, V8, P776, DOI 10.1098/rsif.2010.0511; Craft Meggan E, 2011, Interdiscip Perspect Infect Dis, V2011, P676949, DOI 10.1155/2011/676949; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Ezenwa VO, 2011, INTEGR COMP BIOL, V51, P540, DOI 10.1093/icb/icr058; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Fortuna MA, 2009, ECOLOGY, V90, P934, DOI 10.1890/08-0174.1; Gomez JM, 2012, P ROY SOC B-BIOL SCI, V279, P1754, DOI 10.1098/rspb.2011.2244; Goslee SC, 2007, ECODIST PACKAGE DISS; Griffin RH, 2012, EVOL ECOL, V26, P779, DOI 10.1007/s10682-011-9526-2; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hawlena H, 2005, OECOLOGIA, V146, P200, DOI 10.1007/s00442-005-0187-0; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kilpatrick A.M., 2012, NAT ED KNOWL, V3, P55; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Krasnov BR, 2012, AM NAT, V179, P501, DOI 10.1086/664612; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Lima DP, 2012, J ANIM ECOL, V81, P905, DOI 10.1111/j.1365-2656.2012.01967.x; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Gomez JM, 2013, P NATL ACAD SCI USA, V110, P7738, DOI 10.1073/pnas.1220716110; Newman M.E.J., 2010, NETWORKS INTRO; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Perkins SE, 2009, J ANIM ECOL, V78, P1015, DOI 10.1111/j.1365-2656.2009.01557.x; Pilosof S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6172; Pilosof S, 2013, J ANIM ECOL, V82, P987, DOI 10.1111/1365-2656.12090; Poisot T, 2013, PARASITOLOGY, V140, P1340, DOI 10.1017/S0031182013000851; Poisot T, 2012, METHODS ECOL EVOL, V3, P537, DOI 10.1111/j.2041-210X.2011.00174.x; Poulin R, 2010, TRENDS PARASITOL, V26, P492, DOI 10.1016/j.pt.2010.05.008; R Development Core Team, 2014, R LANG ENV STAT COMP; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Streicker DG, 2013, ECOL LETT, V16, P975, DOI 10.1111/ele.12122; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Tur C, 2014, J ANIM ECOL, V83, P306, DOI 10.1111/1365-2656.12130; VanderWaal KL, 2014, BIOL CONSERV, V169, P136, DOI 10.1016/j.biocon.2013.11.008; VanderWaal KL, 2014, J ANIM ECOL, V83, P406, DOI 10.1111/1365-2656.12137; Walsh PD, 2007, AM NAT, V169, P684, DOI 10.1086/513494; Wells K, 2013, METHODS ECOL EVOL, V4, P1, DOI 10.1111/j.2041-210x.2012.00249.x; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	54	45	47	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0117909	10.1371/journal.pone.0117909	http://dx.doi.org/10.1371/journal.pone.0117909			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748947	gold, Green Submitted, Green Published			2022-12-27	WOS:000350689400011
J	Sowa, J; Bobula, B; Glombik, K; Slusarczyk, J; Basta-Kaim, A; Hess, G				Sowa, Joanna; Bobula, Bartosz; Glombik, Katarzyna; Slusarczyk, Joanna; Basta-Kaim, Agnieszka; Hess, Grzegorz			Prenatal Stress Enhances Excitatory Synaptic Transmission and Impairs Long-Term Potentiation in the Frontal Cortex of Adult Offspring Rats	PLOS ONE			English	Article							MOTOR CORTEX; GLUTAMATERGIC TRANSMISSION; PREFRONTAL CORTEX; RESTRAINT STRESS; FIELD POTENTIALS; BRAIN; PLASTICITY; HIPPOCAMPUS; PROTEINS; LEVEL	The effects of prenatal stress procedure were investigated in 3 months old male rats. Prenatally stressed rats showed depressive-like behavior in the forced swim test, including increased immobility, decreased mobility and decreased climbing. In ex vivo frontal cortex slices originating from prenatally stressed animals, the amplitude of extracellular field potentials (FPs) recorded in cortical layer II/III was larger, and the mean amplitude ratio of pharmacologically-isolated NMDA to the AMPA/kainate component of the field potential-smaller than in control preparations. Prenatal stress also resulted in a reduced magnitude of long-term potentiation (LTP). These effects were accompanied by an increase in the mean frequency, but not the mean amplitude, of spontaneous excitatory postsynaptic currents (sEPSCs) in layer II/III pyramidal neurons. These data demonstrate that stress during pregnancy may lead not only to behavioral disturbances, but also impairs the glutamatergic transmission and long-term synaptic plasticity in the frontal cortex of the adult offspring.	[Sowa, Joanna; Bobula, Bartosz; Hess, Grzegorz] Polish Acad Sci, Inst Pharmacol, Dept Physiol, Krakow, Poland; [Glombik, Katarzyna; Slusarczyk, Joanna; Basta-Kaim, Agnieszka] Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, Krakow, Poland; [Hess, Grzegorz] Jagiellonian Univ, Inst Zool, PL-30060 Krakow, Poland	Polish Academy of Sciences; Polish Academy of Sciences; Jagiellonian University	Basta-Kaim, A (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, Krakow, Poland.	basta@if-pan.krakow.pl	Bobula, Bartosz/P-8260-2019; Hess, Grzegorz/HGQ-0966-2022	Bobula, Bartosz/0000-0001-5167-9277; Glombik, Katarzyna/0000-0002-7695-2556; Basta-Kaim, Agnieszka/0000-0002-3109-0040	European Regional Development Fund [POIG. 01.01.02-12-004/09-00]; project: Interdisciplinary PhD Studies "Molecular sciences for medicine"; European Social Fund within the Human Capital Operational Programme; KNOW - Ministry of Science and Higher Education, Poland; Department of Physiology	European Regional Development Fund(European Commission); project: Interdisciplinary PhD Studies "Molecular sciences for medicine"; European Social Fund within the Human Capital Operational Programme; KNOW - Ministry of Science and Higher Education, Poland; Department of Physiology	BB and AB-K were supported by the grant POIG. 01.01.02-12-004/09-00 part 2.4 "Depression-Mechanisms-Therapy" financed by European Regional Development Fund; KG was supported by the project: Interdisciplinary PhD Studies "Molecular sciences for medicine" (co-financed by the European Social Fund within the Human Capital Operational Programme; J. Sowa and J. Slusarczyk are holders of scholarships from the KNOW sponsored by the Ministry of Science and Higher Education, Poland; GH was supported by the statutory funds of the Department of Physiology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0081775; Basta-Kaim A, 2014, NEUROSCIENCE, V274, P59, DOI 10.1016/j.neuroscience.2014.05.010; Basta-Kaim A, 2014, EUR NEUROPSYCHOPHARM, V24, P1546, DOI 10.1016/j.euroneuro.2014.07.002; Bobula B, 2003, NEUROSCIENCE, V120, P765, DOI 10.1016/S0306-4522(03)00380-4; Bobula B, 2011, PHARMACOL REP, V63, P1404; Bobula B, 2008, PHARMACOL REP, V60, P865; Budziszewska B, 2010, J PHYSIOL PHARMACOL, V61, P207; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DUNCAN GE, 1993, J NEUROSCI, V13, P3932; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Fujioka A, 2006, NEUROSCIENCE, V141, P907, DOI 10.1016/j.neuroscience.2006.04.046; Hamani C, 2010, BIOL PSYCHIAT, V67, P117, DOI 10.1016/j.biopsych.2009.08.025; HESS G, 1994, NEUROSCIENCE, V61, P225, DOI 10.1016/0306-4522(94)90226-7; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Maccari S, 2001, Stress, V4, P169; Mairesse J, 2013, INT J NEUROPSYCHOPH, V16, P323, DOI 10.1017/S1461145711001970; Markham JA, 2011, PSYCHOPHARMACOLOGY, V214, P89, DOI 10.1007/s00213-010-2035-0; Martin ED, 2012, CEREB CORTEX, V22, P1717, DOI 10.1093/cercor/bhr216; Molina DP, 2013, AGE, V35, P1575, DOI 10.1007/s11357-012-9460-4; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Monfils MH, 2004, NEUROSCIENCE, V125, P329, DOI 10.1016/j.neuroscience.2004.01.048; Morley-Fletcher S, 2003, BRAIN RES, V989, P246, DOI 10.1016/S0006-8993(03)03293-1; Mychasiuk R, 2012, SYNAPSE, V66, P308, DOI 10.1002/syn.21512; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Saez I, 2009, J NEUROSCI, V29, P15286, DOI 10.1523/JNEUROSCI.2980-09.2009; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schulz PE, 1997, P NATL ACAD SCI USA, V94, P5888, DOI 10.1073/pnas.94.11.5888; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P509, DOI 10.1113/jphysiol.2002.022095; Son GH, 2006, J NEUROSCI, V26, P3309, DOI 10.1523/JNEUROSCI.3850-05.2006; Stoltz S, 1999, BEHAV BRAIN RES, V106, P127, DOI 10.1016/S0166-4328(99)00100-X; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Szczesny E, 2013, PHARMACOL REP, V65, P1622, DOI 10.1016/S1734-1140(13)71523-8; Szymanska M, 2009, PSYCHONEUROENDOCRINO, V34, P822, DOI 10.1016/j.psyneuen.2008.12.012; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tokarski K, 2008, NEUROSCIENCE, V153, P789, DOI 10.1016/j.neuroscience.2008.03.007; Tokarski K, 2011, J PHYSIOL PHARMACOL, V62, P663; Wabno J, 2013, J NEURAL TRANSM, V120, P711, DOI 10.1007/s00702-012-0919-3; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yaka R, 2007, BEHAV BRAIN RES, V179, P126, DOI 10.1016/j.bbr.2007.01.018; Yang JL, 2006, HIPPOCAMPUS, V16, P431, DOI 10.1002/hipo.20181; Yeh CM, 2012, J PHYSIOL-LONDON, V590, P991, DOI 10.1113/jphysiol.2011.222042; Zhang XH, 2013, NEUROSCIENCE, V250, P333, DOI 10.1016/j.neuroscience.2013.04.031	52	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119407	10.1371/journal.pone.0119407	http://dx.doi.org/10.1371/journal.pone.0119407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749097	gold, Green Submitted, Green Published			2022-12-27	WOS:000350689400072
J	Wang, C; Gao, C; Meng, K; Qiao, HS; Wang, Y				Wang, Chen; Gao, Chao; Meng, Kui; Qiao, Haishi; Wang, Yong			Human Adipocytes Stimulate Invasion of Breast Cancer MCF-7 Cells by Secreting IGFBP-2	PLOS ONE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; MATRIX METALLOPROTEINASES; TISSUE; GROWTH; EXPRESSION; ENDOCRINE; PHENOTYPE; PARACRINE; OBESITY	Background and Aims A better understanding of the effects of human adipocytes on breast cancer cells may lead to the development of new treatment strategies. We explored the effects of adipocytes on the migration and invasion of breast cancer cells both in vitro and in vivo. Methods To study the reciprocal effects of adipocytes and cancer cells, we co-cultured human mature adipocytes and breast cancer cells in a system devoid of heterogeneous cell-cell contact. To analyze the factors that were secreted from adipocytes and that affected the invasive abilities of breast cancer cells, we detected different cytokines in various co-culture media. To study the communication of mature adipocytes and breast cancer cells in vivo, we chose 10 metastatic pathologic samples and 10 non-metastatic pathologic samples to do immunostaining. Results The co-culture media of human MCF-7 breast cancer cells and human mature adipocytes increased motility of MCF-7 cells. In addition, MMP-2 was remarkably up-regulated, whereas E-cadherin was down-regulated in these MCF-7 cells. Based on our co-culture medium chip results, we chose four candidate cytokines and tested their influence on metastasis individually. We found that IGFBP-2 enhanced the invasion ability of MCF-7 cells in vitro more prominently than did the other factors. In vivo, metastatic human breast tumors had higher levels of MMP-2 than did non-metastatic tumor tissue, whereas adipocytes around metastatic breast tumors had higher levels of IGFBP-2 than did adipocytes surrounding non-metastatic breast tumors. Conclusions IGFBP-2 secreted by mature adipocytes plays a key role in promoting the metastatic ability of MCF-7 breast cancer cells.	[Wang, Chen; Qiao, Haishi; Wang, Yong] Nanjing Univ, Sch Med, State Key Lab Chem Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Chen; Qiao, Haishi; Wang, Yong] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China; [Gao, Chao] Jiangsu Prov Hosp, Ctr Clin Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Meng, Kui] Nanjing Univ, Gulou Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University; Nanjing University	Wang, Y (corresponding author), Nanjing Univ, Sch Med, State Key Lab Chem Life Sci, Nanjing 210093, Jiangsu, Peoples R China.	njuwangyong@163.com	wang, chen/GWM-9481-2022; qiao, haishi/ABE-5765-2021		Fundamental Research Funds for the Central Universities [021414350002, 021414340131]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This article is supported by the Fundamental Research Funds for the Central Universities: 021414350002 and 021414340131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andarawewa KL, 2005, CANCER RES, V65, P10862, DOI 10.1158/0008-5472.CAN-05-1231; Carter JC, 2009, PPAR RES, V2009, DOI 10.1155/2009/345320; Celis JE, 2005, MOL CELL PROTEOMICS, V4, P492, DOI 10.1074/mcp.M500030-MCP200; D'Esposito V, 2012, DIABETOLOGIA, V55, P2811, DOI 10.1007/s00125-012-2629-7; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Dirat B, 2010, ENDOCR DEV, V19, P45, DOI 10.1159/000316896; Drabsch Y, 2011, J MAMMARY GLAND BIOL, V16, P97, DOI 10.1007/s10911-011-9217-1; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Foulstone EJ, 2013, ENDOCRINOLOGY, V154, P1780, DOI 10.1210/en.2012-1970; Gnerlich JL, 2013, ANN SURG ONCOL, V20, pS731, DOI 10.1245/s10434-013-3274-1; Guerrero J, 2010, BREAST CANCER RES TR, V119, P497, DOI 10.1007/s10549-009-0491-1; Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Kang XH, 2005, TISSUE ENG, V11, P458, DOI 10.1089/ten.2005.11.458; Kim JH, 2008, CANCER LETT, V261, P253, DOI 10.1016/j.canlet.2007.11.020; Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Miyoshi Y, 2006, INT J CANCER, V118, P1414, DOI 10.1002/ijc.21543; Motrescu ER, 2008, BIOL CHEM, V389, P1037, DOI 10.1515/BC.2008.110; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Ryden M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1847, DOI 10.1152/ajpendo.00040.2007; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Slattery ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063165; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Todorovic-Rakovic N, 2013, J INTERF CYTOK RES, V33, P563, DOI 10.1089/jir.2013.0023; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	32	54	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119348	10.1371/journal.pone.0119348	http://dx.doi.org/10.1371/journal.pone.0119348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747684	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400065
J	Inayatullah, S; Touheed, N; Imtiaz, M				Inayatullah, Syed; Touheed, Nasir; Imtiaz, Muhammad			A Streamlined Artificial Variable Free Version of Simplex Method	PLOS ONE			English	Article							ALGORITHM; TABLEAU	This paper proposes a streamlined form of simplex method which provides some great benefits over traditional simplex method. For instance, it does not need any kind of artificial variables or artificial constraints; it could start with any feasible or infeasible basis of an LP. This method follows the same pivoting sequence as of simplex phase 1 without showing any explicit description of artificial variables which also makes it space efficient. Later in this paper, a dual version of the new method has also been presented which provides a way to easily implement the phase 1 of traditional dual simplex method. For a problem having an initial basis which is both primal and dual infeasible, our methods provide full freedom to the user, that whether to start with primal artificial free version or dual artificial free version without making any reformulation to the LP structure. Last but not the least, it provides a teaching aid for the teachers who want to teach feasibility achievement as a separate topic before teaching optimality achievement.	[Inayatullah, Syed; Imtiaz, Muhammad] Univ Karachi, Dept Math Sci, Karachi, Pakistan; [Touheed, Nasir] Inst Business Adm, Dept Math Sci, Karachi, Pakistan	University of Karachi; Institute of Business Administration, Karachi	Inayatullah, S (corresponding author), Univ Karachi, Dept Math Sci, Karachi, Pakistan.	inayat@uok.edu.pk		Inayatullah, Syed/0000-0002-8576-4653	University of Karachi	University of Karachi	Grant number: Yearly grant 2014; Funding Institution: University of Karachi; Fund received by: Dr. Syed Inayatullah; Initials: SI; URL: www.uok.edu.pk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSHAM H, 1989, MATH COMPUT MODEL, V12, P1051, DOI 10.1016/0895-7177(89)90225-2; Arsham H, 2003, APPL MATH COMPUT, V137, P525, DOI 10.1016/S0096-3003(02)00157-1; Arsham H, 1997, SIAM REV, V39, P736, DOI 10.1137/S0036144596304722; Arsham H., 2006, INT J PURE APPL MATH, V32, P37; Arsham H, 2003, INT J PURE APPL MATH, V4, P53; Boonperm A, 2014, ARTIFICIAL FREE TECH; Dantzig G. B., 1963, LINEAR PROGRAMMING E; Dantzig G.B., 1955, PAC J MATH, V5, P183, DOI [10.2140/pjm.1955.5.183, DOI 10.2140/PJM.1955.5.183]; Dantzig GB, 1951, MAXIMIZATION LINEAR, P339; Darvas F, 1974, J MED CHEM, P799; DEBRUIJN W, 1991, MICROSC MICROANAL M, V2, P281, DOI 10.1051/mmm:0199100202-3028100; Dines LL, 1918, ANN MATH, V20, P191; Enge A, 1998, COUNTEREXAMPLE H ARS; Grattan Guinness I, 1970, OPERATIONAL RES Q, V21, P361; Haefner J.W, 2005, MODELING BIOL SYSTEM; Huangfu Q, 2013, THESIS U EDINBURGH; Illes T, 2002, EUR J OPER RES, V140, P170, DOI 10.1016/S0377-2217(02)00061-9; Inayatullah S, 2010, CANADIAN J COMPUTING, P22, DOI [10.1038/ng.3198, DOI 10.1038/NG.3198]; Jatau J, 1999, B SCI ASS NIGERIAN, V22, P113; Junior H, 2005, COMPUTERS OPERATIONS, P1983; Kaluzny B, 2001, THESIS MCGILL U MONT; Koberstein A., 2005, THESIS; Lanstra J, 1991, HIST MATH PROGRAMMIN; Motzkin T., 1952, RAND CORPORATION TRA, V22; Papparrizos K, 1990, METHODS OPERATIONS R, P73; Pulgarin JAM, 2002, TALANTA, V57, P795, DOI 10.1016/S0039-9140(02)00105-4; Serang O, 2012, PLOS ONE; SHAMIR R, 1987, MANAGE SCI, V33, P301, DOI 10.1287/mnsc.33.3.301; Stojkovic NV, 2001, EUR J OPER RES, V131, P417, DOI 10.1016/S0377-2217(00)00083-7; WAGNER HM, 1956, OPER RES, V4, P443, DOI 10.1287/opre.4.4.443; Wei L, 2006, APPL MATH J CHINES B, V21, P214; Yuekai S, 2013, BMC BIOINFORMATICS	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116156	10.1371/journal.pone.0116156	http://dx.doi.org/10.1371/journal.pone.0116156			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767883	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500004
J	Sibley, KM; Howe, T; Lamb, SE; Lord, SR; Maki, BE; Rose, DJ; Scott, V; Stathokostas, L; Straus, SE; Jaglal, SB				Sibley, Kathryn M.; Howe, Tracey; Lamb, Sarah E.; Lord, Stephen R.; Maki, Brian E.; Rose, Debra J.; Scott, Vicky; Stathokostas, Liza; Straus, Sharon E.; Jaglal, Susan B.			Recommendations for a Core Outcome Set for Measuring Standing Balance in Adult Populations: A Consensus-Based Approach	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; EVALUATION SYSTEMS TEST; MINI-BESTEST; PSYCHOMETRIC PROPERTIES; DETECTABLE CHANGE; CLINICAL UTILITY; CHRONIC STROKE; OLDER-PEOPLE; SHORT-FORM; SCALE	Background Standing balance is imperative for mobility and avoiding falls. Use of an excessive number of standing balance measures has limited the synthesis of balance intervention data and hampered consistent clinical practice. Objective To develop recommendations for a core outcome set (COS) of standing balance measures for research and practice among adults. Methodology A combination of scoping reviews, literature appraisal, anonymous voting and face-to-face meetings with fourteen invited experts from a range of disciplines with international recognition in balance measurement and falls prevention. Consensus was sought over three rounds using pre-established criteria. Data sources The scoping review identified 56 existing standing balance measures validated in adult populations with evidence of use in the past five years, and these were considered for inclusion in the COS. Results Fifteen measures were excluded after the first round of scoring and a further 36 after round two. Five measures were considered in round three. Two measures reached consensus for recommendation, and the expert panel recommended that at a minimum, either the Berg Balance Scale or Mini Balance Evaluation Systems Test be used when measuring standing balance in adult populations. Limitations Inclusion of two measures in the COS may increase the feasibility of potential uptake, but poses challenges for data synthesis. Adoption of the standing balance COS does not constitute a comprehensive balance assessment for any population, and users should include additional validated measures as appropriate. Conclusions The absence of a gold standard for measuring standing balance has contributed to the proliferation of outcome measures. These recommendations represent an important first step towards greater standardization in the assessment and measurement of this critical skill and will inform clinical research and practice internationally.	[Sibley, Kathryn M.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Sibley, Kathryn M.; Maki, Brian E.; Jaglal, Susan B.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Howe, Tracey] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Lamb, Sarah E.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Rehabil Res Ctr, Oxford, England; [Lord, Stephen R.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Maki, Brian E.; Straus, Sharon E.; Jaglal, Susan B.] Univ Toronto, Toronto, ON, Canada; [Rose, Debra J.] Calif State Univ Fullerton, Fullerton, CA 92634 USA; [Scott, Vicky] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Scott, Vicky] British Columbia Injury Res & Prevent Unit, Clayton, Vic, Australia; [Scott, Vicky] Minist Hlth, Clayton, Vic, Australia; [Stathokostas, Liza] Univ Western Ontario, Canadian Ctr Act & Aging, London, ON, Canada	University of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; Glasgow Caledonian University; University of Oxford; Neuroscience Research Australia; University of New South Wales Sydney; University of Toronto; California State University System; California State University Fullerton; University of British Columbia; Western University (University of Western Ontario)	Sibley, KM (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada.	kathryn.sibley@umanitoba.ca		Howe, Tracey/0000-0003-4382-0407; Lamb, Sarah/0000-0003-4349-7195; Jaglal, Susan/0000-0002-2930-1443; Lord, Stephen R/0000-0002-7111-8802	Canadian Institutes of Health Research (CIHR) [MAG133935]; STIHR-CIHR Fellowship from Knowledge Translation Canada; Toronto Rehabilitation Institute; NIHR Oxford CLARHC; BRU; Canadian Foundation for Innovation; Ontario Innovation Trust; Ministry of Research and Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); STIHR-CIHR Fellowship from Knowledge Translation Canada; Toronto Rehabilitation Institute(University of Toronto); NIHR Oxford CLARHC; BRU; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	Funding: The project was funded by a Canadian Institutes of Health Research (CIHR) planning grant (# MAG133935) - http://www.cihr-irsc.gc.ca/e/193.html. KMS was supported by a STIHR-CIHR Fellowship from Knowledge Translation Canada and the Toronto Rehabilitation Institute. SEL is supported by the NIHR Oxford CLARHC and BRU awards. SES holds a Canada Research Chair in Knowledge Translation and Quality of Care. SBJ holds the Toronto Rehabilitation Institute Chair in Rehabilitation Research at the University of Toronto. Infrastructure support was provided by the Toronto Rehabilitation Institute, with grants from the Canadian Foundation for Innovation, the Ontario Innovation Trust and the Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beaupre LA, 2005, J GEN INTERN MED, V20, P1019, DOI 10.1111/j.1525-1497.2005.00219.x; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG K, 1989, Physiotherapy Canada, V41, P304; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Bergstrom M, 2012, TRANSLATION VALIDATI, P1532, DOI [doi: 10.3109/ 09593985.2011.653707 PMID: 22288658, DOI 10.3109/09593985.2011.653707]; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Boers M, 2014, J RHEUMATOL, V41, P978, DOI 10.3899/jrheum.131307; Boulgarides LK, 2003, PHYS THER, V83, P328, DOI 10.1093/ptj/83.4.328; Brusse KJ, 2005, PHYS THER, V85, P134, DOI 10.1093/ptj/85.2.134; Canadian Agency for Drugs and Technologies in Health, 2013, GREY MATT PRACT SEAR; Chou CY, 2006, PHYS THER, V86, P195, DOI 10.1093/ptj/86.2.195; Conradsson M, 2007, PHYS THER, V87, P1155, DOI 10.2522/ptj.20060343; Crocker T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004294.pub3; Dillon CF, 2010, VISION HEARING BALAN; Donoghue D, 2009, J REHABIL MED, V41, P343, DOI 10.2340/16501977-0337; Duncan RP, 2011, ARCH PHYS MED REHAB, V92, P1431, DOI 10.1016/j.apmr.2011.04.008; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Fitch K., 2001, RAND UCLA APPROPRIAT; Flansbjer UB, 2012, PM&R, V4, P165, DOI 10.1016/j.pmrj.2011.11.004; Franchignoni F, 2005, ARCH PHYS MED REHAB, V86, P2225, DOI 10.1016/j.apmr.2005.09.006; Franchignoni F, 2010, J REHABIL MED, V42, P323, DOI 10.2340/16501977-0537; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Godi M, 2013, PHYS THER, V93, P158, DOI 10.2522/ptj.20120171; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haas R, 2012, PHYS THER; Hiengkaew V, 2012, ARCH PHYS MED REHAB, V93, P1201, DOI 10.1016/j.apmr.2012.01.014; Holbein-Jenny MA, 2007, ERGONOMICS, V50, P631, DOI 10.1080/00140130601154814; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Howe TE, 2011, COCHRANE DATABASE SY, V11; Howe TE, 2011, AGE AGEING, V40, P532, DOI 10.1093/ageing/afr082; Jogi P, 2011, PHYSIOTHER CAN, V63, P107, DOI 10.3138/ptc.2009-26; King LA, 2012, COMP MINI BESTEST BE, DOI [10.1155/2012/375419, DOI 10.1155/2012/375419]; La Porta F, 2011, J REHABIL MED, V43, P445, DOI 10.2340/16501977-0800; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Learmonth YC, 2012, INT J REHABIL RES, V35, P69, DOI 10.1097/MRR.0b013e328350b65f; Leddy AL, 2011, J NEUROL PHYS THER, V35, P90, DOI 10.1097/NPT.0b013e31821a620c; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; Lemay JF, 2010, SPINAL CORD, V48, P245, DOI 10.1038/sc.2009.119; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; Lofgren N, 2014, MINI BESTEST CLIN RE; Mao HF, 2002, STROKE, V33, P1022, DOI 10.1161/01.STR.0000012516.63191.C5; McGlynn M, 2007, PHYSIOTHER CAN, V59, P241, DOI DOI 10.3138/ptc.59.4.241; McNeely ME, 2012, GAIT POSTURE, V36, P144, DOI 10.1016/j.gaitpost.2012.02.009; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; O'Hoski S, 2014, PHYS THER, V94, P334, DOI 10.2522/ptj.20130104; Orr R, 2008, SPORTS MED, V38, P317, DOI 10.2165/00007256-200838040-00004; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Qutubuddin AA, 2005, ARCH PHYS MED REHAB, V86, P789, DOI 10.1016/j.apmr.2004.11.005; Rose DJ, 2006, ARCH PHYS MED REHAB, V87, P1478, DOI 10.1016/j.apmr.2006.07.263; Saunders DH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub5; Scalzo PL, 2009, ARQ NEURO-PSIQUIAT, V67, P831, DOI 10.1590/S0004-282X2009000500010; Schlenstedt C, 2014, COMP FULLERTON ADV B; Shumway-Cook A., 2007, MOTOR CONTROL TRANSL; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Sibley KM, 2015, ARCH PHYS MED REHAB, V96, P122, DOI 10.1016/j.apmr.2014.06.021; Sibley KM, 2011, PHYS THER, V91, P1583, DOI 10.2522/ptj.20110063; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Stevenson TJ, 2001, AUST J PHYSIOTHER, V47, P29, DOI 10.1016/S0004-9514(14)60296-8; Sturnieks DL, 2004, J RHEUMATOL, V31, P2272; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Tran D, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-249; Tsang CSL, 2013, PHYS THER, V93, P1102, DOI 10.2522/ptj.20120454; Tyson SF, 2009, CLIN REHABIL, V23, P824, DOI 10.1177/0269215509335018; Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30; Wang CH, 2004, PHYS THER, V84, P430, DOI 10.1093/ptj/84.5.430; Whitney Susan, 2003, Physiother Res Int, V8, P178, DOI 10.1002/pri.288; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Wirz M, 2010, NEUROREHAB NEURAL RE, V24, P70, DOI 10.1177/1545968309341059; Wood-Dauphinee S, 1997, CAN J REHABIL, V10, P35	74	55	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120568	10.1371/journal.pone.0120568	http://dx.doi.org/10.1371/journal.pone.0120568			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768435	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500128
J	Tiedeken, EJ; Stout, JC				Tiedeken, Erin Jo; Stout, Jane C.			Insect-Flower Interaction Network Structure Is Resilient to a Temporary Pulse of Floral Resources from Invasive Rhododendron ponticum	PLOS ONE			English	Article							PLANT-POLLINATOR NETWORKS; ANIMAL MUTUALISTIC NETWORKS; ALIEN PLANT; RELATIVE ABUNDANCE; SEED PRODUCTION; NEST DENSITY; IMPACTS; CONSERVATION; INTEGRATION; TOLERANCE	Invasive alien plants can compete with native plants for resources, and may ultimately decrease native plant diversity and/or abundance in invaded sites. This could have consequences for native mutualistic interactions, such as pollination. Although invasive plants often become highly connected in plant- pollinator interaction networks, in temperate climates they usually only flower for part of the season. Unless sufficient alternative plants flower outside this period, whole- season floral resources may be reduced by invasion. We hypothesized that the cessation of flowering of a dominant invasive plant would lead to dramatic, seasonal compositional changes in plant- pollinator communities, and subsequent changes in network structure. We investigated variation in floral resources, flower- visiting insect communities, and interaction networks during and after the flowering of invasive Rhododendron ponticum in four invaded Irish woodland sites. Floral resources decreased significantly after R. ponticum flowering, but the magnitude of the decrease varied among sites. Neither insect abundance nor richness varied between the two periods (during and after R. ponticum flowering), yet insect community composition was distinct, mostly due to a significant reduction in Bombus abundance after flowering. During flowering R. ponticum was frequently visited by Bombus; after flowering, these highly mobile pollinators presumably left to find alternative floral resources. Despite compositional changes, however, network structural properties remained stable after R. ponticum flowering ceased: generality increased, but quantitative connectance, interaction evenness, vulnerability, H'(2) and network size did not change. This is likely because after R. ponticum flowering, two to three alternative plant species became prominent in networks and insects increased their diet breadth, as indicated by the increase in network- level generality. We conclude that network structure is robust to seasonal changes in floral abundance at sites invaded by alien, massflowering plant species, as long as alternative floral resources remain throughout the season to support the flower- visiting community.	[Tiedeken, Erin Jo; Stout, Jane C.] Univ Dublin Trinity Coll, Dept Bot, Sch Nat Sci, Dublin 2, Ireland; [Tiedeken, Erin Jo; Stout, Jane C.] Univ Dublin Trinity Coll, Trinity Ctr Biodivers Res, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Tiedeken, EJ (corresponding author), Univ Dublin Trinity Coll, Dept Bot, Sch Nat Sci, Dublin 2, Ireland.	tiedekee@tcd.ie	Stout, Jane C/B-1631-2010; borba, jared/D-6810-2015; Stout, Jane/AAS-8867-2020	Stout, Jane C/0000-0002-2027-0863; Stout, Jane/0000-0002-2027-0863	Science Foundation Ireland [10/RFP/EOB2842]; Irish Research Council's EMBARK Postgraduate Scholarship Scheme [RS/2010/2147]; National Science Foundation Graduate Research Fellowship [2010097514]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council's EMBARK Postgraduate Scholarship Scheme(Irish Research Council for Science, Engineering and Technology); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This project was funded by Science Foundation Ireland (http://www.sfi.ie/, grant number 10/RFP/EOB2842 to JCS) and the Irish Research Council's EMBARK Postgraduate Scholarship Scheme (http://research.ie/, grant number RS/2010/2147 to EJT). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (http://www.nsfgrfp.org/, under Grant No. 2010097514 to EJT). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or other funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Albrecht M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0773; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bartomeus I, 2010, J ECOL, V98, P440, DOI 10.1111/j.1365-2745.2009.01629.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bjerknes AL, 2007, BIOL CONSERV, V138, P1, DOI 10.1016/j.biocon.2007.04.015; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Byrne E, 2010, THESIS TRINITY COLL; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Clout M, 2002, TURNING TIDE BIOL IN; CROSS J R, 1975, Journal of Ecology, V63, P345, DOI 10.2307/2258859; CROSS JR, 1981, J ECOL, V69, P807, DOI 10.2307/2259638; Dicks LV, 2002, J ANIM ECOL, V71, P32, DOI 10.1046/j.0021-8790.2001.00572.x; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Dietzsch AC., 2009, THESIS TRINITY COLL; Dietzsch AC, 2011, OECOLOGIA, V167, P469, DOI 10.1007/s00442-011-1987-z; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Ferrero V, 2013, BIOL INVASIONS, V15, P2347, DOI 10.1007/s10530-013-0457-4; Ghazoul J, 2002, ECOL ENTOMOL, V27, P638, DOI 10.1046/j.1365-2311.2002.00438.x; Gibson RH, 2011, OIKOS, V120, P822, DOI 10.1111/j.1600-0706.2010.18927.x; Goulson D, 2000, OIKOS, V88, P547, DOI 10.1034/j.1600-0706.2000.880311.x; Hegland SJ, 2010, BIOL CONSERV, V143, P2092, DOI 10.1016/j.biocon.2010.05.018; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kaiser-Bunbury CN, 2009, PERSPECT PLANT ECOL, V11, P241, DOI 10.1016/j.ppees.2009.04.001; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Martin P. H., 1999, Biological Invasions, V1, P215, DOI 10.1023/A:1010084421858; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Morales CL, 2006, J ECOL, V94, P171, DOI 10.1111/j.1365-2745.2005.01069.x; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; National Biodiversity Data Centre, 2010, ID GUID IR BUMBL; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Padron B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006275; Parnell J, 2011, WEBBS IRISH FLORA; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Power EF, 2011, J APPL ECOL, V48, P561, DOI 10.1111/j.1365-2664.2010.01949.x; PYSEK P, 1995, J VEG SCI, V6, P711, DOI 10.2307/3236442; R Core Team, 2016, R FDN STAT COMP; Rose F., 2006, WILD FLOWER KEY IDEN; Stanley DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065516; Stout JC, 2007, BOT J LINN SOC, V155, P373, DOI 10.1111/j.1095-8339.2007.00719.x; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Stout JC, 2014, ACTA OECOL, V55, P78, DOI 10.1016/j.actao.2013.12.002; Stout JC, 2007, APIDOLOGIE, V38, P198, DOI 10.1051/apido:2006071; Stout JC, 2006, BIODIVERS CONSERV, V15, P755, DOI 10.1007/s10531-004-1065-5; Stubbs AE, 1983, BRIT HOVERFLIES ILLU; Sugiura N, 1996, ECOL RES, V11, P249, DOI 10.1007/BF02347782; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; USHER MB, 1986, PHILOS T ROY SOC B, V314, P695, DOI 10.1098/rstb.1986.0081; Vance NC, 2004, AM J BOT, V91, P2060, DOI 10.3732/ajb.91.12.2060; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vila M, 2009, P ROY SOC B-BIOL SCI, V276, P3887, DOI 10.1098/rspb.2009.1076; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x	76	27	29	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119733	10.1371/journal.pone.0119733	http://dx.doi.org/10.1371/journal.pone.0119733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764085	gold, Green Published, Green Submitted			2022-12-27	WOS:000351276300031
J	Calderon-Rivera, A; Sandoval, A; Gonzalez-Ramirez, R; Gonzalez-Billault, C; Felix, R				Calderon-Rivera, Aida; Sandoval, Alejandro; Gonzalez-Ramirez, Ricardo; Gonzalez-Billault, Christian; Felix, Ricardo			Regulation of Neuronal Ca(v)3.1 Channels by Cyclin-Dependent Kinase 5 (Cdk5)	PLOS ONE			English	Article							GATED CALCIUM-CHANNELS; SURFACE EXPRESSION; ACTIVATOR P35; CELLS; PAIN; PHOSPHORYLATION; DIFFERENTIATION; EPILEPSY; CLONING; ROLES	Low voltage-activated (LVA) T-type Ca2+ channels activate in response to subthreshold membrane depolarizations and therefore represent an important source of Ca2+ influx near the resting membrane potential. In neurons, these proteins significantly contribute to control relevant physiological processes including neuronal excitability, pacemaking and post-inhibitory rebound burst firing. Three subtypes of T-type channels (Ca(v)3.1 to Ca(v)3.3) have been identified, and using functional expression of recombinant channels diverse studies have validated the notion that T-type Ca2+ channels can be modulated by various endogenous ligands as well as by second messenger pathways. In this context, the present study reveals a previously unrecognized role for cyclin-dependent kinase 5 (Cdk5) in the regulation of native T-type channels in N1E-115 neuroblastoma cells, as well as recombinant Ca(v)3.1channels heterologously expressed in HEK-293 cells. Cdk5 and its co-activators play critical roles in the regulation of neuronal differentiation, cortical lamination, neuronal cell migration and axon outgrowth. Our results show that overexpression of Cdk5 causes a significant increase in whole cell patch clamp currents through T-type channels in N1E-115 cells, while siRNA knockdown of Cdk5 greatly reduced these currents. Consistent with this, overexpression of Cdk5 in HEK-293 cells stably expressing Ca(v)3.1channels upregulates macroscopic currents. Furthermore, using site-directed mutagenesis we identified a major phosphorylation site at serine 2234 within the C-terminal region of the Ca(v)3.1subunit. These results highlight a novel role for Cdk5 in the regulation of T-type Ca2+ channels.	[Calderon-Rivera, Aida; Sandoval, Alejandro] UNAM, FES Iztacala, Sch Med, Tlalnepantla, Mexico; [Gonzalez-Ramirez, Ricardo] Dr Manuel Gea Gonzalez Gen Hosp, Dept Mol Biol & Histocompatibil, Minist Hlth, Mexico City, DF, Mexico; [Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Felix, Ricardo] IPN, CINVESTAV, Ctr Res & Adv Studies, Natl Polytech Inst,Dept Cell Biol, Mexico City 07738, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad de Chile; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Felix, R (corresponding author), IPN, CINVESTAV, Ctr Res & Adv Studies, Natl Polytech Inst,Dept Cell Biol, Mexico City 07738, DF, Mexico.	rfelix@cell.cinvestav.mx	Gonzalez-Billault, Christian/P-2393-2019; González-Ramírez, Ricardo/O-1792-2014; Felix, Ricardo/A-6989-2008; Gonzalez-Billault, Christian/K-9622-2013	González-Ramírez, Ricardo/0000-0003-1399-8036; Felix, Ricardo/0000-0002-5383-7176; Sandoval, Alejandro/0000-0002-8558-6033; Gonzalez-Billault, Christian/0000-0003-0335-1482	Conacyt Mexico [128707-Q]; PAPIIT; UNAM [IN-221011]; CONICYT Chile [ACT114]	Conacyt Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT; UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work received funding from the following sources: 128707-Q, Conacyt Mexico, http://www.conacyt.mx/; IN-221011, PAPIIT; UNAM, http://dgapa.unam.mx/html/papiit/papit.html; and ACT114, CONICYT Chile, http://www.conicyt.cl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila G, 2004, CELL MOL NEUROBIOL, V24, P317, DOI 10.1023/B:CEMN.0000022765.52109.26; Avila T, 2006, J CELL PHYSIOL, V209, P448, DOI 10.1002/jcp.20743; Borquez DA, 2013, GENOMICS, V101, P221, DOI 10.1016/j.ygeno.2013.01.003; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Buraei Z, 2005, BIOPHYS J, V89, P1681, DOI 10.1529/biophysj.104.052837; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chemin J, 2007, J BIOL CHEM, V282, P32710, DOI 10.1074/jbc.M702746200; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cribbs LL, 2000, FEBS LETT, V466, P54, DOI 10.1016/S0014-5793(99)01756-1; Francois A, 2014, PFLUG ARCH EUR J PHY, V466, P707, DOI 10.1007/s00424-014-1484-4; Gandini Maria A, 2014, Cold Spring Harb Protoc, V2014, P389, DOI 10.1101/pdb.prot073205; Gonzalez-Ramirez R, 2014, J CELL PHYSIOL, V229, P551, DOI 10.1002/jcp.24432; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lee JH, 1999, J NEUROSCI, V19, P1912; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; Matsushita M, 1996, BRAIN RES, V734, P319, DOI 10.1016/S0006-8993(96)00702-0; Mor M, 2012, AM J PHYSIOL-CELL PH, V303, pC192, DOI 10.1152/ajpcell.00427.2011; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; Nelson MT, 2006, CURR PHARM DESIGN, V12, P2189, DOI 10.2174/138161206777585184; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Panner A, 2005, CELL CALCIUM, V37, P105, DOI 10.1016/j.ceca.2004.07.002; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Su SC, 2012, NEURON, V75, P675, DOI 10.1016/j.neuron.2012.06.023; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Toledo A, 2012, CELL CALCIUM, V52, P377, DOI 10.1016/j.ceca.2012.06.005; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Weiss N, 2013, PFLUG ARCH EUR J PHY, V465, P1159, DOI 10.1007/s00424-013-1259-3; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Yarotskyy V, 2012, J NEUROPHYSIOL, V107, P1942, DOI 10.1152/jn.00993.2011; YOSHII M, 1988, BIOPHYS J, V54, P885, DOI 10.1016/S0006-3495(88)83025-X; Zamponi GW, 2010, PFLUG ARCH EUR J PHY, V460, P395, DOI 10.1007/s00424-009-0772-x	44	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119134	10.1371/journal.pone.0119134	http://dx.doi.org/10.1371/journal.pone.0119134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760945	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000048
J	Leles, B; Chaves, AV; Russo, P; Batista, JAN; Lovato, MB				Leles, Bruno; Chaves, Anderson V.; Russo, Philip; Batista, Joao A. N.; Lovato, Maria Bernadete			Genetic Structure Is Associated with Phenotypic Divergence in Floral Traits and Reproductive Investment in a High-Altitude Orchid from the Iron Quadrangle, Southeastern Brazil	PLOS ONE			English	Article							LOCAL ADAPTATION; POPULATION-GENETICS; LANDSCAPE GENETICS; FLOW; VARIABILITY; DIFFERENTIATION; SPECIATION; EVOLUTION; SOFTWARE; PHYLOGEOGRAPHY	Knowledge of the role of Neotropical montane landscapes in shaping genetic connectivity and local adaptation is essential for understanding the evolutionary processes that have shaped the extraordinary species diversity in these regions. In the present study, we examined the landscape genetics, estimated genetic diversity, and explored genetic relationships with morphological variability and reproductive strategies in seven natural populations of Cattleya liliputana (Orchidaceae). Nuclear microsatellite markers were used for genetic analyses. Spatial Bayesian clustering and population-based analyses revealed significant genetic structuring and high genetic diversity (He = 0.733 +/- 0.03). Strong differentiation was found between populations over short spatial scales (FST = 0.138, p < 0.001), reflecting the landscape discontinuity and isolation. Monmonier's maximum difference algorithm, Bayesian analysis on STRUCTURE and principal component analysis identified one major genetic discontinuity between populations. Divergent genetic groups showed phenotypic divergence in flower traits and reproductive strategies. Increased sexual reproductive effort was associated with rock outcrop type and may be a response to adverse conditions for growth and vegetative reproduction. Here we discuss the effect of restricted gene flow, local adaptation and phenotypic plasticity as drivers of population differentiation in Neotropical montane rock outcrops.	[Leles, Bruno; Chaves, Anderson V.; Russo, Philip; Lovato, Maria Bernadete] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Batista, Joao A. N.] Univ Fed Minas Gerais, Dept Bot, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Leles, B (corresponding author), Univ Estadual Paulista UNESP, Programa Posgrad Ecol & Biodiversidade, Dept Ecol, Rio Claro, SP, Brazil.	lovatomb@icb.ufmg.br; brunopleles@gmail.com	Lovato, Maria B/D-5303-2018; Chaves, Anderson Vieira/AAB-2717-2019; Batista, Joao A N/I-3389-2015; Lovato, Maria B/C-2126-2013; Russo, Philip/P-8784-2015	Lovato, Maria B/0000-0001-7009-3079; Chaves, Anderson Vieira/0000-0002-0934-1763; Batista, Joao A N/0000-0003-4640-0942; Russo, Philip/0000-0002-1607-0009	Fundacao Boticario; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPq	Fundacao Boticario; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Fundacao Boticario and by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais provided resources for editing the language of the manuscript. MBL received research fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RC, 2012, MOL PHYLOGENET EVOL, V62, P880, DOI 10.1016/j.ympev.2011.11.004; Antonelli A, 2010, BIOL J LINN SOC, V100, P597, DOI 10.1111/j.1095-8312.2010.01438.x; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Armbruster WS, 2009, EVOL ECOL, V23, P159, DOI 10.1007/s10682-008-9259-z; Ashman TL, 2006, HEREDITY, V96, P343, DOI 10.1038/sj.hdy.6800815; Azevedo MTA, 2007, BOT J LINN SOC, V153, P33, DOI 10.1111/j.1095-8339.2007.00589.x; Barbosa AR, 2012, AM J BOT, V99, P1477, DOI 10.3732/ajb.1200070; Barros FD, 2012, PLANT BIOLOGY, V14, P208, DOI 10.1111/j.1438-8677.2011.00474.x; BARTHLOTT W, 1996, ERDKUNDE, V50, P317, DOI [DOI 10.3112/ERDKUNDE.1996.04.03, 10.1007/s004250050096, DOI 10.1007/S004250050096]; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Borba EL, 2007, PLANT SYST EVOL, V267, P129, DOI 10.1007/s00606-007-0555-9; Borba EL, 2001, ANN BOT-LONDON, V88, P89, DOI 10.1006/anbo.2001.1435; Burke A, 2003, DIVERS DISTRIB, V9, P375, DOI 10.1046/j.1472-4642.2003.00035.x; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; Caro LM, 2013, J EVOLUTION BIOL, V26, P357, DOI 10.1111/jeb.12055; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Collevatti RG, 2009, ANN BOT-LONDON, V104, P655, DOI 10.1093/aob/mcp157; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; da Cruz DT, 2011, PLANT SYST EVOL, V294, P87, DOI 10.1007/s00606-011-0444-0; Darwin C., 1859, ORIGINS SPECIES MEAN; Development Core Team R, 2012, R LANG ENV STAT COMP; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; DNPM, 2005, FERR; Doyle J. J., 1987, PHYTOCHEM B, P11; Echternacht L, 2011, FLORA, V206, P782, DOI 10.1016/j.flora.2011.04.003; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Friedman J, 2013, NEW PHYTOL, V199, P571, DOI 10.1111/nph.12260; Gaston A, 2013, J EXP BOT, V64, P1837, DOI 10.1093/jxb/ert047; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gentry AH, 1995, P NEOTR MONT FOR BIO; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Gomez JM, 2009, EVOLUTION, V63, P1820, DOI 10.1111/j.1558-5646.2009.00667.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goulart MF, 2011, BIOTROPICA, V43, P695, DOI 10.1111/j.1744-7429.2011.00760.x; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2012, SYST BIOL, V61, P897, DOI 10.1093/sysbio/sys038; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; Gutierrez-Pinto N, 2012, MOL PHYLOGENET EVOL, V64, P156, DOI 10.1016/j.ympev.2012.03.011; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HENDERSON A, 1991, NATURE, V351, P21, DOI 10.1038/351021e0; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jacobi CM, 2007, BIODIVERS CONSERV, V16, P2185, DOI 10.1007/s10531-007-9156-8; Jacobi CM, 2008, AMBIO, V37, P324, DOI 10.1579/0044-7447(2008)37[324:TCOIOT]2.0.CO;2; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Juillet N, 2010, PERSPECT PLANT ECOL, V12, P317, DOI 10.1016/j.ppees.2010.05.001; Kaczorowski RL, 2008, EVOLUTION, V62, P1738, DOI 10.1111/j.1558-5646.2008.00400.x; Kartzinel TR, 2013, MOL ECOL, V22, P6048, DOI 10.1111/mec.12551; Knauer LG, 2007, GEONOMOS, V15, P8190, DOI [DOI 10.18285/GEONOMOS.V15I1.109, 10.18285/geonomos.v15i1.109]; Krizek BA, 2013, J EXP BOT, V64, P1427, DOI 10.1093/jxb/ert025; Leal B, 2013, THESIS U FEDERAL MIN; Lousada JM, 2013, BRAZ J BOT, V36, P45, DOI 10.1007/s40415-013-0001-x; Lousada JM, 2011, GENETICA, V139, P431, DOI 10.1007/s10709-011-9561-5; MAC ARTHUR ROBERT H., 1967; Magurran AE, 1998, PHILOS T R SOC B, V353, P275, DOI 10.1098/rstb.1998.0209; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Mota RC, 2006, THESIS U FEDEAL MINA; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Novello M, 2013, GENET MOL RES, V12, P3274, DOI 10.4238/2013.September.3.3; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Osborne OG, 2013, GENOME BIOL EVOL, V5, P1704, DOI 10.1093/gbe/evt127; Pabst G.F.J., 1975, ORCHIDACEAE BRASILIE, V1; Palma-Silva C, 2011, MOL ECOL, V20, P3185, DOI 10.1111/j.1365-294X.2011.05143.x; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Pfennig DW, 2014, MOL ECOL, V23, P4438, DOI 10.1111/mec.12887; Phillips RD, 2012, MOL ECOL, V21, P5208, DOI 10.1111/mec.12036; Pinheiro F, 2011, J BIOGEOGR, V38, P1923, DOI 10.1111/j.1365-2699.2011.02539.x; Pinheiro F, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-49; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Pritchard JK, 2000, GENETICS, V155, P945; Rapini A., 2008, MEGADIVERSIDADE, V4, P15; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Safford HD, 2007, J BIOGEOGR, V34, P1701, DOI 10.1111/j.1365-2699.2007.01732.x; Salzmann CC, 2007, ANN BOT-LONDON, V100, P757, DOI 10.1093/aob/mcm161; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Silva-Pereira V, 2007, PLANT SYST EVOL, V269, P171, DOI 10.1007/s00606-007-0583-5; Smidt EC, 2006, PLANT SPEC BIOL, V21, P85, DOI 10.1111/j.1442-1984.2006.00154.x; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Spier CA, 2003, MINER DEPOSITA, V38, P751, DOI 10.1007/s00126-003-0371-2; *STATSOFT INC, 2003, STATISTICA DAT AN SO; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Van den Berg C, 2014, PHYTOTAXA, V186, P75, DOI 10.11646/phytotaxa.186.2.2; van den Berg C, 2009, ANN BOT-LONDON, V104, P417, DOI 10.1093/aob/mcp101; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verola CF, 2008, THESIS U CAMPINAS; Willi Y, 2007, J EVOLUTION BIOL, V20, P534, DOI 10.1111/j.1420-9101.2006.01263.x; Withner C., 1990, CATTLEYAS THEIR RELA, V3; Wright JW, 2007, PLANT SOIL, V293, P209, DOI 10.1007/s11104-006-9181-5; Zitari A, 2012, HEREDITY, V108, P219, DOI 10.1038/hdy.2011.61	108	11	11	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120645	10.1371/journal.pone.0120645	http://dx.doi.org/10.1371/journal.pone.0120645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756994	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700071
J	Bashar, K; Healy, DA; Elsheikh, S; Browne, LD; Walsh, MT; Clarke-Moloney, M; Burke, PE; Kavanagh, EG; Walsh, SR				Bashar, Khalid; Healy, Donagh A.; Elsheikh, Sawsan; Browne, Leonard D.; Walsh, Michael T.; Clarke-Moloney, Mary; Burke, Paul E.; Kavanagh, Eamon G.; Walsh, Stewart R.			One-Stage vs. Two-Stage Brachio-Basilic Arteriovenous Fistula for Dialysis Access: A Systematic Review and a Meta-Analysis	PLOS ONE			English	Article							VEIN TRANSPOSITION; VASCULAR ACCESS; OUTCOMES; HEMODIALYSIS; MANAGEMENT; PREDICTORS	Introduction A brachiobasilic arteriovenous fistula (BB-AVF) can provide access for haemodialysis in patients who are not eligible for a more superficial fistula. However, it is unclear whether one-or two-stage BB-AVF is the best option for patients. Aim To systematically assess the difference between both procedures in terms of access maturation, patency and postoperative complications. Methods Online search for randomised controlled trials (RCTs) and observational studies that compared the one-stage versus the two-stage technique for creating a BB-AVF. Results Eight studies were included (849 patients with 859 fistulas), 366 created using a one-stage technique, while 493 in a two-stage approach. There was no statistically significant difference between the two groups in the rate of successful maturation (Pooled risk ratio = 0.95 [0.82, 1.11], P = 0.53). Similarly, the incidence of postoperative haematoma (Pooled risk ratio = 0.73 [0.34, 1.58], P = 0.43), wound infection (Pooled risk ratio = 0.77 [0.35, 1.68], P = 0.51) and steal syndrome (Pooled risk ratio = 0.65 [0.27, 1.53], P = 0.32) were statistically comparable. Conclusion Although more studies seem to favour the two-stage BVT approach, evidence in the literature is not sufficient to draw a final conclusion as the difference between the one-stage and the two-stage approaches for creation of a BB-AVF is not statistically significant in terms of the overall maturation rate and postoperative complications. Patency rates (primary, assisted primary and secondary) were comparable in the majority of studies. Large randomised properly conducted trials with superior methodology and adequate sub-group analysis are needed before making a final recommendation.	[Bashar, Khalid; Healy, Donagh A.; Clarke-Moloney, Mary; Burke, Paul E.; Kavanagh, Eamon G.] Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland; [Elsheikh, Sawsan] James Connolly Mem Hosp, Dept Acute Med, Dublin, Ireland; [Browne, Leonard D.; Walsh, Michael T.] Univ Limerick, CABER, Dept Mech Aeronaut & Biomed Engn, Mat & Surface Sci Inst, Limerick, Ireland; [Walsh, Stewart R.] Natl Univ Ireland, Dept Surg, Galway, Ireland	University of Limerick; University of Limerick; Ollscoil na Gaillimhe-University of Galway	Bashar, K (corresponding author), Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland.	khalid@live.ie	Walsh, Michael T/C-1405-2010; Walsh, Stewart R/AAC-1229-2021	Walsh, Michael T/0000-0002-1672-8106; Walsh, Stewart/0000-0002-1006-9541; Browne, Leonard/0000-0002-9203-1212				Agarwal A, 2014, SEMIN DIALYSIS, V27, P298, DOI 10.1111/sdi.12170; Allon M, 2007, CLIN J AM SOC NEPHRO, V2, P786, DOI 10.2215/CJN.00860207; Anaya-Ayala JE, 2011, J VASC SURG, V53, P720, DOI 10.1016/j.jvs.2010.09.072; [Anonymous], 1997, Am J Kidney Dis, V30, pS150; Bashar K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104931; Centofanti Guilherme, 2011, Int Arch Med, V4, P16, DOI 10.1186/1755-7682-4-16; DAGHER F, 1976, J SURG RES, V20, P373, DOI 10.1016/0022-4804(76)90029-9; DERSIMONIAN R, 1983, HARVARD EDUC REV, V53, P1; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Effat M, 2013, STAGING BRACHIOBASIL, P9; El Mallah S, 1998, INT ANGIOL, V17, P65; Ethier J, 2008, NEPHROL DIAL TRANSPL, V23, P3219, DOI 10.1093/ndt/gfn261; Feldman HI, 2003, AM J KIDNEY DIS, V42, P1000, DOI 10.1016/j.ajkd.2003.07.003; Fluck R, 2011, NEPHRON CLIN PRACT, V118, pC225, DOI 10.1159/000328071; Frankel A, 2006, EUR J VASC ENDOVASC, V31, P417, DOI 10.1016/j.ejvs.2005.10.003; Glickman M, 2014, J VASC ACCESS, V15, pS81, DOI 10.5301/jva.5000260; Harper SJF, 2008, EUR J VASC ENDOVASC, V36, P237, DOI 10.1016/j.ejvs.2008.02.012; Heye S, 2010, EUR J VASC ENDOVASC, V39, P340, DOI 10.1016/j.ejvs.2009.11.036; Hirth RA, 1996, JAMA-J AM MED ASSOC, V276, P1303; Hossny A, 2003, J VASC SURG, V37, P821, DOI 10.1067/mva.2003.181; Ilhan G, 2013, J VASC ACCESS, V14, P83, DOI 10.5301/jva.5000097; Jindal KK, 1999, J AM SOC NEPHROL, V10, pS297; Kakkos SK, 2010, EUR J VASC ENDOVASC, V39, P612, DOI 10.1016/j.ejvs.2010.01.006; Koksoy C, 2009, J VASC SURG, V49, P171, DOI 10.1016/j.jvs.2008.08.002; Lauvao LS, 2009, J VASC SURG, V49, P1499, DOI 10.1016/j.jvs.2009.02.018; Leblanc M, 2003, J Vasc Access, V4, P39; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lynch JR, 2011, CURR OPIN NEPHROL HY, V20, P583, DOI 10.1097/MNH.0b013e32834b33c4; Maya ID, 2009, CLIN J AM SOC NEPHRO, V4, P86, DOI 10.2215/CJN.02910608; McCann M, 2008, J REN CARE, V34, P77, DOI 10.1111/j.1755-6686.2008.00022.x; Mendes RR, 2002, J VASC SURG, V36, P460, DOI 10.1067/mva.2002.126544; NKF-KDOQI, 2006, 2006 UPD CLIN PRACT; Ozcan S, 2013, CARDIOVASC J AFR, V24, P364, DOI 10.5830/CVJA-2013-077; Pisoni RL, 2002, KIDNEY INT, V61, P305, DOI 10.1046/j.1523-1755.2002.00117.x; Rayner HC, 2003, KIDNEY INT, V63, P323, DOI 10.1046/j.1523-1755.2003.00724.x; Sidawy AN, 2002, J VASC SURG, V35, P603, DOI 10.1067/mva.2002.122025; Spergel LM, 2007, J NEPHROL, V20, P388; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Sultan S, 2012, VASC ENDOVASC SURG, V46, P624, DOI 10.1177/1538574412462635; Syed FA, 2012, ANN VASC SURG, V26, P852, DOI 10.1016/j.avsg.2011.12.013; Taghizadeh A, 2003, EUR J VASC ENDOVASC, V26, P670, DOI 10.1016/j.ejvs.2003.09.002; The Nordic Cochrane Centre TCc, 2012, REV MAN REVMAN; Vrakas G, 2013, J VASC SURG, V58, P1300, DOI 10.1016/j.jvs.2013.05.030	43	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0120154	10.1371/journal.pone.0120154	http://dx.doi.org/10.1371/journal.pone.0120154			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751655	Green Published, gold			2022-12-27	WOS:000350692700035
J	Evans, ML; Hori, TS; Rise, ML; Fleming, IA				Evans, Melissa L.; Hori, Tiago S.; Rise, Matthew L.; Fleming, Ian A.			Transcriptomic Responses of Atlantic Salmon (Salmo salar) to Environmental Enrichment during Juvenile Rearing	PLOS ONE			English	Article							WILD; FITNESS; GROWTH; EXPRESSION; BRAIN; DOMESTICATION; CONSERVATION; ADAPTATION; ANIMALS	Captive rearing programs (hatcheries) are often used in conservation and management efforts for at-risk salmonid fish populations. However, hatcheries typically rear juveniles in environments that contrast starkly with natural conditions, which may lead to phenotypic and/or genetic changes that adversely affect the performance of juveniles upon their release to the wild. Environmental enrichment has been proposed as a mechanism to improve the efficacy of population restoration efforts from captive-rearing programs; in this study, we examine the influence of environmental enrichment during embryo and yolk-sac larval rearing on the transcriptome of Atlantic salmon (Salmo salar). Full siblings were reared in either a hatchery environment devoid of structure or an environment enriched with gravel substrate. At the end of endogenous feeding by juveniles, we examined patterns of gene transcript abundance in head tissues using the cGRASP-designed Agilent 4x44K microarray. Significance analysis of microarrays (SAM) indicated that 808 genes were differentially transcribed between the rearing environments and a total of 184 gene ontological (GO) terms were over-or under-represented in this gene list, several associated with mitosis/cell cycle and muscle and heart development. There were also pronounced differences among families in the degree of transcriptional response to rearing environment enrichment, suggesting that gene-by-environment effects, possibly related to parental origin, could influence the efficacy of enrichment interventions.	[Evans, Melissa L.; Hori, Tiago S.; Rise, Matthew L.; Fleming, Ian A.] Mem Univ Newfoundland, Dept Ocean Sci, Ctr Ocean Sci, St John, NF A1C 5S7, Canada	Memorial University Newfoundland	Evans, ML (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Coastal Oregon Marine Expt Stn, 2030 SE Marine Sci Dr, Newport, OR 97365 USA.	melissa.lea.evans@gmail.com	Fleming, Ian/I-7217-2012	Hori, Tiago/0000-0002-6784-0800	Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was conducted as part of the strategic project SMOLTPRO, financed by the Swedish Research Council Formas (http://www.smoltpro.science.gu.se) The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Anderson JH, 2013, EVOL APPL, V6, P165, DOI 10.1111/j.1752-4571.2012.00271.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; Bamberger A, 2009, J FISH BIOL, V74, P1419, DOI 10.1111/j.1095-8649.2009.02208.x; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Berejikian BA, 2000, CAN J FISH AQUAT SCI, V57, P628, DOI 10.1139/f99-288; Bo TH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh026; Booman M, 2011, MAR BIOTECHNOL, V13, P733, DOI 10.1007/s10126-010-9335-6; Bougas B, 2013, HEREDITY, V110, P484, DOI 10.1038/hdy.2012.113; Brown C, 2002, FISH FISH, V3, P79, DOI 10.1046/j.1467-2979.2002.00077.x; CARUNCHO HJ, 1994, J ANAT, V184, P355; Celton M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-15; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Debes PV, 2012, MOL ECOL, V21, P2574, DOI 10.1111/j.1365-294X.2012.05567.x; Department of Fisheries and Oceans Canada, 2013, REC POT ASS S NEWF A, P43; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Einum Sigurd, 2001, Nordic Journal of Freshwater Research, V75, P56; FLEMING IA, 1994, CONSERV BIOL, V8, P886, DOI 10.1046/j.1523-1739.1994.08030863-13.x; Frank M, 1999, J NEUROCHEM, V73, P587, DOI 10.1046/j.1471-4159.1999.0730587.x; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Gonda A, 2009, J EVOLUTION BIOL, V22, P1721, DOI 10.1111/j.1420-9101.2009.01782.x; Gonda A, 2009, P ROY SOC B-BIOL SCI, V276, P2085, DOI 10.1098/rspb.2009.0026; HANSEN T, 1985, AQUACULTURE, V48, P177, DOI 10.1016/0044-8486(85)90103-6; HANSEN TJ, 1985, CAN J FISH AQUAT SCI, V42, P1073, DOI 10.1139/f85-133; Hon i TS, 2012, BMC GENOMICS, V13, P431, DOI [doi: 10.1186/1471-2164-13-431 PM ID: 22928584, DOI 10.1186/1471-2164-13-431]; Jantzen Stuart G, 2011, BMC Res Notes, V4, P88, DOI 10.1186/1756-0500-4-88; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jonsson B, 2011, FISH FISH SER, V33, P1, DOI 10.1007/978-94-007-1189-1_1; Kihslinger RL, 2006, COMP BIOCHEM PHYS A, V145, P145, DOI 10.1016/j.cbpa.2006.06.041; Kihslinger RL, 2006, J EXP BIOL, V209, P504, DOI 10.1242/jeb.02019; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Lema SC, 2005, COMP BIOCHEM PHYS A, V141, P327, DOI 10.1016/j.cbpb.2005.06.003; Lorenzen K, 2012, BIOL REV, V87, P639, DOI 10.1111/j.1469-185X.2011.00215.x; MARR D. H. A., 1963, ANIMAL BEHAVIOUR, V11, P412, DOI 10.1016/S0003-3472(63)80148-7; Mason G, 2013, ANIM BEHAV, V85, P1113, DOI 10.1016/j.anbehav.2013.02.002; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; Maynard DJ, 1994, REV SEMINATURAL CULT, P1; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Meier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085171; Milot E, 2013, EVOL APPL, V6, P472, DOI 10.1111/eva.12028; Naslund J, 2014, FISH FISH IN PRESS; Naslund J, 2013, CAN J FISH AQUAT SCI, V70, P585, DOI 10.1139/cjfas-2012-0302; Naslund J, 2012, CAN J FISH AQUAT SCI, V69, P1481, DOI [10.1139/F2012-074, 10.1139/f2012-074]; Normandeau E, 2009, EVOL APPL, V2, P489, DOI 10.1111/j.1752-4571.2009.00074.x; Pavey Scott A., 2011, BMC Ecology, V11, P31, DOI 10.1186/1472-6785-11-31; Peterson R, 1993, AQUACULT ENG, P85; Salvanes AGV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1331; Schwender H, 2006, NEWSLETTER R PROJECT, V6, P45; Simon RM, 2003, STAT BIOL HLTH, P205; Sneddon LU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018181; Solberg MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054469; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tang SJ, 1999, FEBS LETT, V459, P95, DOI 10.1016/S0014-5793(99)01229-6; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; West-Eberhard Mary Jane, 2003, pi; Winkowski JJ, 2014, THESIS; Xu P, 2011, MAR BIOTECHNOL, V13, P215, DOI 10.1007/s10126-010-9283-1; Xu XY, 2011, COMP BIOCHEM PHYS B, V159, P115, DOI 10.1016/j.cbpb.2011.02.008; Yufera M, 2012, MAR BIOTECHNOL, V14, P423, DOI 10.1007/s10126-011-9422-3	62	12	13	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118378	10.1371/journal.pone.0118378	http://dx.doi.org/10.1371/journal.pone.0118378			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742646	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000350688100016
J	Thandavarayan, RA; Giridharan, VV; Arumugam, S; Suzuki, K; Ko, KM; Krishnamurthy, P; Watanabe, K; Konishi, T				Thandavarayan, Rajarajan A.; Giridharan, Vijayasree V.; Arumugam, Somasundaram; Suzuki, Kenji; Ko, Kam Ming; Krishnamurthy, Prasanna; Watanabe, Kenichi; Konishi, Tetsuya			Schisandrin B Prevents Doxorubicin Induced Cardiac Dysfunction by Modulation of DNA Damage, Oxidative Stress and Inflammation through Inhibition of MAPK/p53 Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; LEFT-VENTRICULAR DYSFUNCTION; INDUCED CARDIOMYOPATHY; ANGIOTENSIN-II; ADRIAMYCIN CARDIOTOXICITY; SUPEROXIDE-PRODUCTION; DIABETES-MELLITUS; INDUCED APOPTOSIS; REACTIVE OXYGEN	Doxorubicin (Dox) is a highly effective antineoplastic drug. However, Dox-induced apoptosis in cardiomyocytes leads to irreversible degenerative cardiomyopathy, which limits Dox clinical application. Schisandrin B (Sch B), a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis, has been shown to protect against oxidative damage in liver, heart and brain tissues in rodents. In current study, we investigated possible protective effects of Sch B against Dox-induced cardiomyopathy in mice. Mice received a single injection of Dox (20 mg/kg IP). Five days after Dox administration, left ventricular (LV) performance was significantly depressed and was improved by Sch B treatment. Sch B prevented the Dox-induced increase in lipid peroxidation, nitrotyrosine formation, and metalloproteinase activation in the heart. In addition, the increased expression of phospho-p38 MAPK and phospho-MAPK activated mitogen kinase 2 levels by Dox were significantly suppressed by Sch B treatment. Sch B also attenuated Dox-induced higher expression of LV proinflammatory cytokines, cardiomyocyte DNA damage, myocardial apoptosis, caspase-3 positive cells and phopho-p53 levels in mice. Moreover, LV expression of NADPH oxidase subunits and reactive oxygen species were significantly less in Sch B treatment mice after Dox injection. These findings suggest that Sch B attenuates Dox-induced cardiotoxicity via antioxidative and anti-inflammatory effects.	[Thandavarayan, Rajarajan A.; Arumugam, Somasundaram; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Akiha Ku, Niigata, Japan; [Thandavarayan, Rajarajan A.; Krishnamurthy, Prasanna] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Giridharan, Vijayasree V.] JKK Nattraja Coll Pharm, Komarapalayam, Tamil Nadu, India; [Suzuki, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol & Hepatol, Niigata, Japan; [Ko, Kam Ming] Hong Kong Univ Sci & Technol, Sect Biochem & Cell Biol, Hong Kong, Hong Kong, Peoples R China; [Konishi, Tetsuya] NUPALS, Basic Studies Generat Funct Foods, NUPALS Liaison RD Promot Devis, Akiha Ku, Niigata, Japan; [Konishi, Tetsuya] Changchun Univ Chinese Med, Changchun, Peoples R China	Niigata University; The Methodist Hospital System; The Methodist Hospital - Houston; Niigata University; Hong Kong University of Science & Technology; Changchun University of Chinese Medicine	Konishi, T (corresponding author), NUPALS, Basic Studies Generat Funct Foods, NUPALS Liaison RD Promot Devis, Akiha Ku, Higashi Jima 265-1, Niigata, Japan.	konishi@nupals.ac.jp	Arumugam, S./AAT-7570-2020	KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Arumugam, Somasundaram/0000-0002-2096-2552	NHLBI NIH HHS [R01 HL116729] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116729] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bien S, 2007, CANCER RES, V67, P10428, DOI 10.1158/0008-5472.CAN-07-1344; Caceres DD, 1999, PHYTOMEDICINE, V6, P217, DOI 10.1016/S0944-7113(99)80012-9; Chaubey RC, 2001, MUTAT RES-GEN TOX EN, V490, P187, DOI 10.1016/S1383-5718(00)00166-2; Chiu PY, 2006, BIOGERONTOLOGY, V7, P199, DOI 10.1007/s10522-006-9017-y; Force T, 1998, HYPERTENSION, V31, P152, DOI 10.1161/01.HYP.31.1.152; Giridharan VV, 2011, FREE RADICAL RES, V45, P950, DOI 10.3109/10715762.2011.571682; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guo LY, 2008, EUR J PHARMACOL, V591, P293, DOI 10.1016/j.ejphar.2008.06.074; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; IP SP, 1995, PLANTA MED, V61, P398, DOI 10.1055/s-2006-958123; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; Konorev EA, 2002, FREE RADICAL BIO MED, V33, P988, DOI 10.1016/S0891-5849(02)00989-9; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Li TM, 2000, CIRCULATION, V102, P2105, DOI 10.1161/01.CIR.102.17.2105; Lou H, 2005, AM J PHYSIOL-HEART C, V288, pH1925, DOI 10.1152/ajpheart.01054.2004; Mak DHF, 1996, MOL CELL BIOCHEM, V165, P161; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MONTI E, 1995, ANTICANCER RES, V15, P193; Muller E, 1999, J CELL PHYSIOL, V181, P462, DOI 10.1002/(SICI)1097-4652(199912)181:3<462::AID-JCP10>3.0.CO;2-T; Neilan TG, 2007, CIRCULATION, V116, P506, DOI 10.1161/CIRCULATIONAHA.106.652339; Nishida H, 2007, J PHARMACOL SCI, V104, P73, DOI 10.1254/jphs.FP0070100; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Olson LE, 2003, CANCER RES, V63, P6602; RINEHART JJ, 1974, ANN INTERN MED, V81, P475, DOI 10.7326/0003-4819-81-4-475; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Steenbergen C, 2002, BASIC RES CARDIOL, V97, P276, DOI 10.1007/s00395-002-0364-9; Takaya T, 2006, ATHEROSCLEROSIS, V186, P402, DOI 10.1016/j.atherosclerosis.2005.08.009; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Thandavarayan RA, 2010, FREE RADICAL BIO MED, V49, P1422, DOI 10.1016/j.freeradbiomed.2010.08.005; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Thandavarayan RA, 2008, BIOCHEM PHARMACOL, V75, P1797, DOI 10.1016/j.bcp.2008.02.003; Tian W, 2000, AM J PHYSIOL-RENAL, V279, pF593, DOI 10.1152/ajprenal.2000.279.4.F593; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Wang NY, 2002, CIRC J, V66, P763, DOI 10.1253/circj.66.763; Wang XJ, 1999, FREE RADICAL RES, V31, P449, DOI 10.1080/10715769900301011; Weinstein DM, 2000, J PHARMACOL EXP THER, V294, P396; Westermann D, 2006, DIABETOLOGIA, V49, P2507, DOI 10.1007/s00125-006-0385-2; Wold LE, 2005, CANCER DETECT PREV, V29, P294, DOI 10.1016/j.cdp.2004.07.008; Zhang GX, 2004, HYPERTENSION, V43, P117, DOI 10.1161/01.HYP.0000105110.12667.F8	52	77	83	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119214	10.1371/journal.pone.0119214	http://dx.doi.org/10.1371/journal.pone.0119214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742619	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100092
J	Brenner, E; Smeets, JBJ				Brenner, Eli; Smeets, Jeroen B. J.			How Moving Backgrounds Influence Interception	PLOS ONE			English	Article							CONTINUOUS VISUAL FEEDBACK; REACHING MOVEMENTS; HAND; MOTION; TARGETS; PERCEPTION; PREDICTION; POSITION; INFORMATION; RESPONSES	Reaching movements towards an object are continuously guided by visual information about the target and the arm. Such guidance increases precision and allows one to adjust the movement if the target unexpectedly moves. On-going arm movements are also influenced by motion in the surrounding. Fast responses to motion in the surrounding could help cope with moving obstacles and with the consequences of changes in one's eye orientation and vantage point. To further evaluate how motion in the surrounding influences interceptive movements we asked subjects to tap a moving target when it reached a second, static target. We varied the direction and location of motion in the surrounding, as well as details of the stimuli that are known to influence eye movements. Subjects were most sensitive to motion in the background when such motion was near the targets. Whether or not the eyes were moving, and the direction of the background motion in relation to the direction in which the eyes were moving, had very little influence on the response to the background motion. We conclude that the responses to background motion are driven by motion near the target rather than by a global analysis of the optic flow and its relation with other information about self-motion.	[Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, MOVE Res Inst, Fac Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Brenner, E (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst, Fac Human Movement Sci, Amsterdam, Netherlands.	e.brenner@fbw.vu.nl	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Netherlands Organisation for Scientific Research (NWO) [464-13-169]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organisation for Scientific Research (NWO) grant 464-13-169; http://www.nwo.nl/en; EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abekawa N, 2010, J NEUROPHYSIOL, V103, P2717, DOI 10.1152/jn.91133.2008; Aivar MP, 2008, EXP BRAIN RES, V190, P251, DOI 10.1007/s00221-008-1475-9; Amano K, 2009, J NEUROPHYSIOL, V101, P888, DOI 10.1152/jn.90993.2008; Brenner E, 1998, EXP BRAIN RES, V122, P467, DOI 10.1007/s002210050535; Brenner E, 1997, J MOTOR BEHAV, V29, P297, DOI 10.1080/00222899709600017; Brenner E, 2003, SPATIAL VISION, V16, P365, DOI 10.1163/156856803322467581; BRENNER E, 1994, EXP BRAIN RES, V99, P316, DOI 10.1007/BF00239598; Brenner E, 2013, EXP BRAIN RES, V230, P207, DOI 10.1007/s00221-013-3645-7; Brenner E, 2011, HUM MOVEMENT SCI, V30, P475, DOI 10.1016/j.humov.2010.12.007; Brenner E, 2009, EXP BRAIN RES, V196, P375, DOI 10.1007/s00221-009-1857-7; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; CARLTON LG, 1981, J EXP PSYCHOL HUMAN, V7, P1019, DOI 10.1037/0096-1523.7.5.1019; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; de Lussanet MHE, 2001, EXP BRAIN RES, V137, P246, DOI 10.1007/s002210000607; de Rugy A, 2012, J NEUROPHYSIOL, V107, P766, DOI 10.1152/jn.00854.2011; Desmurget M, 1996, EXP BRAIN RES, V110, P265; Diaz G, 2013, J VISION, V13, DOI 10.1167/13.1.20; Duncker K, 1929, PSYCHOL FORSCH, V12, P180, DOI 10.1007/BF02409210; Glennerster A, 2006, CURR BIOL, V16, P428, DOI 10.1016/j.cub.2006.01.019; Gomi H, 2006, J NEUROSCI, V26, P5301, DOI 10.1523/JNEUROSCI.0340-06.2006; Gomi H, 2013, J NEUROSCI, V33, P16502, DOI 10.1523/JNEUROSCI.4741-12.2013; Gomi H, 2008, CURR OPIN NEUROBIOL, V18, P558, DOI 10.1016/j.conb.2008.11.002; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Greenwald HS, 2005, VISION RES, V45, P1975, DOI 10.1016/j.visres.2005.01.025; MERGNER T, 1992, EXP BRAIN RES, V89, P655; MOHRMANNLENDLA H, 1991, ERGONOMICS, V34, P353, DOI 10.1080/00140139108967319; PAILHOUS J, 1990, BEHAV BRAIN RES, V38, P275, DOI 10.1016/0166-4328(90)90181-D; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pisella L, 1998, EXP BRAIN RES, V121, P270, DOI 10.1007/s002210050460; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Saijo N, 2005, J NEUROSCI, V25, P4941, DOI 10.1523/JNEUROSCI.4143-04.2005; Saunders JA, 2005, EXP BRAIN RES, V162, P458, DOI 10.1007/s00221-004-2064-1; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; SMEETS JBJ, 1995, BIOL CYBERN, V73, P519, DOI 10.1007/BF00199544; Soechting JF, 2008, J NEUROPHYSIOL, V99, P2956, DOI 10.1152/jn.90308.2008; van Mierlo CM, 2009, J VISION, V9, DOI 10.1167/9.3.25; Voudouris D, 2013, J NEUROPHYSIOL, V110, P1484, DOI 10.1152/jn.00066.2013; Warren PA, 2007, J VISION, V7, DOI 10.1167/7.11.2; Warren PA, 2009, CURR BIOL, V19, P1555, DOI 10.1016/j.cub.2009.07.057; Whitney D, 2005, EXP BRAIN RES, V162, P394, DOI 10.1007/s00221-004-2154-0; Whitney D, 2003, NATURE, V423, P869, DOI 10.1038/nature01693; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119903	10.1371/journal.pone.0119903	http://dx.doi.org/10.1371/journal.pone.0119903			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25767873	gold, Green Submitted, Green Published			2022-12-27	WOS:000351277500100
J	Lu, JY; Cheung, MLM; Huang, BT; Wu, LL; Xie, WJ; Chen, ZJ; Li, DR; Xie, LX				Lu, Jia-Yang; Cheung, Michael Lok-Man; Huang, Bao-Tian; Wu, Li-Li; Xie, Wen-Jia; Chen, Zhi-Jian; Li, De-Rui; Xie, Liang-Xi			Improving Target Coverage and Organ-at-Risk Sparing in Intensity-Modulated Radiotherapy for Cervical Oesophageal Cancer Using a Simple Optimisation Method	PLOS ONE			English	Article							SIMULTANEOUS INTEGRATED BOOST; DIRECT APERTURE OPTIMIZATION; 3D CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; LUNG-CANCER; IMRT; PLANS; HEAD; NECK; CHEMORADIOTHERAPY	Purpose To assess the performance of a simple optimisation method for improving target coverage and organ-at-risk (OAR) sparing in intensity-modulated radiotherapy (IMRT) for cervical oesophageal cancer. Methods For 20 selected patients, clinically acceptable original IMRT plans (Original plans) were created, and two optimisation methods were adopted to improve the plans: 1) a base dose function (BDF)-based method, in which the treatment plans were re-optimised based on the original plans, and 2) a dose-controlling structure (DCS)-based method, in which the original plans were re-optimised by assigning additional constraints for hot and cold spots. The Original, BDF-based and DCS-based plans were compared with regard to target dose homogeneity, conformity, OAR sparing, planning time and monitor units (MUs). Dosimetric verifications were performed and delivery times were recorded for the BDF-based and DCS-based plans. Results The BDF-based plans provided significantly superior dose homogeneity and conformity compared with both the DCS-based and Original plans. The BDF-based method further reduced the doses delivered to the OARs by approximately 1-3%. The re-optimisation time was reduced by approximately 28%, but the MUs and delivery time were slightly increased. All verification tests were passed and no significant differences were found. Conclusion The BDF-based method for the optimisation of IMRT for cervical oesophageal cancer can achieve significantly better dose distributions with better planning efficiency at the expense of slightly more MUs.	[Lu, Jia-Yang; Huang, Bao-Tian; Wu, Li-Li; Xie, Wen-Jia; Chen, Zhi-Jian; Li, De-Rui; Xie, Liang-Xi] Shantou Univ, Dept Radiat Oncol, Canc Hosp, Coll Med, Shantou, Peoples R China; [Cheung, Michael Lok-Man] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China	Shantou University; Chinese University of Hong Kong; Prince of Wales Hospital	Xie, LX (corresponding author), Shantou Univ, Dept Radiat Oncol, Canc Hosp, Coll Med, Shantou, Peoples R China.	xieliangxi1@qq.com			National Natural Science Foundation of China [81171994]; Shantou University Medical College Clinical Research Enhancement Initiative [201425]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shantou University Medical College Clinical Research Enhancement Initiative	Funding: This work was sponsored in part by both National Natural Science Foundation of China (Grant No. 81171994) and Shantou University Medical College Clinical Research Enhancement Initiative (Grant No. 201425). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2005, INT J RADIAT ONCOL, V61, P335, DOI 10.1016/j.ijrobp.2004.06.014; Broderick M, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-8; Budrukkar Ashwini N, 2004, Australas Radiol, V48, P45, DOI 10.1111/j.1440-1673.2004.01241.x; Cao CN, 2014, JAMA OTOLARYNGOL, V140, P918, DOI 10.1001/jamaoto.2014.2013; Cheng MC, 2014, MED DOSIM, V39, P246, DOI 10.1016/j.meddos.2014.03.003; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Dobler B, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-33; Dogan N, 2006, MED PHYS, V33, P4033, DOI 10.1118/1.2357835; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Fenkell L, 2008, RADIOTHER ONCOL, V89, P287, DOI 10.1016/j.radonc.2008.08.008; Freilich J, 2014, DIS ESOPHAG IN PRESS; Guckenberger M, 2010, RADIOTHER ONCOL, V97, P65, DOI 10.1016/j.radonc.2010.04.027; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jeraj R, 2002, PHYS MED BIOL, V47, P391, DOI 10.1088/0031-9155/47/3/303; Jones S, 2008, MED DOSIM, V33, P86, DOI 10.1016/j.meddos.2007.04.002; Kumar G, 2012, JPN J RADIOL, V30, P18, DOI 10.1007/s11604-011-0002-2; Kwint M, 2012, INT J RADIAT ONCOL, V84, pE223, DOI 10.1016/j.ijrobp.2012.03.027; Lin SH, 2012, INT J RADIAT ONCOL, V84, P1078, DOI 10.1016/j.ijrobp.2012.02.015; Lu JY, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140654; Nicolini G, 2012, INT J RADIAT ONCOL, V84, P553, DOI 10.1016/j.ijrobp.2011.12.041; Nutting CM, 2001, RADIOTHER ONCOL, V61, P157, DOI 10.1016/S0167-8140(01)00438-8; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Shridhar R, 2012, J RADIOL ONCOL, V1, P347, DOI 10.1007/s13566-012-0048-5; Shridhar R, 2013, CANCER CONTROL, V20, P97, DOI 10.1177/107327481302000203; Suss P, 2013, PHYS MED BIOL, V58, P1855, DOI 10.1088/0031-9155/58/6/1855; Tucker SL, 2006, INT J RADIAT ONCOL, V66, P754, DOI 10.1016/j.ijrobp.2006.06.002; Verbakel WFAR, 2012, INT J RADIAT ONCOL, V83, pE297, DOI 10.1016/j.ijrobp.2011.12.059; Vineberg KA, 2002, INT J RADIAT ONCOL, V52, P1159, DOI 10.1016/S0360-3016(01)02800-0; Werner-Wasik M, 2010, INT J RADIAT ONCOL, V76, pS86, DOI 10.1016/j.ijrobp.2009.05.070; Xhaferllari I, 2013, J APPL CLIN MED PHYS, V14, P176, DOI 10.1120/jacmp.v14i1.4052; Yu WW, 2014, STRAHLENTHER ONKOL, V190, P979, DOI 10.1007/s00066-014-0636-y	33	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121679	10.1371/journal.pone.0121679	http://dx.doi.org/10.1371/journal.pone.0121679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768733	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500145
J	Zhou, FW; Fortin, JM; Chen, HX; Martinez-Diaz, H; Chang, LJ; Reynolds, BA; Roper, SN				Zhou, Fu-Wen; Fortin, Jeff M.; Chen, Huan-Xin; Martinez-Diaz, Hildabelis; Chang, Lung-Ji; Reynolds, Brent A.; Roper, Steven N.			Functional Integration of Human Neural Precursor Cells in Mouse Cortex	PLOS ONE			English	Article							EXPERIMENTAL CORTICAL DYSPLASIA; EMBRYONIC STEM-CELLS; TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; NEONATAL-RAT-BRAIN; PROGENITOR CELLS; PARKINSONS-DISEASE; PYRAMIDAL NEURONS; SPINAL-CORD; SYNAPTIC ACTIVITY	This study investigates the electrophysiological properties and functional integration of different phenotypes of transplanted human neural precursor cells (hNPCs) in immunodeficient NSG mice. Postnatal day 2 mice received unilateral injections of 100,000 GFP+hNPCs into the right parietal cortex. Eight weeks after transplantation, 1.21% of transplanted hNPCs survived. In these hNPCs, parvalbumin (PV)-, calretinin (CR)-, somatostatin (SS)-positive inhibitory interneurons and excitatory pyramidal neurons were confirmed electrophysiologically and histologically. All GFP+ hNPCs were immunoreactive with antihuman specific nuclear protein. The proportions of PV-, CR-, and SS-positive cells among GFP+cells were 35.5%, 15.7%, and 17.1%, respectively; around 15% of GFP+ cells were identified as pyramidal neurons. Those electrophysiologically and histological identified GFP+hNPCs were shown to fire action potentials with the appropriate firing patterns for different classes of neurons and to display spontaneous excitatory and inhibitory postsynaptic currents (sEPSCs and sIPSCs). The amplitude, frequency and kinetic properties of sEPSCs and sIPSCs in different types of hNPCs were comparable to host cells of the same type. In conclusion, GFP+ hNPCs produce neurons that are competent to integrate functionally into host neocortical neuronal networks. This provides promising data on the potential for hNPCs to serve as therapeutic agents in neurological diseases with abnormal neuronal circuitry such as epilepsy.	[Zhou, Fu-Wen; Fortin, Jeff M.; Chen, Huan-Xin; Martinez-Diaz, Hildabelis; Reynolds, Brent A.; Roper, Steven N.] Univ Florida, Dept Neurosurg, Gainesville, FL 32611 USA; [Zhou, Fu-Wen; Fortin, Jeff M.; Chen, Huan-Xin; Martinez-Diaz, Hildabelis; Reynolds, Brent A.; Roper, Steven N.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Chang, Lung-Ji] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhou, FW (corresponding author), Univ Florida, Dept Neurosurg, Gainesville, FL 32611 USA.	fuwen.zhou@neurosurgery.ufl.edu		Tilahin, Shimelis/0000-0001-8975-8026; Zhou, Fuwen/0000-0002-3500-666X	Wells Foundation; Densch Foundation	Wells Foundation; Densch Foundation	Funding provided by Wells Foundation and Densch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova MA, 2002, DEV BRAIN RES, V134, P143, DOI 10.1016/S0165-3806(02)00273-0; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Cambray S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1817; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Chang L.-J., 2001, Current Gene Therapy, V1, P237, DOI 10.2174/1566523013348634; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Collier TJ, 1999, J NEUROSCI, V19, P5563; Condic ML, 2001, J NEUROSCI, V21, P4782, DOI 10.1523/JNEUROSCI.21-13-04782.2001; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1983, SCIENCE, V221, P966, DOI 10.1126/science.6879196; Gilani AI, 2014, P NATL ACAD SCI USA, V111, P7450, DOI 10.1073/pnas.1316488111; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hammad M, 2014, CEREB CORTEX; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Ideguchi M, 2010, J NEUROSCI, V30, P894, DOI 10.1523/JNEUROSCI.4318-09.2010; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Larsson LC, 2001, CELL TRANSPLANT, V10, P295, DOI 10.3727/000000001783986765; Liker MA, 2003, BRAIN RES, V971, P168, DOI 10.1016/S0006-8993(03)02337-0; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Maisano X, 2012, J NEUROSCI, V32, P46, DOI 10.1523/JNEUROSCI.2683-11.2012; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Mendez I, 2002, J NEUROSURG, V96, P589, DOI 10.3171/jns.2002.96.3.0589; Mukhida K, 2007, STEM CELLS, V25, P2874, DOI 10.1634/stemcells.2007-0326; Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580; Polentes J, 2012, CELL TRANSPLANT, V21, P2587, DOI 10.3727/096368912X653228; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roper SN, 1999, EPILEPSY RES, V37, P63, DOI 10.1016/S0920-1211(99)00035-2; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Southwell DG, 2014, SCIENCE, V344, P167, DOI 10.1126/science.1240622; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Taub AH, 2013, J NEUROSCI, V33, P14359, DOI 10.1523/JNEUROSCI.1748-13.2013; Thompson KW, 2004, EPILEPSIA, V45, P4, DOI 10.1111/j.0013-9580.2004.29503.x; Tong LM, 2014, J NEUROSCI, V34, P9506, DOI 10.1523/JNEUROSCI.0693-14.2014; Tyson JA, 2014, TRENDS NEUROSCI, V37, P169, DOI 10.1016/j.tins.2014.01.003; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Valente MF, 2013, CELL TRANSPLANT, V22, P1237, DOI 10.3727/096368912X657422; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Zhou FW, 2008, J NEUROSCI, V28, P473, DOI 10.1523/JNEUROSCI.3978-07.2008; Zhou FW, 2011, CEREB CORTEX, V21, P1645, DOI 10.1093/cercor/bhq234; Zhou FW, 2009, J NEUROPHYSIOL, V102, P2514, DOI 10.1152/jn.00557.2009; Zietlow R, 2012, EXP NEUROL, V235, P563, DOI 10.1016/j.expneurol.2012.03.010; Zigova T, 1996, DEV BIOL, V173, P459, DOI 10.1006/dbio.1996.0040; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	66	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120281	10.1371/journal.pone.0120281	http://dx.doi.org/10.1371/journal.pone.0120281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763840	Green Submitted, Green Published, gold			2022-12-27	WOS:000351276300038
J	Guo, YJ; Rong, Y; Huang, XJ; Lai, HP; Luo, X; Zhang, ZH; Liu, YW; He, MA; Wu, TC; Chen, WH				Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong			Shift Work and the Relationship with Metabolic Syndrome in Chinese Aged Workers	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CHRONIC DISEASE; SLEEP DURATION; RISK; ASSOCIATION	Background Shift work is indicated to be associated with adverse metabolic disorders. However, potential effects of shift work on metabolic syndrome (MetS) and its components have not been well established. Methods In total, 26,382 workers from Dongfeng-Tongji Cohort were included in this study. Information on shift work history was gathered through questionnaires and metabolic traits were measured. Logistic regression models were used to calculate the odds ratio (OR) and 95% confidence interval (CI) for long-term shift work related with MetS and each component, respectively. Further stratification analysis was performed to detect the differences on MetS between female and male shift workers. Results Long-term shift work was associated with MetS without adjusting for any confounders. Compared with the group of non-shift work, the multivariate-adjusted ORs (95% CI) of MetS associated with 1-10, 11 -20, and >= 20y of shift work were 1.05 (0.95-1.16), 1.14 (1.03-1.26), 1.16 (1.01-1.31), respectively. In female workers, we found a dose-response relationship that every 10 years increase in shift work was associated with a 10% (95% CI: 1%-20%) elevated OR of MetS, while no significant dose-response trend was found among male workers. Furthermore, shift work duration was significantly associated with ORs of high blood pressure (1.07, 1.01-1.13), long waist circumference (1.10, 1.01-1.20) and high glucose levels (1.09, 1.04-1.15). No significant association was observed between shift work and low HDL cholesterol) and raised triglyceride levels. Conclusions Long-term shift work was associated with metabolic syndrome and the association might differ by gender in retired workers. Applicable intervention strategies are needed for prevention of metabolic disorders for shift workers.	[Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China; [Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430074, Peoples R China; [Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Environm Protect, Wuhan 430074, Peoples R China; [Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, WH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China.	wchen@mails.tjmu.edu.cn	Chen, Weihong/D-2177-2011; Liu, Yuewei/J-5147-2019	Chen, Weihong/0000-0001-8689-7311; Liu, Yuewei/0000-0001-5970-4262	National Basic Research Program of China [2011CB503804]; 111 project; Program for Changjiang Scholars; Innovative Research Team in University; China Medical Board 12-13; Graduates' Innovation Fund of Huazhong University of Science Technology	National Basic Research Program of China(National Basic Research Program of China); 111 project(Ministry of Education, China - 111 Project); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Medical Board 12-13; Graduates' Innovation Fund of Huazhong University of Science Technology	The authors gratefully acknowledge the financial support provided by the National Basic Research Program of China (2011CB503804); The 111 project; the Program for Changjiang Scholars; Innovative Research Team in University; China Medical Board 12-13; and Graduates' Innovation Fund of Huazhong University of Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykan AC, 2014, CARDIOL J, V21, P245, DOI 10.5603/CJ.a2013.0126; Bjorvatn B, 2009, SLEEP MED REV, V13, P47, DOI 10.1016/j.smrv.2008.04.009; Chang CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038874; Cooper DC, 2013, CARDIOVASC PSYCHIAT; Copertaro A, 2011, IND HEALTH, V49, P597; David Mika Kivimaki G Batty, 2011, PLOS MED, V8, DOI [10.1371/journal.pmed.1001138, DOI 10.1371/JOURNAL.PMED.1001138]; de Assis MAA, 2003, J HUM NUTR DIET, V16, P283, DOI 10.1046/j.1365-277X.2003.00448.x; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Gumenyuk V, 2012, CHRONOBIOL INT, V29, P928, DOI 10.3109/07420528.2012.699356; Guo YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071107; Hanley AJG, 2005, CIRCULATION, V112, P3713, DOI 10.1161/CIRCULATIONAHA.105.559633; Haus EL, 2013, SLEEP MED REV, V17, P273, DOI 10.1016/j.smrv.2012.08.003; Hublin C, 2010, EUR J EPIDEMIOL, V25, P315, DOI 10.1007/s10654-010-9439-3; Ioja S, 2012, POSTGRAD MED, V124, P119, DOI 10.3810/pgm.2012.07.2573; Itoh H, 2011, IND HEALTH, V49, P658, DOI 10.2486/indhealth.MS1271; Juda M, 2013, J BIOL RHYTHM, V28, P141, DOI 10.1177/0748730412475042; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Karlsson BH, 2003, INT ARCH OCC ENV HEA, V76, P424, DOI 10.1007/s00420-003-0440-y; Kawada T, 2014, ARCH ENVIRON OCCUP H, V69, P55, DOI 10.1080/19338244.2012.732123; Khabour OF, 2013, CLIN EXP HYPERTENS, V35, P361, DOI 10.3109/10641963.2012.732645; Kurl S, 2006, STROKE, V37, P806, DOI 10.1161/01.STR.0000204354.06965.44; Lieu SJ, 2012, J HYPERTENS, V30, P61, DOI 10.1097/HJH.0b013e32834e1ea3; Lin YC, 2009, CHRONOBIOL INT, V26, P740, DOI 10.1080/07420520902929029; Maki KC, 2012, METAB SYNDR RELAT D, V10, P363, DOI 10.1089/met.2012.0020; Mansukhani MP, 2012, POSTGRAD MED, V124, P241, DOI 10.3810/pgm.2012.07.2583; Monk TH, 2012, J SLEEP RES, V17, P273; Nicholson PJ, 2011, OCCUP MED-OXFORD, V61, P443, DOI 10.1093/occmed/kqr078; Pan A, 2013, JAMA INTERN MED, V173, P1328, DOI 10.1001/jamainternmed.2013.6633; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Pilcher JJ, 2000, SLEEP, V23, P155; Rabaeus M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-196; Ramin C, 2015, OCCUP ENVIRON MED, V72, P100, DOI 10.1136/oemed-2014-102292; Sallinen M, 2010, SCAND J WORK ENV HEA, V36, P121, DOI 10.5271/sjweh.2900; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Stefani KM, 2013, DIABETES RES CLIN PR, V102, P250, DOI 10.1016/j.diabres.2013.10.003; Ulas T, 2012, EUR REV MED PHARMACO, V16, P594; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang F, 2014, OBES REV, V15, P709, DOI 10.1111/obr.12194; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; Xu SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078270; Ye HH, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-33; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	44	46	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120632	10.1371/journal.pone.0120632	http://dx.doi.org/10.1371/journal.pone.0120632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761114	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000071
J	Sierra-Corona, R; Davidson, A; Fredrickson, EL; Luna-Soria, H; Suzan-Azpiri, H; Ponce-Guevara, E; Ceballos, G				Sierra-Corona, Rodrigo; Davidson, Ana; Fredrickson, Ed L.; Luna-Soria, Hugo; Suzan-Azpiri, Humberto; Ponce-Guevara, Eduardo; Ceballos, Gerardo			Black-Tailed Prairie Dogs, Cattle, and the Conservation of North America's Arid Grasslands	PLOS ONE			English	Article							ECOLOGICAL CONSEQUENCES; LIVESTOCK; BISON; ECOSYSTEM; PATTERNS; CHALLENGES; COMMUNITIES; COMPETITION	Prairie dogs (Cynomys spp.) have been eliminated from over 95% of their historic range in large part from direct eradication campaigns to reduce their purported competition with cattle for forage. Despite the longstanding importance of this issue to grassland management and conservation, the ecological interactions between cattle and prairie dogs have not been well examined. We address this issue through two complementary experiments to determine if cattle and prairie dogs form a mutualistic grazing association similar to that between prairie dogs and American bison. Our experimental results show that cattle preferentially graze along prairie dog colony edges and use their colony centers for resting, resembling the mutualistic relationship prairie dogs have with American bison. Our results also show that prairie dog colonies are not only an important component of the grassland mosaic for maintaining biodiversity, but also provide benefits to cattle, thereby challenging the longstanding view of prairie dogs as an undesirable pest species in grasslands.	[Sierra-Corona, Rodrigo; Ponce-Guevara, Eduardo; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Davidson, Ana] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Fredrickson, Ed L.] Eastern Kentucky Univ, Dept Agr, Richmond, KY 40475 USA; [Luna-Soria, Hugo; Suzan-Azpiri, Humberto] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidad Autonoma de Queretaro	Sierra-Corona, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	rsierra@iecologia.unam.mx		Ceballos, Gerardo/0000-0001-8374-2656	Consejo Nacional de Ciencia y Tecnologia (CONACyT); J.M. Kaplan Fund; Whithley Fund for Nature; Rufford Fundation; Fundacion Carlos Slim A. C.	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); J.M. Kaplan Fund; Whithley Fund for Nature; Rufford Fundation; Fundacion Carlos Slim A. C.	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT), http://www.conacyt.gob.mx, J.M. Kaplan Fund, http://www.jmkfund.org, The Whithley Fund for Nature, http://whitleyaward.org, Rufford Fundation, http://www.rufford.org, and the Fundacion Carlos Slim A. C., http://fundacioncarlosslim.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER S, 1987, VEGETATIO, V72, P159; Augustine DJ, 2013, ECOL APPL, V23, P850, DOI 10.1890/12-0890.1; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bergstrom BJ, 2013, CONSERV LETT, V11, P1; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Cheng E, 2006, OECOLOGIA, V147, P546, DOI 10.1007/s00442-005-0286-y; CID MS, 1991, J RANGE MANAGE, V44, P100, DOI 10.2307/4002305; COPPOCK DL, 1986, J WILDLIFE MANAGE, V50, P452, DOI 10.2307/3801103; COPPOCK DL, 1983, OECOLOGIA, V56, P10, DOI 10.1007/BF00378211; COTECOCA, 2002, COEF AG ENT FED 1 HE; Curtin Charles, 2006, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V40, P57; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Davidson AD, 2010, ECOLOGY, V91, P3189, DOI 10.1890/09-1277.1; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Derner JD, 2006, FRONT ECOL ENVIRON, V4, P459, DOI 10.1890/1540-9295(2006)4[459:ALWGAB]2.0.CO;2; Derner JD, 2009, RANGELAND ECOL MANAG, V62, P111, DOI 10.2111/08-008.1; Fahnestock JT, 2002, OECOLOGIA, V132, P86, DOI 10.1007/s00442-002-0930-8; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Frank DA, 1998, BIOSCIENCE, V48, P513, DOI 10.2307/1313313; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Ganskopp D, 2006, RANGELAND ECOL MANAG, V59, P189, DOI 10.2111/04-152R1.1; Guenther DA, 2003, J RANGE MANAGE, V56, P410, DOI 10.2307/4003830; Hartnett D.C., 1997, Ecological Studies, V125, P72; HERBEL CH, 1967, J RANGE MANAGE, V20, P296, DOI 10.2307/3895975; Holechek BJL, 2006, RANGELANDS, V28, P7; Howard JL, 2014, FIRE EFFECTS INFORM; HUNTLY N, 1991, ANNU REV ECOL SYST, V22, P477, DOI 10.1146/annurev.ecolsys.22.1.477; IMTA, 2008, EXTR RAP INF CLIM ER; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones S, 1999, ENVIRON HIST, V4, P531, DOI 10.2307/3985400; Knapp AK, 2010, BIOSCIENCE, V49, P39; KNOWLES CJ, 1986, GREAT BASIN NAT, V46, P198; Koford C. B., 1958, WILDLIFE MONOGR, V3, P3; Kotliar NB, 2000, CONSERV BIOL, V14, P1715, DOI 10.1111/j.1523-1739.2000.98384.x; KRUEGER K, 1986, ECOLOGY, V67, P760, DOI 10.2307/1937699; Laliberte AS, 2007, PHOTOGRAMM ENG REM S, V73, P197, DOI 10.14358/PERS.73.2.197; Launchbaugh KL, 2005, RANGELAND ECOL MANAG, V58, P99, DOI 10.2111/03-146.1; Lemaire G, 2011, GRASSLAND PRODUCTIVITY AND ECOSYSTEM SERVICES, pXIII, DOI 10.1079/9781845938093.A; List R, 2010, INT J WILDERNESS, V16, P35; List R, 2007, CONSERV BIOL, V21, P1487, DOI 10.1111/j.1523-1739.2007.00810.x; Martinez-Estevez L, 2013, P 19 C COMP EL FIELD, P1; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; MCCOLLUM FT, 1985, J RANGE MANAGE, V38, P539, DOI 10.2307/3899748; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller BJ, 2007, J WILDLIFE MANAGE, V71, P2801, DOI 10.2193/2007-041; NEUENSCHWANDER L F, 1975, Southwestern Naturalist, V20, P255, DOI 10.2307/3670443; Oki G.S., 2002, GLOBAL DESERTIFICATI, P95; OMEILIA ME, 1982, J RANGE MANAGE, V35, P580, DOI 10.2307/3898641; OSBORN B, 1949, ECOLOGY, V30, P322, DOI 10.2307/1932613; Peinetti HR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00021.1; Pinedo AC, 2013, DIAGNOSTICO ACTUAL S, P126; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; RIEGEL ANDREW, 1941, TRANS KANSAS ACAD SCI, V44, P76, DOI 10.2307/3624869; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; SENFT RL, 1985, J RANGE MANAGE, V38, P82, DOI 10.2307/3899341; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Towne EG, 2005, ECOL APPL, V15, P1550, DOI 10.1890/04-1958; Vanderhye AVR, 1985, INTERSPECIFIC NUTR F, P44; Weltzin JF, 1997, SOUTHWEST NAT, V42, P251; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; WHICKER AD, 1988, BIOSCIENCE, V38, P778, DOI 10.2307/1310787; Wiken E, 1998, PARKS, V8, P9	62	15	15	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118602	10.1371/journal.pone.0118602	http://dx.doi.org/10.1371/journal.pone.0118602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760377	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275000031
J	Yamato, M; Pyenson, ND				Yamato, Maya; Pyenson, Nicholas D.			Early Development and Orientation of the Acoustic Funnel Provides Insight into the Evolution of Sound Reception Pathways in Cetaceans	PLOS ONE			English	Article							POSTNATAL-GROWTH; MIDDLE EOCENE; FETAL GROWTH; BLUE WHALE; ANATOMY; MORPHOLOGY; MAMMALIA; BALEEN; SKULL; ALLOMETRY	Whales receive underwater sounds through a fundamentally different mechanism than their close terrestrial relatives. Instead of hearing through the ear canal, cetaceans hear through specialized fatty tissues leading to an evolutionarily novel feature: an acoustic funnel located anterior to the tympanic aperture. We traced the ontogenetic development of this feature in 56 fetal specimens from 10 different families of toothed (odontocete) and baleen (mysticete) whales, using X-ray computed tomography. We also charted ear ossification patterns through ontogeny to understand the impact of heterochronic developmental processes. We determined that the acoustic funnel arises from a prominent V-shaped structure established early in ontogeny, formed by the malleus and the goniale. In odontocetes, this V-formation develops into a cone-shaped funnel facing anteriorly, directly into intramandibular acoustic fats, which is likely functionally linked to the anterior orientation of sound reception in echolocation. In contrast, the acoustic funnel in balaenopterids rotates laterally, later in fetal development, consistent with a lateral sound reception pathway. Balaenids and several fossil mysticetes retain a somewhat anteriorly oriented acoustic funnel in the mature condition, indicating that a lateral sound reception pathway in balaenopterids may be a recent evolutionary innovation linked to specialized feeding modes, such as lunge-feeding.	[Yamato, Maya] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Yamato, Maya; Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Mammal, Washington, DC 20560 USA; [Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Palaeontol, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Yamato, M (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA.	yamatom@si.edu		Pyenson, Nicholas/0000-0003-4678-5782	NMNH Peter Buck Postdoctoral Fellowship; NMNH Remington Kellogg Fund	NMNH Peter Buck Postdoctoral Fellowship; NMNH Remington Kellogg Fund	Support for this work came from a NMNH Peter Buck Postdoctoral Fellowship to MY, and the NMNH Remington Kellogg Fund to NDP (http://www.mnh.si.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AU WWL, 1984, J ACOUST SOC AM, V75, P255, DOI 10.1121/1.390403; Bajpai S, 2011, J PALEONTOL, V85, P703, DOI 10.1666/10-128.1; Bisconti M, 2001, ITAL J ZOOL, V68, P87, DOI 10.1080/11250000109356390; BOENNINGHAUS G, 1904, ZOOL JB A, V19, P189; Cozzi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037110; Cranford TW, 2008, ANAT REC, V291, P353, DOI 10.1002/ar.20652; Cranford TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011927; CUMMINGS WC, 1971, J ACOUST SOC AM, V50, P1193, DOI 10.1121/1.1912752; de Buffrenil V, 2004, J ZOOL, V262, P371, DOI 10.1017/S0952836903004758; Demere TA, 2008, ZOOL J LINN SOC-LOND, V154, P308, DOI 10.1111/j.1096-3642.2008.00414.x; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; EALES NB, 1950, PHILOS T ROY SOC B, V235, P1, DOI 10.1098/rstb.1950.0013; Ekdale EG, 2015, J ANAT, V226, P22, DOI 10.1111/joa.12253; Ekdale EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021311; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Fordyce R.E., 2009, THERIAN SKULL LEXICO; FRAZER JFD, 1973, J ZOOL, V169, P111; Galatius A, 2010, BIOL J LINN SOC, V99, P278, DOI 10.1111/j.1095-8312.2009.01357.x; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Gingerich PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004366; Gould S. J., 1977, ONTOGENY PHYLOGENY; Haddad D, 2012, ZOOL ANZ, V251, P115, DOI 10.1016/j.jcz.2011.06.004; Johnston C, 2010, MAR MAMMAL SCI, V26, P186, DOI 10.1111/j.1748-7692.2009.00305.x; Kasuya T., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P1; KELLOGG WN, 1958, SCIENCE, V128, P982, DOI 10.1126/science.128.3330.982; Kesteven H. L., 1941, Records of the Australian Museum, V21, P59; Kinkel MD, 2001, J MORPHOL, V249, P126, DOI 10.1002/jmor.1044; Lancaster WC, 2014, MARINE MAMMAL SCI; Laws R. M., 1959, Discovery Reports, V29, P281; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; Marx FG, 2011, J MAMM EVOL, V18, P77, DOI 10.1007/s10914-010-9148-4; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4, DOI 10.1017/S0022336000021454; Mooney TA, 2012, ADV MAR BIOL, V63, P197, DOI 10.1016/B978-0-12-394282-1.00004-1; Moran MM, 2011, ANAT REC, V294, P1743, DOI 10.1002/ar.21388; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; Norris K. S., 1964, P317; NORRIS KS, 1961, BIOL BULL, V120, P163, DOI 10.2307/1539374; Nummela S, 2004, NATURE, V430, P776, DOI 10.1038/nature02720; Nummela S, 1999, HEARING RES, V133, P71, DOI 10.1016/S0378-5955(99)00054-4; OELSCHLAGER HA, 1986, AM J ANAT, V177, P353, DOI 10.1002/aja.1001770306; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; PERRIN WF, 1976, FISH B-NOAA, V74, P229; Pyenson ND, 2013, BIOL J LINN SOC, V108, P586, DOI 10.1111/j.1095-8312.2012.02032.x; Pyenson ND, 2012, NATURE, V485, P498, DOI 10.1038/nature11135; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Rauschmann MA, 2006, J MORPHOL, V267, P1295, DOI 10.1002/jmor.10477; Reese CS, 2001, J AM STAT ASSOC, V96, P915, DOI 10.1198/016214501753208618; Reidenberg J., 2008, ENCY MARINE MAMMALS, P220; REYSENBACH DE HAAN F W, 1957, Acta Otolaryngol Suppl, V134, P1; Ridewood WG, 1923, PHILOS T R SOC LON B, V211, P209, DOI 10.1098/rstb.1923.0005; Roston RA, 2013, ANAT REC, V296, P709, DOI 10.1002/ar.22678; Sterba O, 1999, EMBRYOLOGY DOLPHINS; Sumich James L., 2013, Journal of Cetacean Research and Management, V13, P89; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; THEWISSEN JGM, 1993, NATURE, V361, P444, DOI 10.1038/361444a0; Tsai CH, 2014, EVOL BIOL, V41, P299, DOI 10.1007/s11692-014-9269-4; Wartzok Douglas, 1999, P117; Yamada M., 1953, Scientific Reports of the Whales Research Institute Tokyo, V8, P1; Yamato M, 2012, ANAT REC, V295, P991, DOI 10.1002/ar.22459	61	13	13	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118582	10.1371/journal.pone.0118582	http://dx.doi.org/10.1371/journal.pone.0118582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760328	gold, Green Published			2022-12-27	WOS:000351275000030
J	Acharya, D; Mukherjee, D; Podder, S; Ghosh, TC				Acharya, Debarun; Mukherjee, Dola; Podder, Soumita; Ghosh, Tapash C.			Investigating Different Duplication Pattern of Essential Genes in Mouse and Human	PLOS ONE			English	Article							PROTEIN CONNECTIVITY; EVOLUTIONARY RATES; DUPLICABILITY; COMPLEXITY	Gene duplication is one of the major driving forces shaping genome and organism evolution and thought to be itself regulated by some intrinsic properties of the gene. Comparing the essential genes among mouse and human, we observed that the essential genes avoid duplication in mouse while prefer to remain duplicated in humans. In this study, we wanted to explore the reasons behind such differences in gene essentiality by cross-species comparison of human and mouse. Moreover, we examined essential genes that are duplicated in humans are functionally more redundant than that in mouse. The proportion of paralog pseudogenization of essential genes is higher in mouse than that of humans. These duplicates of essential genes are under stringent dosage regulation in human than in mouse. We also observed slower evolutionary rate in the paralogs of human essential genes than the mouse counterpart. Together, these results clearly indicate that human essential genes are retained as duplicates to serve as backed up copies that may shield themselves from harmful mutations.	[Acharya, Debarun; Mukherjee, Dola; Podder, Soumita; Ghosh, Tapash C.] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Ghosh, TC (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India.	tapash@jcbose.ac.in	Acharya, Debarun/AAV-7259-2021	Acharya, Debarun/0000-0001-5609-9888; Mukherjee, Dola/0000-0003-3286-1473	University Grants Commission (UGC) [F.2-8/2002 (SA-I)]	University Grants Commission (UGC)(University Grants Commission, India)	Funding from University Grants Commission (UGC) Sanction Letter No. F.2-8/2002 (SA-I) dated 04.10.2012, received by DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baudot A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r76; Bhattacharya T, 2010, DNA RES, V17, P261, DOI 10.1093/dnares/dsq019; Chen WH, 2012, MOL BIOL EVOL, V29, P1703, DOI 10.1093/molbev/mss014; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; CLARK AG, 1994, P NATL ACAD SCI USA, V91, P2950, DOI 10.1073/pnas.91.8.2950; D'Antonio M, 2011, PLOS COMPUT BIOL, V7, DOI [10.1371/journal.pcbi.1002028, DOI 10.1371/JOURNAL.PCBI.1002028]; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; He XL, 2006, MOL BIOL EVOL, V23, P144, DOI 10.1093/molbev/msj015; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Li JJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r132; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liang H, 2009, TRENDS GENET, V25, P441, DOI 10.1016/j.tig.2009.08.001; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Lynch M, 2000, GENETICS, V154, P459; Makino T, 2006, GENE, V385, P57, DOI 10.1016/j.gene.2006.06.028; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Ohno S., 1970, EVOLUTION GENE DUPLI; STEPHENS SG, 1951, ADV GENET, V4, P247, DOI 10.1016/S0065-2660(08)60237-0; Su ZX, 2008, J MOL EVOL, V67, P705, DOI 10.1007/s00239-008-9170-9; Waterhouse RM, 2011, GENOME BIOL EVOL, V3, P75, DOI 10.1093/gbe/evq083; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Yang J, 2003, P NATL ACAD SCI USA, V100, P15661, DOI 10.1073/pnas.2536672100; Yang J, 2003, MOL BIOL EVOL, V20, P772, DOI 10.1093/molbev/msg078; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0120784	10.1371/journal.pone.0120784	http://dx.doi.org/10.1371/journal.pone.0120784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751152	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700037
J	Mader, A; von Bronk, B; Ewald, B; Kesel, S; Schnetz, K; Frey, E; Opitz, M				Mader, Andreas; von Bronk, Benedikt; Ewald, Benedikt; Kesel, Sara; Schnetz, Karin; Frey, Erwin; Opitz, Madeleine			Amount of Colicin Release in Escherichia coli Is Regulated by Lysis Gene Expression of the Colicin E2 Operon	PLOS ONE			English	Article							BINDING PROTEIN CSRA; K ACTIVITY GENE; CRYSTAL-STRUCTURE; MITOMYCIN-C; SOS; BACTERIOCINS; EVOLUTION; TRANSCRIPTION; BIODIVERSITY; REPRESSION	The production of bacteriocins in response to worsening environmental conditions is one means of bacteria to outcompete other microorganisms. Colicins, one class of bacteriocins in Escherichia coli, are effective against closely related Enterobacteriaceae. Current research focuses on production, release and uptake of these toxins by bacteria. However, little is known about the quantitative aspects of these dynamic processes. Here, we quantitatively study expression dynamics of the Colicin E2 operon in E. coli on a single cell level using fluorescence time-lapse microscopy. DNA damage, triggering SOS response leads to the heterogeneous expression of this operon including the cea gene encoding the toxin, Colicin E2, and the cel gene coding for the induction of cell lysis and subsequent colicin release. Advancing previous whole population investigations, our time-lapse experiments reveal that at low exogenous stress levels all cells eventually respond after a given time (heterogeneous timing). This heterogeneous timing is lost at high stress levels, at which a synchronized stress response of all cells 60 min after induction via stress can be observed. We further demonstrate, that the amount of colicin released is dependent on cel (lysis) gene expression, independent of the applied exogenous stress level. A heterogeneous response in combination with heterogeneous timing can be biologically significant. It might enable a bacterial population to endure low stress levels, while at high stress levels an immediate and synchronized population wide response can give single surviving cells of the own species the chance to take over the bacterial community after the stress has ceased.	[Mader, Andreas; von Bronk, Benedikt; Ewald, Benedikt; Kesel, Sara; Opitz, Madeleine] Univ Munich, Fac Phys, Ctr NanoSci, Munich, Germany; [Schnetz, Karin] Univ Cologne, Inst Genet, Cologne, Germany; [Frey, Erwin] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany; [Frey, Erwin] Univ Munich, Ctr NanoSci, Dept Phys, Munich, Germany	University of Munich; University of Cologne; University of Munich; University of Munich	Opitz, M (corresponding author), Univ Munich, Fac Phys, Ctr NanoSci, Geschwister Scholl Pl 1, Munich, Germany.	opitz@physik.uni-muenchen.de	Frey, Erwin/M-2613-2017	Frey, Erwin/0000-0001-8792-3358; Schnetz, Karin/0000-0003-4693-6202	DFG [LE 2484/4-1, FR 850/10-1, SPP 1617]; Nano Initiative Munich (NIM); Center for Nanoscience (CeNS)	DFG(German Research Foundation (DFG)); Nano Initiative Munich (NIM); Center for Nanoscience (CeNS)	This work was supported by DFG grant LE 2484/4-1 and FR 850/10-1 part of the SPP 1617, the Nano Initiative Munich (NIM) and the Center for Nanoscience (CeNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chak KF, 1996, P NATL ACAD SCI USA, V93, P6437, DOI 10.1073/pnas.93.13.6437; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; COLE ST, 1985, MOL GEN GENET, V198, P465, DOI 10.1007/BF00332940; Cursino L, 2002, BRAZ J MICROBIOL, V33, P185, DOI 10.1590/S1517-83822002000300001; Davidov Y, 2000, MUTAT RES-GEN TOX EN, V466, P97, DOI 10.1016/S1383-5718(99)00233-8; Dekker N, 1999, J BACTERIOL, V181, P3281, DOI 10.1128/JB.181.10.3281-3283.1999; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; DURKACZ BW, 1974, J BACTERIOL, V117, P940, DOI 10.1128/JB.117.3.940-946.1974; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; Edelstein A., 2010, CURRENT PROTOCOLS MO; FRANK SA, 1994, EVOL ECOL, V8, P369, DOI 10.1007/BF01238189; Ghazaryan L, 2014, ANTON LEEUW INT J G, P1; Ghazaryan L, 2014, ANTON LEEUW INT J G, V105, P823, DOI 10.1007/s10482-014-0136-1; Gillor O, 2008, MICROBIOL-SGM, V154, P1783, DOI 10.1099/mic.0.2007/016139-0; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; HARDY KG, 1972, J BACTERIOL, V112, P1007, DOI 10.1128/JB.112.2.1007-1009.1972; HARDY KG, 1974, MOL GEN GENET, V131, P313, DOI 10.1007/BF00264862; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; HERSCHMAN HR, 1967, J BACTERIOL, V94, P691, DOI 10.1128/JB.94.3.691-699.1967; Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427; James R, 1996, MICROBIOL-SGM, V142, P1569, DOI 10.1099/13500872-142-7-1569; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kamensek S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-283; Keller KL, 2001, MUTAT RES-DNA REPAIR, V486, P21, DOI 10.1016/S0921-8777(01)00077-5; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Ko TP, 1999, STRUCT FOLD DES, V7, P91, DOI 10.1016/S0969-2126(99)80012-4; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Mrak P, 2007, MOL GENET GENOMICS, V277, P391, DOI 10.1007/s00438-006-0185-x; Mulec J, 2003, J BACTERIOL, V185, P654, DOI 10.1128/JB.185.2.654-659.2003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; OZEKI H, 1959, NATURE, V184, P337, DOI 10.1038/184337a0; PUGSLEY AP, 1981, J BACTERIOL, V147, P186, DOI 10.1128/JB.147.1.186-192.1981; PUGSLEY AP, 1985, J GEN MICROBIOL, V131, P2673; PUGSLEY AP, 1983, MOL GEN GENET, V190, P379, DOI 10.1007/BF00331062; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; RILEY MA, 1993, MOL BIOL EVOL, V10, P1048; Riley MA, 1996, J IND MICROBIOL, V17, P151, DOI 10.1007/BF01574688; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; TYLER J, 1975, MOL GEN GENET, V140, P349, DOI 10.1007/BF00267325; vanderWal FJ, 1995, FEMS MICROBIOL REV, V17, P381, DOI 10.1016/0168-6445(95)00022-4; WATSON R, 1980, GENE, V10, P307, DOI 10.1016/0378-1119(80)90151-1; Weber MF, 2014, JOURNAL OF THE ROYAL, V11; Weng MW, 2010, NUCLEIC ACIDS RES, V38, P6976, DOI 10.1093/nar/gkq576; Wojdyla JA, 2012, J MOL BIOL, V417, P79, DOI 10.1016/j.jmb.2012.01.019; Yakhnin H, 2011, MOL MICROBIOL, V81, P689, DOI 10.1111/j.1365-2958.2011.07723.x; Yang TY, 2010, NUCLEIC ACIDS RES, V38, P3936, DOI 10.1093/nar/gkq177; Youssef S, 2011, INTEGR BIOL-UK, V3, P1095, DOI 10.1039/c1ib00035g	56	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119124	10.1371/journal.pone.0119124	http://dx.doi.org/10.1371/journal.pone.0119124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751274	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700016
J	Sakala, IG; Chaudhri, G; Eldi, P; Buller, RM; Karupiah, G				Sakala, Isaac G.; Chaudhri, Geeta; Eldi, Preethi; Buller, R. Mark; Karupiah, Gunasegaran			Deficiency in Th2 Cytokine Responses Exacerbate Orthopoxvirus Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; ECTROMELIA-VIRUS; GENETIC-RESISTANCE; POXVIRUS INFECTION; IMMUNE-RESPONSE; IL-4 RECEPTOR; MICE; EXPRESSION; DIFFERENTIATION; INTERLEUKIN-4	Ectromelia virus (ECTV) causes mousepox in mice, a disease very similar to smallpox in humans. ECTV and variola virus (VARV), the agent of smallpox, are closely related orthopoxviruses. Mousepox is an excellent small animal model to study the genetic and immunologic basis for resistance and susceptibility of humans to smallpox. Resistance to mousepox is dependent on a strong polarized type 1 immune response, associated with robust natural killer (NK) cell, cytotoxic T lymphocyte (CTL) and gamma interferon (IFN-gamma) responses. In contrast, ECTV-susceptible mice generate a type 2 response, associated with weak NK cell, CTL and IFN-gamma responses but robust IL-4 responses. Nonetheless, susceptible strains infected with mutant ECTV lacking virus-encoded IFN-gamma binding protein (vIFN-gamma bp) (ECTV-IFN-gamma bp Delta) control virus replication through generation of type 1 response. Since the IL-4/IL-13/STAT-6 signaling pathways polarize type 2/T helper 2 (Th2) responses with a corresponding suppression of IFN-gamma production, we investigated whether the combined absence of vIFN-gamma bp, and one or more host genes involved in Th2 response development, influence generation of protective immunity. Most mutant mouse strains infected with wild-type (WT) virus succumbed to disease more rapidly than WT animals. Conversely, the disease outcome was significantly improved in WT mice infected with ECTV-IFN-gamma bp Delta but absence of IL-4/IL-13/STAT-6 signaling pathways did not provide any added advantage. Deficiency in IL-13 or STAT-6 resulted in defective CTL responses, higher mortality rates and accelerated deaths. Deficiencies in IL-4/IL-13/STAT-6 signaling pathways significantly reduced the numbers of IFN-gamma producing CD4 and CD8 T cells, indicating an absence of a switch to a Th1-like response. Factors contributing to susceptibility or resistance to mousepox are far more complex than a balance between Th1 and Th2 responses.	[Sakala, Isaac G.; Chaudhri, Geeta; Eldi, Preethi; Karupiah, Gunasegaran] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Infect & Immun Grp, Canberra, ACT 2601, Australia; [Buller, R. Mark] St Louis Univ, Dept Mol Microbiol & Immunol, Hlth Sci Ctr, St Louis, MO 63103 USA	Australian National University; John Curtin School of Medical Research; Saint Louis University	Karupiah, G (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Infect & Immun Grp, Canberra, ACT 2601, Australia.	Guna.Karupiah@anu.edu.au	Karupiah, Gunasegaran/S-3561-2019; Karupiah, Gunasegaran/J-4707-2013	Karupiah, Gunasegaran/0000-0001-6306-4405; Chaudhri, Geeta/0000-0003-3388-2102; Eldi, Preethi/0000-0003-0772-3095	National Health and Medical Research Council of Australia [APP1007980, 471426]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/) grant numbers APP1007980 and 471426. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 1996, TRENDS MICROBIOL, V4, P321, DOI 10.1016/0966-842X(96)10051-2; ALCAMI A, 1995, IMMUNOL TODAY, V16, P474, DOI 10.1016/0167-5699(95)80030-1; Alters SE, 1999, J IMMUNOTHER, V22, P229, DOI 10.1097/00002371-199905000-00005; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Apte SH, 2008, P NATL ACAD SCI USA, V105, P17475, DOI 10.1073/pnas.0809549105; AR R, 1972, SMALLPOX; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Chaudhri G, 2004, P NATL ACAD SCI USA, V101, P9057, DOI 10.1073/pnas.0402949101; Chaudhri G, 2006, J VIROL, V80, P6339, DOI 10.1128/JVI.00116-06; Chen NH, 2011, VIROLOGY, V409, P328, DOI 10.1016/j.virol.2010.10.021; CHEN W, 1992, VIROLOGY, V187, P433, DOI 10.1016/0042-6822(92)90445-U; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; FENNER F, 1949, J IMMUNOL, V63, P341; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Jezek Z, 1988, HUMAN MONKEYPOX; Jin D, 2009, IMMUNOLOGY, V127, P187, DOI 10.1111/j.1365-2567.2008.02935.x; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KARUPIAH G, 1993, J VIROL, V67, P4214, DOI 10.1128/JVI.67.7.4214-4226.1993; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Kienzle N, 2005, J IMMUNOL, V174, P2021, DOI 10.4049/jimmunol.174.4.2021; LIN H, 1993, J IMMUNOL, V151, P4562; Mahalingam S, 2001, P NATL ACAD SCI USA, V98, P6812, DOI 10.1073/pnas.111151098; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; MCFADDEN G, 1995, J LEUKOCYTE BIOL, V57, P731, DOI 10.1002/jlb.57.5.731; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Miller J., 2001, GERMS ULTIMATE WEAPO; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; NobenTrauth N, 1996, SCIENCE, V271, P987, DOI 10.1126/science.271.5251.987; Oldstone M.B.A., 1998, VIRUSES PLAGUES HIST; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Panchanathan V, 2005, P NATL ACAD SCI USA, V102, P12921, DOI 10.1073/pnas.0505180102; Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Paul WE, 2010, IMMUNOL CELL BIOL, V88, P236, DOI 10.1038/icb.2010.2; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Scalzo AA, 2000, METH MOL B, V121, P163; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Stanford MM, 2007, IMMUNOL CELL BIOL, V85, P93, DOI 10.1038/sj.icb.7100033; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; TranchotDiallo J, 1997, AM J REPROD IMMUNOL, V37, P215; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Wijesundara DK, 2013, VACCINE, V31, P4548, DOI 10.1016/j.vaccine.2013.07.062; Wijesundara DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055788; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	56	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118685	10.1371/journal.pone.0118685	http://dx.doi.org/10.1371/journal.pone.0118685			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751266	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000350692700007
J	Ahmad, MK; Khan, AA; Ali, SN; Mahmood, R				Ahmad, Mir Kaisar; Khan, Aijaz Ahmed; Ali, Shaikh Nisar; Mahmood, Riaz			Chemoprotective Effect of Taurine on Potassium Bromate-Induced DNA Damage, DNA-Protein Cross-Linking and Oxidative Stress in Rat Intestine	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; LIPID-PEROXIDATION; CARBOHYDRATE-METABOLISM; EXPRESSION; ACID; MELATONIN; ENZYMES; TISSUES; INJURY; LEVEL	Potassium bromate (KBrO3) is widely used as a food additive and is a major water disinfection by-product. It induces multiple organ toxicity in humans and experimental animals and is a probable human carcinogen. The present study reports the protective effect of dietary antioxidant taurine on KBrO3-induced damage to the rat intestine. Animals were randomly divided into four groups: control, KBrO3 alone, taurine alone and taurine+ KBrO3. Administration of KBrO3 alone led to decrease in the activities of intestinal brush border membrane enzymes while those of antioxidant defence and carbohydrate metabolism were also severely altered. There was increase in DNA damage and DNA-protein cross-linking. Treatment with taurine, prior to administration of KBrO3, resulted in significant attenuation in all these parameters but the administration of taurine alone had no effect. Histological studies supported these biochemical results showing extensive intestinal damage in KBrO3-treated animals and greatly reduced tissue injury in the taurine+ KBrO3 group. These results show that taurine ameliorates bromate induced tissue toxicity and oxidative damage by improving the antioxidant defence, tissue integrity and energy metabolism. Taurine can, therefore, be potentially used as a therapeutic/protective agent against toxicity of KBrO3 and related compounds.	[Ahmad, Mir Kaisar; Ali, Shaikh Nisar; Mahmood, Riaz] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India; [Khan, Aijaz Ahmed] Aligarh Muslim Univ, JN Med Coll, Fac Med, Dept Anat, Aligarh 202001, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Mahmood, R (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India.	riazmahmood2002@yahoo.co.in		Mahmood, Riaz/0000-0001-6726-157X	University Grants Commission (SAP-DRS-III scheme)	University Grants Commission (SAP-DRS-III scheme)(University Grants Commission, India)	Financial support to the department from the University Grants Commission (SAP-DRS-III scheme) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Ahmad MK, 2014, ENVIRON TOXICOL, V29, P138, DOI 10.1002/tox.20780; Ahmad MK, 2013, CHEMOSPHERE, V91, P1221, DOI 10.1016/j.chemosphere.2013.01.008; Ahmad MK, 2012, BIOCHIMIE, V94, P2776, DOI 10.1016/j.biochi.2012.09.001; Akay C, 2013, HUM EXP TOXICOL, V32, P522, DOI 10.1177/0960327113482692; Alam SS, 2011, ENVIRON TOXICOL PHAR, V31, P143, DOI 10.1016/j.etap.2010.10.001; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; Atmaca G, 2004, YONSEI MED J, V45, P776, DOI 10.3349/ymj.2004.45.5.776; Birdsall T C, 1998, Altern Med Rev, V3, P128; Buege J A, 1978, Methods Enzymol, V52, P302; Bull RJ, 1999, TOXICOLOGY, P1041; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chou CT, 2013, AMINO ACIDS, V45, P811, DOI 10.1007/s00726-013-1524-y; Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509; Culling CFA, 1974, HANDBOOK OF HISTOPAT; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; Das J, 2009, DRUG CHEM TOXICOL, V32, P93, DOI 10.1080/01480540802564171; Environmental Protection Agency (EPA), 2001, TOXICOLOGICAL REVIEW; Farooq N, 2004, NUTR RES, V24, P407, DOI 10.1016/j.nutres.2004.01.004; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gay C, 2000, ANAL BIOCHEM, V284, P217, DOI 10.1006/abio.2000.4696; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hagar HH, 2006, CLIN EXP PHARMACOL P, V33, P189, DOI 10.1111/j.1440-1681.2006.04345.x; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Karbownik M, 2006, CELL BIOCHEM FUNCT, V24, P483, DOI 10.1002/cbf.1321; Khan RA, 2013, PAK J PHARM SCI, V26, P567; Khundmiri SJ, 2004, J NEPHROL, V17, P377; Kolisetty N, 2013, ARCH TOXICOL, V87, P1911, DOI 10.1007/s00204-013-1052-2; Konkel MS, 1986, J BIOL CHEM, V261, P6375; Kumari N, 2013, ADV EXP MED BIOL, V775, P19, DOI 10.1007/978-1-4614-6130-2_2; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Limonciel A, 2012, ARCH TOXICOL, V86, P1741, DOI 10.1007/s00204-012-0897-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manna P, 2009, AMINO ACIDS, V36, P417, DOI 10.1007/s00726-008-0094-x; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Messina SA, 2000, ADV EXP MED BIOL, V483, P355; Motawi TK, 2007, J BIOCHEM MOL TOXIC, V21, P280, DOI 10.1002/jbt.20194; Nishioka H, 2006, TOXICOLOGY, V226, P181, DOI 10.1016/j.tox.2006.06.017; OGASAWARA M, 1994, ADV EXP MED BIOL, V359, P71; Roysommuti S, 2003, THAI J PHYSL SCI, V16, P17; Schaffer S, 2003, ADV EXP MED BIOL, V526, P307; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sener G, 2005, PHARMACOLOGY, V74, P37, DOI 10.1159/000083245; Shimizu M, 2009, ADV EXP MED BIOL, V643, P265, DOI 10.1007/978-0-387-75681-3_27; SHONK CE, 1964, CANCER RES, V24, P709; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stasiak M, 2010, NEUROENDOCRINOL LETT, V31, P363; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; VANDERVLIET A, 1992, FREE RADICAL BIO MED, V12, P499, DOI 10.1016/0891-5849(92)90103-N; VERJEE ZHM, 1969, EUR J BIOCHEM, V9, P439, DOI 10.1111/j.1432-1033.1969.tb00628.x; Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274; Yilmaz O, 2007, ENVIRON TOXICOL PHAR, V24, P79, DOI 10.1016/j.etap.2007.05.007; ZHITKOVICH A, 1992, CARCINOGENESIS, V13, P1485, DOI 10.1093/carcin/13.8.1485	56	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119137	10.1371/journal.pone.0119137	http://dx.doi.org/10.1371/journal.pone.0119137			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748174	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400048
J	Cosme, D; Wiens, S				Cosme, Danielle; Wiens, Stefan			Self-Reported Trait Mindfulness and Affective Reactivity: A Motivational Approach Using Multiple Psychophysiological Measures	PLOS ONE			English	Article							EMOTION REGULATION; DISPOSITIONAL MINDFULNESS; NEURAL RESPONSES; MEDITATION; ATTENTION; STARTLE; MECHANISMS; PRACTITIONERS; MODULATION; RUMINATION	As a form of attention, mindfulness is qualitatively receptive and non-reactive, and is thought to facilitate adaptive emotional responding. One suggested mechanism is that mindfulness facilitates disengagement from an affective stimulus and thereby decreases affective reactivity. However, mindfulness has been conceptualized as a state, intervention, and trait. Because evidence is mixed as to whether self-reported trait mindfulness decreases affective reactivity, we used a multi-method approach to study the relationship between individual differences in self-reported trait mindfulness and electrocortical, electrodermal, electromyographic, and self-reported responses to emotional pictures. Specifically, while participants (N = 51) passively viewed pleasant, neutral, and unpleasant IAPS pictures, we recorded high-density (128 channels) electrocortical, electrodermal, and electromyographic data to the pictures as well as to acoustic startle probes presented during the pictures. Afterwards, participants rated their subjective valence and arousal while viewing the pictures again. If trait mindfulness spontaneously reduces general emotional reactivity, then for individuals reporting high rather than low-mindfulness, response differences between emotional and neutral pictures would show relatively decreased early posterior negativity (EPN) and late positive potential (LPP) amplitudes, decreased skin conductance responses, and decreased subjective ratings for valence and arousal. High mindfulness would also be associated with decreased emotional modulation of startle eyeblink and P3 amplitudes. Although results showed clear effects of emotion on the dependent measures, in general, mindfulness did not moderate these effects. For most measures, effect sizes were small with rather narrow confidence intervals. These data do not support the hypothesis that individual differences in self-reported trait mindfulness are related to spontaneous emotional responses during picture viewing.	[Cosme, Danielle; Wiens, Stefan] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Cosme, Danielle] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	Stockholm University; University of Oregon	Wiens, S (corresponding author), Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden.	sws@psychology.su.se	Wiens, Stefan/D-1268-2017; Cosme, Danielle/AAU-6364-2021	Wiens, Stefan/0000-0003-4531-4313; Cosme, Danielle/0000-0001-8956-4053	Stockholm University; Swedish Research Council [421-2010-1697]	Stockholm University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by internal funds from Stockholm University and a research grant from the Swedish Research Council (421-2010-1697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baguley T, 2009, BRIT J PSYCHOL, V100, P603, DOI 10.1348/000712608X377117; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brown KW, 2013, SOC COGN AFFECT NEUR, V8, P93, DOI 10.1093/scan/nss004; Brown KW, 2012, PSYCHONEUROENDOCRINO, V37, P2037, DOI 10.1016/j.psyneuen.2012.04.003; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Bullis JR, 2014, J BEHAV THER EXP PSY, V45, P57, DOI 10.1016/j.jbtep.2013.07.006; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Desbordes G, 2015, MINDFULNESS, V6, P356, DOI 10.1007/s12671-013-0269-8; Drabant EM, 2009, BIOL PSYCHIAT, V65, P367, DOI 10.1016/j.biopsych.2008.09.007; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; Gootjes L, 2011, J PSYCHOPHYSIOL, V25, P87, DOI 10.1027/0269-8803/a000043; Grossman P, 2011, CONTEMP BUDDHISM, V12, P219, DOI 10.1080/14639947.2011.564841; Hertz RM, 2014, MINDFULNESS, P1, DOI [10.1007/s12671-014-0281-7.biopsych.2008.09.007, DOI 10.1007/S12671-014-0281-7.BIOPSYCH.2008.09.007]; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Jain S, 2007, ANN BEHAV MED, V33, P11, DOI 10.1207/s15324796abm3301_2; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Keil A, 2007, COGN AFFECT BEHAV NE, V7, P18, DOI 10.3758/CABN.7.1.18; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 2008, INTERNATIONAL AFFECT; Larson CL, 2005, PSYCHOPHYSIOLOGY, V42, P604, DOI 10.1111/j.1469-8986.2005.00345.x; Lilja Josefine L., 2011, Cognitive Behaviour Therapy, V40, P291, DOI 10.1080/16506073.2011.580367; Luck S, 2005, AN INTRODUCTION TO T; Lykins ELB, 2009, J COGN PSYCHOTHER, V23, P226, DOI 10.1891/0889-8391.23.3.226; Modinos G, 2010, SOC COGN AFFECT NEUR, V5, P369, DOI 10.1093/scan/nsq006; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ortner CNM, 2007, MOTIV EMOTION, V31, P271, DOI 10.1007/s11031-007-9076-7; Ostafin BD, 2014, MINDFULNESS, V5, P520, DOI 10.1007/s12671-013-0206-x; Roemer L, 2009, BEHAV THER, V40, P142, DOI 10.1016/j.beth.2008.04.001; Sahdra BK, 2010, J PERS ASSESS, V92, P116, DOI 10.1080/00223890903425960; Sauer S, 2011, CONSCIOUS COGN, V20, P1558, DOI 10.1016/j.concog.2011.08.002; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 1997, PSYCHOPHYSIOLOGY, V34, P1, DOI 10.1111/j.1469-8986.1997.tb02409.x; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Sobolewski A, 2011, NEUROSCI RES, V71, P44, DOI 10.1016/j.neures.2011.06.002; Spielberger CD, 1983, MANUAL FOR THE STATE; Syrjanen E, 2013, NEUROSCI LETT, V551, P89, DOI 10.1016/j.neulet.2013.07.018; Taylor VA, 2011, NEUROIMAGE, V57, P1524, DOI 10.1016/j.neuroimage.2011.06.001; Teper R, 2014, EMOTION, V14, P105, DOI 10.1037/a0034296; Van Dam NT, 2010, PERS INDIV DIFFER, V49, P805, DOI 10.1016/j.paid.2010.07.020; Van Dam NT, 2009, PERS INDIV DIFFER, V47, P516, DOI 10.1016/j.paid.2009.05.005; Wiens S, 2013, BIOL PSYCHOL, V94, P44, DOI 10.1016/j.biopsycho.2013.05.001	60	15	15	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119466	10.1371/journal.pone.0119466	http://dx.doi.org/10.1371/journal.pone.0119466			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25749431	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400074
J	Kraft, P; Drechsler, C; Gunreben, I; Heuschmann, PU; Kleinschnitz, C				Kraft, Peter; Drechsler, Christiane; Gunreben, Ignaz; Heuschmann, Peter Ulrich; Kleinschnitz, Christoph			Case-Control Study of Platelet Glycoprotein Receptor Ib and IIb/IIIa Expression in Patients with Acute and Chronic Cerebrovascular Disease	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; ACUTE ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; BLOOD COAGULABILITY; INCREASED RISK; ATHEROSCLEROSIS; MICE; IMPACT; POLYMORPHISMS; INFLAMMATION	Background Animal models have been instrumental in defining thrombus formation, including the role of platelet surface glycoprotein (GP) receptors, in acute ischemic stroke (AIS). However, the involvement of GP receptors in human ischemic stroke pathophysiology and their utility as biomarkers for ischemic stroke risk and severity requires elucidation. Aims To determine whether platelet GPIb and GPIIb/IIIa receptors are differentially expressed in patients with AIS and chronic cerebrovascular disease (CCD) compared with healthy volunteers (HV) and to identify predictors of GPIb and GPIIb/IIIa expression. Methods This was a case- control study of 116 patients with AIS or transient ischemic attack (TIA), 117 patients with CCD, and 104 HV who were enrolled at our University hospital from 2010 to 2013. Blood sampling was performed once in the CCD and HV groups, and at several time points in patients with AIS or TIA. Linear regression and analysis of variance were used to analyze correlations between platelet GPIb and GPIIb/IIIa receptor numbers and demographic and clinical parameters. Results GPIb and GPIIb/IIIa receptor numbers did not significantly differ between the AIS, CCD, and HV groups. GPIb receptor expression level correlated significantly with the magnitude of GPIIb/IIIa receptor expression and the neutrophil count. In contrast, GPIIb/IIIa receptor numbers were not associated with peripheral immune-cell sub-population counts. Creactive protein was an independent predictor of GPIIb/IIIa (not GPIb) receptor numbers. Conclusions Platelet GPIb and GPIIb/IIIa receptor numbers did not distinguish between patient or control groups in this study, negating their potential use as a biomarker for predicting stroke risk.	[Kraft, Peter; Gunreben, Ignaz; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Drechsler, Christiane] Univ Hosp Wurzburg, Dept Internal Med, Wurzburg, Germany; [Heuschmann, Peter Ulrich] Univ Hosp Wurzburg, Clin Trial Ctr, Wurzburg, Germany; [Kraft, Peter; Heuschmann, Peter Ulrich] Univ Wurzburg, Comprehens Heart Failure Ctr, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Kraft, P (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany.	kraft_p1@ukw.de; christoph.kleinschnitz@uni-wuerzburg.de		Kleinschnitz, Christoph/0000-0002-1650-8875	German Research Foundation (Deutsche Forschungsgemeinschaft) [Sonderforschungsbereich 688]; German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany)	This publication was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 688) and the German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Baker RI, 2001, BLOOD, V98, P36, DOI 10.1182/blood.V98.1.36; Carlsson LE, 1997, STROKE, V28, P1392, DOI 10.1161/01.STR.28.7.1392; Cassidy EM, 2003, PSYCHIAT RES, V118, P175, DOI 10.1016/S0165-1781(03)00062-3; De Meyer SF, 2012, STROKE, V43, P599, DOI 10.1161/STROKEAHA.111.628867; Girolami A, 2013, J THROMB HAEMOST, V11, P213, DOI 10.1111/jth.12030; Goebel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066960; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Kleinschnitz C, 2009, BLOOD, V113, P3600, DOI 10.1182/blood-2008-09-180695; Kraft P, 2014, CEREBROVASC DIS, V38, P337, DOI 10.1159/000368434; Kraft P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099851; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Kraft P, 2012, J CEREBR BLOOD F MET, V32, P1831, DOI 10.1038/jcbfm.2012.108; Lindemann S, 2007, CURR OPIN LIPIDOL, V18, P566, DOI 10.1097/MOL.0b013e3282ef7c1e; Ling JY, 2013, J HUAZHONG U SCI-MED, V33, P438, DOI 10.1007/s11596-013-1138-3; Loeffen R, 2012, J THROMB HAEMOST, V10, P1207, DOI 10.1111/j.1538-7836.2012.04782.x; Lugli AK, 2011, J THROMB THROMBOLYS, V32, P215, DOI 10.1007/s11239-011-0586-5; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; Qiao JAL, 2010, BIOL CHEM, V391, P893, DOI 10.1515/BC.2010.081; Schuhmann MK, 2015, J CEREBR BLOOD F MET, V35, P6, DOI 10.1038/jcbfm.2014.175; Shpilberg O, 2002, CIRCULATION, V105, P1044, DOI 10.1161/hc0902.104676; Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; Strassel C, 2009, J THROMB HAEMOST, V7, P1935, DOI 10.1111/j.1538-7836.2009.03608.x; Theilmeier G, 2002, BLOOD, V99, P4486, DOI 10.1182/blood.V99.12.4486; van Lammeren GW, 2012, ATHEROSCLEROSIS, V222, P355, DOI 10.1016/j.atherosclerosis.2012.03.008	30	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119810	10.1371/journal.pone.0119810	http://dx.doi.org/10.1371/journal.pone.0119810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748430	gold, Green Submitted, Green Published			2022-12-27	WOS:000350689400089
J	Kim, JO; Song, DW; Kwon, EJ; Hong, SE; Song, HK; Min, CK; Kim, DH				Kim, Jin Ock; Song, Dong Woo; Kwon, Eun Jeong; Hong, Seong-Eui; Song, Hong Ki; Min, Choon Kee; Kim, Do Han			miR-185 Plays an Anti-Hypertrophic Role in the Heart via Multiple Targets in the Calcium-Signaling Pathways	PLOS ONE			English	Article							INDUCED CARDIAC-HYPERTROPHY; GUINEA-PIG MYOCARDIUM; PROTEIN-KINASE-II; FACTOR 1 RECEPTOR; NA+-CA2+ EXCHANGER; PRESSURE-OVERLOAD; DILATED CARDIOMYOPATHY; IN-VITRO; MICRORNAS; FAILURE	MicroRNA (miRNA) is an endogenous non-coding RNA species that either inhibits RNA translation or promotes degradation of target mRNAs. miRNAs often regulate cellular signaling by targeting multiple genes within the pathways. In the present study, using Gene Set Analysis, a useful bioinformatics tool to identify miRNAs with multiple target genes in the same pathways, we identified miR-185 as a key candidate regulator of cardiac hypertrophy. Using a mouse model, we found that miR-185 was significantly down-regulated in myocardial cells during cardiac hypertrophy induced by transverse aortic constriction. To confirm that miR-185 is an anti-hypertrophic miRNA, genetic manipulation studies such as overexpression and knock-down of miR-185 in neonatal rat ventricular myocytes were conducted. The results showed that up-regulation of miR-185 led to anti-hypertrophic effects, while down-regulation led to pro-hypertrophic effects, suggesting that miR-185 has an anti-hypertrophic role in the heart. Our study further identified Camk2d, Ncx1, and Nfatc3 as direct targets of miR-185. The activity of Nuclear Factor of Activated T-cell (NFAT) and calcium/calmodulin-dependent protein kinase II delta (CaMKII delta) was negatively regulated by miR-185 as assessed by NFAT-luciferase activity and western blotting. The expression of phospho-phospholamban (Thr-17), a marker of CaMKII delta activity, was also significantly reduced by miR-185. In conclusion, miR-185 effectively blocked cardiac hypertrophy signaling through multiple targets, rendering it a potential drug target for diseases such as heart failure.	[Kim, Do Han] GIST, Sch Life Sci, Kwangju, South Korea; GIST, Syst Biol Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Kim, DH (corresponding author), GIST, Sch Life Sci, Kwangju, South Korea.	dhkim@gist.ac.kr		Kim, Jin Ock/0000-0002-5323-7808	GIST Systems Biology Infrastructure Establishment Grant; National Research Foundation of Korea (NRF) - Korea Government, the Ministry of Science, ICT & Future Planning [2013M3A9A7046297]	GIST Systems Biology Infrastructure Establishment Grant; National Research Foundation of Korea (NRF) - Korea Government, the Ministry of Science, ICT & Future Planning	This work was supported by the 2014 GIST Systems Biology Infrastructure Establishment Grant and the National Research Foundation of Korea (NRF) grants funded by the Korea Government, the Ministry of Science, ICT & Future Planning (2013M3A9A7046297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2014, J CLIN INVEST, V124, P2651, DOI 10.1172/JCI73579; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castaldi A, 2014, CIRC RES, V115, P273, DOI 10.1161/CIRCRESAHA.115.303252; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; Ding SL, 2011, WIRES RNA, V2, P124, DOI 10.1002/wrna.61; Dulce RA, 2006, J MOL CELL CARDIOL, V41, P807, DOI 10.1016/j.yjmcc.2006.05.016; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Gladka MM, 2012, J MOL CELL CARDIOL, V52, P74, DOI 10.1016/j.yjmcc.2011.09.015; Gray RP, 2001, PFLUG ARCH EUR J PHY, V442, P117, DOI 10.1007/s004240000512; Hagemann D, 2000, J BIOL CHEM, V275, P22532, DOI 10.1074/jbc.C000253200; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Leite-Moreira AM, 2013, DRUG DISCOV TODAY, V18, P1243, DOI 10.1016/j.drudis.2013.07.025; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li QL, 2014, J CELL MOL MED, V18, P919, DOI 10.1111/jcmm.12242; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Lu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024724; Luo M, 2013, SURGERY, V153, P836, DOI 10.1016/j.surg.2012.12.004; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Magee WP, 2003, AM J PHYSIOL-HEART C, V284, pH903, DOI 10.1152/ajpheart.00784.2002; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Namekata I, 2005, LIFE SCI, V77, P312, DOI 10.1016/j.lfs.2004.10.065; Oka T, 2008, CIRC J, V72, P1359, DOI 10.1253/circj.72.1359; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; Saito T, 2003, J MOL CELL CARDIOL, V35, P1153, DOI 10.1016/S0022-2828(03)00234-7; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Shimoyama M, 1999, CIRCULATION, V100, P2449, DOI 10.1161/01.CIR.100.24.2449; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Song DW, 2014, BIOCHEM J, V457, P151, DOI 10.1042/BJ20130833; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Tritsch E, 2013, CARDIOVASC RES, V98, P372, DOI 10.1093/cvr/cvt042; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Verdonck F, 2003, CARDIOVASC RES, V57, P1035, DOI 10.1016/S0008-6363(02)00734-4; Wang CX, 2012, J CELL BIOCHEM, V113, P2040, DOI 10.1002/jcb.24075; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang J, 2013, J BIOL CHEM, V288, P10418, DOI 10.1074/jbc.M112.444463; Wang Yaosheng, 2011, HEART, V97, pA49; Wang ZY, 2001, J BIOL CHEM, V276, P17706, DOI 10.1074/jbc.M100544200; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang Z, ONCOGENE IN PRESS	68	48	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0122509	10.1371/journal.pone.0122509	http://dx.doi.org/10.1371/journal.pone.0122509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767890	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500148
J	Wei, WZ; Giessler, S; Wolinska, J; Ma, XL; Yang, Z; Hu, W; Yin, MB				Wei, Wenzhi; Giessler, Sabine; Wolinska, Justyna; Ma, Xiaolin; Yang, Zhong; Hu, Wei; Yin, Mingbo			Genetic Structure of Daphnia galeata Populations in Eastern China	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDIZATION; SOFTWARE; DISPERSAL; CRUSTACEA; DIFFERENTIATION; COLONIZATION; EVOLUTIONARY; ZOOPLANKTON; DISTINCTION; DIVERSITY	This study presents the first examination of the genetic structure of Daphnia longispina complex populations in Eastern China. Only one species, D. galeata, was present across the eight investigated lakes; as identified by taxon assignment using allelic variation at 15 microsatellite loci. Three genetically differentiated D. galeata subgroups emerged independent of the type of statistical analysis applied. Thus, Bayesian clustering, discriminant analysis based on results from factorial correspondence analysis, and UPGMA clustering consistently showed that populations from two neighbouring lakes were genetically separated from a mixture of genotypes found in other lakes, which formed another two subgroups. Clonal diversity was high in all D. galeata populations, and most samples showed no deviation from Hardy-Weinberg equilibrium, indicating that clonal selection had little effect on the genetic diversity. Overall, populations did not cluster by geographical origin. Further studies will show if the observed pattern can be explained by natural colonization processes or by recent anthropogenic impact on predominantly artificial lakes.	[Wei, Wenzhi] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Giessler, Sabine] Univ Munich, Dept Biol 2, Evolut Okol, Planegg Martinsried, Germany; [Wolinska, Justyna] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany; [Ma, Xiaolin; Yang, Zhong; Hu, Wei; Yin, Mingbo] Fudan Univ, Sch Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China	Yangzhou University; University of Munich; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Fudan University	Yin, MB (corresponding author), Fudan Univ, Sch Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	yinm@fudan.edu.cn	Wolinska, Justyna/N-6455-2014; Yin, Mingbo/E-3677-2017	Yin, Mingbo/0000-0002-0742-5031	National Natural Science Foundation of China [31200284]; Priority Academic Program Development of Jiangsu Higher Education Institutions; German Science Foundation [WO 1587/4-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; German Science Foundation(German Research Foundation (DFG))	Funding: This research was funded by the National Natural Science Foundation of China grant to MY (31200284), the Priority Academic Program Development of Jiangsu Higher Education Institutions to WW, and the German Science Foundation grant to JW (WO 1587/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Belkhir K., 5000 CNRS UMR; Benzie JAH, 2005, CLADOCERA GENUS DAPH; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Brede N, 2006, MOL ECOL NOTES, V6, P536, DOI 10.1111/j.1471-8286.2005.01218.x; Brede N, 2009, P NATL ACAD SCI USA, V106, P4758, DOI 10.1073/pnas.0807187106; BROOKS JOHN L., 1957, MEM CONNECTICUT ACAD ARTS AND SCI, V13, P1; Caceres CE, 1998, OECOLOGIA, V115, P233, DOI 10.1007/s004420050512; Chao A., 2010, PROGRAM SPADE SPECIE; Chiang SC, 1979, FAUNA INCA; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DeMeester L, 1996, ECOSCIENCE, V3, P385, DOI 10.1080/11956860.1996.11682356; DEMOTT WR, 1983, ECOL MONOGR, V53, P321, DOI 10.2307/1942534; Dlouha S, 2010, HYDROBIOLOGIA, V643, P107, DOI 10.1007/s10750-010-0128-8; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; EDMONDSON WT, 1982, LIMNOL OCEANOGR, V27, P272, DOI 10.4319/lo.1982.27.2.0272; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Figuerola J, 2005, AM NAT, V165, P274, DOI 10.1086/427092; FRYER G, 1985, ZOOL J LINN SOC-LOND, V84, P165, DOI 10.1111/j.1096-3642.1985.tb01797.x; Giessler S, 2001, HYDROBIOLOGIA, V442, P55, DOI 10.1023/A:1017504803506; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; Hebert PDN, 1988, MEMORIE I IDROBIOLOG, P439; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; Ishida S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-209; Keller B, 2008, PHILOS T R SOC B, V363, P2943, DOI 10.1098/rstb.2008.0044; Keller B, 2007, LIMNOL OCEANOGR, V52, P984, DOI 10.4319/lo.2007.52.3.0984; Laforsch C, 2004, ECOLOGY, V85, P2302, DOI 10.1890/03-0286; Lampert W, 2011, DAPHNIA DEV MODEL OR; Louette G, 2005, ECOLOGY, V86, P353, DOI 10.1890/04-0403; MORT MA, 1986, EVOLUTION, V40, P756, DOI 10.1111/j.1558-5646.1986.tb00535.x; MORT MA, 1985, HEREDITY, V55, P27, DOI 10.1038/hdy.1985.68; NEI M, 1974, GENETICS, V76, P379; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petrusek A, 2008, ZOOL SCR, V37, P507, DOI 10.1111/j.1463-6409.2008.00336.x; Petrusek A, 2007, FUND APPL LIMNOL, V169, P279, DOI 10.1127/1863-9135/2007/0169-0279; Petrusek A, 2009, P NATL ACAD SCI USA, V106, P2248, DOI 10.1073/pnas.0808075106; Pijanowska J, 1996, J PLANKTON RES, V18, P1407, DOI 10.1093/plankt/18.8.1407; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rellstab C, 2011, LIMNOL OCEANOGR, V56, P292, DOI 10.4319/lo.2011.56.1.0292; SCHWENK K, 1993, MOL BIOL EVOL, V10, P1289; SCHWENK K, 1995, EXPERIENTIA, V51, P465, DOI 10.1007/BF02143199; Schwenk K, 2000, P ROY SOC B-BIOL SCI, V267, P1833, DOI 10.1098/rspb.2000.1218; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Spaak P, 2012, P ROY SOC B-BIOL SCI, V279, P2936, DOI 10.1098/rspb.2012.0280; Stenberg P, 2003, MOL ECOL NOTES, V3, P329, DOI 10.1046/j.1471-8286.2003.00408.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thielsch A, 2012, MOL ECOL RESOUR, V12, P697, DOI 10.1111/j.1755-0998.2012.03142.x; Thielsch A, 2009, MOL ECOL, V18, P1616, DOI 10.1111/j.1365-294X.2009.04130.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WOLF HG, 1987, HYDROBIOLOGIA, V145, P213, DOI 10.1007/BF02530282; Yin MB, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-80; Yin MB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-12; Yin MB, 2010, MOL ECOL, V19, P4168, DOI 10.1111/j.1365-294X.2010.04807.x	58	8	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120168	10.1371/journal.pone.0120168	http://dx.doi.org/10.1371/journal.pone.0120168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768727	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500113
J	Yu, Q; Lou, XM; He, Y				Yu, Qing; Lou, Xiang-ming; He, Yan			Preferential Recruitment of Th17 Cells to Cervical Cancer via CCR6-CCL20 Pathway	PLOS ONE			English	Article							REGULATORY T-CELLS; HEPATOCELLULAR-CARCINOMA; PHENOTYPE; INFLAMMATION; GENERATION; RELEVANCE; ARTHRITIS; SURVIVAL; IMMUNITY; DISEASE	Our previous studies suggest that Th17 cells accumulate within tumor tissues and correlate with recurrence of cervical cancer patients. However, the source of the increased tumor-infiltrating Th17 cells remains poorly understood. We investigated the prevalence, phenotype and trafficking property of Th17 cells in patients with cervical cancer. Our results showed that Th17 cells highly aggregated within tumor tissues in an activated phenotype with markedly increased expression of CCR6. Correspondingly, level of CCL20 in the tumor tissues was significantly higher than that in non-tumor and normal control tissues, and strongly positively associated with Th17 cells. Further, in vitro migration assay showed CCL20 had effective chemotaxis to circulating Th17 cells. In conclusion, Th17 cells are recruited into tumor tissues preferentially through CCR6-CCL20 pathway, which can serve as a novel therapeutic target for cervical cancer.	[Yu, Qing; Lou, Xiang-ming] Hangzhou First Peoples Hosp, Hangzhou Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China; [He, Yan] Yiwu Matern & Child Care Hosp, Dept Pathol, Yiwu, Zhejiang, Peoples R China		Yu, Q (corresponding author), Hangzhou First Peoples Hosp, Hangzhou Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China.	yuqing790226@163.com	yu, qing/HGC-4611-2022					Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen DY, 2012, HUM IMMUNOL, V73, P1068, DOI 10.1016/j.humimm.2012.07.333; Chen DY, 2012, CELL IMMUNOL, V272, P166, DOI 10.1016/j.cellimm.2011.10.015; Chen KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024671; Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Lee JJ, 2011, HEAD NECK-J SCI SPEC, V33, P1301, DOI 10.1002/hed.21607; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Maruyama T, 2010, CANCER SCI, V101, P1947, DOI 10.1111/j.1349-7006.2010.01624.x; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Strober W, 2010, CURR OPIN GASTROEN, V26, P310, DOI 10.1097/MOG.0b013e328339d099; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yu Q, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0795-1; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	33	33	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120855	10.1371/journal.pone.0120855	http://dx.doi.org/10.1371/journal.pone.0120855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768730	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500137
J	Bagger-Sjoback, D; Stromback, K; Hakizimana, P; Plue, J; Larsson, C; Hultcrantz, M; Papatziamos, G; Smeds, H; Danckwardt-Lilliestrom, N; Hellstrom, S; Johansson, A; Tideholm, B; Fridberger, A				Bagger-Sjoback, Dan; Stromback, Karin; Hakizimana, Pierre; Plue, Jan; Larsson, Christina; Hultcrantz, Malou; Papatziamos, Georgios; Smeds, Henrik; Danckwardt-Lilliestrom, Niklas; Hellstrom, Sten; Johansson, Ann; Tideholm, Bo; Fridberger, Anders			A Randomised, Double Blind Trial of N-Acetylcysteine for Hearing Protection during Stapes Surgery	PLOS ONE			English	Article							HIGH-FREQUENCY HEARING; ADVERSE-REACTIONS; ACETYL-CYSTEINE; RISK-FACTORS; NOISE; STAPEDOTOMY; NAC	Background Otosclerosis is a disorder that impairs middle ear function, leading to conductive hearing loss. Surgical treatment results in large improvement of hearing at low sound frequencies, but high-frequency hearing often suffers. A likely reason for this is that inner ear sensory cells are damaged by surgical trauma and loud sounds generated during the operation. Animal studies have shown that antioxidants such as N-Acetylcysteine can protect the inner ear from noise, surgical trauma, and some ototoxic substances, but it is not known if this works in humans. This trial was performed to determine whether antioxidants improve surgical results at high frequencies. Methods We performed a randomized, double-blind and placebo-controlled parallel group clinical trial at three Swedish university clinics. Using block-stratified randomization, 156 adult patients undergoing stapedotomy were assigned to intravenous N-Acetylcysteine (150 mg/kg body weight) or matching placebo (1:1 ratio), starting one hour before surgery. The primary outcome was the hearing threshold at 6 and 8 kHz; secondary outcomes included the severity of tinnitus and vertigo. Findings One year after surgery, high-frequency hearing had improved 2.7 +/- 3.8 dB in the placebo group (67 patients analysed) and 2.4 +/- 3.7 dB in the treated group (72 patients; means +/- 95% confidence interval, p = 0.54; linear mixed model). Surgery improved tinnitus, but there was no significant intergroup difference. Post-operative balance disturbance was common but improved during the first year, without significant difference between groups. Four patients receiving N-Acetylcysteine experienced mild side effects such as nausea and vomiting. Conclusions N-Acetylcysteine has no effect on hearing thresholds, tinnitus, or balance disturbance after stapedotomy.	[Bagger-Sjoback, Dan; Hakizimana, Pierre; Hultcrantz, Malou; Smeds, Henrik; Hellstrom, Sten; Fridberger, Anders] Karolinska Inst, Ctr Hearing & Commun Res, Dept Clin Sci Intervent & Technol, SE-17177 Stockholm, Sweden; [Bagger-Sjoback, Dan; Larsson, Christina; Hultcrantz, Malou; Papatziamos, Georgios; Smeds, Henrik; Tideholm, Bo] Karolinska Univ Hosp, Dept Otolaryngol, SE-17176 Stockholm, Sweden; [Stromback, Karin; Danckwardt-Lilliestrom, Niklas] Acad Hosp, Dept Otolaryngol, SE-75185 Uppsala, Sweden; [Plue, Jan] Stockholm Univ, Dept Phys Geog & Quaternary Geol, SE-10691 Stockholm, Sweden; [Hellstrom, Sten; Johansson, Ann] Karolinska Univ Hosp, Dept Audiol & Neurotol, SE-17176 Stockholm, Sweden; [Hakizimana, Pierre; Fridberger, Anders] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Stockholm University; Karolinska Institutet; Karolinska University Hospital; Linkoping University	Fridberger, A (corresponding author), Karolinska Inst, Ctr Hearing & Commun Res, Dept Clin Sci Intervent & Technol, SE-17177 Stockholm, Sweden.	anders.fridberger@liu.se	Tideholm, Bo/ABH-2103-2021; Fridberger, Anders/E-8977-2010	Fridberger, Anders/0000-0002-7960-1559; Hakizimana, Pierre/0000-0001-9615-3885; Danckwardt-Lilliestrom, Niklas/0000-0002-0687-3457	AFA Forsakrings AB; Swedish Research Council [K2011-63X-14061-11-3]; Research Council for Working Life and Social Research [2006-1526]; Swedish National Association for Hard of Hearing People; Tysta Skolan foundation	AFA Forsakrings AB; Swedish Research Council(Swedish Research CouncilEuropean Commission); Research Council for Working Life and Social Research; Swedish National Association for Hard of Hearing People; Tysta Skolan foundation	The study was funded by grants awarded to AF from AFA Forsakrings AB (www.afa.se), the Swedish Research Council (K2011-63X-14061-11-3; www.vr.se), the Research Council for Working Life and Social Research (2006-1526; www.forte.se), the Swedish National Association for Hard of Hearing People (www.hrf.se), and the Tysta Skolan foundation (tystaskolan.se). The study drug was a gift from AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielefeld EC, 2007, ACTA OTO-LARYNGOL, V127, P914, DOI 10.1080/00016480601110188; BORGSTROM L, 1986, EUR J CLIN PHARMACOL, V31, P217, DOI 10.1007/BF00606662; BROWNING GG, 1992, CLIN OTOLARYNGOL, V17, P317, DOI 10.1111/j.1365-2273.1992.tb01004.x; Duan ML, 2004, HEARING RES, V192, P1, DOI 10.1016/j.heares.2004.02.005; Eastwood H, 2010, HEARING RES, V259, P24, DOI 10.1016/j.heares.2009.08.010; Fetoni AR, 2009, ACTA OTORHINOLARYNGO, V29, P70; Gerard JM, 2008, OTOL NEUROTOL, V29, P290, DOI 10.1097/MAO.0b013e318161ab0f; Hannula S, 2012, INT J AUDIOL, V51, P833, DOI 10.3109/14992027.2012.707334; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Just T, 2012, AURIS NASUS LARYNX, V39, P383, DOI 10.1016/j.anl.2011.07.009; Kramer S, 2006, J AM ACAD AUDIOL, V17, P265, DOI 10.3766/jaaa.17.4.5; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Le Prell CG, 2011, NOISE HEALTH, V13, P432, DOI 10.4103/1463-1741.90317; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Lin CY, 2010, HEARING RES, V269, P42, DOI 10.1016/j.heares.2010.07.005; MAIR IWS, 1986, ANN OTO RHINOL LARYN, V95, P327, DOI 10.1177/000348948609500402; Mann WJ, 1996, OTOLARYNG HEAD NECK, V115, P324, DOI 10.1016/S0194-5998(96)70046-3; Martin MBS, 2008, OTOL NEUROTOL, V29, P447, DOI 10.1097/MAO.0b013e318172d6a3; Meyer SE, 1999, AM J OTOL, V20, P36; Ohinata Y, 2003, BRAIN RES, V966, P265, DOI 10.1016/S0006-8993(02)04205-1; Oishi N, 2011, EXPERT OPIN EMERG DR, V16, P235, DOI 10.1517/14728214.2011.552427; Sandilands EA, 2009, CLIN TOXICOL, V47, P81, DOI 10.1080/15563650802665587; Schmidt LE, 2001, BRIT J CLIN PHARMACO, V51, P87, DOI 10.1046/j.1365-2125.2001.01305.x; Somers T, 2007, ADV OTO-RHINO-LARYNG, V65, P267, DOI 10.1159/000098841; Stromback K, 2012, ACTA OTO-LARYNGOL, V132, P944, DOI 10.3109/00016489.2012.677859; TANGE RA, 1990, ORL J OTO-RHINO-LARY, V52, P16, DOI 10.1159/000276097; Yamasoba T, 1998, BRAIN RES, V784, P82, DOI 10.1016/S0006-8993(97)01156-6; Yin XH, 2011, ACTA OTO-LARYNGOL, V131, P1132, DOI 10.3109/00016489.2011.600725; Zuur Alain F., 2009, P1	29	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0115657	10.1371/journal.pone.0115657	http://dx.doi.org/10.1371/journal.pone.0115657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763866	gold, Green Submitted, Green Published			2022-12-27	WOS:000351276300003
J	Ano, Y; Kutsukake, T; Hoshi, A; Yoshida, A; Nakayama, H				Ano, Yasuhisa; Kutsukake, Toshiko; Hoshi, Ayaka; Yoshida, Aruto; Nakayama, Hiroyuki			Identification of a Novel Dehydroergosterol Enhancing Microglial Anti-Inflammatory Activity in a Dairy Product Fermented with Penicillium candidum	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MACROPHAGES; NEUROINFLAMMATION; INFLAMMATION; DEPOSITION; ORIGIN; CELLS; RISK; MICE; CNS	Despite the ever-increasing number of dementia patients worldwide, fundamental therapeutic approaches to treat this disease remain to be established. Preventive approaches such as diet, exercise and learning attract attention. Several epidemiological studies suggest that ingestion of fermented dairy products prevents cognitive decline in the elderly. These reports indicate that specific ingredients in the fermented dairy products elicit an anti-inflammatory or anti-oxidative activity that facilitates neuroprotection. The responsible components remain to be investigated. A number of studies have shown that inflammation caused by microglia is closely related to exaggeration of the pathology and cognitive decline seen in the elderly. Many researchers have proposed that controlling microglial activities could be effective in preventing and possibly curing dementia. In the present study, to elucidate specific compounds that regulate microglial activity from dairy products, repeated purification by HPLC, combined with evaluation using primary microglia, facilitated the identification of dehydroergosterol (DHE) as a novel component of the extract that enhances microglial anti-inflammatory activity. DHE contains three conjugated double bonds in a steroid ring system and is an analogue of ergosterol. Despite their related chemical structures, the anti-inflammatory activity of DHE is markedly stronger than that of ergosterol. P. candidum for camembert cheese produces DHE, but P. Roqueforti for blue cheese and Aspergillus do not. DHE also induces CD11b-positive microglia cells into CD206-positive M2 type microglia. Neurotoxicity and neuronal cell death induced by excessively activated microglia is suppressed by treatment with DHE. Thus, this is the first report to demonstrate that DHE, identified as a responsible compound in dairy products, can induce microglia into a preferable phenotype for our brain environment and can be safely introduced into the body by consumption of dairy products. We believe the uptake of DHE might help to prevent the onset of dementia.	[Ano, Yasuhisa; Kutsukake, Toshiko; Hoshi, Ayaka; Yoshida, Aruto] Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan; [Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Ano, Y (corresponding author), Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Yasuhisa_Ano@kirin.co.jp			Kirin Company Ltd.	Kirin Company Ltd.	The authors received no specific funding for this work. Kirin Company Ltd. provided support in the form of salaries for authors Yasuhisa Ano, Toshiko Kutsukake, Ayaka Hoshi and Aruto Yoshida but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Camfield DA, 2011, BRIT J NUTR, V106, P159, DOI 10.1017/S0007114511000158; Crichton GE, 2010, ASIA PAC J CLIN NUTR, V19, P161; Desestret V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067063; Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fernandez PL, 2013, J ALZHEIMERS DIS, V33, P297, DOI 10.3233/JAD-2012-121222; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Jiang ZL, 2014, IMMUNOL LETT, V160, P17, DOI 10.1016/j.imlet.2014.03.006; Li ZL, 2014, BRAIN BEHAV IMMUN, V38, P237, DOI 10.1016/j.bbi.2014.02.008; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Malm T, 2010, GLIA, V58, P889, DOI 10.1002/glia.20973; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McIntosh A, 2008, LIPIDS, V43, P1185, DOI 10.1007/s11745-008-3194-1; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Naert G, 2011, CURR ALZHEIMER RES, V8, P151, DOI 10.2174/156720511795256035; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Rezai-Zadeh K, 2011, CURR ALZHEIMER RES, V8, P156, DOI 10.2174/156720511795256017; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Sugama Shuei, 2009, Inflammation & Allergy Drug Targets, V8, P277; Tachibana Y, 2006, YAKUGAKU ZASSHI, V126, P1139, DOI 10.1248/yakushi.126.1139; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Voloboueva LA, 2011, J NEUROSCI RES, V89, P1989, DOI 10.1002/jnr.22768; Weekman EM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-127; Welberg L, 2014, NAT REV NEUROSCI, V15, DOI 10.1038/nrn3678; Wustner D, 2007, CHEM PHYS LIPIDS, V146, P1, DOI 10.1016/j.chemphyslip.2006.12.004	34	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116598	10.1371/journal.pone.0116598	http://dx.doi.org/10.1371/journal.pone.0116598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760331	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275000008
J	Soares, I; Moleirinho, A; Oliveira, GNP; Amorim, A				Soares, Ines; Moleirinho, Ana; Oliveira, Goncalo N. P.; Amorim, Antonio			DivStat: A User-Friendly Tool for Single Nucleotide Polymorphism Analysis of Genomic Diversity	PLOS ONE			English	Article							DNA POLYMORPHISM; GENETIC-VARIATION	Recent developments have led to an enormous increase of publicly available large genomic data, including complete genomes. The 1000 Genomes Project was a major contributor, releasing the results of sequencing a large number of individual genomes, and allowing for a myriad of large scale studies on human genetic variation. However, the tools currently available are insufficient when the goal concerns some analyses of data sets encompassing more than hundreds of base pairs and when considering haplotype sequences of single nucleotide polymorphisms (SNPs). Here, we present a new and potent tool to deal with large data sets allowing the computation of a variety of summary statistics of population genetic data, increasing the speed of data analysis.	[Soares, Ines; Moleirinho, Ana; Amorim, Antonio] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4200465 Oporto, Portugal; [Moleirinho, Ana; Oliveira, Goncalo N. P.; Amorim, Antonio] Univ Porto, Fac Sci, P-4169007 Oporto, Portugal; [Oliveira, Goncalo N. P.] IFIMUP, P-4169007 Oporto, Portugal; [Oliveira, Goncalo N. P.] IN Inst Nanosci & Nanotechnol, P-4169007 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Soares, I (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.	isoares@ipatimup.pt	Amorim, Antonio/A-7938-2008; Soares, Inês/J-9372-2013; Oliveira, Gonçalo/J-3602-2012; Oliveira, Gonçalo/AAD-5885-2022	Amorim, Antonio/0000-0002-7518-6247; Soares, Inês/0000-0001-7146-4273; Oliveira, Gonçalo/0000-0002-2162-1493; Oliveira, Gonçalo/0000-0002-2162-1493	Portuguese Foundation for Science and Technology (FCT) fellowship [SFRH/BD/73508/2010]; FCT	Portuguese Foundation for Science and Technology (FCT) fellowship; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) fellowship (SFRH/BD/73508/2010) to A. M. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partly supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Moleirinho A, 2013, GENOME BIOL EVOL, V5, P559, DOI 10.1093/gbe/evt029; Muddyman D, 2013, GENOME MED, V5, DOI 10.1186/gm504; NEI M, 1981, GENETICS, V97, P145; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soares I, 2011, FORENS SCI INT-GEN S, V3, pE315, DOI 10.1016/j.fsigss.2011.09.020; TAJIMA F, 1989, GENETICS, V123, P585	10	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119851	10.1371/journal.pone.0119851	http://dx.doi.org/10.1371/journal.pone.0119851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756185	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700053
J	Wang, C; Hipp, JR; Butts, CT; Jose, R; Lakon, CM				Wang, Cheng; Hipp, John R.; Butts, Carter T.; Jose, Rupa; Lakon, Cynthia M.			Alcohol Use among Adolescent Youth: The Role of Friendship Networks and Family Factors in Multiple School Studies	PLOS ONE			English	Article							YOUNG ADOLESCENTS; PROBLEM DRINKING; PEER SELECTION; BINGE DRINKING; SUBSTANCE USE; DRUG-USE; DYNAMICS; POPULARITY; DEPRESSION; ADULTHOOD	To explore the co-evolution of friendship tie choice and alcohol use behavior among 1,284 adolescents from 12 small schools and 976 adolescents from one big school sampled in the National Longitudinal Study of Adolescent to Adult Health (AddHealth), we apply a Stochastic Actor-Based (SAB) approach implemented in the R-based Simulation Investigation for Empirical Network Analysis (RSiena) package. Our results indicate the salience of both peer selection and peer influence effects for friendship tie choice and adolescent drinking behavior. Concurrently, the main effect models indicate that parental monitoring and the parental home drinking environment affected adolescent alcohol use in the small school sample, and that parental home drinking environment affected adolescent drinking in the large school sample. In the small school sample, we detect an interaction between the parental home drinking environment and choosing friends that drink as they multiplicatively affect friendship tie choice. Our findings suggest that future research should investigate the synergistic effects of both peer and parental influences for adolescent friendship tie choices and drinking behavior. And given the tendency of adolescents to form ties with their friends' friends, and the evidence of local hierarchy in these networks, popular youth who do not drink may be uniquely positioned and uniquely salient as the highest rank of the hierarchy to cause anti-drinking peer influences to diffuse down the social hierarchy to less popular youth. As such, future interventions should harness prosocial peer influences simultaneously with strategies to increase parental support and monitoring among parents to promote affiliation with prosocial peers.	[Wang, Cheng] Cornell Univ, Dept Sociol, Ithaca, NY 14853 USA; [Hipp, John R.] Univ Calif Irvine, Dept Criminol, Dept Law, Irvine, CA USA; [Hipp, John R.] Univ Calif Irvine, Dept Soc, Irvine, CA USA; [Hipp, John R.; Butts, Carter T.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA; [Butts, Carter T.] Univ Calif Irvine, Dept Stat, Irvine, CA USA; [Jose, Rupa] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Lakon, Cynthia M.] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA	Cornell University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wang, C (corresponding author), Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA.	cw529@cornell.edu			National Institutes of Health [5R21DA031152-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is funded by National Institutes of Health Grant (5R21DA031152-02) administered through the Program in Public Health at the University of California Irvine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 2005, CHILD DEV, V76, P747, DOI 10.1111/j.1467-8624.2005.00875.x; Aseltine RH, 2000, SUBST USE MISUSE, V35, P643, DOI 10.3109/10826080009148415; Bahr Stephen J, 2005, J Prim Prev, V26, P529, DOI 10.1007/s10935-005-0014-8; Balsa AI, 2011, J RES ADOLESCENCE, V21, P559, DOI 10.1111/j.1532-7795.2010.00704.x; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARNES GM, 1994, J RES ADOLESCENCE, V4, P183, DOI DOI 10.1207/S15327795JRA0402_2; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Bifulco R, 2011, AM ECON J-ECON POLIC, V3, P25, DOI 10.1257/pol.3.1.25; Bonnie R.J., 2004, REDUCING UNDERAGE DR; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Bronfenbrenner U, 1981, ECOLOGY HUMAN DEV EX; Brown BB, 1989, PEER RELATIONSHIPS C, P188; Burk WJ, 2012, J STUD ALCOHOL DRUGS, V73, P89, DOI 10.15288/jsad.2012.73.89; Caldwell CH, 2004, AM J COMMUN PSYCHOL, V34, P71, DOI 10.1023/B:AJCP.0000040147.69287.f7; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carpenter C, 2009, AM ECON J-APPL ECON, V1, P164, DOI 10.1257/app.1.1.164; Centers for Disease Control and Prevention, 2011, YOUTH RISK BEH SURV; Chassin L, 1996, J ABNORM PSYCHOL, V105, P70, DOI 10.1037/0021-843X.105.1.70; Chassin L, 2002, J CONSULT CLIN PSYCH, V70, P67, DOI 10.1037//0022-006X.70.1.67; Cheadle JE, 2012, SOC MENT HEALTH, V2, P99, DOI 10.1177/2156869312445211; Cheadle JE, 2012, SOC SCI RES, V41, P1198, DOI 10.1016/j.ssresearch.2012.03.014; de la Haye K, 2013, J RES ADOLESCENCE, V23, P474, DOI 10.1111/jora.12018; DESIMONE A, 1994, ADOLESCENCE, V29, P939; Diego MA, 2003, ADOLESCENCE, V38, P35; Dubow EF, 2008, ADDICTION, V103, P36, DOI 10.1111/j.1360-0443.2008.02175.x; ELLICKSON PL, 1991, J STUD ALCOHOL, V52, P398, DOI 10.15288/jsa.1991.52.398; Ennett ST, 2006, J RES ADOLESCENCE, V16, P159, DOI 10.1111/j.1532-7795.2006.00127.x; Ennett ST, 2008, CHILD DEV, V79, P1777, DOI 10.1111/j.1467-8624.2008.01225.x; Falci C, 2009, SOC FORCES, V87, P2031; Fettes DL, 2011, AM J PUBLIC HEALTH, V101, P2342, DOI 10.2105/AJPH.2011.300266; Fletcher JM, 2009, SOCIOL EDUC, V82, P287, DOI 10.1177/003804070908200401; German M, 2009, J EARLY ADOLESCENCE, V29, P16, DOI 10.1177/0272431608324475; Giletta M, 2012, J ABNORM CHILD PSYCH, V40, P1027, DOI 10.1007/s10802-012-9625-8; Harris KM, 2009, NATL LONGITUDINAL ST; Hingson RW, 2008, J STUD ALCOHOL DRUGS, V69, P192, DOI 10.15288/jsad.2008.69.192; Hirschi T., 1969, CAUSE OF DELINQUENCY; Huisman M, 2003, SOCIOL METHOD RES, V32, P253, DOI 10.1177/0049124103256096; Huisman M, 2008, SOC NETWORKS, V30, P297, DOI 10.1016/j.socnet.2008.04.004; Kirke DM, 2004, SOC NETWORKS, V26, P3, DOI 10.1016/j.socnet.2003.12.001; Knecht AB, 2011, J RES ADOLESCENCE, V21, P475, DOI 10.1111/j.1532-7795.2010.00685.x; Komro KA, 2007, ADDICTION, V102, P1597, DOI 10.1111/j.1360-0443.2007.01941.x; Kreager DA, 2011, AM SOCIOL REV, V76, P737, DOI 10.1177/0003122411416934; Kubik MY, 2003, AM J HEALTH BEHAV, V27, P546, DOI 10.5993/AJHB.27.5.6; Lakon CM, 2014, J YOUTH ADOLESCENCE; Lakon CM, 2010, AM J PUBLIC HEALTH, V100, P1218, DOI 10.2105/AJPH.2009.167973; Leung RK, 2014, HEALTH PSYCHOL REV, V8, P426, DOI 10.1080/17437199.2011.587961; Marshal MP., 2000, APPL DEV SCI, V4, P80, DOI [DOI 10.1207/S1532480XADS0402_3, 10.1207/S1532480XADS0402_3]; Mathys C, 2013, J RES ADOLESCENCE, V23, P513, DOI 10.1111/jora.12031; McKenzie M, 2011, MED J AUSTRALIA, V195, pS27; Mercken L, 2012, J STUD ALCOHOL DRUGS, V73, P99, DOI 10.15288/jsad.2012.73.99; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Mundt MP, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-115; Nash SG, 2005, J ADOLESCENT HEALTH, V37, P19, DOI 10.1016/j.jadohealth.2004.06.004; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nye F.I., 1958, FAM RELAT; Osgood DW, 2013, J RES ADOLESCENCE, V23, P500, DOI 10.1111/jora.12059; Parker JG, 2006, DEV PSYCHOPATHOL, P419, DOI DOI 10.1002/9780470939383.CH12; Parsons SK, 1999, INT J CANCER, P46; Pearson M., 2006, CONNECTIONS, V27, P47; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ripley R. M., 2014, MANUAL SIENA VERSION; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; Simpkins SD, 2013, J RES ADOLESCENCE, V23, P537, DOI 10.1111/j.1532-7795.2012.00836.x; Snijders T. A. B., 2011, SAGE HDB SOCIAL NETW, P501; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; U.S. Department of Health and Human Services, 2007, SURG GEN CALL ACT PR; Urberg KA, 1997, DEV PSYCHOL, V33, P834, DOI 10.1037/0012-1649.33.5.834; Valente TW, 2007, ADDICTION, V102, P1804, DOI 10.1111/j.1360-0443.2007.01992.x; Valente TW, 2003, AM J PUBLIC HEALTH, V93, P1837, DOI 10.2105/AJPH.93.11.1837; Van der Vorst H, 2006, PSYCHOL ADDICT BEHAV, V20, P107, DOI 10.1037/0893-164X.20.2.107; van der Zwaluw CS, 2008, J BEHAV MED, V31, P189, DOI 10.1007/s10865-007-9146-z; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Younisis J., 1980, PARENTS PEERS SOCIAL	74	46	49	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119965	10.1371/journal.pone.0119965	http://dx.doi.org/10.1371/journal.pone.0119965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756364	gold, Green Published			2022-12-27	WOS:000351275700056
J	Hussain, T; Mastrodimos, MB; Raju, SC; Glasgow, HL; Whitney, M; Friedman, B; Moore, JD; Kleinfeld, D; Steinbach, P; Messer, K; Pu, MY; Tsien, RY; Nguyen, QT				Hussain, Timon; Mastrodimos, Melina B.; Raju, Sharat C.; Glasgow, Heather L.; Whitney, Michael; Friedman, Beth; Moore, Jeffrey D.; Kleinfeld, David; Steinbach, Paul; Messer, Karen; Pu, Minya; Tsien, Roger Y.; Nguyen, Quyen T.			Fluorescently Labeled Peptide Increases Identification of Degenerated Facial Nerve Branches during Surgery and Improves Functional Outcome	PLOS ONE			English	Article							ENDONEURIAL CHANGES; RAT; WHISKING; HEAD; TRANSECTION; RECOVERY; MUSCLE; CORTEX	Nerve degeneration after transection injury decreases intraoperative visibility under white light (WL), complicating surgical repair. We show here that the use of fluorescently labeled nerve binding probe (F-NP41) can improve intraoperative visualization of chronically (up to 9 months) denervated nerves. In a mouse model for the repair of chronically denervated facial nerves, the intraoperative use of fluorescent labeling decreased time to nerve identification by 40% compared to surgeries performed under WL alone. Cumulative functional post-operative recovery was also significantly improved in the fluorescence guided group as determined by quantitatively tracking of the recovery of whisker movement at time intervals for 6 weeks post-repair. To our knowledge, this is the first description of an injectable probe that increases visibility of chronically denervated nerves during surgical repair in live animals. Future translation of this probe may improve functional outcome for patients with chronic denervation undergoing surgical repair.	[Hussain, Timon; Mastrodimos, Melina B.; Raju, Sharat C.; Nguyen, Quyen T.] Univ Calif San Diego, Div Head & Neck Surg, La Jolla, CA 92093 USA; [Glasgow, Heather L.; Whitney, Michael; Friedman, Beth; Tsien, Roger Y.; Nguyen, Quyen T.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Moore, Jeffrey D.; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Steinbach, Paul; Tsien, Roger Y.] Howard Hughes Med Inst, San Diego, CA USA; [Messer, Karen; Pu, Minya] Univ Calif San Diego, Moores Canc Ctr, Div Biostat, La Jolla, CA 92093 USA; [Nguyen, Quyen T.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Nguyen, QT (corresponding author), Univ Calif San Diego, Div Head & Neck Surg, La Jolla, CA 92093 USA.	q1nguyen@ucsd.edu	Glasgow, Heather/ABA-9587-2020	Glasgow, Heather/0000-0002-6594-9837	NIH (NIBIB) [R01 EB014929-01]; Burroughs-Wellcome Fund-(CAMS); NIH [R01 NS058668, 03/01/2007-04/30/2018]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058668, R01NS027177] Funding Source: NIH RePORTER	NIH (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Burroughs-Wellcome Fund-(CAMS)(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by NIH (NIBIB) R01 EB014929-01 to QTN (Title: Testing Fluorescently Labeled Probes for Nerve Imaging during Surgery); Burroughs-Wellcome Fund-(CAMS) to QTN (Title: Testing surgery guided by molecular fluorescence imaging); NIH R01 NS058668 to DK, 03/01/2007-04/30/2018 (Title: Sensorimotor Loops in Vibrissa Somatosensation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bascom D A, 2000, Facial Plast Surg, V16, P309, DOI 10.1055/s-2000-15545; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Danner CJ, 2008, OTOLARYNG CLIN N AM, V41, P619, DOI 10.1016/j.otc.2008.01.008; Dohm S, 2000, RESTOR NEUROL NEUROS, V16, P117; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Goh HKC, 2010, LANCET ONCOL, V11, P281, DOI 10.1016/S1470-2045(09)70379-1; Gordon T, 2004, NEUROL RES, V26, P174, DOI 10.1179/016164104225013806; Grosheva M, 2008, BIOL CHEM, V389, P873, DOI 10.1515/BC.2008.100; Guntinas-Lichius O, 2006, AM J SURG, V191, P61, DOI 10.1016/j.amjsurg.2005.05.054; Guntinas-Lichius O, 2005, EUR J NEUROSCI, V21, P391, DOI 10.1111/j.1460-9568.2005.03877.x; Guntinas-Lichius Orlando, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P133, DOI 10.1097/00020840-200404000-00014; Hayashi A, 2007, J RECONSTR MICROSURG, V23, P381, DOI 10.1055/s-2007-992344; Hohman MH, 2013, LARYNGOSCOPE; Hohman MH, 2013, LARYNGOSCOPE; Hohman MH, 2013, JAMA FACIAL PLA 1114; Iseli TA, 2010, LARYNGOSCOPE, V120, P478, DOI 10.1002/lary.20789; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Mehta RP, 2009, CLIN EXP OTORHINOLAR, V2, P1, DOI 10.3342/ceo.2009.2.1.1; Moore JD, 2013, NATURE, V497, P205, DOI 10.1038/nature12076; Ngeow WC, 2010, ORAL SURG ORAL MED O, V109, P357, DOI 10.1016/j.tripleo.2009.06.030; Ozmen OA, 2011, OTOL NEUROTOL, V32, P1341, DOI 10.1097/MAO.0b013e31822e952d; Reddy PG, 1999, LARYNGOSCOPE, V109, P894, DOI 10.1097/00005537-199906000-00010; ROYTTA M, 1988, ACTA NEUROPATHOL, V76, P35; ROYTTA M, 1987, ACTA NEUROPATHOL, V73, P323; Rudman KL, 2012, OTOLARYNG CLIN N AM, V45, P513, DOI 10.1016/j.otc.2011.12.015; Streppel M, 1998, NEUROBIOL AGING, V19, P83, DOI 10.1016/S0197-4580(97)00163-2; Volk GF, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-25; Wei Y, 2013, CELL TISSUE RES; Whitney MA, 2011, NAT BIOTECHNOL, V29, P352, DOI 10.1038/nbt.1764; Wu AP, 2011, LARYNGOSCOPE, V121, P805, DOI 10.1002/lary.21411; Yetiser S, 2007, ANN OTO RHINOL LARYN, V116, P542, DOI 10.1177/000348940711600710	35	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119600	10.1371/journal.pone.0119600	http://dx.doi.org/10.1371/journal.pone.0119600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751149	Green Published, gold			2022-12-27	WOS:000350692700029
J	Schnippel, K; Lince-Deroche, N; van den Handel, T; Molefi, S; Bruce, S; Firnhaber, C				Schnippel, Kathryn; Lince-Deroche, Naomi; van den Handel, Theo; Molefi, Seithati; Bruce, Suann; Firnhaber, Cynthia			Cost Evaluation of Reproductive and Primary Health Care Mobile Service Delivery for Women in Two Rural Districts in South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; ACCESS; COUNTRIES	Background Cervical cancer screening is a critical health service that is often unavailable to women in under-resourced settings. In order to expand access to this and other reproductive and primary health care services, a South African non-governmental organization established a van-based mobile clinic in two rural districts in South Africa. To inform policy and budgeting, we conducted a cost evaluation of this service delivery model. Methods The evaluation was retrospective (October 2012-September 2013 for one district and April-September 2013 for the second district) and conducted from a provider cost perspective. Services evaluated included cervical cancer screening, HIV counselling and testing, syndromic management of sexually transmitted infections (STIs), breast exams, provision of condoms, contraceptives, and general health education. Fixed costs, including vehicle purchase and conversion, equipment, operating costs and mobile clinic staffing, were collected from program records and public sector pricing information. The number of women accessing different services was multiplied by ingredients-based variable costs, reflecting the consumables required. All costs are reported in 2013 USD. Results Fixed costs accounted for most of the total annual costs of the mobile clinics (85% and 94% for the two districts); the largest contributor to annual fixed costs was staff salaries. Average costs per patient were driven by the total number of patients seen, at $46.09 and $76.03 for the two districts. Variable costs for Pap smears were higher than for other services provided, and some services, such as breast exams and STI and tuberculosis symptoms screening, had no marginal cost. Conclusions Staffing costs are the largest component of providing mobile health services to rural communities. Yet, in remote areas where patient volumes do not exceed nursing staff capacity, incorporating multiple services within a cervical cancer screening program is an approach to potentially expand access to health care without added costs.	[Schnippel, Kathryn; Lince-Deroche, Naomi; Firnhaber, Cynthia] Univ Witwatersrand, Dept Internal Med, Hlth Econ & Epidemiol Res Off, Fac Hlth Sci, Johannesburg, South Africa; [van den Handel, Theo; Molefi, Seithati; Bruce, Suann; Firnhaber, Cynthia] Right Care, Johannesburg, South Africa	University of Witwatersrand	Schnippel, K (corresponding author), Univ Witwatersrand, Dept Internal Med, Hlth Econ & Epidemiol Res Off, Fac Hlth Sci, Johannesburg, South Africa.	kschnipp@gmail.com		Schnippel, Kathryn/0000-0003-0757-4325; Lince-Deroche, Naomi/0000-0003-3689-4205	United States Agency for International Development (USAID) [674-A-00-08-00007-00]; Health Economics and Epidemiology Research Office [674-A-12-00029]; First for Women Insurance, a women's insurance company in South Africa	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Health Economics and Epidemiology Research Office; First for Women Insurance, a women's insurance company in South Africa	Funding was provided by the United States Agency for International Development (USAID) (http://www.usaid.gov/) under award number 674-A-00-08-00007-00 for Right to Care (TvdH, SM, SB, CF) and 674-A-12-00029 with the Health Economics and Epidemiology Research Office (KS, NLD, CF). Funding for the mobile clinics was provided by First for Women Insurance, a women's insurance company in South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.	[Anonymous], 2013, HIST EXCH RAT USD ZA; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Automobile Association South Africa, DIESL PRIC; Automobile Association South Africa, PETR PRIC; Automobile Association South Africa, 2012, CALC OP COST VEH; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Department of Public Service Administration, 2013, SAL SCAL TRANSL KEYS; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dyer JJ, 1996, S AFR MED J, V86, P528; Eckert L O, 1999, Infect Dis Obstet Gynecol, V7, P158, DOI 10.1155/S1064744999000253; Evans DB, 2013, B WORLD HEALTH ORGAN, V91, P546, DOI 10.2471/BLT.13.125450; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Firnhaber C, 2010, CANCER CAUSE CONTROL, V21, P433, DOI 10.1007/s10552-009-9475-z; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gavaza P, 2012, PHARMACOECONOMICS, V30, P925, DOI 10.2165/11589450-000000000-00000; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Health Systems Trust, 2012, DISTR HLTH BAR 2010; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; *INT AG RES CANC, 2012, GLOBOCAN 2012; Lewis D. A., 2009, Southern African Journal of Epidemiology & Infection, V24, P6; Lomalisa P, 2000, GYNECOL ONCOL, V77, P460, DOI 10.1006/gyno.2000.5775; Mbulawa ZZA, 2010, J GEN VIROL, V91, P3023, DOI 10.1099/vir.0.020669-0; McIntyre D, 2009, HEALTH ECON POLICY L, V4, P179, DOI 10.1017/S1744133109004836; National Department of Health, 2012, STRAT PLAN MAT NEWB; National Health Laboratory Service, 2013, STAT PRIC LIST; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; South Africa National Department of Health, 2012, SUPPL DEL MAL FAM CO; South African Bureau of Standard, 2011, SUPPL DEL FAM PLANN, P1; South African Department of Health South African Department of Basic Education, 2014, GLOB REP UNAIDS REP, P3; South African National Department of Health, 2000, NAT GUID CERV CANC S; South African Reserve Bank, 2014, RAT; Statistics South Africa, 2013, P0141 STAT S AFR; United National Family Planning Association (UNFPA), 2008, MAK REPR RIGHTS SEX; United Nations, 2007, MILL DEV GOALS REP 2	34	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119236	10.1371/journal.pone.0119236	http://dx.doi.org/10.1371/journal.pone.0119236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751528	gold, Green Published			2022-12-27	WOS:000350692700018
J	Yang, JR; Kuo, CY; Huang, HY; Wu, FT; Huang, YL; Cheng, CY; Su, YT; Wu, HS; Liu, MT				Yang, Ji-Rong; Kuo, Chuan-Yi; Huang, Hsiang-Yi; Wu, Fu-Ting; Huang, Yi-Lung; Cheng, Chieh-Yu; Su, Yu-Ting; Wu, Ho-Sheng; Liu, Ming-Tsan			Characterization of Influenza A (H7N9) Viruses Isolated from Human Cases Imported into Taiwan	PLOS ONE			English	Article							AVIAN INFLUENZA; HUMAN INFECTION; A(H7N9) VIRUS; REASSORTMENT; DIVERSITY; MARKETS; ORIGIN	A novel avian influenza A (H7N9) virus causes severe human infections and was first identified in March 2013 in China. The H7N9 virus has exhibited two epidemiological peaks of infection, occurring in week 15 of 2013 and week 5 of 2014. Taiwan, which is geographically adjacent to China, faces a large risk of being affected by this virus. Through extensive surveillance, launched in April 2013, four laboratory-confirmed H7N9 cases imported from China have been identified in Taiwan. The H7N9 virus isolated from imported case 1 in May 2013 (during the first wave) was found to be closest genetically to a virus from wild birds and differed from the prototype virus, A/Anhui/1/2013, in the MP gene. The other three imported cases were detected in December 2013 and April 2014 (during the second wave). The viruses isolated from cases 2 and 4 were similar in the compositions of their 6 internal genes and distinct from A/Anhui/1/2013 in the PB2 and MP genes, whereas the virus isolated from case 3 exhibited a novel reassortment that has not been identified previously and was different from A/Anhui/1/2013 in the PB2, PA and MP genes. The four imported H7N9 viruses share similar antigenicity with A/Anhui/1/2013, and their HA and NA genes grouped together in their respective phylogenies. In contrast with the HA and NA genes, which exhibited a smaller degree of diversity, the internal genes were heterogeneous and provided potential distinctions between transmission sources in terms of both geography and hosts. It is important to strengthen surveillance of influenza and to share viral genetic data in real-time for reducing the threat of rapid and continuing evolution of H7N9 viruses.	[Yang, Ji-Rong; Kuo, Chuan-Yi; Huang, Hsiang-Yi; Wu, Fu-Ting; Huang, Yi-Lung; Cheng, Chieh-Yu; Su, Yu-Ting; Wu, Ho-Sheng; Liu, Ming-Tsan] Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University	Wu, HS (corresponding author), Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan.	wuhs@cdc.gov.tw; mtliu@cdc.gov.tw			Centers for Disease Control, Ministry of Health and Welfare, Taiwan [MOHW103-CDC-C-315-000101, MOHW103-CDC-C-315-000601]	Centers for Disease Control, Ministry of Health and Welfare, Taiwan	This study was supported by grants from Centers for Disease Control, Ministry of Health and Welfare, Taiwan (MOHW103-CDC-C-315-000101 and MOHW103-CDC-C-315-000601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cui LB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4142; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu W, 2014, J VIROL, V88, P13344, DOI 10.1128/JVI.01777-14; Lo YC, 2013, EURO SURVEILL, V18; Lu J, 2014, J VIROL, V88, P8297, DOI 10.1128/JVI.00630-14; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; To KKW, 2014, J INFECTION, V69, P60, DOI 10.1016/j.jinf.2014.02.012; Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2; WHO, 2014, WHO RISK ASSESSMENT; WHO, 2014, ANTIGENIC AND GENETI; WHO, 2013, REAL TIME RT PCR PRO; WHO, 2014, WHO HUMAN INFECTION; WHO, 2014, MAP AND EPIDEMIOLOGI; WHO, 2012, WHO INFORMATION FOR; World Health Organization, 2011, MANUAL FOR THE LABOR; Yang JR, 2014, J CLIN MICROBIOL, V52, P76, DOI 10.1128/JCM.02467-13; Yang JR, 2009, J CLIN MICROBIOL, V47, P3714, DOI 10.1128/JCM.01646-09; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu XF, 2014, J VIROL, V88, P3423, DOI 10.1128/JVI.02059-13; Zhang J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04846; Zhao BH, 2014, EMERG INFECT DIS, V20, P850, DOI 10.3201/eid2005.131707	32	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119792	10.1371/journal.pone.0119792	http://dx.doi.org/10.1371/journal.pone.0119792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748033	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400087
J	Azimi, MS; Myers, L; Lacey, M; Stewart, SA; Shi, Q; Katakam, PV; Mondal, D; Murfee, WL				Azimi, Mohammad S.; Myers, Leann; Lacey, Michelle; Stewart, Scott A.; Shi, Qirong; Katakam, Prasad V.; Mondal, Debasis; Murfee, Walter L.			An Ex Vivo Model for Anti-Angiogenic Drug Testing on Intact Microvascular Networks	PLOS ONE			English	Article							IN-VITRO; CHORIOALLANTOIC MEMBRANE; SHEAR-STRESS; GROWTH; VEGF; CANCER; TISSUE; ASSAY	New models of angiogenesis that mimic the complexity of real microvascular networks are needed. Recently, our laboratory demonstrated that cultured rat mesentery tissues contain viable microvascular networks and could be used to probe pericyte-endothelial cell interactions. The objective of this study was to demonstrate the efficacy of the rat mesentery culture model for anti-angiogenic drug testing by time-lapse quantification of network growth. Mesenteric windows were harvested from adult rats, secured in place with an insert, and cultured for 3 days according to 3 experimental groups: 1) 10% serum (angiogenesis control), 2) 10% serum + sunitinib (SU11248), and 3) 10% serum + bevacizumab. Labeling with FITC conjugated BSI-lectin on Day 0 and 3 identified endothelial cells along blood and lymphatic microvascular networks. Comparison between day 0 (before) and 3 (after) in networks stimulated by 10% serum demonstrated a dramatic increase in vascular density and capillary sprouting. Growing networks contained proliferating endothelial cells and NG2+ vascular pericytes. Media supplementation with sunitinib (SU11248) or bevacizumab both inhibited the network angiogenic responses. The comparison of the same networks before and after treatment enabled the identification of tissue specific responses. Our results establish, for the first time, the ability to evaluate an anti-angiogenic drug based on time-lapse imaging on an intact microvascular network in an ex vivo scenario.	[Azimi, Mohammad S.; Stewart, Scott A.; Shi, Qirong; Murfee, Walter L.] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Myers, Leann] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Lacey, Michelle] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Katakam, Prasad V.; Mondal, Debasis] Tulane Univ, Dept Pharmacol, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University; Tulane University	Azimi, MS (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.	mazimi@tulane.edu	K, P/AAL-6310-2021	Katakam, Prasad/0000-0002-4708-9140	National Institutes of Health [5-P20GM103629-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (5-P20GM103629-02) to WLM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Albertsson P, 2012, APMIS, V120, P147, DOI 10.1111/j.1600-0463.2011.02830.x; Aref AR, 2013, INTEGR BIOL-UK, V5, P381, DOI 10.1039/c2ib20209c; Chan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050582; Chung AS, 2012, J PATHOL, V227, P404, DOI 10.1002/path.4052; Dib E, 2012, CURR EYE RES, V37, P567, DOI 10.3109/02713683.2011.635916; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Galie PA, 2014, P NATL ACAD SCI USA, V111, P7968, DOI 10.1073/pnas.1310842111; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Hsu YH, 2013, LAB CHIP, V13, P81, DOI [10.1039/c2lc40787f, 10.1039/c2lc407871]; Kaunas R, 2011, CELL MOL BIOENG, V4, P547, DOI 10.1007/s12195-011-0208-5; Lennernas B, 2004, APMIS, V112, P201, DOI 10.1111/j.1600-0463.2004.apm1120306.x; Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074; NICOSIA RF, 1990, LAB INVEST, V63, P115; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; OLIVO M, 1992, ANAT RECORD, V234, P105, DOI 10.1002/ar.1092340112; Osusky Katherine L., 2004, Angiogenesis, V7, P225, DOI 10.1007/s10456-004-3149-y; Peirce SM, 2012, CURR OPIN HEMATOL, V19, P184, DOI 10.1097/MOH.0b013e3283523ea6; Sawamiphak S, 2010, NAT PROTOC, V5, P1659, DOI 10.1038/nprot.2010.130; Skalak Thomas C., 1996, Microcirculation (Philadelphia), V3, P143, DOI 10.3109/10739689609148284; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Stapor PC, 2013, AM J PHYSIOL-HEART C, V304, pH235, DOI 10.1152/ajpheart.00552.2012; Stapor PC, 2012, J VASC RES, V49, P299, DOI 10.1159/000336714; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Sweat RS, 2012, LYMPHAT RES BIOL, V10, P198, DOI 10.1089/lrb.2012.0014; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Unoki N, 2010, INVEST OPHTH VIS SCI, V51, P2347, DOI 10.1167/iovs.09-4158; WILTING J, 1991, ANAT EMBRYOL, V183, P259; Yang M, 2012, JOVE-J VIS EXP, DOI 10.3791/3954	30	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119227	10.1371/journal.pone.0119227	http://dx.doi.org/10.1371/journal.pone.0119227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742654	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100093
J	Liu, XQ; Gao, HH; Xiao, N; Liu, Y; Li, JN; Li, L				Liu, Xueqin; Gao, Huihui; Xiao, Nin; Liu, Yan; Li, Jinnian; Li, Lin			Outer Membrane Protein U (OmpU) Mediates Adhesion of Vibrio mimicus to Host Cells via Two Novel N-Terminal Motifs	PLOS ONE			English	Article							IN-VITRO; ADHERENCE; HEMAGGLUTININS; IDENTIFICATION; OUTBREAK; CHOLERAE; INVASION; CATFISH; GENES; LINE	Vibrio mimicus (V. mimicus) is a causative agent of ascites disease in aquatic animals. Our previous studies have demonstrated that the outer membrane protein U (OmpU) from V. mimicus is an immunoprotective antigen with six immunodominant linear B-cell epitopes. Although the N-terminus of OmpU contains potential binding motifs, it remained unclear whether OmpU possesses adhesion function. Here, the adhesive capacity of recombinant OmpU and V. mimicus to epithelioma papulosum cyprinid (EPC) cells was determined by immunofluorescence and adherence assay. The results showed that after co-incubated with rOmpU, an obvious visible green fluorescence could be observed on the EPC cell surface and the nuclei exhibited blue fluorescence; while the control cell surface did not show any signal, only nuclei exhibited blue fluorescence. The average number of wild-type strain adhered to each cell was 32.3 +/- 4.5. The average adhesion number of OmpU gene deletion mutant was significantly reduced to 10.8 +/- 0.5 (P < 0.01) and restored to 31.3 +/- 2.8 by complement strain (P > 0.05). Pretreatment of cells with rOmpU reduced the average adhesion number of wild-type strain to 9.7 +/- 2.9 (P < 0.01). Likewise, binding was significantly decreased to 8.8 +/- 3.2 (P < 0.01) due to blocking role of OmpU antibodies. To determine binding motifs of OmpU, six immunodominant B-cell epitope peptides labeled with FITC were employed in flow cytometry-based binding assay. Two FITC-labeled epitope peptides (aa90-101 and aa173-192) showed strong binding to EPC cells (the fluorescence positive cell rate was 99 +/- 0.6% and 98 +/- 0.3%, respectively), which could be specifically competed by excess corresponding unlabeled peptides, whereas the remaining four showed a low level of background binding. This is the first demonstration that OmpU possesses adhesion function and its N terminal 90-101 and 173-192 amino acid regions are critical sites for cell surface binding.	[Liu, Xueqin; Gao, Huihui; Xiao, Nin; Liu, Yan; Li, Jinnian; Li, Lin] Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Zoonoses, Hefei, Peoples R China	Anhui Agricultural University	Li, JN (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Zoonoses, Hefei, Peoples R China.	lijinnian2000@163.com	li, lijinnian/HDO-3498-2022		China Natural Science Foundation [31272696]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the China Natural Science Foundation (No.31272696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 1997, INFECT IMMUN, V65, P3662, DOI 10.1128/IAI.65.9.3662-3665.1997; Alam M, 2006, MICROBIOL IMMUNOL, V50, P845, DOI 10.1111/j.1348-0421.2006.tb03859.x; BROCKHOFF G, 1994, CYTOMETRY, V17, P75, DOI 10.1002/cyto.990170110; Cai SH, 2010, DIS AQUAT ORGAN, V90, P63, DOI 10.3354/dao02206; Cen JY, 2013, FISH SHELLFISH IMMUN, V34, P291, DOI 10.1016/j.fsi.2012.11.015; Chitov T, 2009, EUR J CLIN MICROBIOL, V28, P421, DOI 10.1007/s10096-008-0639-7; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Geng Y, 2014, AQUACULTURE, V433, P82, DOI 10.1016/j.aquaculture.2014.05.053; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Gu TianZhao, 1999, Journal of Nanjing Agricultural University, V22, P65; Klemm P, 2010, APPL MICROBIOL BIOT, V88, P451, DOI 10.1007/s00253-010-2805-y; Li XF, 2007, RESERVOIR FISHERIES, V27, P13; Ling SHM, 2000, MICROBIOL-SGM, V146, P7, DOI 10.1099/00221287-146-1-7; Ormonde P, 2000, J BACTERIOL, V182, P2326, DOI 10.1128/JB.182.8.2326-2328.2000; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; [戚莉芳 Qi Lifang], 2013, [中国微生态学杂志, Chinese Journal of Microecology], V25, P630; SANTOS Y, 1991, Journal of Aquatic Animal Health, V3, P297, DOI 10.1577/1548-8667(1991)003&lt;0297:CSAPOF&gt;2.3.CO;2; Shi L, 2000, J HEALTH SCI, V46, P63; Sincock SA, 2001, METHOD CELL BIOL, V64, P511; Singh DV, 2002, J CLIN MICROBIOL, V40, P4321, DOI 10.1128/JCM.40.11.4321-4324.2002; SPERANDIO V, 1995, INFECT IMMUN, V63, P4433, DOI 10.1128/IAI.63.11.4433-4438.1995; Sumio S, 2004, MICROBIOL IMMUNOL, V48, P547; UCHIMURA M, 1992, FEMS MICROBIOL LETT, V91, P73, DOI 10.1016/0378-1097(92)90565-6; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Wang PingPing, 2012, African Journal of Biotechnology, V11, P8751, DOI 10.5897/AJB11.3858; Wang W, 2014, J FISHERY CHINA, V38, P138; Zhang X, 2014, AQUACULTURE, V432, P119, DOI 10.1016/j.aquaculture.2014.04.039; [朱兴国 Zhu Xingguo], 2002, [南京农业大学学报, Journal of Nanjing Agricultural University], V25, P82; Zhuang PeiDe, 2011, Chinese Journal of Zoonoses, V27, P112	29	24	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119026	10.1371/journal.pone.0119026	http://dx.doi.org/10.1371/journal.pone.0119026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742659	gold, Green Submitted, Green Published			2022-12-27	WOS:000350688100072
J	Bialas, J; Groettrup, M; Aichem, A				Bialas, Johanna; Groettrup, Marcus; Aichem, Annette			Conjugation of the Ubiquitin Activating Enzyme UBE1 with the Ubiquitin-Like Modifier FAT10 Targets It for Proteasomal Degradation	PLOS ONE			English	Article							PROTEIN FAT10; CELLULAR-RESPONSE; E1; IDENTIFICATION; CANCERS; E2; FAT10YLATION; SUMO-1; SIGNAL; ALPHA	The ubiquitin-like modifier HLA-F adjacent transcript 10 (FAT10) directly targets its substrates for proteasomal degradation by becoming covalently attached via its C-terminal diglycine motif to internal lysine residues of its substrate proteins. The conjugation machinery consists of the bispecific E1 activating enzyme Ubiquitin-like modifier activating enzyme 6 (UBA6), the likewise bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1 (USE1), and possibly E3 ligases. By mass spectrometry analysis the ubiquitin E1 activating enzyme ubiquitin-activating enzyme 1 (UBE1) was identified as putative substrate of FAT10. Here, we confirm that UBE1 and FAT10 form a stable non-reducible conjugate under overexpression as well as under endogenous conditions after induction of endogenous FAT10 expression with proinflammatory cytokines. FAT10ylation of UBE1 depends on the diglycine motif of FAT10. By specifically downregulating FAT10, UBA6 or USE1 with siRNAs, we show that UBE1 modification depends on the FAT10 conjugation pathway. Furthermore, we confirm that UBE1 does not act as a second E1 activating enzyme for FAT10 but that FAT10ylation of UBE1 leads to its proteasomal degradation, implying a putative regulatory role of FAT10 in the ubiquitin conjugation pathway.	[Bialas, Johanna; Groettrup, Marcus; Aichem, Annette] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland; [Bialas, Johanna; Groettrup, Marcus] Univ Konstanz, Dept Biol, Div Immunol, D-78457 Constance, Germany	University of Konstanz	Aichem, A (corresponding author), Univ Konstanz, Biotechnol Inst Thurgau, Unterseestr 47, CH-8280 Kreuzlingen, Switzerland.	Annette.Aichem@bitg.ch	Groettrup, Marcus/AAT-2623-2020		Konstanz Research School "Chemical Biology" at the University of Konstanz; German Research Foundation (DFG) Collaborative Research Centre [SFB969]; DFG [SPP1365, GR1517/10-1]; Velux Foundation [855]; Thurgauische Stiftung fur Wissenschaft und Forschung; Swiss State Secretariat for Education and Research	Konstanz Research School "Chemical Biology" at the University of Konstanz; German Research Foundation (DFG) Collaborative Research Centre(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Velux Foundation(Velux Fonden); Thurgauische Stiftung fur Wissenschaft und Forschung; Swiss State Secretariat for Education and Research	Funding: JB was funded by the Konstanz Research School "Chemical Biology" at the University of Konstanz; This work was supported by the German Research Foundation (DFG) Collaborative Research Centre SFB969 (Project C01), the DFG Priority Program "SPP1365 Ubiquitin Family Network" (grant GR1517/10-1), the Velux Foundation (grant 855), the Thurgauische Stiftung fur Wissenschaft und Forschung, the Swiss State Secretariat for Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichem A, 2014, FEBS J, V281, P1848, DOI 10.1111/febs.12745; Aichem A, 2012, J CELL SCI, V125, P4576, DOI 10.1242/jcs.107789; Aichem A, 2012, METHODS MOL BIOL, V832, P125, DOI 10.1007/978-1-61779-474-2_7; Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Bett JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030866; Buchsbaum S, 2012, BIOCHEM BIOPH RES CO, V428, P11, DOI 10.1016/j.bbrc.2012.09.110; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; de Mateo S, 2011, PROTEOMICS, V11, P2714, DOI 10.1002/pmic.201000799; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2443, DOI 10.1007/s00018-012-0933-5; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; HAAS AL, 1982, J BIOL CHEM, V257, P2543; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Leidecker O, 2012, CELL CYCLE, V11, P1142, DOI 10.4161/cc.11.6.19559; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Lim CB, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-20; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Moudry P, 2012, CELL CYCLE, V11, P1573, DOI 10.4161/cc.19978; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Rani N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1752; Ren JW, 2011, J CELL SCI, V124, P3665, DOI 10.1242/jcs.087403; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Schliehe C, 2012, J VIROL, V86, P9782, DOI 10.1128/JVI.00694-12; Schmidtke G, 2014, BBA-MOL CELL RES, V1843, P97, DOI 10.1016/j.bbamcr.2013.01.009; Schmidtke G, 2009, FEBS LETT, V583, P591, DOI 10.1016/j.febslet.2009.01.006; SCHWARTZ AL, 1992, P NATL ACAD SCI USA, V89, P5542, DOI 10.1073/pnas.89.12.5542; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985	47	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120329	10.1371/journal.pone.0120329	http://dx.doi.org/10.1371/journal.pone.0120329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768649	Green Submitted, gold, Green Published			2022-12-27	WOS:000351277500120
J	Gonzalez, A; Shimobayashi, M; Eisenberg, T; Merle, DA; Pendl, T; Hall, MN; Moustafa, T				Gonzalez, Asier; Shimobayashi, Mitsugu; Eisenberg, Tobias; Merle, David Adrian; Pendl, Tobias; Hall, Michael N.; Moustafa, Tarek			TORC1 Promotes Phosphorylation of Ribosomal Protein S6 via the AGC Kinase Ypk3 in Saccharomyces cerevisiae	PLOS ONE			English	Article							GROWTH-CONTROL; FISSION YEAST; BUDDING YEAST; RAPAMYCIN; PATHWAY; TARGET; SCH9; METABOLISM; EQUIVALENT; RESISTANCE	The target of rapamycin complex 1 (TORC1) is an evolutionarily conserved sensor of nutrient availability. Genetic and pharmacological studies in the yeast Saccharomyces cerevisiae have provided mechanistic insights on the regulation of TORC1 signaling in response to nutrients. Using a highly specific antibody that recognizes phosphorylation of the bona fide TORC1 target ribosomal protein S6 (Rps6) in yeast, we found that nutrients rapidly induce Rps6 phosphorylation in a TORC1-dependent manner. Moreover, we demonstrate that Ypk3, an AGC kinase which exhibits high homology to human S6 kinase (S6K), is required for the phosphorylation of Rps6 in vivo. Rps6 phosphorylation is completely abolished in cells lacking Ypk3 (ypk3 Delta), whereas Sch9, previously reported to be the yeast ortholog of S6K, is dispensable for Rps6 phosphorylation. Phosphorylation-deficient mutations in regulatory motifs of Ypk3 abrogate Rps6 phosphorylation, and complementation of ypk3. cells with human S6 kinase restores Rps6 phosphorylation in a rapamycin-sensitive manner. Our findings demonstrate that Ypk3 is a critical component of the TORC1 pathway and that the use of a phospho-S6 specific antibody offers a valuable tool to identify new nutrient-dependent and rapamycin-sensitive targets in vivo.	[Gonzalez, Asier; Shimobayashi, Mitsugu; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland; [Eisenberg, Tobias; Merle, David Adrian; Pendl, Tobias; Moustafa, Tarek] Graz Univ, Inst Mol Biosci, Graz, Austria	University of Basel; University of Graz	Moustafa, T (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	tarek.moustafa@uni-graz.at	González, Asier/A-7064-2012; Moustafa, Tarek/P-9509-2016; Eisenberg, Tobias/AAV-7806-2021	Moustafa, Tarek/0000-0002-6755-4687; Shimobayashi, Mitsugu/0000-0002-6936-0990; Hall, Michael N/0000-0002-2998-0757; Eisenberg, Tobias/0000-0003-3559-1130	FEBS Long-Term Fellowship; APART-fellowship of the Austrian Academy of Sciences; SystemsX.ch; Swiss National Science Foundation; Canton of Basel; SFB LIPOTOX - Austrian Science Fund (FWF) [F30]; Austrian Science Fund (FWF) [F 3002] Funding Source: researchfish	FEBS Long-Term Fellowship; APART-fellowship of the Austrian Academy of Sciences; SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Basel; SFB LIPOTOX - Austrian Science Fund (FWF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding: A. G. was the recipient of a FEBS Long-Term Fellowship. T.E. is recipient of an APART-fellowship of the Austrian Academy of Sciences. This work was supported by SystemsX.ch, Swiss National Science Foundation, the Canton of Basel (M.N.H) and by the SFB LIPOTOX F30 funded by the Austrian Science Fund (FWF) to T.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Brachmann CB, 1998, YEAST, V14, P115; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Iesmantavicius V, 2014, MOL CELL PROTEOMICS, V13, P1979, DOI 10.1074/mcp.O113.035683; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; JOHNSON SP, 1987, MOL CELL BIOL, V7, P1338, DOI 10.1128/MCB.7.4.1338; KRUSE C, 1985, P NATL ACAD SCI USA, V82, P7515, DOI 10.1073/pnas.82.22.7515; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Stracka D, 2014, J BIOL CHEM, V289, P25010, DOI 10.1074/jbc.M114.574335; Su B, 2011, CRIT REV BIOCHEM MOL, V46, P527, DOI 10.3109/10409238.2011.618113; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; van Dam TJP, 2011, J MOL EVOL, V73, P209, DOI 10.1007/s00239-011-9469-9; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamane-Sando Y, 2014, MICROBIOLOGYOPEN, V3, P196, DOI 10.1002/mbo3.160	34	59	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120250	10.1371/journal.pone.0120250	http://dx.doi.org/10.1371/journal.pone.0120250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767889	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500116
J	Li, CL; Zhou, LZ; Xu, L; Zhao, NN; Beauchamp, G				Li, Chunlin; Zhou, Lizhi; Xu, Li; Zhao, Niannian; Beauchamp, Guy			Vigilance and Activity Time-Budget Adjustments of Wintering Hooded Cranes, Grus monacha, in Human-Dominated Foraging Habitats	PLOS ONE			English	Article							GROUP-SIZE; PREDATION RISK; FLOCK SIZE; BEHAVIORAL PLASTICITY; SHENGJIN LAKE; BIRDS; AGE; ELK; CONSERVATION; WATERBIRDS	Due to loss and degradation of natural wetlands, waterbirds increasingly rely on surrounding human-dominated habitats to obtain food. Quantifying vigilance patterns, investigating the trade-off among various activities, and examining the underlying mechanisms will help us understand how waterbirds adapt to human-caused disturbances. During two successive winters (November-February of 2012-13 and 2013-14), we studied the hooded crane, Grus monacha, in the Shengjin Lake National Nature Reserve (NNR), China, to investigate how the species responds to human disturbances through vigilance and activity time-budget adjustments. Our results showed striking differences in the behavior of the cranes when foraging in the highly disturbed rice paddy fields found in the buffer zone compared with the degraded natural wetlands in the core area of the NNR. Time spent vigilant decreased with flock size and cranes spent more time vigilant in the human-dominated buffer zone. In the rice paddy fields, the birds were more vigilant but also fed more at the expense of locomotion and maintenance activities. Adult cranes spent more time vigilant and foraged less than juveniles. We recommend habitat recovery in natural wetlands and community co-management in the surrounding human-dominated landscape for conservation of the hooded crane and, generally, for the vast numbers of migratory waterbirds wintering in the middle and lower reaches of the Yangtze River floodplain.	[Li, Chunlin; Zhou, Lizhi; Xu, Li] Anhui Univ, Sch Resources & Environm Engn, Hefei 230039, Peoples R China; [Zhao, Niannian] Shengjin Lake Natl Nat Reserve Management Ctr, Chizhou, Peoples R China; [Beauchamp, Guy] Univ Montreal, Fac Vet Med, Montreal, PQ H3C 3J7, Canada	Anhui University; Universite de Montreal	Zhou, LZ (corresponding author), Anhui Univ, Sch Resources & Environm Engn, Hefei 230039, Peoples R China.	zhoulz@ahu.edu.cn	Zhou, Lizhi/AAF-4535-2021	Zhou, Lizhi/0000-0002-5702-4658	National Natural Sciences Foundation of China [31301897, 31172117]; Ph.D. Programs Foundation of Ministry of Education of China [20133401120014]; Anhui Provincial Natural Science Foundation [1308085QC64]; Anhui Postdoctoral Science Foundation [023033200025]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Postdoctoral Science Foundation	Funding to CL from National Natural Sciences Foundation of China (No. 31301897), the Ph.D. Programs Foundation of Ministry of Education of China (No. 20133401120014), the Anhui Provincial Natural Science Foundation (No. 1308085QC64) and the Anhui Postdoctoral Science Foundation (No. 023033200025). Funding to LZ from National Natural Sciences Foundation of China (No. 31172117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, WATERBIRD SURVEY MID; Arenz CL, 2000, ANIM BEHAV, V59, P535, DOI 10.1006/anbe.1999.1345; Aviles JM, 2007, J AVIAN BIOL, V38, P690, DOI 10.1111/j.2007.0908-8857.04002.x; Barri FR, 2012, EMU, V112, P67, DOI 10.1071/MU10090; Barter M., 2004, WATERBIRD SURVEY MID; Barter Mark, 2005, Forktail, V21, P1; Beauchamp G., 2014, SOCIAL PREDATION GRO; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Beauchamp G, 2010, ETHOLOGY, V116, P645, DOI 10.1111/j.1439-0310.2010.01778.x; Beauchamp G, 2009, ANIM BEHAV, V78, P223, DOI 10.1016/j.anbehav.2009.04.029; Beauchamp G, 2009, BIOL LETTERS, V5, P9, DOI 10.1098/rsbl.2008.0490; Benoist S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082960; BirdLife International, 2014, IUCN 2014 IUCN RED L; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Boukhriss J, 2007, ETHOLOGY, V113, P377, DOI 10.1111/j.1439-0310.2007.01335.x; Cameron EZ, 2005, ANIM BEHAV, V69, P1337, DOI 10.1016/j.anbehav.2004.08.015; Cangjue Z., 2007, CHINESE J WILDLIFE, V29, P15; Cao Lei, 2011, Chinese Birds, V2, P1; Cao L, 2009, NATURE, V460, P173, DOI 10.1038/460173b; Caro Tim, 2005, pXIII; Cezilly F, 2012, IBIS, V154, P161, DOI 10.1111/j.1474-919X.2011.01173.x; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Czech HA, 2002, WATERBIRDS, V25, P56; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Elphick CS, 2010, WATERBIRDS, V33, P1, DOI 10.1675/063.033.s101; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fox AD, 2011, AQUAT CONSERV, V21, P82, DOI 10.1002/aqc.1154; Fraser L.H., 2005, WORLDS LARGEST WETLA, DOI [10.1017/cbo9780511542091, DOI 10.1017/CBO9780511542091]; Frid A, 2002, CONSERV ECOL, V6; Fritz H, 2002, ETHOL ECOL EVOL, V14, P91; Gosselin-Ildari AD, 2012, AM J PRIMATOL, V74, P613, DOI 10.1002/ajp.22013; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; HART A, 1984, ANIM BEHAV, V32, P1216, DOI 10.1016/S0003-3472(84)80239-0; Hope DD, 2014, BEHAV ECOL SOCIOBIOL, V68, P827, DOI 10.1007/s00265-014-1695-x; Johnsgard P.A., 1983, CRANES OF THE WORLD; Kuang FL, 2014, WATERBIRDS, V37, P94, DOI 10.1675/063.037.0112; Lee SD, 2007, BIOL CONSERV, V138, P286, DOI 10.1016/j.biocon.2007.04.007; Li CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032607; Li Herng-Chein, 2012, Taiwania, V57, P99; Li Z, 2009, J ZOOL, V277, P302, DOI 10.1111/j.1469-7998.2008.00541.x; Li ZQ, 2013, WETLANDS, V33, P227, DOI 10.1007/s13157-012-0371-z; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Ma ZJ, 2010, WETLANDS, V30, P15, DOI 10.1007/s13157-009-0001-6; Ma ZJ, 2003, ECOL RES, V18, P321, DOI 10.1046/j.1440-1703.2003.00557.x; Mathot KJ, 2011, ECOL LETT, V14, P1254, DOI 10.1111/j.1461-0248.2011.01698.x; McCormick MI, 2013, ECOL EVOL, V3, P4221, DOI 10.1002/ece3.793; Murray CG, 2013, HYDROBIOLOGIA, V716, P131, DOI 10.1007/s10750-013-1558-x; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2007, ANIM BEHAV, V73, P595, DOI 10.1016/j.anbehav.2006.06.007; Pays O, 2012, ETHOLOGY, V118, P1, DOI 10.1111/j.1439-0310.2011.01974.x; Robinson BG, 2013, ANIM BEHAV, V85, P849, DOI 10.1016/j.anbehav.2013.02.004; TACHA TC, 1988, WILDLIFE MONOGR, P1; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Wang Q, 2002, CRANES RAILS BUSTARD; Wang Z, 2011, BIOL CONSERV, V144, P101, DOI 10.1016/j.biocon.2010.06.025; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wolff JO, 2003, CAN J ZOOL, V81, P266, DOI 10.1139/Z03-011; Wood C, 2010, WATERBIRDS, V33, P30, DOI 10.1675/063.033.s103; Xu Li-Lin, 2008, Wuhan Zhiwuxue Yanjiu, V26, P264; Zhou B, 2009, CHINA J WILDL, V30, P133; Zhou B, 2010, WATERBIRDS, V33, P110, DOI 10.1675/063.033.0114; Zimmer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018977	63	29	38	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118928	10.1371/journal.pone.0118928	http://dx.doi.org/10.1371/journal.pone.0118928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768111	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500054
J	Shabani, P; Khaledi, HN; Beigy, M; Emamgholipour, S; Parvaz, E; Poustchi, H; Doosti, M				Shabani, Parisa; Khaledi, Hassan Naeimi; Beigy, Maani; Emamgholipour, Solaleh; Parvaz, Eskandar; Poustchi, Hossein; Doosti, Mahmood			Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?	PLOS ONE			English	Article							ADIPOSE-TISSUE; STEATOHEPATITIS; ADIPONECTIN; FAMILY; OBESE; PATHOGENESIS; INFLAMMATION; PROGRESSION; EXPRESSION; CYTOKINES	Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common liver diseases. It is robustly linked to obesity and insulin resistance and is regarded as hepatic manifestation of metabolic syndrome (MetS). Adipokines are involved in the pathophysiology of liver diseases. The aim of this study was to evaluate the plasma concentrations of CTRP1 (complement-C1q TNF-related protein 1) in 22 patients with NAFLD, 22 patients with type 2 diabetes mellitus (T2DM), 22 patients with NAFLD+T2DM and 21 healthy controls, as well as their correlation with the level of metabolic and hepatic parameters. Plasma concentration of CTRP1 was measured with ELISA method. Plasma concentration of CTRP1 in patients with NAFLD, T2DM and NAFLD+T2DM were significantly higher than healthy subjects (p<0.0001). Moreover, we observed significant positive correlations between plasma level of CTRP1 and fasting blood glucose (FBG) (p<0.001), homeostasis model assessment of insulin resistance (HOMA-IR) (p<0.001), body mass index (BMI) (p = 0.001), alanine amino transferase (ALT) (p = 0.002), gamma glutamyl transferase (gamma-GT) (p<0.001) and liver stiffness (LS) (p<0.001). Our results indicate the strong association of CTRP1 with insulin resistance in NAFLD. Also, it seems that CTRP1 can be considered as an emerging biomarker for NAFLD, however, more studies are necessary to unravel the role of CTRP1 in NAFLD pathogenesis.	[Shabani, Parisa; Khaledi, Hassan Naeimi; Emamgholipour, Solaleh; Doosti, Mahmood] Univ Tehran Med Sci, Fac Med, Dept Biochem, Tehran, Iran; [Beigy, Maani] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran; [Parvaz, Eskandar] Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, Tehran, Iran; [Poustchi, Hossein] Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tarbiat Modares University; Tehran University of Medical Sciences	Poustchi, H (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran.	h.poustchi@gmail.com; doostimd@sina.tums.ac.ir	Beigy, Maani/S-4091-2019; Emamgholipour, Solaleh/T-6035-2017	Beigy, Maani/0000-0003-2963-3533; Doosti, Mahmood/0000-0003-3011-065X; Emamgholipour, Solaleh/0000-0002-9949-5773				Alam S, 2013, WORLD J HEPATOL, V5, P281, DOI 10.4254/wjh.v5.i5.281; Angulo P, 2004, J HEPATOL, V41, P943, DOI 10.1016/j.jhep.2004.08.020; Asrih M, 2013, J ENDOCRINOL, V218, pR25, DOI 10.1530/JOE-13-0201; Carter-Kent C, 2008, AM J GASTROENTEROL, V103, P1036, DOI 10.1111/j.1572-0241.2007.01709.x; Chalasani N, 2003, AM J GASTROENTEROL, V98, P2771, DOI [10.1016/j.amjgastroenterol.2003.09.037, 10.1111/j.1572-0241.2003.08767.x]; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Du J, 2014, WORLD J GASTROENTERO, V20, P569, DOI 10.3748/wjg.v20.i2.569; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Jarrar MH, 2008, ALIMENT PHARM THER, V27, P412, DOI 10.1111/j.1365-2036.2007.03586.x; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Krawczyk K, 2009, J PHYSIOL PHARMACOL, V60, P71; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Pagano C, 2005, EUR J ENDOCRINOL, V152, P113, DOI 10.1530/eje.1.01821; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Podrini C, 2013, CURR PHARM DESIGN, V19, P2737, DOI 10.2174/1381612811319150009; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Schwenger KJP, 2014, WORLD J GASTROENTERO, V20, P1712, DOI 10.3748/wjg.v20.i7.1712; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Semba T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-120; Sonsuz A, 2002, AM J GASTROENTEROL, V97, P495; Stefan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092238; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wree A, 2014, METABOLISM, V63, P1542, DOI 10.1016/j.metabol.2014.09.001; Xin YP, 2014, ENDOCR J, V61, P841, DOI 10.1507/endocrj.EJ14-0016; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846	36	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118650	10.1371/journal.pone.0118650	http://dx.doi.org/10.1371/journal.pone.0118650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767880	gold, Green Submitted, Green Published			2022-12-27	WOS:000351277500036
J	Yousfi, N; Pruvot, B; Lopez, T; Magadoux, L; Franche, N; Pichon, L; Salvadori, F; Solary, E; Garrido, C; Laurens, V; Chluba, J				Yousfi, Nadhir; Pruvot, Benoist; Lopez, Tatiana; Magadoux, Lea; Franche, Nathalie; Pichon, Laurent; Salvadori, Francoise; Solary, Eric; Garrido, Carmen; Laurens, Veronique; Chluba, Johanna			The Impact of Tumor Nitric Oxide Production on VEGFA Expression and Tumor Growth in a Zebrafish Rat Glioma Xenograft Model	PLOS ONE			English	Article							FLUORESCENT INDICATORS; IN-VIVO; CELLS; TRANSPLANTATION; SYNTHASE; ANGIOGENESIS; PROGRESSION; EMBRYOS; STRESS; CANCER	To investigate the effect of nitric oxide on tumor development, we established a rat tumor xenograft model in zebrafish embryos. The injected tumor cells formed masses in which nitric oxide production could be detected by the use of the cell-permeant DAF-FM-DA (diaminofluorophore 4-amino-5-methylamino-2'-7'-difluorofluorescein diacetate) and DAR-4M-AM (diaminorhodamine-4M). This method revealed that nitric oxide production could be co-localized with the tumor xenograft in 46% of the embryos. In 85% of these embryos, tumors were vascularized and blood vessels were observed on day 4 post injection. Furthermore, we demonstrated by qRT-PCR that the transplanted glioma cells highly expressed Nos2, Vegfa and Cyclin D1 mRNA. In the xenografted embryos we also found increased zebrafish vegfa expression. Glioma and zebrafish derived Vegfa and tumor Cyclin D1 expression could be down regulated by the nitric oxide scavenger 2-(4-Carboxyphenyl)-4,4,5,5-tetra-methylimidazoline-1-oxyl-3-oxide or CPTIO. We conclude that even if there is a heterogeneous nitric oxide production by the xenografted glioma cells that impacts Vegfa and Cyclin D1 expression levels, our results suggest that reduction of nitric oxide levels by nitric oxide scavenging could be an efficient approach to treat glioma.	[Yousfi, Nadhir; Lopez, Tatiana; Garrido, Carmen; Chluba, Johanna] INSERM, UMR 866, Equipe Labellisee Ligue Canc, Dijon, France; [Yousfi, Nadhir; Pruvot, Benoist; Lopez, Tatiana; Pichon, Laurent; Salvadori, Francoise; Laurens, Veronique; Chluba, Johanna] Univ Burgundy, UFR SVTE, Dijon, France; [Magadoux, Lea; Franche, Nathalie; Laurens, Veronique] Ecole Prat Hautes Etud, EA 7269, Dijon, France; [Solary, Eric] Inst Gustave Roussy, INSERM, U1009, Paris, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Chluba, J (corresponding author), INSERM, UMR 866, Equipe Labellisee Ligue Canc, Dijon, France.	Johanna.Chluba@u-bourgogne.fr	Garrido, carmen/G-1633-2018; Garrido, Carolina/GWM-5557-2022; Chluba, Johanna/D-1224-2012	Garrido, carmen/0000-0003-1368-1493; Laurens, Veronique/0000-0002-7841-628X; Solary, Eric/0000-0002-8629-1341; Chluba, Johanna/0000-0001-8779-8016; Lopez, Tatiana/0000-0002-3658-682X	INSERM; Ministere de l'Education Nationale et de l'Enseignement Superieur et de la Recherche; Ligue Contre le Cancer; University of Burgundy; Conseil Regional de Bourgogne; Conseil Regional de Bourgogne [34324]; Ligue Nationale Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale et de l'Enseignement Superieur et de la Recherche; Ligue Contre le Cancer(Ligue nationale contre le cancer); University of Burgundy; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	Funding: This work was supported by the INSERM, the Ministere de l'Education Nationale et de l'Enseignement Superieur et de la Recherche, the Ligue Contre le Cancer, the University of Burgundy, and the Conseil Regional de Bourgogne. NY was supported by the Conseil Regional de Bourgogne by a fellowship of the Feder Program Jeunes chercheurs entreprenneurs (ref. no. 34324) and a fellowship of the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; Burke AJ, 2013, CARCINOGENESIS, V34, P503, DOI 10.1093/carcin/bgt034; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; CORNAIN S, 1975, INT J CANCER, V16, P301, DOI 10.1002/ijc.2910160213; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; Danilova N, 2004, DEV COMP IMMUNOL, V28, P755, DOI 10.1016/j.dci.2003.12.003; Duvillard C, 1999, INT J CANCER, V81, P779, DOI 10.1002/(SICI)1097-0215(19990531)81:5<779::AID-IJC19>3.0.CO;2-I; Flitney FW, 2001, MOL CANCER THER, V10, P1571; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frerart F, 2009, MOL CANCER RES, V7, P1056, DOI 10.1158/1541-7786.MCR-08-0388; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Geiger GA, 2008, CANCER RES, V68, P3396, DOI 10.1158/0008-5472.CAN-07-6396; Ghotra VPS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031281; Gosgnach W, 2000, AM J PHYSIOL-CELL PH, V279, pC1880, DOI 10.1152/ajpcell.2000.279.6.C1880; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; He SN, 2012, J PATHOL, V227, P431, DOI 10.1002/path.4013; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Kojima H, 2001, ANAL CHEM, V73, P1967, DOI 10.1021/ac001136i; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Lepiller S, 2007, FREE RADICAL BIO MED, V43, P619, DOI 10.1016/j.freeradbiomed.2007.05.025; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Li PL, 2011, METHOD CELL BIOL, V105, P403, DOI 10.1016/B978-0-12-381320-6.00017-5; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Nagano T, 2002, CHEM REV, V102, P1235, DOI 10.1021/cr010152s; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Ozawa N, 2004, HYPERTENS RES, V27, P93, DOI 10.1291/hypres.27.93; Poon KL, 2008, DEV DYNAM, V237, P1662, DOI 10.1002/dvdy.21566; Poon KL, 2003, GENE EXPR PATTERNS, V3, P463, DOI 10.1016/S1567-133X(03)00063-2; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Saini R, 2006, J LEUKOCYTE BIOL, V79, P519, DOI 10.1189/jlb.0605320; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Taylor AM, 2009, ZEBRAFISH, V6, P339, DOI 10.1089/zeb.2009.0607; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wink DA, 2008, NITRIC OXIDE-BIOL CH, V19, P65, DOI 10.1016/j.niox.2008.05.003; Yang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085759; Zhao CJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021768, 10.1371/journal.pone.0023925]; Zhao H, 2009, J NEUROSURG, V111, P238, DOI 10.3171/2008.8.JNS08644	44	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120435	10.1371/journal.pone.0120435	http://dx.doi.org/10.1371/journal.pone.0120435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768009	gold, Green Published			2022-12-27	WOS:000351277500125
J	Liu, XL; Wang, JS; Liu, Q; Zhao, PF; Hou, Y; Ma, Y; Guo, QY				Liu, Xingli; Wang, Jingshi; Liu, Qin; Zhao, Pengfei; Hou, Yang; Ma, Yue; Guo, Qiyong			Determination of the Optimal Dose Reduction Level via Iterative Reconstruction Using 640-Slice Volume Chest CT in a Pig Model	PLOS ONE			English	Article							Z-AXIS MODULATION; MULTIDETECTOR CT; IMAGE QUALITY; PEDIATRIC CT; ROW CT; CHILDREN; OPTIMIZATION; ABDOMEN	Aim To determine the optimal dose reduction level of iterative reconstruction technique for paediatric chest CT in pig models. Materials and Methods 27 infant pigs underwent 640-slice volume chest CT with 80kVp and different mAs. Automatic exposure control technique was used, and the index of noise was set to SD10 (Group A, routine dose), SD12.5, SD15, SD17.5, SD20 (Groups from B to E) to reduce dose respectively. Group A was reconstructed with filtered back projection (FBP), and Groups fromB to E were reconstructed using iterative reconstruction (IR). Objective and subjective image quality (IQ) among groups were compared to determine an optimal radiation reduction level. Results The noise and signal-to-noise ratio (SNR) in Group D had no significant statistical difference from that in Group A (P = 1.0). The scores of subjective IQ in Group A were not significantly different from those in Group D (P > 0.05). There were no obvious statistical differences in the objective and subjective index values among the subgroups (small, medium and large subgroups) of Group D. The effective dose (ED) of Group D was 58.9% lower than that of Group A (0.20 +/- 0.05mSv vs 0.48 +/- 0.10mSv, p < 0.001). Conclusions In infant pig chest CT, using iterative reconstruction can provide diagnostic image quality; furthermore, it can reduce the dosage by 58.9%.	[Liu, Qin; Zhao, Pengfei; Hou, Yang; Ma, Yue; Guo, Qiyong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang 36, Liaoning, Peoples R China; [Liu, Xingli] China Med Univ, Shengjing Hosp, Dept Cardiol, Shenyang 110004, Liaoning, Peoples R China; [Wang, Jingshi] Dalian Municipal Women & Childrens Med Cent, Dept Radiol, Dalian 116033, Liaoning, Peoples R China	China Medical University	Guo, QY (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, 36 Sanhao St, Shenyang 36, Liaoning, Peoples R China.	houyang1973@163.com	Yang, Aliza/HGU-3681-2022	Hou, Yang/0000-0002-9184-5441	government funds-Liaoning Science Public Research Funds	government funds-Liaoning Science Public Research Funds	The presented work was supported by government funds-Liaoning Science Public Research Funds [2011] no. 49. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mousily F, 2011, PEDIATR CARDIOL, V32, P426, DOI 10.1007/s00246-010-9873-8; [Anonymous], 2009, 16262 EUR; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Fricke BL, 2003, AM J ROENTGENOL, V180, P407, DOI 10.2214/ajr.180.2.1800407; Greess H, 2004, EUR RADIOL, V14, P995, DOI 10.1007/s00330-004-2301-9; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056295; Kalra MK, 2005, RADIOLOGY, V237, P303, DOI 10.1148/radiol.2371041227; Kalra MK, 2004, RADIOLOGY, V233, P241, DOI 10.1148/radiol.2331031505; Kalra MK, 2004, RADIOLOGY, V232, P347, DOI 10.1148/radiol.2322031304; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Khong P-L, 2012, Annals of the ICRP, V41, P170, DOI 10.1016/j.icrp.2012.06.017; Lee CH, 2008, RADIOGRAPHICS, V28, P1451, DOI 10.1148/rg.285075075; Lee SH, 2012, EUR J RADIOL, V81, pE938, DOI 10.1016/j.ejrad.2012.06.013; Mieville FA, 2013, PEDIATR RADIOL, V43, P558, DOI 10.1007/s00247-012-2554-4; Mulkens TH, 2005, RADIOLOGY, V237, P213, DOI 10.1148/radiol.2363041220; Nievelstein RAJ, 2010, PEDIATR RADIOL, V40, P1324, DOI 10.1007/s00247-010-1714-7; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Singh S, 2009, RADIOLOGY, V252, P200, DOI 10.1148/radiol.2521081554; Tack D, 2003, AM J ROENTGENOL, V181, P331, DOI 10.2214/ajr.181.2.1810331; Thomas KE, 2008, PEDIATR RADIOL, V38, P645, DOI 10.1007/s00247-008-0794-0; Verdun FR, 2008, EUR RADIOL, V18, P1980, DOI 10.1007/s00330-008-0963-4; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013; Yoo RE, 2013, INT J CARDIOVAS IMAG, V29, P669, DOI 10.1007/s10554-012-0113-6	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0117213	10.1371/journal.pone.0117213	http://dx.doi.org/10.1371/journal.pone.0117213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764485	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300008
J	Yang, XR; Killian, JK; Hammond, S; Burke, LS; Bennett, H; Wang, Y; Davis, SR; Strong, LC; Neglia, J; Stovall, M; Weathers, RE; Robison, LL; Bhatia, S; Mabuchi, K; Inskip, PD; Meltzer, P				Yang, Xiaohong R.; Killian, J. Keith; Hammond, Sue; Burke, Laura S.; Bennett, Hunter; Wang, Yonghong; Davis, Sean R.; Strong, Louise C.; Neglia, Joseph; Stovall, Marilyn; Weathers, Rita E.; Robison, Leslie L.; Bhatia, Smita; Mabuchi, Kiyohiko; Inskip, Peter D.; Meltzer, Paul			Characterization of Genomic Alterations in Radiation-Associated Breast Cancer among Childhood Cancer Survivors, Using Comparative Genomic Hybridization (CGH) Arrays	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; SUBTYPES; TUMORS; INSTABILITY; RISK	Ionizing radiation is an established risk factor for breast cancer. Epidemiologic studies of radiation- exposed cohorts have been primarily descriptive; molecular events responsible for the development of radiation-associated breast cancer have not been elucidated. In this study, we used array comparative genomic hybridization (array-CGH) to characterize genome- wide copy number changes in breast tumors collected in the Childhood Cancer Survivor Study (CCSS). Array-CGH data were obtained from 32 cases who developed a second primary breast cancer following chest irradiation at early ages for the treatment of their first cancers, mostly Hodgkin lymphoma. The majority of these cases developed breast cancer before age 45 (91%, n = 29), had invasive ductal tumors (81%, n = 26), estrogen receptor (ER)-positive staining (68%, n = 19 out of 28), and high proliferation as indicated by high Ki67 staining (77%, n = 17 out of 22). Genomic regions with low-copy number gains and losses and high-level amplifications were similar to what has been reported in sporadic breast tumors, however, the frequency of amplifications of the 17q12 region containing human epidermal growth factor receptor 2 (HER2) was much higher among CCSS cases (38%, n = 12). Our findings suggest that second primary breast cancers in CCSS were enriched for an "amplifier" genomic subgroup with highly proliferative breast tumors. Future investigation in a larger irradiated cohort will be needed to confirm our findings.	[Yang, Xiaohong R.; Burke, Laura S.; Bennett, Hunter; Mabuchi, Kiyohiko; Inskip, Peter D.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Killian, J. Keith; Wang, Yonghong; Davis, Sean R.; Meltzer, Paul] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hammond, Sue] Childrens Hosp, Dept Lab Med & Pathol, Columbus, OH 43205 USA; [Hammond, Sue] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Neglia, Joseph] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Stovall, Marilyn; Weathers, Rita E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Robison, Leslie L.] St Jude Childrens Res Hosp, Epidemiol & Canc Control, Memphis, TN 38105 USA; [Bhatia, Smita] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; St Jude Children's Research Hospital; University of Alabama System; University of Alabama Birmingham	Yang, XR (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	royang@mail.nih.gov	Robison, Leslie/N-8122-2018; Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Neglia, Joseph/0000-0002-5525-0598; Bennett, Hunter/0000-0002-8495-1545	Intramural Research Program of the NIH, NCI, Division of Cancer Epidemiology Genetics [U24 CA55727]; NATIONAL CANCER INSTITUTE [P30CA016672, ZICBC011040, ZIABC011091, U24CA055727] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NCI, Division of Cancer Epidemiology Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, NCI, Division of Cancer Epidemiology & Genetics and grant for the CCSS (U24 CA55727).	Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Castiglioni F, 2007, CLIN CANCER RES, V13, P46, DOI 10.1158/1078-0432.CCR-06-1490; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Choi DH, 2003, CANCER-AM CANCER SOC, V98, P1587, DOI 10.1002/cncr.11703; Clemons M, 2000, CANCER TREAT REV, V26, P291, DOI 10.1053/ctrv.2000.0174; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Holm K, 2012, BREAST CANCER RES TR, V133, P583, DOI 10.1007/s10549-011-1817-3; Horst KC, 2014, ANN ONCOL, V25, P848, DOI 10.1093/annonc/mdu017; Inskip PD, 2009, J CLIN ONCOL, V27, P3901, DOI 10.1200/JCO.2008.20.7738; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Keegan THM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3156; Kenney LB, 2004, ANN INTERN MED, V141, P590, DOI 10.7326/0003-4819-141-8-200410190-00006; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Miura S, 2008, CANCER-AM CANCER SOC, V112, P2143, DOI 10.1002/cncr.23414; Morrison DH, 2012, BRIT J CANCER, V107, P382, DOI 10.1038/bjc.2012.219; Moskowitz CS, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.18_suppl.cra9513; Oikawa M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-168; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Pronzato P, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/534256; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Stovall M, 2006, RADIAT RES, V166, P141, DOI 10.1667/RR3525.1; TOKUNAGA M, 1994, RADIAT RES, V138, P209, DOI 10.2307/3578591	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0116078	10.1371/journal.pone.0116078	http://dx.doi.org/10.1371/journal.pone.0116078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764003	Green Submitted, gold, Green Published			2022-12-27	WOS:000351276300004
J	Zhu, MM; Huang, JN; Zhu, BJ; Sun, Q; Xu, X; Miao, YY; Zou, HD				Zhu, Mingming; Huang, Jiannan; Zhu, Bijun; Sun, Qian; Xu, Xian; Miao, Yuyu; Zou, Haidong			Changes of Vision-Related Quality of Life in Retinal Detachment Patients after Cataract Surgery	PLOS ONE			English	Article							VISUAL FUNCTION; POPULATION; OUTCOMES; PHACOEMULSIFICATION; RISK; QUESTIONNAIRE; ACUITY; EYES	Rhegmatenous retinal detachment (RRD) is one of the most serious complications after phacoemulsification combined with intraocular lens implantation surgery. It has been reported that vision-related quality of life (VRQoL), as well as visual acuity rapidly decreased when RRD developed. However, little is known of the VRQoL in those RRD patients after anatomical retinal re-attachment, especially whether or not the VRQoL is higher than that before cataract surgery. In this prospective case series study, we use the Chinese-version low vision quality of life questionnaire (CLVQOL) to assess the changes of VRQoL in age-related cataract patients who suffered from RRD after phacoemulsification with intraocular lens (phaco-IOL) implantation. All participants were asked to complete questionnaires in face-to-face interviews one day before and two weeks after cataract surgery, as well as one day before and three months after RRD surgery. A total of 10,127 consecutive age-related cataract patients were followed up to one year after phaco-IOL implantation; among these patients, 17 were diagnosed as RRD. The total CLVQOL scores and subscale scores except "Mobility" decreased significantly when RRD developed. After retinal surgery, only the score of "General vision and lighting" in the CLVQOL questionnaires improved when compared to the scores two weeks after cataract surgery, although the best corrected visual acuity of all patients significantly raised up. However, the mean CLVQOL scores and subscale scores were still considerably higher than the level prior to cataract surgery. Our study suggests that cataract patients at high risk of postoperative RRD should not deny the opportunity to undergo phaco-IOL implantation, even though potential VRQoL impairment induced by RRD exists.	[Zhu, Mingming; Huang, Jiannan; Zhu, Bijun; Sun, Qian; Xu, Xian; Miao, Yuyu; Zou, Haidong] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Huang, Jiannan; Zou, Haidong] Shanghai Eye Dis Prevent & Treatment Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China.	zouhaidong@hotmail.com		Zou, Haidong/0000-0002-6831-7560				Bhagwandien ACE, 2006, OPHTHALMOLOGY, V113, P643, DOI 10.1016/j.ophtha.2005.10.056; Boberg-Ans G, 2006, ACTA OPHTHALMOL SCAN, V84, P613, DOI 10.1111/j.1600-0420.2006.00719.x; Clark A, 2012, ARCH OPHTHALMOL-CHIC, V130, P882, DOI 10.1001/archophthalmol.2012.164; Desai P, 1996, BRIT J OPHTHALMOL, V80, P868, DOI 10.1136/bjo.80.10.868; Erie JC, 2006, OPHTHALMOLOGY, V113, P2026, DOI 10.1016/j.ophtha.2006.05.054; Gothwal VK, 2010, J CATARACT REFR SURG, V36, P1181, DOI 10.1016/j.jcrs.2010.01.029; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; HOLLADAY JT, 1991, AM J OPHTHALMOL, V111, P372, DOI 10.1016/S0002-9394(14)72328-1; Lau J, 2002, BRIT J OPHTHALMOL, V86, P12, DOI 10.1136/bjo.86.1.12; Monestam E, 1999, J CATARACT REFR SURG, V25, P1127, DOI 10.1016/S0886-3350(99)00135-2; Neuhann IM, 2008, J CATARACT REFR SURG, V34, P1644, DOI 10.1016/j.jcrs.2008.06.022; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Ranta P, 2002, OPHTHALMOLOGY, V109, P1432, DOI 10.1016/S0161-6420(02)01111-9; Saw SM, 2002, J CATARACT REFR SURG, V28, P445, DOI 10.1016/S0886-3350(01)01016-1; Scott IU, 1998, OPHTHALMOLOGY, V105, P795, DOI 10.1016/S0161-6420(98)95017-5; Sheu Shwu-Jiuan, 2005, J Chin Med Assoc, V68, P321, DOI 10.1016/S1726-4901(09)70168-6; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; Tuft SJ, 2006, OPHTHALMOLOGY, V113, P650, DOI 10.1016/j.ophtha.2006.01.001; Wolffsohn JS, 2000, AM J OPHTHALMOL, V130, P793, DOI 10.1016/S0002-9394(00)00610-3; Zou H, 2005, QUAL LIFE RES, V14, P1633, DOI 10.1007/s11136-004-0026-5; Zou HD, 2008, OPHTHAL EPIDEMIOL, V15, P212, DOI 10.1080/09286580701843804; Zou HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028597	22	1	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120505	10.1371/journal.pone.0120505	http://dx.doi.org/10.1371/journal.pone.0120505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764367	gold, Green Submitted, Green Published			2022-12-27	WOS:000351276300043
J	Amer, S; Helal, IB; Kamau, E; Feng, YY; Xiao, LH				Amer, Said; Helal, Ibrahim B.; Kamau, Evelyne; Feng, Yaoyu; Xiao, Lihua			Molecular Characterization of Echinococcus granulosus Sensu Lato from Farm Animals in Egypt	PLOS ONE			English	Article							HUMAN CYSTIC ECHINOCOCCOSIS; IDENTIFICATION; STRAINS; EPIDEMIOLOGY; HUMANS; SHEEP; DOGS; G1	Little is known on the diversity and public health significance of Echinococcus species in livestock in Egypt. In this study, 37 individual hydatid cysts were collected from dromedary camels (n=28), sheep (n=7) and buffalos (n=2). DNA was extracted from protoscoleces/germinal layer of individual cysts and amplified by PCR targeting nuclear (actin II) and mitochondrial (COX1 and NAD1) genes. Direct sequencing of amplicons indicated the presence of Echinococcus canadenesis (G6 genotype) in 26 of 28 camel cysts, 3 of 7 sheep cysts and the 2 buffalo derived cysts. In contrast, Echinococcus granulosus sensu stricto (G1 genotype) was detected in one cyst from a camel and 4 of 7 cysts from sheep, whereas Echinococcus ortleppi (G5 genotype) was detected in one cyst from a camel. This is the first identification of E. ortleppi in Egypt.	[Amer, Said; Xiao, Lihua] Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Amer, Said] Kafr El Sheikh Univ, Fac Sci, Dept Zool, Kafr Al Sheikh, Egypt; [Helal, Ibrahim B.] Tanta Univ, Fac Sci, Dept Zool, Tanta, Egypt; [Kamau, Evelyne] Univ Evry Val Essonne, ISSB, Evry, France; [Feng, Yaoyu] E China Univ Sci & Technol, Sch Resources & Environm Engn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Centers for Disease Control & Prevention - USA; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Tanta University; UDICE-French Research Universities; Universite Paris Saclay; East China University of Science & Technology	Feng, YY (corresponding author), E China Univ Sci & Technol, Sch Resources & Environm Engn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	yyfeng@ecust.edu.cn; lxiao@cdc.gov	Helal, Ibrahim/AAF-7342-2019; Feng, Yaoyu/S-1979-2019; Xiao, Lihua/B-1704-2013; Feng, Yaoyu/B-3076-2014	Helal, Ibrahim/0000-0003-3932-5665; Feng, Yaoyu/0000-0002-8380-1246; Xiao, Lihua/0000-0001-8532-2727; Feng, Yaoyu/0000-0002-8380-1246	Arab Fund for Economic & Social Development "Zamalat Program"; National Natural Science Foundation of China [31110103901]	Arab Fund for Economic & Social Development "Zamalat Program"(Arab Fund for Economic and Social Development); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the Arab Fund for Economic & Social Development "Zamalat Program" and the National Natural Science Foundation of China (Project No. 31110103901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaty HEA, 2012, ACTA TROP, V121, P125, DOI 10.1016/j.actatropica.2011.10.014; Abd El Baki Mohammad H., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P711; Aboelhadid SM, 2013, VET PARASITOL, V193, P292, DOI 10.1016/j.vetpar.2012.11.019; Abushhewa MH, 2010, MOL CELL PROBE, V24, P346, DOI 10.1016/j.mcp.2010.07.005; Adwan G, 2013, EXP PARASITOL, V134, P195, DOI 10.1016/j.exppara.2013.03.024; Ahmed ME, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-127; Alvarez Rojas CA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; Atkinson JAM, 2013, GLOBAL CHANGE BIOL, V19, P677, DOI 10.1111/gcb.12088; Azab Magda E., 2004, Journal of the Egyptian Society of Parasitology, V34, P83; Bart JM, 2006, PARASITOL RES, V98, P130, DOI 10.1007/s00436-005-0015-9; Bart JM, 2004, PARASITOLOGY, V128, P229, DOI [10.1017/S0031182003004359, 10.1017/s0031182003004359]; Beato S, 2010, PARASITOL INT, V59, P638, DOI 10.1016/j.parint.2010.08.004; BOWLES J, 1993, INT J PARASITOL, V23, P969, DOI 10.1016/0020-7519(93)90065-7; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Carmena D, 2014, VET PARASITOL, V202, P69, DOI 10.1016/j.vetpar.2014.03.009; Casulli A, 2010, T ROY SOC TROP MED H, V104, P29, DOI 10.1016/j.trstmh.2009.08.001; da Silva AM, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/583297; DASILVA CMD, 1993, MOL BIOCHEM PARASIT, V60, P209, DOI 10.1016/0166-6851(93)90132-H; Dowling PM, 2000, ANN TROP MED PARASIT, V94, P69, DOI 10.1080/00034980057626; Dyab Kamal A., 2005, Journal of the Egyptian Society of Parasitology, V35, P157; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P100; El Shazly Atef M., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P483; Farjallah S., 2007, Parassitologia (Rome), V49, P239; Guarnera EA, 2004, ACTA TROP, V92, P153, DOI 10.1016/j.actatropica.2004.06.008; Hailemariam Z, 2012, PARASITOL INT, V61, P375, DOI 10.1016/j.parint.2012.01.007; Haridy Fouad M., 2006, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V36, P1087; Ibrahim K, 2011, CHINESE MED J-PEKING, V124, P2829, DOI 10.3760/cma.j.issn.0366-6999.2011.18.006; Ito A, 2007, FUTURE MICROBIOL, V2, P439, DOI 10.2217/17460913.2.4.439; Jabbar A, 2011, MOL CELL PROBE, V25, P49, DOI 10.1016/j.mcp.2010.11.001; Maillard S, 2007, PARASITOL RES, V100, P495, DOI 10.1007/s00436-006-0286-9; Mazyad Said A. M., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P523; McManus DP, 2010, ADV PARASIT, V72, P267, DOI 10.1016/S0065-308X(10)72010-8; McManus DP, 2003, PARASITOLOGY, V127, pS37, DOI 10.1017/S0031182003003524; Moro PL, 2009, PARASITOL INT, V58, P184, DOI 10.1016/j.parint.2009.01.005; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Nakao M, 2013, INT J PARASITOL, V43, P1017, DOI 10.1016/j.ijpara.2013.06.002; Nejad MR, 2012, J HELMINTHOL, V86, P485, DOI 10.1017/S0022149X1100071X; Omer RA, 2010, VET PARASITOL, V169, P340, DOI 10.1016/j.vetpar.2010.01.004; Piccoli L, 2013, CLIN MICROBIOL INFEC, V19, P578, DOI 10.1111/j.1469-0691.2012.03993.x; Sadjadi SM, 2006, PARASITOL INT, V55, pS197, DOI 10.1016/j.parint.2005.11.030; Shahnazi M, 2011, ACTA TROP, V117, P47, DOI 10.1016/j.actatropica.2010.09.002; Sharafi Seyedeh Maryam, 2014, Gastroenterol Hepatol Bed Bench, V7, P82; Sharma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082904; Taha HA, 2012, PARASITOL RES, V111, P1993, DOI 10.1007/s00436-012-3046-z; Thompson RCA, 2002, TRENDS PARASITOL, V18, P452, DOI 10.1016/S1471-4922(02)02358-9; THOMPSON RCA, 1990, INT J PARASITOL, V20, P457, DOI 10.1016/0020-7519(90)90193-Q; Yan N, 2013, VET PARASITOL, V196, P179, DOI 10.1016/j.vetpar.2013.02.010; Zhang WB, 2015, ACTA TROP, V141, P235, DOI 10.1016/j.actatropica.2014.03.014	49	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118509	10.1371/journal.pone.0118509	http://dx.doi.org/10.1371/journal.pone.0118509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760944	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275000025
J	Garcia, SM; Marinho, LSR; Lunardelli, PA; Seneda, MM; Meirelles, FV				Garcia, Sheila Merlo; Rafagnin Marinho, Luciana Simoes; Lunardelli, Paula Alvares; Seneda, Marcelo Marcondes; Meirelles, Flavio Vieira			Developmental Block and Programmed Cell Death in Bos indicus Embryos: Effects of Protein Supplementation Source and Developmental Kinetics	PLOS ONE			English	Article							IN-VITRO; BOVINE EMBRYOS; DNA-DAMAGE; APOPTOSIS; PATTERN; VIVO; MITOCHONDRIAL; CLEAVAGE; TAURUS; SERUM	The aims of this study were to determine if the protein source of the medium influences zebu embryo development and if developmental kinetics, developmental block and programmed cell death are related. The culture medium was supplemented with either fetal calf serum or bovine serum albumin. The embryos were classified as Fast (n = 1,235) or Slow (n = 485) based on the time required to reach the fourth cell cycle (48 h and 90 h post insemination - hpi -, respectively). The Slow group was further separated into two groups: those presenting exactly 4 cells at 48 hpi (Slow/4 cells) and those that reached the fourth cell cycle at 90 hpi (Slow). Blastocyst quality, DNA fragmentation, mitochondrial membrane potential and signs of apoptosis or necrosis were evaluated. The Slow group had higher incidence of developmental block than the Fast group. The embryos supplemented with fetal calf serum had lower quality. DNA fragmentation and mitochondrial membrane potential were absent in embryos at 48 hpi but present at 90 hpi. Early signs of apoptosis were more frequent in the Slow and Slow/4 cell groups than in the Fast group. We concluded that fetal calf serum reduces blastocyst development and quality, but the mechanism appears to be independent of DNA fragmentation. The apoptotic cells detected at 48 hpi reveal a possible mechanism of programmed cell death activation prior to genome activation. The apoptotic cells observed in the slow-developing embryos suggested a relationship between programmed cell death and embryonic developmental kinetics in zebu in vitro-produced embryos.	[Garcia, Sheila Merlo; Meirelles, Flavio Vieira] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Pirassununga, SP, Brazil; [Rafagnin Marinho, Luciana Simoes; Lunardelli, Paula Alvares; Seneda, Marcelo Marcondes] State Univ Londrina UEL, DCV, CCA, Lab Reprod Anim, Londrina, PR, Brazil	Universidade de Sao Paulo; Universidade Estadual de Londrina	Seneda, MM (corresponding author), State Univ Londrina UEL, DCV, CCA, Lab Reprod Anim, Londrina, PR, Brazil.	mseneda@uel.br	Marinho, Luciana Rafagnin/AAZ-4903-2021; Seneda, Marcelo/AAP-9031-2020; Meirelles, Flavio V/B-5048-2010; CTC USP, CEPID 13 18/J-8951-2014	Marinho, Luciana Rafagnin/0000-0002-5816-6076; Meirelles, Flavio V/0000-0003-0372-4920; Merlo Garcia Firetti, Sheila/0000-0003-4076-6265; CTC USP, CEPID 13 18/0000-0002-7123-9524	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP): U$ 7000,00 (http://www.fapesp.br/), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): U$ 3000,00 (http://www.cnpq.br/). Authors who recieved the funding: SMG and FVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez P, 2000, J ANIM SCI, V78, P1291; Bastos GM, 2008, MOL REPROD DEV, V75, P282, DOI 10.1002/mrd.20798; Bo GA, 2003, ANIM REPROD SCI, V78, P307, DOI 10.1016/S0378-4320(03)00097-6; Bohrer RC, 2013, REPRODUCTION, V146, P325, DOI 10.1530/REP-13-0271; Brad AM, 2007, REPRODUCTION, V134, P789, DOI 10.1530/REP-07-0146; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Carvalho JBP, 2008, THERIOGENOLOGY, V69, P167, DOI 10.1016/j.theriogenology.2007.08.035; Chaudhari M, 2009, TOXICOLOGY, V262, P153, DOI 10.1016/j.tox.2009.06.002; Crosier AE, 2000, BIOL REPROD, V62, P1459, DOI 10.1095/biolreprod62.5.1459; Fox J., 2019, R COMPANION APPL REG, V.; GARDNER DK, 1994, BIOL REPROD, V50, P390, DOI 10.1095/biolreprod50.2.390; Gjorret JO, 2007, MOL REPROD DEV, V74, P961, DOI 10.1002/mrd.20714; Gutierrez-Adan A, 2004, MOL REPROD DEV, V68, P441, DOI 10.1002/mrd.20113; Hwang IS, 2013, J VET SCI, V14, P235, DOI 10.4142/jvs.2013.14.3.235; Jousan FD, 2007, MOL REPROD DEV, V74, P189, DOI 10.1002/mrd.20527; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kuzmany A, 2011, THERIOGENOLOGY, V75, P482, DOI 10.1016/j.theriogenology.2010.09.016; Leivas FG, 2011, THERIOGENOLOGY, V75, P429, DOI 10.1016/j.theriogenology.2010.08.017; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Patriarca A, 2009, BIOCHEMISTRY-US, V48, P3279, DOI 10.1021/bi801837e; Pers-Kamczyc E, 2012, REPROD DOMEST ANIM, V47, P899, DOI 10.1111/j.1439-0531.2012.01987.x; Pons I, 2013, J ASSIST REPROD GEN, V30, P1211, DOI 10.1007/s10815-013-0089-8; Pontes JHF, 2011, THERIOGENOLOGY, V75, P1640, DOI 10.1016/j.theriogenology.2010.12.026; Pontes JHF, 2010, THERIOGENOLOGY, V74, P1349, DOI 10.1016/j.theriogenology.2010.06.004; Pontes JHF, 2009, THERIOGENOLOGY, V71, P690, DOI 10.1016/j.theriogenology.2008.09.031; R Core Team, 2018, R LANG ENV STAT COMP; Rooke JA, 2007, THERIOGENOLOGY, V67, P639, DOI 10.1016/j.theriogenology.2006.09.040; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Stigliani S, 2013, HUM REPROD, P1; Sudano MJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102897; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Sugimura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036627; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; VanSoom A, 1997, MOL REPROD DEV, V47, P47, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;47::AID-MRD7&gt;3.0.CO;2-Q; Velker BAM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096602; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; Zheng Wenjing, 2012, Results Probl Cell Differ, V55, P115, DOI 10.1007/978-3-642-30406-4_7	39	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119463	10.1371/journal.pone.0119463	http://dx.doi.org/10.1371/journal.pone.0119463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760989	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000059
J	Mirzaei, MK; Nilsson, AS				Mirzaei, Mohammadali Khan; Nilsson, Anders S.			Isolation of Phages for Phage Therapy: A Comparison of Spot Tests and Efficiency of Plating Analyses for Determination of Host Range and Efficacy	PLOS ONE			English	Article							ESCHERICHIA-COLI; REFERENCE COLLECTION; BACTERIOPHAGE; STRAINS; IDENTIFICATION; P2	Phage therapy, treating bacterial infections with bacteriophages, could be a future alternative to antibiotic treatment of bacterial infections. There are, however, several problems to be solved, mainly associated to the biology of phages, the interaction between phages and their bacterial hosts, but also to the vast variation of pathogenic bacteria which implies that large numbers of different phages are going to be needed. All of these phages must under present regulation of medical products undergo extensive clinical testing before they can be applied. It will consequently be of great economic importance that effective and versatile phages are selected and collected into phage libraries, i.e., the selection must be carried out in a way that it results in highly virulent phages with broad host ranges. We have isolated phages using the Escherichia coli reference (ECOR) collection and compared two methods, spot testing and efficiency of plating (EOP), which are frequently used to identify phages suitable for phage therapy. The analyses of the differences between the two methods show that spot tests often overestimate both the overall virulence and the host range and that the results are not correlated to the results of EOP assays. The conclusion is that single dilution spot tests cannot be used for identification and selection of phages to a phage library and should be replaced by EOP assays. The difference between the two methods can be caused by many factors. We have analysed if the differences and lack of correlation could be caused by lysis from without, bacteriocins in the phage lysate, or by the presence of pro-phages harbouring genes coding for phage resistance systems in the genomes of the bacteria in the ECOR collection.	[Mirzaei, Mohammadali Khan; Nilsson, Anders S.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University	Nilsson, AS (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	anders.s.nilsson@su.se	Khan Mirzaei, Mohammadali/ABB-9778-2021	Khan Mirzaei, Mohammadali/0000-0003-2801-4474	Olle Engqvist Foundation	Olle Engqvist Foundation	This work was funded by the Olle Engqvist Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasifar R, 2014, ARCH VIROL, V159, P2253, DOI 10.1007/s00705-014-2055-x; Abedon Stephen T, 2011, Bacteriophage, V1, P66; Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Abedon ST, 2010, CURR PHARM BIOTECHNO, V11, P28, DOI 10.2174/138920110790725410; Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Al-Fendi A, 2014, J BASIC MICROB, V54, P1036, DOI 10.1002/jobm.201300458; BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BERTANI LE, 1971, ADV GENET, V16, P199, DOI 10.1016/S0065-2660(08)60359-4; Bourdin G, 2014, MICROB BIOTECHNOL, V7, P165, DOI 10.1111/1751-7915.12113; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Brussow H, 2014, CLIN INFECT DIS, V58, P535, DOI 10.1093/cid/cit776; Calendar Richard, 1998, P241; Carlson K, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P437; Castillo D, 2014, MICROB ECOL, V67, P748, DOI 10.1007/s00248-014-0375-8; Cavanagh D, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00417; CLARK WA, 1962, APPL MICROBIOL, V10, P466, DOI 10.1128/AEM.10.5.466-471.1962; Di Lallo G, 2014, J BASIC MICROB, V54, P1210, DOI 10.1002/jobm.201300951; Dziewit L, 2014, J VIROL, V88, P13111, DOI 10.1128/JVI.01875-14; Frampton RA, 2014, APPL ENVIRON MICROB, V80, P2216, DOI 10.1128/AEM.00062-14; Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Keen EC, BACTERIOPHAGE, V4; Kim M, 2014, APPL ENVIRON MICROB, V80, P1026, DOI 10.1128/AEM.03494-13; Kleppen HP, 2012, APPL ENVIRON MICROB, V78, P7299, DOI 10.1128/AEM.00031-12; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Matsushita K, 2009, FEMS MICROBIOL LETT, V291, P201, DOI 10.1111/j.1574-6968.2008.01455.x; Mirzaei MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116294; Mosig G, 1997, VIROLOGY, V230, P72, DOI 10.1006/viro.1997.8464; Nilsson AS, 2014, UPSALA J MED SCI, V119, P192, DOI 10.3109/03009734.2014.902878; Nilsson AS, 2004, MOL BIOL EVOL, V21, P1, DOI 10.1093/molbev/msg223; Nilsson AS, 2006, BACTERIOPHAGES, P365; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Odegrip R, 2006, J BACTERIOL, V188, P1643, DOI 10.1128/JB.188.4.1643-1647.2006; PIERONI P, 1994, J MED MICROBIOL, V41, P423, DOI 10.1099/00222615-41-6-423; Pirnay JP, 2011, PHARM RES-DORDR, V28, P934, DOI 10.1007/s11095-010-0313-5; RILEY MA, 1992, J GEN MICROBIOL, V138, P1345, DOI 10.1099/00221287-138-7-1345; Sambrook J., 2001, MOL CLONING LAB MANU; Silva YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114197; Tsonos J, 2014, VET MICROBIOL, V171, P470, DOI 10.1016/j.vetmic.2013.10.021; Verbeken G, 2014, ARCH IMMUNOL THER EX, V62, P117, DOI 10.1007/s00005-014-0269-y; Viazis S, 2011, J APPL MICROBIOL, V110, P1323, DOI 10.1111/j.1365-2672.2011.04989.x; Wittmann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086935; Wongsuntornpoj S, 2014, VET MICROBIOL, V172, P345, DOI 10.1016/j.vetmic.2014.05.023	47	173	179	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118557	10.1371/journal.pone.0118557	http://dx.doi.org/10.1371/journal.pone.0118557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761060	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000027
J	Peterson, JM; Bell, SS				Peterson, Jennifer M.; Bell, Susan S.			Saltmarsh Boundary Modulates Dispersal of Mangrove Propagules: Implications for Mangrove Migration with Sea-Level Rise	PLOS ONE			English	Article							AVICENNIA-MARINA PROPAGULES; CLIMATE-CHANGE; FRAGMENTED LANDSCAPES; ECOLOGICAL BOUNDARIES; SOUTH FLORIDA; IMPACTS; ECOTONE; LIMITATIONS; GERMINANS; EXPANSION	Few studies have empirically examined the suite of mechanisms that underlie the distributional shifts displayed by organisms in response to changing climatic condition. Mangrove forests are expected to move inland as sea-level rises, encroaching on saltmarsh plants inhabiting higher elevations. Mangrove propagules are transported by tidal waters and propagule dispersal is likely modified upon encountering the mangrove-saltmarsh ecotone, the implications of which are poorly known. Here, using an experimental approach, we record landward and seaward dispersal and subsequent establishment of mangrove propagules that encounter biotic boundaries composed of two types of saltmarsh taxa: succulents and grasses. Our findings revealed that propagules emplaced within saltmarsh vegetation immediately landward of the extant mangrove fringe boundary frequently dispersed in the seaward direction. However, propagules moved seaward less frequently and over shorter distances upon encountering boundaries composed of saltmarsh grasses versus succulents. We uniquely confirmed that the small subset of propagules dispersing landward displayed proportionately higher establishment success than those transported seaward. Although impacts of ecotones on plant dispersal have rarely been investigated in situ, our experimental results indicate that the interplay between tidal transport and physical attributes of saltmarsh vegetation influence boundary permeability to propagules, thereby directing the initial phase of shifting mangrove distributions. The incorporation of tidal inundation information and detailed data on landscape features, such as the structure of saltmarsh vegetation at mangrove boundaries, should improve the accuracy of models that are being developed to forecast mangrove distributional shifts in response to sea-level rise.	[Peterson, Jennifer M.; Bell, Susan S.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Bell, SS (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	sbell@usf.edu			US Department of Commerce, National Oceanic and Atmospheric Administration [NA09NOS4200033]	US Department of Commerce, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was supported by a grant from the US Department of Commerce, National Oceanic and Atmospheric Administration (http://www.noaa.gov) #NA09NOS4200033 to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2002, ENVIRON CONSERV, V29, P39, DOI 10.1017/S0376892902000048; Alleman LK, 2011, ESTUAR COAST, V34, P1068, DOI 10.1007/s12237-011-9404-8; Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berger U, 2008, AQUAT BOT, V89, P260, DOI 10.1016/j.aquabot.2007.12.015; Breitfuss MJ, 2003, ESTUAR COAST SHELF S, V56, P573, DOI 10.1016/S0272-7714(02)00207-X; Breshears DD, 2008, P NATL ACAD SCI USA, V105, P11591, DOI 10.1073/pnas.0806579105; Cadenasso ML, 2003, BIOSCIENCE, V53, P717, DOI 10.1641/0006-3568(2003)053[0717:AIASAT]2.0.CO;2; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; Cadenasso ML, 2001, CONSERV BIOL, V15, P91, DOI 10.1046/j.1523-1739.2001.99309.x; Castro J, 2002, J VEG SCI, V13, P725, DOI 10.1658/1100-9233(2002)013[0725:MBPSCO]2.0.CO;2; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; CLARKE PJ, 1993, AQUAT BOT, V45, P195, DOI 10.1016/0304-3770(93)90021-N; Cohen MCL, 2003, WETL ECOL MANAG, V11, P223, DOI 10.1023/A:1025007331075; De Ryck DJR, 2012, AQUAT BOT, V103, P66, DOI 10.1016/j.aquabot.2012.06.005; DELANGE WP, 1994, J COASTAL RES, V10, P539; Donnelly M, 2014, ESTUAR COAST, V37, P1562, DOI 10.1007/s12237-014-9789-2; Ellison JC, 2008, AQUAT BOT, V89, P93, DOI 10.1016/j.aquabot.2008.02.007; Eslami-Andargoli L, 2009, ESTUAR COAST SHELF S, V85, P292, DOI 10.1016/j.ecss.2009.08.011; Gaiser EE, 2006, HYDROBIOLOGIA, V569, P237, DOI 10.1007/s10750-006-0135-y; Gilman E, 2007, ENVIRON MONIT ASSESS, V124, P105, DOI 10.1007/s10661-006-9212-y; Grinnell J., 1936, Condor, V38, P80, DOI 10.2307/1363554; Guo HY, 2013, GLOBAL CHANGE BIOL, V19, P2765, DOI 10.1111/gcb.12221; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Jiang J, 2014, ESTUAR COAST, V37, P24, DOI 10.1007/s12237-013-9666-4; Keith SA, 2011, DIVERS DISTRIB, V17, P275, DOI 10.1111/j.1472-4642.2010.00734.x; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Krauss KW, 2011, J COAST CONSERV, V15, P629, DOI 10.1007/s11852-011-0153-4; Lopez-Medellin X, 2011, J VEG SCI, V22, P143, DOI 10.1111/j.1654-1103.2010.01232.x; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pepino M, 2012, ECOL APPL, V22, P1435; Peterson JM, 2012, ECOLOGY, V93, P1648, DOI 10.1890/11-1430.1; Renton M, 2013, ECOL MODEL, V249, P50, DOI 10.1016/j.ecolmodel.2012.07.005; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Schultz CB, 2001, ECOLOGY, V82, P1879, DOI 10.1890/0012-9658(2001)082[1879:EMDBIA]2.0.CO;2; Sousa WP, 2007, ECOL MONOGR, V77, P53, DOI 10.1890/05-1935; Teh SY, 2008, ECOL MODEL, V213, P245, DOI 10.1016/j.ecolmodel.2007.12.007; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wasson K, 2013, ESTUAR COAST, V36, P654, DOI 10.1007/s12237-013-9601-8; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	46	24	24	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119128	10.1371/journal.pone.0119128	http://dx.doi.org/10.1371/journal.pone.0119128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760867	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000047
J	Tse, LA; Li, MJ; Chan, WC; Kwok, CH; Leung, SL; Wu, C; Yu, ITS; Yu, WC; Lao, XQ; Wang, XR; Wong, CKM; Lee, PMY; Wang, F; Yang, XR				Tse, Lap Ah; Li, Mengjie; Chan, Wing-cheong; Kwok, Chi-hei; Leung, Siu-lan; Wu, Cherry; Yu, Ignatius Tak-sun; Yu, Wai-cho; Lao, Xiangqian; Wang, Xiaorong; Wong, Carmen Ka-man; Lee, Priscilla Ming-yi; Wang, Feng; Yang, Xiaohong Rose			Familial Risks and Estrogen Receptor-Positive Breast Cancer in Hong Kong Chinese Women	PLOS ONE			English	Article							CONFER SUSCEPTIBILITY; COMMON VARIANTS; POPULATION; HISTORY	Purpose The role of family history to the risk of breast cancer was analyzed by incorporating menopausal status in Hong Kong Chinese women, with a particular respect to the estrogen receptor-positive (ER+) type. Methods Seven hundred and forty seven breast cancer incident cases and 781 hospital controls who had completed information on family cancer history in first-degree relatives (nature father, mother, and siblings) were recruited. Odds ratio for breast cancer were calculated by unconditional multiple logistic regression, stratified by menopausal status (a surrogate of endogenous female sex hormone level and age) and type of relative affected with the disease. Further subgroup analysis by tumor type according to ER status was investigated. Results Altogether 52 (6.96%) breast cancer cases and 23 (2.95%) controls was found that the patients' one or more first-degree relatives had a history of breast cancer, showing an adjusted odds ratio (OR) of 2.41 (95% CI: 1.45-4.02). An excess risk of breast cancer was restricted to the ER+ tumor (OR = 2.43, 95% CI: 1.38-4.28), with a relatively higher risk associated with an affected mother (OR = 3.97, 95% CI: 1.46-10.79) than an affected sister (OR = 2.06, 95% CI: 1.07-3.97), while the relative risk was more prominent in the subgroup of pre-menopausal women. Compared with the breast cancer overall, the familial risks to the ER+ tumor increased progressively with the number of affected first-degree relatives. Conclusions This study provides new insights on a relationship between family breast cancer history, menopausal status, and the ER+ breast cancer. A separate risk prediction model for ER+ tumor in Asian population is desired.	[Tse, Lap Ah; Li, Mengjie; Yu, Ignatius Tak-sun; Lao, Xiangqian; Wang, Xiaorong; Wong, Carmen Ka-man; Lee, Priscilla Ming-yi; Wang, Feng] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chan, Wing-cheong] North Dist Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kwok, Chi-hei] Princess Margaret Hosp, Dept Oncol, Hong Kong, Hong Kong, Peoples R China; [Leung, Siu-lan] Pamela Youde Nethersole Eastern Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Wu, Cherry] North Dist Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Yu, Wai-cho] Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Yang, Xiaohong Rose] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA	Chinese University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tse, LA (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	shelly@cuhk.edu.hk; fwang@cuhk.edu.hk	li, mengjie/GRS-3931-2022; Lao, Xiang Qian/M-5817-2017; Yu, Ignatius Tak Sun/A-9936-2008; wang, xiao/HGB-7081-2022	Lao, Xiang Qian/0000-0002-2645-0128; wang, xiao/0000-0002-4088-3341; Tse, Lap Ah/0000-0003-0355-6218; Wang, Feng/0000-0003-2618-201X; LEE, Priscilla Ming Yi/0000-0002-7688-0126	Research Grants Council of Hong Kong [474811]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Research Grants Council of Hong Kong [Grant number 474811]. The funding source had no role in the study design, data collection, data analysis, or interpretation of the findings.	Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chen W, 2013, BREAST CANCER RES TR, V142, P637, DOI 10.1007/s10549-013-2775-8; Cummings SR, 2005, CANCER EPIDEM BIOMAR, V14, P1047, DOI 10.1158/1055-9965.EPI-04-0375; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; HOPPER JL, 1992, AM J EPIDEMIOL, V136, P1138, DOI 10.1093/oxfordjournals.aje.a116580; International Agency for Research on Cancer, GLOB 2012 EST CANC I; Kilfoy B, 2008, CANCER CAUSE CONTROL, V19, P1139, DOI 10.1007/s10552-008-9181-2; Leung GM, 2002, BRIT J CANCER, V87, P982, DOI 10.1038/sj.bjc.6600583; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Ma HY, 2006, BREAST CANCER RES, V8, DOI [10.1186/bcr1525, 10.1186/bcr1512]; Mack TM, 2002, BRIT J CANCER, V87, P294, DOI 10.1038/sj.bjc.6600429; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; National Cancer Institute, GEN BREAST OV CANC; Neupane B, 2010, J CLIN EPIDEMIOL, V63, P926, DOI 10.1016/j.jclinepi.2009.11.006; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Ponder BAJ, 2005, COLD SH Q B, V70, P35, DOI 10.1101/sqb.2005.70.029; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; YUAN JM, 1988, CANCER RES, V48, P1949; Zhang B, 2014, BREAST CANCER RES TR, V146, P503, DOI 10.1007/s10549-014-3041-4	25	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120741	10.1371/journal.pone.0120741	http://dx.doi.org/10.1371/journal.pone.0120741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756203	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700074
J	Mitsui, T; Araki, A; Imai, A; Sato, S; Miyashita, C; Ito, S; Sasaki, S; Kitta, T; Moriya, K; Cho, K; Morioka, K; Kishi, R; Nonomura, K				Mitsui, Takahiko; Araki, Atsuko; Imai, Ayako; Sato, Sakiko; Miyashita, Chihiro; Ito, Sachiko; Sasaki, Seiko; Kitta, Takeya; Moriya, Kimihiko; Cho, Kazutoshi; Morioka, Keita; Kishi, Reiko; Nonomura, Katsuya			Effects of Prenatal Leydig Cell Function on the Ratio of the Second to Fourth Digit Lengths in School-Aged Children	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; INSULIN-LIKE FACTOR-3; POLYCHLORINATED-BIPHENYLS; COHORT PROFILE; AMNIOTIC-FLUID; TESTOSTERONE; HORMONES; SERUM; ENVIRONMENT; EXPOSURE	Prenatal sex hormones can induce abnormalities in the reproductive system and adversely impact on genital development. We investigated whether sex hormones in cord blood influenced the ratio of the second to fourth digit lengths (2D/4D) in school-aged children. Of the 514 children who participated in a prospective cohort study on birth in Sapporo between 2002 and 2005, the following sex hormone levels were measured in 294 stored cord blood samples (135 boys and 159 girls); testosterone (T), estradiol (E), progesterone, LH, FSH, inhibin B, and insulin-like factor 3 (INSL3). A total of 350 children, who were of school age and could be contacted for this survey, were then requested via mail to send black-and-white photocopies of the palms of both the left and right hands. 2D/4D was calculated in 190 children (88 boys and 102 girls) using photocopies and derived from participants with the characteristics of older mothers, a higher annual household income, higher educational level, and fewer smokers among family members. 2D/4D was significantly lower in males than in females (p<0.01). In the 294 stored cord blood samples, T, T/E, LH, FSH, Inhibin B, and INSL3 levels were significantly higher in samples collected from males than those from females. A multivariate regression model revealed that 2D/4D negatively correlated with INSL3 in males and was significantly higher in males with <0.32 ng/mL of INSL3 (p<0.01). No correlations were observed between other hormones and 2D/4D. In conclusion, 2D/4D in school-aged children, which was significantly lower in males than in females, was affected by prenatal Leydig cell function.	[Mitsui, Takahiko; Imai, Ayako; Sato, Sakiko; Kitta, Takeya; Moriya, Kimihiko; Nonomura, Katsuya] Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan; [Araki, Atsuko; Miyashita, Chihiro; Ito, Sachiko; Kishi, Reiko] Hokkaido Univ, Ctr Environm & Hlth Sci, Sapporo, Hokkaido, Japan; [Sasaki, Seiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Cho, Kazutoshi; Morioka, Keita] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Mitsui, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Urol, Sapporo, Hokkaido, Japan.	mitsui68@med.hokudai.ac.jp	, Takahiko/H-6660-2019; Ikeda-Araki, Atsuko/A-4105-2012	Ikeda-Araki, Atsuko/0000-0002-3065-262X	Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants; Japan Society for the Promotion of Science; Environment Research and Technology Development Fund from Ministry of the Environment, Japan [5C-1252]; Grants-in-Aid for Scientific Research [25860434, 26670321, 24390172, 15K20825] Funding Source: KAKEN	Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environment Research and Technology Development Fund from Ministry of the Environment, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by the Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Grants-in Aid for Scientific Research from the Japan Society for the Promotion of Science, and Environment Research and Technology Development Fund (5C-1252) from the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand-Ivell R, 2008, HUM REPROD, V23, P1180, DOI 10.1093/humrep/den038; Anand-Ivell R, 2014, REPRODUCTION, V147, pR87, DOI 10.1530/REP-13-0486; Araki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109039; Auger J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1532; BenHur H, 1997, CALCIFIED TISSUE INT, V60, P520, DOI 10.1007/s002239900274; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Cao YG, 2008, INT J HYG ENVIR HEAL, V211, P30, DOI 10.1016/j.ijheh.2007.04.005; Folland JP, 2012, AM J PHYS ANTHROPOL, V148, P81, DOI 10.1002/ajpa.22044; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Garcia-Cruz E, 2012, BJU INT, V109, P266, DOI 10.1111/j.1464-410X.2011.10249.x; Hickey M, 2010, PSYCHONEUROENDOCRINO, V35, P1235, DOI 10.1016/j.psyneuen.2010.02.013; Hollier LP, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00064; Hollier LP, 2013, BIOL PSYCHOL, V92, P212, DOI 10.1016/j.biopsycho.2012.10.016; Honekopp Johannes, 2013, Front Endocrinol (Lausanne), V4, P185, DOI 10.3389/fendo.2013.00185; Hsu PC, 2005, J TOXICOL ENV HEAL A, V68, P1447, DOI 10.1080/15287390590967360; Keelan JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042827; Kishi R, 2013, ENVIRON HEALTH PREV, V18, P429, DOI 10.1007/s12199-013-0357-3; Kishi R, 2011, INT J EPIDEMIOL, V40, P611, DOI 10.1093/ije/dyq071; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2011, P NATL ACAD SCI USA, V108, P16143, DOI 10.1073/pnas.1113312108; Manning JT, 2003, ANN HUM BIOL, V30, P579, DOI 10.1080/0301446032000112689; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Okten A, 2002, EARLY HUM DEV, V70, P47, DOI 10.1016/S0378-3782(02)00073-7; Robinson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059991; van de Beek C, 2004, HORM BEHAV, V46, P663, DOI 10.1016/j.yhbeh.2004.06.010; Whitehouse AJO, 2012, J CHILD PSYCHOL PSYC, V53, P726, DOI 10.1111/j.1469-7610.2011.02523.x; Yamashita K, 2007, J CHROMATOGR A, V1173, P120, DOI 10.1016/j.chroma.2007.10.023; Yamashita K, 2007, STEROIDS, V72, P819, DOI 10.1016/j.steroids.2007.07.003; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108	30	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120636	10.1371/journal.pone.0120636	http://dx.doi.org/10.1371/journal.pone.0120636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746668	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400098
J	Zhou, XX; Yang, LT; Qi, YP; Guo, P; Chen, LS				Zhou, Xin-Xing; Yang, Lin-Tong; Qi, Yi-Ping; Guo, Peng; Chen, Li-Song			Mechanisms on Boron-Induced Alleviation of Aluminum-Toxicity in Citrus grandis Seedlings at a Transcriptional Level Revealed by cDNA-AFLP Analysis	PLOS ONE			English	Article							OXIDATIVE STRESS; CELL-WALL; ROOT ELONGATION; DIFFERENTIAL EXPRESSION; SUPPLEMENTAL BORON; PROTEOME ANALYSIS; REPEAT PROTEIN; AL TOXICITY; DNA-DAMAGE; TOLERANCE	The physiological and biochemical mechanisms on boron (B)-induced alleviation of aluminum (B)-toxicity in plants have been examined in some details, but our understanding of the molecular mechanisms underlying these processes is very limited. In this study, we first used the cDNA-AFLP to investigate the gene expression patterns in Citrus grandis roots responsive to B and Al interactions, and isolated 100 differentially expressed genes. Results showed that genes related to detoxification of reactive oxygen species (ROS) and aldehydes (i.e., glutathione S-transferase zeta class-like isoform X1, thioredoxin M-type 4, and 2-alkenal reductase (NADP(+)-dependent)-like), metabolism (i.e., carboxylesterases and lecithin- cholesterol acyltransferase-like 4-like, nicotianamine aminotransferase A-like isoform X3, thiosulfate sulfurtransferase 18-like isoform X1, and FNR, root isozyme 2), cell transport (i.e., non-specific lipid-transfer protein-like protein At2g13820-like and major facilitator superfamily protein), Ca signal and hormone (i.e., calcium-binding protein CML19-like and IAA-amino acid hydrolase ILR1-like 4-like), gene regulation (i.e., Gag-pol polyprotein) and cell wall modification (i.e., glycosyl hydrolase family 10 protein) might play a role in B-induced alleviation of Al-toxicity. Our results are useful not only for our understanding of molecular processes associated with B-induced alleviation of Al-toxicity, but also for obtaining key molecular genes to enhance Al-tolerance of plants in the future.	[Zhou, Xin-Xing; Yang, Lin-Tong; Guo, Peng; Chen, Li-Song] Fujian Agr & Forestry Univ, Coll Resource & Environm Sci, Fuzhou 350002, Peoples R China; [Zhou, Xin-Xing; Yang, Lin-Tong; Guo, Peng; Chen, Li-Song] Fujian Agr & Forestry Univ, Inst Hort Plant Physiol Biochem & Mol Biol, Fuzhou 350002, Peoples R China; [Qi, Yi-Ping] Fujian Acad Med Sci, Inst Mat Med, Fuzhou 350001, Peoples R China; [Chen, Li-Song] Fujian Agr & Forestry Univ, Higher Educ Key Lab Fujian Prov Soil Ecosyst Hlth, Fuzhou 350002, Peoples R China; [Chen, Li-Song] Fujian Agr & Forestry Univ, Fujian Key Lab Plant Mol & Cell Biol, Fuzhou 350002, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Chen, LS (corresponding author), Fujian Agr & Forestry Univ, Coll Resource & Environm Sci, Fuzhou 350002, Peoples R China.	lisongchen2002@hotmail.com	Yang, Lintong/HHD-2975-2022; Chen, Li-Song/W-3896-2017	Chen, Li-Song/0000-0001-8425-1306	China Agriculture Research System; National Natural Science Foundation of China [30771487]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the earmarked fund for China Agriculture Research System and the National Natural Science Foundation of China (No. 30771487).	Achary VMM, 2008, ECOTOX ENVIRON SAFE, V70, P300, DOI 10.1016/j.ecoenv.2007.10.022; Agami RA, 2013, ECOTOX ENVIRON SAFE, V94, P164, DOI 10.1016/j.ecoenv.2013.04.013; Arazi T, 2000, BIOCHEM SOC T, V28, P471, DOI 10.1042/0300-5127:0280471; Banas A, 2005, J BIOL CHEM, V280, P34626, DOI 10.1074/jbc.M504459200; Beato VM, 2011, PLANT PHYSIOL BIOCH, V49, P1350, DOI 10.1016/j.plaphy.2011.06.001; Blevins DG, 1998, ANNU REV PLANT PHYS, V49, P481, DOI 10.1146/annurev.arplant.49.1.481; Boavida LC, 2013, PLANT PHYSIOL, V163, P696, DOI 10.1104/pp.113.216598; Bouvier-Nave P, 2010, PLANT PHYSIOL, V152, P107, DOI 10.1104/pp.109.145672; Camacho-Cristobal JJ, 2008, ENVIRON EXP BOT, V63, P351, DOI 10.1016/j.envexpbot.2007.12.004; Camacho-Cristobal JJ, 2011, PLANT SCI, V181, P85, DOI 10.1016/j.plantsci.2011.05.001; Campanella JJ, 2003, COMP FUNCT GENOM, V4, P584, DOI 10.1002/cfg.340; Chandran D, 2008, PLANTA, V228, P151, DOI 10.1007/s00425-008-0726-0; Chen LiSong, 2012, African Journal of Biotechnology, V11, P5961; Chen LS, 2005, ANN BOT-LONDON, V96, P35, DOI 10.1093/aob/mci145; Chen YA, 2012, PLANT PHYSIOL BIOCH, V55, P23, DOI 10.1016/j.plaphy.2012.03.008; Corrales I, 2008, J PLANT PHYSIOL, V165, P504, DOI 10.1016/j.jplph.2007.03.014; DalCorso G, 2013, METALLOMICS, V5, P1117, DOI 10.1039/c3mt00038a; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Duressa D., 2011, AM J MOL BIOL, V1, P156, DOI [10.4236/ajmb.2011.13016, DOI 10.4236/AJMB.2011.13016]; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Fan F, 2011, ACTA PHYSIOL PLANT, V33, P539, DOI 10.1007/s11738-010-0577-8; Fan W, 2014, PLANT CELL ENVIRON, V37, P1586, DOI 10.1111/pce.12258; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; Gaume A, 2001, PLANT SOIL, V234, P73, DOI 10.1023/A:1010535132296; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Grisel N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-185; Guo B, 2008, NEW PHYTOL, V177, P889, DOI 10.1111/j.1469-8137.2007.02331.x; Gusmaroli G, 2004, PLANT CELL, V16, P2984, DOI 10.1105/tpc.104.025999; Han S, 2008, J PLANT PHYSIOL, V165, P1331, DOI 10.1016/j.jplph.2007.11.002; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Heidarabadi MD, 2011, PLANT PHYSIOL BIOCH, V49, P1377, DOI 10.1016/j.plaphy.2011.09.008; Horst WJ, 2010, ANN BOT-LONDON, V106, P185, DOI 10.1093/aob/mcq053; Hossain AKMZ, 2004, SOIL SCI PLANT NUTR, V50, P189, DOI 10.1080/00380768.2004.10409271; Houde M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-400; HSU PA HO, 1963, SOIL SCI, V96, P230, DOI 10.1097/00010694-196310000-00002; Huang BB, 2008, MOL BIOL REP, V35, P601, DOI 10.1007/s11033-007-9130-2; Ileperuma NR, 2007, BIOCHEMISTRY-US, V46, P1851, DOI 10.1021/bi062046w; Jiang HX, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-102; Jonak C, 2004, PLANT PHYSIOL, V136, P3276, DOI 10.1104/pp.104.045724; Kim S, 2005, PLANT CELL PHYSIOL, V46, P1809, DOI 10.1093/pcp/pci196; Kobayashi K, 2003, J VIROL, V77, P8577, DOI 10.1128/JVI.77.15.8577-8583.2003; Kobayashi Y, 2014, MOL PLANT, V7, P311, DOI 10.1093/mp/sst116; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; KOWALENKO CG, 1976, CAN J SOIL SCI, V56, P537, DOI 10.4141/cjss76-068; Kumari M, 2008, MOL GENET GENOMICS, V279, P339, DOI 10.1007/s00438-007-0316-z; Lee MH, 2006, MOL CELLS, V22, P210; Lee S, 2010, PLANT BIOTECHNOL REP, V4, P165, DOI 10.1007/s11816-010-0131-6; Lemaire S, 1999, PLANT PHYSIOL, V120, P773, DOI 10.1104/pp.120.3.773; LeNoble ME, 1996, PLANT CELL ENVIRON, V19, P1132, DOI 10.1111/j.1365-3040.1996.tb00428.x; LeNoble ME, 1996, PLANT CELL ENVIRON, V19, P1143, DOI 10.1111/j.1365-3040.1996.tb00429.x; Li J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084556; Liu Q, 2008, BIOL PLANTARUM, V52, P87, DOI 10.1007/s10535-008-0014-7; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Lukaszewski KM, 1996, PLANT PHYSIOL, V112, P1; Mano J, 2005, PLANT PHYSIOL, V139, P1773, DOI 10.1104/pp.105.070391; Mao Chuan-zao, 2004, J Zhejiang Univ Sci, V5, P634, DOI 10.1631/jzus.2004.0634; Marchal C, 2014, MOL PLANT, V7, P30, DOI 10.1093/mp/sst162; Maron LG, 2008, NEW PHYTOL, V179, P116, DOI 10.1111/j.1469-8137.2008.02440.x; Martins N, 2013, BIOMETALS, V26, P427, DOI 10.1007/s10534-013-9625-3; McKinnie SMK, 2014, BIOORGAN MED CHEM, V22, P523, DOI 10.1016/j.bmc.2013.10.055; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mishra AK, 2012, GENOMICS, V100, P252, DOI 10.1016/j.ygeno.2012.06.012; Navascues J, 2012, NEW PHYTOL, V193, P625, DOI 10.1111/j.1469-8137.2011.03978.x; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Oh MW, 2014, MOL BIOL REP, V41, P671, DOI 10.1007/s11033-013-2905-8; Ohno H, 2006, J BIOCHEM, V139, P941, DOI 10.1093/jb/mvj119; Okekeogbu I, 2014, PROTEOMES, V2, DOI 10.3390/proteomes2020169; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Papenbrock J, 2011, AMINO ACIDS, V41, P43, DOI 10.1007/s00726-010-0478-6; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Remy E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00201; Rentsch D, 1995, J BIOL CHEM, V270, P30525, DOI 10.1074/jbc.270.51.30525; Rezaee F, 2013, S AFR J BOT, V84, P13, DOI 10.1016/j.sajb.2012.09.006; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Ruiz JM, 2006, PLANT SOIL, V279, P25, DOI 10.1007/s11104-005-7931-4; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; SCHAEDLE M, 1989, TREE PHYSIOL, V5, P337, DOI 10.1093/treephys/5.3.337; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; Shen GX, 2010, PLANT CELL, V22, P811, DOI 10.1105/tpc.109.065979; Shen H, 2004, J EXP BOT, V55, P663, DOI 10.1093/jxb/erh058; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Shim D, 2009, PLANT CELL, V21, P4031, DOI 10.1105/tpc.109.066902; Shu S, 2006, P NATL ACAD SCI USA, V103, P19788, DOI 10.1073/pnas.0609385103; Stass A, 2005, PLANT NUTR FOOD SECU, P692; Stass A, 2007, PHYSIOL PLANTARUM, V131, P283, DOI 10.1111/j.1399-3054.2007.00957.x; Su N, 2012, PLANT PHYSIOL, V159, P227, DOI 10.1104/pp.112.195081; Tabaldi LA, 2009, CHEMOSPHERE, V76, P1402, DOI 10.1016/j.chemosphere.2009.06.011; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Tang N, 2011, BIOL PLANTARUM, V55, P681, DOI 10.1007/s10535-011-0168-6; Tolra R, 2009, J INORG BIOCHEM, V103, P1486, DOI 10.1016/j.jinorgbio.2009.06.013; Tsutsui T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048197; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; von Arnim AG, 2003, CURR OPIN PLANT BIOL, V6, P520, DOI 10.1016/j.pbi.2003.09.006; Wang ZQ, 2014, J PROTEOMICS, V98, P189, DOI 10.1016/j.jprot.2013.12.023; Wojcik P, 2003, J PLANT NUTR, V26, P2439, DOI 10.1081/PLN-120025471; Xiong Y, 2007, PLANT PHYSIOL, V143, P291, DOI 10.1104/pp.106.092106; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xu FJ, 2012, BIOL PLANTARUM, V56, P89, DOI 10.1007/s10535-012-0021-6; Yamaguchi Y, 1999, SOIL SCI PLANT NUTR, V45, P647, DOI 10.1080/00380768.1999.10415828; Yamamoto Y, 2003, PLANT SOIL, V255, P239, DOI 10.1023/A:1026127803156; Yang LT, 2012, MOL BIOL REP, V39, P6353, DOI 10.1007/s11033-012-1457-7; Yang LT, 2011, PLANT SCI, V180, P521, DOI 10.1016/j.plantsci.2010.11.011; Yang Y, 2011, PLANT SOIL, V346, P215, DOI 10.1007/s11104-011-0811-1; Yang YH, 2004, WATER AIR SOIL POLL, V154, P239, DOI 10.1023/B:WATE.0000022969.30022.6e; Yin LN, 2010, PLANT PHYSIOL, V152, P1406, DOI 10.1104/pp.109.151449; Yu M, 2009, PLANT SOIL, V314, P87, DOI 10.1007/s11104-008-9708-z; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zhan J, 2013, PLANT SCI, V210, P108, DOI 10.1016/j.plantsci.2013.05.012; Zhang CJ, 2011, PLANT PHYSIOL, V157, P1884, DOI 10.1104/pp.111.182808; Zhao XF, 2012, PLANT OMICS, V5, P604; Zhen Y, 2007, PHYSIOL PLANTARUM, V131, P542, DOI 10.1111/j.1399-3054.2007.00979.x; Zhou CP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-621; Zhou P, 2014, ENVIRON EXP BOT, V104, P1, DOI 10.1016/j.envexpbot.2014.02.018	120	63	64	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0115485	10.1371/journal.pone.0115485	http://dx.doi.org/10.1371/journal.pone.0115485			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747450	gold, Green Submitted, Green Published			2022-12-27	WOS:000350689400001
J	Steindor, M; Nkwouano, V; Mayatepek, E; Mackenzie, CR; Schramm, D; Jacobsen, M				Steindor, Mathis; Nkwouano, Vanesa; Mayatepek, Ertan; Mackenzie, Colin R.; Schramm, Dirk; Jacobsen, Marc			Rapid Detection and Immune Characterization of Mycobacterium abscessus Infection in Cystic Fibrosis Patients	PLOS ONE			English	Article							CHELONAE SUBSP-ABSCESSUS; T-CELL RESPONSES; TUBERCULIN; SENSITIVITY; AVIUM	Cystic fibrosis patients are highly susceptible to infections with non-tuberculous mycobacteria. Especially Mycobacterium abscessus infections are common but reliable diagnosis is hampered by non-specific clinical symptoms and insensitive mycobacterial culture. In the present study we established novel methods for rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients. We performed Mycobacterium abscessus specific DNA-strip-and quantitative PCR-based analyses of non-cultured sputum samples to detect and characterize Mycobacterium abscessus infections. Concomitantly in vitro T-cell reactivation with purified protein derivatives (PPDs) from different mycobacterial species was used to determine Mycobacterium abscessus specific T-cell cytokine expression of infected cystic fibrosis patients. Four of 35 cystic fibrosis patients (11.4%) were Mycobacterium abscessus culture positive and showed concordant DNA-strip-test results. Quantitative PCR revealed marked differences of mycobacterial burden between cystic fibrosis patients and during disease course. Tandem-repeat analysis classified distinct Mycobacterium abscessus strains of infected cystic fibrosis patients and excluded patient-to-patient transmission. Mycobacterium abscessus specific T-cells were detected in the blood of cystic fibrosis patients with confirmed chronic infection and a sub-group of patients without evidence of Mycobacterium abscessus infection. Comparison of cytokine expression and phenotypic markers revealed increased proportions of CD40L positive T-cells that lack Interleukin-2 expression as a marker for chronic Mycobacterium abscessus infections in cystic fibrosis patients. Direct sputum examination enabled rapid diagnosis and quantification of Mycobacterium abscessus in cystic fibrosis patients. T-cell in vitro reactivation and cytokine expression analyses may contribute to diagnosis of chronic Mycobacterium abscessus infection.	[Steindor, Mathis; Nkwouano, Vanesa; Mayatepek, Ertan; Schramm, Dirk; Jacobsen, Marc] Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany; [Mackenzie, Colin R.] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Mackenzie, Colin R.] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Jacobsen, M (corresponding author), Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat Neonatol & Pediat Cardiol, D-40225 Dusseldorf, Germany.	marc.jacobsen@med.uni-duesseldorf.de	MacKenzie, Colin R/E-9368-2011	MacKenzie, Colin R/0000-0001-7732-2698; Jacobsen, Marc/0000-0002-4703-5652	Jurgen Manchot Foundation	Jurgen Manchot Foundation	This study was supported by the Jurgen Manchot Foundation 'Molecules of Infection II' project to V. Nkwouano and M. Jacobsen. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bange FC, 1999, J CLIN MICROBIOL, V37, P3761, DOI 10.1128/JCM.37.11.3761-3763.1999; Blauwendraat C, 2012, EUR J CLIN MICROBIOL, V31, P1847, DOI 10.1007/s10096-011-1510-9; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Catherinot E, 2013, J CYST FIBROS, V12, P74, DOI 10.1016/j.jcf.2012.06.009; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Vrankrijker AMM, 2010, PAEDIATR RESPIR REV, V11, P246, DOI 10.1016/j.prrv.2010.07.003; Feske M, 2008, CLIN VACCINE IMMUNOL, V15, P1616, DOI 10.1128/CVI.00185-08; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; HANSEN KN, 1989, DAN MED BULL, V36, P399; Hartl D, 2006, J ALLERGY CLIN IMMUN, V117, P204, DOI 10.1016/j.jaci.2005.09.023; Hill Uta G, 2012, J R Soc Med, V105 Suppl 2, pS14, DOI 10.1258/jrsm.2012.12s003; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Kang H, 2014, IMMUNOLOGY, V143, P661, DOI 10.1111/imm.12348; KUSUNOKI S, 1992, INT J SYST BACTERIOL, V42, P240, DOI 10.1099/00207713-42-2-240; Magdorf K, 2008, CLIN MICROBIOL INFEC, V14, P1079, DOI 10.1111/j.1469-0691.2008.02084.x; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Radhakrishnan DK, 2009, PEDIATR PULM, V44, P1100, DOI 10.1002/ppul.21106; Ratner D, 2012, AM J RESP CELL MOL, V46, P715, DOI 10.1165/rcmb.2011-0399RT; Rieber N, 2014, INT J BIOCHEM CELL B, V52, P108, DOI 10.1016/j.biocel.2014.01.017; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; Streitz M, 2011, J INFECT DIS, V203, P378, DOI 10.1093/infdis/jiq065; Warren JR, 2000, AM J RESP CRIT CARE, V161, P1559, DOI 10.1164/ajrccm.161.5.9908063; Whittier S, 1997, J CLIN MICROBIOL, V35, P2706, DOI 10.1128/JCM.35.10.2706-2708.1997; Wong YL, 2012, J CLIN MICROBIOL, V50, P3084, DOI 10.1128/JCM.00753-12	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119737	10.1371/journal.pone.0119737	http://dx.doi.org/10.1371/journal.pone.0119737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742660	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100128
J	Kleppa, E; Klinge, KF; Galaphaththi-Arachchige, HN; Holmen, SD; Lillebo, K; Onsrud, M; Gundersen, SG; Taylor, M; Ndhlovu, P; Kjetland, EF				Kleppa, Elisabeth; Klinge, Kari F.; Galaphaththi-Arachchige, Hashini Nilushika; Holmen, Sigve D.; Lillebo, Kristine; Onsrud, Mathias; Gundersen, Svein Gunnar; Taylor, Myra; Ndhlovu, Patricia; Kjetland, Eyrun F.			Schistosoma haematobium Infection and CD4+T-Cell Levels: A Cross-Sectional Study of Young South African Women	PLOS ONE			English	Article							RURAL ZIMBABWEAN WOMEN; HIV-1 INFECTION; GENITAL SCHISTOSOMIASIS; HELMINTH INFECTION; IMMUNE ACTIVATION; COINFECTION; PROGRESSION; EXCRETION; COUNTS; CD4	Schistosoma (S.) haematobiumcauses urogenital schistosomiasis and has been hypothesized to adversely impact HIV transmission and progression. On the other hand it has been hypothesized that HIV could influence the manifestations of schistosomiasis. In this cross-sectional study, we explored the association between urogenital S. haematobium infection and CD4 cell counts in 792 female high-school students from randomly selected schools in rural KwaZulu-Natal, South Africa. We also investigated the association between low CD4 cell counts in HIV positive women and the number of excreted schistosome eggs in urine. Sixteen percent were HIV positive and 31% had signs of urogenital schistosomiasis (as determined by genital sandy patches and / or abnormal blood vessels on ectocervix / vagina by colposcopy or presence of eggs in urine). After stratifying for HIV status, participants with and without urogenital schistosomiasis had similar CD4 cell counts. Furthermore, there was no significant difference in prevalence of urogenital schistosomiasis in HIV positive women with low and high CD4 cell counts. There was no significant difference in the number of eggs excreted in urine when comparing HIV positive and HIV negative women. Our findings indicate that urogenital schistosomiasis do not influence the number of circulating CD4 cells.	[Kleppa, Elisabeth; Klinge, Kari F.; Galaphaththi-Arachchige, Hashini Nilushika; Holmen, Sigve D.; Lillebo, Kristine; Kjetland, Eyrun F.] Oslo Univ Hosp, Dept Infect Dis, Norwegian Ctr Imported & Trop Dis, Oslo, Norway; [Kleppa, Elisabeth; Holmen, Sigve D.; Lillebo, Kristine] Univ Oslo, Fac Med, Oslo, Norway; [Onsrud, Mathias] Oslo Univ Hosp, Dept Gynaecol, Oslo, Norway; [Gundersen, Svein Gunnar] Sorlandet Hosp, Res Unit, Kristiansand, Norway; [Gundersen, Svein Gunnar] Univ Agder, Dept Global Dev & Planning, Kristiansand, Norway; [Taylor, Myra; Kjetland, Eyrun F.] Univ KwaZulu Natal, Coll Hlth Sci, Nelson R Mandela Sch Med, Discipline Publ Hlth Med, Durban, South Africa; [Ndhlovu, Patricia] Univ London Imperial Coll Sci Technol & Med, London, England	University of Oslo; University of Oslo; University of Oslo; University of Agder; University of Kwazulu Natal; Imperial College London	Kleppa, E (corresponding author), Oslo Univ Hosp, Dept Infect Dis, Norwegian Ctr Imported & Trop Dis, Oslo, Norway.	elisabeth.kleppa@medisin.uio.no		Kjetland, Eyrun Floerecke/0000-0002-5552-1095	South-Eastern Norway Regional Health Authority; Research Council of Norway; European Research Council under the European Union's Seventh Framework Programme (FP7) /ERC Grant [PIRSES-GA-2010-269245]	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); European Research Council under the European Union's Seventh Framework Programme (FP7) /ERC Grant(European Research Council (ERC))	The research project was funded by grants from the South-Eastern Norway Regional Health Authority, The Research Council of Norway and European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) /ERC Grant agreement no. PIRSES-GA-2010-269245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; [Anonymous], 2011, 2011 NATL ANTENATAL; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Borkow G, 2004, CLIN MICROBIOL REV, V17, P1012, DOI 10.1128/CMR.17.4.1012-1030.2004; BRAUNMUNZINGER RA, 1992, TROP MED PARASITOL, V43, P149; Brown M, 2005, J INFECT DIS, V191, P1648, DOI 10.1086/429668; Brown M, 2004, J INFECT DIS, V190, P1869, DOI 10.1086/425042; Colley DG, LANCET; DOEHRING E, 1985, KIDNEY INT, V27, P667, DOI 10.1038/ki.1985.62; Downs JA, 2011, AM J TROP MED HYG, V84, P364, DOI 10.4269/ajtmh.2011.10-0585; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hegertun IEA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002104; Jourdan PM, 2011, AM J TROP MED HYG, V85, P1060, DOI 10.4269/ajtmh.2011.11-0135; Kalinkovich A, 1998, CLIN EXP IMMUNOL, V114, P414; Kallestrup P, 2006, CLIN INFECT DIS, V42, P1781, DOI 10.1086/504380; Kallestrup P, 2005, J INFECT DIS, V192, P1956, DOI 10.1086/497696; Kallestrup P, 2005, J INFECT DIS, V191, P1311, DOI 10.1086/428907; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; Karim QA, 2014, SEX TRANSM INFECT, V90, P620, DOI 10.1136/sextrans-2014-051548; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Kjetland EF, 2005, AM J TROP MED HYG, V72, P311, DOI 10.4269/ajtmh.2005.72.311; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Kleppa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098593; Lawn SD, 2004, J INFECTION, V48, P1, DOI 10.1016/j.jinf.2003.09.001; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mwanakasale V, 2003, AM J TROP MED HYG, V69, P420, DOI 10.4269/ajtmh.2003.69.420; Nausch N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00472; Ndeffo Mbah ML, 2013, TROP MED INT HLTH; [Republic of South Africa Department of Health], 2008, STAND TREATM GUID ES; Sangare LR, 2011, PARASITOLOGY, V138, P1546, DOI 10.1017/S0031182011000357; Secor WE, 2007, CURR OPIN INFECT DIS, V20, P519, DOI 10.1097/QCO.0b013e3282e9ac03; Secor WE, 2012, CURR OPIN HIV AIDS, V7, P254, DOI 10.1097/COH.0b013e328351b9e3; van Lieshout L, 2000, ACTA TROP, V77, P69, DOI 10.1016/S0001-706X(00)00115-7; Walson JL, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub2; Walson JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub3; Weintrob AC, 2010, INT J STD AIDS, V21, P57, DOI 10.1258/ijsa.2009.009164; Wolday D, 2002, JAIDS-J ACQ IMM DEF, V31, P56, DOI 10.1097/00126334-200209010-00008	37	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119326	10.1371/journal.pone.0119326	http://dx.doi.org/10.1371/journal.pone.0119326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768005	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000351277500077
J	Munjal, N; Jawed, K; Wajid, S; Yazdani, SS				Munjal, Neha; Jawed, Kamran; Wajid, Saima; Yazdani, Syed Shams			A Constitutive Expression System for Cellulase Secretion in Escherichia coli and Its Use in Bioethanol Production	PLOS ONE			English	Article							FERMENTATIVE LACTATE-DEHYDROGENASE; HETEROLOGOUS PROTEIN EXPRESSION; BETA-GLUCOSIDASE; OXYGEN AVAILABILITY; CELL-SURFACE; CELLOBIOSE; GENE; STRATEGIES; PATHWAYS; BIOMASS	The production of biofuels from lignocellulosic biomass appears to be attractive and viable due to the abundance and availability of this biomass. The hydrolysis of this biomass, however, is challenging because of the complex lignocellulosic structure. The ability to produce hydrolytic cellulase enzymes in a cost-effective manner will certainly accelerate the process of making lignocellulosic ethanol production a commercial reality. These cellulases may need to be produced aerobically to generate large amounts of protein in a short time or anaerobically to produce biofuels from cellulose via consolidated bioprocessing. Therefore, it is important to identify a promoter that can constitutively drive the expression of cellulases under both aerobic and anaerobic conditions without the need for an inducer. Using lacZ as reporter gene, we analyzed the strength of the promoters of four genes, namely lacZ, gapA, ldhA and pflB, and found that the gapA promoter yielded the maximum expression of the beta-galactosidase enzyme under both aerobic and anaerobic conditions. We further cloned the genes for two cellulolytic enzymes, beta-1,4-endoglucanase and beta-1,4-glucosidase, under the control of the gapA promoter, and we expressed these genes in Escherichia coli, which secreted the products into the extracellular medium. An ethanologenic E. colistrain transformed with the secretory beta-glucosidase gene construct fermented cellobiose in both defined and complex medium. This recombinant strain also fermented wheat straw hydrolysate containing glucose, xylose and cellobiose into ethanol with an 85% efficiency of biotransformation. An ethanologenic strain that constitutively secretes a cellulolytic enzyme is a promising platform for producing lignocellulosic ethanol.	[Munjal, Neha; Jawed, Kamran; Yazdani, Syed Shams] Int Ctr Genet Engn & Biotechnol, Synthet Biol & Biofuels Grp, New Delhi, India; [Yazdani, Syed Shams] Int Ctr Genet Engn & Biotechnol, DBT ICGEB Ctr Adv Bioenergy Res, New Delhi, India; [Wajid, Saima] Jamia Hamdard, Ctr Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; DBT-ICGEB Centre for Advanced Bioenergy Research, New Delhi; Jamia Hamdard University	Yazdani, SS (corresponding author), Int Ctr Genet Engn & Biotechnol, Synthet Biol & Biofuels Grp, Aruna Asaf Ali Marg, New Delhi, India.	shams@icgeb.res.in			Department of Biotechnology, Govt. of India, through Bioenergy Centre [BT/PB/Center/03/2011]	Department of Biotechnology, Govt. of India, through Bioenergy Centre	This work was supported by Department of Biotechnology, Govt. of India, through Bioenergy Centre Grant no. BT/PB/Center/03/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha N, 2012, APPL ENVIRON MICROB, V78, P7447, DOI 10.1128/AEM.01386-12; Adlakha N, 2011, APPL ENVIRON MICROB, V77, P4859, DOI 10.1128/AEM.02808-10; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Belien T, 2006, MOL PLANT MICROBE IN, V19, P1072, DOI 10.1094/MPMI-19-1072; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; Claassen PAM, 1999, APPL MICROBIOL BIOT, V52, P741, DOI 10.1007/s002530051586; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Cripps RE, 2009, METAB ENG, V11, P398, DOI 10.1016/j.ymben.2009.08.005; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Gupta S, 2013, PROTEIN EXPRES PURIF, V88, P20, DOI 10.1016/j.pep.2012.11.006; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Hoyer K, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-14; Ingram LO, 1999, BIOTECHNOL PROGR, V15, P855, DOI 10.1021/bp9901062; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Jiang GRJ, 2001, MICROBIOL-SGM, V147, P2437, DOI 10.1099/00221287-147-9-2437; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; la Grange DC, 2010, APPL MICROBIOL BIOT, V87, P1195, DOI 10.1007/s00253-010-2660-x; Lai XK, 1997, APPL ENVIRON MICROB, V63, P355, DOI 10.1128/AEM.63.2.355-363.1997; Liu L, 2013, BIOENGINEERED, V4, P212, DOI 10.4161/bioe.24761; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Maki M, 2009, INT J BIOL SCI, V5, P500; Margeot A, 2009, CURR OPIN BIOTECH, V20, P372, DOI 10.1016/j.copbio.2009.05.009; Moniruzzaman M, 1997, APPL ENVIRON MICROB, V63, P4633, DOI 10.1128/AEM.63.12.4633-4637.1997; Munjal N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-145; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Saha BC, 1996, APPL ENVIRON MICROB, V62, P3165, DOI 10.1128/AEM.62.9.3165-3170.1996; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; SAWERS G, 1988, J BACTERIOL, V170, P5330, DOI 10.1128/jb.170.11.5330-5336.1988; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; Shin HD, 2014, METAB ENG, V24, P9, DOI 10.1016/j.ymben.2014.04.002; Soma Y, 2012, J BIOSCI BIOENG, V114, P80, DOI 10.1016/j.jbiosc.2012.02.019; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Tabor S., 1990, CURR PROTOC MOL BIOL; Tanaka T, 2011, APPL ENVIRON MICROB, V77, P6265, DOI 10.1128/AEM.00459-11; Tegel H, 2011, FEBS J, V278, P729, DOI 10.1111/j.1742-4658.2010.07991.x; Thouvenot B, 2004, BIOCHEM J, V383, P371, DOI 10.1042/BJ20040792; Zerbs S, 2009, METHOD ENZYMOL, V463, P149, DOI 10.1016/S0076-6879(09)63012-3; Zhou S, 2008, BIOTECHNOL LETT, V30, P335, DOI 10.1007/s10529-007-9544-x	45	16	18	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119917	10.1371/journal.pone.0119917	http://dx.doi.org/10.1371/journal.pone.0119917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768292	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500103
J	Singla, DK; Singla, RD; Abdelli, LS; Glass, C				Singla, Dinender K.; Singla, Reetu D.; Abdelli, Latifa S.; Glass, Carley			Fibroblast Growth Factor-9 Enhances M2 Macrophage Differentiation and Attenuates Adverse Cardiac Remodeling in the Infarcted Diabetic Heart	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; INFLAMMATORY MEDIATORS; FGF9; MONOCYTES; PATHOPHYSIOLOGY; INTERLEUKIN-6; APOPTOSIS; AFFINITY; ALPHA	Inflammation has been implicated as a perpetrator of diabetes and its associated complications. Monocytes, key mediators of inflammation, differentiate into pro-inflammatory M1 macrophages and anti-inflammatory M2 macrophages upon infiltration of damaged tissue. However, the inflammatory cell types, which propagate diabetes progression and consequential adverse disorders, remain unclear. The current study was undertaken to assess monocyte infiltration and the role of fibroblast growth factor-9 (FGF-9) on monocyte to macrophage differentiation and cardioprotection in the diabetic infarcted heart. Db/db diabetic mice were assigned to sham, myocardial infarction (MI), and MI+FGF-9 groups. MI was induced by permanent coronary artery ligation and animals were subjected to 2D transthoracic echocardiography two weeks post-surgery. Immunohistochemical and immunoassay results from heart samples collected suggest significantly increased infiltration of monocytes (Mean +/- SEM; MI: 2.02% +/- 0.23% vs. Sham 0.75% +/- 0.07%; p<0.05) and associated pro-inflammatory cytokines (TNF-alpha, MCP-1, and IL-6), adverse cardiac remodeling (Mean +/- SEM; MI: 33% +/- 3.04% vs. Sham 2.2% +/- 0.33%; p<0.05), and left ventricular dysfunction (Mean +/- SEM; MI: 35.4% +/- 1.25% vs. Sham 49.19% +/- 1.07%; p<0.05) in the MI group. Importantly, treatment of diabetic infarcted myocardium with FGF-9 resulted in significantly decreased monocyte infiltration (Mean +/- SEM; MI+FGF-9: 1.39% +/- 0.1% vs. MI: 2.02% +/- 0.23%; p<0.05), increased M2 macrophage differentiation (Mean +/- SEM; MI+FGF-9: 4.82% +/- 0.86% vs. MI: 0.85% +/- 0.3%; p<0.05) and associated anti-inflammatory cytokines (IL-10 and IL-1RA), reduced adverse remodeling (Mean +/- SEM; MI+FGF-9: 11.59% +/- 1.2% vs. MI: 33% +/- 3.04%; p<0.05), and improved cardiac function (Fractional shortening, Mean +/- SEM; MI+FGF-9: 41.51% +/- 1.68% vs. MI: 35.4% +/- 1.25%; p<0.05). In conclusion, our data suggest FGF-9 possesses novel therapeutic potential in its ability to mediate monocyte to M2 differentiation and confer cardiac protection in the post-MI diabetic heart.	[Singla, Dinender K.; Singla, Reetu D.; Abdelli, Latifa S.; Glass, Carley] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA.	dsingla@ucf.edu		Glass, Carley/0000-0001-9875-1125	national institute of health [RO1 HL090646, R01HL117241]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117241, R01HL090646] Funding Source: NIH RePORTER	national institute of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This paper is supported in part by the grants from national institute of health grants; RO1 HL090646, and R01HL117241 to Dr. Singla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no additional funding sources for this study.	Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Glass C, 2012, CELL TRANSPLANT, V21, P1931, DOI 10.3727/096368911X627561; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; HECHT D, 1995, GROWTH FACTORS, V12, P223, DOI 10.3109/08977199509036882; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Korf-Klingebiel M, 2011, CIRCULATION, V123, P504, DOI 10.1161/CIRCULATIONAHA.110.989665; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Kumar D, 2003, J LAB CLIN MED, V142, P288, DOI 10.1016/S0022-2143(03)00148-3; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Leavy O, 2011, NAT REV IMMUNOL, V11, P715, DOI 10.1038/nri3096; Li SL, 2006, DIABETES, V55, P2611, DOI 10.2337/db06-0164; Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Meng L, 2010, AM J PHYSIOL-HEART C, V298, pH736, DOI 10.1152/ajpheart.00935.2009; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6; Pirvola U, 2004, DEV BIOL, V273, P350, DOI 10.1016/j.ydbio.2004.06.010; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; Van Dam PS, 2013, EUR J PHARMACOL, V719, P180, DOI 10.1016/j.ejphar.2013.07.017; van der Laan AM, 2012, HEART, V98, P1384, DOI 10.1136/heartjnl-2012-301623	36	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120739	10.1371/journal.pone.0120739	http://dx.doi.org/10.1371/journal.pone.0120739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768089	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500134
J	Qiao, JJ; Yu, J; Yu, Z; Li, N; Song, C; Li, M				Qiao, Jing-Jing; Yu, Jing; Yu, Zhe; Li, Na; Song, Chen; Li, Man			Contrast-Enhanced Ultrasonography in Differential Diagnosis of Benign and Malignant Ovarian Tumors	PLOS ONE			English	Article							TRANSVAGINAL SONOGRAPHY; CANCER; ULTRASOUND; METAANALYSIS; MASSES; CHEMOTHERAPY; PARAMETERS; SURVIVAL; DISEASE; IMPACT	Objective To evaluate the accuracy of contrast-enhanced ultrasonography (CEUS) in differential diagnosis of benign and malignant ovarian tumors. Methods The scientific literature databases PubMed, Cochrane Library and CNKI were comprehensively searched for studies relevant to the use of CEUS technique for differential diagnosis of benign and malignant ovarian cancer. Pooled summary statistics for specificity (Spe), sensitivity (Sen), positive and negative likelihood ratios (LR+/LR-), and diagnostic odds ratio (DOR) and their 95%CIs were calculated. Software for statistical analysis included STATA version 12.0 (Stata Corp, College Station, TX, USA) and Meta-Disc version 1.4 (Universidad Complutense, Madrid, Spain). Results Following a stringent selection process, seven high quality clinical trials were found suitable for inclusion in the present meta-analysis. The 7 studies contained a combined total of 375 ovarian cancer patients (198 malignant and 177 benign). Statistical analysis revealed that CEUS was associated with the following performance measures in differential diagnosis of ovarian tumors: pooled Sen was 0.96 (95%CI = 0.92 similar to 0.98); the summary Spe was 0.91 (95%CI = 0.86 similar to 0.94); the pooled LR+ was 10.63 (95%CI = 6.59 similar to 17.17); the pooled LR was 0.04 (95%CI = 0.02 similar to 0.09); and the pooled DOR was 241.04 (95%CI = 92.61 similar to 627.37). The area under the SROC curve was 0.98 (95%CI = 0.20 similar to 1.00). Lastly, publication bias was not detected (t = -0.52, P = 0.626) in the meta-analysis. Conclusions Our results revealed the high clinical value of CEUS in differential diagnosis of benign and malignant ovarian tumors. Further, CEUS may also prove to be useful in differential diagnosis at early stages of this disease.	[Qiao, Jing-Jing; Yu, Jing; Yu, Zhe; Li, Na; Song, Chen; Li, Man] Dalian Med Univ, Dept Oncol 2, Affiliated Hosp 2, Dalian 116027, Peoples R China	Dalian Medical University	Li, M (corresponding author), Dalian Med Univ, Dept Oncol 2, Affiliated Hosp 2, Dalian 116027, Peoples R China.	limanlm_926@163.com			Natural Science Foundation of Liaoning Province [2012010189-401]	Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This study was supported by the Natural Science Foundation of Liaoning Province (No. 2012010189-401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleyguier C, 2009, EUR J RADIOL, V69, P14, DOI 10.1016/j.ejrad.2008.07.037; Banys M, 2009, INT J GYNECOL CANCER, V19, P948, DOI 10.1111/IGC.0b013e3181a23c4c; Bolondi L, 2007, DIGEST LIVER DIS, V39, P187, DOI 10.1016/j.dld.2006.08.008; Dindyal Shiva, 2011, Recent Pat Cardiovasc Drug Discov, V6, P27, DOI 10.2174/157489011794578446; Drescher CW, 2012, CANCER PREV RES, V5, P1015, DOI 10.1158/1940-6207.CAPR-11-0468; Fan T, 2009, GYNECOL ONCOL, V112, P185, DOI 10.1016/j.ygyno.2008.09.021; Fleischer AC, 2008, J ULTRAS MED, V27, P1011, DOI 10.7863/jum.2008.27.7.1011; Fleischer AC, 2009, J ULTRAS MED, V28, P1273, DOI 10.7863/jum.2009.28.10.1273; Gay F, 2012, Diagn Interv Imaging, V93, P37, DOI 10.1016/j.diii.2011.11.007; Gu WR, 2003, CHIN J ULTRASONOGRAP, V12, P21; Hamza TH, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-73; Hassan M, 2011, MED J CHINESE PEOPLE, V23, P2089; Hastings JM, 2012, AM J PRIMATOL, V74, P1088, DOI 10.1002/ajp.22063; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Milne RL, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2797; Mironov S, 2007, RADIOL CLIN N AM, V45, P149, DOI 10.1016/j.rcl.2006.10.012; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Pickles MD, 2009, EUR J RADIOL, V71, P498, DOI 10.1016/j.ejrad.2008.05.007; Quaia E, 2011, EUR RADIOL, V21, P604, DOI 10.1007/s00330-010-1965-6; Rafaelsen SR, 2011, COLORECTAL DIS, V13, P420, DOI 10.1111/j.1463-1318.2010.02288.x; Rubatt JM, 2009, GYNECOL ONCOL, V112, P469, DOI 10.1016/j.ygyno.2008.11.030; Smeenge M, 2011, WORLD J UROL, V29, P581, DOI 10.1007/s00345-011-0747-3; Sorelli PG, 2010, J CLIN ULTRASOUND, V38, P177, DOI 10.1002/jcu.20671; Tang HS, 2009, INT J GYNECOL CANCER, V19, P605, DOI 10.1111/IGC.0b013e3181a389e6; Tsubamoto H, 2014, ANTICANCER RES, V34, P2481; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Wilson SR, 2009, AM J ROENTGENOL, V193, P55, DOI 10.2214/AJR.09.2553; Wu X, 2010, J ULTRAS MED, V29, P609, DOI 10.7863/jum.2010.29.4.609; Yang Fan, 2013, Sichuan Da Xue Xue Bao Yi Xue Ban, V44, P424; Zhang Y, 2013, J CLIN ULTRAOUND MED, V15, P403; Zheng QC, 2011, J CLIN ULTRASOUND ME, V13, P301; Zhou Qi, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2007; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536; 王兴田, 2012, [江苏医药, Jiangsu Medical Journal], V38, P88	35	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118872	10.1371/journal.pone.0118872	http://dx.doi.org/10.1371/journal.pone.0118872			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764442	gold, Green Submitted, Green Published			2022-12-27	WOS:000351276300017
J	Kelly, SE; Spector, TD; Cherkas, LF; Prainsack, B; Harris, JM				Kelly, Susan E.; Spector, Timothy D.; Cherkas, Lynn F.; Prainsack, Barbara; Harris, Juliette M.			Evaluating the Consent Preferences of UK Research Volunteers for Genetic and Clinical Studies	PLOS ONE			English	Article							INFORMED-CONSENT; PUBLIC PERSPECTIVES; INCIDENTAL FINDINGS; BROAD CONSENT; BIOBANK; GOVERNANCE; ATTITUDES; PRIVACY; SCIENCE; ETHICS	Objectives To establish the views of research volunteers on the consent process; to explore their views on the consent process in different research scenarios; to inform debate on emerging models of consent for participation in research. Design, Setting and Participants 2,308 adult volunteers from the TwinsUK Registry (www.twinsuk.ac.uk) completed an online survey about their views on the consent process for use of their DNA and medical information in research. Their views on the re-consenting process in different scenarios were assessed. Results The majority of volunteers preferred to be informed of the identity of the main researcher of a study in which they are participating, which is contrary to current practice. Over 80% were willing to complete the consent process online instead of face to face. On the whole, respondents did not view their DNA differently from their medical information with regard to the consent process. Research participants were more willing to give broad consent to cover future research if their DNA was to be used by the original researcher than by another researcher, even if the disease under investigation varied, in contrast to the traditional 'gold standard' whereby specific consent is required for all new research projects. Discussion In some scenarios, research participants reported that they would be comfortable with not signing a new consent form for future research uses of their data and DNA, and are comfortable with secure, online consent processes rather than traditional face-to-face consent processes. Our findings indicate that the perceived relationship between research participants and researchers plays an important role in shaping preferences regarding the consent process and suggest that this relationship is not captured by traditional consent processes. We argue that the development of new formats of consent should be informed by empirical research on volunteers' perceptions and preferences regarding the consent process.	[Kelly, Susan E.] Univ Exeter, Ctr Study Life Sci Egenis, Exeter, Devon, England; [Spector, Timothy D.; Cherkas, Lynn F.; Prainsack, Barbara; Harris, Juliette M.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Prainsack, Barbara] Kings Coll London, Dept Social Sci Hlth & Med, London, England	University of Exeter; University of London; King's College London; University of London; King's College London	Prainsack, B (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.	barbara.prainsack@kcl.ac.uk	Prainsack, Barbara/AAF-5739-2021	Prainsack, Barbara/0000-0002-6335-1532	Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR) BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) BioResource, Clinical Research Facility and Biomedical Research Centre based at King's College London	Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR) BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) BioResource, Clinical Research Facility and Biomedical Research Centre based at King's College London	TwinsUK: The study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also received support from the National Institute for Health Research (NIHR) BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. Tim Spector is holder of an ERC Advanced Principal Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2011, BIOETHICS, V25, P155, DOI 10.1111/j.1467-8519.2009.01749.x; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; [Anonymous], 2013, PRES COMM STUD BIOET; Braun KL, 2014, BIOPRESERV BIOBANK, V12, P106, DOI 10.1089/bio.2013.0083; Caulfield Timothy, 2003, BMC Med Ethics, V4, pE1; Chadwick R., 2006, J LIFELONG LEARNING, V4, P416; Check Hayden E., 2012, NATURE, DOI [10.1038/nature.2012.10507, DOI 10.1038/NATURE.2012.10507]; Dove ES, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-158; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Hoeyer K, 2005, ARCH INTERN MED, V165, P97, DOI 10.1001/archinte.165.1.97; Hoeyer K, 2003, NEW GENET SOC, V22, P229, DOI 10.1080/1463677032000147199; Hoeyer K, 2004, SCAND J PUBLIC HEALT, V32, P224, DOI 10.1080/14034940310019506; Hoeyer K, 2010, PUBLIC HEALTH GENOM, V13, P345, DOI 10.1159/000262329; Hoeyer Klaus, 2006, Med Health Care Philos, V9, P13, DOI 10.1007/s11019-005-5067-1; Hoeyer K, 2008, BIOTECHNOL GENET ENG, V25, P429, DOI 10.5661/bger-25-429; House of Lords, 2001, HUM GEN DAT CHALL OP; Johnsson L, 2008, PATIENTS REFUSAL CON; Kass NE, 1996, HASTINGS CENT REP, V26, P25, DOI 10.2307/3528467; Kaye J, 2009, REPORT FOR THE WELLC; Kaye J, 2014, EUR J HUM GENET, V22, P1100, DOI 10.1038/ejhg.2013.290; Kotz J., 2012, SCI BUSINESS EXCHANG, V5, DOI [10.1038/scibx.2012.644, DOI 10.1038/SCIBX.2012.644]; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Lunshof JE, 2014, SCIENCE, V343, P373, DOI 10.1126/science.1249382; Manson NC, 2007, RETHINKING INFORMED CONSENT IN BIOETHICS, P1; McGuire AL, 2010, ANNU REV GENOM HUM G, V11, P361, DOI 10.1146/annurev-genom-082509-141711; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Murphy J, 2009, AM J PUBLIC HEALTH, V99, P2128, DOI 10.2105/AJPH.2008.157099; Murphy J, 2008, AM J BIOETHICS, V8, P36, DOI 10.1080/15265160802513093; Murtagh MJ, 2012, PUBLIC HEALTH GENOM, V15, P243, DOI 10.1159/000336673; Platt J, 2014, GENET MED, V16, P11, DOI 10.1038/gim.2013.59; Prainsack B, 2013, MED LAW REV, V21, P71, DOI 10.1093/medlaw/fws040; Rahm AK, 2013, J COMMUN GENET, V4, P445, DOI 10.1007/s12687-013-0146-0; Sheehan M, 2011, PUBLIC HEALTH ETH-UK, V4, P226, DOI 10.1093/phe/phr020; Simon CM, 2011, GENET MED, V13, P821, DOI 10.1097/GIM.0b013e31821d2f88; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; StataCorp, 2007, STAT STAT SOFTW REL; Taylor P, 2008, NATURE, V456, P32, DOI 10.1038/456032a; Tutton R, 2004, TRENDS BIOTECHNOL, V22, P284, DOI 10.1016/j.tibtech.2004.04.007; Viberg J, 2014, EUR J HUM GENET, V22, P437, DOI 10.1038/ejhg.2013.217; Wendler D, 2006, BMJ-BRIT MED J, V332, P544, DOI 10.1136/bmj.332.7540.544; Whitley EA, 2012, PUBLIC HEALTH GENOM, V15, P232, DOI 10.1159/000336544; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x	43	56	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118027	10.1371/journal.pone.0118027	http://dx.doi.org/10.1371/journal.pone.0118027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25761107	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000016
J	Andronic, J; Shirakashi, R; Pickel, SU; Westerling, KM; Klein, T; Holm, T; Sauer, M; Sukhorukov, VL				Andronic, Joseph; Shirakashi, Ryo; Pickel, Simone U.; Westerling, Katherine M.; Klein, Teresa; Holm, Thorge; Sauer, Markus; Sukhorukov, Vladimir L.			Hypotonic Activation of the Myo-Inositol Transporter SLC5A3 in HEK293 Cells Probed by Cell Volumetry, Confocal and Super-Resolution Microscopy	PLOS ONE			English	Article							NA+/MYO-INOSITOL COTRANSPORTER; DOMAIN POTASSIUM CHANNELS; ORGANIC OSMOLYTE CHANNELS; HUMAN T-LYMPHOCYTES; INTRACELLULAR DELIVERY; NUCLEAR-LOCALIZATION; CULTURED ASTROCYTES; FLUORESCENT-PROBES; MECHANISMS; PERMEABILITY	Swelling-activated pathways for myo-inositol, one of the most abundant organic osmolytes in mammalian cells, have not yet been identified. The present study explores the SLC5A3 protein as a possible transporter of myo-inositol in hyponically swollen HEK293 cells. To address this issue, we examined the relationship between the hypotonicity-induced changes in plasma membrane permeability to myo-inositol P-ino [m/s] and expression/localization of SLC5A3. P-ino values were determined by cell volumetry over a wide tonicity range (100-275 mOsm) in myo-inositol-substituted solutions. While being negligible under mild hypotonicity (200-275 mOsm), P-ino grew rapidly at osmolalities below 200 mOsm to reach a maximum of similar to 3 nm/s at 100-125 mOsm, as indicated by fast cell swelling due to myo-inositol influx. The increase in P-ino resulted most likely from the hypotonicity-mediated incorporation of cytosolic SLC5A3 into the plasma membrane, as revealed by confocal fluorescence microscopy of cells expressing EGFP-tagged SLC5A3 and super-resolution imaging of immunostained SLC5A3 by direct stochastic optical reconstruction microscopy (dSTORM). dSTORM in hypotonic cells revealed a surface density of membrane-associated SLC5A3 proteins of 200-2000 localizations/mu m(2). Assuming SLC5A3 to be the major path for myoinositol, a turnover rate of 80-800 myo-inositol molecules per second for a single transporter protein was estimated from combined volumetric and dSTORM data. Hypotonic stress also caused a significant upregulation of SLC5A3 gene expression as detected by semi-quantitative RT-PCR and Western blot analysis. In summary, our data provide first evidence for swelling-mediated activation of SLC5A3 thus suggesting a functional role of this transporter in hypotonic volume regulation of mammalian cells.	[Andronic, Joseph; Pickel, Simone U.; Westerling, Katherine M.; Klein, Teresa; Holm, Thorge; Sauer, Markus; Sukhorukov, Vladimir L.] Univ Wurzburg, Biozentrum, Dept Biotechnol & Biophys, Wurzburg, Germany; [Shirakashi, Ryo] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	University of Wurzburg; University of Tokyo	Sukhorukov, VL (corresponding author), Univ Wurzburg, Biozentrum, Dept Biotechnol & Biophys, Hubland, Wurzburg, Germany.	sukhorukov@biozentrum.uni-wuerzburg.de	Sukhorukov, Vladimir L/ACO-0333-2022; Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Klein, Teresa/0000-0002-1155-0361	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronic J, 2013, BBA-BIOMEMBRANES, V1828, P699, DOI 10.1016/j.bbamem.2012.09.028; Bitoun M, 2000, ADV EXP MED BIOL, V483, P239; Bobak N, 2011, BBA-BIOMEMBRANES, V1808, P2036, DOI 10.1016/j.bbamem.2011.04.013; Brody JR, 2004, BIOTECHNIQUES, V36, P214, DOI 10.2144/04362BM02; Chauvin TR, 2004, BIOL REPROD, V70, P744, DOI 10.1095/biolreprod.103.022731; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Djuzenova CS, 2009, MOL MED REP, V2, P633, DOI 10.3892/mmr_00000149; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Fenili D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024032; Fernandez JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057268; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; GRINSTEIN S, 1982, J GEN PHYSIOL, V80, P801, DOI 10.1085/jgp.80.6.801; HAGER K, 1995, J MEMBRANE BIOL, V143, P103; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Isaacks RE, 1999, J NEUROSCI RES, V57, P866, DOI 10.1002/(SICI)1097-4547(19990915)57:6<866::AID-JNR12>3.3.CO;2-B; Junankar PR, 2000, CELL PHYSIOL BIOCHEM, V10, P355, DOI 10.1159/000016368; Kempson SA, 2004, PFLUG ARCH EUR J PHY, V449, P227, DOI 10.1007/s00424-004-1338-6; Kempson SA, 2003, AM J PHYSIOL-CELL PH, V285, pC1091, DOI 10.1152/ajpcell.00021.2003; Kiesel M, 2006, BIOPHYS J, V90, P4720, DOI 10.1529/biophysj.105.078725; Kinne RKH, 1998, CONTRIB NEPHROL, V123, P34, DOI 10.1159/000059927; Kinne RKH, 2000, CELL PHYSIOL BIOCHEM, V10, P371, DOI 10.1159/000016376; Kirk K, 1997, J MEMBRANE BIOL, V158, P1, DOI 10.1007/s002329900239; Kleinhans FW, 1998, CRYOBIOLOGY, V37, P271, DOI 10.1006/cryo.1998.2135; KWON HM, 1992, J BIOL CHEM, V267, P6297; KWON HM, 1995, CURR OPIN CELL BIOL, V7, P465, DOI 10.1016/0955-0674(95)80002-6; Kwon MS, 2008, J BIOL CHEM, V283, P22400, DOI 10.1074/jbc.M710550200; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lang F, 2011, NESTLE NUTR WORKS SE, V69, P115, DOI 10.1159/000329290; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Loveday D, 2003, J NEUROCHEM, V87, P476, DOI 10.1046/j.1471-4159.2003.02021.x; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Memmel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087052; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC172, DOI 10.1152/ajpcell.1994.266.1.C172; Reuss R, 2004, J MEMBRANE BIOL, V200, P67, DOI 10.1007/s00232-004-0694-7; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Shirakashi R, 2004, INT J HEAT MASS TRAN, V47, P4517, DOI 10.1016/j.ijheatmasstransfer.2004.04.007; Snapp EL, 2011, COLD SPRING HARB PRO, V2011, DOI [10.1101/pdb.top066548, DOI 10.1101/PDB.TOP066548]; Sukhorukov VL, 2006, BIOCHEM BIOPH RES CO, V346, P829, DOI 10.1016/j.bbrc.2006.05.193; Sukhorukov VL, 2009, BBA-BIOMEMBRANES, V1788, P1841, DOI 10.1016/j.bbamem.2009.06.016; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; van de Linde S, 2013, CHEM BIOL, V20, P8, DOI 10.1016/j.chembiol.2012.11.004; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Wright EM, 2013, MOL ASPECTS MED, V34, P183, DOI 10.1016/j.mam.2012.11.002; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004	52	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119990	10.1371/journal.pone.0119990	http://dx.doi.org/10.1371/journal.pone.0119990			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756525	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700057
J	De Korte-Verhoef, MC; Pasman, HRW; Schweitzer, BPM; Francke, AL; Onwuteaka-Philipsen, BD; Deliens, L				De Korte-Verhoef, Maria C.; Pasman, H. Roeline W.; Schweitzer, Bart P. M.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc			How Could Hospitalisations at the End of Life Have Been Avoided? A Qualitative Retrospective Study of the Perspectives of General Practitioners, Nurses and Family Carers	PLOS ONE			English	Article							LUNG-CANCER PATIENTS; DEATH; HOME; NETHERLANDS; PLACE; PREFERENCES; POPULATION; REASONS	Background Although many patients prefer to stay and die at home at the end of life, many are hospitalised. Little is known about how to avoid hospitalisations for patients living at home. Aim To describe how hospitalisation at the end of life can be avoided, from the perspective of the GPs, nurses and family carers. Method A qualitative design with face-to-face interviews was used. Taking 30 cases of patients who died non-suddenly, 26 GPs, 15 nurses and 18 family carers were interviewed in depth. Of the 30 patients, 20 were hospitalised and 10 were not hospitalised in the last three months of life. Results Five key themes that could help avoid hospitalisation at the end of life emerged from the interviews. The key themes were: 1) marking the approach of death, and shifting the mindset; 2) being able to provide acute treatment and care at home; 3) anticipatory discussions and interventions to deal with expected severe problems; 4) guiding and monitoring the patient and family in a holistic way through the illness trajectory; 5) continuity of treatment and care at home. If these five key themes are adopted in an interrelated way, this could help avoid hospitalisations, according to GPs, nurses and family carers. Conclusions The five key themes described in this study can be seen as strategies that could help in avoiding hospitalisation at the end of life. It is recommended that for all patients residing at home, GPs and community nurses work together as a team from the moment that it is marked that death is approaching up to the end of life.	[De Korte-Verhoef, Maria C.; Pasman, H. Roeline W.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [De Korte-Verhoef, Maria C.; Pasman, H. Roeline W.; Francke, Anneke L.; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc] Vrije Univ Amsterdam, Med Ctr, Expertise Ctr Palliat Care VUmc, Inst Hlth & Care Res, Amsterdam, Netherlands; [Schweitzer, Bart P. M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice, Amsterdam, Netherlands; [Francke, Anneke L.] NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Deliens, Luc] Univ Ghent, End of life Care Res Grp, Brussels, Belgium; [Deliens, Luc] Vrije Univ Brussel, Brussels, Belgium	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Institute for Health Services Research; Ghent University; Vrije Universiteit Brussel	De Korte-Verhoef, MC (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	eol@vumc.nl	Wu, Hsin-Lung/C-4134-2009	Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248; Deliens, Luc/0000-0002-8158-2422	ZonMw; Netherlands Organization for Health Research and Development [11510005]	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	This study is funded by ZonMw, the Netherlands Organization for Health Research and Development (No. 11510005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarshi E, 2010, PALLIATIVE MED, V24, P166, DOI 10.1177/0269216309351381; Abel J, 2009, PALLIATIVE MED, V23, P616, DOI 10.1177/0269216309106460; Ahlner-Elmqvist M, 2004, PALLIATIVE MED, V18, P585, DOI 10.1191/0269216304pm924oa; Barbera L, 2008, J PAIN SYMPTOM MANAG, V35, P267, DOI 10.1016/j.jpainsymman.2007.04.019; Borgsteede SD, 2006, BRIT J GEN PRACT, V56, P20; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brumley Richard D, 2003, J Palliat Med, V6, P715, DOI 10.1089/109662103322515220; Choi J, 2010, SUPPORT CARE CANCER, V18, P1445, DOI 10.1007/s00520-009-0767-3; Claessen SJJ, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-42; de Casterle BD, 2012, INT J NURS STUD, V49, P360, DOI 10.1016/j.ijnurstu.2011.09.012; De Korte-Verhoef MC, 2014, SUPPORT CARE CANCER, V22, P645, DOI 10.1007/s00520-013-2019-9; De Roo ML, 2013, J PAIN SYMPTOM MANAG, V46, P556, DOI 10.1016/j.jpainsymman.2012.09.013; Dumont S, 2009, PALLIATIVE MED, V23, P708, DOI 10.1177/0269216309346546; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gott M, 2013, PALLIATIVE MED, V27, P747, DOI 10.1177/0269216312469263; Gott M, 2011, BMJ SUPPORT PALLIAT, V1, P42, DOI [10.1186/1472-684X-12-9, 10.1136/bmj.d1773]; Korte-Verhoef De, 2009, BETER THUIS STERVEN; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Ratner E, 2001, J AM GERIATR SOC, V49, P778, DOI 10.1046/j.1532-5415.2001.49155.x; Reyniers T, 2014, HEALTH PLACE, V27, P77, DOI 10.1016/j.healthplace.2014.02.002; Royal College of General Practitioners and Royal College of Nursing, 2012, MATT LIF DEATH HELP; Sandelowski M, 2012, QUAL HEALTH RES, V22, P1404, DOI 10.1177/1049732312450368; Schweitzer Bart P M, 2009, BMC Palliat Care, V8, P17, DOI 10.1186/1472-684X-8-17; Shaw KL, 2010, PALLIATIVE MED, V24, P317, DOI 10.1177/0269216310362005; Stajduhar KI, 2008, PALLIATIVE MED, V22, P85, DOI 10.1177/0269216307084612; Thoonsen B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-123; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; van der Plas AGM, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-14; Vos MS, 2011, LUNG CANCER, V72, P119, DOI 10.1016/j.lungcan.2010.07.007; Walsh EG, 2012, J AM GERIATR SOC, V60, P821, DOI 10.1111/j.1532-5415.2012.03920.x; Wowchuk SM, 2009, J PALLIAT MED, V12, P797, DOI 10.1089/jpm.2009.0048	31	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118971	10.1371/journal.pone.0118971	http://dx.doi.org/10.1371/journal.pone.0118971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756184	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700033
J	Duarri, A; Nibbeling, EAR; Fokkens, MR; Meijer, M; Boerrigter, M; Verschuuren-Bemelmans, CC; Kremer, BPH; van de Warrenburg, BP; Dooijes, D; Boddeke, E; Sinke, RJ; Verbeek, DS				Duarri, Anna; Nibbeling, Esther A. R.; Fokkens, Michiel R.; Meijer, Michel; Boerrigter, Melissa; Verschuuren-Bemelmans, Corien C.; Kremer, Berry P. H.; van de Warrenburg, Bart P.; Dooijes, Dennis; Boddeke, Erik; Sinke, Richard J.; Verbeek, Dineke S.			Functional Analysis Helps to Define KCNC3 Mutational Spectrum in Dutch Ataxia Cases	PLOS ONE			English	Article							DOMINANT CEREBELLAR-ATAXIA; SPINOCEREBELLAR ATAXIA; POTASSIUM CHANNELS; KV3.3 CHANNELS	Spinocerebellar ataxia type 13 (SCA13) is an autosomal dominantly inherited neurodegenerative disorder of the cerebellum caused by mutations in the voltage gated potassium channel KCNC3. To identify novel pathogenic SCA13 mutations in KCNC3 and to gain insights into the disease prevalence in the Netherlands, we sequenced the entire coding region of KCNC3 in 848 Dutch cerebellar ataxia patients with familial or sporadic origin. We evaluated the pathogenicity of the identified variants by co-segregation analysis and in silico prediction followed by biochemical and electrophysiological studies. We identified 19 variants in KCNC3 including 2 non-coding, 11 missense and 6 synonymous variants. Two missense variants did not co-segregate with the disease and were excluded as potentially disease-causing mutations. We also identified the previously reported p.R420H and p. R423H mutations in our cohort. Of the remaining 7 missense variants, functional analysis revealed that 2 missense variants shifted Kv3.3 channel activation to more negative voltages. These variations were associated with early disease onset and mild intellectual disability. Additionally, one other missense variant shifted channel activation to more positive voltages and was associated with spastic ataxic gait. Whereas, the remaining missense variants did not change any of the channel characteristics. Of these three functional variants, only one variant was in silico predicted to be damaging and segregated with disease. The other two variants were in silico predicted to be benign and co-segregation analysis was not optimal or could only be partially confirmed. Therefore, we conclude that we have identified at least one novel pathogenic mutation in KCNC3 that cause SCA13 and two additionally potential SCA13 mutations. This leads to an estimate of SCA13 prevalence in the Netherlands to be between 0.6% and 1.3%.	[Duarri, Anna; Nibbeling, Esther A. R.; Fokkens, Michiel R.; Boerrigter, Melissa; Verschuuren-Bemelmans, Corien C.; Sinke, Richard J.; Verbeek, Dineke S.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Meijer, Michel; Boddeke, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Med Physiol, Groningen, Netherlands; [Kremer, Berry P. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [van de Warrenburg, Bart P.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Dooijes, Dennis] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Verbeek, DS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	d.s.verbeek@umcg.nl	Boerrigter, Melissa Maria/ABC-6057-2020; Nibbeling, Esther/AAC-3537-2022; van de Warrenburg, Bart PC/D-1935-2010; Duarri, Anna/K-2811-2017	Boerrigter, Melissa Maria/0000-0002-7583-6991; Nibbeling, Esther/0000-0001-8818-3232; van de Warrenburg, Bart PC/0000-0003-4412-1616; Duarri, Anna/0000-0003-4075-5478	Dutch Brain Foundation [2011(1)-105]; University of Groningen, Groningen, the Netherlands; NWO [40-00506-98-9021, 175-010-2009-023]	Dutch Brain Foundation; University of Groningen, Groningen, the Netherlands(Netherlands Government); NWO(Netherlands Organization for Scientific Research (NWO))	This work received financial support from the Dutch Brain Foundation (2011(1)-105) and a Rosalind Franklin Fellowship from the University of Groningen, Groningen, the Netherlands. Part of the work was performed at the UMCG Imaging and Microscopy Center (UMIC), which is sponsored by NWO grants 40-00506-98-9021and 175-010-2009-023.	Bauer P, 2010, J NEUROL NEUROSUR PS, V81, P1229, DOI 10.1136/jnnp.2009.202150; Burk K, 2013, INT J NEUROSCI, V123, P278, DOI 10.3109/00207454.2012.755180; Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Deng QW, 2005, J NEUROSCI, V25, P11531, DOI 10.1523/JNEUROSCI.3672-05.2005; Duarri A, 2013, NEUROGENETICS, V14, P257, DOI 10.1007/s10048-013-0370-0; Duarri A, 2012, ANN NEUROL, V72, P870, DOI 10.1002/ana.23700; Fawcett K, 2013, J NEUROL, V260, P856, DOI 10.1007/s00415-012-6721-1; Figueroa KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017811; Figueroa KP, 2010, HUM MUTAT, V31, P191, DOI 10.1002/humu.21165; Gallego-Iradi C, 2014, NEUROBIOL DIS, V71, P270, DOI 10.1016/j.nbd.2014.08.020; GOLDMANWOHL DS, 1994, J NEUROSCI, V14, P511; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; Irie T, 2014, J PHYSIOL-LONDON, V592, P229, DOI 10.1113/jphysiol.2013.264309; Issa FA, 2012, DIS MODEL MECH; Issa FA, 2011, J NEUROSCI, V31, P6831, DOI 10.1523/JNEUROSCI.6572-10.2011; Jezierska J, 2013, J NEUROL, V260, P1807, DOI 10.1007/s00415-013-6882-6; Joho RH, 2009, CEREBELLUM, V8, P323, DOI 10.1007/s12311-009-0098-4; Martina M, 2003, J NEUROSCI, V23, P5698; Matsukawa H, 2003, J NEUROSCI, V23, P7677; Middlebrooks JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076749; Minassian NA, 2012, J PHYSIOL-LONDON, V590, P1599, DOI 10.1113/jphysiol.2012.228205; Mock AF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-99; Peng L, 2013, INT J NEUROSCI, V123, P450, DOI 10.3109/00207454.2013.763254; Rajakulendran S, 2007, NEUROTHERAPEUTICS, V4, P258, DOI 10.1016/j.nurt.2007.01.010; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Veys K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00205; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Waters MF, 2005, NEUROLOGY, V65, P1111, DOI 10.1212/01.wnl.0000177490.05162.41; Zagha E, 2008, J NEUROSCI, V28, P1291, DOI 10.1523/JNEUROSCI.4358-07.2008; Zhao J, 2013, BIOCHEM J, V454, P259, DOI 10.1042/BJ20130034	32	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116599	10.1371/journal.pone.0116599	http://dx.doi.org/10.1371/journal.pone.0116599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756792	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700009
J	Nanduri, J; Vaddi, DR; Khan, SA; Wang, N; Makarenko, V; Semenza, GL; Prabhakar, NR				Nanduri, Jayasri; Vaddi, Damodara Reddy; Khan, Shakil A.; Wang, Ning; Makarenko, Vladislav; Semenza, Gregg L.; Prabhakar, Nanduri R.			HIF-1 alpha Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase	PLOS ONE			English	Article							PROTEIN-KINASE-C; OXYGEN SPECIES GENERATION; OBSTRUCTIVE SLEEP-APNEA; OXIDATIVE STRESS; CAROTID-BODY; CHROMAFFIN CELLS; NOX FAMILY; PHOSPHORYLATION; RESPONSES; HYPERTENSION	Hypoxia-inducible factor 1 (HIF-1) mediates many of the systemic and cellular responses to intermittent hypoxia (IH), which is an experimental model that simulates O-2 saturation profiles occurring with recurrent apnea. IH-evoked HIF-1 alpha synthesis and stability are due to increased reactive oxygen species (ROS) generated by NADPH oxidases, especially Nox2. However, the mechanisms by which IH activates Nox2 are not known. We recently reported that IH activates xanthine oxidase (XO) and the resulting increase in ROS elevates intracellular calcium levels. Since Nox2 activation requires increased intracellular calcium levels, we hypothesized XO-mediated calcium signaling contributes to Nox activation by IH. We tested this possibility in rat pheochromocytoma PC12 cells subjected to IH consisting alternating cycles of hypoxia (1.5% O-2 for 30 sec) and normoxia (21% O-2 for 5 min). Kinetic analysis revealed that IH-induced XO preceded Nox activation. Inhibition of XO activity either by allopurinol or by siRNA prevented IH-induced Nox activation, translocation of the cytosolic subunits p47(phox) and p67(phox) to the plasma membrane and their interaction with gp91(phox). ROS generated by XO also contribute to IH-evoked Nox activation via calcium-dependent protein kinase C stimulation. More importantly, silencing XO blocked IH-induced upregulation of HIF-1 alpha demonstrating that HIF-1 alpha activation by IH requires Nox2 activation by XO.	[Nanduri, Jayasri; Vaddi, Damodara Reddy; Khan, Shakil A.; Wang, Ning; Makarenko, Vladislav; Prabhakar, Nanduri R.] Univ Chicago, Inst Integrat Physiol, Chicago, IL 60637 USA; [Nanduri, Jayasri; Vaddi, Damodara Reddy; Khan, Shakil A.; Wang, Ning; Makarenko, Vladislav; Prabhakar, Nanduri R.] Univ Chicago, Div Biol Sci, Ctr Syst Biol Sensing O2, Chicago, IL 60637 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat Med Oncol Radiat Oncol & Biol Chem, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, Baltimore, MD USA	University of Chicago; University of Chicago; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Nanduri, J (corresponding author), Univ Chicago, Inst Integrat Physiol, Chicago, IL 60637 USA.	jnanduri@uchicago.edu	Vaddi, Damodara Reddy/AAU-1398-2020	Vaddi, Damodara Reddy/0000-0002-4441-0859	National Institute for Health [HL- -90554]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090554] Funding Source: NIH RePORTER	National Institute for Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NRP and GLS were funded by National Institute for Health HL- -90554. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2012, NAT REV CANCER, V12, P627, DOI 10.1038/nrc3339; Christou Kostas, 2003, Sleep Breath, V7, P105, DOI 10.1007/s11325-003-0105-9; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Grebe M, 2006, AM J RESP CRIT CARE, V173, P897, DOI 10.1164/rccm.200508-1223OC; Khan SA, 2011, ANTIOXID REDOX SIGN, V14, P533, DOI 10.1089/ars.2010.3213; Kumar GK, 2006, J PHYSIOL-LONDON, V575, P229, DOI 10.1113/jphysiol.2006.112524; Kuri BA, 2007, J PHYSIOL-LONDON, V584, P313, DOI 10.1113/jphysiol.2007.140624; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Li JM, 2002, J BIOL CHEM, V277, P19952, DOI 10.1074/jbc.M110073200; Makarenko VV, 2012, AM J PHYSIOL-CELL PH, V303, pC916, DOI 10.1152/ajpcell.00100.2012; Nanduri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075838; Nanduri J, 2009, P NATL ACAD SCI USA, V106, P1199, DOI 10.1073/pnas.0811018106; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; PARKS DA, 1985, GASTROENTEROLOGY, V89, P6, DOI 10.1016/0016-5085(85)90738-3; Peng YJ, 2009, J NEUROSCI, V29, P4903, DOI 10.1523/JNEUROSCI.4768-08.2009; Peng YJ, 2006, J PHYSIOL-LONDON, V577, P705, DOI 10.1113/jphysiol.2006.114033; Peng YJ, 2003, J APPL PHYSIOL, V94, P2342, DOI 10.1152/japplphysiol.00613.2002; Prabhakar NR, 2007, ANTIOXID REDOX SIGN, V9, P1397, DOI 10.1089/ars.2007.1732; Prabhakar NR, 2007, RESP PHYSIOL NEUROBI, V157, P148, DOI 10.1016/j.resp.2006.12.009; Prabhakar Nanduri R, 2006, Novartis Found Symp, V272, P95; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P230, DOI 10.1016/j.resp.2010.08.022; Prabhakar NR, 2006, NOVART FDN SYMP, V272, P100; Prabhakar NR, 2006, NOVART FDN SYMP, V272, P31; Raghuraman G, 2009, ANTIOXID REDOX SIGN, V11, P1777, DOI [10.1089/ars.2008.2368, 10.1089/ARS.2008.2368]; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; Sharma SD, 2009, J APPL PHYSIOL, V106, P12, DOI 10.1152/japplphysiol.90702.2008; Souvannakitti D, 2009, J NEUROPHYSIOL, V101, P2837, DOI 10.1152/jn.00036.2009; Suzuki YJ, 2006, FREE RADICAL BIO MED, V40, P1683, DOI 10.1016/j.freeradbiomed.2006.01.008; Brindeiro CMT, 2007, AM J PHYSIOL-HEART C, V293, pH2971, DOI 10.1152/ajpheart.00219.2007; Young T, 2008, SLEEP, V31, P1071; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Yuan GX, 2013, P NATL ACAD SCI USA, V110, pE1788, DOI 10.1073/pnas.1305961110; Yuan GX, 2011, J CELL PHYSIOL, V226, P2925, DOI 10.1002/jcp.22640; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Yuan GX, 2004, J PHYSIOL-LONDON, V557, P773, DOI 10.1113/jphysiol.2003.058503; Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284	40	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119762	10.1371/journal.pone.0119762	http://dx.doi.org/10.1371/journal.pone.0119762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751622	gold, Green Published, Green Submitted			2022-12-27	WOS:000350692700034
J	Jounai, K; Sugimura, T; Ohshio, K; Fujiwara, D				Jounai, Kenta; Sugimura, Tetsu; Ohshio, Konomi; Fujiwara, Daisuke			Oral Administration of Lactococcus lactis Subsp lactis JCM5805 Enhances Lung Immune Response Resulting in Protection from Murine Parainfluenza Virus Infection	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; BIFIDOBACTERIUM-BREVE YIT4064; INFLUENZA-A VIRUS; SENDAI-VIRUS; T-CELLS; RESPIRATORY-TRACT; I INTERFERON; RNA VIRUSES; RIG-I; RECOGNITION	When activated by viral infection, plasmacytoid dendritic cells (pDCs) play a primary role in the immune response through secretion of IFN-alpha. Lactococcus lactis subsp. lactis JCM5805 (JCM5805) is a strain of lactic acid bacteria (LAB) that activates murine and human pDCs to express type I and type III interferons (IFNs). JCM5805 has also been shown to activate pDCs via a Toll-like receptor 9 (TLR9) dependent pathway. In this study, we investigated the anti-viral effects of oral administration of JCM5805 using a mouse model of murine parainfluenza virus (mPIV1) infection. JCM5805-fed mice showed a drastic improvement in survival rate, prevention of weight loss, and reduction in lung histopathology scores compared to control mice. We further examined the mechanism of anti-viral effects elicited by JCM5805 administration using naive mice. Microscopic observations showed that JCM5805 was incorporated into CD11c(+) immune cells in Peyer's patches (PP) and PP pDCs were significantly activated and the expression levels of IFNs were significantly increased. Interestingly, nevertheless resident pDCs at lung were not activated and expressions levels of IFNs at whole lung tissue were not influenced, the expressions of anti-viral factors induced by IFNs, such as Isg15, Oasl2, and Viperin, at lung were up-regulated in JCM5805-fed mice compared to control mice. Therefore expressed IFNs from intestine might be delivered to lung and IFN stimulated genes might be induced. Furthermore, elevated expressions of type I IFNs from lung lymphocytes were observed in response to mPIV1 ex vivo stimulation in JCM5805-fed mice compared to control. This might be due to increased ratio of pDCs located in lung were significantly increased in JCM5805 group. Taken together, a specific LAB strain might be able to affect anti-viral immunological profile in lung via activation of intestinal pDC leading to enhanced anti-viral phenotype in vivo.	[Jounai, Kenta] Koiwai Dairy Prod Co Ltd, Tech Dev Ctr, Sayama, Osaka, Japan; [Jounai, Kenta; Sugimura, Tetsu; Ohshio, Konomi; Fujiwara, Daisuke] Kirin Co Ltd, Cent Labs Key Technol, Yokohama, Kanagawa, Japan		Jounai, K (corresponding author), Koiwai Dairy Prod Co Ltd, Tech Dev Ctr, Sayama, Osaka, Japan.	Kenta_Jounai@kirin.co.jp						Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Goto H, 2013, BRIT J NUTR, V110, P1810, DOI 10.1017/S0007114513001104; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hori T, 2002, CLIN DIAGN LAB IMMUN, V9, P105, DOI 10.1128/CDLI.9.1.105-108.2002; Hori T, 2001, CLIN DIAGN LAB IMMUN, V8, P593, DOI 10.1128/CDLI.8.3.593-597.2001; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ichikawa S, 2009, BIOSCI BIOTECH BIOCH, V73, P1561, DOI 10.1271/bbb.90058; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Izumo T, 2010, INT IMMUNOPHARMACOL, V10, P1101, DOI 10.1016/j.intimp.2010.06.012; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jounai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032588; Kakuta S, 2002, J INTERF CYTOK RES, V22, P981, DOI 10.1089/10799900260286696; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Kondoh M, 2012, VIRAL IMMUNOL, V25, P86, DOI 10.1089/vim.2011.0056; Kotani Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091857; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Parcina M, 2008, J IMMUNOL, V181, P3823, DOI 10.4049/jimmunol.181.6.3823; PARKER JC, 1978, INFECT IMMUN, V19, P123, DOI 10.1128/IAI.19.1.123-130.1978; Piccioli D, 2009, BLOOD, V113, P4232, DOI 10.1182/blood-2008-10-186890; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sugimura T, 2013, CLIN IMMUNOL, V149, P509, DOI 10.1016/j.clim.2013.10.007; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Takeda S, 2011, INT IMMUNOPHARMACOL, V11, P1976, DOI 10.1016/j.intimp.2011.08.007; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; YASUI H, 1995, J INFECT DIS, V172, P403, DOI 10.1093/infdis/172.2.403; Yasui H, 1999, CLIN DIAGN LAB IMMUN, V6, P186, DOI 10.1128/CDLI.6.2.186-192.1999; Yu D, 1997, GENES CELLS, V2, P457, DOI 10.1046/j.1365-2443.1997.1340332.x	48	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119055	10.1371/journal.pone.0119055	http://dx.doi.org/10.1371/journal.pone.0119055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746923	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400040
J	Taylor-Clark, TE; Wu, KY; Thompson, JA; Yang, K; Bahia, PK; Ajmo, JM				Taylor-Clark, Thomas E.; Wu, Kevin Y.; Thompson, Julie-Ann; Yang, Kiseok; Bahia, Parmvir K.; Ajmo, Joanne M.			Thy1.2 YFP-16 Transgenic Mouse Labels a Subset of Large-Diameter Sensory Neurons that Lack TRPV1 Expression	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; MICROSCOPIC ANALYSIS; NERVE REGENERATION; P2X RECEPTORS; NEURAL CREST; MICE; CHANNELS; LUNGS; TOUCH; PAIN	The Thy1.2 YFP-16 mouse expresses yellow fluorescent protein (YFP) in specific subsets of peripheral and central neurons. The original characterization of this model suggested that YFP was expressed in all sensory neurons, and this model has been subsequently used to study sensory nerve structure and function. Here, we have characterized the expression of YFP in the sensory ganglia (DRG, trigeminal and vagal) of the Thy1.2 YFP-16 mouse, using biochemical, functional and anatomical analyses. Despite previous reports, we found that YFP was only expressed in approximately half of DRG and trigeminal neurons and less than 10% of vagal neurons. YFP-expression was only found in medium and large-diameter neurons that expressed neurofilament but not TRPV1. YFP-expressing neurons failed to respond to selective agonists for TRPV1, P2X(2/3) and TRPM8 channels in Ca2+ imaging assays. Confocal analysis of glabrous skin, hairy skin of the back and ear and skeletal muscle indicated that YFP was expressed in some peripheral terminals with structures consistent with their presumed non-nociceptive nature. In summary, the Thy1.2 YFP-16 mouse expresses robust YFP expression in only a subset of sensory neurons. But this mouse model is not suitable for the study of nociceptive nerves or the function of such nerves in pain and neuropathies.	[Taylor-Clark, Thomas E.; Wu, Kevin Y.; Thompson, Julie-Ann; Yang, Kiseok; Bahia, Parmvir K.; Ajmo, Joanne M.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Taylor-Clark, TE (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	ttaylorc@health.usf.edu			National Heart, Lung & Blood Institute [R01 HL119802]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119802] Funding Source: NIH RePORTER	National Heart, Lung & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Heart, Lung & Blood Institute R01 HL119802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Belle MD, 2007, GENESIS, V45, P679, DOI 10.1002/dvg.20331; Bewick GS, 2014, MECHANOTRANSDUCTION; Burnstock G, 2000, BRIT J ANAESTH, V84, P476, DOI 10.1093/oxfordjournals.bja.a013473; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen YS, 2005, DIABETES, V54, P3112, DOI 10.2337/diabetes.54.11.3112; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fradette J, 1995, BIOCHEM CELL BIOL, V73, P635, DOI 10.1139/o95-070; GREGORY JE, 1979, J PHYSIOL-LONDON, V295, P251, DOI 10.1113/jphysiol.1979.sp012966; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Kollarik M, 2010, J PHYSIOL-LONDON, V588, P4303, DOI 10.1113/jphysiol.2010.192971; Kwong K, 2008, AM J PHYSIOL-LUNG C, V295, pL858, DOI 10.1152/ajplung.90360.2008; LAWSON SN, 1993, BRAIN RES BULL, V30, P239, DOI 10.1016/0361-9230(93)90250-F; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; MILLARD CL, 1988, J COMP NEUROL, V277, P183, DOI 10.1002/cne.902770203; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Nassenstein C, 2010, J PHYSIOL-LONDON, V588, P4769, DOI 10.1113/jphysiol.2010.195339; Nesuashvili L, 2013, MOL PHARMACOL, V83, P1007, DOI 10.1124/mol.112.084319; Niu JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092027; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Roudaut Y, 2012, CHANNELS, V6, P234, DOI 10.4161/chan.22213; Shenton F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107073; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; Simonetti M, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-11; Suzuki M, 2012, P JPN ACAD B-PHYS, V88, P583, DOI 10.2183/pjab.88.583; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Unezaki S, 2009, J NEUROSCI METH, V178, P308, DOI 10.1016/j.jneumeth.2008.12.022; Wu HL, 2012, BIOINORG CHEM APPL, V2012, DOI 10.1155/2012/609796; Yan Y, 2011, EXP NEUROL, V232, P7, DOI 10.1016/j.expneurol.2011.06.013	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119538	10.1371/journal.pone.0119538	http://dx.doi.org/10.1371/journal.pone.0119538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746468	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400078
J	Wehmann, HN; Gustav, D; Kirkerud, NH; Galizia, CG				Wehmann, Henja-Niniane; Gustav, David; Kirkerud, Nicholas H.; Galizia, C. Giovanni			The Sound and the Fury-Bees Hiss when Expecting Danger	PLOS ONE			English	Article							PROBOSCIS EXTENSION RESPONSE; APIS-MELLIFERA; HONEY-BEES; COMMUNICATION; VOCALIZATIONS; BUMBLEBEES; BEHAVIOR; DEFENSE; COLONY	Honey bees are important model systems for the investigation of learning and memory and for a better understanding of the neuronal basics of brain function. Honey bees also possess a rich repertoire of tones and sounds, from queen piping and quacking to worker hissing and buzzing. In this study, we tested whether the worker bees' sounds can be used as a measure of learning. We therefore conditioned honey bees aversively to odours in a walking arena and recorded both their sound production and their movement. Bees were presented with two odours, one of which was paired with an electric shock. Initially, the bees did not produce any sound upon odour presentation, but responded to the electric shock with a strong hissing response. After learning, many bees hissed at the presentation of the learned odour, while fewer bees hissed upon presentation of another odour. We also found that hissing and movement away from the conditioned odour are independent behaviours that can co-occur but do not necessarily do so. Our data suggest that hissing can be used as a readout for learning after olfactory conditioning, but that there are large individual differences between bees concerning their hissing reaction. The basis for this variability and the possible ecological relevance of the bees' hissing remain to be investigated.	[Wehmann, Henja-Niniane; Gustav, David; Kirkerud, Nicholas H.; Galizia, C. Giovanni] Univ Konstanz, Neurobiol, Constance, Germany; [Kirkerud, Nicholas H.] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, Constance, Germany	University of Konstanz; Max Planck Society; University of Konstanz	Gustav, D (corresponding author), Univ Konstanz, Neurobiol, Constance, Germany.	david.gustav@uni-konstanz.de; giovanni.galizia@uni-konstanz.de	Galizia, C Giovanni/A-1771-2009	Galizia, C Giovanni/0000-0001-8292-6031; Kirkerud, Nicholas/0000-0002-8310-5523	Federal Ministry of Food and Agriculture (BMEL) via the Federal Office for Agriculture and Food (BLE)	Federal Ministry of Food and Agriculture (BMEL) via the Federal Office for Agriculture and Food (BLE)	NHK participates in the International Max-Planck Research School for Organismal Biology. This work was supported by funds of the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniadis EA, 1999, BEHAV BRAIN RES, V101, P1, DOI 10.1016/S0166-4328(98)00056-4; Armbruster L, 1922, ARCH BIENENK, V4, P221, DOI [10.1055/s-0033-1360260, DOI 10.1055/S-0033-1360260]; AudacityTeam, 2012, AUD FREE AUD ED REC; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERG DS, 1973, BEHAV BIOL, V8, P733, DOI 10.1016/S0091-6773(73)80115-4; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Burg NMD, 2014, APIDOLOGIE, P1; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Chongsuvivatwong V, 2012, EPICALC EPIDEMIOLOGI; COLLINS AM, 1978, ANN ENTOMOL SOC AM, V71, P906, DOI 10.1093/aesa/71.6.906; ESCH H, 1961, Z VERGL PHYSIOL, V45, P1, DOI 10.1007/BF00297754; ESCH H, 1967, Z VERGL PHYSIOL, V56, P408, DOI 10.1007/BF00298058; Gelman A., 2013, ARM DATA ANAL USING; Gerber B, 1998, NEUROBIOL LEARN MEM, V69, P71, DOI 10.1006/nlme.1997.3801; GINSBURG N, 1960, J COMP PHYSIOL PSYCH, V53, P183, DOI 10.1037/h0048391; GINSBURG N, 1963, J COMP PHYSIOL PSYCH, V56, P1061, DOI 10.1037/h0047774; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Hansson A, 1945, LAUTERZEUGUNG LAUTAU; HARRIS JW, 1992, J INSECT PHYSIOL, V38, P29, DOI 10.1016/0022-1910(92)90019-A; Harris JW, 1999, PHYSIOL ENTOMOL, V24, P285, DOI 10.1046/j.1365-3032.1999.00141.x; Hrncir M, 2006, CONT T ENT, P421; KERR WE, 1960, EVOLUTION, V14, P386, DOI 10.1111/j.1558-5646.1960.tb03100.x; Kinney C, 1998, J EXP ZOOL, V280, P107, DOI 10.1002/(SICI)1097-010X(19980201)280:2<107::AID-JEZ1>3.0.CO;2-S; KIRCHNER WH, 1993, APIDOLOGIE, V24, P297, DOI 10.1051/apido:19930309; Kirchner WH, 1999, INSECT SOC, V46, P239, DOI 10.1007/s000400050140; Kirkerud NH, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00029; Konorski J, 1948, CONDITIONED REFLEXES, VXIV; Labra A, 2007, COPEIA, P1019, DOI 10.1643/0045-8511(2007)7[1019:HSBTLP]2.0.CO;2; LANE H, 1960, SCIENCE, V132, P37, DOI 10.1126/science.132.3418.37; LAVERTY TM, 1988, ANIM BEHAV, V36, P733, DOI 10.1016/S0003-3472(88)80156-8; Ligges U, 2013, TUNER ANAL MUSIC; LINDAUER M, 1955, Z VERGL PHYSIOL, V37, P263, DOI 10.1007/BF00303153; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Maechler M., 2011, LME4 LINEAR MIXED EF; MARKWELL TJ, 1993, NEW ZEAL J ECOL, V17, P85; Martin P., 1963, Insectes Sociaux Paris, V10, P13, DOI 10.1007/BF02223520; MARTIN WF, 1971, COPEIA, P752; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; MICHAEL J, 1984, J EXP ANAL BEHAV, V42, P363, DOI 10.1901/jeab.1984.42-363; NELSON MC, 1980, BEHAV ECOL SOCIOBIOL, V6, P305, DOI 10.1007/BF00292773; Papachristoforou A, 2008, APIDOLOGIE, V39, P468, DOI 10.1051/apido:2008027; PETERS G, 1987, Bonner Zoologische Beitraege, V38, P315; Peters G., 1989, P14; PICKENS ANDREW L., 1928, AUK, V45, P302; R Core Team, 2021, R LANGUAGE ENV STAT; Rangel J, 2008, ANIM BEHAV, V76, P1943, DOI 10.1016/j.anbehav.2008.09.004; Rittschof CC, 2008, ANIM BEHAV, V75, P189, DOI 10.1016/j.anbehav.2007.04.026; SALZINGER K, 1962, J EXP ANAL BEHAV, V5, P383, DOI 10.1901/jeab.1962.5-383; SALZINGER K, 1959, J GEN PSYCHOL, V61, P65, DOI 10.1080/00221309.1959.9710241; SCHUSTERMAN RJ, 1965, SCIENCE, V150, P1743, DOI 10.1126/science.150.3704.1743; SCHUSTERMAN RJ, 1970, SCIENCE, V169, P498, DOI 10.1126/science.169.3944.498; Seeley T.D., 1979, Psyche (Cambridge), V86, P103, DOI 10.1155/1979/80869; Seeley TD, 2004, BEHAV ECOL SOCIOBIOL, V56, P594, DOI 10.1007/s00265-004-0814-5; Sen Sarma M, 2002, ZOOLOGY, V105, P215, DOI 10.1078/0944-2006-00064; SPANGLER HG, 1991, J INSECT BEHAV, V4, P15, DOI 10.1007/BF01092547; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Tautz J, 2003, J COMP PHYSIOL A, V189, P293, DOI 10.1007/s00359-003-0402-6; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; WENNER ADRIAN M., 1962, ANIMAL BEHAVIOUR, V10, P79, DOI 10.1016/0003-3472(62)90135-5; WILSON WA, 1975, ANIM BEHAV, V23, P432, DOI 10.1016/0003-3472(75)90091-3	64	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118708	10.1371/journal.pone.0118708	http://dx.doi.org/10.1371/journal.pone.0118708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747702	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400025
J	Wang, Y; Cui, YZ; Zhou, XY; Han, JX				Wang, Yao; Cui, Yazhou; Zhou, Xiaoyan; Han, Jinxiang			Development of a High-Throughput Resequencing Array for the Detection of Pathogenic Mutations in Osteogenesis Imperfecta	PLOS ONE			English	Article							GENES	Objective Osteogenesis imperfecta (OI) is a rare inherited skeletal disease, characterized by bone fragility and low bone density. The mutations in this disorder have been widely reported to be on various exonal hotspots of the candidate genes, including COL1A1, COL1A2, CRTAP, LEPRE1, and FKBP10, thus creating a great demand for precise genetic tests. However, large genome sizes make the process daunting and the analyses, inefficient and expensive. Therefore, we aimed at developing a fast, accurate, efficient, and cheaper sequencing platform for OI diagnosis; and to this end, use of an advanced array-based technique was proposed. Method A CustomSeq Affymetrix Resequencing Array was established for high-throughput sequencing of five genes simultaneously. Genomic DNA extraction from 13 OI patients and 85 normal controls and amplification using long-range PCR (LR-PCR) were followed by DNA fragmentation and chip hybridization, according to standard Affymetrix protocols. Hybridization signals were determined using GeneChip Sequence Analysis Software (GSEQ). To examine the feasibility, the outcome from new resequencing approach was validated by conventional capillary sequencing method. Result Overall call rates using resequencing array was 96-98% and the agreement between microarray and capillary sequencing was 99.99%. 11 out of 13 OI patients with pathogenic mutations were successfully detected by the chip analysis without adjustment, and one mutation could also be identified using manual visual inspection. Conclusion A high-throughput resequencing array was developed that detects the disease-associated mutations in OI, providing a potential tool to facilitate large-scale genetic screening for OI patients. Through this method, a novel mutation was also found.	[Wang, Yao; Cui, Yazhou; Zhou, Xiaoyan; Han, Jinxiang] Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Key Lab Biotech Drugs, Minist Hlth, Jinan, Shandong, Peoples R China; [Wang, Yao] Shandong Acad Med Sci, Shandong Inst Endocrine & Metab Dis, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Han, JX (corresponding author), Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Key Lab Biotech Drugs, Minist Hlth, Jinan, Shandong, Peoples R China.	samshjx@sina.com		Cui, Yazhou/0000-0002-4732-6791	Key Projects in the National Science & Technology Support Program during the Twelve Five-Year Plan Period from Ministry of Science and Technology of the People's Republic of China	Key Projects in the National Science & Technology Support Program during the Twelve Five-Year Plan Period from Ministry of Science and Technology of the People's Republic of China	This study was supported by the Key Projects in the National Science & Technology Support Program during the Twelve Five-Year Plan Period from Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booij JC, 2011, OPHTHALMOLOGY, V118, P160, DOI 10.1016/j.ophtha.2010.04.022; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chiou KR, 2011, ATHEROSCLEROSIS, V216, P383, DOI 10.1016/j.atherosclerosis.2011.02.006; Choi SJ, 2011, BIOCHEM BIOPH RES CO, V407, P23, DOI 10.1016/j.bbrc.2011.02.078; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Fokstuen S, 2008, HUM MUTAT, V29, P879, DOI 10.1002/humu.20749; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Jensen LR, 2011, EUR J HUM GENET, V19, P717, DOI 10.1038/ejhg.2010.244; Karaman MW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni034; Kataoka K, 2007, PEDIATR INT, V49, P564, DOI 10.1111/j.1442-200X.2007.02422.x; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Liu W, 2007, MOL VIS, V13, P360; McKnight AJ, 2006, J HUM GENET, V51, P383, DOI 10.1007/s10038-006-0368-7; Moul A, 2013, FETAL PEDIAT PATHOLO; Ogawa N, 2011, AM J CARDIOL, V108, P1801, DOI 10.1016/j.amjcard.2011.07.053; Ozcelik H, 2012, J MOL DIAGN, V14, P467, DOI 10.1016/j.jmoldx.2012.03.006; Pandya GA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm918; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Shapiro JR, 2012, J MUSCULOSKEL NEURON, V12, P24; Szoke D, 2009, INT J MOL MED, V23, P217, DOI 10.3892/ijmm_00000120; Teekakirikul P, 2011, CURRENT SEQUENCING U, V7, P7, DOI DOI 10.1002/0471142905.hg0718s69; Ueno T, 2012, CANCER SCI, V103, P131, DOI 10.1111/j.1349-7006.2011.02105.x; Vaish AK, 2012, BMJ CASE REPORTS, V2012; Wilkins EJ, 2012, PARKINSONISM RELAT D, V18, P386, DOI 10.1016/j.parkreldis.2011.12.012; Zhang ZL, 2012, J BONE MINER METAB, V30, P69, DOI 10.1007/s00774-011-0284-6	29	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119553	10.1371/journal.pone.0119553	http://dx.doi.org/10.1371/journal.pone.0119553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742658	Green Submitted, gold, Green Published			2022-12-27	WOS:000350688100121
J	Alvarez, J; Sarradell, J; Morrison, R; Perez, A				Alvarez, Julio; Sarradell, Javier; Morrison, Robert; Perez, Andres			Impact of Porcine Epidemic Diarrhea on Performance of Growing Pigs	PLOS ONE			English	Article							UNITED-STATES; MORTALITY	The impact of porcine epidemic diarrhea virus (PEDv) infection on the US pork industry has mainly been attributed to the mortality that it causes in suckling piglets, and, consequently, much effort has been invested in the quantification of its effect in sow farms. However, no information on the performance of surviving pigs that were exposed to the PEDv as piglets is available. Here, a retrospective cohort study to evaluate the impact of porcine epidemic diarrhea virus (PEDv) infection on growing pigs' performance, as indicated by mortality, average daily gain (ADG), average daily feed intake (ADFI), and feed conversion ratio (FCR) was performed using production records from weaned pigs in nursery and wean-to-finish sites from sow farms that became PEDv-infected between May 2013 and June 2014. Production records from the first batch of growing pigs weaned in infected flows after the PEDv outbreak ("infected batches") were compared with those from pigs weaned within the previous 14 to 120 days ("control batches"). Performance records from infected and control batches, paired by flow, were compared using non-parametric paired tests. Mortality, ADG and FCR were significantly different in PEDv-positive (infected) compared with PEDv-negative (control) batches, with a mean increase of mortality and FCR of 11% and 0.5, respectively, and a decrease of ADG of 0.16 lb/day. Our results demonstrate a poorer performance of growing pigs weaned after a PEDv outbreak compared with those weaned within the previous 14-120 days, suggesting that in addition to the mortality induced by PEDv in suckling pigs, the disease also impairs the performance of surviving pig. These findings help to quantify the impact of PEDv infection in the US and, ultimately, contribute to efforts to quantify the cost-effectiveness of disease prevention and control measures.	[Alvarez, Julio; Morrison, Robert; Perez, Andres] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Sarradell, Javier] Natl Univ Rosario, Fac Vet, Dept Gen & Syst Pathol Sarradell, Casilda, Argentina	University of Minnesota System; University of Minnesota Twin Cities; National University of Rosario	Alvarez, J (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	jalvarez@umn.edu	Alvarez, Julio/H-8292-2013; Perez, Andres/HGD-8377-2022	Alvarez, Julio/0000-0002-8999-9417; 				Campbell E., 2014, BLOOMBERG NEWS; Department of Economics ISU, 2014, EST LIV RET WEAN FEE; Geiger JO, 2013, PORCINE EPIDEMIC DIA; Goede D., 2014, PRODUCTION IMPACT ST; Hill C, 2014, EMERGENCE PORCINE EP, P9; HOLDEN PJ, 1991, AGRI-PRACTICE, V12, P46; Lange de FM, 2009, DIS SWINE, P1055; Losinger WC, 1998, PREV VET MED, V33, P121, DOI 10.1016/S0167-5877(97)00052-4; Maes D, 2001, J SWINE HEALTH PROD, V9, P267; Sawyer W., 2014, THIS LITTLE PIGGY CR, P8; Stein T, 2014, FEEDSTUFFS; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675	12	55	57	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120532	10.1371/journal.pone.0120532	http://dx.doi.org/10.1371/journal.pone.0120532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768287	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500127
J	Chen, L; Chu, C; Kong, XY; Huang, GH; Huang, T; Cai, YD				Chen, Lei; Chu, Chen; Kong, Xiangyin; Huang, Guohua; Huang, Tao; Cai, Yu-Dong			A Hybrid Computational Method for the Discovery of Novel Reproduction-Related Genes	PLOS ONE			English	Article							MITOTIC CELL-DIVISION; TGF-BETA; GERM-CELL; MALE-INFERTILITY; CONSERVED ROLE; GROWTH-FACTOR; EXPRESSION; DIFFERENTIATION; NETWORK; WALKING	Uncovering the molecular mechanisms underlying reproduction is of great importance to infertility treatment and to the generation of healthy offspring. In this study, we discovered novel reproduction-related genes with a hybrid computational method, integrating three different types of method, which offered new clues for further reproduction research. This method was first executed on a weighted graph, constructed based on known protein-protein interactions, to search the shortest paths connecting any two known reproduction-related genes. Genes occurring in these paths were deemed to have a special relationship with reproduction. These newly discovered genes were filtered with a randomization test. Then, the remaining genes were further selected according to their associations with known reproduction-related genes measured by protein-protein interaction score and alignment score obtained by BLAST. The in-depth analysis of the high confidence novel reproduction genes revealed hidden mechanisms of reproduction and provided guidelines for further experimental validations.	[Huang, Guohua; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai 200444, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Chu, Chen] Chinese Acad Sci, State Key Lab Mol Biol, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Huang, Guohua/A-2215-2019; Chen, Lei/A-2275-2011; Chu, Chen/J-6527-2019	Huang, Guohua/0000-0001-6954-3933; Chen, Lei/0000-0003-3068-1583; Chu, Chen/0000-0001-8084-0867; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 61202021, 61373028, 11371008, 61303099]; Innovation Program of the Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; Shanghai Educational Development Foundation [12CG55]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation	National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (31371335, 61202021, 61373028, 11371008, 61303099), the Innovation Program of the Shanghai Municipal Education Commission (12YZ120, 12ZZ087) and the Shanghai Educational Development Foundation (12CG55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aston KI, 2014, ANDROLOGY-US, V2, P315, DOI 10.1111/j.2047-2927.2014.00188.x; Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Attari F, 2014, STEM CELLS DEV, V23, P1050, DOI 10.1089/scd.2013.0438; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Ben-Shushan E, 2014, NOTCH SIGNALING REGU; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Besnard V, 2005, AM J PHYSIOL-LUNG C, V289, pL750, DOI 10.1152/ajplung.00151.2005; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Boulet AM, 2012, DEV BIOL, V371, P235, DOI 10.1016/j.ydbio.2012.08.017; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Carpenter D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-104; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Craven J, 2005, ADV NEURAL INFORM PR, V17, P193; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Dechanet C, 2011, HUM REPROD UPDATE, V17, P76, DOI 10.1093/humupd/dmq033; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Dobashi M, 2002, ASIAN J ANDROL, V4, P105; Dong YL, 2007, BIOL REPROD, V76, P892, DOI 10.1095/biolreprod.106.059089; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Feng YM, 2014, CELL CYCLE, V13, P782, DOI 10.4161/cc.27708; Gormen T. H., 1990, INTRO ALGORITHMS; Hasegawa K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121012; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Hutson LD, 2003, DEV DYNAM, V228, P358, DOI 10.1002/dvdy.10386; Izzi L, 2007, EMBO J, V26, P3132, DOI 10.1038/sj.emboj.7601753; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang M, 2013, MOL BIOSYST, V9, P2720, DOI 10.1039/c3mb70089e; Jiang R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S2; Kawamura S, 2004, INTERNAL MED, V43, P218, DOI 10.2169/internalmedicine.43.218; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kofron M, 2004, DEVELOPMENT, V131, P5065, DOI 10.1242/dev.01396; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; LEYTON L, 1989, CELL, V57, P1123, DOI 10.1016/0092-8674(89)90049-4; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li GD, 2010, MOL ENDOCRINOL, V24, P1404, DOI 10.1210/me.2010-0014; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Macropol K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-283; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Morris RS, 1996, LANCET, V347, P1277, DOI 10.1016/S0140-6736(96)90934-4; Moulos P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-235; Moussad EEDA, 2002, J CLIN PATHOL-MOL PA, V55, P186, DOI 10.1136/mp.55.3.186; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Nusinow DP, 2012, BIOINFORMATICS, V28, P3115, DOI 10.1093/bioinformatics/bts594; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Ouvrier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026966; Park YY, 2010, MOL CELLS, V30, P485, DOI 10.1007/s10059-010-0136-6; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Piao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03022; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Sanchez A, 2010, GOPROFILES R PACKAGE; Sanchez A, 2007, J STAT PLAN INFER, V137, P3975, DOI 10.1016/j.jspi.2007.04.015; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharpe RM, 2002, NAT CELL BIOL, V4, pS33, DOI 10.1038/ncb-nm-fertilityS33; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Shooner C, 2005, REPROD BIOL ENDOCRIN, V3, P1, DOI 10.1186/1477-7827-3-20; Smedley D, 2014, BIOINFORMATICS, V30, P3215, DOI 10.1093/bioinformatics/btu508; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strazzabosco M, 2010, J HEPATOL, V52, P765, DOI 10.1016/j.jhep.2009.12.022; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tulachan SS, 2007, DEV BIOL, V305, P508, DOI 10.1016/j.ydbio.2007.02.033; Vachias C, 2010, DEVELOPMENT, V137, P2703, DOI 10.1242/dev.052183; VANDUIN M, 1994, BIOL REPROD, V51, P607, DOI 10.1095/biolreprod51.4.607; Wang CH, 2014, CELL RES, V24, P610, DOI 10.1038/cr.2014.27; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Wang WG, 2012, DEVELOPMENT, V139, P601, DOI 10.1242/dev.069575; Wang XC, 2010, BIOCHEM BIOPH RES CO, V394, P29, DOI 10.1016/j.bbrc.2010.02.061; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhang J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/523415	90	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0117090	10.1371/journal.pone.0117090	http://dx.doi.org/10.1371/journal.pone.0117090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768094	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500014
J	Chung, NC; Huang, YH; Chang, CH; Liao, JC; Yang, CH; Chen, CC; Liu, IY				Chung, Ni-Chun; Huang, Ying-Hsueh; Chang, Chuan-Hsiung; Liao, James C.; Yang, Chih-Hsien; Chen, Chien-Chang; Liu, Ingrid Y.			Behavior Training Reverses Asymmetry in Hippocampal Transcriptome of the Ca(v)3.2 Knockout Mice	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; GENE-EXPRESSION; GLUTAMATE RECEPTORS; PARKINSONS-DISEASE; CALCIUM-CHANNELS; BRAIN ASYMMETRY; CA2+ CHANNELS; MEMORY; CACNA1H; FEAR	Homozygous Ca(v)3.2 knockout mice, which are defective in the pore-forming subunit of a low voltage activated T-type calcium channel, have been documented to show impaired maintenance of late-phase long-term potentiation (L-LTP) and defective retrieval of contextassociated fear memory. To investigate the role of Ca(v)3.2 in global gene expression, we performed a microarray transcriptome study on the hippocampi of the Ca(v)3.2(-/-) mice and their wild-type littermates, either naive (untrained) or trace fear conditioned. We found a significant left-right asymmetric effect on the hippocampal transcriptome caused by the Ca(v)3.2 knockout. Between the naive Ca(v)3.2(-/-) and the naive wild-type mice, 3522 differentially expressed genes (DEGs) were found in the left hippocampus, but only 4 DEGs were found in the right hippocampus. Remarkably, the effect of Ca(v)3.2 knockout was partially reversed by trace fear conditioning. The number of DEGs in the left hippocampus was reduced to 6 in the Ca(v)3.2 knockout mice after trace fear conditioning, compared with the wild-type naive mice. To our knowledge, these results demonstrate for the first time the asymmetric effects of the Ca(v)3.2 and its partial reversal by behavior training on the hippocampal transcriptome.	[Chung, Ni-Chun; Liu, Ingrid Y.] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Huang, Ying-Hsueh; Chang, Chuan-Hsiung; Yang, Chih-Hsien] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Chen, Chien-Chang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liu, Ingrid Y.] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan	Tzu Chi University; National Yang Ming Chiao Tung University; University of California System; University of California Los Angeles; Academia Sinica - Taiwan; Tzu Chi University	Liu, IY (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	ycliu@mail.tcu.edu.tw	Chen, Chien-Chang/D-2023-2015; Liu, Ingrid Y/AAN-2606-2021	Chen, Chien-Chang/0000-0001-8850-4278; Liao, James/0000-0002-4580-7276	National Science Council, Taiwan [98-2314-B-320-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by National Science Council, Taiwan (#98-2314-B-320-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Arnold OH, 1999, NEUROPSYCHOBIOLOGY, V40, P21, DOI 10.1159/000026593; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; BIANKI VL, 1981, INT J NEUROSCI, V15, P37, DOI 10.3109/00207458108985844; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Carbon M, 2006, J NEUROL SCI, V248, P72, DOI 10.1016/j.jns.2006.05.005; Chan KFY, 2004, EXP NEUROL, V190, P328, DOI 10.1016/j.expneurol.2004.08.001; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029384; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Chevalier M, 2006, EUR J NEUROSCI, V23, P2321, DOI 10.1111/j.1460-9568.2006.04761.x; Chioza B, 2006, EPILEPSY RES, V69, P177, DOI 10.1016/j.eplepsyres.2006.01.009; Costanzo MJ, 2008, BIOORG MED CHEM LETT, V18, P2114, DOI 10.1016/j.bmcl.2008.01.093; Cribbs LL, 2000, FEBS LETT, V466, P54, DOI 10.1016/S0014-5793(99)01756-1; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Alvares LD, 2013, NEUROSCIENCE, V244, P42, DOI 10.1016/j.neuroscience.2013.04.005; Dong SZ, 2007, EUR J NEUROSCI, V26, P101, DOI 10.1111/j.1460-9568.2007.05641.x; Dreosti E, 2014, CURR BIOL, V24, P440, DOI 10.1016/j.cub.2014.01.016; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Gafford GM, 2011, NEUROSCIENCE, V182, P98, DOI 10.1016/j.neuroscience.2011.03.023; Gao ZY, 1998, EUR J NEUROSCI, V10, P2416, DOI 10.1046/j.1460-9568.1998.00252.x; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Hanlon FM, 2005, BEHAV NEUROSCI, V119, P863, DOI 10.1037/0735-7044.119.4.863; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hou GL, 2013, NEUROCHEM RES, V38, P453, DOI 10.1007/s11064-012-0954-3; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; Jellinger KA, 2002, J NEURAL TRANSM-SUPP, P347; Johnson CM, 1997, J NEUROSCI, V17, P6189; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Li BX, 2014, NAT NEUROSCI, V17, P1055, DOI 10.1038/nn.3744; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Liang J, 2007, ANN HUM GENET, V71, P325, DOI 10.1111/j.1469-1809.2006.00332.x; Liang JM, 2006, NEUROSCI LETT, V406, P27, DOI 10.1016/j.neulet.2006.06.073; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Maguire EA, 2003, J NEUROSCI, V23, P5302; Mei B, 2005, BRAIN RES BULL, V67, P1, DOI 10.1016/j.brainresbull.2005.03.023; Moskal JR, 2006, HIPPOCAMPUS, V16, P629, DOI 10.1002/hipo.20198; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Raftogianni A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048337; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Son WY, 2002, DEV GROWTH DIFFER, V44, P181, DOI 10.1046/j.1440-169X.2002.00633.x; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Steenland HW, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-16; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Tran LM, 2005, METAB ENG, V7, P128, DOI 10.1016/j.ymben.2004.12.001; TRANEL D, 1991, BRAIN COGNITION, V15, P187, DOI 10.1016/0278-2626(91)90025-4; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	60	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118832	10.1371/journal.pone.0118832	http://dx.doi.org/10.1371/journal.pone.0118832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768289	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500047
J	Kim, S; Sung, J; Foo, M; Jin, YS; Kim, PJ				Kim, Seunghyeon; Sung, Jaeyun; Foo, Mathias; Jin, Yong-Su; Kim, Pan-Jun			Uncovering the Nutritional Landscape of Food	PLOS ONE			English	Article							CHILDHOOD; NUTRIENT; NETWORK	Recent progresses in data-driven analysis methods, including network-based approaches, are revolutionizing many classical disciplines. These techniques can also be applied to food and nutrition, which must be studied to design healthy diets. Using nutritional information from over 1,000 raw foods, we systematically evaluated the nutrient composition of each food in regards to satisfying daily nutritional requirements. The nutrient balance of a food was quantified and termed nutritional fitness; this measure was based on the food's frequency of occurrence in nutritionally adequate food combinations. Nutritional fitness offers a way to prioritize recommendable foods within a global network of foods, in which foods are connected based on the similarities of their nutrient compositions. We identified a number of key nutrients, such as choline and alpha-linolenic acid, whose levels in foods can critically affect the nutritional fitness of the foods. Analogously, pairs of nutrients can have the same effect. In fact, two nutrients can synergistically affect the nutritional fitness, although the individual nutrients alone may not have an impact. This result, involving the tendency among nutrients to exhibit correlations in their abundances across foods, implies a hidden layer of complexity when exploring for foods whose balance of nutrients within pairs holistically helps meet nutritional requirements. Interestingly, foods with high nutritional fitness successfully maintain this nutrient balance. This effect expands our scope to a diverse repertoire of nutrient-nutrient correlations, which are integrated under a common network framework that yields unexpected yet coherent associations between nutrients. Our nutrient-profiling approach combined with a network-based analysis provides a more unbiased, global view of the relationships between foods and nutrients, and can be extended towards nutritional policies, food marketing, and personalized nutrition.	[Kim, Seunghyeon; Sung, Jaeyun; Foo, Mathias; Kim, Pan-Jun] Asia Pacific Ctr Theoret Phys, Pohang, South Korea; [Kim, Seunghyeon; Kim, Pan-Jun] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Jin, Yong-Su] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Jin, Yong-Su] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kim, PJ (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, South Korea.	pjkim@apctp.org	Foo, Mathias/AAR-9549-2021; Foo, Mathias/GSO-3501-2022; Jin, Yong-Su/L-4530-2013	Foo, Mathias/0000-0003-1400-2659; Sung, Jaeyun/0000-0002-3005-2798	Basic Science Research Program through the National Research Foundation of Korea [NRF-2012R1A1A2008925]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF-2012R1A1A2008925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; Babic Z, 2011, INT J PROD ECON, V130, P218, DOI 10.1016/j.ijpe.2010.12.016; Barrat A., 2009, DYNAMICAL PROCESSES; Boon CS, 2005, CRIT REV FOOD SCI, V45, P511, DOI 10.1080/10408690590957160; Church SM, 2006, NUTR BULL, V31, P15, DOI 10.1111/j.1467-3010.2006.00538.x; Crawford I.M., 1997, AGR FOOD MARKETING M; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; GOLDSMITH GA, 1958, AM J CLIN NUTR, V6, P479, DOI 10.1093/ajcn/6.5.479; Keen C. L., 2006, MINERAL REQUIREMENTS, P304; Kennedy E, 2008, NUTR REV, V66, P703, DOI 10.1111/j.1753-4887.2008.00124.x; Kim SW, 2013, SUSTAINABLE SWINE NU, P217; Kittler P.G., 2008, FOOD CULTURE; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Menaa F, 2013, J FOOD SCI, V78, pR377, DOI 10.1111/1750-3841.12055; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; National Health and Medical Research Council (NHMRC), 2013, AUSTR DIET GUID; National Research Council, 2005, DIET REF INT EN CARB; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Otten JJ, 2006, DIETARY REFERENCE IN, P219; Santika O, 2009, J NUTR, V139, P135, DOI 10.3945/jn.108.092270; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311; Yang Y, 2013, P NATL ACAD SCI USA, V110, P4545, DOI 10.1073/pnas.1216075110; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x	29	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118697	10.1371/journal.pone.0118697	http://dx.doi.org/10.1371/journal.pone.0118697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768022	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500037
J	Mourits, DL; Hartong, DT; Bosscha, MI; Kloos, RJHM; Moll, AC				Mourits, Daphne L.; Hartong, Dyonne T.; Bosscha, Machteld I.; Kloos, Roel J. H. M.; Moll, Annette C.			Worldwide Enucleation Techniques and Materials for Treatment of Retinoblastoma: An International Survey	PLOS ONE			English	Article							ORBITAL IMPLANTS; ANOPHTHALMIC SOCKET; HYDROXYAPATITE; EVISCERATION; MOTILITY; PTOSIS; TRENDS	Purpose To investigate the current practice of enucleation with or without orbital implant for retinoblastoma in countries across the world. Methods A digital survey identifying operation techniques and material used for orbital implants after enucleation in patients with retinoblastoma. Results We received a response of 58 surgeons in 32 different countries. A primary artificial implant is routinely inserted by 42 (72.4%) surgeons. Ten (17.2%) surgeons leave the socket empty, three (5.2%) decide per case. Other surgeons insert a dermis fat graft as a standard primary implant (n=1), or fill the socket in a standard secondary procedure (n=2; one uses dermis fat grafts and one artificial implants). The choice for porous implants was more frequent than for non-porous implants: 27 (58.7%) and 15 (32.6%), respectively. Both porous and non-porous implant types are used by 4 (8.7%) surgeons. Twenty-five surgeons (54.3%) insert bare implants, 11 (23.9%) use separate wrappings, eight (17.4%) use implants with prefab wrapping and two insert implants with and without wrapping depending on type of implant. Attachment of the muscles to the wrapping or implant (at various locations) is done by 31 (53.4%) surgeons. Eleven (19.0%) use a myoconjunctival technique, nine (15.5%) suture the muscles to each other and seven (12.1%) do not reattach the muscles. Measures to improve volume are implant exchange at an older age (n=4), the use of Restylane SQ (n=1) and osmotic expanders (n=1). Pegging is done by two surgeons. Conclusion No (worldwide) consensus exists about the use of material and techniques for enucleation for the treatment of retinoblastoma. Considerations for the use of different techniques are discussed.	[Mourits, Daphne L.; Hartong, Dyonne T.; Bosscha, Machteld I.; Moll, Annette C.] Vrije Univ Amsterdam Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Kloos, Roel J. H. M.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Mourits, DL (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands.	d.mourits@vumc.nl	Bosscha, Machteld/T-2808-2019		ODAS Foundation, Delft, the Netherlands	ODAS Foundation, Delft, the Netherlands(Netherlands Government)	Funding: This study was financially supported by a grant from the ODAS Foundation, Delft, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN L, 1983, OPHTHALMOLOGY, V90, P1116; Baino F, 2014, ACTA BIOMATER, V10, P1064, DOI 10.1016/j.actbio.2013.12.014; Carroll WL, 2010, CANC CHILDREN ADOLES; Choi YJ, 2013, BRIT J OPHTHALMOL, V97, P1530, DOI 10.1136/bjophthalmol-2013-303481; Chojniak MM, 2012, PEDIATR HEMAT ONCOL, V34, P102; Cleres B, 2014, OPHTHALMOLOGE, V111, P572, DOI 10.1007/s00347-013-2950-7; Colen TP, 2000, OPHTHALMOLOGY, V107, P1889, DOI 10.1016/S0161-6420(00)00348-1; Custer PL, 1999, OPHTHALMOLOGY, V106, P513, DOI 10.1016/S0161-6420(99)90109-4; Custer PL, 2003, OPHTHALMOLOGY, V110, P2054, DOI 10.1016/S0161-6420(03)00857-1; Fountain TR, 1999, OPHTHALMIC PLAST REC, V15, P32, DOI 10.1097/00002341-199901000-00008; Hintschich C, 2001, BRIT J OPHTHALMOL, V85, P205, DOI 10.1136/bjo.85.2.205; Jordan DR, 1999, OPHTHALMOLOGY, V106, P505, DOI 10.1016/S0161-6420(99)90108-2; Kaltreider SA, 2003, OPHTHAL PLAST RECONS, V19, P421, DOI 10.1097/01.IOP.0000092799.82563.D7; Kaltreider SA, 2001, ARCH OPHTHALMOL-CHIC, V119, P379, DOI 10.1001/archopht.119.3.379; Kim NJ, 2008, OPHTHALMOLOGICA, V222, P351, DOI 10.1159/000146896; Moshfeghi DM, 2000, SURV OPHTHALMOL, V44, P277, DOI 10.1016/S0039-6257(99)00112-5; Mourits MP, 2012, ORBIT, P1, DOI [10.3109/01676830.2011.638098, DOI 10.3109/01676830.2011.638098]; Mules PH., 1885, T OPHTHAL SOC UK, V5, P200; NUNERY WR, 1993, OPHTHALMIC PLAST REC, V9, P96, DOI 10.1097/00002341-199306000-00004; Peylan-Ramu N, 2001, MED PEDIATR ONCOL, V37, P465, DOI 10.1002/mpo.1231; Sami D, 2007, SURV OPHTHALMOL, V52, P244, DOI 10.1016/j.survophthal.2007.02.007; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; Shildkrot Y, 2011, OPHTHALMOLOGY, V118, P2480, DOI 10.1016/j.ophtha.2011.05.024; Shome D, 2010, OPHTHALMOLOGY, V117, P1638, DOI 10.1016/j.ophtha.2009.12.035; SMIT TJ, 1991, BRIT J OPHTHALMOL, V75, P667, DOI 10.1136/bjo.75.11.667; SMIT TJ, 1990, OPHTHALMOLOGY, V97, P1347; Su GW, 2004, OPHTHAL PLAST RECONS, V20, P274, DOI 10.1097/01.IOP.0000129528.16938.1E; Trichopoulos N, 2005, OPHTHAL PLAST RECONS, V21, P331, DOI 10.1097/01.iop.0000175034.88019.a5; TYERS AG, 1982, T OPHTHAL SOC UK, V102, P90; VISTNES LM, 1976, PLAST RECONSTR SURG, V58, P539, DOI 10.1097/00006534-197611000-00002; Viswanathan P, 2007, BRIT J OPHTHALMOL, V91, P616, DOI 10.1136/bjo.2006.103937; Wells TS, 2011, OPHTHAL PLAST RECONS, V27, P364, DOI 10.1097/IOP.0b013e31821c1298; Yadava Usha, 2004, Indian Journal of Ophthalmology, V52, P221	33	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121292	10.1371/journal.pone.0121292	http://dx.doi.org/10.1371/journal.pone.0121292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767872	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500140
J	Storti, B; Di Rienzo, C; Cardarelli, F; Bizzarri, R; Beltram, F				Storti, Barbara; Di Rienzo, Carmine; Cardarelli, Francesco; Bizzarri, Ranieri; Beltram, Fabio			Unveiling TRPV1 Spatio-Temporal Organization in Live Cell Membranes	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; RESONANCE ENERGY-TRANSFER; FLUORESCENT PROTEIN; CAPSAICIN RECEPTOR; IN-VIVO; CHANNEL SUBUNITS; LIPID RAFTS; ION-CHANNEL; MICROTUBULES; BINDING	Transient Receptor Potential Vanilloid 1 (TRPV1) is a non-selective cation channel that integrates several stimuli into nociception and neurogenic inflammation. Here we investigated the subtle TRPV1 interplay with candidate membrane partners in live cells by a combination of spatio-temporal fluctuation techniques and fluorescence resonance energy transfer (FRET) imaging. We show that TRPV1 is split into three populations with fairly different molecular properties: one binding to caveolin-1 and confined into caveolar structures, one actively guided by microtubules through selective binding, and one which diffuses freely and is not directly implicated in regulating receptor functionality. The emergence of caveolin- 1 as a new interactor of TRPV1 evokes caveolar endocytosis as the main desensitization pathway of TRPV1 receptor, while microtubule binding agrees with previous data suggesting the receptor stabilization in functional form by these cytoskeletal components. Our results shed light on the hitherto unknown relationships between spatial organization and TRPV1 function in live-cell membranes.	[Storti, Barbara; Di Rienzo, Carmine; Bizzarri, Ranieri; Beltram, Fabio] Scuola Normale Super Pisa, NEST, Pisa, Italy; [Storti, Barbara; Di Rienzo, Carmine; Bizzarri, Ranieri; Beltram, Fabio] CNR, Ist Nanosci, I-56100 Pisa, Italy; [Di Rienzo, Carmine; Cardarelli, Francesco; Beltram, Fabio] Ist Italiano Tecnol, NEST, Ctr Nanotechnol Innovat, Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Istituto Italiano di Tecnologia - IIT	Bizzarri, R (corresponding author), Scuola Normale Super Pisa, NEST, Pisa, Italy.	ranieri.bizzarri@nano.cnr.it	Bizzarri, Ranieri/ABH-8343-2020; Storti, Barbara/AAB-7791-2019; Beltram, Fabio/L-9486-2019; Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/H-1779-2011	Storti, Barbara/0000-0002-2758-0426; Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672	Italian Ministry for University and Research (MiUR) under the framework of the FIRB project [RBPR05JH2P]; PRIN [010BJ23MN_004]	Italian Ministry for University and Research (MiUR) under the framework of the FIRB project(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Italian Ministry for University and Research (MiUR) under the framework of the FIRB project RBPR05JH2P and PRIN project 010BJ23MN_004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cortright DN, 2004, EUR J BIOCHEM, V271, P1814, DOI 10.1111/j.1432-1033.2004.04082.x; Digman MA, 2009, MICROSC RES TECHNIQ, V72, P323, DOI 10.1002/jemt.20655; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; Goswami C, 2012, J NEUROCHEM, V123, P1, DOI 10.1111/j.1471-4159.2012.07892.x; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hellmich UA, 2014, HANDB EXP PHARMACOL, V223, P991, DOI 10.1007/978-3-319-05161-1_11; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Holzer P, 2014, BRIT J PHARMACOL, V171, P2469, DOI 10.1111/bph.12723; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Kohler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023798; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Orlichenko L, 2009, MOL BIOL CELL, V20, P4140, DOI 10.1091/mbc.E08-10-1043; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Patterson G, 2001, J CELL SCI, V114, P837; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rienzo C Di, 2013, P NATL ACAD SCI US; Ries J, 2009, BIOPHYS J, V96, P1999, DOI 10.1016/j.bpj.2008.12.3888; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schneckenburger H, 2005, CURR OPIN BIOTECH, V16, P13, DOI 10.1016/j.copbio.2004.12.004; Sowa G, 2001, P NATL ACAD SCI USA, V98, P14072, DOI 10.1073/pnas.241409998; Stepensky D, 2007, BIOCHEM BIOPH RES CO, V359, P752, DOI 10.1016/j.bbrc.2007.05.180; Storti B, 2012, J BIOL CHEM, V287, P7803, DOI 10.1074/jbc.M111.332296; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Wang Y, 2008, NEUROCHEM RES, V33, P2008, DOI 10.1007/s11064-008-9750-5; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	47	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0116900	10.1371/journal.pone.0116900	http://dx.doi.org/10.1371/journal.pone.0116900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764349	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300007
J	Lecube, A; Sampol, G; Hernandez, C; Romero, O; Ciudin, A; Simo, R				Lecube, Albert; Sampol, Gabriel; Hernandez, Cristina; Romero, Odile; Ciudin, Andreea; Simo, Rafael			Characterization of Sleep Breathing Pattern in Patients with Type 2 Diabetes: Sweet Sleep Study	PLOS ONE			English	Article							APNEA; RISK; MELLITUS	Background Although sleep apnea-hypopnea syndrome (SAHS) is highly prevalent in patients with type 2 diabetes (T2D), it is unknown whether or not subjects with and without T2D share the same sleep breathing pattern. Methodology/Principal findings A cross-sectional study in patients with SAHS according to the presence (n = 132) or not (n = 264) of T2D. Both groups were matched by age, gender, BMI, and waist and neck circumferences. A subgroup of 125 subjects was also matched by AHI. The exclusion criteria included chronic respiratory disease, alcohol abuse, use of sedatives, and heart failure. A higher apnea hypopnea index (AHI) was observed in T2D patients [32.2 (10.2-114.0) vs. 25.6 (10.2-123.4) events/hours; p = 0.002). When sleep events were evaluated separately, patients with T2D showed a significant increase in apnea events [8.4 (0.1-87.7) vs. 6.3 (0.0-105.6) e/h; p = 0.044), as well as a two-fold increase in the percentage of time spent with oxygen saturation <90% [15.7 (0.0-97.0) vs. 7.9 (0.0-95.6) %; <0.001)], higher rates of oxygen desaturation events, and also higher daily sleepiness [7.0 (0.0-21.0) vs. 5.0 (0.0-21.0); p = 0.006)] than subjects without T2D. Significant positive correlations between fasting plasma glucose and AHI, the apnea events, and CT90 were observed. Finally, multiple linear regression analyses showed that T2D was independently associated with AHI (R-2 = 0.217), the apnea index (R-2 = 0.194), CT90 (R-2 = 0.222), and desaturation events. Conclusions/significance T2D patients present a different pattern of sleep breathing than subject without diabetes. The most important differences are the severity of hypoxemia and the number of apneas whereas the incidence of hypopnea episodes is similar.	[Lecube, Albert; Hernandez, Cristina; Ciudin, Andreea; Simo, Rafael] Univ Autonoma Barcelona, Inst Recerca & Hosp Univ Vall dHebron VHIR, CIBER Diabet Enfermedades Metab Asociadas CIBERDE, ISCIII,Endocrinol Dept, E-08193 Barcelona, Spain; [Lecube, Albert] Univ Lleida, IRB Lleida, Hosp Univ Arnau de Vilanova, Endocrinol & Nutr Dept, Lleida, Spain; [Sampol, Gabriel; Romero, Odile] Univ Autonoma Barcelona, Inst Recerca & Hosp Univ Vall dHebron VHIR, CIBERES, ISCIII,Dept Neurophysiol,Sleep Unit, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University Hospital Arnau de Vilanova; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Lecube, A (corresponding author), Univ Autonoma Barcelona, Inst Recerca & Hosp Univ Vall dHebron VHIR, CIBER Diabet Enfermedades Metab Asociadas CIBERDE, ISCIII,Endocrinol Dept, E-08193 Barcelona, Spain.	alecube@gmail.com	Romero, Odile/N-8109-2015; CIUDIN, ANDREEA/O-5250-2016; Lecube, Albert/H-3813-2019	Romero, Odile/0000-0002-0147-596X; CIUDIN, ANDREEA/0000-0001-5622-0203; Lecube, Albert/0000-0001-9684-0183; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721	Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria) [PI 12/00803]; Sociedad Espanola Endocrinologia y Nutricion	Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos III); Sociedad Espanola Endocrinologia y Nutricion	This study was supported by grants from the Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria, PI 12/00803), and the Sociedad Espanola Endocrinologia y Nutricion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; [Anonymous], 2011, Adv Cardiol, V46, P139, DOI 10.1159/000325108; Campo A, 2007, EUR RESPIR J, V30, P223, DOI 10.1183/09031936.00115006; Ficker JH, 1998, EUR RESPIR J, V11, P14, DOI 10.1183/09031936.98.11010014; Hartge MM, 2008, DIABETES VASC DIS RE, V4, P84; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lecube A, 2011, CYTOKINE, V54, P121, DOI 10.1016/j.cyto.2011.01.010; Lecube A, 2010, DIABETOLOGIA, V53, P1210, DOI 10.1007/s00125-010-1700-5; Lecube A, 2010, DIABETES-METAB RES, V26, P639, DOI 10.1002/dmrr.1131; Lecube A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004692; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Muraki I, 2010, DIABETOLOGIA, V53, P481, DOI 10.1007/s00125-009-1616-0; Nieto FJ, 2004, AM J RESP CRIT CARE, V169, P354, DOI 10.1164/rccm.200306-756OC; Peltier AC, 2007, SLEEP MED, V8, P149, DOI 10.1016/j.sleep.2006.06.010; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; Ramadan W, 2007, OBESITY, V15, P1409, DOI 10.1038/oby.2007.169; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Sampol Gabriel, 2012, Endocrinol Nutr, V59, P95, DOI 10.1016/j.endonu.2011.12.003; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Williams A, 2007, SLEEP BREATH, V11, P69, DOI 10.1007/s11325-007-0106-1	23	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119073	10.1371/journal.pone.0119073	http://dx.doi.org/10.1371/journal.pone.0119073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760760	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000046
J	Yu, H; Jiang, WZ; Liu, Q; Zhang, H; Piao, MX; Chen, ZD; Bian, MD				Yu, Hui; Jiang, Wenzhu; Liu, Qing; Zhang, Hui; Piao, Mingxin; Chen, Zhengdao; Bian, Mingdi			Expression Pattern and Subcellular Localization of the Ovate Protein Family in Rice	PLOS ONE			English	Article							BRASSINOSTEROID SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR FAMILY; GENE-EXPRESSION; HOMEOBOX GENE; DOMAIN PROTEIN; PLANT-GROWTH; ARABIDOPSIS; CELL; MUTANT; IDENTIFICATION	The Arabidopsis ovate family proteins (AtOFPs) have been shown to function as transcriptional repressors and regulate multiple aspects of plant growth and development. There are 31 genes that encode the full-length OVATE-domain containing proteins in the rice genome. In this study, the gene structure analysis revealed that OsOFPs are intron poor. Phylogenetic analysis suggested that OVATE proteins from rice, Arabidopsis and tomato can be divided into 4 groups (I-IV). Real-time quantitative polymerase chain reaction (RT-qPCR) analysis identified OsOFPs with different tissue-specific expression patterns at all stages of development in the rice plant. Interestingly, nearly half of the total number of OsOFP family was more highly expressed during the seed developmental stage. In addition, seed developmental cis-elements were found in the promoter region of the OsOFPs. Subcellular localization analysis revealed that YFP-OsOFP fusion proteins predominantly localized in the nucleus. Our results suggest that OsOFPs may act as regulatory proteins and play pivotal roles in the growth and development of rice.	[Yu, Hui; Jiang, Wenzhu; Liu, Qing; Zhang, Hui; Piao, Mingxin; Chen, Zhengdao; Bian, Mingdi] Jilin Univ, Coll Plant Sci, Lab Soil & Plant Mol Genet, Changchun 130062, Peoples R China	Jilin University	Bian, MD (corresponding author), Jilin Univ, Coll Plant Sci, Lab Soil & Plant Mol Genet, Changchun 130062, Peoples R China.	bianmd@jlu.edu.cn	Jiang, Wenzhu/AAD-7561-2022		National Major Project, Crop Yield Improvement Using Synthetic Transcription Factor [2010ZX08010-002]	National Major Project, Crop Yield Improvement Using Synthetic Transcription Factor	This work was supported by the National Major Project, Crop Yield Improvement Using Synthetic Transcription Factor (2010ZX08010-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinsug MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030846; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Century K, 2008, PLANT PHYSIOL, V147, P20, DOI 10.1104/pp.108.117887; Dai MQ, 2007, PLANT PHYSIOL, V144, P380, DOI 10.1104/pp.107.095737; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Heang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031325; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Hong Z, 2005, PLANT CELL, V17, P2243, DOI 10.1105/tpc.105.030973; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Jiang YH, 2012, PLANT J, V70, P398, DOI 10.1111/j.1365-313X.2011.04877.x; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Kuijt SJH, 2004, PLANT MOL BIOL, V55, P781, DOI 10.1007/s11103-005-1967-y; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Liu D, 2014, ANN BOT-LONDON, V113, P1219, DOI 10.1093/aob/mcu061; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; Nagamura Y, 2011, PLANT CELL PHYSIOL, V52, P230, DOI 10.1093/pcp/pcq197; Nakagawa H, 2012, PLANT PHYSIOL, V158, P1208, DOI 10.1104/pp.111.187567; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Sato Y, 1996, P NATL ACAD SCI USA, V93, P8117, DOI 10.1073/pnas.93.15.8117; Scott MP, 2000, CELL, V100, P27, DOI 10.1016/S0092-8674(00)81681-5; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsaballa A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-46; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x; Wang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023896; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xue LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031081; Yaish MW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001098; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yoshihara T, 1996, PLANT SCI, V121, P63, DOI 10.1016/S0168-9452(96)04511-6; Yoshii M, 2009, PLANT J, V57, P615, DOI 10.1111/j.1365-313X.2008.03712.x; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhang C, 2012, PLOS GENET, V8, P651, DOI 10.1371/journal.pgen.1002686; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu QH, 2004, PLANT PHYSIOL, V135, P1514, DOI 10.1104/pp.104.041459	58	32	39	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118966	10.1371/journal.pone.0118966	http://dx.doi.org/10.1371/journal.pone.0118966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760462	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275000044
J	Greenlee, MHW; Smith, JD; Platt, EM; Juarez, JR; Timms, LL; Greenlee, JJ				Greenlee, M. Heather West; Smith, Jodi D.; Platt, Ekundayo M.; Juarez, Jessica R.; Timms, Leo L.; Greenlee, Justin J.			Changes in Retinal Function and Morphology Are Early Clinical Signs of Disease in Cattle with Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; CREUTZFELDT-JAKOB-DISEASE; ELECTRORETINOGRAM B-WAVE; PROTEIN GENE PRNP; PRION PROTEIN; EXPERIMENTAL TRANSMISSION; CEREBROSPINAL-FLUID; PARKINSON DISEASE; SUFFOLK SHEEP; DEER	Bovine spongiform encephalopathy (BSE) belongs to a group of fatal, transmissible protein misfolding diseases known as transmissible spongiform encephalopathies (TSEs). All TSEs are caused by accumulation of misfolded prion protein (PrPSc) throughout the central nervous system (CNS), which results in neuronal loss and ultimately death. Like other protein misfolding diseases including Parkinson's disease and Alzheimer's disease, TSEs are generally not diagnosed until the onset of disease after the appearance of unequivocal clinical signs. As such, identification of the earliest clinical signs of disease may facilitate diagnosis. The retina is the most accessible part of the central nervous system, and retinal pathology in TSE affected animals has been previously reported. Here we describe antemortem changes in retinal function and morphology that are detectable in BSE inoculated animals several months (up to 11 months) prior to the appearance of any other signs of clinical disease. We also demonstrate that differences in the severity of these clinical signs reflect the amount of PrPSc accumulation in the retina and the resulting inflammatory response of the tissue. These results are the earliest reported clinical signs associated with TSE infection and provide a basis for understanding the pathology and evaluating therapeutic interventions.	[Greenlee, M. Heather West] Iowa State Univ, Dept Biomed Sci, Ames, IA 50010 USA; [Greenlee, M. Heather West; Platt, Ekundayo M.] Iowa State Univ, Interdept Toxicol Program, Ames, IA 50010 USA; [Smith, Jodi D.; Greenlee, Justin J.] Natl Anim Dis Ctr, Virus & Prion Res Unit, Ames, IA 50010 USA; [Platt, Ekundayo M.] Iowa State Univ, Dept Genet & Cell Biol, Ames, IA 50010 USA; [Juarez, Jessica R.; Timms, Leo L.] Iowa State Univ, Dept Anim Sci, Ames, IA 50010 USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Greenlee, MHW (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50010 USA.	mheather@iastate.edu	Greenlee, Justin/Y-5732-2019	Greenlee, Justin/0000-0003-2202-3054; Smith, Jodi/0000-0001-7952-8024	Agricultural Research Service; Agricultural Research Service, US Department of Agriculture [58-3625-5-114]	Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Agricultural Research Service, US Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the Agricultural Research Service 'Transmission, differentiation, and pathobiology of transmissible spongiform encephalopathies'; and the Specific Cooperative Agreement #58-3625-5-114 with the Agricultural Research Service, US Department of Agriculture. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bannach O, 2013, VET MICROBIOL, V166, P102, DOI 10.1016/j.vetmic.2013.05.021; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Fernandez-Borges N., 2013, INT J CELL BIOL, V2013, DOI [10.1155/2013/583498, DOI 10.1155/2013/583498]; Garcia-Martin E, 2014, RETINA-J RET VIT DIS, V34, P971, DOI 10.1097/IAE.0000000000000028; Garcia-Martin E, 2014, INVEST OPHTH VIS SCI, V55, P696, DOI 10.1167/iovs.13-13062; Garcia-Martin E, 2014, AM J OPHTHALMOL, V157, P470, DOI 10.1016/j.ajo.2013.09.028; Gharbiya M, 2014, J ALZHEIMERS DIS, V40, P907, DOI 10.3233/JAD-132039; Greenlee JJ, 2006, VET PATHOL, V43, P733, DOI 10.1354/vp.43-5-733; Greenlee JJ, 2012, J VET DIAGN INVEST, V24, P1087, DOI 10.1177/1040638712461249; Greenlee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038678; Haley NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081488; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hamir AN, 2008, VET PATHOL, V45, P297, DOI 10.1354/vp.45-3-297; Hamir AN, 2011, J VET DIAGN INVEST, V23, P407, DOI 10.1177/1040638711403404; Hamir AN, 2006, VET PATHOL, V43, P118, DOI 10.1354/vp.43-2-118; Hamir AN, 2006, J COMP PATHOL, V134, P63, DOI 10.1016/j.jcpa.2005.07.001; Hamir AN, 2005, J VET DIAGN INVEST, V17, P3, DOI 10.1177/104063870501700103; Heckenlively J. R., 2006, PRINCIPLES PRACTICE, V2nd; Hortells P, 2006, BRAIN RES, V1108, P188, DOI 10.1016/j.brainres.2006.06.021; Ishikawa A, 2009, JPN J OPHTHALMOL, V53, P31, DOI 10.1007/s10384-008-0608-9; Jeffrey M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091026; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Katz BJ, 2000, J NEURO-OPHTHALMOL, V20, P116, DOI 10.1097/00041327-200020020-00011; Konold Timm, 2012, BMC Res Notes, V5, P674, DOI [10.1186/1756-0500-4-259, 10.1186/1756-0500-5-674]; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Lacroux C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004202; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Luers L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072623; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; Moda F, 2014, NEW ENGL J MED, V371, P530, DOI 10.1056/NEJMoa1404401; Murayama Y, 2014, J GEN VIROL, V95, P2576, DOI 10.1099/vir.0.066225-0; Nichols TA, 2012, J VET DIAGN INVEST, V24, P746, DOI 10.1177/1040638712448060; Omori Y, 2012, J NEUROSCI, V32, P6126, DOI 10.1523/JNEUROSCI.0322-12.2012; Orru CD, 2014, NEW ENGL J MED, V371, P519, DOI 10.1056/NEJMoa1315200; Regnier A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-25; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Ritchie DL, 2009, J GEN VIROL, V90, P3075, DOI 10.1099/vir.0.013227-0; Roth NM, 2014, MOVEMENT DISORD, V29, P1163, DOI 10.1002/mds.25896; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Satue M, 2014, BRIT J OPHTHALMOL, V98, P350, DOI 10.1136/bjophthalmol-2013-304152; Seelig DM, 2015, VET PATHOL, V52, P107, DOI 10.1177/0300985814524798; Shim H, 2012, J BIOL CHEM, V287, P14873, DOI 10.1074/jbc.M112.345751; Smith JD, 2008, J COMP PATHOL, V138, P12, DOI 10.1016/j.jcpa.2007.09.002; Smith JD, 2009, VET PATHOL, V46, P810, DOI 10.1354/vp.08-VP-0206-W-FL; Smith JD, 2009, VET REC, V165, P179, DOI 10.1136/vr.165.6.179; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; Soto C, 2011, TRENDS MOL MED, V17, P14, DOI 10.1016/j.molmed.2010.09.001; Spraker TR, 2010, VET PATHOL, V47, P536, DOI 10.1177/0300985810363702; Vrentas CE, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-167; Watts JC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003990	55	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119431	10.1371/journal.pone.0119431	http://dx.doi.org/10.1371/journal.pone.0119431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756286	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275700045
J	Ioannou, D; Kandukuri, L; Quadri, A; Becerra, V; Simpson, JL; Tempest, HG				Ioannou, Dimitrios; Kandukuri, Lakshmi; Quadri, Ameer; Becerra, Victor; Simpson, Joe Leigh; Tempest, Helen G.			Spatial Positioning of All 24 Chromosomes in the Lymphocytes of Six Subjects: Evidence of Reproducible Positioning and Spatial Repositioning following DNA Damage with Hydrogen Peroxide and Ultraviolet B	PLOS ONE			English	Article							ORDER CHROMATIN ARRANGEMENTS; NUCLEAR ARCHITECTURE; TERRITORY ARRANGEMENTS; SEGMENTAL DUPLICATIONS; GENOME; ORGANIZATION; REPAIR; CELLS; CYTOTOXICITY; GENOTOXICITY	The higher-order organization of chromatin is well-established, with chromosomes occupying distinct positions within the interphase nucleus. Chromatin is susceptible to, and constantly assaulted by both endogenous and exogenous threats. However, the effects of DNA damage on the spatial topology of chromosomes are hitherto, poorly understood. This study investigates the organization of all 24 human chromosomes in lymphocytes from six individuals prior to- and following in-vitro exposure to genotoxic agents: hydrogen peroxide and ultraviolet B. This study is the first to report reproducible distinct hierarchical radial organization of chromosomes with little inter-individual differences between subjects. Perturbed nuclear organization was observed following genotoxic exposure for both agents; however a greater effect was observed for hydrogen peroxide including: 1) More peripheral radial organization; 2) Alterations in the global distribution of chromosomes; and 3) More events of chromosome repositioning (18 events involving 10 chromosomes vs. 11 events involving 9 chromosomes for hydrogen peroxide and ultraviolet B respectively). Evidence is provided of chromosome repositioning and altered nuclear organization following in-vitro exposure to genotoxic agents, with notable differences observed between the two investigated agents. Repositioning of chromosomes following genotoxicity involved recurrent chromosomes and is most likely part of the genomes inherent response to DNA damage. The variances in nuclear organization observed between the two agents likely reflects differences in mobility and/or decondensation of chromatin as a result of differences in the type of DNA damage induced, chromatin regions targeted, and DNA repair mechanisms.	[Ioannou, Dimitrios; Kandukuri, Lakshmi; Quadri, Ameer; Becerra, Victor; Simpson, Joe Leigh; Tempest, Helen G.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA; [Simpson, Joe Leigh] March Dimes Fdn, White Plains, NY USA; [Tempest, Helen G.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Tempest, HG (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA.	htempest@fiu.edu		Tempest, Helen/0000-0002-2369-4127	Department of Defense grant "Mass Scale Biosensor Threat Diagnostic for In-Theater Defense Utilization" [W81XWh-10-1-0732]; Herbert Wertheim College of Medicine at Florida International University (startup funds)	Department of Defense grant "Mass Scale Biosensor Threat Diagnostic for In-Theater Defense Utilization"(United States Department of Defense); Herbert Wertheim College of Medicine at Florida International University (startup funds)	This study was funded in part by a Department of Defense grant "Mass Scale Biosensor Threat Diagnostic for In-Theater Defense Utilization" W81XWh-10-1-0732 for the assessment of chromosomal aberrations following genotoxicity exposure, and supported the following authors DI, LK, JLS and HGT. The authors would also like to acknowledge the financial support for the chromosome territory organization studies provided by the Herbert Wertheim College of Medicine at Florida International University (startup funds awarded to HGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bourne G., 2013, HUMAN INTERPHASE CHR, P9; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Bridger JM, 2014, ADV EXP MED BIOL, V773, P263, DOI 10.1007/978-1-4899-8032-8_12; Buyukleyla M, 2009, ECOTOX ENVIRON SAFE, V72, P943, DOI 10.1016/j.ecoenv.2008.10.005; Cavalli G, 2007, CURR OPIN GENET DEV, V17, P443, DOI 10.1016/j.gde.2007.08.013; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Celik A, 2011, INT J HUM GENET, V11, P23, DOI 10.1080/09723757.2011.11886119; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2006, EUR J HISTOCHEM, V50, P223; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Elcock LS, 2010, BIOCHEM SOC T, V38, P263, DOI 10.1042/BST0380263; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; ESTERVIG D, 1984, PHOTOCHEM PHOTOBIOL, V40, P333, DOI 10.1111/j.1751-1097.1984.tb04595.x; Folle GA, 2008, MUTAT RES-REV MUTAT, V658, P172, DOI 10.1016/j.mrrev.2007.08.005; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; Gazave E, 2005, CHROMOSOME RES, V13, P377, DOI 10.1007/s10577-005-3254-9; Ghosal G, 2013, TRANSL CANCER RES, V2, P107, DOI 10.3978/j.issn.2218-676X.2013.04.01; Gopalakrishnan Kalpana, 2010, Genome Integr, V1, P16, DOI 10.1186/2041-9414-1-16; Green M H, 1999, J Epidemiol, V9, pS48; Habermann FA, 2001, CHROMOSOME RES, V9, P569, DOI 10.1023/A:1012447318535; Houtgraaf JH, 2006, CARDIOVASC REVASCULA, V7, P165, DOI 10.1016/j.carrev.2006.02.002; HSU TC, 1975, GENETICS, V79, P137; Ioannou D, 2011, CHROMOSOME RES, V19, P741, DOI 10.1007/s10577-011-9238-z; Kasurka CB, 2011, TOXICOL IN VITRO, V25, P1480, DOI 10.1016/j.tiv.2011.05.002; Khalil A, 2007, CHROMOSOME RES, V15, P899, DOI 10.1007/s10577-007-1172-8; Koehler D, 2009, EXP CELL RES, V315, P2053, DOI 10.1016/j.yexcr.2009.02.016; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Wei-Feng, 2006, Acta Genetica Sinica, V33, P381, DOI 10.1016/S0379-4172(06)60064-4; MANUELIDIS L, 1990, SCIENCE, V250, P1533, DOI 10.1126/science.2274784; Marella NV, 2009, J CELL PHYSIOL, V221, P130, DOI 10.1002/jcp.21836; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Meaburn KJ, 2005, BIOCHEM SOC T, V33, P1438, DOI 10.1042/BST0331438; Mehta IS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r135; Millan NM, 2012, CHROMOSOME RES, V20, P875, DOI 10.1007/s10577-012-9323-y; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Naidoo Nasheen, 2011, Human Genomics, V5, P577; Oliver B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-214; PARSHAD R, 1980, MUTAT RES, V73, P115, DOI 10.1016/0027-5107(80)90140-2; Postberg J, 2010, ESSAYS BIOCHEM, V48, P1, DOI [10.1042/BSE0480001, 10.1042/bse0480001]; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sanders MH, 2004, CYTOGENET GENOME RES, V104, P35, DOI 10.1159/000077464; SEGUIN LR, 1988, AM J HUM GENET, V42, P468; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Szczerbal I, 2009, CHROMOSOMA, V118, P647, DOI 10.1007/s00412-009-0225-5; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Tanabe H, 2005, CYTOGENET GENOME RES, V108, P255, DOI 10.1159/000080824; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Verschure PJ, 2004, BIOL CELL, V96, P569, DOI 10.1016/j.biolcel.2004.07.001; Wijeratne SSK, 2005, J AGR FOOD CHEM, V53, P8768, DOI 10.1021/jf0512003	61	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118886	10.1371/journal.pone.0118886	http://dx.doi.org/10.1371/journal.pone.0118886			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756782	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700029
J	Li, LP; Zhou, LX; Wang, LH; Xue, HP; Zhao, X				Li, Longping; Zhou, Luoxiong; Wang, Lihong; Xue, Huping; Zhao, Xin			Characterization of Methicillin-Resistant and -Susceptible Staphylococcal Isolates from Bovine Milk in Northwestern China	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; ANTIMICROBIAL RESISTANCE; AUREUS; MASTITIS; GENE; IDENTIFICATION; MUTATIONS; SODA; FOOD	Emergence of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MR-CoNS) in bovine milk is a major public health concern. The primary purpose of this research was to determine molecular genetic characteristics and antibiotic resistance of staphylococcal isolates recovered from milk of mastitic cows in the Shaanxi Province in Northwestern China. One hundred and thirteen methicillin-susceptible Staphylococcus aureus (MSSA), one mecA-positive and phenotype-positive MRSA, seven mecA-and mecC-negative but phenotype-positive MRSA and two MR-CoNS including one oxacillin-susceptible mecA-positive Staphylococcus haemolyticus (OS-MRSH) and one mecA-positive and methicillin-resistant Staphylococcus epidermidis (MRSE) isolates were recovered from 214 quarter milk samples on 4 dairy farms. All above 123 isolates were subjected to antibiotic resistance profiling. S. aureus isolates were also genotyped using the spa typing and the multilocus sequence typing (MLST). Eight MRSA and 2 MR-CoNS isolates were additionally tested for SCCmec types. Resistance was common among isolates against ampicillin or penicillin (80.5%), kanamycin (68.3%), gentamicin (67.5%), tetracycline (43.9%) and chloramphenicol (30.1%). However, no isolate was resistant to vancomycin or teicoplanin. Twenty, 29 and 58 isolates showed resistance to 1, 2 or more than 2 antibiotics, respectively. The predominant multidrug resistance profile was penicillin/ampicillin/kanamycin/gentamicin/tetracycline (46 isolates). Most S. aureus isolates belonged to spa types t524 (n = 63), t11772 (a new type, n = 31) and t4207 (n = 15). At the same time, MLST types ST71 (n = 67) and ST2738 (a new type, n = 45) were identified as dominant sequence types. The mecA-positive and phenotype-positive MRSA isolate had a composite genotype t524-ST71-SCCmecIVa, while 7 mecA-negative but phenotype-positive MRSA isolates were all t524-ST71. The OS-MRSH isolate contained a type V SCCmec cassette, while the MRSE isolate possessed a non-typeable SCCmec. The spa-MLST types t11772-ST2738 (n = 27), t11807-ST2683 (n = 4) and t11771-ST2738 (n = 3) were newly identified genotypes of S. aureus. These new genotypes and multidrug-resistant staphylococci could pose additional threat to animal and human health.	[Li, Longping; Zhou, Luoxiong; Wang, Lihong; Xue, Huping; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zhaoxin@nwsuaf.edu.cn	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332; Li, Longoing/0000-0001-5500-5018	National Science Foundation of China [31372282]; China Thousand Talents Program; University Scientific Research Fund project [Z111021305]; Natural Science and Engineering Research Council of Canada	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Thousand Talents Program; University Scientific Research Fund project; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was financially supported by a grant from the National Science Foundation of China (31372282), the China Thousand Talents Program and a University Scientific Research Fund project (Fund No. Z111021305). This work was also partially supported from a discovery grant by Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba XL, 2014, J ANTIMICROB CHEMOTH, V69, P594, DOI 10.1093/jac/dkt418; Bal EBB, 2010, J MICROBIOL, V48, P267, DOI 10.1007/s12275-010-9373-9; Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10; Brody T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003074; Clinical and Laboratory Standards Institute, 2004, CLSI DOCUMENT M31 S1; Clinical and Laboratory Standards Institute, 2011, CLSI DOCUMENT M100 S; De Buyser ML, 2001, INT J FOOD MICROBIOL, V67, P1, DOI 10.1016/S0168-1605(01)00443-3; Erskine RJ, 2002, J DAIRY SCI, V85, P1111, DOI 10.3168/jds.S0022-0302(02)74172-6; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Fournier C, 2008, RES VET SCI, V85, P439, DOI 10.1016/j.rvsc.2008.01.010; Frey Y, 2013, J DAIRY SCI, V96, P2247, DOI 10.3168/jds.2012-6091; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Ghebremedhin B, 2008, J CLIN MICROBIOL, V46, P1019, DOI 10.1128/JCM.02058-07; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Huber H, 2010, EURO SURVEILL, V15; Ikawaty R, 2009, VET MICROBIOL, V136, P277, DOI 10.1016/j.vetmic.2008.10.034; Kumar R, 2010, CURR MICROBIOL, V60, P379, DOI 10.1007/s00284-009-9553-1; Lovseth A, 2004, J CLIN MICROBIOL, V42, P3869, DOI 10.1128/JCM.42.8.3869-3872.2004; Martineau F, 2000, ANTIMICROB AGENTS CH, V44, P231, DOI 10.1128/AAC.44.2.231-238.2000; Moon JS, 2007, J DAIRY SCI, V90, P1176, DOI 10.3168/jds.S0022-0302(07)71604-1; Oliver SP, 2012, VET CLIN N AM-FOOD A, V28, P165, DOI 10.1016/j.cvfa.2012.03.005; Poyart C, 2001, J CLIN MICROBIOL, V39, P4296, DOI 10.1128/JCM.39.12.4296-4301.2001; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Turkyilmaz S, 2010, ZOONOSES PUBLIC HLTH, V57, P197, DOI 10.1111/j.1863-2378.2009.01257.x; Turutoglu H, 2009, VET RES COMMUN, V33, P945, DOI 10.1007/s11259-009-9313-5; Vanderhaeghen W, 2010, VET MICROBIOL, V144, P166, DOI 10.1016/j.vetmic.2009.12.044; Wang X, 2014, LETT APPL MICROBIOL, V58, P527, DOI 10.1111/lam.12221; Wang X, 2012, FOODBORNE PATHOG DIS, V9, P95, DOI 10.1089/fpd.2011.0987; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	30	31	33	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116699	10.1371/journal.pone.0116699	http://dx.doi.org/10.1371/journal.pone.0116699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756992	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275700011
J	Ma, YL; Wei, JL; Zhang, Q; Chen, L; Wang, JY; Liu, JF; Ding, XD				Ma, Yunlong; Wei, Julong; Zhang, Qin; Chen, Lei; Wang, Jinyong; Liu, Jianfeng; Ding, Xiangdong			A Genome Scan for Selection Signatures in Pigs	PLOS ONE			English	Article							FALSE DISCOVERY RATE; REPRODUCTIVE TRAITS; POSITIVE SELECTION; WIDE SCAN; ASSOCIATION; MUTATION; GENES; QTL; DNA	Identifying signatures of selection can provide a straightforward insight into the mechanism of artificial selection and further uncover the causal genes related to the phenotypic variation. Based on Illumina Porcine60KSNP chip data, four complementary methods, Long-Range Haplotype (LRH), Tajima's D, Cross Population Extend Haplotype Homozygosity Test (XPEHH) and F-ST, were implemented in this study to detect the selection signatures in the whole genome of one typical Chinese indigenous breed, Rongchang, one Chinese cultivated breed, Songliao, and two western breeds, Landrace and Yorkshire. False Discovery Rate (FDR) was implemented to control the false positive rates. In our study, a total of 159, 127, 179 and 159 candidate selection regions with average length of 0.80 Mb, 0.73 Mb, 0.78 Mb and 0.73 Mb were identified in Landrace, Rongchang, Songliao and Yorkshire, respectively, that span approximately 128.00 Mb, 92.38 Mb, 130.30 Mb and 115.40 Mb and account for approximately 3.74-5.33% of genome across all autosomes. The selection regions of 11.52 Mb shared by Landrace and Yorkshire were the longest when chosen pairs from the pool of the four breeds were examined. The overlaps between Yorkshire and Songliao, approximately 9.20 Mb, were greater than those of Yorkshire and Rongchang. Meanwhile, the overlaps between Landrace and Songliao were greater than those of Landrace and Rongchang but less than those of Songliao and Ronchang. Bioinformatics analysis showed that the genes/QTLs relevant to fertility, coat color, and ear morphology were found in candidate selection regions. Some genes, such as LEMD3, MC1R, KIT, TRHR etc. that were reported under selection, were confirmed in our study, and this analysis also demonstrated the diversity of breeds.	[Ma, Yunlong; Wei, Julong; Zhang, Qin; Liu, Jianfeng; Ding, Xiangdong] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod,Minist Agr, Beijing 100094, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, JF (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet Breeding & Reprod,Minist Agr, Beijing 100094, Peoples R China.	liujf@cau.edu.cn; xding@cau.edu.cn			program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; open project of Key Laboratory of pig, Ministry of Agriculture [13405]; National High Technology Research and Development Program of China (863 Program) [2011AA100302]; National Natural Science Foundation of China [31272418, 31272419]; earmarked fund for CARS-36	program for Changjiang Scholar and Innovation Research Team in University; open project of Key Laboratory of pig, Ministry of Agriculture; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for CARS-36	This work was supported provided by the program for Changjiang Scholar and Innovation Research Team in University (IRT1191), the open project of Key Laboratory of pig, Ministry of Agriculture (13405), the earmarked fund for CARS-36, National High Technology Research and Development Program of China (863 Program 2011AA100302) and the National Natural Science Foundation of China (31272418, 31272419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056001, 10.1371/journal.pone.0069836, 10.1371/journal.pone.0063641]; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosse M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5392; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buske B, 2006, ANIM REPROD SCI, V95, P167, DOI 10.1016/j.anireprosci.2005.12.015; Chen KF, 2007, INT J BIOL SCI, V3, P153; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gianola D, 2010, GENET RES, V92, P141, DOI 10.1017/S0016672310000121; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Jiang XL, 2011, ANIM BIOTECHNOL, V22, P30, DOI 10.1080/10495398.2011.547745; Kijas JMH, 1998, GENETICS, V150, P1177; Kmiec M, 2006, J APPL GENET, V47, P139, DOI 10.1007/BF03194613; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Li FE, 2008, CZECH J ANIM SCI, V53, P139, DOI 10.17221/371-CJAS; Lin X, 2010, AM J PHYSIOL-REG I, V298, pR1435, DOI 10.1152/ajpregu.00634.2009; Ma YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094911; Makgahlela ML, 2009, S AFR J ANIM SCI, V39, P127; Meidtner K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-76; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pfaffelhuber P, 2007, POPULATION GENETICS; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Rischkowsky B, 2007, THE STATE OF THE WOR; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Suzuki Y, 2010, GENES GENET SYST, V85, P359, DOI 10.1266/ggs.85.359; TAJIMA F, 1989, GENETICS, V123, P585; Tetzlaff S, 2009, J ANIM BREED GENET, V126, P237, DOI 10.1111/j.1439-0388.2008.00781.x; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Wang HL, 2006, CYTOGENET GENOME RES, V115, P129, DOI 10.1159/000095232; Weller JI, 1998, GENETICS, V150, P1699; Wilkinson S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003453; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang SB, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-7	46	16	20	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116850	10.1371/journal.pone.0116850	http://dx.doi.org/10.1371/journal.pone.0116850			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756180	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275700013
J	Wang, HF; Landrein, S; Dong, WP; Nie, ZL; Kondo, K; Funamoto, T; Wen, J; Zhou, SL				Wang, Hua-Feng; Landrein, Sven; Dong, Wen-Pan; Nie, Ze-Long; Kondo, Katsuhiko; Funamoto, Tsuneo; Wen, Jun; Zhou, Shi-Liang			Molecular Phylogeny and Biogeographic Diversification of Linnaeoideae (Caprifoliaceae s. l.) Disjunctly Distributed in Eurasia, North America and Mexico	PLOS ONE			English	Article							LINNAEEAE CAPRIFOLIACEAE; EASTERN ASIA; LAND-BRIDGE; EVOLUTION; DIPSACALES; HISTORY; NUCLEAR; ABELIA; GENES; GENUS	Linnaeoideae is a small subfamily of erect or creeping shrubs to small trees in Caprifoliaceae that exhibits a wide disjunct distribution in Eurasia, North America and Mexico. Most taxa of the subfamily occur in eastern Asia and Mexico but the monospecific genus Linnaea has a circumboreal to north temperate distribution. In this study, we conducted phylogenetic and biogeographic analyses for Linnaeoideae and its close relatives based on sequences of the nuclear ribosomal ITS and nine plastid (rbcL, trnS-G, matK, trnL-F, ndhA, trnD-psbM, petB-D, trnL-rpl32 and trnH-psbA) markers. Our results support that Linnaeoideae is monophyletic, consisting of four eastern Asian lineages (Abelia, Diabelia, Dipelta and Kolkwitzia), the Mexican Vesalea, and Linnaea. The Mexican Vesalea was formerly placed in Abelia, but it did not form a clade with the eastern Asian Abelia; instead Vesalea and Linnaea are sisters. The divergence time between the eastern Asian lineages and the Mexican Vesalea plus the Linnaea clade was dated to be 50.86 Ma, with a 95% highest posterior density of 42.8 Ma (middle Eocene) to 60.19 Ma (early Paleocene) using the Bayesian relaxed clock estimation. Reconstructed ancestral areas indicated that the common ancestor of Linnaea plus Vesalea may have been widespread in eastern Asia and Mexico or originated in eastern Asia during the Eocene and likely migrated across continents in the Northern Hemisphere via the North Atlantic Land Bridges or the Bering Land Bridge. The Qinling Mountains of eastern Asia are the modern-day center of diversity of Kolkwitzia-DipeltaDiabelia clade. The Diabeliaclade became highly diversified in Japan and eastern China. Populations of Diabelia serrata in Japan and eastern China were found to be genetically identical in this study, suggesting a recent disjunction across the East China Sea, following the last glacial event.	[Wang, Hua-Feng; Dong, Wen-Pan; Wen, Jun; Zhou, Shi-Liang] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Landrein, Sven] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Wang, Hua-Feng] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Nie, Ze-Long] Jishou Univ, Coll Biol & Environm Sci, Key Lab Plant Resources Conservat & Utilizat, Jishou 416000, Hunan, Peoples R China; [Kondo, Katsuhiko] Tokyo Univ Agr, Fac Agr, Dept Agr, Lab Plant Genet & Breeding Sci, Atsugi, Kanagawa 2430034, Japan; [Funamoto, Tsuneo] Showa Pharmaceut Univ, Fundamental Educ & Res Ctr Pharmaceut Sci, Inst Biol, Machida, Tokyo 1948543, Japan; [Wen, Jun] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA; [Wang, Hua-Feng] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing Urban Ecosyst Res Stn, State Key Lab Urban & Reg Ecol, Beijing 100085, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Royal Botanic Gardens, Kew; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jishou University; Tokyo University of Agriculture; Showa Pharmaceutical University; Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Wen, J (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	wenj@si.edu; slzhou@ibcac.ac.cn		, Hua-Feng/0000-0003-3331-2898	Ministry of Science and Technology of China [2012AA021602, 2011FY120200, 2012BAC01B05]; National Natural Science Foundation of China [31270239, 41201049, 31129001]; IICT; Chinese Academy of Sciences	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); IICT; Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was partly supported by grants from the Ministry of Science and Technology of China (2012AA021602, 2011FY120200, 2012BAC01B05), National Natural Science Foundation of China (31270239, 41201049, 31129001), IICT and the Innovation International Collaborative Team Grant from the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Bell CD, 2005, AM J BOT, V92, P284, DOI 10.3732/ajb.92.2.284; Bell Charles D., 2001, Harvard Papers in Botany, V6, P481; BOUFFORD DE, 1983, ANN MO BOT GARD, V70, P423, DOI 10.2307/2992081; Boufford DE, 1998, PHYTOGEOGRAPHY QINLI; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Christenhusz MJM, 2013, PHYTOTAXA, V125, P25, DOI 10.11646/phytotaxa.125.1.4; Crane RP, 1986, TERT RES, V9, P21; Crave PR, 1998, MAGNOLIAS THEIR ALLI, P21; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Donoghue Michael J., 2001, Harvard Papers in Botany, V6, P459; DONOGHUE MJ, 1983, SYST BOT, V8, P45, DOI 10.2307/2418562; Donoghue MJ, 2004, PHILOS T R SOC B, V359, P1633, DOI 10.1098/rstb.2004.1538; Dorofeev P.I., 1963, TERTIARY FLORAS W SI; Dorofeev PI, 1957, CONTRIBUTIONS KNOWLE, P277; DOYLE JA, 1993, PALEOBIOLOGY, V19, P141, DOI 10.1017/S0094837300015840; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fang JY, 2002, ACTA BOT SIN, V44, P1105; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng Y, 2005, SYST BOT, V30, P786, DOI 10.1600/036364405775097851; FRIIS EM, 1985, BIOL SKR DAN VID SEL, V24, P1; Fritsch P, 1996, AM J BOT, V83, P342, DOI 10.2307/2446169; FUKUOKA N, 1968, ACTA PHYTOTAXON GEOBOT, V23, P82; FUKUOKA N, 1972, Memoirs of the Faculty of Science Kyoto University Series of Biology, V6, P15; Hara H, 1983, GINKGOANA, V5, P102; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hong D.Y., 1993, CATHAYA, V5, P1; Hopkins D. M, 1967, BERING LAND BRIDGE; Howarth DG, 2009, MOL BIOL EVOL, V26, P1245, DOI 10.1093/molbev/msp051; Hu JQ, 1988, FLORA REIPUBLICAE PO, V72, P112; Huang WP, 2013, BOT J LINN SOC, V171, P395, DOI 10.1111/j.1095-8339.2012.01321.x; Hulten E, 1968, FLORA ALASKA NEIGHBO; Hulten E, 1986, N TROPIC CANC, V2; Ickert-Bond SM, 2006, MOL PHYLOGENET EVOL, V39, P512, DOI 10.1016/j.ympev.2005.12.003; Ikuse M, 1954, J JAPANESE BOT, V29, P11; Jacobs B, 2010, MOL PHYLOGENET EVOL, V57, P741, DOI 10.1016/j.ympev.2010.08.007; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P263, DOI 10.1671/0272-4634(2003)023[0263:PDTMDI]2.0.CO;2; Kim T, 1998, THESIS CHONBUK NATL; Kim YD, 1999, J PLANT RES, V112, P331, DOI 10.1007/PL00013887; LANCUCKA-SRODONIOWA M, 1967, Acta Palaeobotanica, V8, P1; Landrein S, 2013, INT J PLANT SCI, V174, P200, DOI 10.1086/668251; Landrein S, 2012, BOT J LINN SOC, V169, P692, DOI 10.1111/j.1095-8339.2012.01257.x; Landrein S, 2010, PHYTOTAXA, V3, P34; [李金璐 Li Jinlu], 2013, [植物学报, Chinese Bulletin of Botany], V48, P72; Lu LM, 2013, MOL PHYLOGENET EVOL, V68, P502, DOI 10.1016/j.ympev.2013.04.023; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; MANCHESTER SR, 1995, INT J PLANT SCI, V156, P709, DOI 10.1086/297293; Manchester SR, 1997, REV PALAEOBOT PALYNO, V96, P321; Manchester SR, 2009, J SYST EVOL, V47, P1, DOI 10.1111/j.1759-6831.2009.00001.x; McKenna M.C., 1983, STRUCTURE DEV GREENL, P351, DOI DOI 10.1007/978-1-4613-3485-9_19; Miller M.A., 2010, P GAT COMP ENV WORKS; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Nie ZL, 2009, J SYST EVOL, V47, P416, DOI 10.1111/j.1759-6831.2009.00045.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Pyck N, 2004, BELG J BOT, V137, P125; Qi XS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-41; Qi XS, 2012, AM J BOT, V99, pE304, DOI 10.3732/ajb.1100582; Qiu YX, 2009, TAXON, V58, P1226; Rambaut, 2008, FIGTREE V1 1 1 TREE; Rambaut A, 1996, SE AL SEQUENCE ALIGN; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rehder A, 1911, PLANTAE WILSONIANAE, V1, P118; Reid E, 1926, CATALOGUE CAINOZOIC; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakaguchi S, 2012, MOL ECOL, V21, P3823, DOI 10.1111/j.1365-294X.2012.05652.x; Sanderson MJ, 2001, AM J BOT, V88, P1499, DOI 10.2307/3558458; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Smith SA, 2009, J BIOGEOGR, V36, P2324, DOI 10.1111/j.1365-2699.2009.02160.x; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stevens PF, 2013, ANGIOSPERM PHYLOGENY; Sun H, 2001, TAXON, V50, P1001, DOI 10.2307/1224717; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takhtajan A., 1987, SYSTEMA MAGNOLIOPHYT; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YC, 1994, ACTA PHYTOTAXON SIN, V32, P197; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Villarreal-Q JA, 2000, BRITTONIA, V52, P172, DOI 10.2307/2666508; Villarreal-Q JA, 2013, ACTA BOT MEX, V102, P99; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wen J., 2011, Contributions from the United States National Herbarium, V57, P5; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Wen J., 2010, DARWINS HERITAGE TOD, P252; Wen J., 1996, CURRENT TOPICS MOL E, P37; Wen Jun, 1998, Korean Journal of Plant Taxonomy, V28, P63; Winkworth RC, 2008, MOL PHYLOGENET EVOL, V46, P830, DOI 10.1016/j.ympev.2007.11.021; WOLFE JA, 1975, ANN MO BOT GARD, V62, P264, DOI 10.2307/2395198; Wu Z.Y., 1996, P 1 INT S FLORISTIC, P3, DOI DOI 10.1016/J.GENE.2014.07.049; Wu Zhongliang, 1991, Acta Seismologica Sinica, V13, P1; Xiang QYJ, 2004, EVOLUTION, V58, P2175, DOI 10.1111/j.0014-3820.2004.tb01596.x; Xie L, 2010, MOL PHYLOGENET EVOL, V56, P675, DOI 10.1016/j.ympev.2010.02.018; Yang QE., 2011, FLORA CHINA, V19, P616; Zhang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070449; Zhang WH, 2003, MOL PHYLOGENET EVOL, V26, P176, DOI 10.1016/S1055-7903(02)00303-2; Zhang ZY, 2002, TAXON, V51, P499, DOI 10.2307/1554862; Zhou SL, 2006, ACTA PHYTOTAXON SIN, V44, P467, DOI 10.1360/aps050174; Zhou Shi-Liang, 2004, Acta Botanica Yunnanica, V26, P405	108	29	29	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116485	10.1371/journal.pone.0116485	http://dx.doi.org/10.1371/journal.pone.0116485			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756215	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275700004
J	Wilson, GC; Kuboki, S; Freeman, CM; Nojima, H; Schuster, RM; Edwards, MJ; Lentsch, AB				Wilson, Gregory C.; Kuboki, Satoshi; Freeman, Christopher M.; Nojima, Hiroyuki; Schuster, Rebecca M.; Edwards, Michael J.; Lentsch, Alex B.			CXC Chemokines Function as a Rheostat for Hepatocyte Proliferation and Liver Regeneration	PLOS ONE			English	Article							MICE; ISCHEMIA/REPERFUSION; HEPATECTOMY; NEUTROPHILS; RECEPTOR-2; RECOVERY	Background Our previous in vitro studies have demonstrated dose-dependent effects of CXCR2 ligands on hepatocyte cell death and proliferation. In the current study, we sought to determine if CXCR2 ligand concentration is responsible for the divergent effects of these mediators on liver regeneration after ischemia/reperfusion injury and partial hepatectomy. Methods Murine models of partial ischemia/reperfusion injury and hepatectomy were used to study the effect of CXCR2 ligands on liver regeneration. Results We found that hepatic expression of the CXCR2 ligands, macrophage inflammatory protein-2 (MIP-2) and keratinocyte-derived chemokine (KC), was significantly increased after both I/R injury and partial hepatectomy. However, expression of these ligands after I/R injury was 30-100-fold greater than after hepatectomy. Interestingly, the same pattern of expression was found in ischemic versus non-ischemic liver lobes following I/R injury with expression significantly greater in the ischemic liver lobes. In both systems, lower ligand expression was associated with increased hepatocyte proliferation and liver regeneration in a CXCR2-dependent fashion. To confirm that these effects were related to ligand concentration, we administered exogenous MIP-2 and KC to mice undergoing partial hepatectomy. Mice received a "high" dose that replicated serum levels found after I/R injury and a "low" dose that was similar to that found after hepatectomy. Mice receiving the "high" dose had reduced levels of hepatocyte proliferation and regeneration whereas the "low" dose promoted hepatocyte proliferation and regeneration. Conclusions Together, these data demonstrate that concentrations of CXC chemokines regulate the hepatic proliferative response and subsequent liver regeneration.	[Wilson, Gregory C.; Kuboki, Satoshi; Freeman, Christopher M.; Nojima, Hiroyuki; Schuster, Rebecca M.; Edwards, Michael J.; Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Lentsch, AB (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45220 USA.	alex.lentsch@uc.edu	NOJIMA, HIROYUKI/E-3782-2017	NOJIMA, HIROYUKI/0000-0003-3983-2501; Wilson, Gregory/0000-0001-6237-0136	National Institutes of Health [DK56029, AG025881, GM08478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK056029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants DK56029, AG025881, and GM08478. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Clarke C, 2011, HEPATOLOGY, V53, P261, DOI 10.1002/hep.24028; Clarke CN, 2010, FASEB J, V24, p[749, 743]; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; Colletti LM, 1998, SHOCK, V10, P248, DOI 10.1097/00024382-199810000-00004; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; Hogaboam CM, 1999, FASEB J, V13, P1565, DOI 10.1096/fasebj.13.12.1565; Kuboki S, 2008, HEPATOLOGY, V48, P1213, DOI 10.1002/hep.22471; Lentsch AB, 1998, HEPATOLOGY, V27, P1172; Ren XD, 2003, AM J PATHOL, V163, P563, DOI 10.1016/S0002-9440(10)63684-X; Sakai N, 2011, TRANSPL P, V43, P1967, DOI 10.1016/j.transproceed.2011.03.028; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Van Sweringen HL, 2013, HEPATOLOGY, V57, P331, DOI 10.1002/hep.26049; Van Sweringen HL, 2011, HEPATOLOGY, V54, P1445, DOI 10.1002/hep.24457	15	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120092	10.1371/journal.pone.0120092	http://dx.doi.org/10.1371/journal.pone.0120092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756662	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700058
J	Couch, RD; Dailey, A; Zaidi, F; Navarro, K; Forsyth, CB; Mutlu, E; Engen, PA; Keshavarzian, A				Couch, Robin D.; Dailey, Allyson; Zaidi, Fatima; Navarro, Karl; Forsyth, Christopher B.; Mutlu, Ece; Engen, Phillip A.; Keshavarzian, Ali			Alcohol Induced Alterations to the Human Fecal VOC Metabolome	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; VOLATILE ORGANIC-COMPOUNDS; POSSIBLE MECHANISM; OXIDATIVE STRESS; LIVER-DISEASE; MALE RATS; COMPONENTS; BARRIER; STEATOHEPATITIS; IDENTIFICATION	Studies have shown that excessive alcohol consumption impacts the intestinal microbiota composition, causing disruption of homeostasis (dysbiosis). However, this observed change is not indicative of the dysbiotic intestinal microbiota function that could result in the production of injurious and toxic products. Thus, knowledge of the effects of alcohol on the intestinal microbiota function and their metabolites is warranted, in order to better understand the role of the intestinal microbiota in alcohol associated organ failure. Here, we report the results of a differential metabolomic analysis comparing volatile organic compounds (VOC) detected in the stool of alcoholics and non-alcoholic healthy controls. We performed the analysis with fecal samples collected after passage as well as with samples collected directly from the sigmoid lumen. Regardless of the approach to fecal collection, we found a stool VOC metabolomic signature in alcoholics that is different from healthy controls. The most notable metabolite alterations in the alcoholic samples include: (1) an elevation in the oxidative stress biomarker tetradecane; (2) a decrease in five fatty alcohols with anti-oxidant property; (3) a decrease in the short chain fatty acids propionate and isobutyrate, important in maintaining intestinal epithelial cell health and barrier integrity; (4) a decrease in alcohol consumption natural suppressant caryophyllene; (5) a decrease in natural product and hepatic steatosis attenuator camphene; and (6) decreased dimethyl disulfide and dimethyl trisulfide, microbial products of decomposition. Our results showed that intestinal microbiota function is altered in alcoholics which might promote alcohol associated pathologies.	[Couch, Robin D.; Dailey, Allyson; Zaidi, Fatima; Navarro, Karl] George Mason Univ, Dept Chem & Biochem, Manassas, VA 20109 USA; [Forsyth, Christopher B.; Mutlu, Ece; Engen, Phillip A.; Keshavarzian, Ali] Rush Univ, Div Digest Dis & Nutr, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Forsyth, Christopher B.] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Dept Pharmacol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Dept Mol Biophys & Physiol, Med Ctr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Univ Utrecht, Fac Sci, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	George Mason University; Rush University; Rush University; Rush University; Rush University; Utrecht University	Couch, RD (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA 20109 USA.	rcouch@gmu.edu			National Institutes of Health [1RC2AA019405]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institutes of Health grant 1RC2AA019405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeosun CB, 2013, J ACUTE MED, V3, P138, DOI 10.1016/j.jacme.2013.07.002; Aja P.M., 2014, AM J PHYTOMED CLIN T, V2, P310, DOI DOI 10.1016/j.jht.2014.02.001; Al Mansouri S, 2014, PHARMACOL BIOCHEM BE, V124, P260, DOI 10.1016/j.pbb.2014.06.025; Alpendurada MD, 2000, J CHROMATOGR A, V889, P3; Amal H, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/4/047102; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; BIGATELLO LM, 1987, AM J GASTROENTEROL, V82, P11; BLANK ML, 1991, LIPIDS, V26, P166, DOI 10.1007/BF02544013; BOLAND W, 1984, ANAL VOLATILES; Bos R, 2002, J CHROMATOGR A, V966, P233, DOI 10.1016/S0021-9673(02)00704-5; Bukvicki D, 2012, MOLECULES, V17, P6982, DOI 10.3390/molecules17066982; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Chao W, ANAL VOLATILE FLAVOR; CHIN HW, 1993, J FOOD SCI, V58, P835, DOI 10.1111/j.1365-2621.1993.tb09370.x; Costello BDL, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037023; Couch RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081163; Curran AM, 2010, J FORENSIC SCI, V55, P50, DOI 10.1111/j.1556-4029.2009.01236.x; Das AK, 2013, J ENVIRON BIOL, V34, P569; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dixon E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018471; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Garner CE, 2009, J PEDIATR GASTR NUTR, V49, P559, DOI 10.1097/MPG.0b013e3181a3bfbc; GELMAN RA, 1975, NUTR METAB, V18, P169; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; GRANT BF, 1988, SEMIN LIVER DIS, V8, P12, DOI 10.1055/s-2008-1040525; Huang B, 2010, J AGR FOOD CHEM, V58, P441, DOI 10.1021/jf902643e; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Kim S, 2014, OBESITY, V22, P408, DOI 10.1002/oby.20554; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Mochalski P, 2014, J CHROMATOGR B, V959, P62, DOI 10.1016/j.jchromb.2014.04.006; Mochalski P, 2012, TOXICOL MECH METHOD, V22, P502, DOI 10.3109/15376516.2012.682664; Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Nielsen BL, 2013, PHYSIOL BEHAV, V120, P150, DOI 10.1016/j.physbeh.2013.07.012; Nielsen BL, 2011, BEHAV BRAIN RES, V225, P584, DOI 10.1016/j.bbr.2011.08.026; Nikbin M, 2014, AVICENNA J PHYTOMEDI, V4, P182; Nurzynska-Wierdak R, 2014, NAT PROD COMMUN, V9, P703; Okwu D. E., 2010, Der Pharma Chemica, V2, P261; PARLIMENT TH, 1982, J AGR FOOD CHEM, V30, P1006, DOI 10.1021/jf00114a001; Phillips M, 2004, CLIN CHIM ACTA, V344, P189, DOI 10.1016/j.cccn.2004.02.025; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Quigley Eamonn M M, 2013, Gastroenterol Hepatol (N Y), V9, P560; Ramarathnam N, 1993, J AGR FOOD CHEM US; Rampin O, 2006, BEHAV BRAIN RES, V172, P169, DOI 10.1016/j.bbr.2006.04.005; Rao RK, 1997, AM J PHYSIOL-GASTR L, V273, pG812, DOI 10.1152/ajpgi.1997.273.4.G812; Rizzo WB, 2014, BBA-MOL CELL BIOL L, V1841, P377, DOI 10.1016/j.bbalip.2013.09.001; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005; SEGAL W, 1969, J BACTERIOL, V98, P908, DOI 10.1128/JB.98.3.908-913.1969; Seo SM, 2014, PESTIC BIOCHEM PHYS, V113, P55, DOI 10.1016/j.pestbp.2014.06.001; Smith CJ, 2002, J CHROMATOGR B, V778, P157, DOI 10.1016/S0378-4347(01)00456-X; Sreekanth R, 2013, J PHYS CHEM A, V117, P11261, DOI 10.1021/jp4081355; Voigt RM, 2013, ALCOHOL RES-CURR REV, V35, P87; Wang HJ, 2012, ANNU REV NUTR, V32, P343, DOI 10.1146/annurev-nutr-072610-145138; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018	63	45	45	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119362	10.1371/journal.pone.0119362	http://dx.doi.org/10.1371/journal.pone.0119362			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751150	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700021
J	Missan, DS; Mitchell, K; Subbaram, S; DiPersio, CM				Missan, Dara S.; Mitchell, Kara; Subbaram, Sita; DiPersio, C. Michael			Integrin alpha 3 beta 1 Signaling through MEK/ERK Determines Alternative Polyadenylation of the MMP-9 mRNA Transcript in Immortalized Mouse Keratinocytes	PLOS ONE			English	Article							BREAST-CANCER CELLS; 3' UNTRANSLATED REGIONS; BINDING PROTEIN HUR; GENE-EXPRESSION; TETRASPANIN CD151; REGULATES MMP-9; GELATINASE-B; KAPPA-B; 3'-UNTRANSLATED REGION; SUSTAINED ACTIVATION	Integrin alpha 3 beta 1 is highly expressed in both normal and tumorigenic epidermal keratinocytes where it regulates genes that control cellular function and extracellular matrix remodeling during normal and pathological tissue remodeling processes, including wound healing and development of squamous cell carcinoma (SCC). Previous studies identified a role for alpha 3 beta 1 in immortalized and transformed keratinocytes in the regulation of genes that promote tumorigenesis, invasion, and pro-angiogenic crosstalk to endothelial cells. One such gene, matrix metalloproteinase-9 (MMP-9), is induced by alpha 3 beta 1 through a post-transcriptional mechanism of enhanced mRNA stability. In the current study, we sought to investigate the mechanism through which alpha 3 beta 1 controls MMP-9 mRNA stability. First, we utilized a luciferase reporter assay to show that AU-rich elements (AREs) residing within the 3'-untranslated region (3'-UTR) of the MMP-9 mRNA renders the transcript unstable in a manner that is independent of alpha 3 beta 1. Next, we cloned a truncated variant of the MMP-9 mRNA which is generated through usage of an alternative, upstream polyadenylation signal and lacks the 3'-UTR region containing the destabilizing AREs. Using an RNase protection assay to distinguish "long" (full-length 3'-UTR) and "short" (truncated 3'-UTR) MMP-9 mRNA variants, we demonstrated that the shorter, more stable mRNA that lacks 3'-UTR AREs was preferentially generated in alpha 3 beta 1-expressing keratinocytes compared with alpha 3 beta 1-deficient (i.e., alpha 3-null) keratinocytes. Moreover, we determined that alpha 3 beta 1-dependent alternative polyadenylation was acquired by immortalized keratinocytes, as primary neonatal keratinocytes did not display alpha 3 beta 1-dependent differences in the long and short transcripts. Finally, pharmacological inhibition of the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway in alpha 3 beta 1-expressing keratinocytes caused a shift towards long variant expression, while Raf-1-mediated activation of ERK in alpha 3-null keratinocytes dramatically enhanced short variant expression, indicating a role for ERK/MAPK signaling in alpha 3 beta 1-mediated selection of the proximal polyadenylation site. These findings identify a novel mode of integrin alpha 3 beta 1-mediated gene regulation through alternative polyadenylation.	[Missan, Dara S.; Mitchell, Kara; Subbaram, Sita; DiPersio, C. Michael] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	DiPersio, CM (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA.	dipersm@mail.amc.edu		Missan, Dara/0000-0001-8094-5626	National Institutes of Health from the National Cancer Institute [R01CA129637]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR056390]; NATIONAL CANCER INSTITUTE [R01CA129637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056390] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants to CMD from the National Cancer Institute (R01CA129637) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR056390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Das G, 2011, MOL CARCINOGEN, V50, P412, DOI 10.1002/mc.20723; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; DiPersio CM, 2000, J CELL SCI, V113, P2909; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Eberhardt W, 2002, MOL ENDOCRINOL, V16, P1752, DOI 10.1210/me.2001-0278; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Ernst J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007469; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Headley VV, 2004, MOL CELL BIOCHEM, V258, P109, DOI 10.1023/B:MCBI.0000012841.03400.42; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Huwiler A, 2003, J BIOL CHEM, V278, P51758, DOI 10.1074/jbc.M305722200; Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kim S, 2009, PHYTOMEDICINE, V16, P573, DOI 10.1016/j.phymed.2008.11.006; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; LEBWOHL DE, 1994, ONCOGENE, V9, P1925; Lin YF, 2012, NUCLEIC ACIDS RES, V40, P8460, DOI 10.1093/nar/gks637; Liu DL, 2008, J BIOL CHEM, V283, P28010, DOI 10.1074/jbc.M804895200; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Longmate WM, 2014, J INVEST DERMATOL, V134, P1609, DOI 10.1038/jid.2014.10; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; MASURE S, 1993, EUR J BIOCHEM, V218, P129, DOI 10.1111/j.1432-1033.1993.tb18359.x; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McCawley LJ, 2001, CURR BIOL, V11, pR25, DOI 10.1016/S0960-9822(00)00038-5; McCawley LJ, 1999, J BIOL CHEM, V274, P4347, DOI 10.1074/jbc.274.7.4347; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Missan DS, 2014, J INVEST DERMATOL, V134, P2418, DOI 10.1038/jid.2014.166; Missan DS, 2012, CRIT REV EUKAR GENE, V22, P309, DOI 10.1615/CritRevEukarGeneExpr.v22.i4.50; Mitchell K, 2009, J CELL SCI, V122, P1778, DOI 10.1242/jcs.040956; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Morris AR, 2012, CLIN CANCER RES, V18, P5256, DOI 10.1158/1078-0432.CCR-12-0543; Naipauer J, 2013, BIOCHEM J, V454, P345, DOI 10.1042/BJ20130062; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; OKADA A, 1995, GENE, V164, P317, DOI 10.1016/0378-1119(95)00447-E; Poudel B, 2014, ONCOL LETT, V7, P215, DOI 10.3892/ol.2013.1655; Sachs N, 2012, P NATL ACAD SCI USA, V109, P21468, DOI 10.1073/pnas.1204614110; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sehgal I, 1999, MOL BIOL CELL, V10, P407, DOI 10.1091/mbc.10.2.407; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Subbaram S, 2014, J CELL SCI, V127, P1179, DOI 10.1242/jcs.131227; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; TANAKA H, 1993, BIOCHEM BIOPH RES CO, V190, P732, DOI 10.1006/bbrc.1993.1110; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Touriol C, 1999, J BIOL CHEM, V274, P21402, DOI 10.1074/jbc.274.30.21402; Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; Woods D, 2001, MOL CELL BIOL, V21, P3192, DOI 10.1128/MCB.21.9.3192-3205.2001; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Xia YY, 1996, FEBS LETT, V382, P285, DOI 10.1016/0014-5793(96)00185-8; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Yanez-Mo M, 2008, BLOOD, V112, P3217, DOI 10.1182/blood-2008-02-139394; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	77	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119539	10.1371/journal.pone.0119539	http://dx.doi.org/10.1371/journal.pone.0119539			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751421	Green Published, gold, Green Submitted			2022-12-27	WOS:000350692700026
J	Sun, HY; Li, AM; Chen, S; Zhao, D; Rao, LL; Liang, ZY; Li, S				Sun, Hong-Yue; Li, Ai-Mei; Chen, Shuai; Zhao, Dan; Rao, Li-Lin; Liang, Zhu-Yuan; Li, Shu			Pain Now or Later: An Outgrowth Account of Pain-Minimization	PLOS ONE			English	Article							TIME PREFERENCE; CHOICE; EXPERIENCE	The preference for immediate negative events contradicts the minimizing loss principle given that the value of a delayed negative event is discounted by the amount of time it is delayed. However, this preference is understandable if we assume that the value of a future outcome is not restricted to the discounted utility of the outcome per se but is complemented by an anticipated negative utility assigned to an unoffered dimension, which we termed the "outgrowth." We conducted three studies to establish the existence of the outgrowth and empirically investigated the mechanism underlying the preference for immediate negative outcomes. Study 1 used a content analysis method to examine whether the outgrowth was generated in accompaniment with the delayed negative events. The results revealed that the investigated outgrowth was composed of two elements. The first component is the anticipated negative emotions elicited by the delayed negative event, and the other is the anticipated rumination during the waiting process, in which one cannot stop thinking about the negative event. Study 2 used a follow-up investigation to examine whether people actually experienced the negative emotions they anticipated in a real situation of waiting for a delayed negative event. The results showed that the participants actually experienced a number of negative emotions when waiting for a negative event. Study 3 examined whether the existence of the outgrowth could make the minimizing loss principle work. The results showed that the difference in pain anticipation between the immediate event and the delayed event could significantly predict the timing preference of the negative event. Our findings suggest that people's preference for experiencing negative events sooner serves to minimize the overall negative utility, which is divided into two parts: the discounted utility of the outcome itself and an anticipated negative utility assigned to the outgrowth.	[Sun, Hong-Yue; Li, Ai-Mei; Chen, Shuai; Zhao, Dan] Jinan Univ, Sch Management, Guangzhou, Guangdong, Peoples R China; [Sun, Hong-Yue; Rao, Li-Lin; Liang, Zhu-Yuan; Li, Shu] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Sun, Hong-Yue] Shanghai Normal Univ, Coll Educ, Shanghai, Peoples R China	Jinan University; Chinese Academy of Sciences; Institute of Psychology, CAS; Shanghai Normal University	Li, AM (corresponding author), Jinan Univ, Sch Management, Guangzhou, Guangdong, Peoples R China.	tliaim@jnu.edu.cn; lishu@psych.ac.cn		li, shu/0000-0003-4402-1674	National Basic Research Program of China (973 Program) [2011CB711000]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-8]; National Natural Science Foundation of China [70871054, 71271101]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially supported by the National Basic Research Program of China (973 Program, No. 2011CB711000), the Knowledge Innovation Project of the Chinese Academy of Sciences (No. KSCX2-EW-J-8), and the National Natural Science Foundation of China (No. 70871054; 71271101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Hardisty DJ, 2013, J BEHAV DECIS MAKING, V26, P348, DOI 10.1002/bdm.1771; Hardisty DJ, 2009, J EXP PSYCHOL GEN, V138, P329, DOI 10.1037/a0016433; Harris CR, 2012, J BEHAV DECIS MAKING, V25, P13, DOI 10.1002/bdm.709; HARVEY CM, 1994, J PUBLIC ECON, V53, P31, DOI 10.1016/0047-2727(94)90012-4; Kahneman D, 2000, CHOICES VALUES FRAME; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; LOEWENSTEIN G, 1992, Q J ECON, V107, P573, DOI 10.2307/2118482; Luce RD, 1952, INDIVIDUAL CHOICE BE; MacKeigan L D, 1993, Pharmacoeconomics, V3, P374, DOI 10.2165/00019053-199303050-00005; MISCHEL W, 1969, J PERS SOC PSYCHOL, V11, P363, DOI 10.1037/h0027265; Mitchell TR, 1997, J EXP SOC PSYCHOL, V33, P421, DOI 10.1006/jesp.1997.1333; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Rao LL, 2014, BRAIN TOPOGR, V27, P766, DOI 10.1007/s10548-013-0332-8; REDELMEIER DA, 1993, MED DECIS MAKING, V13, P212, DOI 10.1177/0272989X9301300306; Samuelson Paul, 1937, REV ECON STUD, V4, P155, DOI [DOI 10.2307/2967612, 10.2307/2967612]; SHAFIR E, 1993, COGNITION, V49, P11, DOI 10.1016/0010-0277(93)90034-S; Smith A., 1976, INQUIRY NATURE CAUSE; Steel P, 2006, ACAD MANAGE REV, V31, P889, DOI 10.5465/AMR.2006.22527462; Sweeny K, 2012, SOC PERSONAL PSYCHOL, V6, P258, DOI 10.1111/j.1751-9004.2011.00423.x; Sweeny K, 2014, J PERS SOC PSYCHOL, V106, P1015, DOI 10.1037/a0036031; Van der Pol MM, 2000, HEALTH ECON, V9, P171, DOI 10.1002/(SICI)1099-1050(200003)9:2<171::AID-HEC492>3.0.CO;2-Z; Wirtz D, 2003, PSYCHOL SCI, V14, P520, DOI 10.1111/1467-9280.03455	25	6	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119320	10.1371/journal.pone.0119320	http://dx.doi.org/10.1371/journal.pone.0119320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KQ	25747461	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400063
J	Zhou, XF; Zhang, G; Tian, Y				Zhou, Xiaofeng; Zhang, Guan; Tian, Ye			p53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive Bladder Cancers Treated with Bacillus Calmette-Guerin: A Meta-Analysis	PLOS ONE			English	Article							PROGNOSTIC VALUE; ARG72PRO POLYMORPHISM; UROTHELIAL CARCINOMA; PROTEIN OVEREXPRESSION; PROLIFERATIVE ACTIVITY; MOLECULAR MARKERS; TUMOR RECURRENCE; PRB EXPRESSION; ASSOCIATION; SURVIVAL	Objective Published studies have yielded inconsistent results on the relationship between p53 status and the prognosis of non-muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG) intravesical therapy. Therefore, we performed a meta-analysis to evaluate the prognostic value of p53 in NMIBC treated with BCG. Methods We systematically searched for relevant literature in PubMed, EMBASE, CNKI, and Chinese Wanfang databases. Hazard ratios (HRs) with 95% confidence intervals (CIs) were combined as the effect size (ES) across studies for recurrence-free survival (RFS) and progression-free survival (PFS). Results A total of 11 studies, consisting of 1,049 participants, met the criteria. Overall, there was no clear relationship between p53 status and RFS or PFS for NMIBC patients treated with BCG (HR: 1.40, 95% CI: 0.91-2.16; HR: 1.37, 95% CI: 0.90-2.09, respectively). Obvious heterogeneity was observed across the studies (I-2 = 69.5%, P = 0.001; I-2 = 44.7%, P = 0.081, respectively). In stratified analysis by region, p53 overexpression was a predictor of poor RFS in Asian populations (HR: 1.57, 95% CI: 1.08-2.27). In addition, after excluding the studies that possibly contributed to the heterogeneity by the Galbraith plot, the overall association for RFS became statistically significant (HR: 1.38 95% CI: 1.08-1.77) without evidence of heterogeneity (I-2 = 0.0%, P = 0.499). Conclusion This meta-analysis suggests that p53 overexpression in NMIBC patients treated with BCG may be associated with RFS, especially in Asian populations. Because of the heterogeneity and other limitations, further studies with rigid criteria and large populations are still warranted to confirm our findings.	[Zhou, Xiaofeng; Tian, Ye] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing 100050, Peoples R China; [Zhang, Guan] China Japan Friendship Hosp, Dept Urol, Beijing 100029, Peoples R China	Capital Medical University; China-Japan Friendship Hospital	Tian, Y (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Yongan Rd 95, Beijing 100050, Peoples R China.	dr_tianye@163.com			National Natural Science Foundation of China [81373637]; International S&T Cooperation Program of China (ISTCP) [2014DFE30010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China (ISTCP)	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81373637) and International S&T Cooperation Program of China (ISTCP) (Grant No. 2014DFE30010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb SS, 2011, UROL ANNALS, V3, P119, DOI 10.4103/0974-7796.84954; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bernardini S, 1999, J UROLOGY, V162, P1496, DOI 10.1016/S0022-5347(05)68347-4; Burger M, 2013, EUR UROL, V63, P36, DOI 10.1016/j.eururo.2012.08.061; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cormio L, 2009, ANTICANCER RES, V29, P4201; da Silva GN, 2011, MOL BIOL REP, V38, P4159, DOI 10.1007/s11033-010-0536-x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dolicanin Z, 2011, VOJNOSANIT PREGL, V68, P567, DOI 10.2298/VSP1107567D; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esuvaranathan K, 2007, CANCER-AM CANCER SOC, V109, P1097, DOI 10.1002/cncr.22503; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gontero P, 2000, EUR UROL, V38, P287, DOI 10.1159/000020295; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang DK, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.04.044; Jin M, 2013, ANN ONCOL, V24, P807, DOI 10.1093/annonc/mds508; Lacombe L, 1996, J CLIN ONCOL, V14, P2646, DOI 10.1200/JCO.1996.14.10.2646; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lee E, 1997, Int J Urol, V4, P552, DOI 10.1111/j.1442-2042.1997.tb00307.x; Li DB, 2010, GENET MOL RES, V9, P1599, DOI 10.4238/vol9-3gmr882; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu ZH, 2013, MOL BIOL REP, V40, P2389, DOI 10.1007/s11033-012-2319-z; Lopez-Beltran A, 2004, EUR UROL, V45, P606, DOI 10.1016/j.eururo.2003.11.011; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Malats W, 2005, LANCET ONCOL, V6, P678; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Nakopoulou L, 1998, HUM PATHOL, V29, P146, DOI 10.1016/S0046-8177(98)90225-8; Nepple Kenneth G, 2009, Can Urol Assoc J, V3, pS188; Oderda M, 2013, UROL INT, V90, P184, DOI 10.1159/000343431; Oh JJ, 2010, ONCOLOGY-BASEL, V79, P440, DOI 10.1159/000327214; Park J, 2013, UROL ONCOL-SEMIN ORI, V31, P849, DOI 10.1016/j.urolonc.2011.06.004; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peyromaure M, 2002, UROLOGY, V59, P409, DOI 10.1016/S0090-4295(01)01551-5; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Resnick MJ, 2013, CURR OPIN ONCOL, V25, P281, DOI 10.1097/CCO.0b013e32835eb583; Saint F, 2004, EUR UROL, V45, P475, DOI 10.1016/j.eururo.2003.11.018; Sylvester RJ, 2011, EUR UROL, V60, P431, DOI 10.1016/j.eururo.2011.06.001; van Rhijn BWG, 2012, BJU INT, V110, P1169, DOI 10.1111/j.1464-410X.2012.10996.x; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; Xu T, 2012, ASIAN PAC J CANCER P, V13, P2349, DOI 10.7314/APJCP.2012.13.5.2349; Xu X, 2014, EUR J NUTR, V53, P1615, DOI 10.1007/s00394-014-0667-2; Xylinas E, 2013, BRIT J CANCER, V109, P1460, DOI 10.1038/bjc.2013.372; Yang ZL, 2013, GENE, V512, P408, DOI 10.1016/j.gene.2012.09.085	47	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119476	10.1371/journal.pone.0119476	http://dx.doi.org/10.1371/journal.pone.0119476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742650	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100114
J	Aydin, U; Vorwerk, J; Dumpelmann, M; Kupper, P; Kugel, H; Heers, M; Wellmer, J; Kellinghaus, C; Haueisen, J; Rampp, S; Stefan, H; Wolters, CH				Aydin, Uemit; Vorwerk, Johannes; Duempelmann, Matthias; Kuepper, Philipp; Kugel, Harald; Heers, Marcel; Wellmer, Joerg; Kellinghaus, Christoph; Haueisen, Jens; Rampp, Stefan; Stefan, Hermann; Wolters, Carsten H.			Combined EEG/MEG Can Outperform Single Modality EEG or MEG Source Reconstruction in Presurgical Epilepsy Diagnosis	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SOURCE LOCALIZATION; HEAD MODEL; EPILEPTIFORM ACTIVITY; INTERICTAL SPIKES; HUMAN SKULL; ELECTRICAL-CONDUCTIVITY; EPILEPTOGENIC ZONE; VOLUME CONDUCTOR; INVERSE PROBLEM	We investigated two important means for improving source reconstruction in presurgical epilepsy diagnosis. The first investigation is about the optimal choice of the number of epileptic spikes in averaging to (1) sufficiently reduce the noise bias for an accurate determination of the center of gravity of the epileptic activity and (2) still get an estimation of the extent of the irritative zone. The second study focuses on the differences in single modality EEG (80-electrodes) or MEG (275-gradiometers) and especially on the benefits of combined EEG/MEG (EMEG) source analysis. Both investigations were validated with simultaneous stereo-EEG (sEEG) (167-contacts) and low-density EEG (ldEEG) (21-electrodes). To account for the different sensitivity profiles of EEG and MEG, we constructed a six-compartment finite element head model with anisotropic white matter conductivity, and calibrated the skull conductivity via somatosensory evoked responses. Our results show that, unlike single modality EEG or MEG, combined EMEG uses the complementary information of both modalities and thereby allows accurate source reconstructions also at early instants in time (epileptic spike onset), i.e., time points with low SNR, which are not yet subject to propagation and thus supposed to be closer to the origin of the epileptic activity. EMEG is furthermore able to reveal the propagation pathway at later time points in agreement with sEEG, while EEG or MEG alone reconstructed only parts of it. Subaveraging provides important and accurate information about both the center of gravity and the extent of the epileptogenic tissue that neither single nor grand-averaged spike localizations can supply.	[Aydin, Uemit; Vorwerk, Johannes; Kuepper, Philipp; Wolters, Carsten H.] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Aydin, Uemit; Haueisen, Jens] Tech Univ Ilmenau, Inst Biomed Engn & Informat, Ilmenau, Germany; [Duempelmann, Matthias; Kugel, Harald] Univ Freiburg Klinikum, Epilepsy Ctr, Freiburg, Germany; [Kuepper, Philipp; Kellinghaus, Christoph] Klin Osnabruck, Dept Neurol, Osnabruck, Germany; [Kugel, Harald] Univ Munster, Dept Clin Radiol, D-48149 Munster, Germany; [Heers, Marcel; Wellmer, Joerg; Rampp, Stefan] Univ Knappschaftskrankenhaus Bochum, Ruhr Epileptol Dept Neurol, Bochum, Germany; [Rampp, Stefan; Stefan, Hermann] Univ Erlangen Nurnberg, Dept Neurol, Epilepsy Ctr, Erlangen, Germany	University of Munster; Technische Universitat Ilmenau; University of Freiburg; University of Munster; Ruhr University Bochum; University of Erlangen Nuremberg	Aydin, U (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	umitaydin@ieee.org	Heers, Marcel/GRS-2648-2022; Wolters, Carsten H/R-4234-2016; Aydin, Ümit/HII-7669-2022; Duempelmann, Matthias/K-2583-2012; Heers, Marcel/AAF-9364-2019; Rampp, Stefan/J-9386-2019; Haueisen, Jens/B-7183-2011	Wolters, Carsten H/0000-0001-6233-424X; Duempelmann, Matthias/0000-0002-1476-7777; Heers, Marcel/0000-0001-5545-7014; Rampp, Stefan/0000-0002-4826-1520; Vorwerk, Johannes/0000-0003-3597-4203; Kugel, Harald/0000-0002-4349-1984; Haueisen, Jens/0000-0003-3871-2890; Aydin, Umit/0000-0002-6327-7811	DFG (Deutsche Forschungsgemeinschaft) [WO1425/2-1, 1665, WO1425/5-1, STE380/14-1]; Medical Faculty of Ruhr University Bochum; FoRUM research grant [K062-11]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Medical Faculty of Ruhr University Bochum; FoRUM research grant	This work was supported by DFG (Deutsche Forschungsgemeinschaft) project WO1425/2-1 and the Priority Program 1665 of the DFG (WO1425/5-1) for UA, JV and CHW; DFG project STE380/14-1 for SR and HS; and by the Medical Faculty of Ruhr University Bochum, by a FoRUM research grant (K062-11) for MH and JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre-Arrizubieta Z, 2014, BRAIN TOPOGR, V27, P197, DOI 10.1007/s10548-013-0330-x; Ahlfors S, 2014, 19 INT C BIOM AUG 24; Akhtari M, 2000, BRAIN TOPOGR, V13, P29, DOI 10.1023/A:1007882102297; Akhtari M, 2002, BRAIN TOPOGR, V14, P151, DOI 10.1023/A:1014590923185; Aydin U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093154; Badier JM, 1995, J PHYSIOLOGY-PARIS, V89, P255, DOI 10.1016/0928-4257(96)83642-4; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Bast T, 2006, J CLIN NEUROPHYSIOL, V23, P487, DOI 10.1097/01.wnp.0000232208.14060.c7; Baumann SB, 1997, IEEE T BIO-MED ENG, V44, P220, DOI 10.1109/10.554770; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boon P, 2002, J CLIN NEUROPHYSIOL, V19, P461, DOI 10.1097/00004691-200210000-00009; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Camacho DLA, 1997, J BIOMECH, V30, P1067, DOI 10.1016/S0021-9290(97)00073-0; COHEN D, 1987, PHYS MED BIOL, V32, P85, DOI 10.1088/0031-9155/32/1/013; Crouzeix A, 1999, CLIN NEUROPHYSIOL, V110, P2176, DOI 10.1016/S1388-2457(99)00174-1; Dannhauer M, 2013, BRAIN TOPOGR, V26, P229, DOI 10.1007/s10548-012-0263-9; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; Dassios G, 2007, INVERSE PROBL, V23, P2541, DOI 10.1088/0266-5611/23/6/016; de Munck JC, 2012, HANDBOOK OF NEURAL ACTIVITY MEASUREMENT, P192; Ebersole JS, 2010, J CLIN NEUROPHYSIOL, V27, P360, DOI 10.1097/WNP.0b013e318201ffc4; Ebersole JS, 1999, EEG CL N SU, V50, P167; Fischer MJM, 2005, BRAIN, V128, P153, DOI 10.1093/brain/awh333; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Fuchs M, 2004, CLIN NEUROPHYSIOL, V115, P1442, DOI 10.1016/j.clinph.2004.01.019; Fuchs M, 1998, ADV BIOMAGNETISM RES, V96, P213; Fuchs M, 2007, J CLIN NEUROPHYSIOL, V24, P101, DOI 10.1097/WNP.0b013e318038fb3e; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Genow A, 2004, NEUROIMAGE, V21, P444, DOI 10.1016/j.neuroimage.2003.08.029; Goncalves S, 2003, IEEE T BIO-MED ENG, V50, P1124, DOI 10.1109/TBME.2003.816072; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Guggisberg AG, 2008, NEUROIMAGE, V39, P661, DOI 10.1016/j.neuroimage.2007.09.036; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Hamid L, 2013, IEEE ENG MED BIO, P4819, DOI 10.1109/EMBC.2013.6610626; Haueisen J, 1997, IEEE T BIO-MED ENG, V44, P727, DOI 10.1109/10.605429; Haueisen J, 2012, J CLIN NEUROPHYSIOL, V29, P327, DOI 10.1097/WNP.0b013e3182624491; Heers M, 2014, HUM BRAIN MAPP, V35, P4396, DOI 10.1002/hbm.22482; Hoekema R, 2003, BRAIN TOPOGR, V16, P29, DOI 10.1023/A:1025606415858; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huiskamp G, 1999, IEEE T BIO-MED ENG, V46, P1281, DOI 10.1109/10.797987; Iwasaki M, 2005, EPILEPSIA, V46, P59, DOI 10.1111/j.0013-9580.2005.21104.x; Knake S, 2006, EPILEPSY RES, V69, P80, DOI 10.1016/j.eplepsyres.2006.01.001; Knowlton RC, 2009, ANN NEUROL, V65, P716, DOI 10.1002/ana.21660; Kobayashi K, 2005, EPILEPSIA, V46, P397, DOI 10.1111/j.0013-9580.2005.31404.x; Kohling R, 2000, J NEUROPHYSIOL, V84, P2161, DOI 10.1152/jn.2000.84.4.2161; Lantz G, 2003, J CLIN NEUROPHYSIOL, V20, P311, DOI 10.1097/00004691-200309000-00003; Lew S, 2013, NEUROIMAGE, V76, P282, DOI 10.1016/j.neuroimage.2013.03.017; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Lucka F, 2013, 1 INT C BAS CLIN MUL; Lucka F, 2012, NEUROIMAGE, V61, P1364, DOI 10.1016/j.neuroimage.2012.04.017; Merlet I, 1998, ELECTROEN CLIN NEURO, V107, P206, DOI 10.1016/S0013-4694(98)00055-8; Montes-Restrepo V, 2014, BRAIN TOPOGR, V27, P95, DOI 10.1007/s10548-013-0313-y; MOSHER JC, 1992, IEEE T BIO-MED ENG, V39, P541, DOI 10.1109/10.141192; MOSHER JC, 1993, ELECTROEN CLIN NEURO, V86, P303, DOI 10.1016/0013-4694(93)90043-U; Oishi M, 2006, EPILEPSIA, V47, P355, DOI 10.1111/j.1528-1167.2006.00428.x; Papanicolaou AC, 2005, J CLIN NEUROPHYSIOL, V22, P231, DOI 10.1097/01.WNP.0000172255.62072.E8; Pataraia E, 2004, NEUROLOGY, V62, P943, DOI 10.1212/01.WNL.0000115122.81621.FE; Pataraia E, 2005, NEUROIMAGE, V24, P607, DOI 10.1016/j.neuroimage.2004.09.031; Ramon C, 2004, BRAIN TOPOGR, V16, P245; Rampp S, 2007, EXPERT REV MED DEVIC, V4, P335, DOI 10.1586/17434440.4.3.335; Rice JK, 2013, NEUROIMAGE, V64, P476, DOI 10.1016/j.neuroimage.2012.09.041; Roth BJ, 1997, ELECTROEN CLIN NEURO, V102, P159, DOI 10.1016/S0013-4694(96)95111-5; Rullmann M, 2009, NEUROIMAGE, V44, P399, DOI 10.1016/j.neuroimage.2008.09.009; Ruthotto L, 2012, PHYS MED BIOL, V57, P5715, DOI 10.1088/0031-9155/57/18/5715; Salayev KA, 2006, CLIN NEUROPHYSIOL, V117, P1836, DOI 10.1016/j.clinph.2006.05.003; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Scheler G, 2007, HUM BRAIN MAPP, V28, P315, DOI 10.1002/hbm.20277; Speckmann EJ, 2012, NIEDERMEYERS ELECTRO; Stefan H, 2003, BRAIN, V126, P2396, DOI 10.1093/brain/awg239; Steinstrater O, 2010, HUM BRAIN MAPP, V31, P1907, DOI 10.1002/hbm.20986; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Vorwerk J, 2012, BIOMED TECH BERLI S1, V57; Vorwerk J, 2014, NEUROIMAGE, V100, P590, DOI 10.1016/j.neuroimage.2014.06.040; Wennberg R, 2014, CLIN NEUROPHYSIOL, V125, P886, DOI 10.1016/j.clinph.2013.09.042; Wennberg R, 2013, CLIN NEUROPHYSIOL, V124, P941, DOI 10.1016/j.clinph.2012.10.022; Wolters CH, 2007, IEEE T BIO-MED ENG, V54, P1446, DOI 10.1109/TBME.2007.890736; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P2615, DOI 10.1016/j.clinph.2006.07.319	82	54	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118753	10.1371/journal.pone.0118753	http://dx.doi.org/10.1371/journal.pone.0118753			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761059	Green Published, gold			2022-12-27	WOS:000351275000037
J	Cohen, AA; Milot, E; Li, Q; Bergeron, P; Poirier, R; Dusseault-Belanger, F; Fulop, T; Leroux, M; Legault, V; Metter, EJ; Fried, LP; Ferrucci, L				Cohen, Alan A.; Milot, Emmanuel; Li, Qing; Bergeron, Patrick; Poirier, Roxane; Dusseault-Belanger, Francis; Fueloep, Tamas; Leroux, Maxime; Legault, Veronique; Metter, E. Jeffrey; Fried, Linda P.; Ferrucci, Luigi			Detection of a Novel, Integrative Aging Process Suggests Complex Physiological Integration	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; BIOLOGICAL AGE; SYSTEMS BIOLOGY; HEPCIDIN; ANEMIA; DYSREGULATION; DECLINE; INFLAMMATION; BIOMARKERS; INCREASES	Many studies of aging examine biomarkers one at a time, but complex systems theory and network theory suggest that interpretations of individual markers may be context-dependent. Here, we attempted to detect underlying processes governing the levels of many biomarkers simultaneously by applying principal components analysis to 43 common clinical biomarkers measured longitudinally in 3694 humans from three longitudinal cohort studies on two continents (Women's Health and Aging I & II, InCHIANTI, and the Baltimore Longitudinal Study on Aging). The first axis was associated with anemia, inflammation, and low levels of calcium and albumin. The axis structure was precisely reproduced in all three populations and in all demographic sub-populations (by sex, race, etc.); we call the process represented by the axis "integrated albunemia." Integrated albunemia increases and accelerates with age in all populations, and predicts mortality and frailty - but not chronic disease - even after controlling for age. This suggests a role in the aging process, though causality is not yet clear. Integrated albunemia behaves more stably across populations than its component biomarkers, and thus appears to represent a higher-order physiological process emerging from the structure of underlying regulatory networks. If this is correct, detection of this process has substantial implications for physiological organization more generally.	[Cohen, Alan A.; Li, Qing; Bergeron, Patrick; Legault, Veronique] Univ Sherbrooke, Dept Family Med, Grp Rech PRIMUS, Sherbrooke, PQ J1H 5N4, Canada; [Milot, Emmanuel] Univ Quebec Trois Rivieres, Dept Chem Biochem & Phys, Trois Rivieres, PQ G9A 5H7, Canada; [Poirier, Roxane] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Dusseault-Belanger, Francis] Univ Sherbrooke, Dept Math, Sherbrooke, PQ J1K 2R1, Canada; [Fueloep, Tamas] Univ Sherbrooke, Dept Geriatr, Sherbrooke, PQ J1H 5N4, Canada; [Leroux, Maxime] Univ Quebec, ESG, Dept Econ, Montreal, PQ H2X 3X2, Canada; [Metter, E. Jeffrey; Ferrucci, Luigi] NIA, MedStar Harbor Hosp, Longitudinal Studies Sect, Translat Gerontol Branch,NIH, Baltimore, MD 21225 USA; [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	University of Sherbrooke; University of Quebec; University of Quebec Trois Rivieres; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Quebec; University of Quebec Montreal; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Columbia University	Cohen, AA (corresponding author), Univ Sherbrooke, Dept Family Med, Grp Rech PRIMUS, 3001 12e Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Alan.Cohen@USherbrooke.ca		Cohen, Alan/0000-0003-4113-3988; Li, Qing/0000-0002-4191-9596	FRQ-S; Canadian Institutes of Health Research grant [110789, 120305, 119485]; National Science and Engineering Research Council Discovery Grant [402079-2011]; Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000971, ZIAAG000995, ZIAAG001050] Funding Source: NIH RePORTER	FRQ-S; Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council Discovery Grant; Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AAC is a member of the Fonds de recherche du Quebec - Sante (FRQ-S)-supported Centre de recherche sur le vieillissement and Centre de recherche du CHUS, and is a funded Research Scholar of the FRQ-S. This research was supported by Canadian Institutes of Health Research grant #s 110789, 120305, 119485 and by National Science and Engineering Research Council Discovery Grant # 402079-2011 (all for AAC and TF), as well as by the Intramural Research Program of the National Institute on Aging (EJM and LF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen AA, 2014, EXP GERONTOL, V57, P203, DOI 10.1016/j.exger.2014.04.016; Cohen AA, 2013, MECH AGEING DEV, V134, P110, DOI 10.1016/j.mad.2013.01.004; Cohen AA, 2012, TRENDS ECOL EVOL, V27, P428, DOI 10.1016/j.tree.2012.04.008; Cohen AA, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-1; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Detivaud L, 2005, BLOOD, V106, P746, DOI 10.1182/blood-2004-12-4855; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dusseault-Belanger F, 2013, METAB SYNDR RELAT D, V11, P21, DOI 10.1089/met.2012.0094; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Ferrucci L., 2009, G GERONTOL, V57, P3; Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087; Finch CE, 2007, BIOL HUMAN LONGEVITY; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hoffman JM, 2014, AGING CELL; HOLLAND JH, 1992, DAEDALUS, V121, P17; Hood L, 2003, MECH AGEING DEV, V124, P9, DOI 10.1016/S0047-6374(02)00164-1; Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Kauffman S.A., 1993, ORIGINS ORDER; Kirkwood TBL, 2011, PHILOS T R SOC B, V366, P64, DOI 10.1098/rstb.2010.0275; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004; Kulminski AM, 2013, REJUV RES, V16, P304, DOI 10.1089/rej.2013.1441; Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233; Lipsitz Lewis A, 2004, Sci Aging Knowledge Environ, V2004, ppe16; Matteini AM, 2010, J GERONTOL A-BIOL, V65, P1375, DOI 10.1093/gerona/glq154; Morrisette-Thomas V, 2014, MECH AGEING DEV, V139, P49, DOI 10.1016/j.mad.2014.06.005; NAKAMURA E, 1988, MECH AGEING DEV, V46, P1, DOI 10.1016/0047-6374(88)90109-1; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Park J, 2009, ARCH GERONTOL GERIAT, V49, P7, DOI 10.1016/j.archger.2008.04.003; Pearson CAB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059046; R Core Team, 2018, R LANG ENV STAT COMP; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Seplaki CL, 2005, EXP GERONTOL, V40, P438, DOI 10.1016/j.exger.2005.03.002; Shock N.W., 1984, NORMAL HUMAN AGING B; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Wagner A, 1999, BIOL PHILOS, V14, P83, DOI 10.1023/A:1006580900476; Xu YJ, 2011, REGUL PEPTIDES, V172, P58, DOI 10.1016/j.regpep.2011.08.009; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189	50	45	47	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116489	10.1371/journal.pone.0116489	http://dx.doi.org/10.1371/journal.pone.0116489			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761112	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000005
J	Sloan, CD; Nordsborg, RB; Jacquez, GM; Raaschou-Nielsen, O; Meliker, JR				Sloan, Chantel D.; Nordsborg, Rikke B.; Jacquez, Geoffrey M.; Raaschou-Nielsen, Ole; Meliker, Jaymie R.			Space-Time Analysis of Testicular Cancer Clusters Using Residential Histories: A Case-Control Study in Denmark	PLOS ONE			English	Article							LAST 20 YEARS; BIRTH COHORT; RISK; TRENDS; STATE; USA	Though the etiology is largely unknown, testicular cancer incidence has seen recent significant increases in northern Europe and throughout many Western regions. The most common cancer in males under age 40, age period cohort models have posited exposures in the in utero environment or in early childhood as possible causes of increased risk of testicular cancer. Some of these factors may be tied to geography through being associated with behavioral, cultural, sociodemographic or built environment characteristics. If so, this could result in detectable geographic clusters of cases that could lead to hypotheses regarding environmental targets for intervention. Given a latency period between exposure to an environmental carcinogen and testicular cancer diagnosis, mobility histories are beneficial for spatial cluster analyses. Nearest-neighbor based Q-statistics allow for the incorporation of changes in residency in spatial disease cluster detection. Using these methods, a space-time cluster analysis was conducted on a population-wide case-control population selected from the Danish Cancer Registry with mobility histories since 1971 extracted from the Danish Civil Registration System. Cases (N=3297) were diagnosed between 1991 and 2003, and two sets of controls (N=3297 for each set) matched on sex and date of birth were included in the study. We also examined spatial patterns in maternal residential history for those cases and controls born in 1971 or later (N=589 case-control pairs). Several small clusters were detected when aligning individuals by year prior to diagnosis, age at diagnosis and calendar year of diagnosis. However, the largest of these clusters contained only 2 statistically significant individuals at their center, and were not replicated in SaTScan spatial-only analyses which are less susceptible to multiple testing bias. We found little evidence of local clusters in residential histories of testicular cancer cases in this Danish population.	[Sloan, Chantel D.; Meliker, Jaymie R.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Sloan, Chantel D.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Nordsborg, Rikke B.; Raaschou-Nielsen, Ole] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Jacquez, Geoffrey M.] BioMedware Inc, Ann Arbor, MI USA; [Jacquez, Geoffrey M.] SUNY Buffalo, Dept Geog, Buffalo, NY 14260 USA; [Meliker, Jaymie R.] SUNY Stony Brook, Program Publ Hlth, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Brigham Young University; Danish Cancer Society; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sloan, CD (corresponding author), SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA.	chantel.sloan@byu.edu	Raaschou-Nielsen, Ole/GOK-0338-2022; Sloan-Aagard, Chantel/GWC-7572-2022	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Baastrup Nordsborg, Rikke/0000-0003-4374-8230; Meliker, Jaymie/0000-0002-6408-8596	US National Institute of Environmental Health Sciences [R21 ES015501]; National Cancer Institute [R03 CA125827, 5R44CA135818-03, 5R44CA112743-03]; Danish Cancer Society [DP08090]; Danish Agency for Science, Technology and Innovation [08-032484]; NATIONAL CANCER INSTITUTE [R03CA125827] Funding Source: NIH RePORTER	US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Danish Cancer Society(Danish Cancer Society); Danish Agency for Science, Technology and Innovation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the US National Institute of Environmental Health Sciences (http://www.niehs.nih.gov), R21 ES015501, the National Cancer Institute (http://www.cancer.gov) R03 CA125827, 5R44CA135818-03, and 5R44CA112743-03 *JM), the Danish Cancer Society (grant number DP08090) and the Danish Agency for Science, Technology and Innovation (http://ufm.dk en) (reference number 08-032484)(RBN/ORN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN LM, 1986, CANCER RES, V46, P4812; Condon SK, 2013, CRIT REV TOXICOL, V43, P73, DOI 10.3109/10408444.2012.743504; Ekbom A, 1998, APMIS, V106, P225, DOI 10.1111/j.1699-0463.1998.tb01340.x; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; Genin M, 2013, J PUBLIC HEALTH-HEID, V21, P497, DOI 10.1007/s10389-013-0580-9; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Goodman M, 2013, CRIT REV TOXICOL, V43, P75, DOI 10.3109/10408444.2012.743505; Goovaerts P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-32; Jacobsen R, 2006, INT J ANDROL, V29, P199, DOI 10.1111/j.1365-2605.2005.00605.x; Jacquez Geoffrey M, 2005, Environ Health, V4, P4, DOI 10.1186/1476-069X-4-4; Levine PH, 2014, WORLD J CLIN ONCOL, V5, P539, DOI 10.5306/wjco.v5.i3.539; McGlynn KA, 2003, CANCER, V97, P63, DOI 10.1002/cncr.11054; McKiernan JM, 1999, J UROLOGY, V162, P361, DOI 10.1016/S0022-5347(05)68560-6; Myrup C, 2010, INT J CANCER, V126, P217, DOI 10.1002/ijc.24736; Nordsborg RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060800; Nordsborg RB, 2011, INT J CANCER, V129, P2485, DOI 10.1002/ijc.25897; Pedersen CB, 2006, DAN MED BULL, V53, P441; Prener A, 1996, EPIDEMIOLOGY, V7, P14, DOI 10.1097/00001648-199601000-00004; Rosen A, 2011, EUR UROL, V60, P374, DOI 10.1016/j.eururo.2011.05.004; Ruark E, 2013, NAT GENET, V45, P686, DOI 10.1038/ng.2635; Schmiedel S, 2010, J UROLOGY, V183, P1378, DOI 10.1016/j.juro.2009.12.058; Sherman RL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130264; Sloan CD, 2012, SPAT SPATIO-TEMPORAL, V3, P297, DOI 10.1016/j.sste.2012.09.002; Storm HH, 1997, DAN MED BULL, V44, P535; Toledano MB, 2001, BRIT J CANCER, V84, P1482, DOI 10.1054/bjoc.2001.1739; Valberg M, 2014, AM J EPIDEMIOL, V179, P499, DOI 10.1093/aje/kwt267; Webster Thomas, 2006, Int J Health Geogr, V5, P26, DOI 10.1186/1476-072X-5-26; Wood HM, 2009, J UROLOGY, V181, P452, DOI 10.1016/j.juro.2008.10.074	28	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120285	10.1371/journal.pone.0120285	http://dx.doi.org/10.1371/journal.pone.0120285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756204	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700064
J	Stager, JC; Sporn, LA; Johnson, M; Regalado, S				Stager, J. Curt; Sporn, Lee Ann; Johnson, Melanie; Regalado, Sean			Of Paleo-Genes and Perch: What if an "Alien" Is Actually a Native?	PLOS ONE			English	Article							LAKE-SEDIMENTS; ANCIENT DNA; PATTERNS; COLONIZATION; POPULATION; GENETICS	Documenting whether a biotic taxon is native or alien to an ecosystem has theoretical value for ecological and evolutionary studies, and has practical value because it can potentially identify a taxon as a desirable component of an ecosystem or target it for removal. In some cases, however, such background information is inadequate or unavailable. Here we use paleo-DNA to re-evaluate the historical status of yellow perch in the 6 million acre Adiron-dack State Park of northern New York. Yellow perch DNA in a 2200-year sediment record reveals a long-term native status for these supposedly alien fish and challenges assumptions that they necessarily exclude native trout from upland lakes. Similar approaches could be applied to other species with uncertain historical distributions and could help to identify unrecognized pockets of biodiversity.	[Stager, J. Curt; Sporn, Lee Ann; Johnson, Melanie; Regalado, Sean] Paul Smiths Coll, Div Nat Sci, Paul Smiths, NY 12970 USA		Stager, JC (corresponding author), Paul Smiths Coll, Div Nat Sci, Paul Smiths, NY 12970 USA.	cstager@paulsmiths.edu			National Science Foundation [ATM-0401845]; Paul Smith's College; Div Atmospheric & Geospace Sciences [1358362] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Paul Smith's College; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by National Science Foundation (www.nsf.gov), grant ATM-0401845, to JCS. Paul Smith's College faculty research funds to JCS and LAS (www.paulsmiths.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Bissett A, 2005, LIMNOL OCEANOGR-METH, V3, P533, DOI 10.4319/lom.2005.3.533; Bryan MB, 2005, MOL ECOL, V14, P3757, DOI 10.1111/j.1365-294X.2005.02716.x; Burroughs J, 1904, WAKE ROBIN; Carlson DM, 2004, AM MIDL NAT, V152, P104, DOI 10.1674/0003-0031(2004)152[0104:SOFINY]2.0.CO;2; Clapp DF, 2004, FISHERIES, V29, P11, DOI 10.1577/1548-8446(2004)29[11:YPRAMI]2.0.CO;2; Cooper A, 2000, SCIENCE, V289, P1139; Daniels RA, 1998, GLOBAL ECOL BIOGEOGR, V7, P467, DOI 10.1046/j.1466-822X.1998.00313.x; Demong L, 2001, ROTENONE IN FISHERIES: ARE THE REWARDS WORTH THE RISKS?, P29; Epp LS, 2010, J PALEOLIMNOL, V43, P939, DOI 10.1007/s10933-009-9379-7; Fielder DG, 2008, J GREAT LAKES RES, V34, P506, DOI 10.3394/0380-1330(2008)34[506:EOFCTT]2.0.CO;2; Fuller P, 2014, PERCA FLAVESCENS; George CJ, 1981, PUBLICATIONS B NEW Y, VFW- P171; Greeley J. R., 1933, BIOL SURVEY UPPER HU, P54; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Harig AL, 1995, RESTORING INDIGENOUS; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Krieger DA, 1983, HABITAT SUITABILITY; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Mather F, 1884, MEMORANDA RELATING A, P113; Robinson JM, 2010, T AM FISH SOC, V139, P685, DOI 10.1577/T08-185.1; Sepulveda-Villet OJ, 2012, MOL ECOL, V21, P5795, DOI 10.1111/mec.12044; Sepulveda-Villet OJ, 2009, J GREAT LAKES RES, V35, P107, DOI 10.1016/j.jglr.2008.11.009; Stager JC, 2009, QUATERNARY RES, V72, P47, DOI 10.1016/j.yqres.2009.04.003; Stager J. Curt, 1997, Lake and Reservoir Management, V13, P175; Stager JC, 2003, ADIRONDACK J ENV STU, V10, P6; Stager JC, 2001, ADIRONDACK J ENV STU, V8, P22; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; United States Environmental Protection Agency, 1972, US EPA NAT EUTR SURV, DOI 10.1007/978-1-61779-591-6_21; Waldman JR, 2006, T AM FISH SOC, V135, P1076, DOI 10.1577/T05-055.1; Ward Robert D, 2012, Methods Mol Biol, V858, P423, DOI 10.1007/978-1-61779-591-6_21; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2005, P ROY SOC LONDON B, V272; Xiao X, 2005, APPL ENVIRON MICROB, V71, P7904, DOI 10.1128/AEM.71.12.7904-7909.2005	34	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119071	10.1371/journal.pone.0119071	http://dx.doi.org/10.1371/journal.pone.0119071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751263	Green Submitted, gold, Green Published			2022-12-27	WOS:000350692700015
J	Chai, J; Lee, VCY; Yeung, TWY; Li, RWH; Ho, PC; Ng, EHY				Chai, Joyce; Lee, Vivian Chi-Yan; Yeung, Tracy Wing-Yee; Li, Raymond Wun-Hang; Ho, Pak-Chung; Ng, Ernest Hung-Yu			Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ANTIMULLERIAN HORMONE; IVF; STIMULATION; MANAGEMENT; PROGNOSIS; CYCLE	Objective To determine the live birth and cumulative live birth rates of expected poor ovarian responders according to the Bologna criteria and to compare their outcomes with those of expected normal responders Design Retrospective analysis Setting University infertility clinic Patients A total of 1,152 subfertile women undergoing their first in vitro fertilization (IVF) cycle Interventions Women were classified into 4 groups according to the Bologna criteria for comparison Main Outcome Measure(s) Live birth and cumulative live birth rates Results Women with expected poor response (POR) had the lowest live birth rate than the other 3 groups (23.8%, p = 0.031). Cumulative live birth rates were significantly lower in those with expected POR than those with expected normal ovarian response (NOR) (35.8% vs 62.8%, p < 0.0001). In the subgroup analysis, the cumulative live birth rates in expected PORs were significantly lower in those who had <= 3 oocytes retrieved (18.6% for <= 3 oocytes vs 44.0% for >3 oocytes, p = 0.006) whereas the live birth rates in fresh cycle did not differ (17.8% vs 30.9%, p = 0.108). Conclusion Women who were expected POR according to the Bologna criteria had lower live birth and cumulative live birth than expected NOR but they still can achieve reasonable treatment outcomes and IVF treatment should not be precluded.	[Chai, Joyce; Lee, Vivian Chi-Yan; Yeung, Tracy Wing-Yee; Li, Raymond Wun-Hang; Ho, Pak-Chung; Ng, Ernest Hung-Yu] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chai, J (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	jchai@hkucc.hku.hk		Ng, Ernest/0000-0002-7688-4557				Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; El-Toukhy T, 2002, HUM REPROD, V17, P1519, DOI 10.1093/humrep/17.6.1519; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Garcia-Velasco JA, 2009, HUM REPROD, V24, P496, DOI 10.1093/humrep/den398; Hendriks DJ, 2008, REPROD BIOMED ONLINE, V17, P727, DOI 10.1016/S1472-6483(10)60323-9; Ke H, 2013, J HUAZHONG U SCI-MED, V33, P418, DOI 10.1007/s11596-013-1134-7; Klinkert ER, 2004, FERTIL STERIL, V81, P1247, DOI 10.1016/j.fertnstert.2003.10.030; Kyrou D, 2009, FERTIL STERIL, V91, P749, DOI 10.1016/j.fertnstert.2007.12.077; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; Oudendijk JF, 2012, HUM REPROD UPDATE, V18, P1, DOI 10.1093/humupd/dmr037; Polyzos NP, 2012, HUM REPROD, V27, P3481, DOI 10.1093/humrep/des318; Polyzos NP, 2014, REPROD BIOMED ONLINE, V28, P469, DOI 10.1016/j.rbmo.2013.11.010; Polyzos NP, 2011, FERTIL STERIL, V96, P1058, DOI 10.1016/j.fertnstert.2011.09.048; Reichman DE, 2014, FERTIL STERIL, V101, P1012, DOI 10.1016/j.fertnstert.2013.12.039; Tarlatzis BC, 2003, HUM REPROD UPDATE, V9, P61, DOI 10.1093/humupd/dmg007; Ubaldi F, 2005, REPROD BIOMED ONLINE, V10, P235, DOI 10.1016/S1472-6483(10)60946-7; van der Gaast MH, 2006, REPROD BIOMED ONLINE, V13, P476, DOI 10.1016/S1472-6483(10)60633-5; Venetis CA, 2010, ANN NY ACAD SCI, V1205, P199, DOI 10.1111/j.1749-6632.2010.05665.x; Yeung William S. B., 2009, Hong Kong Medical Journal, V15, P420; Younis JS, 2012, HUM REPROD, V27, P1874, DOI 10.1093/humrep/des118	22	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119149	10.1371/journal.pone.0119149	http://dx.doi.org/10.1371/journal.pone.0119149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748478	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400051
J	Fouhy, F; Deane, J; Rea, MC; O'Sullivan, O; Ross, RP; O'Callaghan, G; Plant, BJ; Stanton, C				Fouhy, Fiona; Deane, Jennifer; Rea, Mary C.; O'Sullivan, Orla; Ross, R. Paul; O'Callaghan, Grace; Plant, Barry J.; Stanton, Catherine			The Effects of Freezing on Faecal Microbiota as Determined Using MiSeq Sequencing and Culture-Based Investigations	PLOS ONE			English	Article							GUT MICROBIOTA; STORAGE-CONDITIONS; DNA EXTRACTION; BACTERIAL; SAMPLES; COLLECTION; DIVERSITY; DISEASE; FLORA	Background High-throughput sequencing has enabled detailed insights into complex microbial environments, including the human gut microbiota. The accuracy of the sequencing data however, is reliant upon appropriate storage of the samples prior to DNA extraction. The aim of this study was to conduct the first MiSeq sequencing investigation into the effects of faecal storage on the microbiota, compared to fresh samples. Culture-based analysis was also completed. Methods Seven faecal samples were collected from healthy adults. Samples were separated into fresh (DNA extracted immediately), snap frozen on dry ice and frozen for 7 days at -80 degrees C prior to DNA extraction or samples frozen at -80 degrees C for 7 days before DNA extraction. Sequencing was completed on the Illumina MiSeq platform. Culturing of total aerobes, anaerobes and bifidobacteria was also completed. Results No significant differences at phylum or family levels between the treatment groups occurred. At genus level only Faecalibacterium and Leuconostoc were significantly different in the fresh samples compared to the snap frozen group (p = 0.0298; p = 0.0330 respectively). Diversity analysis indicated that samples clustered based on the individual donor, rather than by storage group. No significant differences occurred in the culture-based analysis between the fresh, snap or -80 degrees C frozen samples. Conclusions Using the MiSeq platform coupled with culture-based analysis, this study highlighted that limited significant changes in microbiota occur following rapid freezing of faecal samples prior to DNA extraction. Thus, rapid freezing of samples prior to DNA extraction and culturing, preserves the integrity of the microbiota.	[Fouhy, Fiona; Deane, Jennifer; Rea, Mary C.; O'Sullivan, Orla; Stanton, Catherine] Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Deane, Jennifer; O'Callaghan, Grace; Plant, Barry J.] Natl Univ Ireland Univ Coll Cork, HRB Clin Res Facil, Cork, Ireland; [Deane, Jennifer] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Rea, Mary C.; O'Sullivan, Orla; O'Callaghan, Grace; Plant, Barry J.; Stanton, Catherine] Alimentary Pharmabiot Ctr, Cork, Ireland; [Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Coll Sci Engn & Food Sci SEFS, Cork, Ireland; [O'Callaghan, Grace; Plant, Barry J.] Natl Univ Ireland Univ Coll Cork, Cork Univ Hosp, Cork Adult Cyst Fibrosis Ctr, Cork, Cork, Ireland	Teagasc; Health Research Board - Ireland; University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	Stanton, C (corresponding author), Teagasc Food Res Ctr, Fermoy, Cork, Ireland.	catherine.stanton@teagasc.ie	O'Sullivan, Orla/ABE-5980-2020; Stanton, Catherine/A-9549-2015; Ross, Paul/A-7584-2015	O'Sullivan, Orla/0000-0002-4332-1109; Stanton, Catherine/0000-0002-6724-7011; Ross, Paul/0000-0003-4876-8839; Deane, Jennifer/0000-0002-4058-3568; Fouhy, Fiona/0000-0002-8285-7694; Rea, Mary/0000-0003-3782-0232	Teagasc Walsh Fellowship; Science Foundation Ireland; Centre for Science, Engineering and Technology (SFI-CSET) [02/CE/B124]; FP7 [603038]; Science Foundation Ireland (SFI) [SFI/12/RC/2273]	Teagasc Walsh Fellowship; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Centre for Science, Engineering and Technology (SFI-CSET)(Science Foundation Ireland); FP7; Science Foundation Ireland (SFI)(Science Foundation Ireland)	Jennifer Deane is in receipt of a Teagasc Walsh Fellowship. The authors and their work were supported by the Science Foundation Ireland and funded by the Centre for Science, Engineering and Technology (SFI-CSET) grant 02/CE/B124 and by FP7 funded CFMATTERS (Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified, Grant Agreement no. 603038). The Alimentary Pharmabiotic Centre is a research centre funded by Science Foundation Ireland (SFI). This publication has emanated from research supported in part by a research grant from Science Foundation Ireland (SFI) under Grant Number SFI/12/RC/2273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Blaut M, 2002, BRIT J NUTR, V87, pS203, DOI 10.1079/BJN/2002539; Cani PD, 2013, BRIEFINGS FUNCTIONAL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Cuthbertson L, 2014, J CLIN MICROBIOL, V52, P3011, DOI 10.1128/JCM.00764-14; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flores R, 2012, EUR J CLIN INVEST, V42, P848, DOI 10.1111/j.1365-2362.2012.02660.x; Gardiner GE, 2004, APPL ENVIRON MICROB, V70, P1895, DOI 10.1128/AEM.70.4.1895-1906.2004; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Matsuki T, 2014, ADV M C M, P90, DOI 10.1079/9781780640495.0090; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; O'Sullivan O, 2011, J APPL MICROBIOL, V111, P467, DOI 10.1111/j.1365-2672.2011.05067.x; Ott SJ, 2004, DIAGN MICR INFEC DIS, V50, P237, DOI 10.1016/j.diagmicrobio.2004.08.012; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Simpson PJ, 2003, J BACTERIOL, V185, P2571, DOI 10.1128/JB.185.8.2571-2581.2003; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	25	182	192	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119355	10.1371/journal.pone.0119355	http://dx.doi.org/10.1371/journal.pone.0119355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748176	Green Submitted, gold, Green Published			2022-12-27	WOS:000350689400068
J	Ku, CH; Hung, HM; Leong, WC; Chen, HH; Lin, JL; Huang, WH; Yang, HY; Weng, CH; Lin, CM; Lee, SH; Wang, IK; Liang, CC; Chang, CT; Lin, WR; Yen, TH				Ku, Chung-Hsuan; Hung, Huei-Min; Leong, Wa Cheong; Chen, Hsiao-Hui; Lin, Ja-Liang; Huang, Wen-Hung; Yang, Huang-Yu; Weng, Cheng-Hao; Lin, Che-Min; Lee, Shwu-Hua; Wang, I-Kuan; Liang, Chih-Chia; Chang, Chiz-Tzung; Lin, Wey-Ran; Yen, Tzung-Hai			Outcome of Patients with Carbon Monoxide Poisoning at a Far-East Poison Center	PLOS ONE			English	Article							TERM MORTALITY; RISK-FACTORS; TAIWAN; MANAGEMENT; OXYGEN	Introduction Many cases of carbon monoxide poisoning in Taiwan are due to burning charcoal. Nevertheless, few reports have analyzed the mortality rate of these patients who survive to reach a hospital and die despite intensive treatment. Therefore, this study examined the clinical features, physiological markers, and outcomes after carbon monoxide poisoning and the associations between these findings. Methods We analyzed the records of 261 patients who were referred for management of carbon monoxide intoxication between 2000 and 2010. Patients were grouped according to status at discharge as alive (survivor, n = 242) or dead (non-survivor, n = 19). Demographic, clinical, laboratory, and mortality data were obtained for analysis. Results Approximately half of the cases (49.4%) attempted suicide by burning charcoal. Most of the patients were middle-aged adults (33 +/- 19 years), and were referred to our hospital in a relatively short period of time (6 +/- 10 hours). Carbon monoxide produced many serious complications after exposure: fever (26.1%), hypothermia (9.6%), respiratory failure (34.1%), shock (8.4%), myocardial infarction (8.0%), gastrointestinal upset (34.9%), hepatitis (18.4%), renal failure (25.3%), coma (18.0%) and rhabdomyolysis (21.8%). Furthermore, the non-survivors suffered greater incidences of hypothermia (P< 0.001), respiratory failure (P< 0.001), shock (P< 0.001), hepatitis ((P= 0.016), renal failure (P= 0.003), coma (P< 0.001) than survivors. All patients were treated with high concentration of oxygen therapy using non-rebreather mask. However, hyperbaric oxygen therapy was only used in 18.8% of the patients. In a multivariate-Cox-regression model, it was revealed that shock status was a significant predictor for mortality after carbon monoxide poisoning (OR 8.696, 95% CI 2.053-37.370, P= 0.003). Finally, Kaplan-Meier analysis confirmed that patients with shock suffered greater cumulative mortality than without shock (Log-rank test, Chi-square 147.404, P<0.001). Conclusion The mortality rate for medically treated carbon monoxide-poisoned patients at our center was 7.3%. Furthermore, the analysis indicates that shock was most strongly associated with higher risk of mortality.	[Ku, Chung-Hsuan; Leong, Wa Cheong; Chen, Hsiao-Hui; Lin, Ja-Liang; Huang, Wen-Hung; Yang, Huang-Yu; Weng, Cheng-Hao; Yen, Tzung-Hai] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan; [Ku, Chung-Hsuan; Hung, Huei-Min; Leong, Wa Cheong; Chen, Hsiao-Hui; Lin, Ja-Liang; Huang, Wen-Hung; Yang, Huang-Yu; Weng, Cheng-Hao; Yen, Tzung-Hai] Chang Gung Univ, Chang Gung Mem Hosp & Coll Med, Div Clin Toxicol, Linkou, Taiwan; [Hung, Huei-Min] Chang Gung Univ, Chang Gung Mem Hosp & Coll Med, Dept Pediat, Linkou, Taiwan; [Lin, Che-Min; Lee, Shwu-Hua] Chang Gung Univ, Chang Gung Mem Hosp & Coll Med, Dept Psychiat, Linkou, Taiwan; [Wang, I-Kuan; Liang, Chih-Chia; Chang, Chiz-Tzung] China Med Univ, China Med Univ Hosp & Coll Med, Dept Nephrol, Taichung, Taiwan; [Lin, Wey-Ran] Chang Gung Univ, Chang Gung Mem Hosp & Coll Med, Dept Gastroenterol, Linkou, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Ctr Tissue Engn, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan.	m19570@adm.cgmh.org.tw	Lin, Chemin/AAG-9983-2019; Yen, Tzung-Hai/AAQ-4525-2020; huang, wen/GXW-0661-2022	Yen, Tzung-Hai/0000-0002-0907-1505; Lee, Shwu-Hua/0000-0001-5606-1118; YANG, HUANG-YU/0000-0001-6826-9717; Lin, Chemin/0000-0001-6889-4686	Chang Gung Memorial Hospital [CMRPG3D0681, CMRPG3D0071-2, CMRPG3D0011, CMRPG3E0361]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was funded by the Chang Gung Memorial Hospital (CMRPG3D0681, CMRPG3D0071-2, CMRPG3D0011, CMRPG3E0361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP C, P87; Amitai Y, 1998, ARCH NEUROL-CHICAGO, V55, P845, DOI 10.1001/archneur.55.6.845; Beppu T, 2014, AM J NEURORADIOL, V35, P625, DOI 10.3174/ajnr.A3489; Chang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000212; COBURN RF, 1965, J CLIN INVEST, V44, P1899, DOI 10.1172/JCI105296; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Hampson NB, 2008, CRIT CARE MED, V36, P2523, DOI 10.1097/CCM.0b013e31818419d8; Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI; Hampson NB, 2009, CRIT CARE MED, V37, P1941, DOI 10.1097/CCM.0b013e3181a0064f; Hou XM, 2013, EUR NEUROL, V69, P275, DOI 10.1159/000346117; Hou YC, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-674; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105503; Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003; Kessler SM, 2011, J PALLIAT MED, V14, P782, DOI 10.1089/jpm.2011.9682; Lee CTA, 2014, NAT GEOSCI, V7, P10, DOI 10.1038/ngeo2039; Lin CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112160; Lin CM, 2012, GEN HOSP PSYCHIAT, V34, P552, DOI 10.1016/j.genhosppsych.2012.03.015; Liu KY, 2007, J EPIDEMIOL COMMUN H, V61, P248, DOI 10.1136/jech.2006.048553; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Nuckton TJ, 2000, AM J EMERG MED, V18, P703, DOI 10.1053/ajem.2000.16313; Pan YJ, 2010, J AFFECT DISORDERS, V120, P254, DOI 10.1016/j.jad.2009.04.003; Rixen D, 2005, CRIT CARE, V9, P441, DOI 10.1186/cc3526; Shie HG, 2007, INHAL TOXICOL, V19, P905, DOI 10.1080/08958370701432173; Smollin Craig, 2010, BMJ Clin Evid, V2010; Thom SR, 2010, CLIN TOXICOL, V48, P47, DOI 10.3109/15563650903468209; Wang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065672; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Wolf SJ, 2008, ANN EMERG MED, V51, P138, DOI 10.1016/j.annemergmed.2007.10.012; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x	29	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118995	10.1371/journal.pone.0118995	http://dx.doi.org/10.1371/journal.pone.0118995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25745854	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400036
J	Rashed, E; Lizano, P; Dai, HC; Thomas, A; Suzuki, CK; Depre, C; Qiu, HY				Rashed, Eman; Lizano, Paulo; Dai, Huacheng; Thomas, Andrew; Suzuki, Carolyn K.; Depre, Christophe; Qiu, Hongyu			Heat Shock Protein 22 (Hsp22) Regulates Oxidative Phosphorylation upon Its Mitochondrial Translocation with the Inducible Nitric Oxide Synthase in Mammalian Heart	PLOS ONE			English	Article							RAT LIVER MITOCHONDRIA; H11 KINASE; CARDIAC MYOCYTES; SWINE HEART; IN-VIVO; CHAPERONE; SURVIVAL; ISCHEMIA; HYPERTROPHY; INHIBITION	Objectives Stress-inducible heat shock protein 22 (Hsp22) confers protection against ischemia through induction of the inducible isoform of nitric oxide synthase (iNOS). Hsp22 overexpression in vivo stimulates cardiac mitochondrial respiration, whereas Hsp22 deletion in vivo significantly reduces respiration. We hypothesized that Hsp22-mediated regulation of mitochondrial function is dependent upon its mitochondrial translocation together with iNOS. Methods and Results Adenoviruses harboring either the full coding sequence of Hsp22 (Ad-WT-Hsp22) or a mutant lacking a N-terminal 20 amino acid putative mitochondrial localization sequence (Ad-N20-Hsp22) were generated, and infected in rat neonatal cardiomyocytes. Compared to beta-Gal control, WT-Hsp22 accumulated in mitochondria by 2.5 fold (P<0.05) and increased oxygen consumption rates by 2-fold (P<0.01). This latter effect was abolished upon addition of the selective iNOS inhibitor, 1400W. Ad-WT-Hsp22 significantly increased global iNOS expression by about 2.5-fold (P<0.01), and also increased iNOS mitochondrial localization by 4.5 fold vs beta-gal (P<0.05). Upon comparable overexpression, the N20-Hsp22 mutant did not show significant mitochondrial translocation or stimulation of mitochondrial respiration. Moreover, although N20-Hsp22 did increase global iNOS expression by 4.6fold, it did not promote iNOS mitochondrial translocation. Conclusion Translocation of both Hsp22 and iNOS to the mitochondria is necessary for Hsp22-mediated stimulation of oxidative phosphorylation.	[Rashed, Eman; Lizano, Paulo; Dai, Huacheng; Depre, Christophe; Qiu, Hongyu] Rutgers State Univ, New Jersey Med Sch, Dept Cell Biol & Mol Med, New Brunswick, NJ 08903 USA; [Thomas, Andrew] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, New Brunswick, NJ 08903 USA; [Suzuki, Carolyn K.] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, New Brunswick, NJ 08903 USA; [Qiu, Hongyu] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92350 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Loma Linda University	Qiu, HY (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Cell Biol & Mol Med, New Brunswick, NJ 08903 USA.	hqiu@llu.edu	Lizano, Paulo/GPX-3124-2022	Thomas, Andrew/0000-0002-9026-7467	United States National Institute of Health [1R01 HL115195-01]; American Heart Association [0835182N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115195] Funding Source: NIH RePORTER	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is partially supported by a grant 1R01 HL115195-01 (http://www.nih.gov/) from United States National Institute of Health, (H. Q.) and a grant 0835182N from American Heart Association (https://research.americanheart.org) (H. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; Bolli R, 2001, J MOL CELL CARDIOL, V33, P1897, DOI 10.1006/jmcc.2001.1462; Borutaite V, 2005, SHOCK, V23, P319, DOI 10.1097/01.shk.0000156672.36439.2d; Chen L, 2011, AM J PHYSIOL-HEART C, V300, pH1303, DOI 10.1152/ajpheart.00979.2010; Danan IJ, 2007, CARDIOVASC DRUG REV, V25, P14, DOI 10.1111/j.1527-3466.2007.00002.x; Depre C, 1999, CIRCULATION, V99, P578, DOI 10.1161/01.CIR.99.4.578; Depre C, 2006, CIRC RES, V98, P280, DOI 10.1161/01.RES.0000201284.45482.e8; Depre C, 2004, CIRC RES, V95, P433, DOI 10.1161/01.RES.0000138301.42713.18; Depre C, 2003, CARDIOVASC RES, V58, P126, DOI 10.1016/S0008-6363(02)00845-3; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; Depre C, 2001, P NATL ACAD SCI USA, V98, P9336, DOI 10.1073/pnas.171297498; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hase M, 2005, BIOCHEM J, V388, P475, DOI 10.1042/BJ20041314; Hedhli N, 2008, CARDIOVASC RES, V77, P497, DOI 10.1093/cvr/cvm054; HERRMANN JM, 1994, J CELL BIOL, V127, P893, DOI 10.1083/jcb.127.4.893; Lacza Z, 2003, FREE RADICAL BIO MED, V35, P1217, DOI 10.1016/S0891-5849(03)00510-0; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li W, 2004, AM J PHYSIOL-HEART C, V286, pH47, DOI 10.1152/ajpheart.00730.2003; Lin MW, 2007, BIOCHEM PHARMACOL, V73, P1796, DOI 10.1016/j.bcp.2007.02.009; Lizano P, 2013, CARDIOVASC RES, V99, P685, DOI 10.1093/cvr/cvt136; McGreal RS, 2013, EXP EYE RES, V110, P10, DOI 10.1016/j.exer.2013.02.016; McGreal RS, 2012, BBA-GEN SUBJECTS, V1820, P921, DOI 10.1016/j.bbagen.2012.04.004; Minghetti L, 1997, GLIA, V19, P152, DOI 10.1002/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2; Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112; Qiu HY, 2011, CIRCULATION, V124, P406, DOI 10.1161/CIRCULATIONAHA.110.013847; SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Sui XZ, 2009, CIRC RES, V104, P887, DOI 10.1161/CIRCRESAHA.108.192328; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; Wang MJ, 2001, J NEUROCHEM, V77, P830, DOI 10.1046/j.1471-4159.2001.00295.x; Wang Y, 2002, J MOL CELL CARDIOL, V34, P5, DOI 10.1006/jmcc.2001.1482	35	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119537	10.1371/journal.pone.0119537	http://dx.doi.org/10.1371/journal.pone.0119537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746286	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400077
J	Shields, SD; Butt, RP; Dib-Hajj, SD; Waxman, SG				Shields, Shannon D.; Butt, Richard P.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.			Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							SODIUM-CHANNELS; AXON MEMBRANE; CONDUCTION; DYSFUNCTION; EXPRESSION	Cerebellar symptoms significantly diminish quality of life in patients with multiple sclerosis (MS). We previously showed that sodium channel Nav1.8, although normally restricted to peripheral somatosensory neurons, is upregulated in the cerebellum in MS, and that Nav1.8 expression is linked to ataxia and MS-like symptoms in mice. Furthermore, intracer-ebroventricular administration of the Nav1.8 blocker A-803467 temporarily reversed electrophysiological and behavioral manifestations of disease in a mouse MS model; unfortunately A-803467 is not orally bioavailable, diminishing the potential for translation to human patients. In the present study, we assessed the effect of per os (p.o.) dosing of a new orally bioavailable Nav1.8-selective blocker, PF-01247324, in transgenic mice expressing Nav1.8 in Purkinje neurons, and in wildtype mice in the experimental autoimmune encephalomyelitis (EAE) model. PF-01247324 was administered by oral gavage at 1000 mg/kg; control groups received an equal volume of vehicle. Behavioral assays of motor coordination, grip strength, and ataxia were performed. We observed significant improvements in motor coordination and cerebellar-like symptoms in mice that received PF-01247324 compared to control littermates that received vehicle. These preclinical proof-of-concept data suggest that PF-01247324, its derivatives, or other Nav1.8-selective blockers merit further study for providing symptomatic therapy for cerebellar dysfunction in MS and related disorders.	[Shields, Shannon D.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Shields, Shannon D.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA; [Butt, Richard P.] Pfizer Global R&D, Neusentis UK, Cambridge, England; [Shields, Shannon D.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT USA	Yale University; Yale University; Pfizer; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Waxman, SG (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	stephen.waxman@yale.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177	Medical Research Service and Rehabilitation Research Service, Department of Veterans' Affairs [RX000477, BX000605]; Pfizer Research; Neusentis UK, Pfizer Global RD	Medical Research Service and Rehabilitation Research Service, Department of Veterans' Affairs(US Department of Veterans Affairs); Pfizer Research; Neusentis UK, Pfizer Global RD	This work was supported by the Medical Research Service and Rehabilitation Research Service, Department of Veterans' Affairs [grant numbers RX000477 and BX000605] and a grant to Yale University from Pfizer Research. The Center for Neuroscience and Regeneration Research is a collaboration of the Paralyzed Veterans of America and the United Spinal Association with Yale University. Neusentis UK, Pfizer Global R&D provided support in the form of a salary for author RBP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Black JA, 2000, P NATL ACAD SCI USA, V97, P11598, DOI 10.1073/pnas.97.21.11598; BOSTOCK H, 1978, J PHYSIOL-LONDON, V280, P273, DOI 10.1113/jphysiol.1978.sp012384; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; England S, 2009, 2009 NEUR M PLANN; ESPIR MLE, 1970, J NEUROL NEUROSUR PS, V33, P528, DOI 10.1136/jnnp.33.4.528; FOSTER RE, 1980, SCIENCE, V210, P661, DOI 10.1126/science.6159685; Kapoor R, 2010, LANCET NEUROL, V9, P681, DOI 10.1016/S1474-4422(10)70131-9; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; Mills RJ, 2007, COCHRANE DB SYST REV, V1; Payne CE, 2015, BRIT J PHAR IN PRESS; Ramsaransing G, 2000, BRIT MED J, V320, P1113, DOI 10.1136/bmj.320.7242.1113; Renganathan M, 2003, BRAIN RES, V959, P235, DOI 10.1016/S0006-8993(02)03750-2; Saab CY, 2004, EXP BRAIN RES, V158, P1, DOI 10.1007/s00221-004-1867-4; Shields SD, 2012, ANN NEUROL, V71, P186, DOI 10.1002/ana.22665; Solaro C, 2005, NEUROL SCI, V25, P307, DOI 10.1007/s10072-004-0362-9; SWINGLER RJ, 1992, Q J MED, V83, P325; WAXMAN SG, 1978, J NEUROL NEUROSUR PS, V41, P408, DOI 10.1136/jnnp.41.5.408; Waxman SG, 2002, ARCH NEUROL-CHICAGO, V59, P1377, DOI 10.1001/archneur.59.9.1377; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119067	10.1371/journal.pone.0119067	http://dx.doi.org/10.1371/journal.pone.0119067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747279	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400042
J	Chin, LH; Hsu, SP; Zhong, WB; Liang, YC				Chin, Li-Han; Hsu, Sung-Po; Zhong, Wen-Bin; Liang, Yu-Chih			Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells	PLOS ONE			English	Article							FACTOR RECEPTOR; BREAST-CANCER; IN-VITRO; EXPRESSION; KINASE; INVASION; GENE; PATHWAY; CYR61; CREB	Our previous studies have demonstrated that epidermal growth factor (EGF) can induce cell migration through the induction of cysteine-rich protein 61 (Cyr61) in human anaplastic thyroid cancer (ATC) cells. The aim of the present study was to determine the inhibitory effects of combined treatment with the peroxisome proliferator-activated receptor-gamma (PPAR gamma) ligand troglitazone and the cholesterol-lowering drug lovastatin at clinically achievable concentrations on ATC cell migration. Combined treatment with 5 mu M troglitazone and 1 mu M lovastatin exhibited no cytotoxicity but significantly inhibited EGF-induced migration, as determined using wound healing and Boyden chamber assays. Cotreatment with troglitazone and lovastatin altered the epithelial-to-mesenchymal-transition (EMT) -related marker gene expression of the cells; specifically, E-cadherin expression increased and vimentin expression decreased. In addition, cotreatment reduced the number of filopodia, which are believed to be involved in migration, and significantly inhibited EGF-induced Cyr61 mRNA and protein expression as well as Cyr61 secretion. Moreover, the phosphorylation levels of 2 crucial signal molecules for EGF-induced Cyr61 expression, the cAMP response element-binding protein (CREB) and extracellular signal-regulated kinase (ERK), were decreased in cells cotreated with troglitazone and lovastatin. Performing a transient transfection assay revealed that the combined treatment significantly suppressed Cyr61 promoter activity. These results suggest that combined treatment with low doses of troglitazone and lovastatin effectively inhibits ATC cell migration and may serve as a novel therapeutic strategy for metastatic ATC.	[Chin, Li-Han; Hsu, Sung-Po; Zhong, Wen-Bin] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Hsu, Sung-Po; Zhong, Wen-Bin] Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan; [Liang, Yu-Chih] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Liang, Yu-Chih] Taipei Med Univ, Tradit Herbal Med Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Liang, YC (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan.	ycliang@tmu.edu.tw	Hsu, Sung-Po/I-8383-2019	HSU, SUNG-PO/0000-0001-7527-9040	National Science Council of the Republic of China [NSC 101-2320-B-038-017-MY3]; Taipei Medical University [TMU101-AE1-B45]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Taipei Medical University	This work were supported by research grants from the National Science Council of the Republic of China (NSC 101-2320-B-038-017-MY3) and the Taipei Medical University (TMU101-AE1-B45). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bolden A, 2012, PPAR RES, V2012, DOI 10.1155/2012/929052; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Ensinger C, 2004, ANN NY ACAD SCI, V1030, P69, DOI 10.1196/annals.1329.009; FRANSSILA KO, 1975, CANCER-AM CANCER SOC, V36, P1138, DOI 10.1002/1097-0142(197509)36:3<1138::AID-CNCR2820360346>3.0.CO;2-8; Gabrys D, 2008, STRAHLENTHER ONKOL, V184, P48, DOI 10.1007/s00066-008-1805-7; Grommes C, 2004, LANCET ONCOL, V5, P419, DOI 10.1016/S1470-2045(04)01509-8; Guerra A, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S44; Han JS, 2003, EUR J BIOCHEM, V270, P3408, DOI 10.1046/j.1432-1033.2003.03723.x; HOELTING T, 1994, J CLIN ENDOCR METAB, V79, P401, DOI 10.1210/jc.79.2.401; Holstein SA, 2006, CANCER CHEMOTH PHARM, V57, P155, DOI 10.1007/s00280-005-0013-8; Infante E, 2011, J LEUKOCYTE BIOL, V89, P577, DOI 10.1189/jlb.0810441; Kok SH, 2011, ARTHRITIS RHEUM-US, V63, P1010, DOI 10.1002/art.27433; Kunz M, 2003, J BIOL CHEM, V278, P45651, DOI 10.1074/jbc.M301373200; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Kusama T, 2001, CANCER RES, V61, P4885; Li MY, 2006, J CELL PHYSIOL, V209, P428, DOI 10.1002/jcp.20738; Lin BR, 2007, MOL CANCER RES, V5, P1111, DOI 10.1158/1541-7786.MCR-06-0289; LIPPONEN P, 1994, BRIT J CANCER, V69, P1120, DOI 10.1038/bjc.1994.220; Malaguarnera R, 2005, ENDOCR-RELAT CANCER, V12, P953, DOI 10.1677/erc.1.00968; Motomura W, 2005, BIOCHEM BIOPH RES CO, V332, P89, DOI 10.1016/j.bbrc.2005.04.095; NICHOLSON S, 1991, BRIT J CANCER, V63, P146, DOI 10.1038/bjc.1991.30; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2001, J CLIN PATHOL-MOL PA, V54, P170, DOI 10.1136/mp.54.3.170; Shah PP, 2012, ONCOGENE, V31, P3124, DOI 10.1038/onc.2011.488; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Theocharis S, 2004, CANCER TREAT REV, V30, P545, DOI 10.1016/j.ctrv.2004.04.004; Thibault A, 1996, CLIN CANCER RES, V2, P483; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDERLAAN BFAM, 1995, THYROID, V5, P67, DOI 10.1089/thy.1995.5.67; Wang IK, 2000, ONCOLOGY-BASEL, V59, P245, DOI 10.1159/000012168; Wang PS, 2008, MOL CARCINOGEN, V47, P905, DOI 10.1002/mc.20429; Xiao YJ, 2013, RHEUMATOL INT, V33, P389, DOI 10.1007/s00296-012-2383-7; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yao CJ, 2006, INT J CANCER, V118, P773, DOI 10.1002/ijc.21361; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219; Zhong WB, 2005, ENDOCR-RELAT CANCER, V12, P615, DOI 10.1677/erc.1.01012	38	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118674	10.1371/journal.pone.0118674	http://dx.doi.org/10.1371/journal.pone.0118674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742642	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100030
J	Costa, PS; Reis, MP; Avila, MP; Leite, LR; de Araujo, FMG; Salim, ACM; Oliveira, G; Barbosa, F; Chartone-Souza, E; Nascimento, AMA				Costa, Patricia S.; Reis, Mariana P.; Avila, Marcelo P.; Leite, Laura R.; de Araujo, Flavio M. G.; Salim, Anna C. M.; Oliveira, Guilherme; Barbosa, Francisco; Chartone-Souza, Edmar; Nascimento, Andrea M. A.			Metagenome of a Microbial Community Inhabiting a Metal-Rich Tropical Stream Sediment	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FRESH-WATER; SEQUENCE-ANALYSIS; BACTERIAL DIVERSITY; ARCHAEAL; REDUCTION; GENES; CRENARCHAEOTA; CONTAMINATION; RHIZOSPHERE	Here, we describe the metagenome and functional composition of a microbial community in a historically metal-contaminated tropical freshwater stream sediment. The sediment was collected from the Mina Stream located in the Iron Quadrangle (Brazil), one of the world's largest mining regions. Environmental DNA was extracted and was sequenced using SOLiD technology, and a total of 7.9 Gbp was produced. A taxonomic profile that was obtained by comparison to the Greengenes database revealed a complex microbial community with a dominance of Proteobacteria and Parvarcheota. Contigs were recruited by bacterial and archaeal genomes, especially Candidatus Nitrospira defluvii and Nitrosopumilus maritimus, and their presence implicated them in the process of N cycling in the Mina Stream sediment (MSS). Functional reconstruction revealed a large, diverse set of genes for ammonium assimilation and ammonification. These processes have been implicated in the maintenance of the N cycle and the health of the sediment. SEED subsystems functional annotation unveiled a high degree of diversity of metal resistance genes, suggesting that the prokaryotic community is adapted to metal contamination. Furthermore, a high metabolic diversity was detected in the MSS, suggesting that the historical arsenic contamination is no longer affecting the prokaryotic community. These results expand the current knowledge of the microbial taxonomic and functional composition of tropical metal-contaminated freshwater sediments.	[Costa, Patricia S.; Reis, Mariana P.; Avila, Marcelo P.; Barbosa, Francisco; Chartone-Souza, Edmar; Nascimento, Andrea M. A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Leite, Laura R.; de Araujo, Flavio M. G.; Salim, Anna C. M.; Oliveira, Guilherme] Ctr Pesquisas Rene Rachou Fundacao Oswaldo Cruz, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Nascimento, AMA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	amaral@ufmg.br	Barbosa, Francisco/M-6225-2019; Barbosa, Francisco A. R./C-9730-2016; Nascimento, Andréa/ABD-9042-2020; Oliveira, Guilherme/E-2624-2014	Nascimento, Andréa/0000-0002-0447-3505; Costa, Patricia/0000-0002-2166-9497; Oliveira, Guilherme/0000-0003-0054-3438; Barbosa, Francisco Antonio/0000-0002-2026-6936	FAPEMIG [APQ 00801/12, APQ-00463-13]; CNPq [nu472411/2012-8]; CNPq/INCT [15206-7]	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/INCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by FAPEMIG APQ 00801/12 and APQ-00463-13, CNPq nu472411/2012-8, CNPq/INCT no 15206-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlett MA, 2010, CAN J MICROBIOL, V56, P32, DOI [10.1139/W09-099, 10.1139/w09-099]; Borba Ricardo Perobelli, 2004, Rem: Rev. Esc. Minas, V57, P45, DOI 10.1590/S0370-44672004000100009; Borba RP, 2000, REV BRASIL GEOCIENC, V30, P554; Bouskill NJ, 2010, ECOTOXICOLOGY, V19, P317, DOI 10.1007/s10646-009-0414-2; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brummer IHM, 2000, APPL ENVIRON MICROB, V66, P3078, DOI 10.1128/AEM.66.7.3078-3082.2000; Bruneel O, 2008, EXTREMOPHILES, V12, P563, DOI 10.1007/s00792-008-0160-z; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; Bundschuh J, 2012, SCI TOTAL ENVIRON, V429, P2, DOI 10.1016/j.scitotenv.2011.06.024; Cardinali-Rezende J, 2012, BIORESOURCE TECHNOL, V119, P373, DOI 10.1016/j.biortech.2012.05.136; Cardinali-Rezende J, 2011, WORLD J MICROB BIOT, V27, P245, DOI 10.1007/s11274-010-0449-9; Costa PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095655; Dahnke K, 2010, MAR ECOL PROG SER, V408, P7, DOI 10.3354/meps08558; Dahnke K, 2012, BIOGEOSCIENCES DISCU, V9, P6987; Del Rio TG, 2010, STAND GENOMIC SCI, V2, P87, DOI 10.4056/sigs.661199; Deschamps Eleonora, 2002, Journal of Soils and Sediments, V2, P216, DOI 10.1007/BF02991043; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Gillan DC, 2014, ENVIRON MICROBIOL, P1, DOI [10.1111/1462-2920.12620, DOI 10.1111/1462-2920.12620]; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gough HL, 2011, ISME J, V5, P543, DOI 10.1038/ismej.2010.132; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; Gupta RS, 2011, ANTON LEEUW INT J G, V99, P133, DOI 10.1007/s10482-010-9488-3; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Jorgensen CJ, 2009, ENVIRON SCI TECHNOL, V43, P4851, DOI 10.1021/es803417s; Kasting JF, 2002, SCIENCE, V296, P1066, DOI 10.1126/science.1071184; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Krupanidhi S, 2008, INDIAN J MED RES, V128, P448; Legatzki A, 2003, J BACTERIOL, V185, P4354, DOI 10.1128/JB.185.15.4354-4361.2003; Leon C, 2012, WORLD J MICROB BIOT, V28, P1511, DOI 10.1007/s11274-011-0953-6; Liao VHC, 2011, J CONTAM HYDROL, V123, P20, DOI 10.1016/j.jconhyd.2010.12.003; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mailloux BJ, 2013, P NATL ACAD SCI USA, V110, P5331, DOI 10.1073/pnas.1213141110; Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Mondini C, 2003, EUR J SOIL BIOL, V39, P141, DOI 10.1016/S1164-5563(03)00029-3; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nies DH, 1997, METAL IONS IN GENE R; Nies DH, 2006, J MOL MICROB BIOTECH, V11, P82, DOI 10.1159/000092820; Novais A, 2010, ANTIMICROB AGENTS CH, V54, P825, DOI 10.1128/AAC.00959-09; Pankratov TA, 2006, INT J SYST EVOL MICR, V56, P2761, DOI 10.1099/ijs.0.64451-0; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Porat I, 2010, MICROB ECOL, V60, P784, DOI 10.1007/s00248-010-9734-2; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Reis MP, 2013, EXTREMOPHILES, V17, P301, DOI 10.1007/s00792-013-0517-9; Rezende PS, 2011, J BRAZIL CHEM SOC, V22, P910, DOI 10.1590/S0103-50532011000500014; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018; Soge OO, 2008, J ANTIMICROB CHEMOTH, V62, P674, DOI 10.1093/jac/dkn255; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Song B, 2009, FEMS MICROBIOL ECOL, V68, P108, DOI 10.1111/j.1574-6941.2009.00657.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Takeda M, 2012, ARCH MICROBIOL, V194, P667, DOI 10.1007/s00203-012-0801-6; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treude N, 2003, FEMS MICROBIOL ECOL, V44, P261, DOI 10.1016/S0168-6496(03)00048-5; Vishnivetskaya TA, 2011, APPL ENVIRON MICROB, V77, P302, DOI 10.1128/AEM.01715-10; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Xiong JB, 2010, APPL ENVIRON MICROB, V76, P7277, DOI 10.1128/AEM.00500-10; Xu J, 2011, HANDBOOK OF MOLECULA; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	72	42	43	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119465	10.1371/journal.pone.0119465	http://dx.doi.org/10.1371/journal.pone.0119465			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742617	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100113
J	Haditsch, B; Roessler, A; Krisper, P; Frisch, H; Hinghofer-Szalkay, HG; Goswami, N				Haditsch, Bernd; Roessler, Andreas; Krisper, Peter; Frisch, Herwig; Hinghofer-Szalkay, Helmut G.; Goswami, Nandu			Volume Regulation and Renal Function at High Altitude across Gender	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; GLOMERULAR-FILTRATION-RATE; ATRIAL NATRIURETIC PEPTIDE; ACUTE-HYPOXIA; SERUM CREATININE; HUMANS; RESPONSES; EXPOSURE; HORMONES; SODIUM	Aims We investigated changes in volume regulating hormones and renal function at high altitudes and across gender. Methodology Included in this study were 28 subjects (n = 20 males; n = 8 females. ages: 19 - 65 yrs), who ascended to a height of 3440m (HA1), on the 3rd day and to 5050m (HA2), on the 14th day. Plasma and urinary creatinine and urinary osmolality as well as plasma levels of plasma renin activity (PRA), Aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP) were measured. The plasma volume loss (PVL) was estimated from plasma density and hematocrit. Glomerular filtration rate (GFR) was measured based on nocturnal (9 hour) creatinine clearance; this was compared with various methods for estimation of GFR. Results The mean 24-hour urine production increased significantly in both sexes across the expedition. But PVL reached significance only in males. No changes in Na+ in plasma, urine or its fractional excretion were seen at both altitudes. Urinary osmolality decreased upon ascent to the higher altitudes. ADH and PRA decreased significantly at both altitudes in males but only at HA2 in females. However, no changes in aldosterone were seen across the sexes and at different altitudes. ANP increased significantly only in males during the expedition. GFR, derived from 9-h creatinine clearance (CreaCl), decreased in both sexes at HA1 but remained stable at HA2. Conventional Crea[p]-based GFR estimates (eGFR) showed only poor correlation to CreaCl. Conclusions We report details of changes in hormonal patterns across high altitude sojourn. To our knowledge we are not aware of any study that has examined these hormones in same subjects and across gender during high altitude sojourn. Our results also suggest that depending on the estimation formula used, eGFR underestimated the observed decrease in renal function measured by CreaCl, thus opening the debate regarding the use of estimated glomerular filtration rates at high altitudes.	[Haditsch, Bernd; Roessler, Andreas; Hinghofer-Szalkay, Helmut G.; Goswami, Nandu] Med Univ Graz, Inst Physiol, Ctr Physiol Med, A-8010 Graz, Austria; [Krisper, Peter] Med Univ Graz, Div Nephrol, Dept Internal Med, A-8036 Graz, Austria; [Frisch, Herwig] Univ Hosp Vienna, Dept Pediat, A-1090 Vienna, Austria	Medical University of Graz; Medical University of Graz; University Hospital Vienna	Goswami, N (corresponding author), Med Univ Graz, Inst Physiol, Ctr Physiol Med, Harrachgasse 21, A-8010 Graz, Austria.	nandu.goswami@medunigraz.at	Roessler, Andreas/A-5751-2008	Roessler, Andreas/0000-0001-9543-8870	government of Styria; government of Graz; Friedrich Schmiedl Foundation; Lanyar Foundation; TravelMedCenter Leonding/Austria	government of Styria; government of Graz; Friedrich Schmiedl Foundation; Lanyar Foundation; TravelMedCenter Leonding/Austria	This study was supported by the government of Styria and the government of Graz, by a grant of the Friedrich Schmiedl Foundation and a grant of the Lanyar Foundation, and by the TravelMedCenter Leonding/Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHACK R, 1985, J LAB CLIN MED, V106, P12; BARTSCH P, 1988, J APPL PHYSIOL, V65, P1929, DOI 10.1152/jappl.1988.65.5.1929; BARTSCH P, 1991, AVIAT SPACE ENVIR MD, V62, P105; BERGER EY, 1949, J CLIN INVEST, V28, P648, DOI 10.1172/JCI102114; BLUME FD, 1984, JAMA-J AM MED ASSOC, V252, P524, DOI 10.1001/jama.252.4.524; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Goldfarb-Rumyantzev AS, 2014, NEPHROL DIAL TRANSPL, V29, P497, DOI 10.1093/ndt/gft051; Greenleaf JE, 2001, AVIAT SPACE ENVIR MD, V72, P522; Haditsch B, 2007, PHYSIOL RES, V56, P779, DOI 10.33549/physiolres.931032; Hildebrandt W, 2000, J APPL PHYSIOL, V88, P599, DOI 10.1152/jappl.2000.88.2.599; Hinghofer-Szalkay H, 2011, EUR J CLIN INVEST, V41, P1180, DOI 10.1111/j.1365-2362.2011.02523.x; Hinghofer-Szalkay HG, 2008, AM J PHYSIOL-GASTR L, V295, pG332, DOI 10.1152/ajpgi.00042.2008; HONIG A, 1989, AM J PHYSIOL, V257, pR1282, DOI 10.1152/ajpregu.1989.257.6.R1282; Hoyt R.W., 1996, BODY FLUID BALANCE E, P183; JAIN SC, 1980, AVIAT SPACE ENVIR MD, V51, P234; KOLLER EA, 1991, EUR J APPL PHYSIOL O, V62, P228, DOI 10.1007/BF00643747; KRZYWICKI HJ, 1971, J APPL PHYSIOL, V30, P806, DOI 10.1152/jappl.1971.30.6.806; LAWRENCE DL, 1990, AM J PHYSIOL, V258, pE243, DOI 10.1152/ajpendo.1990.258.2.E243; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159; Maresh CM, 2004, AM J PHYSIOL-ENDOC M, V286, pE20, DOI 10.1152/ajpendo.00332.2003; MILLEDGE JS, 1989, CLIN SCI, V77, P509, DOI 10.1042/cs0770509; MILLEDGE JS, 1982, J APPL PHYSIOL, V52, P320, DOI 10.1152/jappl.1982.52.2.320; Modesti PA, 2006, CIRCULATION, V114, P1410, DOI 10.1161/CIRCULATIONAHA.105.605527; OLSEN N, 1992, J APPL PHYSIOL, V73, P2036, DOI 10.1152/jappl.1992.73.5.2036; Pichler J, 2008, ACTA PHYSIOL, V192, P443, DOI 10.1111/j.1748-1716.2007.01758.x; Ramirez G, 1999, AVIAT SPACE ENVIR MD, V70, P73; RENNIE D, 1972, J APPL PHYSIOL, V32, P369, DOI 10.1152/jappl.1972.32.3.369; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roessler A, 2011, EUR J CLIN INVEST, V41, P863, DOI 10.1111/j.1365-2362.2011.02476.x; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Shah MB, 2006, WILD ENVIRON MED, V17, P171, DOI 10.1580/PR43-04; St_ampfli R, 1944, HELV PHYSIOL PHAR S3, VIII, P221; SWENSON ER, 1995, J APPL PHYSIOL, V78, P377, DOI 10.1152/jappl.1995.78.2.377; Zaccaria M, 1998, J CLIN ENDOCR METAB, V83, P570, DOI 10.1210/jc.83.2.570	36	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118730	10.1371/journal.pone.0118730	http://dx.doi.org/10.1371/journal.pone.0118730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742500	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100042
J	Wallner, C; Schira, J; Wagner, JM; Schulte, M; Fischer, S; Hirsch, T; Richter, W; Abraham, S; Kneser, U; Lehnhardt, M; Behr, B				Wallner, Christoph; Schira, Jessica; Wagner, Johannes Maximilian; Schulte, Matthias; Fischer, Sebastian; Hirsch, Tobias; Richter, Wiltrud; Abraham, Stephanie; Kneser, Ulrich; Lehnhardt, Marcus; Behr, Bjoern			Application of VEGFA and FGF-9 Enhances Angiogenesis, Osteogenesis and Bone Remodeling in Type 2 Diabetic Long Bone Regeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FRACTURE REPAIR; CHONDROCYTE DIFFERENTIATION; MATRIX METALLOPROTEINASES; VASCULAR COMPLICATIONS; TISSUE INHIBITOR; GENE-EXPRESSION; CELLS; RAT; PROLIFERATION	Although bone regeneration is typically a reliable process, type 2 diabetes is associated with impaired or delayed healing processes. In addition, angiogenesis, a crucial step in bone regeneration, is often altered in the diabetic state. In this study, different stages of bone regeneration were characterized in an unicortical bone defect model comparing transgenic type 2 diabetic (db(-)/db(-)) and wild type (WT) mice in vivo. We investigated angiogenesis, callus formation and bone remodeling at early, intermediate and late time points by means of histomorphometry as well as protein level analyses. In order to enhance bone regeneration, defects were locally treated with recombinant FGF-9 or VEGFA. Histomorphometry of aniline blue stained sections indicated that bone regeneration is significantly decreased in db(-)/db(-) as opposed to WT mice at intermediate (5 days post operation) and late stages (7 days post operation) of bone regeneration. Moreover, immunohistochemical analysis revealed significantly decreased levels of RUNX-2, PCNA, Osteocalcin and PECAM-1 in db(-)/db(-) defects. In addition, osteoclastogenesis is impaired in db(-)/db(-) indicating altered bone remodeling. These results indicate significant impairments in angiogenesis and osteogenesis in type 2 diabetic bones. Importantly, angiogenesis, osteogenesis and bone remodeling could be reconstituted by application of recombinant FGF-9 and, in part, by VEGFA application. In conclusion, our study demonstrates that type 2 diabetes affects angiogenesis, osteogenesis and subsequently bone remodeling, which in turn leads to decreased bone regeneration. These effects could be reversed by local application of FGF-9 and to a lesser degree VEGFA. These data could serve as a basis for future therapeutic applications aiming at improving bone regeneration in the type 2 diabetic patient population.	[Wallner, Christoph; Schira, Jessica; Hirsch, Tobias; Abraham, Stephanie; Lehnhardt, Marcus; Behr, Bjoern] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Bochum, Germany; [Wagner, Johannes Maximilian; Schulte, Matthias; Fischer, Sebastian; Kneser, Ulrich] Heidelberg Univ, BG Trauma Hosp Ludwigshafen, Dept Plast Surg, Ludwigshafen, Germany; [Richter, Wiltrud] Univ Heidelberg Hosp, Res Ctr Expt Orthopaed, Heidelberg, Germany	Ruhr University Bochum; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Behr, B (corresponding author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Univ Str 150, Bochum, Germany.	bjorn.behr@rub.de	Behr, Björn/AAS-1877-2021; Hirsch, Tobias/AAS-6707-2021; Richter, Wiltrud/V-3217-2017	Hirsch, Tobias/0000-0002-3641-2707; Richter, Wiltrud/0000-0003-4694-2768; , Sebastian/0000-0003-3445-1902; Schira-Heinen, Jessica/0000-0002-2184-9746	German Research Foundation (DFG) [BE 4169/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Funding from the German Research Foundation (DFG) (http://www.dfg.de/) # BE 4169/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zube L, 2009, J ORTHOP RES, V27, P1074, DOI 10.1002/jor.20842; Amin AH, 2010, LAB INVEST, V90, P985, DOI 10.1038/labinvest.2010.86; Beam HA, 2002, J ORTHOPAED RES, V20, P1210, DOI 10.1016/S0736-0266(02)00066-9; Behr B, 2011, TISSUE ENG PT A, V17, P2061, DOI [10.1089/ten.tea.2010.0719, 10.1089/ten.TEA.2010.0719]; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; Behr B, 2010, P NATL ACAD SCI USA, V107, P11853, DOI 10.1073/pnas.1003317107; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Catalfamo DL, 2013, ORAL DIS, V19, P303, DOI 10.1111/odi.12002; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; COZEN L, 1972, CLIN ORTHOP RELAT R, P134; Cunha J.S., 2014, CELL TISSUE RES; D'Souza DR, 2009, J BIOL CHEM, V284, P17947, DOI 10.1074/jbc.M109.002378; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Ding Daofang, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1432; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gandhi A, 2006, BONE, V38, P540, DOI 10.1016/j.bone.2005.10.019; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Gaston MS, 2007, J BONE JOINT SURG BR, V89B, P1553, DOI 10.1302/0301-620X.89B12; Gebauer GP, 2002, J ORTHOPAED RES, V20, P587, DOI 10.1016/S0736-0266(01)00136-X; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010; GUARNERI MP, 1993, J ENDOCRINOL INVEST, V16, P505, DOI 10.1007/BF03348892; Han SY, 2006, NEPHROL DIAL TRANSPL, V21, P2406, DOI 10.1093/ndt/gfl238; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; He HB, 2004, ENDOCRINOLOGY, V145, P447, DOI 10.1210/en.2003-1239; HICKMAN J, 1989, ENDOCRINOLOGY, V124, P701, DOI 10.1210/endo-124-2-701; Horvat S, 1999, LAB ANIM, V33, P380, DOI 10.1258/002367799780487850; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96; Kahveci Z, 2000, BIOTECH HISTOCHEM, V75, P264, DOI 10.3109/10520290009085130; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774; Kawaguchi H, 2010, J BONE MINER RES, V25, P2459, DOI 10.1002/jbmr.146; Keyszer G, 1999, J RHEUMATOL, V26, P251; Khazai NB, 2009, CURR OPIN ENDOCRINOL, V16, P435, DOI 10.1097/MED.0b013e328331c7eb; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lu HF, 2003, ENDOCRINOLOGY, V144, P346, DOI 10.1210/en.2002-220072; Isidro ML, 2010, CURR DIABETES REV, V6, P144, DOI 10.2174/157339910791162970; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Pavlidis D, 2009, EUR J ORTHODONT, V31, P565, DOI 10.1093/ejo/cjp053; Perlman MH, 1999, FOOT ANKLE INT, V20, P491, DOI 10.1177/107110079902000805; RALIS ZA, 1975, MED LAB TECHNOL, V32, P203; Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P673, DOI 10.1111/j.1600-0501.2010.01923.x; Rowe NM, 1999, ANN PLAS SURG, V42, P470, DOI 10.1097/00000637-199905000-00002; Santana RB, 2003, DIABETES, V52, P1502, DOI 10.2337/diabetes.52.6.1502; Scheede-Bergdahl C, 2014, DIABETES VASC DIS RE, V11, P324, DOI 10.1177/1479164114535943; Stepanovic V, 2003, CIRC RES, V92, P1247, DOI 10.1161/01.RES.0000074906.98021.55; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Tatsuyama K, 2000, EUR J HISTOCHEM, V44, P269; Teishima J, 2014, ANTICANCER RES, V34, P695; Tyndall WA, 2003, CLIN ORTHOP RELAT R, P319, DOI 10.1097/01.blo.0000048138.30533.e2; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang AM, 2014, J BIOL CHEM, V289, P11410, DOI 10.1074/jbc.M113.541458; Wang Feng, 2010, Diabetes Res Clin Pract, V88, pe7, DOI 10.1016/j.diabres.2010.01.017; Weyer C, 2013, HYPOADIPONECTINEMIA; Williams GA, 2011, J BONE MINER RES, V26, P1698, DOI 10.1002/jbmr.367; Xu F, 2013, J HUAZHONG U SCI-MED, V33, P244, DOI 10.1007/s11596-013-1105-z; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Yang YQ, 2012, INT J ORAL SCI, V4, P64, DOI 10.1038/ijos.2012.33; Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169	69	52	55	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118823	10.1371/journal.pone.0118823	http://dx.doi.org/10.1371/journal.pone.0118823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742620	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100050
J	Maltarollo, VG; Togashi, M; Nascimento, AS; Honorio, KM				Maltarollo, Vinicius G.; Togashi, Marie; Nascimento, Alessandro S.; Honorio, Kathia M.			Structure-Based Virtual Screening and Discovery of New PPAR delta/gamma Dual Agonist and PPAR delta and gamma Agonists	PLOS ONE			English	Article							PROTEIN-LIGAND DOCKING; HORMONE RECEPTOR SUPERFAMILY; PEROXISOME-PROLIFERATOR; MOLECULAR DOCKING; METABOLIC SYNDROME; BINDING-AFFINITY; ACTIVATION; ALPHA; MODEL; ACID	Peroxisome proliferator-activated receptors (PPARs) are involved in the control of carbohydrate and lipid metabolism and are considered important targets to treat diabetes mellitus and metabolic syndrome. The available PPAR ligands have several side effects leading to health risks justifying the search for new bioactive ligands to activate the PPAR subtypes, in special PPAR delta, the less studied PPAR isoform. Here, we used a structure-based virtual screening protocol in order to find out new PPAR ligands. From a lead-like subset of purchasable compounds, we identified 5 compounds with potential PPAR affinity and, from preliminary in vitro assays, 4 of them showed promising biological activity. Therefore, from our in silico and in vitro protocols, new PPAR ligands are potential candidates to treat metabolic diseases.	[Maltarollo, Vinicius G.; Honorio, Kathia M.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil; [Maltarollo, Vinicius G.] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, Brazil; [Togashi, Marie] Univ Brasilia, Fac Ciencias Saude, Brasilia, DF, Brazil; [Nascimento, Alessandro S.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil; [Honorio, Kathia M.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade de Brasilia; Universidade de Sao Paulo; Universidade de Sao Paulo	Honorio, KM (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.	kmhonorio@usp.br	Maltarollo, Vinicius Gonçalves/AAV-6849-2021; Nascimento, Alessandro/Y-3394-2019; Honorio, Kathia/AAG-9844-2020; Nascimento, Alessandro S/G-9547-2012; Honorio, Kathia M/D-4998-2012; Togashi, Marie/L-3092-2018	Maltarollo, Vinicius Gonçalves/0000-0001-9675-5907; Nascimento, Alessandro/0000-0001-6656-5379; Honorio, Kathia/0000-0002-6938-0676; Nascimento, Alessandro S/0000-0001-6656-5379; Honorio, Kathia M/0000-0002-6938-0676; 	FAPESP [2011/18981-2, 2014/06565-2]; CNPq Brazilian agency; CAPES Brazilian agency	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq Brazilian agency(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Brazilian agency(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to thank FAPESP (2011/18981-2, 2014/06565-2), CNPq and CAPES (Brazilian agencies) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SYBYL 8 1; Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Batista FAH, 2012, PLOS ONE, V7, P1, DOI [10.1093/jscr/2012.7.1, DOI 10.1093/JSCR/2012.7.1]; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bolden A, 2012, PPAR RES, V2012, DOI 10.1155/2012/929052; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Buss ZD, 2012, INFLAMMATION, V35, P280, DOI 10.1007/s10753-011-9316-6; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; Connors RV, 2009, BIOORG MED CHEM LETT, V19, P3550, DOI 10.1016/j.bmcl.2009.04.151; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Epple R, 2006, BIOORG MED CHEM LETT, V16, P5488, DOI 10.1016/j.bmcl.2006.08.052; Evans JL, 2005, CURR DIABETES REV, V1, P299, DOI 10.2174/157339905774574365; Evans KA, 2011, BIOORG MED CHEM LETT, V21, P2345, DOI 10.1016/j.bmcl.2011.02.077; Ewing TJA, 1997, J COMPUT CHEM, V18, P1175, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1175::AID-JCC6>3.0.CO;2-O; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Fyffe SA, 2006, MOL CELL, V21, P1, DOI 10.1016/j.molcel.2005.12.001; Garcia TS, 2011, J BRAZIL CHEM SOC, V22, P65, DOI 10.1590/S0103-50532011000100008; GEY GO, 1952, CANCER RES, V12, P264; Giaginis C, 2009, QSAR COMB SCI, V28, P802, DOI 10.1002/qsar.200860185; Gschwend DA, 1996, J COMPUT AID MOL DES, V10, P123, DOI 10.1007/BF00402820; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Iwashita A, 2007, J PHARMACOL EXP THER, V320, P1087, DOI 10.1124/jpet.106.115758; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jialal I, 2012, METAB SYNDR RELAT D, V10, P159, DOI 10.1089/met.2012.1500; Jin LH, 2011, J BIOL CHEM, V286, P31473, DOI 10.1074/jbc.M111.266023; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Keil S, 2011, CHEMMEDCHEM, V6, P633, DOI 10.1002/cmdc.201100047; Kilgore KS, 2008, CURR OPIN INVEST DR, V9, P463; Krishnamurthy Praveen T., 2013, CURR BIOACT COMPD, V9, P221, DOI [10.2174/157340720903140119153500, DOI 10.2174/157340720903140119153500]; Kroemer RT, 2004, J CHEM INF COMP SCI, V44, P871, DOI 10.1021/ci049970m; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lather V, 2009, QSAR COMB SCI, V28, P447, DOI 10.1002/qsar.200810092; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Liu XY, 2011, PROTEIN PEPTIDE LETT, V18, P1021, DOI 10.2174/092986611796378701; Luckhurst CA, 2011, BIOORG MED CHEM LETT, V21, P492, DOI 10.1016/j.bmcl.2010.10.117; Makino S, 1997, J COMPUT CHEM, V18, P1812, DOI 10.1002/(SICI)1096-987X(19971115)18:14<1812::AID-JCC10>3.0.CO;2-H; Maltarollo VG, 2012, CHEM BIOL DRUG DES, V80, P533, DOI 10.1111/j.1747-0285.2012.01424.x; Maltarollo VG, 2012, J BRAZIL CHEM SOC, V23, P85, DOI 10.1590/S0103-50532012000100013; Maltarollo VG, 2011, J MOL MODEL, V17, P2549, DOI 10.1007/s00894-010-0935-x; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; McEwan Iain J., 2009, V505, P3, DOI 10.1007/978-1-60327-575-0_1; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nascimento AS, 2010, BIOCHIMIE, V92, P499, DOI 10.1016/j.biochi.2010.01.018; Nevin DK, 2011, CURR MED CHEM, V18, P5598; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; Oyama T, 2009, ACTA CRYSTALLOGR D, V65, P786, DOI 10.1107/S0907444909015935; Pereira R, 2006, BIOORG MED CHEM LETT, V16, P49, DOI 10.1016/j.bmcl.2005.09.060; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersson I, 2007, BIOORG MED CHEM LETT, V17, P4625, DOI 10.1016/j.bmcl.2007.05.079; Pouwels Koen B, 2012, Int J Risk Saf Med, V24, P73, DOI 10.3233/JRS-2012-0559; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Robbins GT, 2012, FRONT BIOSCI-LANDMRK, V17, P1816, DOI 10.2741/4021; Robinson E, 2009, PHARMACOL THERAPEUT, V122, P246, DOI 10.1016/j.pharmthera.2009.03.003; Rogenhofer S, 2012, ANTICANCER RES, V32, P3479; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scientific D, 2006, PYMOL V0 99C; Shearer BG, 2008, BIOORG MED CHEM LETT, V18, P5018, DOI 10.1016/j.bmcl.2008.08.011; SHOICHET BK, 1991, J MOL BIOL, V221, P327, DOI 10.1016/0022-2836(91)80222-G; SHOICHET BK, 1992, J COMPUT CHEM, V13, P380, DOI 10.1002/jcc.540130311; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Takada I, 2000, MOL ENDOCRINOL, V14, P733, DOI 10.1210/me.14.5.733; Teramoto R, 2007, J CHEM INF MODEL, V47, P526, DOI 10.1021/ci6004993; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wang Y, 2012, MOL NUTR FOOD RES, V56, P1234, DOI 10.1002/mnfr.201100517; Wickens P, 2007, BIOORG MED CHEM LETT, V17, P4369, DOI 10.1016/j.bmcl.2007.03.057; Wilding JPH, 2012, DIABETES OBES METAB, V14, P973, DOI 10.1111/j.1463-1326.2012.01601.x; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yu Y, 2012, HYPERTENSION, V59, P477, DOI 10.1161/HYPERTENSIONAHA.111.182345; Yue LD, 2005, BIOCHIMIE, V87, P539, DOI 10.1016/j.biochi.2005.02.002; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	86	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118790	10.1371/journal.pone.0118790	http://dx.doi.org/10.1371/journal.pone.0118790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767888	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500044
J	Xu, F; Yao, PP; Xia, Y; Qian, L; Yang, ZN; Xie, RH; Sun, YS; Lu, HJ; Miao, ZP; Li, C; Li, X; Liang, WF; Huang, XX; Xia, SC; Chen, ZP; Jiang, JM; Zhang, YJ; Mei, LL; Liu, SL; Gu, H; Xu, ZY; Fu, XF; Zhu, ZY; Zhu, HP				Xu, Fang; Yao, Ping-Ping; Xia, Yong; Qian, Lei; Yang, Zhang-Nv; Xie, Rong-Hui; Sun, Yi-Sheng; Lu, Hang-Jing; Miao, Zi-Ping; Li, Chan; Li, Xiao; Liang, Wei-Feng; Huang, Xiao-Xiao; Xia, Shi-Chang; Chen, Zhi-Ping; Jiang, Jian-Min; Zhang, Yan-Jun; Mei, Ling-Ling; Liu, She-Lan; Gu, Hua; Xu, Zhi-Yao; Fu, Xiao-Fei; Zhu, Zhi-Yong; Zhu, Han-Ping			Enterovirus 71 Infection Causes Severe Pulmonary Lesions in Gerbils, Meriones unguiculatus, Which Can Be Prevented by Passive Immunization with Specific Antisera	PLOS ONE			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; CENTRAL-NERVOUS-SYSTEM; MOUTH-DISEASE; CLINICAL-FEATURES; RISK-FACTORS; MOUSE MODEL; HAND; FOOT; OUTBREAK; TAIWAN	Neurogenic pulmonary edema caused by severe brainstem encephalitis is the leading cause of death in young children infected by Enterovirus 71 (EV71). However, no pulmonary lesions have been found in EV71-infected transgenic or non-transgenic mouse models. Development of a suitable animal model is important for studying EV71 pathogenesis and assessing effect of therapeutic approaches. We had found neurological disorders in EV71-induced young gerbils previously. Here, we report severe pulmonary lesions characterized with pulmonary congestion and hemorrhage in a gerbil model for EV71 infection. In the EV71-infected gerbils, six 21-day-old or younger gerbils presented with a sudden onset of symptoms and rapid illness progression after inoculation with 1x10(5.5) TCID50 of EV71 via intraperitoneal (IP) or intramuscular (IM) route. Respiratory symptoms were observed along with interstitial pneumonia, pulmonary congestion and extensive lung hemorrhage could be detected in the lung tissues by histopathological examination. EV71 viral titer was found to be peak at late stages of infection. EV71-induced pulmonary lesions, together with severe neurological disorders were also observed in gerbils, accurately mimicking the disease process in EV71-infected patients. Passive transfer with immune sera from EV71 infected adult gerbils with a neutralizing antibody (GMT= 89) prevented severe pulmonary lesion formation after lethal EV71 challenge. These results establish this gerbil model as a useful platform for studying the pathogenesis of EV71-induced pulmonary lesions, immunotherapy and antiviral drugs.	[Xu, Fang; Yao, Ping-Ping; Xia, Yong; Qian, Lei; Yang, Zhang-Nv; Xie, Rong-Hui; Sun, Yi-Sheng; Lu, Hang-Jing; Miao, Zi-Ping; Li, Chan; Xia, Shi-Chang; Chen, Zhi-Ping; Jiang, Jian-Min; Zhang, Yan-Jun; Mei, Ling-Ling; Liu, She-Lan; Gu, Hua; Zhu, Zhi-Yong; Zhu, Han-Ping] Zhejiang Prov Ctr Dis Prevent & Control, Key Lab Vaccine Hemorrhag Fever Renal Syndrome, Hangzhou, Zhejiang, Peoples R China; [Li, Xiao] First Municipal Hosp Hangzhou, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Liang, Wei-Feng] Zhejiang Univ, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Xiao-Xiao] Hangzhou Sixth Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Xu, Zhi-Yao] Wenzhou Med Univ, Wenzhou, Peoples R China; [Fu, Xiao-Fei] Jiaxing Ctr Dis Control & Prevent, Jiaxing, Peoples R China	Zhejiang University; Wenzhou Medical University	Chen, ZP (corresponding author), Zhejiang Prov Ctr Dis Prevent & Control, Key Lab Vaccine Hemorrhag Fever Renal Syndrome, Hangzhou, Zhejiang, Peoples R China.	zhpchen@cdc.zj.cn; hanpingzhu@aliyun.com			Natural Science Foundation of Zhejiang Province [Y3100701]; Medical and Technological Project of Zhejiang Province [2010KYB027]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Medical and Technological Project of Zhejiang Province	The work was granted by Natural Science Foundation of Zhejiang Province (Y3100701) and the Medical and Technological Project of Zhejiang Province (2010KYB027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Fujii K, 2013, P NATL ACAD SCI USA, V110, P14753, DOI 10.1073/pnas.1217563110; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Kao SJ, 2004, CLIN INFECT DIS, V38, P1784, DOI 10.1086/421021; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057591; Liu JN, 2012, ARCH VIROL, V157, P539, DOI 10.1007/s00705-011-1198-2; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Manki A, 1997, Nihon Rinsho, V55, P849; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Pallansch, 2007, FIELDS VIROLOGY, P839; REED L. J., 1938, AMER JOUR HYG, V27, P493; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang YF, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-31; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wu JM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e26; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xiu JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-215; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yang F, 2011, CLIN INFECT DIS, V53, P400, DOI 10.1093/cid/cir346; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yao PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051996; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang DM, 2010, INT J INFECT DIS, V14, pE739, DOI 10.1016/j.ijid.2009.12.002; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	41	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119173	10.1371/journal.pone.0119173	http://dx.doi.org/10.1371/journal.pone.0119173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767882	gold, Green Submitted, Green Published			2022-12-27	WOS:000351277500068
J	Nazha, B; Salloum, RH; Fahed, AC; Nabulsi, M				Nazha, Bassel; Salloum, Rony H.; Fahed, Akl C.; Nabulsi, Mona			Students' Perceptions of Peer-Organized Extra-Curricular Research Course during Medical School: A Qualitative Study	PLOS ONE			English	Article							ASSOCIATION; EDUCATION	Early integration of research education into medical curricula is crucial for evidence-based practice. Yet, many medical students are graduating with no research experience due to the lack of such integration in their medical school programs. The purpose of this study was to explore the impact of a peer-organized, extra-curricular research methodology course on the attitudes of medical students towards research and future academic careers. Twenty one medical students who participated in a peer-organized research course were enrolled in three focus group discussions to explore their experiences, perceptions and attitudes towards research after the course. Discussions were conducted using a semi-structured interview guide, and were transcribed and thematically analyzed for major and minor themes identification. Our findings indicate that students' perceptions of research changed after the course from being difficult initially to becoming possible. Participants felt that their research skills and critical thinking were enhanced and that they would develop research proposals and abstracts successfully. Students praised the peer-assisted teaching approach as being successful in enhancing the learning environment and filling the curricular gap. In conclusion, peer-organized extra-curricular research courses may be a useful option to promote research interest and skills of medical students when gaps in research education in medical curricula exist.	[Nazha, Bassel] NorthShore LIJ Staten Isl Univ Hosp, Dept Internal Med, Staten Isl, NY USA; [Salloum, Rony H.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Fahed, Akl C.] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [Nabulsi, Mona] Amer Univ Beirut, Dept Pediat & Adolescent Med, Fac Med, Beirut, Lebanon	Northwell Health; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; American University of Beirut	Nabulsi, M (corresponding author), Amer Univ Beirut, Dept Pediat & Adolescent Med, Fac Med, Beirut, Lebanon.	bnazha@nshs.edu; mn04@aub.edu.lb						AlHaqwi A, 2010, ED HLTH ABINGDON, V23, P1; Burgoyne LN, 2010, MED EDUC ONLINE, V15, DOI 10.3402/meo.v15i0.5212; Cleland J, 2010, CLIN TEACH, V7, P47, DOI 10.1111/j.1743-498X.2009.00335.x; Creswell J.W., 2018, RES DESIGN QUALITATI, V5th, DOI DOI 10.1097/00006527-199301340-00010; Dandavino M, 2007, MED TEACH, V29, P558, DOI 10.1080/01421590701477449; Henning MA, 2011, CLIN TEACH, V8, P83, DOI 10.1111/j.1743-498X.2011.00439.x; Hren D, 2004, MED EDUC, V38, P81, DOI 10.1111/j.1365-2923.2004.01735.x; Kellehear A., 1993, UNOBTRUSIVE RES GUID; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Montano D.M., 2008, HLTH BEHAV HLTH ED T, P67; Murdoch-Eaton D, 2010, MED TEACH, V32, pE152, DOI 10.3109/01421591003657493; Reinders JJ, 2005, MED EDUC, V39, P237, DOI 10.1111/j.1365-2929.2004.02078.x; SEGAL S, 1990, ACAD MED, V65, P530, DOI 10.1097/00001888-199008000-00010; Ten Cate O, 2007, MED TEACH, V29, P591, DOI 10.1080/01421590701606799; Toker A, 2002, MED TEACH, V24, P634, DOI 10.1080/0142159021000063961; van Schravendijk C, 2013, MED TEACH, V35, pE1243, DOI 10.3109/0142159X.2013.768337	16	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119375	10.1371/journal.pone.0119375	http://dx.doi.org/10.1371/journal.pone.0119375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764441	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300025
J	Anderson, D; Cordell, HJ; Fakiola, M; Francis, RW; Syn, G; Scaman, ESH; Davis, E; Miles, SJ; McLeay, T; Jamieson, SE; Blackwell, JM				Anderson, Denise; Cordell, Heather J.; Fakiola, Michaela; Francis, Richard W.; Syn, Genevieve; Scaman, Elizabeth S. H.; Davis, Elizabeth; Miles, Simon J.; McLeay, Toby; Jamieson, Sarra E.; Blackwell, Jenefer M.			First Genome-Wide Association Study in an Australian Aboriginal Population Provides Insights into Genetic Risk Factors for Body Mass Index and Type 2 Diabetes	PLOS ONE			English	Article							HEALTH SIGNIFICANT PROGRESS; BETA-CELL FUNCTION; COMMON VARIANTS; GENOTYPE IMPUTATION; SUSCEPTIBILITY GENES; WAIST CIRCUMFERENCE; MULTIPLE ALIGNMENT; METABOLIC SYNDROME; LOCI; TRAITS	A body mass index (BMI) >22kg/m(2) is a risk factor for type 2 diabetes (T2D) in Aboriginal Australians. To identify loci associated with BMI and T2D we undertook a genome-wide association study using 1,075,436 quality-controlled single nucleotide polymorphisms (SNPs) genotyped (Illumina 2.5M Duo Beadchip) in 402 individuals in extended pedigrees from a Western Australian Aboriginal community. Imputation using the thousand genomes (1000G) reference panel extended the analysis to 6,724,284 post quality-control autosomal SNPs. No associations achieved genome-wide significance, commonly accepted as P<5x10(-8). Nevertheless, genes/pathways in common with other ethnicities were identified despite the arrival of Aboriginal people in Australia >45,000 years ago. The top hit (rs10868204 P-genotyped = 1.50x10(-6); rs11140653 P-imputed_1000G = 2.90x10(-7)) for BMI lies 5' of NTRK2, the type 2 neurotrophic tyrosine kinase receptor for brain-derived neurotrophic factor (BDNF) that regulates energy balance downstream of melanocortin-4 receptor (MC4R). PIK3C2G (rs12816270 P-genotyped = 8.06x10(-6); rs10841048 P-imputed_1000G = 6.28x10(-7)) was associated with BMI, but not with T2D as reported elsewhere. BMI also associated with CNTNAP2 (rs6960319 P-genotyped = 4.65x10(-5); rs13225016 P-imputed_1000G = 6.57x10(-5)), previously identified as the strongest gene-by-environment interaction for BMI in African-Americans. The top hit (rs11240074 P-genotyped = 5.59x10-6, P-imputed_1000G = 5.73x10(-6)) for T2D lies 5' of BCL9 that, along with TCF7L2, promotes beta-catenin's transcriptional activity in the WNT signaling pathway. Additional hits occurred in genes affecting pancreatic (KCNJ6, KCNA1) and/or GABA (GABRR1, KCNA1) functions. Notable associations observed for genes previously identified at genome-wide significance in other populations included MC4R (P-genotyped = 4.49x10(-4)) for BMI and IGF2BP2 P-imputed_1000G = 2.55x10(-6)) for T2D. Our results may provide novel functional leads in understanding disease pathogenesis in this Australian Aboriginal population.	[Anderson, Denise; Fakiola, Michaela; Francis, Richard W.; Syn, Genevieve; Scaman, Elizabeth S. H.; Davis, Elizabeth; Jamieson, Sarra E.; Blackwell, Jenefer M.] Univ Western Australia, Telethon Kids Inst, Subiaco, WA 6008, Australia; [Cordell, Heather J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Fakiola, Michaela; Blackwell, Jenefer M.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge, England; [Fakiola, Michaela; Blackwell, Jenefer M.] Univ Cambridge, Dept Pathol, Cambridge, England; [Davis, Elizabeth] Princess Margaret Hosp Children, Dept Endocrinol & Diabet, Subiaco, WA 6008, Australia; [Miles, Simon J.; McLeay, Toby] Ngangganawili Aboriginal Hlth Serv, Wiluna, WA 6646, Australia	Telethon Kids Institute; University of Western Australia; Newcastle University - UK; University of Cambridge; University of Cambridge	Blackwell, JM (corresponding author), Univ Western Australia, Telethon Kids Inst, Subiaco, WA 6008, Australia.	jenefer.blackwell@telethonkids.org.au	Blackwell, Jenefer M/H-3015-2015; Francis, Richard/K-2812-2019	Francis, Richard/0000-0003-1580-7934; Davis, Elizabeth/0000-0003-4244-5473; Cordell, Heather/0000-0002-1879-5572; Fakiola, Michaela/0000-0001-9071-4709; Anderson, Denise/0000-0003-0643-4136	Australian National Health and Medical Research Council [APP634301]; Wellcome Trust [087436/Z/08/Z, 102858/Z/13/Z]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by the Australian National Health and Medical Research Council (APP634301). HJC is supported by a Senior Research Fellowship in Basic Biomedical Science from the Wellcome Trust (Grant references 087436/Z/08/Z and 102858/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Al Safar HS, 2013, ANN HUM GENET, V77, P488, DOI 10.1111/ahg.12036; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alsmadi O, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-72; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Brudno M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-66; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Buchner DA, 2012, MAMM GENOME, V23, P431, DOI 10.1007/s00335-012-9400-8; Carlsson S, 2013, DIABETOLOGIA, V56, P1031, DOI 10.1007/s00125-013-2859-3; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Daimon M, 2008, BIOCHEM BIOPH RES CO, V365, P466, DOI 10.1016/j.bbrc.2007.10.180; Daniel M, 2002, DIABETES RES CLIN PR, V57, P23, DOI 10.1016/S0168-8227(02)00006-2; Davenport S, 2005, CLEARED OUT 1 CONTRA; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dodson M, 1999, J MED ETHICS, V25, P204, DOI 10.1136/jme.25.2.204; Donnelly P, 2011, SCIENCE, V331, P1024, DOI 10.1126/science.1204089; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Edwards DRV, 2013, HUM GENET, V132, P323, DOI 10.1007/s00439-012-1246-3; Ereqat S, 2010, ACTA DIABETOL, V47, pS195, DOI 10.1007/s00592-009-0161-0; Eu-ahsunthornwattana J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004445; Fesinmeyer MD, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-6; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gillett G, 2007, SOC SCI MED, V65, P2093, DOI 10.1016/j.socscimed.2007.06.024; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; Grabe Niels, 2002, In Silico Biology, V2, pS1; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Gunther T, 2011, OMICS, V15, P507, DOI 10.1089/omi.2010.0154; Guo TW, 2007, DIABETES, V56, P3082, DOI 10.2337/db07-0621; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Harb G, 2009, DIABETES, V58, P1852, DOI 10.2337/db08-0759; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hindorff LA, 2009, CATALOG PUBLISHED GE; Ho LKF, 1997, BIOCHEM BIOPH RES CO, V235, P130, DOI 10.1006/bbrc.1997.6747; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HUGHES MJ, 1989, BIOCHEMISTRY-US, V28, P9137, DOI 10.1021/bi00449a027; Ikeno M, 2012, NUCLEIC ACIDS RES, V40, P10742, DOI 10.1093/nar/gks874; Johnson W, 2013, AM J HUM BIOL, V25, P378, DOI 10.1002/ajhb.22385; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kowal E., 2012, GENETIC RES ABORIGIN; Kowal E, 2012, BIOMAPPING INDIGENOU; Kowal E, 2012, J BIOETHIC INQ, V9, P419, DOI 10.1007/s11673-012-9391-x; Kowal EE, 2012, MED J AUSTRALIA, V197, P384, DOI 10.5694/mja.12.11113; Kowal EE, 2012, MED J AUSTRALIA, V197, P19, DOI 10.5694/mja12.10531; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kuczmarski RJ, 2000, AM J CLIN NUTR, V72, P1074; Lin HJ, 2013, OPHTHALMIC GENET, V34, P35, DOI 10.3109/13816810.2012.736590; Lin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009697; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018213; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McInnes RR, 2011, AM J HUM GENET, V88, P254, DOI 10.1016/j.ajhg.2011.02.014; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Murphy R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/920214; Naciff JM, 2005, TOXICOL SCI, V86, P396, DOI 10.1093/toxsci/kfi198; Nelson SC, 2013, G3-GENES GENOM GENET, V3, P1795, DOI 10.1534/g3.113.007161; Ning F, 2013, BEHAV GENET, V43, P340, DOI 10.1007/s10519-013-9597-7; Okamoto K, 2010, AM J HUM GENET, V86, P54, DOI 10.1016/j.ajhg.2009.12.009; Olney JJ, 2014, NEUROPEPTIDES, V48, P47, DOI 10.1016/j.npep.2013.11.001; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pugach I, 2013, P NATL ACAD SCI USA, V110, P1803, DOI 10.1073/pnas.1211927110; Qin LJ, 2013, GENET MOL RES, V12, P2990, DOI 10.4238/2013.August.20.1; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Robbins CA, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2012.03484.x; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Saadi H, 2008, DIABETES RES CLIN PR, V80, P392, DOI 10.1016/j.diabres.2008.01.008; SAKURA H, 1995, FEBS LETT, V367, P193, DOI 10.1016/0014-5793(95)00498-X; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shia WC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S23; Skowronski AA, 2014, OBESITY, V22, P1287, DOI 10.1002/oby.20678; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; Tonkinson R., 1991, MARDU ABORIGINES LIV; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; Vuillaume ML, 2014, AM J MED GENET A, V164, P1965, DOI 10.1002/ajmg.a.36587; Wagner R, 2014, MOL METAB, V3, P261, DOI 10.1016/j.molmet.2014.01.001; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xi B, 2014, CLIN ENDOCRINOL, V81, P702, DOI 10.1111/cen.12428; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	105	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119333	10.1371/journal.pone.0119333	http://dx.doi.org/10.1371/journal.pone.0119333			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760438	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000054
J	Besson, MT; Alegria, K; Garrido-Gerter, P; Barros, LF; Lievens, JC				Besson, Marie Therse; Alegria, Karin; Garrido-Gerter, Pamela; Barros, Luis Felipe; Lievens, Jean-Charles			Enhanced Neuronal Glucose Transporter Expression Reveals Metabolic Choice in a HD Drosophila Model	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; COMPLEX-II DEFECTS; HUNTINGTONS-DISEASE; OXIDATIVE STRESS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; IN-VIVO; BRAIN; GENE	Huntington's disease is a neurodegenerative disorder caused by toxic insertions of polyglutamine residues in the Huntingtin protein and characterized by progressive deterioration of cognitive and motor functions. Altered brain glucose metabolism has long been suggested and a possible link has been proposed in HD. However, the precise function of glucose transporters was not yet determined. Here, we report the effects of the specifically-neuronal human glucose transporter expression in neurons of a Drosophila model carrying the exon 1 of the human huntingtin gene with 93 glutamine repeats (HQ93). We demonstrated that overexpression of the human glucose transporter in neurons ameliorated significantly the status of HD flies by increasing their lifespan, reducing their locomotor deficits and rescuing eye neurodegeneration. Then, we investigated whether increasing the major pathways of glucose catabolism, glycolysis and pentose-phosphate pathway (PPP) impacts HD. To mimic increased glycolytic flux, we overexpressed phosphofructokinase (PFK) which catalyzes an irreversible step in glycolysis. Overexpression of PFK did not affect HQ93 fly survival, but protected from photoreceptor loss. Overexpression of glucose-6-phosphate dehydrogenase (G6PD), the key enzyme of the PPP, extended significantly the lifespan of HD flies and rescued eye neurodegeneration. Since G6PD is able to synthesize NADPH involved in cell survival by maintenance of the redox state, we showed that tolerance to experimental oxidative stress was enhanced in flies co-expressing HQ93 and G6PD. Additionally overexpressions of hGluT3, G6PD or PFK were able to circumvent mitochondrial deficits induced by specific silencing of genes necessary for mitochondrial homeostasis. Our study confirms the involvement of bioenergetic deficits in HD course; they can be rescued by specific expression of a glucose transporter in neurons. Finally, the PPP and, to a lesser extent, the glycolysis seem to mediate the hGluT3 protective effects, whereas, in addition, the PPP provides increased protection to oxidative stress.	[Besson, Marie Therse; Lievens, Jean-Charles] Aix Marseille Univ, CNRS, CRN2M, UMR7286, F-13344 Marseille 15, France; [Alegria, Karin; Garrido-Gerter, Pamela; Barros, Luis Felipe] Ctr Estudios Cient, Valdivia, Chile; [Garrido-Gerter, Pamela] Univ Austral Chile, Valdivia, Chile	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universidad Austral de Chile	Besson, MT (corresponding author), Aix Marseille Univ, CNRS, CRN2M, UMR7286, F-13344 Marseille 15, France.	marie-therese.besson@univ-amu.fr		LIEVENS, Jean-Charles/0000-0002-0139-2291	CHDI Foundation, Inc.; Centre National de la Recherche Scientifique (CNRS); Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	CHDI Foundation, Inc.; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	This work was supported by a generous grant from the CHDI Foundation, Inc. and by the Centre National de la Recherche Scientifique (CNRS). The Centro de Estudios Cientificos (CECs) is funded by the Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Besson MT, 2010, HUM MOL GENET, V19, P3372, DOI 10.1093/hmg/ddq249; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bittner C.X., 2010, FRONT NEUROENERGETIC, V2; Bittner CX, 2011, J NEUROSCI, V31, P4709, DOI 10.1523/JNEUROSCI.5311-10.2011; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; Brekke EMF, 2012, J CEREBR BLOOD F MET, V32, P1788, DOI 10.1038/jcbfm.2012.85; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; BUTTERWORTH J, 1985, J NEUROL SCI, V67, P161, DOI 10.1016/0022-510X(85)90112-1; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Cocco T, 2009, NEUROBIOL AGING, V30, P622, DOI 10.1016/j.neurobiolaging.2007.08.002; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Damiano M, 2013, HUM MOL GENET, V22, P3869, DOI 10.1093/hmg/ddt242; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Dunn L, 2014, NEUROBIOL AGING, V35, P1111, DOI 10.1016/j.neurobiolaging.2013.11.001; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Escher SA, 1999, HEREDITAS, V130, P95, DOI 10.1111/j.1601-5223.1999.00095.x; Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Freije WA, 2012, G3-GENES GENOM GENET, V2, P843, DOI 10.1534/g3.112.002584; GAMBERINO WC, 1994, J NEUROCHEM, V63, P1392; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Gouarne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081528; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jeong SJ, 2006, INT J DEV NEUROSCI, V24, P81, DOI 10.1016/j.ijdevneu.2005.10.001; Kim SY, 2005, NEUROCHEM RES, V30, P1245, DOI 10.1007/s11064-005-8796-x; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; Klepac N, 2007, J NEUROL, V254, P1676, DOI 10.1007/s00415-007-0611-y; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Krzyszton-Russjan J, 2013, J BIOENERG BIOMEMBR, V45, P71, DOI 10.1007/s10863-012-9479-3; KUWERT T, 1990, BRAIN, V113, P1405, DOI 10.1093/brain/113.5.1405; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Legan SK, 2008, J BIOL CHEM, V283, P32492, DOI 10.1074/jbc.M805832200; Leino RL, 1997, J NEUROSCI RES, V49, P617; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lievens JC, 2008, HUM MOL GENET, V17, P882, DOI 10.1093/hmg/ddm360; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MAHER F, 1992, BIOCHEM BIOPH RES CO, V182, P703, DOI 10.1016/0006-291X(92)91789-S; Marsh JL, 2004, BIOESSAYS, V26, P485, DOI 10.1002/bies.20029; Mason RP, 2013, NAT GENET, V45, P1249, DOI 10.1038/ng.2732; Mazzola JL, 2002, MOL BRAIN RES, V100, P95, DOI 10.1016/S0169-328X(02)00160-2; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Moumne L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00127; Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Rzezniczak TZ, 2012, G3-GENES GENOM GENET, V2, P1613, DOI 10.1534/g3.112.003715; Senatorov VV, 2003, MOL CELL NEUROSCI, V22, P285, DOI 10.1016/S1044-7431(02)00013-1; Shin H, 2013, J CLIN NEUROL, V9, P21, DOI 10.3988/jcn.2013.9.1.21; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Smith R, 2009, HUM MOL GENET, V18, P3942, DOI 10.1093/hmg/ddp336; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Turner C, 2010, J BIOENERG BIOMEMBR, V42, P193, DOI 10.1007/s10863-010-9290-y; Ugalde C, 2009, ADV EXP MED BIOL, V652, P85, DOI 10.1007/978-90-481-2813-6_7; Umeda-Kameyama Y, 2007, J BIOL CHEM, V282, P11180, DOI 10.1074/jbc.M700937200; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; VANNUCCI SJ, 1994, J NEUROCHEM, V62, P240; Varma H, 2007, P NATL ACAD SCI USA, V104, P14525, DOI 10.1073/pnas.0704482104; Vittori A, 2014, HUM MOL GENET, V23, P3129, DOI 10.1093/hmg/ddu022; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CT, 2012, AGING CELL, V11, P93, DOI 10.1111/j.1474-9726.2011.00762.x; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200	85	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118765	10.1371/journal.pone.0118765	http://dx.doi.org/10.1371/journal.pone.0118765			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761110	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275000038
J	Cuthbert, RJ; Giannoudis, PV; Wang, XN; Nicholson, L; Pawson, D; Lubenko, A; Tan, HB; Dickinson, A; McGonagle, D; Jones, E				Cuthbert, Richard J.; Giannoudis, Peter V.; Wang, Xiao N.; Nicholson, Lindsay; Pawson, David; Lubenko, Anatole; Tan, Hiang B.; Dickinson, Anne; McGonagle, Dennis; Jones, Elena			Examining the Feasibility of Clinical Grade CD271(+) Enrichment of Mesenchymal Stromal Cells for Bone Regeneration	PLOS ONE			English	Article							REAMER-IRRIGATOR-ASPIRATOR; VERSUS-HOST-DISEASE; STEM-CELLS; STEROID-RESISTANT; TRABECULAR BONE; FLOW-CYTOMETRY; MARROW; GROWTH; TRANSPLANTATION; OPTIMIZATION	Introduction Current clinical trials utilize mesenchymal stromal cells (MSCs) expanded in culture, however these interventions carry considerable costs and concerns pertaining to culture-induced losses of potency. This study assessed the feasibility of new clinical-grade technology to obtain uncultured MSC isolates from three human intra-osseous tissue sources based on immunomagnetic selection for CD271-positive cells. Materials and Methods MSCs were isolated from bone marrow (BM) aspirates or surgical waste materials; enzy-matically digested femoral heads (FHs) and reamer irrigator aspirator (RIA) waste fluids. Flow cytometry for the CD45(-/low) CD73(+) CD271(+) phenotype was used to evaluate uncultured MSCs before and after selection, and to measure MSC enrichment in parallel to colony forming-unit fibroblast assay. Trilineage differentiation assays and quantitative polymerase chain-reaction for key transcripts involved in bone regeneration was used to assess the functional utility of isolated cells for bone repair. Results Uncultured CD45(-/ low) CD271(+) MSCs uniformly expressed CD73, CD90 and CD105 but showed variable expression of MSCA-1 and SUSD2 (BM>RIA>FH). MSCs were enriched over 150-fold from BM aspirates and RIA fluids, whereas the highest MSC purities were obtained from FH digests. Enriched fractions expressed increased levels of BMP-2, COL1A2, VEGFC, SPARC and CXCL12 transcripts (BM>RIA>FH), with the highest up-regulation detected for CXCL12 in BM (>1300-fold). Following culture expansion, CD271-selected MSCS were tri-potential and phenotypically identical to plastic adherence-selected MSCs. Discussion A CD271-based GMP-compliant immunomagnetic selection resulted in a substantial increase in MSC purity and elevated expression of transcripts involved in bone formation, vascularisation and chemo-attraction. Although this technology, particularly from RIA fluids, can be immediately applied by orthopaedic surgeons as autologous therapy, further improvements in MSC purities and pre-clinical testing of product safety would be required to develop this process for allogeneic applications.	[Cuthbert, Richard J.; Giannoudis, Peter V.; Tan, Hiang B.; McGonagle, Dennis; Jones, Elena] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Wang, Xiao N.; Nicholson, Lindsay; Dickinson, Anne] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pawson, David; Lubenko, Anatole] Leeds Blood Ctr, Natl Hlth Serv Blood & Transplant, Leeds, W Yorkshire, England	University of Leeds; Newcastle University - UK; NHS Blood & Transplant (NHSBT)	Cuthbert, RJ (corresponding author), Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England.	medrjc@leeds.ac.uk	Giannoudis, Peter/AAA-3617-2020; Jones, Elena/AAL-2818-2021	Giannoudis, Peter/0000-0002-5205-7696; Jones, Elena/0000-0001-9365-2283; Dickinson, Anne/0000-0002-7356-7636	NIHR/LMBRU; WELMEC, a Centre of Excellence in Medical Engineering - Wellcome Trust; EPSRC [WT 088908/Z/09/Z]; Arthritis Research UK [19429]; CellEurope project, FP7-People-ITN [315963]	NIHR/LMBRU(National Institute for Health Research (NIHR)); WELMEC, a Centre of Excellence in Medical Engineering - Wellcome Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Arthritis Research UK(Versus Arthritis); CellEurope project, FP7-People-ITN	This work was part-funded by the NIHR/LMBRU and WELMEC, a Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC, under grant number WT 088908/Z/09/Z. Additional funding came from Arthritis Research UK Award 19429 and CellEurope project, FP7-People-2012-ITN, No. 315963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Bianco P, 2013, EMBO J, V32, P1489, DOI 10.1038/emboj.2013.114; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Carcenac M, 2001, BRIT J CANCER, V85, P1787, DOI 10.1054/bjoc.2001.2170; Churchman SM, 2013, EUR CELLS MATER, V26, P252, DOI 10.22203/eCM.v026a18; Churchman SM, 2012, ARTHRITIS RHEUM-US, V64, P2632, DOI 10.1002/art.34434; Couto DS, 2012, TISSUE ENG PT A, V18, P2386, DOI [10.1089/ten.tea.2011.0639, 10.1089/ten.TEA.2011.0639]; Cox G, 2011, J BONE JOINT SURG BR, V93B, P517, DOI 10.1302/0301-620X.93B4.25506; Cox G, 2012, BONE, V50, P510, DOI 10.1016/j.bone.2011.07.016; Cuthbert R, 2012, CYTOTHERAPY, V14, P431, DOI 10.3109/14653249.2011.651533; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dozza B, 2011, J ORTHOP RES, V29, P961, DOI 10.1002/jor.21333; Dvorak CC, 2013, BONE MARROW TRANSPL, V48, P508, DOI 10.1038/bmt.2012.186; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2013, INT ORTHOP, V37, P2279, DOI 10.1007/s00264-013-2017-z; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Jarocha D, 2006, BLOOD, V108, p725A, DOI 10.1182/blood.V108.11.2566.2566; Jones E, 2010, ARTHRITIS RHEUM-US, V62, P1944, DOI 10.1002/art.27451; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Li H, 2014, STEM CELL REP, V3, P1, DOI [10.1016/j.stemcr.2014.06.009, DOI 10.1016/J.STEMCR.2014.06.009]; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Mabuchi Y, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/507301; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; National Joint Registry for E Wales, 2011, ANN REPORT; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poloni A, 2009, CYTOTHERAPY, V11, P153, DOI 10.1080/14653240802582125; Porter RM, 2009, J ORTHOP RES, V27, P42, DOI 10.1002/jor.20715; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Qian H, 2012, J BIOL CHEM, V287, P25795, DOI 10.1074/jbc.M112.339622; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Sato T, 2011, LAB INVEST, V91, P553, DOI 10.1038/labinvest.2010.202; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; Sivasubramaniyan K, 2013, STEM CELLS DEV, V22, P1944, DOI 10.1089/scd.2012.0584; Sobiesiak M, 2010, STEM CELLS DEV, V19, P669, DOI 10.1089/scd.2009.0290; TERSTAPPEN LWMM, 1988, CYTOMETRY, V9, P548, DOI 10.1002/cyto.990090607; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Veyrat-Masson R, 2007, BRIT J HAEMATOL, V139, P312, DOI 10.1111/j.1365-2141.2007.06786.x; Vulcano E, 2013, EUR REV MED PHARMACO, V17, P2240; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Watson JT, 2013, CELLS TISSUES ORGANS, V197, P496, DOI 10.1159/000348794; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	60	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0117855	10.1371/journal.pone.0117855	http://dx.doi.org/10.1371/journal.pone.0117855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760857	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000013
J	Li, Y; Balasubramanian, U; Cohen, D; Zhang, PW; Mosmiller, E; Sattler, R; Maragakis, NJ; Rothstein, JD				Li, Ying; Balasubramanian, Umamahesw; Cohen, Devon; Zhang, Ping-Wu; Mosmiller, Elizabeth; Sattler, Rita; Maragakis, Nicholas J.; Rothstein, Jeffrey D.			A Comprehensive Library of Familial Human Amyotrophic Lateral Sclerosis Induced Pluripotent Stem Cells	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; HEXANUCLEOTIDE REPEAT; HUMAN FIBROBLASTS; IPS CELLS; ALS; DISEASE; GENE; ASTROCYTES; EFFICIENT; SOD1	Amyotrophic lateral sclerosis is a progressive disease characterized by the loss of upper and lower motor neurons, leading to paralysis of voluntary muscles. About 10% of all ALS cases are familial (fALS), among which 15-20% are linked to Cu/Zn superoxide dismutase (SOD1) mutations, usually inherited in an autosomal dominant manner. To date only one FDA approved drug is available which increases survival moderately. Our understanding of ALS disease mechanisms is largely derived from rodent model studies, however due to the differences between rodents and humans, it is necessary to have humanized models for studies of disease pathogenesis as well as drug development. Therefore, we generated a comprehensive library of a total 22 of fALS patient-specific induced pluripotent stem cell (iPSC) lines. These cells were thoroughly characterized before being deposited into the library. The library of cells includes a variety of C9orf72 mutations, sod1 mutations, FUS, ANG and FIG4 mutations. Certain mutations are represented with more than one line, which allows for studies of variable genetic backgrounds. In addition, these iPSCs can be successfully differentiated to astroglia, a cell type known to play a critical role in ALS disease progression. This library represents a comprehensive resource that can be used for ALS disease modeling and the development of novel therapeutics.	[Li, Ying; Balasubramanian, Umamahesw; Cohen, Devon; Zhang, Ping-Wu; Mosmiller, Elizabeth; Sattler, Rita; Maragakis, Nicholas J.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Li, Ying; Balasubramanian, Umamahesw; Cohen, Devon; Zhang, Ping-Wu; Sattler, Rita; Rothstein, Jeffrey D.] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD 21205 USA; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Mosmiller, Elizabeth; Maragakis, Nicholas J.] Ansari ALS Ctr Stem Cell & Regenerat Res Johns Ho, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	jrothstein@jhmi.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020		National Institutes of Health (NIH/NINDS) [NS069395, 5U24NS078736]; P2ALS; Robert Packard Center for ALS Research; Emerald Foundation; Brain Science Institute and Muscular Dystrophy Association; ALS Association; NIH/NINDS [5U01NS062713]; Department of Defense ALSRP, Ansari Center for ALS Cell Therapy and Regeneration Research at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS078736, R01NS085207, U01NS062713] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); P2ALS; Robert Packard Center for ALS Research; Emerald Foundation; Brain Science Institute and Muscular Dystrophy Association; ALS Association; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense ALSRP, Ansari Center for ALS Cell Therapy and Regeneration Research at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health (NIH/NINDS; NS069395; 5U24NS078736), P2ALS, Robert Packard Center for ALS Research, Emerald Foundation, Brain Science Institute and Muscular Dystrophy Association (to J. D. R.); the ALS Association (Milton Safenowitz Postdoctoral Fellowship to Y. L.); NIH/NINDS 5U01NS062713, Department of Defense ALSRP, Ansari Center for ALS Cell Therapy and Regeneration Research at Johns Hopkins (to N. J. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corti S, 2010, HUM MOL GENET, V19, P3782, DOI 10.1093/hmg/ddq293; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Di Domenico AI, 2008, CLONING STEM CELLS, V10, P217, DOI 10.1089/clo.2008.0016; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Ganel R, 2006, NEUROBIOL DIS, V21, P556, DOI 10.1016/j.nbd.2005.08.014; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mulder D W, 1982, Adv Neurol, V36, P15; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Su Z., 2014, NEURON; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wray S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043099; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	63	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118266	10.1371/journal.pone.0118266	http://dx.doi.org/10.1371/journal.pone.0118266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760436	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275000021
J	Scott, JJ; Breier, JA; Luther, GW; Emerson, D				Scott, Jarrod J.; Breier, John A.; Luther, George W., III; Emerson, David			Microbial Iron Mats at the Mid-Atlantic Ridge and Evidence that Zetaproteobacteria May Be Restricted to Iron-Oxidizing Marine Systems	PLOS ONE			English	Article							SHRIMP RIMICARIS-EXOCULATA; DEEP-SEA; HYDROTHERMAL VENTS; RARE BIOSPHERE; LOIHI SEAMOUNT; GILL CHAMBER; DIVERSITY; BACTERIA; COMMUNITIES; ECOLOGY	Chemolithoautotrophic iron-oxidizing bacteria play an essential role in the global iron cycle. Thus far, the majority of marine iron-oxidizing bacteria have been identified as Zetaproteobacteria, a novel class within the phylum Proteobacteria. Marine iron-oxidizing microbial communities have been found associated with volcanically active seamounts, crustal spreading centers, and coastal waters. However, little is known about the presence and diversity of iron-oxidizing communities at hydrothermal systems along the slow crustal spreading center of the Mid-Atlantic Ridge. From October to November 2012, samples were collected from rust-colored mats at three well-known hydrothermal vent systems on the Mid-Atlantic Ridge (Rainbow, Trans-Atlantic Geotraverse, and Snake Pit) using the ROV Jason II. The goal of these efforts was to determine if iron-oxidizing Zetaproteobacteria were present at sites proximal to black smoker vent fields. Small, diffuse flow venting areas with high iron(II) concentrations and rust-colored microbial mats were observed at all three sites proximal to black smoker chimneys. A novel, syringe-based precision sampler was used to collect discrete microbial iron mat samples at the three sites. The presence of Zetaproteobacteria was confirmed using a combination of 16S rRNA pyrosequencing and single-cell sorting, while light micros-copy revealed a variety of iron-oxyhydroxide structures, indicating that active iron-oxidizing communities exist along the Mid-Atlantic Ridge. Sequencing analysis suggests that these iron mats contain cosmopolitan representatives of Zetaproteobacteria, but also exhibit diversity that may be uncommon at other iron-rich marine sites studied to date. A meta-analysis of publically available data encompassing a variety of aquatic habitats indicates that Zetaproteobacteria are rare if an iron source is not readily available. This work adds to the growing understanding of Zetaproteobacteria ecology and suggests that this organism is likely locally restricted to iron-rich marine environments but may exhibit wide-scale geographic distribution, further underscoring the importance of Zetaproteobacteria in global iron cycling.	[Scott, Jarrod J.; Emerson, David] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Breier, John A.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Luther, George W., III] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE USA	Bigelow Laboratory for Ocean Sciences; Woods Hole Oceanographic Institution; University of Delaware	Scott, JJ (corresponding author), Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA.	jscott@bigelow.org	Luther, George/A-6384-2008	Luther, George/0000-0002-0780-885X; Scott, Jarrod/0000-0001-9863-1318; Breier, John/0000-0002-3591-5548	National Science Foundation [OCE-0926805, OCE-1155754, OCE-1131109]; National Aeronautics and Space Administration [NNX12AG20G]; Division Of Ocean Sciences [1155754, 1131109] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the National Science Foundation [grants OCE-0926805 (DE and JAB), OCE-1155754 (DE), and OCE-1131109 (GWL)] and the National Aeronautics and Space Administration [NNX12AG20G (GWL and DE)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; ALT JC, 1988, MAR GEOL, V81, P227, DOI 10.1016/0025-3227(88)90029-1; Amaral-Zettler Linda, 2010, P223; Baker ET, 2004, GEOPHYS MONOGR SER, V148, P245, DOI 10.1029/148GM10; Bennett SA, 2011, GEOCHIM COSMOCHIM AC, V75, P5526, DOI 10.1016/j.gca.2011.06.039; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bourbonnais A, 2014, ANN MICROBIOL, V64, P1; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brazelton WJ, 2006, APPL ENVIRON MICROB, V72, P6257, DOI 10.1128/AEM.00574-06; Brazelton WJ, 2010, P NATL ACAD SCI USA, V107, P1612, DOI 10.1073/pnas.0905369107; Breier JA, 2012, DEEP-SEA RES PT I, V70, P83, DOI 10.1016/j.dsr.2012.10.006; Chan CS, 2011, ISME J, V5, P717, DOI 10.1038/ismej.2010.173; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Dang HY, 2011, ENVIRON MICROBIOL, V13, P3059, DOI 10.1111/j.1462-2920.2011.02583.x; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Desbruyeres D, 2000, HYDROBIOLOGIA, V440, P201, DOI 10.1023/A:1004175211848; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dubilier N, 2001, NATURE, V411, P298, DOI 10.1038/35077067; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards KJ, 2011, ISME J, V5, P1748, DOI 10.1038/ismej.2011.48; Edwards KJ, 2005, TRENDS MICROBIOL, V13, P449, DOI 10.1016/j.tim.2005.07.005; Ellis D., 1919, IRON BACTERIA; Emerson D, 2004, GEOMICROBIOL J, V21, P405, DOI 10.1080/01490450490485881; Emerson D, 1997, APPL ENVIRON MICROB, V63, P4784, DOI 10.1128/AEM.63.12.4784-4792.1997; Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Emerson D, 2010, OCEANOGRAPHY, V23, P148, DOI 10.5670/oceanog.2010.67; Field EK, 2014, ISME J, P1, DOI [10.1038/ismej.2014.99, DOI 10.1038/ISMEJ.2014.99]; Fleming EJ, 2014, ISME J, V8, P804, DOI 10.1038/ismej.2013.197; Fleming EJ, 2013, FEMS MICROBIOL ECOL, V85, P116, DOI 10.1111/1574-6941.12104; Flores GE, 2012, GEOBIOLOGY, V10, P333, DOI 10.1111/j.1472-4669.2012.00325.x; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Gartman A, 2014, CHEM GEOL, V366, P32, DOI 10.1016/j.chemgeo.2013.12.013; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Govenar B, 2012, OCEANOGRAPHY, V25, P246, DOI 10.5670/oceanog.2012.23; Harder E. C., 1919, IRON DEPOSITING BACT; HAYMON RM, 1983, NATURE, V301, P695, DOI 10.1038/301695a0; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jan C, 2014, ENVIRON MICROBIOL, V16, P2723, DOI 10.1111/1462-2920.12406; Jannasch HW, 1995, P ROY SOC LOND B BIO, V225, P277; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; KEMPTON RA, 1978, NATURE, V275, P252, DOI 10.1038/275252a0; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Kuang JL, 2013, ISME J, V7, P1038, DOI 10.1038/ismej.2012.139; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; MacDonald DJ, 2014, ENVIRON SCI-PROC IMP, V16, P2117, DOI 10.1039/c4em00073k; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Perner M, 2013, GEOBIOLOGY, V11, P340, DOI 10.1111/gbi.12039; Perner M, 2013, ENVIRON MICROBIOL, V15, P1551, DOI 10.1111/1462-2920.12038; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Reysenbach AL, 2006, NATURE, V442, P444, DOI 10.1038/nature04921; Roden EE, 2004, GEOMICROBIOL J, V21, P379, DOI 10.1080/01490450490485872; Roden EE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00172; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Rubin-Blum M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091456; Saito MA, 2013, NAT GEOSCI, V6, P775, DOI [10.1038/ngeo1893, 10.1038/NGEO1893]; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievert SM, 2012, OCEANOGRAPHY, V25, P218, DOI 10.5670/oceanog.2012.21; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025386; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Sylvan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00279-11; Toner BM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00118; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; Von Damm K.L., 1995, SEAFLOOR HYDROTHERMA, P222, DOI DOI 10.1029/GM091P0222; Wang JJ, 2009, ISME J, V3, P715, DOI 10.1038/ismej.2009.7; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; WIRSEN CO, 1993, J GEOPHYS RES-SOL EA, V98, P9693, DOI 10.1029/92JB01556; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237	99	45	46	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119284	10.1371/journal.pone.0119284	http://dx.doi.org/10.1371/journal.pone.0119284			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760332	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000052
J	Verduri, A; Luppi, F; D'Amico, R; Balduzzi, S; Vicini, R; Liverani, A; Ruggieri, V; Plebani, M; Barbaro, MPF; Spanevello, A; Canonica, GW; Papi, A; Fabbri, LM; Beghe, B				Verduri, Alessia; Luppi, Fabrizio; D'Amico, Roberto; Balduzzi, Sara; Vicini, Roberto; Liverani, Anna; Ruggieri, Valentina; Plebani, Mario; Barbaro, Maria Pia Foschino; Spanevello, Antonio; Canonica, Giorgio Walter; Papi, Alberto; Fabbri, Leonardo Michele; Beghe, Bianca		FARM58J2XH Study Grp	Antibiotic Treatment of Severe Exacerbations of Chronic Obstructive Pulmonary Disease with Procalcitonin: A Randomized Noninferiority Trial	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-TRACT INFECTIONS; AZITHROMYCIN; THERAPY; BIOMARKERS; GUIDELINES; GUIDANCE; DYSPNEA	Background The duration of antibiotic treatment of exacerbations of COPD (ECOPD) is controversial. Serum procalcitonin (PCT) is a biomarker of bacterial infection used to identify the cause of ECOPD. Methods and Findings We investigated whether a PCT-guided plan would allow a shorter duration of antibiotic treatment in patients with severe ECOPD. For this multicenter, randomized, non-inferiority trial, we enrolled 184 patients hospitalized with ECOPD from 18 hospitals in Italy. Patients were assigned to receive antibiotics for 10 days (standard group) or for either 3 or 10 days (PCT group). The primary outcome was the rate of ECOPD at 6 months. Having planned to recruit 400 patients, we randomized only 183: 93 in the PCT group and 90 in the standard group. Thus, the completed study was underpowered. The ECOPD rate at 6 months between PCT-guided and standard antibiotic treatment was not significant (% difference, 4.04; 90% confidence interval [CI], -7.23 to 15.31), but the CI included the non-inferiority margin of 15. In the PCT-guided group, about 50% of patients were treated for 3 days, and there was no difference in primary or secondary outcomes compared to patients treated for 10 days. Conclusions Although the primary and secondary clinical outcomes were no different for patients treated for 3 or 10 days in the PCT group, the conclusion that antibiotics can be safely stopped after 3 days in patients with low serum PCT cannot be substantiated statistically. Thus, the results of this study are inconclusive regarding the noninferiority of the PCT-guided plan compared to the standard antibiotic treatment.	[Verduri, Alessia; Luppi, Fabrizio; Ruggieri, Valentina; Fabbri, Leonardo Michele; Beghe, Bianca] Univ Modena & Reggio Emilia, Dept Oncol Haematol & Resp Dis, Modena, Italy; [D'Amico, Roberto; Balduzzi, Sara; Vicini, Roberto] Univ Modena & Reggio Emilia, Dept Diagnost & Clin Med & Publ Hlth, Stat Unit, Modena, Italy; [Liverani, Anna; Plebani, Mario] Univ Padua, Dept Lab Med, Padua, Italy; [Barbaro, Maria Pia Foschino] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Spanevello, Antonio] Univ Insubria, Fdn S Maugeri Tradate, Div Pulm Rehabil, Dept Clin & Expt Med, Varese, Italy; [Canonica, Giorgio Walter] Univ Genoa, Dept Resp & Allerg Dis, Genoa, Italy; [Papi, Alberto] Univ Ferrara, Dept Resp Dis, I-44100 Ferrara, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; University of Padua; University of Foggia; University of Insubria; University of Genoa; University of Ferrara	Fabbri, LM (corresponding author), Univ Modena & Reggio Emilia, Dept Oncol Haematol & Resp Dis, Modena, Italy.	leonardo.fabbri@unimore.it	Plebani, Mario/AAF-4953-2020; Papi, alberto/AAC-1888-2019; canonica, giorgio walter/ABF-2037-2020; Luppi, Fabrizio/AAG-8099-2019; Balduzzi, Sara/S-2887-2019; SPANEVELLO, ANTONIO/AAB-9503-2020; D'Amico, Roberto/I-8106-2014; Reid, David W/B-3263-2011; Fabbri, Leonardo M/I-4055-2012	canonica, giorgio walter/0000-0001-8467-2557; Balduzzi, Sara/0000-0003-1205-1895; SPANEVELLO, ANTONIO/0000-0002-3595-9903; D'Amico, Roberto/0000-0002-3211-6687; Fabbri, Leonardo M/0000-0001-8894-1689; PAPI, ALBERTO/0000-0002-6924-4500; FOSCHINO BARBARO, MARIA PIA/0000-0001-9939-2697; Crimi, Nunzio/0000-0002-8591-4535; LUPPI, FABRIZIO/0000-0001-5775-5947; vicini, roberto/0000-0002-1799-6567	Agenzia Italiana del Farmaco (AIFA, Roma, Italy) [AIFA-FARM58J2XH]; Consorzio Ferrara Ricerche (CFR, Ferrara, Italy); Fondazione Chiesi, Parma, Italy	Agenzia Italiana del Farmaco (AIFA, Roma, Italy); Consorzio Ferrara Ricerche (CFR, Ferrara, Italy); Fondazione Chiesi, Parma, Italy(Chiesi Pharmaceuticals Inc)	This research was supported by Agenzia Italiana del Farmaco (AIFA, Roma, Italy) (AIFA-FARM58J2XH); Consorzio Ferrara Ricerche (CFR, Ferrara, Italy); and Fondazione Chiesi, Parma, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bafadhel M, 2011, CHEST, V139, P1410, DOI 10.1378/chest.10-1747; Baiardini I, 2005, ALLERGY, V60, P482, DOI 10.1111/j.1398-9995.2005.00743.x; Blasi F, 2012, EUR J INTERN MED, V23, P429, DOI 10.1016/j.ejim.2012.05.002; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2005, SWISS MED WKLY, V135, P451; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Daniels JMA, 2010, AM J RESP CRIT CARE, V181, P150, DOI 10.1164/rccm.200906-0837OC; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Global Strategy for the Diagnosis Management and Prevention of COPD, 2014, GLOBAL STRATEGY FOR; *GOLD, 2005, GLOB STRAT DIAGN MAN; Han MLK, 2014, AM J RESP CRIT CARE, V189, P1503, DOI 10.1164/rccm.201402-0207OC; Hurst JR, 2011, AM J RESP CRIT CARE, V184, P625, DOI 10.1164/rccm.201106-1136ED; Isenberg HD, 1992, CLIN MICROBIOLOGY PR; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Koutsokera A, 2012, CHEST, V141, P396, DOI 10.1378/chest.11-0495; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; MAHLER DA, 1995, AM J RESP CRIT CARE, V151, P61, DOI 10.1164/ajrccm.151.1.7812573; MATHIS G, 1993, CLIN CHEM, V39, P1953; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miravitlles M, 2013, AM J RESP CRIT CARE, V188, P1052, DOI 10.1164/rccm.201302-0289PP; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Schuetz P, 2013, JAMA-J AM MED ASSOC, V309, P717, DOI 10.1001/jama.2013.697; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Soler N, 2012, EUR RESPIR J, V40, P1344, DOI 10.1183/09031936.00150211; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Vollenweider DJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010257; White AJ, 2003, THORAX, V58, P73, DOI 10.1136/thorax.58.1.73; Woodhead M, 2011, EUR RESPIR J, V38, P1250, DOI 10.1183/09031936.00105211	33	31	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118241	10.1371/journal.pone.0118241	http://dx.doi.org/10.1371/journal.pone.0118241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760346	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000020
J	Le Bec, J; Courbaud, B; Le Moguedec, G; Pelissier, R				Le Bec, Jimmy; Courbaud, Benoit; Le Moguedec, Gilles; Pelissier, Raphael			Characterizing Tropical Tree Species Growth Strategies: Learning from Inter-Individual Variability and Scale Invariance	PLOS ONE			English	Article							BASAL AREA INCREMENT; COMPETITION INDEXES; FOREST DYNAMICS; RANK REVERSALS; LOW-LIGHT; SIZE; ALLOMETRY; DIVERSITY; MORTALITY; SEEDLINGS	Understanding how tropical tree species differ in their growth strategies is critical to predict forest dynamics and assess species coexistence. Although tree growth is highly variable in tropical forests, species maximum growth is often considered as a major axis synthesizing species strategies, with fast-growing pioneer and slow-growing shade tolerant species as emblematic representatives. We used a hierarchical linear mixed model and 21-years long tree diameter increment series in a monsoon forest of the Western Ghats, India, to characterize species growth strategies and question whether maximum growth summarizes these strategies. We quantified both species responses to biotic and abiotic factors and individual tree effects unexplained by these factors. Growth responses to competition and tree size appeared highly variable among species which led to reversals in performance ranking along those two gradients. However, species-specific responses largely overlapped due to large unexplained variability resulting mostly from inter-individual growth differences consistent over time. On average one-third of the variability captured by our model was explained by covariates. This emphasizes the high dimensionality of the tree growth process, i.e. the fact that trees differ in many dimensions (genetics, life history) influencing their growth response to environmental gradients, some being unmeasured or unmeasurable. In addition, intraspecific variability increased as a power function of species maximum growth partly as a result of higher absolute responses of fast-growing species to competition and tree size. However, covariates explained on average the same proportion of intraspecific variability for slow-and fast-growing species, which showed the same range of relative responses to competition and tree size. These results reflect a scale invariance of the growth process, underlining that slow-and fast-growing species exhibit the same range of growth strategies.	[Le Bec, Jimmy; Pelissier, Raphael] IRD, UMR AMAP, Montpellier, France; [Le Bec, Jimmy] AgroParisTech, Paris, France; [Courbaud, Benoit] IRSTEA, UR EM, St Martin Dheres, France; [Le Moguedec, Gilles] INRA, UMR AMAP, F-34060 Montpellier, France; [Pelissier, Raphael] French Inst Pondicherry, Pondicherry, Tamil Nadu, India	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech; INRAE; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE	Le Bec, J (corresponding author), IRD, UMR AMAP, Montpellier, France.	jimmy.lebec@gmail.com	Pélissier, Raphaël/C-1224-2008	Pélissier, Raphaël/0000-0003-4845-5090	FCPR grant from the French Department of Agriculture, Agri-Food and Forest (MAAF); French Institute of Pondicherry; FIP researchers	FCPR grant from the French Department of Agriculture, Agri-Food and Forest (MAAF); French Institute of Pondicherry; FIP researchers	This study was conducted within the framework of JLB Ph.D. project, funded by a FCPR grant from the French Department of Agriculture, Agri-Food and Forest (MAAF). Data collection at UPSP benefited over the years from constant financial support from the French Institute of Pondicherry with occasional additional funds from various external projects headed by FIP researchers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, IEEE T AUTOM CONTROL, V19; Alder D, 2002, INT FOREST REV, V4, P196, DOI 10.1505/IFOR.4.3.196.17398; Antin C, 2013, TREES-STRUCT FUNCT, V27, P1485, DOI 10.1007/s00468-013-0896-7; Atkin OK, 1998, PLANT CELL ENVIRON, V21, P1007, DOI 10.1046/j.1365-3040.1998.00356.x; Beckage B, 2012, FRONT BIOGEOGR, V3, P145; Bloor JMG, 2003, J ECOL, V91, P77, DOI 10.1046/j.1365-2745.2003.00743.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark JS, 2007, ECOL LETT, V10, P647, DOI 10.1111/j.1461-0248.2007.01041.x; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; CLARK JS, 1990, ECOL MONOGR, V60, P135, DOI 10.2307/1943042; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Contreras MA, 2011, FOREST ECOL MANAG, V262, P1939, DOI 10.1016/j.foreco.2011.08.031; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Courbaud B, 2012, THEOR ECOL-NETH, V5, P61, DOI 10.1007/s12080-010-0095-8; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Eriksson O, 2002, CAN J BOT, V80, P635, DOI [10.1139/B02-044, 10.1139/b02-044]; Gillner S, 2013, FOREST ECOL MANAG, V302, P372, DOI 10.1016/j.foreco.2013.03.032; Gourlet-Fleury S, 2005, ANN FOREST SCI, V62, P785, DOI 10.1051/forest:2005084; Grime JP, 1994, EXPLOITATION ENV HET, P2; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; Johnson DM, 2009, TREE PHYSIOL, V29, P879, DOI 10.1093/treephys/tpp031; Kendal Wayne S., 2004, Ecological Complexity, V1, P193, DOI 10.1016/j.ecocom.2004.05.001; Kitajima K, 2003, FUNCT ECOL, V17, P276, DOI 10.1046/j.1365-2435.2003.07101.x; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Kohyama TS, 2012, J ECOL, V100, P1501, DOI 10.1111/j.1365-2745.2012.02029.x; Lichstein JW, 2007, AM NAT, V170, P807, DOI 10.1086/522937; McMahon SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016253; Moravie MA, 1999, FOREST ECOL MANAG, V117, P221, DOI 10.1016/S0378-1127(98)00480-0; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Newbery DM, 2009, PLANT ECOL, V201, P147, DOI 10.1007/s11258-008-9533-8; Ouedraogo DY, 2013, J ECOL, V101, P1459, DOI 10.1111/1365-2745.12165; Pascal JP, 1996, J TROP ECOL, V12, P191, DOI 10.1017/S026646740000941X; Pelissier R, 1998, J TROP ECOL, V14, P1, DOI 10.1017/S0266467498000017; Pelissier R, 2011, ECOL ARCH, V92, P17; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Poorter L, 2003, PLANT ECOL, V166, P295, DOI 10.1023/A:1023295806147; Poorter L, 2003, ECOLOGY, V84, P602, DOI 10.1890/0012-9658(2003)084[0602:AORFTS]2.0.CO;2; Pretzsch H, 2009, FOREST DYNAMICS, GROWTH AND YIELD: FROM MEASUREMENT TO MODEL, P1, DOI 10.1007/978-3-540-88307-4_1; Pretzsch H, 2010, CAN J FOREST RES, V40, P370, DOI 10.1139/X09-195; Rai S. N., 1979, Malaysian Forester, V42, P53; Rapp JM, 2012, ECOLOGY, V93, P2061, DOI 10.1890/11-1725.1; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Robert A, 2003, J TROP ECOL, V19, P697, DOI 10.1017/S0266467403006096; Ruger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025330; Sack L, 2001, FUNCT ECOL, V15, P145, DOI 10.1046/j.1365-2435.2001.00507.x; Sanchez-Gomez D, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008040; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schnitzer S., 2008, TROPICAL FOREST COMM, P172; Schoonjans F, 2011, EPIDEMIOLOGY, V22, P750, DOI 10.1097/EDE.0b013e318225c1de; Sierra CA, 2009, ECOLOGY, V90, P2711, DOI 10.1890/08-0073.1; SNIJDERS TAB, 1994, SOCIOL METHOD RES, V22, P342, DOI 10.1177/0049124194022003004; Steneker G. A., 1963, Forestry Chronicle, V39, P334; Sterck FJ, 1998, AM J BOT, V85, P266, DOI 10.2307/2446315; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Team R. Development Core. R, 2012, R LANG ENV STAT COMP; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Uriarte M, 2012, ECOLOGY, V93, P191, DOI 10.1890/10-2422.1; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; WALTERS MB, 1993, OECOLOGIA, V94, P7, DOI 10.1007/BF00317294; Weiskittel AR, 2007, FOREST ECOL MANAG, V250, P266, DOI 10.1016/j.foreco.2007.05.026; WEST PW, 1980, CAN J FOREST RES, V10, P71, DOI 10.1139/x80-012; Westbeek MHM, 1999, OECOLOGIA, V120, P19, DOI 10.1007/s004420050828; Wolf M, 2009, THESIS U GRONINGEN N; Zuur Alain F., 2009, P1	71	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117028	10.1371/journal.pone.0117028	http://dx.doi.org/10.1371/journal.pone.0117028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756212	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700014
J	Li, J; Zhang, MM; Tu, K; Wang, J; Feng, B; Zhang, ZN; Lei, J; Li, YQ; Du, JQ; Chen, T				Li, Jing; Zhang, Ming-Ming; Tu, Ke; Wang, Jian; Feng, Ban; Zhang, Zi-Nan; Lei, Jie; Li, Yun-Qing; Du, Jian-Qing; Chen, Tao			The Excitatory Synaptic Transmission of the Nucleus of Solitary Tract Was Potentiated by Chronic Myocardial Infarction in Rats	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; VESICULAR GLUTAMATE TRANSPORTERS; SPINAL-CORD STIMULATION; LONG-TERM POTENTIATION; CARDIAC SYNDROME-X; AMPA RECEPTORS; FEAR MEMORY; BRAIN-STEM; PAIN; ACTIVATION	Angina pectoris is a common clinical symptom that often results from myocardial infarction. One typical characteristic of angina pectoris is that the pain does not match the severity of the myocardial ischemia. One possible explanation is that the intensity of cardiac nociceptive information could be dynamically regulated by certain brain areas. As an important nucleus for processing cardiac nociception, the nucleus of the solitary tract (NTS) has been studied to some extent. However, until now, the morphological and functional involvement of the NTS in chronic myocardial infarction (CMI) has remained unknown. In the present study, by exploring left anterior descending coronary artery ligation surgery, we found that the number of synaptophysin-immunoreactive puncta and Fos-immunoreactive neurons in the rat NTS two weeks after ligation surgery increased significantly. Excitatory pre- and postsynaptic transmission was potentiated. A bath application of a Ca2+ channel inhibitor GABApentin and Ca2+ permeable AMPA receptor antagonist NASPM could reverse the potentiated pre- and postsynaptic transmission, respectively. Meanwhile, rats with CMI showed significantly increased visceral pain behaviors. Microinjection of GABApentin or NASPM into the NTS decreased the CMI-induced visceral pain behaviors. In sum, our results suggest that the NTS is an important area for the process of cardiac afference in chronic myocardial infarction condition.	[Li, Jing; Li, Yun-Qing; Du, Jian-Qing] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian 710061, Peoples R China; [Li, Jing; Zhang, Ming-Ming; Tu, Ke; Wang, Jian; Feng, Ban; Zhang, Zi-Nan; Lei, Jie; Li, Yun-Qing; Du, Jian-Qing; Chen, Tao] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Chen, Tao] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Ctr Neuron & Dis, Xian 710061, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University	Du, JQ (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian 710061, Peoples R China.	dujianq@mail.xjtu.edu.cn; chtkkl@fmmu.edu.cn			National Natural Science Foundation of China [31171068, 31371126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Natural Science Foundation of China (Nos. 31171068 to JQD, 31371126 to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albutaihi IAM, 2004, NEUROSIGNALS, V13, P207, DOI 10.1159/000079336; Balland B, 2006, J PHYSIOL-LONDON, V574, P245, DOI 10.1113/jphysiol.2006.108738; Bayer K, 2004, NEUROPHARMACOLOGY, V46, P743, DOI 10.1016/j.neuropharm.2003.11.010; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Chen T, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-33; Clark CG, 2011, J NEUROSCI, V31, P12318, DOI 10.1523/JNEUROSCI.0746-11.2011; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Corbett EKA, 2005, NEUROSCIENCE, V135, P133, DOI 10.1016/j.neuroscience.2005.06.010; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Favaloro R G, 1968, Ann Thorac Surg, V5, P334; Foreman RD, 1999, ANNU REV PHYSIOL, V61, P143, DOI 10.1146/annurev.physiol.61.1.143; Foreman Robert D, 2009, Cleve Clin J Med, V76 Suppl 2, pS75, DOI 10.3949/ccjm.76.s2.15; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; GULBIS B, 1990, CLIN CHEM, V36, P1784; Hermes SM, 2014, J COMP NEUROL, V522, P642, DOI 10.1002/cne.23438; Hua F, 2004, AM J PHYSIOL-HEART C, V287, pH2728, DOI 10.1152/ajpheart.00180.2004; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Khlaifia A, 2013, J NEUROSCI, V33, P12627, DOI 10.1523/JNEUROSCI.1028-13.2013; Lachamp P, 2003, EUR J NEUROSCI, V17, P892, DOI 10.1046/j.1460-9568.2003.02494.x; Lanza GA, 2005, EUR HEART J, V26, P983, DOI 10.1093/eurheartj/ehi089; Li XY, 2010, SCIENCE, V330, P1400, DOI 10.1126/science.1191792; Liu XH, 2012, NEUROSCIENCE, V220, P322, DOI 10.1016/j.neuroscience.2012.05.024; Liu XH, 2012, NEUROSCIENCE, V207, P326, DOI 10.1016/j.neuroscience.2012.01.042; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; MASERI A, 1978, NEW ENGL J MED, V299, P1271, DOI 10.1056/NEJM197812072992303; MENETREY D, 1987, J COMP NEUROL, V255, P439, DOI 10.1002/cne.902550310; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Patel MK, 2000, BRIT J PHARMACOL, V130, P1731, DOI 10.1038/sj.bjp.0703530; Rosen SD, 2012, CAN J CARDIOL, V28, pS7, DOI 10.1016/j.cjca.2011.09.010; Sestito A, 2008, PAIN, V139, P82, DOI 10.1016/j.pain.2008.03.015; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; Tang XR, 2007, AM J PHYSIOL-REG I, V293, pR2254, DOI 10.1152/ajpregu.00143.2007; WETTERVIK C, 1995, LANCET, V345, P97, DOI 10.1016/S0140-6736(95)90065-9; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Wu LJ, 2007, DEV NEUROBIOL, V67, P146, DOI 10.1002/dneu.20331; Zhang J, 1998, J PHYSIOL-LONDON, V511, P733, DOI 10.1111/j.1469-7793.1998.733bg.x; Zhang MM, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-47; Zhang MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059234; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003	43	5	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118827	10.1371/journal.pone.0118827	http://dx.doi.org/10.1371/journal.pone.0118827			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756354	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700026
J	Meyer, MR; Shah, S; Zhang, J; Rohrs, H; Rao, AG				Meyer, Matthew R.; Shah, Shweta; Zhang, J.; Rohrs, Henry; Rao, A. Gururaj			Evidence for Intermolecular Interactions between the Intracellular Domains of the Arabidopsis Receptor-Like Kinase ACR4, Its Homologs and the Wox5 Transcription Factor	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; BRASSINOSTEROID SIGNAL-TRANSDUCTION; PROTEIN-PROTEIN INTERACTIONS; TGF-BETA RECEPTOR; TYROSINE KINASE; MASS-SPECTROMETRY; GENE FAMILY; ACTIVATION; EXCHANGE; HETERODIMERIZATION	Arabidopsis CRINKLY4 (ACR4) is a receptor-like kinase (RLK) involved in the global development of the plant. The Arabidopsis genome encodes four homologs of ACR4 that contain sequence similarity and analogous architectural elements to ACR4, termed Arabidopsis CRINKLY4 Related (AtCRRs) proteins. Additionally, a signaling module has been previously proposed including a postulated peptide ligand, CLE40, the ACR4 RLK, and the WOX5 transcription factor that engage in a possible feedback mechanism controlling stem cell differentiation. However, little biochemical evidence is available to ascertain the molecular aspects of receptor heterodimerization and the role of phosphorylation in these interactions. Therefore, we have undertaken an investigation of the in vitro interactions between the intracellular domains (ICD) of ACR4, the CRRs and WOX5. We demonstrate that interaction can occur between ACR4 and all four CRRs in the unphosphorylated state. However, phosphorylation dependency is observed for the interaction between ACR4 and CRR3. Furthermore, sequence analysis of the ACR4 gene family has revealed a conserved 'KDSAF' motif that may be involved in protein-protein interactions among the receptor family. We demonstrate that peptides harboring this conserved motif in CRR3 and CRK1are able to bind to the ACR4 kinase domain. Our investigations also indicate that the ACR4 ICD can interact with and phosphorylate the transcription factor WOX5.	[Shah, Shweta; Rao, A. Gururaj] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Meyer, Matthew R.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [Zhang, J.; Rohrs, Henry] Washington Univ, Dept Chem, NIH NCRR Ctr Biomed & Bioorgan Mass Spectrometry, St Louis, MO 63130 USA	Iowa State University; Washington University (WUSTL); Washington University (WUSTL)	Rao, AG (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	gururao@iastate.edu			Iowa State University	Iowa State University	The work was supported by internal funding from Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Bennett T, 2014, DEVELOPMENT, V141, P4055, DOI 10.1242/dev.110148; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; De Bodt S, 2012, NEW PHYTOL, V195, P707, DOI 10.1111/j.1469-8137.2012.04184.x; De Bodt S, 2010, PLANT PHYSIOL, V152, P1167, DOI 10.1104/pp.109.147215; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; Fiers M, 2007, CURR OPIN PLANT BIOL, V10, P39, DOI 10.1016/j.pbi.2006.11.003; Gifford ML, 2003, DEVELOPMENT, V130, P4249, DOI 10.1242/dev.00634; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Haffani YZ, 2004, CAN J BOT, V82, P1, DOI [10.1139/b03-126, 10.1139/B03-126]; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; He F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r181; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kim HH, 1998, BIOCHEM J, V334, P189, DOI 10.1042/bj3340189; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Llompart B, 2003, J BIOL CHEM, V278, P48105, DOI 10.1074/jbc.M307482200; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Meyer MR, 2013, ARCH BIOCHEM BIOPHYS, V535, P101, DOI 10.1016/j.abb.2013.03.014; Meyer MR, 2011, BIOCHEMISTRY-US, V50, P2170, DOI 10.1021/bi101935x; Miwa H, 2009, J PLANT RES, V122, P31, DOI 10.1007/s10265-008-0207-3; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Soong TT, 2008, BIOINFORMATICS, V24, P2608, DOI 10.1093/bioinformatics/btn498; Stahl Y, 2013, CURR BIOL, V23, P362, DOI 10.1016/j.cub.2013.01.045; Stahl Y, 2009, CURR BIOL, V19, P909, DOI 10.1016/j.cub.2009.03.060; Stone JM, 1998, PLANT PHYSIOL, V117, P1217, DOI 10.1104/pp.117.4.1217; Tanaka H, 2002, PLANT CELL PHYSIOL, V43, P419, DOI 10.1093/pcp/pcf052; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang GD, 2010, PROTOPLASMA, V240, P33, DOI 10.1007/s00709-009-0095-y; Wang XZ, 2008, INT J PATTERN RECOGN, V22, P1, DOI 10.1142/S0218001408006065; Watanabe M, 2004, PLANT J, V39, P298, DOI 10.1111/j.1365-313X.2004.02132.x; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yan Xuguang, 2009, V492, P255, DOI 10.1007/978-1-59745-493-3_15; Ye HX, 2011, J INTEGR PLANT BIOL, V53, P455, DOI 10.1111/j.1744-7909.2011.01046.x; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhou B, 2007, METHODS, V42, P227, DOI 10.1016/j.ymeth.2007.02.020; Zhou B, 2006, J BIOL CHEM, V281, P38834, DOI 10.1074/jbc.M608916200	73	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118861	10.1371/journal.pone.0118861	http://dx.doi.org/10.1371/journal.pone.0118861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756623	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700028
J	Weiss, CR; Guan, QD; Ma, YB; Qing, GF; Bernstein, CN; Warrington, RJ; Peng, ZK				Weiss, Carolyn R.; Guan, Qingdong; Ma, Yanbing; Qing, Gefei; Bernstein, Charles N.; Warrington, Richard J.; Peng, Zhikang			The Potential Protective Role of Caveolin-1 in Intestinal Inflammation in TNBS-Induced Murine Colitis	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; E-DEFICIENT MICE; BOWEL-DISEASE; ULCERATIVE-COLITIS; CRITICAL REGULATOR; INSULIN-RECEPTOR; TISSUE FIBROSIS; CROHNS-DISEASE; BREAST-CANCER; MOUSE MODEL	Background Caveolin-1 (Cav-1) is a multifunctional scaffolding protein serving as a platform for the cell's signal-transduction and playing an important role in inflammation. However, its role in inflammatory bowel disease is not clear. A recent study showed that Cav-1 is increased and mediates angiogenesis in dextran sodium sulphate-induced colitis, which are contradictory to our pilot findings in 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis. In the present study, we further clarified the role of Cav-1 in TNBS-induced colitis. Methods In BALB/c mice, acute colitis was induced by intra-rectal administration of one dose TNBS, while chronic colitis was induced by administration of TNBS once a week for 7 weeks. To assess the effects of complete loss of Cav-1, Cav-1 knockout (Cav-1(-/-)) and control wildtype C57 mice received one TNBS administration. Body weight and clinical scores were monitored. Colon Cav-1 and pro-inflammatory cytokine levels were quantified through ELI-SAs. Inflammation was evaluated through histological analysis. Results Colon Cav-1 levels were significantly decreased in TNBS-induced colitis mice when compared to normal mice and also inversely correlated with colon inflammation scores and proinflammatory cytokine levels (IL-17, IFN-gamma and TNF) significantly. Furthermore, after administration of TNBS, Cav-1(-/-) mice showed significantly increased clinical and colon inflammatory scores and body weight loss when compared with control mice. Conclusions and Significance Cav-1 may play a protective role in the development of TNBS-induced colitis. Our findings raise an important issue in the evaluation of specific molecules in animal models that different models may exhibit opposite results because of the different mechanisms involved.	[Weiss, Carolyn R.; Guan, Qingdong; Warrington, Richard J.; Peng, Zhikang] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Weiss, Carolyn R.; Guan, Qingdong; Ma, Yanbing; Peng, Zhikang] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Qing, Gefei] Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada; [Bernstein, Charles N.; Warrington, Richard J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3T 2N2, Canada; [Bernstein, Charles N.] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Peng, ZK (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	zpeng@mich.ca	Guan, Qingdong/C-9631-2018	Guan, Qingdong/0000-0003-1972-487X	CIHR [ROP-92387]; Children's Hospital Research Institute of Manitoba	CIHR(Canadian Institutes of Health Research (CIHR)); Children's Hospital Research Institute of Manitoba	This study was supported by grants from the CIHR (http://www.cihr-irsc.gc.ca/e/193.html) (ROP-92387 to ZP) and the Children's Hospital Research Institute of Manitoba (http://chrim.ca/)(to ZP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Bar F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015; Bender FC, 2000, CANCER RES, V60, P5870; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bouras T, 2004, CANCER BIOL THER, V3, P931, DOI 10.4161/cbt.3.10.1147; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Chidlow JH, 2009, GASTROENTEROLOGY, V136, P575, DOI 10.1053/j.gastro.2008.10.085; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Das M, 2012, ANN MED, V44, P530, DOI 10.3109/07853890.2011.577445; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Feng H, 2010, J BIOL CHEM, V285, P25154, DOI 10.1074/jbc.M110.116897; Fernandez-Hernando C, 2010, AM J PATHOL, V177, P998, DOI 10.2353/ajpath.2010.091287; Fichtner-Feigl S, 2007, J IMMUNOL, V178, P5859, DOI 10.4049/jimmunol.178.9.5859; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Guan QD, 2011, MOL MED, V17, P646, DOI 10.2119/molmed.2010.00252; Guan QD, 2009, VACCINE, V27, P7096, DOI 10.1016/j.vaccine.2009.09.058; Halayko Andrew J, 2008, Proc Am Thorac Soc, V5, P80, DOI 10.1513/pats.200705-057VS; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Hu Q, 2010, J VASC RES, V47, P69, DOI 10.1159/000235927; Ito Y, 2002, BRIT J CANCER, V86, P912, DOI 10.1038/sj.bjc.6600172; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Juhasz M, 2003, J CANCER RES CLIN, V129, P493, DOI 10.1007/s00432-003-0468-0; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; KIM HS, 1992, SCAND J GASTROENTERO, V27, P529, DOI 10.3109/00365529209000116; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Krajewska WM, 2004, CELL MOL BIOL LETT, V9, P195; Le Saux CJ, 2008, J BIOL CHEM, V283, P5760, DOI 10.1074/jbc.M701572200; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Ma YB, 2010, INFLAMM BOWEL DIS, V16, P1040, DOI 10.1002/ibd.21167; Maul J, 2012, LANGENBECK ARCH SURG, V397, P1, DOI 10.1007/s00423-011-0789-4; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; Monteleone G, 2006, CURR OPIN GASTROEN, V22, P361, DOI 10.1097/01.mog.0000231808.10773.8e; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Pizarro TT, 2007, ANNU REV MED, V58, P433, DOI 10.1146/annurev.med.58.121205.100607; Pojoga LH, 2010, ENDOCRINOLOGY, V151, P1236, DOI 10.1210/en.2009-0514; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sainz-Jaspeado M, 2011, ONCOTARGET, V2, P305; Tang HQ, 2010, J IMMUNOL, V185, P2563, DOI 10.4049/jimmunol.0903664; Thompson TC, 2010, PROSTATE CANCER P D, V13, P6, DOI 10.1038/pcan.2009.29; Tsai TH, 2011, SHOCK, V35, P92, DOI 10.1097/SHK.0b013e3181ea45ca; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Watanabe S, 2014, J GASTROENTEROL, V49, P270, DOI 10.1007/s00535-013-0901-3; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yamamoto A, 2013, PHARMACOLOGY, V92, P108, DOI 10.1159/000353192; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962	58	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119004	10.1371/journal.pone.0119004	http://dx.doi.org/10.1371/journal.pone.0119004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756273	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700035
J	Azuma, K; Casey, SC; Urano, T; Horie-Inoue, K; Ouchi, Y; Blumberg, B; Inoue, S				Azuma, Kotaro; Casey, Stephanie C.; Urano, Tomohiko; Horie-Inoue, Kuniko; Ouchi, Yasuyoshi; Blumberg, Bruce; Inoue, Satoshi			Pregnane X Receptor Knockout Mice Display Aging-Dependent Wearing of Articular Cartilage	PLOS ONE			English	Article							VITAMIN-K; AMELOGENESIS IMPERFECTA; OSTEOARTHRITIS; SXR; TRANSCRIPTION; ASSOCIATION; EXPRESSION; FRACTURES; FAM20A; HAND	Steroid and xenobiotic receptor (SXR) and its murine ortholog, pregnane X receptor (PXR), are nuclear receptors that are expressed at high levels in the liver and the intestine where they function as xenobiotic sensors that induce expression of genes involved in detoxification and drug excretion. Recent evidence showed that SXR and PXR are also expressed in bone tissue where they mediate bone metabolism. Here we report that systemic deletion of PXR results in aging-dependent wearing of articular cartilage of knee joints. Histomorphometrical analysis showed remarkable reduction of width and an enlarged gap between femoral and tibial articular cartilage in PXR knockout mice. We hypothesized that genes induced by SXR in chondrocytes have a protective effect on articular cartilage and identified Fam20a (family with sequence similarity 20a) as an SXR-dependent gene induced by the known SXR ligands, rifampicin and vitamin K2. Lastly, we demonstrated the biological significance of Fam20a expression in chondrocytes by evaluating osteoarthritis-related gene expression of primary articular chondrocytes. Consistent with epidemiological findings, our results indicate that SXR/PXR protects against aging-dependent wearing of articular cartilage and that ligands for SXR/PXR have potential role in preventing osteoarthritis caused by aging.	[Azuma, Kotaro; Urano, Tomohiko; Ouchi, Yasuyoshi; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Casey, Stephanie C.; Blumberg, Bruce] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan; [Horie-Inoue, Kuniko; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Hidaka, Saitama 3501241, Japan; [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Minato Ku, Tokyo 1058470, Japan	University of Tokyo; University of California System; University of California Irvine; University of Tokyo; Saitama Medical University; Toranomon Hospital	Inoue, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	INOUE-GER@h.u-tokyo.ac.jp	Urano, Tomohiko/AFS-9574-2022		Cell Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science, Research [24659126]; Ministry of Health, Labor and Welfare; National Institute of Environmental Health Sciences [R01ES021832]; NIH Predoctoral Cancer Biology Training Grant [T32CA9054]; National Cancer Institute; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021832] Funding Source: NIH RePORTER	Cell Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science, Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Predoctoral Cancer Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by: 1) Cell Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology (http://cellinnovation.nig.ac.jp/mext-life/english/html/program/theme.html) (SI); 2) Grants from the Japan Society for the Promotion of Science, Research Project number: 24659126 (http://kaken.nii.ac.jp/d/p/24659126.en.html) (SI); 3) Grants-in-Aid from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo16/0501.html) (SI); 4) Grant from the National Institute of Environmental Health Sciences, Grant number R01ES021832 (http://tools.niehs.nih.gov/portfolio/index.cfm/portfolio/grantDetail/grant_number/R01ES021832) (BB); 5) NIH Predoctoral Cancer Biology Training Grant, T32CA9054, National Cancer Institute (SCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2014, GERIATR GERONTOL INT, V14, P1, DOI 10.1111/ggi.12060; Azuma K, 2010, J ENDOCRINOL, V207, P257, DOI 10.1677/JOE-10-0208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Cockayne S, 2006, ARCH INTERN MED, V166, P1256, DOI 10.1001/archinte.166.12.1256; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garnero P, 2002, ARTHRITIS RHEUM-US, V46, P2613, DOI 10.1002/art.10576; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Misra D, 2013, AM J MED, V126, P243, DOI 10.1016/j.amjmed.2012.10.011; Nalbant D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-11; Neogi T, 2008, ANN RHEUM DIS, V67, P1570, DOI 10.1136/ard.2008.094771; Neogi T, 2006, ARTHRITIS RHEUM, V54, P1255, DOI 10.1002/art.21735; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; O'Sullivan J, 2011, AM J HUM GENET, V88, P616, DOI 10.1016/j.ajhg.2011.04.005; Oka H, 2009, J ORTHOP SCI, V14, P687, DOI 10.1007/s00776-009-1395-y; Shiraki M, 2000, J BONE MINER RES, V15, P515, DOI 10.1359/jbmr.2000.15.3.515; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; Thirion S, 2004, METH MOLEC MED, V100, P1; Urano T, 2007, GERIATR GERONTOL INT, V7, P104, DOI 10.1111/j.1447-0594.2007.00394.x; VILLANUEVA AR, 1989, STAIN TECHNOL, V64, P129, DOI 10.3109/10520298909106985; Vogel P, 2012, VET PATHOL, V49, P998, DOI 10.1177/0300985812453177; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001	28	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119177	10.1371/journal.pone.0119177	http://dx.doi.org/10.1371/journal.pone.0119177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749104	Green Published, gold			2022-12-27	WOS:000350689400055
J	Chiacchiaretta, P; Ferretti, A				Chiacchiaretta, Piero; Ferretti, Antonio			Resting State BOLD Functional Connectivity at 3T: Spin Echo versus Gradient Echo EPI	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; BRAIN ACTIVITY; SPATIAL-RESOLUTION; SIGNAL CHANGES; MOTOR CORTEX; WHOLE-BRAIN; FMRI; ACTIVATION; SENSITIVITY; CONTRAST	Previous evidence showed that, due to refocusing of static dephasing effects around large vessels, spin-echo (SE) BOLD signals offer an increased linearity and promptness with respect to gradient-echo (GE) acquisition, even at low field. These characteristics suggest that, despite the reduced sensitivity, SE fMRI might also provide a potential benefit when investigating spontaneous fluctuations of brain activity. However, there are no reports on the application of spin-echo fMRI for connectivity studies at low field. In this study we compared resting state functional connectivity as measured with GE and SE EPI sequences at 3T. Main results showed that, within subject, the GE sensitivity is overall larger with respect to that of SE, but to a less extent than previously reported for activation studies. Noteworthy, the reduced sensitivity of SE was counterbalanced by a reduced inter-subject variability, resulting in comparable group statistical connectivity maps for the two sequences. Furthermore, the SE method performed better in the ventral portion of the default mode network, a region affected by signal dropout in standard GE acquisition. Future studies should clarify if these features of the SE BOLD signal can be beneficial to distinguish subtle variations of functional connectivity across different populations and/or treatments when vascular confounds or regions affected by signal dropout can be a critical issue.	[Chiacchiaretta, Piero; Ferretti, Antonio] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Chiacchiaretta, Piero; Ferretti, Antonio] Univ G DAnnunzio, ITAB, Chieti, Italy; [Chiacchiaretta, Piero; Ferretti, Antonio] IRCCS Neuromed, Bioengn Unit, Pozzilli, IS, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; IRCCS Neuromed	Chiacchiaretta, P (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	p.chiacchiaretta@unich.it	Chiacchiaretta, Piero/J-3972-2016	Chiacchiaretta, Piero/0000-0003-1089-9809				Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Astafiev SV, 2003, J NEUROSCI, V23, P4689; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1994, NMR BIOMED, V7, P12, DOI 10.1002/nbm.1940070104; BANDETTINI PA, 1995, INT J IMAG SYST TECH, V6, P133, DOI 10.1002/ima.1850060203; BANDETTINI PA, 1993, P 12 ANN M SOC MAGN, P169; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Birn RM, 2001, NEUROIMAGE, V14, P817, DOI 10.1006/nimg.2001.0873; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Brier MR, 2014, BRAIN CONNECT, V4, P299, DOI 10.1089/brain.2014.0236; Chiacchiaretta P, 2013, NEUROIMAGE, V82, P35, DOI 10.1016/j.neuroimage.2013.05.069; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Franco AR, 2013, BRAIN CONNECT, V3, P363, DOI 10.1089/brain.2012.0134; Glover GH, 2000, MAGNETIC RESONANCE M; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Halai AD, 2014, HUM BRAIN MAPP, V35, P4118, DOI 10.1002/hbm.22463; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; Handwerker DA, 2012, NEUROIMAGE, V62, P1017, DOI 10.1016/j.neuroimage.2012.02.015; Harmer J, 2012, NMR BIOMED, V25, P717, DOI 10.1002/nbm.1783; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hulvershorn J, 2005, HUM BRAIN MAPP, V25, P247, DOI 10.1002/hbm.20094; Hulvershorn J, 2005, NEUROIMAGE, V24, P216, DOI 10.1016/j.neuroimage.2004.09.033; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Jochimsen TH, 2004, MAGN RESON MED, V52, P724, DOI 10.1002/mrm.20221; Jones RA, 1998, MAGNET RESON MED, V40, P112, DOI 10.1002/mrm.1910400116; Kohno S, 2009, J CEREBR BLOOD F MET, V29, P1197, DOI 10.1038/jcbfm.2009.45; Koopmans PJ, 2012, NEUROIMAGE, V62, P1939, DOI 10.1016/j.neuroimage.2012.05.080; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Miao XY, 2014, NEUROIMAGE, V84, P575, DOI 10.1016/j.neuroimage.2013.09.019; Norris DG, 2012, NEUROIMAGE, V62, P1109, DOI 10.1016/j.neuroimage.2012.01.003; Norris DG, 2002, NEUROIMAGE, V15, P719, DOI 10.1006/nimg.2001.1005; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Park JC, 2008, J VISION, V8, DOI 10.1167/8.10.8; Parkes LM, 2005, MAGN RESON MED, V54, P1465, DOI 10.1002/mrm.20712; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Schmidt CF, 2005, NEUROIMAGE, V26, P852, DOI 10.1016/j.neuroimage.2005.02.043; Schwarzbauer C, 2010, NEUROIMAGE, V49, P316, DOI 10.1016/j.neuroimage.2009.08.032; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Stern ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036356; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; Zhang N, 2008, NEUROIMAGE, V43, P204, DOI 10.1016/j.neuroimage.2008.06.033; Zhang NY, 2009, NEUROIMAGE, V48, P313, DOI 10.1016/j.neuroimage.2009.06.071	59	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120398	10.1371/journal.pone.0120398	http://dx.doi.org/10.1371/journal.pone.0120398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749359	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400094
J	Han, M; Kim, J				Han, Murui; Kim, Jonghan			Effect of Dietary Iron Loading on Recognition Memory in Growing Rats	PLOS ONE			English	Article							BRAIN IRON; DEFICIENCY ALTERS; NEUROBEHAVIORAL DYSFUNCTIONS; HIPPOCAMPAL-NEURONS; OBJECT RECOGNITION; SUBSTANTIA-NIGRA; NITRIC-OXIDE; METABOLISM; RECEPTORS; ADULT	While nutritional and neurobehavioral problems are associated with both iron deficiency during growth and overload in the elderly, the effect of iron loading in growing ages on neurobehavioral performance has not been fully explored. To characterize the role of dietary iron loading in memory function in the young, weanling rats were fed iron-loading diet (10,000 mg iron/kg diet) or iron-adequate control diet (50 mg/kg) for one month, during which a battery of behavioral tests were conducted. Iron-loaded rats displayed elevated non-heme iron levels in serum and liver, indicating a condition of systemic iron overload. In the brain, non-heme iron was elevated in the prefrontal cortex of iron-loaded rats compared with controls, whereas there was no difference in iron content in other brain regions between the two diet groups. While iron loading did not alter motor coordination or anxiety-like behavior, iron-loaded rats exhibited a better recognition memory, as represented by an increased novel object recognition index (22% increase from the reference value) than control rats (12% increase; P=0.047). Western blot analysis showed an up-regulation of dopamine receptor 1 in the prefrontal cortex from iron-loaded rats (142% increase; P=0.002). Furthermore, levels of glutamate receptors (both NMDA and AMPA) and nicotinic acetylcholine receptor (nAChR) were significantly elevated in the prefrontal cortex of iron-loaded rats (62% increase in NR1; 70% increase in Glu1A; 115% increase in nAChR). Dietary iron loading also increased the expression of NMDA receptors and nAChR in the hippocampus. These results support the idea that iron is essential for learning and memory and further reveal that iron supplementation during developmental and rapidly growing periods of life improves memory performance. Our investigation also demonstrates that both cholinergic and glutamatergic neurotransmission pathways are regulated by dietary iron and provides a molecular basis for the role of iron loading in improved memory.	[Han, Murui; Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA	Northeastern University	Kim, J (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA.	j.kim@neu.edu			NIH [R00 ES017781]; Northeastern University Startup; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES017781] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern University Startup; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIH R00 ES017781 and Northeastern University Startup (J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bartzokis G, 1997, MAGN RESON IMAGING, V15, P29, DOI 10.1016/S0730-725X(96)00234-2; Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6; Bartzokis G, 2000, ARCH GEN PSYCHIAT, V57, P47, DOI 10.1001/archpsyc.57.1.47; Batra Jyoti, 2002, Indian J Clin Biochem, V17, P108, DOI 10.1007/BF02867982; Beard JL, 2006, BEHAV BRAIN RES, V170, P224, DOI 10.1016/j.bbr.2006.02.024; Beard JL, 2005, J NUTR, V135, P267, DOI 10.1093/jn/135.2.267; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; BEARD JL, 1994, PHARMACOL BIOCHEM BE, V48, P621, DOI 10.1016/0091-3057(94)90323-9; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; BENSHACHAR D, 1991, J NEUROCHEM, V57, P2133, DOI 10.1111/j.1471-4159.1991.tb06432.x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Brain JD, 2006, AM J RESP CELL MOL, V34, P330, DOI 10.1165/rcmb.2005-0101OC; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Cass WA, 2007, NEUROBIOL AGING, V28, P258, DOI 10.1016/j.neurobiolaging.2005.12.010; Castro-Caraballo F, 1992, Invest Clin, V33, P121; CHEN Q, 1995, J NUTR BIOCHEM, V6, P486, DOI 10.1016/0955-2863(95)00074-A; Choi BR, 2013, NEUROSCIENCE, V253, P214, DOI 10.1016/j.neuroscience.2013.08.043; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Connor JR, 2006, J ALZHEIMERS DIS, V10, P267; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; de Lima MNM, 2007, EUR J PHARMACOL, V570, P111, DOI 10.1016/j.ejphar.2007.06.002; de Lima MNM, 2005, EUR J NEUROSCI, V21, P2521, DOI 10.1111/j.1460-9568.2005.04083.x; de Lima MNM, 2005, BEHAV BRAIN RES, V156, P139, DOI 10.1016/j.bbr.2004.05.016; DEINARD A, 1981, PEDIATRICS, V68, P828; Ding H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025324; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1971, BIOL NEONATE, V19, P363, DOI 10.1159/000240430; Erikson KM, 2000, J NUTR, V130, P2831, DOI 10.1093/jn/130.11.2831; Erikson KM, 1997, J NUTR, V127, P2030, DOI 10.1093/jn/127.10.2030; Erikson KM, 2001, PHARMACOL BIOCHEM BE, V69, P409, DOI 10.1016/S0091-3057(01)00563-9; FINDLAY E, 1981, PHYSIOL BEHAV, V27, P1089, DOI 10.1016/0031-9384(81)90375-9; Fredriksson A, 1999, TOXICOL APPL PHARM, V159, P25, DOI 10.1006/taap.1999.8711; Fredriksson A, 2000, DEV BRAIN RES, V119, P65, DOI 10.1016/S0165-3806(99)00160-1; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; HILL JM, 1985, BRAIN RES, V342, P18, DOI 10.1016/0006-8993(85)91348-4; Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Huang K, 2012, BIOL TRACE ELEM RES, V146, P79, DOI 10.1007/s12011-011-9230-7; Kahlert S, 2005, J NEUROSCI RES, V79, P262, DOI 10.1002/jnr.20322; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Kim J, 2013, FASEB J, V27, P1657, DOI 10.1096/fj.12-224386; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033533; Kim J, 2011, AM J PHYSIOL-LUNG C, V300, pL659, DOI 10.1152/ajplung.00343.2010; Kishida KT, 2007, ANTIOXID REDOX SIGN, V9, P233, DOI 10.1089/ars.2007.9.233; Li Y, 2011, J NUTR, V141, P2133, DOI 10.3945/jn.111.145946; Lozoff B, 1998, CHILD DEV, V69, P24, DOI 10.1111/j.1467-8624.1998.tb06130.x; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Maaroufi K, 2009, PHYSIOL BEHAV, V96, P343, DOI 10.1016/j.physbeh.2008.10.019; Maelicke A, 2001, BIOL PSYCHIAT, V49, P279, DOI 10.1016/S0006-3223(00)01109-4; MANEV H, 1989, MOL PHARMACOL, V36, P106; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Morgan EH, 2002, DEV NEUROSCI-BASEL, V24, P106, DOI 10.1159/000065699; Moriguchi S, 2004, J PHARMACOL EXP THER, V310, P933, DOI 10.1124/jpet.104.067603; Munoz P, 2011, J BIOL CHEM, V286, P13382, DOI 10.1074/jbc.M110.213785; Nandar W, 2011, J NUTR, V141, p729S, DOI 10.3945/jn.110.130351; Nelson C, 1997, J NUTR, V127, P2282, DOI 10.1093/jn/127.12.2282; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Perez VP, 2010, CURR NEUROVASC RES, V7, P15, DOI 10.2174/156720210790820172; Pinero DJ, 2000, J NUTR, V130, P254, DOI 10.1093/jn/130.2.254; Puig MV, 2012, NEURON, V74, P874, DOI 10.1016/j.neuron.2012.04.018; RAO J, 1995, LAB ANIM SCI, V45, P393; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Schroder N, 2001, BEHAV BRAIN RES, V124, P77, DOI 10.1016/S0166-4328(01)00236-4; SENGSTOCK GJ, 1994, EXP NEUROL, V130, P82, DOI 10.1006/exnr.1994.1187; SENGSTOCK GJ, 1993, J NEUROSCI RES, V35, P67, DOI 10.1002/jnr.490350109; Sobotka TJ, 1996, PHYSIOL BEHAV, V59, P213, DOI 10.1016/0031-9384(95)02030-6; Sripetchwandee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085115; Subramaniam S, 2011, NEUROPHARMACOLOGY, V60, P1187, DOI 10.1016/j.neuropharm.2010.10.025; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TAYLOR EM, 1990, DEV BRAIN RES, V55, P35, DOI 10.1016/0165-3806(90)90103-6; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Wang L, 2008, NEUROSCIENCE, V155, P24, DOI 10.1016/j.neuroscience.2008.03.091; Ward KL, 2007, J NUTR, V137, P1043, DOI 10.1093/jn/137.4.1043; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; WHITTAKER P, 1994, J TRACE ELEM EXP MED, V7, P19; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045; YEHUDA S, 1986, PHARMACOL BIOCHEM BE, V25, P141, DOI 10.1016/0091-3057(86)90244-3; YOUDIM MBH, 1978, P NUTR SOC, V37, P173, DOI 10.1079/PNS19780022; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1	91	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120609	10.1371/journal.pone.0120609	http://dx.doi.org/10.1371/journal.pone.0120609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746420	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400097
J	Rout, SP; Charles, CJ; Garratt, EJ; Laws, AP; Gunn, J; Humphreys, PN				Rout, Simon P.; Charles, Christopher J.; Garratt, Eva J.; Laws, Andrew P.; Gunn, John; Humphreys, Paul N.			Evidence of the Generation of Isosaccharinic Acids and Their Subsequent Degradation by Local Microbial Consortia within Hyper-Alkaline Contaminated Soils, with Relevance to Intermediate Level Radioactive Waste Disposal	PLOS ONE			English	Article							SP-NOV.; GEN. NOV.; ACCUMULATING ORGANISMS; SODA LAKE; BACTERIUM; REDUCTION; CELLULOSE; IDENTIFICATION; PROPIONATE; METHANOGEN	The contamination of surface environments with hydroxide rich wastes leads to the formation of high pH (>11.0) soil profiles. One such site is a legacy lime works at Harpur Hill, Derbyshire where soil profile indicated in-situ pH values up to pH 12. Soil and porewater profiles around the site indicated clear evidence of the presence of the a and beta stereoisomers of isosaccharinic acid (ISA) resulting from the anoxic, alkaline degradation of cellulosic material. ISAs are of particular interest with regards to the disposal of cellulosic materials contained within the intermediate level waste (ILW) inventory of the United Kingdom, where they may influence radionuclide mobility via complexation events occurring within a geological disposal facility (GDF) concept. The mixing of uncontaminated soils with the alkaline leachate of the site resulted in ISA generation, where the rate of generation in-situ is likely to be dependent upon the prevailing temperature of the soil. Microbial consortia present in the uncontaminated soil were capable of surviving conditions imposed by the alkaline leachate and demonstrated the ability to utilise ISAs as a carbon source. Leachate-contaminated soil was sub-cultured in a cellulose degradation product driven microcosm operating at pH 11, the consortia present were capable of the degradation of ISAs and the generation of methane from the resultant H-2/CO2 produced from fermentation processes. Following microbial community analysis, fermentation processes appear to be predominated by Clostridia from the genus Alkaliphilus sp, with methanogenesis being attributed to Methanobacterium and Methanomassiliicoccus sp. The study is the first to identify the generation of ISA within an anthropogenic environment and advocates the notion that microbial activity within an ILW-GDF is likely to influence the impact of ISAs upon radionuclide migration.	[Rout, Simon P.; Charles, Christopher J.; Garratt, Eva J.; Laws, Andrew P.; Humphreys, Paul N.] Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Gunn, John] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England	University of Huddersfield; University of Birmingham	Humphreys, PN (corresponding author), Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England.	p.n.humphreys@hud.ac.uk		Rout, Simon/0000-0001-5778-6145; Humphreys, Paul/0000-0003-3431-7930	Engineering and Physical Sciences Research council [EP/I036354/1]; Radioactive Waste Management Ltd.; University of Huddersfield; Engineering and Physical Sciences Research Council [EP/I036354/1] Funding Source: researchfish; EPSRC [EP/I036354/1] Funding Source: UKRI	Engineering and Physical Sciences Research council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Radioactive Waste Management Ltd.; University of Huddersfield; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was partially supported by both the Engineering and Physical Sciences Research council under grant EP/I036354/1 and by Radioactive Waste Management Ltd. The remaining funds being provided by the University of Huddersfield. The funders had no role in study design, data collection and analysis associated with the paper. RWM ltd did review the paper prior to submission.	Alexander WR, 2011, CYPR NAT AN PROJ CNA; [Anonymous], 2005, 103902005 BS ISO; B.S.I, 2005, 148532005 BS ISO; Bassil NM, 2014, ISME J; BOYER EW, 1973, INT J SYST BACTERIOL, V23, P238, DOI 10.1099/00207713-23-3-238; Burke IT, 2012, GEOMICROBIOL J, V29, P769, DOI 10.1080/01490451.2011.619638; Cao XH, 2003, INT J SYST EVOL MICR, V53, P971, DOI 10.1099/ijs.0.02373-0; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Eaton A. D., 2005, STANDARD METHODS EXA; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Glaus MA, 1999, ANAL CHIM ACTA, V398, P111, DOI 10.1016/S0003-2670(99)00371-2; Greenfield B, 1997, NSSR375 AEA TECHN; Humphreys P. N., 2010, SERCOTAS002274001; Kotelnikova S, 1998, INT J SYST BACTERIOL, V48, P357, DOI 10.1099/00207713-48-2-357; Montero B, 2009, WASTE MANAGE, V29, P1144, DOI 10.1016/j.wasman.2008.08.010; NDA, 2010, NDARWMD033; NDA, 2011, 2010 UK RAD WAST INV; Oehmen A, 2005, BIOTECHNOL BIOENG, V91, P162, DOI 10.1002/bit.20500; Oehmen A, 2006, MICROBIOL-SGM, V152, P2767, DOI 10.1099/mic.0.28065-0; Rai DP, 1998, J SOLUTION CHEM, V27, P1109, DOI 10.1023/A:1022610001043; Randall M, 2013, NSSR375 AEA TECHN; Roh Y, 2007, GEOSCI J, V11, P415, DOI 10.1007/BF02857056; Rout SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107433; Rout SP, 2015, UNDERSTANDING EFFECT; Savage D, 2011, MINERAL MAG, V75, P1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaw PB, 2012, CARBOHYD RES, V349, P6, DOI 10.1016/j.carres.2011.11.022; Simmons Ardyth M., 2010, 1779 US GEOL SURV; Takai K, 2001, INT J SYST EVOL MICR, V51, P1245, DOI 10.1099/00207713-51-4-1245; Van Dyke MI, 2002, APPL ENVIRON MICROB, V68, P2049, DOI 10.1128/AEM.68.4.2049-2053.2002; VanLoon LR, 1997, J ENVIRON POLYM DEGR, V5, P97; VanLoon LR, 1997, ENVIRON SCI TECHNOL, V31, P1243, DOI 10.1021/es960505i; Viollier E, 2000, APPL GEOCHEM, V15, P785, DOI 10.1016/S0883-2927(99)00097-9; Virden BT, 2010, ASTR SCI C 2010 LEAG; Williamson AJ, 2013, APPL ENVIRON MICROB, V79, P3320, DOI 10.1128/AEM.03063-12; Wong MT, 2004, MICROBIOL-SGM, V150, P3741, DOI 10.1099/mic.0.27291-0; WORAKIT S, 1986, INT J SYST BACTERIOL, V36, P380, DOI 10.1099/00207713-36-3-380; Wu XY, 2010, INT J SYST EVOL MICR, V60, P2898, DOI 10.1099/ijs.0.014084-0; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004; Zavarzina DG, 2009, MICROBIOLOGY+, V78, P723, DOI 10.1134/S0026261709060095; Zhilina TN, 2009, MICROBIOLOGY+, V78, P445, DOI 10.1134/S0026261709040080; Zhu JX, 2011, INT J SYST EVOL MICR, V61, P2974, DOI 10.1099/ijs.0.027540-0	43	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119164	10.1371/journal.pone.0119164	http://dx.doi.org/10.1371/journal.pone.0119164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748643	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000350689400053
J	Kitamoto, Y; Arizono, K; Fukui, H; Tomita, K; Kitamura, H; Taguma, Y; Imamura, T				Kitamoto, Yasunori; Arizono, Kenji; Fukui, Hiroyoshi; Tomita, Kimio; Kitamura, Hiroshi; Taguma, Yoshio; Imamura, Takahisa			Urinary Thrombin: A Novel Marker of Glomerular Inflammation for the Diagnosis of Crescentic Glomerulonephritis (Prospective Observational Study)	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; TISSUE FACTOR; PROLIFERATIVE GLOMERULONEPHRITIS; PROCOAGULANT ACTIVITY; NEPHROTIC SYNDROME; FIBRIN DEPOSITION; IGA NEPHROPATHY; EXPRESSION; PROTEINURIA; ANTIBODIES	Background Crescentic glomerulonephritis (CresGN), an uncommon rapidly progressive disease, is characterized by severe glomerular inflammation with fibrin deposition. The lack of specific CresGN biomarkers delays diagnosis and threatens life. Because fibrin deposits in CresGN glomeruli indicate thrombin generation, we hypothesized that thrombin is excreted in urine and is a specific CresGN biomarker. Methods We measured urinary thrombin activity in 200 untreated patients (17 with CresGN, 183 with primary glomerulonephritis) and controls (8 patients with healed CresGN, 11 with nephrosclerosis, and 10 with tubulointerstitial nephritis, and 66 healthy volunteers). CresGN types included 15 pauci-immune and 2 immune complex. We assessed the diagnostic accuracy of thrombinuria in 169 patients with hematuria and proteinuria. Renal biopsy tissues were immunostained for tissue factor and fibrin. We analyzed the relationship of thrombinuria to plasma thrombin-antithrombin complex, hematuria, proteinuria, glomerular filtration rate, glomerular fibrin deposition, antineutrophil cytoplasmic antibodies (ANCAs), and C-reactive protein (CRP). We studied changes in thrombin activities after glucocorticoid treatment in 12 patients with thrombinuria. Results The highest thrombinuria occurrence was in CresGN (70.6%), followed by membranoproliferative glomerulonephritis (41.7%), IgA nephropathy (9.2%), and acute glomerulonephritis (0%). More than 75% of patients with nonproliferative glomerulonephritis manifested no thrombinuria. No controls had thrombinuria. Thrombinuria showed high CresGN specificity (90.1%) and moderate sensitivity (70.6%) and was detected in 4 of 7 patients with ANCA-negative CresGN. In CresGN, thrombinuria was associated with fibrin deposition in glomerular extracapillary tissue, where monocytes/macrophages expressed tissue factor. Thrombinuria in CresGN was unrelated to plasma thrombin-antithrombin complex, hematuria, proteinuria, glomerular filtration rate, and CRP. After glucocorticoid treatment, thrombinuria in patients with CresGN rapidly disappeared but proteinuria and hematuria persisted. Conclusions Thrombinuria was specific for glomerular inflammation, was unaffected by systemic inflammation or coagulation, and demonstrated good diagnostic accuracy for CresGN including ANCA-negative cases. Thrombinuria measurement may provide risk-free diagnosis and screening for CresGN.	[Kitamoto, Yasunori] JCHO Sendai Hosp, Dept Lab Med, Sendai, Miyagi, Japan; [Arizono, Kenji; Fukui, Hiroyoshi] Kumamoto City Hosp, Dept Nephrol, Kumamoto, Japan; [Tomita, Kimio] Kumamoto Univ, Fac Life Sci, Dept Nephrol, Kumamoto, Japan; [Kitamura, Hiroshi; Taguma, Yoshio] JCHO Sendai Hosp, Dept Nephrol, Sendai, Miyagi, Japan; [Imamura, Takahisa] Kumamoto Univ, Dept Mol Pathol, Fac Life Sci, Kumamoto, Japan	Kumamoto University; Kumamoto University	Kitamoto, Y (corresponding author), JCHO Sendai Hosp, Dept Lab Med, Sendai, Miyagi, Japan.	ykitamoto@sendai-shaho.com			Miyagi Kidney Foundation [H16]	Miyagi Kidney Foundation	Miyagi Kidney Foundation; Grant in Aid #H16; YK, http://www.miyajin.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1998, WAKAYAMA MED REP, V39, P37; BARSHAVIT R, 1983, SCIENCE, V220, P728, DOI 10.1126/science.6836310; BRENNER BM, 1978, NEW ENGL J MED, V298, P826, DOI 10.1056/NEJM197804132981507; Bright R., 1827, REPORTS MED CASES, VI; CAMERON H C, 1958, Guys Hosp Rep, V107, P263; Chen M, 2009, NAT REV NEPHROL, V5, P313, DOI 10.1038/nrneph.2009.67; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; DAMICO G, 1992, AM J KIDNEY DIS, V20, P315, DOI 10.1016/S0272-6386(12)70293-7; Erlich JH, 1997, AM J PATHOL, V150, P873; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034; Hedger N, 2000, NEPHROL DIAL TRANSPL, V15, P1593, DOI 10.1093/ndt/15.10.1593; HOLDSWORTH SR, 1985, J CLIN INVEST, V76, P1367, DOI 10.1172/JCI112112; HOOKE DH, 1987, KIDNEY INT, V31, P964, DOI 10.1038/ki.1987.93; Ieiri N, 2005, CLIN NEPHROL, V64, P249; IMAMURA T, 1993, CELL IMMUNOL, V152, P614, DOI 10.1006/cimm.1993.1317; Inagi R, 2007, NEPHROL DIAL TRANSPL, V22, P3311, DOI 10.1093/ndt/gfm391; Jennette JC, 2003, KIDNEY INT, V63, P1164, DOI 10.1046/j.1523-1755.2003.00843.x; Kitamoto Y, 1998, KIDNEY INT, V54, P1767, DOI 10.1046/j.1523-1755.1998.00169.x; Kitamoto Y, 2004, ANN CLIN BIOCHEM, V41, P133, DOI 10.1258/000456304322880023; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; LOLLAR P, 1980, J CLIN INVEST, V66, P1222, DOI 10.1172/JCI109973; Lund T, 2008, TRANSPL INT, V21, P669, DOI 10.1111/j.1432-2277.2008.00664.x; Mathew T.H., 1972, GLOMERULONEPHRITIS, P727; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nachman PH, 2007, BRENNER RECTORS KIDN, P987; PELZER H, 1988, THROMB HAEMOSTASIS, V59, P101; RASMUSSEN N, 1990, J IMMUNOL METHODS, V127, P139, DOI 10.1016/0022-1759(90)90350-5; SAXENA S, 1993, NEPHRON, V65, P56, DOI 10.1159/000187441; Silva FG., 1998, HEPTINSTALLS PATHOLO, V1, P389; Sugiyama H, 2011, CLIN EXP NEPHROL, V15, P493, DOI 10.1007/s10157-011-0430-4; SURANYI MG, 1993, AM J KIDNEY DIS, V21, P251, DOI 10.1016/S0272-6386(12)80742-6; TIPPING PG, 1995, AM J PATHOL, V147, P1736; TIPPING PG, 1988, J CLIN INVEST, V81, P119, DOI 10.1172/JCI113282; Wang YP, 2012, AM J PHYSIOL-RENAL, V302, pF1084, DOI 10.1152/ajprenal.00597.2011; WIGGINS RC, 1985, LAB INVEST, V53, P156; XU YC, 1995, AM J PATHOL, V146, P101; Yamagata K, 2002, NEPHRON, V91, P34, DOI 10.1159/000057602	38	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118704	10.1371/journal.pone.0118704	http://dx.doi.org/10.1371/journal.pone.0118704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742509	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100035
J	Medina-Andres, R; Solano-Peralta, A; Saucedo-Vazquez, JP; Napsucialy-Mendivil, S; Pimentel-Cabrera, JA; Sosa-Torres, ME; Dubrovsky, JG; Lira-Ruan, V				Medina-Andres, Rigoberto; Solano-Peralta, Alejandro; Pablo Saucedo-Vazquez, Juan; Napsucialy-Mendivil, Selene; Arturo Pimentel-Cabrera, Jaime; Elena Sosa-Torres, Martha; Dubrovsky, Joseph G.; Lira-Ruan, Veroica			The Nitric Oxide Production in the Moss Physcomitrella patens Is Mediated by Nitrate Reductase	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; IN-VIVO; SUBCELLULAR-LOCALIZATION; XANTHINE OXIDOREDUCTASE; NO PRODUCTION; SYNTHASE; GROWTH; EMISSION; PLANTS; SIGNAL	During the last 20 years multiple roles of the nitric oxide gas (center dot NO) have been uncovered in plant growth, development and many physiological processes. In seed plants the enzymatic synthesis of center dot NO is mediated by a nitric oxide synthase (NOS)-like activity performed by a still unknown enzyme(s) and nitrate reductase (NR). In green algae the center dot NO production has been linked only to NR activity, although a NOS gene was reported for Ostreococcus tauri and O. lucimarinus, no other Viridiplantae species has such gene. As there is no information about center dot NO synthesis neither for non-vascular plants nor for non-seed vascular plants, the interesting question regarding the evolution of the enzymatic center dot NO production systems during land plant natural history remains open. To address this issue the endogenous center dot NO production by protonema was demonstrated using Electron Paramagnetic Resonance (EPR). The center dot NO signal was almost eliminated in plants treated with sodium tungstate, which also reduced the NR activity, demonstrating that in P. patens NR activity is the main source for center dot NO production. The analysis with confocal laser scanning microscopy (CLSM) confirmed endogenous NO production and showed that center dot NO signal is accumulated in the cytoplasm of protonema cells. The results presented here show for the first time the center dot NO production in a non-vascular plant and demonstrate that the NR-dependent enzymatic synthesis of center dot NO is common for embryophytes and green algae.	[Medina-Andres, Rigoberto; Lira-Ruan, Veroica] Univ Autonoma Estado Morelos, Lab Fisiol & Desarrollo Vegetal, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico; [Solano-Peralta, Alejandro; Pablo Saucedo-Vazquez, Juan; Elena Sosa-Torres, Martha] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim Inorgan & Nucl, Mexico City 04510, DF, Mexico; [Napsucialy-Mendivil, Selene; Dubrovsky, Joseph G.] Univ Nacl Autonoma Mexico, Dept Biol Mol Plantas, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Arturo Pimentel-Cabrera, Jaime] Univ Nacl Autonoma Mexico, Lab Nacl Microscopia Avanzada, Cuernavaca 62191, Morelos, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Lira-Ruan, V (corresponding author), Univ Autonoma Estado Morelos, Lab Fisiol & Desarrollo Vegetal, Ctr Invest Dinam Celular, Inst Invest Ciencias Basicas & Aplicadas, Cuernavaca, Morelos, Mexico.	katlira@uaem.mx	Dubrovsky, Joseph G./B-9479-2008; Solano-Peralta, Alejandro/V-3992-2019	Dubrovsky, Joseph G./0000-0002-2072-4650; Solano-Peralta, Alejandro/0000-0001-9158-423X; Lira Ruan, Veronica/0000-0003-3085-5838; Pimentel Cabrera, Jaime Arturo/0000-0001-8569-0466; Saucedo-Vazquez, Juan Pablo/0000-0002-4314-6363; Sosa-Torres, Martha E./0000-0003-3464-1044	Consejo Nacional de Ciencia y Tecnologia [180226, 128921, 441239]; DGAPA project [IN231111]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA project	This research was funded by Consejo Nacional de Ciencia y Tecnologia, grant 180226 to VLR, grant no 128921 to MEST, and a graduate fellowship no 441239 to RMA (http://www.conacyt.mx). This work was also funded by DGAPA project No IN231111 to MEST (http://dgapa.unam.mx) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abied M, 2012, PLANT J, V71, P787, DOI 10.1111/j.1365-313X.2012.05032.x; Barroso JB, 1999, J BIOL CHEM, V274, P36729, DOI 10.1074/jbc.274.51.36729; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Besson-Bard A, 2009, PLANT SCI, V177, P302, DOI 10.1016/j.plantsci.2009.06.006; Chen YR, 2012, P NATL ACAD SCI USA, V109, P8310, DOI 10.1073/pnas.1201744109; Chiariello N. R., 1989, Plant physiological ecology: field methods and instrumentation., P327; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Lombardo MC, 2006, PLANT SIGNAL BEHAV, V1, P28, DOI 10.4161/psb.1.1.2398; Cueto M, 1996, FEBS LETT, V398, P159, DOI 10.1016/S0014-5793(96)01232-X; DEAN JV, 1986, PLANT PHYSIOL, V82, P718, DOI 10.1104/pp.82.3.718; Decker EL, 2006, PLANT BIOLOGY, V8, P397, DOI 10.1055/s-2006-923952; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Doel JJ, 2001, BBA-GEN SUBJECTS, V1527, P81, DOI 10.1016/S0304-4165(01)00148-9; Durner J, 1999, CURR OPIN PLANT BIOL, V2, P369, DOI 10.1016/S1369-5266(99)00007-2; Foissner I, 2000, PLANT J, V23, P817, DOI 10.1046/j.1365-313X.2000.00835.x; Foresi N, 2010, PLANT CELL, V22, P3816, DOI 10.1105/tpc.109.073510; Garcia-Mata C, 2001, PLANT PHYSIOL, V123, P1196; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Hancock JT, 2012, PERIOD BIOL, V114, P19; Hayat S, 2012, HORTIC ENVIRON BIOTE, V53, P362, DOI 10.1007/s13580-012-0481-9; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Hogg N, 2010, FREE RADICAL BIO MED, V49, P122, DOI 10.1016/j.freeradbiomed.2010.03.009; Hung KT, 2003, J PLANT PHYSIOL, V160, P871, DOI 10.1078/0176-1617-01118; Jasid S, 2006, PLANT PHYSIOL, V142, P1246, DOI 10.1104/pp.106.086918; Kojima H, 2000, ADV MATER, V12, P763, DOI 10.1002/(SICI)1521-4095(200005)12:10<763::AID-ADMA763>3.0.CO;2-R; Kolbert Z, 2010, J PLANT PHYSIOL, V167, P77, DOI 10.1016/j.jplph.2009.08.013; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Lea US, 2004, PLANTA, V219, P59, DOI 10.1007/s00425-004-1209-6; Lehner C, 2009, J PLANT PHYSIOL, V166, P117, DOI 10.1016/j.jplph.2008.02.012; Lin AH, 2012, PLANT PHYSIOL, V158, P451, DOI 10.1104/pp.111.184531; Mallick N, 2000, J PLANT PHYSIOL, V156, P423, DOI 10.1016/S0176-1617(00)80084-X; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Medina-Andres Rigoberto, 2012, Commun Integr Biol, V5, P19; Menand B, 2007, SCIENCE, V316, P1477, DOI 10.1126/science.1142618; Meyer C, 2005, PHOTOSYNTH RES, V83, P181, DOI 10.1007/s11120-004-3548-3; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Mishler BD, 2009, ANNU PLANT REV, V36, P1, DOI 10.1111/b.9781405181891.2009.00001.x; Modolo LV, 2006, PLANT SCI, V171, P34, DOI 10.1016/j.plantsci.2006.02.010; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; Nemie-Feyissa D, 2013, J PLANT PHYSIOL, V170, P662, DOI 10.1016/j.jplph.2012.12.010; Palavan-Unsal N, 2009, BOT REV, V75, P203, DOI 10.1007/s12229-009-9031-2; Pedroso MC, 2000, J EXP BOT, V51, P1027, DOI 10.1093/jexbot/51.347.1027; Perchepied L, 2010, MOL PLANT MICROBE IN, V23, P846, DOI 10.1094/MPMI-23-7-0846; Pires ND, 2013, P NATL ACAD SCI USA, V110, P9571, DOI 10.1073/pnas.1305457110; Planchet E, 2005, PLANT J, V41, P732, DOI 10.1111/j.1365-313X.2005.02335.x; Rasul S, 2012, PLANT CELL ENVIRON, V35, P1483, DOI 10.1111/j.1365-3040.2012.02505.x; RESKI R, 1985, PLANTA, V165, P354, DOI 10.1007/BF00392232; Ribeiro EA, 1999, FEBS LETT, V445, P283, DOI 10.1016/S0014-5793(99)00138-6; Rockel Peter, 2002, Journal of Experimental Botany, V53, P103, DOI 10.1093/jexbot/53.366.103; Sakihama Y, 2002, PLANT CELL PHYSIOL, V43, P290, DOI 10.1093/pcp/pcf034; Samouilov A, 2002, METHOD ENZYMOL, V352, P506; Scheible WR, 1997, PLANT J, V11, P671, DOI 10.1046/j.1365-313X.1997.11040671.x; Seligman K, 2008, PLANT CELL PHYSIOL, V49, P1112, DOI 10.1093/pcp/pcn089; Shaw J, 2004, AM J BOT, V91, P1557, DOI 10.3732/ajb.91.10.1557; Silveira V, 2006, PLANT SCI, V171, P91, DOI 10.1016/j.plantsci.2006.02.015; Simontacchi M, 2013, PLANT CELL REP, V32, P853, DOI 10.1007/s00299-013-1434-1; Tischner R, 2004, FEBS LETT, V576, P151, DOI 10.1016/j.febslet.2004.09.004; Tun NN, 2001, FEBS LETT, V509, P174, DOI 10.1016/S0014-5793(01)03164-7; Vandelle E, 2008, METHOD ENZYMOL, V437, P575, DOI 10.1016/S0076-6879(07)37029-8; Wang JW, 2005, PLANT CELL PHYSIOL, V46, P923, DOI 10.1093/pcp/pci098; Wang YH, 2009, NEW PHYTOL, V182, P851, DOI 10.1111/j.1469-8137.2009.02820.x; WILKINSON JQ, 1993, MOL GEN GENET, V239, P289, DOI 10.1007/BF00281630; Xie YJ, 2013, J EXP BOT, V64, P3045, DOI 10.1093/jxb/ert149; Xiong J, 2012, J EXP BOT, V63, P33, DOI 10.1093/jxb/err268; Xu B, 2014, SCIENCE, V343, P1505, DOI 10.1126/science.1248417; Yamasaki H, 2000, FEBS LETT, V468, P89, DOI 10.1016/S0014-5793(00)01203-5; Yu LZ, 2012, PLANT CELL REP, V31, P1813, DOI 10.1007/s00299-012-1294-0; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996	69	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119400	10.1371/journal.pone.0119400	http://dx.doi.org/10.1371/journal.pone.0119400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742644	gold, Green Published			2022-12-27	WOS:000350688100107
J	Cho, YC; Pan, JY				Cho, Ying-Chiang; Pan, Jen-Yi			Design and Implementation of Website Information Disclosure Assessment System	PLOS ONE			English	Article							WEB; STATE	Internet application technologies, such as cloud computing and cloud storage, have increasingly changed people's lives. Websites contain vast amounts of personal privacy information. In order to protect this information, network security technologies, such as database protection and data encryption, attract many researchers. The most serious problems concerning web vulnerability are e-mail address and network database leakages. These leakages have many causes. For example, malicious users can steal database contents, taking advantage of mistakes made by programmers and administrators. In order to mitigate this type of abuse, a website information disclosure assessment system is proposed in this study. This system utilizes a series of technologies, such as web crawler algorithms, SQL injection attack detection, and web vulnerability mining, to assess a website's information disclosure. Thirty websites, randomly sampled from the top 50 world colleges, were used to collect leakage information. This testing showed the importance of increasing the security and privacy of website information for academic websites.	[Cho, Ying-Chiang; Pan, Jen-Yi] Natl Chung Cheng Univ, Dept Elect Engn, Chiayi 62102, Taiwan	National Chung Cheng University	Cho, YC (corresponding author), Natl Chung Cheng Univ, Dept Elect Engn, 168 Univ Rd, Chiayi 62102, Taiwan.	silvergun@mail2000.com.tw			National Science Council, Taiwan [NSC 102-2221-E-194-036, NSC 101-2221-E-194-005]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank the National Science Council, Taiwan, for partially supporting this research under contract NO. NSC 102-2221-E-194-036 and NO. NSC 101-2221-E-194-005. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim S., 2011, 2011 International Conference on Information Society (i-Society), P241; Andrews M, 2006, IEEE SECUR PRIV, V4, P14, DOI 10.1109/MSP.2006.88; Anley C., 2002, ADV SQL INJECTION SQ; [Anonymous], 2004, P 2004 ACM SIGPLAN S; Arkin B, 2005, IEEE SECUR PRIV, V3, P84, DOI 10.1109/MSP.2005.23; Bau J, 2010, P IEEE S SECUR PRIV, P332, DOI 10.1109/SP.2010.27; Beizer B., 1995, BLACK BOX TESTING TE; Boyd SW, 2004, LECT NOTES COMPUT SC, V3089, P292; Brody R.G., 2007, ACAD ACCOUNT FINANC, V11, P43; Castillo Carlos, 2005, ACM SIGIR FORUM, V39, P55; Cavusoglu H, 2007, IEEE T SOFTWARE ENG, V33, P171, DOI 10.1109/TSE.2007.26; Cho YC, 2013, SCI WORLD J; Daly MK, 2009, ADV PERSISTENT THREA, P4; Doupe A, 2010, LECT NOTES COMPUT SC, V6201, P111, DOI 10.1007/978-3-642-14215-4_7; Downs J.S., 2007, P ANT WORK GROUPS 2, P37, DOI DOI 10.1145/1299015.1299019; Friedman B., 2002, CHI 02 EXTENDED ABST, P746, DOI DOI 10.1145/506443.506577; Garfinkel S, 2002, WEB SECURITY PRIVACY; Guo F, 2005, COMP SEC APPL C 21 A; Heydon A., 1999, World Wide Web, V2, P219, DOI 10.1023/A:1019213109274; Hong J, 2012, COMMUN ACM, V55, P74, DOI 10.1145/2063176.2063197; HURTY WC, 1965, AIAA J, V3, P678, DOI 10.2514/3.2947; Jacob AL, 2003, IEEE SOFTWARE, V20, P50, DOI 10.1109/MS.2003.1196321; Jovanovic N, 2006, SEC PRIV 2006 IEEE S, P6; Kobayashi M, 2000, ACM COMPUT SURV, V32, P144, DOI 10.1145/358923.358934; Luk CK, 2005, ACM SIGPLAN NOTICES, V40, P190, DOI 10.1145/1064978.1065034; Masanes J, 2006, WEB ARCH, pI; McDermott J. P., 2001, Proceedings New Security Paradigm Workshop, P15; Pant G, 2004, WEB DYNAMICS: ADAPTING TO CHANGE IN CONTENT, SIZE TOPOLOG AND USE, P153; Schuetze H, 2004, U.S. Patent, Patent No. [6,751,612, 6751612]; Shkapenyuk V, 2002, PROC INT CONF DATA, P357, DOI 10.1109/ICDE.2002.994750; Shuai Z, 2011, INFORM SECURITY TECH, V9; Spetka S, 1994, P 2 WWW C, V94; Su ZD, 2006, ACM SIGPLAN NOTICES, V41, P372, DOI 10.1145/1111320.1111070; Sun Y, 2007, P 16 INT C WORLD WID, P1123; Takanen A., 2008, ARTECH HSE INF SECUR; Tankard Colin, 2011, Network Security, V2011, P16, DOI 10.1016/S1353-4858(11)70086-1; Vamvatsikos D, 2002, EARTHQUAKE ENG STRUC, V31, P491, DOI 10.1002/eqe.141; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; Wassermann G, 2007, ACM SIGPLAN NOTICES, V42, P32, DOI 10.1145/1273442.1250739	39	7	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0117180	10.1371/journal.pone.0117180	http://dx.doi.org/10.1371/journal.pone.0117180			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768434	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500016
J	Hirakawa, H; Zempo, H; Ogawa, M; Watanabe, R; Suzuki, J; Akazawa, H; Komuro, I; Isobe, M				Hirakawa, Hiroyuki; Zempo, Hirofumi; Ogawa, Masahito; Watanabe, Ryo; Suzuki, Jun-ichi; Akazawa, Hiroshi; Komuro, Issei; Isobe, Mitsuaki			A DPP-4 Inhibitor Suppresses Fibrosis and Inflammation on Experimental Autoimmune Myocarditis in Mice	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; ADENOSINE-DEAMINASE; POTENTIAL ROLE; T-CELLS; CD26; EXPRESSION; TRANSITION; ISCHEMIA; FAILURE; HEART	Myocarditis is a critical inflammatory disorder which causes life-threatening conditions. No specific or effective treatment has been established. DPP-4 inhibitors have salutary effects not only on type 2 diabetes but also on certain cardiovascular diseases. However, the role of a DPP-4 inhibitor on myocarditis has not been investigated. To clarify the effects of a DPP-4 inhibitor on myocarditis, we used an experimental autoimmune myocarditis (EAM) model in Balb/c mice. EAM mice were assigned to the following groups: EAM mice group treated with a DPP-4 inhibitor (linagliptin) (n = 19) and those untreated (n = 22). Pathological analysis revealed that the myocardial fibrosis area ratio in the treated group was significantly lower than in the untreated group. RT-PCR analysis demonstrated that the levels of mRNA expression of IL-2, TNF-alpha, IL-1 beta and IL-6 were significantly lower in the treated group than in the untreated group. Lymphocyte proliferation assay showed that treatment with the DPP-4 inhibitor had no effect on antigen-induced spleen cell proliferation. Administration of the DPP-4 inhibitor remarkably suppressed cardiac fibrosis and reduced inflammatory cytokine gene expression in EAM mice. Thus, the agents present in DPP-4 inhibitors may be useful to treat and/or prevent clinical myocarditis.	[Hirakawa, Hiroyuki; Zempo, Hirofumi; Ogawa, Masahito; Watanabe, Ryo; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Suzuki, Jun-ichi; Akazawa, Hiroshi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo	Suzuki, J (corresponding author), Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan.	junichisuzuki-circ@umin.ac.jp	Zempo, Hirofumi/HHZ-7173-2022	Zempo, Hirofumi/0000-0003-2248-8580; Akazawa, Hiroshi/0000-0002-3574-9607				Bao W, 2014, J VASC SURG, V59, P1098, DOI 10.1016/j.jvs.2013.04.048; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Daniels MD, 2008, AUTOIMMUNITY, V41, P490, DOI 10.1080/08916930802167902; Darsalia V, 2013, DIABETES, V62, P1289, DOI 10.2337/db12-0988; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Futamatsu H, 2005, CIRC RES, V96, P823, DOI 10.1161/01.RES.0000163016.52653.2e; Futamatsua H, 2003, CARDIOVASC RES, V59, P95, DOI 10.1016/S0008-6363(03)00334-1; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Kishimoto C, 2013, INT J CARDIOL, V167, P140, DOI 10.1016/j.ijcard.2011.12.058; Leuschner F, 2009, J AUTOIMMUN, V33, P282, DOI 10.1016/j.jaut.2009.07.009; Liu XM, 2012, CARDIOVASC DRUG THER, V26, P121, DOI 10.1007/s10557-012-6372-6; MARTIN M, 1995, J IMMUNOL, V155, P4630; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; Ohnuma K, 2009, BIOCHEM BIOPH RES CO, V386, P327, DOI 10.1016/j.bbrc.2009.06.027; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Pummerer CL, 1996, J CLIN INVEST, V97, P2057, DOI 10.1172/JCI118642; REINHOLD D, 1994, IMMUNOBIOLOGY, V192, P121, DOI 10.1016/S0171-2985(11)80412-2; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Shauer A, 2013, ISR MED ASSOC J, V15, P180; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shin JW, 2008, EXP CELL RES, V314, P3048, DOI 10.1016/j.yexcr.2008.07.024; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Suzuki JI, 2007, J MOL CELL CARDIOL, V42, P432, DOI 10.1016/j.yjmcc.2006.10.006; Suzuki JI, 2006, J MOL CELL CARDIOL, V40, P688, DOI 10.1016/j.yjmcc.2006.01.006; Tang ZH, 2004, J MOL CELL CARDIOL, V36, P515, DOI 10.1016/j.yjmcc.2004.01.008; Thomas L, 2008, J PHARMACOL EXP THER, V325, P175, DOI 10.1124/jpet.107.135723; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Watanabe R, 2013, AM J PHYSL HEART CIR; Zempo H, 2014, HEART VESSELS; Zhong JX, 2013, ATHEROSCLEROSIS, V226, P305, DOI 10.1016/j.atherosclerosis.2012.09.012; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230	31	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119360	10.1371/journal.pone.0119360	http://dx.doi.org/10.1371/journal.pone.0119360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768281	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500079
J	Zhang, HH; Dai, LF; Chen, N; Zang, LL; Leng, XR; Du, L; Wang, JM; Jiang, YW; Zhang, F; Wu, XR; Wu, Y				Zhang, Haihua; Dai, Lifang; Chen, Na; Zang, Lili; Leng, Xuerong; Du, Li; Wang, Jingmin; Jiang, Yuwu; Zhang, Feng; Wu, Xiru; Wu, Ye			Fifteen Novel EIF2B1-5 Mutations Identified in Chinese Children with Leukoencephalopathy with VanishingWhiteMatter and a Long Term Follow-Up	PLOS ONE			English	Article							VANISHING WHITE-MATTER; GUANINE-NUCLEOTIDE EXCHANGE; EUKARYOTIC TRANSLATION INITIATION; EIF2B-RELATED DISORDERS; CHILDHOOD ATAXIA; NATURAL-HISTORY; DISEASE; SUBUNITS; PHOSPHORYLATION; SELECTION	Leukoencephalopathy with vanishing white matter (VWM) is one of the most prevalent inherited childhood white matter disorders, which caused by mutations in each of the five sub-units of eukaryotic translation initiation factor 2B (EIF2B1-5). In our study, 34 out of the 36 clinically diagnosed children (94%) were identified to have EIF2B1-5 mutations by sequencing. 15 novel mutations were identified. CNVs were not detected in patients with only one mutant allele and mutation-negative determined by gene sequencing. There is a significantly higher incidence of patients with EIF2B3 mutations compared with Caucasian patients (32% vs. 4%). c. 1037T>C (p. Ile346Thr) in EIF2B3 was confirmed to be a founder mutation in Chinese, which probably one of the causes of the genotypic differences between ethnicities. Our average 4.4 years-follow-up on infantile, early childhood and juvenile VWM children suggested a rapid deterioration in motor function. Episodic aggravation was presented in 90% of infantile cases and 71.4% of childhood cases. 10 patients died during the followup. The Kaplan-Meier curve showed that the median survival time is 8.83 +/- 1.51 years. This is the largest sample of children in a VWM follow-up study, which is helpful for a more depth understanding about the natural course.	[Zhang, Haihua; Dai, Lifang; Chen, Na; Zang, Lili; Leng, Xuerong; Du, Li; Wang, Jingmin; Jiang, Yuwu; Wu, Xiru; Wu, Ye] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Zhang, Feng] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Peking University; Fudan University	Wu, Y (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	dryewu@263.net	Zhang, Feng/C-7735-2009; jiang, yu/HGU-0029-2022; leng, xuerong/HHM-7333-2022	Zhang, Feng/0000-0003-4556-8276; 	Natural Science Foundation of China [81171065, 30872793]; National Key Technology RD program [2012BAI09B00]; Key Laboratory Program of the Ministry of Education [2012-RG/ND-0001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD program(National Key Technology R&D Program); Key Laboratory Program of the Ministry of Education	This work was supported by the Natural Science Foundation of China (81171065, 30872793), the National Key Technology R&D program (2012BAI09B00), and the Key Laboratory Program of the Ministry of Education (2012-RG/ND-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Drayna D, 2005, SCI AM, V293, P78, DOI 10.1038/scientificamerican1005-78; Elsby R, 2011, J VIROL, V85, P9716, DOI 10.1128/JVI.05146-11; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kantor L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003783; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Labauge P, 2009, BRAIN, V132, P2161, DOI 10.1093/brain/awp171; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Maletkovic J, 2008, J CHILD NEUROL, V23, P205, DOI 10.1177/0883073807308705; Ohlenbusch Andreas, 2005, Hum Mutat, V25, P411, DOI 10.1002/humu.9325; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pronk JC, 2006, MENT RETARD DEV D R, V12, P123, DOI 10.1002/mrdd.20104; Proud CG, 2012, FUTUR NEUROL, V7, P81, DOI 10.2217/FNL.11.63; Scali O, 2006, NEUROL SCI, V27, P271, DOI 10.1007/s10072-006-0683-y; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Shi W, 2006, CHIN J EVID BASED PE, V2, P122; Shimada S, 2012, AM J MED GENET A, V158A, P1771, DOI 10.1002/ajmg.a.35431; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spilka R, 2014, CELL ONCOL, V37, P253, DOI 10.1007/s13402-014-0181-9; Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van der Lei HDW, 2010, NEUROLOGY, V75, P1555, DOI 10.1212/WNL.0b013e3181f962ae; van Kollenburg B, 2006, NEUROBIOL DIS, V21, P496, DOI 10.1016/j.nbd.2005.08.009; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Wu Y, 2009, J HUM GENET, V54, P74, DOI 10.1038/jhg.2008.10	39	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118001	10.1371/journal.pone.0118001	http://dx.doi.org/10.1371/journal.pone.0118001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761052	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275000015
J	Dunn, TN; Akiyama, T; Lee, HW; Kim, JB; Knotts, TA; Smith, SR; Sears, DD; Carstens, E; Adams, SH				Dunn, Tamara N.; Akiyama, Tasuku; Lee, Hyun Woo; Kim, Jae Bum; Knotts, Trina A.; Smith, Steven R.; Sears, Dorothy D.; Carstens, Earl; Adams, Sean H.			Evaluation of the Synuclein-gamma (SNCG) Gene as a PPAR gamma Target in Murine Adipocytes, Dorsal Root Ganglia Somatosensory Neurons, and Human Adipose Tissue	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ATTENUATES TACTILE ALLODYNIA; DIET-INDUCED OBESITY; PARKINSONS-DISEASE; CHOLESTEROL EFFLUX; INSULIN; PIOGLITAZONE; ALPHA; EXPRESSION; LEPTIN	Recent evidence in adipocytes points to a role for synuclein-gamma in metabolism and lipid droplet dynamics, but interestingly this factor is also robustly expressed in peripheral neurons. Specific regulation of the synuclein-gamma gene (Sncg) by PPAR gamma requires further evaluation, especially in peripheral neurons, prompting us to test if Sncg is a bona fide PPAR gamma target in murine adipocytes and peripheral somatosensory neurons derived from the dorsal root ganglia (DRG). Sncg mRNA was decreased in 3T3-L1 adipocytes (similar to 68%) by rosiglitazone, and this effect was diminished by the PPAR gamma. antagonist T0070907. Chromatin immunoprecipitation experiments confirmed PPAR gamma protein binding at two promoter sequences of Sncg during 3T3-L1 adipogenesis. Rosiglitazone did not affect Sncg mRNA expression in murine cultured DRG neurons. In subcutaneous human WAT samples from two cohorts treated with pioglitazone (> 11 wks), SNCG mRNA expression was reduced, albeit highly variable and most evident in type 2 diabetes. Leptin (Lep) expression, thought to be coordinately-regulated with Sncg based on correlations in human adipose tissue, was also reduced in 3T3-L1 adipocytes by rosiglitazone. However, Lep was unaffected by PPAR. antagonist, and the LXR agonist T0901317 significantly reduced Lep expression (similar to 64%) while not impacting Sncg. The results support the concept that synuclein-gamma shares some, but not all, gene regulators with leptin and is a PPAR gamma target in adipocytes but not DRG neurons. Regulation of synuclein-gamma by cues such as PPAR gamma agonism in adipocytes is logical based on recent evidence for an important role for synuclein-gamma in the maintenance and dynamics of adipocyte lipid droplets.	[Dunn, Tamara N.; Adams, Sean H.] Univ Calif Davis, Grad Grp Nutr Biol, Davis, CA 95616 USA; [Dunn, Tamara N.; Knotts, Trina A.; Adams, Sean H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Akiyama, Tasuku; Carstens, Earl] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Lee, Hyun Woo; Kim, Jae Bum] Seoul Natl Univ, Natl Creat Res Initiat Ctr Adipose Tissue Remodel, Inst Mol Biol & Genet, Dept Biol Sci, Seoul, South Korea; [Knotts, Trina A.; Adams, Sean H.] Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Little Rock, AR 72205 USA; [Knotts, Trina A.; Adams, Sean H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Smith, Steven R.] Florida Hosp, Sanford Burnham Med Res Inst, Orlando, FL USA; [Smith, Steven R.] Florida Hosp, Translat Res Inst, Orlando, FL USA; [Sears, Dorothy D.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Seoul National University (SNU); University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Adventist Health Services; AdventHealth; Sanford Burnham Prebys Medical Discovery Institute; Adventist Health Services; AdventHealth; University of California System; University of California San Diego	Adams, SH (corresponding author), Univ Calif Davis, Grad Grp Nutr Biol, Davis, CA 95616 USA.	shadams@uams.edu	Song, Minsun/I-5701-2015; Smith, Steven/HDM-9496-2022; Sears, Dorothy D/AHE-5524-2022; ADAMS, SEAN/N-9262-2018; Akiyama, Tasuku/AFN-8329-2022	Sears, Dorothy D/0000-0002-9260-3540; ADAMS, SEAN/0000-0002-9515-2319; KIM, Jae Bum/0000-0003-2337-6935; Akiyama, Tasuku/0000-0001-7155-4228; Smith, Steven/0000-0002-5098-8147	intramural USDA-ARS Projects [530651530-016-00D, 5306-51530-019-00D]; Vitamin Cases Consumer Settlement Fund [CHNR08-801]; Takeda Pharmaceuticals North America; Korean government (Ministry of Education, Science, and Technology) [2012-0001241]	intramural USDA-ARS Projects; Vitamin Cases Consumer Settlement Fund; Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); Korean government (Ministry of Education, Science, and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was funded in part by the following: intramural USDA-ARS Projects [530651530-016-00D] and [5306-51530-019-00D] (S.H.A.), the Vitamin Cases Consumer Settlement Fund [CHNR08-801] (to S.H.A.), an unrestricted grant from Takeda Pharmaceuticals North America (to S.R.S.), and a grant from the Korean government (Ministry of Education, Science, and Technology [2012-0001241], to J.B.K.). The USDA is an equal opportunity provider and employer.	Akiyama T, 2012, NEUROSCIENCE, V226, P305, DOI 10.1016/j.neuroscience.2012.09.019; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Bogacka I, 2004, DIABETES CARE, V27, P1660, DOI 10.2337/diacare.27.7.1660; Buchman VL, 1998, NAT NEUROSCI, V1, P101, DOI 10.1038/349; Buchman VL, 1998, J NEUROSCI, V18, P9335; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Carta AR, 2011, NEUROSCIENCE, V194, P250, DOI 10.1016/j.neuroscience.2011.07.046; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Davidson EP, 2010, DIABETES-METAB RES, V26, P306, DOI 10.1002/dmrr.1088; de Lartigue G, 2011, AM J PHYSIOL-ENDOC M, V301, pE187, DOI 10.1152/ajpendo.00056.2011; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Dunn TN, 2014, ADV NUTR, V5, P386, DOI 10.3945/an.113.005439; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Guschina I, 2011, LIPIDS, V46, P121, DOI 10.1007/s11745-010-3486-0; Hammarstedt A, 2005, PROSTAG LEUKOTR ESS, V73, P65, DOI 10.1016/j.plefa.2005.04.008; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Iwai S, 2008, DRUG DISCOV THER, V2, P353; Jia TL, 1999, CANCER RES, V59, P742; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Knotts TA, 2009, PPAR RES, V2009, DOI 10.1155/2009/867678; Lavedan C, 1998, GENOMICS, V54, P173, DOI 10.1006/geno.1998.5556; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lee YS, 2007, MOL CELL BIOL, V27, P438, DOI 10.1128/MCB.00490-06; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Liu C, 2014, CELL METAB, V19, P722, DOI 10.1016/j.cmet.2014.01.021; Lu AP, 2002, J BIOL CHEM, V277, P31364, DOI 10.1074/jbc.M201060200; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Maeda T, 2008, J PHARMACOL SCI, V108, P341, DOI 10.1254/jphs.08207FP; Millership S, 2012, P NATL ACAD SCI USA, V109, P20943, DOI 10.1073/pnas.1210022110; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Oort PJ, 2008, J NUTR, V138, P841, DOI 10.1093/jn/138.5.841; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Ozasa H, 2011, ATHEROSCLEROSIS, V219, P141, DOI 10.1016/j.atherosclerosis.2011.07.113; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Paulino G, 2009, AM J PHYSIOL-ENDOC M, V296, pE898, DOI 10.1152/ajpendo.90796.2008; Petrofsky J, 2005, MED SCI MONITOR, V11, pCR562; Petrofsky JS, 2005, MED SCI MONITOR, V11, pPI43; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Raybould HE, 2008, J PHYSIOL BIOCHEM, V64, P349, DOI 10.1007/BF03174091; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Song CK, 2009, AM J PHYSIOL-REG I, V296, pR501, DOI 10.1152/ajpregu.90786.2008; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Strand DW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.99; Surgucheva IG, 2003, ARCH BIOCHEM BIOPHYS, V410, P167, DOI 10.1016/S0003-9861(02)00664-1; Surgucheva I, 2008, J MOL NEUROSCI, V35, P267, DOI 10.1007/s12031-008-9074-6; Tentolouris N, 2006, ANN NY ACAD SCI, V1083, P129, DOI 10.1196/annals.1367.010; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tung YCL, 2008, J NEUROSCI, V28, P12419, DOI 10.1523/JNEUROSCI.3412-08.2008; van Baak M A, 2001, Obes Rev, V2, P3; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Vaughan CH, 2011, BRAIN RES, V1411, P17, DOI 10.1016/j.brainres.2011.07.003; Wellhoener P, 2000, J CLIN ENDOCR METAB, V85, P1267, DOI 10.1210/jc.85.3.1267; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wu CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-283	64	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0115830	10.1371/journal.pone.0115830	http://dx.doi.org/10.1371/journal.pone.0115830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756178	gold, Green Published			2022-12-27	WOS:000351275700003
J	Molinos, JG; Viana, M; Brennan, M; Donohue, I				Molinos, Jorge Garcia; Viana, Mafalda; Brennan, Michael; Donohue, Ian			Importance of Long-Term Cycles for Predicting Water Level Dynamics in Natural Lakes	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; CLIMATE-CHANGE; FRESH-WATER; SHALLOW LAKE; FLUCTUATIONS; VARIABILITY; BIODIVERSITY; MANAGEMENT; SEDIMENT; QUALITY	Lakes are disproportionately important ecosystems for humanity, containing 77% of the liquid surface freshwater on Earth and comprising key contributors to global biodiversity. With an ever-growing human demand for water and increasing climate uncertainty, there is pressing need for improved understanding of the underlying patterns of natural variability of water resources and consideration of their implications for water resource management and conservation. Here we use Bayesian harmonic regression models to characterise water level dynamics and study the influence of cyclic components in confounding estimation of long-term directional trends in water levels in natural Irish lakes. We found that the lakes were characterised by a common and well-defined annual seasonality and several inter-annual and inter-decadal cycles with strong transient behaviour over time. Importantly, failing to account for the longer-term cyclic components produced a significant overall underestimation of the trend effect. Our findings demonstrate the importance of contextualising lake water resource management to the specific physical setting of lakes.	[Molinos, Jorge Garcia; Viana, Mafalda; Brennan, Michael; Donohue, Ian] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [Donohue, Ian] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Molinos, Jorge Garcia] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	Trinity College Dublin; Trinity College Dublin; National Institute for Environmental Studies - Japan	Molinos, JG (corresponding author), SAMS, Dept Ecol, Oban, Argyll, Scotland.	Jorge.Garcia-Molinos@sams.ac.uk	Molinos, Jorge García/C-9252-2015; Donohue, Ian/A-7270-2010	Molinos, Jorge García/0000-0001-7516-1835; Donohue, Ian/0000-0002-4698-6448; Brennan, Michael/0000-0002-5646-028X	European Union [002862]	European Union(European Commission)	This work was funded by the European Union's INTERREG IVA Cross-border Programme managed by the Special EU Programmes Body under the project "Development of targeted ecological modelling tools for lake management; DOLMANT" (Ref. No: 002862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, LIMNOL OCEANOGR, V50, P1752, DOI 10.4319/lo.2005.50.6.1752; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Biswas AK, 2004, WATER INT, V29, P248, DOI 10.1080/02508060408691775; Coops H, 2002, LAKE RESERV MANAGE, V18, P293, DOI 10.1080/07438140209353935; Crase L, 2008, AUSTRALAS J ENVIRON, V15, P21; Doll P, 2012, J GEODYN, V59-60, P143, DOI 10.1016/j.jog.2011.05.001; Donohue I, 2004, FRESHWATER BIOL, V49, P320, DOI 10.1111/j.1365-2427.2004.01187.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Erb KH, 2009, ECOL ECON, V69, P250, DOI 10.1016/j.ecolecon.2009.07.001; Evtimova VV, 2014, J APPL ECOL, V51, P1282, DOI 10.1111/1365-2664.12297; Foulds D., 1977, CAN WATER RESOUR J, V2, P43, DOI [10.4296/cwrj0201043, DOI 10.4296/CWRJ0201043]; Fox J, 2008, APPL REGRESSION ANAL; GASITH A, 1990, BROCK SPR S, P156; Ghanbari RN, 2008, ADV WATER RESOUR, V31, P1284, DOI 10.1016/j.advwatres.2008.05.002; Gibson JJ, 2006, HYDROL PROCESS, V20, P4155, DOI 10.1002/hyp.6424; GOTTGENS JF, 1994, ARCH HYDROBIOL, V130, P179; Grafton RQ, 2013, NAT CLIM CHANGE, V3, P315, DOI [10.1038/NCLIMATE1746, 10.1038/nclimate1746]; Hakanson L, 2000, ECOL MODEL, V128, P101, DOI 10.1016/S0304-3800(00)00200-3; Hambright KD, 2004, ENVIRON SCI TECHNOL, V38, P6460, DOI 10.1021/es0492992; Hampton SE, 2011, MAR FRESHWATER RES, V62, P350, DOI 10.1071/MF10229; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Hofmann H, 2008, HYDROBIOLOGIA, V613, P85, DOI 10.1007/s10750-008-9474-1; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Ineson S, 2011, NAT GEOSCI, V4, P753, DOI [10.1038/ngeo1282, 10.1038/NGEO1282]; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Johnk KD, 2004, LIMNOLOGICA, V34, P15, DOI 10.1016/S0075-9511(04)80017-3; McDonald RI, 2011, P NATL ACAD SCI USA, V108, P6312, DOI 10.1073/pnas.1011615108; McElwain L., 2007, KEY METEOROLOGICAL I, P31; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Molinos JG, 2014, CLIMATIC CHANGE, V124, P333, DOI 10.1007/s10584-014-1077-4; Molinos JG, 2011, OECOLOGIA, V166, P795, DOI 10.1007/s00442-011-1923-2; Molinos JG, 2010, ECOL APPL, V20, P1794, DOI 10.1890/10-0018.1; Naselli-Flores L, 2003, HYDROBIOLOGIA, V506, P13, DOI 10.1023/B:HYDR.0000008550.34409.06; Nilsson C, 1997, SCIENCE, V276, P798, DOI 10.1126/science.276.5313.798; Noges T, 2003, HYDROBIOLOGIA, V506, P257, DOI 10.1023/B:HYDR.0000008540.06592.48; Pahl-Wostl C, 2007, WATER RESOUR MANAG, V21, P49, DOI 10.1007/s11269-006-9040-4; Palmer MA, 2010, NATURE, V467, P534, DOI 10.1038/467534a; Pasquini AI, 2008, GLOBAL PLANET CHANGE, V63, P290, DOI 10.1016/j.gloplacha.2008.07.001; Plummer M., 2003, P 3 INT WORKSH DISTR; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shiklomanov Igor A., 1993, P13; Shilland P, 2009, REVISED RISK ASSESSM, P127, DOI [10.1007/s13280-014-0523-x, DOI 10.1007/S13280-014-0523-X]; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tomasino M, 2000, HYDROLOG SCI J, V45, P477, DOI 10.1080/02626660009492343; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Vadeboncoeur Y, 2011, BIOSCIENCE, V61, P526, DOI 10.1525/bio.2011.61.7.7; Van Geest GJ, 2005, J APPL ECOL, V42, P251, DOI 10.1111/j.1365-2664.2005.00995.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Wildman RA, 2011, J ENVIRON QUAL, V40, P575, DOI 10.2134/jeq2010.0323; Zhang Q, 2006, J HYDROL, V324, P255, DOI 10.1016/j.jhydrol.2005.09.023; Zohary T, 2011, INLAND WATERS, V1, P47, DOI 10.5268/IW-1.1.406	58	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119253	10.1371/journal.pone.0119253	http://dx.doi.org/10.1371/journal.pone.0119253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757071	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000351275700042
J	Chen, WY; Cui, YH; Zheng, SH; Huang, JH; Li, P; Simoncini, T; Zhang, YF; Fu, XD				Chen, Weiyu; Cui, Yuhong; Zheng, Shuhui; Huang, Jinghe; Li, Ping; Simoncini, Tommaso; Zhang, Yongfu; Fu, Xiaodong			2-Methoxyestradiol Induces Vasodilation by Stimulating NO Release via PPAR gamma/PI3K/Akt Pathway	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ESTRADIOL METABOLITES; POSTMENOPAUSAL WOMEN; HYDROGEN-SULFIDE; CANCER CELLS; ESTROGEN; 17-BETA-ESTRADIOL; INHIBITION; DEFICIENCY; ACTIVATION	The endogenous estradiol metabolite 2-methoxyestradiol (2-ME) reduces atherosclerotic lesion formation, while the underlying mechanisms remain obscure. In this work, we investigated the vasodilatory effect of 2-ME and the role of nitric oxide (NO) involved. In vivo studies using noninvasive tail-cuff methods showed that 2-ME decreased blood pressure in Sprague Dawley rats. Furthermore, in vitro studies showed that cumulative addition of 2-ME to the aorta caused a dose- and endothelium-dependent vasodilation. This effect was unaffected by the pretreatment with the pure estrogen receptor antagonist ICI 182,780, but was largely impaired by endothelial nitric oxide synthase ( eNOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME) or by phosphoinositide 3-kinase (PI3K) inhibitor wortmannin (WM). Moreover, 2-ME (10(-7) (similar to) 10(-5) M) enhanced phosphorylation of Akt and eNOS and promoted NO release from cultured human umbilical endothelial cells (HUVECs). These effects were blocked by PI3K inhibitor WM, or by the transfection with Akt specific siRNA, indicating that endothelial Akt/eNOS/NO cascade plays a crucial role in 2-ME-induced vasodilation. The peroxisome proliferator-activated receptor. (PPAR.) mRNA and protein expression were detected in HUVECs and the antagonist GW9662 or the transfection with specific PPAR. siRNA inhibited 2-ME-induced eNOS and Akt phosphorylation, leading to the impairment of NO production and vasodilation. In conclusion, 2-ME induces vasodilation by stimulating NO release. These actions may be mediated by PPAR. and the subsequent activation of Akt/eNOS cascade in vascular endothelial cells.	[Chen, Weiyu; Cui, Yuhong; Li, Ping; Fu, Xiaodong] Guangzhou Med Univ, Sch Basic Sci, Guangzhou 510182, Guangdong, Peoples R China; [Chen, Weiyu; Huang, Jinghe] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Physiol, Guangzhou 510080, Guangdong, Peoples R China; [Zheng, Shuhui] Sun Yat Sen Univ, Affiliated Hosp 1, Res Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China; [Simoncini, Tommaso] Univ Pisa, Dept Reprod Med & Child Dev, Mol & Cellular Gynecol Endocrinol Lab, I-56100 Pisa, Italy; [Zhang, Yongfu] Guangzhou Women & Childrens Med Ctr, Dept Anesthesiol, Guangzhou 510180, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; University of Pisa	Zhang, YF (corresponding author), Guangzhou Women & Childrens Med Ctr, Dept Anesthesiol, Guangzhou 510180, Guangdong, Peoples R China.	zyongfu@126.com; fuxiaodong27@hotmail.com	Simoncini, Tommaso/AAC-1879-2019	Simoncini, Tommaso/0000-0002-2971-0079; Fu, Xiaodong/0000-0003-2754-8976	National Natural Science Foundation [81270669]; Foundation of Guangzhou Pearl River Science New Star [2011J2200094]; Guangdong Natural Science Foundation [S2013010016548]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation of Guangzhou Pearl River Science New Star; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation (To X.D. Fu., No. 81270669), by the Foundation of Guangzhou Pearl River Science New Star (To X.D. Fu., No: 2011J2200094) and by the Guangdong Natural Science Foundation (To X.D. Fu., No: S2013010016548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Balakumar P, 2012, BRIT J PHARMACOL, V166, P1981, DOI 10.1111/j.1476-5381.2012.01938.x; Barchiesi F, 2006, CIRC RES, V99, P266, DOI 10.1161/01.RES.0000233318.85181.2e; Barchiesi F, 2010, HYPERTENSION, V56, P964, DOI 10.1161/HYPERTENSIONAHA.110.152298; Bonacasa B, 2008, MATURITAS, V61, P310, DOI 10.1016/j.maturitas.2008.09.028; Bourghardt J, 2007, ENDOCRINOLOGY, V148, P4128, DOI 10.1210/en.2007-0259; Dubey RK, 2009, TRENDS ENDOCRIN MET, V20, P374, DOI 10.1016/j.tem.2009.04.007; Dubey RK, 2004, J PHARMACOL EXP THER, V308, P403, DOI 10.1124/jpet.103.058057; Fenoy FJ, 2010, NITRIC OXIDE-BIOL CH, V23, P12, DOI 10.1016/j.niox.2010.03.002; Genazzani AR, 2013, NAT REV ENDOCRINOL, V9, P5, DOI 10.1038/nrendo.2012.228; Gui Y, 2008, AM J PHYSIOL-HEART C, V295, pH1935, DOI 10.1152/ajpheart.00723.2008; Lin HL, 2007, INT J CANCER, V121, P2547, DOI 10.1002/ijc.22963; Hill BJF, 2010, CAN J PHYSIOL PHARM, V88, P147, DOI 10.1139/Y09-120; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kaufmann BA, 2010, ARTERIOSCL THROM VAS, V30, P54, DOI 10.1161/ATVBAHA.109.196386; Kublickiene K, 2008, J CLIN ENDOCR METAB, V93, P1874, DOI 10.1210/jc.2007-2651; Liao WY, 2013, MOL BIOL REP, V40, P6729, DOI 10.1007/s11033-013-2788-8; Miyauchi Y, 2013, P NATL ACAD SCI USA, V110, P16568, DOI 10.1073/pnas.1308755110; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Salama S, 2011, INT J RADIAT ONCOL, V80, P231, DOI 10.1016/j.ijrobp.2010.10.080; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Seeger H, 1999, LIFE SCI, V65, pPL167, DOI 10.1016/S0024-3205(99)00383-5; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Wang GD, 2013, ONCOL REP, V30, P357, DOI 10.3892/or.2013.2469; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yu ZR, 2014, CHEM COMMUN, V50, P2728, DOI 10.1039/c3cc48152b; Zhou KW, 2013, MOL HUM REPROD, V19, P169, DOI 10.1093/molehr/gas044	29	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118902	10.1371/journal.pone.0118902	http://dx.doi.org/10.1371/journal.pone.0118902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748432	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400029
J	Degen, CV; Bishu, K; Zakeri, R; Ogut, O; Redfield, MM; Brozovich, FV				Degen, Chantal V.; Bishu, Kalkidan; Zakeri, Rosita; Ogut, Ozgur; Redfield, Margaret M.; Brozovich, Frank V.			The Emperor's New Clothes: PDE5 and the Heart	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; PULMONARY ARTERIAL-HYPERTENSION; PROTEIN-KINASE I; SMOOTH-MUSCLE; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; CHRONIC INHIBITION; CLINICAL STATUS; FAILURE; SILDENAFIL	Phosphodiesterase-5 (PDE5) is highly expressed in the pulmonary vasculature, but its expression in the myocardium is controversial. Cyclic guanosine monophosphate (cGMP) activates protein kinase G (PKG), which has been hypothesized to blunt cardiac hypertrophy and negative remodeling in heart failure. Although PDE5 has been suggested to play a significant role in the breakdown of cGMP in cardiomyocytes and hence PKG regulation in the myocardium, the RELAX trial, which tested effect of PDE5 inhibition on exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF) failed to show a beneficial effect. These results highlight the controversy regarding the role and expression of PDE5 in the healthy and failing heart. This study used one-and two-dimensional electrophoresis and Western blotting to examine PDE5 expression in mouse (before and after trans-aortic constriction), dog (control and HFpEF) as well as human (healthy and failing) heart. We were unable to detect PDE5 in any cardiac tissue lysate, whereas PDE5 was present in the murine and bovine lung samples used as positive controls. These results indicate that if PDE5 is expressed in cardiac tissue, it is present in very low quantities, as PDE5 was not detected in either humans or any model of heart failure examined. Therefore in cardiac muscle, it is unlikely that PDE5 is involved the regulation of cGMP-PKG signaling, and hence PDE5 does not represent a suitable drug target for the treatment of cardiac hypertrophy. These results highlight the importance of rigorous investigation prior to clinical trial design.	[Degen, Chantal V.; Bishu, Kalkidan; Zakeri, Rosita; Ogut, Ozgur; Redfield, Margaret M.; Brozovich, Frank V.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Brozovich, FV (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Cardiovasc Dis, Rochester, MN 55905 USA.	brozovich.frank@mayo.edu		Zakeri, Rosita/0000-0002-4225-3693	Mayo Foundation for Medical Research and Education; National Institutes of Health [R01 HL105418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105418, U10HL110262] Funding Source: NIH RePORTER	Mayo Foundation for Medical Research and Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the Mayo Foundation for Medical Research and Education (FVB) and the National Institutes of Health, R01 HL105418 (MMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MJ, 2013, CIRCULATION, V127, P1200, DOI 10.1161/CIRCULATIONAHA.112.000056; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Bishu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081325; Bishu K, 2011, CIRCULATION, V124, P2882, DOI 10.1161/CIRCULATIONAHA.111.048520; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Chen HH, 2002, J CARD FAIL, V8, P279, DOI 10.1054/jcaf.2002.128871; Corbin J, 2003, CURR MED RES OPIN, V19, P747, DOI 10.1185/030079903125002522; Corbin JD, 2005, BIOCHEM BIOPH RES CO, V334, P930, DOI 10.1016/j.bbrc.2005.06.183; EGHBALI M, 1988, J MOL CELL CARDIOL, V20, P267, DOI 10.1016/S0022-2828(88)80059-2; FRANCIS GS, 1990, FASEB J, V4, P3068, DOI 10.1096/fasebj.4.13.2210153; Giannetta E, 2012, CIRCULATION, V125, P2323, DOI 10.1161/CIRCULATIONAHA.111.063412; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Hamdani N, 2013, CARDIOVASC RES, V97, P464, DOI 10.1093/cvr/cvs353; Lu ZB, 2010, CIRCULATION, V121, P1474, DOI 10.1161/CIRCULATIONAHA.109.906818; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Mohammed SF, 2012, CARDIOVASC PATHOL, V21, P188, DOI 10.1016/j.carpath.2011.05.002; Mohammed SF, 2010, CIRCULATION, V122, P370, DOI 10.1161/CIRCULATIONAHA.109.915215; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2002, J BIOL CHEM, V277, P3310, DOI 10.1074/jbc.M106562200; Senzaki H, 2001, FASEB J, V15, P1718, DOI 10.1096/fj.00-0538com; Shan XY, 2012, CIRC-HEART FAIL, V5, P79, DOI 10.1161/CIRCHEARTFAILURE.111.961706; Shapiro BP, 2008, CIRCULATION, V118, P1002, DOI 10.1161/CIRCULATIONAHA.108.777326; Shapiro BP, 2007, HYPERTENSION, V50, P503, DOI 10.1161/HYPERTENSIONAHA.107.090092; Sitbon O, 1998, EUR RESPIR J, V12, P265, DOI 10.1183/09031936.98.12020265; Takimoto E, 2005, CIRC RES, V96, P100, DOI 10.1161/01.RES.0000152262.22968.72; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2007, CIRCULATION, V115, P2159, DOI 10.1161/CIRCULATIONAHA.106.643536; Vandeput F, 2009, J PHARMACOL EXP THER, V330, P884, DOI 10.1124/jpet.109.154468; Wallis RM, 1999, AM J CARDIOL, V83, p3C; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009; Zhang M, 2008, CELL SIGNAL, V20, P2231, DOI 10.1016/j.cellsig.2008.08.012	43	25	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118664	10.1371/journal.pone.0118664	http://dx.doi.org/10.1371/journal.pone.0118664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747598	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400024
J	Fukuda, S; Koyama, H; Kondo, K; Fujii, H; Hirayama, Y; Tabata, T; Okamura, M; Yamakawa, T; Okada, S; Hirata, S; Kiyama, H; Kajimoto, O; Watanabe, Y; Inaba, M; Nishizawa, Y				Fukuda, Sanae; Koyama, Hidenori; Kondo, Kazuhiro; Fujii, Hisako; Hirayama, Yoshinobu; Tabata, Tsutomu; Okamura, Mikio; Yamakawa, Tomoyuki; Okada, Shigeki; Hirata, Sumio; Kiyama, Hiroshi; Kajimoto, Osami; Watanabe, Yasuyoshi; Inaba, Masaaki; Nishizawa, Yoshiki			Effects of Nutritional Supplementation on Fatigue, and Autonomic and Immune Dysfunction in Patients with End-Stage Renal Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEART-RATE-VARIABILITY; NERVOUS-SYSTEM; HEMODIALYSIS-PATIENTS; VITAMIN-C; PLASMA; EXERCISE; HORMONE; INFLAMMATION; MORTALITY	Background Fatigue is a predictor of cardiovascular events in patients with end-stage renal disease (ESRD) undergoing hemodialysis treatment. We hypothesized that multinutritional support would improve quality of life, fatigue symptoms, and potential quantitative measures including endocrine, immune and autonomic functions in patients with ESRD undergoing hemodialysis. Methods Two hundred and two hemodialysis patients were randomly assigned to receive active treatment (containing vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, folic acid, vitamin C, carnitine, coenzyme Q10, naive galacto-oligosaccharide, and zinc) or placebo after each dialysis session for 12 weeks. The patients and attending physicians were blinded to the treatment, and 172 patients (86 in each group) completed the study. Fatigue was evaluated via fatigue questionnaire at 0, 4, and 12 weeks. To assess human herpes virus (HHV) 6 and 7 reactivation, numbers of viral DNA copies were determined in saliva by polymerase chain reaction at weeks 0 and 12. Autonomic function was determined via measurement of beat-to-beat variation by using acceleration plethysmography. Results Clinical characteristics, changes in fatigue, quality of life score, endocrine functions, and laboratory data did not differ significantly between the two groups. Several parameters of heart rate variability significantly increased after nutritional treatment compared to placebo. Nutritional drink for 12 weeks significantly suppressed HHV7 DNA copy numbers. Similarly, HHV6 DNA copy numbers tended to be decreased by treatment but without reaching statistical significance. Conclusions Nutritional supplementation may modulate immune and autonomic dysfunction in ESRD patients undergoing hemodialysis.	[Fukuda, Sanae] Univ Welf Sci, Kasiwara, Osaka 5820026, Japan; [Fukuda, Sanae; Watanabe, Yasuyoshi] RIKEN, Ctr Life Sci Technol, Kobe, Hyogo 6500047, Japan; [Fukuda, Sanae; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 5458585, Japan; [Koyama, Hidenori; Inaba, Masaaki; Nishizawa, Yoshiki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 5458585, Japan; [Koyama, Hidenori] Hyogo Coll Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Nishinomiya, Hyogo 6638501, Japan; [Kondo, Kazuhiro] Jikei Univ, Sch Med, Dept Virol, Tokyo 1058461, Japan; [Fujii, Hisako] Osaka City Univ Hosp, Ctr Drug & Food Clin Evaluat, Osaka 5400051, Japan; [Hirayama, Yoshinobu] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu 5258577, Japan; [Tabata, Tsutomu] Inoue Hosp, Suita, Osaka 5640053, Japan; [Okamura, Mikio] Ohno Mem Hosp, Osaka 5500015, Japan; [Yamakawa, Tomoyuki] Shirasagi Hosp, Osaka 5460002, Japan; [Okada, Shigeki] Okada Clin, Osaka 5430056, Japan; [Hirata, Sumio] Kumamoto Univ, Sch Pharm, Kumamoto 8620973, Japan; [Kiyama, Hiroshi] Nagoya Univ, Sch Med, Nagoya, Aichi 4668550, Japan; [Kajimoto, Osami] Osaka City Univ, Grad Sch Med, Dept Med Sci Fatigue, Osaka 5458585, Japan	RIKEN; Osaka Metropolitan University; Osaka Metropolitan University; Hyogo College of Medicine; Jikei University; Osaka Metropolitan University; Ritsumeikan University; Kumamoto University; Nagoya University; Osaka Metropolitan University	Koyama, H (corresponding author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka 5458585, Japan.	hkoyama@hyo-med.ac.jp	Kiyama, Hiroshi/M-8867-2014; Koyama, Hidenori/AAU-2346-2020	Kiyama, Hiroshi/0000-0001-5963-046X; Koyama, Hidenori/0000-0001-7930-2228	Ministry of Education, Culture, Sports, Science and Technology (Japan) [KAKENHI-24500826]; Health Labour Sciences Research Grant (Comprehensive Research on Disability Health and Welfare), Japan [24163001]; Asahi Kasei Kuraray Medical Cooperation	Ministry of Education, Culture, Sports, Science and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labour Sciences Research Grant (Comprehensive Research on Disability Health and Welfare), Japan; Asahi Kasei Kuraray Medical Cooperation	This study was partly supported by grants from the Asahi Kasei Kuraray Medical Cooperation, 21st Century COE Program and Grant-in Aid for Scientific Research (C) (KAKENHI-24500826) by Ministry of Education, Culture, Sports, Science and Technology (Japan), and grants from Health Labour Sciences Research Grant (Comprehensive Research on Disability Health and Welfare [24163001]), Japan. Tsutomo Tabata, Mikio Okamura, Tomoyuki Yamanaka, Shigeki Okada, Sumio Hirata, Yasuyoshi Watanabe and Yosiki Nishizawa received research grants from the Asahi Kasei Kuraray Medical Cooperation, but the sponsors were not involved in the design, execution, analysis, or reporting of the results of this study.	Barron HV, 1996, J AM COLL CARDIOL, V27, P1053, DOI 10.1016/0735-1097(95)00615-X; Bernasconi AR, 2006, NEPHROLOGY, V11, P137, DOI 10.1111/j.1440-1797.2006.00536.x; Brass EP, 2001, AM J KIDNEY DIS, V37, P1018, DOI 10.1016/S0272-6386(05)80019-8; Camm AJ, 1996, CIRCULATION, V93, P1043; Chapenko S, 2012, ADV VIROL, V2012, DOI 10.1155/2012/205085; Chatham JC, 2012, CIRC RES, V111, P666, DOI 10.1161/CIRCRESAHA.112.277392; Cho KH, 2009, AM J PHYSIOL-RENAL, V297, pF106, DOI 10.1152/ajprenal.00126.2009; Dashti-Khavidaki S, 2011, INT J VITAM NUTR RES, V81, P197, DOI 10.1024/0300-9831/a000065; de Pagter PJA, 2008, BIOL BLOOD MARROW TR, V14, P831, DOI 10.1016/j.bbmt.2008.04.016; Elder SJ, 2008, NEPHROL DIAL TRANSPL, V23, P998, DOI 10.1093/ndt/gfm630; Feldt-Rasmussen B, 2007, J AM SOC NEPHROL, V18, P2161, DOI 10.1681/ASN.2006111207; Fujii H, 2013, J RENAL NUTR, V23, P340, DOI 10.1053/j.jrn.2012.12.008; Green J, 2001, QUAL LIFE RES, V10, P93, DOI 10.1023/A:1016630825992; Hayano J, 1999, NEPHROL DIAL TRANSPL, V14, P1480, DOI 10.1093/ndt/14.6.1480; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Kato K, 2006, INT J CARDIOL, V111, P240, DOI 10.1016/j.ijcard.2005.07.020; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kogelnik AM, 2006, J CLIN VIROL, V37, pS33, DOI 10.1016/S1386-6532(06)70009-9; Kondo K, 2008, FATIGUE SCI HUMAN HL, P137; Kotzmann H, 2001, KIDNEY INT, V60, P1578, DOI 10.1046/j.1523-1755.2001.00971.x; Koyama H, 2010, CLIN J AM SOC NEPHRO, V5, P659, DOI 10.2215/CJN.08151109; Pauly DF, 2003, AM J KIDNEY DIS, V41, pS35, DOI 10.1016/S0272-6386(03)00115-X; Piccirillo G, 2004, AM J CARDIOL, V93, P650, DOI 10.1016/j.amjcard.2003.11.043; Ranpuria R, 2008, NEPHROL DIAL TRANSPL, V23, P444, DOI 10.1093/ndt/gfm634; Rubinger D, 2004, NEPHROL DIAL TRANSPL, V19, P2053, DOI 10.1093/ndt/gfh306; Shishioh-Ikejima N, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-73; Takada M, 2010, INT ARCH OCC ENV HEA, V83, P521, DOI 10.1007/s00420-009-0499-1; Tanaka M, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-46; Tranaeus A, 2008, PERITON DIALYSIS INT, V28, pS161; Turkmen K, 2011, CLIN J AM SOC NEPHRO, V6, P1920, DOI 10.2215/CJN.00890111; Unruh M, 2004, KIDNEY INT, V66, P355, DOI 10.1111/j.1523-1755.2004.00738.x; Zheng A, 2008, J NUTR SCI VITAMINOL, V54, P286, DOI 10.3177/jnsv.54.286	32	23	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119578	10.1371/journal.pone.0119578	http://dx.doi.org/10.1371/journal.pone.0119578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746727	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400079
J	Jaeschke, L; Steinbrecher, A; Pischon, T				Jaeschke, Lina; Steinbrecher, Astrid; Pischon, Tobias			Measurement of Waist and Hip Circumference with a Body Surface Scanner: Feasibility, Validity, Reliability, and Correlations with Markers of the Metabolic Syndrome	PLOS ONE			English	Article							MASS INDEX; RISK-FACTORS; ASSOCIATION; VALIDATION; OBESITY; GIRTH	Objective Body surface scanners (BS), which visualize a 3D image of the human body, facilitate the computation of numerous body measures, including height, waist circumference (WC) and hip circumference (HC). However, limited information is available regarding validity and reliability of these automated measurements (AM) and their correlation with parameters of the Metabolic Syndrome (MetS) compared to traditional manual measurements (MM). Methods As part of a cross-sectional feasibility study, AM of WC, HC and height were assessed twice in 60 participants using a 3D BS (Vitus(smart)XXL). Additionally, MM were taken by trained personnel according to WHO guidelines. Participants underwent an interview, bioelectrical impedance analysis, and blood pressure measurement. Blood samples were taken to determine HbA1c, HDL-cholesterol, triglycerides, and uric acid. Validity was assessed based on the agreement between AM and MM, using Bland-Altman-plots, correlation analysis, and paired t-tests. Reliability was assessed using intraclass correlation coefficients (ICC) based on two repeated AM. Further, we calculated age-adjusted Pearson correlation for AM and MM with fat mass, systolic blood pressure, HbA1c, HDL-cholesterol, triglycerides, and uric acid. Results Body measures were higher in AM compared to MM but both measurements were strongly correlated (WC, men, difference = 1.5cm, r = 0.97; women, d = 4.7cm, r = 0.96; HC, men, d = 2.3cm, r = 0.97; women, d = 3.0cm; r = 0.98). Reliability was high for all AM (nearly all ICC>0.98). Correlations of WC, HC, and the waist-to-hip ratio (WHR) with parameters of MetS were similar between AM and MM; for example the correlation of WC assessed by AM with HDL-cholesterol was r = 0.35 in men, and r = -0.48 in women, respectively whereas correlation of WC measured manually with HDL cholesterol was r = -0.41 in men, and r = -0.49 in women, respectively. Conclusions Although AM of WC, HC, and WHR are higher when compared to MM based on WHO guidelines, our data indicate good validity, excellent reliability, and similar correlations to parameters of the MetS.	[Jaeschke, Lina; Steinbrecher, Astrid; Pischon, Tobias] Max Delbrueck Ctr Mol Med MDC, Mol Epidemiol Grp, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Pischon, T (corresponding author), Max Delbrueck Ctr Mol Med MDC, Mol Epidemiol Grp, Berlin, Germany.	tobias.pischon@mdc-berlin.de	Pischon, Tobias/HGE-8577-2022	Pischon, Tobias/0000-0003-1568-767X; Jaeschke, Lina/0000-0002-5661-228X	Helmholtz Association; Federal Ministry of Education and Research (BMBF); Institutes of the Leibniz Association	Helmholtz Association(Helmholtz Association); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Institutes of the Leibniz Association	This project was conducted in the context of the Pretest studies of the German National Cohort (www.nationale-kohorte.de). These were funded by the participating institutes of the Helmholtz Association and by grants by the Federal Ministry of Education and Research (BMBF) to the participating universities and Institutes of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Altman DG, 1990, PRACTICAL STATISTICS; [Anonymous], 2008, KONGRESS DER GESELLS; [Anonymous], ISO 20685 2005; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chiou WK, 2005, ENDOCR J, V52, P139, DOI 10.1507/endocrj.52.139; Choi S, 2011, TEXT RES J, V81, P81, DOI 10.1177/0040517510377822; Daniell N, 2008, KINANTHROPOMETRY, P39; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; FAIRCLOUGH JA, 1984, INJURY, V16, P85, DOI 10.1016/S0020-1383(84)80003-0; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Han H, 2010, INT J IND ERGONOM, V40, P530, DOI 10.1016/j.ergon.2010.06.002; Heuberger R, 2008, INT J CONSUM STUD, V32, P34, DOI 10.1111/j.1470-6431.2007.00626.x; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Janghorbani M, 2012, OBES REV, V13, P1172, DOI 10.1111/j.1467-789X.2012.01030.x; Lennie SC, 2013, J SPORT SCI, V31, P1353, DOI 10.1080/02640414.2013.781664; Lin JD, 2004, CLIN NUTR, V23, P1313, DOI 10.1016/j.clnu.2004.04.005; Lin JD, 2002, J CLIN EPIDEMIOL, V55, P757, DOI 10.1016/S0895-4356(02)00433-X; Lu JM, 2010, APPL ERGON, V41, P236, DOI 10.1016/j.apergo.2009.07.002; Maylia E, 1999, J SPORT REHABIL, V8, P43, DOI 10.1123/jsr.8.1.43; Mckinnon Lashawnda, 2002, J FASH MARK MANAG, V6, P103, DOI [DOI 10.1108/13612020210429458, 10.1108/13612020210429458]; Pepper MR, 2010, J AM COLL NUTR, V29, P179, DOI 10.1080/07315724.2010.10719832; Petrescu L, 2012, 3D BODY SCANNING TEC, V1, P3; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Schulze MB, 2000, EUR J EPIDEMIOL, V16, P891, DOI 10.1023/A:1011020823807; Sebo P, 2008, PREV MED, V47, P389, DOI 10.1016/j.ypmed.2008.06.012; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tomkinson GR, 2013, GAIT POSTURE, V37, P172, DOI 10.1016/j.gaitpost.2012.06.031; Verweij LM, 2013, PUBLIC HEALTH NUTR, V16, P281, DOI 10.1017/S1368980012002741; Wang J, 2006, AM J CLIN NUTR, V83, P809; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; World Health Organization, 2008, REPORT OF A WHO EXPE	36	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119430	10.1371/journal.pone.0119430	http://dx.doi.org/10.1371/journal.pone.0119430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749283	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000350689400073
J	Ling, AL; Robertson, CE; Harris, JK; Frank, DN; Kotter, CV; Stevens, MJ; Pace, NR; Hernandez, MT				Ling, Alison L.; Robertson, Charles E.; Harris, J. Kirk; Frank, Daniel N.; Kotter, Cassandra V.; Stevens, Mark J.; Pace, Norman R.; Hernandez, Mark T.			High-Resolution Microbial Community Succession of Microbially Induced Concrete Corrosion in Working Sanitary Manholes	PLOS ONE			English	Article							CORRODING CONCRETE; OXIDIZING BACTERIA; SEWER SYSTEMS; DIVERSITY; BIODETERIORATION; BIOFILMS; PIPE	Microbially-induced concrete corrosion in headspaces threatens wastewater infrastructure worldwide. Models for predicting corrosion rates in sewer pipe networks rely largely on information from culture-based investigations. In this study, the succession of microbes associated with corroding concrete was characterized over a one-year monitoring campaign using rRNA sequence-based phylogenetic methods. New concrete specimens were exposed in two highly corrosive manholes (high concentrations of hydrogen sulfide and carbon dioxide gas) on the Colorado Front Range for up to a year. Community succession on corroding surfaces was assessed using Illumina MiSeq sequencing of 16S bacterial rRNA amplicons and Sanger sequencing of 16S universal rRNA clones. Microbial communities associated with corrosion fronts presented distinct succession patterns which converged to markedly low a-diversity levels (< 10 taxa) in conjunction with decreasing pH. The microbial community succession pattern observed in this study agreed with culture-based models that implicate acidophilic sulfur-oxidizer Acidithiobacillus spp. in advanced communities, with two notable exceptions. Early communities exposed to alkaline surface pH presented relatively high a-diversity, including heterotrophic, nitrogen-fixing, and sulfur-oxidizing genera, and one community exposed to neutral surface pH presented a diverse transition community comprised of less than 20% sulfur-oxidizers.	[Ling, Alison L.; Hernandez, Mark T.] Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA; [Robertson, Charles E.; Pace, Norman R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Harris, J. Kirk; Stevens, Mark J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Frank, Daniel N.; Kotter, Cassandra V.] Univ Colorado, Sch Med, Dept Infect Dis, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hernandez, MT (corresponding author), Univ Colorado, Dept Civil Environm & Architectural Engn, Boulder, CO 80309 USA.	mark.hernandez@colorado.edu		Ling, Alison/0000-0002-5461-1945; ROBERTSON, CHARLES/0000-0002-4136-4121; Harris, Jonathan/0000-0002-2378-4202	Department of Energy Office of Science Graduate Research Fellowship; Alfred P. Sloan Foundation	Department of Energy Office of Science Graduate Research Fellowship; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Alison Ling was supported by the Department of Energy Office of Science Graduate Research Fellowship. Sequencing was further supported by an Alfred P. Sloan Foundation Grant to Norman Pace. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALNOR D, 1994, CLIN INFECT DIS, V18, P914, DOI 10.1093/clinids/18.6.914; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 2013, R LANG ENV STAT COMP; ASCE, 2013, 2013 REP CARD AM INF; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Cayford BI, 2012, APPL ENVIRON MICROB, V78, P7160, DOI 10.1128/AEM.01582-12; CHO KS, 1995, WATER SCI TECHNOL, V31, P263, DOI 10.1016/0273-1223(95)00343-L; Davis JL, 1998, INT BIODETER BIODEGR, V42, P75, DOI 10.1016/S0964-8305(98)00049-3; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; Domingo JWS, 2011, BIOFOULING, V27, P993, DOI 10.1080/08927014.2011.618637; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gomez-Alvarez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-122; Gu JD, 1998, INT BIODETER BIODEGR, V41, P101, DOI 10.1016/S0964-8305(98)00034-1; HARRISON AP, 1984, ANNU REV MICROBIOL, V38, P265, DOI 10.1146/annurev.mi.38.100184.001405; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; ISLANDER RL, 1991, J ENVIRON ENG-ASCE, V117, P751, DOI 10.1061/(ASCE)0733-9372(1991)117:6(751); Ismail N., 1993, DOBOKU GAKKAI RONBUN, V1993, P133, DOI DOI 10.2208/JSCEJ.1993.474_133; Jensen HS, 2008, WATER SCI TECHNOL, V57, P1721, DOI 10.2166/wst.2008.293; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Lemos LN, 2012, FOLIA MICROBIOL, V57, P409, DOI 10.1007/s12223-012-0155-0; Ling AL, 2014, ENVIRON SCI TECHNOL, V48, P7357, DOI 10.1021/es500763e; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Ngom A, 2004, J GEN APPL MICROBIOL, V50, P17, DOI 10.2323/jgam.50.17; Nica D, 2000, INT BIODETER BIODEGR, V46, P61, DOI 10.1016/S0964-8305(00)00064-0; Okabe S, 2005, APPL ENVIRON MICROB, V71, P2520, DOI 10.1128/AEM.71.5.2520-2529.2005; Okabe S, 2007, APPL ENVIRON MICROB, V73, P971, DOI 10.1128/AEM.02054-06; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCL ACIDS RES, V41; Roberts DJ, 2002, INT BIODETER BIODEGR, V49, P227, DOI 10.1016/S0964-8305(02)00049-5; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; SAND W, 1984, ENVIRON TECHNOL LETT, V5, P517, DOI 10.1080/09593338409384307; Sand W., 1988, Biodeterioration 7. Selected papers presented at the 7th International Biodeterioration Symposium, Cambridge, UK, September 1987., P113; Satoh H, 2009, WATER RES, V43, P4729, DOI 10.1016/j.watres.2009.07.035; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; USEPA, 2009, REHABILITATION OF WA; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296	45	26	29	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116400	10.1371/journal.pone.0116400	http://dx.doi.org/10.1371/journal.pone.0116400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748024	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400005
J	Gori, Y; Wehrens, R; La Porta, N; Camin, F				Gori, Yuri; Wehrens, Ron; La Porta, Nicola; Camin, Federica			Oxygen and Hydrogen Stable Isotope Ratios of Bulk Needles Reveal the Geographic Origin of Norway Spruce in the European Alps	PLOS ONE			English	Article							LIGNIN METHOXYL GROUPS; TREE-RINGS; WOOD; PRECIPITATION; CLIMATE; CELLULOSE; HOMOGENIZATION; CERTIFICATION; TEMPERATURES; AUTHENTICITY	Background Tracking timber is necessary in order to prevent illegal logging and protect local timber production, but there is as yet no suitable analytical traceability method. Stable isotope ratios in plants are known to reflect geographical variations. In this study we analysed four stable isotope ratios in order to develop a model able to identify the geographic origin of Norway spruce in the European Alps. Methodology and Principal Findings delta O-18, delta H-2, delta C-13 and delta N-15 were measured in bulk needles of Picea abies sampled in 20 sites in and around the European Alps. Environmental and spatial variables were found to be related to the measured isotope ratios. An ordinary least squares regression was used to identify the most important factor in stable isotope variability in bulk needles. Spatial autocorrelation was tested for all isotope ratios by means of Moran's I. delta O-18, delta H-2 and delta N-15 values differed significantly between sites. Distance from the coast had the greatest influence on delta H-2, while latitude and longitude were strongly related to delta O-18. delta C-13 values did not appear to have any relationship with geographical position, while delta N-15 values were influenced by distance from the motorway. The regression model improved the explanatory power of the spatial and environmental variables. Positive spatial autocorrelations were found for delta O-18 and delta H-2 values. Conclusions The delta O-18, delta H-2 and delta N-15 values in P. abies bulk needles are a suitable proxy to identify geographic origin as they vary according to geographical position. Although the regression model showed the explanatory variables to have significant power and stability, we conclude that our model might be improved by multivariate spatial interpolation of the delta O-18 and delta H-2 values.	[Gori, Yuri; Wehrens, Ron; La Porta, Nicola; Camin, Federica] Edmund Mach Fdn FEM, Res & Innovat Ctr, Via E Mach 1, I-38010 San Michele All Adige, Trento, Italy	Fondazione Edmund Mach	Gori, Y (corresponding author), Edmund Mach Fdn FEM, Res & Innovat Ctr, Via E Mach 1, I-38010 San Michele All Adige, Trento, Italy.	yuri.gori@gmail.com	La Porta, Nicola/G-8461-2011; Wehrens, Ron/P-4845-2019; Wehrens, Ron/M-8781-2015	La Porta, Nicola/0000-0002-7080-3349; Wehrens, Ron/0000-0002-8798-5599; Wehrens, Ron/0000-0002-8798-5599; Camin, Federica/0000-0003-0509-6745				Ammann M, 1999, OECOLOGIA, V118, P124, DOI 10.1007/s004420050710; Araguas-Araguas L, 2000, HYDROL PROCESS, V14, P1341, DOI 10.1002/1099-1085(20000615)14:8&lt;1341::AID-HYP983&gt;3.0.CO;2-Z; Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; Auld G, 2008, ANNU REV ENV RESOUR, V33, P187, DOI 10.1146/annurev.environ.33.013007.103754; Bank TW, 2006, GUIDELINES FORMULATI; Battipaglia G, 2010, SCI TOTAL ENVIRON, V408, P586, DOI 10.1016/j.scitotenv.2009.09.036; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Boner M, 2004, ANAL BIOANAL CHEM, V378, P301, DOI 10.1007/s00216-003-2347-6; Bontempo L, 2009, RAPID COMMUN MASS SP, V23, P1043, DOI 10.1002/rcm.3968; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Boyle EA, 1997, GEOPHYS RES LETT, V24, P273, DOI 10.1029/97GL00081; Brand WA, 2014, PURE APPL CHEM, V86, P425, DOI 10.1515/pac-2013-1023; Brendel O, 2003, ANN FOREST SCI, V60, P97, DOI 10.1051/forest:2003001; Camin F, 2007, ANAL BIOANAL CHEM, V389, P309, DOI 10.1007/s00216-007-1302-3; Cashore B, 2012, FOREST POLICY ECON, V18, P13, DOI [10.1016/j.forpol.2011.12.005, 10.1016/j.forpol.2012.03.001]; Cressie N., 2011, STAT SPATIO TEMPORAL; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson T.E, 2007, STABLE ISOTOPES INDI; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Degen B, 2007, P INT WORKSH FING ME; Deguilloux MF, 2004, ANN FOREST SCI, V61, P97, DOI 10.1051/forest:2003089; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Douglas J, 2010, WORLD FOR; Dudley N, 1995, BAD HARVEST TIMBER T; Eccel E, 2012, THEOR APPL CLIMATOL, V110, P345, DOI 10.1007/s00704-012-0624-z; Ehleringer JR, 2000, NATURE, V408, P311, DOI 10.1038/35042680; FRANCEY RJ, 1982, NATURE, V297, P28, DOI 10.1038/297028a0; FREYER HD, 1991, TELLUS B, V43, P30, DOI 10.1034/j.1600-0889.1991.00003.x; Gori Y, 2013, RAPID COMMUN MASS SP, V27, P265, DOI 10.1002/rcm.6446; Hawkins BA, 2007, ECOGRAPHY, V30, P375, DOI 10.1111/j.2007.0906-7590.05117.x; Hofstra N, 2010, CLIM DYNAM, V35, P841, DOI 10.1007/s00382-009-0698-1; HOLDSWORTH G, 1991, J GEOPHYS RES-ATMOS, V96, P7483, DOI 10.1029/91JD00048; Horacek M, 2009, RAPID COMMUN MASS SP, V23, P3688, DOI 10.1002/rcm.4309; Jaggi M, 2003, NEW PHYTOL, V158, P51, DOI 10.1046/j.1469-8137.2003.00711.x; Jaggi M, 2002, OECOLOGIA, V131, P325, DOI 10.1007/s00442-002-0881-0; Kagawa A, 2010, J WOOD SCI, V56, P175, DOI 10.1007/s10086-009-1085-6; Keppler F, 2007, NEW PHYTOL, V176, P600, DOI 10.1111/j.1469-8137.2007.02213.x; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Larcher W., 1995, PHYSL PLANT ECOLOGY; Laumer W, 2009, RAPID COMMUN MASS SP, V23, P1934, DOI 10.1002/rcm.4105; Manca G, 2001, J AGR FOOD CHEM, V49, P1404, DOI 10.1021/jf000706c; Mansfield TA, 1981, PHYSL BIOCH DROUGHT; Masson-Delmotte V., 2013, CLIM CHANG 2013 PHYS; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Neteler M, 2010, REMOTE SENS-BASEL, V2, P333, DOI 10.3390/rs1020333; Nielsen LR, 2008, TRACING TIMBER FORES; Pendall E, 2000, GLOB CHANGE BIOL, V6, P287, DOI 10.1046/j.1365-2486.2000.00304.x; Pierrehumbert RT, 1999, GEOPHYS RES LETT, V26, P1345, DOI 10.1029/1999GL900183; R Development Core Team, 2010, LANG ENV STAT COMP, V333, P852, DOI DOI 10.1038/333852A0; ROBARDS K, 1995, ANALYST, V120, P1, DOI 10.1039/an9952000001; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800; ROZANSKI K, 1982, TELLUS, V34, P142, DOI 10.1111/j.2153-3490.1982.tb01801.x; Saurer M, 2004, ATMOS ENVIRON, V38, P2779, DOI 10.1016/j.atmosenv.2004.02.037; Tacconi L., 2007, ILLEGAL LOGGING LAW; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Tjoelker M.G., 2007, BIOL ECOLOGY NORWAY; Vogel B, 2000, ATMOS ENVIRON, V34, P2437, DOI 10.1016/S1352-2310(99)00422-7; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Weber HE, 2000, J VEG SCI, V11, P739, DOI 10.2307/3236580; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	63	11	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118941	10.1371/journal.pone.0118941	http://dx.doi.org/10.1371/journal.pone.0118941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742601	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100064
J	Vijay, S; Rawal, R; Kadian, K; Raghavendra, K; Sharma, A				Vijay, Sonam; Rawal, Ritu; Kadian, Kavita; Raghavendra, Kamaraju; Sharma, Arun			Annotated Differentially Expressed Salivary Proteins of Susceptible and Insecticide-Resistant Mosquitoes of Anopheles stephensi	PLOS ONE			English	Article							GLAND TRANSCRIPTOME; MALARIA; VECTORS; BINDING; GENE	Vector control is one of the major global strategies for control of malaria. However, the major obstacle for vector control is the development of multiple resistances to organochlorine, organophosphorus insecticides and pyrethroids that are currently being used in public health for spraying and in bednets. Salivary glands of vectors are the first target organ for humanvector contact during biting and parasite-vector contact prior to parasite development in the mosquito midguts. The salivary glands secrete anti-haemostatic, anti-inflammatory biologically active molecules to facilitate blood feeding from the host and also inadvertently inject malaria parasites into the vertebrate host. The Anopheles stephensi mosquito, an urban vector of malaria to both human and rodent species has been identified as a reference laboratory model to study mosquito-parasite interactions. In this study, we adopted a conventional proteomic approach of 2D-electrophoresis coupled with MALDI-TOF mass spectrometry and bioinformatics to identify putative differentially expressed annotated functional salivary proteins between An. stephensi susceptible and multiresistant strains with same genetic background. Our results show 2D gel profile and MALDI-TOF comparisons that identified 31 differentially expressed putative modulated proteins in deltamethrin/DDT resistant strains of An. stephensi. Among these 15 proteins were found to be upregulated and 16 proteins were downregulated. Our studies interpret that An. stephensi (multiresistant) caused an upregulated expression of proteins and enzymes like cytochrome 450, short chain dehyrdogenase reductase, phosphodiesterase etc that may have an impact in insecticide resistance and xenobiotic detoxification. Our study elucidates a proteomic response of salivary glands differentially regulated proteins in response to insecticide resistance development which include structural, redox and regulatory enzymes of several pathways. These identified proteins may play a role in regulating mosquito biting behavior patterns and may have implications in the development of malaria parasites in resistant mosquitoes during parasite transmission.	[Vijay, Sonam; Rawal, Ritu; Kadian, Kavita; Sharma, Arun] Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol Lab, New Delhi, India; [Raghavendra, Kamaraju] Natl Inst Malaria Res ICMR, Insecticide Resistance Lab, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Sharma, A (corresponding author), Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol Lab, Sect 8, New Delhi, India.	arushar@gmail.com		Kamaraju, Raghavendra/0000-0002-4098-7095	National Institute of Malaria Research; Indian Council of Medical Research, New Delhi Government of India	National Institute of Malaria Research; Indian Council of Medical Research, New Delhi Government of India(Indian Council of Medical Research (ICMR))	This work has been financially supported by the National Institute of Malaria Research (Intramural) and Indian Council of Medical Research, New Delhi Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alout H, 2014, J INFECT DIS, V210, P1464, DOI 10.1093/infdis/jiu276; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Dash AP, 2007, CURR SCI INDIA, V92, P1571; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Dixit R, 2011, J INSECT PHYSIOL, V57, P1399, DOI 10.1016/j.jinsphys.2011.07.007; Dixit R, 2009, INT J INFECT DIS, V13, P636, DOI 10.1016/j.ijid.2008.07.027; Djegbe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017496; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Isawa H, 2002, J BIOL CHEM, V277, P27651, DOI 10.1074/jbc.M203505200; Jiang XF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0459-2; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Macias V, 2014, INSECT MOL BIOL, V23, P579, DOI 10.1111/imb.12106; Mayoral JG, 2013, ARCH INSECT BIOCHEM, V82, P96, DOI 10.1002/arch.21078; Monteiro RQ, 2005, AN ACAD BRAS CIENC, V77, P275, DOI 10.1590/S0001-37652005000200007; Perera MDB, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-168; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Roxstrom-Lindquist K, 2001, INSECT MOL BIOL, V10, P77, DOI 10.1046/j.1365-2583.2001.00239.x; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Vijay S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/686319; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2013, TEST PROC INS RES MO, DOI [10.1186/1756-3305-6-337, DOI 10.1186/1756-3305-6-337]; WHO-World Health Organization, 2013, WORLD MAL REP TECH R	34	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119666	10.1371/journal.pone.0119666	http://dx.doi.org/10.1371/journal.pone.0119666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742511	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100126
J	Yue, RQ; Tie, SG; Sun, T; Zhang, L; Yang, YJ; Qi, JS; Yan, SF; Han, XH; Wang, HZ; Shen, CJ				Yue, Runqing; Tie, Shuanggui; Sun, Tao; Zhang, Lei; Yang, Yanjun; Qi, Jianshuang; Yan, Shufeng; Han, Xiaohua; Wang, Huizhong; Shen, Chenjia			Genome-Wide Identification and Expression Profiling Analysis of ZmPIN, ZmPILS, ZmLAX and ZmABCB Auxin Transporter Gene Families in Maize (Zea mays L.) under Various Abiotic Stresses	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SALT STRESS; SIGNALING PATHWAYS; ROOT DEVELOPMENT; POLAR TRANSPORT; P-GLYCOPROTEIN; ARABIDOPSIS; PIN; PROTEINS; ABC	The auxin influx carriers auxin resistant 1/like aux 1 (AUX/LAX), efflux carriers pin-formed (PIN) (together with PIN-like proteins) and efflux/conditional P-glycoprotein (ABCB) are major protein families involved in auxin polar transport. However, how they function in responses to exogenous auxin and abiotic stresses in maize is largely unknown. In this work, the latest updated maize (Zea mays L.) reference genome sequence was used to characterize and analyze the ZmLAX, ZmPIN, ZmPILS and ZmABCB family genes from maize. The results showed that five ZmLAXs, fifteen ZmPINs, nine ZmPILSs and thirty-five ZmABCBs were mapped on all ten maize chromosomes. Highly diversified gene structures, nonconservative transmembrane helices and tissue-specific expression patterns suggested the possibility of function diversification for these genes. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to analyze the expression patterns of ZmLAX, ZmPIN, ZmPILS and ZmABCB genes under exogenous auxin and different environmental stresses. The expression levels of most ZmPIN, ZmPILS, ZmLAX and ZmABCB genes were induced in shoots and were reduced in roots by various abiotic stresses (drought, salt and cold stresses). The opposite expression response patterns indicated the dynamic auxin transport between shoots and roots under abiotic stresses. Analysis of the expression patterns of ZmPIN, ZmPILS, ZmLAX and ZmABCB genes under drought, salt and cold treatment may help us to understand the possible roles of maize auxin transporter genes in responses and tolerance to environmental stresses.	[Yue, Runqing; Tie, Shuanggui; Qi, Jianshuang; Yan, Shufeng; Han, Xiaohua] Henan Acad Agr Sci, Zhengzhou 450002, Peoples R China; [Sun, Tao; Yang, Yanjun; Wang, Huizhong; Shen, Chenjia] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Zhang, Lei] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Henan Academy of Agricultural Sciences; Hangzhou Normal University; Washington State University	Tie, SG (corresponding author), Henan Acad Agr Sci, Zhengzhou 450002, Peoples R China.	tieshuanggui308@126.com; whz62@163.com; shencj@hznu.edu.cn			National Natural Science Foundation of China [31401935, 31200913]; Zhejiang Provincial Natural Science Foundation of China [LQ14C060001, LQ13H28006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by the National Natural Science Foundation of China (31401935; 31200913) and Zhejiang Provincial Natural Science Foundation of China under Grant No. LQ14C060001 and LQ13H28006.	Bainbridge K, 2008, GENE DEV, V22, P810, DOI 10.1101/gad.462608; Balzan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00393; Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; Barbez E, 2012, NATURE, V485, P119, DOI 10.1038/nature11001; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Carraro N, 2006, PLANT PHYSIOL, V142, P254, DOI 10.1104/pp.106.080119; Carraro N, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00017; Cazzonelli CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070069; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen MK, 2013, PLANT PHYSIOL, V162, P1978, DOI 10.1104/pp.113.218198; Ha CV, 2013, DNA RES, V20, P511, DOI 10.1093/dnares/dst027; Forestan C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00016; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2010, EUR J CELL BIOL, V89, P231, DOI 10.1016/j.ejcb.2009.11.003; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fukaki H, 1996, PLANT PHYSIOL, V110, P933, DOI 10.1104/pp.110.3.933; Ganguly A, 2014, PLANT CELL, V26, P1570, DOI 10.1105/tpc.113.118422; Ganguly A, 2010, PLANT PHYSIOL, V153, P1046, DOI 10.1104/pp.110.156505; Garay-Arroyo A, 2013, EMBO J, V32, P2884, DOI 10.1038/emboj.2013.216; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Henrichs S, 2012, EMBO J, V31, P2965, DOI 10.1038/emboj.2012.120; Hochholdinger F, 2000, J PLANT PHYSIOL, V157, P315, DOI 10.1016/S0176-1617(00)80053-X; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hoyerova K, 2008, PLANT PHYSIOL, V146, P1128, DOI 10.1104/pp.107.109371; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Jansen L, 2012, PHILOS T R SOC B, V367, P1525, DOI 10.1098/rstb.2011.0239; Kamimoto Y, 2012, PLANT CELL PHYSIOL, V53, P2090, DOI 10.1093/pcp/pcs149; Knoller AS, 2010, J EXP BOT, V61, P3689, DOI 10.1093/jxb/erq180; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Krecek P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-249; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; LIU ZB, 1994, PLANT CELL, V6, P645, DOI 10.1105/tpc.6.5.645; Maruyama-Nakashita A, 2005, PLANT J, V42, P305, DOI 10.1111/j.1365-313X.2005.02363.x; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; Nakamura A, 2004, BIOSCI BIOTECH BIOCH, V68, P952, DOI 10.1271/bbb.68.952; Nisar N, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27898; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Osakabe Y, 2014, NEW PHYTOL, V202, P35, DOI 10.1111/nph.12613; Pang KY, 2013, GENE, V526, P411, DOI 10.1016/j.gene.2013.05.051; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Peret B, 2012, PLANT CELL, V24, P2874, DOI 10.1105/tpc.112.097766; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Rahman A, 2013, PHYSIOL PLANTARUM, V147, P28, DOI 10.1111/j.1399-3054.2012.01617.x; Rashotte AM, 2003, PLANT PHYSIOL, V133, P761, DOI 10.1104/pp.103.022582; Robert HS, 2013, CURR BIOL, V23, P2506, DOI 10.1016/j.cub.2013.09.039; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shen CJ, 2010, FEBS J, V277, P2954, DOI 10.1111/j.1742-4658.2010.07706.x; Shen J, 2015, PROTOPLASMA, V252, P173, DOI 10.1007/s00709-014-0669-1; Shibasaki K, 2009, PLANT CELL, V21, P3823, DOI 10.1105/tpc.109.069906; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Tanaka H, 2006, CELL MOL LIFE SCI, V63, P2738, DOI 10.1007/s00018-006-6116-5; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Titapiwatanakun B, 2009, J EXP BOT, V60, P1093, DOI 10.1093/jxb/ern240; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; WILLIAMS ME, 1992, PLANT CELL, V4, P485, DOI 10.1105/tpc.4.4.485; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Wyatt SE, 2002, PLANT PHYSIOL, V130, P1426, DOI 10.1104/pp.102.010579; Xia ZL, 2012, GENE, V495, P146, DOI 10.1016/j.gene.2011.12.028; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Xu WF, 2012, J EXP BOT, V63, P6105, DOI 10.1093/jxb/ers259; Xu YX, 2014, PLANT J, V79, P106, DOI 10.1111/tpj.12544; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Ye LF, 2013, BIOCHEM BIOPH RES CO, V441, P782, DOI 10.1016/j.bbrc.2013.10.136; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Zahir ZA, 2010, J MICROBIOL BIOTECHN, V20, P1288, DOI 10.4014/jmb.1002.02010; Zazimalova E, 2007, CELL MOL LIFE SCI, V64, P1621, DOI 10.1007/s00018-007-6566-4; Zhang YF, 2014, APPL THERM ENG, V65, P1, DOI 10.1016/j.applthermaleng.2013.12.069; Zhao JL, 2015, PHYSIOL PLANTARUM, V154, P381, DOI 10.1111/ppl.12291; Zhao Y, 2014, PLANT CELL PHYSIOL, V55, P1142, DOI 10.1093/pcp/pcu054; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x; Zorb C, 2013, J PLANT PHYSIOL, V170, P220, DOI 10.1016/j.jplph.2012.09.012; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290	88	52	57	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118751	10.1371/journal.pone.0118751	http://dx.doi.org/10.1371/journal.pone.0118751			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742625	gold, Green Submitted, Green Published			2022-12-27	WOS:000350688100043
J	Inoue, M; Akama, T; Jiang, YB; Chun, TH				Inoue, Mayumi; Akama, Takeshi; Jiang, Yibin; Chun, Tae-Hwa			The Exocyst Complex Regulates Free Fatty Acid Uptake by Adipocytes	PLOS ONE			English	Article							STIMULATED GLUT4 TRAFFICKING; DEPENDENT DIABETES-MELLITUS; INSULIN-RESISTANCE; PLASMA-MEMBRANE; LIPID DROPLETS; MICE LACKING; PROTEIN; PHOSPHORYLATION; TRANSPORT; OBESITY	The exocyst is an octameric molecular complex that drives vesicle trafficking in adipocytes, a rate-limiting step in insulin-dependent glucose uptake. This study assessed the role of the exocyst complex in regulating free fatty acid (FFA) uptake by adipocytes. Upon differentiating into adipocytes, 3T3-L1 cells acquire the ability to incorporate extracellular FFAs in an insulin-dependent manner. A kinetic assay using fluoresceinated FFA (C12 dodecanoic acid) uptake allows the real-time monitoring of FFA internalization by adipocytes. The insulin-dependent uptake of C12 dodecanoic acid by 3T3-L1 adipocytes is mediated by Akt and phosphatidylinositol 3 (PI3)-kinase. Gene silencing of the exocyst components Exo70 and Sec8 significantly reduced insulin-dependent FFA uptake by adipocytes. Consistent with the roles played by Exo70 and Sec8 in FFA uptake, mCherry-tagged Exo70 and HA-tagged Sec8 partially colocalize with lipid droplets within adipocytes, suggesting their active roles in the development of lipid droplets. Tubulin polymerization was also found to regulate FFA uptake in collaboration with the exocyst complex. This study demonstrates a novel role played by the exocyst complex in the regulation of FFA uptake by adipocytes.	[Inoue, Mayumi; Akama, Takeshi; Jiang, Yibin; Chun, Tae-Hwa] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet MEND, Ann Arbor, MI 48109 USA; [Akama, Takeshi; Jiang, Yibin; Chun, Tae-Hwa] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Inoue, M (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet MEND, Ann Arbor, MI 48109 USA.	mayu@umich.edu; taehwa@umich.edu	Chun, Tae-Hwa/H-5959-2019; Akama, Takeshi/C-9392-2011	Chun, Tae-Hwa/0000-0001-9333-2589; Akama, Takeshi/0000-0002-6470-7174	American Heart Association [0730028N]; National Institute of Health [R01DK095137]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK095137] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by the American Heart Association Scientist Development Grant 0730028N (MI) and the National Institute of Health R01DK095137 (THC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y, 2008, J BIOL CHEM, V283, P324, DOI 10.1074/jbc.M706873200; BARTER PJ, 1971, J CLIN INVEST, V50, P583, DOI 10.1172/JCI106528; Berk PD, 1999, MOL CELL BIOCHEM, V192, P17, DOI 10.1023/A:1006832001033; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; CHEN YDI, 1987, J CLIN ENDOCR METAB, V64, P17, DOI 10.1210/jcem-64-1-17; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chun TH, 2014, METHOD ENZYMOL, V538, P15, DOI 10.1016/B978-0-12-800280-3.00002-5; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Dubikovskaya E, 2014, METHOD ENZYMOL, V538, P107, DOI 10.1016/B978-0-12-800280-3.00007-4; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; GROOP LC, 1991, J CLIN ENDOCR METAB, V72, P96, DOI 10.1210/jcem-72-1-96; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kamp F, 2003, J BIOL CHEM, V278, P7988, DOI 10.1074/jbc.M206648200; Kampf JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1207, DOI 10.1152/ajpendo.00259.2007; Krahmer N, 2013, MOL CELL PROTEOMICS, V12, P1115, DOI 10.1074/mcp.M112.020230; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lyons PD, 2009, BIOSCIENCE REP, V29, P229, DOI 10.1042/BSR20080162; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Munoz MC, 2009, J ENDOCRINOL, V201, P185, DOI 10.1677/JOE-08-0276; Nakamura K, 2007, EUR J NEUROSCI, V26, P3054, DOI 10.1111/j.1460-9568.2007.05868.x; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Pohl R, 2004, P NUTR SOC, V63, P259, DOI 10.1079/PNS2004341; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Weisburger JH, 1997, J AM DIET ASSOC, V97, pS16, DOI 10.1016/S0002-8223(97)00725-6; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067561; Xu S, 2013, BIOCHEMISTRY-US, V52, P7254, DOI 10.1021/bi400914c	49	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120289	10.1371/journal.pone.0120289	http://dx.doi.org/10.1371/journal.pone.0120289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768116	gold, Green Submitted, Green Published			2022-12-27	WOS:000351277500118
J	Jones, AC; Antillon, KS; Jenkins, SM; Janos, SN; Overton, HN; Shoshan, DS; Fischer, EG; Trujillo, KA; Bisoffi, M				Jones, Anna C.; Antillon, Kresta S.; Jenkins, Shannon M.; Janos, Sara N.; Overton, Heidi N.; Shoshan, Dor S.; Fischer, Edgar G.; Trujillo, Kristina A.; Bisoffi, Marco			Prostate Field Cancerization: Deregulated Expression of Macrophage Inhibitory Cytokine 1 (MIC-1) and Platelet Derived Growth Factor A (PDGF-A) in Tumor Adjacent Tissue	PLOS ONE			English	Article							GENE-EXPRESSION; INTRAEPITHELIAL NEOPLASIA; CLINICAL-IMPLICATIONS; CANCER; CARCINOGENESIS; INFLAMMATION; RECEPTOR	Prostate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid synthase (FAS). Here we add the two secreted factors macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) to the growing list of protein markers of prostate field cancerization. Expression of MIC-1 and PDGF-A was measured quantitatively by immunofluorescence and comprehensively analyzed using two methods of signal capture and several groupings of data generated in human cancerous (n = 25), histologically normal adjacent (n = 22), and disease-free (n = 6) prostate tissues. A total of 208 digitized images were analyzed. MIC-1 and PDGF-A expression in tumor tissues were elevated 7.1x to 23.4x and 1.7x to 3.7x compared to disease-free tissues, respectively (p< 0.0001 to p = 0.08 and p< 0.01 to p = 0.23, respectively). In support of field cancerization, MIC-1 and PDGF-A expression in adjacent tissues were elevated 7.4x to 38.4x and 1.4x to 2.7x, respectively (p< 0.0001 to p< 0.05 and p< 0.05 to p = 0.51, respectively). Also, MIC-1 and PDGF-A expression were similar in tumor and adjacent tissues (0.3x to 1.0x; p< 0.001 to p = 0.98 for MIC-1; 0.9x to 2.6x; p< 0.01 to p = 1.00 for PDGF-A). All analyses indicated a high level of inter-and intra-tissue heterogeneity across all types of tissues (mean coefficient of variation of 86.0%). Our data shows that MIC-1 and PDGF-A expression is elevated in both prostate tumors and structurally intact adjacent tissues when compared to disease-free specimens, defining field cancerization. These secreted factors could promote tumorigenesis in histologically normal tissues and lead to tumor multifocality. Among several clinical applications, they could also be exploited as indicators of disease in false negative biopsies, identify areas of repeat biopsy, and add molecular information to surgical margins.	[Jones, Anna C.; Antillon, Kresta S.; Jenkins, Shannon M.; Janos, Sara N.; Overton, Heidi N.; Trujillo, Kristina A.; Bisoffi, Marco] Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Trujillo, Kristina A.; Bisoffi, Marco] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Fischer, Edgar G.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Shoshan, Dor S.; Bisoffi, Marco] Chapman Univ, Schmid Coll Sci & Technol, Biochem & Mol Biol, Biol Sci, Orange, CA USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico; University of New Mexico's Health Sciences Center; Chapman University System; Chapman University	Bisoffi, M (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	bisoffi@chapman.edu			National Institutes of Health (NIH) [RR0164880]; NATIONAL CANCER INSTITUTE [R03CA136030] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) Grant RR0164880 and NIH Grant R03CA136030-02 (to M. Bisoffi), the University of New Mexico Cancer Center Support Grant NIH/ NCI P30CA118110, and a Summer Undergraduate Research Fellowship (SURF; to D. S. Shoshan) from the Chapman University Office of Undergraduate Research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Braakhuis BJM, 2004, J PATHOL, V203, P620, DOI 10.1002/path.1549; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Dakubo GD, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-2; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; Epstein JI, 2010, INT J SURG PATHOL, V18, p142S, DOI 10.1177/1066896910370616; Haaland CM, 2009, INT J ONCOL, V35, P537, DOI 10.3892/ijo_00000365; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Heaphy CM, 2010, PROSTATE, V70, P1471, DOI 10.1002/pros.21182; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Heldin CH, 2012, UPSALA J MED SCI, V117, P83, DOI 10.3109/03009734.2012.658119; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Jones AC, 2012, PROSTATE, V72, P1159, DOI 10.1002/pros.22465; Karan D, 2009, CANCER RES, V69, P2, DOI 10.1158/0008-5472.CAN-08-1230; Khaled YS, 2012, CANCER BIOMARK, V11, P183, DOI 10.3233/CBM-2012-00287; Kosari F, 2012, AM J PATHOL, V181, P34, DOI 10.1016/j.ajpath.2012.03.043; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Montironi R, 2000, J CLIN PATHOL, V53, P655, DOI 10.1136/jcp.53.9.655; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Peyromaure M, 2002, J UROLOGY, V167, P218, DOI 10.1016/S0022-5347(05)65416-X; Rosenberg A, 2013, EXPERT OPIN INV DRUG, V22, P787, DOI 10.1517/13543784.2013.787409; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Squire JA, 2011, ADV CANCER RES, V112, P183, DOI 10.1016/B978-0-12-387688-1.00007-7; Svatek RS, 2008, CANCER-AM CANCER SOC, V112, P1058, DOI 10.1002/cncr.23276; Treat EG, 2010, UROLOGY, V75, P724, DOI 10.1016/j.urology.2009.04.032; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	35	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119314	10.1371/journal.pone.0119314	http://dx.doi.org/10.1371/journal.pone.0119314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767870	Green Submitted, gold, Green Published			2022-12-27	WOS:000351277500076
J	Klaassen, EMM; Penders, J; Jobsis, Q; van de Kant, KDG; Thijs, C; Mommers, M; van Schayck, CP; van Eys, G; Koppelman, GH; Dompeling, E				Klaassen, Ester M. M.; Penders, John; Jobsis, Quirijn; van de Kant, Kim D. G.; Thijs, Carel; Mommers, Monique; van Schayck, Constant P.; van Eys, Guillaume; Koppelman, Gerard H.; Dompeling, Edward			An ADAM33 Polymorphism Associates with Progression of Preschool Wheeze into Childhood Asthma: A Prospective Case-Control Study with Replication in a Birth Cohort Study	PLOS ONE			English	Article							GENE POLYMORPHISMS; ORMDL3 EXPRESSION; CANDIDATE GENE; VARIANTS; SUSCEPTIBILITY; DISINTEGRIN; CHILDREN; ATOPY; IGE; EXPOSURE	Background The influence of asthma candidate genes on the development from wheeze to asthma in young children still needs to be defined. Objective To link genetic variants in asthma candidate genes to progression of wheeze to persistent wheeze into childhood asthma. Materials and Methods In a prospective study, children with recurrent wheeze from the ADEM (Asthma DEtection and Monitoring) study were followed until the age of six. At that age a classification (transient wheeze or asthma) was based on symptoms, lung function and medication use. In 198 children the relationship between this classification and 30 polymorphisms in 16 asthma candidate genes was assessed by logistic regression. In case of an association based on a p<0.10, replication analysis was performed in an independent birth cohort study (KOALA study, n = 248 included for the present analysis). Results In the ADEM study, the minor alleles of ADAM33 rs511898 and rs528557 and the ORMDL3/GSDMB rs7216389 polymorphisms were negatively associated, whereas the minor alleles of IL4 rs2243250 and rs2070874 polymorphisms were positively associated with childhood asthma. When replicated in the KOALA study, ADAM33 rs528557 showed a negative association of the CG/GG-genotype with progression of recurrent wheeze into childhood asthma (0.50 (0.26-0.97) p = 0.04) and no association with preschool wheeze. Conclusion Polymorphisms in ADAM33, ORMDL3/GSDMB and IL4 were associated with childhood asthma in a group of children with recurrent wheeze. The replication of the negative association of the CG/GG-genotype of rs528557 ADAM33 with childhood asthma in an independent birth cohort study confirms that a compromised ADAM33 gene may be implicated in the progression of wheeze into childhood asthma.	[Klaassen, Ester M. M.; Jobsis, Quirijn; van de Kant, Kim D. G.; Dompeling, Edward] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Paediat Resp Med, Maastricht, Netherlands; [Penders, John; Thijs, Carel; Mommers, Monique] MUMC, CAPHRI, Dept Epidemiol, Maastricht, Netherlands; [van Schayck, Constant P.] MUMC, CAPHRI, Dept Gen Practice, Maastricht, Netherlands; [van Eys, Guillaume] MUMC, CARIM, Cardiovasc Res Inst, Dept Genet & Cell Biol, Maastricht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp,Groningen Res Inst Asthma &, Dept Paediat Pulmonol & Paediat Allergol, Groningen, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen	Klaassen, EMM (corresponding author), MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Paediat Resp Med, Maastricht, Netherlands.	ester.klaassen@mumc.nl	Koppelman, Gerard/AAG-9187-2020; Penders, John/A-1280-2011; Thijs, Carel/H-8340-2019	Penders, John/0000-0001-9146-5919; Thijs, Carel/0000-0001-6646-5458; Koppelman, Gerard/0000-0001-8567-3252	Dutch Asthma Foundation [NAF3.4.05.033]; Stichting Astma Bestrijding [SAB 2006/018]; Maastricht University Medical Centre [PF 294]; Netherlands Organisation for Health Research and Development (ZonMW) [912-03-031]	Dutch Asthma Foundation; Stichting Astma Bestrijding; Maastricht University Medical Centre; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The ADEM study is funded by unrestricted grants from the Dutch Asthma Foundation (NAF3.4.05.033), Stichting Astma Bestrijding (SAB 2006/018), and Maastricht University Medical Centre (PF 294). The DNA collection of the KOALA study was financially supported by The Netherlands Organisation for Health Research and Development (ZonMW: grant number 912-03-031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basehore MJ, 2004, J ALLERGY CLIN IMMUN, V114, P80, DOI 10.1016/j.jaci.2004.05.035; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Beghe B, 2003, CLIN EXP ALLERGY, V33, P1111, DOI 10.1046/j.1365-2222.2003.01731.x; Bindels P J E, 2008, Ned Tijdschr Geneeskd, V152, P550; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Blekic M, 2013, ANN ALLERG ASTHMA IM, V110, P347, DOI 10.1016/j.anai.2013.01.021; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Bottema RWB, 2010, J ALLERGY CLIN IMMUN, V126, P338, DOI 10.1016/j.jaci.2010.04.024; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Chang JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/270869; de Faria ICJ, 2008, J PEDIAT-BRAZIL, V84, P203, DOI [10.2223/JPED.1783, 10.1590/S0021-75572008000300004]; Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P863, DOI 10.1016/j.jaci.2006.12.665; FRANK EH, 2001, REGRESSION MODELING; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Haitchi HM, 2005, AM J RESP CRIT CARE, V171, P958, DOI 10.1164/rccm.200409-1251OC; Holloway John W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007963; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Howard TD, 2003, J ALLERGY CLIN IMMUN, V112, P717, DOI 10.1016/S0091-6749(03)01939-0; Ito I, 2007, J ALLERGY CLIN IMMUN, V119, P89, DOI 10.1016/j.jaci.2006.08.038; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Kavalar MS, 2012, INT J IMMUNOGENET, V39, P20, DOI 10.1111/j.1744-313X.2011.01051.x; Kedda MA, 2006, EUR J HUM GENET, V14, P1027, DOI 10.1038/sj.ejhg.5201662; Klaassen EMM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/162571; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Lee JH, 2004, CLIN EXP ALLERGY, V34, P860, DOI 10.1111/j.1365-2222.2004.01977.x; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Noguchi E, 2006, CLIN EXP ALLERGY, V36, P602, DOI 10.1111/j.1365-2222.2006.02471.x; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Pinto LA, 2008, J PEDIAT, V84, pS68, DOI [10.1590/S0021-75572008000500010, 10.2223/JPED.1781]; Postma DS, 2004, CLIN EXP ALLERGY, V34, P1, DOI 10.1111/j.1365-2222.2004.01845.x; Raby BA, 2004, J ALLERGY CLIN IMMUN, V113, P1071, DOI 10.1016/j.jaci.2004.03.035; Reijmerink NE, 2009, ALLERGY, V64, P898, DOI 10.1111/j.1398-9995.2009.01939.x; Rigoli L, 2011, INT J IMMUNOPATH PH, V24, P41, DOI 10.1177/03946320110240S409; Sambrook J., 2001, MOL CLONING LAB MANU; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Schubert K, 2006, DIS MARKERS, V22, P127, DOI 10.1155/2006/373620; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; Steyerberg E., 2009, CLIN PREDICTION MODE; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Thomsen SF, 2011, RESP MED, V105, P1147, DOI 10.1016/j.rmed.2011.03.007; van de Kant KDG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-210; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wu H, 2009, ALLERGY, V64, P629, DOI 10.1111/j.1398-9995.2008.01912.x	48	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119349	10.1371/journal.pone.0119349	http://dx.doi.org/10.1371/journal.pone.0119349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768087	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500078
J	Laura, M; Borghi, C; Bobbio, V; Allavena, A				Laura, Marina; Borghi, Cristina; Bobbio, Valentina; Allavena, Andrea			The Effect on the Transcriptome of Anemone coronaria following Infection with Rust (Tranzschelia discolor)	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; DISEASE-RESISTANCE; RNA-SEQ; DIFFERENTIAL EXPRESSION; SEQUENCING TECHNOLOGIES; HYPERSENSITIVE RESPONSE; PATHOGEN INTERACTIONS; FLAVONOL SYNTHASE	In order to understand plant/pathogen interaction, the transcriptome of uninfected (1S) and infected (2I) plant was sequenced at 3'end by the GS FLX 454 platform. De novo assembly of high-quality reads generated 27,231 contigs leaving 37,191 singletons in the 1S and 38,393 in the 2I libraries. ESTcalc tool suggested that 71% of the transcriptome had been captured, with 99% of the genes present being represented by at least one read. Unigene annotation showed that 50.5% of the predicted translation products shared significant homology with protein sequences in GenBank. In all 253 differential transcript abundance (DTAs) were in higher abundance and 52 in lower abundance in the 2I library. 128 higher abundance DTA genes were of fungal origin and 49 were clearly plant sequences. A tBLASTn-based search of the sequences using as query the full length predicted polypeptide product of 50 R genes identified 16 R gene products. Only one R gene (PGIP) was upregulated. The response of the plant to fungal invasion included the up-regulation of several pathogenesis related protein (PR) genes involved in JA signaling and other genes associated with defense response and down regulation of cell wall associated genes, non-race-specific disease resistance1 (NDR1) and other genes like myb, presqualene diphosphate phosphatase (PSDPase), a UDP-glycosyltransferase 74E2-like (UGT). The DTA genes identified here should provide a basis for understanding the A. coronaria/T. discolor interaction and leads for biotechnology-based disease resistance breeding.	[Laura, Marina; Borghi, Cristina; Bobbio, Valentina; Allavena, Andrea] CRA Unita Ric Floricoltura & Specie Ornamentali, I-18038 San Remo, IM, Italy		Laura, M (corresponding author), CRA Unita Ric Floricoltura & Specie Ornamentali, Corso Inglesi 508, I-18038 San Remo, IM, Italy.	marina.laura@entecra.it			Italian Ministry of Agriculture and Forestry [DM 11960/7742010, DM 186/07]	Italian Ministry of Agriculture and Forestry	This work was funded by the Italian Ministry of Agriculture and Forestry (www.politicheagricole.it/) in the framework of the project "RESPAT" (grant number: DM 11960/7742010) and "ANEMOS" (grant number: DM 186/07). AA received the funding.	Ajeet S., 2009, INT J INTEGR BIOL, V7, P117; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreeva L, 1999, INT J EXP PATHOL, V80, P305, DOI 10.1046/j.1365-2613.1999.00128.x; Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Barakat A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-38; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Bluthgen N, 2004, QBIO0407034 ARXIV; Bravo JM, 2003, PLANT MOL BIOL, V52, P745, DOI 10.1023/A:1025016416951; Cacas JL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-144; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Coram TE, 2008, MOL PLANT PATHOL, V9, P157, DOI 10.1111/J.1364-3703.2007.00453.X; De Lorenzo G, 2001, ANNU REV PHYTOPATHOL, V39, P313, DOI 10.1146/annurev.phyto.39.1.313; de Wit P J G M, 2007, Cell Mol Life Sci, V64, P2726; Dean JV, 2005, PLANTA, V221, P287, DOI 10.1007/s00425-004-1430-3; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Duplessis S, 2009, CRIT REV PLANT SCI, V28, P309, DOI 10.1080/07352680903241063; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; El-kereamy A, 2013, CAN J PLANT SCI, V93, P599, DOI [10.4141/CJPS2013-009, 10.4141/cjps2013-009]; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Farnham G, 2006, P NATL ACAD SCI USA, V103, P18828, DOI 10.1073/pnas.0605777103; Fritig B, 1998, CURR OPIN IMMUNOL, V10, P16, DOI 10.1016/S0952-7915(98)80025-3; Fukunaga K, 2006, J BIOL CHEM, V281, P9490, DOI 10.1074/jbc.M512970200; Galgoczy L, 2010, CURRENT RES TECHNOLO, P550; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gao XF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00137; Ghosh M, 2006, ANN BOT-LONDON, V98, P1145, DOI 10.1093/aob/mcl205; Glazebrook J, 1999, CURR OPIN PLANT BIOL, V2, P280, DOI 10.1016/S1369-5266(99)80050-8; Goritschnig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002502; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Grennan AK, 2011, PLANT PHYSIOL, V155, P1750, DOI 10.1104/pp.111.900407; Gruner K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00252; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P61, DOI 10.1016/0048-4059(82)90024-8; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; HERRERAESTRELLA L, 1983, NATURE, V303, P209, DOI 10.1038/303209a0; Hok S, 2010, MOL PLANT MICROBE IN, V23, P1253, DOI 10.1094/MPMI-04-10-0103; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; JOHNSTON DJ, 1993, J EXP BOT, V44, P971, DOI 10.1093/jxb/44.5.971; Joly DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-422; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Karim S, 2007, PLANTA, V225, P1431, DOI 10.1007/s00425-006-0451-5; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Kimbrel JA, 2011, GENES-BASEL, V2, P689, DOI 10.3390/genes2040689; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Laura M, 2013, TRANSGENIC RES, V22, P59, DOI 10.1007/s11248-012-9628-9; Lee EJ, 2010, PLANT CELL, V22, P3489, DOI 10.1105/tpc.110.077958; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Liu ZJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-42; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; LOPEZFRANCO RM, 1990, SYST BOT, V15, P560, DOI 10.2307/2419155; Lukacin R, 2003, PHYTOCHEMISTRY, V62, P287, DOI 10.1016/S0031-9422(02)00567-8; Luo B, 2007, PLANT CELL PHYSIOL, V48, P1790, DOI 10.1093/pcp/pcm152; Mahomed W, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-167; Maimbo M, 2007, PLANT PHYSIOL, V145, P1588, DOI 10.1104/pp.107.105353; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marroni F, 2011, PLANT J, V67, P736, DOI 10.1111/j.1365-313X.2011.04627.x; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Moreno JE, 2013, PLANT PHYSIOL, V162, P1006, DOI 10.1104/pp.113.218164; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nezhad AS, 2013, J EXP BOT, V64, P4709, DOI 10.1093/jxb/ert254; Nishimura S, 2013, PLANT MOL BIOL, V81, P1, DOI 10.1007/s11103-012-9976-0; Nissim Y, 2004, EUPHYTICA, V136, P51, DOI 10.1023/B:EUPH.0000019520.19707.59; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park HJ, 2011, PLANT PATHOLOGY J, V27, P170, DOI 10.5423/PPJ.2011.27.2.170; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; PENG M, 1992, PHYTOPATHOLOGY, V82, P696, DOI 10.1094/Phyto-82-696; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Petriccione M, 2013, J PROTEOMICS, V78, P461, DOI 10.1016/j.jprot.2012.10.014; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Powell ALT, 2000, MOL PLANT MICROBE IN, V13, P942, DOI 10.1094/MPMI.2000.13.9.942; Prescott AG, 2002, PHYTOCHEMISTRY, V60, P589, DOI 10.1016/S0031-9422(02)00155-3; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Rayapuram C, 2008, MOL PLANT MICROBE IN, V21, P988, DOI 10.1094/MPMI-21-7-0988; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SALVI G, 1990, J PLANT PHYSIOL, V136, P513, DOI 10.1016/S0176-1617(11)80206-3; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Schneider DJ, 2010, ANNU REV PHYTOPATHOL, V48, P457, DOI 10.1146/annurev-phyto-073009-114411; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Sohani MM, 2009, PLANT BIOLOGY, V11, P105, DOI 10.1111/j.1438-8677.2008.00139.x; Sohn J, 2000, MOL PLANT MICROBE IN, V13, P629, DOI 10.1094/MPMI.2000.13.6.629; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Szabo LJ, 2001, P NATL ACAD SCI USA, V98, P7654, DOI 10.1073/pnas.151262398; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thara VK, 2003, MOL PLANT PATHOL, V4, P51, DOI 10.1046/j.1364-3703.2003.00142.x; Tremblay A, 2011, SEQUENCING, V2011, P1, DOI DOI 10.1155/2011/827250; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vivier E, 2005, NAT IMMUNOL, V6, P17, DOI 10.1038/ni1153; Wald FA, 2003, PLANT MOL BIOL, V52, P705, DOI 10.1023/A:1025061324856; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XQ, 1996, P NATL ACAD SCI USA, V93, P2598, DOI 10.1073/pnas.93.6.2598; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Way HM, 2000, MOL PLANT PATHOL, V1, P223, DOI 10.1046/j.1364-3703.2000.00027.x; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Worberg A, 2007, ORG DIVERS EVOL, V7, P55, DOI 10.1016/j.ode.2006.08.001; Wulff BBH, 2011, CURR OPIN PLANT BIOL, V14, P468, DOI 10.1016/j.pbi.2011.04.002; Yamamoto H, 2000, PHYTOCHEMISTRY, V53, P7, DOI 10.1016/S0031-9422(99)00471-9; Yu XM, 2010, FUNCT INTEGR GENOMIC, V10, P227, DOI 10.1007/s10142-010-0161-8; Zheng MS, 2004, PLANTA, V218, P740, DOI 10.1007/s00425-003-1169-2	137	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118565	10.1371/journal.pone.0118565	http://dx.doi.org/10.1371/journal.pone.0118565			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768012	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500029
J	Lim, HC; Chu, CC; Seufferheld, MJ; Cameron, SA				Lim, Haw Chuan; Chu, Chia-Ching; Seufferheld, Manfredo J.; Cameron, Sydney A.			Deep Sequencing and Ecological Characterization of Gut Microbial Communities of Diverse Bumble Bee Species	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; WESTERN HONEY-BEE; GEN. NOV.; BACTERIA; HYMENOPTERA; SYMBIONTS; PATTERNS; DECLINE; UNIFRAC; HINDGUT	Gut bacterial communities of bumble bees are correlated with defense against pathogens. Further understanding this host-microbe association is vitally important as bumble bees are currently experiencing global population declines, potentially due in part to emergent diseases. In this study, we used pyrosequencing and community fingerprinting (ARISA) to characterize the gut microbial communities of nine bumble species from across the Bombus phylogeny. Overall, we delimited 74 bacterial taxa (operational taxonomic units or OTUs) belonging to Betaproteobacteria, Gammaproteobacteria, Bacilli, Actinobacteria, Flavobacteria and Alphaproteobacteria. Each bacterial community was taxonomically simple, containing an average of 1.9 common (relative abundance per sample > 5%) bacterial OTUs. The most abundant and prevalent (occurring in 92% of the samples) bacterial OTU, based on 16S rRNA sequences, closely matched that of the previously described Betaproteobacteria species Snodgrassella alvi. Bacteria that were first described in bee-related external environments dominated a number of gut bacterial communities, suggesting that they are not strictly dependent on the internal gut environment. The ARISA data showed a correlation between bacterial community structures and the geographic locations where the bees were sampled, suggesting that at least a subset of the bacterial species may be transmitted environmentally. Using light and fluorescent microscopy, we demonstrated that the gut bacteria form a biofilm on the internal epithelial surface of the ileum, corroborating results obtained from Apis mellifera.	[Lim, Haw Chuan; Seufferheld, Manfredo J.; Cameron, Sydney A.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Chu, Chia-Ching] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lim, HC (corresponding author), Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA.	limhc@si.edu; mseufferheld@gmail.com; scameron@life.illinois.edu	Lim, Haw Chuan/HGB-5079-2022	Chu, Chia-Ching/0000-0002-5032-0163	U.S. Department of Agriculture, National Institute of Food and Agriculture grant [2010-65104-05992]; U.S. Department of Agriculture, National Institute of Food and Agriculture grant grant [2009-35505-06012]	U.S. Department of Agriculture, National Institute of Food and Agriculture grant; U.S. Department of Agriculture, National Institute of Food and Agriculture grant grant	The work was supported by a U.S. Department of Agriculture, National Institute of Food and Agriculture grant (#2010-65104-05992) to SAC and by a U.S. Department of Agriculture, National Institute of Food and Agriculture grant grant (#2009-35505-06012) to MJS. Both grants supported the expenses for pyrosequencing, DNA fingerprinting, and materials/reagents used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg-Gershtein Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067556; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arbetman MP, 2013, BIOL INVASIONS, V15, P489, DOI 10.1007/s10530-012-0311-0; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; DILLON RJ, 1986, J INVERTEBR PATHOL, V47, P350, DOI 10.1016/0022-2011(86)90106-0; Edwards CG, 1998, J APPL MICROBIOL, V84, P698, DOI 10.1046/j.1365-2672.1998.00399.x; Endo A, 2011, INT J SYST EVOL MICR, V61, P898, DOI 10.1099/ijs.0.023838-0; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; GREENBERG B, 1970, Infection and Immunity, V2, P800; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; JAROSZ J, 1979, J INVERTEBR PATHOL, V34, P192, DOI 10.1016/0022-2011(79)90101-0; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jojima Y, 2004, INT J SYST EVOL MICR, V54, P2263, DOI 10.1099/ijs.0.02911-0; King JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003058; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2012, J ANIM ECOL, V81, P1202, DOI 10.1111/j.1365-2656.2012.02004.x; Koch H, 2012, ECOL LETT, V15, P1095, DOI 10.1111/j.1461-0248.2012.01831.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Maharramov J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081475; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; MICHENER C D, 1978, University of Kansas Science Bulletin, V51, P575; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Ozer S, 2012, P 2012 IEEE INT C BI; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Rolfe R., 1997, GASTROINTESTINAL MIC, P501; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2013, MBIO, V4, DOI 10.1128/mBio.00602-12; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Torretta JP, 2006, T AM ENTOMOL SOC, V132, P285; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; VEIVERS PC, 1982, J INSECT PHYSIOL, V28, P947, DOI 10.1016/0022-1910(82)90111-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	76	15	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118566	10.1371/journal.pone.0118566	http://dx.doi.org/10.1371/journal.pone.0118566			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768110	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500030
J	Patil, VP; Karels, TJ; Hik, DS				Patil, Vijay P.; Karels, Timothy J.; Hik, David S.			Ecological, Evolutionary and Social Constraints on Reproductive Effort: Are Hoary Marmots Really Biennial Breeders?	PLOS ONE			English	Article							BODY CONDITION; CLIMATE-CHANGE; SURVIVAL; PATTERNS; COSTS; MASS; SUPPRESSION; POPULATION; HYPOTHESES; BEHAVIOR	Biennial breeding is a rare life-history trait observed in animal species living in harsh, unproductive environments. This reproductive pattern is thought to occur in 10 of 14 species in the genus Marmota, making marmots useful model organisms for studying its ecological and evolutionary implications. Biennial breeding in marmots has been described as an obligate pattern which evolved as a mechanism to mitigate the energetic costs of reproduction (Evolved Constraint hypothesis). However, recent anecdotal evidence suggests that it is a facultative pattern controlled by annual variation in climate and food availability (Environmental Constraint hypothesis). Finally, in social animals like marmots, biennial breeding could result from reproductive competition between females within social groups (Social Constraint hypothesis). We evaluated these three hypotheses using mark-recapture data from an 8-year study of hoary marmot (Marmota caligata) population dynamics in the Yukon. Annual variation in breeding probability was modeled using multi-state markrecapture models, while other reproductive life-history traits were modeled with generalized linear mixed models. Hoary marmots were neither obligate nor facultative biennial breeders, and breeding probability was insensitive to evolved, environmental, or social factors. However, newly mature females were significantly less likely to breed than older individuals. Annual breeding did not result in increased mortality. Female survival and, to a lesser extent, average fecundity were correlated with winter climate, as indexed by the Pacific Decadal Oscillation. Hoary marmots are less conservative breeders than previously believed, and the evidence for biennial breeding throughout Marmota, and in other arctic/alpine/antarctic animals, should be re-examined. Prediction of future population dynamics requires an accurate understanding of life history strategies, and of how life history traits allow animals to cope with changes in weather and other demographic influences.	[Patil, Vijay P.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Patil, Vijay P.; Karels, Timothy J.; Hik, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alaska System; University of Alaska Fairbanks; University of Alberta	Patil, VP (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA.	vppatil@alaska.edu	Hik, David S/B-3462-2009	Hik, David S/0000-0002-8994-9305	Environment Canada; Natural Science and Engineering Research Council of Canada; Yellowstone to Yukon (Y2Y) Science Grants program; Canada Foundation for Innovation; Canada Research Chairs Program; Canadian Circumpolar Institute, University of Alberta	Environment Canada(CGIAR); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Yellowstone to Yukon (Y2Y) Science Grants program; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); Canadian Circumpolar Institute, University of Alberta(University of Alberta)	Funding was provided by Environment Canada, the Natural Science and Engineering Research Council of Canada, the Yellowstone to Yukon (Y2Y) Science Grants program, the Canada Foundation for Innovation, the Canada Research Chairs Program, and the Canadian Circumpolar Institute, University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Allaine D, 2000, BEHAV PROCESS, V51, P21, DOI 10.1016/S0376-6357(00)00116-9; Anderson D. R., 2008, MODEL BASED INFERENC; Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; ARNOLD W, 1990, BEHAV ECOL SOCIOBIOL, V27, P239; Barash D.P., 1973, Animal Behav Monogr, V6, P171, DOI 10.1016/0003-3472(73)90002-X; BARASH DP, 1975, J MAMMAL, V56, P613, DOI 10.2307/1379473; BARASH DP, 1980, BEHAV ECOL SOCIOBIOL, V7, P201, DOI 10.1007/BF00299365; BARASH DP, 1974, ANIM BEHAV, V22, P256, DOI 10.1016/S0003-3472(74)80077-1; Bates D. M., 2010, LME4 MIXED EFFECTS M; BENTON TG, 1995, EVOL ECOL, V9, P559, DOI 10.1007/BF01237655; Blumstein DT, 1998, BEHAV ECOL, V9, P8; Blumstein DT, 1999, OIKOS, V84, P369, DOI 10.2307/3546418; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyd IL, 1999, MARINE MAMMALS, V1, P218; Bryant AA, 2005, CAN J ZOOL, V83, P664, DOI 10.1139/Z05-056; Bryant AA, 1996, CAN J ZOOL, V74, P678, DOI 10.1139/z96-076; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHASTEL O, 1995, IBIS, V137, P360, DOI 10.1111/j.1474-919X.1995.tb08033.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Dane B, 2002, BEHAVIOUR, V139, P1, DOI 10.1163/15685390252902247; DOBSON FS, 1992, AM NAT, V140, P109, DOI 10.1086/285405; Griffin SC, 2008, THESIS U MONTANA; Griffin SC, 2007, AM MIDL NAT, V158, P221, DOI 10.1674/0003-0031(2007)158[221:FOMMOR]2.0.CO;2; Hacklander K, 2003, ANIM BEHAV, V65, P1133, DOI 10.1006/anbe.2003.2159; HANSEN RM, 1975, AM MIDL NAT, V94, P348, DOI 10.2307/2424430; HARVEY PH, 1985, NATURE, V315, P319, DOI 10.1038/315319a0; HECTOR JAL, 1986, IBIS, V128, P9, DOI 10.1111/j.1474-919X.1986.tb02088.x; Holmes W.G., 1984, P250; HOLMES WG, 1979, THESIS U WASHINGTON; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Jouventin P, 2002, P ROY SOC B-BIOL SCI, V269, P1955, DOI 10.1098/rspb.2002.2080; Karels TJ, 2004, OIKOS, V105, P575, DOI 10.1111/j.0030-1299.2004.12732.x; Kenward R., 1996, RANGES 5 ANAL SYSTEM; Kyle CJ, 2007, MOL ECOL, V16, P1245, DOI 10.1111/j.1365-294X.2006.03211.x; Laake J, 2005, PROGRAM MARK GENTLE; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Moore GWK, 2002, NATURE, V420, P401, DOI 10.1038/nature01229; Morrison SF, 2007, J ANIM ECOL, V76, P899, DOI 10.1111/j.1365-2656.2007.01276.x; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; Ozgul A, 2007, OECOLOGIA, V154, P95, DOI 10.1007/s00442-007-0817-9; Patil VP, 2013, OECOLOGIA, V173, P139, DOI 10.1007/s00442-013-2612-0; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Pilastro A, 2003, ECOLOGY, V84, P1784, DOI 10.1890/0012-9658(2003)084[1784:LLARSI]2.0.CO;2; R Developement Team RDC, 2009, R LANG ENV STAT COMP; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schwartz OA, 2005, J ZOOL, V265, P73, DOI 10.1017/S0952836904006089; Scrucca L., 2004, R NEWS, V4, P11; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Stonehouse B., 1960, Q REV BIOL, V35, P17; Taulman JF, 1998, NW NAT, V70, P36; VANHEEZIK YM, 1994, IBIS, V136, P279; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; WEIMERSKIRCH H, 1987, J ANIM ECOL, V56, P1043, DOI 10.2307/4965; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	61	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119081	10.1371/journal.pone.0119081	http://dx.doi.org/10.1371/journal.pone.0119081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768300	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500063
J	Singh, PK; Kumar, A				Singh, Pawan Kumar; Kumar, Ashok			Retinal Photoreceptor Expresses Toll-Like Receptors (TLRs) and Elicits Innate Responses Following TLR Ligand and Bacterial Challenge	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; STAPHYLOCOCCUS-AUREUS; MULLER GLIA; TRANSGENIC MICE; INFLAMMATION; IMMUNITY; ENDOPHTHALMITIS; DANGER; INJURY; TUMORS	Toll-like receptors (TLRs) play an important role in host defense against microbial pathogens. Our previous studies have shown that TLRs are expressed on various retinal cells (Microglia and Muller glia) and orchestrate retinal innate responses in bacterial endophthalmitis. In this study, we used a well-characterized mouse cone photoreceptor cell line (661W); and demonstrated that these cells express all known TLRs. Although the stimulation of 661W cells with TLR ligands (Pam3Cys, Polyl:C, LPS, Flagellin, Poly DT, and ODN) did not alter TLR expression, downstream TLR-signaling pathways (NF-kappa B, p38, and ERK) are activated. Moreover, TLR-activated 661W cells secreted significant amounts of inflammatory mediators (IL-6, IL-1 beta, MIP-2, and KC) in their culture supernatant, as assessed by ELISA. A similar trend was observed in 661W cells challenged with live bacteria (Staphylococcus aureus). Interestingly, the neutralization of TLR2, a major receptor for S. aureus recognition, did not significantly attenuate bacterial-induced inflammatory mediators, suggesting the existence of TLR2-independent mechanisms in photoreceptor cells. Together, these results indicate that photoreceptors constitutively express functional TLRs and possess the ability to initiate innate responses following pathogen challenge, implicating their role in retinal innate immunity.	[Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA; [Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Kumar, A (corresponding author), Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA.	akuma@med.wayne.edu		Singh, Pawan Kumar/0000-0001-5517-1120	NIH/NEI, Research to Prevent Blindness [R01-EY-19888]; NATIONAL EYE INSTITUTE [R01EY019888] Funding Source: NIH RePORTER	NIH/NEI, Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by NIH/NEI R01-EY-19888, Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kochan T, 2012, INFECT IMMUN, V80, P2076, DOI 10.1128/IAI.00149-12; Kumar A, 2006, CURR MOL MED, V6, P327, DOI 10.2174/156652406776894572; Kumar A, 2013, CRIT REV IMMUNOL, V33, P119, DOI 10.1615/CritRevImmunol.2013006618; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029830; Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589; Lin Q, 2011, INT IMMUNOPHARMACOL; McClure R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00386; Pandey RK, 2013, INDIAN J MED RES, V138, P609; Pearlman E, 2013, INT REV IMMUNOL, V32, P4, DOI 10.3109/08830185.2012.749400; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391; Shamsuddin N, 2011, J IMMUNOL, V186, P7089, DOI 10.4049/jimmunol.1100565; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Singh PK, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-33; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Suzuki T, 2011, INVEST OPHTH VIS SCI, V52, P3187, DOI 10.1167/iovs.10-6558; Talreja D, 2014, INVEST OPHTH VIS SCI, V55, P2392, DOI 10.1167/iovs.13-13401; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tu ZD, 2011, J NEUROIMMUNOL, V230, P183, DOI 10.1016/j.jneuroim.2010.07.022; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036560	30	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119541	10.1371/journal.pone.0119541	http://dx.doi.org/10.1371/journal.pone.0119541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767877	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500084
J	Su, LT; Liu, GX; Wang, H; Tian, Y; Zhou, ZH; Han, L; Yan, L				Su, Lingtao; Liu, Guixia; Wang, Han; Tian, Yuan; Zhou, Zhihui; Han, Liang; Yan, Lun			Research on Single Nucleotide Polymorphisms Interaction Detection from Network Perspective	PLOS ONE			English	Article							GENE-GENE; SNPS; ASSOCIATION; TOOL	Single Nucleotide Polymorphisms (SNPs) found in Genome-Wide Association Study (GWAS) mainly influence the susceptibility of complex diseases, but they still could not comprehensively explain the relationships between mutations and diseases. Interactions between SNPs are considered so important for deeply understanding of those relationships that several strategies have been proposed to explore such interactions. However, part of those methods perform poorly when marginal effects of disease loci are weak or absent, others may lack of considering high-order SNPs interactions, few methods have achieved the requirements in both performance and accuracy. Considering the above reasons, not only low-order, but also high-order SNP interactions as well as main-effect SNPs, should be taken into account in detection methods under an acceptable computational complexity. In this paper, a new pairwise (or low-order) interaction detection method IG (Interaction Gain) is introduced, in which disease models are not required and parallel computing is utilized. Furthermore, high-order SNP interactions were proposed to be detected by finding closely connected function modules of the network constructed from IG detection results. Tested by a wide range of simulated datasets and four WTCCC real datasets, the proposed methods accurately detected both low-order and high-order SNP interactions as well as disease-associated main-effect SNPS and it surpasses all competitors in performances. The research will advance complex diseases research by providing more reliable SNP interactions.	[Su, Lingtao; Liu, Guixia; Tian, Yuan; Zhou, Zhihui; Han, Liang; Yan, Lun] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Su, Lingtao; Liu, Guixia; Tian, Yuan; Zhou, Zhihui; Han, Liang; Yan, Lun] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Peoples R China; [Wang, Han] NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China	Jilin University; Jilin University; Northeast Normal University - China	Liu, GX (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	liugx@jlu.edu.cn	tian, yuan/V-2195-2018; siwei, benyi/AAA-5645-2021		National Natural Science Foundation of China [61373051, 61175023]; Science and Technology Development Program of Jilin Province [20140204004GX, 20140520072JH]; Project of Science and Technology Innovation Platform of Computing and Software Science (985 Engineering); Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Fundamental Research Funds for the Central Universities, China [14QNJJ030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Jilin Province; Project of Science and Technology Innovation Platform of Computing and Software Science (985 Engineering); Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by The National Natural Science Foundation of China (grants No. 61373051 and No. 61175023), the Science and Technology Development Program of Jilin Province (grant No. 20140204004GX, No. 20140520072JH), Project of Science and Technology Innovation Platform of Computing and Software Science (985 Engineering), and The Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China, The Fundamental Research Funds for the Central Universities, China (grant No. 14QNJJ030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlborg O, 2000, GENETICS, V155, P2003; Chuang Li-Yeh, 2013, J Clin Bioinforma, V3, P4, DOI 10.1186/2043-9113-3-4; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Curk T, 2011, NUCLEIC ACIDS RES, V39, pW444, DOI 10.1093/nar/gkr321; Fan R, 2011, GENET EPIDEMIOL, V35, P706, DOI 10.1002/gepi.20621; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Liao YY, 2006, RADIOLOGY, V239, P300, DOI 10.1148/radiol.2391051114; Lin HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059688; Liu CN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S17; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Mc Mahon SS, 2014, SEMIN CELL DEV BIOL, V35, P98, DOI 10.1016/j.semcdb.2014.06.011; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sapkota Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064896; Singh M, 2011, RHEUMATOL INT, V31, P421, DOI 10.1007/s00296-010-1449-7; Smith C, 2005, NATURE, V16, P435; Srihari S, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S021972001230002X; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Vogt M, 2007, J CHEM INF MODEL, V47, P337, DOI 10.1021/ci600418u; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Winham SJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-164; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yang C, 2009, BIOINFORMATICS, V25, P504, DOI 10.1093/bioinformatics/btn652	35	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119146	10.1371/journal.pone.0119146	http://dx.doi.org/10.1371/journal.pone.0119146			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763929	gold, Green Submitted, Green Published			2022-12-27	WOS:000351276300021
J	Goldstein, TR; Bloom, P				Goldstein, Thalia R.; Bloom, Paul			Is It Oscar-Worthy? Children's Metarepresentational Understanding of Acting	PLOS ONE			English	Article							BEHAVING-AS-IF; MIND DEVELOPMENT; PRETENSE; TELEVISION; REAL; REPRESENTATION; OBJECT; ACTS; AGE	Although it is an essential aspect of one of the most common forms of entertainment, psychologists know almost nothing about how children understand the act of portraying a character in a realistic manner-realistic acting. Do children possess the sort of meta-theory of acting that adults possess? In two studies we find that, unlike adults, children between the ages of 3-5 do not think that a realistic actor is better at portraying a characteristic than a nonrealistic actor, nor do they prefer one to the other. As they develop, they come to understand that realistic acting is different from nonrealistic acting, but unlike adults, children think that a nonrealistic, pretense-like portrayal is more difficult to achieve than a realistic representation of an emotional or physical state. These findings show that children's metarepresentational understanding of acting is relatively immature at age 5, and that their understanding of this specific domain of pretense lags behind their understanding of pretense in general.	[Goldstein, Thalia R.; Bloom, Paul] Yale Univ, Dept Psychol, New Haven, CT 06902 USA; [Goldstein, Thalia R.] Pace Univ, Dept Psychol, New York, NY 10038 USA	Yale University; Pace University	Goldstein, TR (corresponding author), Yale Univ, Dept Psychol, POB 208205, New Haven, CT 06902 USA.	tgoldstein@pace.edu		Goldstein, Thalia/0000-0002-3892-0852	National Science Foundation Minority Postdoctoral Research Fellowship	National Science Foundation Minority Postdoctoral Research Fellowship	This material is based on work supported by a National Science Foundation Minority Postdoctoral Research Fellowship awarded to the first author in 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM KG, 2011, AM TIME USE SURVEY D; [Anonymous], 2013, ZERO 8 CHILDRENS MED; Benedetti J., 2007, ART ACTOR; Bloom P, 2010, PLEASURE WORKS NEW S; Christakis DA, 2007, PEDIATRICS, V120, P993, DOI 10.1542/peds.2006-3244; FLAVELL JH, 1990, J BROADCAST ELECTRON, V34, P399, DOI 10.1080/08838159009386752; Friedman O, 2007, COGNITION, V105, P103, DOI 10.1016/j.cognition.2006.09.007; Friedman O, 2010, COGNITION, V115, P314, DOI 10.1016/j.cognition.2010.02.001; Goldstein TR, 2011, TRENDS COGN SCI, V15, P141, DOI 10.1016/j.tics.2011.02.003; Goldstein TR, 2015, COGNITIVE DEV COGNIZ; Gordon Robert, 2006, PURPOSE PLAYING MODE; Harris P.L., 2000, WORK IMAGINATION; Jaglom L.M., 1981, NEW DIR CHILD ADOLES, V1981, P9, DOI DOI 10.1002/CD.23219811303; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Lillard A., 2007, PLAY DEV EVOLUTIONAR, P131; Lillard A, 2007, INFANCY, V11, P1, DOI 10.1207/s15327078in1101_1; Lillard AS, 2004, DEV PSYCHOL, V40, P95, DOI 10.1037/0012-1649.40.1.95; Ma LL, 2006, CHILD DEV, V77, P1762, DOI 10.1111/j.1467-8624.2006.00972.x; Mar RA, 2010, COGNITIVE DEV, V25, P69, DOI 10.1016/j.cogdev.2009.11.002; McConachie B, 2008, COGN STUD LIT PERFOR, P1, DOI 10.1057/9780230617025; Meisner S., 1987, ON ACTING; Moll H, 2012, DEV PSYCHOL, V48, P1124, DOI 10.1037/a0025915; NIMOY L, 1975, I AM NOT SPOCK; Nimoy Leonard, 1995, I AM SPOCK; Osborne Robert, 2013, 85 YEARS OSCAR OFFIC; Ossoff, 1998, CHILD STUDY J, V28, P53; Quattrochi J, 2007, PRINCE PAUPER MOVIE; Rakoczy H, 2004, DEV PSYCHOL, V40, P388, DOI 10.1037/0012-1649.40.3.388; Richert RA, 2004, COGNITIVE DEV, V19, P223, DOI 10.1016/j.cogdev.2004.01.001; SKEEN P, 1982, PERCEPT MOTOR SKILL, V54, P883, DOI 10.2466/pms.1982.54.3.883; Sobel DM, 2009, COGNITION, V113, P177, DOI 10.1016/j.cognition.2009.08.002; STANISLAVSKY K, 1948, ACTOR PREPARES; Talwar V, 2007, DEV PSYCHOL, V43, P804, DOI 10.1037/0012-1649.43.3.804; Taylor M., 2001, IMAGINARY COMPANIONS; Walker RF, 2012, DEV PSYCHOL, V48, P509, DOI 10.1037/a0025663; Weisberg DS, 2009, DEVELOPMENTAL SCI, V12, P699, DOI 10.1111/j.1467-7687.2009.00819.x; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; WRIGHT JC, 1994, DEV PSYCHOL, V30, P229, DOI 10.1037/0012-1649.30.2.229; Wyman E, 2009, BRIT J DEV PSYCHOL, V27, P385, DOI 10.1348/026151008X322893	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119604	10.1371/journal.pone.0119604	http://dx.doi.org/10.1371/journal.pone.0119604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25761111	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000061
J	Bates, ORJ; Suki, B; Spector, PS; Bates, JHT				Bates, Oliver R. J.; Suki, Bela; Spector, Peter S.; Bates, Jason H. T.			Structural Defects Lead to Dynamic Entrapment in Cardiac Electrophysiology	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; NONLINEAR DYNAMICS; REENTRANT WAVES; SAFETY FACTOR; MODEL; RING; TISSUE; INHOMOGENEITIES; TERMINATION; EXCITATION	Biological networks are typically comprised of many parts whose interactions are governed by nonlinear dynamics. This potentially imbues them with the ability to support multiple attractors, and therefore to exhibit correspondingly distinct patterns of behavior. In particular, multiple attractors have been demonstrated for the electrical activity of the diseased heart in situations where cardioversion is able to convert a reentrant arrhythmia to a stable normal rhythm. Healthy hearts, however, are typically resilient to abnormal rhythms. This raises the question as to how a healthy cardiac cell network must be altered so that it can support multiple distinct behaviors. Here we demonstrate how anatomic defects can give rise to multistability in the heart as a function of the electrophysiological properties of the cardiac tissue and the timing of activation of ectopic foci. This leads to a form of hysteretic behavior, which we call dynamic entrapment, whereby the heart can become trapped in aberrant attractor as a result of a transient change in tissue properties. We show that this can lead to a highly inconsistent relationship between clinical symptoms and underlying pathophysiology, which raises the possibility that dynamic entrapment may underlie other forms of chronic idiopathic illness.	[Bates, Oliver R. J.; Suki, Bela] Boston Univ, Coll Engn, Boston, MA 02215 USA; [Spector, Peter S.; Bates, Jason H. T.] Univ Vermont, Coll Med, Burlington, VT 05405 USA	Boston University; University of Vermont	Bates, JHT (corresponding author), Univ Vermont, Coll Med, 89 Beaumont Ave, Burlington, VT 05405 USA.	jason.h.bates@uvm.edu			Natural Sciences and Engineering Research Council of Canada; Evslin Family Foundation (PSS)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Evslin Family Foundation (PSS)	Funding provided by a Graduate Fellowship from the Natural Sciences and Engineering Research Council of Canada. URL-http://www.nserc-crsng.gc.ca/index_eng.asp (ORJB) and The Evslin Family Foundation (PSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Anafi RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014413; Bates JHT, 2006, INT C COMPL SYST BOS; Boyle PM, 2010, BIOPHYS J, V98, pL57, DOI 10.1016/j.bpj.2010.03.018; Cappato R, 1999, EUR HEART J, V20, P1766, DOI 10.1053/euhj.1999.1842; Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033; Comtois P, 2007, CHAOS, V17, DOI 10.1063/1.2740673; Comtois P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051927; COURTEMANCHE M, 1993, PHYS REV LETT, V70, P2182, DOI 10.1103/PhysRevLett.70.2182; Franz MR, 1997, J AM COLL CARDIOL, V30, P1785, DOI 10.1016/S0735-1097(97)00385-9; Fuster V, 2011, CIRCULATION, V124, pE333, DOI 10.1161/CIRCULATIONAHA.111.045211; Gaspo R, 1999, J PHARMACOL TOX MET, V42, P11, DOI 10.1016/S1056-8719(99)00042-8; Glass L, 2005, P NATL ACAD SCI USA, V102, P10409, DOI 10.1073/pnas.0504511102; Gong YF, 2007, CIRCULATION, V115, P2094, DOI 10.1161/CIRCULATIONAHA.106.656504; Gonzalez H, 2003, BIOSYSTEMS, V71, P71, DOI 10.1016/S0303-2647(03)00111-4; Gonzalez H, 2000, PROG THEOR PHYS SUPP, P83, DOI 10.1143/PTPS.139.83; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; ITO H, 1992, PHYSICA D, V56, P84, DOI 10.1016/0167-2789(92)90052-O; JOYNER RW, 1981, BIOPHYS J, V35, P113, DOI 10.1016/S0006-3495(81)84778-9; KAPLAN DT, 1988, MATH BIOSCI, V90, P19, DOI 10.1016/0025-5564(88)90056-9; Krogh-Madsen T, 2012, ANNU REV BIOMED ENG, V14, P179, DOI [10.1146/annurev-bioeng-071811-150106, 10.1146/annurev.bioeng-071811-150106]; Lenz TL, 2000, PHARMACOTHERAPY, V20, P776, DOI 10.1592/phco.20.9.776.35208; MACKEY MC, 1987, ANN NY ACAD SCI, V504, P16, DOI 10.1111/j.1749-6632.1987.tb48723.x; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; MILNE JR, 1984, EUR HEART J, V5, P99, DOI 10.1093/oxfordjournals.eurheartj.a061633; Mines GR, 1913, J PHYSIOL-LONDON, V46, P349; Pande A, 2000, PHYS REV E, V61, P6448, DOI 10.1103/PhysRevE.61.6448; Rohr S, 1997, SCIENCE, V275, P841, DOI 10.1126/science.275.5301.841; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Sinha S, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061903; Sinha S, 2002, CHAOS, V12, P893, DOI 10.1063/1.1501176; Spector PS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P586, DOI 10.1161/CIRCEP.110.961524; Sridhar S, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50003; Strogatz SH, 2001, NONLINEAR DYNAMICS C, P512; Waldo AL, 1996, J AM COLL CARDIOL, V28, P707, DOI 10.1016/0735-1097(96)00223-9; Wang Y, 2000, AM J PHYSIOL-HEART C, V278, pH1019, DOI 10.1152/ajpheart.2000.278.4.H1019; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119535	10.1371/journal.pone.0119535	http://dx.doi.org/10.1371/journal.pone.0119535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756656	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275700048
J	Farzadi, L; Ghasemzadeh, A; Bahrami-Asl, Z; Shirdel, H				Farzadi, Laya; Ghasemzadeh, Aliyeh; Bahrami-asl, Zahra; Shirdel, Hossein			Predictors of Irrational Parenthood Cognitions in an Iranian Group of Infertile Women	PLOS ONE			English	Article							QUALITY-OF-LIFE; NATURAL-KILLER-CELL; DEPRESSION; ANXIETY; SUPPORT; STRESS	Objectives The aim of this study was to investigate possible predictors of irrational parenthood cognitions among infertile women seeking treatment. Methods In a cross-sectional study, 300 women who visited an Infertility Center in Iran during 2010 were studied. A pre-validated inventory was used to assess irrational parenthood cognitions. Potential predictors of the total irrational parenthood cognitions score were assessed. Results Mean irrational parenthood cognition score was 39.7( Range 0-56). Through bivariate analysis, the score on irrational parenthood cognition was inversely correlated with age and positively correlated with length of time seeking for infertility treatment and length of time expecting pregnancy. In a multivariate model, infertile women with higher education, especially academic education, or those with higher economic status were less likely to have irrational parenthood cognitions. However, higher motherhood motivation, no previous experience of pregnancy and being under social pressure, from others around, increased the likelihood of having irrational parenthood cognitions. Conclusions Some variables such as female spouse's educational level and being under social pressure can independently predict irrational parenthood cognitions among infertile women that may be of use in designing health promotion plans in order to target the vulnerable women.	[Farzadi, Laya; Ghasemzadeh, Aliyeh] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran; [Bahrami-asl, Zahra] Tabriz Univ Med Sci, Alzahra Univ Hosp, Tabriz, Iran; [Shirdel, Hossein] Islamic Azad Univ, Dept Law, Tabriz Branch, Tabriz, Iran	Tabriz University of Medical Science; Alzahra University; Tabriz University of Medical Science; Islamic Azad University	Ghasemzadeh, A (corresponding author), Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran.	aliyeh.ghasemzadeh@yahoo.com	Ghasemzadeh, Aliyeh/M-5808-2017; Farzadi, Laya/M-2909-2017	Farzadi, Laya/0000-0001-9969-0352				Aliyeh G, 2007, MED SCI MONITOR, V13, pCR313; Amanati L., 2010, Iranian Journal of Obstetrics, Gynecology and Infertility, V12, P25; Amanati L, 2006, THESIS IRAN U MED SC; Borella P, 1999, PSYCHONEUROENDOCRINO, V24, P613, DOI 10.1016/S0306-4530(99)00016-5; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Faramarzi M, 2008, J AFFECT DISORDERS, V108, P159, DOI 10.1016/j.jad.2007.09.002; Farzadi L, 2014, J CLIN RES GOVT, V3, P147, DOI 10.13183/jcrg.v3i2.168; Farzadi L, 2013, J CLIN RES GOVERNANC, V2, P14; Farzadi L, 2008, TAIWAN J OBSTET GYNE, V47, P163, DOI 10.1016/S1028-4559(08)60074-1; Fekkes M, 2003, HUM REPROD, V18, P1536, DOI 10.1093/humrep/deg276; FREEMAN EW, 1985, FERTIL STERIL, V43, P48; Glover L, 1999, FERTIL STERIL, V72, P623, DOI 10.1016/S0015-0282(99)00304-0; Khayata GM, 2003, INT J GYNECOL OBSTET, V80, P183, DOI 10.1016/S0020-7292(02)00387-9; Matsubayashi H, 2004, GEN HOSP PSYCHIAT, V26, P398, DOI 10.1016/j.genhosppsych.2004.05.002; Oddens BJ, 1999, HUM REPROD, V14, P255, DOI 10.1093/humrep/14.1.255; Strauman TJ, 2004, BRAIN BEHAV IMMUN, V18, P544, DOI 10.1016/j.bbi.2004.01.003; STRAUMAN TJ, 1993, J PERS SOC PSYCHOL, V64, P1042, DOI 10.1037/0022-3514.64.6.1042; van BF, 1994, J PSYCHOSOM OBST GYN, V15, P157; Whiteford L M, 1995, Soc Sci Med, V40, P27, DOI 10.1016/0277-9536(94)00124-C	19	3	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0070239	10.1371/journal.pone.0070239	http://dx.doi.org/10.1371/journal.pone.0070239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756990	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275700001
J	Gasparetto, JC; Peccinini, RG; de Francisco, TMG; Cerqueira, LB; Campos, FR; Pontarolo, R				Gasparetto, Joao Cleverson; Peccinini, Rosangela Goncalves; Guimaraes de Francisco, Thais Martins; Cerqueira, Letcia Bonancio; Campos, Francinete Ramos; Pontarolo, Roberto			A Kinetic Study of the Main Guaco Metabolites Using Syrup Formulation and the Identification of an Alternative Route of Coumarin Metabolism in Humans	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BIP. EX BAKER; KAURENOIC ACID; MIKANIA-GLOMERATA; BRONCHODILATOR ACTIVITY; HUMAN SERUM; LAEVIGATA; 7-HYDROXYCOUMARIN; PLASMA; PHARMACOKINETICS	For decades guaco species have been empirically used for the treatment of respiratory diseases. However, studies have shown that the toxic and therapeutic effects of the main guaco metabolites are dose-dependent, and none clinical study was done to evaluate the behavior of these substances in humans. In this work, a pilot study measuring the kinetic profile of the main guaco metabolites was performed leading to the knowledge of an alternative route of coumarin metabolism in humans. Initial screenings demonstrated that the administration of 60 mL of guaco syrup (single dose) did not provide sufficient levels of coumarin (COU), 7-hydroxycoumarin (7-HCOU), o-coumaric acid (OCA) and kaurenoic acid (KAU). The pharmacokinetic parameters were calculated by orally administering 60 mL of guaco syrup spiked with 1500 mg of COU. The kinetic study demonstrated that the plasmatic levels of 7-HCOU (considered the main metabolite of COU) were 10 times lower than the levels of COU, and the kinetic profile of 7-HCOU suggests sequential metabolism in the liver with low access of 7-HCOU to the systemic circulation. The study also demonstrated that OCA is one of the main bioavailable metabolites of COU. Therefore, the hydrolysis of the lactone ring forming a carboxylated compound is one of the possible routes of COU metabolism in humans. The half-lives of COU, 7-HCOU and OCA were approximately 4.0, 1.0 and 3.0 h, respectively and there was evidence that the recommended dosage of guaco syrup did not provide sufficient levels of COU, 7-HCOU or OCA to obtain a bronchodilation effect. Clinical studies are necessary to prove the efficacy and safety of products based on guaco.	[Gasparetto, Joao Cleverson; Guimaraes de Francisco, Thais Martins; Cerqueira, Letcia Bonancio; Campos, Francinete Ramos; Pontarolo, Roberto] Univ Fed Parana, Dept Pharm, Curitiba, PR, Brazil; [Peccinini, Rosangela Goncalves] Univ Estadual Paulista, Dept Nat Act Principles & Toxicol, Araraquara, SP, Brazil	Universidade Federal do Parana; Universidade Estadual Paulista	Pontarolo, R (corresponding author), Univ Fed Parana, Dept Pharm, Curitiba, PR, Brazil.	pontarolo@ufpr.br	CERQUEIRA, LETICIA/H-5121-2016; Campos, Francinete/AAU-1346-2020; Peccinini, Rosangela/G-6068-2015; Pontarolo, Roberto/G-6948-2014	Peccinini, Rosangela/0000-0002-2692-8101; Pontarolo, Roberto/0000-0002-7049-4363; CAMPOS, FRANCINETE/0000-0002-9688-2030	Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JCG received scholarship from Fundacao Araucaria and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Bogan DP, 1996, J CHROMATOGR B, V686, P267, DOI 10.1016/S0378-4347(96)00234-4; BOOTH AN, 1959, J BIOL CHEM, V234, P946; Born SL, 2000, DRUG METAB DISPOS, V28, P218; Cavalcanti BC, 2010, MUTAT RES-GEN TOX EN, V701, P153, DOI 10.1016/j.mrgentox.2010.06.010; Cavalcanti BC, 2006, FOOD CHEM TOXICOL, V44, P388, DOI 10.1016/j.fct.2005.08.011; Choi RJ, 2011, PHYTOMEDICINE, V18, P677, DOI 10.1016/j.phymed.2010.11.010; Costa-Lotufo LV, 2002, TOXICON, V40, P1231, DOI 10.1016/S0041-0101(02)00128-9; de Moura RS, 2002, J PHARM PHARMACOL, V54, P249, DOI 10.1211/0022357021778277; dos Santos SC, 2006, PLANTA MED, V72, P679, DOI 10.1055/s-2006-931577; EGAN DA, 1992, J CHROMATOGR-BIOMED, V582, P137, DOI 10.1016/0378-4347(92)80312-E; Fierro IM, 1999, J ETHNOPHARMACOL, V66, P19, DOI 10.1016/S0378-8741(98)00151-2; Food and D. Administration, 2001, BIOAN METH VAL GUID; Ford RA, 2001, FOOD CHEM TOXICOL, V39, P153, DOI 10.1016/S0278-6915(00)00123-X; Gasparetto JC, 2011, PHARM ANAL ACTA, V2, P1; Gasparetto JC, 2011, J SEP SCI, V34, P740, DOI 10.1002/jssc.201000792; Gasparetto JC, 2010, REV BRAS FARMACOGN, V20, P627, DOI 10.1590/S0102-695X2010000400025; Gasparetto JC, 2012, TOXICITY AND DRUG TESTING, P297; Graca C, 2007, J ETHNOPHARMACOL, V112, P430, DOI 10.1016/j.jep.2007.03.026; Hoult JRS, 1996, GEN PHARMACOL-VASC S, V27, P713, DOI 10.1016/0306-3623(95)02112-4; Houston JB, 1982, PHARMACOL THERAPEUT, V15, P521; Labaune JP, 1993, FARMACOCINETICA, DOI [10.7399/FH.2013.37.6.742, DOI 10.7399/FH.2013.37.6.742]; Lacy A, 2004, CURR PHARM DESIGN, V10, P3797, DOI 10.2174/1381612043382693; Lake BG, 1999, FOOD CHEM TOXICOL, V37, P423, DOI 10.1016/S0278-6915(99)00010-1; LAKE BG, 1989, TOXICOL APPL PHARM, V97, P311, DOI 10.1016/0041-008X(89)90336-0; Napimoga MH, 2010, J PHARM PHARMACOL, V62, P809, DOI 10.1211/jpp.62.07.0001; NTP, 1993, NAT TOX PROGR TECH R, V422, P1; Ramanitrahasimbola D, 2005, J ETHNOPHARMACOL, V102, P400, DOI 10.1016/j.jep.2005.06.037; RITSCHEL WA, 1981, J CLIN PHARMACOL, V21, P294, DOI 10.1002/j.1552-4604.1981.tb01770.x; RITSCHEL WA, 1977, EUR J CLIN PHARMACOL, V12, P457, DOI 10.1007/BF00561066; RITSCHEL WA, 1984, METHOD FIND EXP CLIN, V6, P363; ROVEI V, 1982, BRIT J CLIN PHARMACO, V14, P769, DOI 10.1111/j.1365-2125.1982.tb02035.x; SHILLING WH, 1969, NATURE, V221, P664, DOI 10.1038/221664b0; Silva RZ, 2000, THESIS U FEDERAL SAN; Suyenaga ES, 2002, PHYTOTHER RES, V16, P519, DOI 10.1002/ptr.908; Teske M., 1997, HERBARIUM COMPENDIO; THORNES RD, 1994, J CANCER RES CLIN, V120, pS32, DOI 10.1007/BF01377122; THORNES RD, 1982, LANCET, V2, P328; Tirapelli CR, 2004, EUR J PHARMACOL, V492, P233, DOI 10.1016/j.ejphar.2004.04.003; Tirapelli CR, 2002, FITOTERAPIA, V73, P56, DOI 10.1016/S0367-326X(01)00365-3; Toutain PL, 2004, J VET PHARMACOL THER, V27, P427, DOI 10.1111/j.1365-2885.2004.00600.x; Vasconcelos JF, 2009, EUR J PHARMACOL, V609, P126, DOI 10.1016/j.ejphar.2009.03.027; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501	44	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118922	10.1371/journal.pone.0118922	http://dx.doi.org/10.1371/journal.pone.0118922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757073	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700032
J	Kim, N; Kim, HM; Lee, ES; Lee, JO; Lee, HJ; Lee, SK; Moon, JW; Kim, JH; Kim, JK; Kim, SJ; Park, SH; Chung, CH; Kim, HS				Kim, Nami; Kim, Hong Min; Lee, Eun Soo; Lee, Jung Ok; Lee, Hye Jeong; Lee, Soo Kyung; Moon, Ji Wook; Kim, Ji Hae; Kim, Joong Kwan; Kim, Su Jin; Park, Sun Hwa; Chung, Choon Hee; Kim, Hyeon Soo			Dibenzoylmethane Exerts Metabolic Activity through Regulation of AMP-Activated Protein Kinase (AMPK)-Mediated Glucose Uptake and Adipogenesis Pathways	PLOS ONE			English	Article							CURCUMIN; MUSCLE; CELLS; RAT; STIMULATION; DERIVATIVES; INHIBITION; TRANSPORT; UPSTREAM; CASCADE	Dibenzoylmethane (DBM) has been shown to exert a variety of beneficial effects on human health. However, the mechanism of action is poorly understood. In this study, DBM increased phosphorylation of AMP-activated protein kinase (AMPK) and stimulated glucose uptake in a skeletal muscle cell line. Both knockdown of AMPK with siRNA and inhibition with AMPK inhibitor blocked DBM-induced glucose uptake. DBM increased the concentration of intracellular calcium and glucose uptake due to DBM was abolished by STO-609 (a calcium/calmodulin-dependent protein kinase inhibitor). DBM stimulated phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK), which was blocked by pretreatment with compound C, an AMPK inhibitor. The expression of glucose transporter type 4 (GLUT4) was increased by DBM. The translocation of GLUT4 to the plasma membrane was also increased by DBM in AMPK dependently. In addition, DBM suppressed weight gain and prevented fat accumulation in the liver and abdomen in mice fed a high-fat diet. In preadipocyte cells, DBM decreased the activity of acetyl-CoA carboxylase (ACC), the rate-limiting enzyme of fatty acid synthesis. Expression of the adipogenic gene, fatty acid synthase (FAS), was suppressed by DBM in an AMPK-dependent manner. These results showed that the beneficial metabolic effects of DBM might be due to regulation of glucose uptake via AMPK in skeletal muscle and inhibition of adipogenesis in pre-adipocytes.	[Kim, Nami; Lee, Jung Ok; Lee, Hye Jeong; Lee, Soo Kyung; Moon, Ji Wook; Kim, Ji Hae; Kim, Joong Kwan; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea; [Kim, Hong Min; Lee, Eun Soo; Chung, Choon Hee] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju 220701, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University	Kim, HS (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea.	anatomykim@korea.ac.kr		Chung, Choon/0000-0003-1144-7206	Korean government [NRF-2013R1A2A2A05004796]	Korean government(Korean Government)	The National Research Foundation of Korea funded by the Korean government supported this study (NRF-2013R1A2A2A05004796). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady PA, 1998, J AM COLL CARDIOL, V31, P950, DOI 10.1016/S0735-1097(98)00038-2; CHOSHI T, 1992, CHEM PHARM BULL, V40, P1047; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; FUKAI T, 1994, PHYTOCHEMISTRY, V35, P515, DOI 10.1016/S0031-9422(00)94793-9; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Huang MT, 1998, CARCINOGENESIS, V19, P1697, DOI 10.1093/carcin/19.9.1697; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jackson KM, 2002, CANCER LETT, V178, P161, DOI 10.1016/S0304-3835(01)00844-8; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim JH, 2010, J CELL PHYSIOL, V223, P771, DOI 10.1002/jcp.22093; Lin CC, 2006, CARCINOGENESIS, V27, P131, DOI 10.1093/carcin/bgi199; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Pan Y, 2013, J NUTR BIOCHEM, V24, P146, DOI 10.1016/j.jnutbio.2012.03.012; Pan YB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-323; Rozzo C, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-37; SARABIA V, 1990, BIOCHEM CELL BIOL, V68, P536, DOI 10.1139/o90-076; Somwar R, 2000, DIABETES, V49, P1794, DOI 10.2337/diabetes.49.11.1794; Srinivasan A, 2003, J PHARM PHARM SCI, V6, P327; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; WAHLSTROM B, 1978, ACTA PHARMACOL TOX, V43, P86; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xi X, 2001, J BIOL CHEM, V276, P41029, DOI 10.1074/jbc.M102824200; Yale JF, 2005, J AM SOC NEPHROL, V16, pS7, DOI 10.1681/ASN.2004110974; Zheng A, 2014, CURR CANCER DRUG TAR, V14, P156, DOI 10.2174/1568009613666131126115444	32	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120104	10.1371/journal.pone.0120104	http://dx.doi.org/10.1371/journal.pone.0120104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756788	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275700059
J	Xiao, Y; Ma, F; Lv, YX; Cai, G; Teng, P; Xu, FG; Chen, SG				Xiao, Yi; Ma, Feng; Lv, Yixuan; Cai, Gui; Teng, Peng; Xu, FengGang; Chen, Shanguang			Sustained Attention is Associated with Error Processing Impairment: Evidence from Mental Fatigue Study in Four-Choice Reaction Time Task	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; CROSSMODAL DIVIDED ATTENTION; CHOICE REACTION TASKS; LATE ERP COMPONENTS; BRAIN ACTIVITY; FUNCTIONAL-SIGNIFICANCE; COGNITIVE CONTROL; ANTISACCADE TASK; PERFORMANCE; NEGATIVITY	Attention is important in error processing. Few studies have examined the link between sustained attention and error processing. In this study, we examined how error-related negativity (ERN) of a four-choice reaction time task was reduced in the mental fatigue condition and investigated the role of sustained attention in error processing. Forty-one recruited participants were divided into two groups. In the fatigue experiment group, 20 subjects performed a fatigue experiment and an additional continuous psychomotor vigilance test (PVT) for 1 h. In the normal experiment group, 21 subjects only performed the normal experimental procedures without the PVT test. Fatigue and sustained attention states were assessed with a questionnaire. Event-related potential results showed that ERN (p < 0.005) and peak (p < 0.05) mean amplitudes decreased in the fatigue experiment. ERN amplitudes were significantly associated with the attention and fatigue states in electrodes Fz, FC1, Cz, and FC2. These findings indicated that sustained attention was related to error processing and that decreased attention is likely the cause of error processing impairment.	[Xiao, Yi; Ma, Feng; Lv, Yixuan; Cai, Gui; Teng, Peng; Xu, FengGang; Chen, Shanguang] China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China; [Ma, Feng] Tsinghua Univ, Sch Aerosp, Beijing 100084, Peoples R China; [Lv, Yixuan; Xu, FengGang] Beihang Univ BUAA, Sch Biol Sci & Med Engn, Dept Ergon, Beijing, Peoples R China	Chinese Academy of Sciences; Tsinghua University; Beihang University	Chen, SG (corresponding author), China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China.	Shanguang_chen@126.com			National Basic Research Program of China (973 Program) [2011CB711003]; National Natural Science Foundation of China [71201148]; Foundation of National Key Laboratory of Human Factors Engineering [HF2011-Z-Z-A-01, HF2011-Z-B-02, HF2011-Z-Z-B-02, HF2012-Z-B-02]; China Manned Space Medical Engineering Advanced Research Project [2012SY54B1701]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of National Key Laboratory of Human Factors Engineering; China Manned Space Medical Engineering Advanced Research Project	This study was supported by the National Basic Research Program of China (973 Program; No. 2011CB711003), the National Natural Science Foundation of China (71201148), the Foundation of National Key Laboratory of Human Factors Engineering (Grant Nos. HF2011-Z-Z-A-01, HF2011-Z-B-02, HF2011-Z-Z-B-02, and HF2012-Z-B-02), and the China Manned Space Medical Engineering Advanced Research Project (2012SY54B1701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholow BD, 2012, J ABNORM PSYCHOL, V121, P173, DOI 10.1037/a0023664; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Bates AT, 2002, CLIN NEUROPHYSIOL, V113, P1454, DOI 10.1016/S1388-2457(02)00154-2; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Clayson PE, 2012, SOC COGN AFFECT NEUR, V7, P677, DOI 10.1093/scan/nsr040; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dudschig C, 2009, BRAIN RES, V1296, P56, DOI 10.1016/j.brainres.2009.08.009; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Endrass T, 2010, BIOL PSYCHOL, V84, P257, DOI 10.1016/j.biopsycho.2010.02.002; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grutzmann R, 2014, BIOL PSYCHOL, V96, P1, DOI 10.1016/j.biopsycho.2013.10.007; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8986.2005.00270.x; Hajcak G, 2002, PSYCHIAT RES, V110, P63, DOI 10.1016/S0165-1781(02)00034-3; Hajcak G, 2008, AM J PSYCHIAT, V165, P116, DOI 10.1176/appi.ajp.2007.07010143; HOHNSBEIN J, 1991, ELECTROEN CLIN NEURO, V78, P438, DOI 10.1016/0013-4694(91)90061-8; Hughes G, 2011, NEUROPSYCHOLOGIA, V49, P405, DOI 10.1016/j.neuropsychologia.2010.11.036; Johannes S, 2001, PSYCHIAT RES-NEUROIM, V108, P101, DOI 10.1016/S0925-4927(01)00117-2; Kato Y, 2009, INT J PSYCHOPHYSIOL, V72, P204, DOI 10.1016/j.ijpsycho.2008.12.008; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Maier ME, 2011, NEUROIMAGE, V56, P2339, DOI 10.1016/j.neuroimage.2011.03.083; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Nunez Castellar E, 2010, COGN AFFECT BEHAV NE, V10, P270, DOI DOI 10.3758/CABN.10.2.270; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Park JS, 2001, IND HEALTH, V39, P250, DOI 10.2486/indhealth.39.250; Pfabigan DM, 2013, NEUROPSYCHOLOGIA, V51, P613, DOI 10.1016/j.neuropsychologia.2012.12.008; Riba J, 2005, COGNITIVE BRAIN RES, V25, P554, DOI 10.1016/j.cogbrainres.2005.08.009; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Riesel A, 2013, BIOL PSYCHOL, V93, P377, DOI 10.1016/j.biopsycho.2013.04.007; Riesel A, 2012, PSYCHOPHYSIOLOGY, V49, P239, DOI 10.1111/j.1469-8986.2011.01298.x; Scheffers MK, 1999, PSYCHOPHYSIOLOGY, V36, P149, DOI 10.1111/1469-8986.3620149; Shayler D J, 2000, SPRINGER PRAXIS BOOK, P45; Steinhauser M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00240; Strozyk JV, 2012, BRAIN RES, V1460, P41, DOI 10.1016/j.brainres.2012.04.028; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Wessel JR, 2011, J COGNITIVE NEUROSCI, V23, P3021, DOI 10.1162/jocn.2011.21635; Wessel JR, 2011, NEUROIMAGE, V54, P2105, DOI 10.1016/j.neuroimage.2010.10.033; West R, 2008, CEREB CORTEX, V18, P1112, DOI 10.1093/cercor/bhm142; Wiersema JR, 2005, J NEURAL TRANSM, V112, P1417, DOI 10.1007/s00702-005-0276-6; Wiswede D, 2009, SOCIAL COGNITIVE AFF; Wu JH, 2014, BIOL PSYCHOL, V99, P77, DOI 10.1016/j.biopsycho.2014.03.002; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; YOSHITAKE H, 1971, J SCI LABOUR, V47, P797	53	10	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117837	10.1371/journal.pone.0117837	http://dx.doi.org/10.1371/journal.pone.0117837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756780	gold, Green Published			2022-12-27	WOS:000351275700019
J	Fischer, C; Hofmann, M; Danzer, M; Hofer, K; Kaar, J; Gabriel, C				Fischer, Carina; Hofmann, Martina; Danzer, Martin; Hofer, Katja; Kaar, Jennifer; Gabriel, Christian			Seroprevalence and Incidence of hepatitis E in Blood Donors in Upper Austria	PLOS ONE			English	Article							E VIRUS-INFECTION; DEVELOPED-COUNTRIES; GERMANY; TRANSFUSION; PREVALENCE; ANTIBODIES; FRANCE; PLASMA; TRANSMISSION; ENGLAND	Background In recent years various studies showed, that hepatitis E virus (HEV) is a growing public health problem in many developed countries. Therefore, HEV infections might bear a transmission risk by blood transfusions. The clinical relevance still requires further investigations. The aim of this study was to provide an overview of acute HEV infections in Upper Austrian blood donors as well as a risk estimation of this transfusion-related infection. Methods and Findings A total of 58,915 blood donors were tested for HEV RNA using a commercial HEV RTPCR Kit. 7 of these donors (0.01%) were PCR-positive with normal laboratory parameters in absence of clinical signs of hepatitis. Viral load determined by quantitative real-time PCR showed a HEV nucleic acid concentration of 2,217 293,635 IU/ml. At follow-up testing (2-11 weeks after donation) all blood donors had negative HEV RNA results. Additionally, genotyping was performed by amplification and sequencing of the ORF1 or ORF2 region of the HEV genome. All HEV RNA positive donor samples revealed a genotype 3 isolate. For the antibody screening, anti-HEV IgM and IgG were detected by ELISA. Follow up serological testing revealed that no donor was seropositive for HEV IgM or IgG antibodies at time of donation. Moreover, we verified the prevalence of anti-HEV IgG in 1,203 of the HEV RNA negative tested blood donors. Overall 13.55% showed positive results for anti-HEV IgG. Conclusions In the presented study, we investigated HEV infections in blood donations of Upper Austria over 1 year. We concluded that 1 out of 8,416 blood donations is HEV RNA positive. Seroprevalence of anti HEV IgG results in an age-related increase of 13.55%. Therefore, based on this data, we recommend HEV-PCR screening to prevent transmission of hepatitis E virus by transfusion.	[Fischer, Carina; Hofmann, Martina; Danzer, Martin; Hofer, Katja; Kaar, Jennifer; Gabriel, Christian] Red Cross Transfus Serv Upper Austria, Linz, Austria		Fischer, C (corresponding author), Red Cross Transfus Serv Upper Austria, Linz, Austria.	carinafischer@gmx.at	Gabriel, Christian/A-1689-2014	Gabriel, Christian/0000-0003-2043-9320	Landsteiner Fonds of the Austrian Red Cross	Landsteiner Fonds of the Austrian Red Cross	This research was partially funded by a grant from the Landsteiner Fonds of the Austrian Red Cross. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Baylis SA, 2011, J CLIN MICROBIOL, V49, P1234, DOI 10.1128/JCM.02578-10; Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x; Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Chaussade H, 2013, J CLIN VIROL, V58, P504, DOI 10.1016/j.jcv.2013.08.030; Cleland A, 2013, VOX SANG, V105, P283, DOI 10.1111/vox.12056; Colson P, 2007, EMERG INFECT DIS, V13, P648, DOI 10.3201/eid1304.061387; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; de NA, 2012, NETH J MED, V70, P261; Dreier J, 2014, TRANSFUS MED HEMOTH, V41, P29, DOI 10.1159/000357098; Echevarria JM, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/481016; Faber MS, 2012, EMERG INFECT DIS, V18, P1654, DOI 10.3201/eid1810.111756; Gupta E, 2013, J CLIN VIROL, V58, P374, DOI 10.1016/j.jcv.2013.07.019; Hauser L, 2014, BLOOD, V123, P796, DOI 10.1182/blood-2013-09-524348; Hewitt PE, 2014, LANCET, V384, P1766, DOI 10.1016/S0140-6736(14)61034-5; Huzly D, 2014, EUROSURVEILLANCE, V19; Ijaz S, 2012, VOX SANG, V102, P272, DOI 10.1111/j.1423-0410.2011.01554.x; Krumbholz A, 2014, MED MICROBIOL IMMUN, V203, P273, DOI 10.1007/s00430-014-0336-3; Lagler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087669; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Olsen BR, 2006, SCAND J INFECT DIS, V38, P55, DOI 10.1080/00365540500321470; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Preiss JC, 2006, INFECTION, V34, P173, DOI 10.1007/s15010-006-4132-x; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Riezebos-Brilman A, 2013, J CLIN VIROL, V58, P509, DOI 10.1016/j.jcv.2013.08.022; Rutjes SA, 2009, EMERG INFECT DIS, V15, P381, DOI 10.3201/eid1503.071472; Schielke A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-58; Shata MT, 2008, CLIN INFECT DIS, V47, P1032, DOI 10.1086/591971; STATISTIK AUSTRIA, AS2010 HALT SCHW; STATISTIK AUSTRIA, SCHWEIN NACH BUND 19; Teshale EH, 2011, WORLD J HEPATOL, V3, P285, DOI 10.4254/wjh.v3.i12.285; Vollmer T, 2014, J CLIN MICROBIOL, V52, P2150, DOI 10.1128/JCM.03578-13; Vollmer T, 2012, J CLIN MICROBIOL, V50, P2708, DOI 10.1128/JCM.01119-12; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; Zwettler D, 2012, BERL MUNCH TIERARZTL, V125, P281, DOI 10.2376/0005-9366-125-281	41	69	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119576	10.1371/journal.pone.0119576	http://dx.doi.org/10.1371/journal.pone.0119576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751574	Green Published, gold, Green Submitted			2022-12-27	WOS:000350692700027
J	Billings, SD; Boctor, EM; Taylor, RH				Billings, Seth D.; Boctor, Emad M.; Taylor, Russell H.			Iterative Most-Likely Point Registration (IMLP): A Robust Algorithm for Computing Optimal Shape Alignment	PLOS ONE			English	Article							EM-ICP; 2D	We present a probabilistic registration algorithm that robustly solves the problem of rigid-body alignment between two shapes with high accuracy, by aptly modeling measurement noise in each shape, whether isotropic or anisotropic. For point-cloud shapes, the probabilistic framework additionally enables modeling locally-linear surface regions in the vicinity of each point to further improve registration accuracy. The proposed Iterative Most-Likely Point (IMLP) algorithm is formed as a variant of the popular Iterative Closest Point (ICP) algorithm, which iterates between point-correspondence and point-registration steps. IMLP's probabilistic framework is used to incorporate a generalized noise model into both the correspondence and the registration phases of the algorithm, hence its name as a most-likely point method rather than a closest-point method. To efficiently compute the most-likely correspondences, we devise a novel search strategy based on a principal direction (PD)-tree search. We also propose a new approach to solve the generalized total-least-squares (GTLS) sub-problem of the registration phase, wherein the point correspondences are registered under a generalized noise model. Our GTLS approach has improved accuracy, efficiency, and stability compared to prior methods presented for this problem and offers a straightforward implementation using standard least squares. We evaluate the performance of IMLP relative to a large number of prior algorithms including ICP, a robust variant on ICP, Generalized ICP (GICP), and Coherent Point Drift (CPD), as well as drawing close comparison with the prior anisotropic registration methods of GTLS-ICP and A-ICP. The performance of IMLP is shown to be superior with respect to these algorithms over a wide range of noise conditions, outliers, and misalignments using both mesh and point-cloud representations of various shapes.	[Billings, Seth D.; Boctor, Emad M.; Taylor, Russell H.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Boctor, Emad M.] Johns Hopkins Med Inst, Dept Radiol, Div Med Imaging Phys, Baltimore, MD 21205 USA; [Boctor, Emad M.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Billings, SD (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	sbillin3@jhu.edu			National Science Foundation Graduate Research Fellowship Program (NSF GRFP); National Institutes of Health Graduate Partnership Program (NIH GPP); Hopkins University	National Science Foundation Graduate Research Fellowship Program (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health Graduate Partnership Program (NIH GPP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hopkins University(Johns Hopkins University)	Funding and support for this work was provided by: National Science Foundation Graduate Research Fellowship Program (NSF GRFP, http://www.nsfgrfp.org), National Institutes of Health Graduate Partnership Program (NIH GPP, http://www.nih.gov), a gift from Intuitive Surgical (http://www.intuitivesurgical.com), and Johns Hopkins University internal funds (http://www.jhu.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armesto L, 2010, IEEE INT CONF ROBOT, P1367, DOI 10.1109/ROBOT.2010.5509371; ARUN KS, 1987, IEEE T PATTERN ANAL, V9, P699, DOI 10.1109/TPAMI.1987.4767965; Balachandran R, 2009, SPIE MED IMAGING INT; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Chui HL, 2000, IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P190, DOI 10.1109/MMBIA.2000.852377; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Combes B, 2010, LECT NOTES COMPUT SC, V6362, P594; Craig J.J., 2005, INTRO ROBOTICS MECH; Danilchenko A, 2011, IEEE T MED IMAGING, V30, P679, DOI 10.1109/TMI.2010.2091513; Deguet A., 2008, MIDAS J SYST ARCH CO, P1; Eberly D.H., 2010, GAME PHYS, DOI 10.1201/b18213; Estepar RSJ, 2004, LECT NOTES COMPUT SC, V3216, P234; FIEDLER M, 1971, P AM MATH SOC, V30, P27, DOI 10.2307/2038212; Fitzgibbon AW, 2003, IMAGE VISION COMPUT, V21, P1145, DOI 10.1016/j.imavis.2003.09.004; Gold S, 1998, PATTERN RECOGN, V31, P1019, DOI 10.1016/S0031-3203(98)80010-1; Granger S, 2002, LECT NOTES COMPUT SC, V2353, P418; Horn BKP, 1987, CLOSED FORM SOLUTION, V4; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; Kanatani K., 2005, STAT OPTIMIZATION GE; Larsson Thomas, 2008, Journal of Graphics Tools, V13, P31; Maier-Hein L, 2012, IEEE T PATTERN ANAL, V34, P1520, DOI 10.1109/TPAMI.2011.248; Matei BC, 2006, IEEE T PATTERN ANAL, V28, P1537, DOI 10.1109/TPAMI.2006.205; Maurer CR, 1996, IEEE T MED IMAGING, V15, P836, DOI 10.1109/42.544501; Minguez J, 2006, IEEE T ROBOT, V22, P1047, DOI 10.1109/TRO.2006.878961; Moghari MH, 2007, IEEE T MED IMAGING, V26, P1708, DOI 10.1109/TMI.2007.901984; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Nazem F, 2014, INT J COMPUT ASS RAD, V9, P39, DOI 10.1007/s11548-013-0907-6; Ohta N, 1998, IEICE T INF SYST, VE81D, P1247; Pennec X, 1997, INT J COMPUT VISION, V25, P203, DOI 10.1023/A:1007976002485; Ramsey PH, 1994, TECHNOMETRICS, V36, P430, DOI [10.1080/ 00401706.1994.10485864, DOI 10.1080/00401706.1994.10485864]; Rice J.A., 2006, MATH STAT DATA ANAL; Samet H., 2006, FDN MULTIDIMENSIONAL; Segal A., 2009, ROBOT SCI SYST, V2; Sharp GC, 2002, IEEE T PATTERN ANAL, V24, P90, DOI 10.1109/34.982886; Tamaki T., 2010, Proceedings 2010 First International Conference on Networking and Computing (ICNC 2010), P179, DOI 10.1109/IC-NC.2010.60; Tsin Y, 2004, LECT NOTES COMPUT SC, V3023, P558; Verma N., 2009, P MONTR QUE 25 C UNC, P565; WALKER MW, 1991, CVGIP-IMAG UNDERSTAN, V54, P358, DOI 10.1016/1049-9660(91)90036-O; WENTWORTH WE, 1965, J CHEM EDUC, V42, P96, DOI 10.1021/ed042p96; Williams J. R., 1997, Paper - American Society of Agricultural Engineers, P1; Yildirim EA, 2006, SIAM J OPTIMIZ, V17, P621, DOI 10.1137/050622560; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149	43	43	44	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0117688	10.1371/journal.pone.0117688	http://dx.doi.org/10.1371/journal.pone.0117688			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748700	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400010
J	Karim, ZA; Vemana, HP; Khasawneh, FT				Karim, Zubair A.; Vemana, Hari Priya; Khasawneh, Fadi T.			MALT1-Ubiquitination Triggers Non-Genomic NF-kappa B/IKK Signaling upon Platelet Activation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; B ACTIVATION; ARTERIAL THROMBOSIS; KINASE; MALT1; BCL10; EXPRESSION; INHIBITOR; PROTEIN; NEMO	We have recently shown that IKK complex plays an important non-genomic role in platelet function, i.e., regulates SNARE machinery-dependent membrane fusion. In this connection, it is well known that MALT1, whose activity is modulated by proteasome, plays an important role in the regulation of IKK complex. Therefore, the present studies investigated the mechanism by which IKK signaling is regulated in the context of the platelet proteasome. It was found that platelets express a functional proteasome, and form CARMA/MALT1/Bcl10 (CBM) complex when activated. Using a pharmacological inhibitor, the proteasome was found to regulate platelet function (aggregation, integrin activation, secretion, phosphatidylserine exposure and changes in intracellular calcium). It was also found to regulate thrombogenesis and physiologic hemostasis. We also observed, upon platelet activation, that MALT1 is ubiquitinated, and this coincides with the activation of the IKK/NF-kappa B-signaling pathway. Finally, we observed that the proteasome inhibitor blocks CBM complex formation and the interaction of IKK gamma and MALT1; abrogates SNARE formation, and the association of MALT1 with TAK1 and TAB2, which are upstream of the CBM complex. Thus, our data demonstrate that MALT1 ubiquitination is critical for the engagement of CBM and IKK complexes, thereby directing platelet signals to the NF-kappa B pathway.	[Karim, Zubair A.; Vemana, Hari Priya; Khasawneh, Fadi T.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Karim, ZA (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.	zkarim@westernu.edu			College of Pharmacy, Western University of Health Sciences, Pomona, CA	College of Pharmacy, Western University of Health Sciences, Pomona, CA	This work was supported by funds from the College of Pharmacy, Western University of Health Sciences, Pomona, CA (to F.T.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell RA, 2014, J CLIN INVEST, V124, P3757, DOI DOI 10.1172/JCI75247; Conner EM, 1997, J PHARMACOL EXP THER, V282, P1615; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Daniel J, 2010, NY TIMES BK REV, P6; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Lang F, 2013, THROMB HAEMOSTASIS, V110, P925, DOI 10.1160/TH13-02-0176; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Nayak MK, 2013, J BIOL CHEM, V288, P6826, DOI 10.1074/jbc.M112.403154; Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Ostrowska JK, 2004, THROMB HAEMOSTASIS, V92, P171, DOI 10.1160/TH03-11-0707; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pelzer C, 2013, NAT IMMUNOL, V14, P337, DOI 10.1038/ni.2540; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; READ MA, 1995, IMMUNITY, V2, P493, DOI 10.1016/1074-7613(95)90030-6; Rosebeck S, 2011, FUTURE ONCOL, V7, P613, DOI [10.2217/fon.11.35, 10.2217/FON.11.35]; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shi DS, 2014, J CLIN INVEST, V124, P3757, DOI 10.1172/JCI75247; Staal J, 2011, CELL RES, V21, P40, DOI 10.1038/cr.2010.168; STULL JT, 1993, MOL CELL BIOCHEM, V128, P229, DOI 10.1007/BF01076774; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Suzuki-Inoue K, 2007, THROMB RES, V120, P251, DOI 10.1016/j.thromres.2006.09.003; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wei SJ, 2013, ARTERIOSCL THROM VAS, V33, P241, DOI 10.1161/ATVBAHA.112.300781; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia LJ, 1998, BLOOD, V91, P1625, DOI 10.1182/blood.V91.5.1625.1625_1625_1632	45	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119363	10.1371/journal.pone.0119363	http://dx.doi.org/10.1371/journal.pone.0119363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748427	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400069
J	Luyet, C; Schulze, K; Sayar, BS; Howald, D; Muller, EJ; Galichet, A				Luyet, Camille; Schulze, Katja; Sayar, Beyza S.; Howald, Denise; Mueller, Eliane J.; Galichet, Arnaud			Preclinical Studies Identify Non-Apoptotic Low-Level Caspase-3 as Therapeutic Target in Pemphigus Vulgaris	PLOS ONE			English	Article							CELL-DEATH; TERMINAL DIFFERENTIATION; B IRRADIATION; ULTRAVIOLET-B; MOUSE MODEL; GRANZYME-B; C-MYC; ACTIVATION; MECHANISM; KERATINOCYTES	The majority of pemphigus vulgaris (PV) patients suffer from a live-threatening loss of intercellular adhesion between keratinocytes (acantholysis). The disease is caused by autoantibodies that bind to desmosomal cadherins desmoglein (Dsg) 3 or Dsg3 and Dsg1 in mucous membranes and skin. A currently unresolved controversy in PV is whether apoptosis is involved in the pathogenic process. The objective of this study was to perform preclinical studies to investigate apoptotic pathway activation in PV pathogenesis with the goal to assess its potential for clinical therapy. For this purpose, we investigated mouse and human skin keratinocyte cultures treated with PV antibodies (the experimental Dsg3 monospecific antibody AK23 or PV patients IgG), PV mouse models (passive transfer of AK23 or PVIgG into adult and neonatal mice) as well as PV patients' biopsies (n= 6). A combination of TUNEL assay, analyses of membrane integrity, early apoptotic markers such as cleaved poly-ADP-ribose polymerase (PARP) and the collapse of actin cytoskeleton failed to provide evidence for apoptosis in PV pathogenesis. However, the in vitro and in vivo PV models, allowing to monitor progression of lesion formation, revealed an early, transient and low-level caspase-3 activation. Pharmacological inhibition confirmed the functional implication of caspase-3 in major events in PV such as shedding of Dsg3, keratin retraction, proliferation including c-Myc induction, p38MAPK activation and acantholysis. Together, these data identify low-level caspase-3 activation downstream of disrupted Dsg3 trans-or cis-adhesion as a major event in PV pathogenesis that is non-synonymous with apoptosis and represents, unlike apoptotic components, a promising target for clinical therapy. At a broader level, these results posit that an impairment of adhesive functions in concert with low-level, non-lethal caspase-3 activation can evoke profound cellular changes which may be of relevance for other diseases including cancer.	[Luyet, Camille; Schulze, Katja; Sayar, Beyza S.; Howald, Denise; Mueller, Eliane J.; Galichet, Arnaud] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Mol Dermatol, Bern, Switzerland; [Luyet, Camille; Schulze, Katja; Sayar, Beyza S.; Howald, Denise; Mueller, Eliane J.; Galichet, Arnaud] Univ Bern, Vetsuisse Fac, DermFocus, Bern, Switzerland; [Mueller, Eliane J.] Univ Hosp Bern, Dept Dermatol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern	Galichet, A (corresponding author), Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Mol Dermatol, Bern, Switzerland.	arnaud.galichet@vetsuisse.unibe.ch			Coordination Theme I (Health) of the European Community's FP7 [HEALTH-F2-2008-200515]; Swiss National Science Foundation [31003A_135689]; Martha Stiftung Zurich; Novartis Research Fund, Basel, Switzerland	Coordination Theme I (Health) of the European Community's FP7; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Martha Stiftung Zurich; Novartis Research Fund, Basel, Switzerland	Financial support for CL, BS and AG from "Coordination Theme I (Health) of the European Community's FP7, grant agreement number HEALTH-F2-2008-200515", for CL, BS, KS also from the Swiss National Science Foundation grant 31003A_135689 and the Martha Stiftung Zurich and for KS from the Novartis Research Fund, Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novartis Foundation for biological-medical research is not a commercial source but a Foundation with no rights on generated data or material (please consult the home page http://www.stiftungmedbiol.novartis.com/index.html). This funding does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; [Anonymous], 2006, EMBO J; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Caldelari R, 2010, METHODS MOL BIOL, V633, P125, DOI 10.1007/978-1-59745-019-5_10; Cirillo N, 2008, EXP DERMATOL, V17, P858, DOI 10.1111/j.1600-0625.2008.00719.x; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; Daher A, 2006, EXP DERMATOL, V15, P23, DOI 10.1111/j.0906-6705.2005.00384.x; de Bruin A, 2007, EXP DERMATOL, V16, P468, DOI 10.1111/j.1600-0625.2007.00557.x; Demeret C, 2003, ONCOGENE, V22, P168, DOI 10.1038/sj.onc.1206108; Di Zenzo G, 2012, J CLIN INVEST, V122, P3781, DOI 10.1172/JCI64413; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Fischer U, 2005, CELL DEATH DIFFER, V12, P942, DOI 10.1038/sj.cdd.4401556; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod DR, 2005, J CELL SCI, V118, P5743, DOI 10.1242/jcs.02700; Gniadecki R, 1998, ARCH DERMATOL RES, V290, P528, DOI 10.1007/s004030050347; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Hanakawa Y, 2004, J INVEST DERMATOL, V123, P817, DOI 10.1111/j.0022-202X.2004.23479.x; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Hsu SL, 2006, APOPTOSIS, V11, P765, DOI 10.1007/s10495-006-5880-x; Ishii K, 1997, J IMMUNOL, V159, P2010; Janse IC, 2014, J INVEST DERMATOL, V134, P2039, DOI 10.1038/jid.2014.60; Jennings JM, 2011, J INVEST DERMATOL, V131, P706, DOI 10.1038/jid.2010.389; Khalil H, 2014, TRENDS CELL BIOL, V24, P83, DOI 10.1016/j.tcb.2013.08.002; Kim SM, 2009, TOXICOL APPL PHARM, V241, P210, DOI 10.1016/j.taap.2009.08.024; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Koch PJ, 1998, J CELL SCI, V111, P2529; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Li N, 2009, J IMMUNOL, V182, P711, DOI 10.4049/jimmunol.182.1.711; Lotti R, 2012, CURR PHARM BIOTECHNO, V13, P1877, DOI 10.2174/138920112802273236; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mao XM, 2014, J INVEST DERMATOL, V134, P68, DOI 10.1038/jid.2013.224; McComb S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015328; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Pacheco-Tovar D, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/563091; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perfettini JL, 2003, NAT IMMUNOL, V4, P308, DOI 10.1038/ni0403-308; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Puga I, 2008, IMMUNITY, V29, P193, DOI 10.1016/j.immuni.2008.06.010; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; Rodeck U, 1997, J CELL SCI, V110, P113; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Sayar BS, 2014, EXP DERMATOL, V23, P33, DOI 10.1111/exd.12290; Schmidt E, 2009, AUTOIMMUN REV, V8, P533, DOI 10.1016/j.autrev.2009.01.011; Schmidt E, 2009, AM J PHYSIOL-CELL PH, V296, pC162, DOI 10.1152/ajpcell.00161.2008; Schulze K, 2012, J INVEST DERMATOL, V132, P346, DOI 10.1038/jid.2011.299; Seiffert-Sinha K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106895; Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Suter MM, 1998, ADVANCES IN VETERINARY DERMATOLOGY, VOL 3, P321; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Veraitch O, 2013, J EUR ACAD DERMATOL, V27, P86, DOI 10.1111/j.1468-3083.2011.04363.x; Wang X, 2004, APOPTOSIS, V9, P131, DOI 10.1023/B:APPT.0000018795.05766.1f; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Wu NL, 2011, J INVEST DERMATOL, V131, P874, DOI 10.1038/jid.2010.402; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	74	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119809	10.1371/journal.pone.0119809	http://dx.doi.org/10.1371/journal.pone.0119809			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748204	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400088
J	Torres, LG; Sutton, PJH; Thompson, DR; Delord, K; Weimerskirch, H; Sagar, PM; Sommer, E; Dilley, BJ; Ryan, PG; Phillips, RA				Torres, Leigh G.; Sutton, Philip J. H.; Thompson, David R.; Delord, Karine; Weimerskirch, Henri; Sagar, Paul M.; Sommer, Erica; Dilley, Ben J.; Ryan, Peter G.; Phillips, Richard A.			Poor Transferability of Species Distribution Models for a Pelagic Predator, the Grey Petrel, Indicates Contrasting Habitat Preferences across Ocean Basins	PLOS ONE			English	Article							MARINE PREDATOR; SOUTHERN-OCEAN; REGRESSION; PREDICTION; ACCURACY; SENSITIVITY; SEABIRDS; BEHAVIOR; SUCCESS; REGIONS	Species distribution models (SDMs) are increasingly applied in conservation management to predict suitable habitat for poorly known populations. High predictive performance of SDMs is evident in validations performed within the model calibration area (interpolation), but few studies have assessed SDM transferability to novel areas (extrapolation), particularly across large spatial scales or pelagic ecosystems. We performed rigorous SDM validation tests on distribution data from three populations of a long-ranging marine predator, the grey petrel Procellaria cinerea, to assess model transferability across the Southern Hemisphere (25-65 degrees S). Oceanographic data were combined with tracks of grey petrels from two remote sub-Antarctic islands (Antipodes and Kerguelen) using boosted regression trees to generate three SDMs: one for each island population, and a combined model. The predictive performance of these models was assessed using withheld tracking data from within the model calibration areas (interpolation), and from a third population, Marion Island (extrapolation). Predictive performance was assessed using k-fold cross validation and point biserial correlation. The two population-specific SDMs included the same predictor variables and suggested birds responded to the same broad-scale oceanographic influences. However, all model validation tests, including of the combined model, determined strong interpolation but weak extrapolation capabilities. These results indicate that habitat use reflects both its availability and bird preferences, such that the realized distribution patterns differ for each population. The spatial predictions by the three SDMs were compared with tracking data and fishing effort to demonstrate the conservation pitfalls of extrapolating SDMs outside calibration regions. This exercise revealed that SDM predictions would have led to an underestimate of overlap with fishing effort and potentially misinformed bycatch mitigation efforts. Although SDMs can elucidate potential distribution patterns relative to large-scale climatic and oceanographic conditions, knowledge of local habitat availability and preferences is necessary to understand and successfully predict region-specific realized distribution patterns.	[Torres, Leigh G.] Oregon State Univ, Dept Fisheries & Wildlife, Marine Mammal Inst, Newport, OR 97365 USA; [Sutton, Philip J. H.; Thompson, David R.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Delord, Karine; Weimerskirch, Henri] Ctr Etud Biol Chize, CNRS UPR 1934, Villiers En Bois, France; [Sagar, Paul M.] Natl Inst Water & Atmospher Res Ltd, Christchurch, New Zealand; [Sommer, Erica] Denny Ecol, Cambridge, England; [Dilley, Ben J.; Ryan, Peter G.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Phillips, Richard A.] NERC, British Antarctic Survey, Cambridge, England	Oregon State University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Centre National de la Recherche Scientifique (CNRS); National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Research Foundation - South Africa; University of Cape Town; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Torres, LG (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Marine Mammal Inst, Newport, OR 97365 USA.	leigh.torres@oregonstate.edu	Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019; Thompson, David R/E-2431-2018	Weimerskirch, Henri/0000-0002-0457-586X; Thompson, David R/0000-0001-8518-6307; Sutton, Phil/0000-0003-2936-0918	National Institute of Water and Atmospheric Research, Ltd. (NIWA); New Zealand Ministry for Primary Industries [PRO2006-01]; Institut Polaire Francais Paul-Emile Victor (IPEV, programme) [109]; Prince Albert II de Monaco Foundation; Program ANR Biodiversite REMIGE; Program ANR 07 Biodiv 'Glides'; South African National Antarctic Programme; BirdLife International's Seabird Tracking Fund; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	National Institute of Water and Atmospheric Research, Ltd. (NIWA); New Zealand Ministry for Primary Industries; Institut Polaire Francais Paul-Emile Victor (IPEV, programme); Prince Albert II de Monaco Foundation; Program ANR Biodiversite REMIGE(French National Research Agency (ANR)); Program ANR 07 Biodiv 'Glides'(French National Research Agency (ANR)); South African National Antarctic Programme; BirdLife International's Seabird Tracking Fund; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding and support for this study was provided by the National Institute of Water and Atmospheric Research, Ltd. (NIWA), the New Zealand Ministry for Primary Industries (PRO2006-01), the Institut Polaire Francais Paul-Emile Victor (IPEV, programme no. 109, HW), the Prince Albert II de Monaco Foundation, Program ANR Biodiversite 2005-11 REMIGE, and Program ANR 07 Biodiv 'Glides'. Research at Marion Island is supported by the South African National Antarctic Programme and GLS loggers for this colony were sponsored by BirdLife International's Seabird Tracking Fund. Denny Ecology provided support in the form of a salary for author ES, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aarts G, 2013, J ANIM ECOL, V82, P1135, DOI 10.1111/1365-2656.12061; Barbraud C, 2009, ANIM CONSERV, V12, P258, DOI 10.1111/j.1469-1795.2009.00248.x; BARTLE J A, 1990, Notornis, V37, P146; Bell E, 2002, GREY PETRELS PROCELL; Bester MN, 2002, S AFR J WILDL RES, V32, P65; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Birdlife International, 2013, SEAB TRACK DAT; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; Compton TJ, 2013, J BIOGEOGR, V40, P75, DOI 10.1111/j.1365-2699.2012.02761.x; Dunn JR, 2002, DEEP-SEA RES PT I, V49, P591, DOI 10.1016/S0967-0637(01)00069-3; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Gille ST, 2003, J PHYS OCEANOGR, V33, P1167, DOI 10.1175/1520-0485(2003)033<1167:FOOTSO>2.0.CO;2; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hyrenbach KD, 2006, MAR ECOL PROG SER, V324, P271, DOI 10.3354/meps324271; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Leftwich KN, 1997, T AM FISH SOC, V126, P725, DOI 10.1577/1548-8659(1997)126<0725:FIBATO>2.3.CO;2; Louzao M, 2012, ECOGRAPHY, V35, P1; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Martin J, 2012, J APPL ECOL, V49, P621, DOI 10.1111/j.1365-2664.2012.02139.x; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; Merow C, 2014, ECOGRAPHY; Moore JE, 2008, ANIM CONSERV, V11, P257, DOI 10.1111/j.1469-1795.2008.00197.x; Murray JV, 2011, AUSTRAL ECOL, V36, P76, DOI 10.1111/j.1442-9993.2010.02122.x; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Oppel S, 2012, BIOL CONSERV, V156, P94, DOI 10.1016/j.biocon.2011.11.013; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Ridgeway G, 2007, GEN BOOSTED REGRESSI; Ridoux Vincent, 1994, Marine Ornithology, V22, P1; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Ryan PG., 2008, PRINCE EDWARD ISLAND, P121, DOI [DOI 10.18820/9781928357063/06, https://doi.org/10.18820/9781928357063/06]; Soanes LM, 2013, J APPL ECOL, V50, P671, DOI 10.1111/1365-2664.12069; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Sommer E, 2010, ANTIPODES ISLAND WHI; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thiebot JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071429; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Torres LG, 2013, DIVERS DISTRIB, V19, P1138, DOI 10.1111/ddi.12069; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Vanreusel W, 2007, CONSERV BIOL, V21, P201, DOI 10.1111/j.1523-1739.2006.00577.x; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203; Whittingham MJ, 2003, ECOGRAPHY, V26, P521, DOI 10.1034/j.1600-0587.2003.03522.x; Xavier JC, 2013, ICES J MAR SCI, V70, P46, DOI 10.1093/icesjms/fss167; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004; Zharikov Y, 2007, J APPL ECOL, V44, P748, DOI 10.1111/j.1365-2664.2007.01319.x; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x; Zydelis R, 2011, P ROY SOC B-BIOL SCI, V278, P3191, DOI 10.1098/rspb.2011.0330	61	59	61	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120014	10.1371/journal.pone.0120014	http://dx.doi.org/10.1371/journal.pone.0120014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748948	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000350689400092
J	Zhang, ZL; Bai, ZH; Wang, XB; Bai, L; Miao, F; Pei, HH				Zhang, Zheng-liang; Bai, Zheng-hai; Wang, Xiao-bo; Bai, Ling; Miao, Fei; Pei, Hong-hong			miR-186 and 326 Predict the Prognosis of Pancreatic Ductal Adenocarcinoma and Affect the Proliferation and Migration of Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; MICRORNA; EXPRESSION; SURVIVAL; INVASION; TARGETS; ASSOCIATION; DIAGNOSIS; ACTS	MicroRNAs can function as key tumor suppressors or oncogenes and act as biomarkers for cancer diagnosis or prognosis. Although high-throughput assays have revealed many miRNA biomarkers for pancreatic ductal adenocarcinoma (PDAC), only a few have been validated in independent populations or investigated for functional significance in PDAC pathogenesis. In this study, we correlated the expression of 36 potentially prognostic miRNAs within PDAC tissue with clinico-pathological features and survival in 151 Chinese patients. We then analyzed the functional roles and target genes of two miRNAs in PDAC development. We found that high expression of miR-186 and miR-326 predict poor and improved survival, respectively. miR-186 was over-expressed in PDAC patients compared with controls, especially in patients with large tumors (> 2 cm), lymph node metastasis, or short-term survival (< 24 months). In contrast, miR-326 was down-regulated in patients compared with controls and displayed relatively increased expression in the patients with long-term survival or without venous invasion. Functional experiments revealed that PDAC cell proliferation and migration was decreased following inhibition and enhanced following over-expression of miR-186. In contrast, it was enhanced following inhibition and decreased after over-expression of miR-326. A luciferase assay indicated that miR-186 can bind directly to the 3'-UTR of NR5A2 to repress gene expression. These findings suggest that miR-186 over-expression contributes to the invasive potential of PDAC, likely via suppression of NR5A2, thereby leading to a poor prognosis; high miR-326 expression prolongs survival likely via the decreasing invasive potential of PDAC cells. These two miRNAs can be used as markers for clinical diagnosis and prognosis, and they represent therapeutic targets for PDAC.	[Zhang, Zheng-liang; Bai, Zheng-hai; Wang, Xiao-bo; Bai, Ling; Miao, Fei; Pei, Hong-hong] Xi An Jiao Tong Univ, Affiliated Hosp 2, Emergency Dept, Xian 710004, Shaan Xi, Peoples R China	Xi'an Jiaotong University	Pei, HH (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Emergency Dept, Xian 710004, Shaan Xi, Peoples R China.	peihonghongtwoyuan@163.com			Social Development Guide Plan of Xi'an [5F1203(5)]; Support Project for Youth of The Second Affiliated Hospital of Xi'an Jiaotong University [YJ(QN) 201204]	Social Development Guide Plan of Xi'an; Support Project for Youth of The Second Affiliated Hospital of Xi'an Jiaotong University	The project was supported by the Social Development Guide Plan of Xi'an (5F1203(5)) and the Support Project for Youth of The Second Affiliated Hospital of Xi'an Jiaotong University (YJ(QN) 201204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2013, INDIAN J MED RES, V137, P680; Ben-Moshe NB, 2012, NUCLEIC ACIDS RES, V40, P10614, DOI 10.1093/nar/gks841; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat K, 2012, CURR PHARM DESIGN, V18, P2439, DOI 10.2174/13816128112092439; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Dayem Ullah AZ, 2014, INDIAN J MED RES, V42, pD944, DOI [10.1093/0343959, DOI 10.1093/0343959]; Erdmann K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-82; Flandez M, 2014, GUT, V63, P647, DOI 10.1136/gutjnl-2012-304381; Giovannetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049145; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Jiao LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032068; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Laurila EM, 2012, GENE CHROMOSOME CANC, V51, P557, DOI 10.1002/gcc.21941; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HL, 2013, CARCINOGENESIS, V34, P2145, DOI 10.1093/carcin/bgt158; Liffers ST, 2011, LAB INVEST, V91, P1472, DOI 10.1038/labinvest.2011.99; Long J, 2014, CANCER LETT, V346, P273, DOI 10.1016/j.canlet.2014.01.004; Molero X, 2012, GUT, V61, P1187, DOI 10.1136/gutjnl-2011-300360; Nagao Y, 2012, MODERN PATHOL, V25, P112, DOI 10.1038/modpathol.2011.142; Papaconstantinou IG, 2013, PANCREAS, V42, P67, DOI 10.1097/MPA.0b013e3182592ba7; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Saif MW, 2006, J PANCREAS, V7, P337; von Figura G, 2014, GUT, V63, P656, DOI 10.1136/gutjnl-2012-304287; Wang S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0373-y; Xue Y, 2013, CANCER GENET-NY, V206, P217, DOI 10.1016/j.cancergen.2013.05.020; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yu J, 2010, CANCER BIOL THER, V10, P748, DOI 10.4161/cbt.10.8.13083; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	37	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118814	10.1371/journal.pone.0118814	http://dx.doi.org/10.1371/journal.pone.0118814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742499	Green Published, Green Submitted, gold			2022-12-27	WOS:000350688100049
J	Huang, TH; Yang, J; Liu, GP; Jin, W; Liu, Z; Zhao, SH; Yao, M				Huang, Tinghua; Yang, Jun; Liu, Guopin; Jin, Wei; Liu, Zhi; Zhao, Shuhong; Yao, Min			Quantification of Mature MicroRNAs Using Pincer Probes and Real-Time PCR Amplification	PLOS ONE			English	Article							EXPRESSION; RNAS; TISSUES; CELLS; ASSAY	The robust and reliable detection of small microRNAs (miRNAs) is important to understand the functional significance of miRNAs. Several methods can be used to quantify miRNAs. Selectively quantifying mature miRNAs among miRNA precursors, pri-miRNAs, and other miRNA-like sequences is challenging because of the short length of miRNAs. In this study, we developed a two-step miRNA quantification system based on pincer probe capture and real-time PCR amplification. The performance of the method was tested using synthetic mature miRNAs and clinical RNA samples. Results showed that the method demonstrated dynamic range of seven orders of magnitude and sensitivity of detection of hundreds of copies of miRNA molecules. The use of pincer probes allowed excellent discrimination of mature miRNAs from their precursors with five Cq (quantification cycle) values difference. The developed method also showed good discrimination of highly homologous family members with cross reaction less than 5%. The pincer probe-based approach is a potential alternative to currently used methods for mature miRNA quantification.	[Huang, Tinghua; Liu, Guopin; Jin, Wei] Yangtze Univ, Black Pig Res Inst, Jinzhou, Hubei, Peoples R China; [Huang, Tinghua; Yang, Jun; Liu, Guopin; Liu, Zhi; Yao, Min] Yangtze Univ, Coll Anim Sci, Jinzhou, Hubei, Peoples R China; [Zhao, Shuhong] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China	Yangtze University; Yangtze University; Huazhong Agricultural University	Zhao, SH (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China.	minyao01@126.com			National Natural Science Foundation of China [31402055, 30671138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This project was supported by the National Natural Science Foundation of China (Grant No. 31402055 and 30671138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Duncan DD, 2006, ANAL BIOCHEM, V359, P268, DOI 10.1016/j.ab.2006.08.022; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jonstrup SP, 2006, RNA, V12, P1747, DOI 10.1261/rna.110706; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Lingam Swathi, 2014, Microrna, V3, P18; Lu David P, 2005, J RNAi Gene Silencing, V1, P44; Mocellin S, 2003, TRENDS MOL MED, V9, P189, DOI 10.1016/S1471-4914(03)00047-9; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Siva AC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-17; Streit S, 2009, NAT PROTOC, V4, P37, DOI 10.1038/nprot.2008.216; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tang FC, 2006, NAT PROTOC, V1, P1154, DOI 10.1038/nprot.2006.161; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Wang XS, 2010, INT J MOL SCI, V11, P3138, DOI 10.3390/ijms11093138; Yang HP, 2009, PLANT BIOTECHNOL J, V7, P621, DOI 10.1111/j.1467-7652.2009.00429.x; Yao B, 2009, RNA, V15, P1787, DOI 10.1261/rna.1555209; Zhang DC, 2013, MICROCHIM ACTA, V180, P397, DOI 10.1007/s00604-013-0945-3; Zhang Qi, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P87; Zhou YT, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq556	33	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120160	10.1371/journal.pone.0120160	http://dx.doi.org/10.1371/journal.pone.0120160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768430	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500112
J	Kenealy, TW; Parsons, MJG; Rouse, APB; Doughty, RN; Sheridan, NF; Hindmarsh, JKH; Masson, SC; Rea, HH				Kenealy, Timothy W.; Parsons, Matthew J. G.; Rouse, A. Paul B.; Doughty, Robert N.; Sheridan, Nicolette F.; Hindmarsh, Jennifer K. Harre; Masson, Sarah C.; Rea, Harry H.			Telecare for Diabetes, CHF or COPD: Effect on Quality of Life, Hospital Use and Costs. A Randomised Controlled Trial and Qualitative Evaluation	PLOS ONE			English	Article							WHOLE SYSTEMS DEMONSTRATOR; HEART-FAILURE INDEX; SELF-CARE; RESPIRATORY QUESTIONNAIRE; TELEHEALTH QUESTIONNAIRE; HEALTH-CARE; IMPLEMENTATION; SERVICES; OUTCOMES; DISEASE	Objectives To assess the effect of telecare on health related quality of life, self-care, hospital use, costs and the experiences of patients, informal carers and health care professionals. Methods Patients were randomly assigned either to usual care or to additionally entering their data into a commercially-available electronic device that uploaded data once a day to a nurse-led monitoring station. Patients had congestive heart failure (Site A), chronic obstructive pulmonary disease (Site B), or any long-term condition, mostly diabetes (Site C). Site C contributed only intervention patients - they considered a usual care option to be unethical. The study took place in New Zealand between September 2010 and February 2012, and lasted 3 to 6 months for each patient. The primary outcome was health-related quality of life (SF36). Data on experiences were collected by individual and group interviews and by questionnaire. Results There were 171 patients (98 intervention, 73 control). Quality of life, self-efficacy and disease-specific measures did not change significantly, while anxiety and depression both decreased significantly with the intervention. Hospital admissions, days in hospital, emergency department visits, outpatient visits and costs did not differ significantly between the groups. Patients at all sites were universally positive. Many felt safer and more cared-for, and said that they and their family had learned more about managing their condition. Staff could all see potential benefits of telecare, and, after some initial technical problems, many staff felt that telecare enabled them to effectively monitor more patients. Conclusions Strongly positive patient and staff experiences and attitudes complement and contrast with small or non-significant quantitative changes. Telecare led to patients and families taking a more active role in self-management. It is likely that subgroups of patients benefitted in ways that were not measured or visible within the quantitative data, especially feelings of safety and being cared-for.	[Kenealy, Timothy W.] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; [Parsons, Matthew J. G.] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Rouse, A. Paul B.] Univ Auckland, Univ Auckland Business Sch, Dept Accounting & Finance, Auckland 1, New Zealand; [Doughty, Robert N.; Rea, Harry H.] Univ Auckland, Dept Med, Auckland 1, New Zealand; [Doughty, Robert N.] Auckland City Hosp, Greenlane Cardiovasc Serv, Auckland, New Zealand; [Sheridan, Nicolette F.; Masson, Sarah C.] Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand; [Hindmarsh, Jennifer K. Harre] Ngati Porou Hauora Charitable Trust, Te Puia Springs, Tairawhiti East, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland; Auckland City Hospital; University of Auckland	Kenealy, TW (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand.	t.kenealy@auckland.ac.nz		Kenealy, Timothy/0000-0001-6002-4766; Sheridan, Nicolette/0000-0002-8098-2918; Parsons, Matthew/0000-0003-2004-1347	New Zealand Ministry of Health and District Health Boards New Zealand: Primary Health Care Strategic Innovations Fund [330530/00]	New Zealand Ministry of Health and District Health Boards New Zealand: Primary Health Care Strategic Innovations Fund	This work was supported by New Zealand Ministry of Health and District Health Boards New Zealand: Primary Health Care Strategic Innovations Fund, Agreement number 330530/00. http://www.dhbsharedservices.health.nz/site/sig/primary-care/innovations-area.aspx Note, this fund ran from 2007-9, see file:///C:/Users/tken008/Downloads/InnovFund %20Information%20for%20website%20Sept09.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwani S., 2003, DECADES DISPARITY ET; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Benzeval M, 1995, TACKLING INEQUALITIE; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Boutron I, 2008, ANN INTERN MED, V148, pW60, DOI 10.7326/0003-4819-148-4-200802190-00008-w1; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Cartwright M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f653; Cooper R., 1991, DESIGN COST MANAGEME; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; Goldberg LR, 2003, AM HEART J, V146, P705, DOI 10.1016/S0002-8703(03)00393-4; Greenhalgh T, 2011, MILBANK Q, V89, P533, DOI 10.1111/j.1468-0009.2011.00642.x; Henderson C, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1035; Hendy J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-403; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Lorig K R, 2001, Eff Clin Pract, V4, P256; McAuley KA, 2003, ASIA PAC J CLIN NUTR, V12, P423; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; McLean S, 2011, COCHRANE DB SYST REV; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Parsons J, 2012, AGE AGEING, V41, P24, DOI 10.1093/ageing/afr118; Pawson R., 1997, REALISTIC EVALUATION; Phillips GA, 2006, MED J AUSTRALIA, V184, P602, DOI 10.5694/j.1326-5377.2006.tb00412.x; Riegel B, 2004, J CARD FAIL, V10, P350, DOI 10.1016/j.cardfail.2003.12.001; Riegel B, 2009, J CARDIOVASC NURS, V24, P485, DOI 10.1097/JCN.0b013e3181b4baa0; Roisin R, 2011, GLOBAL STRATEGY INIT; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Satterfield DW, 2003, DIABETES CARE, V26, P2643, DOI 10.2337/diacare.26.9.2643; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Steventon A, 2013, AGE AGEING, V42, P501, DOI 10.1093/ageing/aft008; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; World Health Organization, 2005, PREP HLTH CAR WORKF; Wyrwich KW, 2005, HEALTH SERV RES, V40, P577, DOI 10.1111/j.1475-6773.2005.0l374.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	51	53	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116188	10.1371/journal.pone.0116188	http://dx.doi.org/10.1371/journal.pone.0116188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768023	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500005
J	Prohl, A; Lohr, M; Ostermann, C; Liebler-Tenorio, E; Berndt, A; Schroedl, W; Rothe, M; Schubert, E; Sachse, K; Reinhold, P				Prohl, Annette; Lohr, Markus; Ostermann, Carola; Liebler-Tenorio, Elisabeth; Berndt, Angela; Schroedl, Wieland; Rothe, Michael; Schubert, Evelyn; Sachse, Konrad; Reinhold, Petra			Enrofloxacin and Macrolides Alone or in Combination with Rifampicin as Antimicrobial Treatment in a Bovine Model of Acute Chlamydia psittaci Infection	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SUBCLINICAL PULMONARY ABSCESSES; CHLAMYDOPHILA-PSITTACI; NONGONOCOCCAL URETHRITIS; NATURAL COURSE; EFFICACY; PHARMACOKINETICS; DOXYCYCLINE; AZITHROMYCIN; SAFETY	Chlamydia psittaci is a zoonotic bacterium with a wide host range that can cause respiratory disease in humans and cattle. In the present study, effects of treatment with macrolides and quinolones applied alone or in combination with rifampicin were tested in a previously established bovine model of respiratory C. psittaci infection. Fifty animals were inoculated intrabronchially at the age of 6-8 weeks. Seven served as untreated controls, the others were assigned to seven treatment groups: (i) rifampicin, (ii) enrofloxacin, (iii) enrofloxacin + rifampicin, (iv) azithromycin, (v) azithromycin + rifampicin, (vi) erythromycin, and (vii) erythromycin + rifampicin. Treatment started 30 hours after inoculation and continued until 14 days after inoculation (dpi), when all animals were necropsied. The infection was successful in all animals and sufficient antibiotic levels were detected in blood plasma and tissue of the treated animals. Reisolation of the pathogen was achieved more often from untreated animals than from other groups. Nevertheless, pathogen detection by PCR was possible to the same extent in all animals and there were no significant differences between treated and untreated animals in terms of local (i.e. cell count and differentiation of BALF-cells) and systemic inflammation (i.e. white blood cells and concentration of acute phase protein LBP), clinical signs, and pathological findings at necropsy. Regardless of the reduced reisolation rate in treated animals, the treatment of experimentally induced respiratory C. psittaci infection with enrofloxacin, azithromycin or erythromycin alone or in combination with rifampicin was without obvious benefit for the host, since no significant differences in clinical and pathological findings or inflammatory parameters were detected and all animals recovered clinically within two weeks.	[Prohl, Annette; Lohr, Markus; Ostermann, Carola; Liebler-Tenorio, Elisabeth; Berndt, Angela; Schubert, Evelyn; Sachse, Konrad; Reinhold, Petra] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, D-07743 Jena, Germany; [Schroedl, Wieland] Univ Leipzig, Fac Vet, Inst Bacteriol & Mycol, D-04103 Leipzig, Germany; [Rothe, Michael] LIPIDOMIX GmbH, D-13125 Berlin, Germany; [Schubert, Evelyn; Sachse, Konrad] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, OIE Reference Lab Chlamydiosis, D-07743 Jena, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Leipzig University; Friedrich Loeffler Institute	Reinhold, P (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Naumburger Str 96a, D-07743 Jena, Germany.	petra.reinhold@fli.bund.de	Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786	Federal Ministry of Education and Research (BMBF) of Germany [01 KI 0720]; LIPIDOMIX GmbH	Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF)); LIPIDOMIX GmbH	This study was financially supported by the Federal Ministry of Education and Research (BMBF) of Germany under Grant no. 01 KI 0720 "Zoonotic chlamydiae-Models of chronic and persistent infections in humans and animals". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LIPIDOMIX GmbH provided support in the form of salaries for author Michael Rothe, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	ACOCELLA G, 1983, REV INFECT DIS, V5, pS428; ACOCELLA G, 1978, CLIN PHARMACOKINET, V3, P108, DOI 10.2165/00003088-197803020-00002; Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Biesenkamp-Uhe C, 2007, INFECT IMMUN, V75, P870, DOI 10.1128/IAI.00691-06; Binet R, 2005, ANTIMICROB AGENTS CH, V49, P4455, DOI 10.1128/AAC.49.11.4455-4464.2005; Binet R, 2005, ANTIMICROB AGENTS CH, V49, P2865, DOI 10.1128/AAC.49.7.2865-2873.2005; BLOCK S, 1995, PEDIATR INFECT DIS J, V14, P471, DOI 10.1097/00006454-199506000-00002; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; BOVARNICK MR, 1950, J BACTERIOL, V59, P509, DOI 10.1128/JB.59.4.509-522.1950; Branley JM, 2008, EUR J CLIN MICROBIOL, V27, P269, DOI 10.1007/s10096-007-0431-0; BURROWS GE, 1980, J AM VET MED ASSOC, V176, P1072; Butaye P, 1997, ANTIMICROB AGENTS CH, V41, P2800, DOI 10.1128/AAC.41.12.2800; CAY B, 1989, VET MICROBIOL, V20, P123, DOI 10.1016/0378-1135(89)90035-7; Davis R, 1996, DRUGS, V51, P1019, DOI 10.2165/00003495-199651060-00010; Dessus-Babus S, 1998, ANTIMICROB AGENTS CH, V42, P2474, DOI 10.1128/AAC.42.10.2474; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Dukers-Muijrers NHTM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034108; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; EMEA, 2000, PROD TEAFTEOM UNIT V; *EMEA, 1998, 2 EMEA COMM VET MED; File TM, 1997, ANTIMICROB AGENTS CH, V41, P1965, DOI 10.1128/AAC.41.9.1965; Finch R, 2002, ANTIMICROB AGENTS CH, V46, P1746, DOI 10.1128/AAC.46.6.1746-1754.2002; Gao X, 2008, J STAT PLAN INFER, V138, P2574, DOI 10.1016/j.jspi.2007.10.015; Gerhardt N, 2006, VET REC, V159, P591, DOI 10.1136/vr.159.18.591; Griffith JE, 2010, J VET PHARMACOL THER, V33, P595, DOI 10.1111/j.1365-2885.2010.01169.x; Guzman DSM, 2010, J AVIAN MED SURG, V24, P35, DOI 10.1647/2009-009R.1; HAIGHT TH, 1952, P SOC EXP BIOL MED, V81, P188, DOI 10.3181/00379727-81-19817; Hammerschlag MR, 2000, INT J ANTIMICROB AG, V15, P149, DOI 10.1016/S0924-8579(00)00157-6; Harkinezhad T, 2007, J MED MICROBIOL, V56, P1097, DOI 10.1099/jmm.0.47157-0; Harris JAS, 1998, PEDIATR INFECT DIS J, V17, P865, DOI 10.1097/00006454-199810000-00004; Heddema ER, 2006, J MED MICROBIOL, V55, P1571, DOI 10.1099/jmm.0.46692-0; Hothorn T, 2008, J STAT SOFTW, V28, P1; Jaeger J, 2007, VET RES, V38, P711, DOI 10.1051/vetres:2007027; KAARTINEN L, 1995, J VET PHARMACOL THER, V18, P357, DOI 10.1111/j.1365-2885.1995.tb00604.x; Kauffold J, 2007, ANIM REPROD SCI, V102, P111, DOI 10.1016/j.anireprosci.2006.10.013; Kauffold J, 2006, THERIOGENOLOGY, V66, P1816, DOI 10.1016/j.theriogenology.2006.04.042; Knittler MR, 2014, INT J MED MICROBIOL, V304, P877, DOI 10.1016/j.ijmm.2014.06.010; Konietschke F, 2014, J STAT SOFTW, V61, P1; Krautwald-Junghanns ME, 2013, TIERAERZTL PRAX K H, V41, P392; Krebber R, 2009, ANAL CHIM ACTA, V637, P208, DOI 10.1016/j.aca.2008.11.006; Lakritz J, 1997, AM J VET RES, V58, P56; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Lemon J., 2006, R R NEWS; Lenart J, 2001, ANTIMICROB AGENTS CH, V45, P2198, DOI 10.1128/AAC.45.8.2198-2203.2001; Lenzko H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-29; LIPSKY BA, 1990, AM J MED, V89, P722, DOI 10.1016/0002-9343(90)90212-V; LODE H, 1991, EUR J CLIN MICROBIOL, V10, P807, DOI 10.1007/BF01975832; MALINVERNI R, 1995, ANTIMICROB AGENTS CH, V39, P45, DOI 10.1128/AAC.39.1.45; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; McKellar Q, 1999, ANTIMICROB AGENTS CH, V43, P1988, DOI 10.1128/AAC.43.8.1988; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Moola S, 1999, CHEST, V116, P974, DOI 10.1378/chest.116.4.974; Morre SA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/095646202762226092; Morrissey I, 2002, J ANTIMICROB CHEMOTH, V49, P757, DOI 10.1093/jac/dkf031; NELSON S, 1987, AM REV RESPIR DIS, V136, P1207, DOI 10.1164/ajrccm/136.5.1207; Osman KM, 2013, TRANSBOUND EMERG DIS, V60, P245, DOI 10.1111/j.1865-1682.2012.01337.x; Ostermann C, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-10; Ostermann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064066; Ostermann C, 2013, VET J, V196, P351, DOI 10.1016/j.tvjl.2012.10.035; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Patel T, 2000, RESP MED, V94, P97, DOI 10.1053/rmed.1999.0710; Pitt RA, 2013, INT J STD AIDS, V24, P469, DOI 10.1177/0956462412472815; Prohl A, 2014, PATHOG DIS, P1, DOI [10.1111/2049-632X.12211, DOI 10.1111/2049-632X.12211]; Prohl A, 2014, JOVE-J VIS EXP, DOI 10.3791/51557; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030125; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; Reinhold P, 2011, VET J, V187, P405, DOI 10.1016/j.tvjl.2010.01.008; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Schwebke JR, 2011, CLIN INFECT DIS, V52, P163, DOI 10.1093/cid/ciq074; Senn L, 2005, EXPERT OPIN PHARMACO, V6, P2281, DOI 10.1517/14656566.6.13.2281; Smith KA, 2010, COMPENDIUM MEASURES; Solidoro P, 2013, Minerva Med, V104, P7; STJEAN G, 1991, VET CLIN N AM-FOOD A, V7, P793, DOI 10.1016/S0749-0720(15)31085-9; Theegarten D, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-14; THORNSBERRY C, 1983, REV INFECT DIS, V5, pS412; Thorpe EM, 1996, GENITOURIN MED, V72, P93; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Vanrompay D, 2007, EMERG INFECT DIS, V13, P1108, DOI 10.3201/eid1307.070074; Venner M, 2013, J VET INTERN MED, V27, P171, DOI 10.1111/jvim.12030; Venner M, 2012, VET J, V192, P293, DOI 10.1016/j.tvjl.2011.07.004; Verminnen K, 2008, J CLIN MICROBIOL, V46, P281, DOI 10.1128/JCM.01153-07; WEHRLI W, 1983, REV INFECT DIS, V5, pS407; Whatley J D, 1991, Int J STD AIDS, V2, P248; Wolf K, 1999, ANTIMICROB AGENTS CH, V43, P1491, DOI 10.1128/AAC.43.6.1491; Wolf K, 2010, APPROACHES ANTIMICRO, P36	86	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119736	10.1371/journal.pone.0119736	http://dx.doi.org/10.1371/journal.pone.0119736			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768665	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500096
J	Yang, XL; Liu, CX; Zhang, JX; Han, HY; Wang, XY; Liu, ZL; Xu, YM				Yang, Xinglong; Liu, Chuanxin; Zhang, Jinxiang; Han, Hongying; Wang, Xiuyan; Liu, Zhoulin; Xu, Yanming			Association of Histamine N-Methyltransferase Thr105Ile Polymorphism with Parkinson's Disease and Schizophrenia in Han Chinese: A Case-Control Study	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; METABOLIZING ENZYMES; NEURONAL DEATH; MODEL; DOPAMINE; RISK; GENE; PREVALENCE; ANTAGONISM; MUTATIONS	Parkinson's disease (PD) and schizophrenia (SCZ) are frequent central nervous disorders that have unclear etiologies but that show similarities in their pathogenesis. Since elevated histamine levels in the brain have been associated with PD and SCZ, we wanted to explore whether the Thr105Ile substitution in the histamine N-methyltransferase gene (HNMT-Thr105Ile), which impairs histamine degradation, is associated with either disease. We used the ligase detection reaction to genotype a case-control cohort of Han Chinese patients with PD or SCZ and healthy controls at the HNMT-Thr105Ile locus. The Ile allele was associated with reduced risk of PD (OR 0.516, 95% CI 0.318 to 0.838, p = 0.007) and of SCZ (OR 0.499, 95% CI 0.288 to 0.865, p = 0.011). Genotype frequencies and minor allele frequencies were similar between patients and controls when we compared males with females or early-onset patients with late-onset ones. Genotype and allele frequencies were not significantly different between PD patients with dyskinesia and PD patients without dyskinesia. Our results suggest that the heterozygous Thr/Ile genotype at the HNMT-Thr105Ile locus and the minor Ile105 allele protect against PD and SCZ in Han Chinese.	[Yang, Xinglong; Xu, Yanming] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610041, Sichuan Provinc, Peoples R China; [Liu, Chuanxin] Sichuan Univ, Coll Basic & Forens Med, Chengdu 610041, Sichuan Provinc, Peoples R China; [Liu, Chuanxin] Jining Med Coll, Dept Psychiat, Jining 272051, Shandong, Peoples R China; [Zhang, Jinxiang] Jining Mental Hosp, Dept Psychiat, Jining 272051, Shandong, Peoples R China; [Han, Hongying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Psychiat, Guangzhou 510630, Guangdong, Peoples R China; [Wang, Xiuyan] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha 410011, Hunan, Peoples R China; [Liu, Zhoulin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China	Sichuan University; Sichuan University; Jining Medical University; Sun Yat Sen University; Central South University; Sun Yat Sen University	Xu, YM (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan Provinc, Peoples R China.	neuroxym999@163.com	Xu, yanming/Q-4931-2019		National Natural Science Foundation of China [81471300]; Sichuan Province Applied Basic Research Program [2014JY0247]; Sichuan Key Project of Science and Technology [2010SZ0086]; Ministry of Science and Technology of China [2012AA02A514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Applied Basic Research Program; Sichuan Key Project of Science and Technology; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the National Natural Science Foundation of China (no. 81471300), the Sichuan Province Applied Basic Research Program (no. 2014JY0247), the Sichuan Key Project of Science and Technology (no. 2010SZ0086) and the Ministry of Science and Technology of China (2012AA02A514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2014, J CLIN PSYCHIAT, V75, P274, DOI [10.4088/JCP.13078co7c, 10.4088/JCP.13078tx2c]; Agundez JAG, 2008, NEUROMOL MED, V10, P10, DOI 10.1007/s12017-007-8017-7; Alonso-Navarro H, 2014, CURR DRUG METAB, V15, P129, DOI 10.2174/138920021502140327175404; Anichtchik OV, 2000, EXP NEUROL, V163, P20, DOI 10.1006/exnr.2000.7362; Brisch R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00047; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Chen GL, 2002, CLIN CHIM ACTA, V326, P163, DOI 10.1016/S0009-8981(02)00299-1; Chen ML, 2014, PARKINSONISM RELAT D, V20, P280, DOI 10.1016/j.parkreldis.2013.11.009; COELHO MH, 1991, MOL CHEM NEUROPATHOL, V14, P77, DOI 10.1007/BF03159928; DUCH DS, 1978, BIOCHEM PHARMACOL, V27, P1507, DOI 10.1016/0006-2952(78)90109-0; First MB, 1996, PSYCHIAT CLIN N AM, V19, P29, DOI 10.1016/S0193-953X(05)70271-9; Garcia-Martin E, 2007, CLIN EXP ALLERGY, V37, P1175, DOI 10.1111/j.1365-2222.2007.02769.x; Garcia-Martin E, 2009, PHARMACOGENOMICS, V10, P867, DOI 10.2217/PGS.09.26; Han HY, 2011, PSYCHIAT RES, V190, P163, DOI 10.1016/j.psychres.2011.04.026; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073777; Iwabuchi K, 2005, EUR NEUROPSYCHOPHARM, V15, P185, DOI 10.1016/j.euroneuro.2004.10.001; Johnston TH, 2010, MOVEMENT DISORD, V25, P1379, DOI 10.1002/mds.23069; Kalia LV, 2013, MOVEMENT DISORD, V28, P131, DOI 10.1002/mds.25273; Keeling BH, 2010, PARKINSONISM RELAT D, V16, P112, DOI 10.1016/j.parkreldis.2009.08.011; Kellermayer B, 2013, HUM IMMUNOL, V74, P1701, DOI 10.1016/j.humimm.2013.07.016; Kiyohara C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-89; LANGLAIS PJ, 1994, J NEUROSCI RES, V38, P565, DOI 10.1002/jnr.490380509; Ledesma MC, 2008, NEUROMOL MED, V10, P356, DOI 10.1007/s12017-008-8040-3; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Meskanen K, 2013, J CLIN PSYCHOPHARM, V33, P472, DOI 10.1097/JCP.0b013e3182970490; Miyasaki JM, 2010, J NEUROL, V257, pS309, DOI 10.1007/s00415-010-5718-x; Nowak P, 2008, NEUROTOX RES, V13, P231, DOI 10.1007/BF03033506; Oroszi G, 2005, ALCOHOL CLIN EXP RES, V29, P303, DOI 10.1097/01.ALC.0000156128.28257.2E; Palada V, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.015; Pang YP, 2001, BIOCHEM BIOPH RES CO, V287, P204, DOI 10.1006/bbrc.2001.5570; PRELL GD, 1991, AGENT ACTION SUPPL, V33, P343; PRELL GD, 1995, SCHIZOPHR RES, V14, P93, DOI 10.1016/0920-9964(94)00034-6; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Shan L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.016; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Vizuete ML, 2000, J NEUROCHEM, V75, P540, DOI 10.1046/j.1471-4159.2000.0750540.x; Voisey J, 2012, EUR PSYCHIAT, V27, P372, DOI 10.1016/j.eurpsy.2010.08.004; Wei YL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-42; Yan L, 2000, PHARMACOGENETICS, V10, P261, DOI 10.1097/00008571-200004000-00007; Yan L, 2000, AM J MED GENET, V96, P404, DOI 10.1002/1096-8628(20000612)96:3<404::AID-AJMG31>3.0.CO;2-D	42	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119692	10.1371/journal.pone.0119692	http://dx.doi.org/10.1371/journal.pone.0119692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768024	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500093
J	Zeng, Q; Xiang, YQ; Wu, PH; Lv, X; Qian, CN; Guo, X				Zeng, Qi; Xiang, Yan-Qun; Wu, Pei-Hong; Lv, Xing; Qian, Chao-Nan; Guo, Xiang			A Matched Cohort Study of Standard Chemo-Radiotherapy versus Radiotherapy Alone in Elderly Nasopharyngeal Carcinoma Patients	PLOS ONE			English	Article							RANDOMIZED-TRIAL; CANCER-PATIENTS; NECK-CANCER; CONCURRENT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; OLDER PATIENTS; HEAD; TOXICITY; METAANALYSIS; COMORBIDITY	The impact of standard chemo-radiotherapy (CRT) as preferred therapy for elderly patients (age >= 60 years) with nasopharyngeal carcinoma (NPC) remains unclear. Therefore, a strict matched cohort study was conducted to compare the survival and treatment toxicity of standard chemo-radiotherapy in the elderly NPC patients with those of radiotherapy (RT) alone. From 1998 to 2003, total 498 newly diagnosed elderly non-metastatic NPC patients were abstracted and classified into two groups by the treatments they received. For each patient in the CRT group, a matched pair in RT group was identified by matching for gender, age, histological type, T and N classifications, RT dose to primary tumor and neck nodes, and days of radiotherapy. Treatment tolerability and toxicity were clarified, and treatment outcomes were calculated and compared between the two groups. Two groups were well balanced in clinical characteristics because of the strict matching conditions. Totally 87 pairs can be assessed according to the criteria. The 5-year OS, CSS, FFS, and LR-FFS for CRT and RT groups were 62% versus 40% (P= 0.013), 67% versus 47% (P= 0.018), 65% versus 53% (log-rank: P= 0.064, Breslow: P= 0.048), and 88% versus 72%, (P= 0.019), respectively. There was no significant difference in 5-year D-FFS between the two groups (75% vs. 73%, P= 0.456). The CRT group experienced significantly more Grade >= 3 acute mucositis (46.0% vs. 28.7%, P= 0.019). We concluded that standard chemo-radiotherapy can achieve a reasonable local and regional control in elderly NPC patients with acceptable and reversible acute toxicity. However, distant metastasis remains the dominant failure pattern. When the elderly NPC patients are in good performance status following a complete evaluation of overall functional status and comorbidity conditions, standard chemo-radiotherapy is worthy of recommendation.	[Zeng, Qi; Xiang, Yan-Qun; Wu, Pei-Hong; Lv, Xing; Qian, Chao-Nan; Guo, Xiang] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zeng, Qi; Wu, Pei-Hong] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging & Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Yan-Qun; Lv, Xing; Qian, Chao-Nan; Guo, Xiang] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Guo, X (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	guoxiang_zlyy@163.com	zeng, qi/AAE-9675-2020	zeng, qi/0000-0002-8700-6661	National Natural Science Foundation of China [81172041, 81472525]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project has been funded by National Natural Science Foundation of China (No: 81172041; 81472525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Ardizzoni A, 2005, J CLIN ONCOL, V23, P569, DOI 10.1200/JCO.2005.11.140; Balducci L, 2000, HEMATOL ONCOL CLIN N, V14, P193, DOI 10.1016/S0889-8588(05)70284-7; Balducci L, 2009, CURR OPIN ONCOL, V21, P310, DOI 10.1097/CCO.0b013e32832b4f25; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Bernier J, 2005, NAT CLIN PRACT ONCOL, V2, P305, DOI 10.1038/ncponc0201; BIER H, 1993, EUR ARCH OTO-RHINO-L, V250, P200; Boje CR, 2014, RADIOTHER ONCOL, V110, P91, DOI 10.1016/j.radonc.2013.11.009; Bray F, 2008, CANCER EPIDEM BIOMAR, V17, P2356, DOI 10.1158/1055-9965.EPI-08-0461; Burdette-Radoux S, 2006, ONCOLOGIST, V11, P234, DOI 10.1634/theoncologist.11-3-234; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen QY, 2011, JNCI-J NATL CANCER I, V103, P1761, DOI 10.1093/jnci/djr432; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P2230, DOI 10.1002/cncr.28049; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; DECKER DA, 1983, CANCER, V52, P602, DOI 10.1002/1097-0142(19830815)52:4<602::AID-CNCR2820520404>3.0.CO;2-6; Derks W, 2005, EUR ARCH OTO-RHINO-L, V262, P21, DOI 10.1007/s00405-004-0744-x; Ho HC, 2008, ACTA OTO-LARYNGOL, V128, P930, DOI 10.1080/00016480701767374; Hong MH, 2000, CANCER, V89, P242, DOI 10.1002/1097-0142(20000715)89:2<242::AID-CNCR6>3.0.CO;2-Z; Hoppe S, 2013, J CLIN ONCOL, V31, P3877, DOI 10.1200/JCO.2012.47.7430; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; KENNEDY BJ, 1988, J CLIN ONCOL, V6, P1903, DOI 10.1200/JCO.1988.6.12.1903; Kimmick GG, 1997, DRUG AGING, V10, P34, DOI 10.2165/00002512-199710010-00004; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lin JC, 2003, BRIT J CANCER, V88, P187, DOI 10.1038/sj.bjc.6600716; Liu H, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-70; Ma J, 2001, J CLIN ONCOL, V19, P1350, DOI 10.1200/JCO.2001.19.5.1350; Sze HCK, 2012, ORAL ONCOL, V48, P162, DOI 10.1016/j.oraloncology.2011.08.019; Teo PML, 1999, INT J RADIAT ONCOL, V43, P261, DOI 10.1016/S0360-3016(98)00383-6; Tsao S. Y., 1993, Annals Academy of Medicine Singapore, V22, P638; Unger JM, 2006, J CLIN ONCOL, V24, P141, DOI 10.1200/JCO.2005.02.8928; Yancik R, 1996, ANN EPIDEMIOL, V6, P399, DOI 10.1016/S1047-2797(96)00063-4; Zagonel V, 2001, EUR J CANCER, V37, pS229; Zeng Qi, 2008, Ai Zheng, V27, P289; ZHANG L, 2010, BMC BIOINFORMATIC S1, V11, P558, DOI DOI 10.1186/1471-2407-10-558	35	16	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119593	10.1371/journal.pone.0119593	http://dx.doi.org/10.1371/journal.pone.0119593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768294	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500087
J	Bulatovic, I; Ibarra, C; Osterholm, C; Wang, H; Beltran-Rodriguez, A; Varas-Godoy, M; Mansson-Broberg, A; Uhlen, P; Simon, A; Grinnemo, KH				Bulatovic, Ivana; Ibarra, Cristian; Osterholm, Cecilia; Wang, Heng; Beltran-Rodriguez, Antonio; Varas-Godoy, Manuel; Mansson-Broberg, Agneta; Uhlen, Per; Simon, Andras; Grinnemo, Karl-Henrik			Sublethal Caspase Activation Promotes Generation of Cardiomyocytes from Embryonic Stem Cells	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; BETA-CATENIN; APOPTOSIS; HEART; REGENERATION; PROGENITORS; RENEWAL; MULTIPOTENT; DROSOPHILA; SIGNALS	Generation of new cardiomyocytes is critical for cardiac repair following myocardial injury, but which kind of stimuli is most important for cardiomyocyte regeneration is still unclear. Here we explore if apoptotic stimuli, manifested through caspase activation, influences cardiac progenitor up-regulation and cardiomyocyte differentiation. Using mouse embryonic stem cells as a cellular model, we show that sublethal activation of caspases increases the yield of cardiomyocytes while concurrently promoting the proliferation and differentiation of c-Kit(+)/alpha-actinin(low)cardiac progenitor cells. A broad-spectrum caspase inhibitor blocked these effects. In addition, the caspase inhibitor reversed the mRNA expression of genes expressed in cardiomyocytes and their precursors. Our study demonstrates that sublethal caspase-activation has an important role in cardiomyocyte differentiation and may have significant implications for promoting cardiac regeneration after myocardial injury involving exogenous or endogenous cell sources.	[Bulatovic, Ivana; Osterholm, Cecilia; Grinnemo, Karl-Henrik] Karolinska Inst, Div Cardiothorac Surg & Anesthesiol, Dept Mol Med & Surg, Karolinska Univ Hosp, Stockholm, Sweden; [Ibarra, Cristian; Varas-Godoy, Manuel; Uhlen, Per] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Wang, Heng; Simon, Andras] Karolinska Inst, Dept Cellular & Mol Biol, Stockholm, Sweden; [Beltran-Rodriguez, Antonio] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Mansson-Broberg, Agneta] Karolinska Inst, Div Cardiol, Dept Med Huddinge, Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Grinnemo, KH (corresponding author), Karolinska Inst, Div Cardiothorac Surg & Anesthesiol, Dept Mol Med & Surg, Karolinska Univ Hosp, Stockholm, Sweden.	karl-henrik.grinnemo@karolinska.se	Corbascio, Cecilia Österholm/ABF-2213-2020; Broberg, Agneta Månsson/O-3849-2017	Corbascio, Cecilia Österholm/0000-0001-7506-084X; Grinnemo, Karl-Henrik/0000-0001-6717-3393; Varas-Godoy, Manuel/0000-0001-5857-4793; Uhlen, Per/0000-0003-1446-1062; Simon, Andras/0000-0002-1018-1891; Mansson Broberg, Agneta/0000-0002-1478-0947; Grinnemo, Karl-Henrik/0000-0002-6100-6209	Swedish Research Council; Stockholm County Council; Heart and Lung Foundation; Karolinska Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Research Foundation	This study was supported by grants from the Swedish Research Council, The Stockholm County Council, the Heart and Lung Foundation and the Karolinska Research Foundation. The funders had no esign, data collection and analysis, decision to publish, or preparation of trole in study dhe manuscript.	Abdul-Ghani M, 2008, CELL STEM CELL, V2, P515, DOI 10.1016/j.stem.2008.05.013; Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Akbari-Birgani S, 2014, J BIOL CHEM, V289, P16905, DOI 10.1074/jbc.M113.536730; Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chan SSK, 2009, BIOCHEM BIOPH RES CO, V387, P723, DOI 10.1016/j.bbrc.2009.07.122; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Genead R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036804; Genead R, 2010, STEM CELLS DEV, V19, P1601, DOI 10.1089/scd.2009.0483; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Hunter AL, 2007, FEBS LETT, V581, P879, DOI 10.1016/j.febslet.2007.01.050; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Steinhauser ML, 2011, EMBO MOL MED, V3, P701, DOI 10.1002/emmm.201100175; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; von Roretz C, 2010, J BIOL CHEM, V285, P16806, DOI 10.1074/jbc.M109.087320; Welt FGP, 2013, CIRC-HEART FAIL, V6, P99, DOI 10.1161/CIRCHEARTFAILURE.112.972273	35	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120176	10.1371/journal.pone.0120176	http://dx.doi.org/10.1371/journal.pone.0120176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763592	Green Submitted, Green Published, gold			2022-12-27	WOS:000351276300036
J	Ibrahim, S; Salilew-Wondim, D; Rings, F; Hoelker, M; Neuhoff, C; Tholen, E; Looft, C; Schellander, K; Tesfaye, D				Ibrahim, Sally; Salilew-Wondim, Dessie; Rings, Franca; Hoelker, Michael; Neuhoff, Christiane; Tholen, Ernst; Looft, Christian; Schellander, Karl; Tesfaye, Dawit			Expression Pattern of Inflammatory Response Genes and Their Regulatory MicroRNAs in Bovine Oviductal Cells in Response to Lipopolysaccharide: Implication for Early Embryonic Development	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; FEMALE REPRODUCTIVE-TRACT; TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; IN-VITRO; INDUCED APOPTOSIS; INNATE IMMUNITY; CULTURE; PREGNANCY; DISEASE	In the present study, we used an in vitro model to investigate the response of the oviduct with respect to inflammatory mediators and their regulatory microRNAs in case of bacterial infection and subsequent association with embryo survival. For this, we conducted two experiments. In the first experiment, cultured primary bovine oviductal cells (BOEC) were challenged with lipopolysaccharide (LPS) for 24h and the temporal expression pattern of inflammatory mediators and their regulatory microRNAs were measured at 0, 3, 6, 12, 24 and 48h after LPS treatment. Intriguingly, the temporal patterns of all miRNAs except miR-21 were significantly up-regulated at 6h after LPS treatment. Whereas, we observed significant overexpression of pro-inflammatory mediators as tumor necrosis factor alpha (TNF alpha) and interleukin-1 beta (IL1 beta) after LPS challenge for 24h. On the other hand, the expression level of essential elements like oviductal glycoprotein 1 (OVGP1) and insulin-like growth factor 2 (IGF2) was significantly decreased in challenged groups compared with control. Moreover, miR-155, miR-146a, miR-223, miR-21, miR-16 and miR-215 have shown a clear suppression in challenged group after LPS treatment. In the 2nd experiment there were four groups of blastocysts produced, namely embryo+LPS free media, embryo+LPS, BOEC+embryo and BOEC+embryo+LPS. The suboptimal oviduct environment due to LPS challenge is found to have a significant influence on the expression of inflammatory response genes (TNF alpha and CSF1), stress response genes (SOD and CAT), mitochondrial activity, reactive oxygen species (ROS) accumulation and apoptotic level either in cultured or co-cultured blastocysts. Collectively, LPS challenge led to aberrant changes in oviductal transcriptome profile, which could lead to a suboptimal environment for embryo development.	[Ibrahim, Sally; Salilew-Wondim, Dessie; Rings, Franca; Hoelker, Michael; Neuhoff, Christiane; Tholen, Ernst; Looft, Christian; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, Bonn, Germany	University of Bonn	Tesfaye, D (corresponding author), Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, Bonn, Germany.	tesfaye@itw.uni-bonn.de		Wondim, Dr. Dessie Salilew/0000-0002-8756-0865; Chen, Lu/0000-0002-9580-8576; Ibrahim, Sally/0000-0003-2098-6463				Altmae S, 2012, MOL ENDOCRINOL, V26, P203, DOI 10.1210/me.2011-1196; An L, 2012, ARCH TOXICOL, V86, P1337, DOI 10.1007/s00204-012-0814-6; Balboula AZ, 2010, MOL REPROD DEV, V77, P1031, DOI 10.1002/mrd.21250; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chapwanya A, 2009, THERIOGENOLOGY, V71, P1396, DOI 10.1016/j.theriogenology.2009.01.006; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hailemariam D, 2013, REPROD FERT DEVELOP, P898; Hardy K, 1999, REV REPROD, V4, P125; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2007, REPRODUCTION, V134, P683, DOI 10.1530/REP-07-0229; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Humblot P, 2001, THERIOGENOLOGY, V56, P1417, DOI 10.1016/S0093-691X(01)00644-6; Hunter RHF, 2012, BIOL REV, V87, P244, DOI 10.1111/j.1469-185X.2011.00196.x; Hunter RHF, 2003, REPROD DOMEST ANIM, V38, P147, DOI 10.1046/j.1439-0531.2003.00402.x; Hvid M, 2007, CELL MICROBIOL, V9, P2795, DOI 10.1111/j.1462-5822.2007.00996.x; Jaiswal YK, 2006, INFECT DIS OBSTET GY, V2006, P32050, DOI [DOI 10.1155/IDOG/2006/32050, 10.1155/IDOG/2006/32050]; Kasahara E, 2011, FEBS LETT, V585, P2263, DOI 10.1016/j.febslet.2011.05.049; Kastl L, 2014, FEBS LETT, V588, P175, DOI 10.1016/j.febslet.2013.11.033; Killian GJ, 2004, ANIM REPROD SCI, V82-3, P141, DOI 10.1016/j.anireprosci.2004.04.028; Kowsar R, 2013, J REPROD DEVELOP, V59, P470, DOI 10.1262/jrd.2013-036; Makarevich AV, 2002, BIOL REPROD, V66, P386, DOI 10.1095/biolreprod66.2.386; Makarevich AV MP, 2008, SLOVAK J ANIM SCI, V41, P153; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; McGregor JA, 2000, OBSTET GYNECOL SURV, V55, pS1; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Neira JA, 2010, THERIOGENOLOGY, V73, P595, DOI 10.1016/j.theriogenology.2009.10.015; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Oron E, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045002; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Park J, 2013, J NEUROCHEM, V127, P221, DOI 10.1111/jnc.12361; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Paula-Lopes FF, 2002, BIOL REPROD, V66, P1169, DOI 10.1093/biolreprod/66.4.1169; Raghupathy R, 2008, FRONT BIOSCI-LANDMRK, V13, P985, DOI 10.2741/2737; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Rottmayer R, 2006, REPRODUCTION, V132, P637, DOI 10.1530/rep.1.01136; Rozen S, 2000, Methods Mol Biol, V132, P365; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Sugino N, 1998, BIOL REPROD, V59, P208, DOI 10.1095/biolreprod59.1.208; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Teng GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056709; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Walker CG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-474; Walsh SW, 2011, ANIM REPROD SCI, V123, P127, DOI 10.1016/j.anireprosci.2010.12.001; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Yilmaz O, 2012, THERIOGENOLOGY, V77, P1312, DOI 10.1016/j.theriogenology.2011.10.036	63	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119388	10.1371/journal.pone.0119388	http://dx.doi.org/10.1371/journal.pone.0119388			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764515	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300026
J	Lai, IC; Shih, PH; Yao, CJ; Yeh, CT; Wang-Peng, J; Lui, TN; Chuang, SE; Hu, TS; Lai, TY; Lai, GM				Lai, I-Chun; Shih, Ping-Hsiao; Yao, Chih-Jung; Yeh, Chi-Tai; Wang-Peng, Jacqueline; Lui, Tai-Ngar; Chuang, Suang-En; Hu, Tsai-Shu; Lai, Tung-Yuan; Lai, Gi-Ming			Elimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme Cells	PLOS ONE			English	Article							SIDE POPULATION; PATHWAY; BREAST; GLIOMA; TUMORS; INHIBITION; TARGETS	Glioblastoma multiforme (GBM) is the most common adult malignant glioma with poor prognosis due to the resistance to radiotherapy and chemotherapy, which might be critically involved in the repopulation of cancer stem cells (CSCs) after treatment. We had investigated the characteristics of cancer stem-like side population (SP) cells sorted from GBM cells, and studied the effect of Honokiol targeting on CSCs. GBM8401 SP cells possessed the stem cell markers, such as nestin, CD133 and Oct4, and the expressions of self-renewal related stemness genes, such as SMO, Notch3 and IHH (Indian Hedgehog). Honokiol inhibited the proliferation of both GBM8401 parental cells and SP cells in a dose-dependent manner, the IC50 were 5.3 +/- 0.72 and 11 +/- 1.1 mu M, respectively. The proportions of SP in GBM8401 cells were diminished by Honokiol from 1.5 +/- 0.22% down to 0.3 +/- 0.02% and 0.2 +/- 0.01% at doses of 2.5 mu M and 5 mu M, respectively. The SP cells appeared to have higher expression of O-6-methylguanine-DNA methyltransferase (MGMT) and be more resistant to Temozolomide (TMZ). The resistance to TMZ could be only slightly reversed by MGMT inhibitor O-6-benzylguanine (O-6-BG), but markedly further enhanced by Honokiol addition. Such significant enhancement was accompanied with the higher induction of apoptosis, greater down-regulation of Notch3 as well as its downstream Hes1 expressions in SP cells. Our data indicate that Honokiol might have clinical benefits for the GBM patients who are refractory to TMZ treatment.	[Lai, I-Chun] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Shih, Ping-Hsiao; Yao, Chih-Jung; Yeh, Chi-Tai; Wang-Peng, Jacqueline; Lai, Gi-Ming] Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan; [Shih, Ping-Hsiao] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, New Taipei City, Taiwan; [Yao, Chih-Jung; Wang-Peng, Jacqueline; Hu, Tsai-Shu; Lai, Gi-Ming] Taipei Med Univ, Wan Fang Hosp, Ctr Canc, Taipei, Taiwan; [Yao, Chih-Jung; Lai, Gi-Ming] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Yeh, Chi-Tai] Taipei Med Univ, Shuang Ho Hosp, Ctr Canc, Taipei, Taiwan; [Lui, Tai-Ngar] Taipei Med Univ, Wan Fang Hosp, Div Neurosurg, Taipei, Taiwan; [Chuang, Suang-En; Lai, Gi-Ming] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Lai, Tung-Yuan] Taipei Med Univ, Coll Pharm, Grad Inst Pharmacognosy, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; National Health Research Institutes - Taiwan; Taipei Medical University	Lai, GM (corresponding author), Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan.	gminlai@nhri.org.tw	Chuang, Shuang-En/D-2080-2010; Shih, Ping-Hsiao/GPG-2472-2022	Shih, Ping-Hsiao/0000-0002-8387-105X	Ministry of Health and Welfare, Taiwan [MOHW103-TD-B-111-01]; National Health Research Institutes, Taiwan [03A1 CAPP33-014]; Ministry of Science and Technology, Taiwan [NSC 100-2632-B-038-001-MY3]	Ministry of Health and Welfare, Taiwan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grants from Ministry of Health and Welfare, Taiwan (MOHW103-TD-B-111-01), National Health Research Institutes, Taiwan (03A1 CAPP33-014) and Ministry of Science and Technology, Taiwan (NSC 100-2632-B-038-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Crane C, 2009, J IMMUNOTHER, V32, P585, DOI 10.1097/CJI.0b013e3181a8efe6; Darkes MJM, 2002, AM J CANC, V1, P55, DOI DOI 10.2165/00024669-200201010-00006; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Fukaya R, 2010, CANCER LETT, V291, P150, DOI 10.1016/j.canlet.2009.10.010; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kim BH, 2008, ACTA PHARMACOL SIN, V29, P113, DOI 10.1111/j.1745-7254.2008.00725.x; Kim M, 2002, CLIN CANCER RES, V8, P22; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Lin YR, 2005, NEUROPHARMACOLOGY, V49, P542, DOI 10.1016/j.neuropharm.2005.04.009; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mannal PW, 2011, J SURG ONCOL, V104, P260, DOI 10.1002/jso.21936; McDonald SAC, 2009, VIRCHOWS ARCH, V455, P1, DOI 10.1007/s00428-009-0783-1; Mimeault M, 2010, CANCER LETT, V295, P69, DOI 10.1016/j.canlet.2010.02.015; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Pistollato F, 2010, STEM CELLS, V28, P851, DOI 10.1002/stem.415; Ponnurangam S, 2012, MOL CANCER THER, V11, P963, DOI 10.1158/1535-7163.MCT-11-0999; Quinn JA, 2009, J CLIN ONCOL, V27, P1262, DOI 10.1200/JCO.2008.18.8417; Shin TY, 2001, ARCH PHARM RES, V24, P249, DOI 10.1007/BF02978266; Singh SK, 2003, CANCER RES, V63, P5821; Singh T, 2011, INT J ONCOL, V38, P769, DOI 10.3892/ijo.2011.899; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Ulasov IV, 2011, MOL MED, V17, P103, DOI 10.2119/molmed.2010.00062; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018490; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yang YM, 2008, CANCER INVEST, V26, P741, DOI 10.1080/07357900801901856; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010	30	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0114830	10.1371/journal.pone.0114830	http://dx.doi.org/10.1371/journal.pone.0114830			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763821	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300001
J	Ornelles, DA; Gooding, LR; Garnett-Benson, C				Ornelles, David A.; Gooding, Linda R.; Garnett-Benson, C.			Neonatal Infection with Species C Adenoviruses Confirmed in Viable Cord Blood Lymphocytes	PLOS ONE			English	Article							INTRAUTERINE VIRAL-INFECTION; ACUTE LYMPHOBLASTIC-LEUKEMIA; POLYMERASE-CHAIN-REACTION; GUTHRIE CARDS; CHILDHOOD LEUKEMIA; AMNIOTIC-FLUID; DEOXYRIBONUCLEIC-ACID; PRENATAL ORIGIN; HUMAN TONSIL; DNA	Credible but conflicting reports address the frequency of prenatal infection by species C adenovirus. This question is important because these viruses persist in lymphoid cells and suppress double-stranded DNA-break repair. Consequently, prenatal adenovirus infections may generate the aberrant clones of lymphocytes that precede development of childhood acute lymphoblastic leukemia (ALL). The present study was designed to overcome technical limitations of prior work by processing cord blood lymphocytes within a day of collection, and by analyzing sufficient numbers of lymphocytes to detect adenovirus-containing cells at the lower limits determined by our previous studies of tonsil lymphocytes. By this approach, adenoviral DNA was identified in 19 of 517 (3.7%) samples, providing definitive evidence for the occurrence of prenatal infection with species C adenoviruses in a significant fraction of neonates predominantly of African American and Hispanic ancestry. Cord blood samples were also tested for the presence of the ETV6-RUNX1 translocation, the most common genetic abnormality in childhood ALL. Using a nested PCR assay, the ETV6-RUNX1 transcript was detected in four of 196 adenovirus-negative samples and one of 14 adenovirus-positive cord blood samples. These findings indicate that this method will be suitable for determining concordance between adenovirus infection and the leukemia-associated translocations in newborns.	[Garnett-Benson, C.] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Ornelles, David A.] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC USA; [Gooding, Linda R.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Wake Forest University; Emory University	Garnett-Benson, C (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.	cgarnettbenson@gsu.edu			National Cancer Institute [R01 CA127621]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA127621] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, grant number R01 CA127621 to LRG, DAO, CGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alkhalaf MA, 2013, J MED VIROL, V85, P1947, DOI 10.1002/jmv.23678; [Anonymous], 2014, R LANG ENV STAT COMP; Baschat A A, 2003, J Matern Fetal Neonatal Med, V13, P381, DOI 10.1080/jmf.13.6.381.384; BECK R, 1994, IMMUNOL CELL BIOL, V72, P440, DOI 10.1038/icb.1994.65; Bianchi DW, 2001, CLIN CHEM, V47, P1867; Buscone S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098222; Chirumbolo S, 2011, CYTOM PART B-CLIN CY, V80B, P248, DOI 10.1002/cyto.b.20588; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chow EJ, 2010, CANCER-AM CANCER SOC, V116, P3045, DOI 10.1002/cncr.25099; Delo DM, 2006, METHOD ENZYMOL, V419, P426, DOI 10.1016/S0076-6879(06)19017-5; Durepaire N, 1997, J ACQ IMMUN DEF SYND, V14, P189; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Eguchi-Ishimae M, 2001, BLOOD, V97, P737, DOI 10.1182/blood.V97.3.737; Fernandez-Soria V, 2002, ONCOL REP, V9, P897; Flomenberg P, 1997, J MED VIROL, V51, P182, DOI 10.1002/(SICI)1096-9071(199703)51:3<182::AID-JMV7>3.0.CO;2-2; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Gervasi MT, 2012, J MATERN-FETAL NEO M, V25, P2002, DOI 10.3109/14767058.2012.683899; Greaves M, 2005, EARLY HUM DEV, V81, P123, DOI 10.1016/j.earlhumdev.2004.10.004; Greaves M, 1999, EUR J CANCER, V35, P1941, DOI 10.1016/S0959-8049(99)00296-8; Greaves Mel, 2006, Discov Med, V6, P24; Gruhn B, 2008, LEUKEMIA, V22, P1692, DOI 10.1038/leu.2008.152; Gustafsson B, 2007, BRIT J CANCER, V97, P992, DOI 10.1038/sj.bjc.6603983; Gustafsson B, 2007, PEDIATR HEMAT ONCOL, V24, P607, DOI 10.1080/08880010701640341; Harrell Jr FE, 2012, HMISC HARRELL MISCEL; HARRIS DT, 1992, P NATL ACAD SCI USA, V89, P10006, DOI 10.1073/pnas.89.21.10006; Hart LS, 2005, J BIOL CHEM, V280, P1474, DOI 10.1074/jbc.M409934200; Honkaniemi E, 2010, BRIT J CANCER, V102, P796, DOI 10.1038/sj.bjc.6605581; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; MCLEAN LK, 1995, AM J OBSTET GYNECOL, V173, P1282, DOI 10.1016/0002-9378(95)91371-8; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Meru N, 2002, BLOOD, V99, P531, DOI 10.1182/blood.V99.2.531; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; NEUMANN R, 1987, VIRUS RES, V7, P93, DOI 10.1016/0168-1702(87)90060-8; Nevels M, 2001, J VIROL, V75, P3089, DOI 10.1128/JVI.75.7.3089-3094.2001; O'Connor SM, 2007, ENVIRON HEALTH PERSP, V115, P146, DOI 10.1289/ehp.9024; Olsen M, 2006, J PEDIAT HEMATOL ONC, V28, P734, DOI 10.1097/01.mph.0000243652.33561.0f; Olsen M, 2012, J PEDIAT HEMATOL ONC, V34, P301, DOI 10.1097/MPH.0b013e3182332268; Reddy UM, 2005, FETAL DIAGN THER, V20, P203, DOI 10.1159/000083906; Roman E, 2009, BLOOD CELL MOL DIS, V42, P126, DOI 10.1016/j.bcmd.2008.10.007; ROMANA SP, 1995, BLOOD, V86, P4263, DOI 10.1182/blood.V86.11.4263.bloodjournal86114263; Skorvaga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091116; Smith M, 1997, J IMMUNOTHER, V20, P89, DOI 10.1097/00002371-199703000-00001; Strauchen JA, 2001, AM J CLIN PATHOL, V116, P12; Taub JW, 2004, LEUKEMIA LYMPHOMA, V45, P19, DOI 10.1080/1042819031000149403; Tollefson A.E., 2007, METHODS MOL MED, V130, P223; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; Van den Veyver IB, 1998, MOL GENET METAB, V63, P85, DOI 10.1006/mgme.1997.2651; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Vasconcelos GM, 2008, BRIT J CANCER, V99, P1668, DOI 10.1038/sj.bjc.6604714; von Goessel H, 2009, LEUKEMIA RES, V33, P1082, DOI 10.1016/j.leukres.2008.11.001; Wenstrom KD, 1998, OBSTET GYNECOL, V92, P420, DOI 10.1016/S0029-7844(98)00210-5; Wiemels J, 2012, CHEM-BIOL INTERACT, V196, P59, DOI 10.1016/j.cbi.2012.01.007; ZHANG LQ, 1993, LEUKEMIA, V7, P1865; Zhang YG, 2010, J VIROL, V84, P8799, DOI 10.1128/JVI.00562-10; Zuna J, 2011, BLOOD, V117, P368, DOI 10.1182/blood-2010-09-309070; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	58	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119256	10.1371/journal.pone.0119256	http://dx.doi.org/10.1371/journal.pone.0119256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764068	gold, Green Published, Green Submitted			2022-12-27	WOS:000351276300022
J	Ano, Y; Ozawa, M; Kutsukake, T; Sugiyama, S; Uchida, K; Yoshida, A; Nakayama, H				Ano, Yasuhisa; Ozawa, Makiko; Kutsukake, Toshiko; Sugiyama, Shinya; Uchida, Kazuyuki; Yoshida, Aruto; Nakayama, Hiroyuki			Preventive Effects of a Fermented Dairy Product against Alzheimer's Disease and Identification of a Novel Oleamide with Enhanced Microglial Phagocytosis and Anti-Inflammatory Activity	PLOS ONE			English	Article							FATTY-ACID AMIDES; AMYLOID-BETA; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; TRANSGENIC MICE; MOUSE MODEL; PPAR-GAMMA; INFLAMMATION; IMPAIRMENT; BRAIN	Despite the ever-increasing number of patients with dementia worldwide, fundamental therapeutic approaches to this condition have not been established. Epidemiological studies suggest that intake of fermented dairy products prevents cognitive decline in the elderly. However, the active compounds responsible for the effect remain to be elucidated. The present study aims to elucidate the preventive effects of dairy products on Alzheimer's disease and to identify the responsible component. Here, in a mouse model of Alzheimer's disease (5xFAD), intake of a dairy product fermented with Penicillium candidum had preventive effects on the disease by reducing the accumulation of amyloid beta (A beta) and hippocampal inflammation (TNF-alpha and MIP-1 alpha production), and enhancing hippocampal neurotrophic factors (BDNF and GDNF). A search for preventive substances in the fermented dairy product identified oleamide as a novel dual-active component that enhanced microglial A beta phagocytosis and anti-inflammatory activity towards LPS stimulation in vitro and in vivo. During the fermentation, oleamide was synthesized from oleic acid, which is an abundant component of general dairy products owing to lipase enzymatic amidation. The present study has demonstrated the preventive effect of dairy products on Alzheimer's disease, which was previously reported only epidemiologically. Moreover, oleamide has been identified as an active component of dairy products that is considered to reduce A beta accumulation via enhanced microglial phagocytosis, and to suppress microglial inflammation after A beta deposition. Because fermented dairy products such as camembert cheese are easy to ingest safely as a daily meal, their consumption might represent a preventive strategy for dementia.	[Ano, Yasuhisa; Kutsukake, Toshiko; Yoshida, Aruto] Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Ozawa, Makiko; Uchida, Kazuyuki; Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Sugiyama, Shinya] Koiwai Dairy Prod Co Ltd, Shizukuishi, Iwate 0200507, Japan	University of Tokyo	Ano, Y (corresponding author), Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Yasuhisa_Ano@kirin.co.jp		Ozawa, Makiko/0000-0002-9871-1526	Kirin Company Ltd.; Koiwai Dairy Products Co., Ltd.; Kirin; Koiwai	Kirin Company Ltd.; Koiwai Dairy Products Co., Ltd.; Kirin; Koiwai	The authors received no specific funding for this work. Kirin Company Ltd. and Koiwai Dairy Products Co., Ltd. provided support in the form of salaries for authors Y.A., T.K., A.Y. and S.S., but did not have any role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.]. Pls also update COI: [We declare the following interests. Yasuhisa Ano, Toshiko Kutsukake and Aruto Yoshida are employed by Kirin Company Ltd., and Shinya Sugiyama is employed by Koiwai Dairy Products Co., Ltd. Koiwai Dairy Foods Co., Ltd. is a subsidiary company of Kirin Company, Ltd., and all research was executed at Kirin Company, Ltd. using Kirin's sources under a joint research agreement between Kirin and Koiwai. This does not alter our adherence to all of the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Alkam T, 2007, BEHAV BRAIN RES, V180, P139, DOI 10.1016/j.bbr.2007.03.001; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Awasthi Neeraj Praphulla, 2007, J Oleo Sci, V56, P507; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boger DL, 1998, CURR PHARM DESIGN, V4, P303; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Camfield DA, 2011, BRIT J NUTR, V106, P159, DOI 10.1017/S0007114511000158; Cotman CW, 2005, NEUROCHEM RES, V30, P877, DOI 10.1007/s11064-005-6960-y; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Crichton GE, 2010, ASIA PAC J CLIN NUTR, V19, P161; Dionisi M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-51; Fernandez PL, 2013, J ALZHEIMERS DIS, V33, P297, DOI 10.3233/JAD-2012-121222; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Lu P, 2009, BRIT J PHARMACOL, V157, P1270, DOI 10.1111/j.1476-5381.2009.00295.x; Malm T, 2010, GLIA, V58, P889, DOI 10.1002/glia.20973; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; Miklossy J, 2008, J ALZHEIMERS DIS, V13, P381; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Mrak RE, 2005, J ALZHEIMERS DIS, V8, P369; Naert G, 2011, CURR ALZHEIMER RES, V8, P151, DOI 10.2174/156720511795256035; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oh YT, 2010, NEUROSCI LETT, V474, P148, DOI 10.1016/j.neulet.2010.03.026; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Rezai-Zadeh K, 2011, CURR ALZHEIMER RES, V8, P156, DOI 10.2174/156720511795256017; Sastre M, 2011, CURR ALZHEIMER RES, V8, P132, DOI 10.2174/156720511795256062; Slotema WF, 2003, BIOTECHNOL BIOENG, V82, P664, DOI 10.1002/bit.10613; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Sugama Shuei, 2009, Inflammation & Allergy Drug Targets, V8, P277; Sultana T, 2006, J CHROMATOGR A, V1101, P278, DOI 10.1016/j.chroma.2005.10.027; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Vassallo Neville, 2013, Curr Aging Sci, V6, P150; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3; Yamada K, 2010, BRAIN RES, V1352, P176, DOI 10.1016/j.brainres.2010.07.006; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012	49	59	60	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118512	10.1371/journal.pone.0118512	http://dx.doi.org/10.1371/journal.pone.0118512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760987	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000026
J	Fancourt, BA; Hawkins, CE; Cameron, EZ; Jones, ME; Nicol, SC				Fancourt, Bronwyn A.; Hawkins, Clare E.; Cameron, Elissa Z.; Jones, Menna E.; Nicol, Stewart C.			Devil Declines and Catastrophic Cascades: Is Mesopredator Release of Feral Cats Inhibiting Recovery of the Eastern Quoll?	PLOS ONE			English	Article							FACIAL TUMOR DISEASE; TROPHIC CASCADES; FELIS-CATUS; SOUTHEASTERN AUSTRALIA; DASYURUS-VIVERRINUS; POPULATION DECLINE; PREDATOR; ECOLOGY; IMPACT; CONSERVATION	The eastern quoll (Dasyurus viverrinus) is a medium-sized Australian marsupial carnivore that has recently undergone a rapid and severe population decline over the 10 years to 2009, with no sign of recovery. This decline has been linked to a period of unfavourable weather, but subsequent improved weather conditions have not been matched by quoll recovery. A recent study suggested another mechanism: that declines in Tasmanian devil (Sarcophilus harrisii) populations, due to the spread of the fatal Devil Facial Tumour Disease, have released feral cats (Felis catus) from competitive suppression, with eastern quoll declines linked to a subsequent increase in cat sightings. Yet current evidence of intraguild suppression among devils, cats and quolls is scant and equivocal. We therefore assessed the influences of top-down effects on abundance and activity patterns among devils, feral cats and eastern quolls. Between 2011 and 2013, we monitored four carnivore populations using longitudinal trapping and camera surveys, and performed camera surveys at 12 additional sites throughout the eastern quoll's range. We did not find evidence of a negative relationship between devil and cat abundance, nor of higher cat abundance in areas where devil populations had declined the longest. Cats did not appear to avoid devils spatially; however, there was evidence of temporal separation of cat and devil activity, with reduced separation and increasing nocturnal activity observed in areas where devils had declined the longest. Cats and quolls used the same areas, and there was no evidence that cat and quoll abundances were negatively related. Temporal overlap in observed cat and quoll activity was higher in summer than in winter, but this seasonal difference was unrelated to devil declines. We suggest that cats did not cause the recent quoll decline, but that predation of juvenile quolls by cats could be inhibiting low density quoll populations from recovering their former abundance through a 'predator pit' effect following weather-induced decline. Predation intensity could increase further should cats become increasingly nocturnal in response to devil declines.	[Fancourt, Bronwyn A.; Hawkins, Clare E.; Cameron, Elissa Z.; Jones, Menna E.; Nicol, Stewart C.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia	University of Tasmania	Fancourt, BA (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	Bronwyn.Fancourt@utas.edu.au	Fancourt, Bronwyn/R-4278-2019; Cameron, Elissa/B-8053-2014	Fancourt, Bronwyn/0000-0003-2969-1530; Cameron, Elissa/0000-0002-9243-0547	Holsworth Wildlife Research Endowment; Royal Zoological Society of NSW; Australian Wildlife Society; MA Ingram Trust; Leisure Solutions (through the Foundation for National Parks Wildlife); National Environmental Research Program	Holsworth Wildlife Research Endowment; Royal Zoological Society of NSW; Australian Wildlife Society; MA Ingram Trust; Leisure Solutions (through the Foundation for National Parks Wildlife); National Environmental Research Program	This project was funded by grants from the Holsworth Wildlife Research Endowment, Royal Zoological Society of NSW (Ethel Mary Read grant), Australian Wildlife Society, the MA Ingram Trust, Leisure Solutions (through the Foundation for National Parks & Wildlife) with in-kind support from the Australian Research Foundation and the National Environmental Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Ian, 2008, Conservation Science Western Australia, V7, P1; Agostinelli C., 2013, R PACKAGE CIRCULAR C; Allen BL, 2015, BIOL INVASIONS, V17, P761, DOI 10.1007/s10530-014-0767-1; Allen BL, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-39; [Anonymous], OVERLAP ESTIMATES CO; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; Australian Bureau of Meteorology, 2009, TASM RAINF DEF 1 JAN; Batschelet E, 1981, CIRCULAR STAT BIOL; Beschta RL, 2015, ECOHYDROLOGY, V8, P58, DOI 10.1002/eco.1487; Bischof R, 2014, J ZOOL, V293, P40, DOI 10.1111/jzo.12100; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; CARO TM, 1980, BEHAV NEURAL BIOL, V29, P1, DOI 10.1016/S0163-1047(80)92442-5; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chamaille-Jammes S, 2014, OECOLOGIA, V174, P1151, DOI 10.1007/s00442-013-2843-0; Chase JM, 2003, OIKOS, V101, P187, DOI 10.1034/j.1600-0706.2003.12062.x; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Denny E., 2010, REV CAT ECOLOGY MANA; Department of Primary Industries Parks Water and Environment, 2011, NAT VAL ATL; Dickman CR, APPL ANIM B IN PRESS; Elmhagen B, 2007, ECOL LETT, V10, P197, DOI 10.1111/j.1461-0248.2006.01010.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fancourt B. A., 2010, THESIS; Fancourt BA, 2014, AUST MAMMAL, V36, P247, DOI 10.1071/AM14004; Fancourt Bronwyn A., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P102, DOI 10.1016/j.ijppaw.2014.05.001; Fancourt BA, 2013, AUST MAMMAL, V35, P195, DOI 10.1071/AM13004; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gehrt SD, 2007, BEHAV ECOL, V18, P204, DOI 10.1093/beheco/arl075; Gibson David F., 1994, Australian Mammalogy, V17, P103; Glen AS, 2010, CONSERV GENET, V11, P1099, DOI 10.1007/s10592-009-9888-y; Godsell J., 1982, P199; Godsell J., 1983, THESIS; Guiler ER, 1985, THYLACINE TRAGEDY TA; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hayward MW, 2014, J APPL ECOL, V51, P835, DOI 10.1111/1365-2664.12250; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hollings T, 2014, CONSERV BIOL, V28, P63, DOI 10.1111/cobi.12152; JONES E, 1981, AUST WILDLIFE RES, V8, P537; JONES E, 1982, AUST WILDLIFE RES, V9, P111; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; Jones ME, 1998, J ANIM ECOL, V67, P410, DOI 10.1046/j.1365-2656.1998.00203.x; Jones ME, 2004, ANIM CONSERV, V7, P155, DOI 10.1017/S136794300400126X; Jones ME, 1996, PRELIMINARY ASSESSME; Jones ME, 2007, ECOHEALTH, V4, P326, DOI 10.1007/s10393-007-0120-6; KOENKER R., 2013, QUANTREG QUANTILE RE; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Lazenby B., 2012, THESIS; Lazenby BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059846; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; McKnight M, 2008, IUCN RED LIST THREAT; Meredith M, 2014, OVERVIEW OVERLAP PAC; Molsher R, 1999, WILDLIFE RES, V26, P593, DOI 10.1071/WR98058; Morris DW, 2009, ANN NY ACAD SCI, V1162, P334, DOI 10.1111/j.1749-6632.2009.04494.x; Moseby Katherine E., 2012, International Journal of Ecology, P1; Nicholson KL, 2014, OECOLOGIA, V176, P69, DOI 10.1007/s00442-014-3004-9; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1980, J ANIM ECOL, V49, P667; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Raupach M., 2001, PROJECT DESCRIPTION; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROUNSEVELL DE, 1991, WILDLIFE RES, V18, P699, DOI 10.1071/WR9910699; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Saunders A., 2012, THESIS; Sergio F, 2008, IBIS, V150, P132, DOI 10.1111/j.1474-919X.2008.00786.x; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Taylor Robert J., 1993, Papers and Proceedings of the Royal Society of Tasmania, V127, P33; Terborgh J., 1999, WILD EARTH, P42; Troy S. N., 2014, THESIS; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; van Dijk AIJM, 2013, WATER RESOUR RES, V49, P1040, DOI 10.1002/wrcr.20123; Wang YW, 2012, WILDLIFE RES, V39, P611, DOI 10.1071/WR11210; Weitzman Murray S, 1970, MEASURES OVERLAP INC; Woinarski JCZ, 2014, ACTION PLAN AUSTR MA	92	36	36	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119303	10.1371/journal.pone.0119303	http://dx.doi.org/10.1371/journal.pone.0119303			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760348	gold, Green Published			2022-12-27	WOS:000351275000053
J	Kinoshita, T; Imamura, R; Kushiyama, H; Suda, T				Kinoshita, Takeshi; Imamura, Ryu; Kushiyama, Hiroko; Suda, Takashi			NLRP3 Mediates NF-kappa B Activation and Cytokine Induction in Microbially Induced and Sterile Inflammation	PLOS ONE			English	Article							INNATE IMMUNE ACTIVATION; NALP3 INFLAMMASOME; TOLL-LIKE; INTERLEUKIN-8 PRODUCTION; ASC; PROTEIN; CRYSTALS; INJURY; HYALURONAN; RECEPTORS	Nucleotide-binding domain and leucine-rich repeat-containing family, pyrin domain containing 3 (NLRP3) has recently emerged as a central regulator of innate immunity and inflammation in response to both sterile inflammatory and microbial invasion signals. Although its ability to drive proteolytic procaspase-1 processing has drawn more attention, NLPR3 can also activate NF-kappa B. To clarify the physiological relevance of this latter function, we examined the effect of NLRP3 on NF-kappa B activation and cytokine induction in RNA-interference-based NLRP3-knock down cell lines generated from the human monocytic cell line THP-1. Knocking down NLRP3 reduced NF-kappa B activation and cytokine induction in the early stages of Staphylococcus aureus infection. Expression of cytokine genes induced by Staphylococcus aureus was not inhibited by a caspase-1 inhibitor, and did not occur through an autocrine mechanism in response to newly synthesized cytokines. We also demonstrated that NLRP3 could activate NF-kappa B and induce cytokines in response to sterile signals, monosodium urate crystals and aluminum adjuvant. Thus, NLRP3 mediates NF-kappa B activation in both sterile and microbially induced inflammation. Our findings show that not only does NLRP3 activate caspase-1 post-translationally, but it also induces multiple cytokine genes in the innate immune system.	[Kinoshita, Takeshi; Imamura, Ryu; Kushiyama, Hiroko; Suda, Takashi] Kanazawa Univ, Canc Res Inst, Div Immunol & Mol Biol, Kanazawa, Ishikawa, Japan	Kanazawa University	Suda, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Immunol & Mol Biol, Kanazawa, Ishikawa, Japan.	sudat@staff.kanazawa-u.ac.jp	KINOSHITA, Takeshi/D-8436-2015		Japan Society for the Promotion of Science [23390092, 23590327]; Japanese government	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese government	This work was supported by Grants-in-Aid for Scientific Research (B) (No. 23390092 to TS) and Grants-in-Aid for Scientific Research (C) (No. 23590327 to TK) from the Japan Society for the Promotion of Science, and the basal research budget for the department of immunology and molecular biology, cancer research institute, Kanazawa University from the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Cassel SL, 2010, EUR J IMMUNOL, V40, P607, DOI 10.1002/eji.200940207; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Motani K, 2010, CANCER SCI, V101, P1822, DOI 10.1111/j.1349-7006.2010.01610.x; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Taxman DJ, 2012, J DENT RES, V91, P877, DOI 10.1177/0022034512454541; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zuurbier CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040643	43	36	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119179	10.1371/journal.pone.0119179	http://dx.doi.org/10.1371/journal.pone.0119179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761061	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000050
J	Mansur, S; Ishak, A; Pop, I				Mansur, Syahira; Ishak, Anuar; Pop, Ioan			The Magnetohydrodynamic Stagnation Point Flow of a Nanofluid over a Stretching/Shrinking Sheet with Suction	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; NON-NEWTONIAN NANOFLUID; HEAT-TRANSFER ANALYSIS; THERMAL-RADIATION; PERISTALTIC FLOW; POROUS-MEDIUM; VERTICAL PLATE; VISCOUS-FLOW; FLUID-FLOW; MHD	The magnetohydrodynamic (MHD) stagnation point flow of a nanofluid over a permeable stretching/ shrinking sheet is studied. Numerical results are obtained using boundary value problem solver bvp4c in MATLAB for several values of parameters. The numerical results show that dual solutions exist for the shrinking case, while for the stretching case, the solution is unique. A stability analysis is performed to determine the stability of the dual solutions. For the stable solution, the skin friction is higher in the presence of magnetic field and increases when the suction effect is increased. It is also found that increasing the Brownian motion parameter and the thermophoresis parameter reduces the heat transfer rate at the surface.	[Mansur, Syahira] Univ Tun Hussein Onn Malaysia, Fac Sci Technol & Human Dev, Dept Math & Stat, Batu Pahat, Johor, Malaysia; [Ishak, Anuar] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Math Sci, Ukm Bangi, Selangor, Malaysia; [Pop, Ioan] Univ Babes Bolyai, Dept Math, R-3400 Cluj Napoca, Romania	University of Tun Hussein Onn Malaysia; Universiti Kebangsaan Malaysia; Babes Bolyai University from Cluj	Ishak, A (corresponding author), Univ Tun Hussein Onn Malaysia, Fac Sci Technol & Human Dev, Dept Math & Stat, Batu Pahat, Johor, Malaysia.	anuar_mi@ukm.edu.my	Ishak, Anuar/AAN-1341-2021; Mansur, Syahira/AAH-4368-2021; Ishak, Anuar/F-1093-2010; Pop, Ioan/ABE-6678-2020	Ishak, Anuar/0000-0002-2353-5919; Mansur, Syahira/0000-0003-0057-9035; Ishak, Anuar/0000-0002-2353-5919; Pop, Ioan/0000-0002-0660-6543	Universiti Kebangsaan Malaysia [DIP-2012-31]	Universiti Kebangsaan Malaysia	Funding was provided by Universiti Kebangsaan Malaysia (www.ukm.my); Grant number: DIP-2012-31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar NS, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14185-0; Akbar NS, 2014, INT J THERM SCI, V85, P54, DOI 10.1016/j.ijthermalsci.2014.06.009; Akbar NS, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14155-6; Andersson HI, 2002, ACTA MECH, V158, P121, DOI 10.1007/BF01463174; [Anonymous], 1995, ENHANCING THERMAL CO; Bachok N, 2012, INT J HEAT MASS TRAN, V55, P2102, DOI 10.1016/j.ijheatmasstransfer.2011.12.013; Bachok N, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-623; Bachok N, 2010, INT J THERM SCI, V49, P1663, DOI 10.1016/j.ijthermalsci.2010.01.026; Bejan A., 2013, CONVECTION HEAT TRAN, V4th, P30; Bhattacharyya K, 2011, INT J HEAT MASS TRAN, V54, P302, DOI 10.1016/j.ijheatmasstransfer.2010.09.043; Bhattacharyya K, 2011, INT J HEAT MASS TRAN, V54, P308, DOI 10.1016/j.ijheatmasstransfer.2010.09.041; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Ellahi R, 2013, J POROUS MEDIA, V16, P205, DOI 10.1615/JPorMedia.v16.i3.30; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2012, MATH COMPUT MODEL, V55, P1876, DOI 10.1016/j.mcm.2011.11.043; Fang TG, 2010, COMMUN NONLINEAR SCI, V15, P1831, DOI 10.1016/j.cnsns.2009.07.017; Fischer E.G., 1976, EXTRUSION PLASTICS; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Harris SD, 2009, TRANSPORT POROUS MED, V77, P267, DOI 10.1007/s11242-008-9309-6; Ibrahim W, 2013, INT J HEAT MASS TRAN, V56, P1, DOI 10.1016/j.ijheatmasstransfer.2012.08.034; Ishak A, 2014, INT J MECH AEROSPACE, V8, P872; Ishak A, 2009, NONLINEAR ANAL-REAL, V10, P2909, DOI 10.1016/j.nonrwa.2008.09.010; Khan WA, 2011, INT J THERM SCI, V50, P1207, DOI 10.1016/j.ijthermalsci.2011.02.015; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Kuznetsov AV, 2013, INT J HEAT MASS TRAN, V65, P682, DOI 10.1016/j.ijheatmasstransfer.2013.06.054; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Lok YY, 2011, INT J NUMER METHOD H, V21, P61, DOI 10.1108/09615531111095076; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mandal IC, 2013, AIN SHAMS ENG J, V4, P103, DOI 10.1016/j.asej.2012.06.004; Masuda H., 1993, NETSU BUSSEI, V4, P227, DOI [10.2963/jjtp.7.227, DOI 10.2963/JJTP.7.227]; MERKIN JH, 1986, J ENG MATH, V20, P171, DOI 10.1007/BF00042775; Miklavcic M, 2006, Q APPL MATH, V64, P283, DOI 10.1090/S0033-569X-06-01002-5; Nadeem S, 2014, APPL NANOSCI, V4, P613, DOI 10.1007/s13204-013-0238-5; Nadeem S, 2015, J AEROSPACE ENG, V28, DOI 10.1061/(ASCE)AS.1943-5525.0000299; Nadeem S, 2014, J TAIWAN INST CHEM E, V45, P121, DOI 10.1016/j.jtice.2013.04.006; Nadeem S, 2014, J COMPUT THEOR NANOS, V11, P32, DOI 10.1166/jctn.2014.3313; Nadeem S, 2014, ALEX ENG J, V53, P219, DOI 10.1016/j.aej.2013.11.003; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Saidur R, 2011, RENEW SUST ENERG REV, V15, P1646, DOI 10.1016/j.rser.2010.11.035; Shampine L., 2003, SOLVING ODES MATLAB; Shampine L.F., 2000, TUTORIAL NOTES; Sheikholeslami M, 2014, J COMPUT THEOR NANOS, V11, P486, DOI 10.1166/jctn.2014.3384; Sheikholeslami M, 2014, J MAGN MAGN MATER, V349, P188, DOI 10.1016/j.jmmm.2013.08.040; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Sheikholeslami M, 2014, J MAGN MAGN MATER, V369, P69, DOI 10.1016/j.jmmm.2014.06.017; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Ul Haq R, 2015, PHYSICA E, V65, P17, DOI 10.1016/j.physe.2014.07.013; Ul Haq R, 2014, CENT EUR J PHYS, V12, P862, DOI 10.2478/s11534-014-0522-3; Ul Haq R, 2014, PHYSICA E, V63, P215, DOI 10.1016/j.physe.2014.06.004; Wang CY, 2009, NONLINEAR ANAL-REAL, V10, P375, DOI 10.1016/j.nonrwa.2007.09.013; Wang CY, 2008, INT J NONLIN MECH, V43, P377, DOI 10.1016/j.ijnonlinmec.2007.12.021; Wang CY, 2002, CHEM ENG SCI, V57, P3745, DOI 10.1016/S0009-2509(02)00267-1; Weidman PD, 2006, INT J ENG SCI, V44, P730, DOI 10.1016/j.ijengsci.2006.04.005; Wong KV, 2010, ADV MECH ENG, DOI 10.1155/2010/519659; Yian LY, 2011, SAINS MALAYS, V40, P1179; Zaimi K, 2012, ADV MECH ENG, DOI 10.1155/2012/340354; Zeeshan A, 2014, J COMPUT THEOR NANOS, V11, P646, DOI 10.1166/jctn.2014.3408	58	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0117733	10.1371/journal.pone.0117733	http://dx.doi.org/10.1371/journal.pone.0117733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760733	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000012
J	Radovcic, D; Srsen, AO; Radovcic, J; Frayer, DW				Radovcic, Davorka; Srsen, Ankica Oros; Radovcic, Jakov; Frayer, David W.			Evidence for Neandertal Jewelry: Modified White-Tailed Eagle Claws at Krapina	PLOS ONE			English	Article							MIDDLE STONE-AGE; SHELL BEADS; CAVE; ART	We describe eight, mostly complete white-tailed eagle (Haliaetus [Haliaeetus] albicilla) talons from the Krapina Neandertal site in present-day Croatia, dating to approximately 130 kyrs ago. Four talons bear multiple, edge-smoothed cut marks; eight show polishing facets and/or abrasion. Three of the largest talons have small notches at roughly the same place along the plantar surface, interrupting the proximal margin of the talon blade. These features suggest they were part of a jewelry assemblage,- the manipulations a consequence of mounting the talons in a necklace or bracelet. An associated phalanx articulates with one of the talons and has numerous cut marks, some of which are smoothed. These white-tailed eagle bones, discovered more than 100 years ago, all derive from a single level at Krapina and represent more talons than found in the entire European Mousterian period. Presence of eight talons indicates that the Krapina Neandertals acquired and curated eagle talons for some kind of symbolic purpose. Some have argued that Neandertals lacked symbolic ability or copied this behavior from modern humans. These remains clearly show that the Krapina Neandertals made jewelry well before the appearance of modern humans in Europe, extending ornament production and symbolic activity early into the European Mousterian.	[Radovcic, Davorka; Radovcic, Jakov] Croatian Nat Hist Museum, Dept Geol & Paleontol, Zagreb 10000, Croatia; [Srsen, Ankica Oros] Croatian Acad Sci & Arts, Inst Quaternary Paleontol & Geol, Zagreb 10000, Croatia; [Frayer, David W.] Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA	Croatian Academy of Sciences & Arts; University of Kansas	Frayer, DW (corresponding author), Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA.	frayer@ku.edu	Oros Sršen, Ankica/GLT-5976-2022					BEDNARIK RG, 1995, CURR ANTHROPOL, V36, P605, DOI 10.1086/204406; BEDNARIK RG, 1994, ANTHROPOS, V89, P169; Blasco R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05971; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Carciumaru M, 2002, ANTIQUITY, V76, P681, DOI 10.1017/S0003598X00091122; Carciumaru M., 2009, ANN U VALAHIA TARGOV, VXI, P7; CHASE PG, 1987, J ANTHROPOL ARCHAEOL, V6, P263, DOI 10.1016/0278-4165(87)90003-1; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; Fiore I, 2004, INT J OSTEOARCHAEOL, V14, P273, DOI 10.1002/oa.761; Gavris G.G., 2012, BIRDS PREY DYNAMIC E, P7; GAVRIS GG, 2004, MIDDLE PALEOLITHIC E, V104, P79; Gorjanovi-Kramberger D, 1901, MITT ANTHRO GESELL W, V31, P164; Gorjanovic-Kramberger D., 1906, STUDIEN ENTWICKLUNGS, VII, P9; Hardy BL, 2013, QUATERNARY SCI REV, V82, P23, DOI 10.1016/j.quascirev.2013.09.028; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Klein R., 2009, HUMAN CAREER; Lambrecht, 1933, HDB PALAEORNITHOLOGI; Lambrecht K, 1915, BARLANGKUTATAS, V3, P116; Malez M., 1989, Geoloski Vjesnik (Zagreb), V42, P49; Malez M, 1988, RAD JUG AKAD ZNAN UM, V441, P115; Miracle P.T, 2007, KRAPINA PALEOLITHIC; Miracle P.T, 2011, FRAGMENTS ICE ENV, V21, P85; Moncel MH, 2012, ARCHAEOL ETHNOL ANTH, V40, P24, DOI 10.1016/j.aeae.2012.05.004; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Peresani M., PNAS, V108, P3888; Peresani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068572; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Radov~ci J., 1988, KRAPINA HOMINIDS ILL; Radovcic J, 1988, DRAGUTIN GORJANOVIC; Radovic A, 2009, BIOLOGIA, V64, P156, DOI 10.2478/s11756-009-0011-0; RINK WJ, 1995, NATURE, V378, P24, DOI 10.1038/378024a0; Rodriguez-Vidal J, 2014, P NATL ACAD SCI USA, V111, P13301, DOI 10.1073/pnas.1411529111; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Romandini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101278; Serjeantson D, 2009, CAMB MAN ARCHAEOL, P1; Simek JF, 1997, J HUM EVOL, V32, P561, DOI 10.1006/jhev.1996.0129; Soressi M., 2007, NEANDERTALIENS BIOL, V23, P297, DOI DOI 10.1183/09031936.00022909; Tattersall I., 2013, MASTERS PLANET; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Wilson GL, 1928, ANTH PAPERS AM MUS N, V30, P98; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	44	110	112	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119802	10.1371/journal.pone.0119802	http://dx.doi.org/10.1371/journal.pone.0119802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CD7MQ	25760648	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000066
J	Serratos, IN; Castellanos, P; Pastor, N; Millan-Pacheco, C; Rembao, D; Perez-Montfort, R; Cabrera, N; Reyes-Espinosa, F; Diaz-Garrido, P; Lopez-Macay, A; Martinez-Flores, K; Lopez-Reyes, A; Sanchez-Garcia, A; Cuevas, E; Santamaria, A				Serratos, Iris N.; Castellanos, Pilar; Pastor, Nina; Millan-Pacheco, Cesar; Rembao, Daniel; Perez-Montfort, Ruy; Cabrera, Nallely; Reyes-Espinosa, Francisco; Diaz-Garrido, Paulina; Lopez-Macay, Ambar; Martinez-Flores, Karina; Lopez-Reyes, Alberto; Sanchez-Garcia, Aurora; Cuevas, Elvis; Santamaria, Abel			Modeling the Interaction between Quinolinate and the Receptor for Advanced Glycation End Products (RAGE): Relevance for Early Neuropathological Processes	PLOS ONE			English	Article							ACID-INDUCED NEUROTOXICITY; ENDPRODUCTS RAGE; OXIDATIVE STRESS; CRYSTAL-STRUCTURE; RAT-BRAIN; ACTIVATION; EXCITOTOXICITY; RECOGNITION; ANTIOXIDANT; NEURODEGENERATION	The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor involved in neurodegenerative and inflammatory disorders. RAGE induces cellular signaling upon binding to a variety of ligands. Evidence suggests that RAGE up-regulation is involved in quinolinate (QUIN)-induced toxicity. We investigated the QUIN-induced toxic events associated with early noxious responses, which might be linked to signaling cascades leading to cell death. The extent of early cellular damage caused by this receptor in the rat striatum was characterized by image processing methods. To document the direct interaction between QUIN and RAGE, we determined the binding constant (K-b) of RAGE (VC1 domain) with QUIN through a fluorescence assay. We modeled possible binding sites of QUIN to the VC1 domain for both rat and human RAGE. QUIN was found to bind at multiple sites to the VC1 dimer, each leading to particular mechanistic scenarios for the signaling evoked by QUIN binding, some of which directly alter RAGE oligomerization. This work contributes to the understanding of the phenomenon of RAGE-QUIN recognition, leading to the modulation of RAGE function.	[Serratos, Iris N.; Reyes-Espinosa, Francisco] Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Mexico City 09340, DF, Mexico; [Serratos, Iris N.; Diaz-Garrido, Paulina; Santamaria, Abel] SSA, Manuel Velasco Suarez, Inst Nacl Neurol & Neurocirugia, Lab Aminocidos Excitadores, Mexico City, DF, Mexico; [Castellanos, Pilar] Univ Autonoma Metropolitana Iztapalapa, Dept Ingn Elect, Mexico City 09340, DF, Mexico; [Pastor, Nina] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca, Morelos, Mexico; [Millan-Pacheco, Cesar] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Rembao, Daniel; Sanchez-Garcia, Aurora] Inst Nacl Neurol & Neurocirug, Neuropatol, Manuel Velasco Suarez, Mexico City 09340, DF, Mexico; [Perez-Montfort, Ruy; Cabrera, Nallely] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico; [Lopez-Macay, Ambar; Martinez-Flores, Karina; Lopez-Reyes, Alberto] SSA, Inst Nacl Rehabil, Lab Liquido Sinovial, Mexico City, DF, Mexico; [Cuevas, Elvis] Natl Ctr Toxicol Research, FDA, Div Neurotoxicol, Neurochem Lab, Jefferson, AR USA	Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; US Food & Drug Administration (FDA)	Serratos, IN (corresponding author), Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Mexico City 09340, DF, Mexico.	natzielly@gmail.com; absada@yahoo.com	Espinosa, Francisco Reyes/D-8113-2019; Serratos, Iris N./E-4530-2018; Millan-Pacheco, Cesar/I-4030-2016; Macay, ambar Lopez/ABH-9850-2020; Pastor, Nina/W-4452-2019	Espinosa, Francisco Reyes/0000-0003-0727-8251; Serratos, Iris N./0000-0002-8352-2423; Millan-Pacheco, Cesar/0000-0001-5180-6504; Pastor, Nina/0000-0001-7755-2936; Diaz-Garrido, Paulina/0000-0002-3885-0487; Lopez-Reyes, Alberto/0000-0002-2575-2589; Perez-Montfort, Ruy/0000-0003-0810-1159; Cabrera Gonzalez, Elizabeth Nallely/0000-0001-8766-6996; Martinez-Flores, Karina/0000-0003-0675-0227; Santamaria, Abel/0000-0002-9874-7182; Lopez Macay, Ambar/0000-0002-2916-7424	Consejo Nacional de Ciencia y Tecnologia [168692]; Secretaria de Educacion Publica [12412137]; No code Committe for Aid and Education in Neurochemistry	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Publica; No code Committe for Aid and Education in Neurochemistry	The work was supported by the following: 168692 Consejo Nacional de Ciencia y Tecnologia http://www.conacyt.gob.mx/pci/index.php/component/users/?task = user.login INS; 12412137 Secretaria de Educacion Publica http://promep.sep.gob.mx/solicitudesv3 INS; and No code Committe for Aid and Education in Neurochemistry http://neurochemistry.org/funding/committee-for-aid-and-education-in-neurochemistry-caen.html INS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello Z, 2010, BIOCHEMISTRY-US, V49, P1388, DOI 10.1021/bi9018225; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Borgonovo J, 2009, J NEURAL TRANSM, V116, P1201, DOI 10.1007/s00702-009-0262-5; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Chen RC, 2014, MOL CELL BIOCHEM, V390, P271, DOI 10.1007/s11010-014-1978-6; Chuah YK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/403460; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cuevas E, 2010, NEUROSCI LETT, V474, P74, DOI 10.1016/j.neulet.2010.03.007; Pasquali MAD, 2013, CELL SIGNAL, V25, P939, DOI 10.1016/j.cellsig.2013.01.013; Essa MM, 2013, NEUROTOX RES, V23, P393, DOI 10.1007/s12640-012-9354-3; Feng QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091512; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Gonzalez R. C., 2018, DIGITAL IMAGE PROCES, V4th, P119; Gonzalez-Mondragon E, 2004, BIOCHEMISTRY-US, V43, P3255, DOI 10.1021/bi036077s; Gospodarska E, 2011, BBA-PROTEINS PROTEOM, V1814, P592, DOI 10.1016/j.bbapap.2011.02.011; Grimsley G.R., 2004, CURR PROTOC PROTEIN; Haas SJP, 2004, J ANAT, V204, P271, DOI 10.1111/j.0021-8782.2004.00279.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leclerc Estelle, 2010, Cardiovasc Psychiatry Neurol, V2010, P539581, DOI 10.1155/2010/539581; Lee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069669; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Malik SS, 2014, PROTEINS, V82, P405, DOI 10.1002/prot.24406; MATLAB, 2019, MATLAB VERS 9 10 0 1; Mueller GA, 2013, ALLERGY, V68, P1546, DOI 10.1111/all.12261; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47; Olney JW, 1990, CAN DIS WKLY REP, V16, P57; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Paxinos G., 2007, THE RAT BRAIN IN STE; Perez-De La Cruz V, 2012, INT J TRYPTOPHAN RES, V5, P1, DOI 10.4137/IJTR.S8158; Perez-Severiano F, 2004, NEUROCHEM INT, V45, P1175, DOI 10.1016/j.neuint.2004.06.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reverdatto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065180; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SANCHEZPOZO A, 1982, ANAL BIOCHEM, V127, P159, DOI 10.1016/0003-2697(82)90159-2; Santamaria A, 2003, J NEUROCHEM, V86, P479, DOI 10.1046/j.1471-4159.2003.01857.x; SCHWARCZ R, 1984, LIFE SCI, V35, P19, DOI 10.1016/0024-3205(84)90148-6; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Serratos IN, 2011, J MOL BIOL, V405, P158, DOI 10.1016/j.jmb.2010.10.018; Silva-Adaya D, 2008, J NEUROCHEM, V105, P677, DOI 10.1111/j.1471-4159.2007.05174.x; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stone TW, 2003, CLIN CHEM LAB MED, V41, P852, DOI 10.1515/CCLM.2003.129; Tan L, 2012, J NEUROL SCI, V323, P1, DOI 10.1016/j.jns.2012.08.005; Tenorio-Lopez FA, 2007, CHROMATOGRAPHIA, V65, P725, DOI 10.1365/s10337-007-0241-7; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Todorova J, 2012, ONCOL LETT, V3, P214, DOI 10.3892/ol.2011.459; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Velazquez-Campoy A, 2004, CURR PROTOC CELL BIO; Vicente Miranda H, 2010, J PATHOL, V221, P13, DOI 10.1002/path.2682; Wilton R, 2006, PROTEIN EXPRES PURIF, V47, P25, DOI 10.1016/j.pep.2006.01.008; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Yang WI, 2014, CIRC J, V78, P1197, DOI 10.1253/circj.CJ-13-1235; Yatime L, 2014, J EXP MED, V211, P749, DOI 10.1084/jem.20132526; Yatime L, 2013, FEBS J, V280, P6556, DOI 10.1111/febs.12556; Zadori D, 2012, J NEUROL SCI, V322, P187, DOI 10.1016/j.jns.2012.06.004; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	75	12	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120221	10.1371/journal.pone.0120221	http://dx.doi.org/10.1371/journal.pone.0120221			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757085	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700062
J	Shen, CJ; Xu, HB; Alvarez, X; Lackner, AA; Veazey, RS; Wang, XL				Shen, Chanjuan; Xu, Huanbin; Alvarez, Xavier; Lackner, Andrew A.; Veazey, Ronald S.; Wang, Xiaolei			Reduced Expression of CD27 by Collagenase Treatment: Implications for Interpreting B Cell Data in Tissues	PLOS ONE			English	Article							CD4(+) T-CELLS; GASTROINTESTINAL-TRACT; PERIPHERAL-BLOOD; RHESUS MACAQUE; SIV INFECTION; IN-VIVO; MEMORY; DEPLETION; RESPONSES; IGA	Surface markers have been used to identify distinct cell subpopulations and to delineate various stages of maturation or activation of lymphocytes. In particular CD27 is used for delineation of naive and memory B cell populations, and is readily detected by flow cytometry. We here used flow cytometry to examine the expression of CD27 on lymphocytes isolated from various tissues of rhesus macaques, and found its expression was consistently low to absent on intestinal cell suspensions. However, immunohistochemistry revealed abundant CD27+ cells in intestinal tissue sections. Further investigation showed the marked loss of CD27 expression on processed intestinal cells was due to collagenase digestion of intestinal tissues, yet CD27 expression was recoverable within hours of cell isolation. By combining confocal microscopy, we confirmed that only a fraction of B cells express CD27, in contrast to expression on all T cells from tissues examined including the gut. Taken together, our results suggest that CD27 may be a memory marker for B cells, but not for T cells, since essentially all CD3 T cells expressed CD27. In summary, it is important to consider the influence of isolation procedures on cell surface expression of phenotypic markers, especially when examining tissue-resident lymphocytes by flow cytometry.	[Shen, Chanjuan; Xu, Huanbin; Alvarez, Xavier; Lackner, Andrew A.; Veazey, Ronald S.; Wang, Xiaolei] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA	Tulane University	Wang, XL (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA.	xwang@tulane.edu	Xu, Huanbin/S-4870-2019		NIH [AI099795, AI084793]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [OD011104-51]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099795, R01AI084793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104, S10OD019964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grants AI099795 (XW), AI084793 (RSV), and the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through grant no. OD011104-51. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 1996, J IMMUNOL METHODS, V194, P211, DOI 10.1016/0022-1759(96)00038-5; Agematsu K, 2000, HISTOL HISTOPATHOL, V15, P573, DOI 10.14670/HH-15.573; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Chen Z, 2014, J IMMUNOL METHODS; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kuhrt D, 2011, J IMMUNOL METHODS, V363, P166, DOI 10.1016/j.jim.2010.09.017; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mazzoli S, 1999, J INFECT DIS, V180, P871, DOI 10.1086/314934; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Nagumo H, 1998, J IMMUNOL, V161, P6496; Raman VS, 2003, J IMMUNOL, V171, P5876, DOI 10.4049/jimmunol.171.11.5876; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Thomas MA, 2014, VACCINE, V32, P872, DOI 10.1016/j.vaccine.2013.12.014; Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1997, CLIN IMMUNOL IMMUNOP, V82, P230, DOI 10.1006/clin.1996.4318; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Wang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027207; Xiao YL, 2004, J IMMUNOL, V172, P7432, DOI 10.4049/jimmunol.172.12.7432; Xu HB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00085	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116667	10.1371/journal.pone.0116667	http://dx.doi.org/10.1371/journal.pone.0116667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756877	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275700010
J	Cramer, JM; Thompson, T; Geskin, A; LaFramboise, W; Lagasse, E				Cramer, Julie M.; Thompson, Timothy; Geskin, Albert; LaFramboise, William; Lagasse, Eric			Distinct Human Stem Cell Populations in Small and Large Intestine	PLOS ONE			English	Article							EPITHELIAL-CELLS; COLON-CANCER; HEMATOPOIETIC STEM; LIMITING DILUTION; PROGENITOR CELLS; IN-VITRO; MARKER; LGR5; DIFFERENTIATION; WNT	The intestine is composed of an epithelial layer containing rapidly proliferating cells that mature into two regions, the small and the large intestine. Although previous studies have identified stem cells as the cell-of-origin for intestinal epithelial cells, no studies have directly compared stem cells derived from these anatomically distinct regions. Here, we examine intrinsic differences between primary epithelial cells isolated from human fetal small and large intestine, after in vitro expansion, using the Wnt agonist R-spondin 2. We utilized flow cytometry, fluorescence-activated cell sorting, gene expression analysis and a three-dimensional in vitro differentiation assay to characterize their stem cell properties. We identified stem cell markers that separate subpopulations of colony-forming cells in the small and large intestine and revealed important differences in differentiation, proliferation and disease pathways using gene expression analysis. Single cells from small and large intestine cultures formed organoids that reflect the distinct cellular hierarchy found in vivo and respond differently to identical exogenous cues. Our characterization identified numerous differences between small and large intestine epithelial stem cells suggesting possible connections to intestinal disease.	[Cramer, Julie M.; Lagasse, Eric] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Cramer, Julie M.; Lagasse, Eric] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA; [Thompson, Timothy] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA; [Geskin, Albert; LaFramboise, William] Univ Pittsburgh, Shadyside Hosp, Dept Pathol, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lagasse, E (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.	lagasse@pitt.edu			National Institutes of Health [DK085711]; National Cancer Institute Cancer Center Support grant [P30 CA 47904]; National Institute of Biomedical Imaging and Bioengineering [T32EB001026-06]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK085711 (EL) and National Cancer Institute Cancer Center Support grant P30 CA 47904 (WL). The project described was also supported by Award Number T32EB001026-06 from the National Institute of Biomedical Imaging and Bioengineering. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Biomedical Imaging and Bioengineering or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Chan CHF, 2006, CARCINOGENESIS, V27, P1909, DOI 10.1093/carcin/bgl040; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; EHMANN UK, 1984, J CELL BIOL, V98, P1026, DOI 10.1083/jcb.98.3.1026; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Francipane Maria Giovanna, 2013, Curr Pathobiol Rep, V1, P111; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gemei M, 2012, CANCER; Glebov OK, 2003, CANCER EPIDEM BIOMAR, V12, P755; Howlader N, 2013, SEER CANC STAT REV 1; Hsu HC, 2013, INT J COLORECTAL DIS, V28, P1535, DOI 10.1007/s00384-013-1721-x; Huang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047901; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kazanjian A, 2011, CURR COLORECT CANC R, V7, P121, DOI 10.1007/s11888-011-0090-5; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Mentlein R, 2004, INT REV CYTOL, V235, P165, DOI 10.1016/S0074-7696(04)35004-7; Modica S, 2009, GUT, V58, P1250, DOI 10.1136/gut.2008.158386; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Papapietro O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2816; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Quintero M, 2004, EJSO-EUR J SURG ONC, V30, P465, DOI 10.1016/j.ejso.2004.03.008; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Riemann D, 1999, IMMUNOL TODAY, V20, P83, DOI 10.1016/S0167-5699(98)01398-X; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; WALDMANN H, 1975, IMMUNOLOGY, V28, P1135; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Wang LK, 2010, J GASTROINTEST SURG, V14, P74, DOI 10.1007/s11605-009-1035-z; WEILBAECHER K, 1991, BLOOD, V78, P945; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	51	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118792	10.1371/journal.pone.0118792	http://dx.doi.org/10.1371/journal.pone.0118792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751518	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000350692700010
J	Ngo, CT; Aujoulat, F; Veas, F; Jumas-Bilak, E; Manguin, S				Chung Thuy Ngo; Aujoulat, Fabien; Veas, Francisco; Jumas-Bilak, Estelle; Manguin, Sylvie			Bacterial Diversity Associated with Wild Caught Anopheles Mosquitoes from Dak Nong Province, Vietnam Using Culture and DNA Fingerprint	PLOS ONE			English	Article							THORSELLIA-ANOPHELIS; DIPTERA-CULICIDAE; SEQUENCE-ANALYSIS; GENOMIC ANALYSIS; MIDGUT BACTERIA; GUT MICROBIOTA; GENUS ASAIA; SP. NOV.; IDENTIFICATION; TRANSMISSION	Background Microbiota of Anopheles midgut can modulate vector immunity and block Plasmodium development. Investigation on the bacterial biodiversity in Anopheles, and specifically on the identification of bacteria that might be used in malaria transmission blocking approaches, has been mainly conducted on malaria vectors of Africa. Vietnam is an endemic country for both malaria and Bancroftian filariasis whose parasitic agents can be transmitted by the same Anopheles species. No information on the microbiota of Anopheles mosquitoes in Vietnam was available previous to this study. Method The culture dependent approach, using different mediums, and culture independent (16S rRNA PCR - TTGE) method were used to investigate the bacterial biodiversity in the abdomen of 5 Anopheles species collected from Dak Nong Province, central-south Vietnam. Molecular methods, sequencing and phylogenetic analysis were used to characterize the microbiota. Results and Discussion The microbiota in wild-caught Anopheles was diverse with the presence of 47 bacterial OTUs belonging to 30 genera, including bacterial genera impacting Plasmodium development. The bacteria were affiliated with 4 phyla, Actinobacteria, Bacteroidetes, Firmicutes and Proteobacteria, the latter being the dominant phylum. Four bacterial genera are newly described in Anopheles mosquitoes including Coxiella, Yersinia, Xanthomonas, and Knoellia. The bacterial diversity per specimen was low ranging from 1 to 4. The results show the importance of pairing culture and fingerprint methods to better screen the bacterial community in Anopheles mosquitoes. Conclusion Sampled Anopheles species from central-south Vietnam contained a diverse bacterial microbiota that needs to be investigated further in order to develop new malaria control approaches. The combination of both culture and DNA fingerprint methods allowed a thorough and complementary screening of the bacterial community in Anopheles mosquitoes.	[Chung Thuy Ngo; Veas, Francisco; Manguin, Sylvie] UMR, Fac Pharm, MD3, IRD, Montpellier, France; [Chung Thuy Ngo] Natl Inst Vet Res, Hanoi, Vietnam; [Aujoulat, Fabien; Jumas-Bilak, Estelle] Univ Montpellier I, Fac Pharm, Equipe Pathogenes & Environm, UMR ECOSYM 5119, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Manguin, S (corresponding author), UMR, Fac Pharm, MD3, IRD, Montpellier, France.	sylvie.manguin@ird.fr	Manguin, Sylvie/G-1787-2015; Manguin, Sylvie/GOE-5338-2022	Manguin, Sylvie/0000-0002-5925-7164; Manguin, Sylvie/0000-0002-5925-7164; Aujoulat, Fabien/0000-0001-6180-6903	IRD-DPF, Marseille, France	IRD-DPF, Marseille, France	This study was made possible through support as a PhD research grant (ARTS) provided to CTN by IRD-DPF, Marseille, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2012, ACTA TROP, V121, P71, DOI 10.1016/j.actatropica.2011.11.001; Al-Olayan EM, 2002, INT J PARASITOL, V32, P1133, DOI 10.1016/S0020-7519(02)00087-5; [Anonymous], 2008, BIODIVERSITY MALARIA; [Anonymous], 2013, SE ASIAN J TROP MED, V44, P307; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Bando H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01641; Bergey DH, 1984, BERGEYS MANUAL OF SY; Bernardet JF, 2005, SYST APPL MICROBIOL, V28, P640, DOI 10.1016/j.syapm.2005.03.016; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Brewster JD, 2013, ANAL BIOCHEM, V442, P107, DOI 10.1016/j.ab.2013.07.013; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; Chavshin AR, 2012, ACTA TROP, V121, P129, DOI 10.1016/j.actatropica.2011.10.015; Ngo CT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-316; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Damiani C, 2010, MICROB ECOL, V60, P644, DOI 10.1007/s00248-010-9704-8; Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Gan HM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-431; Garros C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-11; Gendrin M, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P525, DOI 10.5772/55107; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Gundi VAKB, 2009, INT J SYST EVOL MICR, V59, P2956, DOI 10.1099/ijs.0.002865-0; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Kampfer P, 2006, INT J SYST EVOL MICR, V56, P335, DOI 10.1099/ijs.0.63999-0; Kommanee J, 2010, J GEN APPL MICROBIOL, V56, P81, DOI 10.2323/jgam.56.81; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Li W, 2014, MICROB ECOL, V67, P679, DOI 10.1007/s00248-013-0345-6; Lindh JM, 2008, ACTA TROP, V107, P242, DOI 10.1016/j.actatropica.2008.06.008; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Manguin S, 2008, INFECT GENET EVOL, V8, P489, DOI 10.1016/j.meegid.2007.11.004; Manguin S, 2010, INFECT GENET EVOL, V10, P159, DOI 10.1016/j.meegid.2009.11.014; Manguin S, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P549, DOI 10.5772/55610; Michel C, 2005, J APPL MICROBIOL, V99, P323, DOI 10.1111/j.1365-2672.2005.02592.x; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Narciso-da-Rocha C, 2014, SCI TOTAL ENVIRON, V466, P127, DOI 10.1016/j.scitotenv.2013.06.109; Ogier JC, 2002, APPL ENVIRON MICROB, V68, P3691, DOI 10.1128/AEM.68.8.3691-3701.2002; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Roh SW, 2008, J MICROBIOL, V46, P525, DOI 10.1007/s12275-008-0189-9; Roudiere L, 2009, J MICROBIOL METH, V79, P156, DOI 10.1016/j.mimet.2009.08.005; Sharma P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-235; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Sturm G, 2011, INT J SYST EVOL MICR, V61, P956, DOI 10.1099/ijs.0.022780-0; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Villegas LM, 2014, MEM I OSWALDO CRUZ, V109, P672, DOI 10.1590/0074-0276140194; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Walton C, 2007, INFECT GENET EVOL, V7, P93, DOI 10.1016/j.meegid.2006.05.001; Wang S, 2012, P NATL ACAD SCI USA, V109, P9; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Xue D, 2013, WORLD J MICROBIOL BI; Zhang W, 2010, INT J SYST EVOL MICR, V60, P2665, DOI 10.1099/ijs.0.017400-0	68	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118634	10.1371/journal.pone.0118634	http://dx.doi.org/10.1371/journal.pone.0118634			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747513	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400023
J	Cui, JL; Guo, TT; Ren, ZX; Zhang, NS; Wang, ML				Cui, Jin-Long; Guo, Ting-Ting; Ren, Zhen-Xing; Zhang, Na-Sha; Wang, Meng-Liang			Diversity and Antioxidant Activity of Culturable Endophytic Fungi from Alpine Plants of Rhodiola crenulata, R-angusta, and R-sachalinensis	PLOS ONE			English	Article							PESTALOTIOPSIS-MICROSPORA; SALIDROSIDE; L.; CELLS; ROSEA; IMBRICATA; EXTRACTS; RESOURCE; TYROSOL; TAXOL	Rhodiola spp. are rare and endangered alpine plants widely used as medicines and food additives by many civilizations since ancient times. Their main effective ingredients (such as salidroside and p-tyrosol) are praised to exhibit pharmacologic effects on high-altitude sickness and possess anti-aging and other adaptogenic capacities based on their antioxidant properties. In this study, 347 endophytic fungi were isolated from R. crenulata, R. angusta, and R. sachalinensis, and the molecular diversity and antioxidant activities of these fungi were investigated for the first time. These fungi were categorized into 180 morphotypes based on cultural characteristics, and their rRNA gene ITS sequences were analyzed by BLAST search in the GenBank database. Except for 12 unidentified fungi (6.67%), all others were affiliated to at least 57 genera in 20 orders of four phyla, namely, Ascomycota (88.89%), Basidiomycota (2.78%), Zygomycota (1.11%), and Glomeromycota (0.56%), which exhibited high abundance and diversity. Antioxidant assay showed that the DPPH radical-scavenging rates of 114 isolates (63.33%) were >50%, and those of five isolates (Rct45, Rct63, Rct64, Rac76, and Rsc57) were >90%. The EC50 values of five antioxidant assays suggested significant potential of these fungi on scavenging DPPH center dot, O-2-center dot, and OH center dot radicals, as well as scavenging nitrite and chelating Fe2+, which showed preference and selection between endophytic fungi and their hosts. Further research also provided the first evidence that Rac12 could produce salidrosides and p-tyrosol. Results suggested that versatile endophytic fungi associated with Rhodiola known as antioxidants could be exploited as potential sources of novel antioxidant products.	[Cui, Jin-Long; Guo, Ting-Ting; Ren, Zhen-Xing; Zhang, Na-Sha; Wang, Meng-Liang] Shanxi Univ, Inst Appl Chem, Taiyuan 030006, Shanxi Province, Peoples R China; [Guo, Ting-Ting; Zhang, Na-Sha] Shanxi Univ, Inst Biotechnol, Taiyuan 030006, Shanxi Province, Peoples R China	Shanxi University; Shanxi University	Wang, ML (corresponding author), Shanxi Univ, Inst Appl Chem, Taiyuan 030006, Shanxi Province, Peoples R China.	cjl717@sxu.edu.cn						Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Bayman P, 2006, WORLD J MICROB BIOT, V27, P1009; Bosshard PP, 2003, J CLIN MICROBIOL, V41, P4134, DOI 10.1128/JCM.41.9.4134-4140.2003; Chawla R, 2010, J PHARM BIOALLIED SC, V2, P213, DOI 10.4103/0975-7406.68503; Chen SL, 2008, CHROMATOGRAPHIA, V68, P299, DOI 10.1365/s10337-008-0705-4; Chiang HM, 2014, FOOD CHEM TOXICOL, V65, P129, DOI 10.1016/j.fct.2013.12.032; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE; Choi SY, 2006, J AGR FOOD CHEM, V54, P6075, DOI 10.1021/jf060845f; Chu YH, 2014, J AGR FOOD CHEM, V62, P3742, DOI 10.1021/jf5004094; Cui JL, 2011, PHYTOTHER RES, V25, P1189, DOI 10.1002/ptr.3361; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; Ganley RJ, 2004, P NATL ACAD SCI USA, V101, P10107, DOI 10.1073/pnas.0401513101; Guo T, 2011, FOOD CHEM, V127, P1634, DOI 10.1016/j.foodchem.2011.02.030; Gupta V, 2010, FOOD CHEM TOXICOL, V48, P1019, DOI 10.1016/j.fct.2010.01.012; Hamilton CE, 2012, FUNGAL DIVERS, V54, P1, DOI 10.1007/s13225-012-0158-9; Huang WY, 2007, ECON BOT, V61, P14, DOI 10.1663/0013-0001(2007)61[14:APAREF]2.0.CO;2; Hung SK, 2011, PHYTOMEDICINE, V18, P235, DOI 10.1016/j.phymed.2010.08.014; Ishaque S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-70; Khanum F, 2005, COMPR REV FOOD SCI F, V4, P55, DOI 10.1111/j.1541-4337.2005.tb00073.x; Ma CY, 2008, CHROMATOGRAPHIA, V67, P383, DOI 10.1365/s10337-008-0539-0; Ma LQ, 2007, PLANT CELL REP, V26, P989, DOI 10.1007/s00299-007-0317-8; Nicoletti R, 2008, WORLD J MICROB BIOT, V24, P189, DOI 10.1007/s11274-007-9455-y; Ordonez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024; Panossian A, 2010, PHYTOMEDICINE, V17, P481, DOI 10.1016/j.phymed.2010.02.002; Panossian A, 2014, PHYTOMEDICINE, V21, P1325, DOI 10.1016/j.phymed.2014.07.008; Petrini Orlando, 1992, Natural Toxins, V1, P185, DOI 10.1002/nt.2620010306; Raj K., 2010, Pharmacognosy Journal, V2, P431; Ravindran C, 2012, BOT MAR, V55, P269, DOI 10.1515/bot-2011-0095; Redkin SC, 1996, ENDOPHYTIC FUNGI GRA; RODRIGUES KF, 1994, MYCOLOGIA, V86, P376, DOI 10.2307/3760568; Rodriguez R, 2005, P NATL ACAD SCI USA, V102, P3175, DOI 10.1073/pnas.0500367102; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Saucedo-Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098454; Shrestha UB, 2013, BIOL CONSERV, V159, P514, DOI 10.1016/j.biocon.2012.10.032; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Skerget M, 2005, FOOD CHEM, V89, P191, DOI 10.1016/j.foodchem.2004.02.025; Song YC, 2005, BIOL PHARM BULL, V28, P506, DOI 10.1248/bpb.28.506; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel G, 1996, MICROBIOL-UK, V142, P435, DOI 10.1099/13500872-142-2-435; Strobel G, 2002, PHYTOCHEMISTRY, V60, P179, DOI 10.1016/S0031-9422(02)00062-6; Sun LW, 2012, LIFE SCI, V91, P151, DOI 10.1016/j.lfs.2012.06.026; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Surveswaran S, 2007, FOOD CHEM, V102, P938, DOI 10.1016/j.foodchem.2006.06.033; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Wearn JA, 2012, J ECOL, V100, P1085, DOI 10.1111/j.1365-2745.2012.01997.x; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; WynnWilliams DD, 1996, BIODIVERS CONSERV, V5, P1271, DOI 10.1007/BF00051979; Xu L, 2008, LETT APPL MICROBIOL, V46, P68, DOI 10.1111/j.1472-765X.2007.02264.x; Yin H, 2011, PHYTOMEDICINE, V18, P802, DOI 10.1016/j.phymed.2011.01.005; Yu NH, 2014, POLAR BIOL, V37, P27, DOI 10.1007/s00300-013-1406-5; Zhao JT, 2012, J AGR FOOD CHEM, V60, P4314, DOI 10.1021/jf205097y; Zheng P, 2013, APPL MICROBIOL BIOT, V97, P2797, DOI 10.1007/s00253-013-4771-7	56	71	82	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118204	10.1371/journal.pone.0118204	http://dx.doi.org/10.1371/journal.pone.0118204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768014	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500021
J	Moro, C; Cornette, R; Vieaud, A; Bruneau, N; Gourichon, D; Bed'hom, B; Tixier-Boichard, M				Moro, Celine; Cornette, Raphael; Vieaud, Agathe; Bruneau, Nicolas; Gourichon, David; Bed'hom, Bertrand; Tixier-Boichard, Michele			Quantitative Effect of a CNV on a Morphological Trait in Chickens	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENOME	Copy Number Variation has been associated with morphological traits, developmental defects or disease susceptibility. The autosomal dominant Pea-comb mutation in chickens is due to the massive amplification of a CNV in intron 1 of SOX5 and provides a unique opportunity to assess the effect of variation in the number of repeats on quantitative traits such as comb size and comb mass in Pea-comb chickens. The quantitative variation of comb size was estimated by 2D morphometry and the number of repeats (RQ) was estimated by qPCR, in a total of 178 chickens from 3 experimental lines, two of them showing segregation for the Pea-comb mutation. This study included only Pea-comb chickens. Analysis of variance showed highly significant effects of line and sex on comb measurements. Adult body weight (BW) and RQ were handled as covariates. BW significantly influenced comb mass but not comb size. RQ values significantly influenced comb size, and the linear regression coefficient was highest for heterozygous carriers: the higher the number of repeats, the smaller the comb size. A similar trend was observed for comb mass. The CNV contributed to 3.4% of the phenotypic variance of comb size in heterozygous carriers of the CNV, an order of magnitude frequently encountered for QTLs. Surprisingly, there was no such relationship between RQ values and comb size in the homozygous line. It may be concluded that heterozygosity for a CNV in a non-coding region may contribute to phenotypic plasticity.	[Moro, Celine; Vieaud, Agathe; Bruneau, Nicolas; Bed'hom, Bertrand; Tixier-Boichard, Michele] AgroParisTech, Inst Natl Rech Agron, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France; [Cornette, Raphael] Museum Natl Hist Nat, UMR 7205, Inst Systemat, Evolut,Biodivers, F-75231 Paris, France; [Gourichon, David] INRA, Pole Experimentat Avicole Tours UE1295, Nouzilly, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; INRAE	Tixier-Boichard, M (corresponding author), AgroParisTech, Inst Natl Rech Agron, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France.	michele.boichard@jouy.inra.fr	Bed'Hom, Bertrand/G-7313-2011	Bed'Hom, Bertrand/0000-0002-0825-0886; Cornette, Raphael/0000-0003-4182-4201	Animal Genetics division of Institut National de la Recherche Agronomique (INRA)	Animal Genetics division of Institut National de la Recherche Agronomique (INRA)	This study was supported by a grant from the Animal Genetics division of Institut National de la Recherche Agronomique (INRA), in the frame of project funding for the teams of the division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson J., 1933, P 5 WORLDS POULTR C, V2, P273, DOI [10.1513/pats.200908-092RM, DOI 10.1513/PATS.200908-092RM.EMERGING]; Boije H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050890; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; Hai R, 2012, J HUM GENET, V57, P33, DOI 10.1038/jhg.2011.125; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moro C, 2013, 10 FRENCH POULTR RES; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Roussot O, 2003, GENET SEL EVOL, V35, P559, DOI [10.1186/1297-9686-35-6-559, 10.1051/gse:2003039]; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Tian M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-262; Tufvesson M, 1999, J ANIM BREED GENET, V116, P127, DOI 10.1046/j.1439-0388.1999.00179.x; Wright D, 2008, EVOLUTION, V62, P86, DOI 10.1111/j.1558-5646.2007.00281.x; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512	16	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118706	10.1371/journal.pone.0118706	http://dx.doi.org/10.1371/journal.pone.0118706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768125	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500038
J	Aslankoohi, E; Rezaei, MN; Vervoort, Y; Courtin, CM; Verstrepen, KJ				Aslankoohi, Elham; Rezaei, Mohammad Naser; Vervoort, Yannick; Courtin, Christophe M.; Verstrepen, Kevin J.			Glycerol Production by Fermenting Yeast Cells Is Essential for Optimal Bread Dough Fermentation	PLOS ONE			English	Article							CRYOTOLERANT SACCHAROMYCES STRAINS; 3-PHOSPHATE DEHYDROGENASE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; OSMOTIC-STRESS; BAKERS-YEAST; WATER-STRESS; CEREVISIAE; GPD1; OSMOREGULATION; MUTANT	Glycerol is the main compatible solute in yeast Saccharomyces cerevisiae. When faced with osmotic stress, for example during semi-solid state bread dough fermentation, yeast cells produce and accumulate glycerol in order to prevent dehydration by balancing the intracellular osmolarity with that of the environment. However, increased glycerol production also results in decreased CO2 production, which may reduce dough leavening. We investigated the effect of yeast glycerol production level on bread dough fermentation capacity of a commercial bakery strain and a laboratory strain. We find that Delta gpd1 mutants that show decreased glycerol production show impaired dough fermentation. In contrast, overexpression of GPD1 in the laboratory strain results in increased fermentation rates in high-sugar dough and improved gas retention in the fermenting bread dough. Together, our results reveal the crucial role of glycerol production level by fermenting yeast cells in dough fermentation efficiency as well as gas retention in dough, thereby opening up new routes for the selection of improved commercial bakery yeasts.	[Aslankoohi, Elham; Vervoort, Yannick; Verstrepen, Kevin J.] VIB, Lab Syst Biol, Leuven, Belgium; [Aslankoohi, Elham; Vervoort, Yannick; Verstrepen, Kevin J.] Katholieke Univ Leuven, CMPG Lab Genet & Genom, Leuven, Belgium; [Rezaei, Mohammad Naser; Courtin, Christophe M.] Katholieke Univ Leuven, Lab Food Chem & Biochem, Leuven, Belgium; [Rezaei, Mohammad Naser; Courtin, Christophe M.] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Courtin, CM (corresponding author), Katholieke Univ Leuven, Lab Food Chem & Biochem, Leuven, Belgium.	Christophe.Courtin@biw.kuleuven.be; Kevin.Verstrepen@biw.vib-kuleuven.be	Verstrepen, Kevin/AAA-4343-2021; Courtin, Christophe M/Q-1916-2016	Courtin, Christophe M/0000-0002-1203-9063; Verstrepen, Kevin/0000-0002-3077-6219; Rezaei, Mohammad Naser/0000-0002-6626-6739	ERC Starting Grant [241426]; VIB; HFSP research grant [RGP0050/2013]; FWO; IWT; KU Leuven IDO project [IDO/12/011]; FWO project [G.0544.10N]; EMBO YIP program	ERC Starting Grant; VIB; HFSP research grant; FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven IDO project; FWO project(FWO); EMBO YIP program	Research in the lab of KJV is supported by ERC Starting Grant 241426, VIB, EMBO YIP program, HFSP research grant RGP0050/2013, FWO, and IWT. The authors specifically acknowledge financial support from KU Leuven IDO project IDO/12/011 and FWO project funding (G.0544.10N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC International, 2000, APPR METH AN; Abelson J., 2004, GUIDE YEAST GENETICS; ALBERTYN J, 1994, CURR GENET, V25, P12, DOI 10.1007/BF00712960; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; [Anonymous], 2000, AUST J GRAPE WINE R, DOI DOI 10.1111/J.1755-0238.2000.TB00181.X; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Aslankoohi E, 2013, APPL ENVIRON MICROB, V79, P7325, DOI 10.1128/AEM.02649-13; Attfield PV, 2000, LETT APPL MICROBIOL, V31, P323, DOI [10.1046/j.1472-765x.2000.00825.x, 10.1046/j.1472-765X.2000.00825.x]; Baik MY, 2002, CEREAL CHEM, V79, P376, DOI 10.1094/CCHEM.2002.79.3.376; Barrett AH, 2000, CEREAL CHEM, V77, P169, DOI 10.1094/CCHEM.2000.77.2.169; Bell PJL, 2001, LETT APPL MICROBIOL, V32, P224, DOI 10.1046/j.1472-765X.2001.00894.x; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Bertolini L, 1996, AM J ENOL VITICULT, V47, P343; BLOMBERG A, 1989, J BACTERIOL, V171, P1087, DOI 10.1128/jb.171.2.1087-1092.1989; Burke D, 2000, METHODS YEAST GENETI, P205; Cambon B, 2006, APPL ENVIRON MICROB, V72, P4688, DOI 10.1128/AEM.02975-05; CASTELLARI L, 1994, VITIS, V33, P49; CZUCHAJOWSKA Z, 1993, CEREAL FOOD WORLD, V38, P499; ERIKSSON P, 1995, MOL MICROBIOL, V17, P95, DOI 10.1111/j.1365-2958.1995.mmi_17010095.x; Hirasawa R, 2001, FEMS MICROBIOL LETT, V194, P159, DOI 10.1016/S0378-1097(00)00521-8; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Izawa S, 2004, APPL MICROBIOL BIOT, V66, P303, DOI 10.1007/s00253-004-1688-1; Izawa S, 2004, APPL MICROBIOL BIOT, V66, P108, DOI 10.1007/s00253-004-1624-4; Jayaram VB, 2014, FOOD CHEM, V151, P421, DOI 10.1016/j.foodchem.2013.11.025; Kieffer R, 1998, J CEREAL SCI, V27, P53, DOI 10.1006/jcrs.1997.0136; LARSSON K, 1993, MOL MICROBIOL, V10, P1101, DOI 10.1111/j.1365-2958.1993.tb00980.x; Michnick S, 1997, YEAST, V13, P783, DOI 10.1002/(SICI)1097-0061(199707)13:9<783::AID-YEA128>3.0.CO;2-W; Myers DK, 1998, FOOD MICROBIOL, V15, P51, DOI 10.1006/fmic.1997.0131; Nash D, 2006, CEREAL CHEM, V83, P255, DOI 10.1094/CC-83-0255; Nevoigt E, 1997, FEMS MICROBIOL REV, V21, P231, DOI 10.1111/j.1574-6976.1997.tb00352.x; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Oliveira BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087290; Oliveira R, 2003, BBA-BIOMEMBRANES, V1613, P57, DOI 10.1016/S0005-2736(03)00138-X; Remize F, 1999, APPL ENVIRON MICROB, V65, P143; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rezaei MN, 2014, FOOD MICROBIOL, V39, P108, DOI 10.1016/j.fm.2013.11.013; Sambrook J., 2001, MOL CLONING LAB MANU, V1, P2344; Somero G, 2011, COMPR PHYSL; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Toh TH, 2000, S AFRICAN J ENOLOGY, P92; VANECK JH, 1989, J GEN MICROBIOL, V135, P3505; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yeh LT, 2009, J FOOD SCI, V74, pS399, DOI 10.1111/j.1750-3841.2009.01337.x	44	39	41	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119364	10.1371/journal.pone.0119364	http://dx.doi.org/10.1371/journal.pone.0119364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764309	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300024
J	Albersen, M; Bosma, M; Jans, JJM; Hofstede, FC; Van Hasselt, PM; de Sain-van der Velden, MGM; Visser, G; Verhoeven-Duif, NM				Albersen, Monique; Bosma, Marjolein; Jans, Judith J. M.; Hofstede, Floris C.; Van Hasselt, Peter M.; de Sain-van der Velden, Monique G. M.; Visser, Gepke; Verhoeven-Duif, Nanda M.			Vitamin B6 in Plasma and Cerebrospinal Fluid of Children	PLOS ONE			English	Article							PYRIDOXINE DEPENDENT EPILEPSY; PNPO DEFICIENCY; 5'-PHOSPHATE; MUTATIONS; ANTIQUITIN; DIAGNOSIS; SEIZURES; PYRIDOXAL-5'-PHOSPHATE; HYPERHOMOCYSTEINEMIA; HOMOCYSTEINE	Background Over the past years, the essential role of vitamin B6 in brain development and functioning has been recognized and genetic metabolic disorders resulting in functional vitamin B6 deficiency have been identified. However, data on B6 vitamers in children are scarce. Materials and Methods B6 vitamer concentrations in simultaneously sampled plasma and cerebrospinal fluid (CSF) of 70 children with intellectual disability were determined by ultra performance liquid chromatography-tandem mass spectrometry. For ethical reasons, CSF samples could not be obtained from healthy children. The influence of sex, age, epilepsy and treatment with antiepileptic drugs, were investigated. Results The B6 vitamer composition of plasma (pyridoxal phosphate (PLP) > pyridoxic acid > pyridoxal (PL)) differed from that of CSF (PL > PLP > pyridoxic acid > pyridoxamine). Strong correlations were found for B6 vitamers in and between plasma and CSF. Treatment with anti-epileptic drugs resulted in decreased concentrations of PL and PLP in CSF. Conclusion We provide concentrations of all B6 vitamers in plasma and CSF of children with intellectual disability (+/- epilepsy), which can be used in the investigation of known and novel disorders associated with vitamin B6 metabolism as well as in monitoring of the biochemical effects of treatment with vitamin B6.	[Albersen, Monique; Bosma, Marjolein; Jans, Judith J. M.; de Sain-van der Velden, Monique G. M.; Verhoeven-Duif, Nanda M.] UMC Utrecht, Dept Med Genet, Utrecht, Netherlands; [Hofstede, Floris C.; Van Hasselt, Peter M.; Visser, Gepke] Wilhelmina Childrens Hosp, UMC Utrecht, Dept Paediat Metab Dis, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Verhoeven-Duif, NM (corresponding author), UMC Utrecht, Dept Med Genet, Utrecht, Netherlands.	N.Verhoeven@umcutrecht.nl		Jans, Judith/0000-0003-0960-6263				Albersen M, 2014, AM J CLIN NUTR, V100, P587, DOI 10.3945/ajcn.113.082008; Albersen M, 2012, PEDIATRICS, V130, pE191, DOI 10.1542/peds.2011-3751; Apeland T, 2006, CLIN BIOCHEM, V39, P282, DOI 10.1016/j.clinbiochem.2006.01.007; Apeland T, 2003, CLIN CHEM, V49, P1005, DOI 10.1373/49.6.1005; Apeland T, 2002, EPILEPSY RES, V51, P237, DOI 10.1016/S0920-1211(02)00153-5; Bates CJ, 1999, PUBLIC HEALTH NUTR, V2, P529, DOI 10.1017/S1368980099000713; Bates CJ, 1999, CLIN CHIM ACTA, V280, P101, DOI 10.1016/S0009-8981(98)00173-9; Bok LA, 2012, DEV MED CHILD NEUROL, V54, P849, DOI 10.1111/j.1469-8749.2012.04347.x; FLEISHER GA, 1977, CLIN CHEM, V23, P469; Footitt EJ, 2012, J INHERIT METAB DIS, V35, pS18, DOI 10.1007/s10545-012-9493-y; Footitt EJ, 2011, J INHERIT METAB DIS, V34, P529, DOI 10.1007/s10545-011-9279-7; Goyal M, 2013, PEDIATR NEUROL, V48, P227, DOI 10.1016/j.pediatrneurol.2012.11.006; Hartmann H, 2011, DEV MED CHILD NEUROL, V53, P1150, DOI 10.1111/j.1469-8749.2011.04033.x; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; Hoffmann GF, 2007, J INHERIT METAB DIS, V30, P96, DOI 10.1007/s10545-006-0508-4; Jortner BS, 2000, TOXICOL PATHOL, V28, P54, DOI 10.1177/019262330002800108; Khayat M, 2008, MOL GENET METAB, V94, P431, DOI 10.1016/j.ymgme.2008.04.008; Marszall ML, 2009, J CHROMATOGR B, V877, P3151, DOI 10.1016/j.jchromb.2009.08.014; Mercimek-Mahmutoglu S, 2013, MOL GENET METAB, V110, P197, DOI 10.1016/j.ymgme.2013.04.018; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Mills PB, 2014, BRAIN, V137, P1350, DOI 10.1093/brain/awu051; Morris MS, 2008, AM J CLIN NUTR, V87, P1446, DOI 10.1093/ajcn/87.5.1446; Ormazabal A, 2008, MOL GENET METAB, V94, P173, DOI 10.1016/j.ymgme.2008.01.004; Plecko B, 2014, NEUROLOGY, V82, P1425, DOI 10.1212/WNL.0000000000000344; Porri S, 2014, NEUROPEDIATRICS, V45, P64, DOI 10.1055/s-0033-1353489; Ruiz A, 2008, MOL GENET METAB, V93, P216, DOI 10.1016/j.ymgme.2007.10.003; SCHIELE F, 1983, CLIN CHEM, V29, P634; Schwaninger M, 1999, EPILEPSIA, V40, P345, DOI 10.1111/j.1528-1157.1999.tb00716.x; SHIN YS, 1984, LANCET, V2, P870; Stockler S, 2011, MOL GENET METAB, V104, P48, DOI 10.1016/j.ymgme.2011.05.014; van der Ham M, 2012, ANAL CHIM ACTA, V712, P108, DOI 10.1016/j.aca.2011.11.018; Verrotti A, 2000, EPILEPSY RES, V41, P253, DOI 10.1016/S0920-1211(00)00150-9; Vilaseca M A, 2000, Eur J Paediatr Neurol, V4, P269, DOI 10.1053/ejpn.2000.0379; Walker V, 2000, ARCH DIS CHILD, V82, P236, DOI 10.1136/adc.82.3.236; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; WHYTE MP, 1988, J CLIN INVEST, V81, P1234, DOI 10.1172/JCI113440	37	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120972	10.1371/journal.pone.0120972	http://dx.doi.org/10.1371/journal.pone.0120972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760040	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275000073
J	Gilgien, M; Crivelli, P; Sporri, J; Kroll, J; Muller, E				Gilgien, Matthias; Crivelli, Philip; Spoerri, Joerg; Kroll, Joesef; Mueller, Erich			Characterization of Course and Terrain and Their Effect on Skier Speed in World Cup Alpine Ski Racing	PLOS ONE			English	Article							SYSTEMATIC VIDEO ANALYSIS; CRUCIATE LIGAMENT INJURY; RISK; MECHANISMS; KINEMATICS	World Cup (WC) alpine ski racing consists of four main competition disciplines (slalom, giant slalom, super-G and downhill), each with specific course and terrain characteristics. The International Ski Federation (FIS) has regulated course length, altitude drop from start to finish and course setting in order to specify the characteristics of the respective competition disciplines and to control performance and injury-related aspects. However to date, no detailed data on course setting and its adaptation to terrain is available. It is also unknown how course and terrain characteristics influence skier speed. Therefore, the aim of the study was to characterize course setting, terrain geomorphology and their relationship to speed in male WC giant slalom, super-G and downhill. The study revealed that terrain was flatter in downhill compared to the other disciplines. In all disciplines, variability in horizontal gate distance (gate offset) was larger than in gate distance (linear distance from gate to gate). In giant slalom the horizontal gate distance increased with terrain inclination, while super-G and downhill did not show such a connection. In giant slalom and super-G, there was a slight trend towards shorter gate distances as the steepness of the terrain increased. Gates were usually set close to terrain transitions in all three disciplines. Downhill had a larger proportion of extreme terrain inclination changes along the skier trajectory per unit time skiing than the other disciplines. Skier speed decreased with increasing steepness of terrain in all disciplines except for downhill. In steep terrain, speed was found to be controllable by increased horizontal gate distances in giant slalom and by shorter gate distances in giant slalom and super-G. Across the disciplines skier speed was largely explained by course setting and terrain inclination in a multiple linear model.	[Gilgien, Matthias] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Spoerri, Joerg; Kroll, Joesef; Mueller, Erich] Salzburg Univ, Dept Sport Sci & Kinesiol, Hallein Rif, Austria; [Crivelli, Philip] WSL, Inst Snow & Avalanche Res SLF, Grp Snowsports, Davos, Switzerland	Norwegian School of Sport Sciences; Salzburg University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Gilgien, M (corresponding author), Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway.	matthias.gilgien@nih.no		Sporri, Jorg/0000-0002-0353-1021	International Skiing Federation (FIS) through the FIS Injury Surveillance System	International Skiing Federation (FIS) through the FIS Injury Surveillance System	This study was financially supported by the International Skiing Federation (FIS) through the FIS Injury Surveillance System. URL: http://www.fis-ski.com/inside-fis/medical-antidoping/injury-surveillance-system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barelle C, 2004, J APPL BIOMECH, V20, P167, DOI 10.1123/jab.20.2.167; Bere T, 2013, SCAND J MED SCI SPOR; Bere T, 2014, BRIT J SPORT MED, V48, P738, DOI 10.1136/bjsports-2014-093528; Bere T, 2013, AM J SPORT MED, V41, P1067, DOI 10.1177/0363546513479341; Bere T, 2011, BRIT J SPORT MED, V45, P1294, DOI 10.1136/bjsports-2011-090517; Bere T, 2011, AM J SPORT MED, V39, P1421, DOI 10.1177/0363546511405147; Fauve M., 2002, PREPARATION MAINTENA; Federolf P, 2006, ENG SPORT 6, P285; Florenes TW, 2012, SCAND J MED SCI SPOR, V22, P58, DOI 10.1111/j.1600-0838.2010.01147.x; Florenes TW, 2009, BRIT J SPORT MED, V43, P973, DOI 10.1136/bjsm.2009.068759; Gilgien M., 2008, 13 ANN C EUR COLL SP, P569; Gilgien M, 2008, ANN C EUR COLL SPORT; Gilgien M, 2013, J SPORT SCI IN PRESS; Gilgien M., 2014, THESIS NORWEGIAN SCH; Gilgien M, 2014, SENSORS-BASEL, V14, P18433, DOI 10.3390/s141018433; Gilgien M, 2014, BRIT J SPORT MED, V48, P742, DOI 10.1136/bjsports-2013-092994; Gilgien M, 2013, SENSORS-BASEL, V13, P9821, DOI 10.3390/s130809821; Heinrich D, 2014, SCAND J MED SCI SPOR, V24, pE180, DOI 10.1111/sms.12120; Hugentobler M., 2004, TERRAIN MODELLING TR; Kroll J, 2013, SPORT ORTHOPADIE SPO, V29, P288; Luthi A., 2006, ENG SPORT 6, V1, P299; Meyer F, 2012, MED SCI SPORT EXER, V44, P1109, DOI 10.1249/MSS.0b013e3182443315; Nachbauer W, 1996, AM SOC TEST MATER, V1266, P178, DOI 10.1520/STP37927S; Nachbauer W., 2004, P ENG SPORT 5 WINF I, P472; Raschner C, 2012, BRIT J SPORT MED, V46, P1065, DOI 10.1136/bjsports-2012-091050; Reid R.C, 2010, THESIS NORWEGIAN SCH; Ruedl G, 2011, INT J SPORTS MED, V32, P801, DOI 10.1055/s-0031-1279719; Schiestl M., 2006, ENG SPORT, P269; Schindelwig K, 2014, SCAND J MED SCI SPOR; Sporri J, 2012, INT J SPORTS SCI COA, V7, P647, DOI 10.1260/1747-9541.7.4.647; Sporri J, 2012, BRIT J SPORT MED, V46, P1072, DOI 10.1136/bjsports-2012-091425; Sporri J, 2012, BRIT J SPORT MED, V46, P1059, DOI 10.1136/bjsports-2012-091048; Supej M, 2013, SCAND J MED SCI SPOR, V23, pe38, DOI 10.1111/sms.12007; Supej M, 2014, INT J SPORTS PHYSL P; Supej M., 2005, KINESIOLOGY, V37, P151; Wolfsperger F, 2013, INT C SCI SKIING; Yamazaki J, 2014, ANAL SEVERE HE UNPUB	37	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118119	10.1371/journal.pone.0118119	http://dx.doi.org/10.1371/journal.pone.0118119			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760039	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000018
J	Britton, A; Bell, S				Britton, Annie; Bell, Steven			Reasons Why People Change Their Alcohol Consumption in Later Life: Findings from the Whitehall II Cohort Study	PLOS ONE			English	Article							OLDER-PEOPLE; DRINKING	Purpose Harmful alcohol consumption among the ageing population is an important public health issue. Very few studies ask drinkers why they change their consumption in later life. The aim of this paper was to determine whether a group of people aged over 60 years increased or decreased their alcohol consumption over the past decade and to determine the reasons for their change. We also examined whether the responses varied by age, sex and socioeconomic position (SEP). Subjects and Methods Data were taken from 6,011 participants (4,310 men, 1,701 women, age range 61 to 85 years) who completed questionnaires at phase 11 (2012-2013) of the Whitehall II Cohort Study. Results Over half the study members reported a change in alcohol consumption over the past decade (40% decreased, 11% increased). The most common reasons given for decreases were as a health precaution and fewer social occasions. Common reasons for increases were more social occasions and fewer responsibilities. The lowest SEP group was less likely to increase consumption compared to high SEP (RR 0.57, 95% CI 0.40 to 0.81). Women were more likely to increase consumption in response to stress/depression than men (RR1.53, 95% CI 1.04 to 2.25). Compared to high SEP, the lowest SEP group was less likely to reduce as a health precaution (RR 0.61, 95% CI 0.38 to 0.76). Conclusions Alcohol consumption in late life is not fixed. Reasons for change vary by age, sex and SEP. Such information could be used to tailor intervention strategies to reduce harmful consumption.	[Britton, Annie; Bell, Steven] UCL, Res Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Britton, A (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	a.britton@ucl.ac.uk	Rao, Rahul/P-7158-2014	Bell, Steven/0000-0001-6774-3149	European Research Council [309337]; Medical Research Council; British Heart Foundation; National Heart Lung and Blood Institute, US, NIH [R01HL036310]; National Institute on Aging, US, NIH [R01AG013196, R01AG034454]; MRC [MR/K013351/1, MR/M006638/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Medical Research Council [MR/M006638/1, MR/K013351/1] Funding Source: researchfish; Stroke Association [TSA2008/05] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Heart Lung and Blood Institute, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Stroke Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AB and SB are supported by a grant from the European Research Council (309337, PI: Britton, http://www.ucl.ac.uk/alcohol-lifecourse). The Whitehall II study is supported by grants from the Medical Research Council; British Heart Foundation; National Heart Lung and Blood Institute (R01HL036310), US, NIH and the National Institute on Aging (R01AG013196 and R01AG034454), US, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-91; Brunborg GS, ADDICTION IN PRESS; FILLMORE KM, 1991, BRIT J ADDICT, V86, P1221, DOI 10.1111/j.1360-0443.1991.tb01702.x; Goldstein MZ, 1996, PSYCHIATR SERV, V47, P941; Gorman E, 2014, AM J EPIDEMIOL, V180, P941, DOI 10.1093/aje/kwu207; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Immonen S, 2011, INT J GERIATR PSYCH, V26, P1169, DOI 10.1002/gps.2657; Khan N, 2006, AUSTRALAS J AGEING, V25, P97, DOI 10.1111/j.1741-6612.2006.00159.x; Knott CS, 2013, AGE AGEING, V42, P598, DOI 10.1093/ageing/aft039; Kuntsche E, 2005, CLIN PSYCHOL REV, V25, P841, DOI 10.1016/j.cpr.2005.06.002; Lee CM, 2007, J STUD ALCOHOL DRUGS, V68, P714, DOI 10.15288/jsad.2007.68.714; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Moos RH, 2009, ADDICTION, V104, P1293, DOI 10.1111/j.1360-0443.2009.02604.x; Pringle KE, 2005, J AM GERIATR SOC, V53, P1930, DOI 10.1111/j.1532-5415.2005.00474.x; Royal College of Psychiatrists, 2011, CR165ROYAL COLL PSYC; StataCorp, 2013, STATA STAT SOFTW REL; Stockwell T, 2013, INT J EPIDEMIOL, V42, P1792, DOI 10.1093/ije/dyt217; Wang YP, 2013, CURR OPIN PSYCHIATR, V26, P343, DOI 10.1097/YCO.0b013e328360eafd; Wilkinson C, 2014, J PUBLIC HLTH RES, V3; Wilson GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071792; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	21	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119421	10.1371/journal.pone.0119421	http://dx.doi.org/10.1371/journal.pone.0119421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756213	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275700044
J	Wang, X; Wu, SS; MacIntyre, CR; Zhang, HB; Shi, WX; Peng, XM; Duan, W; Yang, P; Zhang, Y; Wang, QY				Wang, Xiaoli; Wu, Shuangsheng; MacIntyre, C. Raina; Zhang, Hongbin; Shi, Weixian; Peng, Xiaomin; Duan, Wei; Yang, Peng; Zhang, Yi; Wang, Quanyi			Using an Adjusted Serfling Regression Model to Improve the Early Warning at the Arrival of Peak Timing of Influenza in Beijing	PLOS ONE			English	Article							SURVEILLANCE; MORTALITY; EPIDEMICS; IMPACT	Serfling-type periodic regression models have been widely used to identify and analyse epidemic of influenza. In these approaches, the baseline is traditionally determined using cleaned historical non-epidemic data. However, we found that the previous exclusion of epidemic seasons was empirical, since year-year variations in the seasonal pattern of activity had been ignored. Therefore, excluding fixed 'epidemic' months did not seem reasonable. We made some adjustments in the rule of epidemic-period removal to avoid potentially subjective definition of the start and end of epidemic periods. We fitted the baseline iteratively. Firstly, we established a Serfling regression model based on the actual observations without any removals. After that, instead of manually excluding a predefined 'epidemic' period (the traditional method), we excluded observations which exceeded a calculated boundary. We then established Serfling regression once more using the cleaned data and excluded observations which exceeded a calculated boundary. We repeated this process until the R-2 value stopped to increase. In addition, the definitions of the onset of influenza epidemic were heterogeneous, which might make it impossible to accurately evaluate the performance of alternative approaches. We then used this modified model to detect the peak timing of influenza instead of the onset of epidemic and compared this model with traditional Serfling models using observed weekly case counts of influenza-like illness (ILIs), in terms of sensitivity, specificity and lead time. A better performance was observed. In summary, we provide an adjusted Serfling model which may have improved performance over traditional models in early warning at arrival of peak timing of influenza.	[Wang, Xiaoli; Wu, Shuangsheng; Shi, Weixian; Peng, Xiaomin; Duan, Wei; Yang, Peng; Zhang, Yi; Wang, Quanyi] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China; [MacIntyre, C. Raina] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Zhang, Hongbin] Univ Elect Sci & Technol China, Sch Elect Engn, Chengdu 610054, Peoples R China	University of New South Wales Sydney; University of Electronic Science & Technology of China	Wang, QY (corresponding author), Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China.	bjcdcxm@126.com		MacIntyre, C Raina/0000-0002-3060-0555	Beijing Municipal Science & Technology Commission [Z131100005613048]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This study was supported by Beijing Municipal Science & Technology Commission (No. Z131100005613048) http://www.bjkw.gov.cn/ n8785584/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	an der Heiden M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064593; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Bock D, 2008, BIOMETRICAL J, V50, P71, DOI 10.1002/bimj.200610362; Brown AM, 2001, COMPUT METH PROG BIO, V65, P191, DOI 10.1016/S0169-2607(00)00124-3; Centre for Health Protection DoH, 2005, WORK GROUP REP COMP; Conway JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-932; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Cowling BJ, 2013, HONG KONG MED J X S4, V19, pS4; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Hutwagner LC, 2005, STAT MED, V24, P543, DOI 10.1002/sim.2034; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Lederman R P, 1993, MCN Am J Matern Child Nurs, V18, P283, DOI 10.1097/00005721-199309000-00015; Muscatello DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064734; Muscatello DJ, 2008, COMMUN DIS INTELL, V32, P435; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Viboud Cecile, 2010, PLoS Curr, V2, pRRN1153; Watkins RE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-263; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; Yang L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-133; Yang P, 2009, EMERG INFECT DIS, V15, P1603, DOI 10.3201/eid1510.081040	29	10	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119923	10.1371/journal.pone.0119923	http://dx.doi.org/10.1371/journal.pone.0119923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756205	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275700054
J	Yu, GJ; Yin, YL; Yu, WH; Liu, W; Jin, YX; Shrestha, A; Yang, Q; Ye, XD; Sun, H				Yu, Guo-Jun; Yin, Ya-Lin; Yu, Wen-Hui; Liu, Wei; Jin, Yan-Xia; Shrestha, Alok; Yang, Qing; Ye, Xiang-Dong; Sun, Hui			Proteome Exploration to Provide a Resource for the Investigation of Ganoderma lucidum	PLOS ONE			English	Article							FUNGAL IMMUNOMODULATORY PROTEIN; CARBOHYDRATE-ACTIVE ENZYMES; TRICARBOXYLIC-ACID CYCLE; LING ZHI-8 LZ-8; NF-KAPPA-B; PHARMACOLOGICAL FUNCTIONS; SACCHAROMYCES-CEREVISIAE; RECOMBINANT EXPRESSION; STAPHYLOCOCCUS-AUREUS; AGROCYBE-AEGERITA	Ganoderma lucidum is a basidiomycete white rot fungus that has been used for medicinal purposes worldwide. Although information concerning its genome and transcriptome has recently been reported, relatively little information is available for G. lucidum at the proteomic level. In this study, protein fractions from G. lucidum at three developmental stages (16-day mycelia, and fruiting bodies at 60 and 90 days) were prepared and subjected to LC-MS/MS analysis. A search against the G. lucidum genome database identified 803 proteins. Among these proteins, 61 lignocellulose degrading proteins were detected, most of which (49 proteins) were found in the 90-day fruiting bodies. Fourteen TCA-cycle related proteins, 17 peptidases, two argonaute-like proteins, and two immunomodulatory proteins were also detected. A majority (470) of the 803 proteins had GO annotations and were classified into 36 GO terms, with "binding", "catalytic activity", and "hydrolase activity"having high percentages. Additionally, 357 out of the 803 proteins were assigned to at least one COG functional category and grouped into 22 COG classifications. Based on the results from the proteomic and sequence alignment analyses, a potentially new immunomodulatory protein (GL18769) was expressed and shown to have high immunomodulatory activity. In this study, proteomic and biochemical analyses of G. lucidum were performed for the first time, revealing that proteins from this fungus can play significant bioactive roles and providing a new foundation for the further functional investigations that this fungus merits.	[Yu, Guo-Jun; Yin, Ya-Lin; Yu, Wen-Hui; Liu, Wei; Jin, Yan-Xia; Shrestha, Alok; Yang, Qing; Ye, Xiang-Dong; Sun, Hui] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Sun, Hui] Wuhan Univ, Key Lab Combinatorial Biosynthesis & Drug Discove, Minist Educ, Wuhan 430072, Peoples R China; [Sun, Hui] Hubei Univ Technol, Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Key Lab Fermentat Engn, Minist Educ, Wuhan, Peoples R China	Wuhan University; Wuhan University; Hubei University of Technology	Sun, H (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	sunhui@whu.edu.cn	Jin, Yanxia/W-8478-2019		National Science Foundation of China (NSFC) [31301426, 31370849]; Research Fund for the Doctoral Program of Higher Education of China program [20130146120019]; National Key Technologies RD Program [2009ZX09103-676, 2012ZX10001-006]; Chinese 111 project [B06018]; Wuhan University project [2042014kf0226]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China program; National Key Technologies RD Program(National Key Technology R&D Program); Chinese 111 project(Ministry of Education, China - 111 Project); Wuhan University project	The present research project was funded by the National Science Foundation of China (NSFC) program [31301426, 31370849] (http://www.nsfc.gov.cn/), the Research Fund for the Doctoral Program of Higher Education of China program [20130146120019], the National Key Technologies R&D Program [2009ZX09103-676, 2012ZX10001-006] (http://www.nmp.gov.cn/), the Chinese 111 project [B06018], and Wuhan University project [No. 2042014kf0226]. The funders had no role in study	Aleksandrov A, 2014, J PHYS CHEM B, V118, P4505, DOI 10.1021/jp412346g; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Aoshima M, 2007, APPL MICROBIOL BIOT, V75, P249, DOI 10.1007/s00253-007-0893-0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao XF, 2001, CARBOHYD RES, V332, P67, DOI 10.1016/S0008-6215(01)00075-1; Barros BHR, 2010, FUNGAL BIOL-UK, V114, P572, DOI 10.1016/j.funbio.2010.04.007; Bharti RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091300; Boh B, 2007, BIOTECHNOL ANN REV, V13, P265, DOI 10.1016/S1387-2656(07)13010-6; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; D'Ambrosio C, 2013, J PROTEOMICS, V78, P39, DOI 10.1016/j.jprot.2012.11.008; D'Souza TM, 1999, APPL ENVIRON MICROB, V65, P5307; de Oliveira JMPF, 2011, APPL MICROBIOL BIOT, V89, P225, DOI 10.1007/s00253-010-2900-0; Douglas CM, 2001, MED MYCOL, V39, P55, DOI 10.1080/mmy.39.1.55.66; Dudhgaonkar S, 2009, INT IMMUNOPHARMACOL, V9, P1272, DOI 10.1016/j.intimp.2009.07.011; Guranowski A, 2004, FEBS LETT, V561, P83, DOI 10.1016/s0014-5793(04)00126-7; Horie K, 2008, J PROTEOME RES, V7, P1819, DOI 10.1021/pr070369o; Horimoto Y, 2009, NEW BIOTECHNOL, V25, P318, DOI 10.1016/j.nbt.2009.03.010; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Hsu HC, 1997, BIOCHEM J, V323, P557, DOI 10.1042/bj3230557; Huang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061127; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Jakucs Elizabeth, 1994, Acta Microbiologica et Immunologica Hungarica, V41, P23; Jiang S, 2012, BIOCHEM J, V443, P369, DOI 10.1042/BJ20112061; Johnson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104155; Johswich A, 2014, J BIOL CHEM, V289, P15927, DOI 10.1074/jbc.M114.563734; Kimura Y, 2002, ANTICANCER RES, V22, P3309; KINO K, 1989, J BIOL CHEM, V264, P472; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; KO JL, 1995, EUR J BIOCHEM, V228, P244, DOI 10.1111/j.1432-1033.1995.tb20256.x; Kuan YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021004; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li F, 2012, PROTEIN EXPRES PURIF, V82, P339, DOI 10.1016/j.pep.2012.01.015; Li P, 2013, NAT PROD RES, V27, P17, DOI 10.1080/14786419.2011.652961; Li SY, 2014, INT J MOL SCI, V15, P17751, DOI 10.3390/ijms151017751; Liebminger E, 2011, J BIOL CHEM, V286, P10793, DOI 10.1074/jbc.M110.178020; Lin CH, 2010, J AGR FOOD CHEM, V58, P12014, DOI 10.1021/jf103068w; Liu DL, 2001, FOOD CHEM TOXICOL, V39, P461, DOI 10.1016/S0278-6915(00)00161-7; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo Hongmei, 2010, Chin Med, V5, P9, DOI 10.1186/1749-8546-5-9; Matallana-Surget S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099076; McNeil MB, 2014, FEBS LETT, V588, P414, DOI 10.1016/j.febslet.2013.12.019; Monteiro R, 2012, J PROTEOMICS, V75, P2892, DOI 10.1016/j.jprot.2011.12.036; Nunes-Nesi A, 2013, CURR OPIN PLANT BIOL, V16, P335, DOI 10.1016/j.pbi.2013.01.004; Ohnuma K, 2011, ADV CLIN CHEM, V53, P51, DOI 10.1016/S0065-2423(11)53003-3; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Rahmad N, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-30; Reinhardt TA, 2012, J PROTEOMICS, V75, P1486, DOI 10.1016/j.jprot.2011.11.017; Ren A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065027; Restelli L, 2014, J PROTEOMICS, V108, P295, DOI 10.1016/j.jprot.2014.05.027; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sanfelix-Haywood N, 2011, J APPL MICROBIOL, V111, P433, DOI 10.1111/j.1365-2672.2011.05045.x; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Scherl A, 2005, J MICROBIOL METH, V60, P247, DOI 10.1016/j.mimet.2004.09.017; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; Sickmann A, 2003, ADV BIOCHEM ENG BIOT, V83, P141; Sripuan T, 2003, BIOSCI BIOTECH BIOCH, V67, P1485, DOI 10.1271/bbb.67.1485; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; TANAKA S, 1989, J BIOL CHEM, V264, P16372; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terol J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-222; Tomm JM, 2013, J INVEST ALLERG CLIN, V23, P443; Wang JG, 2013, CARBOHYD POLYM, V91, P33, DOI 10.1016/j.carbpol.2012.08.017; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056686; Wu GS, 2013, EXPERT OPIN INV DRUG, V22, P981, DOI 10.1517/13543784.2013.805202; Wu X, 2013, INT J MED MUSHROOMS, V15, P383, DOI 10.1615/IntJMedMushr.v15.i4.60; Wu YL, 2009, J PROTEOME RES, V8, P436, DOI 10.1021/pr800554w; Yang JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002179; Yao ZY, 2012, APPL MICROBIOL BIOT, V93, P1999, DOI 10.1007/s00253-011-3541-7; Yin YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051853; Yoon HM, 2013, EXP THER MED, V5, P957, DOI 10.3892/etm.2013.895; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zhang CR, 2008, NAT PROD RES, V22, P1137, DOI 10.1080/14786410601129721; Zhao CG, 2003, BIOCHEM J, V374, P321, DOI 10.1042/BJ20030300; Zheng HY, 2013, PROTEINS, V81, P1031, DOI 10.1002/prot.24227; Zhou XW, 2007, AM J CHINESE MED, V35, P559, DOI 10.1142/S0192415X07005065	83	17	20	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119439	10.1371/journal.pone.0119439	http://dx.doi.org/10.1371/journal.pone.0119439			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756518	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275700047
J	Gasanov, EV; Rafieva, LM; Korzh, VP				Gasanov, Eugene V.; Rafieva, Lola M.; Korzh, Vladimir P.			BDNF-TrkB Axis Regulates Migration of the Lateral Line Primordium and Modulates the Maintenance of Mechanoreceptor Progenitors	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; INNER-EAR; IN-VIVO; ENDOTHELIAL-CELLS; ZEBRAFISH GENES; MOLECULAR-BASIS; HAIR-CELLS; BRAIN; EXPRESSION; RECEPTORS	BDNF and its specialized receptor TrkB are expressed in the developing lateral line system of zebrafish, but their role in this organ is unknown. To tackle this problem in vivo, we used transgenic animals expressing fluorescent markers in different cell types of the lateral line and combined a BDNF gain-of-function approach by BDNF mRNA overexpression and by soaking embryos in a solution of BDNF, with a loss-of-function approach by injecting the antisence ntrk2b-morpholino and treating embryos with the specific Trk inhibitor K252a. Subsequent analysis demonstrated that the BDNF-TrkB axis regulates migration of the lateral line primordium. In particular, BDNF-TrkB influences the expression level of components of chemokine signaling including Cxcr4b, and the generation of progenitors of mechanoreceptors, at the level of expression of Atoh1a-Atp2b1a.	[Gasanov, Eugene V.; Rafieva, Lola M.] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Korzh, Vladimir P.] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Korzh, Vladimir P.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Russian Academy of Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Korzh, VP (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.	vlad@imcb.a-star.edu.sg	Korzh, Vladimir P/H-1596-2011; Gasanov, Eugene/U-7902-2018	Korzh, Vladimir P/0000-0002-6580-7986; Gasanov, Eugene/0000-0002-5020-9406	Institute of Molecular Genetics of the Russian Academy of Science; Russian Foundation for Basic Research (RFBR) [11-08-01046-a, 13-04-01009-a]; Agency for Science, Technology and Research of Singapore	Institute of Molecular Genetics of the Russian Academy of Science; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	EG and LR were supported by the Institute of Molecular Genetics of the Russian Academy of Science and a grant from the Russian Foundation for Basic Research (RFBR). The grant numbers are 11-08-01046-a and 13-04-01009-a. VK was supported by a grant of the Agency for Science, Technology and Research of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04733; Bartkowska K, 2010, ACTA NEUROBIOL EXP, V70, P454; Bianchi LM, 1996, DEVELOPMENT, V122, P1965; Budenz CL, 2012, ANAT REC, V295, P1896, DOI 10.1002/ar.22586; Cao L, 2012, J CELL MOL MED, V16, P3105, DOI 10.1111/j.1582-4934.2012.01621.x; Chen CC, 2014, BRAIN STRUCT FUNCT; Chen D, 2014, AM J PHYSIOL-RENAL, V307, pF64, DOI 10.1152/ajprenal.00547.2013; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Douglas-Escobar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051706; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; FUKUZONO S, 1995, BIOSCI BIOTECH BIOCH, V59, P1727, DOI 10.1271/bbb.59.1727; Germana A, 2010, CELL MOL NEUROBIOL, V30, P787, DOI 10.1007/s10571-010-9506-z; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Gilmour D, 2004, NEURON, V34, P577; Go W, 2010, CELL CALCIUM, V48, P302, DOI 10.1016/j.ceca.2010.09.012; Grade S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055039; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Jansson LC, 2012, NEUROSCIENCE, V224, P223, DOI 10.1016/j.neuroscience.2012.08.038; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Komisarczuk AZ, 2008, DEV DYNAM, V237, P2594, DOI 10.1002/dvdy.21689; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Kotlyanskaya L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003824; Loh SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04289; Lum T, 2001, INT J DEV NEUROSCI, V19, P569, DOI 10.1016/S0736-5748(01)00041-7; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; MARTIN SC, 1995, DEV BIOL, V169, P745, DOI 10.1006/dbio.1995.1184; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Radeloff A, 2006, ACTA OTO-LARYNGOL, V126, P452, DOI 10.1080/00016480500437344; Ramekers D, 2012, HEARING RES, V288, P19, DOI 10.1016/j.heares.2012.03.002; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; Safina D R, 2008, Bioorg Khim, V34, P327; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Suenaga M, 1998, BIOTECHNOL APPL BIOC, V28, P119; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Thisse B, 2001, RR15402 NIH R01 ZFIN; Usui T, 2014, ACTA PHYSIOL, V211, P385, DOI 10.1111/apha.12249; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Van de Water TR, 1999, ANN NY ACAD SCI, V884, P345, DOI 10.1111/j.1749-6632.1999.tb08653.x; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Xu H, 2013, SMALL, V9, P585, DOI 10.1002/smll.201202208; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	52	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119711	10.1371/journal.pone.0119711	http://dx.doi.org/10.1371/journal.pone.0119711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751404	Green Submitted, gold, Green Published			2022-12-27	WOS:000350692700032
J	Khater, F; Balestrino, D; Charbonnel, N; Dufayard, JF; Brisse, S; Forestier, C				Khater, Fida; Balestrino, Damien; Charbonnel, Nicolas; Dufayard, Jean Francois; Brisse, Sylvain; Forestier, Christiane			In Silico Analysis of Usher Encoding Genes in Klebsiella pneumoniae and Characterization of Their Role in Adhesion and Colonization	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; TYPE-3 FIMBRIAE; PHASE VARIATION; MRKD; IDENTIFICATION; ANNOTATION; DIVERSITY; INFECTION; VIRULENCE	Chaperone/usher (CU) assembly pathway is used by a wide range of Enterobacteriaceae to assemble adhesive surface structures called pili or fimbriae that play a role in bacteria-host cell interactions. In silico analysis revealed that the genome of Klebsiella pneumoniae LM21 harbors eight chromosomal CU loci belonging gamma kappa and. clusters. Of these, only two correspond to previously described operons, namely type 1 and type 3-encoding operons. Isogenic usher deletion mutants of K. pneumoniae LM21 were constructed for each locus and their role in adhesion to animal (Intestine 407) and plant (Arabidopsis thaliana) cells, biofilm formation and murine intestinal colonization was investigated. Type 3 pili usher deleted mutant was impaired in all assays, whereas type 1 pili usher deleted mutant only showed attenuation in adhesion to plant cells and in intestinal colonization. The LM21 Delta kpjC mutant was impaired in its capacity to adhere to Arabidopsis cells and to colonize the murine intestine, either alone or in co-inoculation experiments. Deletion of LM21kpgC induced a significant decrease in biofilm formation, in adhesion to animal cells and in colonization of the mice intestine. The LM21. kpaC and LM21. kpeC mutants were only attenuated in biofilm formation and the adhesion abilities to Arabidopsis cells, respectively. No clear in vitro or in vivo effect was observed for LM21. kpbC and LM21. kpdC mutants. The multiplicity of CU loci in K. pneumoniae genome and their specific adhesion pattern probably reflect the ability of the bacteria to adhere to different substrates in its diverse ecological niches.	[Khater, Fida; Balestrino, Damien; Charbonnel, Nicolas; Forestier, Christiane] LMGE UMR CNRS 6023 Clermont Ferrand, F-63000 Clermont Ferrand, France; [Dufayard, Jean Francois] CIRAD, UMR AGAP 1334, F-34398 Montpellier, France; [Brisse, Sylvain] Inst Pasteur, Microbial Evolutionary Genom, F-75015 Paris, France; [Brisse, Sylvain] CNRS, UMR 3525, Paris, France	CIRAD; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Forestier, C (corresponding author), LMGE UMR CNRS 6023 Clermont Ferrand, F-63000 Clermont Ferrand, France.	Christiane.forestier@udamail.fr	Dufayard, Jean-François/AAC-7013-2020; Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108; KHATER, Fida/0000-0003-2810-3928; BALESTRINO, Damien/0000-0001-5378-0379				ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Balestrino D, 2008, ENVIRON MICROBIOL, V10, P685, DOI 10.1111/j.1462-2920.2007.01491.x; Bialek-Davenet S, 2014, EMERG INFEC IN PRESS; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; Boddicker JD, 2006, INFECT IMMUN, V74, P4590, DOI 10.1128/IAI.00129-06; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; Busch A, 2012, PHILOS T R SOC B, V367, P1112, DOI 10.1098/rstb.2011.0206; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; CHEN TH, 1977, INFECT IMMUN, V15, P972, DOI 10.1128/IAI.15.3.972-977.1977; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Clegg S, 2011, J BACTERIOL, V193, P2081, DOI 10.1128/JB.00071-11; Criscuolo A, 2013, GENOMICS, V102, P500, DOI 10.1016/j.ygeno.2013.07.011; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; DUGUID JP, 1959, J GEN MICROBIOL, V21, P271, DOI 10.1099/00221287-21-1-271; Felek S, 2011, MICROBIOL-SGM, V157, P805, DOI 10.1099/mic.0.044826-0; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAAHTELA K, 1986, APPL ENVIRON MICROB, V52, P1074, DOI 10.1128/AEM.52.5.1074-1079.1986; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; HORNICK DB, 1992, INFECT IMMUN, V60, P1577, DOI 10.1128/IAI.60.4.1577-1588.1992; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Lavender HF, 2004, INFECT IMMUN, V72, P4888, DOI 10.1128/IAI.72.8.4888-4890.2004; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Ong CLY, 2008, J BACTERIOL, V190, P1054, DOI 10.1128/JB.01523-07; Ong CLY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-183; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rosen DA, 2008, INFECT IMMUN, V76, P3337, DOI 10.1128/IAI.00090-08; Sahly H, 1997, CLIN DIAGN LAB IMMUN, V4, P393, DOI 10.1128/CDLI.4.4.393-399.1997; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Schembri MA, 2001, MOL MICROBIOL, V41, P1419, DOI 10.1046/j.1365-2958.2001.02613.x; Schroll C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-179; SCHURTZ TA, 1994, INFECT IMMUN, V62, P4186, DOI 10.1128/IAI.62.10.4186-4191.1994; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Struve C, 2009, INFECT IMMUN, V77, P5016, DOI 10.1128/IAI.00585-09; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; van Aartsen JJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-59; van der Velden AWM, 1998, INFECT IMMUN, V66, P2803, DOI 10.1128/IAI.66.6.2803-2808.1998; vanderWoude M, 1996, TRENDS MICROBIOL, V4, P5, DOI 10.1016/0966-842X(96)81498-3; Wu CC, 2010, MICROBIOL-SGM, V156, P1983, DOI 10.1099/mic.0.038158-0; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Wurpel DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052835; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Yue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038596	64	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0116215	10.1371/journal.pone.0116215	http://dx.doi.org/10.1371/journal.pone.0116215			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751658	Green Submitted, Green Published, gold			2022-12-27	WOS:000350692700002
J	Gounaris, E; Heiferman, MJ; Heiferman, JR; Shrivastav, M; Vitello, D; Blatner, NR; Knab, LM; Phillips, JD; Cheon, EC; Grippo, PJ; Khazaie, K; Munshi, HG; Bentrem, DJ				Gounaris, Elias; Heiferman, Michael J.; Heiferman, Jeffrey R.; Shrivastav, Manisha; Vitello, Dominic; Blatner, Nichole R.; Knab, Lawrence M.; Phillips, Joseph D.; Cheon, Eric C.; Grippo, Paul J.; Khazaie, Khashayarsha; Munshi, Hidayatullah G.; Bentrem, David J.			Zileuton, 5-Lipoxygenase Inhibitor, Acts as a Chemopreventive Agent in Intestinal Polyposis, by Modulating Polyp and Systemic Inflammation	PLOS ONE			English	Article							MAST-CELLS; COLORECTAL-CANCER; ANGIOGENESIS; PREVENTION; CELECOXIB; BEVACIZUMAB; CONTRIBUTES; EXPRESSION; FOLFOX4	Purpose Leukotrienes and prostaglandins, products of arachidonic acid metabolism, sustain both systemic and lesion-localized inflammation. Tumor-associated Inflammation can also contribute to the pathogenesis of colon cancer. Patients with inflammatory bowel disease (IBD) have increased risk of developing colon cancer. The levels of 5-lipoxygenase (5-LO), the key enzyme for leukotrienes production, are increased in colon cancer specimens and colonic dysplastic lesions. Here we report that Zileuton, a specific 5-LO inhibitor, can prevent polyp formation by efficiently reducing the tumor-associated and systemic inflammation in APC(Delta 468) mice. Experimental Design In the current study, we inhibited 5-LO by dietary administration of Zileuton in the APC.468 mouse model of polyposis and analyzed the effect of in vivo 5-LO inhibition on tumor-associated and systemic inflammation. Results Zileuton-fed mice developed fewer polyps and displayed marked reduction in systemic and polyp-associated inflammation. Pro-inflammatory cytokines and pro-inflammatory innate and adaptive immunity cells were reduced both in the lesions and systemically. As part of tumor-associated inflammation Leukotriene B4 (LTB4), product of 5-LO activity, is increased focally in human dysplastic lesions. The 5-LO enzymatic activity was reduced in the serum of Zileuton treated polyposis mice. Conclusions This study demonstrates that dietary administration of 5-LO specific inhibitor in the polyposis mouse model decreases polyp burden, and suggests that Zileuton may be a potential chemo-preventive agent in patients that are high-risk of developing colon cancer.	[Gounaris, Elias; Heiferman, Michael J.; Heiferman, Jeffrey R.; Shrivastav, Manisha; Vitello, Dominic; Knab, Lawrence M.; Phillips, Joseph D.; Cheon, Eric C.; Grippo, Paul J.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Gounaris, Elias; Blatner, Nichole R.; Khazaie, Khashayarsha; Munshi, Hidayatullah G.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bentrem, David J.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Gounaris, E (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA.	gounaris@northwestern.edu; dbentrem@nmff.org	Gounaris, Elias/B-3184-2011	Vitello, Dominic/0000-0002-4163-7759	Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility; National Institutes of Health (NIH) [1R01CA160436-01]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA160436] Funding Source: NIH RePORTER	Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility; and National Institutes of Health (NIH) grant 1R01CA160436-01 (to KK and DJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bertran X, 1996, GUT, V38, P899, DOI 10.1136/gut.38.6.899; Cathcart MC, 2011, CANCER METAST REV, V30, P363, DOI 10.1007/s10555-011-9324-x; Chen QY, 2013, J IMMUNOL, V190, P1048, DOI 10.4049/jimmunol.1202455; Cheon EC, 2011, CANCER RES, V71, P1627, DOI 10.1158/0008-5472.CAN-10-1923; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Cohen MH, 2007, ONCOLOGIST, V12, P356, DOI 10.1634/theoncologist.12-3-356; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Edelman MJ, 2008, J CLIN ONCOL, V26, P848, DOI 10.1200/JCO.2007.13.8081; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Gounaris E, 2013, INFLAMM BOWEL DIS, V19, P1339, DOI 10.1097/MIB.0b013e318281f3f8; Gounaris E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002916; Gunning WT, 2002, CANCER RES, V62, P4199; Hu B, 2010, P NATL ACAD SCI US; Khazaie K, 2011, CANCER METAST REV, V30, P45, DOI 10.1007/s10555-011-9286-z; Kim GY, 2009, ARTERIOSCL THROM VAS, V29, P915, DOI 10.1161/ATVBAHA.109.185793; KIM GY, 2010, J IMMUNOL, V184, P3946, DOI DOI 10.4049/JIMMUN0L.0901735; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peters-Golden M, 2001, FEBS LETT, V487, P323, DOI 10.1016/S0014-5793(00)02374-7; Pulendran B, 2008, NAT MED, V14, P489, DOI 10.1038/nm0508-489; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Rossi A, 2010, BRIT J PHARMACOL, V161, P555, DOI 10.1111/j.1476-5381.2010.00930.x; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Strouch MJ, 2010, CLIN CANCER RES, V16, P2257, DOI 10.1158/1078-0432.CCR-09-1230; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tripodo C, 2010, AM J PATHOL, V177, P792, DOI 10.2353/ajpath.2010.091286; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang HW, 2010, CELL CYCLE, V9, P4824, DOI 10.4161/cc.9.24.14322; Ye YN, 2005, EUR J PHARMACOL, V519, P52, DOI 10.1016/j.ejphar.2005.07.009; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; ZINGARELLI B, 1993, AGENTS ACTIONS, V39, P150, DOI 10.1007/BF01998968	43	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0121402	10.1371/journal.pone.0121402	http://dx.doi.org/10.1371/journal.pone.0121402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747113	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400100
J	Vase, L; Baram, S; Takakura, N; Takayama, M; Yajima, H; Kawase, A; Schuster, L; Kaptchuk, TJ; Schou, S; Jensen, TS; Zachariae, R; Svensson, P				Vase, Lene; Baram, Sara; Takakura, Nobuari; Takayama, Miho; Yajima, Hiroyoshi; Kawase, Akiko; Schuster, Lars; Kaptchuk, Ted J.; Schou, Soren; Jensen, Troels Staehelin; Zachariae, Robert; Svensson, Peter			Can Acupuncture Treatment Be Double-Blinded? An Evaluation of Double-Blind Acupuncture Treatment of Postoperative Pain	PLOS ONE			English	Article							PLACEBO NEEDLE; CONTROLLED-TRIAL; VISUAL ANALOG; EFFICACY; EXPECTATIONS; MULTICENTER; COMPONENTS; SUCCESS	Blinding protects against bias but the success of blinding is seldom assessed and reported in clinical trials including studies of acupuncture where blinding represents a major challenge. Recently, needles with the potential for double-blinding were developed, so we tested if acupuncture can be double-blinded in a randomized study of sixty-seven patients with acute pain >= 3 (0-10 scale following third molar removal) who received active acupuncture with a penetrating needle or placebo acupuncture with a non-penetrating needle. To test if acupuncture was administered double-blind, patients and acupuncturists were asked about perceived treatment allocation at the end of the study. To test if there were clues which led to identification of the treatment, deep dull pain associated with needle application and rotation (termed "de qi" in East Asian medicine), and patients' pain levels were assessed. Perceived treatment allocation depended on actual group allocation (p < 0.015) for both patients and acupuncturists, indicating that the needles were not successful in doubleblinding. Up to 68% of patients and 83% of acupuncturists correctly identified the treatment, but for patients the distribution was not far from 50/50. Also, there was a significant interaction between actual or perceived treatment and the experience of de qi (p = 0.027), suggesting that the experience of de qi and possible non-verbal clues contributed to correct identification of the treatment. Yet, of the patients who perceived the treatment as active or placebo, 50% and 23%, respectively, reported de qi. Patients' acute pain levels did not influence the perceived treatment. In conclusion, acupuncture treatment was not fully double-blinded which is similar to observations in pharmacological studies. Still, the nonpenetrating needle is the only needle that allows some degree of practitioner blinding. The study raises questions about alternatives to double-blind randomized clinical trials in the assessment of acupuncture treatment.	[Vase, Lene; Zachariae, Robert] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark; [Vase, Lene; Jensen, Troels Staehelin] Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark; [Baram, Sara; Schou, Soren; Svensson, Peter] Aarhus Univ, Dept Dent, Sect Clin Oral Physiol, Aarhus, Denmark; [Baram, Sara] Aarhus Univ, Dept Dent, Sect Oral & Maxillofacial Surg & Oral Pathol, Aarhus, Denmark; [Takakura, Nobuari; Takayama, Miho; Yajima, Hiroyoshi; Kawase, Akiko] Tokyo Ariake Univ Med & Hlth Sci, Dept Acupuncture & Moxibust, Tokyo, Japan; [Schuster, Lars] Acupuncture Acad, Copenhagen, Denmark; [Schuster, Lars] Acupuncture Acad, Aarhus, Denmark; [Kaptchuk, Ted J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Zachariae, Robert] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Japanese Foundation for Cancer Research; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Aarhus University	Vase, L (corresponding author), Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark.	lenevase@psy.au.dk	Svensson, Peter/H-6735-2012; Takakura, Nobuari/AFS-7564-2022; Jensen, Troels Staehelin/A-3418-2009	Jensen, Troels Staehelin/0000-0002-3487-6380; Zachariae, Robert/0000-0001-9076-3068; Vase, Lene/0000-0002-0379-2256; Baram, Sara/0000-0003-0525-4125	Innovative Medicines Initiative Joint Undertaking [115007]; European Union's Seventh Framework Programme (FP7)	Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7)	Lene Vase is part of the Europain Collaboration, which has received support from the Innovative Medicines Initiative Joint Undertaking, under grant agreement no. 115007, the resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' kind contribution, www.imi.europa.eu. The funding source had the possibility to comment on the design and the reporting of the study, but had no role in the collection, analysis, and interpretation of the data and the decision to submit for publication.	Bausell RB, 2005, EVAL HEALTH PROF, V28, P9, DOI 10.1177/0163278704273081; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Boutron I, 2004, J CLIN EPIDEMIOL, V57, P543, DOI 10.1016/j.jclinepi.2003.12.010; BYINGTON RP, 1985, JAMA-J AM MED ASSOC, V253, P1733, DOI 10.1001/jama.253.12.1733; Cardenas DD, 2002, PAIN, V96, P365, DOI 10.1016/S0304-3959(01)00483-3; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Diener HC, 2006, LANCET NEUROL, V5, P310, DOI 10.1016/S1474-4422(06)70382-9; Fergusson D, 2004, BRIT MED J, V328, P432, DOI 10.1136/bmj.37952.631667.EE; Good P., 1994, PERMUTATIONS TEST PR; GRACELY RH, 1985, LANCET, V1, P43; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Hrobjartsson A, 2007, INT J EPIDEMIOL, V36, P654, DOI 10.1093/ije/dym020; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P374, DOI 10.7326/0003-4819-136-5-200203050-00010; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Kobayashi A, 2010, EVID-BASED COMPL ALT, V7, P359, DOI 10.1093/ecam/nem155; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Lewith GT, 2010, CLIN RES COMPLEMENTA; MARGRAF J, 1991, J CONSULT CLIN PSYCH, V59, P184, DOI 10.1037/0022-006X.59.1.184; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Park Jongbae, 2002, Acupunct Med, V20, P168; Pomeranz B., 2003, BASICS ACUPUNCTURE, P7, DOI [10.1007/978-3-642-18988-3_2, DOI 10.1007/978-3-642-18988-3_2]; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Price DD, 2013, PLACEBO AND PAIN: FROM BENCH TO BEDSIDE, P215, DOI 10.1016/B978-0-12-397928-5.00021-0; RABKIN JG, 1986, PSYCHIAT RES, V19, P75, DOI 10.1016/0165-1781(86)90094-6; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Takakura N, 2009, OPEN MED, V3, P54; Takakura N, 2011, ACUPUNCT MED, V29, P203, DOI 10.1136/aim.2010.002857; Takakura N, 2010, ACUPUNCT MED, V28, P144, DOI 10.1136/aim.2009.001230; Takakura N, 2008, ACUPUNCT MED, V26, P224, DOI 10.1136/aim.26.4.224; Takakura Nobuari, 2007, BMC Complement Altern Med, V7, P31, DOI 10.1186/1472-6882-7-31; Teig Silje, 2006, Acupunct Med, V24, P80; Turner JA, 2002, PAIN, V99, P91, DOI 10.1016/S0304-3959(02)00060-X; Vase L, 2003, PAIN, V105, P17, DOI 10.1016/S0304-3959(03)00073-3; Vase L, 2013, PAIN, V154, P1659, DOI 10.1016/j.pain.2013.05.008; Wiseman N., 1998, PRACTICAL DICT CHINE; World Health Organization, 2008, WHO STAND AC POINT L, P226	39	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119612	10.1371/journal.pone.0119612	http://dx.doi.org/10.1371/journal.pone.0119612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747157	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400081
J	Fillmore, N; Huqi, A; Jaswal, JS; Mori, J; Paulin, R; Haromy, A; Onay-Besikci, A; Ionescu, L; Thebaud, B; Michelakis, E; Lopaschuk, GD				Fillmore, Natasha; Huqi, Alda; Jaswal, Jagdip S.; Mori, Jun; Paulin, Roxane; Haromy, Alois; Onay-Besikci, Arzu; Ionescu, Lavinia; Thebaud, Bernard; Michelakis, Evangelos; Lopaschuk, Gary D.			Effect of Fatty Acids on Human Bone Marrow Mesenchymal Stem Cell Energy Metabolism and Survival	PLOS ONE			English	Article							PROLIFERATION; APOPTOSIS; DIFFERENTIATION; GROWTH; AKT; DEHYDROGENASE; ACTIVATION; OXIDATION; PATHWAY; STRESS	Successful stem cell therapy requires the optimal proliferation, engraftment, and differentiation of stem cells into the desired cell lineage of tissues. However, stem cell therapy clinical trials to date have had limited success, suggesting that a better understanding of stem cell biology is needed. This includes a better understanding of stem cell energy metabolism because of the importance of energy metabolism in stem cell proliferation and differentiation. We report here the first direct evidence that human bone marrow mesenchymal stem cell (BMMSC) energy metabolism is highly glycolytic with low rates of mitochondrial oxidative metabolism. The contribution of glycolysis to ATP production is greater than 97% in undifferentiated BMMSCs, while glucose and fatty acid oxidation combined only contribute 3% of ATP production. We also assessed the effect of physiological levels of fatty acids on human BMMSC survival and energy metabolism. We found that the saturated fatty acid palmitate induces BMMSC apoptosis and decreases proliferation, an effect prevented by the unsaturated fatty acid oleate. Interestingly, chronic exposure of human BMMSCs to physiological levels of palmitate (for 24 hr) reduces palmitate oxidation rates. This decrease in palmitate oxidation is prevented by chronic exposure of the BMMSCs to oleate. These results suggest that reducing saturated fatty acid oxidation can decrease human BMMSC proliferation and cause cell death. These results also suggest that saturated fatty acids may be involved in the long-term impairment of BMMSC survival in vivo.	[Fillmore, Natasha; Huqi, Alda; Jaswal, Jagdip S.; Mori, Jun; Paulin, Roxane; Haromy, Alois; Onay-Besikci, Arzu; Ionescu, Lavinia; Thebaud, Bernard; Michelakis, Evangelos; Lopaschuk, Gary D.] Univ Alberta, Cardiovasc Res Ctr, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	University of Alberta	Lopaschuk, GD (corresponding author), Univ Alberta, Cardiovasc Res Ctr, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada.	gary.lopaschuk@ualberta.ca	Huqi, Alda/AAC-2422-2019; Onay-Besikci, Arzu/AAH-1413-2020	Huqi, Alda/0000-0003-2818-7113; Onay-Besikci, Arzu/0000-0001-6883-1757; Fillmore, Natasha/0000-0002-6723-0869	Canadian Institutes of Health Research [123472]; Alberta Innovates Health Solutions studentship; Alberta Innovates [201200975] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions studentship; Alberta Innovates; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: Supported by a grant from the Canadian Institutes of Health Research 123472. http://www.cihrirsc.gc.ca/e/193.html. GDL is an Alberta Heritage Foundation for Medical Research Scientist. NF holds an Alberta Innovates Health Solutions studentship. http://www.aihealthsolutions.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dawud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039896; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BOONE CW, 1971, IN VITRO CELL DEV B, V7, P174, DOI 10.1007/BF02617963; Burgess RJ, 2014, J INTERN MED, V276, P12, DOI 10.1111/joim.12247; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Copland IB, 2011, SEMIN IMMUNOPATHOL, V33, P535, DOI 10.1007/s00281-011-0274-8; de Meester C, 2014, CARDIOVASC RES, V101, P20, DOI 10.1093/cvr/cvt227; Guarnerio J, 2014, STEM CELL REP, V2, P794, DOI 10.1016/j.stemcr.2014.04.002; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Kang JX, 2014, STEM CELLS, V32, P1092, DOI 10.1002/stem.1620; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kong JY, 2003, ARCH BIOCHEM BIOPHYS, V412, P196, DOI 10.1016/S0003-9861(03)00008-0; Krieg RC, 2004, J BIOCHEM BIOPH METH, V58, P119, DOI 10.1016/j.jbbm.2003.10.002; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Lim SY, 2006, CARDIOVASC RES, V70, P530, DOI 10.1016/j.cardiores.2006.02.016; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lu J, 2012, ENDOCRINOLOGY, V153, P5275, DOI 10.1210/en.2012-1418; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; Pattappa G, 2011, J CELL PHYSIOL, V226, P2562, DOI 10.1002/jcp.22605; Paulin R, 2014, EUR RESPIR J, V43, P531, DOI 10.1183/09031936.00181312; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Smith AN, 2012, J CELL PHYSIOL, V227, P3225, DOI 10.1002/jcp.24013; SORRENTINO D, 1989, J CLIN INVEST, V84, P1325, DOI 10.1172/JCI114301; Sutendra G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001327; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724; Tzouvelekis A, 2013, CURR DRUG TARGETS, V14, P246, DOI 10.2174/1389450111314020009; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wanet A, 2014, INT J BIOCHEM CELL B, V54, P174, DOI 10.1016/j.biocel.2014.07.015; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1924, BIOCHEM Z, V152, P309; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	46	48	53	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120257	10.1371/journal.pone.0120257	http://dx.doi.org/10.1371/journal.pone.0120257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768019	gold, Green Submitted, Green Published			2022-12-27	WOS:000351277500117
J	Kremers, KS; Hollister, RD; Oberbauer, SF				Kremers, Kelseyann S.; Hollister, Robert D.; Oberbauer, Steven F.			Diminished Response of Arctic Plants to Warming over Time	PLOS ONE			English	Article							OPEN-TOP CHAMBERS; CLIMATE-CHANGE; GLOBAL CHANGE; TERRESTRIAL ECOSYSTEMS; NORTHERN ALASKA; CONCEPTUAL-FRAMEWORK; VEGETATION CHANGE; SHRUB ABUNDANCE; SHORT-TERM; TUNDRA	The goal of this study is to determine if the response of arctic plants to warming is consistent across species, locations and time. This study examined the impact of experimental warming and natural temperature variation on plants at Barrow and Atqasuk, Alaska beginning in 1994. We considered observations of plant performance collected from 1994-2000 "shortterm" and those from 2007-2012 "long-term". The plant traits reported are the number of inflorescences, inflorescence height, leaf length, and day of flower emergence. These traits can inform us about larger scale processes such as plant reproductive effort, plant growth, and plant phenology, and therefore provide valuable insight into community dynamics, carbon uptake, and trophic interactions. We categorized traits of all species monitored at each site into temperature response types. We then compared response types across traits, plant growth forms, sites, and over time to analyze the consistency of plant response to warming. Graminoids were the most responsive to warming and showed a positive response to temperature, while shrubs were generally the least responsive. Almost half (49%) of response types (across all traits, species, and sites combined) changed from short-term to long-term. The percent of plants responsive to warming decreased from 57% (short-term) to 46% (long-term). These results indicate that the response of plants to warming varies over time and has diminished overall in recent years.	[Kremers, Kelseyann S.; Hollister, Robert D.] Grand Valley State Univ, Biol, Allendale, MI 49401 USA; [Oberbauer, Steven F.] Florida Int Univ, Biol Sci, Miami, FL 33199 USA	Grand Valley State University; State University System of Florida; Florida International University	Kremers, KS (corresponding author), Univ Notre Dame, Biol Sci, Notre Dame, IN 46556 USA.	kkremers@nd.edu		Hollister, Robert/0000-0002-4764-7691	National Science Foundation [9714103, 0632263, 0856516]; Directorate For Geosciences [0856710] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation, www.nsf.gov, OPP #9714103, #0632263, #0856516 (SO, RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arft AM, 1999, ECOL MONOGR, V64, P91; Bokhorst S, 2013, GLOBAL CHANGE BIOL, V19, P64, DOI 10.1111/gcb.12028; Bolmgren K, 2013, INT J BIOMETEOROL, V57, P367, DOI 10.1007/s00484-012-0560-8; Brooker R, 2003, J VEG SCI, V14, P535, DOI 10.1111/j.1654-1103.2003.tb02180.x; CALLAGHAN TV, 1995, PHILOS T R SOC A, V352, P259, DOI 10.1098/rsta.1995.0069; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; CHAPIN FS, 1983, POLAR BIOL, V2, P47, DOI 10.1007/BF00258285; CHAPIN FS, 1995, NATURE, V377, P199, DOI 10.1038/377199a0; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Diggle PK, 1997, AM J BOT, V84, P154, DOI 10.2307/2446077; Dormann CF, 2002, FUNCT ECOL, V16, P4, DOI 10.1046/j.0269-8463.2001.00596.x; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Eviner VT, 2003, ANNU REV ECOL EVOL S, V34, P455, DOI 10.1146/annurev.ecolsys.34.011802.132342; Fraser LH, 2013, FRONT ECOL ENVIRON, V11, P147, DOI 10.1890/110279; Hill GB, 2011, GLOBAL CHANGE BIOL, V17, P276, DOI 10.1111/j.1365-2486.2010.02244.x; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Hollister RD, 2000, GLOBAL CHANGE BIOL, V6, P835, DOI 10.1046/j.1365-2486.2000.00363.x; Hollister RD, 2005, GLOBAL CHANGE BIOL, V11, P525, DOI 10.1111/j.1365-2486.2005.00926.x; Hollister RD, 2005, ECOLOGY, V86, P1562, DOI 10.1890/04-0520; Hollister RD, 2006, ARCT ANTARCT ALP RES, V38, P206, DOI 10.1657/1523-0430(2006)38[206:STATRT]2.0.CO;2; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Hudson JMG, 2010, J ECOL, V98, P1035, DOI 10.1111/j.1365-2745.2010.01690.x; Iler AM, 2013, AM J BOT, V100, P1398, DOI 10.3732/ajb.1200490; IPCC core writing team: IPCC, 2013, CLIM CHANG 2013 SYNT; JONASSON S, 1992, OIKOS, V63, P420, DOI 10.2307/3544968; Kaarlejarvi E, 2012, ECOSYSTEMS, V15, P1219, DOI 10.1007/s10021-012-9580-9; Korner C, 1999, ALPINE PLANT LIFE FU; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; Liancourt P, 2013, ECOLOGY, V94, P444, DOI 10.1890/12-0780.1; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Liu YZ, 2011, ECOLOGY, V92, P1201, DOI 10.1890/10-2060.1; Loranty M. M., 2011, ENVIRON RES LETT, V6, P1; Luo YQ, 2011, GLOBAL CHANGE BIOL, V17, P843, DOI 10.1111/j.1365-2486.2010.02265.x; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Meloche CG, 2001, AM J BOT, V88, P980, DOI 10.2307/2657079; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REYNOLDS JF, 1992, ARCTIC ECOSYSTEMS CH, P413; Shaver G. R., 1992, ARCTIC ECOSYSTEMS CH, P193; SHAVER GR, 1980, ECOLOGY, V61, P662, DOI 10.2307/1937432; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; SHAVER GR, 1992, BIOSCIENCE, V42, P433, DOI 10.2307/1311862; Shaver GR, 2007, PLANT FUNCTIONAL TYP, P153; Starr G, 2000, GLOBAL CHANGE BIOL, V6, P357, DOI 10.1046/j.1365-2486.2000.00316.x; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Ulrich A., 1978, Vegetation and production ecology of an Alaskan arctic tundra., P457; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; Wahren CHA, 2005, GLOBAL CHANGE BIOL, V11, P537, DOI 10.1111/j.1365-2486.2005.00927.x; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021	53	15	15	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116586	10.1371/journal.pone.0116586	http://dx.doi.org/10.1371/journal.pone.0116586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767881	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500012
J	Yeka, A; Nankabirwa, J; Mpimbaza, A; Kigozi, R; Arinaitwe, E; Drakeley, C; Greenhouse, B; Kamya, MR; Dorsey, G; Staedke, SG				Yeka, Adoke; Nankabirwa, Joaniter; Mpimbaza, Arthur; Kigozi, Ruth; Arinaitwe, Emmanuel; Drakeley, Chris; Greenhouse, Bryan; Kamya, Moses R.; Dorsey, Grant; Staedke, Sarah G.			Factors Associated with Malaria Parasitemia, Anemia and Serological Responses in a Spectrum of Epidemiological Settings in Uganda	PLOS ONE			English	Article							TRANSMISSION INTENSITY; YOUNG-CHILDREN; ATLAS PROJECT; MORBIDITY; TANZANIA; KENYA; INDICATOR; AFRICA; IMPACT; RISK	Background Understanding the current epidemiology of malaria and the relationship between intervention coverage, transmission intensity, and burden of disease is important to guide control activities. We aimed to determine the prevalence of anemia, parasitemia, and serological responses to P. falciparum antigens, and factors associated with these indicators, in three different epidemiological settings in Uganda. Methods and Findings In 2012, cross-sectional surveys were conducted in 200 randomly selected households from each of three sites: Walukuba, Jinja district (peri-urban); Kihihi, Kanungu district (rural); and Nagongera, Tororo district (rural) with corresponding estimates of annual entomologic inoculation rates (aEIR) of 3.8, 26.6, and 125.0, respectively. Of 2737 participants, laboratory testing was done in 2227 (81.4%), including measurement of hemoglobin, parasitemia using microscopy, and serological responses to P. falciparum apical membrane antigen 1 (AMA-1) and merozoite surface protein 1, 19 kilodalton fragment (MSP-119). Analysis of laboratory results was restricted to 1949 (87.5%) participants aged <= 40 years. Prevalence of anemia (hemoglobin < 11.0 g/dL) was significantly higher in Walukuba (18.9%) and Nagongera (17.4%) than in Kihihi (13.1%), and was strongly associated with decreasing age for those <= 5 years at all sites. Parasite prevalence was significantly higher in Nagongera (48.3%) than in Walukuba (12.2%) and Kihihi (12.8%), and significantly increased with age to 11 years, and then significantly decreased at all sites. Seropositivity to AMA-1 was 53.3% in Walukuba, 63.0% in Kihihi, and 83.7% in Nagongera and was associated with increasing age at all sites. AMA-1 seroconversion rates strongly correlated with transmission intensity, while serological responses to MSP-1(19) did not. Conclusion Anemia was predominant in young children and parasitemia peaked by 11 years across 3 sites with varied transmission intensity. Serological responses to AMA-1 appeared to best reflect transmission intensity, and may be a more accurate indicator for malaria surveillance than anemia or parasitemia.	[Yeka, Adoke] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Nankabirwa, Joaniter; Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Mpimbaza, Arthur] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Yeka, Adoke; Nankabirwa, Joaniter; Mpimbaza, Arthur; Kigozi, Ruth; Arinaitwe, Emmanuel; Kamya, Moses R.; Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda; [Drakeley, Chris; Staedke, Sarah G.] London Sch Hyg & Trop Med, London WC1, England; [Greenhouse, Bryan; Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Makerere University; Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco	Yeka, A (corresponding author), Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda.	yadoke@yahoo.com		Greenhouse, Bryan/0000-0003-0287-9111	National Institutes of Health, International Centers of Excellence in Malaria Research (ICMER) program [U19AI089674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	National Institutes of Health, International Centers of Excellence in Malaria Research (ICMER) program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICMER) program (U19AI089674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhwale WS, 2004, ACTA TROP, V91, P167, DOI 10.1016/j.actatropica.2004.02.010; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21; Bukirwa H, 2009, AM J TROP MED HYG, V81, P611, DOI 10.4269/ajtmh.2009.09-0126; BURKOT TR, 1995, ANN TROP MED PARASIT, V89, P125, DOI 10.1080/00034983.1995.11812943; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Estevez PT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-104; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Green HK, 2011, PARASITOLOGY, V138, P1534, DOI 10.1017/S0031182011001016; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Kigozi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042857; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Lusingu JPA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-26; Mathanga DP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-107; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-37; Osterbauer B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-432; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2002, AM J TROP MED HYG, V67, P371, DOI 10.4269/ajtmh.2002.67.371; PREMJI Z, 1995, ACTA TROP, V59, P55, DOI 10.1016/0001-706X(94)00079-G; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; Reithinger R, 2013, T ROY SOC TROP MED H, V107, P769, DOI 10.1093/trstmh/trt096; Riley E, 1996, PARASITOL TODAY, V12, P410, DOI 10.1016/0169-4758(96)80633-8; Roll Back Malaria, 2010, SAV LIV MAL CONTR CO; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Supargiyono S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-444; Talisuna A, 2012, ACTA TROP, V121, P196, DOI 10.1016/j.actatropica.2011.06.013; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004	42	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118901	10.1371/journal.pone.0118901	http://dx.doi.org/10.1371/journal.pone.0118901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768015	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500053
J	Porro, LB; Rayfield, EJ; Clack, JA				Porro, Laura B.; Rayfield, Emily J.; Clack, Jennifer A.			Descriptive Anatomy and Three-Dimensional Reconstruction of the Skull of the Early Tetrapod Acanthostega gunnari Jarvik, 1952	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; VIVO BONE STRAIN; FUNCTIONAL INTERPRETATION; SUTURE MORPHOLOGY; EVOLUTION; BIOMECHANICS; PATTERNS; ORIGIN; ROOF; JAWS	The early tetrapod Acanthostega gunnari is an iconic fossil taxon exhibiting skeletal morphology reflecting the transition of vertebrates from water onto land. Computed tomography data of two Acanthostega skulls was segmented using visualization software to digitally separate bone from matrix and individual bones of the skull from each other. A revised description of cranial and lower jaw anatomy in this taxon based on CT data includes new details of sutural morphology, the previously undescribed quadrate and articular bones, and the mandibular symphysis. Sutural morphology is used to infer loading regime in the skull during feeding, and suggests Acanthostega used its anterior jaws to initially seize prey while smaller posterior teeth were used to restrain struggling prey during ingestion. Novel methods were used to repair and retrodeform the skull, resulting in a three-dimensional digital reconstruction that features a longer postorbital region and more strongly hooked anterior lower jaw than previous attempts while supporting the presence of a midline gap between the nasals and median rostrals.	[Porro, Laura B.; Rayfield, Emily J.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [Porro, Laura B.; Clack, Jennifer A.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Porro, Laura B.] Univ Cambridge, Dept Zool, Cambridge, England	University of London; University of London Royal Veterinary College; University of Bristol; University of Cambridge	Porro, LB (corresponding author), Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England.	lporro@rvc.ac.uk	Rayfield, Emily/F-5038-2010	Rayfield, Emily/0000-0002-2618-750X; Porro, Laura/0000-0002-0546-2381	Marie Curie International Incoming Research Fellowship ("Tetrapods Rising") [303161]; Natural Environment Research Council [NE/G00711X/1] Funding Source: researchfish; NERC [NE/G00711X/1] Funding Source: UKRI	Marie Curie International Incoming Research Fellowship ("Tetrapods Rising"); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is funded by a Marie Curie International Incoming Research Fellowship ("Tetrapods Rising", 303161, (http://cordis.europa.eu/projects/rcn/103929_en.html) to LBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Anderson PSL, 2013, INTEGR COMP BIOL, V53, P197, DOI 10.1093/icb/ict006; Anderson PSL, 2011, NATURE, V476, P206, DOI 10.1038/nature10207; BEAUMONT EH, 1977, PHILOS T ROY SOC B, V280, P29, DOI 10.1098/rstb.1977.0099; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; BOLT JR, 1974, J PALEONTOL, V48, P434; Bright JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031769; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Byron CD, 2004, ANAT REC PART A, V279A, P676, DOI 10.1002/ar.a.20055; CARROLL RL, 1969, BIOL REV, V44, P393, DOI 10.1111/j.1469-185X.1969.tb01218.x; Clack J.A., 1994, Meddelelser om Gronland Geoscience, V31, P1; Clack J. A., 2012, GAINING GROUND ORIGI; CLACK JA, 1988, PALAEONTOLOGY, V31, P699; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; Clack JA, 2003, T ROY SOC EDIN-EARTH, V93, P163; Clack JA, 2002, T ROY SOC EDIN-EARTH, V93, P17, DOI 10.1017/S0263593300000304; CLACK JA, 1989, NATURE, V342, P425, DOI 10.1038/342425a0; Clack JA, 2012, PALAEONTOLOGY, V55, P73, DOI 10.1111/j.1475-4983.2011.01117.x; Clack JA, 2009, ANNU REV EARTH PL SC, V37, P163, DOI 10.1146/annurev.earth.36.031207.124146; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; HERRING SW, 1991, J MORPHOL, V207, P225, DOI 10.1002/jmor.1052070302; Holliday CM, 2010, ANAT REC, V293, P1350, DOI 10.1002/ar.21180; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jasinoski SC, 2010, J MORPHOL, V271, P705, DOI 10.1002/jmor.10828; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; JASLOW CR, 1995, J ZOOL, V235, P193; Kathe W, 1999, ZOOL J LINN SOC-LOND, V126, P1; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Lautenschlager S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052289; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Markey MJ, 2006, J EXP BIOL, V209, P2085, DOI 10.1242/jeb.02266; Markey MJ, 2007, P NATL ACAD SCI USA, V104, P7134, DOI 10.1073/pnas.0701706104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Metzger K., 2002, TOPICS FUNCTIONAL EC, P15; Metzger KA, 2005, ANAT REC PART A, V283A, P331, DOI 10.1002/ar.a.20167; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Neenan JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2689; OLSON EC, 1961, AM ZOOL, V1, P205; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Porro LB, 2010, EARTH ENV SCI T R SO, V101, P351, DOI 10.1017/S175569101102010X; Porro LB, 2011, J MORPHOL, V272, P910, DOI 10.1002/jmor.10957; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; Rafferty KL, 1999, J MORPHOL, V242, P167, DOI 10.1002/(SICI)1097-4687(199911)242:2<167::AID-JMOR8>3.3.CO;2-T; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Reed DA, 2011, J ANAT, V218, P59, DOI 10.1111/j.1469-7580.2010.01319.x; Ross CF, 2011, J ANAT, V218, P112, DOI 10.1111/j.1469-7580.2010.01322.x; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Rucklin M, 2012, NATURE, V491, P748, DOI 10.1038/nature11555; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Save-Soderbergh G., 1932, Medd Grenland, V94 T, P1; Schwenk Kurt, 2000, P175, DOI 10.1016/B978-012632590-4/50009-5; Thomason JJ, 2001, ANAT REC, V264, P325, DOI 10.1002/ar.10025; Tilley EH, 1971, THESIS U NEWCASTLE U; Wang Q, 2008, ANAT REC, V293, P1477; Zollikofer CPE, 1998, EVOL ANTHROPOL, V6, P41, DOI 10.1002/(SICI)1520-6505(1998)6:2<41::AID-EVAN2>3.0.CO;2-Z	62	26	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118882	10.1371/journal.pone.0118882	http://dx.doi.org/10.1371/journal.pone.0118882			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760343	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000351275000042
J	Sibbe, M; Kuner, E; Althof, D; Frotscher, M				Sibbe, Mirjam; Kuner, Emanuel; Althof, Daniel; Frotscher, Michael			Stem- and Progenitor Cell Proliferation in the Dentate Gyrus of the Reeler Mouse	PLOS ONE			English	Article							RADIAL GLIAL-CELLS; ADULT HIPPOCAMPUS; BIPOLAR DISORDER; MUTANT MICE; NEUROGENESIS; NEURONS; SCHIZOPHRENIA; APOER2; MEMORY; MAINTENANCE	Adult hippocampal neurogenesis has been implicated in hippocampus-dependent learning and memory. Furthermore, the decline of neurogenesis accompanying aging could be involved in age-related cognitive deficits. It is believed that the neural stem cell niche comprises a specialized microenvironment regulating stem cell activation and maintenance. However, little is known about the significance of the extracellular matrix in controlling adult stem cells. Reelin is a large glycoprotein of the extracelluar matrix known to be of crucial importance for neuronal migration. Here, we examined the local interrelation between Reelin expressing interneurons and putative hippocampal stem cells and investigated the effects of Reelin deficiency on stem cell and progenitor cell proliferation. Reelin-positive cells are found in close vicinity to putative stem cell processes, which would allow for stem cell regulation by Reelin. We investigated the proliferation of stem cells in the Reelin-deficient reeler hippocampus by Ki67 labeling and found a strong reduction of mitotic cells. A detailed analysis of dividing Type 1, type 2 and type 3 cells indicated that once a stem cell is recruited for proliferation, the progression to the next progenitor stage as well as the number of mitotic cycles is not altered in reeler. Our data point to a role for Reelin in either regulating stem cell quiescence or maintenance.	[Sibbe, Mirjam; Kuner, Emanuel] Univ Freiburg, Inst Anat & Cell Biol, Ctr Neurosci, D-79104 Freiburg, Germany; [Althof, Daniel] Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; [Frotscher, Michael] Ctr Mol Neurobiol, Inst Struct Neurobiol, D-20251 Hamburg, Germany	University of Freiburg; University of Freiburg	Sibbe, M (corresponding author), Univ Freiburg, Inst Anat & Cell Biol, Ctr Neurosci, Albertstr 23, D-79104 Freiburg, Germany.	Mirjam.Sibbe@anat.uni-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [SFB/TR3, FR 620/12-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors' work was supported by Deutsche Forschungsgemeinschaft (DFG) SFB/TR3 and FR 620/12-1. MF is a Senior Research Professor of the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; CAVINESS VS, 1976, J COMP NEUROL, V170, P435, DOI 10.1002/cne.901700404; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Deller T, 1999, EXP NEUROL, V156, P239, DOI 10.1006/exnr.1999.7020; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Drakew A, 2002, EXP NEUROL, V176, P12, DOI 10.1006/exnr.2002.7918; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Fatemi SH, 2001, NEUROREPORT, V12, P3209, DOI 10.1097/00001756-200110290-00014; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim HM, 2002, P NATL ACAD SCI USA, V99, P4020, DOI 10.1073/pnas.062698299; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Massalini S, 2009, MOL CELL NEUROSCI, V42, P341, DOI 10.1016/j.mcn.2009.08.006; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miranda CJ, 2012, AGING CELL; Nguyen L, 2003, J NEUROSCI, V23, P3278; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; STANFIELD BB, 1979, J COMP NEUROL, V185, P393, DOI 10.1002/cne.901850302; Teixeira CM, 2012, J NEUROSCI, V32, P12051, DOI 10.1523/JNEUROSCI.1857-12.2012; Teixeira CM, 2011, NEUROPSYCHOPHARMACOL, V36, P2395, DOI 10.1038/npp.2011.153; Weiss KH, 2003, J COMP NEUROL, V460, P56, DOI 10.1002/cne.10644; Won SJ, 2006, EXP NEUROL, V198, P250, DOI 10.1016/j.expneurol.2005.12.008; Zhao S, 2007, DEV NEUROSCI-BASEL, V29, P84, DOI 10.1159/000096213	40	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119643	10.1371/journal.pone.0119643	http://dx.doi.org/10.1371/journal.pone.0119643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760459	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000065
J	Fieber, C; Janos, M; Koestler, T; Gratz, N; Li, XD; Castiglia, V; Aberle, M; Sauert, M; Wegner, M; Alexopoulou, L; Kirschning, CJ; Chen, ZJJ; von Haeseler, A; Kovarik, P				Fieber, Christina; Janos, Marton; Koestler, Tina; Gratz, Nina; Li, Xiao-Dong; Castiglia, Virginia; Aberle, Marion; Sauert, Martina; Wegner, Mareike; Alexopoulou, Lena; Kirschning, Carsten J.; Chen, Zhijian J.; von Haeseler, Arndt; Kovarik, Pavel			Innate Immune Response to Streptococcus pyogenes Depends on the Combined Activation of TLR13 and TLR2	PLOS ONE			English	Article							GROUP-A-STREPTOCOCCUS; CELLS; RECOGNITION; MACROPHAGES; RECEPTOR; DIFFERENTIATION; PATHOGENESIS; RESISTANCE	Innate immune recognition of the major human-specific Gram-positive pathogen Streptococcus pyogenes is not understood. Here we show that mice employ Toll-like receptor (TLR) 2- and TLR13-mediated recognition of S. pyogenes. These TLR pathways are non-redundant in the in vivo context of animal infection, but are largely redundant in vitro, as only inactivation of both of them abolishes inflammatory cytokine production by macrophages and dendritic cells infected with S. pyogenes. Mechanistically, S. pyogenes is initially recognized in a phagocytosis-independent manner by TLR2 and subsequently by TLR13 upon internalization. We show that the TLR13 response is specifically triggered by S. pyogenes rRNA and that Tlr13(-/-) cells respond to S. pyogenes infection solely by engagement of TLR2. TLR13 is absent from humans and, remarkably, we find no equivalent route for S. pyogenes RNA recognition in human macrophages. Phylogenetic analysis reveals that TLR13 occurs in all kingdoms but only in few mammals, including mice and rats, which are naturally resistant against S. pyogenes. Our study establishes that the dissimilar expression of TLR13 in mice and humans has functional consequences for recognition of S. pyogenes in these organisms.	[Fieber, Christina; Janos, Marton; Gratz, Nina; Castiglia, Virginia; Aberle, Marion; Sauert, Martina; Kovarik, Pavel] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Koestler, Tina; von Haeseler, Arndt] Univ Vienna, Med Univ Vienna, Ctr Integrat Bioinformat Vienna, Max F Perutz Labs, Vienna, Austria; [Wegner, Mareike] Univ Freiburg Klinikum, Univ Hautklin, Freiburg, Germany; [Alexopoulou, Lena] Aix Marseille Univ 2, CIML, Marseille, France; [Kirschning, Carsten J.] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany; [Li, Xiao-Dong; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX 75390 USA; [von Haeseler, Arndt] Univ Vienna, Fac Comp Sci, Bioinformat & Computat Biol, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Duisburg Essen; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Vienna	Kovarik, P (corresponding author), Univ Vienna, Max F Perutz Labs, Vienna, Austria.	pavel.kovarik@univie.ac.at	Alexopoulou, Lena/A-5041-2017; Chen, Zhijian/C-6039-2012; Kovarik, Pavel/D-1184-2014; von Haeseler, Arndt/HCI-9958-2022	Alexopoulou, Lena/0000-0003-4619-697X; Chen, Zhijian/0000-0002-8475-8251; Kovarik, Pavel/0000-0003-2956-0944; von Haeseler, Arndt/0000-0002-3366-4458; Janos, Marton/0000-0003-1266-1466; Sauert, Martina/0000-0002-2179-9515; Li, Xiao-Dong/0000-0002-4349-6996	Austrian Science Fund (FWF) [P24540-B21, W1220-B09]; European Union [FP7-PEOPLE-2012-ITN, PITN-GA-2012-316682]; University of Vienna; Medical University of Vienna; Austrian Science Fund (FWF) [P 24540] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); University of Vienna; Medical University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) grants P24540-B21 and W1220-B09 DP 'Molecular Mechanisms of Cell Signaling' to PK, by funding from the European Union Seventh Framework Programme Marie Curie Initial Training Networks (FP7-PEOPLE-2012-ITN) for the project INBIONET under grant agreement PITN-GA-2012-316682, and by a joint research cluster initiative of the University of Vienna and the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; Fieber C, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00140; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Fox GF, 2002, LAB ANIMAL MED; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Harder J, 2009, J IMMUNOL; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Johansson L, 2010, CLIN INFECT DIS, V51, P58, DOI 10.1086/653116; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koestler T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-417; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Li XD, 2012, ELIFE, V1, DOI 10.7554/eLife.00102; Loof TG, 2008, INFECT IMMUN, V76, P2785, DOI 10.1128/IAI.01680-07; Loof TG, 2010, AM J PATHOL, V176, P754, DOI 10.2353/ajpath.2010.090422; Medina Eva, 2005, Briefings in Functional Genomics & Proteomics, V4, P248, DOI 10.1093/bfgp/4.3.248; Mishalian I, 2011, J IMMUNOL, V187, P6022, DOI 10.4049/jimmunol.1101385; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Navarini AA, 2009, P NATL ACAD SCI USA, V106, P7107, DOI 10.1073/pnas.0901162106; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Sha WW, 2014, P NATL ACAD SCI USA, V111, P16059, DOI 10.1073/pnas.1412487111; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; Signorino G, 2014, INFECT IMMUN, V82, P5013, DOI 10.1128/IAI.02282-14; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Tsatsaronis JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004266; Wessels MR, 2011, NEW ENGL J MED, V364, P648, DOI 10.1056/NEJMcp1009126; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Zinkernagel AS, 2012, J INNATE IMMUN, V4, P213, DOI 10.1159/000329550	51	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119727	10.1371/journal.pone.0119727	http://dx.doi.org/10.1371/journal.pone.0119727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756897	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275700050
J	Krol, K; Brozda, I; Skoneczny, M; Bretne, M; Skoneczna, A				Krol, Kamil; Brozda, Izabela; Skoneczny, Marek; Bretne, Maria; Skoneczna, Adrianna			A Genomic Screen Revealing the Importance of Vesicular Trafficking Pathways in Genome Maintenance and Protection against Genotoxic Stress in Diploid Saccharomyces cerevisiae Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GROSS-CHROMOSOMAL REARRANGEMENTS; NUCLEOTIDE EXCISION-REPAIR; DNA-DAMAGE; WIDE SCREEN; HOMOLOGOUS RECOMBINATION; PROTEASOMAL DEGRADATION; DIFFERENTIAL REGULATION; CELLULAR-RESPONSE; UV-IRRADIATION	The ability to survive stressful conditions is important for every living cell. Certain stresses not only affect the current well-being of cells but may also have far-reaching consequences. Uncurbed oxidative stress can cause DNA damage and decrease cell survival and/or increase mutation rates, and certain substances that generate oxidative damage in the cell mainly act on DNA. Radiomimetic zeocin causes oxidative damage in DNA, predominantly by inducing single- or double-strand breaks. Such lesions can lead to chromosomal rearrangements, especially in diploid cells, in which the two sets of chromosomes facilitate excessive and deleterious recombination. In a global screen for zeocin-oversensitive mutants, we selected 133 genes whose deletion reduces the survival of zeocin-treated diploid Saccharomyces cerevisiae cells. The screen revealed numerous genes associated with stress responses, DNA repair genes, cell cycle progression genes, and chromatin remodeling genes. Notably, the screen also demonstrated the involvement of the vesicular trafficking system in cellular protection against DNA damage. The analyses indicated the importance of vesicular system integrity in various pathways of cellular protection from zeocin-dependent damage, including detoxification and a direct or transitional role in genome maintenance processes that remains unclear. The data showed that deleting genes involved in vesicular trafficking may lead to Rad52 focus accumulation and changes in total DNA content or even cell ploidy alterations, and such deletions may preclude proper DNA repair after zeocin treatment. We postulate that functional vesicular transport is crucial for sustaining an integral genome. We believe that the identification of numerous new genes implicated in genome restoration after genotoxic oxidative stress combined with the detected link between vesicular trafficking and genome integrity will reveal novel molecular processes involved in genome stability in diploid cells.	[Krol, Kamil; Brozda, Izabela; Skoneczna, Adrianna] Polish Acad Sci, Lab Mutagenesis & DNA Repair, Inst Biochem & Biophys, Warsaw, Poland; [Skoneczny, Marek] Polish Acad Sci, Dept Genet, Inst Biochem & Biophys, Warsaw, Poland; [Bretne, Maria] Warsaw Univ Technol, Fac Chem, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Warsaw University of Technology	Skoneczna, A (corresponding author), Polish Acad Sci, Lab Mutagenesis & DNA Repair, Inst Biochem & Biophys, Warsaw, Poland.	ada@ibb.waw.pl	Skoneczna, Adrianna/H-1734-2011; Skoneczny, Marek/S-5390-2019	Skoneczna, Adrianna/0000-0003-4059-2146; Skoneczny, Marek/0000-0001-9922-2276; Rumienczyk, Izabela/0000-0002-2957-8952	Polish National Science Center [2011/03/B/NZ2/00293]	Polish National Science Center	This work was supported by the Polish National Science Center grant 2011/03/B/NZ2/00293 (https://www.ncn.gov.pl/) to AS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AT, 2003, CHEM BIOL, V10, P45, DOI 10.1016/S1074-5521(02)00306-X; Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Alabrudzinska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021124; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Bailly AP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001025; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Bastin-Shanower SA, 2003, MOL CELL BIOL, V23, P3487, DOI 10.1128/MCB.23.10.3487-3496.2003; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; Blanco MG, 2014, MOL CELL, V54, P94, DOI 10.1016/j.molcel.2014.02.011; Bonetti D, 2013, EMBO J, V32, P275, DOI 10.1038/emboj.2012.327; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Chambers AL, 2012, GENE DEV, V26, P2590, DOI 10.1101/gad.199976.112; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen JY, 2008, NUCLEIC ACIDS RES, V36, P3781, DOI 10.1093/nar/gkn302; Chiu J, 2011, J BIOL CHEM, V286, P5204, DOI 10.1074/jbc.M110.172973; Clerici M, 2004, MOL CELL BIOL, V24, P10126, DOI 10.1128/MCB.24.23.10126-10144.2004; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Davermann D, 2002, FREE RADICAL BIO MED, V33, P1209, DOI 10.1016/S0891-5849(02)00984-X; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Dotiwala F, 2013, P NATL ACAD SCI USA, V110, pE41, DOI 10.1073/pnas.1218065109; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flattery-O'Brien JA, 1998, J BIOL CHEM, V273, P8564, DOI 10.1074/jbc.273.15.8564; FOX KR, 1987, BIOCHEM J, V243, P847, DOI 10.1042/bj2430847; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Giannattasio M, 2004, EMBO J, V23, P429, DOI 10.1038/sj.emboj.7600051; Grenon M, 2006, FEMS YEAST RES, V6, P836, DOI 10.1111/j.1567-1364.2006.00076.x; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Heidenreich E, 2003, EMBO J, V22, P2274, DOI 10.1093/emboj/cdg203; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hiraoka M, 2000, GENETICS, V156, P1531; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Huang Y, 2011, DNA REPAIR, V10, P629, DOI 10.1016/j.dnarep.2011.04.010; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Ju DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009877; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Kaliraman V, 2002, CURR GENET, V41, P389, DOI 10.1007/s00294-002-0319-6; Kanaar R, 2008, EMBO J, V27, P581, DOI 10.1038/emboj.2008.11; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Kiel JAKW, 2010, PHILOS T R SOC B, V365, P819, DOI 10.1098/rstb.2009.0237; Kitagawa T, 2007, INFECT IMMUN, V75, P1393, DOI 10.1128/IAI.01321-06; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Krol K, 2015, PLOS ONE; Lesuisse E, 2005, GENETICS, V169, P107, DOI 10.1534/genetics.104.035873; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Lim HH, 1996, MOL GEN GENET, V253, P138, DOI 10.1007/s004380050306; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu H, 2011, GENETICS, V187, P397, DOI 10.1534/genetics.110.125468; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Luo ZL, 2003, J BIOL CHEM, V278, P791, DOI 10.1074/jbc.M209120200; Lyons NA, 2011, MOL CELL, V42, P378, DOI 10.1016/j.molcel.2011.03.023; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Maringele Laura, 2006, Methods Mol Biol, V313, P65; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Norppa H, 2003, MUTAGENESIS, V18, P221, DOI 10.1093/mutage/18.3.221; Novick P, 1989, GENETICS, V121, P659; Ogiwara H, 2007, NUCLEIC ACIDS RES, V35, P4989, DOI 10.1093/nar/gkm523; Ohnishi G, 2004, BIOCHEM BIOPH RES CO, V325, P928, DOI 10.1016/j.bbrc.2004.10.120; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; POVIRK LF, 1979, BIOCHEMISTRY-US, V18, P96, DOI 10.1021/bi00568a015; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RAD MR, 1994, YEAST, V10, P1217, DOI 10.1002/yea.320100910; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Ristic D, 2003, NUCLEIC ACIDS RES, V31, P5229, DOI 10.1093/nar/gkg729; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rog O, 2005, CURR GENET, V47, P18, DOI 10.1007/s00294-004-0548-y; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Saito TL, 2004, NUCLEIC ACIDS RES, V32, pD319, DOI 10.1093/nar/gkh113; Schmidt KH, 2006, METHOD ENZYMOL, V409, P462, DOI 10.1016/S0076-6879(05)09027-0; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Skoneczna A, 2007, J MOL BIOL, V366, P1074, DOI 10.1016/j.jmb.2006.11.093; SLEIGH MJ, 1976, NUCLEIC ACIDS RES, V3, P891, DOI 10.1093/nar/3.4.891; Song W, 2012, GENETICS, V191, P279, DOI 10.1534/genetics.111.138180; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang XG, 2010, GENETICS, V184, P335, DOI 10.1534/genetics.109.112227; Wasko BM, 2009, DNA REPAIR, V8, P162, DOI 10.1016/j.dnarep.2008.09.010; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618; Yu Y, 2011, MOL CELL BIOL, V31, P2311, DOI 10.1128/MCB.01432-10; Yuan DS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni105	107	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120702	10.1371/journal.pone.0120702	http://dx.doi.org/10.1371/journal.pone.0120702			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756177	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275700073
J	Lindgren, H; Lindgren, L; Golovliov, I; Sjostedt, A				Lindgren, Helena; Lindgren, Lena; Golovliov, Igor; Sjostedt, Anders			Mechanisms of Heme Utilization by Francisella tularensis	PLOS ONE			English	Article							LIVE VACCINE STRAIN; VIBRIO-CHOLERAE; IRON-METABOLISM; OUTER-MEMBRANE; SIDEROPHORE; VIRULENCE; IDENTIFICATION; TRANSPORT; GENES; TULAREMIA	Francisella tularensis is a highly virulent facultative intracellular pathogen causing the severe disease tularemia in mammals. As for other bacteria, iron is essential for its growth but very few mechanisms for iron acquisition have been identified. Here, we analyzed if and how F. tularensis can utilize heme, a major source of iron in vivo. This is by no means obvious since the bacterium lacks components of traditional heme-uptake systems. We show that SCHU S4, the prototypic strain of subspecies tularensis, grew in vitro with heme as the sole iron source. By screening a SCHU S4 transposon insertion library, 16 genes were identified as important to efficiently utilize heme, two of which were required to avoid heme toxicity. None of the identified genes appeared to encode components of a potential heme-uptake apparatus. Analysis of SCHU S4 deletion mutants revealed that each of the components FeoB, the siderophore system, and FupA, contributed to the heme-dependent growth. In the case of the former two systems, iron acquisition was impaired, whereas the absence of FupA did not affect iron uptake but led to abnormally high binding of iron to macromolecules. Overall, the present study demonstrates that heme supports growth of F. tularensis and that the requirements for the utilization are highly complex and to some extent novel.	[Sjostedt, Anders] Umea Univ, Dept Clin Microbiol, Clin Bacteriol, Umea, Sweden; Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden	Umea University; Umea University	Sjostedt, A (corresponding author), Umea Univ, Dept Clin Microbiol, Clin Bacteriol, Umea, Sweden.	Anders.Sjostedt@umu.se	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	Swedish Medical Research Council [K2013-56X-22356-01-3]; Kempe foundation; Medical Faculty, Umea University, Umea, Sweden	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Kempe foundation; Medical Faculty, Umea University, Umea, Sweden	The work was funded by the Swedish Medical Research Council (www.vr.se K2013-56X-22356-01-3), the Kempe foundation and the Medical Faculty, Umea University, Umea, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; BERG JM, 1992, INFECT IMMUN, V60, P690, DOI 10.1128/IAI.60.2.690-693.1992; Bolzan AD, 2001, MUTAT RES-REV MUTAT, V488, P25, DOI 10.1016/S1383-5742(00)00062-4; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Douet V, 2009, J BACTERIOL, V191, P795, DOI 10.1128/JB.00845-08; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; OConnell WA, 1996, INFECT IMMUN, V64, P842, DOI 10.1128/IAI.64.3.842-848.1996; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Ramakrishnan G, 2014, MICROBIOL-SGM, V160, P446, DOI 10.1099/mic.0.072835-0; Ramakrishnan G, 2012, J BIOL CHEM, V287, P25191, DOI 10.1074/jbc.M112.371856; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Sen B, 2010, INFECT IMMUN, V78, P4276, DOI 10.1128/IAI.00503-10; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Wyckoff EE, 2007, BIOMETALS, V20, P405, DOI 10.1007/s10534-006-9073-4	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119143	10.1371/journal.pone.0119143	http://dx.doi.org/10.1371/journal.pone.0119143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756756	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700039
J	Balash, C; Sterling, D; Binns, J; Thomas, G; Bose, N				Balash, Cheslav; Sterling, David; Binns, Jonathan; Thomas, Giles; Bose, Neil			The 'W' Prawn-Trawl with Emphasised Drag-Force Transfer to Its Centre Line to Reduce Overall System Drag	PLOS ONE			English	Article								For prawn trawling systems, drag reduction is a high priority as the trawling process is energy intensive. Large benefits have occurred through the use of multiple-net rigs and thin twine in the netting. An additional positive effect of these successful twine-area reduction strategies is the reduced amount of otter board area required to spread the trawl systems, which leads to further drag reduction. The present work investigated the potential of redirecting the drag-strain within a prawn trawl away from the wings and the otter boards to the centre line of the trawl, where top and bottom tongues have been installed, with an aim to minimise the loading/size of the otter boards required to spread the trawl. In the system containing the new 'W' trawl, the drag redirected to the centre-line tongues is transferred forward through a connected sled and towing wires to the trawler. To establish the extent of drag redirection to the centre-line tongues and the relative drag benefits of the new trawl system, conventional and 'W' trawls of 3.65 m headline length were tested firstly over a range of spread ratios in the flume tank, and subsequently at optimum spread ratio in the field. The developed 'W' trawl effectively directed 64% of netting-drag off the wings and onto the centre tongues, which resulted in drag savings in the field of similar to 20% for the associated 'W' trawl/otter-board/sled system compared to the traditional trawl/otter-board arrangement in a single trawl or twin rig configuration. Furthermore, based on previously published data, the new trawl when used in a twin rig system is expected to provide approximately 12% drag reduction compared to quad rig. The twin 'W' trawl system also has benefits over quad rig in that a reduced number of cod-end/By-catch Reduction Device units need to be installed and attended each tow.	[Balash, Cheslav; Binns, Jonathan; Thomas, Giles; Bose, Neil] Univ Tasmania, Australian Maritime Coll, Natl Ctr Maritime Engn & Hydrodynam, Launceston, Tas 7250, Australia; [Sterling, David] Sterling Trawl Gear Serv, Brisbane, Qld, Australia	University of Tasmania	Balash, C (corresponding author), Univ Tasmania, Australian Maritime Coll, Natl Ctr Maritime Engn & Hydrodynam, Launceston, Tas 7250, Australia.	c.balash@amc.edu.au	Bose, Neil/AAG-6329-2019	Bose, Neil/0000-0002-6444-0756; Thomas, Giles/0000-0002-6122-4329	Fisheries Research Development Corporation on the behalf of the Australian Government [2011/209]	Fisheries Research Development Corporation on the behalf of the Australian Government(Fisheries R&D Corp)	The work has been funded by the Fisheries Research Development Corporation on the behalf of the Australian Government (Project #2011/209) (frdc.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balash C., 2014, 3 INT S FISH VESS EN; Balash C., 2012, 2 INT S FISH VESS EN; Balash C, 2015, FISH RES, V164, P206, DOI 10.1016/j.fishres.2014.11.018; Broadhurst MK, 2013, FISH RES, V146, P7, DOI 10.1016/j.fishres.2013.04.001; Parente J, 2008, FISH RES, V93, P117, DOI 10.1016/j.fishres.2008.03.001; Sterling D., 2010, 1 INT S FISH VESS EN	6	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119622	10.1371/journal.pone.0119622	http://dx.doi.org/10.1371/journal.pone.0119622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751251	Green Submitted, Green Published, gold			2022-12-27	WOS:000350692700030
J	Buch, F; Kaman, WE; Bikker, FJ; Yilamujiang, A; Mithofer, A				Buch, Franziska; Kaman, Wendy E.; Bikker, Floris J.; Yilamujiang, Ayufu; Mithoefer, Axel			Nepenthesin Protease Activity Indicates Digestive Fluid Dynamics in Carnivorous Nepenthes Plants	PLOS ONE			English	Article							ASPARTIC PROTEINASES; UNIQUE MEMBER; VENUS FLYTRAP; PITCHERS; ENZYMES; EXPRESSION; SUBFAMILY; BLANCO; TRAPS	Carnivorous plants use different morphological features to attract, trap and digest prey, mainly insects. Plants from the genus Nepenthes possess specialized leaves called pitchers that function as pitfall-traps. These pitchers are filled with a digestive fluid that is generated by the plants themselves. In order to digest caught prey in their pitchers, Nepenthes plants produce various hydrolytic enzymes including aspartic proteases, nepenthesins (Nep). Knowledge about the generation and induction of these proteases is limited. Here, by employing a FRET (fluorescent resonance energy transfer)-based technique that uses a synthetic fluorescent substrate an easy and rapid detection of protease activities in the digestive fluids of various Nepenthes species was feasible. Biochemical studies and the heterologously expressed Nep II from Nepenthes mirabilis proved that the proteolytic activity relied on aspartic proteases, however an acid-mediated auto-activation mechanism was necessary. Employing the FRET-based approach, the induction and dynamics of nepenthesin in the digestive pitcher fluid of various Nepenthes plants could be studied directly with insect (Drosophila melanogaster) prey or plant material. Moreover, we observed that proteolytic activity was induced by the phytohormone jasmonic acid but not by salicylic acid suggesting that jasmonate-dependent signaling pathways are involved in plant carnivory.	[Buch, Franziska; Yilamujiang, Ayufu; Mithoefer, Axel] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Kaman, Wendy E.] Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 CE Rotterdam, Netherlands; [Kaman, Wendy E.; Bikker, Floris J.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, NL-1081 LA Amsterdam, Netherlands; [Kaman, Wendy E.; Bikker, Floris J.] Vrije Univ Amsterdam, NL-1081 LA Amsterdam, Netherlands	Max Planck Society; Erasmus University Rotterdam; Erasmus MC; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Mithofer, A (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Hans Knoll Str 8, D-07745 Jena, Germany.	amithoefer@ice.mpg.de	Bikker, Floris/B-1187-2012; Bikker, Floris/R-1941-2019; Kaman, Wendy/B-2976-2012	Bikker, Floris/0000-0002-9453-4630; 				An CI, 2002, PLANTA, V214, P661, DOI 10.1007/s004250100665; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; Buch F, 2014, PHYTOCHEMISTRY, V100, P43, DOI 10.1016/j.phytochem.2014.01.014; Buch F, 2013, ANN BOT-LONDON, V111, P375, DOI 10.1093/aob/mcs287; Darwin C., 1875, INSECTIVOROUS PLANTS; Eilenberg H, 2006, J EXP BOT, V57, P2775, DOI 10.1093/jxb/erl048; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Gupta R, 2004, PREDICTION N GLYCOSY; Hepburn J. S., 1918, P AM PHILOS SOC, V57, P112; Heslop-Harrison Y, 1975, Front Biol, V43, P525; JENTSCH J, 1972, FEBS LETT, V21, P273, DOI 10.1016/0014-5793(72)80181-9; Juniper B. E., 1989, CARNIVOROUS PLANTS; Kadek A, 2014, PROTEIN EXPRES PURIF, V95, P121, DOI 10.1016/j.pep.2013.12.005; Kaman WE, 2013, ANAL BIOCHEM, V441, P38, DOI 10.1016/j.ab.2013.06.015; Kaman WE, 2011, ANAL CHEM, V83, P2511, DOI 10.1021/ac102764v; Libiakova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104424; LUTTGE U, 1964, PLANTA, V63, P103, DOI 10.1007/BF01894990; Mithofer A, 2014, PLANT BIOLOGY, V16, P982, DOI 10.1111/plb.12148; Mithofer A, 2011, PHYTOCHEMISTRY, V72, P1678, DOI 10.1016/j.phytochem.2010.11.024; Nakamura Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0228; NAKAYAMA S, 1968, P JPN ACAD, V44, P358, DOI 10.2183/pjab1945.44.358; Pavlovic A, 2011, PLANT CELL ENVIRON, V34, P1865, DOI 10.1111/j.1365-3040.2011.02382.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Renner T, 2013, CURR OPIN PLANT BIOL, V16, P436, DOI 10.1016/j.pbi.2013.06.009; Rottloff S, 2011, J EXP BOT, V62, P4639, DOI 10.1093/jxb/err173; Rottloff S, 2009, ANAL BIOCHEM, V394, P135, DOI 10.1016/j.ab.2009.07.013; RUNEBERGROOS P, 1991, EUR J BIOCHEM, V202, P1021, DOI 10.1111/j.1432-1033.1991.tb16465.x; Schulze WX, 2012, MOL CELL PROTEOMICS, V11, P1306, DOI 10.1074/mcp.M112.021006; Simoes I, 2004, EUR J BIOCHEM, V271, P2067, DOI 10.1111/j.1432-1033.2004.04136.x; Stephenson P, 2006, INT J PLANT SCI, V167, P239, DOI 10.1086/499284; Takahashi K, 2005, CURR PROTEIN PEPT SC, V6, P513, DOI 10.2174/138920305774933259; Takahashi K, 2006, CARNIV PL NEWSLETT, V36, P73; Takahashi K, 2011, BIOSCI BIOTECH BIOCH, V75, P346, DOI 10.1271/bbb.100546; TOKES ZA, 1974, PLANTA, V119, P39, DOI 10.1007/BF00390820; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vines S.H., 1897, ANN BOT, V11, P563, DOI 10.1093/oxfordjournals.aob.a088707; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	37	33	34	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118853	10.1371/journal.pone.0118853	http://dx.doi.org/10.1371/journal.pone.0118853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25750992	Green Published, gold			2022-12-27	WOS:000350692700012
J	Duggimpudi, S; Larsson, E; Nabhani, S; Borkhardt, A; Hoell, JI				Duggimpudi, Sujitha; Larsson, Erik; Nabhani, Schafiq; Borkhardt, Arndt; Hoell, Jessica I.			The Cell Cycle Regulator CCDC6 Is a Key Target of RNA-Binding Protein EWS	PLOS ONE			English	Article							SARCOMA; GENE; TRANSCRIPTION; EXPRESSION; FAMILY; MDM2; DEGRADATION; H4(D10S170); CARCINOMAS; MECHANISMS	Genetic translocation of EWSR1 to ETS transcription factor coding region is considered as primary cause for Ewing sarcoma. Previous studies focused on the biology of chimeric transcription factors formed due to this translocation. However, the physiological consequences of heterozygous EWSR1 loss in these tumors have largely remained elusive. Previously, we have identified various mRNAs bound to EWS using PAR-CLIP. In this study, we demonstrate CCDC6, a known cell cycle regulator protein, as a novel target regulated by EWS. siRNA mediated down regulation of EWS caused an elevated apoptosis in cells in a CCDC6-dependant manner. This effect was rescued upon re-expression of CCDC6. This study provides evidence for a novel functional link through which wild-type EWS operates in a target-dependant manner in Ewing sarcoma.	[Duggimpudi, Sujitha; Nabhani, Schafiq; Borkhardt, Arndt; Hoell, Jessica I.] Univ Dusseldorf, Fac Med, Ctr Child & Adolescent Hlth, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Larsson, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	Heinrich Heine University Dusseldorf; University of Gothenburg	Hoell, JI (corresponding author), Univ Dusseldorf, Fac Med, Ctr Child & Adolescent Hlth, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany.	Jessica.hoell@med.uni-duesseldorf.de	Larsson Lekholm, Erik/AHE-0932-2022; Hoell, Jessica/J-8136-2016; Larsson Lekholm, Erik/HDM-8032-2022	Larsson Lekholm, Erik/0000-0003-1400-0119; Hoell, Jessica/0000-0002-5532-9845; Larsson Lekholm, Erik/0000-0003-1400-0119	"Forschungsstipendium der Vereinigung rheinisch-westfalischer Kinder- und Jugendarzte und Kinderchirurgen" fellowship; Elterninitiative Kinderkrebsklinik e.V. Dusseldorf	"Forschungsstipendium der Vereinigung rheinisch-westfalischer Kinder- und Jugendarzte und Kinderchirurgen" fellowship; Elterninitiative Kinderkrebsklinik e.V. Dusseldorf	This work was supported by a "Forschungsstipendium der Vereinigung rheinisch-westfalischer Kinder- und Jugendarzte und Kinderchirurgen" fellowship and Elterninitiative Kinderkrebsklinik e.V. Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 2008, HUM MUTAT, V29, P390, DOI 10.1002/humu.20653; Azuma M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000979; Ballarino M, 2013, ONCOGENE, V32, P4646, DOI 10.1038/onc.2012.490; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Deneen B, 2001, ONCOGENE, V20, P6731, DOI 10.1038/sj.onc.1204875; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Gimenez DG, 2010, PLANTA MED, V76, P133, DOI 10.1055/s-0029-1186048; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang L, 2012, CANCER RES, V72, P1260, DOI 10.1158/0008-5472.CAN-11-2254; Kaufmann B, 2004, GLYCOBIOLOGY, V14, P609, DOI 10.1093/glycob/cwh063; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kovar H., 2011, SARCOMA, V2011, DOI DOI 10.1155/2011/837474; Krejci P, 2009, HUM MUTAT, V30, P1245, DOI 10.1002/humu.21067; Leone V, 2010, ONCOGENE, V29, P4341, DOI 10.1038/onc.2010.179; Lezon-Geyda K, 2001, LEUKEMIA, V15, P954, DOI 10.1038/sj.leu.2402108; Li Q, 2013, CLIN CANCER RES, V19, P34, DOI 10.1158/1078-0432.CCR-12-0053; Li Y, 2010, CANCER LETT, V294, P57, DOI 10.1016/j.canlet.2010.01.022; Lin PP, 2008, CANCER RES, V68, P8968, DOI 10.1158/0008-5472.CAN-08-0573; Merolla F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036177; Paronetto MP, 2014, CELL REP, V7, P1211, DOI 10.1016/j.celrep.2014.03.077; Park H, 2014, CELL CYCLE, V13, P2391, DOI 10.4161/cc.29337; Paronetto Maria Paola, 2013, Int J Cell Biol, V2013, P642853, DOI 10.1155/2013/642853; Pishas KI, 2011, CLIN CANCER RES, V17, P494, DOI 10.1158/1078-0432.CCR-10-1587; Puxeddu E, 2005, MUTAT RES-FUND MOL M, V570, P17, DOI 10.1016/j.mrfmmm.2004.09.010; Rodriguez-Galindo C, 2003, MED PEDIATR ONCOL, V40, P276, DOI 10.1002/mpo.10240; Sangle NA, 2011, ARCH PATHOL LAB MED, V135, P1504, DOI 10.5858/arpa.2010-0482-RS; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; Sohn EJ, 2010, CANCER RES, V70, P1154, DOI 10.1158/0008-5472.CAN-09-1993; Spitzer JI, 2011, GENE CHROMOSOME CANC, V50, P338, DOI 10.1002/gcc.20858; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Thanasopoulou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031007; Thanasopoulou A, 2012, ANTICANCER RES, V32, P907; Ulaner GA, 2004, GENE CHROMOSOME CANC, V41, P155, DOI 10.1002/gcc.20074; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Xia SJ, 2005, EUR J CANCER, V41, P2513, DOI 10.1016/j.ejca.2005.08.003; Zhao JG, 2012, FEBS LETT, V586, P4257, DOI 10.1016/j.febslet.2012.10.029	44	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119066	10.1371/journal.pone.0119066	http://dx.doi.org/10.1371/journal.pone.0119066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751255	Green Submitted, gold, Green Published			2022-12-27	WOS:000350692700014
J	Harlid, S; Xu, ZL; Panduri, V; D'Aloisio, AA; DeRoo, LA; Sandler, DP; Taylor, JA				Harlid, Sophia; Xu, Zongli; Panduri, Vijayalakshmi; D'Aloisio, Aimee A.; DeRoo, Lisa A.; Sandler, Dale P.; Taylor, Jack A.			In Utero Exposure to Diethylstilbestrol and Blood DNA Methylation in Women Ages 40-59 Years from the Sister Study	PLOS ONE			English	Article							GENE-EXPRESSION; DEVELOPMENTAL EXPOSURE; ESTROGEN-RECEPTOR; BREAST-CANCER; MOUSE UTERUS; YOUNG-WOMEN; VAGINA; RISK; MICE	In utero exposure to diethylstilbestrol (DES) has been associated with increased risk of adverse health outcomes such as fertility problems and vaginal as well as breast cancer. Animal studies have linked prenatal DES exposure to lasting DNA methylation changes. We investigated genome-wide DNA methylation and in utero DES exposure in a sample of non-Hispanic white women aged 40-59 years from the Sister Study, a large United States cohort study of women with a family history of breast cancer. Using questionnaire information from women and their mothers, we selected 100 women whose mothers reported taking DES while pregnant and 100 control women whose mothers had not taken DES. DNA methylation in blood was measured at 485,577 CpG sites using the Illumina HumanMethylation450 BeadChip. Associations between CpG methylation and DES exposure status were analyzed using robust linear regression with adjustment for blood cell composition and multiple comparisons. Although four CpGs had p<10(5), after accounting for multiple comparisons using the false discovery rate (FDR), none reached genome-wide significance. In conclusion, adult women exposed to DES in utero had no evidence of large persistent changes in blood DNA methylation.	[Harlid, Sophia; Xu, Zongli; D'Aloisio, Aimee A.; DeRoo, Lisa A.; Sandler, Dale P.; Taylor, Jack A.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Harlid, Sophia; Panduri, Vijayalakshmi; Taylor, Jack A.] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [DeRoo, Lisa A.] Univ Bergen, Dept Global Publ Hlth & Primary Hlth Care, Bergen, Norway	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen	Taylor, JA (corresponding author), NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA.	taylor@niehs.nih.gov	taylor, jack a/C-7154-2019; Harlid, Sophia/AAJ-5809-2021	taylor, jack a/0000-0001-5303-6398; Harlid, Sophia/0000-0001-8540-6891; xu, zongli/0000-0002-9034-8902; Sandler, Dale/0000-0002-6776-0018	NIH, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049033, ZIAES044005, ZICES102445, ZIAES049032] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences.	[Anonymous], 2014, SIST STUD COH DESCR, DOI 1016/j.tox.2012.02.010; Block K, 2000, FASEB J, V14, P1101, DOI 10.1096/fasebj.14.9.1101; Bredfeldt TG, 2010, MOL ENDOCRINOL, V24, P993, DOI 10.1210/me.2009-0438; Bromer JG, 2009, ENDOCRINOLOGY, V150, P3376, DOI 10.1210/en.2009-0071; D'Aloisio AA, 2013, EPIDEMIOLOGY, V24, P277, DOI 10.1097/EDE.0b013e31828062b7; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; HEINONEN OP, 1973, CANCER, V31, P573, DOI 10.1002/1097-0142(197303)31:3<573::AID-CNCR2820310312>3.0.CO;2-#; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamiya K, 1996, EXP CLIN ENDOCR DIAB, V104, P111, DOI 10.1055/s-0029-1211432; Li SF, 1997, CANCER RES, V57, P4356; Li SF, 2003, ANN NY ACAD SCI, V983, P161, DOI 10.1111/j.1749-6632.2003.tb05971.x; Miyagawa S, 2004, J MOL ENDOCRINOL, V32, P663, DOI 10.1677/jme.0.0320663; Nakamura T, 2012, TOXICOLOGY, V296, P13, DOI 10.1016/j.tox.2012.02.010; NELSON KG, 1994, CELL GROWTH DIFFER, V5, P595; Newbold RR, 2007, MOL CARCINOGEN, V46, P783, DOI 10.1002/mc.20308; OBRIEN PC, 1979, OBSTET GYNECOL, V53, P300; Palmer JR, 2002, CANCER CAUSE CONTROL, V13, P753, DOI 10.1023/A:1020254711222; Palmer JR, 2006, CANCER EPIDEM BIOMAR, V15, P1509, DOI 10.1158/1055-9965.EPI-06-0109; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vanhees K, 2011, FASEB J, V25, P797, DOI 10.1096/fj.10-172155; Yamashita S, 2001, HISTOL HISTOPATHOL, V16, P131, DOI 10.14670/HH-16.131	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118757	10.1371/journal.pone.0118757	http://dx.doi.org/10.1371/journal.pone.0118757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751399	Green Submitted, Green Published, gold			2022-12-27	WOS:000350692700009
J	Debnath, T; Ghosh, S; Potlapuvu, US; Kona, L; Kamaraju, SR; Sarkar, S; Gaddam, S; Chelluri, LK				Debnath, Tanya; Ghosh, Sutapa; Potlapuvu, Usha Shalini; Kona, Lakshmi; Kamaraju, Suguna Ratnakar; Sarkar, Suprabhat; Gaddam, Sumanlatha; Chelluri, Lakshmi Kiran			Proliferation and Differentiation Potential of Human Adipose-Derived Stem Cells Grown on Chitosan Hydrogel	PLOS ONE			English	Article							BONE-MARROW; TISSUE; BIOMATERIALS; SCAFFOLD	Applied tissue engineering in regenerative medicine warrants our enhanced understanding of the biomaterials and its function. The aim of this study was to evaluate the proliferation and differentiation potential of human adipose-derived stem cells (hADSCs) grown on chitosan hydrogel. The stability of this hydrogel is pH-dependent and its swelling property is pivotal in providing a favorable matrix for cell growth. The study utilized an economical method of cross linking the chitosan with 0.5% glutaraldehyde. Following the isolation of hADSCs from omentum tissue, these cells were cultured and characterized on chitosan hydrogel. Subsequent assays that were performed included JC-1 staining for the mitochondrial integrity as a surrogate marker for viability, cell proliferation and growth kinetics by MTT assay, lineage specific differentiation under two-dimensional culture conditions. Confocal imaging, scanning electron microscopy (SEM), and flow cytometry were used to evaluate these assays. The study revealed that chitosan hydrogel promotes cell proliferation coupled with > 90% cell viability. Cytotoxicity assays demonstrated safety profile. Furthermore, glutaraldehyde cross linked chitosan showed < 5% cytotoxicity, thus serving as a scaffold and facilitating the expansion and differentiation of hADSCs across endoderm, ectoderm and mesoderm lineages. Additional functionalities can be added to this hydrogel, particularly those that regulate stem cell fate.	[Debnath, Tanya; Potlapuvu, Usha Shalini; Kamaraju, Suguna Ratnakar; Chelluri, Lakshmi Kiran] Global Hosp, Transplant Immunol & Stem Cell Lab, Hyderabad, Andhra Pradesh, India; [Ghosh, Sutapa; Sarkar, Suprabhat] Indian Inst Chem Technol, I&PC Div, Nanomat Lab, Hyderabad 500007, Andhra Pradesh, India; [Kona, Lakshmi] Global Hosp, Dept Bariatr Surg, Hyderabad, Andhra Pradesh, India; [Gaddam, Sumanlatha] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Osmania University	Ghosh, S (corresponding author), Indian Inst Chem Technol, I&PC Div, Nanomat Lab, Hyderabad 500007, Andhra Pradesh, India.	sutapa69arun@gmail.com; lkiran@globalhospitalsindia.com						Beahm EK, 2003, CLIN PLAST SURG, V30, P547, DOI 10.1016/S0094-1298(03)00072-5; Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9; Bissell M J, 1987, Prog Clin Biol Res, V249, P251; Cheburu CN, 2011, MED-SURG J, V115, P864; Cheng YH, 2010, TISSUE ENG PT A, V16, P695, DOI [10.1089/ten.tea.2009.0229, 10.1089/ten.TEA.2009.0229]; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Dhanasekaran M, 2012, CYTOTECHNOLOGY, V64, P497, DOI 10.1007/s10616-012-9427-4; Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI 10.1089/ten.TEA.2009.0398; Distantina S, 2013, ENG J-THAIL, V17, P57, DOI 10.4186/ej.2013.17.3.57; Gomathysankar S, 2014, ARCH PLAST SURG-APS, V41, P452, DOI 10.5999/aps.2014.41.5.452; Gonçalves Vanessa L., 2005, Polímeros, V15, P6, DOI 10.1590/S0104-14282005000100005; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; Hassan W, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt182; Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001; Ikeda T, 2014, BIOMED RES INT, V2014, P8; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kang YM, 2010, INT J MOL SCI, V11, P4140, DOI 10.3390/ijms11104140; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim KS, 2009, TISSUE ENG PT A, V15, P3201, DOI [10.1089/ten.tea.2008.0704, 10.1089/ten.TEA.2008.0704]; Koppula PR, 2009, CELL IMMUNOL, V259, P61, DOI 10.1016/j.cellimm.2009.05.014; Lakshmi KC, 2012, STEM CELLS EXTRACELL; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Li B, 2013, MAR DRUGS, V11, P1534, DOI 10.3390/md11051534; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naderi-Meshkin H, 2014, CELL BIOL INT, V38, P72, DOI 10.1002/cbin.10181; Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022; Patel PN, 2005, J BIOMED MATER RES A, V73A, P313, DOI 10.1002/jbm.a.30291; Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8; ROSSMURPHY SB, 1994, POLYM GELS NETW, V2, P229, DOI 10.1016/0966-7822(94)90007-8; Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270; Salamon A, 2014, MATERIALS, V7, P1342, DOI 10.3390/ma7021342; Song KD, 2010, J MATER SCI-MATER M, V21, P2835, DOI 10.1007/s10856-010-4131-4; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wang LY, 2006, COLLOID SURFACE B, V50, P126, DOI 10.1016/j.colsurfb.2006.05.006; Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003; Zamora DO, 2012, JOVE-J VIS EXP, DOI 10.3791/3624; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	43	41	42	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120803	10.1371/journal.pone.0120803	http://dx.doi.org/10.1371/journal.pone.0120803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746846	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400099
J	Hong, ZK; Reeves, KJ; Sun, Z; Li, ZH; Brown, NJ; Meininger, GA				Hong, Zhongkui; Reeves, Kimberley J.; Sun, Zhe; Li, Zhaohui; Brown, Nicola J.; Meininger, Gerald A.			Vascular Smooth Muscle Cell Stiffness and Adhesion to Collagen I Modified by Vasoactive Agonists	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; INTEGRIN-MEDIATED MECHANOTRANSDUCTION; ACTIN POLYMERIZATION; AORTIC STIFFNESS; N-WASP; ACTIVATION; CONTRACTION; ELASTICITY; SUBUNIT; BINDING	In vascular smooth muscle cells (VSMCs) integrin-mediated adhesion to extracellular matrix (ECM) proteins play important roles in sustaining vascular tone and resistance. The main goal of this study was to determine whether VSMCs adhesion to type I collagen (COL-I) was altered in parallel with the changes in the VSMCs contractile state induced by vasoconstrictors and vasodilators. VSMCs were isolated from rat cremaster skeletal muscle arterioles and maintained in primary culture without passage. Cell adhesion and cell E-modulus were assessed using atomic force microscopy (AFM) by repetitive nano-indentation of the AFM probe on the cell surface at 0.1 Hz sampling frequency and 3200 nm Z-piezo travelling distance (approach and retraction). AFM probes were tipped with a 5 mu m diameter microbead functionalized with COL-I (1mg\ml). Results showed that the vasoconstrictor angiotensin II (ANG-II; 10(-6)) significantly increased (p<0.05) VSMC E-modulus and adhesion probability to COL-I by approximately 35% and 33%, respectively. In contrast, the vasodilator adenosine (ADO; 10(-4)) significantly decreased (p<0.05) VSMC E-modulus and adhesion probability by approximately -33% and -17%, respectively. Similarly, the NO donor (PANOate, 10(-6) M), a potent vasodilator, also significantly decreased (p<0.05) the VSMC E-modulus and COL-I adhesion probability by -38% and -35%, respectively. These observations support the hypothesis that integrin-mediated VSMC adhesion to the ECM protein COL-I is dynamically regulated in parallel with VSMC contractile activation. These data suggest that the signal transduction pathways modulating VSMC contractile activation and relaxation, in addition to ECM adhesion, interact during regulation of contractile state.	[Hong, Zhongkui; Reeves, Kimberley J.; Sun, Zhe; Li, Zhaohui; Meininger, Gerald A.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Brown, Nicola J.] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Hong, Zhongkui; Sun, Zhe; Meininger, Gerald A.] Univ Missouri, Dept Physiol & Pharmacol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Sheffield; University of Missouri System; University of Missouri Columbia	Meininger, GA (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	Meiningerg@missouri.edu	Hong, Zhongkui/AAQ-1787-2021	Brown, Nicola/0000-0002-2100-1905	National Institutes of Health [P01HL095486]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health P01HL095486 to Gerald A. Meininger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian L, 2007, AM J PHYSIOL-REG I, V293, pR1586, DOI 10.1152/ajpregu.00025.2007; BRIESEWITZ R, 1993, J BIOL CHEM, V268, P2989; Butt H-J, 1995, NANOTECHNOLOGY, V6, P7; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Costa KD, 2003, DIS MARKERS, V19, P139, DOI 10.1155/2004/482680; DEAN DC, 1993, AM REV RESPIR DIS, V148, pS43, DOI 10.1164/ajrccm/148.6_Pt_2.S43; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Goldschmidt ME, 2001, CIRC RES, V88, P674, DOI 10.1161/hh0701.089749; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Heerkens EHJ, 2006, HYPERTENSION, V47, P281, DOI 10.1161/01.HYP.0000198428.45132.02; Hillis GS, 1998, BASIC RES CARDIOL, V93, P295, DOI 10.1007/s003950050098; Hong ZK, 2014, J PHYSIOL-LONDON, V592, P1249, DOI 10.1113/jphysiol.2013.264929; Hong ZK, 2012, CARDIOVASC RES, V96, P73, DOI 10.1093/cvr/cvs239; Hutter J.L.A.B., 1993, REV SCI INSTRUM, V64, P6; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Kucik DF, 2001, MOL BIOL CELL, V12, P1509, DOI 10.1091/mbc.12.5.1509; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Martinez-Lemus LA, 2005, AM J PHYSIOL-HEART C, V289, pH322, DOI 10.1152/ajpheart.00923.2003; Min J, 2012, J CELL PHYSL; Moreno-Dominguez A, 2014, J BIOL CHEM; Poythress RH, 2013, AM J PHYSIOL-CELL PH, V305, pC215, DOI 10.1152/ajpcell.00103.2013; Prockop J D, 1995, ANNU REV BIOCHEM, V64, P403; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Sehgel NL, 2013, AM J PHYSIOL-HEART C, V305, pH1281, DOI 10.1152/ajpheart.00232.2013; Sun Z, 2005, AM J PHYSIOL-HEART C, V289, pH2526, DOI 10.1152/ajpheart.00658.2004; Sun Z, 2008, AM J PHYSIOL-CELL PH, V295, pC268, DOI 10.1152/ajpcell.00516.2007; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; Vargas-Pinto R, 2013, BIOPHYS J, V105, P300, DOI 10.1016/j.bpj.2013.05.034; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2007, J BIOL CHEM, V282, P34568, DOI 10.1074/jbc.M704966200; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Zhu Y, 2012, AGING CELL, V11, P741, DOI 10.1111/j.1474-9726.2012.00840.x	40	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119533	10.1371/journal.pone.0119533	http://dx.doi.org/10.1371/journal.pone.0119533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25745858	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000350689400076
J	Jiang, JM; Zhou, CF; Gao, SL; Tian, Y; Wang, CY; Wang, L; Gu, HF; Tang, XQ				Jiang, Jia-Mei; Zhou, Cheng-Fang; Gao, Sheng-Lan; Tian, Ying; Wang, Chun-Yan; Wang, Li; Gu, Hong-Feng; Tang, Xiao-Qing			BDNF-TrkB Pathway Mediates Neuroprotection of Hydrogen Sulfide against Formaldehyde-Induced Toxicity to PC12 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED OXIDATIVE DAMAGE; NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; INDUCED APOPTOSIS; INDUCED NEUROTOXICITY; NEURONAL APOPTOSIS; PREFRONTAL CORTEX; UP-REGULATION; NITRIC-OXIDE	Formaldehyde (FA) is a common environmental contaminant that has toxic effects on the central nervous system (CNS). Our previous data demonstrated that hydrogen sulfide (H2S), the third endogenous gaseous mediator, has protective effects against FA-induced neurotoxicity. As is known to all, Brain-derived neurotropic factor (BDNF), a member of the neurotrophin gene family, mediates its neuroprotective properties via various intracellular signaling pathways triggered by activating the tyrosine kinase receptor B (TrkB). Intriguingly, our previous data have illustrated the upregulatory role of H2S on BDNF protein expression in the hippocampus of rats. Therefore, in this study, we hypothesized that H2S provides neuroprotection against FA toxicity by regulating BDNF-TrkB pathway. In the present study, we found that NaHS, a donor of H2S, upregulated the level of BDNF protein in PC12 cells, and significantly rescued FA-induced downregulation of BDNF levels. Furthermore, we found that pretreatment of PC12 cells with K252a, an inhibitor of the BDNF receptor TrkB, markedly reversed the inhibition of NaHS on FA-induced cytotoxicity and ablated the protective effects of NaHS on FA-induced oxidative stress, including the accumulation of intracellular reactive oxygen species (ROS), 4-hydroxy-2-trans-nonenal (4-HNE), and malondialdehyde (MDA). We also showed that K252a abolished the inhibition of NaHS on FA-induced apoptosis, as well as the activation of caspase-3 in PC12 cells. In addition, K252a reversed the protection of H2S against FA-induced downregulation of Bcl-2 protein expression and upregulation of Bax protein expression in PC12 cells. These data indicate that the BDNF-TrkB pathway mediates the neuroprotection of H2S against FA-induced cytotoxicity, oxidative stress and apoptosis in PC12 cells. These findings provide a novel mechanism underlying the protection of H2S against FA-induced neurotoxicity.	[Jiang, Jia-Mei; Zhou, Cheng-Fang; Gao, Sheng-Lan; Gu, Hong-Feng; Tang, Xiao-Qing] Univ South China, Coll Med, Dept Physiol, Hengyang 421001, Hunan, Peoples R China; [Jiang, Jia-Mei; Zhou, Cheng-Fang; Gao, Sheng-Lan; Gu, Hong-Feng; Tang, Xiao-Qing] Univ South China, Coll Med, Inst Neurosci, Hengyang 421001, Hunan, Peoples R China; [Jiang, Jia-Mei; Gao, Sheng-Lan; Gu, Hong-Feng; Tang, Xiao-Qing] Univ South China, Key Lab Cognit Disorders & Neurodegenerat Dis, Hengyang 421001, Hunan, Peoples R China; [Tian, Ying] Univ South China, Coll Med, Dept Biochem, Hengyang 421001, Hunan, Peoples R China; [Wang, Chun-Yan] Univ South China, Coll Med, Dept Pathophysiol, Hengyang 421001, Hunan, Peoples R China; [Wang, Li] Univ South China, Coll Med, Dept Anthropot, Hengyang 421001, Hunan, Peoples R China	University of South China; University of South China; University of South China; University of South China; University of South China; University of South China	Tian, Y (corresponding author), Univ South China, Coll Med, Dept Biochem, Hengyang 421001, Hunan, Peoples R China.	uscty@163.com; tangxq01001@foxmail.com		Zhou, Chengfang/0000-0001-9716-8181	Natural Science Foundation of China [81202518, 81200985]; Natural Science Foundation of Hunan Province, China [11JJ3117, 12JJ9032]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [[2011]508]; construct program of the key discipline in Hunan province	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); construct program of the key discipline in Hunan province	This study was supported by Natural Science Foundation of China (81200985 and 81202518), Natural Science Foundation of Hunan Province, China (11JJ3117 and 12JJ9032), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry ([2011]508) and the construct program of the key discipline in Hunan province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Arici S, 2014, HUM EXP TOXICOL; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Boyadjieva NI, 2013, ALCOHOL CLIN EXP RES, V37, P1370, DOI 10.1111/acer.12104; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Conner JM, 1997, J NEUROSCI, V17, P2295; Degos V, 2013, ANESTHESIOLOGY, V118, P1123, DOI 10.1097/ALN.0b013e318286cf36; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; Flo-Neyret C, 2001, BRAZ J MED BIOL RES, V34, P639, DOI 10.1590/S0100-879X2001000500012; FLYVHOLM MA, 1993, AM J IND MED, V24, P533, DOI 10.1002/ajim.4700240505; Fournet G, 2013, CURR MED CHEM, V20, P527; Franklin P, 2000, AM J RESP CRIT CARE, V161, P1757, DOI 10.1164/ajrccm.161.5.9905061; Fukamachi Y, 1998, BIOCHEM BIOPH RES CO, V246, P364, DOI 10.1006/bbrc.1998.8621; Gabaizadeh R, 1997, MOL BRAIN RES, V50, P71, DOI 10.1016/S0169-328X(97)00173-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gurel A, 2005, J CHEM NEUROANAT, V29, P173, DOI 10.1016/j.jchemneu.2005.01.001; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Han H, 2001, J BIOL CHEM, V276, P26357, DOI 10.1074/jbc.M011136200; Huang YZ, 2012, J NEUROSCI, V32, P15521, DOI 10.1523/JNEUROSCI.0755-12.2012; Jia J, 2013, NEUROCHEM INT, V62, P1072, DOI 10.1016/j.neuint.2013.04.001; Jourdi H, 2009, NEUROPHARMACOLOGY, V56, P876, DOI 10.1016/j.neuropharm.2009.01.015; Kamat PK, 2013, NEUROSCIENCE, V252, P302, DOI 10.1016/j.neuroscience.2013.07.051; KILBURN KH, 1994, ARCH ENVIRON HEALTH, V49, P37, DOI 10.1080/00039896.1994.9934412; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P795, DOI 10.1089/ars.2005.7.795; Kong SZ, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/310146; Konstantinidou AE, 2007, APOPTOSIS, V12, P695, DOI 10.1007/s10495-006-0001-4; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Lauterbach EC, 2013, INT J MOL SCI, V14, P22558, DOI 10.3390/ijms141122558; Lee M, 2013, GLIA, V61, P1724, DOI 10.1002/glia.22553; Li RX, 1998, GLYCOBIOLOGY, V8, P597, DOI 10.1093/glycob/8.6.597; Li Wei-Wei, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3017; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Liu Y, 2010, NEUROSCIENCE, V169, P1248, DOI 10.1016/j.neuroscience.2010.05.061; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Luo FC, 2012, NEUROTOXICOLOGY, V33, P290, DOI 10.1016/j.neuro.2012.02.004; MESSIHA FS, 1983, NEUROBEH TOXICOL TER, V5, P251; Nguyen TLX, 2010, EXP MOL MED, V42, P583, DOI 10.3858/emm.2010.42.8.060; Okoye G, 2003, J NEUROSCI, V23, P4164; Ozen OA, 2008, SYST BIOL REPROD MED, V54, P169, DOI 10.1080/19396360802422402; Pandya CD, 2013, ASIAN J PSYCHIATR, V6, P22, DOI 10.1016/j.ajp.2012.08.010; Sakamoto K, 2014, EXP EYE RES, V120, P90, DOI 10.1016/j.exer.2014.01.008; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shearn C.T., 2014, J BIOL CHEM; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Songur A, 2010, REV ENVIRON CONTAM T, V203, P105, DOI 10.1007/978-1-4419-1352-4_3; Su B, 2014, J BIOL CHEM, V289, P1213, DOI 10.1074/jbc.M113.526129; Tamagno E, 2003, EXP NEUROL, V180, P144, DOI 10.1016/S0014-4886(02)00059-6; Tang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054829; Tang XQ, 2013, J MOL NEUROSCI, V49, P140, DOI 10.1007/s12031-012-9912-4; Tang XQ, 2012, NEUROCHEM INT, V61, P16, DOI 10.1016/j.neuint.2012.04.011; Tang XQ, 2011, CLIN EXP PHARMACOL P, V38, P208, DOI 10.1111/j.1440-1681.2011.05485.x; TAPLEY P, 1992, ONCOGENE, V7, P371; Tulpule K, 2013, J NEUROCHEM, V127, P7, DOI 10.1111/jnc.12356; Usanmaz SE, 2002, ENVIRON TOXICOL PHAR, V11, P93, DOI 10.1016/S1382-6689(01)00109-0; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang S, 2009, J NEUROSCI RES, V87, P1938, DOI 10.1002/jnr.21999; Wei HJ, 2014, ACTA PHARMACOL SIN, V35, P707, DOI 10.1038/aps.2013.197; Yan Q, 1997, J COMP NEUROL, V378, P135; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yin WL, 2009, LIFE SCI, V85, P269, DOI 10.1016/j.lfs.2009.05.023; Yu J, 2014, NEUROSCI BULL, V30, P172, DOI 10.1007/s12264-013-1416-x; Zararsiz I, 2007, CELL BIOCHEM FUNCT, V25, P413, DOI 10.1002/cbf.1315; Zararsiz I, 2006, CELL BIOCHEM FUNCT, V24, P237, DOI 10.1002/cbf.1204; Zhang JY, 2011, INT J CLIN EXP PATHO, V4, P496; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang R, 2010, J TOXICOL ENV HEAL A, V73, P1477, DOI 10.1080/15287394.2010.511564; Zhao X, 2008, J ALZHEIMERS DIS, V15, P397	73	25	26	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119478	10.1371/journal.pone.0119478	http://dx.doi.org/10.1371/journal.pone.0119478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749582	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400075
J	Wilkens, CA; Gerdtzen, ZP				Wilkens, Camila A.; Gerdtzen, Ziomara P.			Comparative Metabolic Analysis of CHO Cell Clones Obtained through Cell Engineering, for IgG Productivity, Growth and Cell Longevity	PLOS ONE			English	Article							NICOTINAMIDE-ADENINE DINUCLEOTIDE; YEAST PYRUVATE-CARBOXYLASE; FLUX ANALYSIS; EXPRESSION; GLUCOSE; IMPROVEMENT; CULTURE; ERYTHROPOIETIN; MITOCHONDRIA; REDUCTION	Cell engineering has been used to improve animal cells' central carbon metabolism. Due to the central carbon metabolism's inefficiency and limiting input of carbons into the TCA cycle, key reactions belonging to these pathways have been targeted to improve cultures' performance. Previous works have shown the positive effects of overexpressing PYC2, MDH II and fructose transporter. Since each of these modifications was performed in different cell lines and culture conditions, no comparisons between these modifications can be made. In this work we aim at contrasting the effect of each of the modifications by comparing pools of transfected IgG producing CHO cells cultivated in batch cultures. Results of the culture performance of engineered clones indicate that even though all studied clones had a more efficient metabolism, not all of them showed the expected improvement on cell proliferation and/or specific productivity. CHO cells overexpressing PYC2 were able to improve their exponential growth rate but IgG synthesis was decreased, MDH II overexpression lead to a reduction in cell growth and protein production, and cells transfected with the fructose transporter gene were able to increase cell density and reach the same volumetric protein production as parental CHO cells in glucose. We propose that a redox unbalance caused by the new metabolic flux distribution could affect IgG assembly and protein secretion. In addition to reaction dynamics, thermodynamic aspects of metabolism are also discussed to further understand the effect of these modifications over central carbon metabolism.	[Wilkens, Camila A.; Gerdtzen, Ziomara P.] Univ Chile, CeBiB, Dept Chem Engn, Santiago 8370448, Chile	Universidad de Chile	Gerdtzen, ZP (corresponding author), Univ Chile, CeBiB, Dept Chem Engn, Beauchef 850, Santiago 8370448, Chile.	zgerdtze@ing.uchile.cl	Gerdtzen, Ziomara/H-2711-2013	Gerdtzen, Ziomara/0000-0002-7486-8537	V.I. D. UChile Enlace [Fondecyt-2013-14116]; Conicyt Doctorate Fellowship [21100286-2010]; PIA Conicyt [FB0001]; Fondecyt [1130317]; Fondecyt Initiation [11090268]	V.I. D. UChile Enlace; Conicyt Doctorate Fellowship; PIA Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondecyt Initiation(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The authors acknowledge funding from V.I. D. UChile Enlace Fondecyt-2013-14116, Conicyt Doctorate Fellowship 21100286-2010, PIA Conicyt FB0001, Fondecyt Grant 1130317 and Fondecyt Initiation Grant 11090268. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano C, 2000, BIOTECHNOL PROGR, V16, P69, DOI 10.1021/bp990124j; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; BOISSEL JP, 1993, J BIOL CHEM, V268, P15983; Borth N, 2005, BIOTECHNOL PROGR, V21, P106, DOI 10.1021/bp0498241; Chong WPK, 2010, J BIOTECHNOL, V147, P116, DOI 10.1016/j.jbiotec.2010.03.018; EAGLE H, 1958, J BIOL CHEM, V233, P551; Elias CB, 2003, BIOTECHNOL PROGR, V19, P90, DOI 10.1021/bp025572x; Europa AF, 2000, BIOTECHNOL BIOENG, V67, P25, DOI 10.1002/(SICI)1097-0290(20000105)67:1<25::AID-BIT4>3.0.CO;2-K; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fussenegger M, 1997, BIOTECHNOL BIOENG, V55, P927, DOI 10.1002/(SICI)1097-0290(19970920)55:6<927::AID-BIT10>3.0.CO;2-4; Gambhir A, 2003, J BIOSCI BIOENG, V95, P317, DOI 10.1263/jbb.95.317; GLACKEN MW, 1988, BIO-TECHNOL, V6, P1041, DOI 10.1038/nbt0988-1041; GLACKEN MW, 1986, BIOTECHNOL BIOENG, V28, P1376, DOI 10.1002/bit.260280912; Inoue Y, 2010, CYTOTECHNOLOGY, V62, P301, DOI 10.1007/s10616-010-9289-6; Irani N, 2002, J BIOTECHNOL, V93, P269, DOI 10.1016/S0168-1656(01)00409-6; Irani N, 1999, BIOTECHNOL BIOENG, V66, P238, DOI 10.1002/(SICI)1097-0290(1999)66:4<238::AID-BIT5>3.0.CO;2-6; Jones ML, 2010, J IMMUNOL METHODS, V354, P85, DOI 10.1016/j.jim.2010.02.001; KERBEY AL, 1977, BIOCHEM J, V164, P509, DOI 10.1042/bj1640509; Korke R, 2004, J BIOTECHNOL, V107, P1, DOI 10.1016/j.jbiotec.2003.09.007; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; KURANO N, 1990, J BIOTECHNOL, V15, P113, DOI 10.1016/0168-1656(90)90055-G; LONGMORE WJ, 1969, J BIOL CHEM, V244, P6451; MOONEY RA, 1982, EUR J BIOCHEM, V121, P281, DOI 10.1111/j.1432-1033.1982.tb05783.x; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; ROBINSON BH, 1971, J BIOL CHEM, V246, P5280; Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D; SCHUSTER R, 1988, BIOSYSTEMS, V22, P19, DOI 10.1016/0303-2647(88)90047-0; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; SIES H, 1973, EUR J BIOCHEM, V38, P247, DOI 10.1111/j.1432-1033.1973.tb03056.x; Terada S, 1996, CYTOKINE, V8, P889, DOI 10.1006/cyto.1996.0119; Wilkens CA, 2011, BIOTECHNOL BIOPROC E, P16; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wlaschin KF, 2007, J BIOTECHNOL, V131, P168, DOI 10.1016/j.jbiotec.2007.06.006; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yamamoto S, 2012, APPL ENVIRON MICROB, V78, P4447, DOI 10.1128/AEM.07998-11; Zupke C, 1995, APPL MICROBIOL BIOT, V44, P27	37	22	24	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119053	10.1371/journal.pone.0119053	http://dx.doi.org/10.1371/journal.pone.0119053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768021	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500061
J	Berggren, M; Bergstrom, AK; Karlsson, J				Berggren, Martin; Bergstrom, Ann-Kristin; Karlsson, Jan			Intraspecific Autochthonous and Allochthonous Resource Use by Zooplankton in a Humic Lake during the Transitions between Winter, Summer and Fall	PLOS ONE			English	Article							AQUATIC FOOD WEBS; ORGANIC-CARBON; STABLE-ISOTOPES; CRUSTACEAN ZOOPLANKTON; BACTERIAL PRODUCTION; TERRESTRIAL SUPPORT; PHYTOPLANKTON; BOREAL; SUBSIDIES; MATTER	Seasonal patterns in assimilation of externally produced, allochthonous, organic matter into aquatic food webs are poorly understood, especially in brown-water lakes. We studied the allochthony (share biomass of terrestrial origin) in cladoceran, calanoid and cyclopoid micro-crustacean zooplankton from late winter to fall during two years in a small humic lake (Sweden). The use of allochthonous resources was important for sustaining a small population of calanoids in the water column during late winter. However, in summer the calanoids shifted to 100% herbivory, increasing their biomass several-fold by making efficient use of the pelagic primary production. In contrast, the cyclopoids and cladocerans remained at high levels of allochthony throughout the seasons, both groups showing the mean allochthony of 0.56 (range in mean 0.17-0.79 and 0.34-0.75, for the respective group, depending on model parameters). Our study shows that terrestrial organic matter can be an important resource for cyclopoids and cladocerans on an annual basis, forming a significant link between terrestrial organic matter and the higher trophic levels of the food web, but it can also be important for sustaining otherwise herbivorous calanoids during periods of low primary production in late winter.	[Berggren, Martin] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Bergstrom, Ann-Kristin; Karlsson, Jan] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Lund University; Umea University	Berggren, M (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden.	martin.berggren@nateko.lu.se	Berggren, Martin/G-1401-2012	Berggren, Martin/0000-0003-0657-0971	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2010-126]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	MB was supported by a strong research environment funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas grant #2010-126 to D.J. Conley et al.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLGREN G, 1983, ARCH HYDROBIOL, V98, P489; Algesten G, 2004, GLOBAL CHANGE BIOL, V10, P141, DOI 10.1111/j.1365-2486.2003.00721.x; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; Ask J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003951; Barnett AJ, 2007, FRESHWATER BIOL, V52, P796, DOI 10.1111/j.1365-2427.2007.01733.x; Batt RD, 2012, LIMNOL OCEANOGR, V57, P1443, DOI 10.4319/lo.2012.57.5.1443; Berggren M, 2010, ECOL LETT, V13, P870, DOI 10.1111/j.1461-0248.2010.01483.x; Berggren M, 2014, ECOLOGY, V95, P1947, DOI 10.1890/13-0615.1; Berggren M, 2009, LIMNOL OCEANOGR, V54, P1333, DOI 10.4319/lo.2009.54.4.1333; Blackburn N, 1998, APPL ENVIRON MICROB, V64, P3246; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Broglio E, 2003, AQUAT MICROB ECOL, V31, P267, DOI 10.3354/ame031267; Caraco N, 2010, ECOLOGY, V91, P2385, DOI 10.1890/09-0330.1; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; Dobberfuhl DR, 1997, AQUAT MICROB ECOL, V12, P29, DOI 10.3354/ame012029; Doucett RR, 2007, ECOLOGY, V88, P1587, DOI 10.1890/06-1184; Drakare S, 2002, FRESHWATER BIOL, V47, P41, DOI 10.1046/j.1365-2427.2002.00779.x; Fry JC, 1988, METHODS AQUATIC BACT, P27; Gentsch E, 2009, J PLANKTON RES, V31, P45, DOI 10.1093/plankt/fbn097; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; HESSEN DO, 1990, HYDROBIOLOGIA, V206, P217, DOI 10.1007/BF00014087; Iwabuchi T, 2010, ECOL RES, V25, P619, DOI 10.1007/s11284-010-0692-4; Jansson M, 2000, ECOLOGY, V81, P3250, DOI 10.1890/0012-9658(2000)081[3250:AOCAPB]2.0.CO;2; Jansson M, 1999, ARCH HYDROBIOL, V144, P409; Jones RI, 2000, FRESHWATER BIOL, V45, P219, DOI 10.1046/j.1365-2427.2000.00672.x; Karlsson J, 2004, FRESHWATER BIOL, V49, P526, DOI 10.1111/j.1365-2427.2004.01208.x; Karlsson J, 2002, ECOLOGY, V83, P2902, DOI 10.1890/0012-9658(2002)083[2902:SRBPPA]2.0.CO;2; Karlsson J, 2012, LIMNOL OCEANOGR, V57, P1042, DOI 10.4319/lo.2012.57.4.1042; Laudon H, 2013, WATER RESOUR RES, V49, P7154, DOI 10.1002/wrcr.20520; Martin-Creuzburg D, 2011, FEMS MICROBIOL ECOL, V76, P592, DOI 10.1111/j.1574-6941.2011.01076.x; Matthews B, 2006, ECOLOGY, V87, P2800, DOI 10.1890/0012-9658(2006)87[2800:HSATEO]2.0.CO;2; Meili M, 2000, VERH INT VER LIMNOL, V27, P1940; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rautio M, 2011, LIMNOL OCEANOGR, V56, P1513, DOI 10.4319/lo.2011.56.4.1513; SCHINDLER DW, 1972, J FISH RES BOARD CAN, V29, P1627, DOI 10.1139/f72-250; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Solomon CT, 2011, ECOLOGY, V92, P1115, DOI 10.1890/i0012-9658-92-5-1115; Solomon CT, 2009, OECOLOGIA, V161, P313, DOI 10.1007/s00442-009-1370-5; Taipale SJ, 2014, ECOLOGY, V95, P563, DOI 10.1890/13-0650.1; Tittel J, 2009, AQUAT SCI, V71, P46, DOI 10.1007/s00027-008-8121-2; TRANVIK LJ, 1988, MICROBIAL ECOL, V16, P311, DOI 10.1007/BF02011702; Wenzel A, 2012, CAN J FISH AQUAT SCI, V69, P1870, DOI 10.1139/f2012-110; Wenzel A, 2012, FRESHWATER BIOL, V57, P835, DOI 10.1111/j.1365-2427.2012.02751.x; Wesche A, 2007, MAR BIOL, V151, P1309, DOI 10.1007/s00227-006-0560-5; Wilkinson GM, 2013, GLOBAL BIOGEOCHEM CY, V27, P43, DOI 10.1029/2012GB004453; Zigah PK, 2012, BIOGEOSCIENCES, V9, P3663, DOI 10.5194/bg-9-3663-2012	49	35	35	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120575	10.1371/journal.pone.0120575	http://dx.doi.org/10.1371/journal.pone.0120575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764501	Green Submitted, Green Published, gold			2022-12-27	WOS:000351276300044
J	Huang, HY; Lin, JH; Lee, WC				Huang, Hsiao-Yuan; Lin, Jui-Hsiang; Lee, Wen-Chung			A Permutation Test for Oligoset DNA Pooling Studies	PLOS ONE			English	Article							ASSOCIATION; VARIANTS; HERITABILITY; DISEASE; IMPACTS; SNPS; BIAS	Case-control association studies often suffer from population stratification bias. A previous triple combination strategy of stratum matching, genomic controlling, and multiple DNA pooling can correct the bias and save genotyping cost. However the method requires researchers to prepare a multitude of DNA pools-more than 30 case-control pooling sets in total (polyset). In this paper, the authors propose a permutation test for oligoset DNA pooling studies. Monte-Carlo simulations show that the proposed test has a type I error rate under control and a power comparable to that of individual genotyping. For a researcher on a tight budget, oligoset DNA pooling is a viable option.	[Lee, Wen-Chung] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Coll Publ Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		LIN, JUI-HSIANG/0000-0002-1303-2736; Lee, Wen-Chung/0000-0003-3171-7672	Ministry of Science and Technology, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This work is partly supported by grants from the Ministry of Science and Technology, Taiwan (NSC 102-2628-B-002-036-MY3) and the National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Chiang CWK, 2011, HUM GENET, V130, P607, DOI 10.1007/s00439-011-0974-0; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Golan D, 2012, BIOINFORMATICS, V28, pI197, DOI 10.1093/bioinformatics/bts208; Gui HS, 2014, ANN HUM GENET, V78, P381, DOI 10.1111/ahg.12076; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang HY, 2011, J CLIN EPIDEMIOL, V64, P517, DOI 10.1016/j.jclinepi.2010.07.004; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Konig IR, 2004, GENET EPIDEMIOL, V26, P31, DOI 10.1002/gepi.10290; Lee JS, 2011, GENET EPIDEMIOL, V35, P139, DOI 10.1002/gepi.20561; Lee WC, 2005, CANCER EPIDEM BIOMAR, V14, P958, DOI 10.1158/1055-9965.EPI-04-0503; Lee WC, 2004, GENET EPIDEMIOL, V27, P1, DOI 10.1002/gepi.20011; Lee WC, 2008, AM J EPIDEMIOL, V167, P86, DOI 10.1093/aje/kwm257; Lee WC, 2009, J CLIN EPIDEMIOL, V62, P62, DOI 10.1016/j.jclinepi.2008.02.016; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Vinkhuyzen AAE, 2013, ANNU REV GENET, V47, P75, DOI 10.1146/annurev-genet-111212-133258; Witte JS, 1999, AM J EPIDEMIOL, V149, P693; Yamada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020468; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zou GH, 2004, GENET EPIDEMIOL, V26, P1, DOI 10.1002/gepi.10277; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	23	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119096	10.1371/journal.pone.0119096	http://dx.doi.org/10.1371/journal.pone.0119096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763822	Green Submitted, gold, Green Published			2022-12-27	WOS:000351276300019
J	Canessa, S; Heard, GW; Robertson, P; Sluiter, IRK				Canessa, Stefano; Heard, Geoffrey W.; Robertson, Peter; Sluiter, Ian R. K.			Dealing with Trade-Offs in Destructive Sampling Designs for Occupancy Surveys	PLOS ONE			English	Article							DETECTION PROBABILITIES; IMPERFECT DETECTION; SPECIES OCCURRENCE; SITE OCCUPANCY; CONSERVATION; NONDETECTION; PRECISION; ABSENCE; MODELS; RATES	Occupancy surveys should be designed to minimise false absences. This is commonly achieved by increasing replication or increasing the efficiency of surveys. In the case of destructive sampling designs, in which searches of individual microhabitats represent the repeat surveys, minimising false absences leads to an inherent trade-off. Surveyors can sample more low quality microhabitats, bearing the resultant financial costs and producing wider-spread impacts, or they can target high quality microhabitats were the focal species is more likely to be found and risk more severe impacts on local habitat quality. We show how this trade-off can be solved with a decision-theoretic approach, using the Millewa Skink Hemiergis millewae from southern Australia as a case study. Hemiergis millewae is an endangered reptile that is best detected using destructive sampling of grass hummocks. Within sites that were known to be occupied by H. millewae, logistic regression modelling revealed that lizards were more frequently detected in large hummocks. If this model is an accurate representation of the detection process, searching large hummocks is more efficient and requires less replication, but this strategy also entails destruction of the best microhabitats for the species. We developed an optimisation tool to calculate the minimum combination of the number and size of hummocks to search to achieve a given cumulative probability of detecting the species at a site, incorporating weights to reflect the sensitivity of the results to a surveyor's priorities. The optimisation showed that placing high weight on minimising volume necessitates impractical replication, whereas placing high weight on minimising replication requires searching very large hummocks which are less common and may be vital for H. millewae. While destructive sampling methods are sometimes necessary, surveyors must be conscious of the ecological impacts of these methods. This study provides a simple tool for identifying sampling strategies that minimise those impacts.	[Canessa, Stefano; Heard, Geoffrey W.] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Robertson, Peter; Sluiter, Ian R. K.] Federat Univ, Sch Sci Informat Technol & Engn, Ballarat, Vic, Australia	University of Melbourne; Federation University Australia	Canessa, S (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	science@canessas.com	Canessa, Stefano/J-2069-2014	Canessa, Stefano/0000-0002-0932-826X	Mallee Catchment Management Authority; Federation University, Australia; Australian Research Council Centre of Excellence for Environmental Decisions	Mallee Catchment Management Authority; Federation University, Australia; Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	This study was supported by Mallee Catchment Management Authority (PR, IRKS) (http://www.malleecma.vic.gov.au); Federation University, Australia (SC, GH, PR, IRKS) (http://federation.edu.au/); Australian Research Council Centre of Excellence for Environmental Decisions (SC, GH) (http://ceed.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Basset Y., 1996, CANOPY ARTHROPODS, P27; Brown S, 2009, BIOL CONSERV, V142, P432, DOI 10.1016/j.biocon.2008.11.005; Cogger H, 2000, REPTILES AMPHIBIANS; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Goode MJ, 2005, BIOL CONSERV, V125, P47, DOI 10.1016/j.biocon.2005.03.010; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Heyer W.R., 1994, MEASURING MONITORING; Kelly LT, 2011, DIVERS DISTRIB, V17, P462, DOI 10.1111/j.1472-4642.2011.00754.x; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kubecka J, 2012, FISH RES, V123, P1, DOI 10.1016/j.fishres.2011.11.013; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MCARDLE BH, 1990, OIKOS, V57, P276, DOI 10.2307/3565950; McCarthy MA, 2007, CONSERV BIOL, V21, P956, DOI 10.1111/j.1523-1739.2007.00677.x; McDonald PJ, 2012, AUST J ZOOL, V60, P166, DOI 10.1071/ZO12068; Nimmo DG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1062, DOI 10.1111/j.1466-8238.2011.00747.x; Nimmo DG, 2008, VICTORIAN NAT, V125, P110; Otto CRV, 2013, ECOGRAPHY, V36, P1299, DOI 10.1111/j.1600-0587.2013.00137.x; Parris KM, 1999, HERPETOLOGICA, V55, P271; Plummer, 2005, P 3 INT WORKSH DISTR; Robertson P, 2011, SURVEY THREATE UNPUB; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Wintle BA, 2004, ECOL APPL, V14, P703, DOI 10.1890/02-5166; Wintle BA, 2012, DIVERS DISTRIB, V18, P417, DOI 10.1111/j.1472-4642.2011.00874.x	33	0	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120340	10.1371/journal.pone.0120340	http://dx.doi.org/10.1371/journal.pone.0120340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760868	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275000068
J	Han, XY; Stocking, G; Gebbie, MA; Appelbaum, RP				Han, Xueying; Stocking, Galen; Gebbie, Matthew A.; Appelbaum, Richard P.			Will They Stay or Will They Go? International Graduate Students and Their Decisions to Stay or Leave the US upon Graduation	PLOS ONE			English	Article							BRAIN-DRAIN; REGRESSION TREES; CLASSIFICATION; MIGRATION; GLOBALIZATION; COMMUNITIES; EMIGRATION; ENROLLMENT; OVERSEAS; RETURN	The U.S. currently enjoys a position among the world's foremost innovative and scientifically advanced economies but the emergence of new economic powerhouses like China and India threatens to disrupt the global distribution of innovation and economic competitiveness. Among U.S. policy makers, the promotion of advanced education, particularly in the STEM (Science, Technology, Engineering and Mathematics) fields, has become a key strategy for ensuring the U.S.'s position as an innovative economic leader. Since approximately one third of science and engineering post-graduate students in the U.S. are foreign born, the future of the U.S. STEM educational system is intimately tied to issues of global competitiveness and American immigration policy. This study utilizes a combination of national education data, a survey of foreign-born STEM graduate students, and in-depth interviews of a sub-set of those students to explain how a combination of scientists' and engineers' educational decisions, as well as their experience in school, can predict a students' career path and geographical location, which can affect the long-term innovation environment in their home and destination country. This study highlights the fact that the increasing global competitiveness in STEM education and the complex, restrictive nature of U.S. immigration policies are contributing to an environment where the American STEM system may no longer be able to comfortably remain the premier destination for the world's top international students.	[Han, Xueying; Stocking, Galen; Gebbie, Matthew A.; Appelbaum, Richard P.] Univ Calif Santa Barbara, Ctr Nanotechnol Soc, Santa Barbara, CA 93106 USA; [Stocking, Galen] Univ Calif Santa Barbara, Dept Polit Sci, Santa Barbara, CA 93106 USA; [Gebbie, Matthew A.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Appelbaum, Richard P.] Univ Calif Santa Barbara, Global & Int Studies, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Han, XY (corresponding author), Univ Calif Santa Barbara, Ctr Nanotechnol Soc, Santa Barbara, CA 93106 USA.	xueyinghan85@gmail.com		Han, Xueying/0000-0003-4643-2880	National Science Foundation [SES 0938099]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. SES 0938099 awarded to the Center for Nanotechnology in Society at the University of California, Santa Barbara (CNS-UCSB). NSF and CNS-UCSB had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, J URBAN ECON, V69, P43, DOI 10.1016/j.jue.2010.06.003; Alberts HC, 2005, INT MIGR, V43, P131, DOI 10.1111/j.1468-2435.2005.00328.x; Alberts HC, 2007, GEOJOURNAL, V68, P141, DOI 10.1007/s10708-007-9079-7; Altbach PG, 2010, CHANGE MAGAZINE HIGH, V36, P18; Balzer H, 2011, LEARNING INNOVATE ED, V1, P24; Bhagwati J, 1972, J DEV ECON, V1, P19; BRATSBERG B, 1995, ECON EDUC REV, V14, P373, DOI 10.1016/0272-7757(95)00017-E; Carnevale AP, 2010, HELP WANTED PROJECTI, V1, P170; Chang L., 2014, WORLD ED NEWS REV, V27; Chia Siow Yue, 2006, ASIAN ECON POLICY R, V1, P349, DOI DOI 10.1111/J.17483131.2006.00042.X; Ciencia Sem Fronteiras, 2014, THE PROGR; Commander S, 2004, NBER CONF R, P235; Constant A, 2003, J POPUL ECON, V16, P631, DOI 10.1007/s00148-003-0168-8; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Docquier F, 2012, J ECON LIT, V50, P681, DOI 10.1257/jel.50.3.681; Dustmann C, 2002, J DEV ECON, V67, P351, DOI 10.1016/S0304-3878(01)00193-6; Fontes M, 2013, MOBILITIES-UK, V8, P440, DOI 10.1080/17450101.2012.655976; Freedman RB, 2010, AM U GLOBAL MARKET, P1; Gibson J, 2012, ECON J, V122, P339, DOI 10.1111/j.1468-0297.2012.02498.x; Goodman M, 2013, 2014008 NCES US DOE, V1, P60, DOI 10.1352/1944-7558-117.4.316; Hvistendahl M., 2008, CHRONICLE HIGHER ED; Institute of International Education, 2014, OP DOORS INT ED EXCH; Kerr WR, 2008, REV ECON STAT, V90, P518, DOI 10.1162/rest.90.3.518; Lee JJ, 2008, J STUD INT EDUC, V12, P308, DOI 10.1177/1028315307299418; Li M, 2007, HIGH EDUC, V53, P791, DOI 10.1007/s10734-005-5423-3; Loh WY, 2011, WIRES DATA MIN KNOWL, V1, P14, DOI 10.1002/widm.8; Luo YL, 2002, HIGH SKILLED MIGRATI, P253; Mahroum S, 2000, R&D MANAGE, V30, P23, DOI 10.1111/1467-9310.00154; Mazzarol T., 2002, INT J EDUC MANAG, V16, P82, DOI [10.1108/09513540210418403, DOI 10.1108/09513540210418403]; McCormick B, 2001, SCOT J POLIT ECON, V48, P164, DOI 10.1111/1467-9485.00192; Mountford A, 1997, J DEV ECON, V53, P287, DOI 10.1016/S0304-3878(97)00021-7; National Math and Science Initiative, THE STEM CRIS; National Science Board, 2014, NAT SCI FDN, V1, P600; Obama B., 2012, COMMUNICATION; Organization for Economic Cooperation and Development, 2013, TIM US RESK WHAT SUR, V1, P108; Organization for Economic Cooperation and Development, 2013, ED IND FOC INT STUD, V1, P4; President's Council of Advisors on Science and Technology, 2012, ENG EXC PROD ON MILL, V1, P106; Project Atlas, 2013, TRENDS GLOB DAT 2013, P1; Provasnik S, 2012, MATH SCI ACHIEVEMENT, V1, P140; R Core Team, 2012, R LANG ENV STAT COMP; Regets M., 2001, RES POLICY ISSUES HI, V1, P35; Regets M. C., 1999, FOREIGN SCI TECHNOLO; Salisbury MH, 2009, RES HIGH EDUC, V50, P119, DOI 10.1007/s11162-008-9111-x; Saxenian A, 2005, STUD COMP INT DEV, V40, P35, DOI 10.1007/BF02686293; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Stuen ET, 2012, ECON J, V122, P1143, DOI 10.1111/j.1468-0297.2012.02543.x; Sun W, 2013, IZA J MIGR, V2, DOI 10.1186/2193-9039-2-5; Teferra D., 2005, J STUD INT EDUC, V9, P229, DOI [10.1177/1028315305277619, DOI 10.1177/1028315305277619]; Therneau T, 2014, COMPREHENSIVE R ARCH, V1, P34; Tung Rosalie L., 2008, European Management Journal, V26, P298, DOI 10.1016/j.emj.2008.03.005; U. S. Citizenship and Immigration Services, 2015, H 1B FISC YEAR FY 20; U.S. Department of Commerce, 2012, COMP INN CAP US, V1, P160; Vidal JP, 1998, J POPUL ECON, V11, P589, DOI 10.1007/s001480050086; Wadhwa V, 2012, IMMIGRANT EXODUS WHY; Zweig D, 2004, CHINA QUART, P735, DOI 10.1017/S0305741004000566	55	28	29	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118183	10.1371/journal.pone.0118183	http://dx.doi.org/10.1371/journal.pone.0118183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760327	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275000019
J	Turtle, L; McGill, F; Bettridge, J; Matata, C; Christley, R; Solomon, T				Turtle, Lance; McGill, Fiona; Bettridge, Judy; Matata, Claire; Christley, Rob; Solomon, Tom			A Survey of UK Healthcare Workers' Attitudes on Volunteering to Help with the Ebola Outbreak in West Africa	PLOS ONE			English	Article								Objective To understand the barriers and enablers for UK healthcare workers who are considering going to work in the current Ebola outbreak in West Africa, but have not yet volunteered. Design After focus group discussions, and a pilot questionnaire, an anonymous survey was conducted using SurveyMonkey to determine whether people had considered going to West Africa, what factors might make them more or less likely to volunteer, and whether any of these were modifiable factors. Participants The survey was publicised among doctors, nurses, laboratory staff and allied health professionals. 3109 people answered the survey, of whom 472 (15%) were considering going to work in the epidemic but had not yet volunteered. 1791 (57.6%) had not considered going, 704 (22.6%) had considered going but decided not to, 53 (1.7%) had volunteered to go and 14 (0.45%) had already been and worked in the epidemic. Results For those considering going to West Africa, the most important factor preventing them from volunteering was a lack of information to help them decide; fear of getting Ebola and partners' concerns came next. Uncertainty about their potential role, current work commitments and inability to get agreement from their employer were also important barriers, whereas clarity over training would be an important enabler. In contrast, for those who were not considering going, or who had decided against going, family considerations and partner concerns were the most important factors. Conclusions More UK healthcare workers would volunteer to help tackle Ebola in West Africa if there was better information available, including clarity about roles, cover arrangements, and training. This could be achieved with a well-publicised high quality portal of reliable information.	[Turtle, Lance; McGill, Fiona; Bettridge, Judy; Matata, Claire; Christley, Rob; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England; [Turtle, Lance; Christley, Rob; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit, Liverpool L69 7BE, Merseyside, England; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool L9 7LJ, Merseyside, England	University of Liverpool; University of Liverpool; Walton Centre	Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Ronald Ross Bldg, Liverpool L69 7BE, Merseyside, England.	tsolomon@liv.ac.uk		Turtle, Lance/0000-0002-0778-1693; Christley, Robert/0000-0001-9250-3032; Bettridge, Judy/0000-0002-3917-4660; Solomon, Tom/0000-0001-7266-6547	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the University of Liverpool Institute of Infection and Global health; Public Health England (PHE); NIHR; University of Liverpool; Wellcome Trust [087757/Z/08/Z]; National Institute for Health Research [IS-HPU-1112-10117, NF-SI-0514-10177, CL-2013-07-005] Funding Source: researchfish	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the University of Liverpool Institute of Infection and Global health; Public Health England (PHE); NIHR(National Institute for Health Research (NIHR)); University of Liverpool; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the University of Liverpool Institute of Infection and Global health in partnership with Public Health England (PHE). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. LT, FM and CM are funded by the NIHR as a clinical lecturer, doctoral research fellow and research nurse, respectively. This work was conducted independently of influence from the NIHR. This study was sponsored by the University of Liverpool. Dr Lance Turtle was funded by Wellcome Trust postdoctoral clinical fellowship 087757/Z/08/Z. The sponsor took no part in the design, conduct, analysis or writing of this research.	[Anonymous], 2003, Wkly Epidemiol Rec, V78, P223; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P370; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P345; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; British Red Cross, MED STAFF NEED EB RE; Centres for Disease Control and Prevention, SEC CAS EB DIAGN US; Chevalier MS, 2014, MMWR-MORBID MORTAL W, V63, P1087; European Centres for Disease Control and Prevention, NEWS EP UPD 1 EB CAS; GMC General medical council, LIST REG MED PRACT S; Gulland A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6305; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Lewis D, FEAR INDIFFERENCE LE; MacNeil A, 2011, J INFECT DIS, V204, pS761, DOI 10.1093/infdis/jir294; Medecins Sans Frontieres, WORK OV; Medecins Sans Frontieres, W AFR BIOD RESP URG; O'Carroll L., WORLD NEWS; Oksanen J., 2016, R PACKAG; Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x; Read JM, 2015, LANCET, V385, P23, DOI 10.1016/S0140-6736(14)61894-8; Solomon T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6443	21	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120013	10.1371/journal.pone.0120013	http://dx.doi.org/10.1371/journal.pone.0120013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760763	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000351275000067
J	Kaiyala, KJ; Ogimoto, K; Nelson, JT; Schwartz, MW; Morton, GJ				Kaiyala, Karl J.; Ogimoto, Kayoko; Nelson, Jarrell T.; Schwartz, Michael W.; Morton, Gregory J.			Leptin Signaling Is Required for Adaptive Changes in Food Intake, but Not Energy Expenditure, in Response to Different Thermal Conditions	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; OB-OB MICE; BODY-WEIGHT; UNCOUPLING PROTEIN; COLD-ACCLIMATION; CIRCADIAN-RHYTHM; OBESE; THERMOGENESIS; IDENTIFICATION; TEMPERATURE	Survival of free-living animals depends on the ability to maintain core body temperature in the face of rapid and dramatic changes in their thermal environment. If food intake is not adjusted to meet the changing energy demands associated with changes of ambient temperature, a serious challenge to body energy stores can occur. To more fully understand the coupling of thermoregulation to energy homeostasis in normal animals and to investigate the role of the adipose hormone leptin to this process, comprehensive measures of energy homeostasis and core temperature were obtained in leptin-deficient ob/ob mice and their wild-type (WT) littermate controls when housed under cool (14 degrees C), usual (22 degrees C) or similar to thermoneutral (30 degrees C) conditions. Our findings extend previous evidence that WT mice robustly defend normothermia in response to either a lowering (14 degrees C) or an increase (30 degrees C) of ambient temperature without changes in body weight or body composition. In contrast, leptin-deficient, ob/ob mice fail to defend normothermia at ambient temperatures lower than thermoneutrality and exhibit marked losses of both body fat and lean mass when exposed to cooler environments (14 degrees C). Our findings further demonstrate a strong inverse relationship between ambient temperature and energy expenditure in WT mice, a relationship that is preserved in ob/ob mice. However, thermal conductance analysis indicates defective heat retention in ob/ob mice, irrespective of temperature. While a negative relationship between ambient temperature and energy intake also exists in WT mice, this relationship is disrupted in ob/ob mice. Thus, to meet the thermoregulatory demands of different ambient temperatures, leptin signaling is required for adaptive changes in both energy intake and thermal conductance. A better understanding of the mechanisms coupling thermoregulation to energy homeostasis may lead to the development of new approaches for the treatment of obesity.	[Kaiyala, Karl J.] Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Ogimoto, Kayoko; Nelson, Jarrell T.; Schwartz, Michael W.; Morton, Gregory J.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Morton, GJ (corresponding author), Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98105 USA.	gjmorton@u.washington.edu			National Institutes of Health Grants [DK089056, DK083042, DK090320]; NIDDK-funded Nutrition Obesity Research Center (NORC) [DK035816]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101997, R01DK090320, R01DK089056, R01DK083042, P30DK035816, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK-funded Nutrition Obesity Research Center (NORC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK089056 (G.J.M), DK083042 and DK090320 (M.W.S) and by the NIDDK-funded Nutrition Obesity Research Center (NORC, DK035816).	ARMITAGE G, 1984, J PHYSIOL-LONDON, V350, P197, DOI 10.1113/jphysiol.1984.sp015196; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; CHLOUVERAKIS C, 1970, EXPERIENTIA, V26, P1262, DOI 10.1007/BF01898005; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DAUNCEY MJ, 1986, EXPERIENTIA, V42, P547, DOI 10.1007/BF01946696; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Golozoubova V, 2006, AM J PHYSIOL-ENDOC M, V291, pE350, DOI 10.1152/ajpendo.00387.2005; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; HIMMSHAGEN J, 1985, INT J OBESITY, V9, P17; HIMMSHAGEN J, 1985, AM J PHYSIOL, V248, pE531, DOI 10.1152/ajpendo.1985.248.5.E531; HOGAN S, 1980, AM J PHYSIOL, V239, pE301; JANSKY L, 1967, PHYSIOL BOHEMOSLOV, V16, P366; Kaiyala KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103301; Kaiyala KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041473; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lichtenbelt WV, 2014, TRENDS ENDOCRIN MET, V25, P165, DOI 10.1016/j.tem.2014.01.001; MCNAB BK, 1980, PHYSIOL ZOOL, V53, P145, DOI 10.1086/physzool.53.2.30152577; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; MORRISON SD, 1968, J PHYSIOL-LONDON, V197, P305, DOI 10.1113/jphysiol.1968.sp008561; Morton GJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE134, DOI 10.1152/ajpendo.00296.2011; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Ravussin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085876; Ravussin Y, 2012, AM J PHYSIOL-REG I, V303, pR438, DOI 10.1152/ajpregu.00092.2012; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Refinetti R, 2010, FRONT BIOSCI-LANDMRK, V15, P564, DOI 10.2741/3634; Rezai-Zadeh K, 2013, PHYSIOL BEHAV, V121, P49, DOI 10.1016/j.physbeh.2013.02.014; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; ROMSOS DR, 1985, METABOLISM, V34, P931, DOI 10.1016/0026-0495(85)90141-6; Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schleucher E, 2001, COMP BIOCHEM PHYS A, V129, P821, DOI 10.1016/S1095-6433(01)00356-7; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SMITH CK, 1984, METABOLISM, V33, P853, DOI 10.1016/0026-0495(84)90114-8; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thorogood A, 2011, AM J MED, V124, P747, DOI 10.1016/j.amjmed.2011.02.037; THURLBY PL, 1979, BRIT J NUTR, V42, P377, DOI 10.1079/BJN19790127; TRAYHURN P, 1976, P NUTR SOC, V35, pA133; TRAYHURN P, 1978, PFLUG ARCH EUR J PHY, V373, P189, DOI 10.1007/BF00584859; TRAYHURN P, 1977, NATURE, V266, P60, DOI 10.1038/266060a0; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; VINTER J, 1988, INT J OBESITY, V12, P111; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	56	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119391	10.1371/journal.pone.0119391	http://dx.doi.org/10.1371/journal.pone.0119391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756181	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275700043
J	Ratti, PL; Sierra-Pena, M; Manni, R; Simonetta-Moreau, M; Bastin, J; Mace, H; Rascol, O; David, O				Ratti, Pietro-Luca; Sierra-Pena, Maria; Manni, Raffaele; Simonetta-Moreau, Marion; Bastin, Julien; Mace, Harrison; Rascol, Olivier; David, Olivier			Distinctive Features of NREM Parasomnia Behaviors in Parkinson's Disease and Multiple System Atrophy	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; REM-SLEEP; LEWY BODIES; EYE-MOVEMENT; SPATIAL ATTENTION; OVERLAP DISORDER; ACUTE DELIRIUM; DEMENTIA; SLEEPWALKING; TERRORS	Objective To characterize parasomnia behaviors on arousal from NREM sleep in Parkinson's Disease (PD) and Multiple System Atrophy (MSA). Methods From 30 patients with PD, Dementia with Lewy Bodies/Dementia associated with PD, or MSA undergoing nocturnal video-polysomnography for presumed dream enactment behavior, we were able to select 2 PD and 2 MSA patients featuring NREM Parasomnia Behviors (NPBs). We identified episodes during which the subjects seemed to enact dreams or presumed dream-like mentation (NPB arousals) versus episodes with physiological movements (no-NPB arousals). A time-frequency analysis (Morlet Wavelet Transform) of the scalp EEG signals around each NPB and no-NPB arousal onset was performed, and the amplitudes of the spectral frequencies were compared between NPB and no-NPB arousals. Results 19 NPBs were identified, 12 of which consisting of 'elementary' NPBs while 7 resembling confusional arousals. With quantitative EEG analysis, we found an amplitude reduction in the 5-6 Hz band 40 seconds before NPBs arousal as compared to no-NPB arousals at F4 and C4 derivations (p< 0.01). Conclusions Many PD and MSA patients feature various NREM sleep-related behaviors, with clinical and electrophysiological differences and similarities with arousal parasomnias in the general population.	[Ratti, Pietro-Luca; Rascol, Olivier] Toulouse Univ Hosp, Dept Clin Pharmacol, Toulouse, France; [Ratti, Pietro-Luca; Sierra-Pena, Maria; Simonetta-Moreau, Marion] Paul Sabatier Univ, Toulouse, France; [Ratti, Pietro-Luca; Simonetta-Moreau, Marion; Rascol, Olivier] INSERM, UMR Brain Imaging & Neurol Dysfunct 825, Toulouse, France; [Ratti, Pietro-Luca] Civic Hosp EOC Lugano, Sleep & Epilepsy Ctr, Neuroctr Southern Switzerland, Lugano, Switzerland; [Sierra-Pena, Maria; Simonetta-Moreau, Marion] Toulouse Univ Hosp, Dept Neurol, Toulouse, France; [Manni, Raffaele] C Mondino Natl Neurol Inst, Sleep Med & Epilepsy Unit, Pavia, Italy; [Bastin, Julien; Mace, Harrison; Rascol, Olivier] Grenoble Inst Neurosci, Brain Funct & Neuromodulat, Grenoble, France; [Bastin, Julien; David, Olivier] Joseph Fourier Univ, Grenoble, France; [Rascol, Olivier] Toulouse Univ Hosp, Reference Ctr Multiple Syst Atrophy, Toulouse, France	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; IRCCS Fondazione Casimiro Mondino; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU de Toulouse	Ratti, PL (corresponding author), Toulouse Univ Hosp, Dept Clin Pharmacol, Toulouse, France.	pietroluca.ratti@eoc.ch	David, Olivier/S-9463-2019; bastin, julien JDP/H-8785-2017; David, Olivier/A-6068-2009; manni, raffaele/AAB-8804-2019	David, Olivier/0000-0003-0776-0216; bastin, julien JDP/0000-0002-0533-7564; David, Olivier/0000-0003-0776-0216; Ratti, Pietro Luca/0000-0002-9941-6721				[Anonymous], 2014, AASM INT CLASS SLEEP, DOI [10.5665/sleep.3420, DOI 10.5665/SLEEP.3420]; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Bliwise DL, 2000, SLEEP, V23, P671; BOKEY K, 1993, AUST NZ J PSYCHIAT, V27, P694, DOI 10.3109/00048679309075833; Cicolin A, 2011, SLEEP MED, V12, P523, DOI 10.1016/j.sleep.2011.02.002; Di Fabio N, 2013, EUR NEUROL, V70, P297, DOI 10.1159/000353378; Dumitrascu O, 2013, SLEEP MED, V14, P1217, DOI 10.1016/j.sleep.2013.06.012; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Espa F, 2002, SLEEP, V25, P871; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Ferrara M, 2006, BEHAV BRAIN RES, V167, P237, DOI 10.1016/j.bbr.2005.09.012; Flink BJ, 2012, ANESTHESIOLOGY, V116, P788, DOI 10.1097/ALN.0b013e31824b94fc; Frauscher B, 2008, SLEEP, V31, P724, DOI 10.1093/sleep/31.5.724; Frauscher B, 2013, SLEEP MED, V14, P729, DOI 10.1016/j.sleep.2012.09.028; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Iber C., 2007, AASM MANUAL SCORING; Iranzo A, 2005, SLEEP, V28, P203, DOI 10.1093/sleep/28.2.203; Iranzo A, 2011, SLEEP MED, V12, P284, DOI 10.1016/j.sleep.2010.04.021; ISHIGOOKA J, 1985, BIOL PSYCHIAT, V20, P1003, DOI 10.1016/0006-3223(85)90198-2; Jaar O, 2010, SLEEP, V33, P1511, DOI 10.1093/sleep/33.11.1511; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; KUSHIDA CA, 1995, SLEEP, V18, P757; Lee JWY, 1998, GEN HOSP PSYCHIAT, V20, P120, DOI 10.1016/S0163-8343(98)00006-1; Limousin N, 2009, SLEEP MED, V10, P1059, DOI 10.1016/j.sleep.2008.12.006; Lombardi C, 2004, J NEUROL NEUROSUR PS, V75, P341; Manni R, 2013, SLEEP MED, V14, P387, DOI 10.1016/j.sleep.2013.02.007; Manni R, 2010, MOVEMENT DISORD, V25, P985, DOI 10.1002/mds.22990; Manni Raffaele, 2005, Curr Psychiatry Rep, V7, P196, DOI 10.1007/s11920-005-0053-0; Marzano C, 2011, NEUROSCIENCE, V176, P308, DOI 10.1016/j.neuroscience.2010.12.014; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Munoz X, 1998, AM J RESP CRIT CARE, V158, P1306, DOI 10.1164/ajrccm.158.4.9801005; Nielsen TA, 2000, BEHAV BRAIN SCI, V23, P851, DOI 10.1017/S0140525X0000399X; Oberholzer M, 2011, J NEUROL, V258, P1261, DOI 10.1007/s00415-011-5922-3; Pao WC, 2013, NEUROLOGIST, V19, P1, DOI 10.1097/NRL.0b013e31827c6bdd; Poryazova R, 2007, ARCH NEUROL-CHICAGO, V64, P1524, DOI 10.1001/archneur.64.10.1524; Ratti PL, 2012, SLEEP MED, V13, P926, DOI 10.1016/j.sleep.2012.04.015; Schenck CH, 1997, SLEEP, V20, P972, DOI 10.1093/sleep/20.11.972; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Tassinari CA, 2009, REV NEUROL-FRANCE, V165, P762, DOI 10.1016/j.neurol.2009.08.002; Terzaghi M, 2013, MOVEMENT DISORD, V28, P1416, DOI 10.1002/mds.25523; Terzaghi M, 2010, MOVEMENT DISORD, V25, P647, DOI 10.1002/mds.22726; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Uguccioni G, 2013, SLEEP MED, V14, P391, DOI 10.1016/j.sleep.2013.01.014; Vetrugno R, 2009, SLEEP MED, V10, P247, DOI 10.1016/j.sleep.2008.01.009; Wenning GK, 2004, MOVEMENT DISORD, V19, P1391, DOI 10.1002/mds.20255; Whitney JF, 1996, AM J EMERG MED, V14, P270, DOI 10.1016/S0735-6757(96)90174-6; Zadra A, 2004, J SLEEP RES, V13, P279, DOI 10.1111/j.1365-2869.2004.00404.x	50	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120973	10.1371/journal.pone.0120973	http://dx.doi.org/10.1371/journal.pone.0120973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756280	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275700075
J	Anchan, R; Gerami-Naini, B; Lindsey, JS; Ho, JWK; Kiezun, A; Lipskind, S; Ng, N; LiCausi, JA; Kim, CS; Brezina, P; Tuschl, T; Maas, R; Kearns, WG; Williams, Z				Anchan, Raymond; Gerami-Naini, Behzad; Lindsey, Jennifer S.; Ho, Joshua W. K.; Kiezun, Adam; Lipskind, Shane; Ng, Nicholas; LiCausi, Joseph A.; Kim, Chloe S.; Brezina, Paul; Tuschl, Thomas; Maas, Richard; Kearns, William G.; Williams, Zev			Efficient Differentiation of Steroidogenic and Germ-Like Cells from Epigenetically-Related iPSCs Derived from Ovarian Granulosa Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; COPY NUMBER; TRANSDIFFERENTIATION; GENERATION; MEMORY; CHEMOTHERAPY; FIBROBLASTS; NUCLEAR; CUMULUS	To explore restoration of ovarian function using epigenetically-related, induced pluripotent stem cells (iPSCs), we functionally evaluated the epigenetic memory of novel iPSC lines, derived from mouse and human ovarian granulosa cells (GCs) using c-Myc, Klf4, Sox2 and Oct4 retroviral vectors. The stem cell identity of the mouse and human GC-derived iPSCs (mGriPSCs, hGriPSCs) was verified by demonstrating embryonic stem cell (ESC) antigen expression using immunocytochemistry and RT-PCR analysis, as well as formation of embryoid bodies (EBs) and teratomas that are capable of differentiating into cells from all three germ layers. GriPSCs' gene expression profiles associate more closely with those of ESCs than of the originating GCs as demonstrated by genome-wide analysis of mRNA and microRNA. A comparative analysis of EBs generated from three different mouse cell lines (mGriPSCs; fibroblast-derived iPSC, mFiPSCs; G4 embryonic stem cells, G4 mESCs) revealed that differentiated mGriPSC-EBs synthesize 10-fold more estradiol (E2) than either differentiated FiPSC- or mESC-EBs under identical culture conditions. By contrast, mESC-EBs primarily synthesize progesterone (P4) and FiPSC-EBs produce neither E2 nor P4. Differentiated mGriPSC-EBs also express ovarian markers (AMHR, FSHR, Cyp19a1, ER and Inha) as well as markers of early gametogenesis (Mvh, Dazl, Gdf9, Boule and Zp1) more frequently than EBs of the other cell lines. These results provide evidence of preferential homotypic differentiation of mGriPSCs into ovarian cell types. Collectively, our data support the hypothesis that generating iPSCs from the desired tissue type may prove advantageous due to the iPSCs' epigenetic memory.	[Anchan, Raymond; Lindsey, Jennifer S.; Lipskind, Shane; Ng, Nicholas; LiCausi, Joseph A.] Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Reprod Endocrinol & Infertil,Med Sch, Boston, MA 02115 USA; [Gerami-Naini, Behzad; Kim, Chloe S.; Maas, Richard] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Genet,Med Sch, Boston, MA 02115 USA; [Ho, Joshua W. K.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Ho, Joshua W. K.] Univ New S Wales, Sydney, NSW, Australia; [Kiezun, Adam] Broad Inst MIT & Harvard, Computat Methods Dev, Canc Genome Anal, Cambridge, MA USA; [Brezina, Paul; Kearns, William G.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Brezina, Paul; Kearns, William G.] LabCorp, Ctr Preimplantat Genet, Rockville, MD USA; [Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; [Williams, Zev] Albert Einstein Coll Med, Div Reprod Endocrinol & Infertil, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Anchan, R (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Reprod Endocrinol & Infertil,Med Sch, Boston, MA 02115 USA.	ranchan@partners.org	Kearns, William/AAE-7699-2020; Ho, Joshua W. K./AAK-7759-2020	Ho, Joshua W. K./0000-0003-2331-7011	Presidential New Investigator Award/Klarman Family Foundation; Brigham and Women's Hospital (BWH); Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology BWH; NIH [K12HD001255]	Presidential New Investigator Award/Klarman Family Foundation; Brigham and Women's Hospital (BWH); Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology BWH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided to RA by the Presidential New Investigator Award/Klarman Family Foundation, Brigham and Women's Hospital (BWH), support from the Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology BWH, and NIH K12HD001255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Anchan RM, 2010, CRIT REV ONCOL HEMAT, V74, P175, DOI 10.1016/j.critrevonc.2009.09.006; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; BOLAND NI, 1993, BIOL REPROD, V48, P798, DOI 10.1095/biolreprod48.4.798; Brown Miguel, 2013, Frontiers in Genetics, V4, P145, DOI 10.3389/fgene.2013.00145; Carabatsos MJ, 2000, DEV BIOL, V226, P167, DOI 10.1006/dbio.2000.9863; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cooke JP, 2013, CIRC RES, V112, P748, DOI 10.1161/CIRCRESAHA.113.301053; De la Fuente R, 2001, DEV BIOL, V229, P224, DOI 10.1006/dbio.2000.9947; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dzafic E, 2013, J ASSIST REPROD GEN, V30, P1255, DOI 10.1007/s10815-013-0068-0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Halley-Stott RP, 2013, BRIEF FUNCT GENOMICS, V12, P164, DOI 10.1093/bfgp/elt011; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Krishnakumar R, 2013, CURR OPIN GENET DEV, V23, P548, DOI 10.1016/j.gde.2013.06.005; Lan CW, 2013, J CLIN ENDOCR METAB, V98, P3713, DOI 10.1210/jc.2012-4302; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lipskind S, 2013, SOC GYN INV 2013 M O; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maatouk DM, 2013, DEV BIOL, V383, P295, DOI 10.1016/j.ydbio.2013.08.026; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Minton Susan E, 2002, Cancer Control, V9, P466; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Oki Y, 2012, BIOCHEM J, V447, P239, DOI 10.1042/BJ20120172; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Society for Assisted Reproductive Technology CORS, 2013, CLIN REP SUMM 2011 A; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Stoilova B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065169; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian CH, 2011, PROTEIN CELL, V2, P128, DOI 10.1007/s13238-011-1012-7; VANDERHYDEN BC, 1995, BIOL REPROD, V53, P1243, DOI 10.1095/biolreprod53.6.1243; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Woods DC, 2013, REPROD SCI, V20, P524, DOI 10.1177/1933719113483017; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2013, ACTA BIOCH BIOPH SIN, V45, P289, DOI 10.1093/abbs/gmt008	60	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119275	10.1371/journal.pone.0119275	http://dx.doi.org/10.1371/journal.pone.0119275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751620	Green Published, gold, Green Submitted			2022-12-27	WOS:000350692700019
J	Mottus, R; Realo, A; Allik, J; Esko, T; Metspalu, A; Johnson, W				Mottus, Rene; Realo, Anu; Allik, Jueri; Esko, Tonu; Metspalu, Andres; Johnson, Wendy			Within-Trait Heterogeneity in Age Group Differences in Personality Domains and Facets: Implications for the Development and Coherence of Personality Traits	PLOS ONE			English	Article							NEO-PI-R; BIG 5; 5-FACTOR MODEL; MEASUREMENT INVARIANCE; FACTORIAL INVARIANCE; MIDDLE ADULTHOOD; INTELLIGENCE; SCALES; COVARIANCE; STABILITY	The study investigated differences in the Five-Factor Model (FFM) domains and facets across adulthood. The main questions were whether personality scales reflected coherent units of trait development and thereby coherent personality traits more generally. These questions were addressed by testing if the components of the trait scales (items for facet scales and facets for domain scales) showed consistent age group differences. For this, measurement invariance (MI) framework was used. In a sample of 2,711 Estonians who had completed the NEO Personality Inventory 3 (NEO PI-3), more than half of the facet scales and one domain scale did not meet the criterion for weak MI (factor loading equality) across 12 age groups spanning ages from 18 to 91 years. Furthermore, none of the facet and domain scales met the criterion for strong MI (intercept equality), suggesting that items of the same facets and facets of the same domains varied in age group differences. When items were residualized for their respective facets, 46% of them had significant (p < 0.0002) residual age-correlations. When facets were residualized for their domain scores, a majority had significant (p < 0.002) residual age-correlations. For each domain, a series of latent factors were specified using random quarters of their items: scores of such latent factors varied notably (within domains) in correlations with age. We argue that manifestations of aetiologically coherent traits should show similar age group differences. Given this, the FFM domains and facets as embodied in the NEO PI-3 do not reflect aetiologically coherent traits.	[Mottus, Rene; Johnson, Wendy] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Mottus, Rene; Realo, Anu; Allik, Jueri] Univ Tartu, Dept Psychol, EE-50090 Tartu, Estonia; [Allik, Jueri; Metspalu, Andres] Estonian Acad Sci, EE-200103 Tallinn, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Esko, Tonu] Broad Inst, Cambridge, MA USA; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	University of Edinburgh; University of Tartu; Estonian Academy of Sciences; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Tartu	Mottus, R (corresponding author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	rene.mottus@ed.ac.uk	Realo, Anu/M-9524-2016; Allik, Jüri/D-5609-2009; Allik, Jüri/N-3038-2019	Allik, Jüri/0000-0002-8358-4747; Allik, Jüri/0000-0002-8358-4747; Esko, Tonu/0000-0003-1982-6569	Estonian Ministry of Education, and Research [IUT02-13, SF0180029s08]; FP7 grants [201413, 245536]; Estonian Government [SF0180142s08]; University of Tartu; European Union	Estonian Ministry of Education, and Research(Ministry of Education and Research, Estonia); FP7 grants; Estonian Government; University of Tartu; European Union(European Commission)	This research was supported by the Estonian Ministry of Education, and Research (Institutional Research Grant IUT02-13 and SF0180029s08). The Estonian Genome Centre of the University of Tartu was financed by two FP7 grants (201413, 245536), by the Estonian Government (SF0180142s08), by the University of Tartu (SP1GVARENG), and by the European Union, through the European Regional Development Fund in the framework of the Centre of Excellence in Genomics. The funder played no role in the conception of the study described in this article or in writing the article.	Allemand M, 2008, PSYCHOL AGING, V23, P545, DOI 10.1037/a0013239; Allemand M, 2008, DEV PSYCHOL, V44, P758, DOI 10.1037/0012-1649.44.3.758; Allemand M, 2007, J PERS, V75, P323, DOI 10.1111/j.1467-6494.2006.00441.x; Allik J, 2009, EUR J PERSONALITY, V23, P567, DOI 10.1002/per.721; Bjornebekk A, 2013, NEUROIMAGE, V65, P194, DOI 10.1016/j.neuroimage.2012.10.009; Bleidorn W, 2009, J PERS SOC PSYCHOL, V97, P142, DOI 10.1037/a0015434; Borsboom D, 2006, PSYCHOMETRIKA, V71, P425, DOI 10.1007/s11336-006-1447-6; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Cattell RB, 1946, B J PSYCHOL-GEN SECT, V36, P88, DOI 10.1111/j.2044-8295.1946.tb01110.x; Cheung GW, 1999, J MANAGE, V25, P1, DOI 10.1177/014920639902500101; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; CHOU CP, 1991, BRIT J MATH STAT PSY, V44, P347, DOI 10.1111/j.2044-8317.1991.tb00966.x; Costa PT, 2007, REVISED NEO PERSONAL; Cramer AOJ, 2012, EUR J PERSONALITY, V26, P414, DOI 10.1002/per.1866; Cramer AOJ, 2011, EUR J PERSONALITY, V25, P270; De Fruyt F, 2009, ASSESSMENT, V16, P301, DOI 10.1177/1073191109333760; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Donnellan AB, 2008, PSYCHOL AGING, V23, P558, DOI 10.1037/a0012897; Epskamp S., 2013, SEMPLOT PATH DIAGRAM; Gignac GE, 2007, PERS INDIV DIFFER, V43, P1051, DOI 10.1016/j.paid.2007.02.024; Gottfredson L. S., 1997, INTELLIGENCE, V24, P24, DOI DOI 10.1016/S0160-2896(97)90014-3; Hopwood CJ, 2010, PERS SOC PSYCHOL REV, V14, P332, DOI 10.1177/1088868310361240; Horn J.L., 2012, CONT INTELLECTUAL AS, P73; HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; Jackson JJ, 2009, J PERS SOC PSYCHOL, V96, P446, DOI 10.1037/a0014156; Jang KL, 1998, J PERS SOC PSYCHOL, V74, P1556, DOI 10.1037/0022-3514.74.6.1556; Jensen, 1997, G FACTOR SCI MENTAL; Judge TA, 2013, J APPL PSYCHOL, V98, P875, DOI 10.1037/a0033901; Kallasmaa T, 2000, EUR J PERSONALITY, V14, P265, DOI 10.1002/1099-0984(200005/06)14:3<265::AID-PER376>3.0.CO;2-B; Lehmann R, 2013, DEV PSYCHOL, V49, P365, DOI 10.1037/a0028277; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Lucas RE, 2011, J PERS SOC PSYCHOL, V101, P847, DOI 10.1037/a0024298; Lucas RE, 2009, DEV PSYCHOL, V45, P1353, DOI 10.1037/a0013914; Marsh HW, 2013, DEV PSYCHOL, V49, P1194, DOI 10.1037/a0026913; Marsh HW, 2010, PSYCHOL ASSESSMENT, V22, P471, DOI 10.1037/a0019227; McCrae R.R., 2008, HDB PERSONALITY THEO, P159; McCrae RR, 2015, PERS SOC PSYCHOL REV, V19, P97, DOI 10.1177/1088868314541857; McCrae RR, 2005, J PERS ASSESS, V84, P261, DOI 10.1207/s15327752jpa8403_05; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McCrae RR, 1996, J PERS SOC PSYCHOL, V70, P552, DOI 10.1037/0022-3514.70.3.552; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Millsap RE, 2004, PSYCHOL METHODS, V9, P93, DOI 10.1037/1082-989X.9.1.93; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Mottus R, 2012, PSYCHOL AGING, V27, P243, DOI 10.1037/a0023690; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Pace VL, 2010, PERS INDIV DIFFER, V49, P669, DOI 10.1016/j.paid.2010.06.014; Paunonen SV, 2001, J PERS SOC PSYCHOL, V81, P524, DOI 10.1037/0022-3514.81.3.524; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Revelle W, 2013, PROCEDURES PERSONALI; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Soto CJ, 2012, J PERS, V80, P881, DOI 10.1111/j.1467-6494.2011.00752.x; Soubelet A, 2011, J PERS, V79, P741, DOI 10.1111/j.1467-6494.2011.00700.x; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Terracciano A, 2005, PSYCHOL AGING, V20, P493, DOI 10.1037/0882-7974.20.3.493; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Thalmayer AG, 2014, EUR J PERSONALITY, V28, P482, DOI 10.1002/per.1969; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; van der Maas HLJ, 2006, PSYCHOL REV, V113, P842, DOI 10.1037/0033-295X.113.4.842; Wicherts J. M., 2010, EDUC MEAS-ISSUES PRA, V29, P39, DOI [DOI 10.1111/J.1745-3992.2010.00182.X, 10.1111/j.1745-3992.2010.00182.x]; Wortman J, 2012, PSYCHOL AGING, V27, P867, DOI 10.1037/a0029322; Yuan KH, 2002, PSYCHOMETRIKA, V67, P539, DOI 10.1007/BF02295130; Zecca G, 2013, J CROSS CULT PSYCHOL, V44, P684, DOI 10.1177/0022022112468943; Zimprich D, 2012, PSYCHOL ASSESSMENT, V24, P173, DOI 10.1037/a0025265	70	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119667	10.1371/journal.pone.0119667	http://dx.doi.org/10.1371/journal.pone.0119667			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9LT	25751273	Green Submitted, Green Published, gold			2022-12-27	WOS:000350692700031
J	Williams, RR; Venkatesh, I; Pearse, DD; Udvadia, AJ; Bunge, MB				Williams, Ryan R.; Venkatesh, Ishwariya; Pearse, Damien D.; Udvadia, Ava J.; Bunge, Mary Bartlett			MASH1/Ascl1a Leads to GAP43 Expression and Axon Regeneration in the Adult CNS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LOOP-HELIX PROTEINS; SPINAL-CORD; GENE-EXPRESSION; NEURONAL DIFFERENTIATION; DOPAMINERGIC-NEURONS; DIRECT CONVERSION; HUMAN FIBROBLASTS; HAIR-CELLS; GROWTH	Unlike CNS neurons in adult mammals, neurons in fish and embryonic mammals can regenerate their axons after injury. These divergent regenerative responses are in part mediated by the growth-associated expression of select transcription factors. The basic helixloop-helix (bHLH) transcription factor, MASH1/Ascl1a, is transiently expressed during the development of many neuronal subtypes and regulates the expression of genes that mediate cell fate determination and differentiation. In the adult zebrafish (Danio rerio), Ascl1a is also transiently expressed in retinal ganglion cells (RGCs) that regenerate axons after optic nerve crush. Utilizing transgenic zebrafish with a 3.6 kb GAP43 promoter that drives expression of an enhanced green fluorescent protein (EGFP), we observed that knock-down of Ascl1a expression reduces both regenerative gap43 gene expression and axonal growth after injury compared to controls. In mammals, the development of noradrenergic brainstem neurons requires MASH1 expression. In contrast to zebrafish RGCs, however, MASH1 is not expressed in the mammalian brainstem after spinal cord injury (SCI). Therefore, we utilized adeno-associated viral (AAV) vectors to overexpress MASH1 in four month old rat (Rattus norvegicus) brainstem neurons in an attempt to promote axon regeneration after SCI. We discovered that after complete transection of the thoracic spinal cord and implantation of a Schwann cell bridge, animals that express MASH1 exhibit increased noradrenergic axon regeneration and improvement in hindlimb joint movements compared to controls. Together these data demonstrate that MASH1/Ascl1a is a fundamental regulator of axonal growth across vertebrates and can induce modifications to the intrinsic state of neurons to promote functional regeneration in response to CNS injury.	[Williams, Ryan R.; Pearse, Damien D.; Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Venkatesh, Ishwariya; Udvadia, Ava J.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Pearse, Damien D.; Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Bunge, Mary Bartlett] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	University of Miami; University of Wisconsin System; University of Wisconsin Milwaukee; University of Miami; University of Miami	Bunge, MB (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	MBunge@miami.edu	Pearse, Damien D/D-3176-2011; Udvadia, Ava J/W-8127-2018	Pearse, Damien D/0000-0003-1783-221X; Udvadia, Ava J/0000-0002-8678-252X	National Institute of Neurological Disorders and Stroke [09923, 056281]; Miami Project to Cure Paralysis; Buoniconti Fund to Cure Paralysis; Christine E. Lynn Distinguished Professorship in Neuroscience; Shaw Scientist Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923, R01NS056281] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miami Project to Cure Paralysis; Buoniconti Fund to Cure Paralysis; Christine E. Lynn Distinguished Professorship in Neuroscience; Shaw Scientist Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by National Institute of Neurological Disorders and Stroke grants 09923 (MBB) and 056281 (DDP and MBB). The Miami Project to Cure Paralysis, the Buoniconti Fund to Cure Paralysis, Christine E. Lynn Distinguished Professorship in Neuroscience (MBB), and the Shaw Scientist Award (AJU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Cau E, 2003, DEVELOPMENT, V130, P2455, DOI 10.1242/dev.00452; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Chiaramello A, 1996, J BIOL CHEM, V271, P22035, DOI 10.1074/jbc.271.36.22035; Farah MH, 2000, DEVELOPMENT, V127, P693; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; FAWCETT JW, 1992, TRENDS NEUROSCI, V15, P5, DOI 10.1016/0166-2236(92)90338-9; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; Fujimori KE, 2008, BRAIN RES, V1245, P1, DOI 10.1016/j.brainres.2008.09.071; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Geoffroy CG, 2009, STEM CELLS, V27, P847, DOI 10.1002/stem.17; Ghil SH, 2002, EXP MOL MED, V34, P367, DOI 10.1038/emm.2002.52; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Hamada M, 2006, NEUROBIOL DIS, V22, P509, DOI 10.1016/j.nbd.2005.12.020; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; HOULE JD, 1988, J COMP NEUROL, V269, P535, DOI 10.1002/cne.902690406; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kabos P, 2002, NEUROREPORT, V13, P2385, DOI 10.1097/00001756-200212200-00002; KALIL K, 1979, SCIENCE, V205, P1158, DOI 10.1126/science.472734; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kusik BW, 2010, DEV DYNAM, V239, P482, DOI 10.1002/dvdy.22190; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Liu YH, 2004, MOL CELL BIOL, V24, P2662, DOI 10.1128/MCB.24.7.2662-2672.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo LC, 1998, DEVELOPMENT, V125, P609; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Nicholls J, 1996, TRENDS NEUROSCI, V19, P229, DOI 10.1016/0166-2236(96)10021-7; Obayashi S, 2009, CELL MOL NEUROBIOL, V29, P423, DOI 10.1007/s10571-008-9338-2; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pollak J, 2013, DEVELOPMENT, V140, P2619, DOI 10.1242/dev.091355; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Rossignol S, 1998, ANN NY ACAD SCI, V860, P346, DOI 10.1111/j.1749-6632.1998.tb09061.x; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Stanke M, 2004, MOL CELL NEUROSCI, V25, P374, DOI 10.1016/j.mcn.2003.10.021; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; Udvadia AJ, 2001, DEVELOPMENT, V128, P1175; Udvadia AJ, 2008, GENE EXPR PATTERNS, V8, P382, DOI 10.1016/j.gep.2008.05.002; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wiliams RR, 2012, PROG BRAIN RES, V201, P295, DOI 10.1016/B978-0-444-59544-7.00014-7; Williams RR, 2015, CELL TRANSPLANT, V24, P115, DOI 10.3727/096368913X674657; Williams RR, 2012, J GENE MED, V14, P20, DOI 10.1002/jgm.1628; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Yu PP, 2011, EXP NEUROL, V231, P38, DOI 10.1016/j.expneurol.2011.05.013; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zou SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057280	76	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0118918	10.1371/journal.pone.0118918	http://dx.doi.org/10.1371/journal.pone.0118918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751153	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700013
J	Appelqvist, C; Al-Hamdani, ZK; Jonsson, PR; Havenhand, JN				Appelqvist, Christin; Al-Hamdani, Zyad K.; Jonsson, Per R.; Havenhand, Jon N.			Climate Envelope Modeling and Dispersal Simulations Show Little Risk of Range Extension of the Shipworm, Teredo navalis (L.), in the Baltic Sea	PLOS ONE			English	Article							SWEDISH WEST COAST; DISSOLVED-OXYGEN; GEOGRAPHICAL-DISTRIBUTION; LARVAL DEVELOPMENT; CYCLOPE-NERITEA; BANKIA-GOULDI; MARINE; BIVALVIA; SHIFTS; TEREDINIDAE	The shipworm, Teredo navalis, is absent from most of the Baltic Sea. In the last 20 years, increased frequency of T. navalis has been reported along the southern Baltic Sea coasts of Denmark, Germany, and Sweden, indicating possible range-extensions into previously unoccupied areas. We evaluated the effects of historical and projected near-future changes in salinity, temperature, and oxygen on the risk of spread of T. navalis in the Baltic. Specifically, we developed a simple, GIS-based, mechanistic climate envelope model to predict the spatial distribution of favourable conditions for adult reproduction and larval metamorphosis of T. navalis, based on published environmental tolerances to these factors. In addition, we used a high-resolution three-dimensional hydrographic model to simulate the probability of spread of T. navalis larvae within the study area. Climate envelope modeling showed that projected near-future climate change is not likely to change the overall distribution of T. navalis in the region, but will prolong the breeding season and increase the risk of shipworm establishment at the margins of the current range. Dispersal simulations indicated that the majority of larvae were philopatric, but those that spread over a wider area typically spread to areas unfavourable for their survival. Overall, therefore, we found no substantive evidence for climate-change related shifts in the distribution of T. navalis in the Baltic Sea, and no evidence for increased risk of spread in the near-future.	[Appelqvist, Christin; Jonsson, Per R.; Havenhand, Jon N.] Univ Gothenburg, Dept Biol Environm Sci, S-45296 Tjarno, Stromstad, Sweden; [Al-Hamdani, Zyad K.] Geol Survey Denmark & Greenland, DK-1350 Copenhagen K, Denmark	University of Gothenburg; Geological Survey Of Denmark & Greenland	Havenhand, JN (corresponding author), Univ Gothenburg, Dept Biol Environm Sci, S-45296 Tjarno, Stromstad, Sweden.	jon.havenhand@bioenv.gu.se	Alhamdani, Z-K-/AAW-9316-2020	Havenhand, Jonathan/0000-0001-6721-7763; Jonsson, Per/0000-0002-1793-5473	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning ("FORMAS") [2004-631]; EU ("WreckProtect", FP7) [226225]; Swedish Research Council VR; Swedish Research Council FORMAS	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning ("FORMAS")(Swedish Research Council Formas); EU ("WreckProtect", FP7); Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was conducted with financial support from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning ("FORMAS" grant no. 2004-631: CA JH), the EU ("WreckProtect", FP7 grant no. 226225: CA ZAL JH), and a Linnaeus grant from the Swedish Research Councils VR and FORMAS (http://cemeb.science.gu.se/: PJ JH). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; BAKER SM, 1992, BIOL BULL, V182, P265, DOI 10.2307/1542120; Beaugrand G, 2013, NAT CLIM CHANGE, V3, P263, DOI 10.1038/NCLIMATE1753; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; Bjordal CG, 2008, J ARCHAEOL SCI, V35, P862, DOI 10.1016/j.jas.2007.06.005; Bjordal CG, 2012, CONSERV MANAGE ARCHA, V14, P201, DOI 10.1179/1350503312Z.00000000017; Blum HF, 1922, U CALIFORNIA PUBLICA, V224, P349; Bonsdorff E, 2006, J EXP MAR BIOL ECOL, V330, P383, DOI 10.1016/j.jembe.2005.12.041; Borges LMS, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-13; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Carlton JT, 1999, MALACOLOGIA, V41, P439; Cederlund CO, 2004, MONITORING SAFEGUARD; Chen JH, 2007, FISH SHELLFISH IMMUN, V22, P272, DOI 10.1016/j.fsi.2006.06.003; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Clapp W. F., 1963, MARINE BORERS ANNOTA; Couceiro L, 2012, INTEGR ZOOL, V7, P286, DOI 10.1111/j.1749-4877.2012.00305.x; CULLINEY JL, 1975, MAR BIOL, V29, P245, DOI 10.1007/BF00391850; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Distel DL, 2011, MOL PHYLOGENET EVOL, V61, P245, DOI 10.1016/j.ympev.2011.05.019; DOOS K, 1995, J GEOPHYS RES-OCEANS, V100, P13499, DOI 10.1029/95JC00337; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Elith J, ANN REV ECOLOGY EVOL, V402009, P677; GALLAGER SM, 1981, J EXP MAR BIOL ECOL, V52, P63, DOI 10.1016/0022-0981(81)90171-4; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Goddard JHR, 2002, VELIGER, V45, P331; Grave BH, 1928, BIOL BULL-US, V55, P260, DOI 10.2307/1537080; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; HOAGLAND KE, 1986, AM MALACOL BULL, V4, P89; Hordoir R, 2013, CONT SHELF RES, V64, P1, DOI 10.1016/j.csr.2013.05.006; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IMAI TAKEO, 1950, TOHOKU JOUR AGRIC RES, V1, P199; Karlson K, OCEANOGRAPHY MARINE, V40, P427; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kristensen E., 1969, Videnskabelige Meddelelser Dansk naturh Foren, V132, P199; KRISTENSEN ES, 1979, OPHELIA, V18, P235; Kuhl H., 1972, OCEAN MAR BIOL ANN R, V10, P225; LANE CE, 1952, AM J PHYSIOL, V171, P741; Langer MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054443; Leonel RMV, 2002, J MAR BIOL ASSOC UK, V82, P1039, DOI 10.1017/S002531540200663X; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2065, DOI 10.1111/j.1365-2486.2007.01424.x; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lodola A, 2013, ITAL J ZOOL, V80, P303, DOI 10.1080/11250003.2013.775363; Long WC, 2008, J EXP MAR BIOL ECOL, V359, P34, DOI 10.1016/j.jembe.2008.02.013; Loosanoff V. L., 1963, Advances in Marine Biology, V1, P1, DOI 10.1016/S0065-2881(08)60257-6; MacLeod Colin D., 2009, Endangered Species Research, V7, P125, DOI 10.3354/esr00197; Madec G, 2008, NEMO OCEAN ENGINE; MANN R, 1985, J EXP MAR BIOL ECOL, V85, P211, DOI 10.1016/0022-0981(85)90159-5; Meier HEM, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034005; MORRISON G, 1971, J FISH RES BOARD CAN, V28, P379, DOI 10.1139/f71-050; NAIR NB, 1971, ADV MAR BIOL, V9, P335, DOI 10.1016/S0065-2881(08)60345-4; Neumann T, 2000, J MARINE SYST, V25, P405, DOI 10.1016/S0924-7963(00)00030-0; Noppe KN, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P116; NORMAN E, 1977, OPHELIA, V16, P233, DOI 10.1080/00785326.1977.10425473; NORMAN E, 1976, Material und Organismen (Berlin), V11, P303; Norman E., 1976, Material und Organismen Beihefte, V3, P531; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Przeslawski R, 2012, ESTUAR COAST SHELF S, V113, P205, DOI 10.1016/j.ecss.2012.08.005; Rilov G, 2009, BIOL INVASIONS MARIN, V204; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Roginskaya IS, 1997, VELIGER, V40, P160; SCHELTEMA RS, 1971, MAR BIOL, V11, P5, DOI 10.1007/BF00348015; Serrano E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052739; Shanks AL, 2009, BIOL BULL-US, V216, P373; Simon-Bouhet B, 2006, MOL ECOL, V15, P1699, DOI 10.1111/j.1365-294X.2006.02881.x; Soldatova IN., 1961, T I OCEANOL, V59, P167; Soldatova IN, 1961, T I OCEANOL, V59, P161; Sordyl VH, 1998, DTSCH GEWAESSERKUNDL, V42, P142; Spicer JI, 2003, SARSIA, V88, P302, DOI 10.1080/00364820310002263; Tuente U, 2002, HELGOLAND MAR RES, V56, P87, DOI 10.1007/s10152-002-0101-7; Turner R.D., 1966, PROVIDES GORGEOUSLY; Uhrenholdt T, 11805776 DHI; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Wichmann G, 2005, RISK FACTOR WATER SP; Winsor P, 2001, CLIM RES, V18, P5, DOI 10.3354/cr018005	82	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119217	10.1371/journal.pone.0119217	http://dx.doi.org/10.1371/journal.pone.0119217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768305	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500071
J	Bezzina, C; Verret, L; Juan, C; Remaud, J; Halley, H; Rampon, C; Dahan, L				Bezzina, Charlotte; Verret, Laure; Juan, Cecile; Remaud, Jessica; Halley, Helene; Rampon, Claire; Dahan, Lionel			Early Onset of Hypersynchronous Network Activity and Expression of a Marker of Chronic Seizures in the Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; TRANSGENIC MICE; NEUROPEPTIDE-Y; NEURONAL-ACTIVITY; SPATIAL MEMORY; COGNITIVE IMPAIRMENTS; EPILEPTIFORM ACTIVITY; FUNCTIONAL-CHANGES; LIMBIC SEIZURES; RAT HIPPOCAMPUS	Cortical and hippocampal hypersynchrony of neuronal networks seems to be an early event in Alzheimer's disease pathogenesis. Many mouse models of the disease also present neuronal network hypersynchrony, as evidenced by higher susceptibility to pharmacologically-induced seizures, electroencephalographic seizures accompanied by spontaneous interictal spikes and expression of markers of chronic seizures such as neuropeptide Y ectopic expression in mossy fibers. This network hypersynchrony is thought to contribute to memory deficits, but whether it precedes the onset of memory deficits or not in mouse models remains unknown. The earliest memory impairments in the Tg2576 mouse model of Alzheimer's disease have been observed at 3 months of age. We thus assessed network hypersynchrony in Tg2576 and non-transgenic male mice at 1.5, 3 and 6 months of age. As soon as 1.5 months of age, Tg2576 mice presented higher seizure susceptibility to systemic injection of a GABA(A) receptor antagonist. They also displayed spontaneous interictal spikes on EEG recordings. Some Tg2576 mice presented hippocampal ectopic expression of neuropeptide Y which incidence seems to increase with age among the Tg2576 population. Our data reveal that network hypersynchrony appears very early in Tg2576 mice, before any demonstrated memory impairments.	[Bezzina, Charlotte; Verret, Laure; Juan, Cecile; Remaud, Jessica; Halley, Helene; Rampon, Claire; Dahan, Lionel] Univ Toulouse, UPS, Ctr Rech Cognit Anim, F-31062 Toulouse 09, France; [Bezzina, Charlotte; Verret, Laure; Juan, Cecile; Remaud, Jessica; Halley, Helene; Rampon, Claire; Dahan, Lionel] CNRS, Ctr Rech Cognit Anim, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dahan, L (corresponding author), Univ Toulouse, UPS, Ctr Rech Cognit Anim, 118 Route Narbonne, F-31062 Toulouse 09, France.	lionel.dahan@univ-tlse3.fr	Dahan, Lionel/C-2760-2009; Verret, Laure/D-9224-2017	Verret, Laure/0000-0001-5272-6063; Dahan, Lionel/0000-0001-7810-6233; rampon, claire/0000-0001-8551-8682	Agence Nationale pour la Recherche [ANR-10-05-MALZ]; Centre National de la Recherche Scientifique; University of Toulouse; Agence Regionale de Sante; French Ministry of Research	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse; Agence Regionale de Sante; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	The authors acknowledge the support of the Agence Nationale pour la Recherche (ANR-10-05-MALZ to CR); the Centre National de la Recherche Scientifique (CNRS, PEPS to LD), the University of Toulouse. C. Bezzina was supported by the Agence Regionale de Sante and J. Remaud was supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; COLMERS WF, 1994, TRENDS NEUROSCI, V17, P373, DOI 10.1016/0166-2236(94)90046-9; Corbett BF, 2013, J NEUROSCI, V33, P7020, DOI 10.1523/JNEUROSCI.2325-12.2013; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Duffy AM, 2015, NEUROBIOL AGING, V36, P134, DOI 10.1016/j.neurobiolaging.2014.07.001; FORSTL H, 1992, ARCH NEUROL-CHICAGO, V49, P1038, DOI 10.1001/archneur.1992.00530340054018; Francis BM, 2012, NEUROBIOL AGING, V33, P555, DOI 10.1016/j.neurobiolaging.2010.04.003; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Higgins GA, 2003, BEHAV PHARMACOL, V14, P419, DOI 10.1097/01.fbp.0000088420.18414.ff; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; KLAPSTEIN GJ, 1993, HIPPOCAMPUS, V3, P103, DOI 10.1002/hipo.450030111; Kleen JK, 2013, NEUROLOGY, V81, P18, DOI 10.1212/WNL.0b013e318297ee50; Kleen JK, 2010, ANN NEUROL, V67, P250, DOI 10.1002/ana.21896; Krezymon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076497; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; Lassalle JM, 2008, BEHAV BRAIN RES, V191, P104, DOI 10.1016/j.bbr.2008.03.017; Lee SH, 2012, J NEUROSCI, V32, P5953, DOI 10.1523/JNEUROSCI.0465-12.2012; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Mann DMA, 2001, AM J PATHOL, V158, P2165, DOI 10.1016/S0002-9440(10)64688-3; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Orban G, 2010, BRAIN RES, V1354, P227, DOI 10.1016/j.brainres.2010.07.061; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sjogren T, 1952, ACTA PSYCH NEUROL SC, V82, P9; SPERK G, 1992, NEUROSCIENCE, V50, P831, DOI 10.1016/0306-4522(92)90207-I; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Vegh MJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0076-z; Verret L, 2013, NEUROBIOL AGING, V34, P211, DOI 10.1016/j.neurobiolaging.2012.05.013; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vezzani A, 1996, EPILEPSY RES, V26, P267, DOI 10.1016/S0920-1211(96)00059-9; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Westmark CJ, 2008, INT J CLIN EXP PATHO, V1, P157; Zilberter M, 2013, J NEUROCHEM, V125, P157, DOI 10.1111/jnc.12127	61	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119910	10.1371/journal.pone.0119910	http://dx.doi.org/10.1371/journal.pone.0119910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768013	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500101
J	Cai, SR; Chen, JH; Chen, CQ; Wu, KM; Zhang, XH; Song, W; He, YL				Cai Shirong; Chen Jianhui; Chen Chuangqi; Wu Kaiming; Zhang Xinhua; Song Wu; He Yulong			Survival of Proper Hepatic Artery Lymph Node Metastasis in Patients with Gastric Cancer: Implications for D2 Lymphadenectomy	PLOS ONE			English	Article							ADENOCARCINOMA	Background and Aims There is a discrepancy between the American Joint Committee on Cancer (AJCC) guidelines (7th edition) and the Japanese treatment guidelines (3rd edition) with regard to the extent of D2 lymphadenectomy for gastric cancer. In the AJCC, hepatic artery station (No. 12a) lymph node (LN) metastasis is classified as distant metastasis, whereas in the Japanese guidelines, this classified is regional metastasis. This study aimed to evaluate whether it is appropriate to reclassify No. 12a LN metastasis as distant metastasis in consideration of survival outcome. Methods In this retrospective analysis, data from patients with gastric cancer who underwent regular D2 or greater lymphadenectomy between 1996 and 2006 were evaluated to determine any association between the clinicopathological features of hepatic artery LNs and survival prognosis. Results Among the 247 patients with gastric cancer who underwent No. 12 LN harvest, 45 (18.2%) were positive for No. 12a LN metastasis. No. 12a LN metastasis was significantly associated with poor clinicopathological features, advanced tumor stage, and poor overall survival. The 5-year survival rate of patients with No. 12a LN metastasis was significantly better than that of patients with distant metastasis (P < 0.05), but was similar to that of patients with LN involvement in the D2 lymphadenectomy region (P > 0.05). No. 12a LN metastasis was shown to significantly influence survival outcome in univariate analysis, but was not identified as a significant independent predictor in multivariate analysis. In logistic multivariate regression analysis, T stage, N stage, and station No. 3, 5, and 6 LN metastasis were independent predictors of No. 12a LN involvement. Conclusions It is inappropriate to reclassify No. 12a LN metastasis as distant metastasis. We propose that this be considered as regional metastasis and be included in the extent of D2 lymphadenectomy to improve survival outcomes in patients with gastric cancer.	[Cai Shirong; Chen Jianhui; Chen Chuangqi; Wu Kaiming; Zhang Xinhua; Song Wu; He Yulong] Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China; [Cai Shirong; Chen Jianhui; Chen Chuangqi; Wu Kaiming; Zhang Xinhua; Song Wu; He Yulong] Sun Yat Sen Univ, Gastr Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	He, YL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China.	YLH@medmail.com.cn			National Nature Science Foundation of China [30972883, 81272637]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants from the National Nature Science Foundation of China (No. 30972883, No. 81272637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Degiuli M, 2014, BRIT J SURG, V101, P23, DOI 10.1002/bjs.9345; Dikken JL, 2012, ANN SURG ONCOL, V19, P2443, DOI 10.1245/s10434-012-2403-6; Edge SB, 2010, AJCC CANC STAGING MA; Greene FLPA, 2002, AJCC CANC STAGING MA, P99; Japanese Gastric Cancer Association, 2011, GASTRIC CANC; Jiang L, 2013, J SURG ONCOL, V107, P807, DOI 10.1002/jso.23325; Kim HI, 2013, ANN SURG ONCOL, V20, P2713, DOI 10.1245/s10434-013-2898-5; Kim R, 2013, CRIT REV ONCOL HEMAT, V88, P416, DOI 10.1016/j.critrevonc.2013.05.007; Lee SL, 2014, BRIT J SURG, V101, P518, DOI 10.1002/bjs.9438; Marrelli D, 2012, ANN SURG, V255, P486, DOI 10.1097/SLA.0b013e3182389b1a; Menges M, 2011, WORLD J GASTRO ONCOL, V3, P10, DOI 10.4251/wjgo.v3.i1.10; Sobin L, 2010, UICC TNM CLASSIFICAT; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2	14	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118953	10.1371/journal.pone.0118953	http://dx.doi.org/10.1371/journal.pone.0118953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768441	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500056
J	Liccioli, S; Bialowas, C; Ruckstuhl, KE; Massolo, A				Liccioli, Stefano; Bialowas, Carly; Ruckstuhl, Kathreen E.; Massolo, Alessandro			Feeding Ecology Informs Parasite Epidemiology: Prey Selection Modulates Encounter Rate with Echinococcus multilocularis in Urban Coyotes	PLOS ONE			English	Article							WHITE-TAILED DEER; RED-BACKED VOLE; CANIS-LATRANS; ALVEOLAR ECHINOCOCCOSIS; MYODES-GAPPERI; PREDATION; FOXES; MORTALITY; LEUCKART; WINTER	We investigated the role of urban coyote feeding ecology in the transmission of Echinococcus multilocularis, the causative agent of Alveolar Echinococcosis in humans. As coyotes can play a main role in the maintenance of this zoonotic parasite within North American urban settings, such study can ultimately aid disease risk management. Between June 2012 and June 2013, we collected 251 coyote feces and conducted trapping of small mammals (n = 971) in five parks in the city of Calgary, Alberta, Canada. We investigated E. multilocularis epidemiology by assessing seasonal variations of coyote diet and the selective consumption of different rodent intermediate host species. Furthermore, accounting for small mammal digestibility and coyote defecation rates we estimated the number of small mammal preys ingested by coyote and consequently, coyote encounter rates with the parasite. Dominant food items included small mammals, fruit and vegetation, although hare and deer were seasonally relevant. The lowest frequency of occurrence per scat of small mammals was recorded in winter (39.4 %), when consumption of deer was highest (36.4 %). However, highest encounter rates (number of infected hosts predated/season) with E. multilocularis (95% CI: 1.0 - 22.4), combined with the lack of predation on non-competent small mammal species, suggest that winter is the critical season for transmission and control of this parasite. Within the small mammal assemblage, voles (Microtus pennsylvanicus and Myodes gapperi) were the selected preys of urban coyotes and likely played a key role for the maintenance of the urban sylvatic life-cycle of E. multilocularis in Calgary.	[Liccioli, Stefano; Bialowas, Carly; Massolo, Alessandro] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB T2N 4Z6, Canada; [Liccioli, Stefano; Bialowas, Carly; Ruckstuhl, Kathreen E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Massolo, A (corresponding author), Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	amassolo@ucalgary.ca	Massolo, Alessandro/AAO-5344-2021; Massolo, Alessandro/I-3437-2012; Ruckstuhl, Kathreen Eva/B-4469-2013	Massolo, Alessandro/0000-0002-6333-4281; Ruckstuhl, Kathreen/0000-0002-2949-242X; Liccioli, Stefano/0000-0003-1548-731X	Canadian Institutes of Health Research [736488]; Institute for Public Health [10002391]; Calgary Parks [RT: 10001048]; University of Calgary, Department of Ecosystem & Public Health (University of Calgary); Alberta Innovates Health Solutions [10006087]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Public Health; Calgary Parks; University of Calgary, Department of Ecosystem & Public Health (University of Calgary); Alberta Innovates Health Solutions	Funding: This work has been supported by the following funders: Canadian Institutes of Health Research (RT#: 736488; http://www.cihr-irsc.gc.ca/e/193.html), Institute for Public Health (RT#: 10002391; http://obrieniph.ucalgary.ca/), and Calgary Parks (RT: 10001048; http://www.calgary.ca/CSPS/Parks/Pages/home.aspx). SL was supported by studentships from the University of Calgary, Department of Ecosystem & Public Health (University of Calgary) and Alberta Innovates Health Solutions (RT#: 10006087; http://www.aihealthsolutions.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorjan A. S., 1969, MANUAL IDENTIFICATIO; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; BONDRUPNIELSEN S, 1987, CAN J ZOOL, V65, P277, DOI 10.1139/z87-043; BOWEN WD, 1981, CAN J ZOOL, V59, P639, DOI 10.1139/z81-094; Burlet P, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-6; BYERS CR, 1984, J WILDLIFE MANAGE, V48, P1050, DOI 10.2307/3801467; Catalano S, 2012, EMERG INFECT DIS, V18, P1625, DOI [10.3201/eid1810.120119, 10.3201/eid.1810.120119]; CHAMRAD ALBERT D., 1964, J WILDL MAGMT, V28, P473, DOI 10.2307/3798199; Ciucci P, 1996, WILDLIFE BIOL, V2, P37, DOI 10.2981/wlb.1996.006; Craig PS, 1996, ADV PARASIT, V38, P169, DOI 10.1016/S0065-308X(08)60035-4; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; Eckert J., 2001, WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern, pi; ENGEMAN RM, 1993, WILDLIFE SOC B, V21, P70; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Foley J., 2006, CALGARYS NATURAL PAR; GESE EM, 1995, AM MIDL NAT, V133, P36, DOI 10.2307/2426345; Gese EM, 1996, CAN J ZOOL, V74, P784, DOI 10.1139/z96-090; Gesy K, 2013, PARASITOLOGY, V140, P1133, DOI 10.1017/S0031182013000607; Giraudoux P, 2003, PARASITOLOGY, V127, pS121, DOI 10.1017/S0031182003003512; Giraudoux P, 2013, PARASITOLOGY, V140, P1655, DOI 10.1017/S0031182013000644; Grigione MM, 2011, URBAN ECOSYST, V14, P655, DOI 10.1007/s11252-011-0159-6; Guerra D, 2014, PARASITOLOGY, P1; HAMLIN KL, 1984, J WILDLIFE MANAGE, V48, P489, DOI 10.2307/3801181; HARRISON DJ, 1989, J WILDLIFE MANAGE, V53, P181, DOI 10.2307/3801327; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hegglin D, 2007, FUNCT ECOL, V21, P552, DOI 10.1111/j.1365-2435.2007.01257.x; HNATIUK JM, 1966, CAN J ZOOLOG, V44, P493, DOI 10.1139/z66-048; HOLMES JC, 1971, CAN J ZOOLOG, V49, P575, DOI 10.1139/z71-090; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jones JK, 1992, ILLUSTRATED KEY SKUL; Jung TS, 2006, CAN FIELD NAT, V120, P331, DOI 10.22621/cfn.v120i3.324; Kapel CMO, 2006, INT J PARASITOL, V36, P79, DOI 10.1016/j.ijpara.2005.08.012; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly BT, 1997, CAN J ZOOL, V75, P1811, DOI 10.1139/z97-810; Kelly BT., 1991, CARNIVORE SCAT ANAL; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Lafferty KD, 1999, PARASITOL TODAY, V15, P111, DOI 10.1016/S0169-4758(99)01397-6; LEE CF, 1969, CAN J ZOOLOG, V47, P733, DOI 10.1139/z69-124; LEIBY PD, 1970, J PARASITOL, V56, P1141, DOI 10.2307/3277560; Levi T, 2012, ECOLOGY, V93, P921, DOI 10.1890/11-0165.1; Liccioli S, 2012, CAN J ZOOL, V90, P1023, DOI [10.1139/Z2012-070, 10.1139/z2012-070]; Liccioli S, 2014, INT J PARASITOL, V44, P457, DOI 10.1016/j.ijpara.2014.03.007; Liccioli S, 2013, PARASITOL INT, V62, P355, DOI 10.1016/j.parint.2013.03.007; Lidicker WZ, 2000, OIKOS, V91, P435; Lingle S, 2002, ECOLOGY, V83, P2037; LITVAITIS JA, 1980, J WILDLIFE MANAGE, V44, P62, DOI 10.2307/3808351; Loucks CJ, 2003, CONSERV BIOL, V17, P558, DOI 10.1046/j.1523-1739.2003.01494.x; Loveridge AJ, 2003, J ZOOL, V259, P143, DOI 10.1017/S0952836902003114; Lukasik VM., 2012, CITIES ENV, V4, P8, DOI DOI 10.15365/CATE.4182011; Monroy-Vilchis O, 2006, SOUTHWEST NAT, V51, P272, DOI 10.1894/0038-4909(2006)51[272:DAEROC]2.0.CO;2; Moore T.D., 1997, IDENTIFICATION DORSA; Morey PS, 2007, AM MIDL NAT, V158, P147, DOI 10.1674/0003-0031(2007)158[147:SATVIT]2.0.CO;2; NELLIS CH, 1976, J WILDLIFE MANAGE, V40, P389, DOI 10.2307/3799940; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P471, DOI 10.2307/3801108; Prugh LR, 2005, OIKOS, V110, P253, DOI 10.1111/j.0030-1299.2005.13478.x; PRUITT W O JR, 1984, Carnegie Museum of Natural History Special Publication, P1; Quinn T, 1997, NORTHWEST SCI, V71, P1; Ramakrishnan U, 1999, BIOL CONSERV, V89, P113, DOI 10.1016/S0006-3207(98)00159-1; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; Saitoh T, 1998, RES POPUL ECOL, V40, P97, DOI 10.1007/BF02765225; Schwingel H, 2010, NORTHEAST NAT, V17, P531, DOI 10.1656/045.017.0402; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; THURBER JM, 1992, CAN J ZOOL, V70, P2494, DOI 10.1139/z92-335; Tsukada H, 2000, PARASITOLOGY, V120, P423, DOI 10.1017/S0031182099005582; VanDeelen TR, 1997, J WILDLIFE MANAGE, V61, P903, DOI 10.2307/3802199; VEIT P, 1995, PARASITOLOGY, V110, P79, DOI 10.1017/S0031182000081075; Viel JF, 1999, AM J TROP MED HYG, V61, P559, DOI 10.4269/ajtmh.1999.61.559; VILLAGE A, 1990, J ZOOL, V222, P681, DOI 10.1111/j.1469-7998.1990.tb06023.x; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153	71	17	17	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121646	10.1371/journal.pone.0121646	http://dx.doi.org/10.1371/journal.pone.0121646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768437	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500144
J	Liu, Y; Xi, DG; Li, ZL				Liu, Yu; Xi, Du-Gang; Li, Zhao-Liang			Determination of the Optimal Training Principle and Input Variables in Artificial Neural Network Model for the Biweekly Chlorophyll-a Prediction: A Case Study of the Yuqiao Reservoir, China	PLOS ONE			English	Article							REGRESSION-MODELS	Predicting the levels of chlorophyll-a (Chl-a) is a vital component of water quality management, which ensures that urban drinking water is safe from harmful algal blooms. This study developed a model to predict Chl-a levels in the Yuqiao Reservoir (Tianjin, China) biweekly using water quality and meteorological data from 1999-2012. First, six artificial neural networks (ANNs) and two non-ANN methods (principal component analysis and the support vector regression model) were compared to determine the appropriate training principle. Subsequently, three predictors with different input variables were developed to examine the feasibility of incorporating meteorological factors into Chl-a prediction, which usually only uses water quality data. Finally, a sensitivity analysis was performed to examine how the Chl-a predictor reacts to changes in input variables. The results were as follows: first, ANN is a powerful predictive alternative to the traditional modeling techniques used for Chl-a prediction. The back program (BP) model yields slightly better results than all other ANNs, with the normalized mean square error (NMSE), the correlation coefficient (Corr), and the NashSutcliffe coefficient of efficiency (NSE) at 0.003 mg/l, 0.880 and 0.754, respectively, in the testing period. Second, the incorporation of meteorological data greatly improved Chl-a prediction compared to models solely using water quality factors or meteorological data; the correlation coefficient increased from 0.574-0.686 to 0.880 when meteorological data were included. Finally, the Chl-a predictor is more sensitive to air pressure and pH compared to other water quality and meteorological variables.	[Liu, Yu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Liu, Yu] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Xi, Du-Gang] PLA Informat Engn Univ, Zhengzhou, Peoples R China; [Xi, Du-Gang] Naval Inst Hydrog Surveying & Charting, Tianjin, Peoples R China; [Li, Zhao-Liang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Agriinformat, Minist Agr, Beijing 100193, Peoples R China; [Li, Zhao-Liang] CNRS, UdS, ICube, F-67412 Illkirch Graffenstaden, France	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; PLA Information Engineering University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Li, ZL (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	lizhaoliang@caas.cn			National Natural Science Foundation of China [41301379, 41231170]; China Postdoctoral Science Foundation [2013M541029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China under grants 41301379 and 41231170 and the China Postdoctoral Science Foundation under grant 2013M541029. The funders covered the money needed in the study design, data collection and publishing of the manuscript.	Camdevyren H, 2005, ECOL MODEL, V181, P581, DOI 10.1016/j.ecolmodel.2004.06.043; CHAPRA S.C, 1997, SURFACE WATER QUALIT, P844; Chen CW, 1970, J SANITARY ENG DIVIS, V96, P1085; Cho KH, 2009, SCI TOTAL ENVIRON, V407, P2536, DOI 10.1016/j.scitotenv.2009.01.017; DITORO DM, 1971, ADV CHEM SER, P131; French M, 1994, COMPUTER TECHNIQUES, VII, P87; Jeong KS, 2006, ECOL INFORM, V1, P235, DOI 10.1016/j.ecoinf.2006.04.001; Karul C, 2006, ECOLOGICAL INFORM, P309; Lee JHW, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P187, DOI 10.1007/1-4020-3655-8_13; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; Liu Y, 2010, ECOL MODEL, V221, P681, DOI 10.1016/j.ecolmodel.2009.03.010; Liu Y, 2009, SENSORS-BASEL, V9, P5558, DOI 10.3390/s90705558; Luo HuaJun, 2012, Journal of Environmental Protection, V3, P420, DOI 10.4236/jep.2012.35052; Maier HR, 2001, ECOL MODEL, V146, P85, DOI 10.1016/S0304-3800(01)00298-8; Malek S, 2012, BMC BIOINFORMATICS, V12, pS12; Martin J.L., 1998, HYDRODYNAMICS TRANSP, P816; Onderka M, 2007, ECOL MODEL, V209, P412, DOI 10.1016/j.ecolmodel.2007.07.028; Orlob G.T., 1983, MATH MODELING WATER, P518; Primpas I, 2010, ECOL INDIC, V10, P178, DOI 10.1016/j.ecolind.2009.04.007; Xu M, 2005, J ENVIRON SCI, V17, P946; Yabunaka K, 1997, WATER SCI TECHNOL, V36, P89, DOI 10.1016/S0273-1223(97)00464-2	21	4	5	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119082	10.1371/journal.pone.0119082	http://dx.doi.org/10.1371/journal.pone.0119082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768650	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500064
J	Tong, Q; Cai, Q; de Mooij, T; Xu, X; Dai, SM; Qu, WC; Zhao, DB				Tong, Qiang; Cai, Qing; de Mooij, Tristan; Xu, Xia; Dai, Shengming; Qu, Wenchun; Zhao, Dongbao			Adverse Events of Anti-Tumor Necrosis Factor alpha Therapy in Ankylosing Spondylitis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TNF-ALPHA; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; INFLIXIMAB; BLOCKERS; DISEASE; SAFETY; POLYMORPHISM; ETANERCEPT	Objective This study aims to investigate the prevalence of short-term and long-term adverse events associated with tumor necrosis factor-alpha (TNF-alpha) blocker treatment in Chinese Han patients suffering from ankylosing spondylitis (AS). Methods The study included 402 Chinese Han AS patients treated with TNF-alpha blockers. Baseline data was collected. All patients were monitored for adverse events 2 hours following administration. Long-term treatment was evaluated at 8, 12, 52 and 104 weeks follow-up for 172 patients treated with TNF-alpha blockers. Results Short-term adverse events occurred in 20.15% (81/402), including rash (3.5%; 14/402), pruritus (1.2%; 5/402), nausea (2.2%; 9/402), headache (0.7%; 3/402), skin allergies (4.0%; 16/402), fever (0.5%; 2/402), palpitations (3.0%; 12/402), dyspnea (0.5%; 2/402), chest pain (0.2%; 2/402), abdominal pain (1.0%; 4/402), hypertension (2.2%; 9/402), papilledema (0.5%; 2/402), laryngeal edema (0.2%; 1/402) and premature ventricular contraction (0.2%; 1/402). Long-term adverse events occurred in 59 (34.3%; 59/172) patients, including pneumonia (7.6%; 13/172), urinary tract infections (9.9%; 17/172), otitis media (4.7%; 8/172), tuberculosis (3.5%; 17/172), abscess (1.2%; 2/172), oral candidiasis (0.6%; 1/172), elevation of transaminase (1.7%; 3/172), anemia (1.2%; 2/172), hematuresis (0.6%; 1/172), constipation (2.3%; 4/172), weight loss (0.6%; 1/172), exfoliative dermatitis (0.6%; 1/172). CRP, ESR and disease duration were found to be associated with an increased risk of immediate and long-term adverse events (P<0.05). Long-term treatment with Infliximab was associated with more adverse events than rhTNFR-Fc (P<0.01). Conclusion This study reports on the prevalence of adverse events in short-term and long-term treatment with TNF-alpha blocker monotherapy in Chinese Han AS patients. Duration of disease, erythrocyte sedimentation rate, and c-reactive protein serum levels were found to be associated with increased adverse events with anti-TNF-alpha therapy. Long-term treatment with Infliximab was associated with more adverse events than rhTNFR-Fc.	[Tong, Qiang; Cai, Qing; Xu, Xia; Dai, Shengming; Zhao, Dongbao] Second Mil Med Univ, Dept Rheumatol & Immunol, Shanghai 200433, Peoples R China; [de Mooij, Tristan] Mayo Clin, Dept Neurosurg, Rochester, MN 55902 USA; [Qu, Wenchun] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55902 USA; [Qu, Wenchun] Mayo Clin, Dept Anesthesiol Pain Div, Rochester, MN 55902 USA	Naval Medical University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Zhao, DB (corresponding author), Second Mil Med Univ, Dept Rheumatol & Immunol, 168 Changhai Rd, Shanghai 200433, Peoples R China.	dongbaozhao@163.com	Tong, Qiang/AAA-2670-2021	Dai, Sheng-Ming/0000-0001-8876-4205	National Natural Science Foundation of China (NSFC) [H1008, 81302580]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding has generously been supplied by National Natural Science Foundation of China (NSFC) under grant number H1008, 81302580 to Qiang Tong (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten D, 2003, ANN RHEUM DIS, V62, P829, DOI 10.1136/ard.62.9.829; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Bakland G, 2011, J RHEUMATOL, V38, P479, DOI 10.3899/jrheum.100686; de Moraes JCB, 2010, REV BRAS REUMATOL, V50, P165, DOI 10.1590/S0482-50042010000200006; Bonafede M, 2012, ADV THER, V29, P664, DOI 10.1007/s12325-012-0037-5; Braun J, 2011, ARTHRITIS RHEUM-US, V63, P1543, DOI 10.1002/art.30223; Callhoff J, 2014, ANN RHEUM DIS; Dillon CF, 2011, AM J MED SCI, V341, P281, DOI 10.1097/MAJ.0b013e31820f8c83; Dixon WG, 2006, ARTHRITIS RHEUM-US, V54, P2368, DOI 10.1002/art.21978; Eudy A, 2014, LUPUS; Fouache D, 2009, RHEUMATOLOGY, V48, P761, DOI 10.1093/rheumatology/kep083; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gerloni V, 2008, ANN RHEUM DIS, V67, P1145, DOI 10.1136/ard.2007.069484; Guellec D, 2014, JOINT BONE SPINE, V81, P308, DOI 10.1016/j.jbspin.2014.01.003; Huang Feng, 2006, Zhonghua Nei Ke Za Zhi, V45, P122; Kapetanovic MC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2020; Lee HH, 2007, BRIT J DERMATOL, V156, P486, DOI 10.1111/j.1365-2133.2007.07682.x; Martin-Mola E, 2010, CLIN EXP RHEUMATOL, V28, P238; Nagy Gabriella, 2011, Orvosi Hetilap, V152, P212, DOI 10.1556/OH.2011.28987; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Peisajovich A, 2008, EXPERT REV CLIN IMMU, V4, P379, DOI 10.1586/1744666X.4.3.379; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Schett G, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/1478-6354-13-S1-S4, 10.1186/ar3095]; Suwannalai P, 2009, INT J RHEUM DIS, V12, P118, DOI 10.1111/j.1756-185X.2009.01393.x; Tong Q, 2013, PHARMACOGENOMICS, V14, P1691, DOI 10.2217/pgs.13.146; Tong Q, 2012, PHARMACOGENOMICS, V13, P1459, DOI [10.2217/PGS.12.133, 10.2217/pgs.12.133]; Tristano AG, 2010, J NEUROL, V257, P1421, DOI 10.1007/s00415-010-5591-7; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vultaggio A, 2010, ALLERGY, V65, P657, DOI 10.1111/j.1398-9995.2009.02280.x	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119897	10.1371/journal.pone.0119897	http://dx.doi.org/10.1371/journal.pone.0119897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764452	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300034
J	Versluis, M; de Lange, MJ; van Pelt, SI; Ruivenkamp, CAL; Kroes, WGM; Cao, JF; Jager, MJ; Luyten, GPM; van der Velden, PA				Versluis, Mieke; de lange, Mark J.; van Pelt, Sake I.; Ruivenkamp, Claudia A. L.; Kroes, Wilma G. M.; Cao, Jinfeng; Jager, Martine J.; Luyten, Gre P. M.; van der Velden, Pieter A.			Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; ABNORMALITIES; GENOME	Background Uveal melanoma (UM) development and progression is correlated with specific molecular changes. Recurrent mutations in GNAQ and GNA11 initiate UM development while tumour progression is correlated with monosomy of chromosome 3 and gain of chromosome 8q. Hence, molecular analysis of UM is useful for diagnosis and prognosis. The aim of this study is to evaluate the use of digital PCR (dPCR) for molecular analysis of UM. Methods A series of 66 UM was analysed with dPCR for three hotspot mutations in GNAQ/GNA11 with mutation specific probes. The status of chromosomes 3 and 8 were analysed with genomic probes. The results of dPCR analysis were cross-validated with Sanger sequencing, SNP array analysis, and karyotyping. Results Using dPCR, we were able to reconstitute the molecular profile of 66 enucleated UM. With digital PCR, GNAQ/GNA11 mutations were detected in 60 of the 66 UM. Sanger sequencing revealed three rare variants, and, combined, these assays revealed GNAQ/GNA11 mutations in 95% of UM. Monosomy 3 was present in 43 and chromosome 8 aberrations in 52 of the 66 UM. Survival analysis showed that increasing 8q copy numbers were positively correlated with metastasis risk. Conclusion Molecular analysis with dPCR is fast and sensitive. Just like the recurrent genomic aberrations of chromosome 3 and 8, hotspot mutations in GNAQ and GNA11 are effectively detected in heterogeneous samples. Increased sensitivity contributes to the number of mutations and chromosomal aberrations detected. Moreover, quantification of copy number with dPCR validated 8q dosage as a sensitive prognostic tool in UM, of which implementation in disease prediction models will further improve prognostication.	[Versluis, Mieke; de lange, Mark J.; van Pelt, Sake I.; Cao, Jinfeng; Jager, Martine J.; Luyten, Gre P. M.; van der Velden, Pieter A.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [Ruivenkamp, Claudia A. L.; Kroes, Wilma G. M.] Leiden Univ, Med Ctr, Dept Clin Genet, Lab Diagnost Genome Anal LDGA, Leiden, Netherlands; [Cao, Jinfeng] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun 130023, Peoples R China	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Jilin University	de Lange, MJ (corresponding author), Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands.	delange@lumc.nl	Jager, Martine/AAR-3525-2020; Kroes, Wilma/AAC-4436-2022	Jager, Martine/0000-0003-2261-3820; Kroes, Wilma/0000-0002-9469-2807; van der Velden, Pieter/0000-0002-5710-9256	Dutch cancer society [UL2011-4991]	Dutch cancer society(KWF Kankerbestrijding)	The work was supported by Dutch cancer society, grant no. UL2011-4991, received by PAvdV.	Cassoux N, 2014, BRIT J OPHTHALMOL, V98, P769, DOI 10.1136/bjophthalmol-2013-303867; Damato B, 2010, CLIN CANCER RES, V16, P6083, DOI 10.1158/1078-0432.CCR-10-2076; Damato B, 2009, INVEST OPHTH VIS SCI, V50, P3048, DOI 10.1167/iovs.08-3165; DELACHAPELLE A, 1982, CANCER GENET CYTOGEN, V5, P173, DOI 10.1016/0165-4608(82)90007-3; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; Ewens KG, 2013, INVEST OPHTH VIS SCI, V54, P5721, DOI 10.1167/iovs.13-12195; Hoglund M, 2004, INT J CANCER, V108, P57, DOI 10.1002/ijc.11558; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; MCLEAN IW, 1983, AM J OPHTHALMOL, V96, P502, DOI 10.1016/S0002-9394(14)77914-0; Parrella P, 2001, INVEST OPHTH VIS SCI, V42, P1679; Parrella P, 1999, CANCER RES, V59, P3032; Prescher G, 1996, LANCET, V347, P1222; PRESCHER G, 1990, J NATL CANCER I, V82, P1765, DOI 10.1093/jnci/82.22.1765; PRESCHER G, 1994, CANCER GENET CYTOGEN, V77, P144, DOI 10.1016/0165-4608(94)90230-5; SINGH AD, 1994, CANCER GENET CYTOGEN, V72, P109, DOI 10.1016/0165-4608(94)90125-2; Sisley K, 1997, GENE CHROMOSOME CANC, V19, P22, DOI 10.1002/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2; Trolet J, 2009, INVEST OPHTH VIS SCI, V50, P2572, DOI 10.1167/iovs.08-2296; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2008, NATURE; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973	21	67	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0116371	10.1371/journal.pone.0116371	http://dx.doi.org/10.1371/journal.pone.0116371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764247	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300006
J	Dawes, P; Emsley, R; Cruickshanks, KJ; Moore, DR; Fortnum, H; Edmondson-Jones, M; McCormack, A; Munro, KJ				Dawes, Piers; Emsley, Richard; Cruickshanks, Karen J.; Moore, David R.; Fortnum, Heather; Edmondson-Jones, Mark; McCormack, Abby; Munro, Kevin J.			Hearing Loss and Cognition: The Role of Hearing Aids, Social Isolation and Depression	PLOS ONE			English	Article							OLDER-ADULTS; SELF-EFFICACY; IMPAIRMENT; DECLINE; AGE; LIFE; ASSOCIATION; POPULATION; CONNECTION; PREVALENCE	Hearing loss is associated with poor cognitive performance and incident dementia and may contribute to cognitive decline. Treating hearing loss with hearing aids may ameliorate cognitive decline. The purpose of this study was to test whether use of hearing aids was associated with better cognitive performance, and if this relationship was mediated via social isolation and/or depression. Structural equation modelling of associations between hearing loss, cognitive performance, social isolation, depression and hearing aid use was carried out with a subsample of the UK Biobank data set (n = 164,770) of UK adults aged 40 to 69 years who completed a hearing test. Age, sex, general health and socioeconomic status were controlled for as potential confounders. Hearing aid use was associated with better cognition, independently of social isolation and depression. This finding was consistent with the hypothesis that hearing aids may improve cognitive performance, although if hearing aids do have a positive effect on cognition it is not likely to be via reduction of the adverse effects of hearing loss on social isolation or depression. We suggest that any positive effects of hearing aid use on cognition may be via improvement in audibility or associated increases in self-efficacy. Alternatively, positive associations between hearing aid use and cognition may be accounted for by more cognitively able people seeking and using hearing aids. Further research is required to determine the direction of association, if there is any direct causal relationship between hearing aid use and better cognition, and whether hearing aid use results in reduction in rates of cognitive decline measured longitudinally.	[Dawes, Piers; Munro, Kevin J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Emsley, Richard] Univ Manchester, Ctr Biostat, Inst Populat Hlth, Manchester, Lancs, England; [Cruickshanks, Karen J.] Univ Wisconsin, Populat Hlth Sci & Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA; [Moore, David R.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Moore, David R.] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati, OH USA; [Moore, David R.; Fortnum, Heather; Edmondson-Jones, Mark; McCormack, Abby] NIHR Nottingham Hearing Biomed Res Unit, Nottingham, England; [Moore, David R.; McCormack, Abby] MRC, Inst Hearing Res, Nottingham, England; [Fortnum, Heather; Edmondson-Jones, Mark] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham NG7 2RD, England; [Munro, Kevin J.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Wisconsin System; University of Wisconsin Madison; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Nottingham; University of Manchester	Dawes, P (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	piers.dawes@manchester.ac.uk	Emsley, Richard/N-1342-2016; munro, kevin/A-2899-2015	Emsley, Richard/0000-0002-1218-675X; munro, kevin/0000-0001-6543-9098; Hunter, Abby/0000-0002-6533-6918; Dawes, Piers/0000-0003-3180-9884	National Institute for Health Research (NIHR); Intramural Programme of the Medical Research Council [U135097130]; Cincinnati Children's Hospital; Research to Prevent Blindness;  [R37AG11099];  [R01AG021917]; Medical Research Council [MC_qA137853, MC_U135097130] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R37AG011099, R01AG021917] Funding Source: NIH RePORTER; MRC [MC_U135097130] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Intramural Programme of the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cincinnati Children's Hospital; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This paper presents independent research funded in part by the National Institute for Health Research (NIHR). The Nottingham Hearing Biomedical Research Unit is funded by the National Institute for Health Research. DRM was supported by the Intramural Programme of the Medical Research Council [grant U135097130] and by Cincinnati Children's Hospital. KJC was supported by R37AG11099, R01AG021917 and an Unrestricted Grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; BANDURA A, 1989, DEV PSYCHOL, V25, P729, DOI 10.1037/0012-1649.25.5.729; Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Berg AO, 2002, ANN INTERN MED, V136, P760, DOI 10.7326/0003-4819-136-10-200205210-00012; Birren JE, 1964, PSYCHOL AGING; BOUFFARDBOUCHARD T, 1990, J SOC PSYCHOL, V130, P353, DOI 10.1080/00224545.1990.9924591; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Hall J.S., 2006, DEV NEW ENGLISH SENT; Kalluri S, 2012, AM J AUDIOL, V21, P338, DOI 10.1044/1059-0889(2012/12-0026); Kline R.B., 2011, PRINCIPLES PRACTICE; Kochkin S., 2000, HEAR REV, V7, P6; Kramer SE, 2002, J AGING HEALTH, V14, P122, DOI 10.1177/089826430201400107; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin MY, 2004, J AM GERIATR SOC, V52, P1996, DOI 10.1111/j.1532-5415.2004.52554.x; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Moyer VA, 2012, ANN INTERN MED, V157, P655, DOI 10.7326/0003-4819-157-9-201211060-00526; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; Norman P., 2010, APPL SPAT ANAL POLIC, V3, P107, DOI [10.1007/s12061-009-9036-6, DOI 10.1007/S12061-009-9036-6]; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; RABBITT P, 1991, ACTA OTO-LARYNGOL, P167; Smits C, 2004, INT J AUDIOL, V43, P15, DOI 10.1080/14992020400050004; Steffens DC, 2006, ARCH GEN PSYCHIAT, V63, P130, DOI 10.1001/archpsyc.63.2.130; Strawbridge WJ, 2000, GERONTOLOGIST, V40, P320, DOI 10.1093/geront/40.3.320; Tay T, 2006, GERONTOLOGY, V52, P386, DOI 10.1159/000095129; TeschRomer C, 1997, J GERONTOL B-PSYCHOL, V52, pP127, DOI 10.1093/geronb/52B.3.P127; Ulhmann R.F., 1989, JAMA-J AM MED ASSOC, V261, P1916; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; Vlaming MSMG, 2011, ACTA ACUST UNITED AC, V97, P175, DOI 10.3813/AAA.918397; Wahl HW, 2003, GENERATIONS, V27, P39; Wimo A, 2010, WORLD ALZHEIMER REPO	34	238	243	6	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119616	10.1371/journal.pone.0119616	http://dx.doi.org/10.1371/journal.pone.0119616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760329	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000063
J	Makino, S; Zhulyn, O; Mo, R; Puviindran, V; Zhang, XY; Murata, T; Fukumura, R; Ishitsuka, Y; Kotaki, H; Matsumaru, D; Ishii, S; Hui, CC; Gondo, Y				Makino, Shigeru; Zhulyn, Olena; Mo, Rong; Puviindran, Vijitha; Zhang, Xiaoyun; Murata, Takuya; Fukumura, Ryutaro; Ishitsuka, Yuichi; Kotaki, Hayato; Matsumaru, Daisuke; Ishii, Shunsuke; Hui, Chi-Chung; Gondo, Yoichi			T396I Mutation of Mouse Sufu Reduces the Stability and Activity of Gli3 Repressor	PLOS ONE			English	Article							SONIC HEDGEHOG; INDEPENDENT REGULATION; NEGATIVE REGULATOR; SUPPRESSOR; SHH; ACTIVATION; DETERMINANT; INVOLVEMENT; MUTANTS; DEFECTS	Hedgehog signaling is primarily transduced by two transcription factors: Gli2, which mainly acts as a full-length activator, and Gli3, which tends to be proteolytically processed from a full-length form (Gli3(FL)) to an N-terminal repressor (Gli3(REP)). Recent studies using a Sufu knockout mouse have indicated that Sufu is involved in regulating Gli2 and Gli3 activator and repressor activity at multiple steps of the signaling cascade; however, the mechanism of specific Gli2 and Gli3 regulation remains to be elucidated. In this study, we established an allelic series of ENU-induced mouse strains. Analysis of one of the missense alleles, Sufu(T396I), showed that Thr(396)residue of Sufu played a key role in regulation of Gli3 activity. Sufu(T396I)/(T396I) embryos exhibited severe polydactyly, which is indicative of compromised Gli3 activity. Concomitantly, significant quantitative reductions of unprocessed Gli3 (Gli3(FL)) and processed Gli3 (Gli3(REP)) were observed in vivo as well as in vitro. Genetic experiments showed that patterning defects in the limb buds of Sufu(T396I)/(T396I) were rescued by a constitutive Gli3(REP) allele (Gli3.699), strongly suggesting that Sufu(T396I) reduced the truncated Gli3 repressor. In contrast, Sufu(T396I) qualitatively exhibited no mutational effects on Gli2 regulation. Taken together, the results of this study show that the Thr396residue of Sufu is specifically required for regulation of Gli3 but not Gli2. This implies a novel Sufu-mediated mechanism in which Gli2 activator and Gli3 repressor are differentially regulated.	[Makino, Shigeru; Murata, Takuya; Fukumura, Ryutaro; Ishitsuka, Yuichi; Kotaki, Hayato; Gondo, Yoichi] RIKEN, BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki, Japan; [Zhulyn, Olena; Mo, Rong; Puviindran, Vijitha; Zhang, Xiaoyun; Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Zhulyn, Olena; Mo, Rong; Puviindran, Vijitha; Zhang, Xiaoyun; Hui, Chi-Chung] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Matsumaru, Daisuke] Wakayama Med Univ, Inst Adv Med, Dept Dev Genet, Wakayama, Japan; [Ishii, Shunsuke] RIKEN, Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki, Japan	RIKEN; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wakayama Medical University; RIKEN	Makino, S (corresponding author), RIKEN, BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki, Japan.	shmakino@brc.riken.jp	Murata, Takuya/L-3298-2016; Gondo, Yoichi/A-5375-2016; Ishii, Shunsuke/A-5271-2016; Murata, Takuya/AAE-8001-2020	Murata, Takuya/0000-0003-4185-1883; Gondo, Yoichi/0000-0003-2184-6489; Ishii, Shunsuke/0000-0002-6530-2478; Murata, Takuya/0000-0003-4185-1883; Matsumaru, Daisuke/0000-0002-1832-624X	JSPS (Japan Society for the Promotion of Science) [21700454, 25440096, 21240043, 25241016, 15200032]; Incentive Research Grant of RIKEN; Grants-in-Aid for Scientific Research [25440096] Funding Source: KAKEN	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Incentive Research Grant of RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 21700454, (SM), 25440096 (SM), 21240043 (YG, SM, TM, and RF), 25241016 (YG), 15200032 (YG) and Incentive Research Grant of RIKEN (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cherry AL, 2013, ACTA CRYSTALLOGR D, V69, P2563, DOI 10.1107/S0907444913028473; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Ding Q, 1998, DEVELOPMENT, V125, P2533; Galli A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000901; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; Hill P, 2009, DEV BIOL, V328, P506, DOI 10.1016/j.ydbio.2009.02.017; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Law KKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050193; Liu JL, 2012, DEV BIOL, V362, P141, DOI 10.1016/j.ydbio.2011.11.022; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Mo R, 1997, DEVELOPMENT, V124, P113; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Park HL, 2000, DEVELOPMENT, V127, P1593; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Stone DM, 1999, J CELL SCI, V112, P4437; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zeller R, 2010, CURR OPIN GENET DEV, V20, P384, DOI 10.1016/j.gde.2010.04.014; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002	53	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119455	10.1371/journal.pone.0119455	http://dx.doi.org/10.1371/journal.pone.0119455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760946	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000058
J	Andersson, J; Hjalten, J; Dynesius, M				Andersson, Jon; Hjalten, Joakim; Dynesius, Mats			Wood-Inhabiting Beetles in Low Stumps, High Stumps and Logs on Boreal Clear-Cuts: Implications for Dead Wood Management	PLOS ONE			English	Article							SAPROXYLIC BEETLES; SPECIES RICHNESS; FOMES-FOMENTARIUS; FUNCTIONAL-GROUPS; FOREST LANDSCAPE; SPRUCE FORESTS; NORWAY SPRUCE; PICEA-ABIES; SWEDEN; BIODIVERSITY	The increasing demand for biofuels from logging residues require serious attention on the importance of dead wood substrates on clear-cuts for the many forestry-intolerant saproxylic (wood-inhabiting) species. In particular, the emerging harvest of low stumps motivates further study of these substrates. On ten clear-cuts we compared the species richness, abundance and species composition of saproxylic beetles hatching from four to nine year old low stumps, high stumps and logs of Norway spruce. By using emergence traps we collected a total of 2,670 saproxylic beetles among 195 species during the summers of 2006, 2007 and 2009. We found that the species assemblages differed significantly between high stumps and logs all three years. The species assemblages of low stumps, on the other hand, were intermediate to those found in logs and high stumps. There were also significant difference in species richness between the three examined years, and we found significant effect of substrate type on richness of predators and fungivores. As shown in previous studies of low stumps on clear-cuts they can sustain large numbers of different saproxylic beetles, including red-listed species. Our study does, in addition to this fact, highlight a possible problem in creating just one type of substrate as a tool for conservation in forestry. Species assemblages in high stumps did not differ significantly from those found in low stumps. Instead logs, which constitute a scarcer substrate type on clear-cuts, provided habitat for a more distinct assemblage of saproxylic species than high stumps. It can therefore be questioned whether high stumps are an optimal tool for nature conservation in clear-cutting forestry. Our results also indicate that low stumps constitute an equally important substrate as high stumps and logs, and we therefore suggest that stump harvesting is done after carefully evaluating measures to provide habitat for saproxylic organisms.	[Andersson, Jon; Hjalten, Joakim] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Dynesius, Mats] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Swedish University of Agricultural Sciences; Umea University	Andersson, J (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	Jon.Andersson@slu.se	Dynesius, Mats/A-6219-2009	Dynesius, Mats/0000-0003-0628-4203; Hjalten, Joakim/0000-0002-8279-6633	Swedish Energy Agency	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	The study was financed by The Swedish Energy Agency (http://www.energimyndigheten.se, Grant to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson M, 2006, FOREST ECOL MANAG, V226, P230, DOI 10.1016/j.foreco.2006.01.046; Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; [Anonymous], 2007, SAPROXYLIC DATABASE; Bates D, LME4 LINEAR MIXED EF; BERG A, 1994, CONSERV BIOL, V8, P718, DOI 10.1046/j.1523-1739.1994.08030718.x; Berglund H, 2011, ECOGRAPHY, V34, P864, DOI 10.1111/j.1600-0587.2010.06141.x; Berglund H, 2011, FOREST ECOL MANAG, V261, P1293, DOI 10.1016/j.foreco.2011.01.008; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Bouget C, 2012, CAN J FOREST RES, V42, P1421, DOI [10.1139/X2012-078, 10.1139/x2012-078]; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; Dahlberg A, 2004, VEDLEVANDE ARTERS KR; Dahlberg A, 2011, CAN J FOREST RES, V41, P1220, DOI [10.1139/X11-034, 10.1139/x11-034]; Djupstrom LB, 2012, BIOL CONSERV, V155, P44, DOI 10.1016/j.biocon.2012.06.009; Egnell G, 2007, ENERGIMYNDIGHETEN, P40; Ekbom B, 2006, FOREST ECOL MANAG, V221, P2, DOI 10.1016/j.foreco.2005.10.038; Erajaa S, 2010, SILVA FENN, V44, P203, DOI 10.14214/sf.150; Esseen P-A, 1992, ECOLOGICAL PRINCIPLE, P252; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Faldt J, 1999, J CHEM ECOL, V25, P567, DOI 10.1023/A:1020958005023; Fossestol KO, 2009, SCAND J FOREST RES, V24, P403, DOI 10.1080/02827580903143871; Franc N, 2007, CAN J FOREST RES, V37, P2494, DOI 10.1139/X07-096; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gardenfors U., 2010, RED LIST SWEDISH SPE; Geijer E, 2014, J FOREST ECON, V20, P111, DOI 10.1016/j.jfe.2014.01.001; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hjalten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041100; Hjalten J, 2010, FOREST ECOL MANAG, V260, P1149, DOI 10.1016/j.foreco.2010.07.003; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johansson T, 2007, FOREST ECOL MANAG, V242, P496, DOI 10.1016/j.foreco.2007.01.062; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jonsell M, 2007, BIOL CONSERV, V138, P89, DOI 10.1016/j.biocon.2007.04.003; Jonsell M, 2011, SILVA FENN, V45, P1053, DOI 10.14214/sf.86; Jonsell Mats, 2001, Ecological Bulletins, V49, P173; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Kaila L, 1997, BIODIVERS CONSERV, V6, P1, DOI 10.1023/A:1018399401248; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Kruys N, 1999, CAN J FOREST RES, V29, P1295, DOI 10.1139/cjfr-29-8-1295; Linder P, 1997, FOREST ECOL MANAG, V98, P17, DOI 10.1016/S0378-1127(97)00076-5; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; Lindhe A, 2004, FOREST ECOL MANAG, V203, P1, DOI 10.1016/j.foreco.2004.07.047; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oksanen J., **DATA OBJECT**; Ols C, 2013, FOREST ECOL MANAG, V290, P15, DOI 10.1016/j.foreco.2012.08.040; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; R Development Core Team, R LANG ENV STAT COMP; Russo D, 2011, J INSECT CONSERV, V15, P685, DOI 10.1007/s10841-010-9366-3; Schroeder LM, 2006, CAN J FOREST RES, V36, P2168, DOI 10.1139/X06-119; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Silfverberg H., 2004, ENUMERATIO NOVA COEL; Speight M.C., 1989, SAPROXYLIC INVERTEBR; Stenbacka F, 2010, ECOL APPL, V20, P2310, DOI 10.1890/09-0815.1; Stokland JN, 2012, ECOL BIODIVERS CONS, P110; Sverdrup-Thygeson A, 2002, BIOL CONSERV, V106, P347, DOI 10.1016/S0006-3207(01)00261-0; Thunes KH, 1997, J NAT HIST, V31, P471, DOI 10.1080/00222939700770241; Walmsley JD, 2010, FORESTRY, V83, P17, DOI 10.1093/forestry/cpp028; Wang Y, MVABUND STAT METHODS; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Weslien J, 2011, J ANIM ECOL, V80, P1155, DOI 10.1111/j.1365-2656.2011.01860.x; Wikars LO, 2005, CAN ENTOMOL, V137, P304, DOI 10.4039/N04-104	62	30	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118896	10.1371/journal.pone.0118896	http://dx.doi.org/10.1371/journal.pone.0118896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756871	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275700030
J	Chen, Q; Xu, HS; Xu, AJ; Ross, T; Bowler, E; Hu, Y; Lesnefsky, EJ				Chen, Qun; Xu, Haishan; Xu, Aijun; Ross, Thomas; Bowler, Elizabeth; Hu, Ying; Lesnefsky, Edward J.			Inhibition of Bcl-2 Sensitizes Mitochondrial Permeability Transition Pore (MPTP) Opening in Ischemia-Damaged Mitochondria	PLOS ONE			English	Article							RAT-HEART MITOCHONDRIA; ELECTRON-TRANSPORT; MEMBRANE PERMEABILIZATION; CYTOCHROME-OXIDASE; MYOCARDIAL INJURY; CARDIAC ISCHEMIA; REPERFUSION; APOPTOSIS; PROTECTS; CARDIOPROTECTION	Background Mitochondria are critical to cardiac injury during reperfusion as a result of damage sustained during ischemia, including the loss of bcl-2. We asked if bcl-2 depletion not only leads to selective permeation of the outer mitochondrial membrane (MOMP) favoring cytochrome c release and programmed cell death, but also favors opening of the mitochondrial permeability transition pore (MPTP). An increase in MPTP susceptibility would support a role for bcl-2 depletion mediated cell death in the calcium overload setting of early reperfusion via MPTP as well as later in reperfusion via MOMP as myocardial calcium content normalizes. Methods Calcium retention capacity (CRC) was used to reflect the sensitivity of the MPTP opening in isolated cardiac mitochondria. To study the relationship between bcl-2 inhibition and MPTP opening, mitochondria were incubated with a bcl-2 inhibitor (HA14-1) and CRC measured. The contribution of preserved bcl-2 content to MPTP opening following ischemia-reperfusion was explored using transgenic bcl-2 overexpressed mice. Results CRC was decreased in mitochondria following reperfusion compared to ischemia alone, indicating that reperfusion further sensitizes to MPTP opening. Incubation of ischemia-damaged mitochondria with increasing HA14-1concentrations increased calcium-stimulated MPTP opening, supporting that functional inhibition of bcl-2 during simulated reperfusion favors MPTP opening. Moreover, HA14-1 sensitivity was increased by ischemia compared to non-ischemic controls. Overexpression of bcl-2 attenuated MPTP opening in following ischemia-reperfusion. HA14-1 inhibition also increased the permeability of the outer membrane in the absence of exogenous calcium, indicating that bcl-2 inhibition favors MOMP when calcium is low. Conclusions The depletion and functional inhibition of bcl-2 contributes to cardiac injury by increasing susceptibility to MPTP opening in high calcium environments and MOMP in the absence of calcium overload. Thus, ischemia-damaged mitochondria with decreased bcl-2 content are susceptible to MPTP opening in early reperfusion and MOMP later in reperfusion when cytosolic calcium has normalized.	[Chen, Qun; Xu, Haishan; Xu, Aijun; Ross, Thomas; Bowler, Elizabeth; Hu, Ying; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Med, Pauley Heart Ctr, Div Cardiol, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Med, Pauley Heart Ctr, Div Biochem, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] McGuire Dept Vet Affairs Med Ctr, Richmond, VA USA; [Xu, Aijun] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Anesthesiol, Wuhan 430074, Peoples R China; [Bowler, Elizabeth] Univ W England, Bristol BS16 1QY, Avon, England	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Huazhong University of Science & Technology; University of West England	Lesnefsky, EJ (corresponding author), Virginia Commonwealth Univ, Dept Med, Pauley Heart Ctr, Div Cardiol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	edward.lesnefsky@va.gov	Chen, Qun/HGD-0868-2022		Office of Research and Development, Medical Research Service, Department of Veterans Affairs; Scientist Development Grant from the American Heart Association; Pauley Heart Center of Virginia Commonwealth University	Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Scientist Development Grant from the American Heart Association(American Heart Association); Pauley Heart Center of Virginia Commonwealth University	This work was supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs (EJL), a Scientist Development Grant from the American Heart Association (QC) and the Pauley Heart Center of Virginia Commonwealth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JZ, 2001, AM J PHYSIOL-HEART C, V281, pH1508, DOI 10.1152/ajpheart.2001.281.4.H1508; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chen Q, 2006, J PHARMACOL EXP THER, V316, P200, DOI 10.1124/jpet.105.091702; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Chen Q, 2012, J CARDIOVASC PHARM, V59, P101, DOI 10.1097/FJC.0b013e31823827cc; Chen Q, 2011, BIOCHEM BIOPH RES CO, V415, P533, DOI 10.1016/j.bbrc.2011.10.037; Chen Q, 2011, FEBS LETT, V585, P921, DOI 10.1016/j.febslet.2011.02.029; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Lesnefsky EJ, 1977, AM J PHYSIOL-HEART C, V273, pH1544; Murphy E, 2005, TRENDS CARDIOVAS MED, V15, P283, DOI 10.1016/j.tcm.2005.09.002; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Obame FN, 2007, J PHARMACOL EXP THER, V323, P336, DOI 10.1124/jpet.107.124255; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Ozaki T, 2007, J BIOCHEM, V142, P365, DOI 10.1093/jb/mvm143; Paillard M, 2009, J MOL CELL CARDIOL, V46, P902, DOI 10.1016/j.yjmcc.2009.02.017; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Xu AJ, 2013, BIOCHEM BIOPH RES CO, V435, P627, DOI 10.1016/j.bbrc.2013.05.033; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	32	40	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118834	10.1371/journal.pone.0118834	http://dx.doi.org/10.1371/journal.pone.0118834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756500	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700027
J	Kim, S; Lee, H; Lee, S; Yoon, Y; Choi, KH				Kim, Sejeong; Lee, Heeyoung; Lee, Soomin; Yoon, Yohan; Choi, Kyoung-Hee			Antimicrobial Action of Oleanolic Acid on Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; URSOLIC ACIDS; EPIDEMIOLOGY; PREVALENCE; RESISTANCE; LACTATE; MODE	This study investigated the antimicrobial action of oleanolic acid against Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis. To determine the cytotoxicity of oleanolic acid, HEp-2 cells were incubated with oleanolic acid at 37 degrees C. MICs (minimal inhibition concentrations) for Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis were determined using two-fold microdilutions of oleanolic acid, and bacterial cell viability was then assessed by exposing the bacteria to oleanolic acid at 2 x MIC. To investigate the mode of antimicrobial action of oleanolic acid, we measured leakage of compounds absorbing at 280 nm, along with propidium iodide uptake. Scanning electron microscope (SEM) images were also analysed. The viability of HEp-2 cells decreased (P < 0.05) at oleanolic acid concentrations greater than 128 mu g mL(-1). The MICs were 16-32 mu g mL(-1) for Listeria monocytogenes and 32-64 mu g mL(-1) for Enterococcus faecium and Enterococcus faecalis, and bacterial cell viability decreased (P < 0.05) about 3-4 log CFU mL(-1) after exposure to 2 x MIC of oleanolic acid. Leakage of 280 nm absorbing materials and propidium iodide uptake was higher in oleanolic acid-treated cells than in the control. The cell membrane was damaged in oleanolic acid-treated cells, but the control group had intact cell membrane in SEM images. The results indicate that oleanolic acid can kill Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis by destroying the bacterial cell membrane.	[Kim, Sejeong; Lee, Heeyoung; Lee, Soomin; Yoon, Yohan] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Choi, Kyoung-Hee] Wonkwang Univ, Coll Dent, Dept Oral Microbiol, Iksan, Jeonbuk, South Korea	Sookmyung Women's University; Wonkwang University	Yoon, Y (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea.	yyoon@sookmyung.ac.kr; kheechoi@wku.ac.kr		Kim, Sejeong/0000-0001-9741-8056	Wonkwang University	Wonkwang University	This paper was supported by Wonkwang University in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzitey F, 2013, FOOD CONTROL, V32, P607, DOI 10.1016/j.foodcont.2012.12.016; Bereksi N, 2002, J APPL MICROBIOL, V92, P556, DOI 10.1046/j.1365-2672.2002.01564.x; Cox SD, 2000, J APPL MICROBIOL, V88, P170, DOI 10.1046/j.1365-2672.2000.00943.x; de Gonzalez MTN, 2004, J FOOD PROTECT, V67, P915; Ennaji Hayat, 2008, Infect Drug Resist, V1, P45; Fontanay S, 2008, J ETHNOPHARMACOL, V120, P272, DOI 10.1016/j.jep.2008.09.001; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Gelsomino R, 2002, APPL ENVIRON MICROB, V68, P3560, DOI 10.1128/AEM.68.7.3560-3565.2002; Horiuchi K, 2007, BIOL PHARM BULL, V30, P1147, DOI 10.1248/bpb.30.1147; Hung CY, 2001, LEBENSM-WISS TECHNOL, V34, P306, DOI 10.1006/fstl.2001.0775; Hunt CP, 1998, BRIT J BIOMED SCI, V55, P149; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Jimenez-Arellanes A, 2007, J ETHNOPHARMACOL, V111, P202, DOI 10.1016/j.jep.2006.11.033; Kinjo J, 1999, CHEM PHARM BULL, V47, P290, DOI 10.1248/cpb.47.290; Kozai K, 1999, MICROBIOS, V97, P179; Kurek A, 2014, POL J MICROBIOL, V63, P21; Kurek A, 2010, ANTON LEEUW INT J G, V97, P61, DOI 10.1007/s10482-009-9388-6; LEE BL, 1991, ANTIMICROB AGENTS CH, V35, P2505, DOI 10.1128/AAC.35.12.2505; Madlala HP, 2012, RENAL FAILURE, V34, P767, DOI 10.3109/0886022X.2012.678172; Majhenic AC, 2005, INT J FOOD MICROBIOL, V102, P239, DOI 10.1016/j.ijfoodmicro.2004.12.021; Mbandi E, 2002, INT J FOOD MICROBIOL, V76, P191, DOI 10.1016/S0168-1605(02)00026-0; Mellegard H, 2011, INT J FOOD MICROBIOL, V148, P48, DOI 10.1016/j.ijfoodmicro.2011.04.023; Ovesna Z, 2004, NEOPLASMA, V51, P327; Rahimi E, 2012, J FOOD PROTECT, V75, P2223, DOI 10.4315/0362-028X.JFP-11-565; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Reddy MV, 2010, EUR J MED CHEM, V45, P3125, DOI 10.1016/j.ejmech.2010.03.049; Saavedra L, 2003, INT J FOOD MICROBIOL, V88, P241, DOI 10.1016/S0168-1605(03)00186-7; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Szakiel A, 2008, PLANTA MED, V74, P1709, DOI 10.1055/s-0028-1088315; Templer SP, 2008, J FOOD PROTECT, V71, P2100, DOI 10.4315/0362-028X-71.10.2100; Tyagi AK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/382927; Wang X, 2010, CHEM-BIOL INTERACT, V184, P328, DOI 10.1016/j.cbi.2010.01.034; Wolska KI, 2010, CENT EUR J BIOL, V5, P543, DOI 10.2478/s11535-010-0045-x; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yan SL, 2010, TOXICOL IN VITRO, V24, P842, DOI 10.1016/j.tiv.2009.12.008; Yoon Y, 2010, KOREAN J FOOD SCI AN, V30, P717, DOI 10.5851/kosfa.2010.30.5.717; Zhou K, 2008, FOOD CONTROL, V19, P817, DOI 10.1016/j.foodcont.2007.08.008; 윤요한, 2010, [Journal of Life Science, 생명과학회지], V20, P321	38	29	33	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118800	10.1371/journal.pone.0118800	http://dx.doi.org/10.1371/journal.pone.0118800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756202	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275700024
J	Manavalan, LP; Prince, SJ; Musket, TA; Chaky, J; Deshmukh, R; Vuong, TD; Song, L; Cregan, PB; Nelson, JC; Shannon, JG; Specht, JE; Nguyen, HT				Manavalan, Lakshmi P.; Prince, Silvas J.; Musket, Theresa A.; Chaky, Julian; Deshmukh, Rupesh; Vuong, Tri D.; Song, Li; Cregan, Perry B.; Nelson, James C.; Shannon, J. Grover; Specht, James E.; Nguyen, Henry T.			Identification of Novel QTL Governing Root Architectural Traits in an Interspecific Soybean Population	PLOS ONE			English	Article							CYST-NEMATODE RESISTANCE; RECOMBINANT INBRED LINES; GLYCINE-SOJA SIEB.; DROUGHT TOLERANCE; TRANSCRIPTION FACTOR; NITROGEN-FIXATION; WATER RELATIONS; YIELD; SEED; WILD	Cultivated soybean (Glycine max L.) cv. Dunbar (PI 552538) and wild G. soja (PI 326582A) exhibited significant differences in root architecture and root-related traits. In this study, phenotypic variability for root traits among 251 BC2F5 backcross inbred lines (BILs) developed from the cross Dunbar/PI 326582A were identified. The root systems of the parents and BILs were evaluated in controlled environmental conditions using a cone system at seedling stage. The G. max parent Dunbar contributed phenotypically favorable alleles at a major quantitative trait locus on chromosome 8 (Satt315-I locus) that governed root traits (tap root length and lateral root number) and shoot length. This QTL accounted for >10% of the phenotypic variation of both tap root and shoot length. This QTL region was found to control various shoot-and root-related traits across soybean genetic backgrounds. Within the confidence interval of this region, eleven transcription factors (TFs) were identified. Based on RNA sequencing and Affymetrix expression data, key TFs including MYB, AP2-EREBP and bZIP TFs were identified in this QTL interval with high expression in roots and nodules. The backcross inbred lines with different parental allelic combination showed different expression pattern for six transcription factors selected based on their expression pattern in root tissues. It appears that the marker interval Satt315-I locus on chromosome 8 contain an essential QTL contributing to early root and shoot growth in soybean.	[Manavalan, Lakshmi P.; Prince, Silvas J.; Musket, Theresa A.; Deshmukh, Rupesh; Vuong, Tri D.; Song, Li; Shannon, J. Grover; Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Chaky, Julian; Specht, James E.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Cregan, Perry B.] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Nelson, James C.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); Kansas State University	Nguyen, HT (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	nguyenhenry@missouri.edu	Deshmukh, Rupesh Kailasrao/C-6479-2012; prince, silvas/I-1100-2019; PRINCE, SILVAS/I-6550-2019; Nelson, James/K-4263-2019	Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; PRINCE, SILVAS/0000-0002-7609-3210; 	United Soybean Board; Missouri Soybean Merchandising Council	United Soybean Board; Missouri Soybean Merchandising Council	This research was supported by the United Soybean Board, http://unitedsoybean.org/, and Missouri Soybean Merchandising Council, http://mosoy.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Haleem H, 2011, THEOR APPL GENET, V122, P935, DOI 10.1007/s00122-010-1500-9; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Alcivar A, 2007, J AGR FOOD ENV SCI, V1, P1; Arahana VS, 2001, CROP SCI, V41, P180, DOI 10.2135/cropsci2001.411180x; Bauer S., 2007, Nematropica, V37, P277; Brensha W., 2012, J PLANT GENOME SCI, V1, P1, DOI DOI 10.5147/JPGS.2012.0051; Myers DB, 2007, CROP SCI, V47, P1498, DOI 10.2135/cropsci2006.07.0460; Brucker E, 2005, THEOR APPL GENET, V111, P44, DOI 10.1007/s00122-005-1970-3; Carter TE, 2004, SOYBEANS IMPROVEMENT, P301; Chen P, 2007, J PLANT REGIST, V1, P166, DOI 10.3198/jpr2007.01.0046crg; Chen YY, 2006, CROP SCI, V46, P2041, DOI 10.2135/cropsci2005.12.0466; Ha CV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/759657; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Concibido VC, 2003, THEOR APPL GENET, V106, P575, DOI 10.1007/s00122-002-1071-5; CORTES PM, 1986, CROP SCI, V26, P993, DOI 10.2135/cropsci1986.0011183X002600050031x; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Devi MJ, 2013, CROP SCI, V53, P2072, DOI 10.2135/cropsci2013.02.0095; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Fenta B.A., 2011, SOYBEAN GENETICS NOV, P181; GIZLICE Z, 1994, CROP SCI, V34, P1143, DOI 10.2135/cropsci1994.0011183X003400050001x; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guo B, 2005, THEOR APPL GENET, V111, P965, DOI 10.1007/s00122-005-0031-2; Han YP, 2012, THEOR APPL GENET, V125, P671, DOI 10.1007/s00122-012-1859-x; HARTMAN GL, 1992, PLANT DIS, V76, P396, DOI 10.1094/PD-76-0396; Hoeck JA, 2003, CROP SCI, V43, P68, DOI 10.2135/cropsci2003.0068; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hufstetler EV, 2007, CROP SCI, V47, P25, DOI 10.2135/cropsci2006.04.0243; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Joshi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S15; Kabelka EA, 2004, CROP SCI, V44, P784, DOI 10.2135/cropsci2004.0784; Kanamaru K, 2008, BREEDING SCI, V58, P393, DOI 10.1270/jsbbs.58.393; Kim HK, 2005, PLANT BREEDING, V124, P582, DOI 10.1111/j.1439-0523.2005.01152.x; Kim KS, 2010, THEOR APPL GENET, V120, P1063, DOI 10.1007/s00122-009-1234-8; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lauter ANM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-702; Lenis JM, 2011, J AGRON CROP SCI, V197, P302, DOI 10.1111/j.1439-037X.2011.00466.x; Li DD, 2008, CROP SCI, V48, P571, DOI 10.2135/cropsci2007.06.0361; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Liang HZ, 2014, THEOR APPL GENET, V127, P2127, DOI 10.1007/s00122-014-2366-z; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Liu Ying, 2005, Acta Agronomica Sinica, V31, P1132; [刘莹 LIU Ying], 2007, [大豆科学, Soybean Science], V26, P127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C., 2010, ACTA AGRON SIN, V36, P1476; Manavalan LP, 2010, PLANT SOIL, V330, P503, DOI 10.1007/s11104-009-0222-8; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Matsuo N, 2013, PLANT PROD SCI, V16, P374, DOI 10.1626/pps.16.374; Middleton PH, 2007, PLANT CELL, V19, P1221, DOI 10.1105/tpc.106.048264; Nguyen HT, 1997, CROP SCI, V37, P1426, DOI 10.2135/cropsci1997.0011183X003700050002x; Nishimura R, 2002, PLANT CELL PHYSIOL, V43, P853, DOI 10.1093/pcp/pcf098; Pantalone VR, 1996, CROP SCI, V36, P456, DOI 10.2135/cropsci1996.0011183X003600020039x; PETRIE CL, 1992, AUST J PLANT PHYSIOL, V19, P591, DOI 10.1071/PP9920591; Pooprompan P., 2006, Kasetsart Journal, Natural Sciences, V40, P573; Price AH, 2002, PLANT MOL BIOL, V48, P683, DOI 10.1023/A:1014805625790; Prince S. J., 2013, GENOMICS BREEDING CL, P67, DOI 10.1007/978-3-642-37048-9; Prince SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1334-6; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1139/G06-112; Rodriguez-Uribe L, 2006, J EXP BOT, V57, P1391, DOI 10.1093/jxb/erj118; Rong Z., 2011, ACTA AGRON SIN, V37, P1151, DOI DOI 10.1016/S1875-2780(11)60032-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Salas P, 2006, THEOR APPL GENET, V113, P1459, DOI 10.1007/s00122-006-0392-1; Sayama T, 2009, PLANT SCI, V176, P514, DOI 10.1016/j.plantsci.2009.01.007; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Sinclair TR, 2007, FIELD CROP RES, V101, P68, DOI 10.1016/j.fcr.2006.09.010; SPONCHIADO BN, 1989, EXP AGR, V25, P249, DOI 10.1017/S0014479700016756; Suji KK, 2012, FIELD CROP RES, V137, P89, DOI 10.1016/j.fcr.2012.08.006; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley SD, 1996, THEOR APPL GENET, V92, P213, DOI 10.1007/BF00223378; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; TAYLOR HM, 1978, Z ACKER PFLANZENBAU, V146, P33; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tuberosa R, 2011, ROOT GENOMICS, P179; Turner NC, 2001, ADV AGRON, V71, P193, DOI 10.1016/S0065-2113(01)71015-2; Varshney RK, 2011, ROOT GENOMICS, P233; Wang D, 2004, THEOR APPL GENET, V108, P458, DOI 10.1007/s00122-003-1449-z; Wasson AP, 2012, J EXP BOT, V63, P3485, DOI 10.1093/jxb/ers111; WEISEMANN JM, 1992, THEOR APPL GENET, V85, P136, DOI 10.1007/BF00222850; Xiao JH, 1998, GENETICS, V150, P899	81	47	51	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120490	10.1371/journal.pone.0120490	http://dx.doi.org/10.1371/journal.pone.0120490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756528	Green Published, gold			2022-12-27	WOS:000351275700067
J	Thandavan, TMK; Gani, SMA; Wong, CS; Nor, RM				Thandavan, Tamil Many K.; Gani, Siti Meriam Abdul; Wong, Chiow San; Nor, Roslan Md.			Enhanced Photoluminescence and Raman Properties of Al-Doped ZnO Nanostructures Prepared Using Thermal Chemical Vapor Deposition of Methanol Assisted with Heated Brass	PLOS ONE			English	Article							ZINC-OXIDE FILMS; THIN-FILMS; METHYL FORMATE; DEHYDROGENATION; NANOPARTICLES; FABRICATION; NANOWIRES; DECOMPOSITION; OXIDATION; NETWORKS	Vapor phase transport (VPT) assisted by mixture of methanol and acetone via thermal evaporation of brass (CuZn) was used to prepare un-doped and Al-doped zinc oxide (ZnO) nanostructures (NSs). The structure and morphology were characterized by field emission scanning electron microscopy (FESEM) and x-ray diffraction (XRD). Photoluminescence (PL) properties of un-doped and Al-doped ZnO showed significant changes in the optical properties providing evidence for several types of defects such as zinc interstitials (Zn-i), oxygen interstitials (O-i), zinc vacancy (V-zn), singly charged zinc vacancy (V-Zn(-)), oxygen vacancy (V-o), singly charged oxygen vacancy (V-o(+)) and oxygen anti-site defects (O-Zn) in the grown NSs. The Al-doped ZnO NSs have exhibited shifted PL peaks at near band edge (NBE) and red luminescence compared to the un-doped ZnO. The Raman scattering results provided evidence of Al doping into the ZnO NSs due to peak shift from 145 cm(-1) to an anomalous peak at 138 cm(-1). Presence of enhanced Raman signal at around 274 and 743 cm(-1) further confirmed Al in ZnO NSs. The enhanced D and G band in all Al-doped ZnO NSs shows possible functionalization and doping process in ZnO NSs.	[Thandavan, Tamil Many K.; Wong, Chiow San; Nor, Roslan Md.] Univ Malaya, Dept Phys, Plasma Technol Res Ctr, Kuala Lumpur 59100, Malaysia; [Gani, Siti Meriam Abdul] Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Kuala Lumpur 59100, Malaysia	Universiti Malaya; Universiti Malaya	Thandavan, TMK (corresponding author), Univ Malaya, Dept Phys, Plasma Technol Res Ctr, Kuala Lumpur 59100, Malaysia.	tamilmanykthandavan@gmail.com; rmdnor@um.edu.my	NOR, ROSLAN MD/B-5221-2010; K Thandavan, Tamil Many/AEQ-6139-2022; Thandavan, Tamil Many K/J-2458-2014; Wong, C.S./C-1047-2010	NOR, ROSLAN MD/0000-0003-0649-2272; Thandavan, Tamil Many K/0000-0003-4965-7540; Wong, C.S./0000-0002-7186-2578	Peruntukan Penyelidikan Pascasiswazah (PPP) of University Malaya [PS212/2009A]; UMRG [RG247-12AFR]	Peruntukan Penyelidikan Pascasiswazah (PPP) of University Malaya; UMRG	This work is supported by Peruntukan Penyelidikan Pascasiswazah (PPP) of University Malaya Grant No.: PS212/2009A and UMRG Grant No.: RG247-12AFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2009, J APPL PHYS, V105, DOI 10.1063/1.3054175; AI M, 1984, APPL CATAL, V11, P259, DOI 10.1016/S0166-9834(00)81884-9; Bahedi K., 2009, 2009 3rd ICTON Mediterranean Winter Conference (ICTON-MW 2009); Baskoutas S, 2007, THIN SOLID FILMS, V515, P8461, DOI 10.1016/j.tsf.2007.03.150; Ben Ayadi Z, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/44/445702; Bruice P. Y., 2006, ORGANIC CHEM; Bundesmann C, 2003, APPL PHYS LETT, V83, P1974, DOI 10.1063/1.1609251; CHEN AK, 1995, SURF SCI, V343, P17, DOI 10.1016/0039-6028(95)00649-4; Chrissanthopoulos A, 2011, PHOTONIC NANOSTRUCT, V9, P132, DOI 10.1016/j.photonics.2010.11.002; Cusco R, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.165202; Das J, 2010, PHYSICA B, V405, P2492, DOI 10.1016/j.physb.2010.03.020; El Manouni A, 2006, SUPERLATTICE MICROST, V39, P185, DOI 10.1016/j.spmi.2005.08.041; Fang XS, 2009, CRIT REV SOLID STATE, V34, P190, DOI 10.1080/10408430903245393; Feng QJ, 2010, APPL SURF SCI, V257, P1084, DOI 10.1016/j.apsusc.2010.08.018; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; GUERRERORUIZ A, 1991, APPL CATAL, V72, P119, DOI 10.1016/0166-9834(91)85033-R; Guo M, 2004, CHINESE CHEM LETT, V15, P1113; Harikumar KR, 1999, J PHYS CHEM B, V103, P2445, DOI 10.1021/jp983730q; Harikumar KR, 1999, CHEM COMMUN, P341, DOI 10.1039/a808076c; Henley SJ, 2004, SURF COAT TECH, V177, P271, DOI 10.1016/j.surfcoat.2003.09.005; Hrkac V, 2013, J APPL CRYSTALLOGR, V46, P396, DOI 10.1107/S0021889812051333; Hsieh CT, 2003, APPL PHYS LETT, V83, P3383, DOI 10.1063/1.1619229; Jagadish C, 2006, ZINC OXIDE BULK, THIN FILMS AND NANOSTRUCTURES: PROCESSING, PROPERTIES AND APPLICATIONS, P1; Jeong C, 2008, JPN J APPL PHYS, V47, P5656, DOI 10.1143/JJAP.47.5656; Jun MC, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-639; Khan Wasi, 2013, International Journal of Modern Physics: Conference Series, V22, P630, DOI 10.1142/S2010194513010775; Khanderi J, 2009, J MATER CHEM, V19, P5039, DOI 10.1039/b904822g; Kim HW, 2010, CURR APPL PHYS, V10, P60, DOI 10.1016/j.cap.2009.04.012; Kim J-H, 2012, APPL PHYS EXPRESS, V5; Kim S, 2006, J CRYST GROWTH, V290, P485, DOI 10.1016/j.jcrysgro.2006.01.043; Lao CS, 2006, NANO LETT, V6, P263, DOI 10.1021/nl052239p; LEVIS RJ, 1989, J AM CHEM SOC, V111, P4605, DOI 10.1021/ja00195a013; Lim YS, 2006, MAT SCI ENG B-SOLID, V129, P100, DOI 10.1016/j.mseb.2005.12.021; Liu KW, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291106; Liu W, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2169908; Liu YD, 2009, J ALLOY COMPD, V485, P529, DOI 10.1016/j.jallcom.2009.06.019; Lockman Z, 2010, J ALLOY COMPD, V493, P699, DOI 10.1016/j.jallcom.2009.12.196; Lu CG, 2011, IEEE PHOTONIC TECH L, V23, P561, DOI 10.1109/LPT.2011.2116154; Lupan O, 2009, SOL ENERG MAT SOL C, V93, P1417, DOI 10.1016/j.solmat.2009.03.012; MILOSLAVSKII VK, 1972, PHYS STATUS SOLIDI B, V51, pK99, DOI 10.1002/pssb.2220510252; Mishra YK, 2014, KONA POWDER PART J, P92; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Panchakarla LS, 2007, J CLUST SCI, V18, P660, DOI 10.1007/S10876-007-0129-6; Patterson CH, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144432; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Rufael TS, 1997, SURF SCI, V384, P156, DOI 10.1016/S0039-6028(97)00197-0; Shan FK, 2003, J KOREAN PHYS SOC, V42, pS1374; Thandavan TMK, 2014, MATER EXPRESS, V4, P475, DOI 10.1166/mex.2014.1193; Thandavan TMK, 2014, J NANOMATER, V2014, DOI 10.1155/2014/105875; TONNER SP, 1984, IND ENG CHEM PROD RD, V23, P384, DOI 10.1021/i300015a012; Tonto P, 2008, CERAM INT, V34, P57, DOI 10.1016/j.ceramint.2006.08.003; Van LH, 2008, J ALLOY COMPD, V449, P207, DOI 10.1016/j.jallcom.2006.02.114; Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349; WAGNER P, 1974, J PHYS CHEM SOLIDS, V35, P327, DOI 10.1016/S0022-3697(74)80026-0; Wang L, 2010, J PHYS CHEM C, V114, P17358, DOI 10.1021/jp104706q; Wang M, 2007, MATER LETT, V61, P1118, DOI 10.1016/j.matlet.2006.06.065; Wang SL, 2010, J ALLOY COMPD, V502, P118, DOI 10.1016/j.jallcom.2010.04.042; Wei OY, 2008, MATER LETT, V62, P2557, DOI 10.1016/j.matlet.2007.12.051; Willander M, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/33/332001; Ye JD, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3067997; Yi GY, 2005, SEMICONDUCTOR SCI TE, V20; Zeng HB, 2010, ADV FUNCT MATER, V20, P561, DOI 10.1002/adfm.200901884; Zhang SB, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.075205; Zhang WY, 2010, OPTOELECTRON ADV MAT, V4, P1651; Zhou HM, 2007, THIN SOLID FILMS, V515, P6909, DOI 10.1016/j.tsf.2007.01.041	66	38	39	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0121756	10.1371/journal.pone.0121756	http://dx.doi.org/10.1371/journal.pone.0121756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756598	Green Published, gold			2022-12-27	WOS:000351275700078
J	Tsai, YL; Wang, MC; Hsueh, PR; Liu, MC; Hu, RM; Wu, YJ; Liaw, SJ				Tsai, Yi-Lin; Wang, Min-Cheng; Hsueh, Po-Ren; Liu, Ming-Che; Hu, Rouh-Mei; Wu, Yue-Jin; Liaw, Shwu-Jen			Overexpression of an Outer Membrane Protein Associated with Decreased Susceptibility to Carbapenems in Proteus mirabilis	PLOS ONE			English	Article							ESCHERICHIA-COLI; BETA-LACTAMASE; IMIPENEM RESISTANCE; STRESS RESPONSES; ENTEROBACTERIACEAE; IDENTIFICATION; MECHANISMS; KLEBSIELLA; EXPRESSION; MUTANTS	Proteus mirabilis isolates commonly have decreased susceptibility to imipenem. Previously, we found P. mirabilis hfq mutant was more resistant to imipenem and an outer membrane protein (OMP) could be involved. Therefore, we investigated the role of this OMP in carbapenem susceptibility. By SDS-PAGE we found this OMP (named ImpR) was increased in hfq mutant and LC-MS/MS revealed it to be the homologue of Salmonella YbfM, which is a porin for chitobiose and subject to MicM (a small RNA) regulation. We demonstrated that ImpR overexpression resulted in increased carbapenem MICs in the laboratory strain and clinical isolates. Chitobiose induced expression of chb (a chitobiose utilization operon). Real-time RT-PCR and SDS-PAGE were performed to elucidate the relationship of hfq, impR, chb and MicM in P. mirabilis. We found MicM RNA was decreased in hfq mutant and chbBC-intergenic region (chbBC-IGR) overexpression strain (chbIGRov), while impR mRNA was increased in hfq mutant, micM mutant and chbIGRov strain. In addition, mutation of hfq or micM and overexpression of chbBC-IGR increased ImpR protein level. Accordingly, chitobiose made wild-type have higher levels of ImpR protein and are more resistant to carbapenems. Hfq- and MicM-complemented strains restored wild-type MICs. Mutation of both impR and hfq eliminated the increase in carbapenem MICs observed in hfq mutant and ImpR-complementation of hfq/impR double mutant resulted in MICs as hfq mutant, indicating that the ImpR-dependent decreased carbapenem susceptibility of hfq mutant. These indicate MicM was antisense to impR mRNA and was negatively-regulated by chbBC-IGR. Together, overexpression of ImpR contributed to the decreased carbapenem susceptibility in P. mirabilis.	[Tsai, Yi-Lin; Wang, Min-Cheng; Liu, Ming-Che; Liaw, Shwu-Jen] Natl Taiwan Univ, Coll Med, Dept & Grad Inst, Clin Lab Sci & Med Biotechnol, Taipei, Taiwan; [Hsueh, Po-Ren; Liaw, Shwu-Jen] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Lab Med & Internal Med, Taipei, Taiwan; [Hu, Rouh-Mei] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Wu, Yue-Jin] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Asia University Taiwan; National Yang Ming Chiao Tung University	Liaw, SJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept & Grad Inst, Clin Lab Sci & Med Biotechnol, Taipei, Taiwan.	sjliaw@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	HSUEH, PO-REN/0000-0002-7502-9225; LIAW, SHWU-JEN/0000-0002-2666-5284	National Science Council [NSC 101-2320-B-002-028]; National Taiwan University Hospital, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital, Taipei, Taiwan	This work was supported by grants from National Science Council (NSC 101-2320-B-002-028) and National Taiwan University Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott I, 2013, EXPERT REV ANTI-INFE, V11, P395, DOI [10.1586/ERI.13.21, 10.1586/eri.13.21]; Baquero F, 2001, DRUG RESIST UPDATE, V4, P93, DOI 10.1054/drup.2001.0196; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Clinical and Laboratory Standards Institute, 2012, M07A9 CLIN LAB STAND; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Fernandez-Cuenca F, 2003, J ANTIMICROB CHEMOTH, V51, P565, DOI 10.1093/jac/dkg097; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098; FUKUOKA T, 1991, ANTIMICROB AGENTS CH, V35, P529, DOI 10.1128/AAC.35.3.529; Gupta N, 2013, MICROBIOL-SGM, V159, P205, DOI 10.1099/mic.0.061937-0; Huang YW, 2013, J ANTIMICROB CHEMOTH, V68, P1987, DOI 10.1093/jac/dkt148; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jiang SS, 2010, ANTIMICROB AGENTS CH, V54, P2000, DOI 10.1128/AAC.01384-09; Lin HH, 2011, J BACTERIOL, V193, P5833, DOI 10.1128/JB.05359-11; MEHTAR S, 1991, J ANTIMICROB CHEMOTH, V28, P612, DOI 10.1093/jac/28.4.612; NEUWIRTH C, 1995, J ANTIMICROB CHEMOTH, V36, P335, DOI 10.1093/jac/36.2.335; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Overturf GD, 2010, PEDIATR INFECT DIS J, V29, P68, DOI 10.1097/INF.0b013e3181c9c118; Pagani L, 2002, J CLIN MICROBIOL, V40, P1549, DOI 10.1128/JCM.40.4.1549-1552.2002; Perez F, 2013, CLEV CLIN J MED, V80, P225, DOI 10.3949/ccjm.80a.12182; Poole K, 2012, TRENDS MICROBIOL, V20, P227, DOI 10.1016/j.tim.2012.02.004; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Tenover FC, 2009, J CLIN MICROBIOL, V47, P294, DOI 10.1128/JCM.01797-08; Tibbetts R, 2008, J CLIN MICROBIOL, V46, P3080, DOI 10.1128/JCM.00979-08; Tomas MDM, 2005, ANTIMICROB AGENTS CH, V49, P5172, DOI 10.1128/AAC.49.12.5172-5175.2005; Verma SC, 2012, J BACTERIOL, V194, P4959, DOI 10.1128/JB.00533-12; Villar HE, 1997, J ANTIMICROB CHEMOTH, V40, P365, DOI 10.1093/jac/40.3.365; Vogel J, 2009, MOL MICROBIOL, V73, P737, DOI 10.1111/j.1365-2958.2009.06806.x; Vourli S, 2006, CLIN MICROBIOL INFEC, V12, P691, DOI 10.1111/j.1469-0691.2006.01489.x; Wang MC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085626, 10.1371/journal.pone.0111040]; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Wu YJ, 2009, J CHIN CHEM SOC-TAIP, V56, P688, DOI 10.1002/jccs.200900103	36	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120395	10.1371/journal.pone.0120395	http://dx.doi.org/10.1371/journal.pone.0120395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756370	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700066
J	Brinks, R; Landwehr, S				Brinks, Ralph; Landwehr, Sandra			Change Rates and Prevalence of a Dichotomous Variable: Simulations and Applications	PLOS ONE			English	Article							AGE-SPECIFIC INCIDENCE; GLOBAL BURDEN; MORTALITY; GERMANY; SMOKING; DISEASE; TRENDS; STATES; COSTS	A common modelling approach in public health and epidemiology divides the population under study into compartments containing persons that share the same status. Here we consider a three-state model with the compartments: A, B and Dead. States A and B may be the states of any dichotomous variable, for example, Healthy and Ill, respectively. The transitions between the states are described by change rates, which depend on calendar time and on age. So far, a rigorous mathematical calculation of the prevalence of property B has been difficult, which has limited the use of the model in epidemiology and public health. We develop a partial differential equation (PDE) that simplifies the use of the three-state model. To demonstrate the validity of the PDE, it is applied to two simulation studies, one about a hypothetical chronic disease and one about dementia in Germany. In two further applications, the PDE may provide insights into smoking behaviour of males in Germany and the knowledge about the ovulatory cycle in Egyptian women.	[Brinks, Ralph; Landwehr, Sandra] German Diabet Ctr, Inst Epidemiol & Biometry, Dusseldorf, Germany; [Landwehr, Sandra] Univ Dusseldorf, Dept Med Stat, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Brinks, R (corresponding author), German Diabet Ctr, Inst Epidemiol & Biometry, Dusseldorf, Germany.	ralph.brinks@ddz.uni-duesseldorf.de						[Anonymous], 2011, UNAIDS MIDDLE E N AF; Bell BM, SIAM J SCI COMPUTING, V35, pB511; Brinks R, 2013, STAT MED, V32, P2070, DOI 10.1002/sim.5651; Brinks R, 2012, EUR J EPIDEMIOL, V27, P791, DOI 10.1007/s10654-012-9726-2; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Federal Statistical Office of Germany, 2013, MORT GERM; FIX EVELYN, 1951, HUMAN BIOL, V23, P205; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; ICF International, 2013, DEM HLTH SURV EGIR01; John U, 2001, GESUNDHEITSWESEN, V63, P363, DOI 10.1055/s-2001-15684; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150; Kirkwood BR, 2003, ESSENTIAL MED STAT; Murray C, 1996, GLOBAL BURDEN DIS, V1, P201; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Neubauer S, 2006, TOB CONTROL, V15, P464, DOI 10.1136/tc.2006.016030; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Schulze A, BUNDES GESUNDHEITSSU; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waldeyer R, 2013, DIABETIC MED, V30, P999, DOI 10.1111/dme.12177; Ziegler U, 2009, GESUNDHEITSWESEN, V71, P281, DOI 10.1055/s-0028-1119384	24	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118955	10.1371/journal.pone.0118955	http://dx.doi.org/10.1371/journal.pone.0118955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749133	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400033
J	Vergauwen, H; Tambuyzer, B; Jennes, K; Degroote, J; Wang, W; De Smet, S; Michiels, J; Van Ginneken, C				Vergauwen, Hans; Tambuyzer, Bart; Jennes, Karen; Degroote, Jeroen; Wang, Wei; De Smet, Stefaan; Michiels, Joris; Van Ginneken, Chris			Trolox and Ascorbic Acid Reduce Direct and Indirect Oxidative Stress in the IPEC-J2 Cells, an In Vitro Model for the Porcine Gastrointestinal Tract	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TYROSINE PHOSPHORYLATION; BARRIER DISRUPTION; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; DNA-DAMAGE; GLUTATHIONE; LINE; PATHOGENESIS; PROTEIN	Oxidative stress in the small intestinal epithelium is a major cause of barrier malfunction and failure to regenerate. This study presents a functional in vitro model using the porcine small intestinal epithelial cell line IPEC-J2 to examine the effects of oxidative stress and to estimate the antioxidant and regenerative potential of Trolox, ascorbic acid and glutathione monoethyl ester. Hydrogen peroxide and diethyl maleate affected the tight junction (zona occludens-1) distribution, significantly increased intracellular oxidative stress (CM-H(2)DCFDA) and decreased the monolayer integrity (transepithelial electrical resistance and FD-4 permeability), viability (neutral red) and wound healing capacity (scratch assay). Trolox (2 mM) and 1 mM ascorbic acid pre-treatment significantly reduced intracellular oxidative stress, increased wound healing capacity and reduced FD-4 permeability in oxidatively stressed IPEC-J2 cell monolayers. All antioxidant pre-treatments increased transepithelial electrical resistance and viability only in diethyl maleate-treated cells. Glutathione monoethyl ester (10 mM) pretreatment significantly decreased intracellular oxidative stress and monolayer permeability only in diethyl maleate-treated cells. These data demonstrate that the IPEC-J2 oxidative stress model is a valuable tool to screen antioxidants before validation in piglets.	[Vergauwen, Hans; Tambuyzer, Bart; Jennes, Karen; Van Ginneken, Chris] Univ Antwerp, Fac Biomed Pharmaceut & Vet Sci, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium; [Degroote, Jeroen; Wang, Wei; Michiels, Joris] Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, B-9000 Ghent, Belgium; [Degroote, Jeroen; Wang, Wei; De Smet, Stefaan; Michiels, Joris] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual LANUPRO, Melle, Belgium	University of Antwerp; Ghent University; Ghent University	Van Ginneken, C (corresponding author), Univ Antwerp, Fac Biomed Pharmaceut & Vet Sci, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium.	chris.vanginneken@uantwerpen.be	DeSmet, Stefaan/N-7576-2017; Van Ginneken, Chris/AAK-2559-2020	DeSmet, Stefaan/0000-0003-1422-805X; Van Ginneken, Chris/0000-0002-1622-9120	IWT_LO by the agency for Innovation by Science and Technology [100856]	IWT_LO by the agency for Innovation by Science and Technology	This work was supported by the IWT_LO 100856 project provided by the agency for Innovation by Science and Technology. (http://www.iwt.be/) (CVG SDS JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J NUTR; [Anonymous], 2004, BRIT J PHARMACOL; Banan A, 2000, FREE RADICAL BIO MED, V28, P727, DOI 10.1016/S0891-5849(00)00160-X; BERSCHNEIDER H M, 1989, Gastroenterology, V96, pA41; Bizzozero OA, 2007, NEUROCHEM RES, V32, P2114, DOI 10.1007/s11064-007-9377-y; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; BOYLAND E, 1967, BIOCHEM J, V104, P95, DOI 10.1042/bj1040095; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; BRITT SG, 1992, J RECEPTOR RES, V12, P181, DOI 10.3109/10799899209074791; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Cai X, 2013, MOL CELLULAR BIOCH; Carrasco-Pozo C, 2013, J AGR FOOD CHEM; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; Dolara P, 2012, EUR J NUTR, V51, P769, DOI 10.1007/s00394-012-0389-2; Dymkowska D, 2009, ACTA BIOCHIM POL, V56, P711; Ebert B, 2007, TOXICOL SCI, V96, P227, DOI 10.1093/toxsci/kfl147; Fagundes DS, 2011, REV ESP ENFERM DIG, V103, P396, DOI 10.4321/s1130-01082011000800002; Geens MM, 2011, CYTOTECHNOLOGY, V63, P415, DOI 10.1007/s10616-011-9362-9; Guellich A, 2007, AM J PHYSIOL-HEART C, V293, pH93, DOI 10.1152/ajpheart.00037.2007; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Herring TA, 2007, DIGEST DIS SCI, V52, P3005, DOI 10.1007/s10620-006-9663-6; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Kale G, 2003, BIOCH BIOPHYSICAL RE, V302, P324; Kaurinovic B, 2012, MOLECULES, V17, P11156, DOI 10.3390/molecules170911156; Kim M, 2012, SURG INFECT, V13, P18, DOI 10.1089/sur.2011.057; Kumar A, 2012, J CANCER RES THER, V8, P254, DOI 10.4103/0973-1482.98980; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Mariani V, 2009, VET IMMUNOL IMMUNOP, V131, P278, DOI 10.1016/j.vetimm.2009.04.006; McCracken VJ, 2001, CELL MICROBIOL, V3, P1, DOI 10.1046/j.1462-5822.2001.00090.x; Nogueira V, 2013, CLIN CANC RES OFF J; Ozhegov EV, 2012, B EXP BIOL MED+, V152, P420, DOI 10.1007/s10517-012-1543-9; Palafox-Carlos H, 2011, J FOOD SCI, V76, pR6, DOI 10.1111/j.1750-3841.2010.01957.x; Paszti-Gere E, 2013, ACTA PHYSIOL HUNG, V100, P89, DOI 10.1556/APhysiol.100.2013.1.9; Paszti-Gere E, 2012, INFLAMMATION, V35, P994, DOI 10.1007/s10753-011-9403-8; Rao R, 1999, BIOCHEM PHARMACOL, V57, P685, DOI 10.1016/S0006-2952(98)00333-5; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Rao RK, 1997, AM J PHYSIOL-GASTR L, V273, pG812, DOI 10.1152/ajpgi.1997.273.4.G812; Rao RK, 2000, AM J PHYSIOL-GASTR L, V279, pG332, DOI 10.1152/ajpgi.2000.279.2.G332; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Rosignoli P, 2001, CARCINOGENESIS, V22, P1675, DOI 10.1093/carcin/22.10.1675; Samarasinghe DA, 2000, HEPATOLOGY, V31, P160, DOI 10.1002/hep.510310124; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Seth A, 2009, FASEB J, V23; SPECTOR A, 1987, EXP EYE RES, V45, P453, DOI 10.1016/S0014-4835(87)80130-6; STADDON JM, 1995, J CELL SCI, V108, P609; Testa MP, 2011, JOVE-J VIS EXP, DOI 10.3791/2841; Trombino S, 2012, MOLECULES, V17, P12734, DOI 10.3390/molecules171112734; Tupe RS, 2010, EUR J NUTR, V49, P53, DOI 10.1007/s00394-009-0048-4; Wang N, 2012, DIGEST DIS SCI, V57, P1792, DOI 10.1007/s10620-012-2094-7; Yoshida T, 1996, J CHROMATOGR B, V678, P157, DOI 10.1016/0378-4347(95)00489-0; Yu Linda Chia-Hui, 2012, World J Gastrointest Pathophysiol, V3, P27, DOI 10.4291/wjgp.v3.i1.27; Zafrilla P, 2006, CURR MED CHEM, V13, P1075, DOI 10.2174/092986706776360978; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004	58	44	46	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120485	10.1371/journal.pone.0120485	http://dx.doi.org/10.1371/journal.pone.0120485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25745867	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400096
J	Yamauchi, T; Kuroda, Y; Morita, T; Shichinohe, H; Houkin, K; Dezawa, M; Kuroda, S				Yamauchi, Tomohiro; Kuroda, Yasumasa; Morita, Takahiro; Shichinohe, Hideo; Houkin, Kiyohiro; Dezawa, Mari; Kuroda, Satoshi			Therapeutic Effects of Human Multilineage-Differentiating Stress Enduring (MUSE) Cell Transplantation into Infarct Brain of Mice	PLOS ONE			English	Article							MARROW STROMAL CELLS; PLURIPOTENT STEM-CELLS; CEREBRAL INFARCT; ISCHEMIC-STROKE; RAT MODEL; SPINAL-CORD; DISEASE; INJURY; MIGRATION; RECOVERY	Objective Bone marrow stromal cells (BMSCs) are heterogeneous and their therapeutic effect is pleiotropic. Multilineage-differentiating stress enduring (Muse) cells are recently identified to comprise several percentages of BMSCs, being able to differentiate into triploblastic lineages including neuronal cells and act as tissue repair cells. This study was aimed to clarify how Muse and non-Muse cells in BMSCs contribute to functional recovery after ischemic stroke. Methods Human BMSCs were separated into stage specific embryonic antigen-3-positive Muse cells and -negative non-Muse cells. Immunodeficient mice were subjected to permanent middle cerebral artery occlusion and received transplantation of vehicle, Muse, non-Muse or BMSCs (2.5x10(4) cells) into the ipsilateral striatum 7 days later. Results Motor function recovery in BMSC and non-Muse groups became apparent at 21 days after transplantation, but reached the plateau thereafter. In Muse group, functional recovery was not observed for up to 28 days post-transplantation, but became apparent at 35 days post-transplantation. On immunohistochemistry, only Muse cells were integrated into peri-infarct cortex and differentiate into Tuj-1- and NeuN-expressing cells, while negligible number of BMSCs and non-Muse cells remained in the peri-infarct area at 42 days post-transplantation. Conclusions These findings strongly suggest that Muse cells and non-Muse cells may contribute differently to tissue regeneration and functional recovery. Muse cells may be more responsible for replacement of the lost neurons through their integration into the peri-infarct cortex and spontaneous differentiation into neuronal marker-positive cells. Non-Muse cells do not remain in the host brain and may exhibit trophic effects rather than cell replacement.	[Yamauchi, Tomohiro; Shichinohe, Hideo; Houkin, Kiyohiro; Kuroda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Kuroda, Yasumasa; Morita, Takahiro; Dezawa, Mari] Tohoku Univ, Grad Sch Med, Dept Stem Cell Biol & Histol, Sendai, Miyagi 980, Japan; [Kuroda, Satoshi] Toyama Univ, Grad Sch Med & Pharmacol Sci, Dept Neurosurg, Toyama 930, Japan	Hokkaido University; Tohoku University; University of Toyama	Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.	skuroda@med.u-toyama.ac.jp			Grants-in-Aid for Scientific Research [25293305] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abe K, 2012, J CEREBR BLOOD F MET, V32, P1317, DOI 10.1038/jcbfm.2011.187; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Kalaria RN, 2012, STROKE, V43, P2526, DOI 10.1161/STROKEAHA.112.655803; Kawabori M, 2013, NEUROPATHOLOGY, V33, P140, DOI 10.1111/j.1440-1789.2012.01335.x; Kuroda S, 2013, ACTA NEUROBIOL EXP, V73, P57; Kuroda Y, 2013, NAT PROTOC, V8, P1391, DOI 10.1038/nprot.2013.076; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Mundra V, 2013, MOL PHARMACEUT, V10, P77, DOI 10.1021/mp3005148; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2014, NEUROREHABIL NEURAL; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2010, DEMENT GERIATR COGN, V30, P293, DOI 10.1159/000320486; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Taguchi Akihiko, 2010, J Exp Stroke Transl Med, V3, P28; Takasaki K, 2011, J PHARMACOL SCI, V116, P232, DOI 10.1254/jphs.11013FP; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; Wakao Shohei, 2012, Cells, V1, P1045, DOI 10.3390/cells1041045; Wakao S, 2014, PATHOL INT, V64, P1, DOI 10.1111/pin.12129; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Wang LQ, 2013, NEUROL RES, V35, P470, DOI 10.1179/1743132813Y.0000000210; Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092; Yang ZZ, 2014, NEUROSCI BULL, V30, P524, DOI 10.1007/s12264-013-1431-y	32	47	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0116009	10.1371/journal.pone.0116009	http://dx.doi.org/10.1371/journal.pone.0116009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747577	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400002
J	Zhao, ST; Li, JC				Zhao, Shitao; Li, Jincheng			Sphingosine-1-Phosphate Induces the Migration of Thyroid Follicular Carcinoma Cells through the MicroRNA-17/PTK6/ERK1/2 Pathway	PLOS ONE			English	Article							BRK TYROSINE KINASE; BREAST-TUMOR KINASE; CANCER CELLS; SPHINGOSINE 1-PHOSPHATE; MICRORNA PRECURSORS; NUCLEAR EXPORT; EXPRESSION; CLUSTER; RECEPTORS; SURVIVAL	Sphingosine-1-phosphate (S1P) is a bioactive lipid known to play a role in tumorigenesis and cancer progression. However, the molecular mechanisms of S1P regulated migration of papillary thyroid cancer cells are still unknown. In this study, we showed that S1P induced PTK6 mRNA and protein expression in two thyroid follicular cancer cell lines (ML-1 and FTC-133). Further studies demonstrated that induced PTK6 and its downstream signal component (ERK1/2) are involved in S1P-induced migration. Upon investigating the mechanisms behind this event, we found that miR-17 inhibited the expression of PTK6 through direct binding to its 3'-UTR. Through overexpression and knockdown studies, we found that miR-17 can significantly inhibit S1P-induced migration in thyroid follicular cancer cells. Interestingly, overexpression or knockdown of PTK6 or ERK1/2 effectively removed the inhibition of S1P-induced migration by miR-17. Furthermore, we showed that S1P decreased miR-17 expression levels. Meanwhile, in papillary thyroid cancers, miR-17 is downregulated and negatively associated with clinical staging, whereas PTK6 is upregulated and positively associated with clinical stages. Collectively, our work defines a novel signaling pathway implicated in the control of thyroid cancer migration.	[Zhao, Shitao; Li, Jincheng] Liaoning Med Univ, Affiliated Hosp 1, Dept Breast & Thyroid Sugery, Jinzhou, Liaoning, Peoples R China	Jinzhou Medical University	Li, JC (corresponding author), Liaoning Med Univ, Affiliated Hosp 1, Dept Breast & Thyroid Sugery, Jinzhou, Liaoning, Peoples R China.	liaoyiruxian@163.com			Social Development Research Plan of the Liaoning Province Science and Technology Department [2010225034]	Social Development Research Plan of the Liaoning Province Science and Technology Department	This work was supported by the Social Development Research Plan of the Liaoning Province Science and Technology Department (Grant No. 2010225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai MD, 2013, CANCER BIOL THER, V14, P237, DOI 10.4161/cbt.23295; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chang CC, 2013, ORAL ONCOL, V49, P923, DOI 10.1016/j.oraloncology.2013.03.430; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Haegebarth A, 2004, J BIOL CHEM, V279, P54398, DOI 10.1074/jbc.M409579200; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jevnaker AM, 2011, J CELL PHYSIOL, V226, P2257, DOI 10.1002/jcp.22562; Kalhori V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066189; LEE ST, 1993, ONCOGENE, V8, P3403; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Liu XK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-59; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Murphy BL, 2013, CANCER RES, V73, P7068, DOI 10.1158/0008-5472.CAN-13-0927; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Ono H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096060; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Peng M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.43; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhao C, 2013, ONCOTARGETS THER, V6, P183, DOI 10.2147/OTT.S41283	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119148	10.1371/journal.pone.0119148	http://dx.doi.org/10.1371/journal.pone.0119148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748447	Green Submitted, Green Published, gold			2022-12-27	WOS:000350689400050
J	Lim, JC; Phal, PM; Desmond, PM; Nichols, AD; Kokkinos, C; Danesh-Meyer, HV; Kaye, AH; Moffat, BA				Lim, Jeremy C.; Phal, Pramit M.; Desmond, Patricia M.; Nichols, Andrew D.; Kokkinos, Chris; Danesh-Meyer, Helen V.; Kaye, Andrew H.; Moffat, Bradford A.			Probabilistic MRI Tractography of the Optic Radiation Using Constrained Spherical Deconvolution: A Feasibility Study	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; VISUAL-FIELD DEFICITS; IN-DIFFUSION MRI; MEYERS LOOP; OPTIMIZATION; VARIABILITY; ROBUST; BRAIN	Background and Purpose Imaging the optic radiation (OR) is of considerable interest in studying diseases affecting the visual pathway and for pre-surgical planning of temporal lobe resections. The purpose of this study was to investigate the clinical feasibility of using probabilistic diffusion tractography based on constrained spherical deconvolution (CSD) to image the optic radiation. It was hypothesized that CSD would provide improved tracking of the OR compared with the widely used ball-and-stick model. Methods Diffusion weighted MRI (30 directions) was performed on twenty patients with no known visual deficits. Tractography was performed using probabilistic algorithms based on fiber orientation distribution models of local white matter trajectories. The performance of these algorithms was evaluated by comparing computational times and receiver operating characteristic results, and by correlation of anatomical landmark distances to dissection estimates. Results The results showed that it was consistently feasible to reconstruct individual optic radiations from clinically practical (4.5 minute acquisition) diffusion weighted imaging data sets using CSD. Tractography based on the CSD model resulted in significantly shorter computational times, improved receiver operating characteristic results, and shorter Meyer's loop to temporal pole distances (in closer agreement with dissection studies) when compared to the ball-and-stick based algorithm. Conclusions Accurate tractography of the optic radiation can be accomplished using diffusion MRI data collected within a clinically practical timeframe. CSD based tractography was faster, more accurate and had better correlation with known anatomical landmarks than ball-and-stick tractography.	[Lim, Jeremy C.; Phal, Pramit M.; Desmond, Patricia M.; Moffat, Bradford A.] Univ Melbourne, Dept Radiol, Melbourne, Vic 3050, Australia; [Lim, Jeremy C.; Phal, Pramit M.; Desmond, Patricia M.; Kokkinos, Chris; Moffat, Bradford A.] Royal Melbourne Hosp, Dept Radiol, Parkville, Vic 3050, Australia; [Nichols, Andrew D.; Danesh-Meyer, Helen V.; Kaye, Andrew H.] Univ Melbourne, Dept Surg, Melbourne, Vic 3050, Australia; [Nichols, Andrew D.; Kaye, Andrew H.] Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia; [Danesh-Meyer, Helen V.] Univ Auckland, Dept Ophthalmol, Auckland 1, New Zealand	University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Auckland	Moffat, BA (corresponding author), Univ Melbourne, Dept Radiol, Melbourne, Vic 3050, Australia.	bmoffat@unimelb.edu.au	Moffat, Bradford/L-3777-2019; Desmond, Patricia/D-1966-2014	Moffat, Bradford/0000-0002-0278-4801; Desmond, Patricia/0000-0002-4803-6323; Kaye, Andrew Henry/0000-0001-5049-8861	Australian NHMRC [566992, 454790]; Royal Melbourne Hospital Neuroscience foundation; Melbourne Brain Centre, a Melville-Hughes (University of Melbourne) scholarship; Royal Australian College of Surgery; Cancer Australia [509322]	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Royal Melbourne Hospital Neuroscience foundation; Melbourne Brain Centre, a Melville-Hughes (University of Melbourne) scholarship; Royal Australian College of Surgery; Cancer Australia	This work was supported by the Australian NHMRC (566992, 454790), The Royal Melbourne Hospital Neuroscience foundation, The Melbourne Brain Centre, a Melville-Hughes (University of Melbourne) scholarship (ADN), the Royal Australian College of Surgery (ADN) and Cancer Australia (509322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Benjamin CFA, 2014, HUM BRAIN MAPP, V35, P683, DOI 10.1002/hbm.22204; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Chen X, 2009, NEUROIMAGE, V45, P286, DOI 10.1016/j.neuroimage.2008.11.038; Choi CY, 2006, NEUROSURGERY, V59, P228, DOI 10.1227/01.NEU.0000223374.69144.81; Ciccarelli O, 2005, HUM BRAIN MAPP, V25, P308, DOI 10.1002/hbm.20101; Ciccarelli O, 2003, NEUROIMAGE, V19, P1545, DOI 10.1016/S1053-8119(03)00190-3; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Clatworthy PL, 2010, NEUROIMAGE, V49, P2001, DOI 10.1016/j.neuroimage.2009.10.083; Clayden JD, 2006, NEUROIMAGE, V33, P482, DOI 10.1016/j.neuroimage.2006.07.016; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; EBELING U, 1988, ACTA NEUROCHIR, V92, P29, DOI 10.1007/BF01401969; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Ludwig E., 1956, ATLAS CEREBRI HUMANI; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rubino P, 2005, NEUROSURGERY, V57; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; VANBUREN JM, 1958, BRAIN, V81, P15, DOI 10.1093/brain/81.1.15; White ML, 2010, CLIN IMAG, V34, P413, DOI 10.1016/j.clinimag.2009.11.010; Winston GP, 2012, ANN NEUROL, V71, P334, DOI 10.1002/ana.22619; Winston GP, 2011, EPILEPSIA, V52, P1430, DOI 10.1111/j.1528-1167.2011.03088.x; Wu WT, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822efcae; Yamamoto T, 2005, AM J OPHTHALMOL, V140, P781, DOI 10.1016/j.ajo.2005.05.018; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	36	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118948	10.1371/journal.pone.0118948	http://dx.doi.org/10.1371/journal.pone.0118948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742640	Green Published, gold			2022-12-27	WOS:000350688100065
J	Cai, Y; Hirata, A; Nakayama, S; VanderLaan, PA; Levantini, E; Yamamoto, M; Hirai, H; Wong, KK; Costa, DB; Watanabe, H; Kobayashi, SS				Cai, Yi; Hirata, Ayako; Nakayama, Sohei; VanderLaan, Paul A.; Levantini, Elena; Yamamoto, Mihoko; Hirai, Hideyo; Wong, Kwok-Kin; Costa, Daniel B.; Watanabe, Hideo; Kobayashi, Susumu S.			CCAAT/Enhancer Binding Protein beta Is Dispensable for Development of Lung Adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-CELL PROLIFERATION; C/EBP-BETA; TRANSCRIPTION FACTORS; DIFFERENTIAL EXPRESSION; DOWN-REGULATION; ALPHA; CANCER; FAMILY; GENE; EXPANSION	Lung cancer is the leading cause of cancer death worldwide. Although disruption of normal proliferation and differentiation is a vital component of tumorigenesis, the mechanisms of this process in lung cancer are still unclear. A transcription factor, C/EBP beta is a critical regulator of proliferation and/or differentiation in multiple tissues. In lung, C/EBP beta is expressed in alveolar pneumocytes and bronchial epithelial cells; however, its roles on normal lung homeostasis and lung cancer development have not been well described. Here we investigated whether C/EBP beta is required for normal lung development and whether its aberrant expression and/or activity contribute to lung tumorigenesis. We showed that C/EBP beta was expressed in both human normal pneumocytes and lung adenocarcinoma cell lines. We found that overall lung architecture was maintained in Cebpb knockout mice. Neither overexpression of nuclear C/EBP beta nor suppression of CEBPB expression had significant effects on cell proliferation. C/EBP beta expression and activity remained unchanged upon EGF stimulation. Furthermore, deletion of Cebpb had no impact on lung tumor burden in a lung specific, conditional mutant EGFR lung cancer mouse model. Analyses of data from The Cancer Genome Atlas (TCGA) revealed that expression, promoter methylation, or copy number of CEBPB was not significantly altered in human lung adenocarcinoma. Taken together, our data suggest that C/EBP beta is dispensable for development of lung adenocarcinoma.	[Cai, Yi; Hirata, Ayako; Nakayama, Sohei; Levantini, Elena; Yamamoto, Mihoko; Costa, Daniel B.; Kobayashi, Susumu S.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [VanderLaan, Paul A.] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Levantini, Elena] CNR, Natl Res Council, Inst Biomed Technol, I-56100 Pisa, Italy; [Hirata, Ayako; Hirai, Hideyo] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan; [Wong, Kwok-Kin; Watanabe, Hideo] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Watanabe, Hideo] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA USA; [Kobayashi, Susumu S.] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Kyoto University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Watanabe, H (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	hideo_watanabe@dfci.harvard.edu; skobayas@bidmc.harvard.edu	levantini, elena/AAK-7201-2021; VanderLaan, Paul Andrew/AAX-8124-2020; Levantini, Elena/AGY-0242-2022	levantini, elena/0000-0003-4612-3105; VanderLaan, Paul Andrew/0000-0002-7234-5652; wong, kwok kin/0000-0001-6323-235X; Nakayama, Sohei/0000-0002-6487-0422; Costa, Daniel/0000-0002-0689-395X	National Institution of Health [R00CA126026, R01CA169259]; Harvard Stem Cell Institute [DP-0110-12-00]; Lung Cancer Foundation of America-International Association; American Cancer Society [RSG-13-047, RSG-11-186]; Bonnie J. Addario Lung Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA169259, R00CA126026] Funding Source: NIH RePORTER	National Institution of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Lung Cancer Foundation of America-International Association; American Cancer Society(American Cancer Society); Bonnie J. Addario Lung Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by National Institution of Health grants (R00CA126026 and R01CA169259 to S. S. K.); Harvard Stem Cell Institute (DP-0110-12-00); an Lung Cancer Foundation of America-International Association to Study Lung Cancer grant (D. B. C.); an American Cancer Society grant (RSG-13-047 to S. S. K. and RSG-11-186 to D. B. C.); and Bonnie J. Addario Lung Cancer Foundation grant (S. N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM T, 1992, J BIOL CHEM, V267, P5021; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Burgess-Beusse BL, 1999, HEPATOLOGY, V29, P597, DOI 10.1002/hep.510290245; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; Cersosimo RJ, 2002, AM J HEALTH-SYST PH, V59, P611, DOI 10.1093/ajhp/59.7.611; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Costa DB, 2007, LUNG CANCER, V56, P97, DOI 10.1016/j.lungcan.2006.11.023; Costa DB, 2006, LUNG CANCER, V53, P253, DOI 10.1016/j.lungcan.2006.04.011; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Dubois-Pot-Schneider H, 2014, HEPATOLOGY, V60, P2077, DOI 10.1002/hep.27353; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Halmos B, 2002, CANCER RES, V62, P528; Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Liloglou Triantafillos, 2014, Cancer Lett, V342, P200, DOI 10.1016/j.canlet.2012.04.018; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Nakayama S, 2014, CANCER RES, V74, P5891, DOI 10.1158/0008-5472.CAN-14-0184; NATSUKA S, 1992, BLOOD, V79, P460; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Roos AB, 2012, DEV DYNAM, V241, P911, DOI 10.1002/dvdy.23773; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sugahara K, 1999, CELL TISSUE RES, V297, P261, DOI 10.1007/s004410051354; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; XING Z, 1994, J IMMUNOL, V153, P4059; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Yeh JE, 2013, CURR OPIN ONCOL, V25, P652, DOI 10.1097/01.cco.0000432528.88101.1a	45	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120647	10.1371/journal.pone.0120647	http://dx.doi.org/10.1371/journal.pone.0120647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767874	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500132
J	Kim, YU; Lim, H; Jung, HE; Wetsel, RA; Chung, Y				Kim, Young Uk; Lim, Hoyong; Jung, Ha Eun; Wetsel, Rick A.; Chung, Yeonseok			Regulation of Autoimmune Germinal Center Reactions in Lupus-Prone BXD2 Mice by Follicular Helper T Cells	PLOS ONE			English	Article							B-CELLS; T(H)17 CELLS; IL-21; DIFFERENTIATION; EXPRESSION; INTERLEUKIN-17; ACTIVATION; GENERATION; PHENOTYPE; EXPANSION	BXD2 mice spontaneously develop autoantibodies and subsequent glomerulonephritis, offering a useful animal model to study autoimmune lupus. Although initial studies showed a critical contribution of IL-17 and Th17 cells in mediating autoimmune B cell responses in BXD2 mice, the role of follicular helper T (Tfh) cells remains incompletely understood. We found that both the frequency of Th17 cells and the levels of IL-17 in circulation in BXD2 mice were comparable to those of wild-type. By contrast, the frequency of PD-1(+)CXCR5(+) Tfh cells was significantly increased in BXD2 mice compared with wild-type mice, while the frequency of PD-1(+)CXCR5(+)Foxp3(+) follicular regulatory T (Tfr) cells was reduced in the former group. The frequency of Tfh cells rather than that of Th17 cells was positively correlated with the frequency of germinal center B cells as well as the levels of autoantibodies to dsDNA. More importantly, CXCR5(+) CD4(+) T cells isolated from BXD2 mice induced the production of IgG from naive B cells in an IL-21-dependent manner, while CCR6(+) CD4(+) T cells failed to do so. These results together demonstrate that Tfh cells rather than Th17 cells contribute to the autoimmune germinal center reactions in BXD2 mice.	[Kim, Young Uk; Jung, Ha Eun; Wetsel, Rick A.] Univ Texas Med Sch Houston, Inst Mol Med, Ctr Immunol & Autoimmune Dis, Houston, TX USA; [Kim, Young Uk; Wetsel, Rick A.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Lim, Hoyong; Chung, Yeonseok] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Immunobiol Lab, Seoul, South Korea; [Lim, Hoyong] Korea Natl Inst Hlth, Div Aids, Cheongwon, Chungbuk, South Korea	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology	Chung, Y (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Immunobiol Lab, Seoul, South Korea.	yeonseok@snu.ac.kr		Chung, Yeonseok/0000-0001-5780-4841; Kim, Young Uk/0000-0002-2518-0189	SNU; National Research Foundation of Korea (NRF) - Korea government (MEST) [2014R1A2A1A11054364]; National Institutes of Health [1R01HL118361]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118361] Funding Source: NIH RePORTER	SNU; National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work is supported by research grants SNU invitation for distinguished scholar (to YC), 2014R1A2A1A11054364 (to YC) from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST), 1R01HL118361 (to YC and RAW) from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Cheng F, 2009, ANN RHEUM DIS, V68, P604, DOI 10.1136/ard.2008.097089; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Feng XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051982; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hsu HC, 2006, ARTHRITIS RHEUM-US, V54, P343, DOI 10.1002/art.21550; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hsu HC, 2007, J IMMUNOL, V178, P5357, DOI 10.4049/jimmunol.178.8.5357; Hsu HC, 2011, ARTHRITIS RHEUM-US, V63, P2038, DOI 10.1002/art.30257; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma J., 2012, CLIN DEV IMMUNOL, V2012, P827; Martin JC, 2014, CLIN IMMUNOL, V154, P1, DOI 10.1016/j.clim.2014.05.004; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; MORSE HC, 1979, J EXP MED, V149, P1183, DOI 10.1084/jem.149.5.1183; Mountz JD, 2005, SCAND J IMMUNOL, V61, P128, DOI 10.1111/j.0300-9475.2005.01548.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Vincent FB, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4277; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu YL, 2005, ARTHRITIS RHEUM-US, V52, P3257, DOI 10.1002/art.21354; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Zhang X, 2013, OCHSNER J, V13, P131; Zhao XF, 2010, MOL BIOL REP, V37, P81, DOI 10.1007/s11033-009-9533-3; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	50	29	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120294	10.1371/journal.pone.0120294	http://dx.doi.org/10.1371/journal.pone.0120294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768299	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500119
J	Ma, SQ; Johnson, D; Ashby, C; Xiong, DH; Cramer, CL; Moore, JH; Zhang, SZ; Huang, XZ				Ma, Shiqian; Johnson, Daniel; Ashby, Cody; Xiong, Donghai; Cramer, Carole L.; Moore, Jason H.; Zhang, Shuzhong; Huang, Xiuzhen			SPARCoC: A New Framework for Molecular Pattern Discovery and Cancer Gene Identification	PLOS ONE			English	Article							LUNG-CANCER; TUMOR HETEROGENEITY; EXPRESSION; CLASSIFICATION; ADENOCARCINOMA; PREDICTION; SURVIVAL	It is challenging to cluster cancer patients of a certain histopathological type into molecular subtypes of clinical importance and identify gene signatures directly relevant to the subtypes. Current clustering approaches have inherent limitations, which prevent them from gauging the subtle heterogeneity of the molecular subtypes. In this paper we present a new framework: SPARCoC (Sparse-CoClust), which is based on a novel Common-background and Sparse-foreground Decomposition (CSD) model and the Maximum Block Improvement (MBI) co-clustering technique. SPARCoC has clear advantages compared with widely-used alternative approaches: hierarchical clustering (Hclust) and nonnegative matrix factorization (NMF). We apply SPARCoC to the study of lung adenocarcinoma (ADCA), an extremely heterogeneous histological type, and a significant challenge for molecular subtyping. For testing and verification, we use high quality gene expression profiling data of lung ADCA patients, and identify prognostic gene signatures which could cluster patients into subgroups that are significantly different in their overall survival (with p-values < 0.05). Our results are only based on gene expression profiling data analysis, without incorporating any other feature selection or clinical information; we are able to replicate our findings with completely independent datasets. SPARCoC is broadly applicable to large-scale genomic data to empower pattern discovery and cancer gene identification.	[Ma, Shiqian] Chinese Univ Hong Kong, Dept Syst Engn & Engn Management, Shatin, Hong Kong, Peoples R China; [Johnson, Daniel; Ashby, Cody] Arkansas State Univ, Mol Biosci Program, Jonesboro, AR 72467 USA; [Xiong, Donghai] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Xiong, Donghai] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [Cramer, Carole L.] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72467 USA; [Cramer, Carole L.] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72467 USA; [Moore, Jason H.] Dartmouth Coll, Geisel Sch Med, Lebanon, NH 03756 USA; [Zhang, Shuzhong] Univ Minnesota, Dept Ind & Syst Engn, Minneapolis, MN 55455 USA; [Huang, Xiuzhen] Arkansas State Univ, Dept Comp Sci, Jonesboro, AR 72467 USA	Chinese University of Hong Kong; Arkansas State University; Medical College of Wisconsin; Medical College of Wisconsin; Arkansas State University; Arkansas State University; Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities; Arkansas State University	Zhang, SZ (corresponding author), Univ Minnesota, Dept Ind & Syst Engn, Minneapolis, MN 55455 USA.	zhangs@umn.edu; xhuang@astate.edu	Moore, Jason H./AAV-9645-2021	Moore, Jason H./0000-0002-5015-1099; Ashby, Cody/0000-0002-9361-0283	Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS) [CUHK 439513]; NSF [CMMI-1161242]; NIH [LM010098, LM009012]; National Institute of Health grants from the National Center for Research Resources [P20RR016460]; National Institute of General Medical Sciences [P20GM103429]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098, R01LM009012] Funding Source: NIH RePORTER; EPSCoR [1003970] Funding Source: National Science Foundation	Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health grants from the National Center for Research Resources; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	S.M. is supported by Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS) (Project ID: CUHK 439513). S.Z. is supported by NSF grant (CMMI-1161242). J.M. is supported by NIH grants LM010098 and LM009012. This work is also partially supported by the National Institute of Health grants from the National Center for Research Resources (P20RR016460) and the National Institute of General Medical Sciences (P20GM103429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Bryant CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011712; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chandrasekaran V, 2011, SIAM J OPTIMIZ, V21, P572, DOI 10.1137/090761793; Cho H., 2004, P 4 SIAM INT C DAT M; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dettling M, 2004, BIOINFORMATICS, V20, P3583, DOI 10.1093/bioinformatics/bth447; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Lee M, 2010, BIOMETRICS, V66, P1087, DOI 10.1111/j.1541-0420.2010.01392.x; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Li X, 2013, IEEE T IMAGE P UNPUB; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030880; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Park YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044225; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Shabalin AA, 2009, ANN APPL STAT, V3, P985, DOI 10.1214/09-AOAS239; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Urbach D, 2012, TRENDS GENET, V28, P538, DOI 10.1016/j.tig.2012.07.001; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Zhang SZ, 2012, LECT NOTES COMPUT SC, V7632, P59, DOI 10.1007/978-3-642-34123-6_6; Zhang SZ, 2011, LECT N BIOINFORMAT, V7036, P1, DOI 10.1007/978-3-642-24855-9_1	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0117135	10.1371/journal.pone.0117135	http://dx.doi.org/10.1371/journal.pone.0117135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768286	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500015
J	Modin, O; Alam, SS; Persson, F; Wilen, BM				Modin, Oskar; Alam, Soroush Saheb; Persson, Frank; Wilen, Britt-Marie			Sorption and Release of Organics by Primary, Anaerobic, and Aerobic Activated Sludge Mixed with Raw Municipal Wastewater	PLOS ONE			English	Article							SIZE DISTRIBUTION; MATTER; BIOSORPTION; REMOVAL; CARBON; PERFORMANCE; ABSORBENCY	New activated sludge processes that utilize sorption as a major mechanism for organics removal are being developed to maximize energy recovery from wastewater organics, or as enhanced primary treatment technologies. To model and optimize sorption-based activated sludge processes, further knowledge about sorption of organics onto sludge is needed. This study compared primary-, anaerobic-, and aerobic activated sludge as sorbents, determined sorption capacity and kinetics, and investigated some characteristics of the organics being sorbed. Batch sorption assays were carried out without aeration at a mixing velocity of 200 rpm. Only aerobic activated sludge showed net sorption of organics. Sorption of dissolved organics occurred by a near-instantaneous sorption event followed by a slower process that obeyed 1st order kinetics. Sorption of particulates also followed 1st order kinetics but there was no instantaneous sorption event; instead there was a release of particles upon mixing. The 5-min sorption capacity of activated sludge was 6.5 +/- 10.8 mg total organic carbon (TOC) per g volatile suspend solids (VSS) for particulate organics and 5.0 +/- 4.7 mgTOC/gVSS for dissolved organics. The observed instantaneous sorption appeared to be mainly due to organics larger than 20 kDa in size being sorbed, although molecules with a size of about 200 Da with strong UV absorbance at 215-230 nm were also rapidly removed.	[Modin, Oskar; Alam, Soroush Saheb; Persson, Frank; Wilen, Britt-Marie] Chalmers Univ Technol, Dept Civil & Environm Engn, Div Water Environm Technol, S-41296 Gothenburg, Sweden	Chalmers University of Technology	Modin, O (corresponding author), Chalmers Univ Technol, Dept Civil & Environm Engn, Div Water Environm Technol, S-41296 Gothenburg, Sweden.	oskar.modin@chalmers.se	Modin, Oskar/D-8440-2014; Modin, Oskar/AAN-4715-2020; Persson, Frank/F-7209-2016; Saheb Alam, Soroush/P-8176-2015; Wilen, Britt-Marie/B-5042-2016	Modin, Oskar/0000-0002-9232-6096; Modin, Oskar/0000-0002-9232-6096; Persson, Frank/0000-0002-0269-9375; Saheb Alam, Soroush/0000-0002-0028-458X; Wilen, Britt-Marie/0000-0001-6155-7759	Swedish Research Council Formas [2012-1433]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The project was funded by the Swedish Research Council Formas (http://formas.se/), grant number 2012-1433. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardern E., 1914, J SOC CHEM IND LOND, V33, P523, DOI [DOI 10.1002/JCTB.5000331005, DOI 10.1002/JCTB.50003]; Barbot E, 2010, CHEM ENG J, V163, P230, DOI 10.1016/j.cej.2010.07.050; Boehnke B, 1997, WATER ENG MANAG, V144, P30; Boehnke B, 1998, WATER ENG MANAG, V145, P31; Boehnke B, 1997, WATER ENG MANAG, V144, P18; Brandstetter A, 1996, Z PFLANZ BODENKUNDE, V159, P605, DOI 10.1002/jpln.1996.3581590612; Clescerl L.S., 1999, STANDARD METHODS EXA, V20th ed.; Constantine T., 2012, P WATER ENV FED, P5771; Diamantis V, 2014, BIORESOURCE TECHNOL, V156, P314, DOI 10.1016/j.biortech.2014.01.061; Dulekgurgen E, 2006, WATER RES, V40, P273, DOI 10.1016/j.watres.2005.10.032; Faust L, 2014, WATER RES, V56, P258, DOI 10.1016/j.watres.2014.03.006; Guellil A, 2001, WATER RES, V35, P143, DOI 10.1016/S0043-1354(00)00240-2; Gustavsson DJI, 2013, WATER SCI TECHNOL, V68, P887, DOI 10.2166/wst.2013.318; Henze M, 2000, ACTIVATED SLUDGE MOD, DOI [10.1007/s00449-010-0446-2, DOI 10.1007/S00449-010-0446-2]; Huang JC, 2000, J ENVIRON SCI HEAL A, V35, P123, DOI 10.1080/10934520009376958; IMHOFF K, 1955, SEWAGE IND WASTES, V27, P431; Jimenez JA, 2005, WATER ENVIRON RES, V77, P437, DOI 10.2175/106143005X67340; Jorand F, 1995, RECENT PROGR GENIE P, V44, P61; Korshin GV, 1997, WATER RES, V31, P1787, DOI 10.1016/S0043-1354(97)00006-7; Lim CP, 2015, BIOCHEM ENG J, V93, P128, DOI 10.1016/j.bej.2014.10.003; McConnell J.S., 1993, J ARKANSAS ACAD SCI, V47, P73; RENSINK JH, 1991, WATER SCI TECHNOL, V23, P857, DOI 10.2166/wst.1991.0537; RIFFAT R, 1995, WATER ENVIRON RES, V67, P1104, DOI 10.2175/106143095X133365; ROSS RD, 1985, J WATER POLLUT CON F, V57, P1022; Schmid FX, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0003142, DOI 10.1038/NPG.ELS.0003142]; Shon HK, 2006, KOREAN J CHEM ENG, V23, P581, DOI 10.1007/BF02706798; Tan KN, 1997, ENVIRON MONIT ASSESS, V44, P211, DOI 10.1023/A:1005732506663; Tchobanoglous G., 2004, WASTEWATER ENG TREAT; ULLRICH AH, 1951, SEWAGE IND WASTES, V23, P1248; VERSPRILLE AI, 1985, WATER SCI TECHNOL, V17, P235, DOI 10.2166/wst.1985.0133; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; YAMAMOTO K, 1989, WATER SCI TECHNOL, V21, P43, DOI 10.2166/wst.1989.0209; Yetis U, 2002, ENVIRON TECHNOL, V23, P363, DOI 10.1080/09593332508618395; Zhao W, 2000, ACTA BIOTECHNOL, V20, P53, DOI 10.1002/abio.370200109	34	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119371	10.1371/journal.pone.0119371	http://dx.doi.org/10.1371/journal.pone.0119371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768429	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500080
J	Watkins, DA; Mvundura, M; Nordet, P; Mayosi, BM				Watkins, David A.; Mvundura, Mercy; Nordet, Porfirio; Mayosi, Bongani M.			A Cost-Effectiveness Analysis of a Program to Control Rheumatic Fever and Rheumatic Heart Disease in Pinar del Rio, Cuba	PLOS ONE			English	Article							PRIMARY PREVENTION; GLOBAL BURDEN; PHARYNGITIS; MANAGEMENT; HEALTH	Background Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) persist in many low-and middle-income countries. To date, the cost-effectiveness of population-based, combined primary and secondary prevention strategies has not been assessed. In the Pinar del Rio province of Cuba, a comprehensive ARF/RHD control program was undertaken over 1986 - 1996. The present study analyzes the cost-effectiveness of this Cuban program. Methods and Findings We developed a decision tree model based on the natural history of ARF/RHD, comparing the costs and effectiveness of the 10-year Cuban program to a "do nothing" approach. Our population of interest was the cohort of children aged 5 - 24 years resident in Pinar del Rio in 1986. We assessed costs and health outcomes over a lifetime horizon, and we took the healthcare system perspective on costs but did not apply a discount rate. We used epidemiologic, clinical, and direct medical cost inputs that were previously collected for publications on the Cuban program. We estimated health gains as disability-adjusted life years (DALYs) averted using standard approaches developed for the Global Burden of Disease studies. Cost-effectiveness acceptability thresholds were defined by one and three times per capita gross domestic product per DALY averted. We also conducted an uncertainty analysis using Monte Carlo simulations and several scenario analyses exploring the impact of alternative assumptions about the program's effects and costs. We found that, compared to doing nothing, the Cuban program averted 5051 DALYs (1844 per 100,000 school-aged children) and saved $7,848,590 (2010 USD) despite a total program cost of $202,890 over 10 years. In the scenario analyses, the program remained cost saving when a lower level of effectiveness and a reduction in averted years of life lost were assumed. In a worst-case scenario including 20-fold higher costs, the program still had a 100% of being cost-effective and an 85% chance of being cost saving. Conclusions A 10-year program to control ARF/RHD in Pinar del Rio, Cuba dramatically reduced morbidity and premature mortality in children and young adults and was cost saving. The results of our analysis were robust to higher program costs and more conservative assumptions about the program's effectiveness. It is possible that the program's effectiveness resulted from synergies between primary and secondary prevention strategies. The findings of this study have implications for non-communicable disease policymaking in other resource-limited settings.	[Watkins, David A.] Univ Washington, Div Gen Internal Med, Dept Med, Seattle, WA 98195 USA; [Watkins, David A.; Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Watkins, David A.; Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Mvundura, Mercy] PATH, Seattle, WA USA; [Nordet, Porfirio] WHO, Retired Cardiovasc Dis Programme, CH-1211 Geneva, Switzerland	University of Washington; University of Washington Seattle; University of Cape Town; University of Cape Town; World Health Organization	Watkins, DA (corresponding author), Univ Washington, Div Gen Internal Med, Dept Med, Seattle, WA 98195 USA.	davidaw@uw.edu	Watkins, David/ABC-3783-2020	Watkins, David/0000-0001-6341-9595; Mvundura, Mercy/0000-0002-7711-9558	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		ARGUEDAS A, 1992, J PEDIATR-US, V121, P569, DOI 10.1016/S0022-3476(05)81146-1; Bach JF, 1996, LANCET, V347, P644, DOI 10.1016/S0140-6736(96)91202-7; Carapetis JR, 2007, NEW ENGL J MED, V357, P439, DOI 10.1056/NEJMp078039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; GORDIS L, 1985, CIRCULATION, V72, P1155, DOI 10.1161/01.CIR.72.6.1155; Irlam J, 2013, CIRC-CARDIOVASC QUAL, V6, P343, DOI 10.1161/CIRCOUTCOMES.111.000032; Karthikeyan G, 2009, CIRCULATION, V120, P709, DOI 10.1161/CIRCULATIONAHA.108.836510; Lopez RR, 1986, FIEBRE REUMATICA EST; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manji RA, 2013, EXPERT REV PHARM OUT, V13, P715, DOI 10.1586/14737167.2013.852470; Michaud CRR, 1999, RHEUMATIC FEVER, P485; Nordet P, 2008, CARDIOVASC J AFR, V19, P135; Organization WH, 2016, GLOBAL STATUS REPORT; R Core Team, R LANG ENV STAT COMP; Remenyi B, 2013, NAT REV CARDIOL, V10, P284, DOI 10.1038/nrcardio.2013.34; Robertson KA, 2006, SAMJ S AFR MED J, V96, P241; Robertson KA, 2008, SAMJ S AFR MED J, V98, P780; Soudarssanane MB, 2007, INDIAN J PEDIATR, V74, P567, DOI 10.1007/s12098-007-0094-y; TOMPKINS RK, 1977, ANN INTERN MED, V86, P481, DOI 10.7326/0003-4819-86-4-481; Van Howe RS, 2006, PEDIATRICS, V117, P609, DOI 10.1542/peds.2005-0879; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2001, NAT BURD DIS MAN; WHO Expert Consultation Report, 2001, RHEUM FEV RHEUM HEAR; World Bank, 2014, CUB COUNTR PROF; World Bank, 2014, INFL CONS PRIC ANN; World Health Organization (WHO), 2013, LIF EXP LIF TABL COU; Wyber R, 2014, B WORLD HEALTH ORGAN, V92, P768, DOI 10.2471/BLT.13.134486	29	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121363	10.1371/journal.pone.0121363	http://dx.doi.org/10.1371/journal.pone.0121363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768008	Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500141
J	Zhu, L; Wu, GY; Zhou, X; Li, JL; Wen, Z; Lin, FC				Zhu, Ling; Wu, Guangyao; Zhou, Xin; Li, Jielan; Wen, Zhi; Lin, Fuchun			Altered Spontaneous Brain Activity in Patients with Acute Spinal Cord Injury Revealed by Resting-State Functional MRI	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN MOTOR CORTEX; REGIONAL HOMOGENEITY; COGNITIVE CONTROL; PARAPLEGIC PATIENTS; AREAS; REORGANIZATION; FMRI; ORGANIZATION; METAANALYSIS	Background Previous neuroimaging studies have provided evidence of structural and functional reorganization of brain in patients with chronic spinal cord injury (SCI). However, it remains unknown whether the spontaneous brain activity changes in acute SCI. In this study, we investigated intrinsic brain activity in acute SCI patients using a regional homogeneity (ReHo) analysis based on resting-state functional magnetic resonance imaging. Methods A total of 15 patients with acute SCI and 16 healthy controls participated in the study. The ReHo value was used to evaluate spontaneous brain activity, and voxel-wise comparisons of ReHo were performed to identify brain regions with altered spontaneous brain activity between groups. We also assessed the associations between ReHo and the clinical scores in brain regions showing changed spontaneous brain activity. Results Compared with the controls, the acute SCI patients showed decreased ReHo in the bilateral primary motor cortex/primary somatosensory cortex, bilateral supplementary motor area/dorsal lateral prefrontal cortex, right inferior frontal gyrus, bilateral dorsal anterior cingulate cortex and bilateral caudate; and increased ReHo in bilateral precuneus, the left inferior parietal lobe, the left brainstem/hippocampus, the left cingulate motor area, bilateral insula, bilateral thalamus and bilateral cerebellum. The average ReHo values of the left thalamus and right insula were negatively correlated with the international standards for the neurological classification of spinal cord injury motor scores. Conclusion Our findings indicate that acute distant neuronal damage has an immediate impact on spontaneous brain activity. In acute SCI patients, the ReHo was prominently altered in brain regions involved in motor execution and cognitive control, default mode network, and which are associated with sensorimotor compensatory reorganization. Abnormal ReHo values in the left thalamus and right insula could serve as potential biomarkers for assessment of neuronal damage and the prediction of clinical outcomes in acute SCI.	[Zhu, Ling; Wu, Guangyao; Li, Jielan; Wen, Zhi] Wuhan Univ, Zhongnan Hosp, Dept Magnet Resonance Imaging, Wuhan 430072, Hubei, Peoples R China; [Zhou, Xin; Lin, Fuchun] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Hubei, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Wu, GY (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Magnet Resonance Imaging, Wuhan 430072, Hubei, Peoples R China.	wuguangy2002@163.com; fclin@wipm.ac.cn	Lin, Fuchun/D-2371-2012; Lin, Fuchun/M-2789-2019; Zhou, Xin/D-9987-2016	Lin, Fuchun/0000-0002-2282-6474; Lin, Fuchun/0000-0002-2282-6474; Zhou, Xin/0000-0002-5580-7907; Wu, Guangyao/0000-0002-0456-3682; Wen, Zhi/0000-0003-2946-3650	Natural Science Foundation of China [81171315, 81227902]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Nos. 81171315 and 81227902 to GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cermik TF, 2006, BRAIN RES, V1109, P54, DOI 10.1016/j.brainres.2006.06.044; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Fang WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069199; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Gerloff C, 1998, BRAIN, V121, P1695, DOI 10.1093/brain/121.9.1695; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Guleria S, 2008, J NEUROSCI RES, V86, P2271, DOI 10.1002/jnr.21664; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hiroshima S, 2014, NEUROL MED-CHIR, V54, P511, DOI 10.2176/nmc.oa2012-0321; Hotz-Boendermaker S, 2011, NEUROREHAB NEURAL RE, V25, P469, DOI 10.1177/1545968310389184; Jain N, 1997, NATURE, V386, P495, DOI 10.1038/386495a0; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Liakakis G, 2011, BEHAV BRAIN RES, V225, P341, DOI 10.1016/j.bbr.2011.06.022; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mestres-Misse A, 2012, NEUROIMAGE, V62, P41, DOI 10.1016/j.neuroimage.2012.05.021; Mutha PK, 2014, CORTEX, V57, P299, DOI 10.1016/j.cortex.2014.03.001; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelled G, 2004, MAGN RESON MED, V52, P913, DOI 10.1002/mrm.20229; Philip NS, 2013, PSYCHIAT RES-NEUROIM, V214, P247, DOI 10.1016/j.pscychresns.2013.07.013; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Procyk E, 2006, J NEUROSCI, V26, P11313, DOI 10.1523/JNEUROSCI.2157-06.2006; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Song YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089493; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Wu T, 2007, NEUROSCI LETT, V423, P189, DOI 10.1016/j.neulet.2007.06.057; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	47	21	25	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118816	10.1371/journal.pone.0118816	http://dx.doi.org/10.1371/journal.pone.0118816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768010	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500045
J	Kuosmanen, SM; Hartikainen, J; Hippelainen, M; Kokki, H; Levonen, AL; Tavi, P				Kuosmanen, Suvi M.; Hartikainen, Juha; Hippelainen, Mikko; Kokki, Hannu; Levonen, Anna-Liisa; Tavi, Pasi			MicroRNA Profiling of Pericardial Fluid Samples from Patients with Heart Failure	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SMOOTH-MUSCLE-CELLS; CIRCULATING MICRORNAS; ENDOTHELIAL-CELLS; CARDIOVASCULAR-DISEASES; NONCODING RNAS; STEM-CELLS; EXPRESSION; EXOSOMES; GROWTH	Aims Multicellular organisms maintain vital functions through intercellular communication. Release of extracellular vesicles that carry signals to even distant target organs is one way of accomplishing this communication. MicroRNAs can also be secreted from the cells in exo-somes and act as paracrine signalling molecules. In addition, microRNAs have been implicated in the pathogenesis of a large number of diseases, including cardiovascular diseases, and are considered as promising candidate biomarkers due to their relative stability and easy quantification from clinical samples. Pericardial fluid contains hormones secreted by the heart and is known to reflect the cardiac function. In this study, we sought to investigate whether pericardial fluid contains microRNAs and if so, whether they could be used to distinguish between different cardiovascular pathologies and disease stages. Methods and Results Pericardial fluid was collected from heart failure patients during open-heart surgery. MicroRNA profiles of altogether 51 patients were measured by quantitative real-time PCR (qPCR) using Exiqon human panels I and II. On the average, 256 microRNAs were detected per sample, and 70 microRNAs out of 742 profiled microRNAs were detected in every sample. The five most abundant microRNAs in pericardial fluid were miR-21-5b, miR-451a, miR-125b-5p, let-7b-5p and miR-16-5p. No specific signatures for cardiovascular pathologies or clinically assessed heart failure stages could be detected from the profiles and, overall, microRNA profiles of the samples were found to be very similar despite the heterogeneity in the study population. Conclusion Measured microRNA profiles did not separate the samples according to the clinical features of the patients. However, several previously identified heart failure marker microRNAs were detected. The pericardial fluid microRNA profile appeared to be a result of an active and selective secretory process indicating that microRNAs may act as paracrine signalling factors by mediating the local crosstalk between cardiac cells.	[Kuosmanen, Suvi M.; Levonen, Anna-Liisa; Tavi, Pasi] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Hartikainen, Juha; Kokki, Hannu] Univ Eastern Finland, Sch Med, Kuopio, Finland; [Hartikainen, Juha; Hippelainen, Mikko] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Kokki, Hannu] Kuopio Univ Hosp, Anesthesia Serv, SF-70210 Kuopio, Finland; [Kokki, Hannu] Kuopio Univ Hosp, Operat Serv, SF-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Levonen, AL (corresponding author), Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, Kuopio, Finland.	Anna-Liisa.Levonen@uef.fi; Pasi.Tavi@uef.fi	Linna-Kuosmanen, Suvi/P-4574-2018	Linna-Kuosmanen, Suvi/0000-0002-3278-2727; Levonen, Anna-Liisa/0000-0002-6575-2137	European Regional Development Fund of the Finnish Funding Agency for Technology and Innovation; Academy of Finland; Sigrid Juselius Foundation; Instrufoundation	European Regional Development Fund of the Finnish Funding Agency for Technology and Innovation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Instrufoundation	This work was supported by the European Regional Development Fund of the Finnish Funding Agency for Technology and Innovation (PT), the Academy of Finland (ALL, PT), the Sigrid Juselius Foundation (ALL, PT), and the Instrufoundation (SMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Abe N, 2006, J AM COLL CARDIOL, V48, P1387, DOI 10.1016/j.jacc.2006.06.048; Adam O, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0278-0; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bao MH, 2013, INT J MOL SCI, V14, P23086, DOI 10.3390/ijms141123086; Barile L, 2014, CARDIOVASC RES; Ben-Horin S, 2005, AM J MED, V118, P636, DOI 10.1016/j.amjmed.2005.01.066; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Bostjancic E, 2009, DIS MARKERS, V27, P255, DOI 10.3233/DMA-2009-0671; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen LJ, 2013, BIOCHEM BIOPH RES CO, V431, P566, DOI 10.1016/j.bbrc.2013.01.015; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Corda S, 1997, CIRC RES, V81, P679; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Elzenaar I, 2013, CLIN PHARMACOL THER, V94, P480, DOI 10.1038/clpt.2013.138; Emanueli C, 2013, CELL RES, V23, P866, DOI 10.1038/cr.2013.57; Fan Kuan-Lu, 2013, Indian Heart J, V65, P12, DOI 10.1016/j.ihj.2012.12.022; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; Fujita M, 2001, INT J CARDIOL, V77, P113, DOI 10.1016/S0167-5273(00)00462-9; GIBSON AT, 1978, J PHYSIOL-LONDON, V277, P367, DOI 10.1113/jphysiol.1978.sp012277; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Goldraich LA, 2014, BIOMARKERS, V19, P135, DOI 10.3109/1354750X.2013.870605; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; Harada M, 2014, CIRC RES, V114, P689, DOI 10.1161/CIRCRESAHA.114.301798; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Horkay F, 1997, LIFE SCI, V62, P267, DOI 10.1016/S0024-3205(97)01105-3; Huang SL, 2014, CIRC-CARDIOVASC GENE, V7, P189, DOI 10.1161/CIRCGENETICS.113.000294; Iwakura A, 2000, J AM COLL CARDIOL, V35, P1785, DOI 10.1016/S0735-1097(00)00651-3; Kamanu TKK, 2013, SCI REP-UK, V3, DOI 10.1038/srep02940; Kane NM, 2012, STEM CELLS, V30, P643, DOI 10.1002/stem.1026; Kirby TJ, 2013, FREE RADICAL BIO MED, V64, P95, DOI 10.1016/j.freeradbiomed.2013.07.004; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Lai CTM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-73; Li ZC, 2014, SCI WORLD J, DOI 10.1155/2014/931845; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Long GW, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-178; Long GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050926; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Lv P, 2014, INT J MOL SCI, V15, P5774, DOI 10.3390/ijms15045774; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Melman YF, 2014, CIRC-HEART FAIL, V7, P203, DOI 10.1161/CIRCHEARTFAILURE.113.000266; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Ren JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080738; Sahoo S, 2014, CIRC RES, V114, P333, DOI 10.1161/CIRCRESAHA.114.300639; Sala V, 2014, CELL MOL LIFE SCI, V71, P1439, DOI 10.1007/s00018-013-1504-0; Selmeci L, 2000, CORONARY ARTERY DIS, V11, P53, DOI 10.1097/00019501-200002000-00010; Shan Z, 2013, CHINESE MED J-PEKING, V126, P515, DOI 10.3760/cma.j.issn.0366-6999.20122289; Sluijter JPG, 2014, CARDIOVASC RES, V102, P302, DOI 10.1093/cvr/cvu022; Tambara K, 2002, HEART, V87, P242, DOI 10.1136/heart.87.3.242; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tijsen AJ, 2012, CARDIOVASC RES, V93, P573, DOI 10.1093/cvr/cvr344; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Vacchi-Suzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052442; Viereck J, 2014, CARDIOVASC RES, V102, P290, DOI 10.1093/cvr/cvu039; Voellenkle C, 2010, PHYSIOL GENOMICS, V42, P420, DOI 10.1152/physiolgenomics.00211.2009; Waldenstrom A, 2014, CIRC RES, V114, P315, DOI 10.1161/CIRCRESAHA.114.300584; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Wang XH, 2014, CARDIOVASC RES, V102, P385, DOI 10.1093/cvr/cvu044; Watanabe M, 2009, CLIN CARDIOL, V32, P159, DOI 10.1002/clc.20306; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Yellon DM, 2014, CIRC RES, V114, P325, DOI 10.1161/CIRCRESAHA.113.300636; Yoneda T, 2000, JPN CIRC J, V64, P495, DOI 10.1253/jcj.64.495; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883	78	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119646	10.1371/journal.pone.0119646	http://dx.doi.org/10.1371/journal.pone.0119646			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763857	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300029
J	Martinez, MC; Kok, CC; Baleriola, C; Robertson, P; Rawlinson, WD				Martinez, Maria Carmela; Kok, Chee Choy; Baleriola, Cristina; Robertson, Peter; Rawlinson, William D.			Investigation of Occult Hepatitis B Virus Infection in Anti-HBc Positive Patients from a Liver Clinic	PLOS ONE			English	Article							BLOOD-DONORS; SURFACE-ANTIGEN; MOLECULAR CHARACTERIZATION; GENOTYPE-C; GENE VARIANTS; CARRIERS; MUTANTS; SERUM; PREVALENCE; CHINA	Occult hepatitis B infection (OBI) is manifested by presence of very low levels (< 200IU/mL) of Hepatitis B viral DNA (HBV DNA) in the blood and the liver while exhibiting undetectable HBV surface antigen (HBsAg). The molecular mechanisms underlying this occurrence are still not completely understood. This study investigated the prevalence of OBI in a high-risk Australian population and compared the HBV S gene sequences of our cohort with reference sequences. Serum from HBV DNA positive, HBsAg negative, and hepatitis B core antibody (anti-HBc) positive patients (study cohort) were obtained from samples tested at SEALS Serology Laboratory using the Abbott Architect, as part of screening and diagnostic testing. From a total of 228,108 samples reviewed, 1,451 patients were tested for all three OBI markers. Only 10 patients (0.69%) out of the 1,451 patients were found to fit the selection criteria for OBI. Sequence analysis of the HBV S gene from 5 suspected OBI infected patients showed increased sequence variability in the ` a' epitope of the major hydrophilic region compared to reference sequences. In addition, a total of eight consistent nucleotide substitutions resulting in seven amino acid changes were observed, and three patients had truncated S gene sequence. These mutations appeared to be stable and may result in alterations in HBsAg conformation. These may negatively impact the affinity of hepatitis B surface antibody (anti-HBs) and may explain the false negative results in serological HBV diagnosis. These changes may also enable the virus to persist in the liver by evading immune surveillance. Further studies on a bigger cohort are required to determine whether these amino acid variations have been acquired in the process of immune escape and serve as markers of OBI.	[Martinez, Maria Carmela; Rawlinson, William D.] Prince Wales Hosp, Div Virol, Sydney, NSW, Australia; [Kok, Chee Choy; Baleriola, Cristina; Robertson, Peter; Rawlinson, William D.] Prince Wales Hosp, SEALS Microbiol, Sydney, NSW, Australia; [Martinez, Maria Carmela; Rawlinson, William D.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Baleriola, C (corresponding author), Prince Wales Hosp, SEALS Microbiol, Sydney, NSW, Australia.	Cristina.Baleriola@sesiahs.health.nsw.gov.au		Rawlinson, William/0000-0003-0988-7827				Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; Candotti D, 2009, J HEPATOL, V51, P798, DOI 10.1016/j.jhep.2009.05.020; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chemin I, 2005, J CLIN VIROL, V34, pS15, DOI 10.1016/S1386-6532(05)80005-8; Coleman PF, 1999, J MED VIROL, V59, P19, DOI 10.1002/(SICI)1096-9071(199909)59:1<19::AID-JMV4>3.0.CO;2-B; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Firnhaber C, 2009, INT J INFECT DIS, V13, P488, DOI 10.1016/j.ijid.2008.08.018; Health Protection Agency, 2007, REC PROT HBV GEN ANT; Hofer M, 1998, EUR J CLIN MICROBIOL, V17, P6, DOI 10.1007/BF01584356; Hou JL, 2001, HEPATOLOGY, V34, P1027, DOI 10.1053/jhep.2001.28708; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Huang XY, 2013, J MED VIROL, V85, P979, DOI 10.1002/jmv.23556; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Katsoulidou A, 2009, J MED VIROL, V81, P815, DOI 10.1002/jmv.21499; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kim SM, 2007, J INFECTION, V54, P185, DOI 10.1016/j.jinf.2006.02.002; Liu CJ, 2006, J CLIN VIROL, V36, pS33, DOI 10.1016/S1386-6532(06)80007-7; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Moerman B, 2004, Clin Lab, V50, P159; Morsica G, 2009, INFECTION, V37, P445, DOI 10.1007/s15010-008-8194-9; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Pujol FH, 2009, CANCER LETT, V286, P80, DOI 10.1016/j.canlet.2009.07.013; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Scheiblauer H, 2006, J MED VIROL, V78, pS66, DOI 10.1002/jmv.20611; Schmeltzer P, 2010, DIGEST DIS SCI, V55, P3328, DOI 10.1007/s10620-010-1413-0; Schories M, 2000, J HEPATOL, V33, P799, DOI 10.1016/S0168-8278(00)80313-X; Squadrito G, 2014, ANN GASTROENTEROL, V27, P15; Tian YJ, 2007, J CLIN MICROBIOL, V45, P2971, DOI 10.1128/JCM.00508-07; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Wang JT, 2002, TRANSFUSION, V42, P1592, DOI 10.1046/j.1537-2995.2002.00274.x; Weinberger KM, 2000, J GEN VIROL, V81, P1165, DOI 10.1099/0022-1317-81-5-1165; Yuan Q, 2010, J CLIN MICROBIOL, V48, P357, DOI 10.1128/JCM.01781-09	33	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0117275	10.1371/journal.pone.0117275	http://dx.doi.org/10.1371/journal.pone.0117275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763579	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300009
J	Pontes, B; Girldez, R; Aguilar-Ruiz, JS				Pontes, Beatriz; Girldez, Ral; Aguilar-Ruiz, Jess S.			Quality Measures for Gene Expression Biclusters	PLOS ONE			English	Article							PREDICTION	An noticeable number of biclustering approaches have been proposed proposed for the study of gene expression data, especially for discovering functionally related gene sets under different subsets of experimental conditions. In this context, recognizing groups of co-expressed or co-regulated genes, that is, genes which follow a similar expression pattern, is one of the main objectives. Due to the problem complexity, heuristic searches are usually used instead of exhaustive algorithms. Furthermore, most of biclustering approaches use a measure or cost function that determines the quality of biclusters. Having a suitable quality metric for bicluster is a critical aspect, not only for guiding the search, but also for establishing a comparison criteria among the results obtained by different biclustering techniques. In this paper, we analyse a large number of existing approaches to quality measures for gene expression biclusters, as well as we present a comparative study of them based on their capability to recognize different expression patterns in biclusters.	[Pontes, Beatriz] Univ Seville, Dept Comp Languages, Seville, Spain; [Girldez, Ral; Aguilar-Ruiz, Jess S.] Pablo Olavide Univ, Sch Engn, Seville, Spain	University of Sevilla; Universidad Pablo de Olavide	Pontes, B (corresponding author), Univ Seville, Dept Comp Languages, Seville, Spain.	bepontes@us.es	Aguilar-Ruiz, Jesus S./J-1938-2019; Aguilar-Ruiz, Jesus S/L-9135-2014	Aguilar-Ruiz, Jesus S./0000-0002-2666-293X; Aguilar-Ruiz, Jesus S/0000-0002-2666-293X	Spanish Ministry of Economy and Competitiveness [TIN2011-28956-C02]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research has been supported by the Spanish Ministry of Economy and Competitiveness under grant TIN2011-28956-C02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Ruiz JS, 2005, BIOINFORMATICS, V21, P3840, DOI 10.1093/bioinformatics/bti641; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayadi W, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-9; Baldi P, 2002, DNA MICROARRAYS GENE; BLAND JM, 1995, BRIT MED J, V310, P633, DOI 10.1136/bmj.310.6980.633; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bozdag D, 2010, 1 ACM INT C BIOINFOR, P265, DOI [DOI 10.1145/1854776.1854814, 10.1145/1854776.1854814]; Bozdag D, 2009, LECT N BIOINFORMAT, V5462, P151, DOI 10.1007/978-3-642-00727-9_16; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Divina F, 2006, IEEE T KNOWL DATA EN, V18, P590, DOI 10.1109/TKDE.2006.74; Divina F, 2012, COMPUT BIOL MED, V42, P245, DOI 10.1016/j.compbiomed.2011.11.015; Eren K, 2012, BRIEFINGS BIOINFORMA; Flores JL, 2013, COMPUT METH PROG BIO, V112, P367, DOI 10.1016/j.cmpb.2013.07.025; Gan XC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-209; Giraldez R, 2007, FUZZ SYST C FUZZ IEE, P1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Harpaz R., 2006, EXPLOITING GEOMETRY; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Liu XW, 2007, BIOINFORMATICS, V23, P50, DOI 10.1093/bioinformatics/btl560; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Mitra S, 2009, INFORM FUSION, V10, P242, DOI 10.1016/j.inffus.2008.11.006; Mukhopadhyay A, 2010, CURR BIOINFORM, V5, P204, DOI 10.2174/157489310792006701; Mukhopadhyay Anirban, 2009, Journal of Bioinformatics and Computational Biology, V7, P853, DOI 10.1142/S0219720009004370; Nepomuceno JA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-3; Piatetslcy-Shapiro G., 2003, CAPTURING BEST PRACT, P407; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pontes B, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-4; Pontes B, 2010, LECT N BIOINFORMAT, V6282, P242, DOI 10.1007/978-3-642-16001-1_21; Tanay A, 2005, HDB COMPUTATIONAL MO, V9, P26, DOI [10.1109/TCBB.2004.2, DOI 10.1109/TCBB.2004.2]; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Teng L, 2008, J SIGNAL PROCESS SYS, V50, P267, DOI 10.1007/s11265-007-0121-2; Tilstone C, 2003, NATURE, V424, P610, DOI 10.1038/424610a; Wang H., 2002, P 2002 ACM SIGMOD IN, P394, DOI DOI 10.1145/564691.564737; Yang WH, 2011, IEEE T KNOWL DATA EN, V23, P568, DOI 10.1109/TKDE.2010.150; Yip KY, 2004, IEEE T KNOWL DATA EN, V16, P1387, DOI 10.1109/TKDE.2004.74	39	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0115497	10.1371/journal.pone.0115497	http://dx.doi.org/10.1371/journal.pone.0115497			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763839	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300002
J	Wan, YQ; Liu, YH; Wang, XB; Wu, JL; Liu, KZ; Zhou, J; Liu, L; Zhang, CX				Wan, Yunqiang; Liu, Yuanhui; Wang, Xiaobin; Wu, Jiali; Liu, Kezhi; Zhou, Jun; Liu, Li; Zhang, Chunxiang			Identification of Differential MicroRNAs in Cerebrospinal Fluid and Serum of Patients with Major Depressive Disorder	PLOS ONE			English	Article							DISEASE; EXPRESSION; BDNF; ASSOCIATION; INVOLVEMENT; BIOMARKER; BEHAVIOR; STRESS; GENES; MODEL	Major depression is a debilitating disease. To date, the development of biomarkers of major depressive disorder (MDD) remains a challenge. Recently, alterations in the expression of microRNAs (miRNAs) from post-mortem brain tissue and peripheral blood have been linked to MDD. The goals of this study were to detect the differential miRNAs in cerebrospinal fluid (CSF) and serum of MDD patients. First, the relative expression levels of 179 miRNAs (relative high levels in serum) were analyzed by miRNA PCR Panel in the CSF of MDD patients. Then, the differentially altered miRNAs from CSF were further assessed by qRT-PCR in the serum of the same patients. Finally, the serum differentially altered miRNAs were further validated by qRT-PCR in the serum of another MDD patients. The CSF-results indicated that 11 miRNAs in MDD patients were significantly higher than these in control subjects, and 5 miRNAs were significantly lower than these in control subjects. The serum-results from the same patients showed that 3 miRNAs (miR-221-3p, miR-34a-5p, and let-7d-3p) of the 11 miRNAs were significantly higher than these in control subjects, and 1 miRNA (miR-451a) of 5 miRNAs was significantly lower than these in control subjects. The up-regulation of miR-221-3p, miR-34a-5p, let-7d-3p and down-regulation of miR-451a was further validated in another 32 MDD patients. ROC analysis showed that the area under curve of let-7d-3p, miR-34a-5p, miR-221-3p and miR-451a was 0.94, 0.98, 0.97 and 0.94, with specificity of 90.48%, 95.24%, 90.48% and 90.48%, and sensitivity of 93.75%, 96.88%, 90.63% and 84.85%, respectively. In addition, target gene prediction found that the altered miRNAs are involved in affecting some important genes and pathway related to MDD. Our results suggested that differentially altered miRNAs in CSF might be involved in MDD, and serum miR-221-3p, miR-34a-5p, let-7d-3p, and miR-451a might be able to serve as biomarkers for MDD.	[Wan, Yunqiang; Liu, Yuanhui; Wang, Xiaobin; Wu, Jiali; Zhou, Jun; Liu, Li] Luzhou Med Coll, Dept Anesthesiol & Psychiat, Affiliated Hosp, Luzhou, Sichuan Provinc, Peoples R China; [Liu, Kezhi] Luzhou Med Coll, Dept Psychiat, Affiliated Hosp, Luzhou, Sichuan Provinc, Peoples R China; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Chicago, IL 60612 USA	Southwest Medical University; Southwest Medical University; Rush University	Wang, XB (corresponding author), Luzhou Med Coll, Dept Anesthesiol & Psychiat, Affiliated Hosp, Luzhou, Sichuan Provinc, Peoples R China.	wangxiaobin67@163.com	zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495; Zhou, Jun/0000-0002-7571-9314	Projects of the National Natural Science Foundation of China [81271478]; International Cooperation, Department of Science & Technology of Sichuan Province [2011HH0031]; Department of Education of Sichuan Province [14106]; Innovative Team, Department of Education of Sichuan Province [14TD0018]	Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation, Department of Science & Technology of Sichuan Province; Department of Education of Sichuan Province; Innovative Team, Department of Education of Sichuan Province	This project was supported by the Projects of the National Natural Science Foundation of China (Grant No. 81271478); International Cooperation, Department of Science & Technology of Sichuan Province (Grant No. 2011HH0031); Department of Education of Sichuan Province (Grant No. 14106); and Innovative Team, Department of Education of Sichuan Province (Grant No. 14TD0018) to X. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Angelucci F, 2011, PHARMACOLOGY, V87, P5, DOI 10.1159/000322528; Baraniskin A, 2012, NEURO-ONCOLOGY, V14, P29, DOI 10.1093/neuonc/nor169; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bocchio-Chiavetto L, 2013, EUR NEUROPSYCHOPHARM, V23, P602, DOI 10.1016/j.euroneuro.2012.06.013; Cappuzzo F, 2014, CLIN COLORECTAL CANC, V13, P37, DOI 10.1016/j.clcc.2013.11.006; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Choi Eunhyun, 2014, Cells, V3, P899, DOI 10.3390/cells3030899; Croce N, 2013, MOL CELL BIOCHEM, V376, P189, DOI 10.1007/s11010-013-1567-0; Dwivedi Y, 2011, J CHEM NEUROANAT, V42, P142, DOI 10.1016/j.jchemneu.2011.04.002; Fan HM, 2014, J PSYCHIATR RES, V59, P45, DOI 10.1016/j.jpsychires.2014.08.007; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gallego JA, 2012, J MOL NEUROSCI, V47, P243, DOI 10.1007/s12031-012-9731-7; Ghourchian Shadi, 2014, Med J Islam Repub Iran, V28, P9; Golimbet VE, 2014, B EXP BIOL MED+, V156, P680, DOI 10.1007/s10517-014-2424-1; Kishi T, 2010, J AFFECT DISORDERS, V126, P167, DOI 10.1016/j.jad.2010.04.003; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leibrock C, 2013, CELL PHYSIOL BIOCHEM, V32, P766, DOI 10.1159/000354478; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Liu BB, 2015, PSYCHOPHARMACOLOGY, V232, P541, DOI 10.1007/s00213-014-3690-3; Liu XL, 2014, J AFFECT DISORDERS, V163, P133, DOI 10.1016/j.jad.2013.12.035; Muller M, 2014, NEUROBIOL AGING, V35, P152, DOI 10.1016/j.neurobiolaging.2013.07.005; Oh DH, 2014, J NEURAL TRANSM, V121, P783, DOI 10.1007/s00702-014-1189-z; Oved K, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.86; Prins SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083166; Ray MT, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.26; Serafini G, 2014, CELL MOL NEUROBIOL, V34, P17, DOI 10.1007/s10571-013-9997-5; Smalheiser NR, 2014, PLOS ONE, V7; Varendi K, 2014, CELL MOL LIFE SCI, V71, P4443, DOI 10.1007/s00018-014-1628-x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wan QR, 2014, BEHAV BRAIN RES, V271, P1, DOI 10.1016/j.bbr.2014.05.031; Wang ZW, 2014, J AFFECT DISORDERS, V162, P116, DOI 10.1016/j.jad.2014.03.047; Wibrand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041688; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zhou XX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065040, 10.1371/journal.pone.0062245]	35	117	122	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0121975	10.1371/journal.pone.0121975	http://dx.doi.org/10.1371/journal.pone.0121975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763923	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300048
J	Ledochowski, L; Ruedl, G; Taylor, AH; Kopp, M				Ledochowski, Larissa; Ruedl, Gerhard; Taylor, Adrian H.; Kopp, Martin			Acute Effects of Brisk Walking on Sugary Snack Cravings in Overweight People, Affect and Responses to a Manipulated Stress Situation and to a Sugary Snack Cue: A Crossover Study	PLOS ONE			English	Article							BLOOD-PRESSURE RESPONSES; REGULAR CHOCOLATE EATERS; FOOD-CRAVINGS; EATING BEHAVIOR; EXERCISE; VALIDATION; SMOKING; TRAIT; MOOD; INTERFERENCE	Research has shown that acute exercise reduces urges for chocolate in normal weight people. This study aimed to examine the effects of an acute exercise bout on urges to consume sugary snacks, affect as well as 'psychological and physiological responses' to stress and a 'sugary snack cue', in overweight individuals. Following 3 days of chocolate-abstinence, 47 overweight, sugary snack consumers were assessed, in 2 randomly ordered conditions, in a within-subject design: 15-min brisk walk or passive control. Following each, participants completed 2 tasks: Stroop color-word interference task, and handling sugary snacks. Urges for sugary snacks, affective activation and valence were assessed. ANOVAs revealed significant condition x time interaction effects for: urges to consume sugary snacks, affective valence and activation. Obtained data show that exercise reduces urges for sugary snacks and attenuates urges in response to the stress situation and the cue in overweight people.	[Ledochowski, Larissa; Ruedl, Gerhard; Kopp, Martin] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria; [Taylor, Adrian H.] Univ Plymouth, Peninsula Sch Med, Plymouth PL6 8BX, Devon, England; [Taylor, Adrian H.] Univ Plymouth, Peninsula Sch Dent, Plymouth PL6 8BX, Devon, England	University of Innsbruck; University of Plymouth; University of Plymouth	Ledochowski, L (corresponding author), Univ Innsbruck, Dept Sport Sci, Furstenweg 185, A-6020 Innsbruck, Austria.	larissa.ledochowski@uibk.ac.at	Kopp, Martin/K-1369-2017; Taylor, Adrian/GME-5077-2022	Kopp, Martin/0000-0002-3011-387X; Taylor, Adrian/0000-0003-2701-9468				Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Borg G., 1998, BORGS PERCEIVED EXER; Borg G., 2004, DEUT ARZTEBLATT, V101, P1016; Bruinsma K, 1999, J AM DIET ASSOC, V99, P1249, DOI 10.1016/S0002-8223(99)00307-7; Cepeda-Benito A, 2000, BEHAV THER, V31, P151, DOI 10.1016/S0005-7894(00)80009-X; Cepeda-Benito A, 2000, BEHAV RES THER, V38, P1125, DOI 10.1016/S0005-7967(99)00141-2; COOLS J, 1992, J ABNORM PSYCHOL, V101, P348, DOI 10.1037/0021-843X.101.2.348; Ekkekakis P, 2000, J BEHAV MED, V23, P245, DOI 10.1023/A:1005558025163; Ekkekakis P, 2002, PSYCHOL SPORT EXERC, V2, P205; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Hamer M, 2006, BIOL PSYCHOL, V71, P183, DOI 10.1016/j.biopsycho.2005.04.004; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; King NA, 2012, BRIT J SPORT MED, V46, P315, DOI 10.1136/bjsm.2010.082495; Kopp M, 2012, DIABETES RES CLIN PR, V95, P25, DOI 10.1016/j.diabres.2011.09.017; Macht M, 2007, APPETITE, V49, P667, DOI 10.1016/j.appet.2007.05.004; Macht M, 2006, APPETITE, V46, P332, DOI 10.1016/j.appet.2006.01.014; Oh H, 2014, HEALTH PSYCHOL, V33, P349, DOI 10.1037/a0032423; Oh H, 2013, APPETITE, V71, P144, DOI 10.1016/j.appet.2013.07.015; Oh H, 2012, APPETITE, V58, P387, DOI 10.1016/j.appet.2011.11.006; Ouwehand C, 2008, OBESITY, V16, P1788, DOI 10.1038/oby.2008.316; Polivy J, 2005, INT J EAT DISORDER, V38, P301, DOI 10.1002/eat.20195; Renaud P, 1997, INT J PSYCHOPHYSIOL, V27, P87, DOI 10.1016/S0167-8760(97)00049-4; Rodriguez S, 2005, BIOL PSYCHOL, V70, P9, DOI 10.1016/j.biopsycho.2004.10.001; Rodriguez S, 2007, APPETITE, V49, P245, DOI 10.1016/j.appet.2007.01.001; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Shaban R, 2008, AUSTRALAS EMERG NURS, V11, P1, DOI 10.1016/j.aenj.2007.12.003; STONE AA, 1994, PSYCHOL HEALTH, V9, P425, DOI 10.1080/08870449408407469; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SVEBAK S, 1985, J PERS SOC PSYCHOL, V48, P107, DOI 10.1037/0022-3514.48.1.107; Tanofsky-Kraff M, 2000, INT J EAT DISORDER, V27, P411, DOI 10.1002/(SICI)1098-108X(200005)27:4<411::AID-EAT5>3.0.CO;2-P; Taylor A, 2006, PSYCHOPHARMACOLOGY, V184, P247, DOI 10.1007/s00213-005-0275-1; Taylor AH, 2007, ADDICTION, V102, P534, DOI 10.1111/j.1360-0443.2006.01739.x; Taylor AH, 2009, APPETITE, V52, P155, DOI 10.1016/j.appet.2008.09.004; Tetley AC, 2010, EAT BEHAV, V11, P138, DOI 10.1016/j.eatbeh.2009.12.004; Thayer R.E., 2003, CALM ENERGY PEOPLE R; THAYER RE, 1987, J PERS SOC PSYCHOL, V52, P119, DOI 10.1037/0022-3514.52.1.119; THAYER RE, 1978, PSYCHOL REP, V42, P747, DOI 10.2466/pr0.1978.42.3.747; THAYER RE, 1993, PERS INDIV DIFFER, V14, P97, DOI 10.1016/0191-8869(93)90178-6; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Van Landuyt LM, 2000, J SPORT EXERCISE PSY, V22, P208, DOI 10.1123/jsep.22.3.208; Wardle J, 2000, J PSYCHOSOM RES, V48, P195, DOI 10.1016/S0022-3999(00)00076-3; WEINGARTEN HP, 1991, APPETITE, V17, P167, DOI 10.1016/0195-6663(91)90019-O; Zellner DA, 1999, APPETITE, V33, P61, DOI 10.1006/appe.1999.0234	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119278	10.1371/journal.pone.0119278	http://dx.doi.org/10.1371/journal.pone.0119278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760042	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000051
J	Czarniak, P; Bint, L; Favie, L; Parsons, R; Hughes, J; Sunderland, B				Czarniak, Petra; Bint, Lewis; Favie, Laurent; Parsons, Richard; Hughes, Jeff; Sunderland, Bruce			Clinical Setting Influences Off-Label and Unlicensed Prescribing in a Paediatric Teaching Hospital	PLOS ONE			English	Article							INTENSIVE-CARE UNIT; DRUG-USE; MEDICATION USE; CHILDREN; MEDICINES; WARDS; FINLAND	Purpose To estimate the prevalence of off-label and unlicensed prescribing during 2008 at a major paediatric teaching hospital in Western Australia. Methods A 12-month retrospective study was conducted at Princess Margaret Hospital using medication chart records randomly selected from 145,550 patient encounters from the Emergency Department, Inpatient Wards and Outpatient Clinics. Patient and prescribing data were collected. Drugs were classified as off-label or unlicensed based on Australian registration data. A hierarchical system of age, indication, route of administration and dosage was used. Drugs were classified according to the Anatomical Therapeutic Chemical Code. Results A total of 1,037 paediatric patients were selected where 2,654 prescriptions for 330 different drugs were prescribed to 699 patients (67.4%). Most off-label drugs (n = 295; 43.3%) were from the nervous system; a majority of unlicensed drugs were systemic hormonal preparations excluding sex hormones (n = 22, 32.4%). Inpatients were prescribed more off-label drugs than outpatients or Emergency Department patients (p < 0.0001). Most off-label prescribing occurred in infants and children (31.7% and 35.9% respectively) and the highest percentage of unlicensed prescribing (7.2%) occurred in infants (p < 0.0001). There were 25.7% of off-label and 2.6% of unlicensed medications prescribed across all three settings. Common reasons for off-label prescribing were dosage (47.4%) and age (43.2%). Conclusion This study confirmed off-label and unlicensed use of drugs remains common. Further, that prevalence of both is influenced by the clinical setting, which has implications in regards to medication misadventure, and the need to have systems in place to minimise medication errors. Further, there remains a need for changes in the regulatory system in Australia to ensure that manufacturers incorporate, as it becomes available, evidence regarding efficacy and safety of their drugs in children in the official product information.	[Czarniak, Petra; Parsons, Richard; Hughes, Jeff; Sunderland, Bruce] Curtin Univ, Bentley, WA, Australia; [Bint, Lewis] Princess Margaret Hosp, Subiaco, WA, Australia; [Favie, Laurent] Univ Utrecht, Dept Pharmaceut Sci, NL-3508 TC Utrecht, Netherlands	Curtin University; Utrecht University	Czarniak, P (corresponding author), Curtin Univ, Bentley, WA, Australia.	P.Czarniak@curtin.edu.au						AMH Children's Dosing Companion, 2013, AMH CHILDR DOS COMP; [Anonymous], 2008, THER GOODS ADM PROD; Avenel S, 2000, ARCH PEDIATRIE, V7, P143, DOI 10.1016/S0929-693X(00)88083-5; Bajcetic M, 2005, EUR J CLIN PHARMACOL, V61, P775, DOI 10.1007/s00228-005-0981-y; Ballard CDJ, 2013, J PAEDIATR CHILD H, V49, P38, DOI 10.1111/jpc.12065; Barr J, 2002, AM J PERINAT, V19, P67, DOI 10.1055/s-2002-23557; Conroy S, 2003, ANN ONCOL, V14, P42, DOI 10.1093/annonc/mdg031; Conroy S, 1999, ARCH DIS CHILD-FETAL, V80, pF142, DOI 10.1136/fn.80.2.F142; Conroy S, 2001, PAEDIATR ANAESTH, V11, P431, DOI 10.1046/j.1460-9592.2001.00697.x; Conroy S, 2000, BRIT MED J, V320, P79, DOI 10.1136/bmj.320.7227.79; Craig J S, 2001, Ir Med J, V94, P237; Di Paolo Ermindo R, 2006, Swiss Med Wkly, V136, P218; European Medicines Agency, 2001, ICH TOP E11 CLIN INV; Gavrilov V, 2000, ISRAEL MED ASSOC J, V2, P595; Hsien L, 2008, PHARM WORLD SCI, V30, P497, DOI 10.1007/s11096-008-9193-8; LEE JHW, 2013, J HYDRO ENVIRON RES, V0007; Lindell-Osuagwu L, 2014, J CLIN PHARM THER, V39, P144, DOI 10.1111/jcpt.12119; Lindell-Osuagwu L, 2009, J CLIN PHARM THER, V34, P277, DOI 10.1111/j.1365-2710.2008.01005.x; McKinzie JP, 1997, AM J EMERG MED, V15, P118, DOI 10.1016/S0735-6757(97)90079-6; MIMS Australia, 2008, MONTHL IND MED SPEC; Neubert A, 2004, DRUG SAFETY, V27, P1059, DOI 10.2165/00002018-200427130-00006; O'Donnell CPF, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e52; Palcevski G, 2012, EUR J CLIN PHARMACOL, V68, P1073, DOI 10.1007/s00228-012-1221-x; Ribeiro M, 2012, I CONF SENS TECHNOL, P1, DOI 10.1109/ICSensT.2012.6461670; Santos DB, 2008, EUR J CLIN PHARMACOL, V64, P1111, DOI 10.1007/s00228-008-0543-1; Sinha Y, 2007, J PAEDIATR CHILD H, V43, P107, DOI 10.1111/j.1440-1754.2007.00970.x; 't Jong GW, 2002, EUR J CLIN PHARMACOL, V58, P293, DOI 10.1007/s00228-002-0479-9; 't Jong GW, 2001, PEDIATRICS, V108, P1089, DOI 10.1542/peds.108.5.1089; Turner S, 1996, LANCET, V347, P549, DOI 10.1016/S0140-6736(96)91182-4; Turner Sean, 1999, Australian Journal of Hospital Pharmacy, V29, P265; Zanon D, 2012, EUROPEAN J PEDIAT, P1	31	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120630	10.1371/journal.pone.0120630	http://dx.doi.org/10.1371/journal.pone.0120630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756896	Green Published, gold			2022-12-27	WOS:000351275700070
J	Nakanishi, A; Kishikawa, J; Tamakoshi, M; Yokoyama, K				Nakanishi, Atsuko; Kishikawa, Jun-ichi; Tamakoshi, Masatada; Yokoyama, Ken			The Ingenious Structure of Central Rotor Apparatus in VoV1; Key for Both Complex Disassembly and Energy Coupling between V-1 and V-o	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ROTARY MOTOR; ATPASE; SUBUNIT; V-1-ATPASE; STALK; INHIBITION; MECHANISM	Vacuolar type rotary H+-ATPases (VoV1) couple ATP synthesis/hydrolysis by V-1 with proton translocation by V-o via rotation of a central rotor apparatus composed of the V-1-DF rotor shaft, a socket-like V-o-C (eukaryotic V-o-d) and the hydrophobic rotor ring. Reconstitution experiments using subcomplexes revealed a weak binding affinity of V-1-DF to V-o-C despite the fact that torque needs to be transmitted between V-1-DF and V-o-C for the tight energy coupling between V-1 and V-o. Mutation of a short helix at the tip of V-1-DF caused intramolecular uncoupling of VoV1, suggesting that proper fitting of the short helix of V-1-D into the socket of V-o-C is required for tight energy coupling between V-1 and V-o. To account for the apparently contradictory properties of the interaction between V-1-DF and V-o-C (weak binding affinity but strict requirement for torque transmission), we propose a model in which the relationship between V-1-DF and V-o-C corresponds to that between a slotted screwdriver and a head of slotted screw. This model is consistent with our previous result in which the central rotor apparatus is not the major factor for the association of V-1 with V-o (Kishikawa and Yokoyama, J Biol Chem. 2012 24597-24603).	[Nakanishi, Atsuko; Kishikawa, Jun-ichi; Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 603, Japan; [Tamakoshi, Masatada] Tokyo Univ Pharm & Life Sci, Dept Mol Biol, Hachioji, Tokyo 19203, Japan	Kyoto Sangyo University; Tokyo University of Pharmacy & Life Sciences	Yokoyama, K (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 603, Japan.	yokoken@cc.kyoto-su.ac.jp		Nakanishi, Atsuko/0000-0001-8262-0796; Kishikawa, Jun-ichi/0000-0003-3913-7330	Ministry of Education, Science, Sports and Culture of Japan [24370059, 26650039]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan No. 24370059 and 26650039 to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kakinuma Y, 1999, J BIOENERG BIOMEMBR, V31, P7, DOI 10.1023/A:1005499126939; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kishikawa J, 2014, J BIOL CHEM, V289, P403, DOI 10.1074/jbc.M113.523498; Kishikawa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064695; Kishikawa J, 2012, J BIOL CHEM, V287, P24597, DOI 10.1074/jbc.M112.367813; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Soga N, 2012, J BIOL CHEM, V287, P9633, DOI 10.1074/jbc.M111.335356; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Takeda M, 2009, BIOPHYS J, V96, P1210, DOI 10.1016/j.bpj.2008.10.031; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; Tani K, 2013, MICROSCOPY-JPN, V62, P467, DOI 10.1093/jmicro/dft020; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119602	10.1371/journal.pone.0119602	http://dx.doi.org/10.1371/journal.pone.0119602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756791	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275700049
J	Schneider, N; Goncalves, FDC; Pinto, FO; Lopez, PLD; Araujo, AB; Pfaffenseller, B; Passos, EP; Cirne-Lima, EO; Meurer, L; Lamers, ML; Paz, AH				Schneider, Natalia; Goncalves, Fabiany da Costa; Pinto, Fernanda Otesbelgue; da Costa Lopez, Patrcia Luciana; Araujo, Anelise Bergmann; Pfaffenseller, Bianca; Passos, Eduardo Pandolfi; Cirne-Lima, Elizabeth Obino; Meurer, Luise; Lamers, Marcelo Lazzaron; Paz, Ana Helena			Dexamethasone and Azathioprine Promote Cytoskeletal Changes and Affect Mesenchymal Stem Cell Migratory Behavior	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; UMBILICAL-CORD; INTERNATIONAL-SOCIETY; EXPERIMENTAL COLITIS; THERAPY; ADHESION; TRANSPLANTATION; PROLIFERATION; EXPRESSION	Glucocorticoids and immunosuppressive drugs are commonly used to treat inflammatory disorders, such as inflammatory bowel disease (IBD), and despite a few improvements, the remission of IBD is still difficult to maintain. Due to their immunomodulatory properties, mesenchymal stem cells (MSCs) have emerged as regulators of the immune response, and their viability and activation of their migratory properties are essential for successful cell therapy. However, little is known about the effects of immunosuppressant drugs used in IBD treatment on MSC behavior. The aim of this study was to evaluate MSC viability, nuclear morphometry, cell polarity, F-actin and focal adhesion kinase (FAK) distribution, and cell migratory properties in the presence of the immunosuppressive drugs azathioprine (AZA) and dexamethasone (DEX). After an initial characterization, MSCs were treated with DEX (10 mu M) or AZA (1 mu M) for 24 hrs or 7 days. Neither drug had an effect on cell viability or nuclear morphometry. However, AZA treatment induced a more elongated cell shape, while DEX was associated with a more rounded cell shape (P < 0.05) with a higher presence of ventral actin stress fibers (P < 0.05) and a decrease in protrusion stability. After 7 days of treatment, AZA improved the cell spatial trajectory (ST) and increased the migration speed (24.35%, P < 0.05, n = 4), while DEX impaired ST and migration speed after 24 hrs and 7 days of treatment (-28.69% and -25.37%, respectively; P < 0.05, n = 4). In conclusion, our data suggest that these immunosuppressive drugs each affect MSC morphology and migratory capacity differently, possibly impacting the success of cell therapy.	[Schneider, Natalia; Goncalves, Fabiany da Costa; Pinto, Fernanda Otesbelgue; Passos, Eduardo Pandolfi; Cirne-Lima, Elizabeth Obino; Paz, Ana Helena] Hosp Clin Porto Alegre, Expt Res Ctr, Embryol & Cell Differentiat Lab, BR-90035 Porto Alegre, RS, Brazil; [Schneider, Natalia; Goncalves, Fabiany da Costa; Meurer, Luise; Paz, Ana Helena] Univ Fed Rio Grande do Sul, Grad Program Gastroenterol & Hepatol Sci, BR-90035 Porto Alegre, RS, Brazil; [da Costa Lopez, Patrcia Luciana; Araujo, Anelise Bergmann; Pfaffenseller, Bianca] Hosp Clin Porto Alegre, Expt Res Ctr, BR-90035 Porto Alegre, RS, Brazil; [Lamers, Marcelo Lazzaron; Paz, Ana Helena] Univ Fed Rio Grande do Sul, Hlth Basic Sci Inst, Dept Morphol Sci, BR-90050 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Paz, AH (corresponding author), Hosp Clin Porto Alegre, Expt Res Ctr, Embryol & Cell Differentiat Lab, Ramiro Barcelos 2350, BR-90035 Porto Alegre, RS, Brazil.	anahpaz@gmail.com	Araújo, Anelise/W-4990-2019; Pfaffenseller, Bianca/AAA-3635-2021; Passos, Eduardo P/A-2842-2012; Paz, Ana Helena/V-6082-2019; LAMERS, MARCELO/A-5291-2013; Cirne-Lima, Elizabeth Obino/N-9796-2018	Araújo, Anelise/0000-0001-5277-1964; LAMERS, MARCELO/0000-0001-5296-5662; Otesbelgue Pinto, Fernanda/0000-0003-0549-2457; Paz, Ana Helena/0000-0003-3668-7054; Schneider Nunes, Natalia/0000-0003-1950-4391	FIPE (Fundo de Incentivo a Pesquisa e Eventos) from Hospital de Clinicas de Porto Alegre; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [479527/2012-1]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FIPE (Fundo de Incentivo a Pesquisa e Eventos) from Hospital de Clinicas de Porto Alegre; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Authors would like to thank FIPE (Fundo de Incentivo a Pesquisa e Eventos) from Hospital de Clinicas de Porto Alegre, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (#479527/2012-1) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for research funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2013, GUT, V62, P1131, DOI 10.1136/gutjnl-2012-302152; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Buron F, 2009, TRANSPL P, V41, P3347, DOI 10.1016/j.transproceed.2009.08.030; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Charwat S, 2008, EXP HEMATOL, V36, P672, DOI 10.1016/j.exphem.2008.01.005; Chen JC, 2013, J CELL MOL MED, V17, P863, DOI 10.1111/jcmm.12069; Chen X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.537; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; ClinicalTrials, OS THER PHAS 3 MULT; ClinicalTrials.gov, RAND DOUBL BLIND PLA; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Martinez-Montiel MD, 2014, WORLD J GASTROENTERO, V20, P1211, DOI 10.3748/wjg.v20.i5.1211; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duijvestein M, 2011, CYTOTHERAPY, V13, P1066, DOI 10.3109/14653249.2011.597379; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Filippi-Chiela EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042522; Forbes GM, 2014, CLIN GASTROENTEROL H, V12, P64, DOI 10.1016/j.cgh.2013.06.021; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Gazouli M, 2014, INFLAMM BOWEL DIS, V20, P952, DOI 10.1097/01.MIB.0000442922.85569.21; Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700; Giamarellos-Bourboulis EJ, 2010, CYTOKINE, V49, P89, DOI 10.1016/j.cyto.2009.08.016; Goncalves FD, 2014, WORLD J GASTROENTERO, V20, P18228, DOI 10.3748/wjg.v20.i48.18228; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hoogduijn MJ, 2008, TRANSPLANTATION, V86, P1283, DOI 10.1097/TP.0b013e31818aa536; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Igarashi J, 2013, AM J PHYSIOL-CELL PH, V304, pC790, DOI 10.1152/ajpcell.00268.2012; Indumathi S, 2013, TISSUE CELL, V45, P434, DOI 10.1016/j.tice.2013.07.007; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kholodenko IV, 2012, B EXP BIOL MED+, V154, P118, DOI 10.1007/s10517-012-1890-6; Kim JW, 2013, SPINE, V38, pE1065, DOI 10.1097/BRS.0b013e31829839fa; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Li Li, 2011, Front Med, V5, P33, DOI 10.1007/s11684-011-0114-1; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Li XY, 2014, INT J MOL MED, V34, P695, DOI 10.3892/ijmm.2014.1821; Liang J, 2012, GUT, V61, P468, DOI 10.1136/gutjnl-2011-300083; Liang L, 2011, CELL TRANSPLANT, V20, P1395, DOI 10.3727/096368910X557245; Liu L, 2009, INT IMMUNOPHARMACOL, V9, P1568, DOI 10.1016/j.intimp.2009.09.013; Lopez PLC, 2012, ONCOLOGY-BASEL, V83, P75, DOI 10.1159/000337978; Maijenburg MW, 2012, STEM CELLS DEV, V21, P19, DOI 10.1089/scd.2011.0270; Mancheno-Corvo P, 2013, BIORESEARCH OPEN ACC, V2, P431, DOI 10.1089/biores.2013.0040; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moggio A, 2012, FERTIL STERIL, V98, P1521, DOI 10.1016/j.fertnstert.2012.08.003; Mokbel AN, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-259; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller N, 2013, J IMMUNOL, V190, P4360, DOI 10.4049/jimmunol.1201520; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Nuzzi R, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/946090; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pham PTT, 2012, NEPHROL DIAL TRANSPL, V27, P2965, DOI 10.1093/ndt/gfr731; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Qiu YY, 2012, CYTOTHERAPY, V14, P285, DOI 10.3109/14653249.2011.651532; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Schroll S, 2005, REGUL PEPTIDES, V131, P1, DOI 10.1016/j.regpep.2005.03.001; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Song IH, 2009, J ORTHOP RES, V27, P216, DOI 10.1002/jor.20726; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Xinaris C, 2013, CELL TRANSPLANT, V22, P423, DOI 10.3727/096368912X653246; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhu YZ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt436; Zhuo W, 2013, TRANSPL P, V45, P503, DOI 10.1016/j.transproceed.2012.07.162	79	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120538	10.1371/journal.pone.0120538	http://dx.doi.org/10.1371/journal.pone.0120538			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756665	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700068
J	Li, SY; Li, QR; Li, Y; Li, L; Tian, HM; Sun, X				Li, Sheyu; Li, Qianrui; Li, Yun; Li, Ling; Tian, Haoming; Sun, Xin			Acetyl-L-Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							ANTIRETROVIRAL TOXIC NEUROPATHY; DIABETIC-NEUROPATHY; NERVE REGENERATION; DOUBLE-BLIND; MULTICENTER; ACID	Objective Acetyl-L-carnitine (ALC), a constructive molecule in fatty acid metabolism, is an agent potentially effective for treating peripheral neuropathic pain (PNP). Its effect, however, remains uncertain. We aimed to access the efficacy and safety of ALC for the treatment of patients with PNP. Methods We searched MEDLINE (1996-2014), EMBase (1974-2014), and CENTRAL (May 2014) up to June 27, 2014 for randomized controlled trials (RCTs) comparing ALC with placebo or other active medications in diabetic and non-diabetic PNP patients that reported the change of pain using visual analogue scale (VAS). Mean difference (MD) and 95% confidence interval (CI) were used for pooling continuous data. Results Four RCTs comparing ALC with placebo and reporting in three articles (n = 523) were included. Compared with placebo, ALC significantly reduced VAS scores of PNP patients (MD of VAS, 1.20; 95% CI, 0.68-1.72, P < 0.00001). In the subgroup analysis, the effect of ALC on VAS was similar in different administration routes (intramuscular-oral sequential subgroup: MD, 1.19; 95% CI, 0.34-2.04, P = 0.006; oral only subgroup: pooled MD, 1.15; 95% CI, 0.33-1.96, P = 0.006), and ALC appeared more effective in diabetic PNP patients than non-diabetic PNP patients (diabetic subgroup: MD, 1.47; 95% CI, 1.06-1.87, P < 0.00001; non-diabetic subgroup: MD, 0.71; 95% CI, -0.01-1.43, P = 0.05). No severe adverse events were reported related to ALC. The common adverse events were pain, headache, paraesthesia, hyperesthesia, retching, biliary colic, and gastrointestinal disorders. The rates of total adverse events were similar in ALC and control group. Conclusion The current evidence suggests that ALC has a moderate effect in reducing pain measured on VAS in PNP patients with acceptable safety. Larger trials with longer follow-up, however, are warranted to establish the effects.	[Li, Sheyu; Li, Qianrui; Li, Yun; Tian, Haoming] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610041, Peoples R China; [Li, Ling; Sun, Xin] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Tian, HM (corresponding author), Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610041, Peoples R China.	hmtian999@126.com; sunx79@hotmail.com	Li, Sheyu/O-3242-2016	Li, Sheyu/0000-0003-0060-0287; Tian, Haoming/0000-0002-1921-4733				Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Bianchi G, 2005, EUR J CANCER, V41, P1746, DOI 10.1016/j.ejca.2005.04.028; Bril V, 2011, NEUROLOGY, V76, P1758, DOI 10.1212/WNL.0b013e3182166ebe; Chiechio S, 2006, CURR NEUROPHARMACOL, V4, P233, DOI 10.2174/157015906778019509; CURTI D, 1989, MECH AGEING DEV, V47, P39, DOI 10.1016/0047-6374(89)90005-5; De Grandis Domenico, 2002, Drugs R D, V3, P223, DOI 10.2165/00126839-200203040-00001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Finnerup NB, 2013, HAND CLINIC, V115, P279, DOI 10.1016/B978-0-444-52902-2.00017-5; FRITZ IB, 1959, AM J PHYSIOL, V197, P297, DOI 10.1152/ajplegacy.1959.197.2.297; Han YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087191; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hur J, 2013, DIABETES CARE, V36, P4043, DOI 10.2337/dc12-2530; Jensen MP, 2007, NEUROLOGY, V68, P1178, DOI 10.1212/01.wnl.0000259085.61898.9e; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111979; MANTEL N, 1959, J NATL CANCER I, V22, P719; Memeo A, 2008, CLIN DRUG INVEST, V28, P495, DOI 10.2165/00044011-200828080-00004; Mondal S, 2014, CLIN CANCER INVESTIG, V3, P213, DOI 10.4103/2278-0513.132113; ONOFRJ M, 1995, INT J CLIN PHARM RES, V15, P9; Onofrj M, 2013, EXPERT REV NEUROTHER, V13, P925, DOI 10.1586/14737175.2013.814930; Osio M, 2006, J PERIPHER NERV SYST, V11, P72, DOI 10.1111/j.1085-9489.2006.00066.x; Phillips TJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014433; Pittler MH, 2008, CLIN J PAIN, V24, P731, DOI 10.1097/AJP.0b013e3181759231; QUATRARO A, 1995, DIABETOLOGIA, V38, P123, DOI 10.1007/BF02369363; Radat F, 2013, EUR J PAIN, V17, P1547, DOI 10.1002/j.1532-2149.2013.00334.x; Sima AAF, 2005, DIABETES CARE, V28, P89, DOI 10.2337/diacare.28.1.89; Singh R, 2014, PHARMACOL RES, V80, P21, DOI 10.1016/j.phrs.2013.12.005; Tamamogullari N, 1999, J DIABETES COMPLICAT, V13, P251, DOI 10.1016/S1056-8727(99)00052-5; Ulvi H, 2010, TURK J MED SCI, V40, P169, DOI 10.3906/sag-0807-7; Youle M, 2007, HIV MED, V8, P241, DOI 10.1111/j.1468-1293.2007.00467.x	30	19	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119479	10.1371/journal.pone.0119479	http://dx.doi.org/10.1371/journal.pone.0119479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751285	gold, Green Published, Green Submitted			2022-12-27	WOS:000350692700025
J	Halvorson, KG; Barton, KL; Schroeder, K; Misuraca, KL; Hoeman, C; Chung, A; Crabtree, DM; Cordero, FJ; Singh, R; Spasojevic, I; Berlow, N; Pal, R; Becher, OJ				Halvorson, Kyle G.; Barton, Kelly L.; Schroeder, Kristin; Misuraca, Katherine L.; Hoeman, Christine; Chung, Alex; Crabtree, Donna M.; Cordero, Francisco J.; Singh, Raj; Spasojevic, Ivan; Berlow, Noah; Pal, Ranadip; Becher, Oren J.			A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; BRAIN-STEM GLIOMAS; ACTIVATING ACVR1 MUTATIONS; RAT GLIOBLASTOMA CELLS; HIGH-GRADE GLIOMAS; PEDIATRIC GLIOBLASTOMA; GENE-EXPRESSION; HISTONE H3.3; RECEPTOR; CANCER	Diffuse intrinsic pontine gliomas (DIPGs) represent a particularly lethal type of pediatric brain cancer with no effective therapeutic options. Our laboratory has previously reported the development of genetically engineered DIPG mouse models using the RCAS/tv-a system, including a model driven by PDGF-B, H3.3K27M, and p53 loss. These models can serve as a platform in which to test novel therapeutics prior to the initiation of human clinical trials. In this study, an in vitro high-throughput drug screen as part of the DIPG preclinical consortium using cell-lines derived from our DIPG models identified BMS-754807 as a drug of interest in DIPG. BMS-754807 is a potent and reversible small molecule multi-kinase inhibitor with many targets including IGF-1R, IR, MET, TRKA, TRKB, AURKA, AURKB. In vitro evaluation showed significant cytotoxic effects with an IC50 of 0.13 mu M, significant inhibition of proliferation at a concentration of 1.5 mu M, as well as inhibition of AKT activation. Interestingly, IGF-1R signaling was absent in serum-free cultures from the PDGF-B; H3.3K27M; p53 deficient model suggesting that the antitumor activity of BMS-754807 in this model is independent of IGF-1R. In vivo, systemic administration of BMS-754807 to DIPG-bearing mice did not prolong survival. Pharmacokinetic analysis demonstrated that tumor tissue drug concentrations of BMS-754807 were well below the identified IC50, suggesting that inadequate drug delivery may limit in vivo efficacy. In summary, an unbiased in vitro drug screen identified BMS-754807 as a potential therapeutic agent in DIPG, but BMS-754807 treatment in vivo by systemic delivery did not significantly prolong survival of DIPGbearing mice.	[Halvorson, Kyle G.; Barton, Kelly L.; Schroeder, Kristin; Hoeman, Christine; Chung, Alex; Crabtree, Donna M.; Cordero, Francisco J.; Singh, Raj; Becher, Oren J.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Halvorson, Kyle G.; Barton, Kelly L.; Hoeman, Christine; Chung, Alex; Crabtree, Donna M.; Cordero, Francisco J.; Singh, Raj; Becher, Oren J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Halvorson, Kyle G.; Schroeder, Kristin; Becher, Oren J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Halvorson, Kyle G.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Misuraca, Katherine L.] Duke Univ, Grad Program Mol Canc Biol, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Univ, Dept Med Oncol, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Canc Inst, PK PD Core Lab, Pharmaceut Serv, Durham, NC USA; [Berlow, Noah; Pal, Ranadip] Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Texas Tech University System; Texas Tech University	Becher, OJ (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.	oren.becher@duke.edu	Becher, Oren/AAI-7495-2020; Pal, Ranadip/F-3905-2012	Becher, Oren/0000-0003-4016-8492; Pal, Ranadip/0000-0002-9311-5901	Rory David Deutsch Foundation; Department of Defense award [W81XWH-11-1-0608]; Joshua's Wish Foundation Summer Research Grant; Children's Oncology Group (COG) CNS Committee; DIPG Collaborative (The Cure Starts Now Foundation, Reflections of Grace Foundation, Smiles for Sophie Foundation, Cancer-Free Kids Foundation, Carly's Crusade Foundation, Jeffrey Thomas Hayden Foundation, Soar with Grace Foundation); Accelerate Brain Cancer Cures Foundation [ABC2]; Lyla Nsouli Foundation; CureSearch for Childhood Cancer; Team Julian Foundation; COG Chair's [5UOCA098543];  [T32];  [R25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER	Rory David Deutsch Foundation; Department of Defense award(United States Department of Defense); Joshua's Wish Foundation Summer Research Grant; Children's Oncology Group (COG) CNS Committee; DIPG Collaborative (The Cure Starts Now Foundation, Reflections of Grace Foundation, Smiles for Sophie Foundation, Cancer-Free Kids Foundation, Carly's Crusade Foundation, Jeffrey Thomas Hayden Foundation, Soar with Grace Foundation); Accelerate Brain Cancer Cures Foundation; Lyla Nsouli Foundation; CureSearch for Childhood Cancer; Team Julian Foundation; COG Chair's; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Rory David Deutsch Foundation, and a Department of Defense award (W81XWH-11-1-0608) to OJB. KS was supported by a T32 award (PI Henry Friedman). KH was supported by a R25 award (PI John Sampson). RS was supported by a Joshua's Wish Foundation Summer Research Grant. The drug screen was supported by the Children's Oncology Group (COG) CNS Committee, The DIPG Collaborative (The Cure Starts Now Foundation, Reflections of Grace Foundation, Smiles for Sophie Foundation, Cancer-Free Kids Foundation, Carly's Crusade Foundation, Jeffrey Thomas Hayden Foundation, Soar with Grace Foundation), Accelerate Brain Cancer Cures Foundation (ABC2), The Lyla Nsouli Foundation, CureSearch for Childhood Cancer, The Team Julian Foundation and the COG Chair's Grant (5UOCA098543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT AL, 1993, NEUROSURGERY, V33, P1026; Awasthi N, 2012, MOL CANCER THER, V11, P2644, DOI 10.1158/1535-7163.MCT-12-0447; Barton KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077639; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; BERGER MS, 1983, NEUROSURGERY, V12, P298, DOI 10.1227/00006123-198303000-00008; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Buczkowicz P, 2013, BRAIN PATHOL, V23, P244, DOI 10.1111/j.1750-3639.2012.00633.x; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Fontebasso AM, 2014, NAT GENET, V46, P462, DOI 10.1038/ng.2950; Freeman CR, 1998, INT J RADIAT ONCOL, V40, P265, DOI 10.1016/S0360-3016(97)00572-5; Grill J, 2012, PEDIATR BLOOD CANCER, V58, P489, DOI 10.1002/pbc.24060; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Hou XN, 2011, CANCER RES, V71, P7597, DOI 10.1158/0008-5472.CAN-11-1080; Huang F, 2010, CANCER RES, V70, P7221, DOI 10.1158/0008-5472.CAN-10-0391; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kolb EA, 2011, PEDIATR BLOOD CANCER, V56, P595, DOI 10.1002/pbc.22741; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; LITTMAN P, 1980, CANCER, V45, P2787, DOI 10.1002/1097-0142(19800601)45:11<2787::AID-CNCR2820451113>3.0.CO;2-V; Minturn JE, 2013, CURR TREAT OPTION NE, V15, P316, DOI 10.1007/s11940-013-0225-x; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; RESNICOFF M, 1994, CANCER RES, V54, P2218; RESNICOFF M, 1994, LAB INVEST, V71, P657; Ries L.A.G., 1999, CANC INCIDENCE SURVI; Roujeau T, 2007, J NEUROSURG, V107, P1, DOI 10.3171/PED-07/07/001; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Scotlandi K, 2002, INT J CANCER, V101, P11, DOI 10.1002/ijc.10537; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; Wojtalla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047109; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yin SC, 2010, NEURO-ONCOLOGY, V12, P19, DOI 10.1093/neuonc/nop008; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463	41	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118926	10.1371/journal.pone.0118926	http://dx.doi.org/10.1371/journal.pone.0118926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748921	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400032
J	Mayerhofer, B; Stoger, A; Pietzka, AT; Fernandez, HL; Prewein, B; Sorschag, S; Kunert, R; Allerberger, F; Ruppitsch, W				Mayerhofer, Benjamin; Stoeger, Anna; Pietzka, Ariane T.; Fernandez, Haizpea Lasa; Prewein, Bernhard; Sorschag, Sieglinde; Kunert, Renate; Allerberger, Franz; Ruppitsch, Werner			Improved Protocol for Rapid Identification of Certain Spa Types Using High Resolution Melting Curve Analysis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; DNA; SEQUENCE; REGION	Methicillin-resistant Staphylococcus aureus is one of the most significant pathogens associated with health care. For efficient surveillance, control and outbreak investigation, S. aureus typing is essential. A high resolution melting curve analysis was developed and evaluated for rapid identification of the most frequent spa types found in an Austrian hospital consortium covering 2,435 beds. Among 557 methicillin-resistant Staphylococcus aureus isolates 38 different spa types were identified by sequence analysis of the hypervariable region X of the protein A gene (spa). Identification of spa types through their characteristic high resolution melting curve profiles was considerably improved by double spiking with genomic DNA from spa type t030 and spa type t003 and allowed unambiguous and fast identification of the ten most frequent spa types t001 (58%), t003 (12%), t190 (9%), t041 (5%), t022 (2%), t032 (2%), t008 (2%), t002 (1%), t5712 (1%) and t2203 (1%), representing 93% of all isolates within this hospital consortium. The performance of the assay was evaluated by testing samples with unknown spa types from the daily routine and by testing three different high resolution melting curve analysis real-time PCR instruments. The ten most frequent spa types were identified from all samples and on all instruments with 100% specificity and 100% sensitivity. Compared to classical spa typing by sequence analysis, this gene scanning assay is faster, cheaper and can be performed in a single closed tube assay format. Therefore it is an optimal screening tool to detect the most frequent endemic spa types and to exclude non-endemic spa types within a hospital.	[Mayerhofer, Benjamin] Univ Appl Sci Wiener Neustadt, Dept Biomed Analyt, Wiener Neustadt, Austria; [Mayerhofer, Benjamin; Stoeger, Anna; Pietzka, Ariane T.; Fernandez, Haizpea Lasa; Prewein, Bernhard; Allerberger, Franz; Ruppitsch, Werner] Austrian Agcy Hlth & Food Safety, Inst Med Microbiol & Hyg, Vienna, Austria; [Sorschag, Sieglinde] KABEG, Klinikum Klagenfurt, Inst Lab Diagnost & Microbiol, Klagenfurt, Austria; [Prewein, Bernhard; Kunert, Renate; Ruppitsch, Werner] Univ Nat Resources & Life Sci, Dept Biotechnol, Inst Appl Microbiol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Ruppitsch, W (corresponding author), Austrian Agcy Hlth & Food Safety, Inst Med Microbiol & Hyg, Vienna, Austria.	werner.ruppitsch@ages.at	Ruppitsch, Werner/AAC-9295-2019; Kunert, Renate E/B-9185-2018	Ruppitsch, Werner/0000-0001-9940-3333; Kunert, Renate E/0000-0002-3397-3621; LASA FERNANDEZ, HAIZPEA/0000-0003-3551-9606; Allerberger, Franz/0000-0002-0045-8164	Leonardo da Vinci GLOBAL TRAINING grant	Leonardo da Vinci GLOBAL TRAINING grant	This work was supported by a Leonardo da Vinci GLOBAL TRAINING grant to HLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JHK, 2013, J MICROBIOL METH, V92, P99, DOI 10.1016/j.mimet.2012.11.006; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Druml B, 2014, FOOD CHEM, V158, P245, DOI 10.1016/j.foodchem.2014.02.111; Ferber D, 2010, SCIENCE, V329, P1010, DOI 10.1126/science.329.5995.1010; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Johnson AP, 2011, J ANTIMICROB CHEMOTH, V66, pIV43, DOI 10.1093/jac/dkr076; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Palais RA, 2005, ANAL BIOCHEM, V346, P167, DOI 10.1016/j.ab.2005.08.010; Pietzka AT, 2009, J ANTIMICROB CHEMOTH, V63, P1121, DOI 10.1093/jac/dkp124; Platt AR, 2007, BIOTECHNIQUES, V43, P58, DOI 10.2144/000112499; Ruppitsch W, 2006, J CLIN MICROBIOL, V44, P2442, DOI 10.1128/JCM.00113-06; Schmid D, 2013, AM J INFECT CONTROL, V41, P617, DOI 10.1016/j.ajic.2012.09.013; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Votintseva AA, 2014, J CLIN MICROBIOL, V52, P1192, DOI 10.1128/JCM.03254-13; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Zeinzinger J, 2012, APPL ENVIRON MICROB, V78, P3352, DOI 10.1128/AEM.07668-11	24	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116713	10.1371/journal.pone.0116713	http://dx.doi.org/10.1371/journal.pone.0116713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768007	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500013
J	Araneda, R; De Volder, AG; Deggouj, N; Renier, L				Araneda, Rodrigo; De Volder, Anne G.; Deggouj, Naima; Renier, Laurent			Altered Inhibitory Control and Increased Sensitivity to Cross-Modal Interference in Tinnitus during Auditory and Visual Tasks	PLOS ONE			English	Article							SELECTIVE ATTENTION; PREFRONTAL CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; GENERATION; NEUROSCIENCE; STIMULATION; SUPPRESSION; PERCEPTION; MODULATION	Tinnitus is the perception of sound in the absence of external stimulus. Currently, the pathophysiology of tinnitus is not fully understood, but recent studies indicate that alterations in the brain involve non-auditory areas, including the prefrontal cortex. In experiment 1, we used a go/no-go paradigm to evaluate the target detection speed and the inhibitory control in tinnitus participants (TP) and control subjects (CS), both in unimodal and bimodal conditions in the auditory and visual modalities. We also tested whether the sound frequency used for target and distractors affected the performance. We observed that TP were slower and made more false alarms than CS in all unimodal auditory conditions. TP were also slower than CS in the bimodal conditions. In addition, when comparing the response times in bimodal and auditory unimodal conditions, the expected gain in bimodal conditions was present in CS, but not in TP when tinnitus-matched frequency sounds were used as targets. In experiment 2, we tested the sensitivity to cross-modal interference in TP during auditory and visual go/no-go tasks where each stimulus was preceded by an irrelevant pre-stimulus in the untested modality (e.g. high frequency auditory pre-stimulus in visual no/no-go condition). We observed that TP had longer response times than CS and made more false alarms in all conditions. In addition, the highest false alarm rate occurred in TP when tinnitusmatched/ high frequency sounds were used as pre-stimulus. We conclude that the inhibitory control is altered in TP and that TP are abnormally sensitive to cross-modal interference, reflecting difficulties to ignore irrelevant stimuli. The fact that the strongest interference effect was caused by tinnitus-like auditory stimulation is consistent with the hypothesis according to which such stimulations generate emotional responses that affect cognitive processing in TP. We postulate that executive functions deficits play a key-role in the perception and maintenance of tinnitus.	[Araneda, Rodrigo; De Volder, Anne G.; Deggouj, Naima; Renier, Laurent] Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium; [Deggouj, Naima] Catholic Univ Louvain, Dept Otorhinolaryngol & Head & Neck Surg, B-1200 Brussels, Belgium; [Deggouj, Naima] Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Renier, L (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium.	laurent.renier@uclouvain.be	Araneda, Rodrigo/AHB-4339-2022	Araneda, Rodrigo/0000-0002-0890-5504	Becas Chile Program (Chile); Brussels Institute for Research and Innovation (INNOVIRIS, Belgium); FRSM (Belgium) [3.4502.08]	Becas Chile Program (Chile); Brussels Institute for Research and Innovation (INNOVIRIS, Belgium)(Innoviris); FRSM (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The Becas Chile Program (Chile), Brussels Institute for Research and Innovation (INNOVIRIS, Belgium), the FRSM grant #3.4502.08 (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Andersson G, 2000, J SPEECH LANG HEAR R, V43, P1168, DOI 10.1044/jslhr.4305.1168; Andersson G, 2005, CYBERPSYCHOL BEHAV, V8, P32, DOI 10.1089/cpb.2005.8.32; Andersson G, 2002, CLIN OTOLARYNGOL, V27, P270, DOI 10.1046/j.1365-2273.2002.00581.x; Banbury SP, 2001, HUM FACTORS, V43, P12, DOI 10.1518/001872001775992462; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Dalton P, 2009, Q J EXP PSYCHOL, V62, P2126, DOI 10.1080/17470210903023646; Das SK, 2012, LARYNGOSCOPE, V122, P2533, DOI 10.1002/lary.23555; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P16, DOI 10.1016/j.neubiorev.2013.03.021; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Gallace A, 2006, PERCEPT PSYCHOPHYS, V68, P1191, DOI 10.3758/BF03193720; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Hesser H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064540; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Langguth B, 2011, CURR MED RES OPIN, V27, P1635, DOI 10.1185/03007995.2011.595781; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Laurens KR, 2005, HUM BRAIN MAPP, V24, P35, DOI 10.1002/hbm.20062; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Liesefeld AM, 2014, PSYCHOL SCI, V25, P325, DOI 10.1177/0956797613501170; Machado L, 2013, Q J EXP PSYCHOL, V66, P138, DOI 10.1080/17470218.2012.701651; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Newman C W, 1998, J Am Acad Audiol, V9, P153; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Puel JL, 2002, ADV OTO-RHINO-LARYNG, V59, P124; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Ries M, 2005, NEUROPSYCHOLOGY, V19, P476, DOI 10.1037/0894-4105.19.4.476; Roberts LE, 2013, NEUROSCI BIOBEHAV R, V37, P1754, DOI 10.1016/j.neubiorev.2013.07.007; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Scharf B, 1997, HEARING RES, V103, P101, DOI 10.1016/S0378-5955(96)00168-2; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Schrobsdorff H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00491; Seydell-Greenwald A, 2012, BRAIN RES, V1485, P22, DOI 10.1016/j.brainres.2012.08.052; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Vanneste S, 2013, EXP BRAIN RES, V226, P25, DOI 10.1007/s00221-013-3406-7; Vanneste S, 2012, EXP BRAIN RES, V221, P345, DOI 10.1007/s00221-012-3177-6; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; Walther S, 2010, NEUROREPORT, V21, P191, DOI 10.1097/WNR.0b013e328335640f; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wittekindt A, 2014, J NEUROSCI, V34, P9995, DOI 10.1523/JNEUROSCI.4861-13.2014; Zhang JS, 2013, HEARING RES, V295, P38, DOI 10.1016/j.heares.2012.05.007	63	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120387	10.1371/journal.pone.0120387	http://dx.doi.org/10.1371/journal.pone.0120387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763867	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300039
J	Bezie, S; Picarda, E; Tesson, L; Renaudin, K; Durand, J; Menoret, S; Merieau, E; Chiffoleau, E; Guillonneau, C; Caron, L; Anegon, I				Bezie, Severine; Picarda, Elodie; Tesson, Laurent; Renaudin, Karine; Durand, Justine; Menoret, Severine; Merieau, Emmanuel; Chiffoleau, Elise; Guillonneau, Carole; Caron, Lise; Anegon, Ignacio			Fibrinogen-Like Protein 2/Fibroleukin Induces Long-Term Allograft Survival in a Rat Model through Regulatory B Cells	PLOS ONE			English	Article							RENAL-TRANSPLANT TOLERANCE; T-CELLS; PROTHROMBINASE ACTIVITY; TARGETED DELETION; IMMUNE-RESPONSES; VIRAL-HEPATITIS; DENDRITIC CELLS; CD8(+) TREGS; IFN-GAMMA; REJECTION	We previously described that in a rat model of heart transplantation tolerance was dependent on CD8+CD45RC(low) Tregs that over-expressed fibrinogen-like protein 2 (FGL2)/fibroleukin. Little is known on the immunoregulatory properties of FGL2. Here we analyzed the transplantation tolerance mechanisms that are present in Lewis 1A rats treated with FGL2. Over-expression of FGL2 in vivo through adenovirus associated virus-mediated gene transfer without any further treatment resulted in inhibition of cardiac allograft rejection. Adoptive cell transfer of splenocytes from FGL2-treated rats with long-term graft survival (> 80 days) in animals that were transplanted with cardiac allografts inhibited acute and chronic organ rejection in a donor-specific and transferable tolerance manner, since iterative adoptive transfer up to a sixth consecutive recipient resulted in transplantation tolerance. Adoptive cell transfer also efficiently inhibited anti-donor antibody production. Analysis of all possible cell populations among splenocytes revealed that B lymphocytes were sufficient for this adoptive cell tolerance. These B cells were also capable of inhibiting the proliferation of CD4(+) T cells in response to allogeneic stimuli. Moreover, gene transfer of FGL2 in B cell deficient rats did not prolong graft survival. Thus, this is the first description of FGL2 resulting in long-term allograft survival. Furthermore, allograft tolerance was transferable and B cells were the main cells responsible for this effect.	[Bezie, Severine; Picarda, Elodie; Tesson, Laurent; Durand, Justine; Menoret, Severine; Merieau, Emmanuel; Chiffoleau, Elise; Guillonneau, Carole; Caron, Lise; Anegon, Ignacio] CHU Nantes, INSERM UMR ITUN 1064, Fac Med, F-44035 Nantes 01, France; [Renaudin, Karine] CHU Nantes, Fac Med, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Anegon, I (corresponding author), CHU Nantes, INSERM UMR ITUN 1064, Fac Med, F-44035 Nantes 01, France.	Ignacio.Anegon@inserm.fr	Chiffoleau, Elise/N-2982-2018; Anegon, Ignacio/I-7760-2018; Anegon, Ignacio/I-7498-2018	Chiffoleau, Elise/0000-0001-6167-682X; 	French Transplantation Society; Fondation Progreffe; Roche Organ Transplantation Research Foundation; Labex IGO project - Investissements d'Avenir French Government program [ANR-11-LABX-0016-01]	French Transplantation Society; Fondation Progreffe; Roche Organ Transplantation Research Foundation; Labex IGO project - Investissements d'Avenir French Government program(French National Research Agency (ANR))	Support was provided by the French Transplantation Society and the Fondation Progreffe to SB and the Roche Organ Transplantation Research Foundation to IA. This work has been carried out thanks to the support of the Labex IGO project (no. ANR-11-LABX-0016-01) funded by the Investissements d'Avenir French Government program, managed by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Anjubault T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033713; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; BRUGGEMANN M, 1989, J IMMUNOL, V142, P3145; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chan CWY, 2002, J IMMUNOL, V168, P5170, DOI 10.4049/jimmunol.168.10.5170; CUTURI MC, 1994, EUR J IMMUNOL, V24, P1627, DOI 10.1002/eji.1830240726; Deng SP, 2007, J IMMUNOL, V178, P6028, DOI 10.4049/jimmunol.178.10.6028; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Foerster K, 2010, J HEPATOL, V53, P608, DOI 10.1016/j.jhep.2010.04.020; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Ghanekar A, 2004, J IMMUNOL, V172, P5693, DOI 10.4049/jimmunol.172.9.5693; Guillonneau C, 2007, J CLIN INVEST, V117, P1096, DOI 10.1172/JCI28801; Guillonneau C, 2010, CURR OPIN ORGAN TRAN, V15, P751, DOI 10.1097/MOT.0b013e32834016d1; Guillot C, 2002, J IMMUNOL, V168, P1600, DOI 10.4049/jimmunol.168.4.1600; Hancock WW, 2004, P NATL ACAD SCI USA, V101, P3005, DOI 10.1073/pnas.0308369101; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Kendal AR, 2010, CURR OPIN IMMUNOL, V22, P560, DOI 10.1016/j.coi.2010.08.002; Le Guiner C, 2007, CURR GENE THER, V7, P334; Le Texier L, 2011, AM J TRANSPLANT, V11, P429, DOI 10.1111/j.1600-6143.2010.03336.x; Lee KM, 2012, AM J TRANSPLANT, V12, P2072, DOI 10.1111/j.1600-6143.2012.04055.x; Li XL, 2010, J IMMUNOL, V185, P823, DOI 10.4049/jimmunol.1000120; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Melnyk MC, 2011, SCAND J RHEUMATOL, V40, P269, DOI 10.3109/03009742.2010.536163; Mendicino M, 2005, CIRCULATION, V112, P248, DOI 10.1161/CIRCULATIONAHA.105.534271; Menoret S, 2010, EUR J IMMUNOL, V40, P2932, DOI 10.1002/eji.201040939; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Ning Q, 2005, J IMMUNOL, V174, P7403, DOI 10.4049/jimmunol.174.11.7403; Pallier A, 2010, KIDNEY INT, V78, P503, DOI 10.1038/ki.2010.162; Picarda E, 2014, J CLIN INVEST, V124, P2497, DOI 10.1172/JCI71533; Picarda E, 2011, IMMUNOTHERAPY-UK, V3, P35, DOI [10.2217/IMT.11.37, 10.2217/imt.11.37]; Qian L, 2012, BLOOD, V120, P581, DOI 10.1182/blood-2011-08-377242; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; SCHWARTZ BS, 1982, J EXP MED, V155, P1464, DOI 10.1084/jem.155.5.1464; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; Shalev I, 2009, HEPATOLOGY, V49, P387, DOI 10.1002/hep.22684; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Wei B, 2005, P NATL ACAD SCI USA, V102, P2010, DOI 10.1073/pnas.0409449102; Xie L, 2012, LIVER TRANSPLANT, V18, P444, DOI 10.1002/lt.22480; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	49	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119686	10.1371/journal.pone.0119686	http://dx.doi.org/10.1371/journal.pone.0119686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763980	Green Published, Green Submitted, gold			2022-12-27	WOS:000351276300030
J	Oberckal, J; Kovacic, L; Sribar, J; Leonardi, A; Dolinar, K; Janez, AP; Krizaj, I				Oberckal, Jernej; Kovacic, Lidija; Sribar, Jernej; Leonardi, Adrijana; Dolinar, Klemen; Janez, Anja Pucer; Krizaj, Igor			On the Role of Protein Disulfide Isomerase in the Retrograde Cell Transport of Secreted Phospholipases A(2)	PLOS ONE			English	Article							CHOLERA-TOXIN; GROUP-V; ENDOPLASMIC-RETICULUM; EMERGING ROLES; PDI FAMILY; GROUP-II; AMMODYTOXIN; MECHANISMS; MEMBRANE; ENZYMES	Following the finding that ammodytoxin (Atx), a neurotoxic secreted phospholipase A(2) (sPLA(2)) in snake venom, binds specifically to protein disulfide isomerase (PDI) in vitro we show that these proteins also interact in living rat PC12 cells that are able to internalize this group IIA (GIIA) sPLA(2). Atx and PDI co-localize in both differentiated and non-differentiated PC12 cells, as shown by fluorescence microscopy. Based on a model of the complex between Atx and yeast PDI (yPDI), a three-dimensional model of the complex between Atx and human PDI (hPDI) was constructed. The Atx binding site on hPDI is situated between domains b and b '. Atx interacts hPDI with an extensive area on its interfacial binding surface. The mammalian GIB, GIIA, GV and GX sPLA(2)s have the same fold as Atx. The first three sPLA(2)s have been detected intracellularly but not the last one. The models of their complexes with hPDI were constructed by replacement of Atx with the respective mammalian sPLA(2) in the Atx-hPDI complex and molecular docking of the structures. According to the generated models, mammalian GIB, GIIA and GV sPLA(2)s form complexes with hPDI very similar to that with Atx. The contact area between GX sPLA(2) and hPDI is however different from that of the other sPLA(2)s. Heterologous competition of Atx binding to hPDI with GV and GX sPLA(2)s confirmed the model-based expectation that GV sPLA(2) was a more effective inhibitor than GX sPLA(2), thus validating our model. The results suggest a role of hPDI in the (patho) physiology of some snake venom and mammalian sPLA(2)s by assisting the retrograde transport of these molecules from the cell surface. The sPLA(2)-hPDI model constitutes a valuable tool to facilitate further insights into this process and into the (patho) physiology of sPLA(2)s in relation to their action intracellularly.	[Oberckal, Jernej; Kovacic, Lidija; Sribar, Jernej; Leonardi, Adrijana; Dolinar, Klemen; Janez, Anja Pucer; Krizaj, Igor] Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia; [Krizaj, Igor] Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Krizaj, I (corresponding author), Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia.	igor.krizaj@ijs.si		Sribar, Jernej/0000-0003-0646-5602	Slovenian Research Agency [P1-0207, Z1-4071]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants P1-0207 (to IK) and Z1-4071 (to LK) from the Slovenian Research Agency (http://www.arrs.gov.si/sl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Birts CN, 2008, J BIOL CHEM, V283, P5034, DOI 10.1074/jbc.M708844200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brglez V, 2014, BIOCHIMIE, V107, P114, DOI 10.1016/j.biochi.2014.09.023; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DODDS D, 1995, J NEUROCHEM, V64, P2339; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eerola LI, 2006, BBA-MOL CELL BIOL L, V1761, P745, DOI 10.1016/j.bbalip.2006.04.002; Fayard JM, 1998, J CELL SCI, V111, P985; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Forster ML, 2009, J BIOL CHEM, V284, P13045, DOI 10.1074/jbc.M808352200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUBENSEK F, 1980, PERIOD BIOL, V82, P443; Herkert M, 2001, EUR J NEUROSCI, V14, P821, DOI 10.1046/j.0953-816x.2001.01699.x; Hseu MJ, 1997, BIOCHEM BIOPH RES CO, V239, P18, DOI 10.1006/bbrc.1997.7416; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; Kovacic L, 2007, BIOORG CHEM, V35, P295, DOI 10.1016/j.bioorg.2006.12.002; Kovacic L, 2010, PROTEIN ENG DES SEL, V23, P479, DOI 10.1093/protein/gzq019; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Krizaj I, 2014, PROTEIN PEPTIDE LETT, V21, P1201; Krizaj I, 2011, TOXICON, V58, P219, DOI 10.1016/j.toxicon.2011.06.009; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Leslie Christina C, 2004, Methods Mol Biol, V284, P229; Logonder U, 2009, EXP NEUROL, V219, P591, DOI 10.1016/j.expneurol.2009.07.017; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Macchioni L, 2004, J BIOL CHEM, V279, P37860, DOI 10.1074/jbc.M303855200; Murakami M, 2013, BIOCHIMIE, V95, P43, DOI 10.1016/j.biochi.2012.09.007; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Nardicchi V, 2007, BBA-MOL CELL BIOL L, V1771, P1345, DOI 10.1016/j.bbalip.2007.08.007; Petan T, 2005, BIOCHEMISTRY-US, V44, P12535, DOI 10.1021/bi051024r; Petrovic U, 2005, BIOCHEM J, V391, P383, DOI 10.1042/BJ20050417; Petrovic U, 2004, BIOCHEM BIOPH RES CO, V324, P981, DOI 10.1016/j.bbrc.2004.09.144; Praznikar ZJ, 2008, BBA-MOL CELL RES, V1783, P1129, DOI 10.1016/j.bbamcr.2008.01.011; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Saul FA, 2010, J STRUCT BIOL, V169, P360, DOI 10.1016/j.jsb.2009.10.010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Sribar J, 2005, BIOCHEM BIOPH RES CO, V329, P733, DOI 10.1016/j.bbrc.2005.02.036; Sribar J, 2001, J BIOL CHEM, V276, P12493, DOI 10.1074/jbc.C100048200; Sribar J, 2011, ACTA CHIM SLOV, V58, P678; Taylor M, 2011, J BIOL CHEM, V286, P22090, DOI 10.1074/jbc.M111.237966; Taylor M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018825; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	55	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120692	10.1371/journal.pone.0120692	http://dx.doi.org/10.1371/journal.pone.0120692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763817	Green Published, gold, Green Submitted			2022-12-27	WOS:000351276300046
J	Ghosh, CC; Mukherjee, A; David, S; Milam, KE; Hunter, JT; Parikh, SM				Ghosh, Chandra C.; Mukherjee, Aditi; David, Sascha; Milam, Katelyn E.; Hunter, Jon T.; Parikh, Samir M.			Angiopoietin-1 Requires Oxidant Signaling through p47phox to Promote Endothelial Barrier Defense	PLOS ONE			English	Article							MULTIPLE-ORGAN DYSFUNCTION; VASCULAR LEAKAGE; AGONIST PEPTIDE; NADPH OXIDASE; LUNG INJURY; RECEPTOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION; CONTRIBUTE	Background Reactive oxygen species (ROS) are largely considered to be pathogenic to normal endothelial function in disease states such as sepsis. We hypothesized that Angiopoietin-1 (Angpt-1), an endogenous agonist of the endothelial-specific receptor, Tie-2, promotes barrier defense by activating NADPH oxidase (NOX) signaling. Methods and Findings Using primary human microvascular endothelial cells (HMVECs), we found that Angpt-1 stimulation induces phosphorylation of p47phox and a brief oxidative burst that is lost when chemical inhibitors of NOX activity or siRNA against the NOX component p47phox were applied. As a result, there was attenuated ROS activity, disrupted junctional contacts, enhanced actin stress fiber accumulation, and induced gap formation between confluent HMVECs. All of these changes were associated with weakened barrier function. The ability of Angpt-1 to prevent identical changes induced by inflammatory permeability mediators, thrombin and lipopolysaccharides (LPS), was abrogated by p47phox knockdown. P47phox was required for Angpt-1 to activate Rac1 and inhibit mediator-induced activation of the small GTPase RhoA. Finally, Angpt-1 gene transfer prevented vascular leakage in wildtype mice exposed to systemically administered LPS, but not in p47phox knock out (p47(-/-)) littermates. Conclusions These results suggest an essential role for NOX signaling in Angpt-1-mediated endothelial barrier defense against mediators of systemic inflammation. More broadly, oxidants generated for signal transduction may have a barrier-promoting role in vascular endothelium.	[Ghosh, Chandra C.; Mukherjee, Aditi; Milam, Katelyn E.; Hunter, Jon T.; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Ghosh, Chandra C.; Mukherjee, Aditi; Milam, Katelyn E.; Hunter, Jon T.; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Ghosh, Chandra C.; Mukherjee, Aditi; Milam, Katelyn E.; Hunter, Jon T.; Parikh, Samir M.] Harvard Univ, Sch Med, Boston, MA USA; [David, Sascha] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Hannover Medical School	Ghosh, CC (corresponding author), Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA.	cghosh@bidmc.harvard.edu; sparikh1@bidmc.harvard.edu	David, Sascha/AAL-6909-2021		National Institutes of Health [R01-HL093234, DK095072]; American Diabetes Association; German Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125275, R01HL093234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SMP is supported by the National Institutes of Health (R01-HL093234 and DK095072) and the American Diabetes Association. SD is supported by funding from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Ahmad S, 2010, HYPERTENSION, V56, P477, DOI 10.1161/HYPERTENSIONAHA.110.155556; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bilan DS, 2013, ACS CHEM BIOL, V8, P535, DOI 10.1021/cb300625g; Cascone I, 2003, BLOOD, V102, P2482, DOI 10.1182/blood-2003-03-0670; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; David S, 2012, CRIT CARE M IN PRESS; David S, 2011, ARTERIOSCLER THROMB; David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31; David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005; David S, 2011, AM J PHYSIOL-LUNG C, V300, pL851, DOI 10.1152/ajplung.00459.2010; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Ghosh CC, 2012, P NATL ACAD SCI USA, V109, P10024, DOI 10.1073/pnas.1120755109; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Hwang JA, 2009, BIOCHEM BIOPH RES CO, V381, P592, DOI 10.1016/j.bbrc.2009.02.096; Kim DH, 2009, KIDNEY INT, V76, P1180, DOI 10.1038/ki.2009.387; Kim YM, 2006, CANCER RES, V66, P6167, DOI 10.1158/0008-5472.CAN-05-3640; Kumpers P, 2011, CRIT CARE, V15, DOI 10.1186/cc10523; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mishina NM, 2013, METHOD ENZYMOL, V526, P45, DOI 10.1016/B978-0-12-405883-5.00003-X; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Stielow C, 2006, BIOCHEM BIOPH RES CO, V344, P200, DOI 10.1016/j.bbrc.2006.03.114; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Xie ZH, 2014, AM J RESP CRIT CARE, V189, P1145, DOI 10.1164/rccm.201310-1746LE	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119577	10.1371/journal.pone.0119577	http://dx.doi.org/10.1371/journal.pone.0119577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761062	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000060
J	Chang, MY; Chang, CH; Chen, CH; Cheng, B; Lin, YD; Luo, CY; Wu, HL; Yang, YJ; Chen, JH; Hsieh, PCH				Chang, Ming-Yao; Chang, Chih-Han; Chen, Chien-Hsi; Cheng, Bill; Lin, Yi-Dong; Luo, Chwan-Yau; Wu, Hua-Lin; Yang, Yu-Jen; Chen, Jyh-Hong; Hsieh, Patrick C. H.			The Time Window for Therapy with Peptide Nanofibers Combined with Autologous Bone Marrow Cells in Pigs after Acute Myocardial Infarction	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; MESENCHYMAL STEM-CELLS; MONONUCLEAR-CELLS; DOUBLE-BLIND; DELIVERY; DISEASE; REPAIR; METAANALYSIS; INJECTION; APOPTOSIS	Background We previously showed that injection of peptide nanofibers (NF) combined with autologous bone marrow mononuclear cells (MNC) immediately after coronary artery ligation improves cardiac performance in pigs. To evaluate the clinical feasibility, this study was performed to determine the therapeutic time window for NF/MNC therapy in acute myocardial infarction (MI). Methods and Results A total of 45 adult minipigs were randomly grouped into 7 groups: sham or MI plus treatment with NS (normal saline), or NF or MNC alone at 1 day (1D)post-MI, or NF/MNC at 1, 4, or 7 days post-MI (N>6). Cardiac function was assessed by echocardiography and ventricular catheterization. Compared with the NS control, pigs treated with NF/MNC at 1 day post-MI (NF/MC-1D) had the greatest improvement in left ventricle ejection fraction (LVEF; 55.1 +/- 1.6%; P<0.01 vs. NS) 2 months after MI. In contrast, pigs treated with either NF/MNC-4D or NF/MNC-7D showed 48.9 +/- 0.8%( P<0.05 vs. NS) and 43.5 +/- 2.3%(n.s.vs. NS) improvements, respectively. The +dP/dt and -dP/dt, infarct size and interstitial collagen content were also improved in the NF/MNC-1D and -4D groups but not in the -7D group. Mechanistically, MNC quality and the states of systemic inflammation and damaged heart tissue influence the therapeutic efficiency of NF/MNC therapy, as revealed by another independent study using 16 pigs. Conclusions Injection of NF/MNC at 1 or 4 days, but not at 7 days post-MI, improves cardiac performance and prevents ventricular remodeling, confirming the importance of early intervention when using this therapy for acute MI.	[Chang, Ming-Yao; Chang, Chih-Han; Hsieh, Patrick C. H.] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Chen, Chien-Hsi; Cheng, Bill; Lin, Yi-Dong; Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Luo, Chwan-Yau; Yang, Yu-Jen; Hsieh, Patrick C. H.] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Wu, Hua-Lin] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chen, Jyh-Hong] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Hsieh, PCH (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	phsieh@ibms.sinica.edu.tw		Cheng, Bill/0000-0002-0692-4349	National Research Program for Biopharmaceuticals [DOH101-TD-PB-111-TM027, DOH101-TD-PB-111-TM028]; National Science Council [NSC101-2325-B-006-013]; National Health Research Institutes [NHRI-EX101-10026SI]; Academia Sinica Translational Medicine Program; Celgene Cellular Therapeutics; Meridigen Biotech Co.	National Research Program for Biopharmaceuticals; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Academia Sinica Translational Medicine Program; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); Meridigen Biotech Co.	This work was supported by the National Research Program for Biopharmaceuticals (DOH101-TD-PB-111-TM027 and DOH101-TD-PB-111-TM028), the National Science Council (NSC101-2325-B-006-013), the National Health Research Institutes (NHRI-EX101-10026SI), the Academia Sinica Translational Medicine Program and Celgene Cellular Therapeutics and Meridigen Biotech Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Chen CH, 2013, MOL THER, V21, P670, DOI 10.1038/mt.2012.268; Dhanantwari P, 2008, BIOCHEM BIOPH RES CO, V371, P298, DOI 10.1016/j.bbrc.2008.04.070; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841; Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Robbers LF, 2014, RADIOLOGY; Rosenberg M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-115; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035; Swijnenburg RJ, 2010, CIRC-CARDIOVASC IMAG, V3, P77, DOI 10.1161/CIRCIMAGING.109.872085; Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670; van der Laan AM, 2013, EUR HEART J; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang X., 2011, SCI TRANSL MED, V3; Yuan CJ, 2013, INT J CARDIOL, V168, P2767, DOI 10.1016/j.ijcard.2013.03.131; Zhang Y, 2011, CARDIOVASC PATHOL, V20, P204, DOI [10.1016/j.carpath.2010.06.007, 10.1088/1674-1056/20/11/110204]	31	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0115430	10.1371/journal.pone.0115430	http://dx.doi.org/10.1371/journal.pone.0115430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757076	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700002
J	Gutierrez, AP; Yanez, JM; Fukui, S; Swift, B; Davidson, WS				Gutierrez, Alejandro P.; Yanez, Jose M.; Fukui, Steve; Swift, Bruce; Davidson, William S.			Genome-Wide Association Study (GWAS) for Growth Rate and Age at Sexual Maturation in Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; BODY-WEIGHT; GENETIC-IMPROVEMENT; COHO SALMON; MATURITY; QTL; PARAMETERS; SELECTION	Early sexual maturation is considered a serious drawback for Atlantic salmon aquaculture as it retards growth, increases production times and affects flesh quality. Although both growth and sexual maturation are thought to be complex processes controlled by several genetic and environmental factors, selection for these traits has been continuously accomplished since the beginning of Atlantic salmon selective breeding programs. In this genome-wide association study (GWAS) we used a 6.5K single-nucleotide polymorphism (SNP) array to genotype similar to 480 individuals from the Cermaq Canada broodstock program and search for SNPs associated with growth and age at sexual maturation. Using a mixed model approach we identified markers showing a significant association with growth, grilsing (early sexual maturation) and late sexual maturation. The most significant associations were found for grilsing, with markers located in Ssa10, Ssa02, Ssa13, Ssa25 and Ssa12, and for late maturation with markers located in Ssa28, Ssa01 and Ssa21. A lower level of association was detected with growth on Ssa13. Candidate genes, which were linked to these genetic markers, were identified and some of them show a direct relationship with developmental processes, especially for those in association with sexual maturation. However, the relatively low power to detect genetic markers associated with growth (days to 5 kg) in this GWAS indicates the need to use a higher density SNP array in order to overcome the low levels of linkage disequilibrium observed in Atlantic salmon before the information can be incorporated into a selective breeding program.	[Gutierrez, Alejandro P.; Davidson, William S.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Yanez, Jose M.] Univ Chile, Fac Vet & Anim Sci, Santiago, Chile; [Fukui, Steve] Cermaq Canada, Campbell River, BC, Canada; [Swift, Bruce] TRI GEN Fish Improvement Ltd, Agassiz, BC, Canada	Simon Fraser University; Universidad de Chile	Davidson, WS (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	wdavidso@sfu.ca	Davidson, Willie/M-1992-2019; Yáñez, José M/H-5279-2013	Yáñez, José M/0000-0002-6612-4087	Natural Sciences and Engineering Research Council of Canada [STPGP/381479-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding provided by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), Strategic grant: STPGP/381479-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BAILEY GS, 1970, J BIOL CHEM, V245, P5927; Baranski M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-17; Boulding EG, 2008, HEREDITY, V101, P381, DOI 10.1038/hdy.2008.67; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Debacker K, 2007, HUM MOL GENET, V16, pR150, DOI 10.1093/hmg/ddm136; Easton AA, 2011, J FISH BIOL, V78, P602, DOI 10.1111/j.1095-8649.2010.02881.x; Eisbrenner WS, 2014, HEREDITY, V113, P86, DOI 10.1038/hdy.2013.55; FERGUSON MM, 1985, CAN J GENET CYTOL, V27, P289, DOI 10.1139/g85-043; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gidskehaug L, 2011, BIOINFORMATICS, V27, P303, DOI 10.1093/bioinformatics/btq673; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Gjedrem T, 2012, AQUACULTURE, V344, P12, DOI 10.1016/j.aquaculture.2012.03.003; GJERDE B, 1984, AQUACULTURE, V38, P229, DOI 10.1016/0044-8486(84)90147-9; GJERDE B, 1994, LIVEST PROD SCI, V38, P133, DOI 10.1016/0301-6226(94)90057-4; GJERDE B, 1986, AQUACULTURE, V57, P37, DOI 10.1016/0044-8486(86)90179-1; Gjoen HM, 1997, ICES J MAR SCI, V54, P1009, DOI 10.1016/S1054-3139(97)80005-7; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gutierrez AP, 2012, AQUACULTURE, V358, P61, DOI 10.1016/j.aquaculture.2012.06.017; Gutierrez AP, 2013, MAR BIOTECHNOL, P1; Haidle L, 2008, MAR BIOTECHNOL, V10, P579, DOI 10.1007/s10126-008-9098-5; Hata Y, 1998, NEUROSCI RES, V32, P1, DOI 10.1016/S0168-0102(98)00069-8; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Horstgen-Schwark G, 1998, AQUACULTURE, V167, P123, DOI 10.1016/S0044-8486(98)00308-1; Houston RD, 2009, ANIM GENET, V40, P753, DOI 10.1111/j.1365-2052.2009.01883.x; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Huang YZ, 2010, J APPL GENET, V51, P199, DOI 10.1007/BF03195728; Johnston SE, 2014, MOL ECOL, V23, P3452, DOI 10.1111/mec.12832; Jonasson J, 1997, AQUACULTURE, V157, P205, DOI 10.1016/S0044-8486(97)00060-4; Kause A, 2003, AQUACULTURE, V228, P53, DOI 10.1016/S0044-8486(03)00244-8; Kent M. P., 2009, PLANT AN GEN 17 C SA; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Kuttner E, 2011, MOL GENET GENOMICS, V286, P67, DOI 10.1007/s00438-011-0628-x; Leder EH, 2006, J HERED, V97, P74, DOI 10.1093/jhered/esj004; LIEN S, 2011, BMC GENOMICS, V12, DOI DOI 10.1186/1471-2164-12-; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Martyniuk CJ, 2003, J FISH BIOL, V63, P746, DOI 10.1046/j.1095-8649.2003.00188.x; McClelland EK, 2010, HEREDITY, V105, P562, DOI 10.1038/hdy.2010.22; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Moghadam HK, 2007, MOL GENET GENOMICS, V277, P647, DOI 10.1007/s00438-007-0215-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; NAEVDAL G, 1983, AQUACULTURE, V33, P97, DOI 10.1016/0044-8486(83)90390-3; O'Malley KG, 2010, J HERED, V101, P628, DOI 10.1093/jhered/esq063; O'Malley KG, 2003, J HERED, V94, P273, DOI 10.1093/jhered/esg067; Paibomesai Marion I, 2010, BMC Res Notes, V3, P215, DOI 10.1186/1756-0500-3-215; Pedersen S, 2013, AQUACULTURE, V410, P164, DOI 10.1016/j.aquaculture.2013.06.039; Phillips RB, 2006, GENETICS, V174, P1661, DOI 10.1534/genetics.105.055269; Phillips RB, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-46; Quinton CD, 2005, AQUACULTURE, V247, P211, DOI 10.1016/j.aquaculture.2005.02.030; Reid DP, 2005, HEREDITY, V94, P166, DOI 10.1038/sj.hdy.6800590; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Sarafidou T, 2004, GENOMICS, V84, P69, DOI 10.1016/j.ygeno.2003.12.017; Sodeland M, 2013, AQUACULTURE, V408, P169, DOI 10.1016/j.aquaculture.2013.05.029; Sonesson A. K., 2007, Marker-assisted selection: current status and future perspectives in crops, livestock, forestry and fish, P309; Sonesson AK, 2007, GENET SEL EVOL, V39, P301, DOI 10.1051/gse:2007005; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; SUMPTER JP, 1992, AQUACULTURE, V100, P299, DOI 10.1016/0044-8486(92)90386-Y; Suzuki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033558; SVED J A, 1971, Theoretical Population Biology, V2, P125; THOMPSON EA, 1990, BIOMETRICS, V46, P399, DOI 10.2307/2531445; Thorpe J.E., 1994, Aquaculture and Fisheries Management, V25, P77; Thorpe JE, 1998, AQUACULTURE, V168, P95, DOI 10.1016/S0044-8486(98)00342-1; WILD V, 1994, AQUACULTURE, V128, P51, DOI 10.1016/0044-8486(94)90101-5; Withler RE, 2007, AQUACULTURE, V272, pS318, DOI 10.1016/j.aquaculture.2007.07.201; Wringe BF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-63	71	101	108	4	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119730	10.1371/journal.pone.0119730	http://dx.doi.org/10.1371/journal.pone.0119730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757012	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700051
J	Aso, T; Matsuo, M; Kiyohara, H; Taguchi, K; Rikimaru, F; Shimokawa, M; Segawa, Y; Higaki, Y; Umeno, H; Nakashima, T; Masuda, M				Aso, Takeichiro; Matsuo, Mioko; Kiyohara, Hideyuki; Taguchi, Kenichi; Rikimaru, Fumihide; Shimokawa, Mototsugu; Segawa, Yuichi; Higaki, Yuichiro; Umeno, Hirohito; Nakashima, Tadashi; Masuda, Muneyuki			Induction of CD44 Variant 9-Expressing Cancer Stem Cells Might Attenuate the Efficacy of Chemoradioselection and Worsens the Prognosis of Patients with Advanced Head and Neck Cancer	PLOS ONE			English	Article							LOCOREGIONALLY ADVANCED HEAD; ORGAN PRESERVATION; CHEMOTHERAPY; CHEMORADIOTHERAPY; CHEMORADIATION; CHEMOSELECTION; FLUOROURACIL; RADIOTHERAPY; EXPRESSION; DOCETAXEL	Background At our institute, a chemoradioselection strategy has been used to select patients for organ preservation on the basis of response to an initial 30-40 Gy concurrent chemoradiotherapy (CCRT). Patients with a favorable response (i.e., chemoradioselected; CRS) have demonstrated better outcomes than those with an unfavorable response (i.e., nonchemoradioselected; N-CRS). Successful targeting of molecules that attenuate the efficacy of chmoradioselection may improve results. Thus, the aim of this study was to evaluate the association of a novel cancer stem cell (CSC) marker, CD44 variant 9 (CD44v9), with cellular refractoriness to chemoradioselection in advanced head and neck squamous cell carcinoma (HNSCC). Materials and Methods Through a medical chart search, 102 patients with advanced HNSCC treated with chemoradioselection from 1997 to 2008 were enrolled. According to our algorithm, 30 patients were CRC following induction CCRT and 72 patients were N-CRS. Using the conventional immunohistochemical technique, biopsy specimens and surgically removed tumor specimens were immunostained with the anti-CD44v9 specific antibodies. Results The intrinsic expression levels of CD44v9 in the biopsy specimens did not correlate with the chemoradioselection and patient survival. However, in N-CRS patients, the CD44v9-positive group demonstrated significantly (P = 0.008) worse prognosis, than the CD44v9-negative group. Multivariate analyses demonstrated that among four candidate factors (T, N, response to CCRT, and CD44v9), CD44v9 positivity (HR: 3.145, 95% CI: 1.235-8.008, P = 0.0163) was significantly correlated with the poor prognosis, along with advanced N stage (HR: 3.525, 95% CI: 1.054-9.060, P = 0.0228). Furthermore, the survival rate of the CD44v9-induced group was significantly (P = 0.04) worse than the CD44v9-non-induced group. Conclusions CCRT-induced CD44v9-expressing CSCs appear to be a major hurdle to chemoradioselection. CD44v9-targeting seems to be a promising strategy to enhance the efficacy of chemoradioselection and consequent organ preservation and survival.	[Aso, Takeichiro; Matsuo, Mioko; Kiyohara, Hideyuki; Rikimaru, Fumihide; Higaki, Yuichiro; Masuda, Muneyuki] Kyushu Natl Canc Ctr, Dept Head & Neck Surg, Minami Ku, Fukuoka 8111395, Japan; [Taguchi, Kenichi] Kyushu Natl Canc Ctr, Dept Pathol, Minami Ku, Fukuoka 8111395, Japan; [Shimokawa, Mototsugu] Kyushu Natl Canc Ctr, Dept Canc Informat Res, Minami Ku, Fukuoka 8111395, Japan; [Segawa, Yuichi] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol & Head & Neck Surg, Higashi Ku, Fukuoka 8128582, Japan; [Umeno, Hirohito; Nakashima, Tadashi] Kurume Univ, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Fukuoka 8300011, Japan	Kyushu University; Kurume University	Masuda, M (corresponding author), Kyushu Natl Canc Ctr, Dept Head & Neck Surg, Minami Ku, 3-1-1 Notame, Fukuoka 8111395, Japan.	mmuneyuki@jcom.home.ne.jp		Masuda, Muneyuki/0000-0002-7479-8356; Kiyohara, Hideyuki/0000-0003-0048-5039	Grants-in-Aid for Scientific Research [24592600] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adelstein DJ, 2006, J CLIN ONCOL, V24, P1064, DOI 10.1200/JCO.2005.01.5867; Argiris A, 2004, CLIN CANCER RES, V10, P1956, DOI 10.1158/1078-0432.CCR-03-1077; Bankfalvi A, 2002, J PATHOL, V198, P343, DOI 10.1002/path.1204; Corry J, 2010, LANCET ONCOL, V11, P287, DOI 10.1016/S1470-2045(09)70384-5; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Hanna GJ, 2013, ONCOLOGIST, V18, P288, DOI 10.1634/theoncologist.2012-0286; Hirata K, 2013, BRIT J CANCER, V109, P379, DOI 10.1038/bjc.2013.314; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; Imai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062002; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; Kumamoto Y, 2002, HEAD NECK-J SCI SPEC, V24, P637, DOI 10.1002/hed.10114; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Masuda M, 2012, CLIN APPL RECENT APP; Masuda M, HEAD NECK; Masuda M, 2013, MOL ONCOL, V7, P14, DOI 10.1016/j.molonc.2012.10.009; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Oh SY, 2013, EUR J CANCER, V49, P272, DOI 10.1016/j.ejca.2012.06.004; Posner MR, 2010, ANN ONCOL, V21, P246, DOI 10.1093/annonc/mdq291; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Urba S, 2006, J CLIN ONCOL, V24, P593, DOI 10.1200/JCO.2005.01.2047; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Worden FP, 2009, LARYNGOSCOPE, V119, P1510, DOI 10.1002/lary.20294; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T	31	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0116596	10.1371/journal.pone.0116596	http://dx.doi.org/10.1371/journal.pone.0116596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751671	Green Published, Green Submitted, gold			2022-12-27	WOS:000350692700003
J	Kim, S; Lee, Y; Koo, JS				Kim, Sewha; Lee, YuKyung; Koo, Ja Seung			Differential Expression of Lipid Metabolism-Related Proteins in Different Breast Cancer Subtypes	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; PROGNOSTIC-FACTORS; ANDROGEN RECEPTOR; MOLECULAR SUBTYPE; GENE-EXPRESSION; 2-DEOXY-D-GLUCOSE; INHIBITION; MEMBRANE; ENERGY; TUMORS	Purpose This study aimed to determine the expression and clinical significance of proteins that are involved in lipid metabolism in human breast tumors. Methods Tumors from 476 breast cancer patients were used to construct tissue microarrays. Then, immunohistochemistry (IHC) for hormone-sensitive lipase (HSL), Perilipin 1 (PLIN1), fatty acid binding protein 4 (FABP4), carnitine palmitoyltransferase IA (CPT-1A), acyl-CoA oxidase 1 (ACOX-1), and fatty acid synthase (FASN) was performed on these microarrays. Results Breast tumors were classified into 4 subtypes: luminal A (n = 242; 50.8%), luminal B (n = 134; 28.2%), human epidermal growth factor receptor 2 (HER2) (n = 50; 10.5%), and triple negative breast cancer (TNBC) (n = 50; 10.5%). The expression of PLIN1 (p < 0.001), FABP4 (p = 0.029), CPT-1A (p = 0.001), ACOX-1 (p < 0.001), and FASN (p < 0.001) differed significantly among these tumor subtypes. Notably, PLIN1, CPT-1A, and FASN expression was highest in HER2 tumors and lowest in TNBC tumors. Similarly, the expression of FABP4 and ACOX-1 was highest in HER2 tumors and lowest in luminal A tumors. In addition, ACOX-1 positivity was associated with significantly shorter overall survival (p = 0.018). When tumor subtype was considered, FABP4 positivity was associated with significantly shorter disease-free survival (p = 0.005) and overall survival (p = 0.041) in TNBC. Conclusion Lipid metabolism-related proteins are differentially expressed in different IHC subtypes of breast cancer and some are associated with decreased survival rates.	[Kim, Sewha; Lee, YuKyung; Koo, Ja Seung] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Koo, JS (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, 50 Yonsei Ro, Seoul 120752, South Korea.	kjs1976@yuhs.ac		koo, ja seung/0000-0003-4546-4709	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1420080]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1420080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aft RL, 2002, BRIT J CANCER, V87, P805, DOI 10.1038/sj.bjc.6600547; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bieche I, 2001, CARCINOGENESIS, V22, P1521, DOI 10.1093/carcin/22.9.1521; Brglez V, 2014, BIOCHIMIE; Brglez V, 2014, BIOCHEM BIOPH RES CO, V445, P230, DOI 10.1016/j.bbrc.2014.01.182; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chang H, 2003, BIOCHEM BIOPH RES CO, V302, P95, DOI 10.1016/S0006-291X(03)00111-6; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; ISOLA JJ, 1993, J PATHOL, V170, P31, DOI 10.1002/path.1711700106; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; Jones C, 2001, BRIT J CANCER, V85, P422, DOI 10.1054/bjoc.2001.1869; Kim SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101004; Kim S, 2013, ENDOCR-RELAT CANCER, V20, P339, DOI 10.1530/ERC-12-0398; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Lee JS, 2013, PHYTOTHER RES, V27, P713, DOI 10.1002/ptr.4778; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Pucer A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-111; Puig T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3077; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Uehara H, 2014, INT J CANC; Vullo D, 2003, BIOORG MED CHEM LETT, V13, P1005, DOI 10.1016/S0960-894X(03)00091-X; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Won KY, 2010, HUM PATHOL, V41, P107, DOI 10.1016/j.humpath.2009.07.006; Yang Ming, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P257, DOI 10.3760/cma.j.issn.0529-5807.2013.04.010; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516	41	89	90	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119473	10.1371/journal.pone.0119473	http://dx.doi.org/10.1371/journal.pone.0119473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751270	Green Submitted, Green Published, gold			2022-12-27	WOS:000350692700024
J	Tsuno, K; Kawakami, N; Tsutsumi, A; Shimazu, A; Inoue, A; Odagiri, Y; Yoshikawa, T; Haratani, T; Shimomitsu, T; Kawachi, I				Tsuno, Kanami; Kawakami, Norito; Tsutsumi, Akizumi; Shimazu, Akihito; Inoue, Akiomi; Odagiri, Yuko; Yoshikawa, Toru; Haratani, Takashi; Shimomitsu, Teruichi; Kawachi, Ichiro			Socioeconomic Determinants of Bullying in the Workplace: A National Representative Sample in Japan	PLOS ONE			English	Article							PSYCHOSOCIAL WORK-ENVIRONMENT; UNCERTAINTY MANAGEMENT; PSYCHOLOGICAL HEALTH; SAFETY CLIMATE; JOB RESOURCES; SOCIAL-STATUS; PREVALENCE; RISK; RELIABILITY; POPULATION	Bullying in the workplace is an increasingly recognized threat to employee health. We sought to test three hypotheses related to the determinants of workplace bullying: power distance at work; safety climate; and frustration related to perceived social inequality. A questionnaire survey was administered to a nationally representative community-based sample of 5,000 residents in Japan aged 20-60 years. The questionnaire included questions about employment, occupation, company size, education, household income, and subjective social status (SSS). We inquired about both the witnessing and personal experience of workplace bullying during the past 30 days. Among 2,384 respondents, data were analyzed from 1,546 workers. Multiple logistic regression analyses were used to examine the social determinants of workplace bullying. Six percent and 15 percent of the total sample reported experiencing or witnessing workplace bullying, respectively. After adjusting for gender and age, temporary employees (Odds Ratio [OR]: 2.45 [95% Confidence Interval (CI) = 1.03-5.85]), junior high school graduates (OR: 2.62 [95% CI: 1.01-6.79]), workers with lowest household income (OR: 4.13 [95% CI: 1.58-10.8]), and workers in the lowest SSS stratum (OR: 4.21 [95% CI: 1.66-10.7]) were at increased risk of experiencing workplace bullying. When all variables were entered simultaneously in the model, a significant inverse association was observed between higher SSS and experiencing bullying (p = 0.002). Similarly in terms of witnessing bullying; SSS was significantly inversely associated (p = 0.017) while temporary employees reported a significantly higher risk of witnessing bullying compared to permanent workers (OR: 2.25 [95% CI: 1.04 to 4.87]). The significant association between SSS and experiencing/witnessing workplace bullying supports the frustration hypothesis. The power distance hypothesis was also partly supported by the finding that temporary employees experienced a higher prevalence of workplace bullying.	[Tsuno, Kanami] Wakayama Med Univ, Dept Hyg, Wakayama, Japan; [Tsuno, Kanami; Kawakami, Norito; Shimazu, Akihito; Inoue, Akiomi] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa, Japan; [Inoue, Akiomi] Univ Occupat & Environm Hlth, Dept Mental Hlth, Fukuoka, Japan; [Odagiri, Yuko; Shimomitsu, Teruichi] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Tokyo 1608402, Japan; [Yoshikawa, Toru] Inst Sci Labour, Dept Res, Kawasaki, Kanagawa, Japan; [Haratani, Takashi] Natl Inst Occupat Safety & Hlth, Hlth Adm & Psychosocial Factor Res Grp, Sagamihara, Kanagawa, Japan; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Wakayama Medical University; University of Tokyo; Kitasato University; University of Occupational & Environmental Health - Japan; Tokyo Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Tsuno, K (corresponding author), Wakayama Med Univ, Dept Hyg, Wakayama, Japan.	tsuno@wakayama-med.ac.jp	Yoshikawa, Toru/K-9984-2019; Tsuno, Kanami/D-4388-2013	Yoshikawa, Toru/0000-0003-0383-1814; Tsuno, Kanami/0000-0001-9399-6596; Odagiri, Yuko/0000-0002-7603-4800	Ministry of Health, Labour and Welfare, Japan [H21-Rodo-Ippan-001, 14070101-01]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Health and Labor Sciences Research Grant 2009-2011 (H21-Rodo-Ippan-001) and the Work-related Diseases Clinical Research Grant 2014 (14070101-01) from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Agervold M, 2004, WORK STRESS, V18, P336, DOI 10.1080/02678370412331319794; Asakura T, 2008, RISORSA UOMO, V14, P1; CLARK C, 1940, CONDITIONS EC PROGR, P337; DODGE KA, 1994, CHILD DEV, V65, P649, DOI 10.2307/1131407; Dollard J, 1939, FRUSTRATION AGGRESSI, DOI 10.1037/10022-000; Dollard MF, 2010, J OCCUP ORGAN PSYCH, V83, P579, DOI 10.1348/096317909X470690; Due P, 2003, J EPIDEMIOL COMMUN H, V57, P692, DOI 10.1136/jech.57.9.692; Einarsen S, 2003, BULLYING EMOTIONAL A, P3, DOI DOI 10.1201/9780203164662.PT1; Hauge LJ, 2007, WORK STRESS, V21, P220, DOI 10.1080/02678370701705810; Hoel H., 2001, EUROPEAN J WORK ORG, V10, P443, DOI DOI 10.1080/13594320143000780; Hoshuyama T, 2007, OCCUP MED-OXFORD, V57, P126, DOI 10.1093/occmed/kql157; Inoue A, 2014, IND HEALTH, V52, P175, DOI 10.2486/indhealth.2013-0185; JACKMAN MR, 1973, AM SOCIOL REV, V38, P569, DOI 10.2307/2094408; Kausto J, 2005, EUR J WORK ORGAN PSY, V14, P431, DOI 10.1080/13594320500349813; Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P779, DOI 10.1136/oem.60.10.779; Kristensen TS, 2002, SCAND J PUBLIC HEALT, V30, P41, DOI 10.1177/14034948020300032401; Law R, 2011, ACCIDENT ANAL PREV, V43, P1782, DOI 10.1016/j.aap.2011.04.010; Leymann H., 1996, EUROPEAN J WORK ORG, V5, P165, DOI [10.1080/13594329608414853, DOI 10.1080/13594329608414853]; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Ministry of Health Labor and Welfare, SUMM REP COMPR SURV; Ministry of Internal Affairs and Communications, ANN REP LAB FORC SUR; Niedhammer I, 2007, INT ARCH OCC ENV HEA, V80, P346, DOI 10.1007/s00420-006-0139-y; Nielsen MB, 2013, INT ARCH OCC ENV HEA, V86, P875, DOI 10.1007/s00420-012-0825-x; Nielsen MB, 2011, BULLYING AND HARASSMENT IN THE WORKPLACE: DEVELOPMENTS IN THEORY, RESEARCH, AND PRACTICE, 2ND EDITION, P149; Nielsen MB, 2010, J OCCUP ORGAN PSYCH, V83, P955, DOI 10.1348/096317909X481256; Operario D, 2004, PSYCHOL HEALTH, V19, P237, DOI 10.1080/08870440310001638098; Ortega A, 2009, INT ARCH OCC ENV HEA, V82, P417, DOI 10.1007/s00420-008-0339-8; Quinlan M, 2001, INT J HEALTH SERV, V31, P335, DOI 10.2190/607H-TTV0-QCN6-YLT4; Rugulies R, 2012, SCAND J WORK ENV HEA, V38, P218, DOI 10.5271/sjweh.3278; Sakurai K, 2010, SOC SCI MED, V70, P1832, DOI 10.1016/j.socscimed.2010.01.019; Salin D., 2001, EUR J WORK ORGAN PSY, V10, P425, DOI DOI 10.1080/13594320143000771; Salin D, 2011, BULLYING AND HARASSMENT IN THE WORKPLACE: DEVELOPMENTS IN THEORY, RESEARCH, AND PRACTICE, 2ND EDITION, P227; Scheler Max, 1973, RESSENTIMENT; Takaki J, 2010, J OCCUP HEALTH, V52, P367, DOI 10.1539/joh.L10081; Takigawa Y, 2013, CLARIFICATION MECH F; Tsuno K, 2012, JAPANESE J OCCUP MEN, V20, P221; Tsuno K, 2010, J OCCUP HEALTH, V52, P216, DOI 10.1539/joh.L10036; van den Bos K, 2002, ADV EXP SOC PSYCHOL, V34, P1, DOI 10.1016/S0065-2601(02)80003-X; van den Bos K, 2001, J PERS SOC PSYCHOL, V80, P931, DOI 10.1037/0022-3514.80.6.931; Vartia M., 1996, EUR J WORK ORGAN PSY, V5, P203, DOI DOI 10.1080/13594329608414855; Vaughn MG, 2010, PSYCHIAT QUART, V81, P183, DOI 10.1007/s11126-010-9128-0; Vingard E, 2005, SCAND J PUBLIC HEALT, V33, P370, DOI 10.1080/14034940510005860; Virtanen P, 2002, J EPIDEMIOL COMMUN H, V56, P569, DOI 10.1136/jech.56.8.569; Zapf D, 2011, BULLYING AND HARASSMENT IN THE WORKPLACE: DEVELOPMENTS IN THEORY, RESEARCH, AND PRACTICE, 2ND EDITION, P75	45	24	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119435	10.1371/journal.pone.0119435	http://dx.doi.org/10.1371/journal.pone.0119435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9LT	25751252	Green Submitted, Green Published, gold			2022-12-27	WOS:000350692700022
J	Hosnjak, L; Kocjan, BJ; Pirs, B; Seme, K; Poljak, M				Hosnjak, Lea; Kocjan, Bostjan J.; Pirs, Branko; Seme, Katja; Poljak, Mario			Characterization of Two Novel Gammapapillomaviruses, HPV179 and HPV184, Isolated from Common Warts of a Renal-Transplant Recipient	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; HIGH VIRAL LOAD; GENETIC DIVERSITY; ANOGENITAL HAIRS; DNA; INFECTION; PCR; SPECTRUM; BETAPAPILLOMAVIRUS; CLASSIFICATION	Gammapapillomavirus (Gamma-PV) is a diverse and rapidly expanding PV-genus, currently consisting of 76 fully characterized human papillomavirus (HPV) types. In this study, DNA genomes of two novel HPV types, HPV179 and HPV184, obtained from two distinct facial verrucae vulgares specimens of a 64 year-old renal-transplant recipient, were fully cloned, sequenced and characterized. HPV179 and HPV184 genomes comprise 7,228-bp and 7,324-bp, respectively, and contain four early (E1, E2, E6 and E7) and two late genes (L1 and L2); the non-coding region is typically positioned between L1 and E6 genes. Phylogenetic analysis of the L1 nucleotide sequence placed both novel types within the Gamma-PV genus: HPV179 was classified as a novel member of species Gamma-15, additionally containing HPV135 and HPV146, while HPV184 was classified as a single member of a novel species Gamma-25. HPV179 and HPV184 type-specific quantitative real-time PCRs were further developed and used in combination with human beta-globin gene quantitative real-time PCR to determine the prevalence and viral load of the novel types in the patient's facial warts and several follow-up skin specimens, and in a representative collection, a total of 569 samples, of HPV-associated benign and malignant neoplasms, hair follicles and anal and oral mucosa specimens obtained from immunocompetent individuals. HPV179 and HPV184 viral loads in patients' facial warts were estimated to be 2,463 and 3,200 genome copies per single cell, respectively, suggesting their active role in the development of common warts in organ-transplant recipients. In addition, in this particular patient, both novel types had established a persistent infection of the skin for more than four years. Among immunocompetent individuals, HPV179 was further detected in low-copy numbers in a few skin specimens, indicating its cutaneous tissue tropism, while HPV184 was further detected in low-copy numbers in one mucosal and a few skin specimens, suggesting its dual tissue tropism.	[Hosnjak, Lea; Kocjan, Bostjan J.; Seme, Katja; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Pirs, Branko] Private Ctr Laser & Aesthet Dermatol, Ljubljana, Slovenia	University of Ljubljana	Poljak, M (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	mario.poljak@mf.uni-lj.si			European Union; European Social Fund; Republic of Slovenia, Ministry for Education, Science and Sport	European Union(European Commission); European Social Fund(European Social Fund (ESF)); Republic of Slovenia, Ministry for Education, Science and Sport	This article is a result of doctoral research, in part financed by the European Union, European Social Fund and the Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational Programme for Human Resources development for the period 2007 - 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bao YM, 2014, ARCH VIROL, V159, P3293, DOI 10.1007/s00705-014-2197-x; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Chen G, 2001, J VIROL, V75, P292, DOI 10.1128/JVI.75.1.292-302.2001; Chouhy D, 2013, J GEN VIROL, V94, P2480, DOI 10.1099/vir.0.055137-0; Chouhy D, 2013, J GEN VIROL, V94, P524, DOI 10.1099/vir.0.048157-0; Cubie HA, 2013, VIROLOGY, V445, P21, DOI 10.1016/j.virol.2013.06.007; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Doorbar J., 1996, HUMAN PAPILLOMAVIRUS, P58; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Forslund O, 2003, J VIROL METHODS, V110, P129, DOI 10.1016/S0166-0934(03)00109-5; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2013, J INFECT DIS, V208, P1335, DOI 10.1093/infdis/jit326; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Harwood CA, 1999, J CLIN MICROBIOL, V37, P3545, DOI 10.1128/JCM.37.11.3545-3555.1999; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; Jancar N, 2009, EUR J OBSTET GYN R B, V145, P184, DOI 10.1016/j.ejogrb.2009.04.030; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kocjan Bogtjan J., 2005, Infection Genetics and Evolution, V5, P255, DOI 10.1016/j.meegid.2004.05.009; Kohler A, 2009, BRIT J DERMATOL, V161, P528, DOI 10.1111/j.1365-2133.2009.09297.x; Kohler A, 2010, VIROLOGY, V399, P129, DOI 10.1016/j.virol.2009.12.023; Komlos KF, 2013, ACTA DERMATOVEN ALP, V21, P31, DOI 10.2478/v10162-012-0028-x; Komlos KF, 2012, J MED VIROL, V84, P1233, DOI 10.1002/jmv.23318; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022414; Leiding JW, 2012, J ALLERGY CLIN IMMUN, V130, P1030, DOI 10.1016/j.jaci.2012.07.049; Li LL, 2009, J GEN VIROL, V90, P2413, DOI 10.1099/vir.0.012344-0; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Ma YF, 2014, J VIROL, V88, P4786, DOI 10.1128/JVI.00093-14; Martin E, 2014, J CLIN VIROL, V59, P30, DOI 10.1016/j.jcv.2013.10.028; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; MATSUKURA T, 1992, VIROLOGY, V190, P561, DOI 10.1016/0042-6822(92)91254-R; Milosevic M, 2010, CENT EUR J MED, V5, P698, DOI 10.2478/s11536-010-0019-4; Mokili JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058404; OBALEK S, 1992, J INVEST DERMATOL, V98, P936, DOI 10.1111/1523-1747.ep12460892; Odar K, 2014, J CELL MOL MED, V18, P635, DOI 10.1111/jcmm.12211; Poljak M, 2009, J INFECT DIS, V199, P1270, DOI 10.1086/597619; Potocnik M, 2007, ACTA DERMATOVEN ALP, V16, P91; Potocnik M, 2006, J MED VIROL, V78, P1673, DOI 10.1002/jmv.20753; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Quint KD, 2015, J PATHOL, V235, P342, DOI 10.1002/path.4425; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; SHAMANIN V, 1994, J GEN VIROL, V75, P1149, DOI 10.1099/0022-1317-75-5-1149; Sichero L, 2013, VIROLOGY, V443, P214, DOI 10.1016/j.virol.2013.04.024; Silling S, 2014, EMERG INFECT DIS, V20, P142, DOI 10.3201/eid2001.130999; Sri JC, 2012, J AM ACAD DERMATOL, V66, P292, DOI 10.1016/j.jaad.2010.12.011; Staheli JP, 2009, METHODS, V49, P32, DOI 10.1016/j.ymeth.2009.05.011; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas M, 2008, VIROLOGY, V376, P371, DOI 10.1016/j.virol.2008.03.021; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; Ure AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089342; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; van Duin M, 2002, INT J CANCER, V98, P590, DOI 10.1002/ijc.10232; Venuti A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-140	60	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119154	10.1371/journal.pone.0119154	http://dx.doi.org/10.1371/journal.pone.0119154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748516	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400052
J	Klassen, R; Grunewald, P; Thuring, KL; Eichler, C; Helm, M; Schaffrath, R				Klassen, Roland; Grunewald, Pia; Thuering, Kathrin L.; Eichler, Christian; Helm, Mark; Schaffrath, Raffael			Loss of Anticodon Wobble Uridine Modifications Affects tRNA(Lys) Function and Protein Levels in Saccharomyces cerevisiae	PLOS ONE			English	Article							KLUYVEROMYCES-LACTIS ZYMOCIN; TRANSFER-RNA MODIFICATION; ELONGATOR FUNCTION; KILLER TOXIN; YEAST; GENE; COMPLEX; TARGET; IDENTIFICATION; CASSETTES	In eukaryotes, wobble uridines in the anticodons of tRNA(UUU)(Lys), tRNA(UUC)(Glu) and tRNA(UUG)(Gln) are modified to 5-methoxy-carbonyl-methyl-2-thio-uridine (mcm(5)s(2)U). While mutations in subunits of the Elongator complex (Elp1-Elp6), which disable mcm(5) side chain formation, or removal of components of the thiolation pathway (Ncs2/Ncs6, Urm1, Uba4) are individually tolerated, the combination of both modification defects has been reported to have lethal effects on Saccharomyces cerevisiae. Contrary to such absolute requirement of mcm(5)s(2)U for viability, we demonstrate here that in the S. cerevisiae S288C-derived background, both pathways can be simultaneously inactivated, resulting in combined loss of tRNA anticodon modifications (mcm(5)U and s(2)U) without a lethal effect. However, an elp3 disruption strain displays synthetic sick interaction and synergistic temperature sensitivity when combined with either uba4 or urm1 mutations, suggesting major translational defects in the absence of mcm(5)s(2)U modifications. Consistent with this notion, we find cellular protein levels drastically decreased in an elp3uba4 double mutant and show that this effect as well as growth phenotypes can be partially rescued by excess of tRNA(UUU)(Lys). These results may indicate a global translational or protein homeostasis defect in cells simultaneously lacking mcm(5) and s(2) wobble uridine modification that could account for growth impairment and mainly originates from tRNA(UUU)(Lys) hypomodification and malfunction.	[Klassen, Roland; Grunewald, Pia; Eichler, Christian; Schaffrath, Raffael] Univ Kassel, Fachgebiet Mikrobiol, Inst Biol, D-34125 Kassel, Germany; [Thuering, Kathrin L.; Helm, Mark] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany	Universitat Kassel; Johannes Gutenberg University of Mainz	Klassen, R (corresponding author), Univ Kassel, Fachgebiet Mikrobiol, Inst Biol, D-34125 Kassel, Germany.	roland.klassen@uni-kassel.de; schaffrath@uni-kassel.de	Helm, Mark/AAD-5433-2022	Klassen, Roland/0000-0002-0809-0050; Helm, Mark/0000-0002-0154-0928	Zentrale Forschungsforderung Universitat Kassel, Germany [SysTRAM 4-5595-02]; Deutsche Forschungsgemeinschaft Bonn Bad-Godesberg, Germany [SCHA750/15-1, HE 3397/8]; FCI (Fonds der Chemischen Industrie) fellowship	Zentrale Forschungsforderung Universitat Kassel, Germany; Deutsche Forschungsgemeinschaft Bonn Bad-Godesberg, Germany(German Research Foundation (DFG)); FCI (Fonds der Chemischen Industrie) fellowship	The authors gratefully acknowledge support by the Zentrale Forschungsforderung Universitat Kassel, Germany (www.uni-kassel.de/uni/?zff; grant number SysTRAM 4-5595-02 to RS) and the Deutsche Forschungsgemeinschaft Bonn Bad-Godesberg, Germany (www.dfg.de; grant numbers SCHA750/15-1 to RS and HE 3397/8 to MH). KT was supported by an FCI (Fonds der Chemischen Industrie, www.vci.de) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alings F, 2015, RNA, V21, P202, DOI 10.1261/rna.048199.114; Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; Bauer F, 2012, CELL REPORTS, V1, P424, DOI 10.1016/j.celrep.2012.04.001; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE RL, 1983, J BIOL CHEM, V258, P2193; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020783; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Damon JR, 2014, MOL BIOL CELL; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Fichtner L, 2002, MOL MICROBIOL, V43, P783, DOI 10.1046/j.1365-2958.2002.02794.x; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Han L, 2015, RNA, V21, P188, DOI 10.1261/rna.048173.114; HEINISCH J, 1986, MOL GEN GENET, V202, P75, DOI 10.1007/BF00330520; Helm M, 2014, CHEM BIOL, V21, P174, DOI 10.1016/j.chembiol.2013.10.015; Hoyt MA, 2008, YEAST, V25, P199, DOI 10.1002/yea.1579; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Huang Q, 2012, NUCLEIC ACIDS RES, V40, P10463, DOI 10.1093/nar/gks783; Jablonowski D, 2007, BIOCHEM SOC T, V35, P1533, DOI 10.1042/BST0351533; Jablonowski D, 2006, MOL MICROBIOL, V59, P677, DOI 10.1111/j.1365-2958.2005.04972.x; Jablonowski D, 2004, MOL BIOL CELL, V15, P1459, DOI 10.1091/mbc.E03-10-0750; Jablonowski D, 2001, MOL MICROBIOL, V42, P1095, DOI 10.1046/j.1365-2958.2001.02705.x; Jablonowski D, 2009, EUKARYOT CELL, V8, P1637, DOI 10.1128/EC.00205-09; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Kellner S, 2014, CHEM COMMUN, V50, P3516, DOI 10.1039/c3cc49114e; Kemp AJ, 2013, MOL MICROBIOL, V87, P284, DOI 10.1111/mmi.12096; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; Mehlgarten C, 2003, MOL GENET GENOMICS, V269, P188, DOI 10.1007/s00438-003-0807-5; Mehlgarten C, 2010, MOL MICROBIOL, V76, P1082, DOI 10.1111/j.1365-2958.2010.07163.x; Mehlgarten C, 2009, MOL MICROBIOL, V73, P869, DOI 10.1111/j.1365-2958.2009.06811.x; Patil A, 2012, RNA BIOL, V9, P990, DOI 10.4161/rna.20531; Patil A, 2012, CELL CYCLE, V11, P3656, DOI 10.4161/cc.21919; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Scheidt V, 2014, MICROB CELL, V1, P416, DOI 10.15698/mic2014.12.179; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Studte P, 2008, MOL MICROBIOL, V69, P1266, DOI 10.1111/j.1365-2958.2008.06358.x; Zabel R, 2008, MOL MICROBIOL, V69, P175, DOI 10.1111/j.1365-2958.2008.06273.x; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zinshteyn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003675	54	44	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119261	10.1371/journal.pone.0119261	http://dx.doi.org/10.1371/journal.pone.0119261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747122	gold, Green Published			2022-12-27	WOS:000350689400061
J	Zhou, YJ; Ma, XM; Wang, D; Qin, W; Zhu, JJ; Zhuo, CJ; Yu, CS				Zhou, Yujing; Ma, Xiaomei; Wang, Di; Qin, Wen; Zhu, Jiajia; Zhuo, Chuanjun; Yu, Chunshui			The Selective Impairment of Resting-State Functional Connectivity of the Lateral Subregion of the Frontal Pole in Schizophrenia	PLOS ONE			English	Article							PREFRONTAL CORTEX AREA-10; SUSCEPTIBILITY ARTIFACTS; COGNITIVE DEFICITS; BIPOLAR DISORDER; MATTER VOLUMES; GRAY; FMRI; MRI; METAANALYSIS; RETRIEVAL	Objective Although extensive resting-state functional connectivity (rsFC) changes have been reported in schizophrenia, rsFC changes of the frontal pole (FP) remain unclear. The FP contains several subregions with different connection patterns; however, it is unknown whether the FP subregions are differentially affected in schizophrenia. To explore this possibility, we compared rsFC differences of the FP subregions between schizophrenia patients and healthy controls. Method One hundred healthy controls and 91 patients with schizophrenia underwent resting-state functional MRI with a sensitivity-encoded spiral-in (SENSE-SPIRAL) imaging sequence to reduced susceptibility-induced signal loss and distortion. The FP was subdivided into the orbital (FPo), medial (FPm), and lateral (FPl) subregions. Mean fMRI time series were extracted for each FP subregion and entered into a seed-based rsFC analysis. Results The FP subregions exhibited differential rsFC patterns in both healthy controls and schizophrenia patients. Direct comparison between groups revealed reduced rsFCs between the bilateral FPl and several cognitive-related regions, including the dorsolateral prefrontal cortex, medial prefrontal cortex, anterior cingulate cortex, posterior cingulate cortex/precuneus, temporal cortex and inferior parietal lobule in schizophrenia. Although the FPl exhibited obvious atrophy, rsFC changes were unrelated to volumetric atrophy in the FPl, to duration of illness, and to antipsychotic medication dosage. No significant differences were observed in the rsFCs of other FP subregions. Conclusion These findings suggest a selective (the lateral subregion) functional disconnection of the FP subregions in schizophrenia.	[Zhou, Yujing; Ma, Xiaomei; Wang, Di; Qin, Wen; Zhu, Jiajia; Zhuo, Chuanjun; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Zhou, Yujing; Ma, Xiaomei; Wang, Di; Qin, Wen; Zhu, Jiajia; Zhuo, Chuanjun; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin, Peoples R China; [Zhuo, Chuanjun] Tianjin Anding Hosp, Tianjin Mental Hlth Ctr, Dept Psychiat Funct Neuroimaging Lab, Tianjin, Peoples R China; [Zhuo, Chuanjun] Tianjin Anding Hosp, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Zhuo, CJ (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	iamdoforyou@163.com; chunshuiyu@tijmu.edu.cn	QIN, WEN/F-3783-2015	QIN, WEN/0000-0002-9121-8296; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [81425013, 91332113, 81271551, 81301201]; Tianjin High School Science & Technology Fund Planning Project; Tianjin Key Technology RD Program [14ZCZDSY00018]; National Key Clinical Specialty Project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin High School Science & Technology Fund Planning Project; Tianjin Key Technology RD Program; National Key Clinical Specialty Project	This study was supported by grants from the Natural Science Foundation of China (81425013, 91332113, 81271551 and 81301201), the Tianjin High School Science & Technology Fund Planning Project, the Tianjin Key Technology R&D Program (14ZCZDSY00018), and the National Key Clinical Specialty Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CC, 2013, CURR MED CHEM, V20, P428; Adams Rick, 2007, Neuropsychiatr Dis Treat, V3, P87, DOI 10.2147/nedt.2007.3.1.87; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Antonova E, 2005, BIOL PSYCHIAT, V58, P457, DOI 10.1016/j.biopsych.2005.04.036; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Baiano M, 2007, SCHIZOPHR RES, V93, P1, DOI 10.1016/j.schres.2007.02.012; Bhojraj TS, 2011, NEUROIMAGE, V54, pS272, DOI 10.1016/j.neuroimage.2010.04.257; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Bosia M, 2012, CURR TOP MED CHEM, V12, P2284, DOI 10.2174/156802612805289917; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Calhoun VD, 2006, HUM BRAIN MAPP, V27, P47, DOI 10.1002/hbm.20166; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Fornito A, 2009, SCHIZOPHRENIA BULL, V35, P973, DOI 10.1093/schbul/sbn025; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Glover GH, 2012, NEUROIMAGE, V62, P706, DOI 10.1016/j.neuroimage.2011.10.039; Goghari VM, 2011, SCHIZOPHRENIA BULL, V37, P1281, DOI 10.1093/schbul/sbq046; Gorno-Tempini ML, 2002, NEUROIMAGE, V15, P136, DOI 10.1006/nimg.2001.0967; Grosselin A, 2010, ENCEPHALE, V36, P277, DOI 10.1016/j.encep.2009.12.011; Huang MX, 2010, BRAIN TOPOGR, V23, P82, DOI 10.1007/s10548-009-0122-5; Jamadar S, 2013, BIOL PSYCHIAT, V73, P555, DOI 10.1016/j.biopsych.2012.07.027; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; Kawada R, 2009, PROG NEURO-PSYCHOPH, V33, P1255, DOI 10.1016/j.pnpbp.2009.07.014; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim DI, 2010, NEUROINFORMATICS, V8, P213, DOI 10.1007/s12021-010-9077-7; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Liu HG, 2013, J NEUROSCI, V33, P6782, DOI 10.1523/JNEUROSCI.4882-12.2013; Maguire EA, 2001, BRAIN, V124, P1156, DOI 10.1093/brain/124.6.1156; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Mitelman SA, 2007, NEUROIMAGE, V37, P449, DOI 10.1016/j.neuroimage.2007.04.070; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ragland JD, 2005, AM J PSYCHIAT, V162, P1840, DOI 10.1176/appi.ajp.162.10.1840; Ragland JD, 2009, AM J PSYCHIAT, V166, P863, DOI 10.1176/appi.ajp.2009.08091307; Rosso IM, 2010, SCHIZOPHR RES, V123, P15, DOI 10.1016/j.schres.2010.06.015; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Truong TK, 2008, MAGN RESON MED, V59, P221, DOI 10.1002/mrm.21473; Tu PC, 2013, SCHIZOPHR RES, V147, P339, DOI 10.1016/j.schres.2013.04.011; van der Meer L, 2013, SCHIZOPHRENIA BULL, V39, P1352, DOI 10.1093/schbul/sbs122; Velanova K, 2003, J NEUROSCI, V23, P8460; Wendelken C, 2010, J COGNITIVE NEUROSCI, V22, P837, DOI 10.1162/jocn.2009.21226; White CN, 2014, J COGNITIVE NEUROSCI, V26, P1601, DOI 10.1162/jocn_a_00567; Wolf RC, 2008, EUR PSYCHIAT, V23, P541, DOI 10.1016/j.eurpsy.2008.02.002; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018	56	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119176	10.1371/journal.pone.0119176	http://dx.doi.org/10.1371/journal.pone.0119176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748858	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400054
J	Bekrater-Bodmann, R; Schredl, M; Diers, M; Reinhard, I; Foell, J; Trojan, J; Fuchs, X; Flor, H				Bekrater-Bodmann, Robin; Schredl, Michael; Diers, Martin; Reinhard, Iris; Foell, Jens; Trojan, Joerg; Fuchs, Xaver; Flor, Herta			Post-Amputation Pain Is Associated with the Recall of an Impaired Body Representation in Dreams-Results from a Nation-Wide Survey on Limb Amputees	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHANTOM PAIN; AFFECTIVE DISTRESS; SENSATIONS; FREQUENCY; PEOPLE; BIAS	The experience of post-amputation pain such as phantom limb pain (PLP) and residual limb pain (RLP), is a common consequence of limb amputation, and its presence has negative effects on a person's well-being. The continuity hypothesis of dreams suggests that the presence of such aversive experiences in the waking state should be reflected in dream content, with the recalled body representation reflecting a cognitive proxy of negative impact. In the present study, we epidemiologically assessed the presence of post-amputation pain and other amputation-related information as well as recalled body representation in dreams in a sample of 3,234 unilateral limb amputees. Data on the site and time of amputation, residual limb length, prosthesis use, lifetime prevalence of mental disorders, presence of post-amputation pain, and presence of non-painful phantom phenomena were included in logistic regression analyses using recalled body representation in dreams (impaired, intact, no memory) as dependent variable. The effects of age, sex, and frequency of dream recall were controlled for. About 22% of the subjects indicated that they were not able to remember their body representation in dreams, another 24% of the amputees recalled themselves as always intact, and only a minority of less than 3% recalled themselves as always impaired. Almost 35% of the amputees dreamed of themselves in a mixed fashion. We found that lower-limb amputation as well as the presence of PLP and RLP was positively associated with the recall of an impaired body representation in dreams. The presence of nonpainful phantom phenomena, however, had no influence. These results complement previous findings and indicate complex interactions of physical body appearance and mental body representation, probably modulated by distress in the waking state. The findings are discussed against the background of alterations in cognitive processes after amputation and hypotheses suggesting an innate body model.	[Bekrater-Bodmann, Robin; Diers, Martin; Foell, Jens; Trojan, Joerg; Fuchs, Xaver; Flor, Herta] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Schredl, Michael] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Sleep Lab, Mannheim, Germany; [Reinhard, Iris] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Div Biostat, Mannheim, Germany; [Foell, Jens] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Trojan, Joerg] Univ Koblenz Landau, Dept Psychol, Landau, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; State University System of Florida; Florida State University; University of Koblenz & Landau	Bekrater-Bodmann, R (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany.	r.bekrater-bodmann@zi-mannheim.de	Trojan, Jörg/C-1616-2009; Fuchs, Xaver/HCI-1160-2022; Diers, Martin/M-9155-2013	Trojan, Jörg/0000-0003-4110-2647; Diers, Martin/0000-0002-3257-7299; Flor, Herta/0000-0003-4809-5398	'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND) project - European Community's Seventh Framework Programme (FP7)/ERC [230249]	'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND) project - European Community's Seventh Framework Programme (FP7)/ERC	This research was supported by the 'Phantom phenomena: A window to the mind and the brain (PHANTOMMIND) project awarded to HF, which receives research funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No. 230249. The views expressed in this manuscript are those of the authors and do not reflect the official policy of the European Community. The European Community had no influence on collection, analysis, and interpretation of the data as well as the decision to submit the paper for publication. No one except the specified persons has been involved in the preparation of the manuscript.	Alessandria M, 2011, CONSCIOUS COGN, V20, P1831, DOI 10.1016/j.concog.2011.06.013; BRADLEY B, 1983, BRIT J CLIN PSYCHOL, V22, P173, DOI 10.1111/j.2044-8260.1983.tb00598.x; Brugger P, 2008, CONSCIOUS COGN, V17, P1272, DOI 10.1016/j.concog.2008.01.005; Claudio V, 2012, CLIN PSYCHOL PSYCHOT, V19, P375, DOI 10.1002/cpp.751; CRONHOLM B, 1951, Acta Psychiatr Neurol Scand Suppl, V72, P1; Darnall BD, 2005, ARCH PHYS MED REHAB, V86, P650, DOI 10.1016/j.apmr.2004.10.028; Demet K, 2003, DISABIL REHABIL, V25, P480, DOI 10.1080/0963828031000090434; Desmond DM, 2007, J PSYCHOSOM RES, V62, P15, DOI 10.1016/j.jpsychores.2006.07.027; Desmond DM, 2006, J PAIN SYMPTOM MANAG, V31, P362, DOI 10.1016/j.jpainsymman.2005.08.014; Dijkstra PU, 2002, J PAIN SYMPTOM MANAG, V24, P578, DOI 10.1016/S0885-3924(02)00538-9; Ehde DM, 2000, ARCH PHYS MED REHAB, V81, P1039, DOI 10.1053/apmr.2000.7583; Ephraim PL, 2005, ARCH PHYS MED REHAB, V86, P1910, DOI 10.1016/j.apmr.2005.03.031; FRANK B, 1989, PSYCHOPATHOLOGY, V22, P182, DOI 10.1159/000284594; Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7; Hanley MA, 2009, AM J PHYS MED REHAB, V88, P742, DOI 10.1097/PHM.0b013e3181b306ec; HOUGHTON AD, 1994, ANN ROY COLL SURG, V76, P22; Kern U, 2009, SCHMERZ, V23, P479, DOI 10.1007/s00482-009-0786-5; Kooijman CM, 2000, PAIN, V87, P33, DOI 10.1016/S0304-3959(00)00264-5; Melzack R, 1997, BRAIN, V120, P1603, DOI 10.1093/brain/120.9.1603; Mulder T, 2008, CONSCIOUS COGN, V17, P1266, DOI 10.1016/j.concog.2007.04.001; NEWTON PM, 1970, J ABNORM PSYCHOL, V76, P134, DOI 10.1037/h0029666; Pesant N, 2006, J CLIN PSYCHOL, V62, P111, DOI 10.1002/jclp.20212; POHJOLAINEN T, 1991, PROSTHET ORTHOT INT, V15, P178; Sato H, 2011, ANXIETY STRESS COPIN, V24, P359, DOI 10.1080/10615806.2010.543132; Saurat MT, 2011, CONSCIOUS COGN, V20, P1425, DOI 10.1016/j.concog.2011.05.015; Schley MT, 2008, J TRAUMA, V65, P858, DOI 10.1097/TA.0b013e31812eed9e; Schredl M, 2002, DREAMING, V12, P17, DOI 10.1023/A:1013890421674; Schredl M, 2004, PERCEPT MOTOR SKILL, V98, P1422, DOI 10.2466/pms.98.3c.1422-1426; Schredl M, 1997, PERCEPT MOTOR SKILL, V84, P1305, DOI 10.2466/pms.1997.84.3c.1305; Schredl M, 1998, CONSCIOUS COGN, V7, P634, DOI 10.1006/ccog.1998.0356; Schredl M., 2008, TRAUM; Schredl M., 2007, NEW SCI DREAMING VOL, P79; Schredl M., 2013, INT J DREAM RES, V6, P119, DOI DOI 10.11588/IJODR.2013.2.11127; Schredl M, 2011, SLEEP HYPN, V13, P1; Schredl M, 2006, SLEEP HYPNOSIS, V5; Schredl M, 2003, SLEEP HYPNOSIS, P14; Schredl M, 2008, PERCEPT MOTOR SKILL, V106, P699, DOI 10.2466/PMS.106.3.699-702; Schredl M, 2009, SLEEP MED REV, V13, P215, DOI 10.1016/j.smrv.2008.06.002; SHERMAN RA, 1984, PAIN, V18, P83, DOI 10.1016/0304-3959(84)90128-3; SHUKLA GD, 1982, BRIT J PSYCHIAT, V141, P54, DOI 10.1192/bjp.141.1.54; Sinha R, 2011, PROSTHET ORTHOT INT, V35, P90, DOI 10.1177/0309364610397087; Statistisches Bundesamt, 2014, STAT SCHWERB MENSCH; Tran TB, 2011, EMOTION, V11, P145, DOI 10.1037/a0021754; van der Schans CP, 2002, J PAIN SYMPTOM MANAG, V24, P429, DOI 10.1016/S0885-3924(02)00511-0; Vetrugno R, 2008, J NEUROL NEUROSUR PS, V79, P481, DOI 10.1136/jnnp.2007.129783; Voss U, 2011, CONSCIOUS COGN, V20, P673, DOI 10.1016/j.concog.2010.10.020; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Wartan SW, 1997, BRIT J ANAESTH, V78, P652, DOI 10.1093/bja/78.6.652; Winter C, 2001, SCHMERZ, V15, P172, DOI 10.1007/s004820170019	49	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119552	10.1371/journal.pone.0119552	http://dx.doi.org/10.1371/journal.pone.0119552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742626	Green Published, gold, Green Submitted			2022-12-27	WOS:000350688100120
J	Hu, AH; Diener, BL; Josephson, MB; Grunstein, MM				Hu, Aihua; Diener, Barry L.; Josephson, Maureen B.; Grunstein, Michael M.			Constitutively Active Signaling by the G Protein beta gamma-Subunit Mediates Intrinsically Increased Phosphodiesterase-4 Activity in Human Asthmatic Airway Smooth Muscle Cells	PLOS ONE			English	Article							SMALL-MOLECULE DISRUPTION; RAS-DEPENDENT ACTIVATION; COUPLED RECEPTOR; ADRENOCEPTOR RESPONSIVENESS; UP-REGULATION; KINASE; MECHANISM; ROFLUMILAST; HYPERRESPONSIVENESS; DESENSITIZATION	Signaling by the G beta gamma subunit of Gi protein, leading to downstream c-Src-induced activation of the Ras/c-Raf1/MEK-ERK1/2 signaling pathway and its upregulation of phosphodiesterase-4 (PDE4) activity, was recently shown to mediate the heightened contractility in proasthmatic sensitized isolated airway smooth muscle (ASM), as well as allergen-induced airway hyperresponsiveness and inflammation in an in vivo animal model of allergic asthma. This study investigated whether cultured human ASM (HASM) cells derived from asthmatic donor lungs exhibit constitutively increased PDE activity that is attributed to intrinsically upregulated G beta gamma signaling coupled to c-Src activation of the Ras/MEK/ERK1/2 cascade. We show that, relative to normal cells, asthmatic HASM cells constitutively exhibit markedly increased intrinsic PDE4 activity coupled to heightened G beta gamma-regulated phosphorylation of c-Src and ERK1/2, and direct co-localization of the latter with the PDE4D isoform. These signaling events and their induction of heightened PDE activity are acutely suppressed by treating asthmatic HASM cells with a G beta gamma inhibitor. Importantly, along with increased G beta gamma activation, asthmatic HASM cells also exhibit constitutively increased direct binding of the small Rap1 GTPase-activating protein, Rap1GAP, to the alpha-subunit of Gi protein, which serves to cooperatively facilitate Ras activation and, thereby, enable enhanced G beta gamma-regulated ERK1/2-stimulated PDE activity. Collectively, these data are the first to identify that intrinsically increased signaling via the G beta gamma subunit, facilitated by Rap1GAP recruitment to the alpha-subunit, mediates the constitutively increased PDE4 activity detected in asthmatic HASM cells. These new findings support the notion that interventions targeted at suppressing G beta gamma signaling may lead to novel approaches to treat asthma.	[Hu, Aihua; Diener, Barry L.; Josephson, Maureen B.; Grunstein, Michael M.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Grunstein, Michael M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Grunstein, MM (corresponding author), Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA.	mgrun@med.upenn.edu			National Institutes of Health Heart, Lung, Blood Institute [HL-097739]; Jacqueline E. Swartz Endowed Fellowship in Pediatric Pulmonology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097739] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jacqueline E. Swartz Endowed Fellowship in Pediatric Pulmonology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Heart, Lung, Blood Institute grant HL-097739 to MMG, and the Jacqueline E. Swartz Endowed Fellowship in Pediatric Pulmonology to MBJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman ED, 2006, ANN ALLERG ASTHMA IM, V96, P679, DOI 10.1016/S1081-1206(10)61065-4; Billington CK, 2008, AM J RESP CELL MOL, V38, P1, DOI 10.1165/rcmb.2007-0171OC; Billington CK, 2003, RESP RES, V4; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Chang M, 2000, J BIOL CHEM, V275, P7021, DOI 10.1074/jbc.275.10.7021; Chapman RW, 2007, EUR J PHARMACOL, V571, P215, DOI 10.1016/j.ejphar.2007.05.074; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Druey KM, 2009, IMMUNOL RES, V43, P62, DOI 10.1007/s12026-008-8050-0; Gerthoffer WT, 2003, RESP PHYSIOL NEUROBI, V137, P237, DOI 10.1016/S1569-9048(03)00150-2; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Hakonarson H, 2003, RESP PHYSIOL NEUROBI, V137, P263, DOI 10.1016/S1569-9048(03)00152-6; HAKONARSON H, 1995, AM J PHYSIOL-LUNG C, V269, pL645, DOI 10.1152/ajplung.1995.269.5.L645; Hakonarson H, 1996, J CLIN INVEST, V97, P2593, DOI 10.1172/JCI118708; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hu AH, 2008, AM J PHYSIOL-LUNG C, V294, pL1055, DOI 10.1152/ajplung.00021.2008; Hu AH, 2009, AM J PHYSIOL-LUNG C, V296, pL790, DOI 10.1152/ajplung.90572.2008; Kanehiro A, 2001, AM J RESP CRIT CARE, V163, P173, DOI 10.1164/ajrccm.163.1.2001118; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Louw C, 2007, RESPIRATION, V74, P411, DOI 10.1159/000095677; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Nino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032078; Nino G, 2010, J ALLERGY CLIN IMMUN, V125, P1020, DOI 10.1016/j.jaci.2010.02.007; Nino G, 2009, AM J PHYSIOL-LUNG C, V297, pL746, DOI 10.1152/ajplung.00079.2009; Okada S, 1998, EMBO J, V17, P2554, DOI 10.1093/emboj/17.9.2554; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun JG, 2006, LIFE SCI, V79, P2077, DOI 10.1016/j.lfs.2006.07.001; Tang HF, 2005, AM J RESP CRIT CARE, V171, P823, DOI 10.1164/rccm.200406-771OC; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; van Dam Teunis J P, 2011, Small GTPases, V2, P4; van Schalkwyk E, 2005, J ALLERGY CLIN IMMUN, V116, P292, DOI 10.1016/j.jaci.2005.04.023; Willard FS, 2007, CELL SIGNAL, V19, P428, DOI 10.1016/j.cellsig.2006.07.013	45	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0118712	10.1371/journal.pone.0118712	http://dx.doi.org/10.1371/journal.pone.0118712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742624	gold, Green Published, Green Submitted			2022-12-27	WOS:000350688100036
J	Hwang, B; Phan, FP; McCool, K; Choi, EY; You, JS; Johnson, A; Audhya, A; Miyamoto, S				Hwang, Byounghoon; Phan, Funita P.; McCool, Kevin; Choi, Eun Young; You, Jinsam; Johnson, Adam; Audhya, Anjon; Miyamoto, Shigeki			Quantification of Cellular NEMO Content and Its Impact on NF-kappa B Activation by Genotoxic Stress	PLOS ONE			English	Article							UBIQUITIN CHAINS; POSTTRANSLATIONAL MODIFICATIONS; KINASE COMPLEX; IKK-GAMMA; MODULATOR; COMPONENT; PATHWAY; BINDING; PROTEIN; DOMAIN	NF-kappa B essential modulator, NEMO, plays a key role in canonical NF-kappa B signaling induced by a variety of stimuli, including cytokines and genotoxic agents. To dissect the different biochemical and functional roles of NEMO in NF-kappa B signaling, various mutant forms of NEMO have been previously analyzed. However, transient or stable overexpression of wild-type NEMO can significantly inhibit NF-kappa B activation, thereby confounding the analysis of NEMO mutant phenotypes. What levels of NEMO overexpression lead to such an artifact and what levels are tolerated with no significant impact on NEMO function in NF-kappa B activation are currently unknown. Here we purified full-length recombinant human NEMO protein and used it as a standard to quantify the average number of NEMO molecules per cell in a 1.3E2 NEMO-deficient murine pre-B cell clone stably reconstituted with full-length human NEMO (C5). We determined that the C5 cell clone has an average of 4 x 10(5) molecules of NEMO per cell. Stable reconstitution of 1.3E2 cells with different numbers of NEMO molecules per cell has demonstrated that a 10-fold range of NEMO expression (0.6-6x10(5) molecules per cell) yields statistically equivalent NF-kappa B activation in response to the DNA damaging agent etoposide. Using the C5 cell line, we also quantified the number of NEMO molecules per cell in several commonly employed human cell lines. These results establish baseline numbers of endogenous NEMO per cell and highlight surprisingly normal functionality of NEMO in the DNA damage pathway over a wide range of expression levels that can provide a guideline for future NEMO reconstitution studies.	[Hwang, Byounghoon; Phan, Funita P.; McCool, Kevin; Choi, Eun Young; Miyamoto, Shigeki] Univ Wisconsin, Dept Oncol, Madison, WI 53706 USA; [Phan, Funita P.; Johnson, Adam; Miyamoto, Shigeki] Univ Wisconsin, Integrated Program Biochem, Madison, WI USA; [McCool, Kevin; Miyamoto, Shigeki] Univ Wisconsin, Mol & Cellular Pharmacol, Madison, WI USA; [Johnson, Adam; Audhya, Anjon] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [You, Jinsam] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University-Purdue University Indianapolis	Miyamoto, S (corresponding author), Univ Wisconsin, Dept Oncol, Madison, WI 53706 USA.	smiyamot@wisc.edu			NIH [R01 GM083681, R01 CA077474]; NCI Training in Cancer Biology [T32 CA009135]; NATIONAL CANCER INSTITUTE [R01CA077474, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110567, R01GM083681, T32GM008692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Training in Cancer Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grants R01 GM083681 and R01 CA077474 to SM and NCI Training in Cancer Biology T32 CA009135 to FPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Choudhary A, 2013, P NATL ACAD SCI USA, V110, P13026, DOI 10.1073/pnas.1308203110; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cote SM, 2013, BIOCHEMISTRY-US, V52, P9141, DOI 10.1021/bi401368r; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Higgs RE, 2007, J PROTEOME RES, V6, P1758, DOI 10.1021/pr0605320; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Park A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095101; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rudolph D, 2000, GENE DEV, V14, P854; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0116374	10.1371/journal.pone.0116374	http://dx.doi.org/10.1371/journal.pone.0116374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742655	Green Published, gold			2022-12-27	WOS:000350688100002
J	Wang, LR; Santella, AJ; Huang, RZ; Kou, LL; You, LJ; Zhang, XN; Wang, S; Wang, JY; Gao, LF; Yin, J; Zhuang, GH				Wang, Lirong; Santella, Anthony J.; Huang, Ruizhe; Kou, Lingling; You, Lijuan; Zhang, Xiaona; Wang, Shu; Wang, Jingyao; Gao, Longfei; Yin, Juan; Zhuang, Guihua			Knowledge of HIV and Willingness to Conduct Oral Rapid HIV Testing among Dentists in Xi'an China	PLOS ONE			English	Article							PERSONS AWARE; TRANSMISSION; HIV/AIDS; RISK; ATTITUDES; UNAWARE; INTERVENTION; PREVENTION; RETENTION; EVOLUTION	Introduction China is considered a country of low HIV prevalence (780,000 people living with HIV), however, HIV infections among high-risk populations continue to grow at alarming rates. Voluntary Counseling and Testing services were first implemented in 2003, and oral rapid HIV testing (ORHT) began in 2012. Dentists, as oral health experts, would be well placed to conduct ORHT. We assessed willingness of dentists to undertake ORHT in their clinical practice. Methods A cross-sectional, paper-based survey of dentists from the Xi'an region of China was conducted from April to June 2013. Dentists were recruited from Shaanxi Stomatological Association using a stratified sampling methodology. A 40-item survey was used to measure knowledge of HIV, attitudes toward people living with HIV and willingness to conduct ORHT. Results 477 dentists completed the survey with a mean HIV knowledge test score of 13.2/18 (SD 1.9). If made available in the dental setting, 276 (57.9%) preferred to use blood to diagnose HIV, only 190 (39.8%) preferred saliva or both. Four hundred and thirty-five (91.2%) thought that ORHT was needed in dental clinics. Female dentists felt more accepting of ORHT than males (93.8% vs. 87.8%; chi(2)=5.145; p<0.05). 42.6% of the participants who responded thought that lack of education on ORHT for dentists was the most urgent problem to solve for ORHT, 144 (31.3%) thought that lack of support for ORHT from patients was the most urgent problem. There was statistically significant difference among dental hospital, dentistry and department of dentistry (chi(2)=24.176; p<0.05). Conclusions The majority of Chinese dentists thought that ORHT was needed in the dental setting. Providing opportunities for dentists and dental students to learn about HIV testing guidelines and practices is needed as well as feasibility and implementation science research.	[Wang, Lirong; Kou, Lingling; You, Lijuan; Zhang, Xiaona; Wang, Shu; Wang, Jingyao; Gao, Longfei; Yin, Juan; Zhuang, Guihua] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Xian 710049, Shaanxi, Peoples R China; [Santella, Anthony J.] Univ Sydney, Sydney Med Sch, Western Sydney Sexual Hlth Ctr, Sydney, NSW 2006, Australia; [Huang, Ruizhe] Xi An Jiao Tong Univ, Hlth Sci Ctr, Stomatol Hosp, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; University of Sydney; Xi'an Jiaotong University	Zhuang, GH (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Xian 710049, Shaanxi, Peoples R China.	zhuanggh@mail.xjtu.edu.cn						Aggarwal A, 2013, J DENT EDUC, V77, P1209; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dietz CA, 2008, AIDS PATIENT CARE ST, V22, P205, DOI 10.1089/apc.2007.0235; Glick M, 2005, J AM DENT ASSOC, V136, P1541, DOI 10.14219/jada.archive.2005.0084; Glick M, 2005, J AM DENT ASSOC, V136, P1206, DOI 10.14219/jada.archive.2005.0326; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hutchinson MK, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-11; Khosravanifard B., 2012, Eastern Mediterranean Health Journal, V18, P928; Li L, 2012, CHINA BUSINESS  1202; Li N, 2014, INT J ENV RES PUB HE, V11, P4528, DOI 10.3390/ijerph110404528; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; Ministry of Health of the People's Republic of China, 2012, HIV CHIN FACTS FIG; Morin SF, 2008, JAIDS-J ACQ IMM DEF, V49, P544, DOI 10.1097/QAI.0b013e31818d5def; Pai NP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000367; Park JC, 2011, J PERIODONTAL IMPLAN, V41, P3, DOI [10.5051/jpis.2011.41.1.3, 10.5051/jpis.2010.40.1.3]; Pollack HA, 2014, AM J PUBLIC HEALTH, V104, P872, DOI 10.2105/AJPH.2013.301700; Pollack HA, 2010, AM J PUBLIC HEALTH, V100, P88, DOI 10.2105/AJPH.2008.157230; Reznik D, 2006, DIMENS DENT HYG, V4, P14; Santella AJ, 2013, INT J DENT HYG, V11, P287, DOI 10.1111/idh.12022; Santella Anthony J, 2012, J Dent Hyg, V86, P265; Seipone K., 2004, Morbidity and Mortality Weekly Report, V53, P1083; Shah SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-269; Siegel K, 2012, AM J PUBLIC HEALTH, V102, P625, DOI 10.2105/AJPH.2011.300509; Sun XH, 2010, INT J EPIDEMIOL, V39, pII4, DOI 10.1093/ije/dyq217; Tang Hou-lin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P1004; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; van Wijk PTL, 2010, EUR J PUBLIC HEALTH, V20, P281, DOI 10.1093/eurpub/ckp163; Vernillo AT, 2007, J DENT EDUC, V71, P1534; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Zhang DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086609; Zhang YaLan, 2013, Journal of Tropical Medicine (Guangzhou), V13, P1385	35	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119274	10.1371/journal.pone.0119274	http://dx.doi.org/10.1371/journal.pone.0119274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9KG	25742600	Green Submitted, gold, Green Published			2022-12-27	WOS:000350688100099
J	Williams, K; Williams, K; Baucher, HM; Plenefisch, J				Williams, Kyle; Williams, Kristen; Baucher, Hallie M.; Plenefisch, John			The Tail Domain Is Essential but the Head Domain Dispensable for C. elegans Intermediate Filament IFA-2 Function	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MUSCLE-CELL ATTACHMENT; IN-VITRO; END DOMAINS; TRANSMEMBRANE PROTEIN; ASSEMBLY PROPERTIES; TISSUE INTEGRITY; VIMENTIN; KERATINS; ROD	The intermediate filament protein IFA-2 is essential for the structural integrity of the Caenorhabditis elegans epidermis. It is one of the major components of the fibrous organelle, an epidermal structure comprised of apical and basal hemidesmosomes linked by cytoplasmic intermediate filaments that serve to transmit force from the muscle to the cuticle. Mutations of IFA-2 result in epidermal fragility and separation of the apical and basal epidermal surfaces during postembryonic growth. An IFA-2 lacking the head domain fully rescues the IFA-2 null mutant, whereas an IFA-2 lacking the tail domain cannot. Conversely, an isolated IFA-2 head was able to localize to fibrous organelles whereas the tail was not. Taken together these results suggest that the head domain contains redundant signals for IF localization, whereas non-redundant essential functions map to the IFA-2, tail, although the tail is unlikely to be directly involved in fibrous organelle localization.	[Williams, Kyle; Williams, Kristen; Baucher, Hallie M.; Plenefisch, John] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Plenefisch, J (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	john.plenefisch@utoledo.edu			National Institutes of Health [1R15GM086807]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM086807] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a National Institutes of Health grant 1R15GM086807 to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREOLI JM, 1994, EXP CELL RES, V214, P177, DOI 10.1006/excr.1994.1247; BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293; Bar H, 2010, J MOL BIOL, V397, P1188, DOI 10.1016/j.jmb.2010.02.024; Bercher M, 2001, J CELL BIOL, V154, P415, DOI 10.1083/jcb.200103035; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; Ching GY, 1999, J CELL SCI, V112, P2233; COULOMBE PA, 1990, J CELL BIOL, V111, P3049, DOI 10.1083/jcb.111.6.3049; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; Godsel LM, 2008, TRENDS CELL BIOL, V18, P28, DOI 10.1016/j.tcb.2007.11.004; Gu L, 2004, EXP CELL RES, V298, P249, DOI 10.1016/j.yexcr.2004.04.020; Gupta Bhagwati P, 2012, WormBook, P1, DOI 10.1895/wormbook.1.152.1; Hapiak V, 2003, DEV BIOL, V263, P330, DOI 10.1016/j.ydbio.2003.08.001; HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466; Hong L, 2001, J CELL BIOL, V154, P403, DOI 10.1083/jcb.200007075; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; HRESKO MC, 1994, J CELL BIOL, V124, P491, DOI 10.1083/jcb.124.4.491; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Karabinos A, 2004, EUR J CELL BIOL, V83, P457, DOI 10.1078/0171-9335-00407; Karabinos A, 2003, J MOL BIOL, V333, P307, DOI 10.1016/j.jmb.2003.08.041; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lowrie DJ, 2000, J STRUCT BIOL, V132, P83, DOI 10.1006/jsbi.2000.4315; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miao LQ, 2013, J CELL SCI, V126, P427, DOI 10.1242/jcs.105817; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Peixoto CA, 1998, J PARASITOL, V84, P45, DOI 10.2307/3284528; Plenefisch JD, 2000, DEVELOPMENT, V127, P1197; Shoeman RL, 2002, EXP CELL RES, V279, P344, DOI 10.1006/excr.2002.5618; Waterston R., 1988, NEMATODE C ELEGANS, P281; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Yates DM, 2009, EUR J CELL BIOL, V88, P193, DOI 10.1016/j.ejcb.2008.11.004; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765	43	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119282	10.1371/journal.pone.0119282	http://dx.doi.org/10.1371/journal.pone.0119282			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742641	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100100
J	Bashar, K; Zafar, A; Elsheikh, S; Healy, DA; Clarke-Moloney, M; Casserly, L; Burke, PE; Kavanagh, EG; Walsh, SR				Bashar, Khalid; Zafar, Adeel; Elsheikh, Sawsan; Healy, Donagh A.; Clarke-Moloney, Mary; Casserly, Liam; Burke, Paul E.; Kavanagh, Eamon G.; Walsh, Stewart R.			Predictive Parameters of Arteriovenous Fistula Functional Maturation in a Population of Patients with End-Stage Renal Disease	PLOS ONE			English	Article							VASCULAR ACCESS; SURVIVAL; OUTCOMES; STENOSIS	Introduction With increasing numbers of patients diagnosed with ESRD, arteriovenous fistula (AVF) maturation has become a major factor in improving both dialysis related outcomes and quality of life of those patients. Compared to other types of access it has been established that a functional AVF access is the least likely to be associated with thrombosis, infection, hospital admissions, secondary interventions to maintain patency and death. Aim Study of demographic factors implicated in the functional maturation of arteriovenous fistulas. Also, to explore any possible association between preoperative haematological investigations and functional maturation. Methods We performed a retrospective chart review of all patients with ESRD who were referred to the vascular service in the University Hospital of Limerick for creation of vascular access for HD. We included patients with primary AVFs; and excluded those who underwent secondary procedures. Results Overall AVF functional maturation rate in our study was 53.7%(52/97). Female gender showed significant association with nonmaturation (P = 0.004) and was the only predictor for non-maturation in a logistic regression model (P = 0.011). Patients who had history of renal transplant (P = 0.036), had relatively lower haemoglobin levels (P = 0.01) and were on calcium channel blockers (P = 0.001) showed better functional maturation rates. Conclusion Female gender was found to be associated with functional non-maturation, while a history kidney transplant, calcium channel-blocker agents and low haemoglobin levels were all associated with successful functional maturation. In view of the conflicting evidence in the literature, large prospective multi-centre registry-based studies with well-defined outcomes are needed.	[Bashar, Khalid; Zafar, Adeel; Healy, Donagh A.; Clarke-Moloney, Mary; Burke, Paul E.; Kavanagh, Eamon G.] Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland; [Elsheikh, Sawsan] James Connolly Mem Hosp, Dept Acute Med, Dublin, Ireland; [Casserly, Liam] Univ Hosp Limerick, Dept Nephrol, Limerick, Ireland; [Walsh, Stewart R.] Natl Univ Ireland, Dept Surg, Galway, Ireland	University of Limerick; University of Limerick; Ollscoil na Gaillimhe-University of Galway	Bashar, K (corresponding author), Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland.	khalid@live.ie	Walsh, Stewart R/AAC-1229-2021	Walsh, Stewart/0000-0002-1006-9541				Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Allon M, 2001, KIDNEY INT, V60, P2013, DOI 10.1046/j.1523-1755.2001.00031.x; Allon M, 2007, CLIN J AM SOC NEPHRO, V2, P786, DOI 10.2215/CJN.00860207; Allon M, 2011, AM J KIDNEY DIS, V58, P437, DOI 10.1053/j.ajkd.2011.04.018; Amorim Pedro, 2013, Rev Port Cir Cardiotorac Vasc, V20, P211; Bashar K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104931; Bhalodia R, 2011, SEMIN DIALYSIS, V24, P355, DOI 10.1111/j.1525-139X.2010.00760.x; Centre Ecotox Centre Suisse d'ecotoxicologie appliquee (Eawag/EPFL), 2012, SURV QUAL SED SUISS, P34; Chand DH, 2009, PEDIATR NEPHROL, V24, P1121, DOI 10.1007/s00467-008-0812-3; Conte MS, 2011, J VASC SURG, V54, P1383, DOI 10.1016/j.jvs.2011.05.005; Corp I, 2013, IBM SPSS STAT WIND V; COX JL, 1991, PROG CARDIOVASC DIS, V34, P45, DOI 10.1016/0033-0620(91)90019-I; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; Dixon BS, 2002, AM J KIDNEY DIS, V39, P92, DOI 10.1053/ajkd.2002.29886; Feldman HI, 2003, AM J KIDNEY DIS, V42, P1000, DOI 10.1016/j.ajkd.2003.07.003; Frankel A, 2006, EUR J VASC ENDOVASC, V31, P417, DOI 10.1016/j.ejvs.2005.10.003; Jemcov TK, 2013, J VASC ACCESS, V14, P356, DOI 10.5301/jva.5000163; KDOQI NKF-, 2006, UPD CLIN PRACT GUID; Lee T, 2011, CLIN J AM SOC NEPHRO, V6, P575, DOI 10.2215/CJN.06630810; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lok CE, 2005, KIDNEY INT, V67, P2462, DOI 10.1111/j.1523-1755.2005.00355.x; MILLER VM, 1992, AM J PHYSIOL, V263, pH103, DOI 10.1152/ajpheart.1992.263.1.H103; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Ocak G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-79; Oliver MJ, 2001, KIDNEY INT, V60, P1532, DOI 10.1046/j.1523-1755.2001.00956.x; Peterson WJ, 2008, CLIN J AM SOC NEPHRO, V3, P437, DOI 10.2215/CJN.03480807; Pisoni RL, 2002, KIDNEY INT, V61, P305, DOI 10.1046/j.1523-1755.2002.00117.x; Polkinghorne KR, 2004, J AM SOC NEPHROL, V15, P477, DOI 10.1097/01.ASN.0000109668.05157.05; Rayner HC, 2004, AM J KIDNEY DIS, V44, pS22, DOI 10.1053/j.ajkd.2004.08.007; Rayner HC, 2003, KIDNEY INT, V63, P323, DOI 10.1046/j.1523-1755.2003.00724.x; Renaud CJ, 2012, J VASC SURG, V56, P433, DOI 10.1016/j.jvs.2012.01.063; Rodriguez JA, 2000, NEPHROL DIAL TRANSPL, V15, P402, DOI 10.1093/ndt/15.3.402; Salmela B, 2013, CLIN J AM SOC NEPHRO, V8, P962, DOI 10.2215/CJN.03860412; Santoro A, 2006, J NEPHROL, V19, P259; Sedlacek M, 2001, AM J KIDNEY DIS, V38, P560, DOI 10.1053/ajkd.2001.26873; Stoumpos S, 2014, AM J NEPHROL, V39, P491, DOI 10.1159/000362744; Yilmaz H, 2014, RENAL FAILURE, V36, P1390, DOI 10.3109/0886022X.2014.945183; Zadeh MK, 2008, J VASC ACCESS, V9, P133, DOI 10.1177/112972980800900210; Zadeh MK, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/942950	39	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119958	10.1371/journal.pone.0119958	http://dx.doi.org/10.1371/journal.pone.0119958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768440	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500104
J	Wang, SH; Bao, YL; Meng, QM; Xia, YJ; Zhao, YC; Wang, Y; Tang, F; ZhuGe, XK; Yu, SQ; Han, XG; Dai, JJ; Lu, CP				Wang, Shaohui; Bao, Yinli; Meng, Qingmei; Xia, Yongjie; Zhao, Yichao; Wang, Yang; Tang, Fang; ZhuGe, Xiangkai; Yu, Shengqing; Han, Xiangan; Dai, Jianjun; Lu, Chengping			IbeR Facilitates Stress-Resistance, Invasion and Pathogenicity of Avian Pathogenic Escherichia coli	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; BLOOD-BRAIN-BARRIER; BACTERIOPHAGE-T7 RNA-POLYMERASE; NEONATAL MENINGITIS; VIRULENCE FACTOR; AUTOTRANSPORTER ADHESIN; TYPE-1 FIMBRIAE; URINARY-TRACT; IN-VIVO; EXPRESSION	Systemic infections by avian pathogenic Escherichia coli (APEC) are economically devastating to poultry industries worldwide. IbeR, located on genomic island GimA, was shown to serve as an RpoS-like regulator in rpoS gene mutation neonatal meningitis E. coli(NMEC) RS218. However, the role of IbeR in pathogenicity of APEC carrying active RpoS has not yet been investigated. We showed that the APEC IbeR could elicit antibodies in infected ducks, suggesting that IbeR might be involved in APEC pathogenicity. To investigate the function of IbeR in APEC pathogenesis, mutant and complementation strains were constructed and characterized. Inactivation of ibeR led to attenuated virulence and reduced invasion capacity towards DF-1 cells, brains and cerebrospinal fluid (CSF) in vitro and in vivo. Bactericidal assays demonstrated that the mutant strain had impaired resistance to environmental stress and specific pathogen-free (SPF) chicken serum. These virulence-related phenotypes were restored by genetic complementation. Quantitative real-time reverse transcription PCR revealed that IbeR controlled expression of stress-resistance genes and virulence genes, which might led to the associated virulence phenotype.	[Wang, Shaohui; Zhao, Yichao; Wang, Yang; Yu, Shengqing; Han, Xiangan] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China; [Wang, Shaohui; Bao, Yinli; Meng, Qingmei; Xia, Yongjie; Wang, Yang; Tang, Fang; ZhuGe, Xiangkai; Dai, Jianjun; Lu, Chengping] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing 210095, Jiangsu, Peoples R China; [Xia, Yongjie] Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Fudan University	Dai, JJ (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing 210095, Jiangsu, Peoples R China.	daijianjun@njau.edu.cn; lucp@njau.edu.cn	Dai, Jianjun/ABB-7353-2021	Han, Xiangan/0000-0001-5625-637X	National Natural Science Foundation of China [81201266, 31370045]; Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Basic Fund for Institutes - Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences [2013JB05]; Fundamental Research Funds for Central Universities - Nanjing Agricultural University [KYZ201326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Basic Fund for Institutes - Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Fundamental Research Funds for Central Universities - Nanjing Agricultural University	This work was supported by supported by the funds of the National Natural Science Foundation of China (81201266, 31370045), The Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), The National Basic Fund for Institutes, which is supported by Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences (2013JB05) and The Fundamental Research Funds for Central Universities which is supported by Nanjing Agricultural University (KYZ201326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x; Chi F, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/520283; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Dai JJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-236; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; Dho-Moulin M, 1999, VET RES, V30, P299; Ewers C, 2003, BERL MUNCH TIERARZTL, V116, P381; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Flechard M, 2012, J BACTERIOL, V194, P4550, DOI 10.1128/JB.00089-12; Gao QQ, 2013, J BACTERIOL, V195, P2474, DOI 10.1128/JB.02074-12; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Gunther NW, 2002, INFECT IMMUN, V70, P3344, DOI 10.1128/IAI.70.7.3344-3354.2002; Han XA, 2013, MICROB PATHOGENESIS, V55, P21, DOI 10.1016/j.micpath.2012.09.008; Hoffman JA, 1999, INFECT IMMUN, V67, P3566, DOI 10.1128/IAI.67.7.3566-3570.1999; Houdouin V, 2002, INFECT IMMUN, V70, P5865, DOI 10.1128/IAI.70.10.5865-5869.2002; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039; Johnson JR, 2002, J INFECT DIS, V186, P859, DOI 10.1086/342490; Kim K S, 2000, Subcell Biochem, V33, P47; Kim KS, 2001, INFECT IMMUN, V69, P5217, DOI 10.1128/IAI.69.9.5217-5222.2001; Kim KS, 2002, J INFECT DIS, V186, pS220, DOI 10.1086/344284; La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; MOBLEY HLT, 1993, MOL MICROBIOL, V10, P143, DOI 10.1111/j.1365-2958.1993.tb00911.x; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Pourbakhsh SA, 1997, MICROB PATHOGENESIS, V22, P331, DOI 10.1006/mpat.1996.0116; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; REED L. J., 1938, AMER JOUR HYG, V27, P493; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Wang SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00588; Wang SH, 2012, VET MICROBIOL, V159, P411, DOI 10.1016/j.vetmic.2012.04.015; Wang SH, 2011, FEMS IMMUNOL MED MIC, V63, P328, DOI 10.1111/j.1574-695X.2011.00862.x; Wang SH, 2011, INFECT IMMUN, V79, P279, DOI 10.1128/IAI.00821-10; Zhang K, 2009, MED MICROBIOL IMMUN, V198, P195, DOI 10.1007/s00430-009-0119-4; ZhuGe XK, 2013, INFECT IMMUN, V81, P2437, DOI 10.1128/IAI.00102-13	39	12	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119698	10.1371/journal.pone.0119698	http://dx.doi.org/10.1371/journal.pone.0119698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768126	gold, Green Published, Green Submitted			2022-12-27	WOS:000351277500094
J	Zhu, SL; Shala, A; Bezginov, A; Sljoka, A; Audette, G; Wilson, DJ				Zhu, Shaolong; Shala, Agnesa; Bezginov, Alexandr; Sljoka, Adnan; Audette, Gerald; Wilson, Derek J.			Hyperphosphorylation of Intrinsically Disordered Tau Protein Induces an Amyloidogenic Shift in Its Conformational Ensemble	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; GLYCOGEN-SYNTHASE KINASE-3-BETA; PHOSPHORYLATION SITES; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; DYNAMICS; KINASE; DOMAIN; AGGREGATION; REGIONS	Tau is an intrinsically disordered protein (IDP) whose primary physiological role is to stabilize microtubules in neuronal axons at all stages of development. In Alzheimer's and other tauopathies, tau forms intracellular insoluble amyloid aggregates known as neurofibrillary tangles, a process that appears in many cases to be preceded by hyperphosphorylation of tau monomers. Understanding the shift in conformational bias induced by hyperphosphorylation is key to elucidating the structural factors that drive tau pathology, however, as an IDP, tau is not amenable to conventional structural characterization. In this work, we employ a straightforward technique based on Time-Resolved ElectroSpray Ionization Mass Spectrometry (TRESI-MS) and Hydrogen/Deuterium Exchange (HDX) to provide a detailed picture of residual structure in tau, and the shifts in conformational bias induced by hyperphosphorylation. By comparing the native and hyperphosphorylated ensembles, we are able to define specific conformational biases that can easily be rationalized as enhancing amyloidogenic propensity. Representative structures for the native and hyperphosphorylated tau ensembles were generated by refinement of a broad sample of conformations generated by low-computational complexity modeling, based on agreement with the TRESI-HDX profiles.	[Zhu, Shaolong; Shala, Agnesa; Audette, Gerald; Wilson, Derek J.] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Bezginov, Alexandr] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sljoka, Adnan] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Wilson, Derek J.] York Univ, Fac Sci, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada	York University - Canada; University of Toronto; Toronto Metropolitan University; York University - Canada	Wilson, DJ (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada.	dkwilson@yorku.ca	Audette, Gerald F./E-2609-2012	Audette, Gerald F./0000-0002-5695-9830; Sljoka, Adnan/0000-0002-2398-9523	Natural Sciences and Research Council of Canada [22522]; Alzheimer's Society of Canada [56798]	Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alzheimer's Society of Canada	Funding: This work was supported by the Natural Sciences and Research Council of Canada Disocvery Grant (22522) and Alzheimer's Society of Canada Biomedical Grant (56798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Barghorn Stefan, 2004, V299, P35; BRION JP, 1986, LANCET, V2, P1098, DOI 10.1016/S0140-6736(86)90495-2; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Farrell DW, 2010, PROTEINS, V78, P2908, DOI 10.1002/prot.22810; Ferguson PL, 2007, ANAL CHEM, V79, P153, DOI 10.1021/ac061261f; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Keppel TR, 2011, BIOCHEMISTRY-US, V50, P8722, DOI 10.1021/bi200875p; Konermann L, 2003, MASS SPECTROM REV, V22, P1, DOI 10.1002/mas.10044; Konermann L, 2014, ANAL CHEM, V86, P213, DOI 10.1021/ac4039306; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kragelj J, 2013, CHEMPHYSCHEM, V14, P3034, DOI 10.1002/cphc.201300387; Kunze G, 2012, BBA-BIOMEMBRANES, V1818, P2302, DOI 10.1016/j.bbamem.2012.03.019; Lee HG, 2005, TRENDS MOL MED, V11, P164, DOI 10.1016/j.molmed.2005.02.008; Liuni P, 2012, ANGEW CHEM INT EDIT, V51, P9666, DOI 10.1002/anie.201204903; Liuni P, 2010, RAPID COMMUN MASS SP, V24, P315, DOI 10.1002/rcm.4391; Mandelkow EM, 2012, COLD SPRING HARB PER, V2, P25; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Nath A, 2012, BIOPHYS J, V103, P1940, DOI 10.1016/j.bpj.2012.09.032; Nubling G, 2012, EXP NEUROL, V237, P470, DOI 10.1016/j.expneurol.2012.07.018; Ozenne V, 2012, J AM CHEM SOC, V134, P15138, DOI 10.1021/ja306905s; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; Resetca D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.595454; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Rob T, 2012, ANAL CHEM, V84, P3771, DOI 10.1021/ac300365u; Rob T, 2009, J AM SOC MASS SPECTR, V20, P124, DOI 10.1016/j.jasms.2008.09.005; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Sljoka A, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056013; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WANG QM, 1994, J BIOL CHEM, V269, P14566; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Zhang Y-Z, 2003, THESIS U PENNSYLVANI	50	59	59	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120416	10.1371/journal.pone.0120416	http://dx.doi.org/10.1371/journal.pone.0120416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767879	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500124
J	Aguado-Orea, J; Pine, JM				Aguado-Orea, Javier; Pine, Julian M.			Comparing Different Models of the Development of Verb Inflection in Early Child Spanish	PLOS ONE			English	Article							ACQUISITION; AGREEMENT	How children acquire knowledge of verb inflection is a long-standing question in language acquisition research. In the present study, we test the predictions of some current constructivist and generativist accounts of the development of verb inflection by focusing on data from two Spanish-speaking children between the ages of 2;0 and 2;6. The constructivist claim that children's early knowledge of verb inflection is only partially productive is tested by comparing the average number of different inflections per verb in matched samples of child and adult speech. The generativist claim that children's early use of verb inflection is essentially error-free is tested by investigating the rate at which the children made subject-verb agreement errors in different parts of the present tense paradigm. Our results show: 1) that, although even adults' use of verb inflection in Spanish tends to look somewhat lexically restricted, both children's use of verb inflection was significantly less flexible than that of their caregivers, and 2) that, although the rate at which the two children produced subject-verb agreement errors in their speech was very low, this overall error rate hid a consistent pattern of error in which error rates were substantially higher in low frequency than in high frequency contexts, and substantially higher for low frequency than for high frequency verbs. These results undermine the claim that children's use of verb inflection is fully productive from the earliest observable stages, and are consistent with the constructivist claim that knowledge of verb inflection develops only gradually.	[Aguado-Orea, Javier] Sheffield Hallam Univ, Dept Psychol Sociol & Polit, Sheffield S1 1WB, S Yorkshire, England; [Pine, Julian M.] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England	Sheffield Hallam University; University of Liverpool	Pine, JM (corresponding author), Sheffield Hallam Univ, Dept Psychol Sociol & Polit, Sheffield S1 1WB, S Yorkshire, England.	Julian.Pine@liverpool.ac.uk	Aguado-Orea, Javier/GZG-9326-2022; Aguado-Orea, Javier/D-1042-2012	Aguado-Orea, Javier/0000-0002-2311-5295	School of Psychology at the University of Nottingham; ESRC [ES/L008955/1] Funding Source: UKRI; Economic and Social Research Council [ES/L008955/1] Funding Source: researchfish	School of Psychology at the University of Nottingham; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by a Postgraduate Studentship from the School of Psychology at the University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Orea J.J., 2004, THESIS U NOTTINGHAM; Akhtar N, 1997, DEV PSYCHOL, V33, P952, DOI 10.1037/0012-1649.33.6.952; Alcoba Santiago, 1999, GRAMATICA DESCRIPTIV, P4915; Barton ME, 1994, INPUT INTERACTION LA, P107; BERKO J, 1958, WORD, V14, P150, DOI 10.1080/00437956.1958.11659661; Blom E, 2013, FIRST LANG, V33, P225, DOI 10.1177/0142723713487612; BLOOM L, 1980, LANGUAGE, V56, P386, DOI 10.2307/413762; Brown R., 1973, 1 LANGUAGE EARLY STA; CAZDEN CB, 1968, CHILD DEV, V39, P433; Cipriani P, 1991, LACQUISIZIONE MORFOS; Clahsen H., 1996, GENERATIVE PERSPECTI, P129, DOI DOI 10.1075/LALD.14.08CLA; de Villiers J G, 1973, J Psycholinguist Res, V2, P267, DOI 10.1007/BF01067106; Deen KU, 2005, PROC ANN BUCLD, P156; Gathercole V. C. M., 1999, INT J BILINGUAL, V3, P133, DOI DOI 10.1177/13670069990030020401; Gathercole VCM, 2002, LANG LEARN, V52, P679; Grinstead John, 2009, P 3 C GEN APPR LANG, V3, P36; Harris T., 1996, GENERATIVE PERSPECTI, P1, DOI DOI 10.1075/LALD.14; Hoekstra T, 1998, LINGUA, V106, P81, DOI 10.1016/S0024-3841(98)00030-8; HYAMS N, 1994, OTHER CHILDREN, OTHER LANGUAGES, P11; JACKSONMALDONADO D, 1993, J CHILD LANG, V20, P523, DOI 10.1017/S0305000900008461; LEGATE JA, 2007, LANGUAGE ACQUISITION, V0014; Lopez Ornat S., 1994, ADQUISICION LENGUA E; MACWHINNEY B, 1978, MONOGR SOC RES CHILD, V43, P1, DOI 10.2307/1166047; MacWhinney B., 2000, CHILDES PROJECT, V2; Maratsos M, 2000, J CHILD LANG, V27, P183, DOI 10.1017/S0305000999004067; OLGUIN R, 1993, COGNITIVE DEV, V8, P245, DOI 10.1016/S0885-2014(93)80001-A; PEREZPEREIRA M, 1989, J PSYCHOLINGUIST RES, V18, P289; Pine JM, 1998, LINGUISTICS, V36, P807, DOI 10.1515/ling.1998.36.4.807; Pine JM, 2013, COGNITION, V127, P345, DOI 10.1016/j.cognition.2013.02.006; Pinker Steven., 1984, LANGUAGE LEARNABILIT; PIZZUTO E, 1992, J CHILD LANG, V19, P491, DOI 10.1017/S0305000900011557; Radford A., 1995, ESSEX REPORTS LINGUI, V5, P23; Rasanen SHM, 2014, J CHILD LANG, V41, P756, DOI 10.1017/S0305000913000159; Rubino RB, 1998, J CHILD LANG, V25, P35, DOI 10.1017/S0305000997003310; Serra M., 2000, ADQUISICION LENGUAJE; Serra M., 1992, LANGUAGE ACQUISITION; Theakston AL, 2005, COGN LINGUIST, V16, P247, DOI 10.1515/cogl.2005.16.1.247; Tomasello M, 2000, TRENDS COGN SCI, V4, P156, DOI 10.1016/S1364-6613(00)01462-5; Wexler K, 1998, LINGUA, V106, P23, DOI 10.1016/S0024-3841(98)00029-1; Wilson S, 2003, J CHILD LANG, V30, P75, DOI 10.1017/S0305000902005512; Yang C, 2013, P NATL ACAD SCI USA, V110, P6324, DOI 10.1073/pnas.1216803110; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	42	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119613	10.1371/journal.pone.0119613	http://dx.doi.org/10.1371/journal.pone.0119613			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CD7MQ	25760035	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000351275000062
J	Li, JJ; Xia, YJ; Liu, T; Wang, JS; Dai, WQ; Wang, F; Zheng, YY; Chen, K; Li, SN; Abudumijiti, H; Zhou, Z; Wang, JR; Lu, WX; Zhu, R; Yang, J; Zhang, HW; Yin, Q; Wang, CF; Zhou, YQ; Lu, J; Zhou, YQ; Guo, CY				Li, Jingjing; Xia, Yujing; Liu, Tong; Wang, Junshan; Dai, Weiqi; Wang, Fan; Zheng, Yuanyuan; Chen, Kan; Li, Sainan; Abudumijiti, Huerxidan; Zhou, Zheng; Wang, Jianrong; Lu, Wenxia; Zhu, Rong; Yang, Jing; Zhang, Huawei; Yin, Qin; Wang, Chengfen; Zhou, Yuqing; Lu, Jie; Zhou, Yingqun; Guo, Chuanyong			Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; EXPERIMENTAL LIVER-INJURY; TNF-ALPHA; ENDOPLASMIC-RETICULUM; INTERFERON-GAMMA; IN-VITRO; INFLAMMATION; KINASE; MECHANISMS	Objective Astaxanthin, a potent antioxidant, exhibits a wide range of biological activities, including antioxidant, atherosclerosis and antitumor activities. However, its effect on concanavalin A (ConA)-induced autoimmune hepatitis remains unclear. The aim of this study was to investigate the protective effects of astaxanthin on ConA-induced hepatitis in mice, and to elucidate the mechanisms of regulation. Materials and Methods Autoimmune hepatitis was induced in in Balb/C mice using ConA (25 mg/kg), and astaxanthin was orally administered daily at two doses (20 mg/kg and 40 mg/kg) for 14 days before ConA injection. Levels of serum liver enzymes and the histopathology of inflammatory cytokines and other maker proteins were determined at three time points (2, 8 and 24 h). Primary hepatocytes were pretreated with astaxanthin (80 mu M) in vitro 24 h before stimulation with TNF-alpha (10 ng/ml). The apoptosis rate and related protein expression were determined 24 h after the administration of TNF-a. Results Astaxanthin attenuated serum liver enzymes and pathological damage by reducing the release of inflammatory factors. It performed anti-apoptotic effects via the descending phosphorylation of Bcl-2 through the down-regulation of the JNK/p-JNK pathway. Conclusion This research firstly expounded that astaxanthin reduced immune liver injury in ConA-induced autoimmune hepatitis. The mode of action appears to be downregulation of JNK/p-JNK-mediated apoptosis and autophagy.	[Li, Jingjing; Xia, Yujing; Liu, Tong; Wang, Junshan; Dai, Weiqi; Wang, Fan; Zheng, Yuanyuan; Chen, Kan; Li, Sainan; Abudumijiti, Huerxidan; Yang, Jing; Wang, Chengfen; Lu, Jie; Zhou, Yingqun; Guo, Chuanyong] Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Zhou, Zheng; Wang, Jianrong; Lu, Wenxia; Zhu, Rong] Nanjing Med Univ, Clin Med Coll 1, Dept Gastroenterol, Shanghai Peoples Hosp 10, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Huawei; Yin, Qin; Zhou, Yuqing] Soochow Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Suzhou 215006, Peoples R China	Tongji University; Nanjing Medical University; Soochow University - China	Zhou, YQ (corresponding author), Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China.	yqzh02@163.com; yqzh02@163.com; guochuanyong@hotmail.com	Zhou, Yu/HHN-3071-2022; Lu, Wenxia/GPK-3897-2022	Lu, Wenxia/0000-0003-2848-7570; Guo, Chuanyong/0000-0002-6527-4673; Li, Sainan/0000-0002-1880-6294	National Natural Science Foundation of China [81270515]; China Foundation for Hepatitis Prevention and Control WBN liver Disease Research Fund [20100021, 20120005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Foundation for Hepatitis Prevention and Control WBN liver Disease Research Fund	This study was supported by the National Natural Science Foundation of China (grant No. 81270515), China Foundation for Hepatitis Prevention and Control WBN liver Disease Research Fund (grant No. 20100021 and 20120005). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Bhuvaneswari S, 2014, CELL STRESS CHAPERON, V19, P183, DOI 10.1007/s12192-013-0443-x; Bozza M, 1999, HEPATOLOGY, V30, P1441, DOI 10.1002/hep.510300616; Chen NY, 2001, CANCER RES, V61, P3908; Cheng P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/935251; Chew BP, 1999, ANTICANCER RES, V19, P1849; Cho H, 2014, J NAT PRODUCTS; Choi YS, 2014, GUT; Cui JZ, 2012, BIOCHEM BIOPH RES CO, V422, P268, DOI 10.1016/j.bbrc.2012.04.145; Czaja AJ, 2012, DIGEST DIS SCI, V57, P2248, DOI 10.1007/s10620-012-2179-3; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dyson JK, 2014, J HEPATOL; Fassett RG, 2009, FUTUR CARDIOL, V5, P333, DOI 10.2217/FCA.09.19; Fassett RG, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-17; Goda S, 2014, INT ENDOD J; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Gutowska I, 2013, TOXICOL IND HLTH; Hama S, 2012, J PHARM SCI-US, V101, P2909, DOI 10.1002/jps.23216; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kou W, 2014, SAUDI MED J, V35, P945; Ksontini R, 1998, J IMMUNOL, V160, P4082; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lee SJ, 2003, MOL CELLS, V16, P97; Liberal R, 2011, BEST PRACT RES CL GA, V25, P653, DOI 10.1016/j.bpg.2011.09.009; Liu XB, 2007, BIOCHEM BIOPH RES CO, V357, P187, DOI 10.1016/j.bbrc.2007.03.120; Lu Y, 2014, PAIN; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Nakao R, 2010, ANTICANCER RES, V30, P2721; Nakao R, 2010, ANTICANCER RES, V30, P2171; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Rao AR, 2013, J AGR FOOD CHEM, V61, P3842, DOI 10.1021/jf304609j; Renton JP, 2010, J NEUROSCI RES, V88, P2239, DOI 10.1002/jnr.22381; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Shen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087977; Shen M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/954502; Shen M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/461536; Speranza L, 2012, MAR DRUGS, V10, P890, DOI 10.3390/md10040890; Strassburg CP, 2011, BEST PRACT RES CL GA, V25, P673, DOI 10.1016/j.bpg.2011.08.003; Streetz K, 2001, J IMMUNOL, V167, P514, DOI 10.4049/jimmunol.167.1.514; Suzuki Y, 2006, EXP EYE RES, V82, P275, DOI 10.1016/j.exer.2005.06.023; Tao YY, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-449; Tiegs G, 2007, Z GASTROENTEROL, V45, P63, DOI 10.1055/s-2006-927397; TIEGS G, 1989, BIOCHEM PHARMACOL, V38, P627, DOI 10.1016/0006-2952(89)90208-6; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tu CT, 2011, MOL CELL BIOCHEM, V358, P53, DOI [10.1007/s11010-011-0920-4, 10.1007/s11010-011-0978-z]; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Volk A, 2014, J EXP MED, V211, P1093, DOI 10.1084/jem.20130990; Wang CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108855; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Wolf D, 2001, J IMMUNOL, V166, P1300, DOI 10.4049/jimmunol.166.2.1300; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhang NN, 2012, INFLAMM RES, V61, P17, DOI 10.1007/s00011-011-0383-9	58	61	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120440	10.1371/journal.pone.0120440	http://dx.doi.org/10.1371/journal.pone.0120440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761053	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000070
J	Sircova, A; Karimi, F; Osin, EN; Lee, S; Holme, P; Strombom, D				Sircova, Anna; Karimi, Fariba; Osin, Evgeny N.; Lee, Sungmin; Holme, Petter; Strombom, Daniel			Simulating Irrational Human Behavior to Prevent Resource Depletion	PLOS ONE			English	Article							PRO-ENVIRONMENTAL BEHAVIOR; SOCIAL DILEMMAS; TIME PERSPECTIVE; COOPERATION; ATTITUDES	In a situation with a limited common resource, cooperation between individuals sharing the resource is essential. However, people often act upon self-interest in irrational ways that threaten the long-term survival of the whole group. A lack of sustainable or environmentally responsible behavior is often observed. In this study, we examine how the maximization of benefits principle works in a wider social interactive context of personality preferences in order to gain a more realistic insight into the evolution of cooperation. We used time perspective (TP), a concept reflecting individual differences in orientation towards past, present, or future, and relevant for making sustainable choices. We developed a personality-driven agent-based model that explores the role of personality in the outcomes of social dilemmas and includes multiple facets of diversity: (1) The agents have different behavior strategies: individual differences derived by applying cluster analysis to survey data from 22 countries (N = 10,940) and resulting in 7 cross-cultural profiles of TP; (2) The non-uniform distribution of the types of agents across countries; (3) The diverse interactions between the agents; and (4) diverse responses to those interactions in a well-mixed population. As one of the results, we introduced an index of overall cooperation for each of the 22 countries, which was validated against cultural, economic, and sustainability indicators (HDI, dimensions of national culture, and Environment Performance Index). It was associated with higher human development, higher individualism, lower power distance, and better environmental performance. The findings illustrate how individual differences in TP can be simulated to predict the ways people in different countries solve the personal vs. common gain dilemma in the global limited-resource situation. This interdisciplinary approach to social simulation can be adopted to explain the possible causes of global environmental issues and to predict their possible outcomes.	[Sircova, Anna] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Karimi, Fariba; Lee, Sungmin; Holme, Petter] Umea Univ, Dept Phys, Umea, Sweden; [Osin, Evgeny N.] Natl Res Univ, Higher Sch Econ, Int Lab Posit Psychol Personal & Motivat, Moscow, Russia; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea; [Strombom, Daniel] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden; [Strombom, Daniel] Lafayette Coll, Dept Biol, Easton, PA 18042 USA	Umea University; Umea University; HSE University (National Research University Higher School of Economics); Sungkyunkwan University (SKKU); Uppsala University; Lafayette College	Sircova, A (corresponding author), Umea Univ, Dept Psychol, S-90187 Umea, Sweden.	anna.sircova@gmail.com; fariba.karimi@physics.umu.se; holme@skku.edu	Holme, Petter/A-7646-2008; Lee, Sungmin/F-2317-2010; Osin, Evgeny N./G-6558-2012	Holme, Petter/0000-0003-2156-1096; Lee, Sungmin/0000-0001-7902-3229; Osin, Evgeny N./0000-0003-3330-5647; Strombom, Daniel/0000-0002-9564-2529; Karimi, Fariba/0000-0002-0037-2475	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2011947]; Swedish Research Council; Basic Research Program of the National Research University Higher School of Economics	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Swedish Research Council(Swedish Research CouncilEuropean Commission); Basic Research Program of the National Research University Higher School of Economics	PH was partly supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2011947), the Swedish Research Council (FK and PH), and the Basic Research Program of the National Research University Higher School of Economics (ENO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Richard, 2012, BBC NEWS; [Anonymous], 2009, CLUSTER ANAL; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Bergman LR, 1997, DEV PSYCHOPATHOL, V9, P291, DOI 10.1017/S095457949700206X; Boniwell I, 2010, J POSIT PSYCHOL, V5, P24, DOI 10.1080/17439760903271181; Boyd JN, 2005, TIME PERSPECTIVE HLT, P85; Campbell DFJ, 2012, DEMOCRACY RANKING ED; Chen CC, 1998, ACAD MANAGE REV, V23, P285, DOI 10.2307/259375; Durkin J., 1994, EXPERT SYSTEMS DESIG; Durlauf S., 2008, NEW PALGRAVE DICT EC, Vsecond; Franzen A, 2010, EUR SOCIOL REV, V26, P219, DOI 10.1093/esr/jcp018; Ghasem-Aghaee N, 2007, COMPUT HUM BEHAV, V23, P2983, DOI 10.1016/j.chb.2006.08.012; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hofstede G., 2010, CULTURES ORG SOFTWAR; Hsu A., 2014, 2014 ENV PERFORMANCE; Joireman J., 2006, JUDGMENTS TIME INTER, P82, DOI DOI 10.1093/ACPR0F:0S0/9780195177664.003.0006; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Lewin K, 1938, SOCIOMETRY, V1, P292, DOI 10.2307/2785585; Lewin Kurt, 1951, FIELD THEORY SOCIAL, P238; Magnusson D, 2003, NEW DIR CHILD ADOLES, V101, P3, DOI 10.1002/cd.79; MESSICK DM, 1995, PSYCHOL REV, V102, P131, DOI 10.1037/0033-295X.102.1.131; Milfont T. L., 2012, OXFORD HDB ENV CONSE, P181; Milfont TL, 2012, INT J PSYCHOL, V47, P325, DOI 10.1080/00207594.2011.647029; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oishi S, 2010, PERSPECT PSYCHOL SCI, V5, P356, DOI 10.1177/1745691610374588; Ostrom E., 2015, GOVERNING COMMONS, DOI DOI 10.1017/CBO9781316423936; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Schultz PW, 1999, J ENVIRON PSYCHOL, V19, P255; Sen A., 1994, HUMAN DEV INDEX METH; Sircova A, 2014, SAGE OPEN, V4, DOI 10.1177/2158244013515686; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Turaga RMR, 2010, ANN NY ACAD SCI, V1185, P211, DOI 10.1111/j.1749-6632.2009.05163.x; Van de Vijver F. J. R., 2011, CROSS CULTURAL RES M, P17, DOI DOI 10.1017/CBO9780511779381.003; Van Lange PAM, 2013, ORGAN BEHAV HUM DEC, V120, P125, DOI 10.1016/j.obhdp.2012.11.003; Van Lange PAM, 2008, SOC ISS POLICY REV, V2, P127, DOI 10.1111/j.1751-2409.2008.00013.x; Weber JM, 2004, PERS SOC PSYCHOL REV, V8, P281, DOI 10.1207/s15327957pspr0803_4; Wiberg M, 2012, INT J ED PSYCHOL ASS, V12, P95; World Commission on Environment and Development (WCED), 1987, A42427 UN; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035; Zimbardo PG, 2012, TIME PARADOX USING N	44	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0117612	10.1371/journal.pone.0117612	http://dx.doi.org/10.1371/journal.pone.0117612			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760635	Green Submitted, Green Published, gold			2022-12-27	WOS:000351275000011
J	Goto, M; Goto, A; Ikeda, N; Noda, H; Shibuya, K; Noda, M				Goto, Maki; Goto, Atsushi; Ikeda, Nayu; Noda, Hiroyuki; Shibuya, Kenji; Noda, Mitsuhiko			Factors Associated with Untreated Diabetes: Analysis of Data from 20,496 Participants in the Japanese National Health and Nutrition Survey	PLOS ONE			English	Article							ENDOGENOUS SEX-HORMONES; SCREENING SCORE; MELLITUS; RISK; POPULATION; COMPLICATIONS; HEMOGLOBIN; DIAGNOSIS; COSTS; A1C	Objective We aimed to examine factors associated with untreated diabetes in a nationally representative sample of the Japanese population. Research Design and Methods We pooled data from the Japanese National Health and Nutrition Survey from 2005 to 2009 (n = 20,496). Individuals aged 20 years and older were included in the analysis. We classified participants as having diabetes if they had HbA1c levels >= 6.5% (>= 48 mmol/mol). People with diabetes who self-reported that they were not currently receiving diabetic treatment were considered to be untreated. We conducted a multinomial logistic regression analysis to determine factors associated with untreated diabetes relative to non-diabetic individuals. Results Of 20,496 participants who were included in the analysis, untreated diabetes was present in 748 (3.6%). Among participants with untreated diabetes, 48.3% were previously diagnosed with diabetes, and 46.5% had HbA1c levels >= 7.0% (>= 53 mmol/mol). Participants with untreated diabetes were significantly more likely than non-diabetic participants to be male, older, and currently smoking, have lower HDL cholesterol levels and higher BMI, non-HDL cholesterol levels, and systolic blood pressure. Conclusions A substantial proportion of people in Japan with untreated diabetes have poor glycemic control. Targeting relevant factors for untreated diabetes in screening programs may be effective to enhance the treatment and control of diabetes.	[Goto, Maki; Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan; [Ikeda, Nayu] Natl Inst Hlth & Nutr, Ctr Int Collaborat & Partnership, Tokyo 162, Japan; [Noda, Hiroyuki] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Publ Hlth, Osaka, Japan; [Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Institute of Health & Nutrition - Japan; Osaka University; University of Tokyo	Noda, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan.	mnoda@hosp.ncgm.go.jp	Noda, Hiroyuki/ABC-1692-2021; Noda, Mitsuhiko/W-3905-2019; Ikeda, Nayu/J-9890-2019	Noda, Hiroyuki/0000-0001-9086-3771; Noda, Mitsuhiko/0000-0003-0413-4631; Ikeda, Nayu/0000-0002-3424-1991; Shibuya, Kenji/0000-0003-2528-7530	Japan Society for the Promotion of Science [24590785]; Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus) from the Ministry of Health, Labour and Welfare of Japan [H22-019, H25-016]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus) from the Ministry of Health, Labour and Welfare of Japan	This study was funded by the Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (No. 24590785), and Health Sciences Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus H22-019 and H25-016) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005; Choi KM, 2005, J CLIN ENDOCR METAB, V90, P175, DOI 10.1210/jc.2004-1795; Clarke P, 2003, DIABETIC MED, V20, P442, DOI 10.1046/j.1464-5491.2003.00972.x; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Heianza Y, 2013, J CLIN ENDOCR METAB, V98, P1051, DOI 10.1210/jc.2012-3092; Herman WH, 2013, DIABETES CARE, V36, P775, DOI 10.2337/dc13-0270; Huang ES, 2007, DIABETES CARE, V30, P2478, DOI 10.2337/dc07-0499; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Katanoda K, 2002, J NUTR SCI VITAMINOL, V48, P423, DOI 10.3177/jnsv.48.423; Katanoda K, 2005, NUTRITION, V21, P964, DOI 10.1016/j.nut.2005.02.004; Lauruschkat AH, 2005, CIRCULATION, V112, P2397, DOI 10.1161/CIRCULATIONAHA.105.534545; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Ministry of Health Labour and Welfare, 2011, NAT HLTH NUTR SURV 2; Ministry of Health Labour and Welfare, 2012, REF DAT HLTH JAP 21; Nakamura M, 2013, J EPIDEMIOL, V23, P28, DOI 10.2188/jea.JE20120032; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Tekumit H, 2010, ANN THORAC SURG, V89, P1482, DOI 10.1016/j.athoracsur.2009.11.033; Tokudome S, 2012, LANCET, V379, pE44, DOI 10.1016/S0140-6736(12)60466-8; Vaidya D, 2008, METABOLISM, V57, P782, DOI 10.1016/j.metabol.2008.01.019; Yoshiike N, 1998, J Epidemiol, V8, P160	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118749	10.1371/journal.pone.0118749	http://dx.doi.org/10.1371/journal.pone.0118749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756183	Green Published, Green Submitted, gold			2022-12-27	WOS:000351275700023
J	Ho, LT; Yin, WH; Chuang, SY; Tseng, WK; Wu, YW; Hsieh, IC; Lin, TH; Li, YH; Huang, LC; Wang, KY; Ueng, KC; Fang, CC; Pan, WH; Yeh, HI; Wu, CC; Chen, JW				Ho, Li-Ting; Yin, Wei-Hsian; Chuang, Shao-Yuan; Tseng, Wei-Kung; Wu, Yen-Wen; Hsieh, I-Chang; Lin, Tsung-Hsien; Li, Yi-Heng; Huang, Lien-Chi; Wang, Kuo-Yang; Ueng, Kwo-Chang; Fang, Ching-Chang; Pan, Wen-Harn; Yeh, Hung-I; Wu, Chau-Chung; Chen, Jaw-Wen		Taiwanese Secondary Prevention Pat	Determinants for Achieving the LDL-C Target of Lipid Control for Secondary Prevention of Cardiovascular Events in Taiwan	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HIGH BLOOD CHOLESTEROL; NCEP EXPERT PANEL; LOWERING-THERAPY; HEART-DISEASE; MYOCARDIAL-INFARCTION; EUROPEAN COUNTRIES; GENDER-DIFFERENCES; SERUM-CHOLESTEROL; VASCULAR-DISEASE	Background Epidemiological and clinical studies have clearly established the link between low-density lipoprotein cholesterol (LDL-C) and atherosclerosis-related cardiovascular consequences. Although it has been a common practice for physicians to prescribe lipid-lowering therapy for patients with dyslipidemia, the achievement rate is still not satisfied in Taiwan. Therefore, the determinants for achieving the LDL-C target needed to be clarified for better healthcare of the patients with dyslipidemia. Method This registry-type prospective observational study enrolled the patients with cardiovascular diseases (coronary artery disease (CAD) and cerebrovascular disease (CVD)) from 18 medical centers across Taiwan, and clinically followed them for five years. At every clinical visit, vital signs, clinical endpoints, adverse events, concurrent medications and laboratory specimens were obtained as thoroughly as possible. The lipid profile (total cholesterol, high-density lipoprotein cholesterol, LDL-C, triglyceride), liver enzymes, and creatinine phosphokinase were evaluated at baseline, and every year thereafter. The cross sectional observational data was analyzed for this report. Result Among the 3,486 registered patients, 54% had their LDL-C < 100 mg/dL. By univariate analysis, the patients achieving the LDL-C target were associated with older age, more male sex, taller height, lower blood pressure, more under lipid-lowering therapy, more smoking cessation, more history of CAD, DM, physical activity, but less history of CVD. The multivariate analysis showed statin therapy was the most significant independent determinant for achieving the treatment target, followed by age, history of CAD, diabetes, blood pressure, and sex. However, most patients were on regimens of very-low to low equipotent doses of statins. Conclusion Although the lipid treatment guideline adherence is improving in recent years, only 54% of the patients with cardiovascular diseases have achieved their LDL-C target in Taiwan, and the most significant determinant for this was statin therapy.	[Ho, Li-Ting; Wu, Chau-Chung] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei 10764, Taiwan; [Yin, Wei-Hsian] Natl Yang Ming Univ, Cheng Hsin Gen Hosp, Ctr Heart, Div Cardiol, Taipei 112, Taiwan; [Yin, Wei-Hsian] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chuang, Shao-Yuan; Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Tseng, Wei-Kung] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Tseng, Wei-Kung] E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Div Cardiol, New Taipei City, Taiwan; [Wu, Yen-Wen] Far Eastern Mem Hosp, Dept Nucl Med, New Taipei City, Taiwan; [Hsieh, I-Chang] Chang Gung Mem Hosp, Dept Cardiol 2, New Taipei City, Taiwan; [Lin, Tsung-Hsien] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Lin, Tsung-Hsien] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Li, Yi-Heng] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Li, Yi-Heng] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan; [Huang, Lien-Chi] Taipei Union Hosp, Dept Cardiol, Taipei, Taiwan; [Wang, Kuo-Yang] Chung Shan Med Univ, Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan; [Wang, Kuo-Yang] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Ueng, Kwo-Chang] Chung Shan Med Univ Hosp, Sch Med, Taichung 40201, Taiwan; [Ueng, Kwo-Chang] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung 40201, Taiwan; [Fang, Ching-Chang] Tainan Municipal Hosp, Dept Internal Med, Div Cardiol, Tainan, Taiwan; [Yeh, Hung-I] Mackay Med Coll, Mackay Mem Hosp, New Taipei City, Taiwan; [Wu, Chau-Chung] Natl Taiwan Univ, Coll Med, Dept Primary Care Med, Taipei 10764, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	National Taiwan University; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; I Shou University; E-Da Hospital; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Chung Shan Medical University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Mackay Medical College; Mackay Memorial Hospital; National Taiwan University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wu, CC (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei 10764, Taiwan.	chauchungwu@ntu.edu.tw	CHUANG, shao-yuan/ABB-4057-2020; Chuang, Shao-Yuan/B-3478-2011	CHUANG, shao-yuan/0000-0003-2138-4771; Lin, Tsung-Hsien/0000-0002-7226-8730; WU, YEN-WEN/0000-0003-1520-1166	Taiwan Society of Lipids & Atherosclerosis; Taiwan Ministry of Science and Technology [NRPB-TR11: 100-2325-B-002-075]	Taiwan Society of Lipids & Atherosclerosis; Taiwan Ministry of Science and Technology	The Taiwan Consortium of Lipid and Atherosclerosis is sponsored by Taiwan Society of Lipids & Atherosclerosis since 2009 and Taiwan Ministry of Science and Technology since 2012 (Project code: NRPB-TR11: 100-2325-B-002-075).	Anderson RD, 2007, CIRCULATION, V115, P823, DOI 10.1161/CIRCULATIONAHA.106.685859; Chandratheva A, 2010, STROKE, V41, P1108, DOI 10.1161/STROKEAHA.109.576611; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cooney M T, 2009, Ir Med J, V102, P113; Deedwania P, 2007, CIRCULATION, V115, P700, DOI 10.1161/CIRCULATIONAHA.106.654756; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Heeley E, 2012, INT J STROKE, V7, P649, DOI 10.1111/j.1747-4949.2011.00613.x; Jaussi A, 2010, EUR J CARDIOV PREV R, V17, P363, DOI 10.1097/HJR.0b013e328333c1d9; Jeng JS, 2015, J FORMOS MED ASSOC, V114, P1000, DOI 10.1016/j.jfma.2013.10.007; Jones PH, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001800; Kim HS, 2008, CURR MED RES OPIN, V24, P1951, DOI [10.1185/03007990802138731, 10.1185/03007990802138731 ]; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kuznik A, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-31; LAROSA JC, 1990, CIRCULATION, V81, P1721, DOI 10.1161/01.CIR.81.5.1721; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; MARTIN MJ, 1986, LANCET, V2, P933; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Pearson TA, 2000, ARCH INTERN MED, V160, P459, DOI 10.1001/archinte.160.4.459; Primatesta P, 2000, BMJ-BRIT MED J, V321, P1322, DOI 10.1136/bmj.321.7272.1322; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Reibis RK, 2009, J WOMENS HEALTH, V18, P1123, DOI 10.1089/jwh.2008.1082; Ruckert IM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-50; Saposnik G, 2009, STROKE, V40, P1417, DOI 10.1161/STROKEAHA.108.533018; Selim MH, 2012, STROKE, V43, P1996, DOI 10.1161/STROKEAHA.111.648832; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Singh M, 2013, AM J THER; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Yin WH, 2012, INT J GERONTOL, V6, P241, DOI 10.1016/j.ijge.2012.09.001; Zhao SP, 2014, ATHEROSCLEROSIS, V235, P463, DOI 10.1016/j.atherosclerosis.2014.05.916	37	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116513	10.1371/journal.pone.0116513	http://dx.doi.org/10.1371/journal.pone.0116513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756522	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275700007
J	Maani, R; Yang, YH; Kalra, S				Maani, Rouzbeh; Yang, Yee Hong; Kalra, Sanjay			Voxel-Based Texture Analysis of the Brain	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CORPUS-CALLOSUM; MRI; PATTERN; ATROPHY; FEATURES; MAPS	This paper presents a novel voxel-based method for texture analysis of brain images. Texture analysis is a powerful quantitative approach for analyzing voxel intensities and their interrelationships, but has been thus far limited to analyzing regions of interest. The proposed method provides a 3D statistical map comparing texture features on a voxel-by-voxel basis. The validity of the method was examined on artificially generated effects as well as on real MRI data in Alzheimer's Disease (AD). The artificially generated effects included hyperintense and hypointense signals added to T1-weighted brain MRIs from 30 healthy subjects. The AD dataset included 30 patients with AD and 30 age/sex matched healthy control subjects. The proposed method detected artificial effects with high accuracy and revealed statistically significant differences between the AD and control groups. This paper extends the usage of texture analysis beyond the current region of interest analysis to voxel-by-voxel 3D statistical mapping and provides a hypothesis-free analysis tool to study cerebral pathology in neurological diseases.	[Maani, Rouzbeh; Yang, Yee Hong; Kalra, Sanjay] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Kalra, Sanjay] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Kalra, Sanjay] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Kalra, S (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	sanjay.kalra@ualberta.ca		Kalra, Sanjay/0000-0003-4762-8746	Natural Sciences and Engineering Research Council of Canada; Killam Memorial Scholarship; Alberta Innovates Graduate Student Scholarship; ALS Society of Canada; ALS Association	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Killam Memorial Scholarship; Alberta Innovates Graduate Student Scholarship; ALS Society of Canada; ALS Association	This work was supported by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to YHY; Killam Memorial Scholarship (http://killamlaureates.ca/) to RM; Alberta Innovates Graduate Student Scholarship (www.albertatechfutures.ca) to RM; ALS Society of Canada (https://www.als.ca/) to SK; and ALS Association (www.alsa.org/) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bernasconi A, 2001, ANN NEUROL, V49, P770, DOI 10.1002/ana.1013; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Chaim TM, 2007, PSYCHIAT RES-NEUROIM, V154, P59, DOI 10.1016/j.pscychresns.2006.04.003; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; de Oliveira MS, 2011, AM J NEURORADIOL, V32, P60, DOI 10.3174/ajnr.A2232; Freeborough PA, 1998, IEEE T MED IMAGING, V17, P475, DOI 10.1109/42.712137; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Glodzik L, 2012, NEUROBIOL AGING, V33, P1215, DOI 10.1016/j.neurobiolaging.2011.02.012; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herlidou-Meme S, 2003, MAGN RESON IMAGING, V21, P989, DOI 10.1016/S0730-725X(03)00212-1; Irish M, 2014, HUM BRAIN MAPP, V35, P1422, DOI 10.1002/hbm.22263; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kurani AS, 2004, Proceedings of the Seventh IASTED International Conference on Computer Graphics and Imaging, P447; Maani R, 2014, IEEE T IMAGE PROCESS, V23, P4625, DOI 10.1109/TIP.2014.2351620; Maani R, 2013, PATTERN RECOGN, V46, P2103, DOI 10.1016/j.patcog.2013.01.014; Maani R, 2013, IEEE T IMAGE PROCESS, V22, P2409, DOI 10.1109/TIP.2013.2249081; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mayerhoefer ME, 2009, MED PHYS, V36, P1236, DOI 10.1118/1.3081408; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Sankar T, 2008, HUM BRAIN MAPP, V29, P931, DOI 10.1002/hbm.20437; Shiino A, 2006, NEUROIMAGE, V33, P17, DOI 10.1016/j.neuroimage.2006.06.010; Shin J, 2010, NEUROIMAGE, V52, P488, DOI 10.1016/j.neuroimage.2010.04.013; Thomann PA, 2006, DEMENT GERIATR COGN, V21, P215, DOI 10.1159/000090971; Tozer DJ, 2009, J MAGN RESON IMAGING, V30, P506, DOI 10.1002/jmri.21885; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Whitwell JL, 2007, BRAIN, V130, P708, DOI 10.1093/brain/awl388; Yu O, 2001, MAGN RESON IMAGING, V19, P1305, DOI 10.1016/S0730-725X(01)00464-7; Zhang J, 2008, MAGN RESON IMAGING, V26, P1160, DOI 10.1016/j.mri.2008.01.016; Zhang YY, 2009, NEUROIMAGE, V47, P107, DOI 10.1016/j.neuroimage.2009.03.075; Zook JM, 2005, MAGN RESON IMAGING, V23, P671, DOI 10.1016/j.mri.2005.04.002	36	35	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117759	10.1371/journal.pone.0117759	http://dx.doi.org/10.1371/journal.pone.0117759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756621	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275700018
J	Searle, LJ; Meric, G; Porcelli, I; Sheppard, SK; Lucchini, S				Searle, Laura J.; Meric, Guillaume; Porcelli, Ida; Sheppard, Samuel K.; Lucchini, Sacha			Variation in Siderophore Biosynthetic Gene Distribution and Production across Environmental and Faecal Populations of Escherichia coli	PLOS ONE			English	Article							PHYLOGENETIC DISTRIBUTION; PLANT COLONIZATION; VIRULENCE GENES; IRON UPTAKE; STRAINS; RHIZOSPHERE; AEROBACTIN; TRAITS; PREVALENCE; GROWTH	Iron is essential for Escherichia coli growth and survival in the host and the external environment, but its availability is generally low due to the poor solubility of its ferric form in aqueous environments and the presence of iron-withholding proteins in the host. Most E. coli can increase access to iron by excreting siderophores such as enterobactin, which have a very strong affinity for Fe3+. A smaller proportion of isolates can generate up to 3 additional siderophores linked with pathogenesis; aerobactin, salmochelin, and yersiniabactin. However, non-pathogenic E. coli are also able to synthesise these virulence-associated siderophores. This raises questions about their role in the ecology of E. coli, beyond virulence, and whether specific siderophores might be linked with persistence in the external environment. Under the assumption that selection favours phenotypes that confer a fitness advantage, we compared siderophore production and gene distribution in E. coli isolated either from agricultural plants or the faeces of healthy mammals. This population-level comparison has revealed that under iron limiting growth conditions plant-associated isolates produced lower amounts of siderophores than faecal isolates. Additionally, multiplex PCR showed that environmental isolates were less likely to contain loci associated with aerobactin and yersiniabactin synthesis. Although aerobactin was linked with strong siderophore excretion, a significant difference in production was still observed between plant and faecal isolates when the analysis was restricted to strains only able to synthesise enterobactin. This finding suggests that the regulatory response to iron limitation may be an important trait associated with adaptation to the non-host environment. Our findings are consistent with the hypothesis that the ability to produce multiple siderophores facilitates E. coli gut colonisation and plays an important role in E. coli commensalism.	[Searle, Laura J.; Meric, Guillaume; Porcelli, Ida; Lucchini, Sacha] Inst Food Res, Gut Hlth & Food Safety, Norwich NR4 7UA, Norfolk, England; [Meric, Guillaume; Sheppard, Samuel K.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Sheppard, Samuel K.] Univ Oxford, Dept Zool, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Swansea University; University of Oxford	Lucchini, S (corresponding author), Inst Food Res, Gut Hlth & Food Safety, Norwich NR4 7UA, Norfolk, England.	sacha.lucchini@ifr.ac.uk	Méric, Guillaume/R-3947-2017; Méric, Guillaume/AAD-2364-2019	Méric, Guillaume/0000-0001-6288-9958; Méric, Guillaume/0000-0001-6288-9958; Sheppard, Samuel/0000-0001-6901-3203	Biotechnology and Biological Sciences Research Council, DTG Studentship [BB/J004529/1, BB/I02464X/1]; Wellcome Trust [088786/C/09/Z]; Biotechnology and Biological Sciences Research Council [1105690, BB/I02464X/1] Funding Source: researchfish; Health and Care Research Wales [HF-14-13] Funding Source: researchfish; BBSRC [BB/I02464X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, DTG Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Health and Care Research Wales; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SL, IP, GM received funding from Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), grant number: BB/J004529/1. LJS received funding from Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), DTG Studentship. SKS received funding from Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), grant number: BB/I02464X/1; Wellcome Trust (http://www.wellcome.ac.uk), grant number 088786/C/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergholz PW, 2011, APPL ENVIRON MICROB, V77, P211, DOI 10.1128/AEM.01880-10; Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1; Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Chen SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005497; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Crowley DE, 2007, MICROBIAL SIDEROPHOR; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; DEVOS CR, 1986, PLANT PHYSIOL, V81, P842, DOI 10.1104/pp.81.3.842; Diallo S, 2011, FEMS MICROBIOL ECOL, V75, P351, DOI 10.1111/j.1574-6941.2010.01023.x; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Hao LY, 2012, APPL ENVIRON MICROB, V78, P4561, DOI 10.1128/AEM.07867-11; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hilali F, 2000, INFECT IMMUN, V68, P3983, DOI 10.1128/IAI.68.7.3983-3989.2000; Jackson SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-349; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Johnson JR, 2005, J CLIN MICROBIOL, V43, P6064, DOI 10.1128/JCM.43.12.6064-6072.2005; Johnson JR, 2001, ASM NEWS, V67, P288; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; JURKEVITCH E, 1992, APPL ENVIRON MICROB, V58, P119, DOI 10.1128/AEM.58.1.119-124.1992; Kudinha T, 2012, APPL ENVIRON MICROB, V78, P1198, DOI 10.1128/AEM.06921-11; Kummerli R, 2009, P ROY SOC B-BIOL SCI, V276, P3531, DOI 10.1098/rspb.2009.0861; Lee S, 2010, ANN CLIN LAB SCI, V40, P361; Lv HT, 2014, J PROTEOME RES, V13, P1397, DOI 10.1021/pr4009749; Mao BH, 2012, J CLIN MICROBIOL, V50, P449, DOI 10.1128/JCM.00640-11; Meric G, 2013, ENVIRON MICROBIOL, V15, P487, DOI 10.1111/j.1462-2920.2012.02852.x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; MILLER RD, 1986, EVOLUTION, V40, P1, DOI 10.1111/j.1558-5646.1986.tb05712.x; Nowrouzian F, 2003, PEDIATR RES, V54, P8, DOI 10.1203/01.PDR.0000069843.20655.EE; Nowrouzian F, 2001, EPIDEMIOL INFECT, V126, P11, DOI 10.1017/S0950268801005118; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Payne SM, 1984, METHOD ENZYMOL, V235, P329; Pi HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050020; REID RK, 1984, PEDOBIOLOGIA, V26, P263; RUSSO TA, 1995, J INFECT DIS, V172, P440, DOI 10.1093/infdis/172.2.440; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Tedin K, 1996, J BIOL CHEM, V271, P17675, DOI 10.1074/jbc.271.30.17675; Unno T, 2011, MICROBES ENVIRON, V26, P198, DOI 10.1264/jsme2.ME10194; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vokes SA, 1999, MOL MICROBIOL, V33, P63, DOI 10.1046/j.1365-2958.1999.01448.x; Vollmerhausen TL, 2011, J MED MICROBIOL, V60, P574, DOI 10.1099/jmm.0.027037-0; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; White AP, 2011, APPL ENVIRON MICROB, V77, P7620, DOI 10.1128/AEM.05909-11	47	38	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117906	10.1371/journal.pone.0117906	http://dx.doi.org/10.1371/journal.pone.0117906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756870	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700020
J	Kuczius, T; Zhang, WL; Merkel, V; Mellmann, A; Tarr, PI; Karch, H				Kuczius, Thorsten; Zhang, Wenlan; Merkel, Viktor; Mellmann, Alexander; Tarr, Phillip I.; Karch, Helge			Agitation Down-Regulates Immunoglobulin Binding Protein EibG Expression in Shiga Toxin-Producing Escherichia coli (STEC)	PLOS ONE			English	Article							TRIMERIC AUTOTRANSPORTER ADHESINS; CYTOLETHAL DISTENDING TOXIN; AEROMONAS-SALMONICIDA; BIOFILM FORMATION; TYPE-1 FIMBRIAE; FC-RECEPTORS; GROUP-A; IGG FC; HETEROGENEITY; STREPTOCOCCI	Shiga toxin (Stx)-producing Escherichia coli (STEC) carrying eibG synthesize Escherichia coli immunoglobulin binding protein (EibG). EibG nonspecifically binds to immunoglobulins and tends to aggregate in multimers but is poorly expressed in wild-type strains. To study synthesis of the proteins and their regulation in the pathogens, we identified natural growth conditions that increased EibG synthesis. EibG proteins as well as corresponding mRNA were highly expressed under static growth conditions while shearing stress created by agitation during growth repressed protein synthesis. Further regulation effects were driven by reduced oxygen tension, and pH up-regulated EibG expression, but to a lesser extent than growth conditions while decreased temperature down-regulated EibG. Bacteria with increased EibG expression during static growth conditions showed a distinct phenotype with chain formation and biofilm generation, which disappeared with motion. High and low EibG expression was reversible indicating a process with up- and down-regulation of the protein expression. Our findings indicate that shear stress represses EibG expression and might reduce bacterial attachments to cells and surfaces.	[Kuczius, Thorsten; Zhang, Wenlan; Merkel, Viktor; Mellmann, Alexander; Karch, Helge] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Kuczius, Thorsten; Zhang, Wenlan; Merkel, Viktor; Mellmann, Alexander; Karch, Helge] Univ Hosp Munster, D-48149 Munster, Germany; [Tarr, Phillip I.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63105 USA	University of Munster; University of Munster; Washington University (WUSTL)	Kuczius, T (corresponding author), Univ Munster, Inst Hyg, Robert Koch Str 41, D-48149 Munster, Germany.	tkuczius@uni-muenster.de		Mellmann, Alexander/0000-0002-0649-5185	Federal Ministry of Education and Research Network Zoonoses [01KI1012B]; Interdisciplinary Center of Clinical Research (IZKF) Munster [Me2/021/12, Muth2/028/10]; Medical Faculty Munster [BD9817044]	Federal Ministry of Education and Research Network Zoonoses; Interdisciplinary Center of Clinical Research (IZKF) Munster; Medical Faculty Munster	Funding provided by Federal Ministry of Education and Research Network Zoonoses (no. 01KI1012B); Interdisciplinary Center of Clinical Research (IZKF) Munster, no. Me2/021/12 and Muth2/028/10; Medical Faculty Munster (BD9817044). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardiau M, 2010, J APPL MICROBIOL, V109, P2214, DOI 10.1111/j.1365-2672.2010.04855.x; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Bielaszewska M, 2009, J CLIN MICROBIOL, V47, P2061, DOI 10.1128/JCM.00201-09; Blumer C, 2005, MICROBIOL-SGM, V151, P3287, DOI 10.1099/mic.0.28098-0; BOUVET JP, 1994, INT J IMMUNOPHARMACO, V16, P419, DOI 10.1016/0192-0561(94)90031-0; Brockmeyer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006100; Brunder W, 1996, MICROBIOL-SGM, V142, P3305, DOI 10.1099/13500872-142-11-3305; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Colon-Gonzalez M, 2004, RES MICROBIOL, V155, P514, DOI 10.1016/j.resmic.2004.03.004; FORSGREN A, 1966, J IMMUNOL, V97, P822; Ghumra A, 2007, MOL IMMUNOL, V44, P2144, DOI 10.1016/j.molimm.2006.09.019; GROVER S, 1991, J IMMUNOL METHODS, V141, P187, DOI 10.1016/0022-1759(91)90145-6; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; House B, 2009, MICROBIOL-SGM, V155, P2907, DOI 10.1099/mic.0.025171-0; KARCH H, 1989, J CLIN MICROBIOL, V27, P1180, DOI 10.1128/JCM.27.6.1180-1186.1989; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KRONVALL G, 1973, J IMMUNOL, V111, P1401; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Leo JC, 2011, STRUCTURE, V19, P1021, DOI 10.1016/j.str.2011.03.021; Leo JC, 2009, MOL IMMUNOL, V46, P1860, DOI 10.1016/j.molimm.2009.02.024; Lu Y, 2006, INFECT IMMUN, V74, P5747, DOI 10.1128/IAI.00724-06; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Merkel V, 2010, INFECT IMMUN, V78, P3625, DOI 10.1128/IAI.00006-10; Mikula KM, 2012, J BACTERIOL, V194, P827, DOI 10.1128/JB.05322-11; MUNN CB, 1982, INFECT IMMUN, V36, P1069, DOI 10.1128/IAI.36.3.1069-1075.1982; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; PHIPPS BM, 1988, J BIOL CHEM, V263, P9298; Pleass RJ, 2009, MOL IMMUNOL, V46, P2439, DOI 10.1016/j.molimm.2009.04.023; Raeder R, 1996, J INFECT DIS, V173, P888, DOI 10.1093/infdis/173.4.888; RAEDER R, 1993, INFECT IMMUN, V61, P1378, DOI 10.1128/IAI.61.4.1378-1384.1993; Sandt CH, 2000, INFECT IMMUN, V68, P2205, DOI 10.1128/IAI.68.4.2205-2214.2000; Sandt CH, 2001, INFECT IMMUN, V69, P7293, DOI 10.1128/IAI.69.12.7293-7203.2001; Schlieker C, 2002, J BIOTECHNOL, V96, P13, DOI 10.1016/S0168-1656(02)00033-0; SOKURENKO EV, 1992, INFECT IMMUN, V60, P4709, DOI 10.1128/IAI.60.11.4709-4719.1992; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; Zavyalov VP, 1996, FEMS IMMUNOL MED MIC, V14, P53, DOI 10.1111/j.1574-695X.1996.tb00267.x	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119583	10.1371/journal.pone.0119583	http://dx.doi.org/10.1371/journal.pone.0119583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746924	Green Submitted, gold, Green Published			2022-12-27	WOS:000350689400080
J	Purahong, W; Stempfhuber, B; Lentendu, G; Francioli, D; Reitz, T; Buscot, F; Schloter, M; Kruger, D				Purahong, Witoon; Stempfhuber, Barbara; Lentendu, Guillaume; Francioli, Davide; Reitz, Thomas; Buscot, Francois; Schloter, Michael; Krueger, Dirk			Influence of Commonly Used Primer Systems on Automated Ribosomal Intergenic Spacer Analysis of Bacterial Communities in Environmental Samples	PLOS ONE			English	Article							DIVERSITY; SETS	Due to the high diversity of bacteria in many ecosystems, their slow generation times, specific but mostly unknown nutrient requirements and syntrophic interactions, isolation based approaches in microbial ecology mostly fail to describe microbial community structure. Thus, cultivation independent techniques, which rely on directly extracted nucleic acids from the environment, are a well-used alternative. For example, bacterial automated ribosomal intergenic spacer analysis (B-ARISA) is one of the widely used methods for fingerprinting bacterial communities after PCR-based amplification of selected regions of the operon coding for rRNA genes using community DNA. However, B-ARISA alone does not provide any taxonomic information and the results may be severely biased in relation to the primer set selection. Furthermore, amplified DNA stemming from mitochondrial or chloroplast templates might strongly bias the obtained fingerprints. In this study, we determined the applicability of three different B-ARISA primer sets to the study of bacterial communities. The results from in silico analysis harnessing publicly available sequence databases showed that all three primer sets tested are specific to bacteria but only two primers sets assure high bacterial taxa coverage (1406f/23Sr and ITSF/ITSReub). Considering the study of bacteria in a plant interface, the primer set ITSF/ITSReub was found to amplify (in silico) sequences of some important crop species such as Sorghum bicolor and Zea mays. Bacterial genera and plant species potentially amplified by different primer sets are given. These data were confirmed when DNA extracted from soil and plant samples were analyzed. The presented information could be useful when interpreting existing B-ARISA results and planning B-ARISA experiments, especially when plant DNA can be expected.	[Purahong, Witoon; Lentendu, Guillaume; Francioli, Davide; Reitz, Thomas; Buscot, Francois; Krueger, Dirk] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Purahong, Witoon; Schloter, Michael] Tech Univ Munich, Chair Soil Sci, Oberschleissheim, Germany; [Stempfhuber, Barbara; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Oberschleissheim, Germany; [Lentendu, Guillaume; Buscot, Francois] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Buscot, Francois] German Ctr Integrat Biodivers Res IDiv, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leipzig University	Purahong, W (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany.	witoon.purahong@ufz.de; schloter@helmholtz-muenchen.de	Schloter, 1Michael/H-9151-2013; Francioli, Davide/AAR-1035-2020; Reitz, Thomas/AFP-6355-2022; Purahong, Witoon/AAX-8455-2021; Lentendu, Guillaume/ABF-4468-2020; Buscot, Francois/A-4125-2016; Kruger, Dirk/C-3316-2012	Francioli, Davide/0000-0001-6572-3574; Purahong, Witoon/0000-0002-4113-6428; Lentendu, Guillaume/0000-0003-3826-6253; Buscot, Francois/0000-0002-2364-0006; Kruger, Dirk/0000-0002-7305-5104	DFG Priority Program 'Infrastructure-Biodiversity-Exploratories' [KR 3587/1-1, KR 3587/3-2, SCHL 446/13-2, 1374]; Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	DFG Priority Program 'Infrastructure-Biodiversity-Exploratories'(German Research Foundation (DFG)); Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE)	This work was funded in part by the DFG Priority Program 1374 on 'Infrastructure-Biodiversity-Exploratories' (KR 3587/1-1, KR 3587/3-2, SCHL 446/13-2). W. Purahong also was kindly supported by the Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders DFG and HIGRADE had no input into the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Frossard A, 2012, ENVIRON MICROBIOL, V14, P2971, DOI 10.1111/j.1462-2920.2012.02865.x; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Jones SE, 2007, APPL ENVIRON MICROB, V73, P659, DOI 10.1128/AEM.02130-06; Merbach I, 2013, ARCH AGRON SOIL SCI, V59, P1041, DOI 10.1080/03650340.2012.702895; Petric I, 2011, J MICROBIOL METH, V84, P454, DOI 10.1016/j.mimet.2011.01.016; Ranjard L, 2000, APPL ENVIRON MICROB, V66, P5334, DOI 10.1128/AEM.66.12.5334-5339.2000; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9	13	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118967	10.1371/journal.pone.0118967	http://dx.doi.org/10.1371/journal.pone.0118967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749323	Green Published, gold			2022-12-27	WOS:000350689400034
J	Seiffert, J; Hussain, F; Wiegman, C; Li, F; Bey, L; Baker, W; Porter, A; Ryan, MP; Chang, Y; Gow, A; Zhang, JF; Zhu, J; Tetley, TD; Chung, KF				Seiffert, Joanna; Hussain, Farhana; Wiegman, Coen; Li, Feng; Bey, Leo; Baker, Warren; Porter, Alexandra; Ryan, Mary P.; Chang, Yan; Gow, Andrew; Zhang, Junfeng; Zhu, Jie; Tetley, Terry D.; Chung, Kian Fan			Pulmonary Toxicity of Instilled Silver Nanoparticles: Influence of Size, Coating and Rat Strain	PLOS ONE			English	Article							BROWN-NORWAY RATS; CONSUMER SPRAY PRODUCTS; ION RELEASE KINETICS; INTRATRACHEAL INSTILLATION; AIRWAY HYPERRESPONSIVENESS; NANO-SILVER; INHALATION; INFLAMMATION; EXPOSURE; CELLS	Particle size and surface chemistry are potential determinants of silver nanoparticle (AgNP) respiratory toxicity that may also depend on the lung inflammatory state. We compared the effects of intratracheally-administered AgNPs (20nm and 110nm; polyvinylpyrrolidone (PVP) and citrate-capped; 0.1 mg/Kg) in Brown-Norway (BN) and Sprague-Dawley (SD) rats. In BN rats, there was both a neutrophilic and eosinophilic response, while in SD rats, there was a neutrophilic response at day 1, greatest for the 20nm citrate-capped AgNPs. Eosinophilic cationic protein was increased in bronchoalveolar lavage (BAL) in BN and SD rats on day 1. BAL protein and malondialdehyde levels were increased in BN rats at 1 and 7 days, and BAL KC, CCL11 and IL-13 levels at day 1, with increased expression of CCL11 in lung tissue. Pulmonary resistance increased and compliance decreased at day 1, with persistence at day 7. The 20nm, but not the 110 nm, AgNPs increased bronchial hyperresponsiveness on day 1, which continued at day 7 for the citrate-capped AgNPs only. The 20nm versus the 110 nm size were more proinflammatory in terms of neutrophil influx, but there was little difference between the citrate-capped versus the PVP-capped AgNPs. AgNPs can induce pulmonary eosinophilic and neutrophilic inflammation with bronchial hyperresponsiveness, features characteristic of asthma.	[Seiffert, Joanna; Hussain, Farhana; Wiegman, Coen; Li, Feng; Baker, Warren; Zhu, Jie; Tetley, Terry D.; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis, London, England; [Bey, Leo; Porter, Alexandra; Ryan, Mary P.] Univ London Imperial Coll Sci Technol & Med, Dept Mat Sci Chem, Chem, London, England; [Bey, Leo; Porter, Alexandra; Ryan, Mary P.] Univ London Imperial Coll Sci Technol & Med, London Ctr Nanotechnol, London, England; [Bey, Leo] Univ Malaya, Fac Engn Bldg, Dept Mech Engn, Kuala Lumpur, Malaysia; [Chang, Yan] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gow, Andrew] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Zhang, Junfeng] Duke Univ, Nicholas Sch Environm, Durham, NC 27706 USA; [Zhang, Junfeng] Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA	Imperial College London; Imperial College London; Imperial College London; University of London; University College London; Universiti Malaya; University of Southern California; Rutgers State University New Brunswick; Duke University; Duke University	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis, London, England.	f.chung@imperial.ac.uk	Gow, Andrew/N-8566-2013; Zhang, Junfeng/AAJ-9183-2020; Chung, Kian Fan/B-1872-2012; Tetley, Teresa D/B-3288-2016; Gow, Andrew/AAR-2309-2020	Gow, Andrew/0000-0003-0876-5158; Zhang, Junfeng/0000-0003-3759-6672; Chung, Kian Fan/0000-0001-7101-1426; Gow, Andrew/0000-0003-0876-5158; Wiegman, Coen/0000-0001-9161-0581	US National Institute for Environmental Health Sciences [U19ES019536]; UK National Environmental Research Council [NE/H012893]; Medical Research Council [G0700926] Funding Source: researchfish; Natural Environment Research Council [NE/H012893/1] Funding Source: researchfish; MRC [G0700926] Funding Source: UKRI; NERC [NE/H012893/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES019536] Funding Source: NIH RePORTER	US National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UK National Environmental Research Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by grants from US National Institute for Environmental Health Sciences grant number U19ES019536 (http://www.niehs.nih.gov/research/supported/index.cfm), and from the UK National Environmental Research Council grant NE/H012893 (http://www.nerc.ac.uk/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Bae E, 2010, ENVIRON TOXICOL CHEM, V29, P2154, DOI 10.1002/etc.278; Baisch BL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-5; Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002; Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14; Braydich-Stolle LK, 2010, TOXICOL SCI, V116, P577, DOI 10.1093/toxsci/kfq148; Careau E, 2002, AM J RESP CELL MOL, V26, P579, DOI 10.1165/ajrcmb.26.5.4737; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cho WS, 2012, NANOTOXICOLOGY, V6, P22, DOI 10.3109/17435390.2011.552810; Cho WS, 2010, ENVIRON HEALTH PERSP, V118, P1699, DOI 10.1289/ehp.1002201; ELWOOD W, 1992, INT ARCH ALLERGY IMM, V99, P91, DOI 10.1159/000236340; ELWOOD W, 1991, J ALLERGY CLIN IMMUN, V88, P951, DOI 10.1016/0091-6749(91)90253-K; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Haberl N, 2013, BEILSTEIN J NANOTECH, V4, P933, DOI 10.3762/bjnano.4.105; HACZKU A, 1995, IMMUNOLOGY, V85, P598; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Huang YS, 2007, BURNS, V33, P161, DOI 10.1016/j.burns.2006.06.020; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim YS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-20; Kittler CG S., 2010, JOURNAL OF MATERIAL, V20, P512; Lankveld DPK, 2010, BIOMATERIALS, V31, P8350, DOI 10.1016/j.biomaterials.2010.07.045; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Leo BF, 2013, ENVIRON SCI TECHNOL, V47, P11232, DOI 10.1021/es403377p; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Loeschner K, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-18; Ma R, 2012, ENVIRON SCI TECHNOL, V46, P752, DOI 10.1021/es201686j; Nazarenko Y, 2011, J EXPO SCI ENV EPID, V21, P515, DOI 10.1038/jes.2011.10; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OLIVENSTEIN R, 1993, J CLIN INVEST, V92, P1477, DOI 10.1172/JCI116725; Park EJ, 2011, ARCH PHARM RES, V34, P299, DOI 10.1007/s12272-011-0216-y; Park EJ, 2010, ENVIRON TOXICOL PHAR, V30, P162, DOI 10.1016/j.etap.2010.05.004; PRITCHARD JN, 1985, ENVIRON RES, V36, P268, DOI 10.1016/0013-9351(85)90025-8; Quadros ME, 2011, ENVIRON SCI TECHNOL, V45, P10713, DOI 10.1021/es202770m; Stebounova LV, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-5; Sung JH, 2008, INHAL TOXICOL, V20, P567, DOI 10.1080/08958370701874671 ; Sung JH, 2009, TOXICOL SCI, V108, P452, DOI 10.1093/toxsci/kfn246; Suresh AK, 2012, LANGMUIR, V28, P2727, DOI 10.1021/la2042058; Thorley AJ, 2013, PHARMACOL THERAPEUT, V140, P176, DOI 10.1016/j.pharmthera.2013.06.008; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; WASERMAN S, 1992, J ALLERGY CLIN IMMUN, V90, P661, DOI 10.1016/0091-6749(92)90140-W; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhang W, 2011, ENVIRON SCI TECHNOL, V45, P4422, DOI 10.1021/es104205a	44	77	81	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119726	10.1371/journal.pone.0119726	http://dx.doi.org/10.1371/journal.pone.0119726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747867	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400086
J	Hroncova, Z; Havlik, J; Killer, J; Doskocil, I; Tyl, J; Kamler, M; Titera, D; Hakl, J; Mrazek, J; Bunesova, V; Rada, V				Hroncova, Zuzana; Havlik, Jaroslav; Killer, Jiri; Doskocil, Ivo; Tyl, Jan; Kamler, Martin; Titera, Dalibor; Hakl, Josef; Mrazek, Jakub; Bunesova, Vera; Rada, Vojtech			Variation in Honey Bee Gut Microbial Diversity Affected by Ontogenetic Stage, Age and Geographic Location	PLOS ONE			English	Article							BOMBI SP NOV.; GEN. NOV.; DIGESTIVE-TRACT; DEVELOPMENTAL-STAGES; BACTERIAL DIVERSITY; HYMENOPTERA; MEMBER; STOMACH; LARVAE	Social honey bees, Apis mellifera, host a set of distinct microbiota, which is similar across the continents and various honey bee species. Some of these bacteria, such as lactobacilli, have been linked to immunity and defence against pathogens. Pathogen defence is crucial, particularly in larval stages, as many pathogens affect the brood. However, information on larval microbiota is conflicting. Seven developmental stages and drones were sampled from 3 colonies at each of the 4 geographic locations of Apis mellifera carnica, and the samples were maintained separately for analysis. We analysed the variation and abundance of important bacterial groups and taxa in the collected bees. Major bacterial groups were evaluated over the entire life of honey bee individuals, where digestive tracts of same aged bees were sampled in the course of time. The results showed that the microbial tract of 6-day-old 5th instar larvae were nearly equally rich in total microbial counts per total digestive tract weight as foraging bees, showing a high percentage of various lactobacilli (Firmicutes) and Gilliamella apicola (Gammaproteobacteria 1). However, during pupation, microbial counts were significantly reduced but recovered quickly by 6 days post-emergence. Between emergence and day 6, imago reached the highest counts of Firmicutes and Gammaproteobacteria, which then gradually declined with bee age. Redundancy analysis conducted using denaturing gradient gel electrophoresis identified bacterial species that were characteristic of each developmental stage. The results suggest that 3-day 4th instar larvae contain low microbial counts that increase 2-fold by day 6 and then decrease during pupation. Microbial succession of the imago begins soon after emergence. We found that bacterial counts do not show only yearly cycles within a colony, but vary on the individual level. Sampling and pooling adult bees or 6th day larvae may lead to high errors and variability, as both of these stages may be undergoing dynamic succession.	[Hroncova, Zuzana; Havlik, Jaroslav; Killer, Jiri; Doskocil, Ivo; Bunesova, Vera; Rada, Vojtech] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Microbiol Nutr & Dietet, Prague, Czech Republic; [Killer, Jiri; Mrazek, Jakub] Acad Sci Czech Republ, Inst Anim Physiol & Genet Vvi, Prague, Czech Republic; [Tyl, Jan; Kamler, Martin; Titera, Dalibor] Bee Res Inst Dol, Libcice Nad Vltavou, Czech Republic; [Titera, Dalibor] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Hakl, Josef] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Forage Crops & Grassland Management, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Bee Research Institute at Dol; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Havlik, J (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Microbiol Nutr & Dietet, Prague, Czech Republic.	havlik@af.czu.cz	Mrazek, Jakub/AAS-9861-2020; Hroncova, Zuzana/Y-3038-2018; Hakl, Josef/F-3689-2018; Killer, Jiri/G-7197-2014; Killer, Jiri/R-4276-2018; Havlík, Jaroslav/F-3371-2011; Doskocil, Ivo/I-7814-2016; Mrazek, Jakub/B-7764-2017; Bunesova, Vera/R-4013-2018	Mrazek, Jakub/0000-0003-1907-3333; Hroncova, Zuzana/0000-0003-0065-3418; Hakl, Josef/0000-0003-4822-3441; Killer, Jiri/0000-0002-8878-7826; Havlík, Jaroslav/0000-0003-1900-0951; Doskocil, Ivo/0000-0002-7373-1360; Mrazek, Jakub/0000-0003-1907-3333; Bunesova, Vera/0000-0002-7596-4360; Kamler, Martin/0000-0001-7542-7867	National Agency for Agricultural Research-NAZV of the Ministry of Agriculture of Czech Republic [QJ 1210047]; Internal Grant Agency (CIGA) of the Czech University of Life Sciences Prague [20132013]	National Agency for Agricultural Research-NAZV of the Ministry of Agriculture of Czech Republic; Internal Grant Agency (CIGA) of the Czech University of Life Sciences Prague	This research was supported by the National Agency for Agricultural Research-NAZV of the Ministry of Agriculture of Czech Republic, project No. QJ 1210047 and the Internal Grant Agency (CIGA) of the Czech University of Life Sciences Prague, project No. 20132013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Corby-Harris V, 2014, APPL ENVIRON MICROB, V80, P7460, DOI 10.1128/AEM.02043-14; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Engel P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004596; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Engel P, 2013, GUT MICROBES, V4, P60, DOI 10.4161/gmic.22517; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1971, ANN ENTOMOL SOC AM, V64, P315, DOI 10.1093/aesa/64.1.315; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Killer J, 2014, INT J SYST EVOL MICR, V64, P2611, DOI 10.1099/ijs.0.063602-0; Killer J, 2014, INT J SYST EVOL MICR, V64, P152, DOI 10.1099/ijs.0.053033-0; Killer J, 2013, SYST APPL MICROBIOL, V36, P11, DOI 10.1016/j.syapm.2012.09.001; Killer J, 2011, INT J SYST EVOL MICR, V61, P1315, DOI 10.1099/ijs.0.022525-0; Killer J, 2010, SYST APPL MICROBIOL, V33, P359, DOI 10.1016/j.syapm.2010.08.002; Killer J, 2009, INT J SYST EVOL MICR, V59, P2020, DOI 10.1099/ijs.0.002915-0; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Ludvigsen J, 2013, THESIS NORWEGIAN U L; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Mrazek J, 2008, FOLIA MICROBIOL, V53, P229, DOI 10.1007/s12223-008-0032-z; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2014, INT J SYST EVOL MICR, V64, P3109, DOI 10.1099/ijs.0.059600-0; Patruica S, 2012, B ENTOMOL RES, V102, P619, DOI 10.1017/S0007485312000144; Powell JE, 2014, APPL ENVIRON MICROB, V80, P7378, DOI 10.1128/AEM.01861-14; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Rettedal EA, 2010, FEMS MICROBIOL LETT, V312, P55, DOI 10.1111/j.1574-6968.2010.02097.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Yoshiyama M, 2009, J INVERTEBR PATHOL, V102, P91, DOI 10.1016/j.jip.2009.07.005; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14	45	55	60	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118707	10.1371/journal.pone.0118707	http://dx.doi.org/10.1371/journal.pone.0118707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768309	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000351277500039
J	Lawson, MA; Paton-Hough, JM; Evans, HR; Walker, RE; Harris, W; Ratnabalan, D; Snowden, JA; Chantry, AD				Lawson, Michelle A.; Paton-Hough, Julia M.; Evans, Holly R.; Walker, Rebecca E.; Harris, William; Ratnabalan, Dharshi; Snowden, John A.; Chantry, Andrew D.			NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease	PLOS ONE			English	Article							MULTIPLE-MYELOMA; MOUSE MODEL; TUMOR BURDEN; MURINE MODEL; CELLS; DIFFERENTIATION; INHIBITION; ACTIVATION; INDUCTION; LESIONS	Animal models of multiple myeloma vary in terms of consistency of onset, degree of tumour burden and degree of myeloma bone disease. Here we describe five pre-clinical models of myeloma in NOD/SCID-GAMMA mice to specifically study the effects of therapeutic agents on myeloma bone disease. Groups of 7-8 week old female irradiated NOD/SCID-GAMMA mice were injected intravenously via the tail vein with either 1x10(6) JJN3, U266, XG-1 or OPM-2 human myeloma cell lines or patient-derivedmyeloma cells. At the first signs of morbidity in each tumour group all animals were sacrificed. Tumour load was measured by histological analysis, and bone disease was assessed by micro-CT and standard histomorphometric methods. Mice injected with JJN3, U266 or OPM-2 cells showed high tumour bone marrow infiltration of the long bones with low variability, resulting in osteolytic lesions. In contrast, mice injected with XG-1 or patient-derivedmyeloma cells showed lower tumour bone marrow infiltration and less bone disease with high variability. Injection of JJN3 cells into NOD/SCID-GAMMA mice resulted in an aggressive, short-term model of myeloma with mice exhibiting signs of morbidity 3 weeks later. Treating these mice with zoledronic acid at the time of tumour cell injection or once tumour was established prevented JJN3-induced bone disease but did not reduce tumour burden, whereas, carfilzomib treatment given once tumour was established significantly reduced tumour burden. Injection of U266, XG-1, OPM-2 and patient-derivedmyeloma cells resulted in less aggressive longer-term models of myeloma with mice exhibiting signs of morbidity 8 weeks later. Treating U266-induced disease with zoledronic acid prevented the formation of osteolytic lesions and trabecular bone loss as well as reducing tumour burden whereas, carfilzomib treatment only reduced tumour burden. In summary, JJN3, U266 or OPM-2 cells injected into NOD/SCID-GAMMA mice provide robust models to study anti-myeloma therapies, particularly those targetingmyeloma bone disease.	[Lawson, Michelle A.; Paton-Hough, Julia M.; Evans, Holly R.; Walker, Rebecca E.; Harris, William; Ratnabalan, Dharshi; Snowden, John A.; Chantry, Andrew D.] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Lawson, Michelle A.; Paton-Hough, Julia M.; Evans, Holly R.; Walker, Rebecca E.; Harris, William; Ratnabalan, Dharshi; Chantry, Andrew D.] Univ Sheffield, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [Snowden, John A.; Chantry, Andrew D.] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Lawson, MA (corresponding author), Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England.	m.a.lawson@sheffield.ac.uk	Lawson, Michelle/M-6095-2019; Harris, William Stephen/T-1674-2019	Lawson, Michelle/0000-0002-5446-923X; Harris, William Stephen/0000-0003-3042-9353; Chantry, Andrew/0000-0002-2797-7626; SNOWDEN, JOHN/0000-0001-6819-3476	Yorkshire Cancer Research & Cancer Research UK (Pump Priming & Development Fund); Leukaemia and Lymphoma Research (Specialist Programme) [12053]	Yorkshire Cancer Research & Cancer Research UK (Pump Priming & Development Fund); Leukaemia and Lymphoma Research (Specialist Programme)	Yorkshire Cancer Research (http://yorkshirecancerresearch.org.uk) & Cancer Research UK (http://www.cancerresearchuk.org) (Pump Priming & Development Fund) and Leukaemia and Lymphoma Research (Specialist Programme Grant No. 12053, http://leukaemialymphomaresearch.org.uk) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartee E, 2012, BIOL BLOOD MARROW TR, V18, P1540, DOI 10.1016/j.bbmt.2012.04.004; Carpenter RO, 2013, CLIN CANCER RES, V19, P2048, DOI 10.1158/1078-0432.CCR-12-2422; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chaidos A, 2013, BLOOD, V121, P318, DOI 10.1182/blood-2012-06-436220; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Croucher PI, 2003, J BONE MINER RES, V18, P482, DOI 10.1359/jbmr.2003.18.3.482; Cruz JC, 2001, EXP HEMATOL, V29, P441, DOI 10.1016/S0301-472X(01)00618-X; Dallas SL, 1999, BLOOD, V93, P1697, DOI 10.1182/blood.V93.5.1697.405a17_1697_1706; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Epstein Joshua, 2005, V113, P183, DOI 10.1385/1-59259-916-8:183; EVANS CE, 1989, J BONE JOINT SURG BR, V71, P288, DOI 10.1302/0301-620X.71B2.2925748; EVANS CE, 1992, CLIN EXP METASTAS, V10, P33, DOI 10.1007/BF00163574; Fryer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057641; Fuhler GM, 2012, MOL MED, V18, P65, DOI 10.2119/molmed.2011.00178; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Giuliani N, 2005, BLOOD, V106, P2472, DOI 10.1182/blood-2004-12-4986; Hjorth-Hansen H, 1999, J BONE MINER RES, V14, P256, DOI 10.1359/jbmr.1999.14.2.256; Hofgaard PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051892; Hu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074191; HUANG YW, 1993, CANCER RES, V53, P1392; Hurchla MA, 2013, LEUKEMIA, V27, P430, DOI 10.1038/leu.2012.183; Koduru S, 2012, BLOOD, V119, P2302, DOI 10.1182/blood-2011-08-376236; Miyakawa Y, 2004, BIOCHEM BIOPH RES CO, V313, P258, DOI 10.1016/j.bbrc.2003.11.120; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; Schueler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079939; Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884; Swift BE, 2012, HAEMATOL-HEMATOL J, V97, P1020, DOI 10.3324/haematol.2011.054254; Udi J, 2013, BRIT J HAEMATOL, V161, P104, DOI 10.1111/bjh.12226; Vanderkerken K, 1996, BRIT J CANCER, V73, P1463, DOI 10.1038/bjc.1996.277	29	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119546	10.1371/journal.pone.0119546	http://dx.doi.org/10.1371/journal.pone.0119546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768011	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000351277500085
J	Stein, V; Kubala, MH; Steen, J; Grimmond, SM; Alexandrov, K				Stein, Viktor; Kubala, Marta H.; Steen, Jason; Grimmond, Sean M.; Alexandrov, Kirill			Towards the Systematic Mapping and Engineering of the Protein Prenylation Machinery in Saccharomyces cerevisiae	PLOS ONE			English	Article							GERANYLGERANYLTRANSFERASE TYPE-I; PLASMA-MEMBRANE LOCALIZATION; A-FACTOR; SUBSTRATE RECOGNITION; PEPTIDE LIBRARIES; RAS PROTEINS; FARNESYLTRANSFERASE; YEAST; GENE; SPECIFICITY	Protein prenylation is a widespread and highly conserved eukaryotic post-translational modification that endows proteins with the ability to reversibly attach to intracellular membranes. The dynamic interaction of prenylated proteins with intracellular membranes is essential for their signalling functions and is frequently deregulated in disease processes such as cancer. As a result, protein prenylation has been pharmacologically targeted by numerous drug discovery programs, albeit with limited success. To a large extent, this can be attributed to an insufficient understanding of the interplay of different protein prenyltransferases and the combinatorial diversity of the prenylatable sequence space. Here, we report a high-throughput, growth-based genetic selection assay in Saccharomyces cerevisiae based on the Ras Recruitment System which, for the first time, has allowed us to create a comprehensive map of prenylatable protein sequences in S. cerevisiae. We demonstrate that potential prenylatable space is sparsely (6.2%) occupied leaving room for creation of synthetic orthogonal prenylatable sequences. To experimentally demonstrate that, we used the developed platform to engineer mutant farnesyltransferases that efficiently prenylate substrate motives that are not recognised by endogenous protein prenyltransferases. These uncoupled mutants can now be used as starting points for the systematic engineering of the eukaryotic protein prenylation machinery.	[Stein, Viktor; Kubala, Marta H.; Steen, Jason; Grimmond, Sean M.; Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Stein, V (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	k.alexandrov@uq.edu.au; v.stein@uq.edu.au	Grimmond, Sean M/J-5304-2016; Grimmond, Sean/K-3246-2019; Stein, Viktor/AAL-6191-2021; Alexandrov, Kirill/A-5830-2013	Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Steen, Jason/0000-0003-1351-5815; Alexandrov, Kirill/0000-0002-0957-6511; Stein, Viktor/0000-0001-6965-3657	Australian Research Council [DP1094080, FT0991611]; National Health and Medical Research Council [569652, APP1037320]; Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding: This work was supported by the Australian Research Council [DP1094080, FT0991611] and National Health and Medical Research Council [Project Grant 569652, Program Grant APP1037320] to KA. Funding for open access charge: Australian Research Council and National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; CAPLIN BE, 1994, BBA-PROTEIN STRUCT M, V1205, P39, DOI 10.1016/0167-4838(94)90089-2; Charron G, 2013, P NATL ACAD SCI USA, V110, P11085, DOI 10.1073/pnas.1302564110; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Gangopadhyay SA, 2014, BIOCHEMISTRY-US, V53, P434, DOI 10.1021/bi4011732; GOMEZ R, 1993, BIOCHEM J, V289, P25, DOI 10.1042/bj2890025; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; Hougland JL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404954; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; Hougland JL, 2009, BIOCHEMISTRY-US, V48, P1691, DOI 10.1021/bi801710g; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Kohler F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng016; Kovtun O, 2011, METHODS, V55, P58, DOI 10.1016/j.ymeth.2011.06.006; Krzysiak AJ, 2010, BIOORG MED CHEM LETT, V20, P767, DOI 10.1016/j.bmcl.2009.11.011; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; London N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002170; Maroun M, 1999, Nucleic Acids Res, V27, pe4, DOI 10.1093/nar/27.13.e4; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556; Nguyen Uyen T T, 2010, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1403s62; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; OHYA Y, 1993, MOL BIOL CELL, V4, P1017, DOI 10.1091/mbc.4.10.1017; OHYA Y, 1991, J BIOL CHEM, V266, P12356; PETITJEAN A, 1990, GENETICS, V124, P797; Porcu G, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-197; POWERS S, 1986, CELL, V47, P413, DOI 10.1016/0092-8674(86)90598-2; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sanchez-Mir L, 2014, MOL CELL BIOL, V34, P2745, DOI 10.1128/MCB.01515-13; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Stein V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp589; Tamanoi Fuyuhiko, 2011, Genes Cancer, V2, P210, DOI 10.1177/1947601911407322; Terry KL, 2006, BIOCHEMISTRY-US, V45, P9746, DOI 10.1021/bi060295e; Trueblood CE, 1997, P NATL ACAD SCI USA, V94, P10774, DOI 10.1073/pnas.94.20.10774; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000; Villiers BRM, 2010, PROTEIN ENG DES SEL, V23, P1, DOI 10.1093/protein/gzp063; Wang YC, 2014, ACS CHEM BIOL, V9, P1726, DOI 10.1021/cb5002312; Wang YC, 2012, CHEM COMMUN, V48, P8228, DOI 10.1039/c2cc31713c; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yalovsky S, 1997, MOL CELL BIOL, V17, P1986, DOI 10.1128/MCB.17.4.1986; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120716	10.1371/journal.pone.0120716	http://dx.doi.org/10.1371/journal.pone.0120716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768003	Green Published, gold, Green Submitted			2022-12-27	WOS:000351277500133
J	Casas-Monroy, O; Linley, RD; Adams, JK; Chan, FT; Drake, DAR; Bailey, SA				Casas-Monroy, Oscar; Linley, Robert D.; Adams, Jennifer K.; Chan, Farrah T.; Drake, D. Andrew R.; Bailey, Sarah A.			Relative Invasion Risk for Plankton across Marine and Freshwater Systems: Examining Efficacy of Proposed International Ballast Water Discharge Standards	PLOS ONE			English	Article							PROPAGULE PRESSURE; SHIPS; ESTABLISHMENT; TEMPERATURE; SALINITY; EXCHANGE; COASTAL; COMMUNITIES; TRANSPORT; SURVIVAL	Understanding the implications of different management strategies is necessary to identify best conservation trajectories for ecosystems exposed to anthropogenic stressors. For example, science-based risk assessments at large scales are needed to understand efficacy of different vector management approaches aimed at preventing biological invasions associated with commercial shipping. We conducted a landscape-scale analysis to examine the relative invasion risk of ballast water discharges among different shipping pathways (e.g., Transoceanic, Coastal or Domestic), ecosystems (e.g., freshwater, brackish and marine), and timescales (annual and per discharge event) under current and future management regimes. The arrival and survival potential of nonindigenous species (NIS) was estimated based on directional shipping networks and their associated propagule pressure, environmental similarity between donor-recipient ecosystems (based on salinity and temperature), and effects of current and future management strategies (i.e., ballast water exchange and treatment to meet proposed international biological discharge standards). Our findings show that current requirements for ballast water exchange effectively reduce invasion risk to freshwater ecosystems but are less protective of marine ecosystems because of greater environmental mismatch between source (oceanic) and recipient (freshwater) ecoregions. Future requirements for ballast water treatment are expected to reduce risk of zooplankton NIS introductions across ecosystem types but are expected to be less effective in reducing risk of phytoplankton NIS. This large-scale risk assessment across heterogeneous ecosystems represents a major step towards understanding the likelihood of invasion in relation to shipping networks, the relative efficacy of different invasion management regimes and seizing opportunities to reduce the ecological and economic implications of biological invasions.	[Casas-Monroy, Oscar; Linley, Robert D.; Adams, Jennifer K.; Bailey, Sarah A.] Fisheries & Oceans Canada, Great Lakes Lab Fisheries & Aquat Sci, Burlington, ON L7S 1A1, Canada; [Chan, Farrah T.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Drake, D. Andrew R.] Univ Toronto Scarborough, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada	Fisheries & Oceans Canada; University of Windsor; University of Toronto; University Toronto Scarborough	Casas-Monroy, O (corresponding author), Fisheries & Oceans Canada, Great Lakes Lab Fisheries & Aquat Sci, 867 Lakeshore Rd, Burlington, ON L7S 1A1, Canada.	Oscar.Casas-Monroy@dfo-mpo.gc.ca	Bailey, Sarah/E-8356-2010	Bailey, Sarah/0000-0003-3635-919X; Chan, Farrah/0000-0002-1062-6707; Adams, Jennifer/0000-0002-0380-3832	Natural Sciences and Engineering Research Council of Canada [371454-2010 RGPIN]; Transport Canada through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program; Fisheries and Oceans Canada through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Transport Canada through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program; Fisheries and Oceans Canada through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program	Funding for this study was provided by Transport Canada and Fisheries and Oceans Canada, both directly and through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (SAB), #371454-2010 RGPIN. (https://www.tc.gc.ca, http://www.dfo-mpo.gc.ca, http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo AA, 2014, BIOL INVASIONS, V16, P793, DOI 10.1007/s10530-013-0537-5; Albert RJ, 2013, ECOL APPL, V23, P289, DOI 10.1890/12-0669.1; ANGER K, 1991, MAR ECOL PROG SER, V72, P103, DOI 10.3354/meps072103; [Anonymous], 2012, TRANSP CAN DIS PAP C; Antonov J.I., 2006, WORLD OCEAN ATLAS 20, V2, P182; Bailey SA, 2011, ENVIRON SCI TECHNOL, V45, P2554, DOI 10.1021/es102655j; Bailey SA, 2009, CAN J FISH AQUAT SCI, V66, P261, DOI 10.1139/F08-200; Barry SC, 2008, ICES J MAR SCI, V65, P121, DOI 10.1093/icesjms/fsn004; Bradie J, 2015, J APPL ECOL, V52, P100, DOI 10.1111/1365-2664.12376; Briski E, 2013, ENVIRON SCI TECHNOL, V47, P1216, DOI 10.1021/es3029445; Briski E, 2012, J APPL ECOL, V49, P1124, DOI 10.1111/j.1365-2664.2012.02186.x; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Browne RA, 2000, J EXP MAR BIOL ECOL, V244, P29, DOI 10.1016/S0022-0981(99)00125-2; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; CARVER CE, 2002, ASSESSMENT RISK BALL; Casas-Monroy O, 2012, THESIS U QUEBEC RIMO; Casas-Monroy O, 2014, DFO CAN SCI ADVIS SE, P128; Chan FT, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1517; Chan FT, 2013, BIOL INVASIONS, V15, P295, DOI 10.1007/s10530-012-0284-z; Cordell JR, 2009, AQUAT CONSERV, V19, P322, DOI 10.1002/aqc.986; Dextrase AJ, 2006, BIOL INVASIONS, V8, P13, DOI 10.1007/s10530-005-0232-2; DiBacco C, 2012, ICES J MAR SCI, V69, P483, DOI 10.1093/icesjms/fsr133; Dickman M, 1999, MAR ECOL PROG SER, V176, P253, DOI 10.3354/meps176253; Drake JM, 2006, BIOL INVASIONS, V8, P365, DOI 10.1007/s10530-004-8122-6; Duncan RP, 2014, METHODS ECOL EVOL, V5, P1255, DOI 10.1111/2041-210X.12288; Gertzen EL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00170.1; Gollasch Stephan, 2007, Aquatic Invasions, V2, P313, DOI 10.3391/ai.2007.2.4.3; Gregg Matthew, 2009, Aquatic Invasions, V4, P521, DOI 10.3391/ai.2009.4.3.14; Hulme PE, 2006, J APPL ECOL, V46, P10; Humphrey DB, 2008, THESIS U BRIT COLUMB; IMO, 2004, INT CONV CONTR MAN S; Jerde CL, 2007, AM NAT, V170, P1, DOI 10.1086/518179; Johnson TB, 2005, J GREAT LAKES RES, V31, P238, DOI 10.1016/S0380-1330(05)70317-8; Katsanevakis S, 2013, OCEAN COAST MANAGE, V76, P64, DOI 10.1016/j.ocecoaman.2013.02.024; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Klein G, 2009, ACTA BOT CROAT, V68, P325; Lavoie DM, 1999, ESTUAR COAST SHELF S, V48, P551, DOI 10.1006/ecss.1999.0467; Lawrence DJ, 2010, BIOL CONSERV, V143, P700, DOI 10.1016/j.biocon.2009.12.008; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Levings CD, 2004, DFO CAN SCI ADVIS SE, P118; LEWIS MA, 1997, SPATIAL ECOLOGY ROLE; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; McCollin T, 2008, MAR POLLUT BULL, V56, P834, DOI 10.1016/j.marpolbul.2008.02.004; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; NRC [National Research Council], 2011, ASS REL PROP PRESS I; Roy S, 2012, CAN J FISH AQUAT SCI, V69, P627, DOI [10.1139/F2012-008, 10.1139/f2012-008]; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 2013, ECOL APPL, V23, P311, DOI 10.1890/11-1660.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Simard N, 2011, J PLANKTON RES, V33, P1378, DOI 10.1093/plankt/fbr038; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Simkanin C, 2009, MAR POLLUT BULL, V58, P366, DOI 10.1016/j.marpolbul.2008.10.013; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Steichen JL, 2012, MAR POLLUT BULL, V64, P779, DOI 10.1016/j.marpolbul.2012.01.028; Taylor MD, 2007, MAR ECOL PROG SER, V350, P41, DOI 10.3354/meps07016; Tsolaki E, 2010, J CHEM TECHNOL BIOT, V85, P19, DOI 10.1002/jctb.2276; US EPA, 2013, VESS GEN PERM DISCH; Verween A, 2007, J EXP MAR BIOL ECOL, V348, P111, DOI 10.1016/j.jembe.2007.04.011; Ware C, 2014, DIVERS DISTRIB, V20, P10, DOI 10.1111/ddi.12117; Wonham MJ, 2013, ECOL APPL, V23, P1691, DOI 10.1890/12-1985.1	60	28	28	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118267	10.1371/journal.pone.0118267	http://dx.doi.org/10.1371/journal.pone.0118267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763859	gold, Green Published, Green Submitted			2022-12-27	WOS:000351276300012
J	Mastrocola, R; Collino, M; Nigro, D; Chiazza, F; D'Antona, G; Aragno, M; Minetto, MA				Mastrocola, Raffaella; Collino, Massimo; Nigro, Debora; Chiazza, Fausto; D'Antona, Giuseppe; Aragno, Manuela; Minetto, Marco A.			Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle	PLOS ONE			English	Article							GENE-EXPRESSION; VASCULAR COMPLICATIONS; INSULIN-RESISTANCE; LIPID-SYNTHESIS; FATTY LIVER; RECEPTOR; RAGE; AGES; MICE; SREBP-1C	Aim of this study was to investigate whether advanced glycation end-products (AGEs) accumulate in skeletal myofibers of two different animal models of diabesity and whether this accumulation could be associated to myosteatosis. Male C57Bl/6j mice and leptin-deficient ob/ob mice were divided into three groups and underwent 15 weeks of dietary manipulation: standard diet-fed C57 group (C57, n = 10), high-fat high-sugar diet-fed C57 group (HFHS, n = 10), and standard diet-fed ob/ob group (OB/OB, n = 8). HFHS mice and OB/OB mice developed glycometabolic abnormalities in association with decreased mass of the gastrocnemius muscle, fast-to-slow transition of muscle fibers, and lipid accumulation (that occurred preferentially in slow compared to fast fibers). Moreover, we found in muscle fibers of HFHS and OB/OB mice accumulation of AGEs that was preferential for the lipid-accumulating cells, increased expression of the lipogenic pathway SCAP/SREBP, and co-localisation between AGEs and SCAP-(hyper) expressing cells (suggestive for SCAP glycosylation). The increased expression of the SCAP/SREBP lipogenic pathway in muscle fibers is a possible mechanism underlying lipid accumulation and linking myosteatosis to muscle fiber atrophy and fast-to-slow transition that occur in response to diabesity.	[Mastrocola, Raffaella; Nigro, Debora; Aragno, Manuela] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Collino, Massimo; Chiazza, Fausto] Univ Turin, Dept Drug Sci & Technol, Turin, Italy; [D'Antona, Giuseppe] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Minetto, Marco A.] Univ Turin, Dept Med Sci, Div Endocrinol Diabetol & Metab, Turin, Italy	University of Turin; University of Turin; University of Pavia; University of Turin	Minetto, MA (corresponding author), Univ Turin, Dept Med Sci, Div Endocrinol Diabetol & Metab, Turin, Italy.	marco.minetto@unito.it	Chiazza, Fausto/I-5559-2015; Collino, Massimo/AAK-8532-2020	Collino, Massimo/0000-0001-8782-3496; ARAGNO, Manuela/0000-0002-0453-5235; Mastrocola, Raffaella/0000-0002-0104-6129; D'Antona, Giuseppe/0000-0002-0683-5565; Chiazza, Fausto/0000-0001-7273-0051	bank foundation "Fondazione CARIPLO" of Milano, Italy; University of Turin	bank foundation "Fondazione CARIPLO" of Milano, Italy; University of Turin	This study was supported by the bank foundation "Fondazione CARIPLO" of Milano, Italy (Project: "Steroid myopathy: Molecular, Histopathological, and Electrophysiological Characterization") and by a grant (ex 60%) from the University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, CURR MED CHEM, V17, P2232, DOI 10.2174/092986710791331086; Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/509502; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bifulco M, 2007, J AM DIET ASSOC, V107, P2058, DOI 10.1016/j.jada.2007.09.012; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Canepari M, 2010, ACTA PHYSIOL, V199, P465, DOI 10.1111/j.1748-1716.2010.02118.x; Cassese A, 2008, J BIOL CHEM, V283, P36088, DOI 10.1074/jbc.M801698200; Chen HB, 2014, MOL CELL ENDOCRINOL, V395, P69, DOI 10.1016/j.mce.2014.07.021; Chilelli NC, 2013, NUTR METAB CARDIOVAS, V23, P913, DOI 10.1016/j.numecd.2013.04.004; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Collino M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/569623; de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007; Dessalle K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050878; El-Bassossy HM, 2014, TOXICOL MECH METHOD, V24, P536, DOI 10.3109/15376516.2014.945109; Endo M, 2007, EXP BIOL MED, V232, P614; Filhoulaud G, 2013, TRENDS ENDOCRIN MET, V24, P257, DOI 10.1016/j.tem.2013.01.003; Gumucio JP, 2014, J SHOULDER ELB SURG, V23, P99, DOI 10.1016/j.jse.2013.04.011; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kemp JG, 2009, INT J OBESITY, V33, P831, DOI 10.1038/ijo.2009.100; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lee TW, 2014, INT J CARDIOL, V173, P236, DOI 10.1016/j.ijcard.2014.02.041; Mahajan N, 2013, INT J CARDIOL, V168, P1788, DOI 10.1016/j.ijcard.2013.05.013; Mastrocola R, 2013, AM J PHYSIOL-GASTR L, V305, pG398, DOI 10.1152/ajpgi.00450.2012; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Miljkovic I, 2010, CURR OPIN CLIN NUTR, V13, P260, DOI 10.1097/MCO.0b013e328337d826; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Puddu Alessandra, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P132; Ramamurthy B, 2013, BIOGERONTOLOGY, V14, P293, DOI 10.1007/s10522-013-9430-y; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Song F, 2012, ARTERIOSCL THROM VAS, V32, P1760, DOI 10.1161/ATVBAHA.111.241877; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; Tsintzas K, 2013, CLIN SCI, V124, P675, DOI 10.1042/CS20120481; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Yamagishi S, 2011, CURR DRUG TARGETS, V12, P2096, DOI 10.2174/138945011798829456; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yang DH, 2014, INT J MED SCI, V11, P453, DOI 10.7150/ijms.8172; Yuan Y, 2011, AM J PHYSIOL-RENAL, V301, pF236, DOI 10.1152/ajprenal.00646.2010	48	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0119587	10.1371/journal.pone.0119587	http://dx.doi.org/10.1371/journal.pone.0119587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25750996	Green Published, gold, Green Submitted			2022-12-27	WOS:000350692700028
J	Herbeck, J; Ghorai, S; Chen, LN; Rinaldo, CR; Margolick, JB; Detels, R; Jacobson, L; Wolinsky, S; Mullins, JI				Herbeck, Joshua; Ghorai, Suvankar; Chen, Lennie; Rinaldo, Charles R.; Margolick, Joseph B.; Detels, Roger; Jacobson, Lisa; Wolinsky, Steven; Mullins, James I.			p21(WAF1/CIP1) RNA Expression in Highly HIV-1 Exposed, Uninfected Individuals	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIGEN CLASS-I; T-CELLS; INFECTION; POLYMORPHISM; RESTRICTION; ASSOCIATION; RESISTANCE; AIDS; SUSCEPTIBILITY	Some individuals remain HIV-1 antibody and PCR negative after repeated exposures to the virus, and are referred to as HIV-exposed seronegatives (HESN). However, the causes of resistance to HIV-1 infection in cases other than those with a homozygous CCR5 Delta 32 deletion are unclear. We hypothesized that human p21(WAF1/CIP1) (a cyclin-dependent kinase inhibitor) could play a role in resistance to HIV-1 infection in HESN, as p21 expression has been associated with suppression of HIV-1 in elite controllers and reported to block HIV-1 integration in cell culture. We measured p21 RNA expression in PBMC from 40 HESN and 40 low exposure HIV-1 seroconverters (LESC) prior to their infection using a real-time PCR assay. Comparing the 20 HESN with the highest exposure risk (median = 111 partners/2.5 years prior to the 20 LESC with the lowest exposure risk (median = 1 partner/2.5 years prior), p21 expression trended higher in HESN in only one of two experiments (P = 0.11 vs. P = 0.80). Additionally, comparison of p21 expression in the top 40 HESN (median = 73 partners/year) and lowest 40 LESC (median = 2 partners/year) showed no difference between the groups (P = 0.84). There was a weak linear trend between risk of infection after exposure and increasing p21 gene expression (R-2 = 0.02, P = 0.12), but again only in one experiment. Hence, if p21 expression contributes to the resistance to viral infection in HESN, it likely plays a minor role evident only in those with extremely high levels of exposure to HIV-1.	[Herbeck, Joshua] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ghorai, Suvankar; Chen, Lennie; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Pittsburgh, PA USA; [Margolick, Joseph B.] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Detels, Roger] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Jacobson, Lisa] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Wolinsky, Steven] Northwestern Univ, Dept Med, Chicago, IL 60611 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; University of California System; University of California Los Angeles; Johns Hopkins University; Northwestern University	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu	Wolinsky, Steven/B-2893-2012	GHORAI, SUVANKAR/0000-0003-0800-3970; Jacobson, Lisa P./0000-0003-1722-6826; Wolinsky, Steven/0000-0002-9625-6697	National Institutes of Health [R37-047734, U01-AI35041, U01-AI35042, U01-AI35040, UM1-AI35043, U01-AI35039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, U01AI035040, UM1AI035043, U01AI035039, U01AI035042, U01AI035041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by the National Institutes of Health (J.I.M; R37-047734) (C.R.R.; U01-AI35041) (J.B.M., U01-AI35042) (R.D.; U01-AI35040) (L.J.; UM1-AI35043) (S.W.; U01-AI35039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouch A, 2013, P NATL ACAD SCI USA, V110, pE3997, DOI 10.1073/pnas.1306719110; Arias CF, 2007, J IMMUNOL, V178, P2296, DOI 10.4049/jimmunol.178.4.2296; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Bergamaschi A, 2009, J VIROL, V83, P12253, DOI 10.1128/JVI.01395-09; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Castedo M, 2005, BIOCHEM BIOPH RES CO, V331, P701, DOI 10.1016/j.bbrc.2005.03.188; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Clark E, 2000, J VIROL, V74, P5040, DOI 10.1128/JVI.74.11.5040-5052.2000; Colobran R, 2005, J IMMUNOL, V174, P5655, DOI 10.4049/jimmunol.174.9.5655; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DETELS R, 1994, J ACQ IMMUN DEF SYND, V7, P1263; Gandhi SK, 2008, J VIROL, V82, P3125, DOI 10.1128/JVI.01533-07; Garden GA, 2005, BIOCHEM BIOPH RES CO, V331, P799, DOI 10.1016/j.bbrc.2005.03.185; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lederman MM, 2010, J INFECT DIS, V202, pS333, DOI 10.1086/655967; Liu CL, 2003, J INFECT DIS, V187, P1404, DOI 10.1086/374394; Mackelprang RD, 2014, J INFECT DIS, V209, P1623, DOI 10.1093/infdis/jit807; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; Nakayama EE, 2013, AIDS RES HUM RETROVI; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Valcke HS, 2006, AIDS, V20, P1984, DOI 10.1097/01.aids.0000247124.35129.e1; Young JM, 2011, AIDS RES HUM RETROV, V27, P737, DOI [10.1089/aid.2010.0313, 10.1089/AID.2010.0313]; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119218	10.1371/journal.pone.0119218	http://dx.doi.org/10.1371/journal.pone.0119218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25746435	Green Published, Green Accepted, gold			2022-12-27	WOS:000350689400058
J	Lv, FF; Cao, J; Liu, ZB; Wang, ZH; Zhang, J; Zhang, S; Wang, LP; Zhao, XM; Shao, ZM; Wang, BY; Hu, XC				Lv, Fangfang; Cao, Jun; Liu, Zhebin; Wang, Zhonghua; Zhang, Jian; Zhang, Sheng; Wang, Leiping; Zhao, Xinmin; Shao, Zhimin; Wang, Biyun; Hu, Xichun			Phase II Study of Pseudomonas aeruginosa-Mannose-Sensitive Hemagglutinin in Combination with Capecitabine for Her-2-Negative Metastatic Breast Cancer Pretreated with Anthracycline and Taxane	PLOS ONE			English	Article							PLUS CAPECITABINE; MULTICENTER; TRIAL; MONOTHERAPY; THERAPY	Purpose Metastatic breast cancer (MBC) remains an incurable disease despite major therapeutic advances. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin (PA-MSHA) has been established to have anti-proliferative effects against breast cancer cells in preclinical experiments, and is indicated for treatment of cancer in China. We performed a phase II trial combining PA-MSHA with capecitabine in patients with heavily pretreated MBC. Methods Eligibility criteria included human epidermal growth factor receptor 2-negative MBC, prior therapy with anthracyclines and taxanes, at least one prior chemotherapy regimen for metastatic disease or early relapse after a taxane plus anthracycline adjuvant regimen, and adequate organ function and performance status. PA-MSHA 1 mg was administered subcutaneously every other day and capecitabine 1000 mg/m(2) orally twice a day for 2 weeks on, 1 week off. The primary end point was progression-free survival. Results A total of 97 patients were enrolled. Median progression-free survival (PFS) was 4.0 months [95% confidence interval (CI) 3.0-4.9], which was not significantly different from that in historical controls. However, median PFS was significantly longer (8.2 months; 95% CI 6.7-9.7) in 24 patients with moderate immune-related adverse events (irAEs) such as fever or skin induration at the injection site than in those with no or mild irAEs (3.1 months, 95% CI 2.5-3.6; p = 0.003). Overall survival was also improved in these patients (25.4 vs. 16.4 months; p = 0.044). PA-MSHA has a good safety profile, with only 6 patients (6.2 %) discontinuing treatment. PA-MSHA did not increase capecitabine-related toxicities such as hand-foot syndrome, nausea, and vomiting. Conclusion Adding PA-MSHA to capecitabine has a good safety profile in patients with heavily pretreated MBC, although benefit from this regimen might occur only in patients with moderate PA-MSHA-related adverse events.	[Lv, Fangfang; Cao, Jun; Wang, Zhonghua; Zhang, Jian; Zhang, Sheng; Wang, Leiping; Zhao, Xinmin; Wang, Biyun; Hu, Xichun] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Lv, Fangfang; Cao, Jun; Liu, Zhebin; Wang, Zhonghua; Zhang, Jian; Zhang, Sheng; Wang, Leiping; Zhao, Xinmin; Shao, Zhimin; Wang, Biyun; Hu, Xichun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Liu, Zhebin; Shao, Zhimin] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, BY (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China.	pro_wangbiyun@163.com; xchu2009@hotmail.com			National Natural Science Foundation of China [81202080]; Natural Science Foundation of Shanghai [12ZR1442400, 12ZR1406400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	The study was funded by the National Natural Science Foundation of China (contract grant number: 81202080) and Natural Science Foundation of Shanghai (contract grant numbers: 12ZR1442400 and 12ZR1406400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum JL, 2001, CANCER, V92, P1759, DOI 10.1002/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A; Cameron D, 2010, ONCOLOGIST, V15, P924, DOI 10.1634/theoncologist.2009-0181; Chen Wei-Dong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P1204; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Crown JP, 2013, J CLIN ONCOL, V31, P2870, DOI 10.1200/JCO.2012.43.3391; Fumoleau P, 2004, EUR J CANCER, V40, P536, DOI 10.1016/j.ejca.2003.11.007; Hoos A, 2007, J IMMUNOTHER, V30, P1, DOI 10.1097/01.cji.0000211341.88835.ae; Liu ZB, 2010, ONCOGENE, V29, P2996, DOI 10.1038/onc.2010.70; Liu ZB, 2009, J CELL BIOCHEM, V108, P195, DOI 10.1002/jcb.22241; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; MU X, 1986, Weishengwu Xuebao, V26, P176; Oostendorp LJM, 2011, LANCET ONCOL, V12, P1053, DOI 10.1016/S1470-2045(11)70045-6; Reichardt P, 2003, ANN ONCOL, V14, P1227, DOI 10.1093/annonc/mdg346; Roche, 2006, XELODA CAP PRESCR IN; Thomas ES, 2007, J CLIN ONCOL, V25, P5210, DOI 10.1200/JCO.2007.12.6557; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	16	3	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118607	10.1371/journal.pone.0118607	http://dx.doi.org/10.1371/journal.pone.0118607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768439	Green Submitted, Green Published, gold			2022-12-27	WOS:000351277500032
J	Qin, F; Wang, YF; Ferguson, DK; Chen, WL; Li, YM; Cai, Z; Wang, Q; Ma, HZ; Li, CS				Qin, Feng; Wang, Yu-Fei; Ferguson, David K.; Chen, Wen-Li; Li, Ya-Meng; Cai, Zhe; Wang, Qing; Ma, Hong-Zhen; Li, Cheng-Sen			Utility of Surface Pollen Assemblages to Delimit Eastern Eurasian Steppe Types	PLOS ONE			English	Article							VEGETATION; PRECIPITATION; GRASSLANDS; TRANSECT; SEQUENCE; SPECTRA; RECORDS; LAKE; TOOL	Modern pollen records have been used to successfully distinguish between specific prairie types in North America. Whether the pollen records can be used to detect the occurrence of Eurasian steppe, or even to further delimit various steppe types was until now unclear. Here we characterized modern pollen assemblages of meadow steppe, typical steppe and desert steppe from eastern Eurasia along an ecological humidity gradient. The multivariate ordination of the pollen data indicated that Eurasian steppe types could be clearly differentiated. The different steppe types could be distinguished primarily by xerophilous elements in the pollen assemblages. Redundancy analysis indicated that the relative abundances of Ephedra, Tamarix, Nitraria and Zygophyllaceae were positively correlated with aridity. The relative abundances of Ephedra increased from meadow steppe to typical steppe and desert steppe. Tamarix and Zygophyllaceae were found in both typical steppe and desert steppe, but not in meadow steppe. Nitraria was only found in desert steppe. The relative abundances of xerophilous elements were greater in desert steppe than in typical steppe. These findings indicate that Eurasian steppe types can be differentiated based on recent pollen rain.	[Qin, Feng; Wang, Yu-Fei; Ferguson, David K.; Chen, Wen-Li; Cai, Zhe; Li, Cheng-Sen] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing 100093, Peoples R China; [Ferguson, David K.] Univ Vienna, Inst Palaeontol, A-1090 Vienna, Austria; [Li, Ya-Meng] Linyi Univ, Inst Geol & Paleontol, Linyi 276005, Peoples R China; [Wang, Qing] Beijing Acad Sci & Technol, Beijing Radiat Ctr, Beijing 100875, Peoples R China; [Ma, Hong-Zhen] Beijing Forestry Univ, Coll Landscape Architecture, Beijing 100083, Peoples R China; [Qin, Feng] Chinese Acad Sci, Key Lab Land Surface Pattern & Simulat, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; University of Vienna; Linyi University; Beijing Academy of Science & Technology; Beijing Forestry University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wang, YF (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Nanxincun 20, Beijing 100093, Peoples R China.	wangyf@ibcas.ac.cn; lics@ibcas.ac.cn			China National Key Basic Research Program [2014CB954201]; National Natural Science Foundation of China [30990241]; State Key Laboratory of Systematic and Evolutionary Botany [LSEB2012-09]	China National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Systematic and Evolutionary Botany	This research was supported by the China National Key Basic Research Program (2014CB954201), the National Natural Science Foundation of China (No. 30990241), and the State Key Laboratory of Systematic and Evolutionary Botany (No. LSEB2012-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen S.H., 2005, METEOR SCI TECHNOL, V33, P340; Court-Picon M, 2005, REV PALAEOBOT PALYNO, V135, P13, DOI 10.1016/j.revpalbo.2005.02.003; Davies CP, 2001, J BIOGEOGR, V28, P1195, DOI 10.1046/j.1365-2699.2001.00630.x; De Martonne E., 1926, METEOROLOGIE, P449; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; ELMOSLIMANY AP, 1990, REV PALAEOBOT PALYNO, V64, P343, DOI 10.1016/0034-6667(90)90150-H; Fall PL, 2012, REV PALAEOBOT PALYNO, V185, P79, DOI 10.1016/j.revpalbo.2012.08.002; Gaillard M.-J., 1992, VEGETAT HIST ARCHAEO, V1, P3, DOI DOI 10.1007/BF00190697; Gosling WD, 2009, REV PALAEOBOT PALYNO, V153, P70, DOI 10.1016/j.revpalbo.2008.06.007; Grimm E.C., 2011, TILIA 1 7 16; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hicks S, 1996, VEG HIST ARCHAEOBOT, V5, P257; Hou JiHua, 2004, Acta Phytoecologica Sinica, V28, P609; Hoyt CA, 2000, J BIOGEOGR, V27, P687, DOI 10.1046/j.1365-2699.2000.00437.x; Institute of Botany and South China Institute of Botany, 1982, ANG POLL FLOR TROP S; Institute of Botany Chinese Academy of Sciences, 1976, SPOR PTER SIN; Integrated Survey Team of Inner Mongolia and Ningxia Chinese Academy of Sciences (ISTIMN), 1985, VEG INN MONG; Leps J, 2003, MULTIVARIATE ANAL EC; Li XQ, 1999, ACTA BOT SIN, V41, P782; [李月丛 Li Yuecong], 2005, [生态学报, Acta Ecologica Sinica], V25, P555; Lin R, 1991, FLORA CHINA, V76; Liu HY, 1999, REV PALAEOBOT PALYNO, V105, P237, DOI 10.1016/S0034-6667(98)00074-8; Ma YZ, 2008, J BIOGEOGR, V35, P1512, DOI 10.1111/j.1365-2699.2007.01871.x; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Mazier F, 2006, HOLOCENE, V16, P91, DOI 10.1191/0959683606hl908rp; Mensing SA, 2004, QUATERNARY RES, V62, P29, DOI 10.1016/j.yqres.2004.04.002; Moore P.D., 1991, BLACKWELL SCI PUBLI; Prentice IC, 1996, CLIM DYNAM, V12, P185, DOI 10.1007/BF00211617; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; [舒军武 SHU Jun-wu], 2009, [微体古生物学报, Acta Micropalaeontologica Sinica], V26, P405; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Wan T, 1999, POLLEN MORPHOLOGY MO; Wang F.Y., 1996, ACTA BOT SIN, V38, P902; Wang FX, 1995, POLLEN FLORA CHINA; Wang L, 2006, PALAEOGEOGR PALAEOCL, V241, P118, DOI 10.1016/j.palaeo.2006.06.012; Wang W, 2011, QUATERN INT, V229, P74, DOI 10.1016/j.quaint.2010.06.005; Weng Cheng-Yu, 1993, Acta Botanica Sinica, V35, P69; Wu ZY, 1980, VEGETATION CHINA, P505; Xi Y.Z., 1994, YUSHANIA, V11, P119; Xu QH, 2009, REV PALAEOBOT PALYNO, V153, P86, DOI 10.1016/j.revpalbo.2008.07.003; [许清海 Xu Qinghai], 2005, [地理研究, Geographical Research], V24, P394; Xu QH, 2007, SCI CHINA SER D, V50, P582, DOI 10.1007/s11430-007-2044-y; Zhang Y, 2010, GLOBAL ECOL BIOGEOGR, V19, P621, DOI 10.1111/j.1466-8238.2010.00534.x; Zhao Y, 2012, HOLOCENE, V22, P1385, DOI 10.1177/0959683612449762	49	7	8	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119412	10.1371/journal.pone.0119412	http://dx.doi.org/10.1371/journal.pone.0119412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763576	Green Submitted, Green Published, gold			2022-12-27	WOS:000351276300027
J	Jing, L; Wang, WL; Zhang, SS; Xie, MJ; Tian, DS; Luo, X; Wang, DW; Ning, Q; Lu, JG; Wang, W				Jing, Liang; Wang, Wenlong; Zhang, Shuangshuang; Xie, Minjie; Tian, Daishi; Luo, Xiang; Wang, Daowen; Ning, Qin; Lu, Jiagao; Wang, Wei			Targeted Inhibitory Effect of Lenti-SM22alpha-p27-EGFP Recombinant Lentiviral Vectors on Proliferation of Vascular Smooth Muscle Cells without Compromising Re-Endothelialization in a Rat Carotid Artery Balloon Injury Model	PLOS ONE			English	Article							IN-STENT RESTENOSIS; INTRATHECAL INJECTION; ELUTING STENTS; PACLITAXEL; EXPRESSION; GENE; APOPTOSIS; RAPAMYCIN; REENDOTHELIALIZATION; IMPLANTATION	Aims In-stent restenosis remains a serious problem after the implantation of drug-eluting stents, which is attributable to neointima formation and re-endothelialization. Here, we tried to find a new method which aims at selectively inhibiting proliferation of vascular smooth muscle cells (VSMC) proliferation without inhibition of re-endothelialization. Methods and Results We used the smooth muscle-specific SM22alpha promoter in a recombinant lentiviral vector to drive overexpression of cell-cycle inhibitor, p27, in VSMCs. p27 effectively inhibited VSMC proliferation mediated by cell cycle arrest at the G0/G1 checkpoint. The SM22alpha-p27 lentiviral vector inhibited VSMC proliferation more effectively than paclitaxel. Rats infected with Lenti-SM22alpha-p27 had a significantly lower intima/media (I/M) ratio and also showed inhibition of restenosis on day 28 after balloon injury. Moreover, the repair of injured endothelium, and re-endothelialization of the carotid artery wall, was not affected by the smooth muscle cell-specific expression of p27. Conclusion A recombinant lentiviral vector carrying the SM22alpha promoter was used to effectively infect and selectively overexpress p27 protein in VSMCs, leading to inhibition of intimal hyperplasia without compromising endothelial repair.	[Jing, Liang; Xie, Minjie; Tian, Daishi; Luo, Xiang; Wang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Peoples R China; [Wang, Wenlong; Zhang, Shuangshuang; Wang, Daowen; Ning, Qin; Lu, Jiagao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Cardiovasc Med, Wuhan 430030, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept & Inst Infect Dis, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Lu, JG (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Cardiovasc Med, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	lujiagao@tjh.tjmu.edu.cn; wwang@vip.126.com	Zhang, Shuangshuang/GVS-0109-2022	Tian, Dai-shi/0000-0002-7627-0811	Natural Science Foundation of China [81030021, 30870641]; National Basic Research Program [2011CB504403]; Program for Changjiang Scholars and Innovative Research Team in University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from Natural Science Foundation of China (81030021 to WW, 30870641 to LJ) and National Basic Research Program (2011CB504403 to WW) and Program for Changjiang Scholars and Innovative Research Team in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauriedel G, 2008, J VASC RES, V45, P173, DOI 10.1159/000110417; Blumenschein GR, 2008, J CLIN ONCOL, V26, P1879, DOI 10.1200/JCO.2007.12.2689; Breen DM, 2009, ARTERIOSCL THROM VAS, V29, P1060, DOI 10.1161/ATVBAHA.109.185447; Cheng W, 2009, EUR J PHARMACOL, V614, P44, DOI 10.1016/j.ejphar.2009.04.052; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; El-Kareh AW, 2008, AAPS J, V10, P15, DOI 10.1208/s12248-007-9003-6; Fasciano S, 2005, J BIOL CHEM, V280, P15682, DOI 10.1074/jbc.M411458200; Fuchs AT, 2008, ENDOTHELIUM-J ENDOTH, V15, P85, DOI 10.1080/10623320802092484; Gabrielson M, 2013, ONCOL REP, V29, P1268, DOI 10.3892/or.2013.2247; Henley D, 2007, CANCER CHEMOTH PHARM, V59, P235, DOI 10.1007/s00280-006-0262-1; Hoppmann P, 2009, JACC-CARDIOVASC INTE, V2, P1149, DOI 10.1016/j.jcin.2009.08.021; Huang YY, 2009, J INTERV CARDIOL, V22, P466, DOI 10.1111/j.1540-8183.2009.00489.x; Hughes TS, 2009, MOL THER, V17, P88, DOI 10.1038/mt.2008.230; Jean-Baptiste E, 2012, EUR J VASC ENDOVASC, V43, P188, DOI 10.1016/j.ejvs.2011.10.017; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Jimenez-Valero Santiago, 2008, Ther Adv Cardiovasc Dis, V2, P137, DOI 10.1177/1753944708090573; Katsaros KM, 2008, J THROMB HAEMOST, V6, P508, DOI 10.1111/j.1538-7836.2007.02884.x; KEMP PR, 1995, BIOCHEM J, V310, P1037, DOI 10.1042/bj3101037; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; LANDAU C, 1994, NEW ENGL J MED, V330, P981, DOI 10.1056/NEJM199404073301407; Li Y, 2009, CLIN CANCER RES, V15, P6724, DOI 10.1158/1078-0432.CCR-09-1296; Liao PC, 2005, LIFE SCI, V76, P1623, DOI 10.1016/j.lfs.2004.09.021; Lin Ping, 2009, Shengli Xuebao, V61, P331; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Oliver LN, 2008, INT J CARDIOL, V126, P216, DOI 10.1016/j.ijcard.2007.03.132; OSBOURN JK, 1995, GENE, V154, P249, DOI 10.1016/0378-1119(94)00847-L; Pan JJ, 2009, J CLIN ONCOL, V27, P799, DOI 10.1200/JCO.2008.18.9670; Paul A, 2012, BIOMATERIALS, V33, P7655, DOI 10.1016/j.biomaterials.2012.06.096; Pelisek J, 2006, J GENE MED, V8, P835, DOI 10.1002/jgm.905; POPMA JJ, 1991, CIRCULATION, V84, P1426, DOI 10.1161/01.CIR.84.3.1426; Shammas NW, 2009, CARDIOVASC REVASCULA, V10, P151, DOI 10.1016/j.carrev.2009.01.007; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shu CH, 1997, APOPTOSIS, V2, P463, DOI 10.1023/A:1026422111457; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Sroka IM, 2010, MOL PHARMACOL, V77, P255, DOI 10.1124/mol.109.060327; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; Tepe G, 2006, STROKE, V37, P492, DOI 10.1161/01.STR.0000199080.94177.ba; Thipparaboina R, 2013, INT J PHARMACEUT, V454, P4, DOI 10.1016/j.ijpharm.2013.07.005; Tiroch K, 2009, CARDIOLOGY, V112, P263, DOI 10.1159/000151695; Tu KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068574; Wang Jin, 2005, Yaoxue Xuebao, V40, P1099; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yang J, 2013, BIOMATERIALS, V34, P1635, DOI 10.1016/j.biomaterials.2012.11.006; Zhao YM, 2008, ACTA PHARMACOL SIN, V29, P481, DOI 10.1111/j.1745-7254.2008.00767.x; Zisis Charalambos, 2004, Interact Cardiovasc Thorac Surg, V3, P245, DOI 10.1016/j.icvts.2003.10.001	48	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118826	10.1371/journal.pone.0118826	http://dx.doi.org/10.1371/journal.pone.0118826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760326	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275000041
J	Zheng, YL; Zhang, LP; Zhang, XL; Wang, K; Zheng, YJ				Zheng, Yan-Ling; Zhang, Li-Ping; Zhang, Xue-Liang; Wang, Kai; Zheng, Yu-Jian			Forecast Model Analysis for the Morbidity of Tuberculosis in Xinjiang, China	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; HEMORRHAGIC-FEVER; RENAL SYNDROME; DENGUE INCIDENCE; ARIMA MODEL; PREDICTION	Tuberculosis is a major global public health problem, which also affects economic and social development. China has the second largest burden of tuberculosis in the world. The tuberculosis morbidity in Xinjiang is much higher than the national situation; therefore, there is an urgent need for monitoring and predicting tuberculosis morbidity so as to make the control of tuberculosis more effective. Recently, the Box-Jenkins approach, specifically the autoregressive integrated moving average (ARIMA) model, is typically applied to predict the morbidity of infectious diseases; it can take into account changing trends, periodic changes, and random disturbances in time series. Autoregressive conditional heteroscedasticity (ARCH) models are the prevalent tools used to deal with time series heteroscedasticity. In this study, based on the data of the tuberculosis morbidity from January 2004 to June 2014 in Xinjiang, we establish the single ARIMA (1, 1, 2) (1, 1, 1)(12) model and the combined ARIMA (1, 1, 2) (1, 1, 1)(12)-ARCH (1) model, which can be used to predict the tuberculosis morbidity successfully in Xinjiang. Comparative analyses show that the combined model is more effective. To the best of our knowledge, this is the first study to establish the ARIMA model and ARIMA-ARCH model for prediction and monitoring the monthly morbidity of tuberculosis in Xinjiang. Based on the results of this study, the ARIMA (1, 1, 2) (1, 1, 1)(12)-ARCH (1) model is suggested to give tuberculosis surveillance by providing estimates on tuberculosis morbidity trends in Xinjiang, China.	[Zheng, Yan-Ling; Zhang, Li-Ping; Zheng, Yu-Jian] Xinjiang Med Univ, Coll Publ Hlth, Urumqi 830011, Peoples R China; [Zheng, Yan-Ling; Zhang, Li-Ping; Zhang, Xue-Liang; Wang, Kai] Xinjiang Med Univ, Coll Med Engn & Technol, Urumqi 830011, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Zheng, YJ (corresponding author), Xinjiang Med Univ, Coll Publ Hlth, Urumqi 830011, Peoples R China.	zhyujian6@hotmail.com	Zhang, Li/GWM-7501-2022		National Natural Science Foundation of P.R. China [11461073, 81260410]; Academic Discipline Project of Xinjiang Medical University Health Measurements and Health Economics [XYDXK50780308]; Research and Innovation Project of Xinjiang Graduate [XJGRI2014101]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Academic Discipline Project of Xinjiang Medical University Health Measurements and Health Economics; Research and Innovation Project of Xinjiang Graduate	The entire study and the paper were financially supported by the National Natural Science Foundation of P.R. China (grant no. 11461073 and 81260410) and Academic Discipline Project of Xinjiang Medical University Health Measurements and Health Economics (grant no. XYDXK50780308) and Research and Innovation Project of Xinjiang Graduate (grant no. XJGRI2014101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MODEL SELECTION MODE; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Catalano R, 2001, J CLIN EPIDEMIOL, V54, P830, DOI 10.1016/S0895-4356(01)00348-1; Chinese Center for Disease Control and Prevention, 2010, CURR SIT TUB; Cunha GB, 2010, REV SOC BRASILEIRA M, V43, P67; Earnest A, 2005, BMC HEALTH SERV RES, V5, P316; Engle R, 2001, J ECON PERSPECT, V15, P157, DOI 10.1257/jep.15.4.157; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Guan P, 2004, WORLD J GASTROENTERO, V10, P3579, DOI 10.3748/wjg.v10.i24.3579; Guo Li-chun, 2008, Journal of China Medical University, V37, P839; Guo ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101113; KUHN L, 1994, AM J EPIDEMIOL, V140, P943, DOI 10.1093/oxfordjournals.aje.a117183; Lee YS, 2011, KNOWL-BASED SYST, V24, P66, DOI 10.1016/j.knosys.2010.07.006; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Liu HP, 2011, APPL ENERG, V88, P724, DOI 10.1016/j.apenergy.2010.09.028; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Nsoesie EO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002779; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Purwanto, 2012, APPL INTELL, V37, P511, DOI 10.1007/s10489-012-0344-1; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Rojas I, 2008, NEUROCOMPUTING, V71, P519, DOI 10.1016/j.neucom.2007.07.018; Tol RSJ, 1997, THEOR APPL CLIMATOL, V56, P113, DOI 10.1007/BF00863788; Wang YJ, 2006, CHINESE J VECTOR BIO, V17, P333; Wongkoon S, 2012, ASIAN PAC J TROP MED, V5, P249, DOI 10.1016/S1995-7645(12)60034-0; Wu Wei, 2008, Journal of China Medical University, V37, P52; Wu ZeMing, 2006, Zhongguo Meijieshengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V17, P223; Yi Jing, 2007, Zhonghua Yufang Yixue Zazhi, V41, P118; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang LP, 2014, COMPUT BIOL MED, V49, P67, DOI 10.1016/j.compbiomed.2014.02.008	37	29	45	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116832	10.1371/journal.pone.0116832	http://dx.doi.org/10.1371/journal.pone.0116832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760345	gold, Green Submitted, Green Published			2022-12-27	WOS:000351275000009
J	Bao, K; Bostanci, N; Selevsek, N; Thurnheer, T; Belibasakis, GN				Bao, Kai; Bostanci, Nagihan; Selevsek, Nathalie; Thurnheer, Thomas; Belibasakis, Georgios N.			Quantitative Proteomics Reveal Distinct Protein Regulations Caused by Aggregatibacter actinomycetemcomitans within Subgingival Biofilms	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; FUSOBACTERIUM-NUCLEATUM; TANNERELLA-FORSYTHIA; PERIODONTITIS; MODEL; COMMUNITIES; VALIDATION; DISRUPTION; EXPRESSION	Periodontitis is an infectious disease that causes the inflammatory destruction of the tooth-supporting (periodontal) tissues, caused by polymicrobial biofilm communities growing on the tooth surface. Aggressive periodontitis is strongly associated with the presence of Aggregatibacter actinomycetemcomitans in the subgingival biofilms. Nevertheless, whether and how A. actinomycetemcomitans orchestrates molecular changes within the biofilm is unclear. The aim of this work was to decipher the interactions between A. actinomycetemcomitans and other bacterial species in a multi-species biofilm using proteomic analysis. An in vitro 10-species "subgingival" biofilm model, or its derivative that included additionally A. actinomycetemcomitans, were anaerobically cultivated on hydroxyapatite discs for 64 h. When present, A. actinomycetemcomitans formed dense intra-species clumps within the biofilm mass, and did not affect the numbers of the other species in the biofilm. Liquid chromatography- tandem mass spectrometry was used to identify the proteomic content of the biofilm lysate. A total of 3225 and 3352 proteins were identified in the biofilm, in presence or absence of A. actinomycetemcomitans, respectively. Label-free quantitative proteomics revealed that 483 out of the 728 quantified bacterial proteins (excluding those of A. actinomycetemcomitans) were accordingly regulated. Interestingly, all quantified proteins from Prevotella intermedia were up-regulated, and most quantified proteins from Campylobacter rectus, Streptococcus anginosus, and Porphyromonas gingivalis were down-regulated in presence of A. actinomycetemcomitans. Enrichment of Gene Ontology pathway analysis showed that the regulated groups of proteins were responsible primarily for changes in the metabolic rate, the ferric iron-binding, and the 5S RNA binding capacities, on the universal biofilm level. While the presence of A. actinomycetemcomitans did not affect the numeric composition or absolute protein numbers of the other biofilm species, it caused qualitative changes in their overall protein expression profile. These molecular shifts within the biofilm warrant further investigation on their potential impact on its virulence properties, and association with periodontal pathogenesis.	[Bao, Kai; Bostanci, Nagihan] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Oral Translat Res, Zurich, Switzerland; [Selevsek, Nathalie] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Thurnheer, Thomas; Belibasakis, Georgios N.] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Oral Microbiol & Immunol, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Belibasakis, GN (corresponding author), Univ Zurich, Ctr Dent Med, Inst Oral Biol, Oral Microbiol & Immunol, Zurich, Switzerland.	George.Belibasakis@zzm.uzh.ch	Belibasakis, Georgios/AAL-3159-2020; Bostanci, Nagihan/ABD-5524-2020; Bao, Kai/S-4223-2017	Belibasakis, Georgios/0000-0002-8164-0653; Bostanci, Nagihan/0000-0002-6742-3556; Bao, Kai/0000-0002-1183-5607; Thurnheer, Thomas/0000-0002-8615-8209				Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ammann TW, 2013, J PERIODONTAL RES, V48, P517, DOI 10.1111/jre.12034; Ammann TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083090; Ammann TW, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-227; Bachtiar EW, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00094; Bao K, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0258-7; Belibasakis GN, 2014, MOL ORAL MICROBIOL, V29, P174, DOI 10.1111/omi.12053; Belibasakis GN, 2014, J PERIODONTOL, V85, P204, DOI 10.1902/jop.2013.130144; Belibasakis GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081581; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; Comas I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-147; Daep CA, 2011, INFECT IMMUN, V79, P67, DOI 10.1128/IAI.00361-10; Dahlen G, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23977; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; GMUR R, 1983, INFECT IMMUN, V42, P459; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hajishengallis G, 2015, VIRULENCE; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Haraguchi A, 2014, MOL ORAL MICROBIOL, V29, P131, DOI 10.1111/omi.12051; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Hendrickson EL, 2014, MICROBIOLOGYOPEN, V3, P729, DOI 10.1002/mbo3.204; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Hendrickson EL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-185; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lamont RJ, 2014, TRENDS MOL MED; Lin X, 2008, J BACTERIOL, V190, P4367, DOI 10.1128/JB.01898-07; Lundberg KC, 2015, MOL CELL PROTEOMICS, V14, P109, DOI 10.1074/mcp.M114.042242; Mahajan A, 2013, SCI WORLD J, DOI 10.1155/2013/765434; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Orth RKH, 2011, MOL ORAL MICROBIOL, V26, P229, DOI 10.1111/j.2041-1014.2011.00612.x; Pereira CS, 2012, MOL MICROBIOL, V84, P93, DOI 10.1111/j.1365-2958.2012.08010.x; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Periasamy S, 2009, INFECT IMMUN, V77, P3542, DOI 10.1128/IAI.00345-09; Raja M, 2014, J CLIN DIAGN RES, V8, pZE13, DOI 10.7860/JCDR/2014/9845.4766; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Reddi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043899; Rhodes ER, 2007, BIOMETALS, V20, P365, DOI 10.1007/s10534-006-9058-3; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Roberts AP, 2006, PERIODONTOL 2000, V42, P36, DOI 10.1111/j.1600-0757.2006.00149.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Settem RP, 2012, INFECT IMMUN, V80, P2436, DOI 10.1128/IAI.06276-11; Shao HJ, 2007, J BACTERIOL, V189, P5559, DOI 10.1128/JB.00387-07; Sharma A, 2005, ORAL MICROBIOL IMMUN, V20, P39, DOI 10.1111/j.1399-302X.2004.00175.x; Shen YY, 2015, J PROTEOMICS, V112, P274, DOI 10.1016/j.jprot.2014.10.006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takasaki K, 2013, J PERIODONTAL RES, V48, P286, DOI 10.1111/jre.12006; Thurnheer T, 2014, INTEGRATION NONORAL; Tsaousoglou P, 2014, J MED MICROBIOL, V63, P284, DOI 10.1099/jmm.0.065441-0; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu XP, 2001, INFECT IMMUN, V69, P4465, DOI 10.1128/IAI.69.7.4465-4472.2001; Zainal-Abidin Z, 2012, J PROTEOME RES, V11, P4449, DOI 10.1021/pr300201c; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071727; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	71	31	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119222	10.1371/journal.pone.0119222	http://dx.doi.org/10.1371/journal.pone.0119222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756960	gold, Green Published, Green Accepted			2022-12-27	WOS:000351275700041
J	Guo, SL; Ku, LX; Qi, JS; Tian, ZQ; Han, T; Zhang, LK; Su, HH; Ren, ZZ; Chen, YH				Guo, Shulei; Ku, Lixia; Qi, Jianshuang; Tian, Zhiqiang; Han, Tuo; Zhang, Liangkun; Su, Huihui; Ren, Zhenzhen; Chen, Yanhui			Genetic Analysis and Major Quantitative Trait Locus Mapping of Leaf Widths at Different Positions in Multiple Populations	PLOS ONE			English	Article							MENDELIAN FACTORS; MAIZE; GROWTH; ARCHITECTURE; COACTIVATOR; YIELD	Background Leaf width is an important agricultural trait in maize. Leaf development is dependent on cell proliferation and expansion, and these processes exhibit polarity with respect to the longitudinal and transverse axes of the leaf. However, the molecular mechanism of the genetic control of seed vigor remains unknown in maize, and a better understanding of this mechanism is required. Methodology/Principal Findings To reveal the genetic architecture of leaf width, a comprehensive evaluation using four RIL populations was performed, followed by a meta-analysis. Forty-six QTLs associated with the widths of leaves at different positions above the uppermost ear were detected in the four RIL populations in three environments. The individual effects of the QTLs ranged from 4.33% to 18.01% of the observed phenotypic variation, with 14 QTLs showing effects of over 10%. We identified three common QTLs associated with leaf width at all of the examined positions, in addition to one common QTL associated with leaf width at three of the positions and six common QTLs associated with leaf width at two of the positions. The results indicate that leaf width at different leaf positions may be affected by one QTL or several of the same QTLs. Such traits may also be regulated by many different QTLs. Thirty-one of the forty-six initial QTLs were integrated into eight mQTLs through a meta-analysis, and 10 of the 14 initial QTLs presenting an R2> 10% were integrated into six mQTLs. Conclusions/Significance mQTL1-2, mQTL3-1, mQTL7, and mQTL8 were composed of the initial QTLs showing an R2> 10% and included four to six of the initial QTLs that were associated with two to four positions in a single population. Therefore, these four chromosome regions may be hot spots for important QTLs for these traits. Thus, they warrant further studies and may be useful for marker-assisted breeding.	[Guo, Shulei; Ku, Lixia; Tian, Zhiqiang; Han, Tuo; Zhang, Liangkun; Su, Huihui; Ren, Zhenzhen; Chen, Yanhui] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China; [Guo, Shulei; Ku, Lixia; Tian, Zhiqiang; Han, Tuo; Zhang, Liangkun; Su, Huihui; Ren, Zhenzhen; Chen, Yanhui] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China; [Qi, Jianshuang] Henan Acad Agr Sci, Res Inst Food Crops, Zhengzhou 450002, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Academy of Agricultural Sciences	Chen, YH (corresponding author), Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China.	chy9890@163.com			National Natural Science Foundation of China [31230055]; Science and Technology Innovation Talents of Henan University [13HASTIT002]; Corn Industry Technology System in Henan Province [S2010-02]; Key Base Research Project of Henan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Talents of Henan University; Corn Industry Technology System in Henan Province; Key Base Research Project of Henan Province	This work was supported by grants from the National Natural Science Foundation of China (No. 31230055), the Science and Technology Innovation Talents of Henan University (No. 13HASTIT002), the Corn Industry Technology System in Henan Province (S2010-02), and the Key Base Research Project of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2010, THEOR APPL GENET; [Anonymous], 2012, J EXP BOT; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Doerge RW, 1996, GENETICS, V142, P285; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; DUVICK DN, 1992, MAYDICA, V37, P69; DUVICK DN, 1977, MAYDICA, V22, P187; Fujino K, 2008, MOL GENET GENOMICS, V279, P499, DOI 10.1007/s00438-008-0328-3; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Goffinet B, 2000, GENETICS, V155, P463; Henderson DC, 2005, DEV BIOL, V282, P455, DOI 10.1016/j.ydbio.2005.03.027; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Kim JH, 2004, P NATL ACAD SCI USA, V101, P13374, DOI 10.1073/pnas.0405450101; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Knapp SJ., 1985, CROP SCI, V25, P192, DOI [10.2135/cropsci1985.0011183X002500010046x, DOI 10.2135/cropsci1985.0011183X002500010046x]; LANDER ES, 1989, GENETICS, V121, P185; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Lynch M., 1998, GENETICS ANAL QUANTI; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Sazuka T, 2009, PLANT J, V60, P227, DOI 10.1111/j.1365-313X.2009.03952.x; Scanlon MJ, 2000, CURR OPIN PLANT BIOL, V3, P31, DOI 10.1016/S1369-5266(99)00040-0; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; Scanlon MJ, 2000, GENETICS, V155, P1379; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Timmermans MCP, 1998, DEVELOPMENT, V125, P2813; Trachsel S, 2009, THEOR APPL GENET, V119, P1413, DOI 10.1007/s00122-009-1144-9; Tsiantis M, 2001, PLANT CELL, V13, P733, DOI 10.1105/tpc.13.4.733; Tsukaya H, 2002, ARABIDOPSIS BOOK; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; ZENG ZB, 1994, GENETICS, V136, P1457	35	11	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119095	10.1371/journal.pone.0119095	http://dx.doi.org/10.1371/journal.pone.0119095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756495	Green Submitted, gold, Green Published			2022-12-27	WOS:000351275700037
J	Mischiati, C; Ura, B; Roncoroni, L; Elli, L; Cervellati, C; Squerzanti, M; Conte, D; Doneda, L; de Laureto, PP; de Franceschi, G; Calza, R; Barrero, CA; Merali, S; Ferrari, C; Bergamini, CM; Agostinelli, E				Mischiati, Carlo; Ura, Blendi; Roncoroni, Leda; Elli, Luca; Cervellati, Carlo; Squerzanti, Monica; Conte, Dario; Doneda, Luisa; de laureto, Patrizia Polverino; de Franceschi, Giorgia; Calza, Roberta; Barrero, Carlos A.; Merali, Salim; Ferrari, Carlo; Bergamini, Carlo M.; Agostinelli, Enzo			Changes in Protein Expression in Two Cholangiocarcinoma Cell Lines Undergoing Formation of Multicellular Tumor Spheroids In Vitro	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; TISSUE TRANSGLUTAMINASE; MECHANICAL STRAIN; INITIATING CELLS; CANCER CELLS; STEM-CELLS; IDENTIFICATION; HEAD; METASTASIS	Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates with worsening disease progression due to its implications in metastases and resistance to therapeutic interventions. Although EMT is known to occur in several types of solid tumors, the information concerning tumors arising from the epithelia of the bile tract is still limited. In order to approach the problem of EMT in cholangiocarcinoma, we decided to investigate the changes in protein expression occurring in two cell lines under conditions leading to growth as adherent monolayers or to formation of multicellular tumor spheroids (MCTS), which are considered culture models that better mimic the growth characteristics of in-vivo solid tumors. In our system, changes in phenotypes occur with only a decrease in transmembrane E-cadherin and vimentin expression, minor changes in the transglutaminase protein/activity but with significant differences in the proteome profiles, with declining and increasing expression in 6 and in 16 proteins identified by mass spectrometry. The arising protein patterns were analyzed based on canonical pathways and network analysis. These results suggest that significant metabolic rearrangements occur during the conversion of cholangiocarcinomas cells to the MCTS phenotype, which most likely affect the carbohydrate metabolism, protein folding, cytoskeletal activity, and tissue sensitivity to oxygen.	[Mischiati, Carlo; Cervellati, Carlo; Squerzanti, Monica; Calza, Roberta; Bergamini, Carlo M.] Univ Ferrara, Dept Biomed & Surg Sci, I-44100 Ferrara, Italy; [Ura, Blendi] Univ Trieste, IRCCS Burlo Garofalo, Inst Maternal & Child Hlth, Trieste, Italy; [Roncoroni, Leda; Elli, Luca; Conte, Dario] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ctr Prevent & Diag Coeliac Disease Gastroenterol, Milan, Italy; [Roncoroni, Leda; Doneda, Luisa] Univ Milan, Dept Biomed Surg & Odontoiatr Sci, Milan, Italy; [de laureto, Patrizia Polverino; de Franceschi, Giorgia] Univ Padua, CRIBI Ctr Innovat Biotechnol, Padua, Italy; [Barrero, Carlos A.; Merali, Salim] Temple Univ, Sch Pharm, Moulder Ctr Drug Discovery Res, Philadelphia, PA 19122 USA; [Ferrari, Carlo] Le Marche Polytech Univ, Fac Med, Dept Clin & Mol Sci, Ancona, Italy; [Agostinelli, Enzo] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Agostinelli, Enzo] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Agostinelli, Enzo] CNR, Inst Biol, Rome, Italy; [Agostinelli, Enzo] Inst Mol Pathol, Rome, Italy	University of Ferrara; IRCCS Burlo Garofolo; University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Padua; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Marche Polytechnic University; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Bergamini, CM (corresponding author), Univ Ferrara, Dept Biomed & Surg Sci, I-44100 Ferrara, Italy.	bgc@unife.it	Cervellati, Carlo/K-6453-2015; Elli, Luca/K-6084-2016; Ferrari, Carlo/D-5663-2017; Mischiati, Carlo/AAF-2016-2020; Carlo, Bergamini/K-5664-2016	Cervellati, Carlo/0000-0003-4777-6300; Elli, Luca/0000-0002-0873-0759; Ferrari, Carlo/0000-0002-5461-6842; Carlo, Bergamini/0000-0002-9430-8625; Mischiati, Carlo/0000-0002-0029-2205; Barrero, Carlos/0000-0001-5779-6642; URA, BLENDI/0000-0003-2669-439X	University of Ferrara; San Marco Bioenergie, Bando d'Argenta, FE; Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca); Istituto Superiore di Sanita "Project Italy-USA"; Istituto Pasteur Fondazione Cenci Bolognetti	University of Ferrara; San Marco Bioenergie, Bando d'Argenta, FE; Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita "Project Italy-USA"; Istituto Pasteur Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This research was financially supported by grants from University of Ferrara (to CMB) and from San Marco Bioenergie, Bando d'Argenta, FE (to CM). Further, it was funded by the Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca), by Istituto Superiore di Sanita "Project Italy-USA" and by Istituto Pasteur Fondazione Cenci Bolognetti (to EA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376; Bastid J, 2012, CANCER METAST REV, V31, P277, DOI 10.1007/s10555-011-9344-6; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bergamini Carlo M, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P1; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budillon A, 2013, AMINO ACIDS, V44, P63, DOI 10.1007/s00726-011-1167-9; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CARBONEL.J, 1973, EUR J BIOCHEM, V37, P148, DOI 10.1111/j.1432-1033.1973.tb02969.x; Carcoforo P, 2013, MOL MED REP, V7, P1700, DOI 10.3892/mmr.2013.1375; Gallardo-Perez JC, 2014, BBA-MOL CELL RES, V1843, P1043, DOI 10.1016/j.bbamcr.2014.01.013; Cervellati C, 2012, AMINO ACIDS, V42, P2233, DOI 10.1007/s00726-011-0963-6; Chu K, 2013, ONCOTARGET, V4, P446, DOI 10.18632/oncotarget.872; Cleland W. W., 1969, METHOD ENZYMOL, V13, P30, DOI 10.1016/0076-6879(69)13011-6; Dupourque D, 1969, CYTOPLASMIC MITOCHON, V13, P116; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Girard YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075345; Grassian AR, 2014, CURR OPIN GASTROEN, V30, P295, DOI 10.1097/MOG.0000000000000050; Gu MJ, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201806; Huang SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077497; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jung HJ, 2012, BLOOD, V119, P2568, DOI 10.1182/blood-2011-09-377598; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai TS, 2007, FASEB J, V21, P4131, DOI 10.1096/fj.06-7598com; Li TY, 2010, ANN SURG ONCOL, V17, P1937, DOI 10.1245/s10434-010-0925-3; Mathias RA, 2009, BBA-PROTEINS PROTEOM, V1794, P1325, DOI 10.1016/j.bbapap.2009.05.001; McMahon KM, 2012, J PROTEOME RES, V11, P2863, DOI 10.1021/pr2012472; Nijkamp MM, 2011, RADIOTHER ONCOL, V99, P344, DOI 10.1016/j.radonc.2011.05.066; Okamoto K, 2012, INT J ONCOL, V41, P573, DOI 10.3892/ijo.2012.1499; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Prensner JR, 2011, NAT MED, V17, P291, DOI 10.1038/nm0311-291; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; RICHARDS OC, 1961, J BIOL CHEM, V236, P3185; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Roncoroni L, 2008, LIVER INT, V28, P1426, DOI 10.1111/j.1478-3231.2008.01749.x; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Smith A, 2013, ORAL ONCOL, V49, P287, DOI 10.1016/j.oraloncology.2012.10.009; Techasen A, 2012, ASIAN PAC J CANCER P, V13, P115, DOI 10.7314/APJCP.2012.13.KKSuppl.115; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Yao XL, 2014, EUR REV MED PHARMACO, V18, P3149; Yao X, 2014, BIOCHEM BIOPH RES CO, V455, P277, DOI 10.1016/j.bbrc.2014.11.007; Yonglitthipagon P, 2012, CLIN BIOCHEM, V45, P827, DOI 10.1016/j.clinbiochem.2012.04.004; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	54	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118906	10.1371/journal.pone.0118906	http://dx.doi.org/10.1371/journal.pone.0118906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756965	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700031
J	Pfarr, K; Danciu, C; Arlt, O; Neske, C; Dehelean, C; Pfeilschifter, JM; Radeke, HH				Pfarr, Kathrin; Danciu, Corina; Arlt, Olga; Neske, Christina; Dehelean, Cristina; Pfeilschifter, Josef M.; Radeke, Heinfried H.			Simultaneous and Dose Dependent Melanoma Cytotoxic and Immune Stimulatory Activity of Betulin	PLOS ONE			English	Article							ISOFLAVONE GENISTEIN; CELL-DEATH; T-CELLS; ACID; CANCER; SPHINGOSINE-1-PHOSPHATE; FINGOLIMOD; DISCOVERY; CARCINOMA; APOPTOSIS	Conventional cytostatic cancer treatments rarely result in the complete eradication of tumor cells. Therefore, new therapeutic strategies focus on antagonizing the immunosuppressive activity of established tumors. In particular, recent studies of antigen-loaded dendritic cells (DCs) eliciting a specific antitumor immune response has raised the hopes of achieving the complete elimination of tumor tissue. Genistein, fingolimod and betulin have already been described as active compounds in different types of cancer. Herein, we applied an integrated screening approach to characterize both their cytostatic and their immune-modulating properties side-by-side. As will be described in detail, our data confirmed that all three compounds exerted proapoptotic and antiproliferative activity in different B16 melanoma cell lines to a given extent, as revealed by an MTT assay, CFSE and DAPI staining. However, while genistein and fingolimod also affected the survival of primary bone marrow (BM) derived DCs of C57BL/6 mice, betulin exhibited a lower cytotoxicity for BMDCs in comparison to the melanoma cells. Moreover, we could show for the first time, that only betulin caused a simultaneous, highly specific immune-stimulating activity, as measured by the IL-12p70 release of Toll-like receptor 4-stimulated BMDCs by ELISA, which was due to increased IL-12p35 mRNA expression. Interestingly, the activation of DCs resulted in enhanced T lymphocyte stimulation, indicated by increased IL-2 and IFN-gamma production of cytotoxic T cells in spleen cell co-culture assays which led to a decreased viability of B16 cells in an antigen specific model system. This may overcome the immunosuppressive environment of a tumor and destroy tumor cells more effectively in vivo if the immune response is specific targeted against the tumor tissue by antigen-loaded dendritic cells. In summary, cytostatic agents, such as betulin, that simultaneously exhibit immune stimulatory activity may serve as lead compounds and hold great promise as a novel approach for an integrated cancer therapy.	[Pfarr, Kathrin; Arlt, Olga; Neske, Christina; Pfeilschifter, Josef M.; Radeke, Heinfried H.] Goethe Univ Frankfurt, Inst Gen Pharmacol & Toxicol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Danciu, Corina; Dehelean, Cristina] Univ Med & Farm Timisoara, Fac Pharm, Dept Pharmacognosy, Timisoara, Romania; [Danciu, Corina; Dehelean, Cristina] Univ Med & Farm Timisoara, Fac Pharm, Dept Toxicol, Timisoara, Romania	Goethe University Frankfurt; Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Radeke, HH (corresponding author), Goethe Univ Frankfurt, Inst Gen Pharmacol & Toxicol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	radeke@em.uni-frankfurt.de	Radeke, Heinfried H/E-3772-2013	Radeke, Heinfried H/0000-0002-4499-2510; Multhoff, Gabriele/0000-0002-2616-3137; Danciu, Corina/0000-0001-5999-1214	DFG Graduate School [1172]; European Social Fund, Human Resources Development Operational Programme [POSDRU/159/1.5/S/136893]	DFG Graduate School(German Research Foundation (DFG)); European Social Fund, Human Resources Development Operational Programme	This project was made possible by a grant to HHR of Merck KGaA to the DFG Graduate School 1172 in support of the PhD thesis of KP. CD was supported by the European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/136893. Both funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaker H, 2013, ADV CANCER RES, V117, P143, DOI 10.1016/B978-0-12-394274-6.00006-6; Bajetta E, 2002, SEMIN ONCOL, V29, P427, DOI 10.1053/sonc.2002.35238; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Chiba K, 2012, FUTURE MED CHEM, V4, P771, DOI [10.4155/FMC.12.25, 10.4155/fmc.12.25]; Danciu C, 2013, NAT PROD COMMUN, V8, P343; Danciu C, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-58; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Dehelean CA, 2013, J BIOMED NANOTECHNOL, V9, P577, DOI 10.1166/jbn.2013.1563; Ehrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Enzenmuller S, 2013, CANCER LETT, V329, P27, DOI 10.1016/j.canlet.2012.09.007; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Fulda S, 2008, INT J MOL SCI, V9, P1096, DOI 10.3390/ijms9061096; Fulda S, 2009, DRUG DISCOV TODAY, V14, P885, DOI 10.1016/j.drudis.2009.05.015; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Li CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032380; Li Y, 2010, MOL CARCINOGEN, V49, P630, DOI 10.1002/mc.20638; Liu Y, 2012, MOL CELLS, V33, P517, DOI 10.1007/s10059-012-0022-5; Mahmoud AM, 2014, J STEROID BIOCHEM, V140, P116, DOI 10.1016/j.jsbmb.2013.12.010; Martin SF, 2008, J EXP MED, V205, P2151, DOI 10.1084/jem.20070509; Mullauer FB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005361; Nagahara Y, 2001, JPN J CANCER RES, V92, P680, DOI 10.1111/j.1349-7006.2001.tb01148.x; Oaks JJ, 2013, BLOOD, V122, P1923, DOI 10.1182/blood-2013-03-492181; Pernmpongkosol S, 2002, INT J CANCER, V98, P167, DOI 10.1002/ijc.10178; Piotrowska H, 2012, MUTAT RES-REV MUTAT, V750, P60, DOI 10.1016/j.mrrev.2011.11.001; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Pradere J, 2013, ONCOGENE; Rigel D. S., 2011, CANC SKIN; Schroder M, 2011, MOL IMMUNOL, V48, P1139, DOI 10.1016/j.molimm.2011.02.007; Sharma N, 2013, J LEUKOCYTE BIOL, V93, P521, DOI 10.1189/jlb.0712328; Shi MQ, 2006, J LEUKOCYTE BIOL, V80, P1354, DOI 10.1189/jlb.0506321; Sodhi A, 2011, IMMUNOBIOLOGY, V216, P358, DOI 10.1016/j.imbio.2010.07.002; Soica CM, 2012, NAT PROD RES, V26, P968, DOI 10.1080/14786419.2010.545352; Szuster-Ciesielska A, 2011, TOXICOLOGY, V280, P152, DOI 10.1016/j.tox.2010.12.006; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Wan Y, 2013, INT IMMUNOPHARMACOL, V17, P184, DOI 10.1016/j.intimp.2013.06.012; Wei HC, 1998, CARCINOGENESIS, V19, P1509, DOI 10.1093/carcin/19.8.1509; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047979; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Zeng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034830; Zhang N, 2010, AUTOPHAGY, V6, P1157, DOI 10.4161/auto.6.8.13614; Zhou X, 2014, NUTRITION, V30, P90, DOI 10.1016/j.nut.2013.06.006; Zitvogel L, 1996, J EXP MED, V183, P87, DOI 10.1084/jem.183.1.87; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	46	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118802	10.1371/journal.pone.0118802	http://dx.doi.org/10.1371/journal.pone.0118802			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756279	gold, Green Published, Green Submitted			2022-12-27	WOS:000351275700025
J	Tlauka, M				Tlauka, Michael			The Processing of Object Identity Information by Women and Men	PLOS ONE			English	Article							HUNTER-GATHERER THEORY; SEX-DIFFERENCES; GENDER-DIFFERENCES; LOCATION MEMORY; SPATIAL ABILITIES; FEMALE ADVANTAGE; PERFORMANCE; HYPOTHESIS; KNOWLEDGE; SELECTION	The study examined whether women excel at tasks which require processing the identity of objects information as has been suggested in the context of the well-known object location memory task. In a computer-simulated task, university students were shown simulated indoor and outdoor house scenes. After studying a scene the students were presented with two images. One was the original image and the other a modified version in which one object was either rotated by ninety degrees or substituted with a similar looking object. The participants were asked to indicate the original image. The main finding was that no sex effect was obtained in this task. The female and male students did not differ on a verbal ability test, and their 2D:4D ratios were found to be comparable.	Flinders Univ S Australia, Adelaide, SA 5001, Australia	Flinders University South Australia	Tlauka, M (corresponding author), Flinders Univ S Australia, Adelaide, SA 5001, Australia.	Michael.tlauka@flinders.edu.au						Australian Council of Educational Research, 1960, COOP READ COMPR TEST; Choi J, 2005, LEARN INDIVID DIFFER, V15, P237, DOI 10.1016/j.lindif.2005.02.001; Collins DW, 1997, BEHAV NEUROSCI, V111, P845, DOI 10.1037/0735-7044.111.4.845; CSATHO A, 2003, LEARN INDIVID DIFFER, V13, P239; De Goede M, 2008, BRAIN COGNITION, V66, P232, DOI 10.1016/j.bandc.2007.08.004; EALS M, 1994, ETHOL SOCIOBIOL, V15, P95, DOI 10.1016/0162-3095(94)90020-5; GAULIN SJC, 1989, ANIM BEHAV, V37, P322, DOI 10.1016/0003-3472(89)90121-8; GAULIN SJC, 1986, AM NAT, V127, P74, DOI 10.1086/284468; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P634, DOI 10.1001/archneur.1985.04060070024012; Hollingworth A, 2006, J EXP PSYCHOL LEARN, V32, P58, DOI 10.1037/0278-7393.32.1.58; Honda A, 2009, LEARN INDIVID DIFFER, V19, P234, DOI 10.1016/j.lindif.2008.11.005; James TW, 1997, EVOL HUM BEHAV, V18, P155, DOI 10.1016/S1090-5138(97)00004-4; Jones CM, 2003, BEHAV NEUROSCI, V117, P403, DOI 10.1037/0735-7044.117.3.403; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; Kempel P, 2005, INTELLIGENCE, V33, P215, DOI 10.1016/j.intell.2004.11.004; Lejbak L, 2009, BRAIN COGNITION, V69, P148, DOI 10.1016/j.bandc.2008.06.006; Levy LJ, 2005, BEHAV NEUROSCI, V119, P853, DOI 10.1037/0735-7044.119.4.853; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Malinowski JC, 2001, J ENVIRON PSYCHOL, V21, P73, DOI 10.1006/jevp.2000.0183; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; Manning JT., 2002, DIGIT RATIO POINTER; Neave N, 2005, HUM NATURE-INT BIOS, V16, P146, DOI 10.1007/s12110-005-1001-8; Persson J, 2013, BEHAV BRAIN RES, V256, P219, DOI 10.1016/j.bbr.2013.07.050; PRESSON CC, 1994, PERCEPTION, V23, P1447, DOI 10.1068/p231447; RIESER JJ, 1989, J EXP PSYCHOL LEARN, V15, P1157, DOI 10.1037/0278-7393.15.6.1157; Ruggiero G, 2008, MEMORY, V16, P821, DOI 10.1080/09658210802307695; Sherry DF, 1997, TRENDS COGN SCI, V1, P50, DOI 10.1016/S1364-6613(97)01015-2; Silverman I., 1992, ADAPTED MIND EVOLUTI, P533; Silverman I, 2007, ARCH SEX BEHAV, V36, P261, DOI 10.1007/s10508-006-9168-6; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tlauka M, 2005, J ENVIRON PSYCHOL, V25, P111, DOI 10.1016/j.jenvp.2004.12.002; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Voyer D, 2007, PSYCHON B REV, V14, P23, DOI 10.3758/BF03194024; Williams TJ, 2000, NATURE, V404, P455, DOI 10.1038/35006555; [No title captured]	35	2	2	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118984	10.1371/journal.pone.0118984	http://dx.doi.org/10.1371/journal.pone.0118984			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756200	Green Published, gold, Green Submitted			2022-12-27	WOS:000351275700034
J	Santamaria, N; Bello, G; Pousis, C; Vassallo-Agius, R; de la Gandara, F; Corriero, A				Santamaria, Nicoletta; Bello, Giambattista; Pousis, Chrysovalentinos; Vassallo-Agius, Robert; de la Gandara, Fernando; Corriero, Aldo			Fin Spine Bone Resorption in Atlantic Bluefin Tuna, Thunnus thynnus, and Comparison between Wild and Captive-Reared Specimens	PLOS ONE			English	Article							GERM-CELL PROLIFERATION; HORMONE AGONIST GNRHA; DORSAL FIN; REPRODUCTIVE MATURATION; VERTEBRAL SKELETON; AGE ESTIMATION; L. 1758; STRESS; TEMPERATURE; APOPTOSIS	Bone resorption in the first spine of the first dorsal fin of Atlantic bluefin tuna (ABFT) has long been considered for age estimation studies. In the present paper spine bone resorption was assessed in wild (aged 1 to 13 years) and captive-reared (aged 2 to 11 years) ABFT sampled from the Mediterranean Sea. Total surface (TS), solid surface (SS) and reabsorbed surface (RS) were measured in spine transverse sections in order to obtain proportions of SS and RS. The spine section surface was found to be isometrically correlated to the fish fork length by a power equation. The fraction of solid spine bone progressively decreased according to a logarithmic equation correlating SS/TS to both fish size and age. The values ranged from 57% in the smallest examined individuals to 37% in the largest specimens. This phenomenon was further enhanced in captive-reared ABFT where SS/TS was 22% in the largest measured specimen. The difference between the fraction of SS of wild and captive-reared ABFT was highly significant. In each year class from 1- to 7-year-old wild specimens, the fraction of spine reabsorbed surface was significantly higher in specimens collected from March to May than in those sampled during the rest of the year. In 4-year-old fish the normal SS increase during the summer did not occur, possibly coinciding with their first sexual maturity. According to the correlations between SS/TS and age, the rate of spine bone resorption was significantly higher, even almost double, in captive-reared specimens. This could be attributed to the wider context of systemic dysfunctions occurring in reared ABFT, and may be related to a number of factors, including nutritional deficiencies, alteration of endocrine profile, cortisol-induced stress, and loss of spine functions during locomotion in rearing conditions.	[Santamaria, Nicoletta; Bello, Giambattista; Pousis, Chrysovalentinos; Corriero, Aldo] Univ Bari Aldo Moro, Sect Vet Med & Anim Prod, Dept Emergency & Organ Transplantat, Valenzano, BA, Italy; [Vassallo-Agius, Robert] Malta Aquaculture Res Ctr, Marsaxlokk, Malta; [de la Gandara, Fernando] Inst Espanol Oceanog, Ctr Oceanog Murcia, Puerto De Mazarron, Spain	Universita degli Studi di Bari Aldo Moro; Spanish Institute of Oceanography	Corriero, A (corresponding author), Univ Bari Aldo Moro, Sect Vet Med & Anim Prod, Dept Emergency & Organ Transplantat, Valenzano, BA, Italy.	aldo.corriero@uniba.it	de la GÃndara, Fernando/ABC-4724-2020; Corriero, Aldo/AAH-1542-2021; de la Gandara, Fernando/H-5377-2017	Corriero, Aldo/0000-0001-7068-9438; de la Gandara, Fernando/0000-0001-6045-7510; Pousis, Chrysovalentinos/0000-0003-4355-2393	EU [Q5RS-2002-01355, 212797]; Italian Strategic Project of the Apulian Region [PS_085]	EU(European Commission); Italian Strategic Project of the Apulian Region	Funding provided by EU 5th Framework Programme contract Q5RS-2002-01355 "Reproduction of the bluefin tuna in captivity - a feasibility study for the domestication of Thunnus thynnus (REPRODOTT)". Responsible: G. De Metrio (retired). Italian Strategic Project of the Apulian Region PS_085 "Set up of an integrated system for bluefin tuna farming" (ALLOTUNA). Responsible: A. Corriero. EU 5th Framework Programme grant number 212797 " From capture based to SELF-sustained aquaculture and Domestication of bluefin tuna, Thunnus thynnus (SELFDOTT): Responsible: A. Corriero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 1997, J EXP BIOL, V200, P2617; AMPRINO R., 1956, PUBL STAZ ZOOL NAPOLI, V28, P62; Aranda G, 2011, AQUACULTURE, V317, P255, DOI 10.1016/j.aquaculture.2011.04.030; Ashley-Ross MA, 2002, J EXP ZOOL, V293, P561, DOI 10.1002/jez.10183; BARTON BA, 1988, PROG FISH CULT, V50, P16, DOI 10.1577/1548-8640(1988)050&lt;0016:FADCAS&gt;2.3.CO;2; BARTON BA, 1995, PROG FISH CULT, V57, P267, DOI 10.1577/1548-8640(1995)057&lt;0267:PROJWT&gt;2.3.CO;2; BARTON BA, 1987, AQUACULTURE, V62, P299, DOI 10.1016/0044-8486(87)90172-4; Berkovich N, 2013, GEN COMP ENDOCR, V194, P10, DOI 10.1016/j.ygcen.2013.08.005; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; CAREY FG, 1973, COMP BIOCHEM PHYSIOL, V44, P375, DOI 10.1016/0300-9629(73)90490-8; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P205, DOI 10.1016/0010-406X(69)91336-X; Carey FG., 1981, COMPANION ANIMAL PHY, P216; Compean-Jimenez G., 1983, NOAA TECH REP NMFS, V8, P77; Corriero A, 2007, AQUACULTURE, V272, P675, DOI 10.1016/j.aquaculture.2007.08.030; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Corriero A, 2011, J FISH DIS, V34, P853, DOI 10.1111/j.1365-2761.2011.01303.x; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Corriero A, 2009, ANIM REPROD SCI, V116, P346, DOI 10.1016/j.anireprosci.2009.02.013; Corriero A, 2013, MAR POLLUT BULL, V71, P23, DOI 10.1016/j.marpolbul.2013.03.041; Cort J. L., 1991, COL VOL SCI PAP ICCA, V35, P213; Cort JL, 1991, WORLD M STOCK ASS BL, P130; De Metrio G, 2010, J APPL ICHTHYOL, V26, P596, DOI 10.1111/j.1439-0426.2010.01475.x; De Metrio G., 2001, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V52, P776; Drucker EG, 2001, J EXP BIOL, V204, P2943; Ferreira Leonor C G, 1999, J Morphol, V239, P297, DOI 10.1002/(SICI)1097-4687(199903)239:3<297::AID-JMOR6>3.0.CO;2-U; GRAHAM JB, 1975, FISH B-NOAA, V73, P219; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Hove JR, 2001, J EXP BIOL, V204, P1459; Jayne BC, 1996, J MORPHOL, V228, P307, DOI 10.1002/(SICI)1097-4687(199606)228:3<307::AID-JMOR3>3.0.CO;2-Z; Kacem A, 2000, COMP BIOCHEM PHYS A, V125, P479, DOI 10.1016/S1095-6433(00)00174-4; LOPEZ E, 1980, CALCIFIED TISSUE INT, V32, P83, DOI 10.1007/BF02408525; Luque PL, 2014, J FISH BIOL, V84, P1876, DOI 10.1111/jfb.12406; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mather FJ, 1995, NMFSSEFSC370 NOAA; Megalofonou P, 2000, J FISH BIOL, V57, P700, DOI 10.1006/jfbi.2000.1345; Megalofonou P, 2000, J MAR BIOL ASSOC UK, V80, P753, DOI 10.1017/S0025315400002678; Micera E, 2010, AQUAC RES, V41, P1396, DOI 10.1111/j.1365-2109.2009.02429.x; MOSS ML, 1963, ANN NY ACAD SCI, V109, P337, DOI 10.1111/j.1749-6632.1963.tb13475.x; Mylonas CC, 2007, REV FISH SCI, V15, P183, DOI 10.1080/10641260701484572; Mylonas CC, 2010, REV FISH SCI, V18, P266, DOI 10.1080/10641262.2010.509520; Passantino L, 2014, J FISH DIS, V37, P241, DOI 10.1111/jfd.12102; Persson P, 1997, J COMP PHYSIOL B, V167, P468, DOI 10.1007/s003600050098; Pousis C, 2012, ANIM REPROD SCI, V132, P101, DOI 10.1016/j.anireprosci.2012.03.014; Pousis C, 2011, ANIM REPROD SCI, V123, P98, DOI 10.1016/j.anireprosci.2010.10.005; Rodriguez-Barreto D, 2012, AQUACULTURE, V360, P1, DOI 10.1016/j.aquaculture.2012.07.013; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Rosenfeld H, 2012, GEN COMP ENDOCR, V175, P55, DOI 10.1016/j.ygcen.2011.09.013; Santamaria N, 2009, J APPL ICHTHYOL, V25, P38, DOI 10.1111/j.1439-0426.2009.01191.x; Sbaihi M, 2009, J ENDOCRINOL, V201, P241, DOI 10.1677/JOE-08-0492; Schreck C.B., 1981, P295; Schreck CB, 2010, GEN COMP ENDOCR, V165, P549, DOI 10.1016/j.ygcen.2009.07.004; Schreck CB, 2000, BIOLOGY OF ANIMAL STRESS, P147, DOI 10.1079/9780851993591.0147; Shahar Ron, 2013, Bonekey Rep, V2, P343, DOI 10.1038/bonekey.2013.77; Suquet M, 2010, J APPL ICHTHYOL, V26, P775, DOI 10.1111/j.1439-0426.2010.01533.x; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Tortonese E., 1975, BOLOGNA EDIZIONI CAL, V2, P358; Valeiras X., 2008, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V62, P1629; Watanabe T, 2003, AQUACULTURE, V227, P35, DOI 10.1016/S0044-8486(03)00494-0; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Zaboukas N, 2007, SCI MAR, V71, P691, DOI 10.3989/scimar.2007.71n4691; Zhu Q, 2002, J FLUID MECH, V468, P1, DOI 10.1017/S002211200200143X; Zupa R, 2013, J APPL ICHTHYOL, V29, P71, DOI 10.1111/j.1439-0426.2012.02045.x; Zupa R, 2014, AQUAC RES, V45, P1733, DOI 10.1111/are.12110	65	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2015	10	3							e0121924	10.1371/journal.pone.0121924	http://dx.doi.org/10.1371/journal.pone.0121924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9LT	25751271	Green Submitted, gold, Green Published			2022-12-27	WOS:000350692700040
J	Chausse, B; Vieira-Lara, MA; Sanchez, AB; Medeiros, MHG; Kowaltowski, AJ				Chausse, Bruno; Vieira-Lara, Marcel A.; Sanchez, Angelica B.; Medeiros, Marisa H. G.; Kowaltowski, Alicia J.			Intermittent Fasting Results in Tissue-Specific Changes in Bioenergetics and Redox State	PLOS ONE			English	Article							ONSET DIETARY RESTRICTION; OXIDATIVE DNA-DAMAGE; CALORIC RESTRICTION; RADICAL PRODUCTION; STRESS; INCREASE; RAT; ENZYMES; EVERY; ASSAY	Intermittent fasting (IF) is a dietary intervention often used as an alternative to caloric restriction (CR) and characterized by 24 hour cycles alternating ad libitum feeding and fasting. Although the consequences of CR are well studied, the effects of IF on redox status are not. Here, we address the effects of IF on redox state markers in different tissues in order to uncover how changes in feeding frequency alter redox balance in rats. IF rats displayed lower body mass due to decreased energy conversion efficiency. Livers in IF rats presented increased mitochondrial respiratory capacity and enhanced levels of protein carbonyls. Surprisingly, IF animals also presented an increase in oxidative damage in the brain that was not related to changes in mitochondrial bioenergetics. Conversely, IF promoted a substantial protection against oxidative damage in the heart. No difference in mitochondrial bioenergetics or redox homeostasis was observed in skeletal muscles of IF animals. Overall, IF affects redox balance in a tissue-specific manner, leading to redox imbalance in the liver and brain and protection against oxidative damage in the heart.	[Chausse, Bruno; Vieira-Lara, Marcel A.; Sanchez, Angelica B.; Medeiros, Marisa H. G.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo	Kowaltowski, AJ (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	alicia@iq.usp.br	Kowaltowski, Alicia J/H-8698-2012; Medeiros, Marisa H. G./A-5212-2008; de Medeiros, Marisa Helena Gennari/AAA-8015-2019; Chausse, Bruno/D-7449-2015; Sanchez, Angélica/ABD-4656-2020	Medeiros, Marisa H. G./0000-0002-5438-1174; de Medeiros, Marisa Helena Gennari/0000-0002-5438-1174; Vieira-Lara, Marcel/0000-0003-3115-3520; Sanchez, Angelica Bianchini/0000-0001-7107-7193	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/51906]; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma) [13/07937-8]; John Simon Guggenheim Memorial Foundation; FAPESP [13/14203-0]; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma); John Simon Guggenheim Memorial Foundation; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant 10/51906, Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma), Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma), Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID Redoxoma) grant 13/07937-8, and the John Simon Guggenheim Memorial Foundation. MAVL (grant 13/14203-0) is supported by an undergraduate fellowship from FAPESP. BC is supported by a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson RM, 2005, AGE, V27, P17, DOI 10.1007/s11357-005-3286-2; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Armeni T, 1998, MECH AGEING DEV, V101, P101, DOI 10.1016/S0047-6374(97)00167-X; Cardoso AR, 2012, FREE RADICAL BIO MED, V52, P2201, DOI 10.1016/j.freeradbiomed.2012.03.008; Carlson Anton J., 1946, JOUR NUTRITION, V31, P363, DOI 10.1093/jn/31.3.363; Caro P, 2008, REJUV RES, V11, P621, DOI 10.1089/rej.2008.0704; Castello L, 2010, FREE RADICAL BIO MED, V48, P47, DOI 10.1016/j.freeradbiomed.2009.10.003; Cerqueira FM, 2013, AGEING RES REV, V12, P22, DOI 10.1016/j.arr.2012.03.009; Cerqueira FM, 2011, FREE RADICAL BIO MED, V51, P1454, DOI 10.1016/j.freeradbiomed.2011.07.006; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; Chandrasekar B, 2001, AM J PHYSIOL-HEART C, V280, pH2094, DOI 10.1152/ajpheart.2001.280.5.H2094; Chausse B, 2014, ENDOCRINOLOGY, V155, P2456, DOI 10.1210/en.2013-2057; Esworthy RS, 1999, CURRENT PROTOCOLS TO; Ferranti R, 2003, FEBS LETT, V536, P51, DOI 10.1016/S0014-5793(03)00007-3; GOLDSTEI.DB, 1968, ANAL BIOCHEM, V24, P431, DOI 10.1016/0003-2697(68)90148-6; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Hutter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kaneko T, 1997, FREE RADICAL BIO MED, V23, P76, DOI 10.1016/S0891-5849(96)00622-3; Kowaltowski AJ, 2011, REDOX REP, V16, P237, DOI 10.1179/1351000211Y.0000000014; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Mattson MP, 2005, J NUTR BIOCHEM, V16, P129, DOI 10.1016/j.jnutbio.2004.12.007; Nicholls DG, 2002, BIOENERGETICS, V3; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Radak Z, 2002, EXP GERONTOL, V37, P1423, DOI 10.1016/S0531-5565(02)00116-X; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; Sharma S, 2010, BIOGERONTOLOGY, V11, P197, DOI 10.1007/s10522-009-9240-4; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; TATUM VL, 1990, LIPIDS, V25, P226, DOI 10.1007/BF02535752; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Walsh ME, 2014, FREE RADICAL BIO MED, V66, P88, DOI 10.1016/j.freeradbiomed.2013.05.037; Wolf FI, 2005, EXP GERONTOL, V40, P181, DOI 10.1016/j.exger.2004.11.002	40	42	42	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120413	10.1371/journal.pone.0120413	http://dx.doi.org/10.1371/journal.pone.0120413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749501	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400095
J	Chen, L; Yu, B; Zhang, YF; Gao, X; Zhu, L; Ma, TH; Yang, H				Chen, Lei; Yu, Bo; Zhang, Yaofang; Gao, Xin; Zhu, Liang; Ma, Tonghui; Yang, Hong			Bioactivity-Guided Fractionation of an Antidiarrheal Chinese Herb Rhodiola kirilowii (Regel) Maxim Reveals (-)-Epicatechin-3-Gallate and (-)-Epigallocatechin-3-Gallate as Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator	PLOS ONE			English	Article							NATURAL-PRODUCTS; CFTR INHIBITORS; MOLECULAR-BASIS; CHOLERA-TOXIN; CHANNEL; THERAPY; DISCOVERY; EGCG; ACTIVATORS; RESOURCES	Cystic fibrosis transmembrane conductance regulator (CFTR) is the principal apical route for transepithelial fluid transport induced by enterotoxin. Inhibition of CFTR has been confirmed as a pharmaceutical approach for the treatment of secretory diarrhea. Many traditional Chinese herbal medicines, like Rhodiola kirilowii (Regel) Maxim, have long been used for the treatment of secretory diarrhea. However, the active ingredients responsible for their therapeutic effectiveness remain unknown. The purpose of this study is to identify CFTR inhibitors from Rhodiola kirilowii (Regel) Maxim via bioactivity-directed isolation strategy. We first identified fractions of Rhodiola kirilowii (Regel) Maxim that inhibited CFTR Cl- channel activity. Further bioactivity-directed fractionation led to the identification of (-)-epigallocatechin-3-gallate (EGCG) as CFTR Cl- channel inhibitor. Analysis of 5 commercially available EGCG analogs including (+)-catechins (C), (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin-3-gallate (ECG) and EGCG revealed that ECG also had CFTR inhibitory activity. EGCG dose-dependently and reversibly inhibited CFTR Cl- channel activity in transfected FRT cells with an IC50 value around 100 mu M. In ex vivo studies, EGCG and ECG inhibited CFTR-mediated short-circuit currents in isolated rat colonic mucosa in a dose-dependent manner. In an intestinal closed-loop model in mice, intraluminal application of EGCG (10 mu g) and ECG (10 mu g) significantly reduced cholera toxin-induced intestinal fluid secretion. CFTR Cl-channel is a molecular target of natural compounds EGCG and ECG. CFTR inhibition may account, at least in part, for the antidiarrheal activity of Rhodiola kirilowii (Regel) Maxim. EGCG and ECG could be new lead compounds for development of CFTR-related diseases such as secretory diarrhea.	[Chen, Lei; Yu, Bo; Ma, Tonghui; Yang, Hong] Liaoning Normal Univ, Sch Life Sci, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian 116029, Peoples R China; [Zhang, Yaofang; Zhu, Liang; Ma, Tonghui] Dalian Med Univ, Coll Basic Med Sci, Dalian 116044, Peoples R China; [Gao, Xin] Yanbian Univ, Sch Med, Yanji 133002, Peoples R China	Liaoning Normal University; Dalian Medical University; Yanbian University	Yang, H (corresponding author), Liaoning Normal Univ, Sch Life Sci, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian 116029, Peoples R China.	hyanglnnu@gmail.com		Ma, Tonghui/0000-0001-9338-1030	National Natural Science Foundation of China [81473265, 31471099, 81173109, 30973577]; Specialized Research Fund for the Doctoral Program of Higher Education [20112136110002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (No. 81473265; 31471099; 81173109; 30973577), Specialized Research Fund for the Doctoral Program of Higher Education (20112136110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Chen D, 2011, ADV CLIN CHEM, V53, P155, DOI 10.1016/S0065-2423(11)53007-0; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; He CY, 2004, CHEM RES CHINESE U, V20, P334; Hsiao WLW, 2010, PLANTA MED, V76, P1118, DOI 10.1055/s-0030-1250186; Huang ZJ, 2011, MINI-REV MED CHEM, V11, P1122, DOI 10.2174/138955711797655362; Jiang MA, 2010, PLANTA MED, V76, P2048, DOI 10.1055/s-0030-1250456; Li T, 2013, ANTIVIR RES, V97, P1, DOI 10.1016/j.antiviral.2012.10.006; Li XM, 2011, MT SINAI J MED, V78, P697, DOI 10.1002/msj.20294; Luzhetskyy A, 2007, CURR OPIN INVEST DR, V8, P608; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; May BH, 2012, J ALTERN COMPLEM MED, V18, P1101, DOI 10.1089/acm.2011.0587; Moran O, 2008, J CYST FIBROS, V7, P483, DOI 10.1016/j.jcf.2008.05.003; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Muanprasat C, 2007, BIOL PHARM BULL, V30, P502, DOI 10.1248/bpb.30.502; Muanprasat C, 2012, J PHARMACOL SCI, V118, P82, DOI 10.1254/jphs.11153FP; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Reygaert W, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00162; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Smith AJ, 2013, MOL PHARMACEUT, V10, P2948, DOI 10.1021/mp4000794; Thiagarajah JR, 2012, CLIN PHARMACOL THER, V92, P287, DOI 10.1038/clpt.2012.114; Thiagarajah JR, 2013, CURR OPIN PHARMACOL, V13, P888, DOI 10.1016/j.coph.2013.08.005; Thiagarajah JR, 2005, TRENDS PHARMACOL SCI, V26, P172, DOI 10.1016/j.tips.2005.02.003; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; TODA M, 1992, MICROBIOL IMMUNOL, V36, P999, DOI 10.1111/j.1348-0421.1992.tb02103.x; Velazquez C, 2009, J ETHNOPHARMACOL, V126, P455, DOI 10.1016/j.jep.2009.09.016; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Verkman AS, 2013, CURR PHARM DESIGN, V19, P3529, DOI 10.2174/13816128113199990321; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wang XF, 2004, EXP PHYSIOL, V89, P417, DOI 10.1113/expphysiol.2003.027003; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yang SP, 2012, ACTA PHARMACOL SIN, V33, P1147, DOI 10.1038/aps.2012.105; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zhang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094302	42	21	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119122	10.1371/journal.pone.0119122	http://dx.doi.org/10.1371/journal.pone.0119122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747701	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400045
J	Chen, TS; Liu, JN; Li, N; Wang, SJ; Liu, H; Li, JY; Zhang, Y; Bu, PL				Chen, Tongshuai; Liu, Junni; Li, Na; Wang, Shujian; Liu, Hui; Li, Jingyuan; Zhang, Yun; Bu, Peili			Mouse SIRT3 Attenuates Hypertrophy-Related Lipid Accumulation in the Heart through the Deacetylation of LCAD	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; FATTY-ACID OXIDATION; DEPENDENT DEACETYLASE; LYSINE ACETYLATION; WALL STRESS; MITOCHONDRIAL; HOMOLOG; GENE; METABOLISM; ACTIVATION	Cardiac hypertrophy is an adaptive response to pressure, volume stress, and loss of contractile mass from prior infarction. Metabolic changes in cardiac hypertrophy include suppression of fatty acid oxidation and enhancement of glucose utilization, which could result in lipid accumulation in the heart. SIRT3, a mitochondrial NAD+-dependent deacetylase, has been demonstrated to play a crucial role in controlling the acetylation status of many enzymes participating in energy metabolism. However, the role of SIRT3 in the pathogenesis of hypertrophy-related lipid accumulation remains unclear. In this study, hypertrophy-related lipid accumulation was investigated using a mouse cardiac hypertrophy model induced by transverse aortic constriction (TAC). We showed that mice developed heart failure six weeks after TAC. Furthermore, abnormal lipid accumulation and decreased palmitate oxidation rates were observed in the hypertrophic hearts, and these changes were particularly significant in SIRT3-KO mice. We also demonstrated that the short form of SIRT3 was downregulated in wild-type (WT) hypertrophic hearts and that this change was accompanied by a higher acetylation level of long-chain acyl CoA dehydrogenase (LCAD), which is a key enzyme participating in fatty acid oxidation. In addition, SIRT3 may play an essential role in attenuating lipid accumulation in the heart through the deacetylation of LCAD.	[Chen, Tongshuai; Li, Na; Wang, Shujian; Liu, Hui; Li, Jingyuan; Zhang, Yun; Bu, Peili] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China; [Chen, Tongshuai; Liu, Junni; Li, Na; Wang, Shujian; Liu, Hui; Li, Jingyuan; Zhang, Yun; Bu, Peili] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Chen, Tongshuai; Liu, Junni; Li, Na; Wang, Shujian; Liu, Hui; Li, Jingyuan; Zhang, Yun; Bu, Peili] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Bu, PL (corresponding author), Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China.	bupeili@gmail.com.cn			National Natural Science Foundation of China [81170133, 81070074]; National 973 Basic Research Program of China [2012CB722406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81170133, 81070074) and the National 973 Basic Research Program of China (No. 2012CB722406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; CHVAPIL M, 1984, PLAST RECONSTR SURG, V73, P438, DOI 10.1097/00006534-198403000-00018; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Fang ZQ, 2014, FOOD CHEM TOXICOL, V66, P210, DOI 10.1016/j.fct.2014.01.049; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gao Shumin, 2011, Curr Protoc Mouse Biol, V1, P71; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; HOOD WP, 1968, AM J CARDIOL, V22, P550, DOI 10.1016/0002-9149(68)90161-6; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lehman John J, 2002, Heart Fail Rev, V7, P175; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; LITWIN SE, 1990, AM J PHYSIOL, V258, pH51, DOI 10.1152/ajpheart.1990.258.1.H51; Liu JN, 2013, INT J MOL SCI, V14, P5633, DOI 10.3390/ijms14035633; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Ohsawa S, 2006, FEBS LETT, V580, P5875, DOI 10.1016/j.febslet.2006.09.051; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; SANDLER H, 1963, CIRC RES, V13, P91, DOI 10.1161/01.RES.13.2.91; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	96	100	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0118909	10.1371/journal.pone.0118909	http://dx.doi.org/10.1371/journal.pone.0118909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748450	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400030
J	Li, J; Zhao, WG; Shen, ZF; Yuan, T; Liu, SN; Liu, Q; Fu, Y; Sun, W				Li, Juan; Zhao, Wei-Gang; Shen, Zhu-Fang; Yuan, Tao; Liu, Shuai-Nan; Liu, Quan; Fu, Yong; Sun, Wei			Comparative Proteome Analysis of Brown Adipose Tissue in Obese C57BL/6J Mice Using iTRAQ-Coupled 2D LC-MS/MS	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; DEPENDENT ANION CHANNEL; HIGH-FAT DIET; CYTOCHROME-C; CELL-DEATH; OXIDATIVE STRESS; ADULT HUMANS; MITOCHONDRIA; AIF; EXPRESSION	High-fat diet (HFD) leads to the development of obesity accompanied by insulin resistance, which increases the risk of type 2 diabetes mellitus and cardiovascular disease. Brown adipose tissue (BAT) plays an essential role in energy metabolism, thus it will give us promising treatment targets through elucidating underlying mechanisms of BAT in obesity. In this study, female C57BL/6J mice were fed HFD or normal diet (ND) for 22 weeks. Hyperinsulinemic- euglycemic clamp was performed to evaluate insulin sensitivity, which was independently correlated with obesity. Using isobaric tag for relative and absolute quantification (iTRAQ) coupled with 2D LC-MS/MS, we quantitated 3048 proteins in BAT. As compared HFD with ND, we obtained 727 differentially expressed proteins. Functional analysis found that those proteins were mainly assigned to the pathway of mitochondrial function. In this pathway, carnitine O-palmitoyltransferase 2 (CPT2), uncoupling protein 1 (UCP1) and apoptosis-inducing factor 1 (AIF1) were up-regulated significantly by HFD, and they were confirmed by western blotting. The results indicated that HFD might induce the apoptosis of brown adipocytes via the up-regulated AIF1. Meanwhile, HFD also stimulated fatty acid beta-oxidation and raised compensatory energy consuming through the increases of CPT2 and UCP1, respectively. However, the apoptosis of brown adipocytes might weaken the compensatory energy expenditure, and finally contribute to overweight/obesity. So, preventing the apoptosis of brown adipocytes may be the key target to treat obesity.	[Li, Juan; Zhao, Wei-Gang; Yuan, Tao; Fu, Yong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Endocrinol, Key Lab Endocrinol,Minist Hlth, Beijing 100730, Peoples R China; [Li, Juan; Zhao, Wei-Gang; Yuan, Tao; Fu, Yong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shen, Zhu-Fang; Liu, Shuai-Nan; Liu, Quan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China; [Shen, Zhu-Fang; Liu, Shuai-Nan; Liu, Quan] Chinese Acad Med Sci, Peking Union Med Coll, Diabet Res Ctr, Beijing 100730, Peoples R China; [Sun, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci,Core Facil Instrument, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Zhao, WG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Endocrinol, Key Lab Endocrinol,Minist Hlth, Beijing 100730, Peoples R China.	xiehezhaoweigang@163.com; sunwei1018@sina.com			Beijing Natural Science Foundation [7122144]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	WGZ was supported by Beijing Natural Science Foundation (7122144, http://www.bjnsf.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2004, AM J PHYSIOL-GASTR L, V287, pG695, DOI 10.1152/ajpgi.00415.2003; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Ben-Hail Danya, 2014, Cold Spring Harb Protoc, V2014, P161, DOI 10.1101/pdb.top066241; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; de Beeck KO, 2011, HEARING RES, V281, P18, DOI 10.1016/j.heares.2011.07.002; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; Eaton S, 2001, BIOCHEM BIOPH RES CO, V285, P537, DOI 10.1006/bbrc.2001.5201; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Ho JH, 2013, J PROTEOME RES, V12, P1120, DOI 10.1021/pr300662j; Joo JI, 2011, PROTEOMICS, V11, P1429, DOI 10.1002/pmic.201000515; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu SN, 2012, ACTA PHARM SIN B, V2, P403, DOI 10.1016/j.apsb.2012.06.009; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Okita N, 2012, MECH AGEING DEV, V133, P255, DOI 10.1016/j.mad.2012.02.003; Parysow O, 2007, CLIN NUCL MED, V32, P351, DOI 10.1097/01.rlu.0000259570.69163.04; Pintus F, 2012, AGING-US, V4, P734, DOI 10.18632/aging.100505; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Tsujimoto Y, 2002, BIOCHIMIE, V84, P187, DOI 10.1016/S0300-9084(02)01370-6; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vasagiri N, 2014, MOL BIOL REP; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x	48	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119350	10.1371/journal.pone.0119350	http://dx.doi.org/10.1371/journal.pone.0119350			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25747866	Green Published, gold, Green Submitted			2022-12-27	WOS:000350689400066
J	Mallol, A; Santalo, J; Ibanez, E				Mallol, Anna; Santalo, Josep; Ibanez, Elena			Improved Development of Somatic Cell Cloned Mouse Embryos by Vitamin C and Latrunculin A	PLOS ONE			English	Article							NUCLEAR TRANSFER EMBRYOS; IN-VITRO DEVELOPMENT; L-ASCORBIC-ACID; HISTONE DEACETYLASE; DNA DEMETHYLATION; BOVINE EMBRYOS; MAMMALIAN DEVELOPMENT; ALPHA-TOCOPHEROL; PORCINE OOCYTES; VALPROIC ACID	Impaired development of embryos produced by somatic cell nuclear transfer (SCNT) is mostly associated with faulty reprogramming of the somatic nucleus to a totipotent state and can be improved by treatment with epigenetic modifiers. Here we report that addition of 100 mu M vitamin C (VitC) to embryo culture medium for at least 16 h post-activation significantly increases mouse blastocyst formation and, when combined with the use of latrunculin A (LatA) during micromanipulation and activation procedures, also development to term. In spite of this, no significant effects on pluripotency (OCT4 and NANOG) or nuclear reprogramming markers (H3K14 acetylation, H3K9 methylation and DNA methylation and hydroxymethylation) could be detected. The use of LatA alone significantly improved in vitro development, but not full-term development. On the other hand, the simultaneous treatment of cloned embryos with VitC and the histone deacetylase inhibitor psammaplin A (PsA), in combination with the use of LatA, resulted in cloning efficiencies equivalent to those of VitC or PsA treatments alone, and the effects on pluripotency and nuclear reprogramming markers were less evident than when only the PsA treatment was applied. These results suggest that although both epigenetic modifiers improve cloning efficiencies, possibly through different mechanisms, they do not show an additive effect when combined. Improvement of SCNT efficiency is essential for its applications in reproductive and therapeutic cloning, and identification of molecules which increase this efficiency should facilitate studies on the mechanism of nuclear reprogramming and acquisition of totipotency.	[Mallol, Anna; Santalo, Josep; Ibanez, Elena] Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Cellular Fisiol & Immunol, Bellaterra, Spain	Autonomous University of Barcelona	Ibanez, E (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Biol Cellular Fisiol & Immunol, Bellaterra, Spain.	elena.ibanez@uab.cat	Santalo, Josep/K-4979-2014; Mallol, Anna/L-2393-2017; Ibáñez, Elena/K-4320-2014; Santalo, Josep/AAE-8022-2020	Santalo, Josep/0000-0002-1698-9699; Mallol, Anna/0000-0001-7366-0980; Ibáñez, Elena/0000-0002-0275-6958; Santalo, Josep/0000-0002-1698-9699	Spanish Ministerio de Ciencia e Innovacion [AGL 2011-23784]; Generalitat de Catalunya [2009 SGR 282]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (AGL 2011-23784) and the Generalitat de Catalunya (2009 SGR 282). AM is a predoctoral fellow of the Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, BIOL REPROD; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Cavaleri FM, 2008, MECH DEVELOP, V125, P153, DOI 10.1016/j.mod.2007.09.007; Chan MM, 2012, NAT GENET, V44, P978, DOI 10.1038/ng.2382; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Chawalit S, 2012, REPROD SCI, V19, P976, DOI 10.1177/1933719112440049; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Costa-Borges N, 2010, CELL REPROGRAM, V12, P437, DOI 10.1089/cell.2009.0108; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gurdon JB, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002659; Himaki T, 2010, CELL REPROGRAM, V12, P127, DOI 10.1089/cell.2009.0066; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huang YY, 2011, BIOCHEM BIOPH RES CO, V411, P397, DOI 10.1016/j.bbrc.2011.06.160; Jafari S, 2011, MOL REPROD DEV, V78, P576, DOI 10.1002/mrd.21344; Jeong YW, 2006, THERIOGENOLOGY, V66, P2104, DOI 10.1016/j.theriogenology.2006.06.007; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kere M, 2013, J REPROD DEVELOP, V59, P78; Kim DH, 2007, EXP MOL MED, V39, P47, DOI 10.1038/emm.2007.6; Kim DY, 1999, ARCH PHARM RES, V22, P25, DOI 10.1007/BF02976431; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Krishnakumar R, 2013, CURR OPIN GENET DEV, V23, P548, DOI 10.1016/j.gde.2013.06.005; Lee AR, 2010, DIFFERENTIATION, V80, pS28, DOI 10.1016/j.diff.2010.09.041; Li Q, 2014, CELL REPROGRAM, V16, P290, DOI 10.1089/cell.2013.0088; Maalouf WE, 2008, EPIGENETICS-US, V3, P199, DOI 10.4161/epi.3.4.6497; Maalouf WE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-11; Mallol A, 2014, CELL REPROGRAM, V16, P392, DOI 10.1089/cell.2014.0012; Mallol A, 2013, SYST BIOL REPROD MED, V59, P117, DOI 10.3109/19396368.2012.760120; Mason K, 2012, ANIM REPROD SCI, V134, P45, DOI 10.1016/j.anireprosci.2012.08.010; Meng QG, 2008, CLONING STEM CELLS, V10, P429, DOI 10.1089/clo.2008.0003; Miyoshi K, 2010, CELL REPROGRAM, V12, P67, DOI 10.1089/cell.2009.0032; Monfort A, 2013, EMBO REP, V14, P337, DOI 10.1038/embor.2013.29; Moreira PN, 2003, MOL REPROD DEV, V66, P98, DOI 10.1002/mrd.10335; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Park SJ, 2012, CELL REPROGRAM, V14, P398, DOI 10.1089/cell.2012.0007; Tao Y, 2004, REPROD DOMEST ANIM, V39, P52, DOI 10.1046/j.1439-0531.2003.00478.x; Tatemoto H, 2001, BIOL REPROD, V65, P1800, DOI 10.1095/biolreprod65.6.1800; Terashita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078380; Terashita Y, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098764; Tsuji Y, 2009, ZYGOTE, V17, P109, DOI 10.1017/S0967199408005133; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang X, 2002, FERTIL STERIL, V78, P1272, DOI 10.1016/S0015-0282(02)04236-X; Wongsrikeao P, 2007, MOL REPROD DEV, V74, P694, DOI 10.1002/mrd.20640; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038	58	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0120033	10.1371/journal.pone.0120033	http://dx.doi.org/10.1371/journal.pone.0120033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25749170	Green Published, Green Submitted, gold			2022-12-27	WOS:000350689400093
J	Narihiro, T; Kim, NK; Mei, R; Nobu, MK; Liu, WT				Narihiro, Takashi; Kim, Na-Kyung; Mei, Ran; Nobu, Masaru K.; Liu, Wen-Tso			Microbial Community Analysis of Anaerobic Reactors Treating Soft Drink Wastewater	PLOS ONE			English	Article							IMMOBILIZED CELL BIOREACTORS; SP-NOV.; METHANOGENIC CONSORTIA; POLYETHYLENE-GLYCOL; TROPHIC GROUPS; GEN.-NOV.; INDUSTRY; BACTERIUM; DIGESTION; SLUDGE	The anaerobic packed-bed (AP) and hybrid packed-bed (HP) reactors containing methanogenic microbial consortia were applied to treat synthetic soft drink wastewater, which contains polyethylene glycol (PEG) and fructose as the primary constituents. The AP and HP reactors achieved high COD removal efficiency (>95%) after 80 and 33 days of the operation, respectively, and operated stably over 2 years. 16S rRNA gene pyrotag analyses on a total of 25 biofilm samples generated 98,057 reads, which were clustered into 2,882 operational taxonomic units (OTUs). Both AP and HP communities were predominated by Bacteroidetes, Chloroflexi, Firmicutes, and candidate phylum KSB3 that may degrade organic compound in wastewater treatment processes. Other OTUs related to uncharacterized Geobacter and Spirochaetes clades and candidate phylum GN04 were also detected at high abundance; however, their relationship to wastewater treatment has remained unclear. In particular, KSB3, GN04, Bacteroidetes, and Chloroflexi are consistently associated with the organic loading rate (OLR) increase to 1.5 g COD/L-d. Interestingly, KSB3 and GN04 dramatically decrease in both reactors after further OLR increase to 2.0 g COD/L-d. These results indicate that OLR strongly influences microbial community composition. This suggests that specific uncultivated taxa may take central roles in COD removal from soft drink wastewater depending on OLR.	[Narihiro, Takashi; Kim, Na-Kyung; Mei, Ran; Nobu, Masaru K.; Liu, Wen-Tso] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Narihiro, Takashi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Higashi Ku, Tsukuba, Ibaraki 3058566, Japan	University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Advanced Industrial Science & Technology (AIST)	Liu, WT (corresponding author), Univ Illinois, Dept Civil & Environm Engn, 205 North Mathews Ave, Urbana, IL 61801 USA.	wtliu@illinois.edu	Narihiro, Takashi/L-8617-2016; Liu, Wen-Tso/C-8788-2011	Narihiro, Takashi/0000-0003-2936-7204; Liu, Wen-Tso/0000-0002-8700-9803; Mei, Ran/0000-0002-6464-6519	PepsiCo Inc.; Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign	PepsiCo Inc.; Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign	This study was supported by PepsiCo Inc., and Masaru Nobu was supported by the Teracon fellowship from the Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign. Takashi Narihiro was a visiting scholar from Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology, Japan. The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript in this study.	[Anonymous], 1997, CHEMICAL OXYGEN DEMA; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Blanc FC, 1984, PROCEEDINGS OF THE 3, P243; BORJA R, 1994, J CHEM TECHNOL BIOT, V60, P327, DOI 10.1002/jctb.280600314; BORJA R, 1993, BIOTECHNOL LETT, V15, P767, DOI 10.1007/BF01080153; Camperos ER, 2004, WATER SCI TECHNOL, V50, P107, DOI 10.2166/wst.2004.0101; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen J. P., 2006, WASTE TREATMENT IN T, P255; Chen SY, 2005, INT J SYST EVOL MICR, V55, P2257, DOI 10.1099/ijs.0.63807-0; Coates JD, 2001, INT J SYST EVOL MICR, V51, P581, DOI 10.1099/00207713-51-2-581; COLWELL R. K., 2013, ESTIMATES STATISTICA; De Vuyst L, 2011, INT J FOOD MICROBIOL, V149, P73, DOI 10.1016/j.ijfoodmicro.2011.03.003; DWYER DF, 1986, APPL ENVIRON MICROB, V52, P852, DOI 10.1128/AEM.52.4.852-856.1986; DWYER DF, 1983, APPL ENVIRON MICROB, V46, P185, DOI 10.1128/AEM.46.1.185-190.1983; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eeckhaut V, 2010, INT J SYST EVOL MICR, V60, P1108, DOI 10.1099/ijs.0.015289-0; Euromonitor International, 2014, PASSPORT GLOBAL MARK; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia-Morales MA, 2012, J ENVIRON SCI HEAL A, V47, P22, DOI 10.1080/10934529.2012.629575; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1307, DOI 10.1128/AEM.70.3.1307-1314.2004; Grady JLCP, 1999, BIOLOGICAL WASTEWATE; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; HANOVER LM, 1993, AM J CLIN NUTR, V58, P724, DOI 10.1093/ajcn/58.5.724S; Haroon H, 2013, J CHEM SOC PAKISTAN, V35, P5; Harper SR, 1997, WATER SCI TECHNOL, V36, P33, DOI 10.1016/S0273-1223(97)00504-0; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Hemm D, 2001, US Patent, Patent No. [6,108,578, 6108578]; HOUSLEY JN, 1994, J INST WATER ENV MAN, V8, P239; Hsine EA, 2005, ENVIRON TECHNOL, V26, P1309, DOI 10.1080/09593332608618605; Ito T, 2012, BIORESOURCE TECHNOL, V123, P599, DOI 10.1016/j.biortech.2012.07.108; Kalyuzhnyi SV, 1997, APPL BIOCHEM BIOTECH, V66, P291, DOI 10.1007/BF02785595; Kampmann K, 2012, APPL ENVIRON MICROB, V78, P2106, DOI 10.1128/AEM.06394-11; Kato S, 2012, ENVIRON MICROBIOL, V14, P1646, DOI 10.1111/j.1462-2920.2011.02611.x; Kato S, 2010, MICROBES ENVIRON, V25, P145, DOI 10.1264/jsme2.ME10122; Lee SH, 2013, BIORESOURCE TECHNOL, V145, P25, DOI 10.1016/j.biortech.2013.02.070; Leps J., 2003, MULTIVARIATE ANALYSI; Mata-Alvarez J, 2000, BIORESOURCE TECHNOL, V74, P3, DOI 10.1016/S0960-8524(00)00023-7; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MIN H, 1989, APPL ENVIRON MICROB, V55, P488, DOI 10.1128/AEM.55.2.488-491.1989; Miyaki H, 2000, DESALINATION, V131, P47, DOI 10.1016/S0011-9164(00)90005-5; Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11; Narihiro T, 2015, ENVIRON MICROBIOL, V17, P1707, DOI 10.1111/1462-2920.12616; Narihiro T, 2012, WATER RES, V46, P2167, DOI 10.1016/j.watres.2012.01.034; Narihiro T, 2009, MICROBES ENVIRON, V24, P88, DOI 10.1264/jsme2.ME08561; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Ng KK, 2011, WATER RES, V45, P4269, DOI 10.1016/j.watres.2011.05.031; Peixoto G, 2011, INT J HYDROGEN ENERG, V36, P8953, DOI 10.1016/j.ijhydene.2011.05.014; Pons M.-N., 2004, COMPUTER APPLICATION, V37, P299, DOI [10.1016/S1474-6670(17)32597-1, DOI 10.1016/S1474-6670(17)32597-1]; Qiu YL, 2014, ARCH MICROBIOL, V196, P149, DOI 10.1007/s00203-013-0951-1; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHINK B, 1983, APPL ENVIRON MICROB, V45, P1905, DOI 10.1128/AEM.45.6.1905-1913.1983; Schink B., 2013, PROKARYOTES PROKARYO, P471, DOI DOI 10.1007/978-3-642-30123-0_59; Sekiguchi Y, 2004, STRICT AND FACULTATIVE ANAEROBES: MEDICAL AND ENVIRONMENTAL ASPECTS, P361; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Tamaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025263; TEBAI L, 1992, WATER SCI TECHNOL, V25, P45, DOI 10.2166/wst.1992.0008; Ueki A, 2006, INT J SYST EVOL MICR, V56, P39, DOI 10.1099/ijs.0.63896-0; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Yamada T, 2007, ISME J, V1, P246, DOI 10.1038/ismej.2007.28; Yamada T, 2011, APPL ENVIRON MICROB, V77, P2081, DOI 10.1128/AEM.02475-10; Zheng D, 2006, BIOTECHNOL BIOENG, V94, P458, DOI 10.1002/bit.20870	65	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2015	10	3							e0119131	10.1371/journal.pone.0119131	http://dx.doi.org/10.1371/journal.pone.0119131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KQ	25748027	gold, Green Published, Green Submitted			2022-12-27	WOS:000350689400047
J	Chow, CY; Avila, FW; Clark, AG; Wolfner, MF				Chow, Clement Y.; Avila, Frank W.; Clark, Andrew G.; Wolfner, Mariana F.			Induction of Excessive Endoplasmic Reticulum Stress in the Drosophila Male Accessory Gland Results in Infertility	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SEMINAL PROTEINS; GENE-EXPRESSION; ER STRESS; MELANOGASTER; FEMALE; REVEALS; IRE1; FATE	Endoplasmic reticulum (ER) stress occurs when misfolded proteins accumulate in the lumen of the ER. A cell responds to ER stress with the unfolded protein response (UPR), a complex program of transcriptional and translational changes aimed at clearing misfolded proteins. Secretory tissues and cells are particularly well adapted to respond to ER stress because their function requires high protein production and secretory load. The insect male accessory gland (AG) is a secretory tissue involved in male fertility. The AG secretes many seminal fluid proteins (SFPs) essential for male reproduction. Among adult Drosophila tissues, we find that genes upregulated by ER stress are most highly expressed in the AG, suggesting that the AG is already undergoing high levels of ER stress due to its normal secretory functions. We hypothesized that induction of excessive ER stress in the AG above basal levels, would perturb normal function and provide a genetic tool for studying AG and SFP biology. To test this, we genetically induced excessive ER stress in the AG by conditional 1) expression of a misfolded protein or 2) knockdown of the UPR regulatory protein, BiP. Both genetic manipulations induced excessive ER stress in the AG, as indicated by the increase in Xbp1 splicing, a marker of ER stress. Both models resulted in a large decrease in or loss of SFP production and male infertility. Sperm production, motility, and transfer appeared unaffected. The induction of strong ER stress in the insect male AG may provide a simple way for studying or manipulating male fertility, as it eliminates AG function while preserving sperm production.	[Chow, Clement Y.; Avila, Frank W.; Clark, Andrew G.; Wolfner, Mariana F.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Cornell University	Chow, CY (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	cyc8@cornell.edu	Avila, Frank/AAH-9459-2021	Clark, Andrew/0000-0001-7159-8511; Avila, Frank/0000-0002-7278-0646	National Institutes of Health [R01-HD059060, R01-HD038921]; National Institutes of Health/National Institute of Child Health and Human Development training grant in reproductive genomics [T32-HD052471]; National Institutes of Health/National Research Service Award fellowship [1F32GM093663-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471, R01HD038921, R01HD059060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of Child Health and Human Development training grant in reproductive genomics; National Institutes of Health/National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-HD059060 to AGC and MFW and R01-HD038921 to MW. For part of this research, CYC was supported by a traineeship under a National Institutes of Health/National Institute of Child Health and Human Development training grant in reproductive genomics (T32-HD052471). Subsequently he was supported by a National Institutes of Health/National Research Service Award fellowship 1F32GM093663-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EM, 2007, J INSECT PHYSIOL, V53, P319, DOI 10.1016/j.jinsphys.2006.12.003; Alfonso-Parra C, 2014, J INSECT PHYSIOL, V70, P117, DOI 10.1016/j.jinsphys.2014.07.004; Appocher C, 2014, HUM MOL GENET, V23, P6762, DOI 10.1093/hmg/ddu393; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Avila FW, 2009, P NATL ACAD SCI USA, V106, P15796, DOI 10.1073/pnas.0904029106; BERTRAM MJ, 1992, MECH DEVELOP, V38, P33, DOI 10.1016/0925-4773(92)90036-J; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chow CY, 2013, P NATL ACAD SCI USA, V110, P9013, DOI 10.1073/pnas.1307125110; DIBENEDETTO AJ, 1990, DEV BIOL, V139, P134, DOI 10.1016/0012-1606(90)90284-P; Findlay GD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004108; FOWLER GL, 1973, ADV GENET, V17, P293, DOI 10.1016/S0065-2660(08)60173-X; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; GILBERT DG, 1981, J INSECT PHYSIOL, V27, P641, DOI 10.1016/0022-1910(81)90112-8; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Gligorov D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003395; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2013, BIOCHIM BIOPHYS ACTA; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; KALB JM, 1993, P NATL ACAD SCI USA, V90, P8093, DOI 10.1073/pnas.90.17.8093; Kang MJ, 2012, NAT CELL BIOL, V14, P409, DOI 10.1038/ncb2447; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Kaufmann P, 1942, AM NAT, V76, P445, DOI 10.1086/281068; LaFlamme BA, 2014, GENETICS, V196, P1117, DOI 10.1534/genetics.113.160101; LEFEVRE G, 1962, GENETICS, V42, P1719; Manier MK, 2010, SCIENCE, V328, P354, DOI 10.1126/science.1187096; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; MONSMA SA, 1990, DEV BIOL, V142, P465, DOI 10.1016/0012-1606(90)90368-S; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; Moustaqim-Barrette A, 2014, HUM MOL GENET, V23, P1975, DOI 10.1093/hmg/ddt594; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; Ram KR, 2009, P NATL ACAD SCI USA, V106, P15384, DOI 10.1073/pnas.0902923106; Ram KR, 2006, P NATL ACAD SCI USA, V103, P18674, DOI 10.1073/pnas.0606228103; Rosenbaum EE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004349; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Ryoo HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075774; Sone M, 2013, CELL STRESS CHAPERON, V18, P307, DOI 10.1007/s12192-012-0383-x; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069147; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wolfner M.F., 2007, P183; Xue L, 2002, DEVELOPMENT, V129, P339; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	46	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2015	10	3							e0119386	10.1371/journal.pone.0119386	http://dx.doi.org/10.1371/journal.pone.0119386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9KG	25742606	Green Submitted, Green Published, gold			2022-12-27	WOS:000350688100106
